PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Tian, Y; Nam, S; Liu, L; Yakushijin, F; Yakushijin, K; Buettner, R; Liang, W; Yang, F; Ma, YL; Horne, D; Jove, R				Tian, Yan; Nam, Sangkil; Liu, Lucy; Yakushijin, Fumiko; Yakushijin, Kenichi; Buettner, Ralf; Liang, Wei; Yang, Fan; Ma, Yuelong; Horne, David; Jove, Richard			Spirooxindole Derivative SOID-8 Induces Apoptosis Associated with Inhibition of JAK2/STAT3 Signaling in Melanoma Cells	PLOS ONE			English	Article							POTENT ANTITUMOR-ACTIVITY; CANCER-CELLS; NATURAL-PRODUCTS; STAT3; THERAPY; TRANSDUCER; ACTIVATOR; DISCOVERY; PATHWAY; AGE	Melanoma is generally refractory to current chemotherapy, thus new treatment strategies are needed. In this study, we synthesized a series of spirooxindole derivatives (SOID-1 to SOID-12) and evaluated their antitumor effects on melanoma. Among the 12 spirooxindole derivatives, SOID-8 showed the strongest antitumor activity by viability screening. SOID-8 inhibited viability of A2058, A375, SK-MEL-5 and SK-MEL-28 human melanoma cells in a dose-and time-dependent manner. SOID-8 also induced apoptosis of these tumor cells, which was confirmed by positive Annexin V staining and an increase of poly(ADP-ribose) polymerase cleavage. The antiapoptotic protein Mcl-1, a member of the Bcl-2 family, was downregulated and correlated with SOID-8 induced apoptosis. In addition, SOID-8 reduced tyrosine phosphorylation of Signal Tansducer and Activator of Transcription 3 (STAT3) in both dose-and time-dependent manners. This inhibition was associated with decreased levels of phosphorylation of Janus-activated kinase-2 (JAK2), an upstream kinase that mediates STAT3 phosphorylation at Tyr705. Accordingly, SOID-8 inhibited IL-6-induced activation of STAT3 and JAK2 in melanoma cells. Finally, SOID-8 suppressed melanoma tumor growth in a mouse xenograft model, accompanied with a decrease of phosphorylation of JAK2 and STAT3. Our results indicate that the antitumor activity of SOID-8 is at least partially due to inhibition of JAK2/STAT3 signaling in melanoma cells. These findings suggest that the spirooxindole derivative SOID-8 is a promising lead compound for further development of new preventive and therapeutic agents for melanoma.	[Tian, Yan; Nam, Sangkil; Liu, Lucy; Yakushijin, Fumiko; Yakushijin, Kenichi; Buettner, Ralf; Liang, Wei; Yang, Fan; Ma, Yuelong; Horne, David; Jove, Richard] City Hope Comprehens Canc Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Jove, R (corresponding author), City Hope Comprehens Canc Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA.	rjove@coh.org			National Institutes of Health [R01-CA115674-05]; NATIONAL CANCER INSTITUTE [R01CA115674] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported financially by National Institutes of Health grant R01-CA115674-05 to R. Jove. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Berwick M, 2009, DERMATOL CLIN, V27, P205, DOI 10.1016/j.det.2008.12.002; Bhaskar G, 2012, EUR J MED CHEM, V51, P79, DOI 10.1016/j.ejmech.2012.02.024; Blaskovich MA, 2003, CANCER RES, V63, P1270; Chen T, 2010, J COMB CHEM, V12, P659, DOI 10.1021/cc100064c; Chen XH, 2009, J AM CHEM SOC, V131, P13819, DOI 10.1021/ja905302f; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chowdhury S, 2011, BIOORG MED CHEM LETT, V21, P3676, DOI 10.1016/j.bmcl.2011.04.088; Dounay AB, 2003, J AM CHEM SOC, V125, P6261, DOI 10.1021/ja034525d; Eggermont AMM, 2011, EUR J CANCER, V47, P2150, DOI 10.1016/j.ejca.2011.06.052; Finn L, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-23; Galliford CV, 2007, ANGEW CHEM INT EDIT, V46, P8748, DOI 10.1002/anie.200701342; GAO SP, 2006, SCI STKE, pPE30; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Ji ZY, 2010, MOL ASPECTS MED, V31, P194, DOI 10.1016/j.mam.2010.02.004; Jiang XX, 2010, J AM CHEM SOC, V132, P15328, DOI 10.1021/ja106349m; Kim BH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-36; Ko JM, 2011, J PATHOL, V223, P241, DOI 10.1002/path.2804; Kortylewski M, 2005, CANCER METAST REV, V24, P315, DOI 10.1007/s10555-005-1580-1; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Liu L, 2011, CANCER RES, V71, P3972, DOI 10.1158/0008-5472.CAN-10-3852; Liu XY, 2012, BIOCHEM PHARMACOL, V83, P1456, DOI 10.1016/j.bcp.2012.02.010; Liu YL, 2010, ORG BIOMOL CHEM, V8, P3847, DOI 10.1039/c0ob00174k; Maddika S, 2007, DRUG RESIST UPDATE, V10, P13, DOI 10.1016/j.drup.2007.01.003; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Miyake FY, 2004, ANGEW CHEM INT EDIT, V43, P5357, DOI 10.1002/anie.200460419; Nam S, 2005, P NATL ACAD SCI USA, V102, P5998, DOI 10.1073/pnas.0409467102; Page BDG, 2011, EXPERT OPIN THER PAT, V21, P65, DOI 10.1517/13543776.2011.539205; Paterson I, 2005, SCIENCE, V310, P451, DOI 10.1126/science.1116364; Sansone P, 2012, J CLIN ONCOL, V30, P1005, DOI 10.1200/JCO.2010.31.8907; Senft D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030821; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Sun JZ, 2005, ONCOGENE, V24, P3236, DOI 10.1038/sj.onc.1208470; Yang F, 2008, MOL CANCER THER, V7, P3519, DOI 10.1158/1535-7163.MCT-08-0138; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	36	29	29	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49306	10.1371/journal.pone.0049306	http://dx.doi.org/10.1371/journal.pone.0049306			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166634	Green Published, gold, Green Submitted			2022-12-27	WOS:000311885300026
J	Sunkara, LT; Jiang, WY; Zhang, GL				Sunkara, Lakshmi T.; Jiang, Weiyu; Zhang, Guolong			Modulation of Antimicrobial Host Defense Peptide Gene Expression by Free Fatty Acids	PLOS ONE			English	Article							ENTERICA SEROVAR ENTERITIDIS; INTESTINAL EPITHELIAL-CELLS; CATHELICIDIN LL-37; BUTYRATE; SALMONELLA; CHICKEN; ANTIBACTERIAL; COLONIZATION; INVASION; POULTRY	Routine use of antibiotics at subtherapeutic levels in animal feed drives the emergence of antimicrobial resistance. Development of antibiotic-alternative approaches to disease control and prevention for food animals is imperatively needed. Previously, we showed that butyrate, a major species of short-chain fatty acids (SCFAs) fermented from undigested fiber by intestinal microflora, is a potent inducer of endogenous antimicrobial host defense peptide (HDP) genes in the chicken (PLoS One 2011, 6: e27225). In the present study, we further revealed that, in chicken HD11 macrophages and primary monocytes, induction of HDPs is largely in an inverse correlation with the aliphatic hydrocarbon chain length of free fatty acids, with SCFAs being the most potent, medium-chain fatty acids moderate and long-chain fatty acids marginal. Additionally, three SCFAs, namely acetate, propionate, and butyrate, exerted a strong synergy in augmenting HDP gene expression in chicken cells. Consistently, supplementation of chickens with a combination of three SCFAs in water resulted in a further reduction of Salmonella enteritidis in the cecum as compared to feeding of individual SCFAs. More importantly, free fatty acids enhanced HDP gene expression without triggering proinflammatory interleukin-1 beta production. Taken together, oral supplementation of SCFAs is capable of boosting host immunity and disease resistance, with potential for infectious disease control and prevention in animal agriculture without relying on antibiotics.	[Sunkara, Lakshmi T.; Jiang, Weiyu; Zhang, Guolong] Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA; [Zhang, Guolong] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Zhang, Guolong] Oklahoma State Univ, Dept Physiol Sci, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Zhang, GL (corresponding author), Oklahoma State Univ, Dept Anim Sci, Stillwater, OK 74078 USA.	zguolon@okstate.edu	Sunkara, Lakshmi/B-8108-2014; Zhang, Guolong/HCI-5587-2022; Zhang, Guolong/AAU-8197-2020	Sunkara, Lakshmi/0000-0003-2023-5010; Zhang, Guolong/0000-0003-4781-5816; jiang, weiyu/0000-0001-6199-4289	U.S. Department of Agriculture National Institute of Food and Agriculture [2008-35204-04544]; Oklahoma Center for the Advancement of Science and Technology [AR07.2-087]; Oklahoma Agricultural Experiment Station [H-2811]	U.S. Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Oklahoma Center for the Advancement of Science and Technology; Oklahoma Agricultural Experiment Station	This work was supported by a U.S. Department of Agriculture National Institute of Food and Agriculture grant (2008-35204-04544), Oklahoma Center for the Advancement of Science and Technology grant AR07.2-087, and Oklahoma Agricultural Experiment Station project H-2811. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; Bommineni YR, 2007, FEBS J, V274, P418, DOI 10.1111/j.1742-4658.2006.05589.x; Brogden KA, 2003, INT J ANTIMICROB AG, V22, P465, DOI 10.1016/S0924-8579(03)00180-8; Canani RB, 2011, WORLD J GASTROENTERO, V17, P1519, DOI [10.3748/wjg.v17.i12. 1519, 10.3748/wjg.v17.i12.1519]; COUSENS LS, 1979, J BIOL CHEM, V254, P1716; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Guilloteau P, 2010, NUTR RES REV, V23, P366, DOI 10.1017/S0954422410000247; Hallert C, 2003, INFLAMM BOWEL DIS, V9, P116, DOI 10.1097/00054725-200303000-00005; Hamer HM, 2008, ALIMENT PHARM THER, V27, P104, DOI 10.1111/j.1365-2036.2007.03562.x; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hinnebusch BF, 2002, J NUTR, V132, P1012, DOI 10.1093/jn/132.5.1012; Kaiser MG, 2002, POULTRY SCI, V81, P657, DOI 10.1093/ps/81.5.657; Nakatsuji T, 2010, J INVEST DERMATOL, V130, P985, DOI 10.1038/jid.2009.384; *NAT COMM CLIN LAB, 2003, M7A6 NAT COMM CLIN L; NIEMAN C, 1954, BACTERIOL REV, V18, P147, DOI 10.1128/MMBR.18.2.147-163.1954; Schauber J, 2004, MOL IMMUNOL, V41, P847, DOI 10.1016/j.molimm.2004.05.005; Schauber J, 2003, GUT, V52, P735, DOI 10.1136/gut.52.5.735; Schwab M, 2008, IMMUNOLOGY, V125, P241, DOI 10.1111/j.1365-2567.2008.02834.x; Sunkara LT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027225; Thompson JL, 1997, BRIT POULTRY SCI, V38, P59, DOI 10.1080/00071669708417941; van Dijk A, 2007, ANTIMICROB AGENTS CH, V51, P912, DOI 10.1128/AAC.00568-06; Van Immerseel F, 2006, AVIAN PATHOL, V35, P182, DOI 10.1080/03079450600711045; Van Immerseel F, 2005, POULTRY SCI, V84, P1851, DOI 10.1093/ps/84.12.1851; Van Immerseel F, 2004, APPL ENVIRON MICROB, V70, P3582, DOI 10.1128/AEM.70.6.3582-3587.2004; Van Immerseel F, 2003, INT J FOOD MICROBIOL, V85, P237, DOI 10.1016/S0168-1605(02)00542-1; Vanhoutvin SALW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006759; Wu ST, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036940; Xiao YJ, 2006, FEBS J, V273, P2581, DOI 10.1111/j.1742-4658.2006.05261.x; Xiao YJ, 2009, J INNATE IMMUN, V1, P268, DOI 10.1159/000174822; Xiao YJ, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-56; Xiao YJ, 2006, J BIOL CHEM, V281, P2858, DOI 10.1074/jbc.M507180200; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	34	88	102	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49558	10.1371/journal.pone.0049558	http://dx.doi.org/10.1371/journal.pone.0049558			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166711	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300053
J	Ben Yehezkel, T; Biezuner, T; Linshiz, G; Mazor, Y; Shapiro, E				Ben Yehezkel, Tuval; Biezuner, Tamir; Linshiz, Gregory; Mazor, Yair; Shapiro, Ehud			Programmable In Vivo Selection of Arbitrary DNA Sequences	PLOS ONE			English	Article							SMALL HETEROLOGOUS SEQUENCES; NUCLEIC-ACIDS; DIRECTED EVOLUTION; MISMATCH REPAIR	The extraordinary fidelity, sensory and regulatory capacity of natural intracellular machinery is generally confined to their endogenous environment. Nevertheless, synthetic bio-molecular components have been engineered to interface with the cellular transcription, splicing and translation machinery in vivo by embedding functional features such as promoters, introns and ribosome binding sites, respectively, into their design. Tapping and directing the power of intracellular molecular processing towards synthetic bio-molecular inputs is potentially a powerful approach, albeit limited by our ability to streamline the interface of synthetic components with the intracellular machinery in vivo. Here we show how a library of synthetic DNA devices, each bearing an input DNA sequence and a logical selection module, can be designed to direct its own probing and processing by interfacing with the bacterial DNA mismatch repair (MMR) system in vivo and selecting for the most abundant variant, regardless of its function. The device provides proof of concept for programmable, function-independent DNA selection in vivo and provides a unique example of a logical-functional interface of an engineered synthetic component with a complex endogenous cellular system. Further research into the design, construction and operation of synthetic devices in vivo may lead to other functional devices that interface with other complex cellular processes for both research and applied purposes.	[Ben Yehezkel, Tuval; Biezuner, Tamir; Linshiz, Gregory; Mazor, Yair; Shapiro, Ehud] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Ben Yehezkel, T (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel.	Ehud.Shapiro@weizmann.ac.il			Grants-in-Aid for Scientific Research [22360139] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adar R, 2004, P NATL ACAD SCI USA, V101, P9960, DOI 10.1073/pnas.0400731101; ADLEMAN LM, 1994, SCIENCE, V266, P1021, DOI 10.1126/science.7973651; Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Ben Yehezkel T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn457; Benenson Y, 2001, NATURE, V414, P430, DOI 10.1038/35106533; Benenson Y, 2004, NATURE, V429, P423, DOI 10.1038/nature02551; Carr P, 2004, NUCL ACIDS RES; Chen YY, 2010, P NATL ACAD SCI USA, V107, P8531, DOI 10.1073/pnas.1001721107; Chen ZL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni148; Fang WH, 1997, J BIOL CHEM, V272, P22714, DOI 10.1074/jbc.272.36.22714; Goessl C, 2003, EXPERT REV MOL DIAGN, V3, P431, DOI 10.1586/14737159.3.4.431; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; KELMAN Z, 1995, ANNU REV BIOCHEM, V64, P171, DOI 10.1146/annurev.bi.64.070195.001131; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; Linshiz G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.26; Marti TM, 2002, J CELL PHYSIOL, V191, P28, DOI 10.1002/jcp.10077; PARKER BO, 1992, P NATL ACAD SCI USA, V89, P1730, DOI 10.1073/pnas.89.5.1730; Rinaudo K, 2007, NAT BIOTECHNOL, V25, P795, DOI 10.1038/nbt1307; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Sugiyama M, 2007, BIOORGAN MED CHEM, V15, P5905, DOI 10.1016/j.bmc.2007.05.062; Tian JD, 2004, NATURE, V432, P1050, DOI 10.1038/nature03151; Win MN, 2008, SCIENCE, V322, P456, DOI 10.1126/science.1160311; Wright CF, 2009, HUM REPROD UPDATE, V15, P139, DOI 10.1093/humupd/dmn047; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Xiong AS, 2006, NAT PROTOC, V1, P791, DOI 10.1038/nprot.2006.103	26	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e47795	10.1371/journal.pone.0047795	http://dx.doi.org/10.1371/journal.pone.0047795			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155373	Green Published, gold			2022-12-27	WOS:000311151900007
J	Lidgard, DC; Bowen, WD; Jonsen, ID; Iverson, SJ				Lidgard, Damian C.; Bowen, W. Don; Jonsen, Ian D.; Iverson, Sara J.			Animal-Borne Acoustic Transceivers Reveal Patterns of at-Sea Associations in an Upper-Trophic Level Predator	PLOS ONE			English	Article							HALICHOERUS-GRYPUS; GREY SEAL; INTRASPECIFIC VARIATION; SABLE ISLAND; BEHAVIOR; MOVEMENTS; TRACKING; EXPENDITURE; ECOLOGY; TACTICS	Satellite telemetry data have substantially increased our understanding of habitat use and foraging behaviour of upper-trophic marine predators, but fall short of providing an understanding of their social behaviour. We sought to determine whether novel acoustic and archival GPS data could be used to examine at-sea associations among grey seals (Halichoerus grypus) during the fall foraging period. Fifteen grey seals from Sable Island, Canada were deployed with Vemco Mobile Transceivers and Satellite-GPS transmitters in October 2009, 13 of which were recaptured and units retrieved 79 +/- 2.3 days later during the following breeding season, December 2009-January 2010. An association between two individuals was defined as a cluster of acoustic detections where the time between detections was <30 min. Bathymetry, travel rate, and behavioural state (slow and fast movement) were determined for each GPS archival point (3.7 +/- 0.1 locations recorded per hour). Behavioural state was estimated using a hidden Markov model. All seals had been involved in associations with other instrumented seals while at sea, with a total of 1,872 acoustic detections recorded in 201 associations. The median number of detections per association was 3 (range: 1-151) and the median duration of an association was 0.17 h (range: <0.1-11.3 h). Linear mixed-effects models showed that associations occurred when seals were exhibiting slow movement (0.24 +/- 0.01 ms(-1)) on shallow (53.4 +/- 3.7 m) offshore banks where dominant prey is known to occur. These results suggest the occurrence of short-term associations among multiple individuals at foraging grounds and provide new insights into the foraging ecology of this upper-trophic marine predator.	[Lidgard, Damian C.; Jonsen, Ian D.; Iverson, Sara J.] Dalhousie Univ, Dept Biol, Halifax, NS, Canada	Dalhousie University	Lidgard, DC (corresponding author), Dalhousie Univ, Dept Biol, Halifax, NS, Canada.	damian.lidgard@dal.ca	Bowen, William/AAE-7204-2022	Bowen, William/0000-0001-8334-5677; Iverson, Sara/0000-0003-2842-4094; Jonsen, Ian/0000-0001-5423-6076				Alexander R.D., 1974, Annual Rev Ecol Syst, V5, P325, DOI 10.1146/annurev.es.05.110174.001545; Animal Behaviour Society, 2006, ANIM BEHAV, V71, P245, DOI DOI 10.1016/J.ANBEHAV.2005.10.001; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Bailey DW, 2000, APPL ANIM BEHAV SCI, V68, P93, DOI 10.1016/S0168-1591(00)00091-5; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Beck CA, 2003, ANIM BEHAV, V66, P777, DOI 10.1006/anbe.2003.2284; Beck CA, 2003, J ANIM ECOL, V72, P280, DOI 10.1046/j.1365-2656.2003.00704.x; Beck CA, 2007, J ANIM ECOL, V76, P490, DOI 10.1111/j.1365-2656.2007.01215.x; Boness D.J., 1991, P1; BONESS DJ, 1994, BEHAV ECOL SOCIOBIOL, V34, P95; Bowen WD, 2007, MAR MAMMAL SCI, V23, P48, DOI 10.1111/j.1748-7692.2006.00085.x; Bowen W.D., 2007, NAMMCO Scientific Publications, V6, P123; Bowen WD, 1997, MAR ECOL PROG SER, V158, P267, DOI 10.3354/meps158267; BOWEN WD, 1994, MAR ECOL PROG SER, V112, P1, DOI 10.3354/meps112001; Breed GA, 2006, P R SOC B, V273, P2319, DOI 10.1098/rspb.2006.3581; Breed GA, 2011, MAR ECOL PROG SER, V431, P267, DOI 10.3354/meps09134; Breed GA, 2009, ECOLOGY, V90, P3209, DOI 10.1890/07-1483.1; BRODIE P, 1983, CAN J FISH AQUAT SCI, V40, P267, DOI 10.1139/f83-040; Byrant E, 2007, TR01 WILDTR TEL SYST; Carson S, 2011, SPATIAL POINT PROCES; Cooke SJ, 2011, FISHERIES, V36, P583, DOI 10.1080/03632415.2011.633464; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Darling FF, 1939, NATURALIST RONA; DFO, 2003, 2003004 DFO CAN SCI; Hammill MO, 2007, 2007084 DFO CAN SCI; Harting J. E., 1898, Nature, Vlvii, P465; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hayes SA, 2011, ENVIRON BIOL FISH, P1; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; HINDE RA, 1976, MAN, V11, P1, DOI 10.2307/2800384; Holland Kim N., 2010, Endangered Species Research, V10, P287; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Kuhn Carey E., 2010, Endangered Species Research, V12, P125, DOI 10.3354/esr00297; Kuhn CE, 2009, MAR ECOL PROG SER, V393, P97, DOI 10.3354/meps08229; le Boeuf B.J., 1991, P45; Le Boeuf BJ, 2000, ECOL MONOGR, V70, P353, DOI 10.1890/0012-9615(2000)070[0353:FEONES]2.0.CO;2; Lidgard DC, 2005, BEHAV ECOL, V16, P541, DOI 10.1093/beheco/ari023; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; LOTT DF, 1984, BEHAVIOUR, V88, P266, DOI 10.1163/156853984X00353; McConnell B, 2002, J ANIM ECOL, V71, P65, DOI 10.1046/j.0021-8790.2001.00576.x; MCLAREN IA, 1993, BIOL REV, V68, P1, DOI 10.1111/j.1469-185X.1993.tb00731.x; Patterson TA, 2009, J ANIM ECOL, V78, P1113, DOI 10.1111/j.1365-2656.2009.01583.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; SCHUSTERMAN RJ, 1981, PSYCHOL REC, V31, P125, DOI 10.1007/BF03394729; SIH A, 1994, J FISH BIOL, V45, P111, DOI 10.1111/j.1095-8649.1994.tb01087.x; STOBO WT, 1990, CANADIAN B FISHERIES, V0222, P00199; Stokesbury M.J.S., 2009, CHALLENGES DIADROMOU; Trzcinski MK, 2006, ECOL APPL, V16, P2276, DOI 10.1890/1051-0761(2006)016[2276:CDOAAC]2.0.CO;2; Venables WN., 2002, MODERN APPL STAT S 4; Wessel P., 1995, EOS T AM GEOPHYS UN, V79, P329, DOI [10.1029/95EO00198, DOI 10.1029/95EO00198]; Whitehead H., 2008, ANAL ANIMAL SOC; Zucchini W, 2009, MONOGR STAT APPL PRO, V110, P3	54	25	25	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48962	10.1371/journal.pone.0048962	http://dx.doi.org/10.1371/journal.pone.0048962			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155435	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900070
J	Frampton, M; Houlston, R				Frampton, Matthew; Houlston, Richard			Generation of Artificial FASTQ Files to Evaluate the Performance of Next-Generation Sequencing Pipelines	PLOS ONE			English	Article							FRAMEWORK; SIMULATOR; VARIANTS; FORMAT; GENOME	Pipelines for the analysis of Next-Generation Sequencing (NGS) data are generally composed of a set of different publicly available software, configured together in order to map short reads of a genome and call variants. The fidelity of pipelines is variable. We have developed ArtificialFastqGenerator, which takes a reference genome sequence as input and outputs artificial paired-end FASTQ files containing Phred quality scores. Since these artificial FASTQs are derived from the reference genome, it provides a gold-standard for read-alignment and variant-calling, thereby enabling the performance of any NGS pipeline to be evaluated. The user can customise DNA template/read length, the modelling of coverage based on GC content, whether to use real Phred base quality scores taken from existing FASTQ files, and whether to simulate sequencing errors. Detailed coverage and error summary statistics are outputted. Here we describe ArtificialFastqGenerator and illustrate its implementation in evaluating a typical bespoke NGS analysis pipeline under different experimental conditions. ArtificialFastqGenerator was released in January 2012. Source code, example files and binaries are freely available under the terms of the GNU General Public License v3.0. from https://sourceforge.net/projects/artfastqgen/.	[Frampton, Matthew; Houlston, Richard] Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England	University of London; Institute of Cancer Research - UK	Frampton, M (corresponding author), Inst Canc Res, Div Genet & Epidemiol, Sutton, Surrey, England.	Matthew.Frampton@icr.ac.uk		Houlston, Richard/0000-0002-5268-0242	Cancer Research UK [C1298/A8362]	Cancer Research UK(Cancer Research UK)	Funding provided by Cancer Research UK (C1298/A8362 - Bobby Moore Fund for Cancer Research UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Holtgrewe M., 2010, TECHNICAL REPORT; Hu XS, 2012, BIOINFORMATICS, V28, P1533, DOI 10.1093/bioinformatics/bts187; Huang WC, 2012, BIOINFORMATICS, V28, P593, DOI 10.1093/bioinformatics/btr708; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meacham F, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-451; Rimmer A, PLATYPUS INTEGRATED; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Tewhey R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r116	12	29	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49110	10.1371/journal.pone.0049110	http://dx.doi.org/10.1371/journal.pone.0049110			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152858	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234000050
J	Chaen, T; Konno, T; Egashira, M; Bai, RL; Nomura, N; Nomura, S; Hirota, Y; Sakurai, T; Imakawa, K				Chaen, Takashi; Konno, Toshihiro; Egashira, Mahiro; Bai, Rulan; Nomura, Nana; Nomura, Shintaro; Hirota, Yasushi; Sakurai, Toshihiro; Imakawa, Kazuhiko			Estrogen-Dependent Uterine Secretion of Osteopontin Activates Blastocyst Adhesion Competence	PLOS ONE			English	Article							MOUSE PERIIMPLANTATION BLASTOCYSTS; LUMINAL EPITHELIUM; IMPLANTATION; INTEGRIN; KINASE; FIBRONECTIN; EXPRESSION; EMBRYO; GROWTH; ATTACHMENT	Embryo implantation is a highly orchestrated process that involves blastocyst-uterine interactions. This process is confined to a defined interval during gestation referred to as the "window of embryo implantation receptivity''. In mice this receptive period is controlled by ovarian estrogen and involves a coordination of blastocyst adhesion competence and uterine receptivity. Mechanisms coordinating the acquisition of blastocyst adhesion competence and uterine receptivity are largely unknown. Here, we show that ovarian estrogen indirectly regulates blastocyst adhesion competence. Acquisition of blastocyst adhesion competence was attributed to integrin activation (e.g. formation of adhesion complexes) rather than de novo integrin synthesis. Osteopontin (OPN) was identified as an estrogen-dependent uterine endometrial gland secretory factor responsible for activating blastocyst adhesion competence. Increased adhesion complex assembly in OPN-treated blastocysts was mediated through focal adhesion kinase (FAK)- and phosphatidylinositol 3-kinase (PI3K)-dependent signaling pathways. These findings define for the first time specific regulatory components of an estrogen-dependent pathway coordinating blastocyst adhesion competence and uterine receptivity. Citation: Chaen T, Konno T, Egashira M, Bai R, Nomura N, et al. (2012) Estrogen-Dependent Uterine Secretion of Osteopontin Activates Blastocyst Adhesion Competence. PLoS ONE 7(11): e48933. doi:10.1371/journal.pone.0048933	[Chaen, Takashi; Konno, Toshihiro; Egashira, Mahiro; Bai, Rulan; Nomura, Nana; Sakurai, Toshihiro; Imakawa, Kazuhiko] Univ Tokyo, Dept Vet Med Sci, Lab Anim Breeding, Bunkyo Ku, Tokyo, Japan; [Nomura, Shintaro] Nagahama Inst Biosci & Technol, Dept Anim Biosci, Nagahama, Shiga, Japan; [Hirota, Yasushi] Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Konno, T (corresponding author), Univ Tokyo, Dept Vet Med Sci, Lab Anim Breeding, Bunkyo Ku, Tokyo, Japan.	konnot@gmail.com	Imakawa, Kazuhiko/AAD-3211-2022; Hirota, Yasushi/AAD-8713-2020; Konno, Toshihiro/AAH-6276-2020	Hirota, Yasushi/0000-0003-0241-9780; Konno, Toshihiro/0000-0001-8141-6996	Promotion of Basic Research Activities for Innovative Bioscience (BRAIN)	Promotion of Basic Research Activities for Innovative Bioscience (BRAIN)	This work was supported by the program for Promotion of Basic Research Activities for Innovative Bioscience (BRAIN)(http://www.naro.affrc.go.jp/brain/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aplin John D, 2004, Reprod Biol Endocrinol, V2, P48; Armant DR, 2005, DEV BIOL, V280, P260, DOI 10.1016/j.ydbio.2005.02.009; ARMANT DR, 1986, P NATL ACAD SCI USA, V83, P6751, DOI 10.1073/pnas.83.18.6751; Bellahcene A, 2008, NAT REV CANCER, V8, P212, DOI 10.1038/nrc2345; CAMPBELL S, 1995, HUM REPROD, V10, P1571, DOI 10.1093/HUMREP/10.6.1571; Dao B, 1996, CONTRACEPTION, V54, P253, DOI 10.1016/S0010-7824(96)00196-5; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fong YC, 2009, LUNG CANCER, V64, P263, DOI 10.1016/j.lungcan.2008.09.003; Fujita Y, 2002, FEBS LETT, V528, P101, DOI 10.1016/S0014-5793(02)03262-3; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Illera MJ, 2003, BIOL REPROD, V68, P766, DOI 10.1093/biolreprod/68.3.766; Jessmon P, 2010, BIOL REPROD, V82, P921, DOI 10.1095/biolreprod.109.082305; Johnson GA, 2003, BIOL REPROD, V69, P1458, DOI 10.1095/biolreprod.103.020651; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kent LN, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-97; Kida T, 2011, ATHEROSCLEROSIS, V214, P288, DOI 10.1016/j.atherosclerosis.2010.11.001; Konno T, 2011, PHYSIOL GENOMICS, V43, P930, DOI 10.1152/physiolgenomics.00069.2011; Konno T, 2010, ENDOCRINOLOGY, V151, P4537, DOI 10.1210/en.2010-0440; Lee KY, 2007, TRENDS ENDOCRIN MET, V18, P234, DOI 10.1016/j.tem.2007.06.002; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Liaw L, 1998, J CLIN INVEST, V101, P1468; Ma WG, 2003, P NATL ACAD SCI USA, V100, P2963, DOI 10.1073/pnas.0530162100; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mohamed OA, 2004, BIOL REPROD, V71, P417, DOI 10.1095/biolreprod.103.025692; NOMURA S, 1988, J CELL BIOL, V106, P441, DOI 10.1083/jcb.106.2.441; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Pugh D M, 1982, Arch Toxicol Suppl, V5, P209; Qiu Q, 2004, MOL HUM REPROD, V10, P677, DOI 10.1093/molehr/gah088; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Schultz JF, 1997, DEV GENET, V21, P31, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;31::AID-DVG4&gt;3.0.CO;2-9; SCHULTZ JF, 1995, J BIOL CHEM, V270, P11522, DOI 10.1074/jbc.270.19.11522; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Slack-Davis JK, 2007, J BIOL CHEM, V282, P14845, DOI 10.1074/jbc.M606695200; Song HS, 2000, MOL ENDOCRINOL, V14, P1147, DOI 10.1210/me.14.8.1147; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; SUTHERLAND AE, 1993, DEVELOPMENT, V119, P1175; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang J, 2002, CELLS TISSUES ORGANS, V172, P190, DOI 10.1159/000066970; White FJ, 2006, REPRODUCTION, V132, P919, DOI 10.1530/REP-06-0068; YELIAN FD, 1995, MOL REPROD DEV, V41, P435, DOI 10.1002/mrd.1080410406; YOSHINAGA K, 1988, ANN NY ACAD SCI, V541, P424, DOI 10.1111/j.1749-6632.1988.tb22279.x; Yoshinaga K, 2010, AM J REPROD IMMUNOL, V63, P413, DOI 10.1111/j.1600-0897.2010.00853.x; Zheng XX, 1995, P NATL ACAD SCI USA, V92, P12426, DOI 10.1073/pnas.92.26.12426	46	32	38	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48933	10.1371/journal.pone.0048933	http://dx.doi.org/10.1371/journal.pone.0048933			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152823	gold, Green Published, Green Submitted			2022-12-27	WOS:000312272600030
J	O'Dwyer, L; Lamberton, F; Matura, S; Tanner, C; Scheibe, M; Miller, J; Rujescu, D; Prvulovic, D; Hampel, H				O'Dwyer, Laurence; Lamberton, Franck; Matura, Silke; Tanner, Colby; Scheibe, Monika; Miller, Julia; Rujescu, Dan; Prvulovic, David; Hampel, Harald			Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study	PLOS ONE			English	Article							APOLIPOPROTEIN-E EPSILON-4; SEMANTIC MEMORY ACTIVATION; REGIONAL BRAIN ATROPHY; ALZHEIMERS-DISEASE; GENETIC RISK; E GENOTYPE; OLDER-ADULTS; ENTORHINAL CORTEX; COGNITIVE DECLINE; ONSET ALZHEIMERS	The E4 allele of the ApoE gene has consistently been shown to be related to an increased risk of Alzheimer's disease (AD). The E4 allele is also associated with functional and structural grey matter (GM) changes in healthy young, middle-aged and older subjects. Here, we assess volumes of deep grey matter structures of 22 healthy younger ApoE4 carriers and 22 non-carriers (20-38 years). Volumes of the nucleus accumbens, amygdala, caudate nucleus, hippocampus, pallidum, putamen, thalamus and brain stem were calculated by FMRIB's Integrated Registration and Segmentation Tool (FIRST) algorithm. A significant drop in volume was found in the right hippocampus of ApoE4 carriers (ApoE4+) relative to non-carriers (ApoE42), while there was a borderline significant decrease in the volume of the left hippocampus of ApoE4 carriers. The volumes of no other structures were found to be significantly affected by genotype. Atrophy has been found to be a sensitive marker of neurodegenerative changes, and our results show that within a healthy young population, the presence of the ApoE4+ carrier gene leads to volume reduction in a structure that is vitally important for memory formation. Our results suggest that the hippocampus may be particularly vulnerable to further degeneration in ApoE4 carriers as they enter middle and old age. Although volume reductions were noted bilaterally in the hippocampus, atrophy was more pronounced in the right hippocampus. This finding relates to previous work which has noted a compensatory increase in right hemisphere activity in ApoE4 carriers in response to preclinical declines in memory function. Possession of the ApoE4 allele may lead to greater predilection for right hemisphere atrophy even in healthy young subjects in their twenties. Citation: O'Dwyer L, Lamberton F, Matura S, Tanner C, Scheibe M, et al. (2012) Reduced Hippocampal Volume in Healthy Young ApoE4 Carriers: An MRI Study. PLoS ONE 7(11): e48895. doi: 10.1371/journal.pone.0048895	[O'Dwyer, Laurence; Matura, Silke; Scheibe, Monika; Miller, Julia; Prvulovic, David; Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany; [Lamberton, Franck] Univ Caen, UMS 3408, CNRS, GIP CYCERON, F-14032 Caen, France; [Tanner, Colby] Trinity Coll Dublin, Dept Zool, Dublin, Ireland; [Rujescu, Dan] Univ Munich, Dept Psychiat, D-8000 Munich, Germany	Goethe University Frankfurt; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Caen Normandie; Trinity College Dublin; University of Munich	O'Dwyer, L (corresponding author), Goethe Univ Frankfurt, Dept Psychiat Psychosomat Med & Psychotherapy, Frankfurt, Germany.	larodwyer@gmail.com	Lamberton, Franck/GRO-7517-2022; Rujescu, Dan/GRS-3875-2022	Lamberton, Franck/0000-0002-4655-4397; Hampel, Harald/0000-0003-0894-8982	School of Medicine, Goethe University, Frankfurt, Germany; Irish Research Council for Science, Engineering and Technology (IRCSET)	School of Medicine, Goethe University, Frankfurt, Germany; Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	This work was supported by institutional research funds of the School of Medicine, Goethe University, Frankfurt, Germany to HH. This work was also supported by the Neurodegeneration & Alzheimer's disease research grant of the Landesoffensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz (LOEWE) program "Neuronal Coordination Research Focus Frankfurt" (NeFF) to HH and DP. CT was supported by a fellowship from the Irish Research Council for Science, Engineering and Technology (IRCSET). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	AKAIKE H, 1979, BIOMETRIKA, V66, P237, DOI 10.1093/biomet/66.2.237; Alexopoulos P, 2011, J ALZHEIMERS DIS, V26, P207, DOI 10.3233/JAD-2011-110356; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2002, MODEL SELECTION MULT; Barboriak DP, 2000, NEUROLOGY, V54, P2150, DOI 10.1212/WNL.54.11.2150; Barnes LL, 2005, ARCH GEN PSYCHIAT, V62, P685, DOI 10.1001/archpsyc.62.6.685; Bartres-Faz D, 2008, NEUROBIOL AGING, V29, P1644, DOI 10.1016/j.neurobiolaging.2007.04.021; Bates D., 2011, PACKAGE LME4 LINEAR, V1; Beck AT, 1996, PSYCHOL ASSESS; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; Beffert U, 2006, CURR BIOL, V16, P2446, DOI 10.1016/j.cub.2006.10.029; Benedict R, 1997, BRIEFVISUOSPATIAL ME; BENJAMIN R, 1994, LANCET, V343, P1565, DOI 10.1016/S0140-6736(94)92961-0; Bigler ED, 2000, AM J NEURORADIOL, V21, P1857; Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E; Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Cherbuin N, 2008, J GERONTOL A-BIOL, V63, P501, DOI 10.1093/gerona/63.5.501; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cosentino S, 2008, NEUROLOGY, V70, P1842, DOI 10.1212/01.wnl.0000304038.37421.cc; Crawley M.J., 2007, R BOOK; Delis DC., 2000, CALIFORNIA VERBAL LE; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Dennis NA, 2010, ALZHEIMERS DEMENT, V6, P303, DOI 10.1016/j.jalz.2009.07.003; Du AT, 2006, NEUROBIOL AGING, V27, P733, DOI 10.1016/j.neurobiolaging.2005.03.021; Dumanis SB, 2009, J NEUROSCI, V29, P15317, DOI 10.1523/JNEUROSCI.4026-09.2009; Filbey FM, 2006, NEUROREPORT, V17, P1585, DOI 10.1097/01.wnr.0000234745.27571.d1; Filbey FM, 2010, BRAIN IMAGING BEHAV, V4, P177, DOI 10.1007/s11682-010-9097-9; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Filippini N, 2009, NEUROIMAGE, V44, P724, DOI 10.1016/j.neuroimage.2008.10.003; Finch CE, 1999, NEUROBIOL AGING, V20, P407, DOI 10.1016/S0197-4580(99)00053-6; Frisoni GB, 1999, NEUROLOGY, V52, P91, DOI 10.1212/WNL.52.1.91; Frisoni GB, 2008, NEUROLOGY, V70, P2194, DOI 10.1212/01.wnl.0000313844.18381.a9; Geroldi C, 1999, NEUROLOGY, V53, P1825, DOI 10.1212/WNL.53.8.1825; Geroldi C, 2000, J NEUROL NEUROSUR PS, V68, P93, DOI 10.1136/jnnp.68.1.93; Gold JM, 1997, ARCH GEN PSYCHIAT, V54, P159; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Han SD, 2008, ALZHEIMERS DEMENT, V4, P251, DOI 10.1016/j.jalz.2008.02.006; Hashimoto M, 2001, NEUROLOGY, V57, P1461, DOI 10.1212/WNL.57.8.1461; Hautzinger M., 2006, BECK DEPRESSIONS INV; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Jak AJ, 2007, DEMENT GERIATR COGN, V23, P382, DOI 10.1159/000101340; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kharrazi H, 2008, CLIN BIOCHEM, V41, P932, DOI 10.1016/j.clinbiochem.2008.05.001; Kukolja J, 2010, NEUROSCIENCE, V168, P487, DOI 10.1016/j.neuroscience.2010.03.044; Lehrl S., 1995, MEHRFACHWAHL WORTSCH; Lehtovirta M, 1996, J NEUROL NEUROSUR PS, V60, P644, DOI 10.1136/jnnp.60.6.644; LEHTOVIRTA M, 1995, NEUROSCIENCE, V67, P65, DOI 10.1016/0306-4522(95)00014-A; Lemaitre H, 2005, NEUROIMAGE, V24, P1205, DOI 10.1016/j.neuroimage.2004.10.016; Lind J, 2006, BRAIN, V129, P1240, DOI 10.1093/brain/awl054; Liu F, 2010, NEUROBIOL AGING, V31, P1831, DOI 10.1016/j.neurobiolaging.2008.09.015; Lu PH, 2011, J ALZHEIMERS DIS, V23, P433, DOI 10.3233/JAD-2010-101398; Marchant NL, 2010, NEUROPSYCHOPHARMACOL, V35, P1090, DOI 10.1038/npp.2009.214; Minati L, 2009, AM J ALZHEIMERS DIS, V24, P95, DOI 10.1177/1533317508328602; Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103; Mori E, 2002, ANN NEUROL, V51, P209, DOI 10.1002/ana.10093; Mueller SG, 2009, HIPPOCAMPUS, V19, P558, DOI 10.1002/hipo.20614; Niemann H., 2008, CALIFORNIA VERBAL LE; O'Dwyer L, 2011, J ALZHEIMERS DIS; O'Dwyer L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036024; OKUIZUMI K, 1994, NAT GENET, V7, P10, DOI 10.1038/ng0594-10b; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Patenaude B, 2011, NEUROIMAGE, V56, P907, DOI 10.1016/j.neuroimage.2011.02.046; Pedraza O, 2004, J INT NEUROPSYCH SOC, V10, P664, DOI 10.1017/S1355617704105080; Plassman BL, 1997, NEUROLOGY, V48, P985, DOI 10.1212/WNL.48.4.985; Reiman EM, 2004, P NATL ACAD SCI USA, V101, P284, DOI 10.1073/pnas.2635903100; Reiman EM, 1998, ANN NEUROL, V44, P288, DOI 10.1002/ana.410440226; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Scarmeas N, 2005, J NEUROL NEUROSUR PS, V76, P1440, DOI 10.1136/jnnp.2004.053645; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schiepers OJG, 2011, MOL PSYCHIAT; Schmidt H, 1996, CLIN GENET, V50, P293; Seidenberg M, 2009, NEUROLOGY, V73, P612, DOI 10.1212/WNL.0b013e3181b389ad; Shaw P, 2007, LANCET NEUROL, V6, P494, DOI 10.1016/S1474-4422(07)70106-0; Sidiropoulos C, 2011, ACTA NEUROPSYCHIATR, V23, P132, DOI 10.1111/j.1601-5215.2011.00546.x; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2001, J COMPUT ASSIST TOMO, V25, P466, DOI 10.1097/00004728-200105000-00022; SOININEN H, 1995, NEUROLOGY, V45, P391, DOI 10.1212/WNL.45.2.391; Tohgi H, 1997, NEUROSCI LETT, V236, P21, DOI 10.1016/S0304-3940(97)00743-X; Trivedi MA, 2008, NEUROPSYCHOLOGIA, V46, P1667, DOI 10.1016/j.neuropsychologia.2007.11.035; Tuminello ER, 2011, INT J ALZHEIMERS DIS, V2011, DOI 10.4061/2011/726197; Verghese PB, 2011, LANCET NEUROL, V10, P241, DOI 10.1016/S1474-4422(10)70325-2; Wechsler D, 1997, WMS 3 ADM SCORING MA; WILSON PWF, 1994, JAMA-J AM MED ASSOC, V272, P1666, DOI 10.1001/jama.272.21.1666; Wishart HA, 2006, NEUROLOGY, V67, P1221, DOI 10.1212/01.wnl.0000238079.00472.3a; Woodard JL, 2009, BRAIN, V132, P2068, DOI 10.1093/brain/awp157; ZANNIS VI, 1982, J LIPID RES, V23, P911; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	92	107	107	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48895	10.1371/journal.pone.0048895	http://dx.doi.org/10.1371/journal.pone.0048895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152815	Green Published, gold			2022-12-27	WOS:000312272600025
J	Zhang, ZH; Feduccia, A; James, HF				Zhang, Zihui; Feduccia, Alan; James, Helen F.			A Late Miocene Accipitrid (Aves: Accipitriformes) from Nebraska and Its Implications for the Divergence of Old World Vultures	PLOS ONE			English	Article							CYTOCHROME-B GENE; NUCLEOTIDE-SEQUENCES; PHYLOGENY; HISTORY; BIRD; DNA	Background: Old World vultures are likely polyphyletic, representing two subfamilies, the Aegypiinae and Gypaetinae, and some genera of the latter may be of independent origin. Evidence concerning the origin, as well as the timing of the divergence of each subfamily and even genera of the Gypaetinae has been elusive. Methodology/Principal Findings: Compared with the Old World, the New World has an unexpectedly diverse and rich fossil component of Old World vultures. Here we describe a new accipitriform bird, Anchigyps voorhiesi gen. et sp. nov., from the Ash Hollow Formation (Upper Clarendonian, Late Miocene) of Nebraska. It represents a form close in morphology to the Old World vultures. Characteristics of its wing bones suggest it was less specialized for soaring than modern vultures. It was likely an opportunistic predator or scavenger having a grasping foot and a mandible morphologically similar to modern carrion-feeding birds. Conclusions/Significance: The new fossil reported here is intermediate in morphology between the bulk of accipitrids and the Old World gypaetine vultures, representing a basal lineage of Accipitridae trending towards the vulturine habit, and of its Late Miocene age suggests the divergence of true gypaetine vultures, may have occurred during or slightly before the Miocene. Citation: Zhang Z, Feduccia A, James HF (2012) A Late Miocene Accipitrid (Aves: Accipitriformes) from Nebraska and Its Implications for the Divergence of Old World Vultures. PLoS ONE 7(11): e48842. doi: 10.1371/journal.pone.0048842	[Feduccia, Alan] Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA; [Zhang, Zihui] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [James, Helen F.] Smithsonian Inst, Dept Vertebrate Zool, Natl Museum Nat Hist, MRC 116, Washington, DC 20560 USA	University of North Carolina; University of North Carolina Chapel Hill; Capital Normal University; Smithsonian Institution; Smithsonian National Museum of Natural History	Feduccia, A (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	feduccia@bio.unc.edu		James, Helen/0000-0002-2495-6133	National Natural Science Foundation of China [30870263, 31071877]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported partly by the National Natural Science Foundation of China (30870263, 31071877). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1985, NATL GEOGRAPHIC SOC; Baumel Julian J., 1993, Publications of the Nuttall Ornithological Club, V23, P45; Brodkorb P., 1964, Bulletin of the Florida State Museum Biological Sciences, V8, P195; Brown L. H., 1968, EAGLES HAWKS FALCONS; DEBOER LEM, 1984, GENETICA, V65, P89, DOI 10.1007/BF00056767; EMSLIE S D, 1985, Contributions to Geology University of Wyoming, V23, P63; FEDUCCIA A, 1989, IBIS, V131, P349, DOI 10.1111/j.1474-919X.1989.tb02784.x; Feduccia A., 1999, ORIGIN EVOLUTION BIR, V2; Feduccia Alan, 1992, Natural History Museum of Los Angeles County Science Series, V36, P239; FISHER HI, 1946, AM MIDL NAT, V35, P545, DOI 10.2307/2421553; Griffiths CS, 2007, J AVIAN BIOL, V38, P587, DOI 10.1111/j.2007.0908-8857.03971.x; Hertel F, 1995, AUK, V112, P890, DOI 10.2307/4089021; HOU LH, 1984, VERTEBRAT PALASIATIC, V22, P14; Howard H, 1932, CARNEGIE I WASHINGTO, V429; HOWARD HILDEGARDE, 1929, UNIV CALIFORNIA PUBL ZOOL, V32, P301; HOWARD HILDEGARDE, 1966, LOS ANGELES COUNTY MUS CONT RIB SCI, V107, P1; JOLLIE M, 1977, Evolutionary Theory, V2, P209; JOLLIE M, 1977, Evolutionary Theory, V3, P1; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Linnaeus C, 1758, SYSTEMA NATURAE; Mayr G., 2009, PALEOGENE FOSSIL BIR, DOI DOI 10.1007/978-3-540-89628-9; Miller A. H., 1939, Condor, V41, P153, DOI 10.2307/1364004; Miller LH, 1916, U CALIFORNIA PUBLICA, V9, P105; MILLER LOYE, 1942, UNIV CALIFORNIA PUBL ZOOL, V47, P47; Mundy P., 1992, VULTURES AFRICA; Rich P.V., 1983, P3; Rich P.V., 1980, CONTRIBUTIONS TO VERTEBRATE EVOLUTION, V5, P1; Seibold I, 1995, PHILOS T ROY SOC B, V350, P163, DOI 10.1098/rstb.1995.0150; VIELLOT LJP, 1816, ANAL NOUVELLE ORNITH; Voorhies M.R., 1981, National Geographic Magazine, V159, P66; VOORHIES MR, 1979, SCIENCE, V206, P331, DOI 10.1126/science.206.4416.331; VOOUS KH, 1973, IBIS, V115, P612, DOI 10.1111/j.1474-919X.1973.tb02004.x; WEBB SD, 1977, ANNU REV ECOL SYST, V8, P355, DOI 10.1146/annurev.es.08.110177.002035; Wetmore Alexander, 1943, CONDOR, V45, P229, DOI 10.2307/1364069; WETMORE ALEXANDER, 1936, PROC U S NAT MUS, V84, P73; Wink M, 1995, Z NATURFORSCH C, V50, P868; Wink Michael, 2004, P483; Zhang ZH, 2010, J ORNITHOL, V151, P401, DOI 10.1007/s10336-009-0468-1	38	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48842	10.1371/journal.pone.0048842	http://dx.doi.org/10.1371/journal.pone.0048842			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152811	gold, Green Published			2022-12-27	WOS:000312272600023
J	Ampuero, J; Ranchal, I; Nunez, D; Diaz-Herrero, MD; Maraver, M; del Campo, JA; Rojas, A; Camacho, I; Figueruela, B; Bautista, JD; Romero-Gomez, M				Ampuero, Javier; Ranchal, Isidora; Nunez, David; del Mar Diaz-Herrero, Maria; Maraver, Marta; Antonio del Campo, Jose; Rojas, Angela; Camacho, Ines; Figueruela, Blanca; Bautista, Juan D.; Romero-Gomez, Manuel			Metformin Inhibits Glutaminase Activity and Protects against Hepatic Encephalopathy	PLOS ONE			English	Article							PHOSPHATE-ACTIVATED GLUTAMINASE; HEPATOCELLULAR-CARCINOMA; DIABETIC-PATIENTS; INFLAMMATION; CYTOKINE; RISK	Aim: To investigate the influence of metformin use on liver dysfunction and hepatic encephalopathy in a retrospective cohort of diabetic cirrhotic patients. To analyze the impact of metformin on glutaminase activity and ammonia production in vitro. Methods: Eighty-two cirrhotic patients with type 2 diabetes were included. Forty-one patients were classified as insulin sensitizers experienced (metformin) and 41 as controls (cirrhotic patients with type 2 diabetes mellitus without metformin treatment). Baseline analysis included: insulin, glucose, glucagon, leptin, adiponectin, TNFr2, AST, ALT. HOMA-IR was calculated. Baseline HE risk was calculated according to minimal hepatic encephalopathy, oral glutamine challenge and mutations in glutaminase gene. We performed an experimental study in vitro including an enzymatic activity assay where glutaminase inhibition was measured according to different metformin concentrations. In Caco2 cells, glutaminase activity inhibition was evaluated by ammonia production at 24, 48 and 72 hours after metformina treatment. Results: Hepatic encephalopathy was diagnosed during follow-up in 23.2% (19/82): 4.9% (2/41) in patients receiving metformin and 41.5% (17/41) in patients without metformin treatment (logRank 9.81; p = 0.002). In multivariate analysis, metformin use [H. R. 11.4 (95% CI: 1.2-108.8); p = 0.034], age at diagnosis [H. R. 1.12 (95% CI: 1.04-1.2); p = 0.002], female sex [H. R. 10.4 (95% CI: 1.5-71.6); p = 0.017] and HE risk [H. R. 21.3 (95% CI: 2.8-163.4); p = 0.003] were found independently associated with hepatic encephalopathy. In the enzymatic assay, glutaminase activity inhibition reached 68% with metformin 100 mM. In Caco2 cells, metformin (20 mM) decreased glutaminase activity up to 24% at 72 hours post-treatment (p < 0.05). Conclusions: Metformin was found independently related to overt hepatic encephalopathy in patients with type 2 diabetes mellitus and high risk of hepatic encephalopathy. Metformin inhibits glutaminase activity in vitro. Therefore, metformin use seems to be protective against hepatic encephalopathy in diabetic cirrhotic patients.	[Ampuero, Javier; Ranchal, Isidora; Nunez, David; Maraver, Marta; Antonio del Campo, Jose; Rojas, Angela; Camacho, Ines; Figueruela, Blanca; Romero-Gomez, Manuel] Univ Seville, Hosp Univ Valme, Unit Clin Management Digest Dis, Seville, Spain; [Ampuero, Javier; Ranchal, Isidora; Nunez, David; Maraver, Marta; Antonio del Campo, Jose; Rojas, Angela; Camacho, Ines; Figueruela, Blanca; Romero-Gomez, Manuel] Univ Seville, Hosp Univ Valme, CIBERehd, Seville, Spain; [del Mar Diaz-Herrero, Maria; Bautista, Juan D.] Univ Seville, Dept Mol Biol, Seville, Spain	Hospital Valme; University of Sevilla; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Valme; University of Sevilla; University of Sevilla	Romero-Gomez, M (corresponding author), Univ Seville, Hosp Univ Valme, Unit Clin Management Digest Dis, Seville, Spain.	mromerogomez@us.es	Palomas, Juan D Bautista/L-2343-2014; IBIS, DIGESTIVAS/O-1913-2015; Ampuero, Javier/AAI-2582-2019; Romero-Gomez, Manuel/L-8030-2014	Palomas, Juan D Bautista/0000-0001-9567-5390; Ampuero, Javier/0000-0002-8332-2122; Romero-Gomez, Manuel/0000-0001-8494-8947; Ranchal, Isidora/0000-0001-7870-7768	Proyecto de Excelencia [CTS-7991/2011]; Consejeria de Economia; Junta de Andalucia; Goverment of Andalusia, Spain	Proyecto de Excelencia; Consejeria de Economia; Junta de Andalucia(Junta de Andalucia); Goverment of Andalusia, Spain	Proyecto de Excelencia (CTS-7991/2011). Consejeria de Economia. Junta de Andalucia. Goverment of Andalusia, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhaider AA, 2011, CHEM-BIOL INTERACT, V192, P233, DOI 10.1016/j.cbi.2011.03.014; Baglietto-Vargas D, 2004, BIOCHEM J, V381, P483, DOI 10.1042/BJ20040523; Basu S, 2011, INT J CLIN EXP MED, V4, P164; Bustamante J, 1999, J HEPATOL, V30, P890, DOI 10.1016/S0168-8278(99)80144-5; Donadon V, 2010, LIVER INT, V30, P750, DOI 10.1111/j.1478-3231.2010.02223.x; Goldberg RB, 2009, J CLIN ENDOCR METAB, V94, P3171, DOI 10.1210/jc.2008-2534; Gundling F, 2011, LIVER INT, V31, P1406, DOI 10.1111/j.1478-3231.2011.02577.x; Jun DW, 2010, DIGEST DIS SCI, V55, P1465, DOI 10.1007/s10620-009-0870-9; Kennedy L, 2006, DIABETES CARE, V29, P1; Lai SW, 2012, AM J GASTROENTEROL, V107, P46, DOI 10.1038/ajg.2011.384; Evia-Viscarra ML, 2012, J PEDIATR ENDOCR MET, V25, P41, DOI 10.1515/jpem-2011-0469; Majid S, 2009, INDIAN J GASTROENTER, V28, P93, DOI 10.1007/s12664-009-0034-z; Romero-Gomez M, 2005, METAB BRAIN DIS, V20, P319, DOI 10.1007/s11011-005-7913-5; Romero-Gomez M, 2002, J HEPATOL, V37, P781, DOI 10.1016/S0168-8278(02)00330-6; Romero-Gomez M, 2001, AM J GASTROENTEROL, V96, P2718, DOI 10.1016/S0002-9270(01)02692-2; Romero-Gomez M, 2010, ANN INTERN MED, V153, P281, DOI 10.7326/0003-4819-153-5-201009070-00002; Romero-Gomez M, 2010, EXPERT OPIN PHARMACO, V11, P1317, DOI 10.1517/14656561003724721; Sharma Praveen, 2010, Saudi J Gastroenterol, V16, P181, DOI 10.4103/1319-3767.65189; Sigal SH, 2006, AM J GASTROENTEROL, V101, P1490, DOI 10.1111/j.1572-0241.2006.00649.x; Van Wagner Lisa B, 2011, Therap Adv Gastroenterol, V4, P249, DOI 10.1177/1756283X11403809; WATFORD M, 1984, BIOCHEM J, V224, P207, DOI 10.1042/bj2240207	21	39	41	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49279	10.1371/journal.pone.0049279	http://dx.doi.org/10.1371/journal.pone.0049279			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166628	gold, Green Published, Green Submitted			2022-12-27	WOS:000311272300037
J	Gibson, MA; Gurmu, E				Gibson, Mhairi A.; Gurmu, Eshetu			Rural to Urban Migration Is an Unforeseen Impact of Development Intervention in Ethiopia	PLOS ONE			English	Article							OUT-MIGRATION; FERTILITY; COMPETITION; INVESTMENT; DISPERSAL	Rural development initiatives across the developing world are designed to improve community well-being and livelihoods. However they may also have unforeseen consequences, in some cases placing further demands on stretched public services. In this paper we use data from a longitudinal study of five Ethiopian villages to investigate the impact of a recent rural development initiative, installing village-level water taps, on rural to urban migration of young adults. Our previous research has identified that tap stands dramatically reduced child mortality, but were also associated with increased fertility. We demonstrate that the installation of taps is associated with increased rural-urban migration of young adults (15-30 years) over a 15 year period (15.5% migrate out, n = 1912 from 1280 rural households). Young adults with access to this rural development intervention had three times the relative risk of migrating to urban centres compared to those without the development. We also identify that family dynamics, specifically sibling competition for limited household resources (e.g. food, heritable land and marriage opportunities), are key to understanding the timing of out-migration. Birth of a younger sibling doubled the odds of out-migration and starting married life reduced it. Rural out-migration appears to be a response to increasing rural resource scarcity, principally competition for agricultural land. Strategies for livelihood diversification include education and off-farm casual wage-labour. However, jobs and services are limited in urban centres, few migrants send large cash remittances back to their families, and most return to their villages within one year without advanced qualifications. One benefit for returning migrants may be through enhanced social prestige and mate-acquisition on return to rural areas. These findings have wide implications for current understanding of the processes which initiate rural-to-urban migration and transitions to low fertility, as well as for the design and implementation of development intervention across the rural and urban developing world.	[Gibson, Mhairi A.] Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England	University of Bristol	Gibson, MA (corresponding author), Univ Bristol, Dept Archaeol & Anthropol, Bristol, Avon, England.	mhairi.gibson@bristol.ac.uk	Gibson, Mhairi A/D-4726-2009	Gibson, Mhairi A/0000-0001-7963-4759; Gurmu, Eshetu/0000-0001-7487-0058				Agadjanian V, 2011, DEMOGRAPHY, V48, P1029, DOI 10.1007/s13524-011-0039-y; Allison P.D., 1984, EVENT HIST ANAL REGR; Alvergne A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022515; Beise J, 2008, AM J HUM BIOL, V20, P325, DOI 10.1002/ajhb.20730; BILSBORROW RE, 1987, DEMOGRAPHY, V24, P191, DOI 10.2307/2061629; Black R, 2011, NATURE, V478, P447, DOI 10.1038/478477a; BOWLES S, 1970, REV ECON STAT, V52, P356, DOI 10.2307/1926312; Byass P, 2003, SCAND J PUBLIC HEALT, V31, P58, DOI 10.1080/14034940210133726; Central Statistical Authority (CSA), 1998, 1994 POP HOUS CENS E, VI; Cohen JE, 2003, SCIENCE, V302, P1172, DOI 10.1126/science.1088665; Cohen JH, 2011, ANNU REV ANTHROPOL, V40, P103, DOI 10.1146/annurev-anthro-081309-145851; CSA ICF, 2012, ETH DEM HLTH SURV 20; Degefe B, 2001, 2 ANN REPORT ETHIOPI, V2; Dyson T, 2011, POPUL DEV REV, P34; Ellison PT, 2003, AM J HUM BIOL, V15, P342, DOI 10.1002/ajhb.10152; Ezra M, 2001, INT MIGR REV, V35, P749, DOI 10.1111/j.1747-7379.2001.tb00039.x; Fernandez B, 2010, GENDER DEV, V18, P249, DOI DOI 10.1080/13552074.2010.491335; Gibson MA, 2002, CURR ANTHROPOL, V43, P631, DOI 10.1086/342428; Gibson MA, 2006, PLOS MED, V3, P476, DOI 10.1371/journal.pmed.0030087; Gibson MA, 2011, P NATL ACAD SCI USA, V108, P2200, DOI 10.1073/pnas.1010241108; Gibson MA, 2011, EVOL HUM BEHAV, V32, P97, DOI 10.1016/j.evolhumbehav.2010.10.002; Gurmu E, 2005, FERTILITY TRANSITION; Gurmu E, 2008, J BIOSOC SCI, V40, P339, DOI 10.1017/S002193200700260X; Hadley C, 2011, AM J PHYS ANTHROPOL, V144, P643, DOI 10.1002/ajpa.21463; HARRIS JR, 1970, AM ECON REV, V60, P126; Hrdy SarahBlaffer., 2009, MOTHERS OTHERS EVOLU; Kaplan H, 1996, YEARB PHYS ANTHROPOL, V39, P91; Low BS, 2006, CULTURAL PSYCHOL IMM, P15; Lutz W, 2011, SCIENCE, V333, P587, DOI 10.1126/science.1206964; Mace R, 2008, SCIENCE, V319, P764, DOI 10.1126/science.1153960; Mohapatra S, 2009, WORLD BANK POLICY RE; Mueller V, 2011, 1090 IFPRI; Neill DB, 2010, HUM NATURE-INT BIOS, V21, P99, DOI 10.1007/s12110-010-9083-3; Sear R, 2008, EVOL HUM BEHAV, V29, P1, DOI 10.1016/j.evolhumbehav.2007.10.001; Silkin T., 1998, HITOSA WATER SUPPLY; Tacoli C, 2002, CHANGING RURAL URBAN; Taylor JE, 1999, INT MIGR, V37, P63, DOI 10.1111/1468-2435.00066; Towner MC, 2001, HUM NATURE-INT BIOS, V12, P321, DOI 10.1007/s12110-001-1002-1; UN-HABITAT, 2008, ETH URB PROF; *UNFPA, 2007, STAT WORLD POP 2007; UNFPA-TechnicalDivision, 2012, POP MATT SUST DEV; United Nations, 2011, WORLD POP PROSP WORL; WorldBank, 2009, SYST CIT HARN URB GR; Yamaguchi K., 1991, EVENT HIST ANAL	44	26	28	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48708	10.1371/journal.pone.0048708	http://dx.doi.org/10.1371/journal.pone.0048708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155400	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900034
J	Haro, KJ; Sheth, A; Scheinberg, DA				Haro, Kurtis J.; Sheth, Aneesh; Scheinberg, David A.			Dysregulation of IRP1-Mediated Iron Metabolism Causes Gamma Ray-specific Radioresistance in Leukemia Cells	PLOS ONE			English	Article							OXIDATIVE STRESS; DEINOCOCCUS-RADIODURANS; REGULATORY PROTEIN-1; HYDROGEN-PEROXIDE; CELLULAR-RESPONSE; ESCHERICHIA-COLI; ALPHA-PARTICLES; H-FERRITIN; RADIATION; DAMAGE	Iron is required for nearly all organisms, playing important roles in oxygen transport and many enzymatic reactions. Excess iron, however, can be cytotoxic. Emerging evidence suggests that radioresistance can be achieved in lower organisms by the protection of proteins, but not DNA, immediately following ionizing radiation (IR) exposure, allowing for improved DNA repair. One potential mechanism for protein protection is controlling and limiting the amount of free iron in cells, as has been demonstrated in the extremophile Deinococcus Radiodurans, reducing the potential for oxidative damage to proteins during exposure to IR. We found that iron regulatory protein 1 (IRP1) expression was markedly reduced in human myeloid leukemia HL60 cells resistant to low linear energy transfer (LET) gamma rays, but not to high LET alpha particles. Stable knockdown of IRP1 by short-hairpin RNA (shRNA) interference in radiosensitive parental cells led to radioresistance to low LET IR, reduced intracellular Fenton chemistry, reduced protein oxidation, and more rapid DNA double-strand break (DSB) repair. The mechanism of radioresistance appeared to be related to attenuated free radical-mediated cell death. Control of intracellular iron by IRPs may be a novel radioresistance mechanism in mammalian cells.	[Haro, Kurtis J.; Sheth, Aneesh; Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Haro, KJ (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	d-scheinberg@ski.mskcc.org			NATIONAL CANCER INSTITUTE [R01CA055349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM073546] Funding Source: NIH RePORTER; NCI NIH HHS [R01-CA55349, R01 CA055349, P01 CA023766] Funding Source: Medline; NIGMS NIH HHS [T32 GM073546] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BARENDSEN GW, 1994, RADIAT RES, V139, P257, DOI 10.2307/3578823; Belmokhtar CA, 2001, ONCOGENE, V20, P3354, DOI 10.1038/sj.onc.1204436; BLOCHER D, 1988, INT J RADIAT BIOL, V54, P761, DOI 10.1080/09553008814552201; Campbell JL, 2006, DNA REPAIR; CHARLTON DE, 1991, INT J RADIAT BIOL, V59, P447, DOI 10.1080/09553009114550401; Daly MJ, 2007, PLOS BIOL, V5, P769, DOI 10.1371/journal.pbio.0050092; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2004, SCIENCE, V306, P1025, DOI 10.1126/science.1103185; Du J, 2004, INT J BIOCHEM CELL B, V36, P2334, DOI 10.1016/j.biocel.2004.05.012; Epsztejn S, 1999, BLOOD, V94, P3593, DOI 10.1182/blood.V94.10.3593.422k26_3593_3603; FENECH M, 1985, MUTAT RES, V147, P29, DOI 10.1016/0165-1161(85)90015-9; Franken NAP, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-64; Galy B, 2010, CELL METAB, V12, P194, DOI 10.1016/j.cmet.2010.06.007; Goralska M, 2001, INVEST OPHTH VIS SCI, V42, P1721; HAHN SM, 1992, CANCER RES, V52, P1750; Hall EJ, 2012, RADIOBIOLOGY RADIOLO; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jakubowski W, 2000, CELL BIOL INT, V24, P757, DOI 10.1006/cbir.2000.0556; KARIN M, 1981, J BIOL CHEM, V256, P3245; Keyer K, 1996, P NATL ACAD SCI USA, V93, P13635, DOI 10.1073/pnas.93.24.13635; Krisko A, 2012, P NATL ACAD SCI US; Krisko A, 2010, P NATL ACAD SCI USA, V107, P14373, DOI 10.1073/pnas.1009312107; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; LEVI S, 1988, J BIOL CHEM, V263, P18086; MacKenzie EL, 2008, FREE RADICAL BIO MED, V44, P1762, DOI 10.1016/j.freeradbiomed.2008.01.031; MITCHELL JB, 1991, ARCH BIOCHEM BIOPHYS, V289, P62, DOI 10.1016/0003-9861(91)90442-L; Neti PVSV, 2004, RADIAT RES, V161, P732, DOI 10.1667/RR3181; Orino K, 2001, BIOCHEM J, V357, P241, DOI 10.1042/0264-6021:3570241; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Seideman JH, 2011, RAD RES; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Sobota JM, 2011, P NATL ACAD SCI USA, V108, P5402, DOI 10.1073/pnas.1100410108; Theunissen J-WF, 2006, DNA REPAIR METHODS S; Volz K, 2008, CURR OPIN STRUC BIOL, V18, P106, DOI 10.1016/j.sbi.2007.12.010; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200	38	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48841	10.1371/journal.pone.0048841	http://dx.doi.org/10.1371/journal.pone.0048841			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155415	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900049
J	Ji, ZB; Wang, GZ; Xie, ZJ; Wang, JM; Zhang, CL; Dong, F; Chen, CX				Ji, Zhibin; Wang, Guizhi; Xie, Zhijing; Wang, Jianmin; Zhang, Chunlan; Dong, Fei; Chen, Cunxian			Identification of Novel and Differentially Expressed MicroRNAs of Dairy Goat Mammary Gland Tissues Using Solexa Sequencing and Bioinformatics	PLOS ONE			English	Article							COMPUTATIONAL IDENTIFICATION; ANNOTATION; INFORMATION; INTEGRATION; BIOGENESIS; PREDICTION; MECHANISM; ONTOLOGY; GENOMICS; FEATURES	MicroRNAs are small, noncoding RNA molecules that regulate gene expression at the post-transcriptional level and play an important role in various biological processes. Although most microRNAs expression profiles studies have been performed in humans or rodents, relatively limited knowledge also exists in other mammalian species. The identification of the full repertoire of microRNAs expressed in the lactating mammary gland of Capra hircus would significantly increase our understanding of the physiology of lactating mammary glands. In this study, two libraries were constructed using the lactating mammary gland tissues of Laoshan dairy goats (Capra hircus) during peak and late lactation. Solexa high-throughput sequencing technique and bioinformatics were used to determine the abundance and differential expression of the microRNAs between peak and late lactation. As a result, 19,044,002 and 7,385,833 clean reads were obtained, respectively, and 1,113 conserved known microRNAs and 31 potential novel microRNA candidates were identified. A total of 697 conserved microRNAs were significantly differentially expressed with a P-value<0.01, 272 microRNAs were up-regulated and 425 microRNAs were down-regulated during peak lactation. The results were validated using real-time quantitative RT-PCR. 762,557 annotated mRNA transcripts were predicted as putative target gene candidates. The GO annotation and KEGG pathway analysis suggested that differentially expressed microRNAs were involved in mammary gland physiology, including signal transduction, and cell-cell and cell-extracellular communications. This study provided the first global of the microRNA in Capra hircus and expanded the repertoire of microRNAs. Our results have great significance and value for the elucidation of complex regulatory networks between microRNAs and mRNAs and for the study of mammary gland physiology and lactation.	[Ji, Zhibin; Wang, Guizhi; Xie, Zhijing; Wang, Jianmin; Zhang, Chunlan; Dong, Fei; Chen, Cunxian] Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China	Key Laboratory of Animal Biotechnology & Disease Control & Prevention of Shandong Province; Shandong Agricultural University	Ji, ZB (corresponding author), Shandong Agr Univ, Coll Anim Sci & Vet Med, Shandong Prov Key Lab Anim Biotechnol & Dis Contr, Tai An, Shandong, Peoples R China.	wangjm@sdau.edu.cn	WANG, Jianmin/M-2002-2016	WANG, Jianmin/0000-0001-5678-8202; Ji, Zhibin/0000-0003-1762-2204				Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Archibald AL, 2010, ANIM GENET, V41, P449, DOI 10.1111/j.1365-2052.2010.02100.x; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Berezikov E, 2006, NAT GENET, V38, pS2, DOI 10.1038/ng1794; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Borralho PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023787; Brown JR, 2005, DRUG DISCOV TODAY, V10, P595, DOI 10.1016/S1359-6446(05)03399-4; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dong QH, 2012, J HERED, V103, P268, DOI 10.1093/jhered/esr127; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang P, 2007, NUCLEIC ACIDS RES, V35, pW339, DOI 10.1093/nar/gkm368; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li SY, 2011, SCI CHINA LIFE SCI, V54, P806, DOI 10.1007/s11427-011-4213-7; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Li Y, 2012, NUCLEIC ACIDS RES, V40, P4298, DOI 10.1093/nar/gks043; Liffers ST, 2011, LAB INVEST, V91, P1472, DOI 10.1038/labinvest.2011.99; Liu SP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-148; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Morozova O, 2008, GENOMICS, V92, P255, DOI 10.1016/j.ygeno.2008.07.001; Rathjen T, 2009, FEBS LETT, V583, P1422, DOI 10.1016/j.febslet.2009.03.048; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Ruby JG, 2007, GENOME RES, V17, P1850, DOI 10.1101/gr.6597907; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Silveri L, 2006, REPROD NUTR DEV, V46, P549, DOI 10.1051/rnd:2006026; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Tanaka T, 2009, DIFFERENTIATION, V77, P181, DOI 10.1016/j.diff.2008.10.001; Ucar A, 2010, NAT GENET, V42, P1101, DOI 10.1038/ng.709; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang L, 2007, FEBS LETT, V581, P3848, DOI 10.1016/j.febslet.2007.07.010; Wei YY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r6; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Yan Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019148; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang J, 2012, J BIOL CHEM, V287, P21093, DOI 10.1074/jbc.M111.330381; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zuker M, 1998, RNA, V4, P669, DOI 10.1017/S1355838298980116; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	60	59	66	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49463	10.1371/journal.pone.0049463	http://dx.doi.org/10.1371/journal.pone.0049463			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166677	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900146
J	Kingma, EM; de Jonge, P; van der Harst, P; Ormel, J; Rosmalen, JGM				Kingma, Eva M.; de Jonge, Peter; van der Harst, Pim; Ormel, Johan; Rosmalen, Judith G. M.			The Association between Intelligence and Telomere Length: A Longitudinal Population Based Study	PLOS ONE			English	Article							COGNITIVE FUNCTION; STRESS HORMONES; HEALTH; MORTALITY; DISEASE; OBESITY; WOMEN; COHORT; RISK; IQ	Low intelligence has been associated with poor health and mortality, but underlying mechanisms remain obscure. We hypothesized that low intelligence is associated with accelerated biological ageing as reflected by telomere length; we suggested potential mediation of this association by unhealthy behaviors and low socioeconomic position. The study was performed in a longitudinal population-based cohort study of 895 participants (46.8% males). Intelligence was measured with the Generalized Aptitude-Test Battery at mean age 52.8 years (33-79 years, SD = 11.3). Leukocyte telomere length was measured by PCR. Lifestyle and socioeconomic factors were assessed using written self-report measures. Linear regression analyses, adjusted for age, sex, and telomere length measured at the first assessment wave (T1), showed that low intelligence was associated with shorter leukocyte telomere length at approximately 2 years follow-up (beta = .081, t = 2.160, p = .031). Nearly 40% of this association was explained by an unhealthy lifestyle, while low socioeconomic position did not add any significant mediation. Low intelligence may be a risk factor for accelerated biological ageing, thereby providing an explanation for its association with poor health and mortality.	[Kingma, Eva M.; de Jonge, Peter; Ormel, Johan; Rosmalen, Judith G. M.] Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands	University of Groningen	Kingma, EM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands.	E.M.Kingma@umcg.nl	ormel, johan/AAC-5584-2019; de Jonge, peter/L-6395-2013; Rosmalen, Judith G.M./F-5375-2011; Ormel, Johan/C-6094-2013	ormel, johan/0000-0002-5463-037X; de Jonge, peter/0000-0002-0866-6929; Rosmalen, Judith G.M./0000-0002-6393-0032; 				Awad N, 2004, J CLIN EXP NEUROPSYC, V26, P1044, DOI 10.1080/13803390490514875; Batty GD, 2008, J EPIDEMIOL COMMUN H, V62, P522, DOI 10.1136/jech.2007.064881; Batty GD, 2009, J EPIDEMIOL COMMUN H, V63, P839, DOI 10.1136/jech.2009.088427; Batty GD, 2008, J AM GERIATR SOC, V56, P769, DOI 10.1111/j.1532-5415.2008.01616.x; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2006, BMJ-BRIT MED J, V332, P580, DOI 10.1136/bmj.38723.660637.AE; Baum A, 1999, ANN NY ACAD SCI, V896, P131, DOI 10.1111/j.1749-6632.1999.tb08111.x; Bosch F, 1981, MANUAL GEN APTITUDE; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Buhrman B., 1988, REV INCOME WEALTH, V2, P115; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Cherkas LF, 2008, ARCH INTERN MED, V168, P154, DOI 10.1001/archinternmed.2007.39; Damjanovic AK, 2007, J IMMUNOL, V179, P4249, DOI 10.4049/jimmunol.179.6.4249; Dandona P, 2004, TRENDS IMMUNOL, V25, P4, DOI 10.1016/j.it.2003.10.013; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Gottfredson LS, 2003, INTELLIGENCE, V31, P343, DOI 10.1016/S0160-2896(02)00085-5; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; Harris SE, 2006, NEUROSCI LETT, V406, P260, DOI 10.1016/j.neulet.2006.07.055; Harris SE, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.013; Hatch SL, 2007, SOC SCI MED, V64, P2285, DOI 10.1016/j.socscimed.2007.02.027; Hatch SL, 2007, AM J COMMUN PSYCHOL, V40, P313, DOI 10.1007/s10464-007-9134-z; Kiecolt-Glaser JK, 1999, JAMA-J AM MED ASSOC, V282, P2259, DOI 10.1001/jama.282.23.2259; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Kingma EM, 2009, J EPIDEMIOL COMMUN H, V63, P900, DOI 10.1136/jech.2008.081638; Kvaavik E, 2010, ARCH INTERN MED, V170, P711, DOI 10.1001/archinternmed.2010.76; Macintyre S, 1998, HUMAN BIOL SOCIAL IN, P20; Manolio TA, 2003, CURR HYPERTENS REP, V5, P255, DOI 10.1007/s11906-003-0029-6; McEwen BS, 2008, EUR J PHARMACOL, V583, P174, DOI 10.1016/j.ejphar.2007.11.071; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Parks CG, 2009, CANCER EPIDEM BIOMAR, V18, P551, DOI 10.1158/1055-9965.EPI-08-0614; Pinto-Sietsma SJ, 2000, J AM SOC NEPHROL, V11, P1882, DOI 10.1681/ASN.V11101882; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Puterman E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010837; Robertson T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041805; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Singh-Manoux A, 2005, AM J EPIDEMIOL, V161, P831, DOI 10.1093/aje/kwi109; Valdes AM, 2010, NEUROBIOL AGING, V31, P986, DOI 10.1016/j.neurobiolaging.2008.07.012; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Werner C, 2009, CIRCULATION, V120, P2438, DOI 10.1161/CIRCULATIONAHA.109.861005; Yaffe K, 2011, NEUROBIOL AGING, V32, P2055, DOI 10.1016/j.neurobiolaging.2009.12.006; Zhu HD, 2011, CLIN SCI, V120, P427, DOI 10.1042/CS20100385	43	15	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49356	10.1371/journal.pone.0049356	http://dx.doi.org/10.1371/journal.pone.0049356			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166646	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900129
J	Ponzio, TA; Fields, RL; Rashid, OM; Salinas, YD; Lubelski, D; Gainer, H				Ponzio, Todd A.; Fields, Raymond L.; Rashid, Omar M.; Salinas, Yasmmyn D.; Lubelski, Daniel; Gainer, Harold			Cell-Type Specific Expression of the Vasopressin Gene Analyzed by AAV Mediated Gene Delivery of Promoter Deletion Constructs into the Rat SON In Vivo	PLOS ONE			English	Article							HYPOTHALAMO-NEUROHYPOPHYSEAL SYSTEM; MESSENGER RIBONUCLEIC-ACIDS; POLYMERASE-CHAIN-REACTION; MAGNOCELLULAR NEURONS; ADENOASSOCIATED VIRUS; ARGININE-VASOPRESSIN; SUPRAOPTIC NUCLEUS; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; BOVINE VASOPRESSIN; OXYTOCIN GENES	The magnocellular neurons (MCNs) in the supraoptic nucleus ( SON) of the hypothalamus selectively express either oxytocin (Oxt) or vasopressin (Avp) neuropeptide genes. In this paper we examine the cis-regulatory domains in the Avp gene promoter that are responsible for its cell-type specific expression. AAV vectors that contain various Avp gene promoter deletion constructs using EGFP as the reporter were stereotaxically injected into the rat SON. Two weeks following the injection immunohistochemical assays of EGFP expression from these constructs were done to determine whether the expressed EGFP reporter co-localizes with either the Oxt- or Avp-immunoreactivity in the MCNs. The results identify three major enhancer domains located at -2.0 to -1.5 kbp, -1.5 to -950 bp, and -950 to -543 bp in the Avp gene promoter that regulate the expression in Avp MCNs. The results also show that cell-type specific expression in Avp MCNs is maintained in constructs containing at least 288 bp of the promoter region upstream of the transcription start site, but this specificity is lost at 116 bp and below. Based on these data, we hypothesize that the -288 bp to -116 bp domain contains an Avp MCN specific activator and a possible repressor that inhibits expression in Oxt- MCNs, thereby leading to the cell-type specific expression of the Avp gene only in the Avp-MCNs.			Ponzio, TA (corresponding author), USN, Med Res Ctr, Off Technol Transfer, Silver Spring, MD USA.	gainerh@ninds.nih.gov	Ponzio, Todd/AAV-2374-2021	Ponzio, Todd/0000-0002-3174-1229	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Antunes-Rodrigues J, 2004, PHYSIOL REV, V84, P169, DOI 10.1152/physrev.00017.2003; Armstrong WE, 1995, PROG NEUROBIOL, V47, P291, DOI 10.1016/0301-0082(95)00025-9; BENBARAK Y, 1985, J NEUROSCI, V5, P81; Bergshoeff AS, 2004, ANTIMICROB AGENTS CH, V48, P1904, DOI 10.1128/AAC.48.5.1904-1907.2004; Bienemann AS, 2003, MOL THER, V7, P588, DOI 10.1016/S1525-0016(03)00069-8; BROWNSTEIN MJ, 1980, SCIENCE, V207, P373, DOI 10.1126/science.6153132; Burbach JPH, 2001, PHYSIOL REV, V81, P1197, DOI 10.1152/physrev.2001.81.3.1197; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Chen H, 1998, GENE THER, V5, P50, DOI 10.1038/sj.gt.3300547; Davies J, 2003, J NEUROENDOCRINOL, V15, P42, DOI 10.1046/j.1365-2826.2003.00865.x; de Backer MWA, 2010, HUM GENE THER, V21, P673, DOI 10.1089/hum.2009.169; Doherty FC, 2011, J NEUROSCI METH, V197, P238, DOI 10.1016/j.jneumeth.2011.02.026; Fields RL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032085; Fields RL, 2003, J NEUROSCI, V23, P7801; Garza JC, 2008, J ENDOCRINOL, V197, P471, DOI 10.1677/JOE-08-0009; Geddes BJ, 1996, ENDOCRINOLOGY, V137, P5166, DOI 10.1210/en.137.11.5166; Geller SF, 2007, MOL VIS, V13, P730; Glasgow E, 1999, ENDOCRINOLOGY, V140, P5391, DOI 10.1210/en.140.11.5391; Grace CO, 1999, NEUROPEPTIDES, V33, P81, DOI 10.1054/npep.1999.0018; HARA Y, 1990, MOL BRAIN RES, V8, P319, DOI 10.1016/0169-328X(90)90045-F; Heinrichs M, 2009, FRONT NEUROENDOCRIN, V30, P548, DOI 10.1016/j.yfrne.2009.05.005; Hindmarch C, 2006, P NATL ACAD SCI USA, V103, P1609, DOI 10.1073/pnas.0507450103; Ideno J, 2003, MOL THER, V8, P895, DOI 10.1016/j.ymthe.2003.08.019; Insel TR, 2010, NEURON, V65, P768, DOI 10.1016/j.neuron.2010.03.005; Iwasaki Y, 1997, ENDOCRINOLOGY, V138, P5266, DOI 10.1210/en.138.12.5266; Jeong SW, 2001, EXP NEUROL, V171, P255, DOI 10.1006/exnr.2001.7785; Jin XW, 1999, CELL, V96, P57, DOI 10.1016/S0092-8674(00)80959-9; Kim JK, 1996, MOL CELL ENDOCRINOL, V123, P179, DOI 10.1016/S0303-7207(96)03912-3; KIYAMA H, 1990, J NEUROENDOCRINOL, V2, P257, DOI 10.1111/j.1365-2826.1990.tb00401.x; Knobloch S, 2011, NEURON IN PRESS, V70, P291; Kuroda H, 2008, J GENE MED, V10, P1163, DOI 10.1002/jgm.1249; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; Lim ST, 2010, PHARMACOL RES, V61, P14, DOI 10.1016/j.phrs.2009.10.002; Lo HR, 2004, BIOTECHNOL PROGR, V20, P354, DOI 10.1021/bp034132i; MEZEY E, 1991, ENDOCRINOLOGY, V129, P1814, DOI 10.1210/endo-129-4-1814; MIYATA S, 1994, BRAIN RES BULL, V34, P169, DOI 10.1016/0361-9230(94)90057-4; MOHR E, 1990, FEBS LETT, V260, P305, DOI 10.1016/0014-5793(90)80130-B; Munoz E, 2002, J BIOL CHEM, V277, P36009, DOI 10.1074/jbc.M203909200; Murphy D, 2003, J NEUROENDOCRINOL, V15, P109, DOI 10.1046/j.1365-2826.2003.00964.x; Mutsuga N, 2005, ENDOCRINOLOGY, V146, P1254, DOI 10.1210/en.2004-1202; Negrete A, 2007, J GENE MED, V9, P938, DOI 10.1002/jgm.1092; O'Reilly D.R., 1994, BACULOVIRUS EXPRESSI; Okazaki T, 1997, J BIOL CHEM, V272, P32274, DOI 10.1074/jbc.272.51.32274; Osten P, 2007, Handb Exp Pharmacol, P177; Papale A, 2009, J NEUROSCI METH, V185, P1, DOI 10.1016/j.jneumeth.2009.08.013; PARDY K, 1992, J BIOL CHEM, V267, P21746; Qiu J, 2007, J NEUROSCI, V27, P2196, DOI 10.1523/JNEUROSCI.5420-06.2007; RUPPERT S, 1984, NATURE, V308, P554, DOI 10.1038/308554a0; SAUSVILLE E, 1985, J BIOL CHEM, V260, P236; Smith RH, 2009, MOL THER, V17, P1888, DOI 10.1038/mt.2009.128; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Ueta Y, 2005, ENDOCRINOLOGY, V146, P406, DOI 10.1210/en.2004-0830; Urabe M, 2002, HUM GENE THER, V13, P1935, DOI 10.1089/10430340260355347; van den Pol AN, 2009, J COMP NEUROL, V516, P456, DOI 10.1002/cne.22131; Wang B, 2008, GENE THER, V15, P1489, DOI 10.1038/gt.2008.104; WHITNALL MH, 1985, J NEUROSCI, V5, P98; Xi D, 1999, ENDOCRINOLOGY, V140, P4677, DOI 10.1210/en.140.10.4677; Yoshida M, 2006, ENDOCRINOLOGY, V147, P2850, DOI 10.1210/en.2005-1222; Young WS, 2003, NEUROENDOCRINOLOGY, V78, P185, DOI 10.1159/000073702; Zhang B, 2001, J NEUROENDOCRINOL, V13, P29, DOI 10.1046/j.1365-2826.2001.00593.x; Zhang BJ, 2005, CELL MOL NEUROBIOL, V25, P581, DOI 10.1007/s10571-005-3970-x	61	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48860	10.1371/journal.pone.0048860	http://dx.doi.org/10.1371/journal.pone.0048860			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155418	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900052
J	Sun, JR; Perng, CL; Chan, MC; Morita, Y; Lin, JC; Su, CM; Wang, WY; Chang, TY; Chiueh, TS				Sun, Jun-Ren; Perng, Cherng-Lih; Chan, Ming-Chin; Morita, Yuji; Lin, Jung-Chung; Su, Chih-Mao; Wang, Wei-Yao; Chang, Tein-Yao; Chiueh, Tzong-Shi			A Truncated AdeS Kinase Protein Generated by ISAba1 Insertion Correlates with Tigecycline Resistance in Acinetobacter baumannii	PLOS ONE			English	Article							EFFLUX PUMP; CARBAPENEM RESISTANCE; MULTIDRUG-RESISTANCE; GENOME SEQUENCE; ADEABC; EXPRESSION; GENE; OVEREXPRESSION; BLA(OXA-23); ACQUISITION	Over-expression of AdeABC efflux pump stimulated continuously by the mutated AdeRS two component system has been found to result in antimicrobial resistance, even tigecycline (TGC) resistance, in multidrug-resistant Acinetobacter baumannii (MRAB). Although the insertion sequence, ISAba1, contributes to one of the AdeRS mutations, the detail mechanism remains unclear. In the present study we collected 130 TGC-resistant isolates from 317 carbapenem resistant MRAB (MRAB-C) isolates, and 38 of them were characterized with ISAba1 insertion in the adeS gene. The relationship between the expression of AdeABC efflux pump and TGC resistant was verified indirectly by successfully reducing TGC resistance with NMP, an efflux pump inhibitor. Further analysis showed that the remaining gene following the ISAba1 insertion was still transcribed to generate a truncated AdeS protein by the Pout promoter on ISAba1 instead of frame shift or pre-termination. Through introducing a series of recombinant adeRS constructs into a adeRS knockout strain, we demonstrated the truncated AdeS protein was constitutively produced and stimulating the expression of AdeABC efflux pump via interaction with AdeR. Our findings suggest a mechanism of antimicrobial resistance induced by an aberrant cytoplasmic sensor derived from an insertion element.	[Sun, Jun-Ren; Wang, Wei-Yao; Chang, Tein-Yao; Chiueh, Tzong-Shi] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan	National Defense Medical Center	Sun, JR (corresponding author), Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.	drche0523@gmail.com		Sun, jun-ren/0000-0002-8769-9170	Grants-in-Aid for Scientific Research [23790106] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Adams MD, 2010, ANTIMICROB AGENTS CH, V54, P3569, DOI 10.1128/AAC.00057-10; Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; Aranda J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-279; Chen TL, 2008, ANTIMICROB AGENTS CH, V52, P2573, DOI 10.1128/AAC.00393-08; Cheung J, 2010, CURR OPIN MICROBIOL, V13, P116, DOI 10.1016/j.mib.2010.01.016; Cortez-Cordova J, 2011, INT J ANTIMICROB AG, V37, P420, DOI 10.1016/j.ijantimicag.2011.01.006; Corvec S, 2003, J ANTIMICROB CHEMOTH, V52, P629, DOI 10.1093/jac/dkg407; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P333, DOI 10.1128/AAC.01037-09; Damier-Piolle L, 2008, ANTIMICROB AGENTS CH, V52, P557, DOI 10.1128/AAC.00732-07; Dijkshoorn L, 2007, NAT REV MICROBIOL, V5, P939, DOI 10.1038/nrmicro1789; Dorsey CW, 2002, APPL ENVIRON MICROB, V68, P6353, DOI 10.1128/AEM.68.12.6353-6360.2002; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Gordon NC, 2009, J ANTIMICROB CHEMOTH, V63, P775, DOI 10.1093/jac/dkn555; Gorisch H, 2003, BBA-PROTEINS PROTEOM, V1647, P98, DOI 10.1016/S1570-9639(03)00066-9; Hornsey M, 2010, J ANTIMICROB CHEMOTH, V65, P1589, DOI 10.1093/jac/dkq218; Hu WS, 2007, ANTIMICROB AGENTS CH, V51, P3844, DOI 10.1128/AAC.01512-06; Lee Y, 2011, ANTIMICROB AGENTS CH, V55, P361, DOI 10.1128/AAC.01672-09; Magnet S, 2001, ANTIMICROB AGENTS CH, V45, P3375, DOI 10.1128/AAC.45.12.3375-3380.2001; Marchand I, 2004, ANTIMICROB AGENTS CH, V48, P3298, DOI 10.1128/AAC.48.9.3298-3304.2004; Mern DS, 2010, MICROBIOL-SGM, V156, P1505, DOI 10.1099/mic.0.032847-0; Morita Y, 2010, J MICROBIOL METH, V82, P205, DOI 10.1016/j.mimet.2010.06.001; Murat D, 2006, J BIOL CHEM, V281, P6850, DOI 10.1074/jbc.M509926200; Mussi MA, 2005, ANTIMICROB AGENTS CH, V49, P1432, DOI 10.1128/AAC.49.4.1432-1440.2005; Park JY, 2011, J BACTERIOL, V193, P6393, DOI 10.1128/JB.06109-11; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Peleg AY, 2007, ANTIMICROB AGENTS CH, V51, P2065, DOI 10.1128/AAC.01198-06; Poirel L, 2006, CLIN MICROBIOL INFEC, V12, P826, DOI 10.1111/j.1469-0691.2006.01456.x; Poirel L, 2006, ANTIMICROB AGENTS CH, V50, P1442, DOI 10.1128/AAC.50.4.1442-1448.2006; Poirel L, 2008, ANTIMICROB AGENTS CH, V52, P1252, DOI 10.1128/AAC.01304-07; Ruzin A, 2007, J ANTIMICROB CHEMOTH, V59, P1001, DOI 10.1093/jac/dkm058; Ruzin A, 2010, MICROB DRUG RESIST, V16, P87, DOI 10.1089/mdr.2009.0131; Segal H, 2005, FEMS MICROBIOL LETT, V243, P425, DOI 10.1016/j.femsle.2005.01.005; Segal H, 2004, ANTIMICROB AGENTS CH, V48, P612, DOI 10.1128/AAC.48.2.612-614.2004; Segal H, 2007, ANTIMICROB AGENTS CH, V51, P3040, DOI 10.1128/AAC.00594-07; Seifert H, 2005, J CLIN MICROBIOL, V43, P4328, DOI 10.1128/JCM.43.9.4328-4335.2005; Sun JR, 2010, ANTIMICROB AGENTS CH, V54, P4934, DOI 10.1128/AAC.00414-10; Syn CKC, 2000, ANAL BIOCHEM, V278, P86, DOI 10.1006/abio.1999.4410; Szurmant H, 2007, CURR OPIN STRUC BIOL, V17, P706, DOI 10.1016/j.sbi.2007.08.019; Turton JF, 2006, FEMS MICROBIOL LETT, V258, P72, DOI 10.1111/j.1574-6968.2006.00195.x; Vallenet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001805; Vila J, 2007, J ANTIMICROB CHEMOTH, V59, P1210, DOI 10.1093/jac/dkl509; Wieczorek P, 2008, FOLIA HISTOCHEM CYTO, V46, P257, DOI 10.2478/v10042-008-0056-x; Yahav D, 2011, J ANTIMICROB CHEMOTH, V66, P1963, DOI 10.1093/jac/dkr242; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Zhou H, 2007, J MED MICROBIOL, V56, P1076, DOI 10.1099/jmm.0.47206-0	47	53	64	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49534	10.1371/journal.pone.0049534	http://dx.doi.org/10.1371/journal.pone.0049534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166700	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900157
J	Huo, TY; Barth, RF; Yang, WL; Nakkula, RJ; Koynova, R; Tenchov, B; Chaudhury, AR; Agius, L; Boulikas, T; Elleaume, H; Lee, RJ				Huo, Tianyao; Barth, Rolf F.; Yang, Weilian; Nakkula, Robin J.; Koynova, Rumiana; Tenchov, Boris; Chaudhury, Abhik Ray; Agius, Lawrence; Boulikas, Teni; Elleaume, Helene; Lee, Robert J.			Preparation, Biodistribution and Neurotoxicity of Liposomal Cisplatin following Convection Enhanced Delivery in Normal and F98 Glioma Bearing Rats	PLOS ONE			English	Article							CELL LUNG-CANCER; INTRACEREBRAL DELIVERY; PHOTON IRRADIATION; BRAIN; CARBOPLATIN; FORMULATION; ISSUES; DRUGS; NEUROPATHOLOGY; PATHOLOGISTS	The purpose of this study was to evaluate two novel liposomal formulations of cisplatin as potential therapeutic agents for treatment of the F98 rat glioma. The first was a commercially produced agent, Lipoplatin (TM), which currently is in a Phase III clinical trial for treatment of non-small cell lung cancer (NSCLC). The second, produced in our laboratory, was based on the ability of cisplatin to form coordination complexes with lipid cholesteryl hemisuccinate (CHEMS). The in vitro tumoricidal activity of the former previously has been described in detail by other investigators. The CHEMS liposomal formulation had a Pt loading efficiency of 25% and showed more potent in vitro cytotoxicity against F98 glioma cells than free cisplatin at 24 h. In vivo CHEMS liposomes showed high retention at 24 h after intracerebral (i.e.) convection enhanced delivery (CED) to F98 glioma bearing rats. Neurotoxicologic studies were carried out in non-tumor bearing Fischer rats following i.e. CED of Lipoplatin (TM) or CHEMS liposomes or their "hollow'' counterparts. Unexpectedly, Lipoplatin (TM) was highly neurotoxic when given i.e. by CED and resulted in death immediately following or within a few days after administration. Similarly "hollow'' Lipoplatin (TM) liposomes showed similar neurotoxicity indicating that this was due to the liposomes themselves rather than the cisplatin. This was particularly surprising since Lipoplatin (TM) has been well tolerated when administered intravenously. In contrast, CHEMS liposomes and their "hollow'' counterparts were clinically well tolerated. However, a variety of dose dependent neuropathologic changes from none to severe were seen at either 10 or 14 d following their administration. These findings suggest that further refinements in the design and formulation of cisplatin containing liposomes will be required before they can be administered i.e. by CED for the treatment of brain tumors and that a formulation that may be safe when given systemically may be highly neurotoxic when administered directly into the brain.	[Huo, Tianyao; Barth, Rolf F.; Yang, Weilian; Nakkula, Robin J.; Chaudhury, Abhik Ray] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Koynova, Rumiana; Tenchov, Boris; Lee, Robert J.] Ohio State Univ, Coll Pharm, Div Pharmaceut, Columbus, OH 43210 USA; [Agius, Lawrence] Mater Dei Hosp, Dept Pathol, Msida, Malta; [Agius, Lawrence] Univ Malta, Sch Med, Msida, Malta; [Boulikas, Teni] Regulon Inc, Mountain View, CA USA; [Elleaume, Helene] European Synchrotron Radiat Facil, F-38043 Grenoble, France	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Malta; European Synchrotron Radiation Facility (ESRF)	Barth, RF (corresponding author), Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA.	rolf.barth@osumc.edu	Koynova, Rumiana/A-5938-2009; Tenchov, Boris/W-5547-2019; Elleaume, Hélène/F-2554-2013	Koynova, Rumiana/0000-0003-4698-6832; Elleaume, Hélène/0000-0002-3991-9503	Musella Foundation; Brad Kaminsky Foundation; Kevin Mullin Memorial Fund	Musella Foundation; Brad Kaminsky Foundation; Kevin Mullin Memorial Fund	Support for this study was generously provided by the Musella Foundation, the Brad Kaminsky Foundation, and the Kevin Mullin Memorial Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barth RF, 2009, J NEURO-ONCOL, V94, P299, DOI 10.1007/s11060-009-9875-7; Biston MC, 2004, CANCER RES, V64, P2317, DOI 10.1158/0008-5472.CAN-03-3600; Bobyk L, EXP CLIN CA IN PRESS; Bolon B, 2011, TOXICOL PATHOL, V39, P234, DOI 10.1177/0192623310385142; Boulikas T, 2005, ANTICANCER RES, V25, P3031; Boulikas T, 2009, EXPERT OPIN INV DRUG, V18, P1197, DOI 10.1517/13543780903114168; Burger KNJ, 2002, NAT MED, V8, P81, DOI 10.1038/nm0102-81; Chang HI, 2012, INT J NANOMED, V7, P49, DOI 10.2147/IJN.S26766; Charest G, 2012, INT J RADIAT ONCOL, V84, P244, DOI 10.1016/j.ijrobp.2011.10.054; Charest G, 2010, J NEURO-ONCOL, V97, P187, DOI 10.1007/s11060-009-0011-5; Dickinson PJ, 2008, J NEUROSURG, V108, P989, DOI 10.3171/JNS/2008/108/5/0989; Dickinson PJ, 2010, NEURO-ONCOLOGY, V12, P928, DOI 10.1093/neuonc/noq046; Fiandaca MS, 2011, TOXINS, V3, P369, DOI 10.3390/toxins3040369; Hall WA, 2009, CURR DRUG TARGETS, V10, P126, DOI 10.2174/138945009787354575; Hamelers IHL, 2007, J LIPOSOME RES, V17, P183, DOI 10.1080/08982100701530290; Hubbs AF, 2011, TOXICOL PATHOL, V39, P301, DOI 10.1177/0192623310390705; Husain K, 2004, PHARMACOL RES, V50, P291, DOI 10.1016/j.phrs.2004.04.001; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Klein J. P., 2003, SURVIVAL ANAL TECHNI; Krug HF, 2011, ANGEW CHEM INT EDIT, V50, P1260, DOI 10.1002/anie.201001037; Mamot C, 2004, J NEURO-ONCOL, V68, P1, DOI 10.1023/B:NEON.0000024743.56415.4b; McWhinney SR, 2009, MOL CANCER THER, V8, P10, DOI 10.1158/1535-7163.MCT-08-0840; Miyata S, 2011, NEUROSURGERY, V68, P1380, DOI 10.1227/NEU.0b013e31820b52aa; Muldoon LL, 2007, J CLIN ONCOL, V25, P2295, DOI 10.1200/JCO.2006.09.9861; Ostermann K, 2011, J NEURO-ONCOL, V103, P635, DOI 10.1007/s11060-010-0435-y; Perry A, 2006, ACTA NEUROPATHOL, V111, P197, DOI 10.1007/s00401-005-0023-y; Phillips WT, 2012, NEURO-ONCOLOGY, V14, P416, DOI 10.1093/neuonc/nos060; Raizer J, 2011, TOXICOL PATHOL, V39, P152, DOI 10.1177/0192623310391482; Richardson RM, 2011, STEREOT FUNCT NEUROS, V89, P141, DOI 10.1159/000323544; Rousseau J, 2007, CLIN CANCER RES, V13, P5195, DOI 10.1158/1078-0432.CCR-07-1002; Rousseau J, 2010, J NEURO-ONCOL, V98, P287, DOI 10.1007/s11060-009-0074-3; Rousseau J, 2009, INT J RADIAT ONCOL, V73, P530, DOI 10.1016/j.ijrobp.2008.09.018; Saito R, 2004, CANCER RES, V64, P2572, DOI 10.1158/0008-5472.CAN-03-3631; Serpe L, 2006, NANOMATERIALS CANC T, V6, P1, DOI DOI 10.1002/9783527610419.NTLS0060; SIDDIK ZH, 1987, BRIT J CANCER, V55, P375, DOI 10.1038/bjc.1987.75; Stathopoulos GP, 2012, J DRUG DELIV, V2012, DOI 10.1155/2012/581363; Stathopoulos GP, 2011, CANCER CHEMOTH PHARM, V68, P945, DOI 10.1007/s00280-011-1572-5; Stathopoulos GP, 2010, ANN ONCOL, V21, P2227, DOI 10.1093/annonc/mdq234; Wittgen BPH, 2007, CLIN CANCER RES, V13, P2414, DOI 10.1158/1078-0432.CCR-06-1480; Yang WL, 2011, J NEURO-ONCOL, V101, P379, DOI 10.1007/s11060-010-0272-z; Yang WL, 1996, NEUROSURGERY, V38, P985, DOI 10.1097/00006123-199605000-00027	41	43	45	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48752	10.1371/journal.pone.0048752	http://dx.doi.org/10.1371/journal.pone.0048752			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152799	Green Published, gold			2022-12-27	WOS:000311234600010
J	Pan, H; Hanada, S; Zhao, J; Mao, L; Ma, MZQ				Pan, Hong; Hanada, Sayaka; Zhao, Jun; Mao, Li; Ma, Mark Zhi-Qing			Protein Secretion Is Required for Pregnancy-Associated Plasma Protein-A to Promote Lung Cancer Growth In Vivo	PLOS ONE			English	Article							PAPP-A; INSULIN; RECEPTOR; RISK; CELLS; FIBROBLASTS; INHIBITION; EXPRESSION; DOMINANT; PROSTATE	Pregnancy-associated plasma protein-A (PAPPA) has been reported to regulate the activity of insulin-like growth factor (IGF) signal pathway through proteolytic degradation of IGF binding proteins (IGFBPs) thereby increasing the local concentration of free IGFs available to receptors. In this study we found that PAPPA is secreted from two out of seven lung cancer cell lines examined. None of immortalized normal bronchial epithelial cells (HBE) tested secrets PAPPA. There is no correlation between expression level and secretion of PAPPA in these cells. A cell line over-expressing PAPPA accompanied with secretion shows no notable changes in proliferation under cell culture conditions in vitro, but displays significantly augmentation of tumor growth in vivo in a xenograft model. In contrast, a cell line over-expressing PAPPA without secretion exhibits reduction of tumor growth both in vitro and in vivo. Down-regulation of PAPPA expression and secretion by RNAi knockdown decreases tumor growth after implanted in vivo. The tumor promoting activity of PAPPA appears to be mediated mainly through augmentation of the IGF signaling pathway as indicated by notable increases in downstream Akt kinase phosphorylation in tumor samples. Our results indicate that PAPPA secretion may play an important role in lung cancer growth and progression. Citation: Pan H, Hanada S, Zhao J, Mao L, Ma MZ-Q (2012) Protein Secretion Is Required for Pregnancy-Associated Plasma Protein-A to Promote Lung Cancer Growth In Vivo. PLoS ONE 7(11): e48799. doi:10.1371/journal.pone.0048799	[Pan, Hong; Hanada, Sayaka; Zhao, Jun; Mao, Li; Ma, Mark Zhi-Qing] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Mao, Li] Univ Maryland, Expt Therapeut Program, Greenbaum Canc Ctr, Baltimore, MD 21201 USA; [Pan, Hong] Guangxi Univ, Affiliated Tumor Hosp, Dept Thorac Surg, Nanning, Guangxi Provinc, Peoples R China; [Zhao, Jun] Peking Univ, Dept Thorac Med Oncol, Beijing Canc Hosp, Sch Oncol,Beijing Canc Inst Canc Res, Beijing 100871, Peoples R China	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Guangxi University; Peking University	Ma, MZQ (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	zma@umaryland.edu	Mao, Li/C-7570-2011	Mao, Li/0000-0001-7263-3358	National Institute of Health [R01 CA126818, R01 CA136635]; NATIONAL CANCER INSTITUTE [R01CA126818, R01CA136635] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research was supported in part by National Institute of Health grants R01 CA126818 and R01 CA136635. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bayes-Genis A, 2001, NEW ENGL J MED, V345, P1022, DOI 10.1056/NEJMoa003147; Bayes-Genis A, 2001, ARTERIOSCL THROM VAS, V21, P335, DOI 10.1161/01.ATV.21.3.335; Belfiore A, 2009, ENDOCR REV, V30, P586, DOI 10.1210/er.2008-0047; Boldt HB, 2007, GROWTH HORM IGF RES, V17, P10, DOI 10.1016/j.ghir.2006.11.003; Boldt HB, 2011, ENDOCRINOLOGY, V152, P1470, DOI 10.1210/en.2010-1095; Bulut I, 2009, AM J MED SCI, V337, P241, DOI 10.1097/MAJ.0b013e31818967a3; Bunn RC, 2003, TRENDS ENDOCRIN MET, V14, P176, DOI 10.1016/S1043-2760(03)00049-3; Callahan G, 2003, ONCOGENE, V22, P590, DOI 10.1038/sj.onc.1206171; Chan JM, 1998, SCIENCE, V279, P563, DOI 10.1126/science.279.5350.563; Chen BK, 2003, J CLIN ENDOCR METAB, V88, P4465, DOI 10.1210/jc.2003-030193; Chitnis MM, 2008, CLIN CANCER RES, V14, P6364, DOI 10.1158/1078-0432.CCR-07-4879; Conover CA, 2001, ENDOCRINOLOGY, V142, P2155, DOI 10.1210/en.142.5.2155; Conover CA, 2007, AM J PHYSIOL-HEART C, V292, pH994, DOI 10.1152/ajpheart.00798.2006; Conover Cheryl A., 1995, Progress in Growth Factor Research, V6, P301, DOI 10.1016/0955-2235(95)00032-1; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; DECHIARA TM, 1990, NATURE, V345, P78, DOI 10.1038/345078a0; Douglas JB, 2010, CANCER EPIDEM BIOMAR, V19, P2298, DOI 10.1158/1055-9965.EPI-10-0400; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Gerard N, 2004, J ENDOCRINOL, V182, P457, DOI 10.1677/joe.0.1820457; Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761; Kalli KR, 2004, INT J CANCER, V110, P633, DOI 10.1002/ijc.20185; Lawrence JB, 1999, P NATL ACAD SCI USA, V96, P3149, DOI 10.1073/pnas.96.6.3149; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/S0092-8674(05)80084-4; Mikkelsen JH, 2008, J BIOL CHEM, V283, P16772, DOI 10.1074/jbc.M802429200; Ortiz CO, 2003, J BONE MINER RES, V18, P1066, DOI 10.1359/jbmr.2003.18.6.1066; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Renehan AG, 2004, LANCET, V363, P1346, DOI 10.1016/S0140-6736(04)16044-3; Rosenzweig SA, 2010, BIOCHEM PHARMACOL, V80, P1115, DOI 10.1016/j.bcp.2010.06.013; SELL C, 1993, P NATL ACAD SCI USA, V90, P11217, DOI 10.1073/pnas.90.23.11217; Wu JH, 2008, EMBO J, V27, P1985, DOI 10.1038/emboj.2008.116	34	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48799	10.1371/journal.pone.0048799	http://dx.doi.org/10.1371/journal.pone.0048799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152806	Green Published, gold, Green Submitted			2022-12-27	WOS:000312272600021
J	Roura, S; Bago, JR; Soler-Botija, C; Pujal, JM; Galvez-Monton, C; Prat-Vidal, C; Llucia-Valldeperas, A; Blanco, J; Bayes-Genis, A				Roura, Santiago; Bago, Juli R.; Soler-Botija, Carolina; Pujal, Josep M.; Galvez-Monton, Carolina; Prat-Vidal, Cristina; Llucia-Valldeperas, Aida; Blanco, Jeronimo; Bayes-Genis, Antoni			Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells Promote Vascular Growth In Vivo	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; MYOCARDIAL-INFARCTION; HEART-FAILURE; TISSUE-REPAIR; ANGIOGENESIS; EXPRESSION; NEOVASCULARIZATION; DIFFERENTIATION; RECRUITMENT; PHENOTYPE	Stem cell therapies are promising strategies to regenerate human injured tissues, including ischemic myocardium. Here, we examined the acquisition of properties associated with vascular growth by human umbilical cord blood-derived mesenchymal stem cells (UCBMSCs), and whether they promoted vascular growth in vivo. UCBMSCs were induced in endothelial cell-specific growth medium (EGM-2) acquiring new cell markers, increased Ac-LDL uptake, and migratory capacity as assessed by qRT-PCR, Western blotting, indirect immunofluorescence, and invasion assays. Angiogenic and vasculogenic potentials could be anticipated by in vitro experiments showing self organization into Matrigel-mediated cell networks, and activation of circulating angiogenic-supportive myeloid cells. In mice, following subcutaneous co-injection with Matrigel, UCBMSCs modified to co-express bioluminescent (luciferases) and fluorescent proteins were demonstrated to participate in the formation of new microvasculature connected with the host circulatory system. Response of UCBMSCs to ischemia was explored in a mouse model of acute myocardial infarction (MI). UCBMSCs transplanted using a fibrin patch survived 4 weeks post-implantation and organized into CD31(+)network structures above the infarcted myocardium. MI-treated animals showed a reduced infarct scar and a larger vessel-occupied area in comparison with MI-control animals. Taken together, the presented results show that UCBMSCs can be induced in vitro to acquire angiogenic and vasculogenic properties and contribute to vascular growth in vivo.	[Roura, Santiago; Soler-Botija, Carolina; Pujal, Josep M.; Galvez-Monton, Carolina; Prat-Vidal, Cristina; Llucia-Valldeperas, Aida; Bayes-Genis, Antoni] Fundacio Inst Invest Ciencies Salut Germans Trias, ICREC Res Program, Badalona, Spain; [Bago, Juli R.; Blanco, Jeronimo] CSIC ICCC, Cardiovasc Res Ctr, Barcelona, Spain; [Bago, Juli R.; Blanco, Jeronimo] Networking Biomed Res Ctr Bioengn Biomat & Nanome, Barcelona, Spain; [Bayes-Genis, Antoni] Univ Hosp Germans Trias & Pujol, Serv Cardiol, Badalona, Spain; [Bayes-Genis, Antoni] Univ Autonoma Barcelona, Dept Med, E-08193 Barcelona, Spain	Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Autonomous University of Barcelona	Bayes-Genis, A (corresponding author), Fundacio Inst Invest Ciencies Salut Germans Trias, ICREC Res Program, Badalona, Spain.	abayes.germanstrias@gencat.cat	Bayes-Genis, Antonio/AAV-9422-2021; Llucià-Valldeperas, Aida/L-6259-2014; Blanco, Jeronimo/H-2764-2015; BAGO, JULI R/M-3526-2018; Bayes-Genis, Antoni/C-4002-2015; Pujal, Josep-Maria/B-3306-2011; Prat-Vidal, Cristina/C-2726-2013; Prat-Vidal, Cristina/AAP-9571-2020; Galvez-Monton, Carolina/K-4480-2014	Bayes-Genis, Antonio/0000-0002-3044-197X; Llucià-Valldeperas, Aida/0000-0002-9723-8343; Blanco, Jeronimo/0000-0003-3765-0640; BAGO, JULI R/0000-0002-2862-4048; Bayes-Genis, Antoni/0000-0002-3044-197X; Prat-Vidal, Cristina/0000-0002-5621-1101; Prat-Vidal, Cristina/0000-0002-5621-1101; Galvez-Monton, Carolina/0000-0003-2254-9371; Roura, Santiago/0000-0003-4063-9661; Soler-Botija, Carolina/0000-0002-4584-9134	Ministerio de Educacion y Ciencia [SAF2008-05144-C02-01, SAF 2009-07102, SAF2011-30067-C02-01]; European Comission 7th Framework Programme (RECATABI) [NMP3-SL-2009-229239]; Fundacio Marato TV3 [080330]; Fundacio Privada Daniel Bravo Andreu	Ministerio de Educacion y Ciencia(Spanish Government); European Comission 7th Framework Programme (RECATABI); Fundacio Marato TV3; Fundacio Privada Daniel Bravo Andreu	This work was supported by grants from Ministerio de Educacion y Ciencia (SAF2008-05144-C02-01, SAF 2009-07102, and SAF2011-30067-C02-01), European Comission 7th Framework Programme (RECATABI, NMP3-SL-2009-229239), Fundacio Marato TV3 (080330) and Fundacio Privada Daniel Bravo Andreu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almendro N, 1996, J IMMUNOL, V157, P5411; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bayes-Genis A, 2010, J MOL CELL CARDIOL, V49, P771, DOI 10.1016/j.yjmcc.2010.08.010; Chachques JC, 2009, EUR J CARDIO-THORAC, V35, P201, DOI 10.1016/j.ejcts.2008.09.028; Choi JH, 2004, J BIOL CHEM, V279, P49430, DOI 10.1074/jbc.M402088200; Christman KL, 2004, TISSUE ENG, V10, P403, DOI 10.1089/107632704323061762; Critser PJ, 2010, CURR OPIN ORGAN TRAN, V15, P68, DOI 10.1097/MOT.0b013e32833454b5; Djonov V, 2000, CIRC RES, V86, P286, DOI 10.1161/01.RES.86.3.286; Duffy GP, 2010, TISSUE ENG PT A, V16, P2755, DOI 10.1089/ten.tea.2009.0623; Giraud MN, 2008, ARTIF ORGANS, V32, P692, DOI 10.1111/j.1525-1594.2008.00595.x; Gratzinger D, 2003, FASEB J, V17, P1458, DOI 10.1096/fj.02-1040com; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Heydarkhan-Hagvall S, 2008, CELLS TISSUES ORGANS, V187, P263, DOI 10.1159/000113407; Hill JM, 2003, NEW ENGL J MED, V348, P593, DOI 10.1056/NEJMoa022287; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hur J, 2004, ARTERIOSCL THROM VAS, V24, P288, DOI 10.1161/01.ATV.0000114236.77009.06; Iacobas I, 2010, ARTERIOSCL THROM VAS, V30, P1110, DOI 10.1161/ATVBAHA.109.191601; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Kofidis T, 2004, J THORAC CARDIOV SUR, V128, P571, DOI 10.1016/j.jtcvs.2004.05.021; Kovacic JC, 2008, TRENDS CARDIOVAS MED, V18, P45, DOI 10.1016/j.tcm.2007.12.002; Kumar AHS, 2010, ARTERIOSCL THROM VAS, V30, P1080, DOI 10.1161/ATVBAHA.109.198895; Lee SP, 2006, CIRCULATION, V114, P150, DOI 10.1161/CIRCULATIONAHA.105.595918; Liao WB, 2009, CELL PHYSIOL BIOCHEM, V24, P307, DOI 10.1159/000233255; Liu D, 2008, ONCOGENE, V27, P2989, DOI 10.1038/sj.onc.1210959; Liu D, 2003, ARTERIOSCL THROM VAS, V23, P2002, DOI 10.1161/01.ATV.0000098644.03153.6F; Loges S, 2009, J THROMB HAEMOST, V7, P21, DOI 10.1111/j.1538-7836.2008.03203.x; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Ma N, 2005, CARDIOVASC RES, V66, P45, DOI 10.1016/j.cardiores.2004.12.013; Mansson-Broberg A, 2008, BIOCHEM BIOPH RES CO, V373, P355, DOI 10.1016/j.bbrc.2008.06.036; Martinez-Estrada OM, 2005, CARDIOVASC RES, V65, P328, DOI 10.1016/j.cardiores.2004.11.015; Masuda S, 2008, ADV DRUG DELIVER REV, V60, P277, DOI 10.1016/j.addr.2007.08.031; Maulik N, 2008, J MOL CELL CARDIOL, V44, P219, DOI 10.1016/j.yjmcc.2007.11.012; Medina RJ, 2011, MOL MED, V17, P1045, DOI 10.2119/molmed.2011.00129; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Povsic TJ, 2011, AM HEART J, V162, P654, DOI 10.1016/j.ahj.2011.07.020; Prat-Vidal C, 2007, TRANSPL P, V39, P2434, DOI 10.1016/j.transproceed.2007.06.016; Ramirez G, 2011, LAB INVEST, V91, P1206, DOI 10.1038/labinvest.2011.80; Reinisch A, 2009, BLOOD, V113, P6716, DOI 10.1182/blood-2008-09-181362; Roura S, 2007, EUR J HEART FAIL, V9, P995, DOI 10.1016/j.ejheart.2007.07.008; Roura S, 2010, BASIC RES CARDIOL, V105, P419, DOI 10.1007/s00395-009-0081-8; Salcedo R, 1999, AM J PATHOL, V154, P1125, DOI 10.1016/S0002-9440(10)65365-5; Schmeckpeper J, 2009, DIFFERENTIATION, V78, P169, DOI 10.1016/j.diff.2009.01.002; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Simpson D, 2007, STEM CELLS, V25, P2350, DOI 10.1634/stemcells.2007-0132; Suehiro J, 2010, BLOOD, V115, P2520, DOI 10.1182/blood-2009-07-233478; Szlavik V, 2008, J CELL BIOCHEM, V103, P284, DOI 10.1002/jcb.21404; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Vilalta M, 2009, BIOMATERIALS, V30, P4986, DOI 10.1016/j.biomaterials.2009.05.056; Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471	53	56	57	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49447	10.1371/journal.pone.0049447	http://dx.doi.org/10.1371/journal.pone.0049447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166670	Green Published, Green Submitted, gold			2022-12-27	WOS:000311885300042
J	Christian, BM; Miles, LK; Macrae, CN				Christian, Brittany M.; Miles, Lynden K.; Macrae, C. Neil			Your Space or Mine? Mapping Self in Time	PLOS ONE			English	Article							EPISODIC FUTURE THOUGHT; CONSTRUAL-LEVEL THEORY; AUTOBIOGRAPHICAL MEMORIES; PHENOMENAL CHARACTERISTICS; PSYCHOLOGICAL DISTANCE; REMINISCENCE BUMP; OTHER-EVENTS; LIFE-SPAN; RECALL; TRAVEL	While humans are capable of mentally transcending the here and now, this faculty for mental time travel (MTT) is dependent upon an underlying cognitive representation of time. To this end, linguistic, cognitive and behavioral evidence has revealed that people understand abstract temporal constructs by mapping them to concrete spatial domains (e. g. past = backward, future = forward). However, very little research has investigated factors that may determine the topographical characteristics of these spatiotemporal maps. Guided by the imperative role of episodic content for retrospective and prospective thought (i.e., MTT), here we explored the possibility that the spatialization of time is influenced by the amount of episodic detail a temporal unit contains. In two experiments, participants mapped temporal events along mediolateral (Experiment 1) and anterioposterior (Experiment 2) spatial planes. Importantly, the temporal units varied in self-relevance as they pertained to temporally proximal or distal events in the participant's own life, the life of a best friend or the life of an unfamiliar other. Converging evidence from both experiments revealed that the amount of space used to represent time varied as a function of target (self, best friend or unfamiliar other) and temporal distance. Specifically, self-time was represented as occupying more space than time pertaining to other targets, but only for temporally proximal events. These results demonstrate the malleability of space-time mapping and suggest that there is a self-specific conceptualization of time that may influence MTT as well as other temporally relevant cognitive phenomena.	[Christian, Brittany M.; Miles, Lynden K.; Macrae, C. Neil] Univ Aberdeen, Sch Psychol, Aberdeen, Scotland	University of Aberdeen	Christian, BM (corresponding author), Univ Aberdeen, Sch Psychol, Aberdeen, Scotland.	b.christian@abdn.ac.uk	Miles, Lynden/C-5168-2008; Macrae, Neil/C-4761-2008; Miles, Lynden/X-1557-2019	Miles, Lynden/0000-0002-4164-3470; Miles, Lynden/0000-0002-4164-3470				Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; Addis DR, 2004, HIPPOCAMPUS, V14, P752, DOI 10.1002/hipo.10215; Alverson H, 1994, UNIVERSAL METAPHORS; Arzy S, 2008, J NEUROSCI, V28, P6502, DOI 10.1523/JNEUROSCI.5712-07.2008; Arzy S, 2009, CONSCIOUS COGN, V18, P781, DOI 10.1016/j.concog.2009.05.007; Atance CM, 2001, TRENDS COGN SCI, V5, P533, DOI 10.1016/S1364-6613(00)01804-0; Bar M, 2009, PHILOS T R SOC B, V364, P1235, DOI 10.1098/rstb.2008.0310; Berntsen D, 2004, MEM COGNITION, V32, P427, DOI 10.3758/BF03195836; Berntsen D, 2002, PSYCHOL AGING, V17, P636, DOI 10.1037//0882-7974.17.4.636; Berntsen D, 2008, CONSCIOUS COGN, V17, P1093, DOI 10.1016/j.concog.2008.03.001; Betz AL, 1997, MEM COGNITION, V25, P701, DOI 10.3758/BF03211313; Boroditsky L, 2001, COGNITIVE PSYCHOL, V43, P1, DOI 10.1006/cogp.2001.0748; Boroditsky L, 2000, COGNITION, V75, P1, DOI 10.1016/S0010-0277(99)00073-6; Boroditsky L, 2011, COGNITION, V118, P123, DOI 10.1016/j.cognition.2010.09.010; Boroditsky L, 2010, PSYCHOL SCI, V21, P1635, DOI 10.1177/0956797610386621; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Buehler R., 1995, EUROPEAN REV SOCIAL, V6, P1, DOI [DOI 10.1080/14792779343000112, 10.1080/14792779343000112]; Casasanto D, 2008, COGNITION, V106, P579, DOI 10.1016/j.cognition.2007.03.004; Casasanto D, 2010, LECT NOTES ARTIF INT, V6222, P335; Cohen D, 2002, PSYCHOL SCI, V13, P55, DOI 10.1111/1467-9280.00409; Cohen DJ, 2011, PSYCHON B REV, V18, P331, DOI 10.3758/s13423-011-0059-z; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; D'Argembeau A, 2004, CONSCIOUS COGN, V13, P844, DOI 10.1016/j.concog.2004.07.007; D'Argembeau A, 2008, J ABNORM PSYCHOL, V117, P247, DOI 10.1037/0021-843X.117.1.247; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Gluck J, 2007, MEM COGNITION, V35, P1928, DOI 10.3758/BF03192926; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Henderson MD, 2011, SOC PSYCHOL-GERMANY, V42, P165, DOI 10.1027/1864-9335/a000060; JOHNSON MK, 1988, J EXP PSYCHOL GEN, V117, P371, DOI 10.1037/0096-3445.117.4.371; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Klein SB, 2012, PERS SOC PSYCHOL REV, V16, P283, DOI 10.1177/1088868311434214; Kranjec A, 2010, COGNITION, V114, P111, DOI 10.1016/j.cognition.2009.09.008; Lakoff G., 1999, PHILOS FLESH; Lakoff George, 2003, METAPHOR WE LIVE BY; Liberman N, 2008, SCIENCE, V322, P1201, DOI 10.1126/science.1161958; Maglio SJ, 2011, PSYCHON B REV, V18, P165, DOI 10.3758/s13423-010-0025-1; MAKI RH, 1985, B PSYCHONOMIC SOC, V23, P169; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Miles LK, 2011, PSYCHON B REV, V18, P598, DOI 10.3758/s13423-011-0068-y; Miles LK, 2010, Q J EXP PSYCHOL, V63, P2113, DOI 10.1080/17470218.2010.524932; Miles LK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010825; Miles LK, 2010, PSYCHOL SCI, V21, P222, DOI 10.1177/0956797609359333; NIGRO G, 1983, COGNITIVE PSYCHOL, V15, P467, DOI 10.1016/0010-0285(83)90016-6; Nunez R, 2012, COGNITION, V124, P25, DOI 10.1016/j.cognition.2012.03.007; Nunez RE, 2006, COGNITIVE SCI, V30, P401, DOI 10.1207/s15516709cog0000_62; Oliveri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007933; Ouellet M, 2010, EXP PSYCHOL, V57, P308, DOI 10.1027/1618-3169/a000036; Ouellet M, 2010, J EXP PSYCHOL HUMAN, V36, P17, DOI 10.1037/a0017176; Piefke M, 2003, BRAIN, V126, P650, DOI 10.1093/brain/awg064; Rathbone CJ, 2008, MEM COGNITION, V36, P1403, DOI 10.3758/MC.36.8.1403; Rice HJ, 2009, CONSCIOUS COGN, V18, P877, DOI 10.1016/j.concog.2009.07.004; Robinson J A, 1993, Memory, V1, P169; ROGERS TB, 1977, J PERS SOC PSYCHOL, V35, P677, DOI 10.1037/0022-3514.35.9.677; Rubin DC, 2003, MEM COGNITION, V31, P1, DOI 10.3758/BF03196077; Santiago J, 2007, PSYCHON B REV, V14, P512, DOI 10.3758/BF03194099; Schacter DL, 2007, NATURE, V445, P27, DOI 10.1038/445027a; Semin GR, 1999, J PERS SOC PSYCHOL, V76, P877, DOI 10.1037/0022-3514.76.6.877; Seno T, 2011, ATTEN PERCEPT PSYCHO, V73, P1467, DOI 10.3758/s13414-011-0129-3; SKOWRONSKI JJ, 1991, J PERS SOC PSYCHOL, V60, P831, DOI 10.1037/0022-3514.60.6.831; Spreng RN, 2006, MEM COGNITION, V34, P1644, DOI 10.3758/BF03195927; Stephan E, 2010, J PERS SOC PSYCHOL, V98, P268, DOI 10.1037/a0016960; Suddendorf T, 2007, BEHAV BRAIN SCI, V30, P299, DOI 10.1017/S0140525X07001975; Symons CS, 1977, PSYCHOL BULL, V121, P371; Szpunar KK, 2008, CONSCIOUS COGN, V17, P330, DOI 10.1016/j.concog.2007.04.006; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; Torralbo A, 2006, COGNITIVE SCI, V30, P745, DOI 10.1207/s15516709cog0000_67; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; Trutoiu LC, 2009, COMPUT GRAPH-UK, V33, P47, DOI 10.1016/j.cag.2008.11.008; TULVING E, 1985, AM PSYCHOL, V40, P385, DOI 10.1037/0003-066x.40.4.385; Tulving E., 2002, PRINCIPLES FRONTAL L, P311, DOI [10.1093/acprof:oso/9780195134971.003.0020, DOI 10.1093/ACPROF:OSO/9780195134971.003.0020]; TVERSKY B, 1991, COGNITIVE PSYCHOL, V23, P515, DOI 10.1016/0010-0285(91)90005-9; Vallesi A, 2008, COGNITION, V107, P501, DOI 10.1016/j.cognition.2007.10.011; Van Sommers P, 1984, DRAWING COGNITION DE; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002	76	5	5	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49228	10.1371/journal.pone.0049228	http://dx.doi.org/10.1371/journal.pone.0049228			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039UP	23166617	gold, Green Published			2022-12-27	WOS:000311272300033
J	Hartling, L; Chisholm, A; Thomson, D; Dryden, DM				Hartling, Lisa; Chisholm, Annabritt; Thomson, Denise; Dryden, Donna M.			A Descriptive Analysis of Overviews of Reviews Published between 2000 and 2011	PLOS ONE			English	Article							BRONCHIOLITIS; QUALITY	Background: Overviews of systematic reviews compile data from multiple systematic reviews (SRs) and are a new method of evidence synthesis. Objectives: To describe the methodological approaches in overviews of interventions. Design: Descriptive study. Methods: We searched 4 databases from 2000 to July 2011; we handsearched Evidence-based Child Health: A Cochrane Review Journal. We defined an overview as a study that: stated a clear objective; examined an intervention; used explicit methods to identify SRs; collected and synthesized outcome data from the SRs; and intended to include only SRs. We did not restrict inclusion by population characteristics (e. g., adult or children only). Two researchers independently screened studies and applied eligibility criteria. One researcher extracted data with verification by a second. We conducted a descriptive analysis. Results: From 2,245 citations, 75 overviews were included. The number of overviews increased from 1 in 2000 to 14 in 2010. The interventions were pharmacological (n = 20, 26.7%), non-pharmacological (n = 26, 34.7%), or both (n = 29, 38.7%). Inclusion criteria were clearly stated in 65 overviews. Thirty-three (44%) overviews searched at least 2 databases. The majority reported the years and databases searched (n = 46, 61%), and provided key words (n = 58, 77%). Thirty-nine (52%) overviews included Cochrane SRs only. Two reviewers independently screened and completed full text review in 29 overviews (39%). Methods of data extraction were reported in 45 (60%). Information on quality of individual studies was extracted from the original SRs in 27 (36%) overviews. Quality assessment of the SRs was performed in 28 (37%) overviews; at least 9 different tools were used. Quality of the body of evidence was assessed in 13 (17%) overviews. Most overviews provided a narrative or descriptive analysis of the included SRs. One overview conducted indirect analyses and the other conducted mixed treatment comparisons. Publication bias was discussed in 18 (24%) overviews. Conclusions: This study shows considerable variation in the methods used for overviews. There is a need for methodological rigor and consistency in overviews, as well as empirical evidence to support the methods employed.	[Hartling, Lisa; Chisholm, Annabritt; Thomson, Denise; Dryden, Donna M.] Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada; [Hartling, Lisa; Thomson, Denise] Univ Alberta, Dept Pediat, Cochrane Child Hlth Field, Edmonton, AB, Canada	University of Alberta; University of Alberta	Hartling, L (corresponding author), Univ Alberta, Dept Pediat, Alberta Res Ctr Hlth Evidence, Edmonton, AB, Canada.	hartling@ualberta.ca		Thomson, Denise/0000-0002-4972-5331				Bialy L, 2006, EVID BASED CHILD HLT, V1, P939; Canadian Coordinating Office of Health Technology Assessment, COMPUS PROC EV BAS B; Chandler J., 2011, METHODOLOGICAL STAND; Fuller H, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004883; Gadomski AM, 2010, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001266.pub2, 10.1002/14651858.CD001266.pub3]; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Hartling L, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003123.PUB2; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Institute of Medicine, 2011, FIND WHAT WORKS HLTH; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; OXMAN AD, 1991, J CLIN EPIDEMIOL, V44, P1271, DOI 10.1016/0895-4356(91)90160-B; Oxman Andrew D, 2006, Health Res Policy Syst, V4, P20, DOI 10.1186/1478-4505-4-20; Patel H, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004878; Perrotta C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004873.pub3; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Smith V, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-15; Ventre K, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000181.pub3; Ventre K, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005150.pub2	19	90	92	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49667	10.1371/journal.pone.0049667	http://dx.doi.org/10.1371/journal.pone.0049667			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166744	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300065
J	He, J; Xu, Y; Qiu, LX; Li, J; Zhou, XY; Sun, MH; Wang, JC; Yang, YJ; Jin, L; Wei, QY; Wang, YN				He, Jing; Xu, Yu; Qiu, Li-Xin; Li, Jin; Zhou, Xiao-Yan; Sun, Meng-Hong; Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li; Wei, Qing-Yi; Wang, Yanong			Polymorphisms in ERCC1 and XPF Genes and Risk of Gastric Cancer in an Eastern Chinese Population	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; DNA-REPAIR; SUSCEPTIBILITY; ADENOCARCINOMAS; ESOPHAGEAL; TOBACCO; LINK	Background: Inherited functional single nucleotide polymorphisms (SNPs) in DNA repair genes may alter DNA repair capacity and thus contribute to cancer risk. Methods: Three ERCC1 functional SNPs (rs2298881C>A, rs3212986C>A and rs11615G>A) and two XPF/ERCC4 functional SNPs (rs2276466C>G and rs6498486A>C) were genotyped for 1125 gastric adenocarcinoma cases and 1196 cancer-free controls by Taqman assays. Odds ratios (OR) and 95% confidence intervals (CI) were used to estimate risk associations, and false-positive report probabilities (FPRP) were calculated for assessing significant findings. Results: ERCC1 rs2298881C and rs11615A variant genotypes were associated with increased gastric cancer risk (adjusted OR = 1.33, 95% CI = 1.05-1.67 for rs2298881 AC/CC and adjusted OR = 1.23, 95% CI = 1.05-1.46 for rs11615 AG/AA, compared with their common genotype AA and GG, respectively). Patients with 2-3 ERCC1 risk genotypes had significant increased risk (adjusted OR = 1.56, 95% CI = 1.27-1.93), compared with those with 0-1 ERCC1 risk genotypes, and this risk was more significantly in subgroups of never drinkers, non-gastric cardia adenocarcinoma (NGCA) and clinical stage I+II. All these risks were not observed for XPF SNPs. Conclusions: These findings suggest that functional ERCC1 SNPs may contribute to risk of gastric cancer. Larger and well-designed studies with different ethnic populations are needed to validate our findings.	[He, Jing; Wei, Qing-Yi] Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China; [He, Jing; Qiu, Li-Xin; Li, Jin] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Xu, Yu; Wang, Yanong] Fudan Univ, Shanghai Canc Ctr, Dept Gastr Canc & Soft Tissue Sarcoma Surg, Shanghai 200433, Peoples R China; [Qiu, Li-Xin; Li, Jin] Fudan Univ, Shanghai Canc Ctr, Dept Med Oncol, Shanghai 200433, Peoples R China; [Zhou, Xiao-Yan; Sun, Meng-Hong] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li] Fudan Univ, Minist Educ, Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Wang, Jiu-Cun; Yang, Ya-Jun; Jin, Li] Fudan Taizhou Inst Hlth Sci, Taizhou, Jiangsu, Peoples R China; [Wei, Qing-Yi] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA	Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; Fudan University; University of Texas System; UTMD Anderson Cancer Center	Wei, QY (corresponding author), Fudan Univ, Shanghai Canc Ctr, Canc Res Lab, Shanghai 200433, Peoples R China.	weiqingyi@yahoo.com; wangyn1111@hotmail.com	Jin, Li/C-1468-2009; He, Jing/M-5774-2015; Jin, Li/M-5063-2019	Jin, Li/0000-0002-4546-2415; He, Jing/0000-0002-1954-2892; 	China's Thousand Talents Program at Fudan University; Ministry of Health [201002007]	China's Thousand Talents Program at Fudan University; Ministry of Health	This research was supported by funds from China's Thousand Talents Program at Fudan University and the grant from the Ministry of Health (grant number 201002007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abnet CC, 2010, NAT GENET, V42, P764, DOI 10.1038/ng.649; Chow WH, 1998, JNCI-J NATL CANCER I, V90, P150, DOI 10.1093/jnci/90.2.150; Cleaver JE, 2000, J DERMATOL SCI, V23, P1, DOI 10.1016/S0923-1811(99)00088-2; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Deng QH, 2011, MED ONCOL, V28, P667, DOI 10.1007/s12032-010-9507-2; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; Friedberg EC, 2003, NATURE, V421, P436, DOI 10.1038/nature01408; Gammon MD, 1997, J NATL CANCER I, V89, P1277, DOI 10.1093/jnci/89.17.1277; He J, 2012, HUM GENET, V131, P1235, DOI 10.1007/s00439-012-1152-8; Hu Zhibin, 2007, Gastrointest Cancer Res, V1, P12; Isla D, 2004, ANN ONCOL, V15, P1194, DOI 10.1093/annonc/mdh319; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Mayne ST, 2002, J NUTR, V132, p3467S, DOI 10.1093/jn/132.11.3467S; Neumann AS, 2005, MOL CARCINOGEN, V42, P65, DOI 10.1002/mc.20069; ODONOVAN A, 1994, NATURE, V371, P432, DOI 10.1038/371432a0; Palli D, 2010, MUTAGENESIS, V25, P569, DOI 10.1093/mutage/geq042; Reed E, 1998, CANCER TREAT REV, V24, P331, DOI 10.1016/S0305-7372(98)90056-1; Rodriguez G, 2006, INT J CANCER, V118, P1420, DOI 10.1002/ijc.21516; Ruzzo A, 2007, CLIN CHEM LAB MED, V45, P822, DOI 10.1515/CCLM.2007.143; Sasco AJ, 1999, HUM EXP TOXICOL, V18, P192, DOI 10.1191/096032799678839905; Shi TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038606; Shi YY, 2011, NAT GENET, V43, P1215, DOI 10.1038/ng.978; Sun XC, 2009, LUNG CANCER, V65, P230, DOI 10.1016/j.lungcan.2008.11.014; Thun MJ, 2008, PLOS MED, V5, P1357, DOI 10.1371/journal.pmed.0050185; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; VANDUIN M, 1986, CELL, V44, P913, DOI 10.1016/0092-8674(86)90014-0; Vineis P, 2009, JNCI-J NATL CANCER I, V101, P24, DOI 10.1093/jnci/djn437; Wacholder S, 2004, J NATL CANCER I, V96, P434, DOI 10.1093/jnci/djh075; Wang AT, 2011, GENE DEV, V25, P1859, DOI 10.1101/gad.15699211; Wang XF, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-223; Washington K, 2010, ANN SURG ONCOL, V17, P3077, DOI 10.1245/s10434-010-1362-z; Wood RD, 2001, SCIENCE, V291, P1284, DOI 10.1126/science.1056154; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Zhang LQ, 2012, MUTAGENESIS, V27, P67, DOI 10.1093/mutage/ger062	34	40	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49308	10.1371/journal.pone.0049308	http://dx.doi.org/10.1371/journal.pone.0049308			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166636	gold, Green Submitted, Green Published			2022-12-27	WOS:000311272300038
J	Crean, AJ; Dwyer, JM; Marshall, DJ				Crean, Angela J.; Dwyer, John M.; Marshall, Dustin J.			Fertilization Is Not a New Beginning: The Relationship between Sperm Longevity and Offspring Performance	PLOS ONE			English	Article							EGG SIZE; COMPETITION; EVOLUTION; PLASTICITY; SELECTION; INHERITANCE; VELOCITY; QUALITY; AGE	Sperm are the most diverse cell type known: varying not only among- and within-species, but also among- and within-ejaculates of a single male. Recently, the causes and consequences of variability in sperm phenotypes have received much attention, but the importance of within-ejaculate variability remains largely unknown. Correlative evidence suggests that reduced within-ejaculate variation in sperm phenotype increases a male's fertilization success in competitive conditions; but the transgenerational consequences of within-ejaculate variation in sperm phenotype remain relatively unexplored. Here we examine the relationship between sperm longevity and offspring performance in a marine invertebrate with external fertilization, Styela plicata. Offspring sired by longer-lived sperm had higher performance compared to offspring sired by freshly-extracted sperm of the same ejaculate, both in the laboratory and the field. This indicates that within-ejaculate differences in sperm longevity can influence offspring fitness - a source of variability in offspring phenotypes that has not previously been considered. Links between sperm phenotype and offspring performance may constrain responses to selection on either sperm or offspring traits, with broad ecological and evolutionary implications.	[Crean, Angela J.; Dwyer, John M.; Marshall, Dustin J.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia	University of Queensland	Crean, AJ (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	a.crean@unsw.edu.au	Crean, Angela J/U-8568-2018; Dwyer, John M./O-5579-2017; Marshall, Dustin/C-3450-2016	Crean, Angela J/0000-0003-2605-6435; Dwyer, John M./0000-0001-7389-5528; Marshall, Dustin/0000-0001-6651-6219				Allen RM, 2008, AM NAT, V171, P225, DOI 10.1086/524952; Bates D, 2009, R PACKAGE LINEAR MIX; Birkhead T.R., 1998, SPERM COMPETITION SE, P91; Birkhead TR, 2005, NATURE, V434, P383, DOI 10.1038/nature03374; BIRKHEAD TR, 1993, J THEOR BIOL, V161, P51, DOI 10.1006/jtbi.1993.1039; Birkhead TR, 2002, NAT REV GENET, V3, P262, DOI 10.1038/nrg774; Chippindale AK, 1996, EVOLUTION, V50, P753, DOI [10.2307/2410848, 10.1111/j.1558-5646.1996.tb03885.x]; COHEN J, 1974, J REPROD FERTIL, V39, P297, DOI 10.1530/jrf.0.0390297; Cornwallis CK, 2007, AM NAT, V170, P758, DOI 10.1086/521955; Crean AJ, 2008, P NATL ACAD SCI USA, V105, P13508, DOI 10.1073/pnas.0806590105; Crean AJ, 2009, PHILOS T R SOC B, V364, P1087, DOI 10.1098/rstb.2008.0237; De Block M, 2005, ECOLOGY, V86, P185, DOI 10.1890/04-0116; de Boer P, 2010, MOL HUM REPROD, V16, P48, DOI 10.1093/molehr/gap098; Einum S, 2004, EVOL ECOL RES, V6, P443; Fitzpatrick JL, 2007, BIOL REPROD, V77, P280, DOI 10.1095/biolreprod.106.059550; Fitzpatrick JL, 2011, EVOLUTION, V65, P3006, DOI 10.1111/j.1558-5646.2011.01343.x; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Higginson DM, 2011, BIOL REV, V86, P249, DOI 10.1111/j.1469-185X.2010.00147.x; Hunter FM, 2002, CURR BIOL, V12, P121, DOI 10.1016/S0960-9822(01)00647-9; Immler S, 2008, EVOLUTION, V62, P1538, DOI 10.1111/j.1558-5646.2008.00393.x; Immler S, 2008, REPRODUCTION, V135, P275, DOI 10.1530/REP-07-0482; Immler S, 2010, EVOLUTION, V64, P1634, DOI 10.1111/j.1558-5646.2009.00924.x; Jablonka E, 2009, Q REV BIOL, V84, P131, DOI 10.1086/598822; Joseph SB, 2004, TRENDS ECOL EVOL, V19, P592, DOI 10.1016/j.tree.2004.08.004; KOTT P, 1972, Memoirs of the Queensland Museum, V16, P233; Levitan DR, 2006, INTEGR COMP BIOL, V46, P298, DOI 10.1093/icb/icj025; Levitan DR, 2000, P ROY SOC B-BIOL SCI, V267, P531, DOI 10.1098/rspb.2000.1032; LEVITAN DR, 1991, BIOL BULL, V181, P371, DOI 10.2307/1542357; LEVITAN DR, 1993, AM NAT, V141, P517, DOI 10.1086/285489; Manriquez PH, 2001, MAR ECOL PROG SER, V224, P87, DOI 10.3354/meps224087; Marshall DJ, 2002, ECOL LETT, V5, P173, DOI 10.1046/j.1461-0248.2002.00257.x; Marshall DJ, 2008, ECOLOGY, V89, P2506, DOI 10.1890/07-0267.1; MORAN NA, 1994, ANNU REV ECOL SYST, V25, P573, DOI 10.1146/annurev.es.25.110194.003041; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Pechenik JA, 2006, INTEGR COMP BIOL, V46, P323, DOI 10.1093/icb/icj028; Pitnick S, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P69, DOI 10.1016/B978-0-12-372568-4.00003-3; Pizzari T, 2009, SPERM BIOLOGY: AN EVOLUTIONARY PERSPECTIVE, P207, DOI 10.1016/B978-0-12-372568-4.00006-9; Plaistow SJ, 2007, AM NAT, V170, P520, DOI 10.1086/521238; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; TRIPPEL EA, 1994, COPEIA, P1025; Zeh JA, 2008, GENETICA, V134, P45, DOI 10.1007/s10709-007-9192-z	44	28	28	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49167	10.1371/journal.pone.0049167	http://dx.doi.org/10.1371/journal.pone.0049167			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155458	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900093
J	Meagher, RK; Mason, GJ				Meagher, Rebecca K.; Mason, Georgia J.			Environmental Enrichment Reduces Signs of Boredom in Caged Mink	PLOS ONE			English	Article							FALSE DISCOVERY RATE; MUSTELA-VISON; SENSATION SEEKING; RATTUS-NORVEGICUS; BEHAVIOR; STRESS; WELFARE; APATHY; DEPRESSION; EXPERIENCE	Animals housed in impoverished cages are often labelled 'bored'. They have also been called 'apathetic' or 'depressed', particularly when profoundly inactive. However, these terms are rarely operationally defined and validated. As a negative state caused by under-stimulation, boredom should increase interest in stimuli of all kinds. Apathy (lack of interest), by contrast, should manifest as decreased interest in all stimuli, while anhedonia (loss of pleasure, a depressive symptom) should specifically decrease interest in normally rewarding stimuli. We tested the hypotheses that mink, a model carnivore, experience more boredom, depression-like apathy, or anhedonia in non-enriched (NE) cages than in complex, enriched (E) cages. We exposed 29 subjects (13 E, 16 NE) to ten stimuli categorized a priori as aversive (e.g. air puffs), rewarding (e.g. evoking chasing) or ambiguous/neutral (e.g. candles). Interest in stimuli was assessed via latencies to contact, contact durations, and durations oriented to stimuli. NE mink contacted all stimuli faster (P=0.003) than E mink, and spent longer oriented to/in contact with them, albeit only significantly so for ambiguous ones (treatment*type P<0.013). With stimulus category removed from statistical models, interest in all stimuli was consistently higher among NE mink (P<0.0001 for all measures). NE mink also consumed more food rewards (P=0.037). Finally, we investigated whether lying down while awake and stereotypic behaviour (both increased by NE housing) predicted these responses. Lying awake positively co-varied with certain measures of increased exploration. In contrast, stereotypic 'scrabbling' or locomotion (e.g. pacing) did not. Overall, NE mink showed no evidence of apathy or depression, but instead a heightened investigation of diverse stimuli consistent with boredom. This state was potentially indicated by spending much time lying still but awake (although this result requires replication). Boredom can thus be operationalized and assessed empirically in non-human animals. It can also be reduced by environmental enrichment.	[Meagher, Rebecca K.; Mason, Georgia J.] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada	University of Guelph	Meagher, RK (corresponding author), Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada.	rmeagher@uoguelph.ca	Meagher, Rebecca/G-6530-2013	Meagher, Rebecca/0000-0002-6576-8155				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Anisman H, 2005, NEUROSCI BIOBEHAV R, V29, P525, DOI 10.1016/j.neubiorev.2005.03.007; Anna I, 2002, LAB ANIM-UK, V36, P243, DOI 10.1258/002367702320162379; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Benjamini Y, 1999, J STAT PLAN INFER, V82, P163, DOI 10.1016/S0378-3758(99)00040-3; Berlyne D.E., 1960, CONFLICT AROUSAL CUR, DOI [10.1037/11164-000, DOI 10.1037/11164-000]; Bolhuis JE, 2006, APPL ANIM BEHAV SCI, V101, P68, DOI 10.1016/j.applanim.2006.01.001; BOLLES RC, 1965, J COMP PHYSIOL PSYCH, V60, P93, DOI 10.1037/h0022320; Bracke MBM, 2008, APPL ANIM BEHAV SCI, V109, P39, DOI 10.1016/j.applanim.2007.01.014; Bushnell PJ, 1998, PSYCHOPHARMACOLOGY, V138, P231, DOI 10.1007/s002130050668; Cabib S, 2006, STEREOTYPIC ANIMAL BEHAVIOUR: FUNDAMENTALS AND APPLICATIONS TO WELFARE, 2ND EDIITON, P227, DOI 10.1079/9780851990040.0227; Carlstead Kathy, 1996, P317; CARTON S, 1992, PERS INDIV DIFFER, V13, P843, DOI 10.1016/0191-8869(92)90059-X; Cooper JJ, 2000, APPL ANIM BEHAV SCI, V66, P135, DOI 10.1016/S0168-1591(99)00069-6; Dahlborn K, 1996, SCAND J LAB ANIM SCI, V23, P97; Dallaire JA, APPL ANIMAL BEHAV SC; Dallaire JA, 2011, BEHAV BRAIN RES, V224, P213, DOI 10.1016/j.bbr.2011.03.061; Diez-Leon M., 2010, P 44 C ISAE, P96; Dwyer CM, 2004, ANIM WELFARE, V13, P269; Eastwood JD, 2012, PERSPECT PSYCHOL SCI, V7, P482, DOI 10.1177/1745691612456044; FITZGIBBON CD, 1994, BEHAV ECOL SOCIOBIOL, V34, P139; Gilmer WS, 2003, J AFFECT DISORDERS, V75, P97, DOI 10.1016/S0165-0327(03)00046-6; GLOVER H, 1992, J TRAUMA STRESS, V5, P643, DOI 10.1007/BF00979232; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Goldberg YK, 2011, J SOC CLIN PSYCHOL, V30, P647, DOI 10.1521/jscp.2011.30.6.647; Gray J.A., 1987, PSYCHOL FEAR STRESS, V2nd, P422; GUNN D, 1995, APPL ANIM BEHAV SCI, V45, P277, DOI 10.1016/0168-1591(95)00627-5; Harris MB, 2000, J APPL SOC PSYCHOL, V30, P576, DOI 10.1111/j.1559-1816.2000.tb02497.x; Hartley P, 2003, ANIM WELFARE, V12, P709; Henn FA, 2005, NEUROSCI BIOBEHAV R, V29, P799, DOI 10.1016/j.neubiorev.2005.03.019; Hogan JA, 1967, J COMP PHYSL PSYCHOL, V64; JONES RB, 1982, DEV PSYCHOBIOL, V15, P105, DOI 10.1002/dev.420150203; Joseph JE, 2009, PSYCHOL SCI, V20, P215, DOI 10.1111/j.1467-9280.2009.02283.x; Kiley-Worthington M., 1977, BEHAV PROBLEMS FARM; Kirkden R.D., 2000, ASSESSING MOTIVATION; KLEIN SL, 1994, PHYSIOL BEHAV, V56, P291, DOI 10.1016/0031-9384(94)90197-X; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; MAIER SF, 1984, PROG NEURO-PSYCHOPH, V8, P435, DOI 10.1016/S0278-5846(84)80032-9; Malmkvist J, 2002, ANIM BEHAV, V64, P487, DOI 10.1006/anbe.2002.3058; Malmkvist J, 2001, FEAR FARM MINK MUSTE; MARIN RS, 1993, J AFFECT DISORDERS, V28, P117, DOI 10.1016/0165-0327(93)90040-Q; MARIN RS, 1991, PSYCHIAT RES, V38, P143, DOI 10.1016/0165-1781(91)90040-V; MARIN RS, 1990, AM J PSYCHIAT, V147, P22; Mason GJ, 2004, ANIM WELFARE, V13, pS57; McFarland D, 1987, OXFORD COMPANION ANI, P398; Meagher R, 2011, WELFARE SIGNIFICANCE; Meagher R, 2012, P 11 N AM ISAE, P32; Meagher RK, 2011, APPL ANIM BEHAV SCI, V133, P254, DOI 10.1016/j.applanim.2011.05.009; Meyer-Holzapfel M., 1968, ABNORMAL BEHAV ANIMA, P476; Michel G, 1997, ENCEPHALE, V23, P403; MITCHELL R, 1977, DEV MED CHILD NEUROL, V19, P545; Mononen J, 2012, ANIM WELFARE, V21, P363, DOI 10.7120/09627286.21.3.363; Morgan KN, 2007, APPL ANIM BEHAV SCI, V102, P262, DOI 10.1016/j.applanim.2006.05.032; Morris D, 1964, S ZOOLOGICAL SOC LON, P13; NEWBERRY RC, 1995, APPL ANIM BEHAV SCI, V44, P229, DOI 10.1016/0168-1591(95)00616-Z; Nimon AJ, 1999, ANIM WELFARE, V8, P205; PAQUETTE D, 1988, ZOO BIOL, V7, P15, DOI 10.1002/zoo.1430070103; Pliner P, 1997, PHYSIOL BEHAV, V61, P331, DOI 10.1016/S0031-9384(96)00406-4; RENNER MJ, 1986, J COMP PSYCHOL, V100, P229, DOI 10.1037/0735-7036.100.3.229; RENNER MJ, 1987, J COMP PSYCHOL, V101, P94; Roberti JW, 2004, J RES PERS, V38, P256, DOI 10.1016/S0092-6566(03)00067-9; Robinson MH, 1998, ANIM WELFARE, V7, P151; Russell P.A., 1983, P22; Russell PA, 1983, EXPLORATION ANIMALS, P72; Samuels D.J., 1974, J DRUG EDUC, V4, P421, DOI [https://doi.org/10.2190/VJHU-MRAR-NLG6-1XBH, DOI 10.2190/VJHU-MRAR-NLG6-1XBH]; Sockeel P, 2006, J NEUROL NEUROSUR PS, V77, P579, DOI 10.1136/jnnp.2005.075929; Spruijt BM, 2001, APPL ANIM BEHAV SCI, V72, P145, DOI 10.1016/S0168-1591(00)00204-5; Stairs DJ, 2006, BEHAV PHARMACOL, V17, P597, DOI 10.1097/01.fbp.0000236271.72300.0e; Stevenson M.F., 1983, P176; STOLBA A, 1980, APPL ANIM ETHOL, V6, P382, DOI 10.1016/0304-3762(80)90140-6; Taylor L, 1973, PSYCHOL SURVIVAL EXP; Turner M, 1999, J CHILD PSYCHOL PSYC, V40, P839, DOI 10.1111/1469-7610.00502; van der Harst JE, 2003, BEHAV BRAIN RES, V142, P151, DOI 10.1016/S0166-4328(02)00403-5; Wemelsfelder F., 1990, The experimental animal in biomedical research. Volume 1. A survey of scientific and ethical issues for investigators., P243; Wemelsfelder F., 1997, Animal welfare., P35; Wemelsfelder F., 1993, STEREOTYPIC BEHAV FU, P95; WILLNER P, 1987, PSYCHOPHARMACOLOGY, V93, P358; Wood-Gush D. G. M., 1989, Journal of Agricultural Ethics, V2, P161, DOI 10.1007/BF01826929; WOODGUSH DGM, 1983, APPL ANIM ETHOL, V10, P209, DOI 10.1016/0304-3762(83)90142-6; ZUCKERMAN M, 1990, J PERS, V58, P313, DOI 10.1111/j.1467-6494.1990.tb00918.x	81	67	67	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49180	10.1371/journal.pone.0049180	http://dx.doi.org/10.1371/journal.pone.0049180			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155462	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000311151900097
J	Rodriguez-Pulido, M; Martin-Acebes, MA; Escribano-Romero, E; Blazquez, AB; Sobrino, F; Borrego, B; Saiz, M; Saiz, JC				Rodriguez-Pulido, Miguel; Martin-Acebes, Miguel A.; Escribano-Romero, Estela; Blazquez, Ana-Belen; Sobrino, Francisco; Borrego, Belen; Saiz, Margarita; Saiz, Juan-Carlos			Protection against West Nile Virus Infection in Mice after Inoculation with Type I Interferon-Inducing RNA Transcripts	PLOS ONE			English	Article							NONCODING REGIONS; INNATE IMMUNITY; ENCEPHALITIS; CELLS; INCREASES; MOSQUITOS; ALPHA; RISK	West Nile virus (WNV) is a neurovirulent single stranded RNA mosquito-borne flavivirus, whose main natural hosts are birds, but it also infects humans and horses. Nowadays, no human vaccine is commercially available and clinical treatment is only supportive. Recently, it has been shown that RNA transcripts, mimicking structural domains in the non-coding regions (NCRs) of the foot-and mouth disease virus (FMDV) induce a potent IFN response and antiviral activity in transfected cultured cells, and also reduced mice susceptibility to FMDV. By using different transcripts combinations, administration schedules, and infecting routes and doses, we have demonstrated that these FMDV RNA transcripts protect suckling and adult mice against lethal challenge with WNV. The protective activity induced by the transcripts was systemic and dependent on the infection route and dose. These results confirm the antiviral potential of these synthetic RNAs for fighting viruses of different families relevant for human and animal health.	[Rodriguez-Pulido, Miguel; Sobrino, Francisco; Saiz, Margarita] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Rodriguez-Pulido, M (corresponding author), Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jcsaiz@inia.es	Martin-Acebes, Miguel A./L-2258-2014; Borrego, Belén/K-2179-2014; Pulido, Miguel Rodriguez/L-7644-2014; Escribano-Romero, Estela/H-1495-2015; Blazquez, Ana/G-9791-2015; Sáiz, Margarita/F-2604-2015	Martin-Acebes, Miguel A./0000-0001-6015-3613; Borrego, Belén/0000-0002-0801-9166; Pulido, Miguel Rodriguez/0000-0003-2101-8974; Escribano-Romero, Estela/0000-0002-5036-7607; Blazquez, Ana/0000-0002-0847-0977; Sáiz, Margarita/0000-0003-3893-7926; Sobrino, Francisco/0000-0003-4968-8291; Saiz, Juan-Carlos/0000-0001-8269-5544				Alonso-Padilla J, 2009, EPIDEMIOL INFECT, V137, P1163, DOI 10.1017/S0950268809002325; Alonso-Padilla J, 2011, VACCINE, V29, P1830, DOI 10.1016/j.vaccine.2010.12.081; Alonso-Padilla J, 2010, J VIROL METHODS, V166, P37, DOI 10.1016/j.jviromet.2010.02.013; Blazquez AB, 2010, VIRUS RES, V151, P240, DOI 10.1016/j.virusres.2010.04.009; Chan-Tack KM, 2005, SCAND J INFECT DIS, V37, P944, DOI 10.1080/00365540500262690; Cordoba L, 2007, J GEN VIROL, V88, P476, DOI 10.1099/vir.0.82439-0; Daffis S, 2007, PLOS PATHOG, V3, P1005, DOI 10.1371/journal.ppat.0030106; DeBiasi RL, 2006, NAT CLIN PRACT NEURO, V2, P264, DOI 10.1038/ncpneuro0176; Diamond MS, 2009, ANTIVIR RES, V83, P214, DOI 10.1016/j.antiviral.2009.05.006; Diamond MS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000452; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082; Glass WG, 2005, J EXP MED, V202, P1087, DOI 10.1084/jem.20042530; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; Hayes EB, 2005, EMERG INFECT DIS, V11, P1167, DOI 10.3201/eid1108.050289a; Kalil AC, 2005, CLIN INFECT DIS, V40, P764, DOI 10.1086/427945; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lewis M, 2007, PHARMACOTHERAPY, V27, P455, DOI 10.1592/phco.27.3.455; Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321; Martin-Acebes MA, 2012, WORLD J VIR IN PRESS; Martin-Acebes MA, 2011, J GEN VIROL, V92, P831, DOI 10.1099/vir.0.027185-0; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; Morrey John D., 2004, Antiviral Chemistry & Chemotherapy, V15, P101; Pascolo Steve, 2008, V183, P221; RICHMOND JY, 1969, P NATL ACAD SCI USA, V64, P81, DOI 10.1073/pnas.64.1.81; Rios JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010537; Rodriguez-Pulido M, 2011, ANTIVIR RES, V92, P500, DOI 10.1016/j.antiviral.2011.10.005; Rodriguez-Pulido M, 2011, J VIROL, V85, P6492, DOI 10.1128/JVI.00599-11; RUBINSTEIN S, 1981, J VIROL, V37, P755, DOI 10.1128/JVI.37.2.755-758.1981; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12; Semple SC, 2010, NAT BIOTECHNOL, V28, P172, DOI 10.1038/nbt.1602; Smithburn KC., 1940, AM J TROP MED HYG, V1, P471, DOI 10.4269/ajtmh.1940.s1-20.471; Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]	40	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49494	10.1371/journal.pone.0049494	http://dx.doi.org/10.1371/journal.pone.0049494			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166685	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900151
J	Gilljam, KM; Muller, R; Liabakk, NB; Otterlei, M				Gilljam, Karin M.; Mueller, Rebekka; Liabakk, Nina B.; Otterlei, Marit			Nucleotide Excision Repair Is Associated with the Replisome and Its Efficiency Depends on a Direct Interaction between XPA and PCNA	PLOS ONE			English	Article							XERODERMA-PIGMENTOSUM; DNA-REPAIR; DAMAGE-RECOGNITION; BINDING DOMAIN; S PHASE; PROTEIN; COMPLEX; ATR; RPA; IDENTIFICATION	Proliferating cell nuclear antigen (PCNA) is an essential protein for DNA replication, DNA repair, cell cycle regulation, chromatin remodeling, and epigenetics. Many proteins interact with PCNA through the PCNA interacting peptide (PIP)-box or the newly identified AlkB homolog 2 PCNA interacting motif (APIM). The xeroderma pigmentosum group A (XPA) protein, with a central but somewhat elusive role in nucleotide excision repair (NER), contains the APIM sequence suggesting an interaction with PCNA. With an in vivo based approach, using modern techniques in live human cells, we show that APIM in XPA is a functional PCNA interacting motif and that efficient NER of UV lesions is dependent on an intact APIM sequence in XPA. We show that XPA(-/-) cells complemented with XPA containing a mutated APIM sequence have increased UV sensitivity, reduced repair of cyclobutane pyrimidine dimers and (6-4) photoproducts, and are consequently more arrested in S phase as compared to XPA(-/-) cells complemented with wild type XPA. Notably, XPA colocalizes with PCNA in replication foci and is loaded on newly synthesized DNA in undamaged cells. In addition, the TFIIH subunit XPD, as well as XPF are loaded on DNA together with XPA, and XPC and XPG colocalize with PCNA in replication foci. Altogether, our results suggest a presence of the NER complex in the vicinity of the replisome and a novel role of NER in post-replicative repair.	[Gilljam, Karin M.; Mueller, Rebekka; Liabakk, Nina B.; Otterlei, Marit] Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Otterlei, M (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway.	marit.otterlei@ntnu.no		Otterlei, Marit/0000-0002-5232-1186	National Program for Research in Functional Genomics in Norway (FUGE) from The Research Council of Norway; Cancer Fund at St. Olav's Hospital, Trondheim, Norway; Norwegian Cancer Society; Liaison Committee; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU), Norway	National Program for Research in Functional Genomics in Norway (FUGE) from The Research Council of Norway; Cancer Fund at St. Olav's Hospital, Trondheim, Norway; Norwegian Cancer Society(Norwegian Cancer Society); Liaison Committee; Central Norway Regional Health Authority (RHA); Norwegian University of Science and Technology (NTNU), Norway	This work was supported by The National Program for Research in Functional Genomics in Norway (FUGE) from The Research Council of Norway, The Cancer Fund at St. Olav's Hospital, Trondheim, Norway, and The Norwegian Cancer Society and The Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU), Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Auclair Y, 2008, P NATL ACAD SCI USA, V105, P17896, DOI 10.1073/pnas.0801585105; Bunick CG, 2006, BIOCHEMISTRY-US, V45, P14965, DOI 10.1021/bi061370o; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Clark AB, 2000, J BIOL CHEM, V275, P36498, DOI 10.1074/jbc.C000513200; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; D Bomgarden R, 2006, EMBO J, V25, P2605, DOI 10.1038/sj.emboj.7601123; DOVC P, 1995, J ANIM SCI, V73, P3493; ELVERS I, 2011, NUCL ACIDS RES; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Gillet LCJ, 2006, CHEM REV, V106, P253, DOI 10.1021/cr040483f; Gilljam KM, 2009, J CELL BIOL, V186, P645, DOI 10.1083/jcb.200903138; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; Hoogstraten D, 2008, J CELL SCI, V121, P2850, DOI 10.1242/jcs.031708; Ikegami T, 1998, NAT STRUCT BIOL, V5, P701, DOI 10.1038/1400; Kang TH, 2011, NUCLEIC ACIDS RES, V39, P3176, DOI 10.1093/nar/gkq1318; Kaufmann WK, 2010, CARCINOGENESIS, V31, P751, DOI 10.1093/carcin/bgp230; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; Kuraoka I, 1996, MUTAT RES-DNA REPAIR, V362, P87, DOI 10.1016/0921-8777(95)00038-0; Lange SS, 2011, NAT REV CANCER, V11, P96, DOI 10.1038/nrc2998; LI L, 1995, MOL CELL BIOL, V15, P5396; Luijsterburg MS, 2010, J CELL BIOL, V189, P445, DOI 10.1083/jcb.200909175; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; MATSUDA T, 1995, J BIOL CHEM, V270, P4152, DOI 10.1074/jbc.270.8.4152; MATYUS L, 1992, J PHOTOCH PHOTOBIO B, V12, P323, DOI 10.1016/1011-1344(92)85039-W; Missura M, 2001, EMBO J, V20, P3554, DOI 10.1093/emboj/20.13.3554; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Naegeli H, 2011, DNA REPAIR, V10, P673, DOI 10.1016/j.dnarep.2011.04.019; Nakatsu Y, 2000, J BIOL CHEM, V275, P34931, DOI 10.1074/jbc.M004936200; Nitta M, 2000, NUCLEIC ACIDS RES, V28, P4212, DOI 10.1093/nar/28.21.4212; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; ODONOVAN A, 1994, J BIOL CHEM, V269, P15965; Otterlei M, 1999, EMBO J, V18, P3834, DOI 10.1093/emboj/18.13.3834; Otterlei M, 2006, J CELL SCI, V119, P5137, DOI 10.1242/jcs.03291; PARK CH, 1995, J BIOL CHEM, V270, P4896, DOI 10.1074/jbc.270.9.4896; PARK CH, 1994, P NATL ACAD SCI USA, V91, P5017, DOI 10.1073/pnas.91.11.5017; Rademakers S, 2003, MOL CELL BIOL, V23, P5755, DOI 10.1128/MCB.23.16.5755-5767.2003; Shell SM, 2009, J BIOL CHEM, V284, P24213, DOI 10.1074/jbc.M109.000745; SHIVJI MKK, 1992, CELL, V69, P367, DOI 10.1016/0092-8674(92)90416-A; Sirbu BM, 2012, NAT PROTOC, V7, P594, DOI 10.1038/nprot.2012.010; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Tashiro S, 1996, ONCOGENE, V12, P2165; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; Ward IM, 2001, J BIOL CHEM, V276, P47759, DOI 10.1074/jbc.C100569200; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yang ZG, 2002, BIOCHEMISTRY-US, V41, P13012, DOI 10.1021/bi026064z; You JS, 2003, J BIOL CHEM, V278, P7476, DOI 10.1074/jbc.M210603200	47	46	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49199	10.1371/journal.pone.0049199	http://dx.doi.org/10.1371/journal.pone.0049199			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152873	Green Submitted, gold, Green Published			2022-12-27	WOS:000311234600029
J	Eickholt, C; Siekiera, M; Kirmanoglou, K; Rodenbeck, A; Heussen, N; Schauerte, P; Lichtenberg, A; Balzer, J; Rassaf, T; Perings, S; Kelm, M; Shin, DI; Meyer, C				Eickholt, Christian; Siekiera, Marcus; Kirmanoglou, Kiriakos; Rodenbeck, Astrid; Heussen, Nicole; Schauerte, Patrick; Lichtenberg, Artur; Balzer, Jan; Rassaf, Tienush; Perings, Stefan; Kelm, Malte; Shin, Dong-In; Meyer, Christian			Improvement of Left Ventricular Function under Cardiac Resynchronization Therapy Goes along with a Reduced Incidence of Ventricular Arrhythmia	PLOS ONE			English	Article							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; CONGESTIVE-HEART-FAILURE; SOCIETY-OF-CARDIOLOGY; EUROPEAN-SOCIETY; RESYNCHRONISATION THERAPY; DILATED CARDIOMYOPATHY; FOLLOW-UP; ASSOCIATION; TRIAL; CRT	Objectives: The beneficial effects of cardiac resynchronization therapy (CRT) are thought to result from favorable left ventricular (LV) reverse remodeling, however CRT is only successful in about 70% of patients. Whether response to CRT is associated with a decrease in ventricular arrhythmias (VA) is still discussed controversially. Therefore, we investigated the incidence of VA in CRT responders in comparison with non-responders. Methods: In this nonrandomized, two-center, observational study patients with moderate-to-severe heart failure, LV ejection fraction (LVEF) <= 35%, and QRS duration >120 ms undergoing CRT were included. After 6 months patients were classified as CRT responders or non-responders. Incidence of VA was compared between both groups by Kaplan-Meier analysis and Cox regression analysis. ROC analysis was performed to determine the aptitude of LVEF cut-off values to predict VA. Results: In total 126 consecutive patients (64 +/- 11years; 67% male) were included, 74 were classified as responders and 52 as non-responders. While the mean LVEF at baseline was comparable in both groups (25 +/- 7% vs. 24 +/- 8%; P = 0.4583) only the responder group showed an improvement of LVEF (36 +/- 6% vs. 24 +/- 7; p<0.0001) under CRT. In total in 56 patients VA were observed during a mean follow-up of 28 +/- 14 months, with CRT responders experiencing fewer VA than non-responders (35% vs. 58%, p<0.0061). Secondary preventive CRT implantation was associated with a higher likelihood of VA. As determined by ROC analysis an increase of LVEF by >7% was found to be a predictor of a significantly lower incidence of VA (AUC = 0.606). Conclusions: Improvement of left ventricular function under cardiac resynchronization therapy goes along with a reduced incidence of ventricular arrhythmia.	[Eickholt, Christian; Siekiera, Marcus; Kirmanoglou, Kiriakos; Balzer, Jan; Rassaf, Tienush; Perings, Stefan; Kelm, Malte; Shin, Dong-In; Meyer, Christian] Univ Dusseldorf, Fac Med, Dept Cardiol Pulmol & Angiol, D-40225 Dusseldorf, Germany; [Rodenbeck, Astrid; Schauerte, Patrick] Univ Hosp RWTH Aachen, Div Cardiol Pulmol & Angiol, Aachen, Germany; [Heussen, Nicole] Univ Hosp RWTH Aachen, Dept Med Stat, Aachen, Germany; [Lichtenberg, Artur] Univ Dusseldorf, Dept Cardiovasc Surg, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; RWTH Aachen University; RWTH Aachen University Hospital; RWTH Aachen University; RWTH Aachen University Hospital; Heinrich Heine University Dusseldorf	Meyer, C (corresponding author), Univ Dusseldorf, Fac Med, Dept Cardiol Pulmol & Angiol, D-40225 Dusseldorf, Germany.	christian.meyer@med.uni-duesseldorf.de	Heussen, Nicole/Q-5309-2019; Eickholt, Christian/G-1466-2013; Heussen, Nicole/C-7006-2013; Meyer, Christian/G-2440-2013	Heussen, Nicole/0000-0002-6134-7206; Eickholt, Christian/0000-0002-5458-9688; Kelm, Malte/0000-0003-0060-1052; Meyer, Christian/0000-0002-9877-1393; Meyer, Christian/0000-0003-0217-3960	European Heart Rhythm Association; Hans-und-Gertie-Fischer Stiftung	European Heart Rhythm Association; Hans-und-Gertie-Fischer Stiftung	CM received support as a fellow of the European Heart Rhythm Association for the 1-year fellowship (advanced program) in interventional electrophysiology (mentor: Prof Helmut Purerfellner). CM is also the recipient of a research grant from the Hans-und-Gertie-Fischer Stiftung. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba T, 2012, J CARDIOVASC TRANSL, V5, P170, DOI 10.1007/s12265-012-9348-9; Aiba T, 2010, CURR OPIN CARDIOL, V25, P29, DOI 10.1097/HCO.0b013e328333d3d6; Anand IS, 2009, CIRCULATION, V119, P969, DOI 10.1161/CIRCULATIONAHA.108.793273; Arya A, 2005, HEART RHYTHM, V2, P1094, DOI 10.1016/j.hrthm.2005.07.007; Barsheshet A, 2011, J AM COLL CARDIOL, V57, P2416, DOI 10.1016/j.jacc.2010.12.041; Bax JJ, 2005, J AM COLL CARDIOL, V46, P2168, DOI 10.1016/j.jacc.2005.09.020; Boriani G, 2006, INT J CARDIOL, V108, P165, DOI 10.1016/j.ijcard.2005.04.029; Boriani G, 2010, FUND CLIN PHARMACOL, V24, P575, DOI 10.1111/j.1472-8206.2010.00853.x; Bradley DJ, 2003, JAMA-J AM MED ASSOC, V289, P730, DOI 10.1001/jama.289.6.730; Butter C, 2006, AM HEART J, V151, P115, DOI 10.1016/j.ahj.2005.02.047; Chakir K, 2009, CIRCULATION, V119, P1231, DOI 10.1161/CIRCULATIONAHA.108.774752; Chan CP, 2008, AM J CARDIOL, V102, P602, DOI 10.1016/j.amjcard.2008.04.032; Cleland JGF, 2006, EUR HEART J, V27, P1928, DOI 10.1093/eurheartj/ehl099; Daubert JC, 2012, HEART RHYTHM, V9, P1524, DOI 10.1016/j.hrthm.2012.07.025; Di Biase L, 2008, J AM COLL CARDIOL, V52, P1442, DOI 10.1016/j.jacc.2008.07.043; Di Cori A, 2005, J INTERV CARD ELECTR, V12, P231, DOI 10.1007/s10840-005-0338-6; Fish JM, 2005, J AM COLL CARDIOL, V46, P2340, DOI 10.1016/j.jacc.2005.08.035; Gehi AK, 2006, JAMA-J AM MED ASSOC, V296, P2839, DOI 10.1001/jama.296.23.2839; Guerra JM, 2003, J CARDIOVASC ELECTR, V14, P1245, DOI 10.1046/j.1540-8167.2003.03303.x; Higgins SL, 2000, J AM COLL CARDIOL, V36, P824, DOI 10.1016/S0735-1097(00)00795-6; Higgins SL, 2003, J AM COLL CARDIOL, V42, P1454, DOI 10.1016/S0735-1097(03)01042-8; Jenkins C, 2009, EUR HEART J, V30, P98, DOI 10.1093/eurheartj/ehn484; Kass DA, 2009, HEART RHYTHM, V6, P1660, DOI 10.1016/j.hrthm.2009.08.017; Kies P, 2005, AM J CARDIOL, V95, P1111, DOI 10.1016/j.amjcard.2005.01.029; Knappe D, 2011, CIRC-HEART FAIL, V4, P433, DOI 10.1161/CIRCHEARTFAILURE.111.962902; Koneru JN, 2011, CIRC-ARRHYTHMIA ELEC, V4, P778, DOI 10.1161/CIRCEP.110.961243; Kronborg MB, 2010, EUROPACE, V12, P216, DOI 10.1093/europace/eup364; Kurita T, 2011, J ELECTROCARDIOL, V44, P736, DOI 10.1016/j.jelectrocard.2011.09.002; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lellouche N, 2011, EUROPACE, V13, P1180, DOI 10.1093/europace/eur106; Leon AR, 2005, J CARDIOVASC ELECTR, V16, P100, DOI 10.1046/j.1540-8167.2005.04600.x; Lin G, 2008, HEART, V94, P186, DOI 10.1136/hrt.2007.118372; Linde C, 2002, J AM COLL CARDIOL, V40, P111, DOI 10.1016/S0735-1097(02)01932-0; Linde C, 2012, HEART RHYTHM, V9, pS3, DOI 10.1016/j.hrthm.2012.04.026; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Metra M, 2007, EUR J HEART FAIL, V9, P684, DOI 10.1016/j.ejheart.2007.04.003; Meyer C, 2009, INT HEART J, V50, P741, DOI 10.1536/ihj.50.741; Penicka M, 2004, CIRCULATION, V109, P978, DOI 10.1161/01.CIR.0000116765.43251.D7; Pouleur AC, 2011, EUR HEART J, V32, P1720, DOI 10.1093/eurheartj/ehr185; Sachse FB, 2012, CIRC RES, V110, P588, DOI 10.1161/CIRCRESAHA.111.257428; Singh JP, 2012, EUR HEART J, V33, P305, DOI 10.1093/eurheartj/ehr366; Steffel J, 2011, HEART, V97, P1668, DOI 10.1136/heartjnl-2011-300222; Sutton MSJ, 2009, CIRCULATION, V120, P1858, DOI 10.1161/CIRCULATIONAHA.108.818724; Ukkonen H, 2008, EUROPACE, V10, P114, DOI 10.1093/europace/eun228; Ypenburg C, 2006, J AM COLL CARDIOL, V48, P464, DOI 10.1016/j.jacc.2006.04.072; Ypenburg C, 2009, J AM COLL CARDIOL, V53, P483, DOI 10.1016/j.jacc.2008.10.032	46	12	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48926	10.1371/journal.pone.0048926	http://dx.doi.org/10.1371/journal.pone.0048926			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152822	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000035
J	Saygili, T; Akincilar, SC; Akgul, B; Nalbant, A				Saygili, Tahsin; Akincilar, Semih Can; Akgul, Bunyamin; Nalbant, Ayten			Aggregatibacter actinomycetemcomitans GroEL Protein Promotes Conversion of Human CD4+T Cells into IFN gamma IL10 Producing Tbet+Th1 Cells	PLOS ONE			English	Article							EFFECTOR T-CELLS; INTERFERON-GAMMA; INTERLEUKIN-10; INFECTION; INDUCTION; SECRETION; HOMOLOGS; ANTIBODY; DISTINCT; SUBSET	One of the heat shock family protein (Hsp) expressing bacteria is the gram negative, periodontal pathogen Aggregatibacter actinomycetemcomitans (Aa). A. actinomycetemcomitans' Hsp is a 64-kDa GroEL-protein, which has been shown to influence the host cells. In this study we used recombinant A. actinomycetemcomitans GroEL (rAaGroEL) protein as a model antigen to study GroEL-mediated T cell immune response. Human peripheral mononuclear cells (PBMCs), when stimulated with recombinant rAaGroEL, expressed early activation marker CD69 and IL-2R (CD25). CD25 and CD69 expressions were higher in CD4+ T cells compared to CD8+ T cells. rAaGroEL-responding CD4+ T cells expressed IL-10, IFN gamma and TNF alpha cytokines. Interestingly, there were also IL-10 and IFN gamma double cytokine producing CD4+ T cells. Additionally, IFN gamma expressing CD4+ T cells were also T-bet positive. Altogether the results suggest that rAaGroEL protein affects CD4+ T cells to differentiate into IFN gamma IL10-secreting T-bet+ Th1 cells.	[Saygili, Tahsin; Akincilar, Semih Can; Akgul, Bunyamin; Nalbant, Ayten] Izmir Inst Technol, Dept Mol Biol & Genet, Mol Immunol & Gene Regulat Lab, Urla Izmir, Turkey	Izmir Institute of Technology	Nalbant, A (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Mol Immunol & Gene Regulat Lab, Urla Izmir, Turkey.	aytennalbant@iyte.edu.tr	Akgül, Bünyamin/AAY-2958-2020	Akgül, Bünyamin/0000-0001-9877-9689; AKINCILAR, Semih Can/0000-0001-7588-2771	Scientific and Technological Research Council of Turkey (TUBITAK) [106T417]	Scientific and Technological Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by a grant from the Scientific and Technological Research Council of Turkey (TUBITAK) (Project# 106T417 to Ayten Nalbant). The funders had no role in study design, data collection and analysis, desicion to publish, or preparation of the manuscript.	Bansal A, 2010, MOL CELL BIOCHEM, V337, P213, DOI 10.1007/s11010-009-0301-4; BOYUM A, 1991, SCAND J IMMUNOL, V34, P697, DOI 10.1111/j.1365-3083.1991.tb01594.x; Chen JZ, 2009, CELL IMMUNOL, V254, P85, DOI 10.1016/j.cellimm.2008.09.001; Chen X, 2010, CURR DIR AUTOIMMUN, V11, P119, DOI 10.1159/000289201; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Gerosa F, 1999, CLIN IMMUNOL, V92, P224, DOI 10.1006/clim.1999.4752; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Henderson B, 2006, INFECT IMMUN, V74, P3693, DOI 10.1128/IAI.01882-05; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Leclerq S, 2002, J MED MICROBIOL, V51, P20, DOI 10.1099/0022-1317-51-1-20; Levy-Rimler G, 2002, FEBS LETT, V529, P1, DOI 10.1016/S0014-5793(02)03178-2; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Nalbant A, 2003, ORAL MICROBIOL IMMUN, V18, P339, DOI 10.1046/j.0902-0055.2003.00082.x; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Oliveira SC, 1996, CELL IMMUNOL, V172, P262, DOI 10.1006/cimm.1996.0241; Pohl-Koppe A, 1998, J IMMUNOL, V160, P1804; Qamra R, 2004, J MOL BIOL, V342, P605, DOI 10.1016/j.jmb.2004.07.066; RUBIN LA, 1985, J IMMUNOL, V135, P3172; Sharma SA, 1997, CLIN DIAGN LAB IMMUN, V4, P440, DOI 10.1128/CDLI.4.4.440-446.1997; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tabeta K, 2001, ORAL MICROBIOL IMMUN, V16, P290, DOI 10.1034/j.1399-302X.2001.016005290.x; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; ZIEGLER SF, 1993, EUR J IMMUNOL, V23, P1643, DOI 10.1002/eji.1830230737	25	15	15	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49252	10.1371/journal.pone.0049252	http://dx.doi.org/10.1371/journal.pone.0049252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152883	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000056
J	Davis, B; Johnston, R; Baker, R; Sheaves, M				Davis, Ben; Johnston, Ross; Baker, Ronald; Sheaves, Marcus			Fish Utilisation of Wetland Nurseries with Complex Hydrological Connectivity	PLOS ONE			English	Article							NORTHERN AUSTRALIAN ESTUARY; CHANOS-CHANOS; LIFE-HISTORY; WHITE PERCH; RIVER; FAUNA; ASSEMBLAGES; TURBIDITY; MILKFISH; SALINITY	The physical and faunal characteristics of coastal wetlands are driven by dynamics of hydrological connectivity to adjacent habitats. Wetlands on estuary floodplains are particularly dynamic, driven by a complex interplay of tidal marine connections and seasonal freshwater flooding, often with unknown consequences for fish using these habitats. To understand the patterns and subsequent processes driving fish assemblage structure in such wetlands, we examined the nature and diversity of temporal utilisation patterns at a species or genus level over three annual cycles in a tropical Australian estuarine wetland system. Four general patterns of utilisation were apparent based on CPUE and size-structure dynamics: (i) classic nursery utlisation (use by recently settled recruits for their first year) (ii) interrupted peristence (iii) delayed recruitment (iv) facultative wetland residence. Despite the small self-recruiting 'facultative wetland resident' group, wetland occupancy seems largely driven by connectivity to the subtidal estuary channel. Variable connection regimes (i. e. frequency and timing of connections) within and between different wetland units (e. g. individual pools, lagoons, swamps) will therefore interact with the diversity of species recruitment schedules to generate variable wetland assemblages in time and space. In addition, the assemblage structure is heavily modified by freshwater flow, through simultaneously curtailing persistence of the 'interrupted persistence' group, establishing connectivity for freshwater spawned members of both the 'facultative wetland resident' and 'delayed recruitment group', and apparently mediating use of intermediate nursery habitats for marine-spawned members of the 'delayed recruitment' group. The diversity of utilisation pattern and the complexity of associated drivers means assemblage compositions, and therefore ecosystem functioning, is likely to vary among years depending on variations in hydrological connectivity. Consequently, there is a need to incorporate this diversity into understandings of habitat function, conservation and management. Citation: Davis B, Johnston R, Baker R, Sheaves M (2012) Fish Utilisation of Wetland Nurseries with Complex Hydrological Connectivity. PLoS ONE 7(11): e49107. doi:10.1371/journal.pone.0049107	[Davis, Ben; Johnston, Ross; Baker, Ronald; Sheaves, Marcus] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Davis, B (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia.	benjamin.davis@my.jcu.edu.au	Sheaves, Marcus J/G-4283-2012; Baker, Ronald/J-9060-2014	Sheaves, Marcus J/0000-0003-0662-3439; Baker, Ronald/0000-0001-8408-0324	International Postgraduate Research Scholarship; Marine & Tropical Biology Research Faculty	International Postgraduate Research Scholarship(Australian Government); Marine & Tropical Biology Research Faculty	This research was conducted as part of a PhD thesis supported by an International Postgraduate Research Scholarship awarded by the Marine & Tropical Biology Research Faculty. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrantes K, 2008, ESTUAR COAST SHELF S, V80, P401, DOI 10.1016/j.ecss.2008.09.009; Allen DM, 2007, MAR ECOL PROG SER, V329, P57, DOI 10.3354/meps329057; BAGARINAO T, 1994, ENVIRON BIOL FISH, V39, P23, DOI 10.1007/BF00004752; Barletta M, 2005, J FISH BIOL, V66, P45, DOI 10.1111/j.0022-1112.2005.00582.x; BISHOP KA, 1995, AUST J ECOL, V20, P81, DOI 10.1111/j.1442-9993.1995.tb00524.x; Bishop KA, 1986, ECOLOGICAL STUDIES F; BLABER SJM, 1989, ESTUAR COAST SHELF S, V29, P509, DOI 10.1016/0272-7714(89)90008-5; Botsford Louis W., 1998, Canadian Special Publication of Fisheries and Aquatic Sciences, V125, P295; Bretsch K, 2006, ESTUAR COAST, V29, P474, DOI 10.1007/BF02784995; Brockmeyer R.E. Jr, 1997, Wetlands Ecology and Management, V4, P93, DOI 10.1007/BF01876231; Cai W, 2001, CLIM DYNAM, V17, P421, DOI 10.1007/PL00013738; CYRUS DP, 1992, ESTUAR COAST SHELF S, V35, P545, DOI 10.1016/S0272-7714(05)80038-1; DAVIS TLO, 1988, ENVIRON BIOL FISH, V21, P161, DOI 10.1007/BF00004860; DAVIS TLO, 1984, AUST J MAR FRESH RES, V35, P673; DESILVA SS, 1988, J FISH BIOL, V33, P689; Elliott M, 2007, FISH FISH, V8, P241, DOI 10.1111/j.1467-2679.2007.00253.x; Ellis WL, 2008, MAR ECOL PROG SER, V370, P207, DOI 10.3354/meps07567; Froese F., 2009, FISHBASE; Gehrke P, 2006, RES PRIORITIES SUSTA; Gomes LC, 2012, HYDROBIOLOGIA, V685, P97, DOI 10.1007/s10750-011-0870-6; Hohausova E, 2010, MAR FRESHWATER RES, V61, P682, DOI 10.1071/MF09140; Houston W, 2006, CONTRIBUTION FLOODPL, P209; Hyland SJ, 2002, QO02005 DEP PRIM IND; Johnston R, 2008, MAR ECOL PROG SER, V357, P255, DOI 10.3354/meps07297; Johnston R, 2007, J EXP MAR BIOL ECOL, V353, P164, DOI 10.1016/j.jembe.2007.05.039; Kothavala Z, 1999, ENVIRON MODELL SOFTW, V14, P243, DOI 10.1016/S1364-8152(98)00076-0; KOWARSKY J, 1981, AUST J MAR FRESH RES, V32, P93; KUMAGAI S, 1985, MAR ECOL PROG SER, V22, P1, DOI 10.3354/meps022001; Leis JM, 2009, MAR FRESHWATER RES, V60, P211, DOI 10.1071/MF08186; LEIS JM, 1991, ENVIRON BIOL FISH, V30, P395, DOI 10.1007/BF02027983; Leis JM, 2000, LAVAE INDO PACIFIC C, P82; McGrath P, 2009, T AM FISH SOC, V138, P966, DOI 10.1577/T08-176.1; Menon NN, 2000, HYDROBIOLOGIA, V430, P149, DOI 10.1023/A:1004033400255; Miskiewicz AG, 1998, LARVAE TEMPERATE AUS, P204; Miskiewicz AG, 1998, LARVAE TEMPERATE AUS, P226; Molony Brett W., 1998, Mangroves and Salt Marshes, V2, P177, DOI 10.1023/A:1009999621151; MOORE R, 1982, AUST J MAR FRESH RES, V33, P647; North EW, 2006, FISH OCEANOGR, V15, P429, DOI 10.1111/j.1365-2419.2005.00389.x; POLLOCK BR, 1983, J FISH BIOL, V22, P409, DOI 10.1111/j.1095-8649.1983.tb04762.x; PUCKRIDGE JT, 1990, AUST J MAR FRESH RES, V41, P695; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Ram ASP, 2003, LIMNOL OCEANOGR, V48, P1601, DOI 10.4319/lo.2003.48.4.1601; REYNOLDS LF, 1982, AUST J MAR FRESH RES, V33, P663; Ridd PV, 2002, ESTUAR COAST SHELF S, V54, P1039, DOI 10.1006/ecss.2001.0876; ROBERTSON AI, 1990, ESTUAR COAST SHELF S, V31, P723, DOI 10.1016/0272-7714(90)90022-J; Rountree RA, 2007, AQUAT ECOL, V41, P25, DOI 10.1007/s10452-006-9052-4; RUELLO NV, 1976, AUST J MAR FRESH RES, V27, P667; RUSSELL DJ, 1983, AUST J MAR FRESH RES, V34, P805; RUSSELL DJ, 1985, AUST J MAR FRESH RES, V36, P191, DOI 10.1071/MF9850191; Sanford LP, 2001, ESTUARIES, V24, P655, DOI 10.2307/1352874; SATO M, 1980, JPN J ICHTHYOL, V26, P315; Sheaves M, 2008, MAR ECOL PROG SER, V357, P225, DOI 10.3354/meps07292; Sheaves M, 2007, MAR FRESHWATER RES, V58, P931, DOI 10.1071/MF06246; Sheaves M, 2007, ESTUAR COAST, V30, P507, DOI 10.1007/BF02819397; Sheaves M, 2010, MAR ECOL PROG SER, V410, P143, DOI 10.3354/meps08655; Sheaves M, 2009, MAR ECOL PROG SER, V391, P107, DOI 10.3354/meps08121; Sheaves M, 2009, MAR ECOL PROG SER, V385, P245, DOI 10.3354/meps08040; Shen KN, 2009, MAR ECOL PROG SER, V387, P255, DOI 10.3354/meps08119; Staunton-Smith J, 1999, MAR FRESHWATER RES, V50, P643, DOI 10.1071/MF99007; Staunton-Smith J, 2004, MAR FRESHWATER RES, V55, P787, DOI 10.1071/MF03198; Thomas BE, 2001, MAR ECOL PROG SER, V209, P275, DOI 10.3354/meps209275; Ueda H, 2004, ECOL RES, V19, P625, DOI 10.1111/j.1440-1703.2004.00677.x; WALKER KF, 1985, HYDROBIOLOGIA, V125, P111, DOI 10.1007/BF00045929; WHITFIELD A K, 1979, Environmental Biology of Fishes, V4, P77, DOI 10.1007/BF00005931; WHITFIELD AK, 1990, ENVIRON BIOL FISH, V28, P295, DOI 10.1007/BF00751043	66	29	29	1	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49107	10.1371/journal.pone.0049107	http://dx.doi.org/10.1371/journal.pone.0049107			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152857	Green Published, Green Accepted, gold			2022-12-27	WOS:000312272600045
J	Lazard, DS; Vincent, C; Venail, F; Van de Heyning, P; Truy, E; Sterkers, O; Skarzynski, PH; Skarzynski, H; Schauwers, K; O'Leary, S; Mawman, D; Maat, B; Kleine-Punte, A; Huber, AM; Green, K; Govaerts, PJ; Fraysse, B; Dowell, R; Dillier, N; Burke, E; Beynon, A; Bergeron, F; Baskent, D; Artieres, F; Blamey, PJ				Lazard, Diane S.; Vincent, Christophe; Venail, Frederic; Van de Heyning, Paul; Truy, Eric; Sterkers, Olivier; Skarzynski, Piotr H.; Skarzynski, Henryk; Schauwers, Karen; O'Leary, Stephen; Mawman, Deborah; Maat, Bert; Kleine-Punte, Andrea; Huber, Alexander M.; Green, Kevin; Govaerts, Paul J.; Fraysse, Bernard; Dowell, Richard; Dillier, Norbert; Burke, Elaine; Beynon, Andy; Bergeron, Francois; Baskent, Deniz; Artieres, Francoise; Blamey, Peter J.			Pre-, Per- and Postoperative Factors Affecting Performance of Postlinguistically Deaf Adults Using Cochlear Implants: A New Conceptual Model over Time	PLOS ONE			English	Article							SPEECH RECOGNITION; RESIDUAL HEARING; ELECTRODE ARRAYS; NOISE-REDUCTION; EAR; INSERTION; RECIPIENTS; SYSTEMS; ASYMMETRY; POSITION	Objective: To test the influence of multiple factors on cochlear implant (CI) speech performance in quiet and in noise for postlinguistically deaf adults, and to design a model of predicted auditory performance with a CI as a function of the significant factors. Study Design: Retrospective multi-centre study. Methods: Data from 2251 patients implanted since 2003 in 15 international centres were collected. Speech scores in quiet and in noise were converted into percentile ranks to remove differences between centres. The influence of 15 pre-, per- and postoperative factors, such as the duration of moderate hearing loss (mHL), the surgical approach (cochleostomy or round window approach), the angle of insertion, the percentage of active electrodes, and the brand of device were tested. The usual factors, duration of profound HL (pHL), age, etiology, duration of CI experience, that are already known to have an influence, were included in the statistical analyses. Results: The significant factors were: the pure tone average threshold of the better ear, the brand of device, the percentage of active electrodes, the use of hearing aids (HAs) during the period of pHL, and the duration of mHL. Conclusions: A new model was designed showing a decrease of performance that started during the period of mHL, and became faster during the period of pHL. The use of bilateral HAs slowed down the related central reorganization that is the likely cause of the decreased performance. Citation: Lazard DS, Vincent C, Venail F, Van de Heyning P, Truy E, et al. (2012) Pre-, Per- and Postoperative Factors Affecting Performance of Postlinguistically Deaf Adults Using Cochlear Implants: A New Conceptual Model over Time. PLoS ONE 7(11):e48739. doi:10.1371/journal.pone.0048739	[Lazard, Diane S.; Blamey, Peter J.] Bion Inst, Melbourne, Vic, Australia; [Vincent, Christophe] Hop R Salengro, CHRU Lille, Serv Otol & Otoneurol, Lille, France; [Venail, Frederic; Artieres, Francoise] CHU Gui de Chauliac, Serv ORL & Chirurg Cervicofaciale, Montpellier, France; [Van de Heyning, Paul; Kleine-Punte, Andrea] Univ Antwerp, Dept Otorhinolaryngol & Head & Neck Surg, Univ Antwerp Hosp, B-2020 Antwerp, Belgium; [Truy, Eric] Hop Edouard Herriot, Hosp Civils Lyon, Dept ORL Chirurg Cervicomaxillofaciale & Audiopho, Lyon, France; [Sterkers, Olivier] Hop Beaujon, AP HP, Serv ORL & Chirurg Cervicofaciale, Clichy, France; [Skarzynski, Piotr H.; Skarzynski, Henryk] Inst Physiol & Pathol Hearing, Warsaw, Poland; [Skarzynski, Piotr H.] Inst Sensory Organs, Kajetany, Poland; [Schauwers, Karen; Govaerts, Paul J.] Eargrp, Antwerp, Belgium; [O'Leary, Stephen; Dowell, Richard; Blamey, Peter J.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Cochlear Implant Clin, Dept Otolaryngol, Melbourne, Vic 3002, Australia; [Mawman, Deborah; Green, Kevin] Univ Manchester, Cent Manchester Univ Hosp NHS Fdn Trust, Manchester, Lancs, England; [Maat, Bert; Baskent, Deniz] Univ Groningen, Univ Med Ctr Groningen, Dept Otorhinolaryngol Head & Neck Surg, Cochlear Implant Ctr No Netherlands, Groningen, Netherlands; [Huber, Alexander M.; Dillier, Norbert] Univ Zurich Hosp, Dept Otorhinolaryngol, CH-8091 Zurich, Switzerland; [Fraysse, Bernard] Hop Univ Purpan, Serv ORL & Chirurg Cervicofaciale, Toulouse, France; [Burke, Elaine] St Thomas Hosp, Auditory Implants Dept, London, England; [Beynon, Andy] Radboud Univ Nijmegen, Med Ctr, Mijmegen, Netherlands; [Bergeron, Francois] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Baskent, Deniz] Univ Groningen, Grad Sch Med Sci, Res Sch Behav & Cognit Neurosci, Groningen, Netherlands; [Artieres, Francoise] Inst St Pierre, Serv Audiophonol & ORL, Palavas Les Flots, France	Bionics Institute; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Montpellier; University of Antwerp; CHU Lyon; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institute of Physiology & Hearing Pathology; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Manchester; University of Groningen; University of Zurich; University Zurich Hospital; CHU de Toulouse; Guy's & St Thomas' NHS Foundation Trust; Radboud University Nijmegen; Laval University; University of Groningen	Lazard, DS (corresponding author), Bion Inst, Melbourne, Vic, Australia.	dianelazard@yahoo.fr	Venail, Frederic/AAG-5682-2020; Huber, Alexander M/A-2693-2009; Heyning, Paul H Vande/I-8278-2017; Dillier, Norbert/M-1301-2016; Skarzynski, Piotr H./A-9642-2012; Vincent, Christophe/F-6261-2016; truy, eric/J-9097-2017; Dowell, Richard/AAX-7046-2020; Beynon, Andy/L-4198-2015; Beynon, Andy/D-3476-2009	Huber, Alexander M/0000-0002-8888-8483; Heyning, Paul H Vande/0000-0002-8424-3717; Dillier, Norbert/0000-0002-6394-6915; Skarzynski, Piotr H./0000-0002-4978-1915; Vincent, Christophe/0000-0003-3201-7213; truy, eric/0000-0002-1769-8623; Beynon, Andy/0000-0002-3191-6113; Beynon, Andy/0000-0002-3191-6113; Blamey, Peter/0000-0002-7579-2255; Lazard, Diane/0000-0001-8329-1381; Skarzynski, Henryk/0000-0001-7141-9851; O'Leary, Stephen/0000-0001-6926-2103	Fondation Bettencourt-Schueller; Neurelec; Victorian Government through its Operational Infrastructure Support Program	Fondation Bettencourt-Schueller; Neurelec; Victorian Government through its Operational Infrastructure Support Program	DL was funded by Fondation Bettencourt-Schueller. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.; Most of the authors of this paper are involved in the purchase and application of cochlear implants from one or more of the four largest manufacturers (Advanced Bionics, Cochlear Limited, Med-El, and Neurelec). Peter Blamey is a co-inventor of technologies used in the device manufactured by Cochlear Limited and formerly received a share of royalties from the University of Melbourne. He is not a shareholder in Cochlear and no longer receives royalties. The hearing aid company, Blamey & Saunders Hearing Pty Ltd, regularly refers people with severe-to-profound hearing loss to cochlear implant clinics whenever it seems likely that a CI will provide a better clinical outcome than a HA. The Bionics Institute has a small shareholding in Cochlear Limited. DL received travel support from Cochlear in 2010/11. Neurelec partially funded her PhD work in 2009/10, but was not involved in the research project (fMRI). This dataset is a very rare resource enabling comparison of different devices from different manufacturers and from different cochlear implant clinics and the data analysts (Blamey and Lazard) designed the study and analysis in a way that treats data for these different devices equivalently to avoid any possibility of bias. Statistically significant differences between the device brands were found in the analysis, and the device brands have been de-identified in the manuscript to avoid use of the data for commercial advantage. This has been a difficult decision because de-identification of the brands is also withholding important information about clinical outcomes from potential patients and clinicians. The authors agree to share the (de-identified) data on request for academic, non-commercial purposes if the paper is published.; Salome Fontolliet (Faculte de medecine, Universite Laval, Quebec, Canada), Assia Terranti (Service d'otologie et d'otoneurologie, Hopital R.-Salengro, CHRU de Lille, Lille, France), Alexandra Rousset (Department of Otolaryngology, The University of Melbourne Cochlear Implant Clinic, The Royal Victorian Eye and Ear Hospital, Melbourne, Australia), Isabelle Mosnier (AP-HP, Hopital Beaujon, Service d'ORL et Chirurgie Cervico-Faciale, Clichy, France), Stephane Gallego (Hospices Civils de Lyon, Hopital Edouard Herriot, Departement d'ORL, de Chirurgie Cervico-Maxillo-Faciale et d'Audiophonologie, Lyon, France), Mathieu Marx (Hopital Universitaire Purpan, Service d'ORL et Chirurgie Cervico-Faciale, Toulouse, France), Alec Fitzgerald O' Connor (St Thomas' Hospital, Auditory Implants Department, London, United Kingdom) are acknowledged for their contribution in collecting a great amount of data. The Bionics Institute acknowledges the support it receives from the Victorian Government through its Operational Infrastructure Support Program.	Addams-Williams J, 2011, Cochlear Implants Int, V12 Suppl 2, pS36, DOI 10.1179/146701011X13074645127478; Blamey P, 1996, Audiol Neurootol, V1, P293; Blamey Peter J, 2005, Trends Amplif, V9, P77, DOI 10.1177/108471380500900203; BLAMEY PJ, 1992, ANN OTO RHINOL LARYN, V101, P342, DOI 10.1177/000348949210100410; Champoux F, 2009, NEUROPSYCHOLOGIA, V47, P17, DOI 10.1016/j.neuropsychologia.2008.08.028; Chen JM, 2001, OTOL NEUROTOL, V22, P335, DOI 10.1097/00129492-200105000-00011; Cullen RD, 2004, LARYNGOSCOPE, V114, P2218, DOI 10.1097/01.mlg.0000149462.88327.7f; DOOLEY GJ, 1993, ARCH OTOLARYNGOL, V119, P55; Finley CC, 2008, OTOL NEUROTOL, V29, P920, DOI 10.1097/MAO.0b013e318184f492; Firszt JB, 2009, OTOL NEUROTOL, V30, P146, DOI 10.1097/MAO.0b013e3181924ff8; Francis HW, 2005, EAR HEARING, V26, p7S, DOI 10.1097/00003446-200508001-00003; Friedland David R, 2009, Trends Amplif, V13, P124, DOI 10.1177/1084713809336422; Friedland DR, 2003, OTOL NEUROTOL, V24, P582, DOI 10.1097/00129492-200307000-00009; Giraud AL, 2007, RESTOR NEUROL NEUROS, V25, P381; Hamacher V, 1997, AM J OTOL, V18, pS46; Johnson JA, 2010, EAR HEARING, V31, P47, DOI 10.1097/AUD.0b013e3181b8397c; Kiefer J, 1998, AUDIOLOGY, V37, P382; Lambertz N, 2005, COGNITIVE BRAIN RES, V25, P884, DOI 10.1016/j.cogbrainres.2005.09.010; Lazard DS, 2011, NEUROPSYCHOLOGIA, V49, P2475, DOI 10.1016/j.neuropsychologia.2011.04.025; Lazard DS, 2010, NEUROIMAGE, V49, P3443, DOI 10.1016/j.neuroimage.2009.11.013; Lazard DS, 2013, HUM BRAIN MAPP, V34, P1208, DOI 10.1002/hbm.21504; Lazard DS, 2012, LARYNGOSCOPE, V122, P167, DOI 10.1002/lary.22370; Lenarz Thomas, 1998, Acta Oto-Rhino-Laryngologica Belgica, V52, P183; Loizou PC, 2005, J ACOUST SOC AM, V118, P2791, DOI 10.1121/1.2065847; Loizou Philipos C, 2006, Adv Otorhinolaryngol, V64, P109, DOI 10.1159/000094648; McDermott HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022358; Morris LG, 2007, OTOL NEUROTOL, V28, P25, DOI 10.1097/01.mao.0000244365.24449.00; OLEARY MJ, 1991, ANN OTO RHINOL LARYN, V100, P695, DOI 10.1177/000348949110000901; Olson AD, 2008, J AM ACAD AUDIOL, V19, P657, DOI 10.3766/jaaa.19.9.2; Pisoni David B, 2011, Ear Hear, V32, p60S, DOI 10.1097/AUD.0b013e3181ffd58e; Potts LG, 2009, J AM ACAD AUDIOL, V20, P353, DOI 10.3766/jaaa.20.6.4; Radeloff A, 2008, OTOL NEUROTOL, V29, P131, DOI 10.1097/MAO.0b013e318157f0ea; Rubinstein JT, 1999, AM J OTOL, V20, P445; Skarzynski H, 2010, MED SCI MONITOR, V16, pCR555; Skinner MW, 2007, ANN OTO RHINOL LARYN, V116, P2, DOI 10.1177/000348940711600401; Skinner MW, 2002, JARO-J ASSOC RES OTO, V3, P332, DOI 10.1007/s101620020013; Souter MA, 2011, OTOL NEUROTOL, V32, P58, DOI 10.1097/MAO.0b013e3182009f52; Spahr AJ, 2007, EAR HEARING, V28, P260, DOI 10.1097/AUD.0b013e3180312607; Strelnikov K, 2010, CEREB CORTEX, V20, P1217, DOI 10.1093/cercor/bhp183; Sucher Catherine M, 2009, Cochlear Implants Int, V10 Suppl 1, P96, DOI 10.1179/cim.2009.10.Supplement-1.96; Toner J, 2004, EAR HEARING, V25, P310, DOI 10.1097/01.AUD.0000134549.48718.53; van den Broek E, 2009, INT J AUDIOL, V48, P618, DOI 10.1080/14992020902931566; Verbist BM, 2008, AM J NEURORADIOL, V29, P1382, DOI 10.3174/ajnr.A1108; Yukawa K, 2004, AUDIOL NEURO-OTOL, V9, P163, DOI 10.1159/000077267; Zeng FG, 2011, SPRINGER HANDB AUDIT, V39, P1, DOI 10.1007/978-1-4419-9434-9_1	45	232	237	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48739	10.1371/journal.pone.0048739	http://dx.doi.org/10.1371/journal.pone.0048739			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152797	Green Accepted, gold, Green Published			2022-12-27	WOS:000312272600019
J	Li, XS; Ma, GJ				Li, Xingshan; Ma, Guojie			Word Boundaries Affect Visual Attention in Chinese Reading	PLOS ONE			English	Article							MODEL; PERCEPTION	In two experiments, we explored attention deployment during the reading of Chinese words using a probe detection task. In both experiments, Chinese readers saw four simplified Chinese characters briefly, and then a probe was presented at one of the character positions. The four characters constituted either one word or two words of two characters each. Reaction time was shorter when the probe was at the character 2 position than the character 3 position in the two-word condition, but not in the one-word condition. In Experiment 2, there were more trials and the materials were more carefully controlled, and the results replicated that of Experiment 1. These results suggest that word boundary information affects attentional deployment in Chinese reading. Citation: Li X, Ma G (2012) Word Boundaries Affect Visual Attention in Chinese Reading. PLoS ONE 7(11): e48905. doi:10.1371/journal.pone.0048905	[Li, Xingshan; Ma, Guojie] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS	Li, XS (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	lixs@psych.ac.cn	Li, Xingshan/HHM-6328-2022	Ma, Guojie/0000-0002-3688-9118	Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-YW-BR-6]; Natural Science Foundation of China [31070904]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-BR-6) and by a grant from the Natural Science Foundation of China (31070904). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen LH, 2011, ATTEN PERCEPT PSYCHO, V73, P1010, DOI 10.3758/s13414-010-0083-5; EGLY R, 1994, J EXP PSYCHOL GEN, V123, P161, DOI 10.1037/0096-3445.123.2.161; Engbert R, 2005, PSYCHOL REV, V112, P777, DOI 10.1037/0033-295X.112.4.777; Li XS, 2008, PSYCHON B REV, V15, P945, DOI 10.3758/PBR.15.5.945; Li XS, 2009, COGNITIVE PSYCHOL, V58, P525, DOI 10.1016/j.cogpsych.2009.02.003; MCCLELLAND JL, 1986, COGNITIVE PSYCHOL, V18, P1, DOI 10.1016/0010-0285(86)90015-0; MCCLELLAND JL, 1981, PSYCHOL REV, V88, P375, DOI 10.1037/0033-295X.88.5.375; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; RANEY GE, 1995, CAN J EXP PSYCHOL, V49, P151, DOI 10.1037/1196-1961.49.2.151; REICHER GM, 1969, J EXP PSYCHOL, V81, P275, DOI 10.1037/h0027768; Reichle ED, 1998, PSYCHOL REV, V105, P125, DOI 10.1037/0033-295X.105.1.125	11	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48905	10.1371/journal.pone.0048905	http://dx.doi.org/10.1371/journal.pone.0048905			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053LI	23152819	gold, Green Submitted, Green Published			2022-12-27	WOS:000312272600027
J	Mirina, A; Atzmon, G; Ye, K; Bergman, A				Mirina, Alexandra; Atzmon, Gil; Ye, Kenny; Bergman, Aviv			Gene Size Matters	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DATABASE; RISK	In this work we show that in genome-wide association studies (GWAS) there is a strong bias favoring of genes covered by larger numbers of SNPs. Thus, we state here that there is a need for correction for such bias when performing downstream gene-level analysis, e. g. pathway analysis and gene-set analysis. We investigate several methods of obtaining gene level statistical significance in GWAS, and compare their effectiveness in correcting such bias. We also propose a simple algorithm based on first order statistic that corrects such bias. Citation: Mirina A, Atzmon G, Ye K, Bergman A (2012) Gene Size Matters. PLoS ONE 7(11): e49093. doi: 10.1371/journal.pone.	[Ye, Kenny] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Mirina, Alexandra; Bergman, Aviv] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10467 USA; [Atzmon, Gil] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Atzmon, Gil] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Ye, K (corresponding author), Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA.	kenny.ye@einstein.yu.edu; aviv@einstein.yu.edu	Ye, Kenny/U-2341-2019; Ye, Kenny/GSM-7731-2022	Ye, Kenny/0000-0002-1466-855X; 	Ellison Medical Foundation Senior Scholar Award [AG-SS-2235]; National Institutes of Health [R01-AG028872, Project-1 of P01-AG027734]; NATIONAL INSTITUTE ON AGING [R01AG028872, P01AG027734] Funding Source: NIH RePORTER	Ellison Medical Foundation Senior Scholar Award(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by Ellison Medical Foundation Senior Scholar Award AG-SS-2235 (http://www.ellisonfoundation.org/) and National Institutes of Health grants R01-AG028872 and Project-1 of P01-AG027734 (http://www.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Dunlop MG, 2012, NAT GENET, V44, P770, DOI 10.1038/ng.2293; Fisher R., 1970, STAT METHODS RES WOR; Han MR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-90; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Junkins HA, CATALOG PUBLISHED GE; Lenth RV., 2006, JAVA APPLETS POWER S; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; TIMMANN C, 2012, NATURE	13	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49093	10.1371/journal.pone.0049093	http://dx.doi.org/10.1371/journal.pone.0049093			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152854	Green Submitted, Green Published, gold			2022-12-27	WOS:000312272600043
J	Sgaier, SK; Gupta, RS; Rao, R; Gaikwad, A; Harangule, S; Dhamne, S; Gowda, S; Jayakumar, S; Ramesh, BM				Sgaier, Sema K.; Gupta, Radhay S.; Rao, Raghuram; Gaikwad, Ajay; Harangule, Sonali; Dhamne, Suvidha; Gowda, Sateesh; Jayakumar, Sylvia; Ramesh, Banadakoppa M.			Prevention of Parent to Child Transmission (PPTCT) Program Data in India: An Emerging Data Set for Appraising the HIV Epidemic	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; SOUTH-INDIA; POPULATION; PREVALENCE; UTILITY; TRENDS	Background: Evidence based resource allocation and decentralized planning of an effective HIV/AIDS response requires reliable information on levels and trends of HIV at national and sub-national geographic levels. HIV sentinel surveillance data from antenatal clinics (HSS-ANC) has been an important data source to assess the HIV/AIDS epidemic in India, but has a number of limitations. We assess the value of Prevention of Parent to Child Transmission (PPTCT) programme data to appraise the HIV epidemic in India. Methods/Findings: HIV data from PPTCT sites were compared to HSS-ANC and general population level surveys at various geographic levels in the states of Karnataka, Maharashtra and Andhra Pradesh. Chi-square tests were used to ascertain statistical significance. PPTCT HIV prevalence was significantly lower than HSS-ANC HIV prevalence (0.92% vs. 1.22% in Andhra Pradesh, 0.65% vs. 0.89% in Karnataka, 0.52% vs. 0.60% in Maharashtra, p<0.001 for all three states). In all three states, HIV prevalence from PPTCT centres that were part of the sentinel surveillance was comparable to HSS-ANC prevalence but significantly higher than PPTCT centres that were not part of the sentinel surveillance. HIV prevalence from PPTCT data was comparable to that from general population surveys. In all three states, significant declines in HIV prevalence between 2007 and 2010 were observed with the PPTCT data set. District level analyses of HIV trends and subdistrict level analysis of HIV prevalence were possible using the PPTCT and not the HSS-ANC data sets. Conclusion: HIV prevalence from PPTCT may be a better proxy for general population prevalence than HSS-ANC. PPTCT data allow for analysis of HIV prevalence and trends at smaller geographic units, which is important for decentralized planning of HIV/AIDS programming. With further improvements to the system, India could replace its HSS-ANC with PPTCT programme data for surveillance.	[Sgaier, Sema K.; Jayakumar, Sylvia] Bill & Melinda Gates Fdn, Global Hlth Program, HIV Div, New Delhi, India; [Gupta, Radhay S.; Rao, Raghuram] Natl AIDS Control Org, Basic Serv, New Delhi, India; [Gaikwad, Ajay; Harangule, Sonali; Dhamne, Suvidha; Gowda, Sateesh; Ramesh, Banadakoppa M.] India Hlth Act Trust, Bangalore, Karnataka, India; [Ramesh, Banadakoppa M.] Karnataka Hlth Promot Trust, Bangalore, Karnataka, India; [Ramesh, Banadakoppa M.] Univ Manitoba, Dept Community Hlth Sci, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Sgaier, SK (corresponding author), Bill & Melinda Gates Fdn, Global Hlth Program, HIV Div, New Delhi, India.	sema.sgaier@gatesfoundation.org	Jayakumar, Sylvia/HHC-2583-2022		Public Health Foundation of India	Public Health Foundation of India	We thank NACO and SACS for providing the data, the Public Health Foundation of India for funding the study, Dr. Stephen Moses and Chris Parker for providing valuable comments on the manuscript, and the District AIDS Programme Control Unit officers in the three states for assisting with data collection and corrections.	[Anonymous], 2006, REP TECHN GROUP POP; Arora P, 2008, LANCET, V372, P289, DOI 10.1016/S0140-6736(08)61105-8; Bautista-Arredondo S, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327625.69974.08; Dandona L, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-308; Dandona L, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-31; [Department of AIDS Control National AIDS Control Organisation Ministry of Health and Family Welfare Government of India], 2012, GOV IND ANN REP 2011; Gouws E, 2008, SEX TRANSM INFECT, V84, pI17, DOI 10.1136/sti.2008.030452; Guidelines working group for Centers for Disease Contro, 2001, UPD GUID EV PUBL HLT; Hladik W, 2005, AIDS, V19, pS19, DOI 10.1097/01.aids.0000172873.82509.5e; International Institute for Population Sciences (IIPS) and Macro International, 2008, NAT FAM HLTH SURV NF; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2010, COUNTR PROGR REP UNG; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; Kumar R, 2010, INDIAN J MED RES, V132, P256; LAL S, 2003, INDIAN J COMMUNITY M, V28, P3; Mehendale S, 2010, INDIAN J MED RES, V132, P245; Ministry of Health and Family Welfare. Indian Institute of Population Sciences, 2010, DISTR LEV HOUS FAC S; Moses SA, 2006, AIDS S ASIA UNDERSTA; NACO, 2008, OP GUID HIV SENT SUR; National AIDS Control Organisation (NACO), 2006, TECHN REP IND HIV ES; [National AIDS Control Organization (NACO) Ministry of Health and Family Welfare Government of India], 1998, ANN SENT SURV HIV IN; [National AIDS Control Organization (NACO) Ministry of Health and Family Welfare Government of India], 2007, PREV PAR CHILD TRANS; [National AIDS Control Organization (NACO) Ministry of Health and Family Welfare Government of India], 2007, OP GUID INT COUNS TE; Office of the Registrar General and Census Commissioner Government of India, 2011, CENS 2011 PROV POP T; Office of the Registrar General and Census Commissioner India, 2009, SAMPL REG SYST B; Office of the Registrar General and Census Commissioner India, 2008, SAMPL REG SYST B; Rajaram S, 2008, HIV STIS BELGAUM DIS; Rajaram SBJ, 2010, LEVELS TRENDS HIV ST; Rajaram SSB, 2009, HIV STIS BELLARY DIS; Seguy N, 2006, PUBLIC HEALTH REP, V121, P695, DOI 10.1177/003335490612100609; Sgaier SK, 2012, SEX TRANSM INFECT, V88, P240, DOI 10.1136/sextrans-2011-050382; Wilson D, 2008, LANCET, V372, P423, DOI 10.1016/S0140-6736(08)60883-1; World Health Organization and Joint United Nations Programmes on HIV/AIDS, 2011, GUID 2 GEN HIV SURV	32	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48827	10.1371/journal.pone.0048827	http://dx.doi.org/10.1371/journal.pone.0048827			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166595	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300015
J	Zhong, KL; Song, WG; Wang, Q; Wang, C; Liu, X; Chen, DW; Zhu, ZL; Wu, YQ; Zhang, WJ; Zhang, MH				Zhong, Kaili; Song, Wengang; Wang, Qian; Wang, Chao; Liu, Xi; Chen, Dongwei; Zhu, Zhongli; Wu, Yiqing; Zhang, Weijing; Zhang, Minghui			Murine Myeloid Dendritic Cells That Phagocytose Apoptotic T Cells Inhibit the Immune Response via NO	PLOS ONE			English	Article							NITRIC-OXIDE; ANTIINFLAMMATORY RESPONSE; DEPENDENT BLOCKADE; STEM-CELLS; INDUCE; STAT3; ACTIVATION; TOLERANCE; PATHWAY; DC	The contraction phase of antigen-specific immune responses involves the apoptotic loss of numerous activated lymphocytes. While apoptotic cells are known to induce immune suppression, the mechanisms involved therein are still ambiguous. Some reports have speculated that macrophages can induce regulatory T cells (Tregs) after engulfing apoptotic cells. In this study, we showed that dendritic cells (DCs) that phagocytose apoptotic T cells acquire inhibitory function (named DCapos) toward CD4(+) and CD8(+) T cells. These inhibitory DCs could not induce the generation of Tregs, but they were found to directly inhibit mDCs that initiate CD4(+) and CD8(+) T cell proliferation both in vitro and in vivo. Soluble factors including NO play a role in the DCapos-induced suppression of CD4(+) and CD8(+) T cell proliferation. Further results showed that STAT3 phosphorylation and inducible nitric oxide synthase (iNOS) generation were enhanced when DCs were co-cultured with apoptotic cells. Both iNOS transcription and NO secretion were inhibited in the presence of the specific p-STAT3 inhibitor JSI-124. All the data indicated that apoptotic cells could turn DCs to inhibitory DCs, which might play important roles in the suppression of immune responses. STAT3 activation and the consequent release of NO are responsible for the inhibitory functions of DCapos.	[Zhong, Kaili; Zhang, Weijing] Acad Mil Med Sci, Affiliated Hosp, Dept Lymphoma, Beijing, Peoples R China; [Song, Wengang; Wang, Qian; Zhu, Zhongli] Taishan Med Coll, Dept Immunol, Tai An, Shandong, Peoples R China; [Wang, Chao; Liu, Xi; Chen, Dongwei; Wu, Yiqing; Zhang, Minghui] Tsinghua Univ, Sch Med, Inst Immunol, Beijing 100084, Peoples R China	Academy of Military Medical Sciences - China; Shandong First Medical University & Shandong Academy of Medical Sciences; Tsinghua University	Zhang, WJ (corresponding author), Acad Mil Med Sci, Affiliated Hosp, Dept Lymphoma, Beijing, Peoples R China.	zhangwj3072@163.com; mh-zhang@tsinghua.edu.cn	Zhang, Weijing/GQA-9455-2022		National Natural Science Foundation of China [81172791]; Project of Science and Technology of Shandong Province [2011GSF11835]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD) [200558]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Science and Technology of Shandong Province; Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD)(Foundation for the Author of National Excellent Doctoral Dissertation of China)	This work was supported by Grants from the National Natural Science Foundation of China (81172791), http://159.226.244.22/portal/Proj_List.asp, Project of Science and Technology of Shandong Province (2011GSF11835), Foundation for the Author of National Excellent Doctoral Dissertation of PR China (FANEDD, 200558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarilyo G, 2010, EUR J IMMUNOL, V40, P699, DOI 10.1002/eji.200838951; Bai B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007869; Cao XM, 1996, MOL CELL BIOL, V16, P1595; Cheng FD, 2003, IMMUNITY, V19, P425, DOI 10.1016/S1074-7613(03)00232-2; Fransen JH, 2009, AUTOIMMUNITY, V42, P325, DOI 10.1080/08916930902828049; Haidinger M, 2010, J IMMUNOL, V185, P3919, DOI 10.4049/jimmunol.1000296; Huang CF, 2008, J NEUROIMMUNOL, V204, P118, DOI 10.1016/j.jneuroim.2008.07.004; Hutton JF, 2009, J LEUKOCYTE BIOL, V85, P445, DOI 10.1189/jlb.1008620; Karaghiosoff M, 2000, IMMUNITY, V13, P549, DOI 10.1016/S1074-7613(00)00054-6; Kushwah R, 2010, EUR J IMMUNOL, V40, P1022, DOI 10.1002/eji.200939782; Kushwah R, 2009, J IMMUNOL, V183, P7104, DOI 10.4049/jimmunol.0900824; Li Q, 2008, EUR J IMMUNOL, V38, P2751, DOI 10.1002/eji.200838542; Liu QY, 2009, J IMMUNOL, V182, P6207, DOI 10.4049/jimmunol.0803926; Liu X, 2003, CANCER GENE THER, V10, P529, DOI 10.1038/sj.cgt.7700596; Lleo A, 2008, J AUTOIMMUN, V31, P257, DOI 10.1016/j.jaut.2008.04.009; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Marguti I, 2009, IMMUNOLOGY, V127, P50, DOI 10.1111/j.1365-2567.2008.02927.x; Meliilo JA, 2010, J IMMUNOL, V184, P2638, DOI 10.4049/jimmunol.0902960; Morelli AE, 2003, BLOOD, V101, P611, DOI 10.1182/blood-2002-06-1769; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nefedova Y, 2005, J IMMUNOL, V175, P4338, DOI 10.4049/jimmunol.175.7.4338; Park SY, 2008, CYTOKINE, V44, P126, DOI 10.1016/j.cyto.2008.07.006; Park SJ, 2004, J IMMUNOL, V173, P3844, DOI 10.4049/jimmunol.173.6.3844; Perruche S, 2008, NAT MED, V14, P528, DOI 10.1038/nm1749; Ren GW, 2008, J IMMUNOL, V181, P3277, DOI 10.4049/jimmunol.181.5.3277; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Sen P, 2007, BLOOD, V109, P653, DOI 10.1182/blood-2006-04-017368; Shao WH, 2009, CLIN IMMUNOL, V133, P138, DOI 10.1016/j.clim.2009.06.002; Steinman RM, 2000, J EXP MED, V191, P411, DOI 10.1084/jem.191.3.411; Sun YP, 2009, J IMMUNOL, V182, P5899, DOI 10.4049/jimmunol.0804388; Tang H, 2006, BLOOD, V108, P1189, DOI 10.1182/blood-2006-01-007187; Tassiulas I, 2007, HUM IMMUNOL, V68, P156, DOI 10.1016/j.humimm.2006.12.008; Thorp EB, 2010, APOPTOSIS, V15, P1124, DOI 10.1007/s10495-010-0516-6; Walker MR, 2005, P NATL ACAD SCI USA, V102, P4103, DOI 10.1073/pnas.0407691102; Wallet MA, 2008, J EXP MED, V205, P219, DOI 10.1084/jem.20062293; Wang TH, 2004, NAT MED, V10, P48, DOI 10.1038/nm976; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Williams CA, 2008, IMMUNOLOGY, V124, P89, DOI 10.1111/j.1365-2567.2007.02743.x; Yamazaki S, 2008, J IMMUNOL, V181, P6923, DOI 10.4049/jimmunol.181.10.6923; Yi ZA, 2009, BLOOD, V114, P3191, DOI 10.1182/blood-2009-03-207522; Yu ZY, 2004, J AM SOC NEPHROL, V15, P585, DOI 10.1097/01.ASN.0000114556.19556.F9; Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138; Zhang MH, 2004, NAT IMMUNOL, V5, P1124, DOI 10.1038/ni1130; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	44	13	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49378	10.1371/journal.pone.0049378	http://dx.doi.org/10.1371/journal.pone.0049378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166651	gold, Green Submitted, Green Published			2022-12-27	WOS:000311272300039
J	Gill, N; Ferreira, RBR; Antunes, LCM; Willing, BP; Sekirov, I; Al-Zahrani, F; Hartmann, M; Finlay, BB				Gill, Navkiran; Ferreira, Rosana B. R.; Antunes, L. Caetano M.; Willing, Benjamin P.; Sekirov, Inna; Al-Zahrani, Fatimah; Hartmann, Martin; Finlay, B. Brett			Neutrophil Elastase Alters the Murine Gut Microbiota Resulting in Enhanced Salmonella Colonization	PLOS ONE			English	Article							INTESTINAL MICROBIOTA; RIBOSOMAL-RNA; INFLAMMATION; TYPHIMURIUM; SUSCEPTIBILITY; INFECTION; HEALTH; CELLS	The intestinal microbiota has been found to play a central role in the colonization of Salmonella enterica serovar Typhimurium in the gastrointestinal tract. In this study, we present a novel process through which Salmonella benefit from inflammatory induced changes in the microbiota in order to facilitate disease. We show that Salmonella infection in mice causes recruitment of neutrophils to the gut lumen, resulting in significant changes in the composition of the intestinal microbiota. This occurs through the production of the enzyme elastase by neutrophils. Administration of recombinant neutrophil elastase to infected animals under conditions that do not elicit neutrophil recruitment caused shifts in microbiota composition that favored Salmonella colonization, while inhibition of neutrophil elastase reduced colonization. This study reveals a new relationship between the microbiota and the host during infection.	[Gill, Navkiran; Ferreira, Rosana B. R.; Antunes, L. Caetano M.; Willing, Benjamin P.; Sekirov, Inna; Finlay, B. Brett] Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Gill, N (corresponding author), Univ British Columbia, Michael Smith Labs, Vancouver, BC V5Z 1M9, Canada.	bfinlay@interchange.ubc.ca	Ferreira, Rosana/E-5169-2013; Hartmann, Martin/M-9371-2016; Ferreira, Rosana BR/A-3682-2019; Martha Antunes, Luis Caetano/B-6864-2012; Willing, Benjamin/AAA-9650-2019; Antunes, Luis Caetano Martha/P-4988-2019	Hartmann, Martin/0000-0001-8069-5284; Ferreira, Rosana BR/0000-0002-7162-0026; Martha Antunes, Luis Caetano/0000-0002-4933-2570; 	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Antunes LCM, 2011, INFECT IMMUN, V79, P1759, DOI 10.1128/IAI.01373-10; Antunes LCM, 2011, ANTIMICROB AGENTS CH, V55, P1494, DOI 10.1128/AAC.01664-10; Antunes LCM, 2011, GUT MICROBES, V2, P105, DOI 10.4161/gmic.2.2.15610; Arnott IDR, 2001, EUR J GASTROEN HEPAT, V13, P239, DOI 10.1097/00042737-200103000-00004; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Bergman MA, 2005, INFECT IMMUN, V73, P7226, DOI 10.1128/IAI.73.11.7226-7235.2005; Bevins CL, 2011, NAT REV MICROBIOL, V9, P356, DOI 10.1038/nrmicro2546; BOHNHOFF M, 1954, P SOC EXP BIOL MED, V86, P132, DOI 10.3181/00379727-86-21030; Carr KD, 2011, EUR J IMMUNOL, DOI 101002/eji201041363; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Desantis TZ, 2011, ISME J; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ferreira RBR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020338; Gill N, 2011, CELL MICROBIOL, V13, P660, DOI 10.1111/j.1462-5822.2011.01578.x; Hao XL, 2011, BIOINFORMATICS, V27, P611, DOI 10.1093/bioinformatics/btq725; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hartmann M, 2010, J MICROBIOL METH, V83, P250, DOI 10.1016/j.mimet.2010.08.008; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Legendre P., 2012, NUMERICAL ECOLOGY; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; MILLER CP, 1963, J INFECT DIS, V113, P59, DOI 10.1093/infdis/113.1.59; Mumy KL, 2009, CURR OPIN PHARMACOL, V9, P697, DOI 10.1016/j.coph.2009.10.004; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Osborne CA, 2006, APPL ENVIRON MICROB, V72, P1270, DOI 10.1128/AEM.72.2.1270-1278.2006; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Sekirov I, 2008, INFECT IMMUN, V76, P4726, DOI 10.1128/IAI.00319-08; Sekirov I, 2010, GUT MICROBES, V1, P30, DOI 10.4161/gmic.1.1.10950; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Stelter C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020749; Tate MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017618; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Yanagihara K, 2007, EXP LUNG RES, V33, P71, DOI 10.1080/01902140701198500	38	46	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49646	10.1371/journal.pone.0049646	http://dx.doi.org/10.1371/journal.pone.0049646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155475	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900178
J	Grizante, MB; Brandt, R; Kohlsdorf, T				Grizante, Mariana B.; Brandt, Renata; Kohlsdorf, Tiana			Evolution of Body Elongation in Gymnophthalmid Lizards: Relationships with Climate	PLOS ONE			English	Article							CONVERGENT EVOLUTION; PRINCIPAL-COMPONENTS; PATTERNS; FORM; PERSPECTIVE; LOCOMOTION; RESOLUTION; SQUAMATA; MAINLAND; REPTILES	The evolution of elongated body shapes in vertebrates has intrigued biologists for decades and is particularly recurrent among squamates. Several aspects might explain how the environment influences the evolution of body elongation, but climate needs to be incorporated in this scenario to evaluate how it contributes to morphological evolution. Climatic parameters include temperature and precipitation, two variables that likely influence environmental characteristics, including soil texture and substrate coverage, which may define the selective pressures acting during the evolution of morphology. Due to development of geographic information system (GIS) techniques, these variables can now be included in evolutionary biology studies and were used in the present study to test for associations between variation in body shape and climate in the tropical lizard family Gymnophthalmidae. We first investigated how the morphological traits that define body shape are correlated in these lizards and then tested for associations between a descriptor of body elongation and climate. Our analyses revealed that the evolution of body elongation in Gymnophthalmidae involved concomitant changes in different morphological traits: trunk elongation was coupled with limb shortening and a reduction in body diameter, and the gradual variation along this axis was illustrated by less-elongated morphologies exhibiting shorter trunks and longer limbs. The variation identified in Gymnophthalmidae body shape was associated with climate, with the species from more arid environments usually being more elongated. Aridity is associated with high temperatures and low precipitation, which affect additional environmental features, including the habitat structure. This feature may influence the evolution of body shape because contrasting environments likely impose distinct demands for organismal performance in several activities, such as locomotion and thermoregulation. The present study establishes a connection between morphology and a broader natural component, climate, and introduces new questions about the spatial distribution of morphological variation among squamates.	[Grizante, Mariana B.; Brandt, Renata; Kohlsdorf, Tiana] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Grizante, MB (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Biol, BR-14049 Ribeirao Preto, SP, Brazil.	tiana@usp.br	Brandt, Renata/H-4112-2013; Fapesp, Biota/F-8655-2017; Kohlsdorf, Tiana/C-3463-2012	Brandt, Renata/0000-0002-8725-2360; Fapesp, Biota/0000-0002-9887-8449; Kohlsdorf, Tiana/0000-0002-3873-2042; Bortoletto Grizante, Mariana/0000-0001-5209-8589				Avila-Pires T.C.S., 1995, Zoologische Verhandelingen (Leiden), V299, P1; Barros FC, 2011, J EVOLUTION BIOL, V24, P2423, DOI 10.1111/j.1420-9101.2011.02372.x; BARTHOLOMEW G. A., 1964, PHYSIOL ZOOL, V37, P341; Brandley MC, 2008, EVOLUTION, V62, P2042, DOI 10.1111/j.1558-5646.2008.00430.x; Brandt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020040; Buchholtz EA, 2007, EVOL DEV, V9, P278, DOI 10.1111/j.1525-142X.2007.00160.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calsbeek R, 2006, EVOL ECOL, V20, P377, DOI 10.1007/s10682-006-0007-y; Cassimiro J, 2008, ZOOTAXA, P59, DOI 10.11646/zootaxa.1761.1.6; Castoe TA, 2004, SYST BIOL, V53, P448, DOI 10.1080/10635150490445797; Clusella-Trullas S, 2011, AM NAT, V177, P738, DOI 10.1086/660021; DUNHAM AE, 1978, ECOLOGY, V59, P770, DOI 10.2307/1938781; DUNSON WA, 1991, AM NAT, V138, P1067, DOI 10.1086/285270; GANS C, 1975, AM ZOOL, V15, P455; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Greer AE, 2003, J HERPETOL, V37, P554, DOI 10.1670/138-02N; GRIFFITH H, 1990, COPEIA, P751, DOI 10.2307/1446441; Grizante MB, 2010, J EVOLUTION BIOL, V23, P98, DOI 10.1111/j.1420-9101.2009.01868.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Irschick DJ, 1997, ECOLOGY, V78, P2191, DOI 10.2307/2265955; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Kohlsdorf T, 2006, EVOLUTION, V60, P1896; Kozak KH, 2008, TRENDS ECOL EVOL, V23, P141, DOI 10.1016/j.tree.2008.02.001; LANDE R, 1978, EVOLUTION, V32, P73, DOI 10.1111/j.1558-5646.1978.tb01099.x; Lee MSY, 1998, BIOL J LINN SOC, V65, P369, DOI 10.1111/j.1095-8312.1998.tb01148.x; Lejeune TM, 1998, J EXP BIOL, V201, P2071; Luxbacher AM, 2009, J EVOLUTION BIOL, V22, P1669, DOI 10.1111/j.1420-9101.2009.01779.x; Maddison WP, 2011, MESQUITE MODULAR SYS; Midford PE, 2010, PDAP PDTREE TRANSLAT; MOERMOND TC, 1979, ECOLOGY, V60, P152, DOI 10.2307/1936477; Narita Y, 2005, J EXP ZOOL PART B, V304B, P91, DOI 10.1002/jez.b.21029; Oufiero CE, 2011, EVOLUTION, V65, P3590, DOI 10.1111/j.1558-5646.2011.01405.x; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PAGEL MD, 1992, J THEOR BIOL, V156, P431, DOI 10.1016/S0022-5193(05)80637-X; Parra-Olea G, 2001, P NATL ACAD SCI USA, V98, P7888, DOI 10.1073/pnas.131203598; Pellegrino KCM, 1999, HEREDITAS, V131, P15, DOI 10.1111/j.1601-5223.1999.00015.x; Pellegrino KCM, 2001, BIOL J LINN SOC, V74, P315, DOI 10.1006/bijl.2001.0580; POUNDS JA, 1988, ECOL MONOGR, V58, P299, DOI 10.2307/1942542; PRESCH W, 1980, COPEIA, P36, DOI 10.2307/1444132; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RENOUS S, 1989, COPEIA, P837, DOI 10.2307/1445966; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Revell LJ, 2010, METHODS ECOL EVOL, V1, P319, DOI 10.1111/j.2041-210X.2010.00044.x; Revell LJ, 2009, EVOLUTION, V63, P3258, DOI 10.1111/j.1558-5646.2009.00804.x; Rodrigues MT, 1996, J HERPETOL, V30, P513, DOI 10.2307/1565694; SCHMIDTNIELSEN K, 1989, SCALING WHY IS ANIMA; SHERBROOKE W C, 1975, Biotropica, V7, P194, DOI 10.2307/2989623; SHINE R, 1986, COPEIA, P525, DOI 10.2307/1445013; Skinner A, 2009, EVOL BIOL, V36, P292, DOI 10.1007/s11692-009-9064-9; Tieleman BI, 2003, P ROY SOC B-BIOL SCI, V270, P207, DOI 10.1098/rspb.2002.2205; VITT LJ, 1982, J HERPETOL, V16, P325, DOI 10.2307/1563730; Ward AB, 2004, ZOOLOGY, V107, P205, DOI 10.1016/j.zool.2004.04.003; Ward AB, 2007, BIOL J LINN SOC, V90, P97, DOI 10.1111/j.1095-8312.2007.00714.x; Warheit KI, 1999, EVOLUTION, V53, P1226, DOI 10.1111/j.1558-5646.1999.tb04535.x; Wiens JJ, 2006, EVOLUTION, V60, P123, DOI 10.1111/j.0014-3820.2006.tb01088.x; Wiens JJ, 2001, EVOLUTION, V55, P2303; Williams EE, 1983, LIZARD ECOLOGY STUDI; Yamada T, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-145	62	38	38	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49772	10.1371/journal.pone.0049772	http://dx.doi.org/10.1371/journal.pone.0049772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166767	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900191
J	Hasan, MA; Abbott, D; Baumert, M				Hasan, Muhammad A.; Abbott, Derek; Baumert, Mathias			Beat-to-Beat Vectorcardiographic Analysis of Ventricular Depolarization and Repolarization in Myocardial Infarction	PLOS ONE			English	Article							QT INTERVAL VARIABILITY; WAVE MORPHOLOGY; 12-LEAD ELECTROCARDIOGRAM; RISK STRATIFICATION; CARDIOVASCULAR MORTALITY; HEART-FAILURE; ECG; CARDIOMYOPATHY; DISPERSION; DERIVATION	Objectives: Increased beat-to-beat variability in the QT interval has been associated with heart disease and mortality. The purpose of this study was to investigate the beat-to-beat spatial and temporal variations of ventricular depolarization and repolarization in vectorcardiogram (VCG) for characterising myocardial infarction (MI) patients. Methods: Standard 12-lead ECGs of 84 MI patients (22 f, 63 +/- 12 yrs; 62 m, 56 +/- 10 yrs) and 69 healthy subjects (17 f, 42 +/- 18 yrs; 52 m, 40 +/- 13 yrs) were investigated. To extract the beat-to-beat QT intervals, a template-matching algorithm and the singular value decomposition method have been applied to synthesise the ECG data to VCG. Spatial and temporal variations in the QRS complex and T-wave loops were studied by investigating several descriptors (point-to-point distance variability, mean loop length, T-wave morphology dispersion, percentage of loop area, total cosine R-to-T). Results: Point-to-point distance variability of QRS and T-loops (0.13 +/- 0.04 vs. 0.10 +/- 0.04, p<0.0001 and 0.16 +/- 0.07 vs. 0.13 +/- 0.06, p<0.05) were significantly larger in the MI group than in the control group. The average T-wave morphology dispersion was significantly higher in the MI group than in the control group (62 degrees +/- 8 degrees vs. 38 degrees +/- 16 degrees, p<0.0001). Further, its beat-to-beat variability appeared significantly lower in the MI group than in the control group (12 degrees +/- 5 degrees vs. 15 degrees +/- 6 degrees, p<0.005). Moreover, the average percentage of the T-loop area was found significantly lower in the MI group than the controls (46 +/- 17 vs. 55 +/- 15, p<0.001). Finally, the average and beat-to-beat variability of total cosine R-to-T were not found statistically significant between both groups. Conclusions: Beat-to-beat assessment of VCG parameters may have diagnostic attributes that might help in identifying MI patients.	[Hasan, Muhammad A.; Abbott, Derek; Baumert, Mathias] Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia	University of Adelaide	Baumert, M (corresponding author), Univ Adelaide, Sch Elect & Elect Engn, Adelaide, SA, Australia.	mathias.baumert@adelaide.edu.au	Hasan, Muhammad/B-4870-2016; Abbott, Derek/E-8352-2011; Baumert, Mathias/A-8324-2008	Hasan, Muhammad/0000-0002-2447-0299; Abbott, Derek/0000-0002-0945-2674; Baumert, Mathias/0000-0003-2984-2167				Acar B, 1999, MED BIOL ENG COMPUT, V37, P574, DOI 10.1007/BF02513351; Acar B, 1999, IEEE T BIOMEDICAL EN; Atiga WL, 1998, J CARDIOVASC ELECTR, V9, P899, DOI 10.1111/j.1540-8167.1998.tb00130.x; Baumert M, 2008, SLEEP, V31, P959; Baumert M, 2011, AM J PHYSIOL-HEART C, V300, pH1412, DOI 10.1152/ajpheart.01184.2010; BELLOCH JA, 2007, COMPUT CARDIOL, P435; Berger RD, 1997, CIRCULATION, V96, P1557, DOI 10.1161/01.CIR.96.5.1557; Carlson J, 2005, EUROPACE, V7, pS39, DOI 10.1016/j.eupc.2005.04.012; CHOU TC, 1986, J AM COLL CARDIOL, V8, P791, DOI 10.1016/S0735-1097(86)80419-3; Cortez DL, 2010, J ELECTROCARDIOL, V43, P302, DOI 10.1016/j.jelectrocard.2010.03.010; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Guillem MS, 2008, J ELECTROCARDIOL, V41, P19, DOI 10.1016/j.jelectrocard.2007.07.003; Haarmark C, 2009, J ELECTROCARDIOL, V42, P555, DOI 10.1016/j.jelectrocard.2009.06.009; Hasan MA, 2012, ANN NONINVAS ELECTRO, V17, P195, DOI 10.1111/j.1542-474X.2012.00508.x; Huang HC, 2009, EUROPACE, V11, P1522, DOI 10.1093/europace/eup294; Jindal RD, 2009, SCHIZOPHR RES, V113, P176, DOI 10.1016/j.schres.2009.06.003; Kentta T, 2011, EUROPACE, V13, P701, DOI 10.1093/europace/euq461; Kentta T, 2010, ANN NONINVAS ELECTRO, V15, P264, DOI 10.1111/j.1542-474X.2010.00374.x; Lin CY, 2007, NEPHROL DIAL TRANSPL, V22, P2645, DOI 10.1093/ndt/gfm238; Man S, 2009, COMPUT CARDIOL, V36, P277; Murabayashi T, 2002, J ELECTROCARDIOL, V35, P19, DOI 10.1054/jelc.2002.30250; Ono T, 2005, CIRC J, V69, P666, DOI 10.1253/circj.69.666; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Perkiomaki JS, 2006, AM J CARDIOL, V97, P353, DOI 10.1016/j.amjcard.2005.08.052; PERKIOMAKI JS, 1995, J AM COLL CARDIOL, V26, P174, DOI 10.1016/0735-1097(95)00122-G; Piccirillo G, 2009, J AM COLL CARDIOL, V54, P840, DOI 10.1016/j.jacc.2009.06.008; Porthan K, 2009, HEART RHYTHM, V6, P1202, DOI 10.1016/j.hrthm.2009.05.006; RAUTAHARJU PM, 1973, J ELECTROCARDIOL, V6, P103, DOI 10.1016/S0022-0736(73)80003-2; Shvilkin A, 2010, HEART RHYTHM, V7, P1085, DOI 10.1016/j.hrthm.2010.05.024; Shvilkin A, 2009, HEART RHYTHM, V6, P943, DOI 10.1016/j.hrthm.2009.03.025; Smetana P, 2004, AM J PHYSIOL-HEART C, V286, pH131, DOI 10.1152/ajpheart.00479.2003; Sornmo L, 1998, J ELECTROCARDIOL, V31, P336, DOI 10.1016/S0022-0736(98)90019-X; Strauss DG, 2009, J ELECTROCARDIOL, V42, P190, DOI 10.1016/j.jelectrocard.2008.12.018; Szydlo K, 2010, CARDIOL J, V17, P244; Tereshchenko LG, 2010, HEART RHYTHM, V7, P1606, DOI 10.1016/j.hrthm.2010.08.022; Turrini P, 2001, CIRCULATION, V103, P3075, DOI 10.1161/01.CIR.103.25.3075; Vrtovec B, 2000, J ELECTROCARDIOL, V33, P119, DOI 10.1016/S0022-0736(00)80068-0; Zabel M, 2000, CIRCULATION, V102, P1252, DOI 10.1161/01.CIR.102.11.1252	38	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49489	10.1371/journal.pone.0049489	http://dx.doi.org/10.1371/journal.pone.0049489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166683	Green Published, gold			2022-12-27	WOS:000311151900150
J	Holman, AG; Gabuzda, D				Holman, Alexander G.; Gabuzda, Dana			A Machine Learning Approach for Identifying Amino Acid Signatures in the HIV Env Gene Predictive of Dementia	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; ACTIVE ANTIRETROVIRAL THERAPY; ENHANCES MACROPHAGE TROPISM; CENTRAL-NERVOUS-SYSTEM; TYPE-1 R5 ENVELOPES; V3 LOOP; NEUROCOGNITIVE DISORDERS; CEREBROSPINAL-FLUID; AIDS PATIENTS; CHEMOKINE RECEPTORS	The identification of nucleotide sequence variations in viral pathogens linked to disease and clinical outcomes is important for developing vaccines and therapies. However, identifying these genetic variations in rapidly evolving pathogens adapting to selection pressures unique to each host presents several challenges. Machine learning tools provide new opportunities to address these challenges. In HIV infection, virus replicating within the brain causes HIV-associated dementia (HAD) and milder forms of neurocognitive impairment in 20-30% of patients with unsuppressed viremia. HIV neurotropism is primarily determined by the viral envelope (env) gene. To identify amino acid signatures in the HIV env gene predictive of HAD, we developed a machine learning pipeline using the PART rule-learning algorithm and C4.5 decision tree inducer to train a classifier on a meta-dataset (n = 860 env sequences from 78 patients: 40 HAD, 38 non-HAD). To increase the flexibility and biological relevance of our analysis, we included 4 numeric factors describing amino acid hydrophobicity, polarity, bulkiness, and charge, in addition to amino acid identities. The classifier had 75% predictive accuracy in leave-one-out cross-validation, and identified 5 signatures associated with HAD diagnosis (p<0.05, Fisher's exact test). These HAD signatures were found in the majority of brain sequences from 8 of 10 HAD patients from an independent cohort. Additionally, 2 HAD signatures were validated against env sequences from CSF of a second independent cohort. This analysis provides insight into viral genetic determinants associated with HAD, and develops novel methods for applying machine learning tools to analyze the genetics of rapidly evolving pathogens.	[Holman, Alexander G.; Gabuzda, Dana] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Holman, AG (corresponding author), Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA.	Dana_Gabuzda@dfci.harvard.edu			NATIONAL CANCER INSTITUTE [P30CA006516] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH083588, U01MH083545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA028994] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA06516, P30 CA006516] Funding Source: Medline; NIAID NIH HHS [P30 AI060354] Funding Source: Medline; NIDA NIH HHS [DP1 DA028994, DA28994] Funding Source: Medline; NIMH NIH HHS [R01 MH083588, U01 MH083545, MH83588] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Albright AV, 1999, J VIROL, V73, P205, DOI 10.1128/JVI.73.1.205-213.1999; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Atchley WR, 2007, MOL BIOL EVOL, V24, P192, DOI 10.1093/molbev/msl143; Atchley WR, 2005, P NATL ACAD SCI USA, V102, P6395, DOI 10.1073/pnas.0408677102; Becker JT, 2011, BRAIN IMAGING BEHAV, V5, P77, DOI 10.1007/s11682-011-9113-8; Bhaskaran K, 2008, ANN NEUROL, V63, P213, DOI 10.1002/ana.21225; Bickel PJ, 1996, AIDS RES HUM RETROV, V12, P1401, DOI 10.1089/aid.1996.12.1401; Brown RJP, 2011, J VIROL, V85, P6024, DOI 10.1128/JVI.00131-11; Campo D, 2008, LECT N BIOINFORMAT, V4983, P146, DOI 10.1007/978-3-540-79450-9_14; CARRILLO A, 1993, VIROLOGY, V197, P817, DOI 10.1006/viro.1993.1664; CATASTI P, 1995, J BIOL CHEM, V270, P2224, DOI 10.1074/jbc.270.5.2224; Childers ME, 2008, J NEUROVIROL, V14, P550, DOI 10.1080/13550280802372313; Childs EA, 1999, NEUROLOGY, V52, P607, DOI 10.1212/WNL.52.3.607; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Cormier EG, 2001, J VIROL, V75, P5541, DOI 10.1128/JVI.75.12.5541-5549.2001; DAVIS LE, 1992, NEUROLOGY, V42, P1736, DOI 10.1212/WNL.42.9.1736; del Palacio M, 2012, REV MED VIROL, V22, P33, DOI 10.1002/rmv.711; Duenas-Decamp MJ, 2009, J VIROL, V83, P2575, DOI 10.1128/JVI.02133-08; Dunfee R, 2006, CURR HIV RES, V4, P267, DOI 10.2174/157016206777709500; Dunfee RL, 2007, VIROLOGY, V367, P222, DOI 10.1016/j.virol.2007.05.029; Dunfee RL, 2006, P NATL ACAD SCI USA, V103, P15160, DOI 10.1073/pnas.0605513103; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Ellis RJ, 2002, ARCH NEUROL-CHICAGO, V59, P923, DOI 10.1001/archneur.59.6.923; Everall I, 2009, J NEUROVIROL, V15, P360, DOI 10.3109/13550280903131915; Frank E, 2004, BIOINFORMATICS, V20, P2479, DOI 10.1093/bioinformatics/bth261; Frank E., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P144; FREED EO, 1991, AIDS RES HUM RETROV, V7, P807, DOI 10.1089/aid.1991.7.807; Frost SDW, 2001, P NATL ACAD SCI USA, V98, P6975, DOI 10.1073/pnas.131056998; Frost SDW, 2005, J VIROL, V79, P6523, DOI 10.1128/JVI.79.10.6523-6527.2005; Fu XJ, 2004, IEEE IJCNN, P291, DOI 10.1109/IJCNN.2004.1379916; Gabuzda D, 2000, J NEUROVIROL, V6, pS24; GABUZDA DH, 1986, ANN NEUROL, V20, P289, DOI 10.1002/ana.410200304; Garden GA, 2002, J NEUROSCI, V22, P4015, DOI 10.1523/JNEUROSCI.22-10-04015.2002; GARTNER S, 1986, JAMA-J AM MED ASSOC, V256, P2365, DOI 10.1001/jama.256.17.2365; Gewehr JE, 2007, BIOINFORMATICS, V23, P651, DOI 10.1093/bioinformatics/btl671; Ghorpade A, 1998, J VIROL, V72, P3351, DOI 10.1128/JVI.72.4.3351-3361.1998; Gnanakaran S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002209; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Gorry PR, 2001, J VIROL, V75, P10073, DOI 10.1128/JVI.75.21.10073-10089.2001; Gorry PR, 2002, J VIROL, V76, P6277, DOI 10.1128/JVI.76.12.6277-6292.2002; Gras G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-30; Gray L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-42; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; Heaton RK, 2011, J NEUROVIROL, V17, P3, DOI 10.1007/s13365-010-0006-1; Holm GH, 2005, J VIROL, V79, P6299, DOI 10.1128/JVI.79.10.6299-6311.2005; Holman AG, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-43; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; HWANG SS, 1991, SCIENCE, V253, P71, DOI 10.1126/science.1905842; Inza I, 2004, ARTIF INTELL MED, V31, P91, DOI 10.1016/j.artmed.2004.01.007; JANSSEN RS, 1991, NEUROLOGY, V41, P778; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kawashima S, 2008, NUCLEIC ACIDS RES, V36, pD202, DOI 10.1093/nar/gkm998; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; KOENIG S, 1995, NAT MED, V1, P330, DOI 10.1038/nm0495-330; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; KORBER BTM, 1993, P NATL ACAD SCI USA, V90, P7176, DOI 10.1073/pnas.90.15.7176; Kramer-Hammerle S, 2005, VIRUS RES, V111, P194, DOI 10.1016/j.virusres.2005.04.009; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Li S, 1999, J VIROL, V73, P9741, DOI 10.1128/JVI.73.12.9741-9755.1999; Marcotte TD, 2003, ARCH NEUROL-CHICAGO, V60, P1406, DOI 10.1001/archneur.60.10.1406; McArthur JC, 1997, ANN NEUROL, V42, P689, DOI 10.1002/ana.410420504; McArthur JC, 2010, ANN NEUROL, V67, P699, DOI 10.1002/ana.22053; McArthur JC, 2010, AIDS, V24, P1367, DOI 10.1097/QAD.0b013e3283391d56; McCombe JA, 2013, HIV MED, V14, P99, DOI 10.1111/j.1468-1293.2012.01043.x; McPhail Megan E, 2011, Curr HIV/AIDS Rep, V8, P249, DOI 10.1007/s11904-011-0091-7; Mjolsness E, 2001, SCIENCE, V293, P2051, DOI 10.1126/science.293.5537.2051; Musich T, 2011, J VIROL, V85, P2397, DOI 10.1128/JVI.02187-10; Neuenburg JK, 2002, JAIDS-J ACQ IMM DEF, V31, P171, DOI 10.1097/00126334-200210010-00007; Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003; Peters PJ, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-5; Peters PJ, 2004, J VIROL, V78, P6915, DOI 10.1128/JVI.78.13.6915-6926.2004; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Pillai SK, 2006, BRAIN, V129, P1872, DOI 10.1093/brain/awl136; Pillai SK, 2005, J VIROL, V79, P1734, DOI 10.1128/JVI.79.3.1734-1742.2005; Pond SLK, 2008, STAT MED, V27, P4779, DOI 10.1002/sim.3192; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Poon AFY, 2007, PLOS COMPUT BIOL, V3, P2279, DOI 10.1371/journal.pcbi.0030231; Power C, 1998, J VIROL, V72, P9045, DOI 10.1128/JVI.72.11.9045-9053.1998; POWER C, 1994, J VIROL, V68, P4643, DOI 10.1128/JVI.68.7.4643-4649.1994; Quinlan J. R., 1993, C4 5; Ritola K, 2005, J VIROL, V79, P10830, DOI 10.1128/JVI.79.16.10830-10834.2005; Rizzuto CD, 1998, SCIENCE, V280, P1949, DOI 10.1126/science.280.5371.1949; Sacktor N, 2002, J NEUROVIROL, V8, P136, DOI 10.1080/13550280290049615; Sanjuan R, 2004, EVOLUTION, V58, P1185; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schnell G, 2010, J VIROL, V84, P2395, DOI 10.1128/JVI.01863-09; Schnell G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000395; Schouten J, 2011, AIDS, V25, P561, DOI 10.1097/QAD.0b013e3283437f9a; Sevigny JJ, 2004, NEUROLOGY, V63, P2084, DOI 10.1212/01.WNL.0000145763.68284.15; Shah M, 2006, AIDS RES HUM RETROV, V22, P177, DOI 10.1089/aid.2006.22.177; Shapshak P, 1999, AIDS RES HUM RETROV, V15, P811, DOI 10.1089/088922299310719; Shieh JTC, 2000, J VIROL, V74, P693, DOI 10.1128/JVI.74.2.693-701.2000; Shiramizu B, 2005, AIDS, V19, P45, DOI 10.1097/00002030-200501030-00005; SLATKIN M, 1989, GENETICS, V123, P603; Sterjovski J, 2010, VIROLOGY, V404, P269, DOI 10.1016/j.virol.2010.05.006; Strain MC, 2005, J VIROL, V79, P1772, DOI 10.1128/JVI.79.3.1772-1788.2005; Thomas ER, 2007, VIROLOGY, V360, P105, DOI 10.1016/j.virol.2006.09.036; van Marle G, 2005, J NEUROVIROL, V11, P107, DOI 10.1080/13550280590922838; Witten IH, 2011, MOR KAUF D, P1; Witten I. H., 2005, DATA MINING PRACTICA; Yadav A, 2009, J NEUROIMMUNE PHARM, V4, P430, DOI 10.1007/s11481-009-9174-2; Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06	104	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49538	10.1371/journal.pone.0049538	http://dx.doi.org/10.1371/journal.pone.0049538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166702	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900159
J	Lloyd-Jones, TJ; Roberts, MV; Leek, EC; Fouquet, NC; Truchanowicz, EG				Lloyd-Jones, Toby J.; Roberts, Mark V.; Leek, E. Charles; Fouquet, Nathalie C.; Truchanowicz, Ewa G.			The Time Course of Activation of Object Shape and Shape plus Colour Representations during Memory Retrieval	PLOS ONE			English	Article							ELECTROPHYSIOLOGICAL EVIDENCE; NEURAL MECHANISMS; IMPLICIT MEMORY; ERP COMPONENT; REPETITION; FEATURES; RECOGNITION; BINDING; INTEGRATION; FILES	Little is known about the timing of activating memory for objects and their associated perceptual properties, such as colour, and yet this is important for theories of human cognition. We investigated the time course associated with early cognitive processes related to the activation of object shape and object shape+colour representations respectively, during memory retrieval as assessed by repetition priming in an event-related potential (ERP) study. The main findings were as follows: (1) we identified a unique early modulation of mean ERP amplitude during the N1 that was associated with the activation of object shape independently of colour; (2) we also found a subsequent early P2 modulation of mean amplitude over the same electrode clusters associated with the activation of object shape+colour representations; (3) these findings were apparent across both familiar (i.e., correctly coloured - yellow banana) and novel (i.e., incorrectly coloured - blue strawberry) objects; and (4) neither of the modulations of mean ERP amplitude were evident during the P3. Together the findings delineate the timing of object shape and colour memory systems and support the notion that perceptual representations of object shape mediate the retrieval of temporary shape+colour representations for familiar and novel objects.	[Lloyd-Jones, Toby J.; Fouquet, Nathalie C.] Swansea Univ, Swansea, W Glam, Wales	Swansea University	Lloyd-Jones, TJ (corresponding author), Swansea Univ, Swansea, W Glam, Wales.	t.j.lloyd-jones@swansea.ac.uk		Leek, Charles/0000-0001-9258-7504				Allan K, 1998, ACTA PSYCHOL, V98, P231, DOI 10.1016/S0001-6918(97)00044-9; [Anonymous], 2008, STAT POWER ANAL BEHA; Barrett HC, 2006, PSYCHOL REV, V113, P628, DOI 10.1037/0033-295X.113.3.628; BIEDERMAN I, 1991, PERCEPTION, V20, P585, DOI 10.1068/p200585; BIEDERMAN I, 1992, J EXP PSYCHOL HUMAN, V18, P121, DOI 10.1037/0096-1523.18.1.121; Bowers JS, 2002, COGNITIVE PSYCHOL, V45, P413, DOI 10.1016/S0010-0285(02)00506-6; Chao LL, 1999, J COGNITIVE NEUROSCI, V11, P25, DOI 10.1162/089892999563229; Cimpian A, 2005, DEV PSYCHOL, V41, P1003, DOI 10.1037/0012-1649.41.6.1003; Coulson S, 2002, MEM COGNITION, V30, P958, DOI 10.3758/BF03195780; Curran T, 2002, COGN AFFECT BEHAV NE, V2, P1, DOI 10.3758/CABN.2.1.1; Dobbins IG, 2004, NATURE, V428, P316, DOI 10.1038/nature02400; Downing PE, 2009, CURR BIOL, V19, pR160, DOI 10.1016/j.cub.2008.12.037; Dyson BJ, 2004, J EXP PSYCHOL HUMAN, V30, P1117, DOI 10.1037/0096-1523.30.6.1117; Friedman D, 2001, NEUROSCI BIOBEHAV R, V25, P355, DOI 10.1016/S0149-7634(01)00019-7; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Frund I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001675; Gegenfurtner KR, 2000, CURR BIOL, V10, P805, DOI 10.1016/S0960-9822(00)00563-7; Gilbert JR, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00030; Gotts SJ, 2012, COG NEUROSCI IFIRST, P1; GRAF P, 1989, J EXP PSYCHOL LEARN, V15, P930, DOI 10.1037/0278-7393.15.5.930; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Henson RN, 2004, NEUROIMAGE, V21, P1674, DOI 10.1016/j.neuroimage.2003.12.020; Henson RNA, 2003, PROG NEUROBIOL, V70, P53, DOI 10.1016/S0301-0082(03)00086-8; Hommel B, 2004, VIS COGN, V11, P483, DOI 10.1080/13506280344000400; Hommel B, 2007, PSYCHOL RES-PSYCH FO, V71, P42, DOI 10.1007/s00426-005-0035-1; Hommel B, 2009, PSYCHOL RES-PSYCH FO, V73, P1, DOI 10.1007/s00426-008-0186-y; Horner AJ, 2008, NEUROPSYCHOLOGIA, V46, P1979, DOI 10.1016/j.neuropsychologia.2008.01.018; Houston RJ, 2004, INT J PSYCHOPHYSIOL, V53, P57, DOI 10.1016/j.ijpsycho.2004.02.003; Humphreys GW, 2009, J EXP PSYCHOL HUMAN, V35, P627, DOI 10.1037/a0013705; HUMPHREYS GW, 1995, MEMORY, V3, P535, DOI 10.1080/09658219508253164; Humphreys GW, 2001, VIS COGN, V8, P381, DOI 10.1080/13506280143000061; HUMPHREYS GW, 2001, BEHAV BRAIN SCI, V24, P447; JOORDENS S, 1994, J EXP PSYCHOL LEARN, V20, P1051, DOI 10.1037/0278-7393.20.5.1051; Joseph JE, 1997, ACTA PSYCHOL, V97, P95, DOI 10.1016/S0001-6918(97)00026-7; KAHNEMAN D, 1992, COGNITIVE PSYCHOL, V24, P175, DOI 10.1016/0010-0285(92)90007-O; Keizer AW, 2008, BEHAV BRAIN FUNC, V4, P50; Leek EC, 2009, Q J EXP PSYCHOL, V62, P814, DOI 10.1080/17470210802303826; Leek EC, 2005, J EXP PSYCHOL HUMAN, V31, P668, DOI 10.1037/0096-1523.31.4.668; Lloyd-Jones TJ, 2007, MEM COGNITION, V35, P816, DOI 10.3758/BF03193317; Lloyd-Jones TJ, 2009, Q J EXP PSYCHOL, V62, P310, DOI 10.1080/17470210801954827; Lu AT, 2010, NEUROSCI LETT, V469, P405, DOI 10.1016/j.neulet.2009.12.039; Luck S.J., 2005, INTRO EVENT RELATED; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Martin CD, 2010, PLOS ONE, V5, P1; Martinovic J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003781; Miceli G, 2001, NAT NEUROSCI, V4, P662, DOI 10.1038/88497; Musen G, 1999, J EXP PSYCHOL LEARN, V25, P275, DOI 10.1037/0278-7393.25.1.275; O'Craven KM, 1999, NATURE, V401, P584, DOI 10.1038/44134; Olivers CNL, 2003, J EXP PSYCHOL HUMAN, V29, P650, DOI 10.1037/0096-1523.29.3.650; Omoto S, 2007, NEUROSCI LETT, V429, P22, DOI 10.1016/j.neulet.2007.09.075; Picton TW, 2002, PSYCHOPHYSIOLOGY, V37, P127; PRICE CJ, 1989, Q J EXP PSYCHOL-A, V41, P797, DOI 10.1080/14640748908402394; Proverbio AM, 2004, COGNITIVE BRAIN RES, V18, P288, DOI 10.1016/j.cogbrainres.2003.10.020; Race EA, 2010, CEREB CORTEX, V20, P1726, DOI 10.1093/cercor/bhp233; RAJARAM S, 1993, J EXP PSYCHOL LEARN, V19, P765, DOI 10.1037/0278-7393.19.4.765; Roediger H. L., 1993, HANDB NEUR, P63; Roediger Henry L. Iii, 1993, P17; ROEDIGER HL, 1990, AM PSYCHOL, V45, P1043, DOI 10.1037/0003-066X.45.9.1043; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Schendan HE, 2003, J COGNITIVE NEUROSCI, V15, P111, DOI 10.1162/089892903321107864; Schendan HE, 2002, NEUROPSYCHOLOGIA, V40, P931, DOI 10.1016/S0028-3932(01)00176-2; Seymour K, 2010, CEREB CORTEX, V20, P1946, DOI 10.1093/cercor/bhp265; Smith LB, 1999, CARN S COGN, P277; Smith LB., 2000, BREAKING WORD LEARNI, P51, DOI [10.1093/acprof:oso/9780195130324.003.003, DOI 10.1093/ACPROF:OSO/9780195130324.003.003]; Soldan A, 2006, J EXP PSYCHOL LEARN, V32, P230, DOI 10.1037/0278-7393.32.2.230; Srinivas K, 1996, MEM COGNITION, V24, P441, DOI 10.3758/BF03200933; Tanaka J, 2001, TRENDS COGN SCI, V5, P211, DOI 10.1016/S1364-6613(00)01626-0; Tek S, 2012, COGNITIVE DEV, V27, P28, DOI 10.1016/j.cogdev.2011.09.009; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; VanRullen R, 2009, VIS COGN, V17, P103, DOI 10.1080/13506280802196451; Vernon David, 2003, Quarterly Journal of Experimental Psychology Section A Human Experimental Psychology, V56A, P779, DOI 10.1080/02724980244000684; Wang G, 2007, CLIN NEUROPHYSIOL, V118, P372, DOI 10.1016/j.clinph.2006.10.012; Wang G, 2010, CLIN NEUROPHYSIOL, V121, P1473, DOI 10.1016/j.clinph.2010.03.032; Wei P, 2011, NEUROIMAGE, V57, P235, DOI 10.1016/j.neuroimage.2011.04.024; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Woods DL, 1998, PERCEPT PSYCHOPHYS, V60, P239, DOI 10.3758/BF03206033; Zimmer HD, 2010, NEUROSCI BIOBEHAV R, V34, P1066, DOI 10.1016/j.neubiorev.2010.01.014; Zmigrod S, SEEING PERC IN PRESS; Zmigrod S, 2009, ATTEN PERCEPT PSYCHO, V71, P352, DOI 10.3758/APP.71.2.352; Zurron M, 2009, INT J PSYCHOPHYSIOL, V72, P246, DOI 10.1016/j.ijpsycho.2009.01.002	84	12	13	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48550	10.1371/journal.pone.0048550	http://dx.doi.org/10.1371/journal.pone.0048550			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155393	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900027
J	Murall, CL; McCann, KS; Bauch, CT				Murall, Carmen Lia; McCann, Kevin S.; Bauch, Chris T.			Food Webs in the Human Body: Linking Ecological Theory to Viral Dynamics	PLOS ONE			English	Article							EVOLUTIONARY CONSEQUENCES; HIV-1 INFECTION; WITHIN-HOST; TRADE-OFF; POPULATION; SMOKING; DISEASE; CELLS; HPV; PAPILLOMAVIRUSES	The dynamics of in-host infections are central to predicting the progression of natural infections and the effectiveness of drugs or vaccines, however, they are not well understood. Here, we apply food web theory to in-host disease networks of the human body that are structured similarly to food web models that treat both predation and competition simultaneously. We show that in-host trade-offs, an under-studied aspect of disease ecology, are fundamental to understanding the outcomes of competing viral strains under differential immune responses. Further, and importantly, our analysis shows that the outcome of competition between virulent and non-virulent strains can be highly contingent on the abiotic conditions prevailing in the human body. These results suggest the alarming idea that even subtle behavioral changes that alter the human body (e.g. weight gain, smoking) may switch the environmental conditions in a manner that suddenly allows a virulent strain to dominate and replace less virulent strains. These ecological results therefore cast new light on the control of disease in the human body, and highlight the importance of longitudinal empirical studies across host variation gradients, as well as, of studies focused on delineating life history trade-offs within hosts.	[Murall, Carmen Lia; McCann, Kevin S.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada	University of Guelph	Murall, CL (corresponding author), Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada.	cmurall@uoguelph.ca	Murall, Carmen Lia/J-2793-2019	Murall, Carmen Lia/0000-0002-1543-4501	Canadian Institutes of Health Research [MOP 89710] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Adams BM, 2005, J COMPUT APPL MATH, V184, P10, DOI 10.1016/j.cam.2005.02.004; Alizon S, 2009, J EVOLUTION BIOL, V22, P245, DOI 10.1111/j.1420-9101.2008.01658.x; Althaus CL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016468; Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Antia R, 2003, J THEOR BIOL, V221, P585, DOI 10.1006/jtbi.2003.3208; Bauer AL, 2009, INFORM SCIENCES, V179, P1379, DOI 10.1016/j.ins.2008.11.012; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; BENDER EA, 1984, ECOLOGY, V65, P1, DOI 10.2307/1939452; Booth M, 2008, PARASITOLOGY, V135, P749, DOI 10.1017/S0031182008000413; Christensen ND, 2010, FUTURE VIROL, V5, P163, DOI 10.2217/FVL.10.1; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; Culp TD, 2004, VIROLOGY, V319, P152, DOI 10.1016/j.virol.2003.11.004; Day T, 2008, VACCINE, V26, pC1, DOI 10.1016/j.vaccine.2008.02.006; De Boer RJ, 2001, J VIROL, V75, P10663, DOI 10.1128/JVI.75.22.10663-10669.2001; De Paepe M, 2006, PLOS BIOL, V4, P1248, DOI 10.1371/journal.pbio.0040193; Dennehy JJ, 2006, AM NAT, V167, P429, DOI 10.1086/499381; Doorbar J, 2005, J CLIN VIROL, V32, pS7, DOI 10.1016/j.jcv.2004.12.006; Fenton A, 2010, PARASITOLOGY, V137, P1027, DOI 10.1017/S0031182009991788; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Frattini MG, 1996, P NATL ACAD SCI USA, V93, P3062, DOI 10.1073/pnas.93.7.3062; Funk GA, 2005, J THEOR BIOL, V233, P221, DOI 10.1016/j.jtbi.2004.10.004; Gandon S, 2003, P ROY SOC B-BIOL SCI, V270, P1129, DOI 10.1098/rspb.2003.2370; Garcia-Vallve S, 2005, TRENDS MICROBIOL, V13, P514, DOI 10.1016/j.tim.2005.09.003; Gilchrist MA, 2006, THEOR POPUL BIOL, V69, P145, DOI 10.1016/j.tpb.2005.07.002; Greenberg D, 2009, CLIN INFECT DIS, V49, P213, DOI 10.1086/599828; Grenfell B, 1997, TRENDS ECOL EVOL, V12, P395, DOI 10.1016/S0169-5347(97)01174-9; HOLT RD, 1977, THEOR POPUL BIOL, V12, P197, DOI 10.1016/0040-5809(77)90042-9; Holt RD, 1997, MULTITROPHIC INTERACTIONS IN TERRESTRIAL SYSTEMS, P333; Lafferty KD, 2008, ECOL LETT, V11, P533, DOI 10.1111/j.1461-0248.2008.01174.x; Levin BR, 2001, CLIN MICROBIOL INFEC, V7, P24, DOI 10.1046/j.1469-0691.2001.00070.x; Liang H, 2010, ANN APPL STAT, V4, P460, DOI 10.1214/09-AOAS290; Luchters SMF, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-18; McKenzie ND, 2010, GYNECOL ONCOL, V116, P572, DOI 10.1016/j.ygyno.2009.10.058; Merikukka M, 2011, INT J CANCER, V128, P1114, DOI 10.1002/ijc.25675; Mideo N, 2008, AM NAT, V172, pE214, DOI 10.1086/591684; Mideo N, 2008, TRENDS ECOL EVOL, V23, P511, DOI 10.1016/j.tree.2008.05.009; Mideo N, 2009, TRENDS PARASITOL, V25, P261, DOI 10.1016/j.pt.2009.03.001; Nadais RD, 2006, GYNECOL ONCOL, V102, P356, DOI 10.1016/j.ygyno.2005.12.030; Nair V, 2005, VET J, V170, P175, DOI 10.1016/j.tvjl.2004.05.009; Nowak MA, 1996, SCIENCE, V272, P74, DOI 10.1126/science.272.5258.74; Nowak MA., 2000, VIRAL DYNAMICS MATH; O'Gorman EJ, 2009, P NATL ACAD SCI USA, V106, P13393, DOI 10.1073/pnas.0903682106; Pedersen AB, 2007, TRENDS ECOL EVOL, V22, P133, DOI 10.1016/j.tree.2006.11.005; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Quint W, 2012, J PATHOL, V227, P62, DOI 10.1002/path.3970; Ribeiro RM, 2002, P NATL ACAD SCI USA, V99, P15572, DOI 10.1073/pnas.242358099; Schiller JT, 2008, VACCINE, V26, pK53, DOI 10.1016/j.vaccine.2008.06.002; Simen-Kapeu A, 2008, SCAND J INFECT DIS, V40, P745, DOI 10.1080/00365540801995360; Smith VH, 1996, TRENDS ECOL EVOL, V11, P386, DOI 10.1016/0169-5347(96)20067-9; Staempfli MR, 2009, NAT REV IMMUNOL, V9, P377, DOI 10.1038/nri2530; Stanley MA, 2006, PAPILLOMAVIRUS RESEARCH: FROM NATURAL HISTORY TO VACCINES AND BEYOND, P311; Tilman D., 1982, Monographs in Population Biology, pi; Tota J, 2011, EPIDEMIOLOGIC APPROA; Vaccarella S, 2011, J INFECT DIS, V204, P385, DOI 10.1093/infdis/jir286; Wang HK, 2009, GENE DEV, V23, P181, DOI 10.1101/gad.1735109; Williams PD, 2008, MOL ECOL, V17, P485, DOI 10.1111/j.1365-294X.2007.03418.x; Wodarz D, 2009, EVOLUTION, V63, P2326, DOI 10.1111/j.1558-5646.2009.00727.x; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535; Xi LF, 2009, CANCER EPIDEM BIOMAR, V18, P3490, DOI 10.1158/1055-9965.EPI-09-0763	60	10	10	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48812	10.1371/journal.pone.0048812	http://dx.doi.org/10.1371/journal.pone.0048812			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155409	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900043
J	Ohlsson, C; Lorentzon, M; Norjavaara, E; Kindblom, JM				Ohlsson, Claes; Lorentzon, Mattias; Norjavaara, Ensio; Kindblom, Jenny M.			Age at Adiposity Rebound Is Associated with Fat Mass in Young Adult Males-The GOOD Study	PLOS ONE			English	Article							CORTICAL BONE SIZE; INDEPENDENT PREDICTOR; BODY-COMPOSITION; CHILDHOOD; GROWTH; ADOLESCENCE; OBESITY; HEIGHT; LEPTIN; RISK	Objective: Age at adiposity rebound (AR) is associated with obesity and Type 2 Diabetes in adults. The aim of the present study was to investigate the role of age at AR in adult fat mass, fat distribution and pubertal timing for a Swedish cohort. Patients and Methods: This is a retrospective cohort study. Detailed growth charts were retrieved for the men participating in the population-based GOOD (Gothenburg Osteoporosis and Obesity Determinants) study (n = 573). Body composition was analysed using dual X-ray absorptiometry and computed tomography at 18-20 years of age. Age and BMI at AR were calculated using pediatric growth charts and AR was defined as the lowest BMI between 3 and 9 years of age. Results: Subjects were divided into early (age at AR below 5.4 years of age), middle (age at AR 5.4 to 6.8 years of age) and late (age at AR after 6.8 years of age) age at AR tertiles. Subjects in the early age at AR tertile had higher young adult BMI (+8%), whole body fat mass (+34%) and amount of subcutaneous adipose tissue (+61%) than the subjects in the middle and late tertiles (p < 0.01). The early age at AR tertile had an increased risk of obesity (Odds Ratio 4.1 [ 95% CI 1.2-13.9]) compared with the middle and late tertiles. In addition, the early age at AR tertile had Peak Height Velocity (PHV) 7 months earlier than the late tertile. Conclusions: Early age at AR was associated with young adult obesity as a consequence of a high amount of subcutaneous adipose tissue in men. In addition we made the novel observation that early age at AR was associated with an early puberty in men.	[Ohlsson, Claes; Lorentzon, Mattias; Kindblom, Jenny M.] Gothenburg Univ, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden	University of Gothenburg	Ohlsson, C (corresponding author), Gothenburg Univ, Sahlgrenska Acad, Inst Med, Ctr Bone & Arthrit Res, Gothenburg, Sweden.	jenny.kindblom@gu.se	Lorentzon, Mattias/W-7878-2019; Ohlsson, Claes/AGP-3544-2022	Lorentzon, Mattias/0000-0003-0749-1431; Ohlsson, Claes/0000-0002-9633-2805; Norjavaara, Ensio/0000-0003-0415-4843; Kindblom, Jenny/0000-0001-8437-0639				CHOWDHURY B, 1994, INT J OBESITY, V18, P219; Cole T J, 2004, BMC Pediatr, V4, P6; Dietz WH, 2000, LANCET, V356, P2027, DOI 10.1016/S0140-6736(00)03396-1; Eriksson JG, 2003, DIABETOLOGIA, V46, P190, DOI 10.1007/s00125-002-1012-5; Fox Caroline S, 2007, CIRCULATION; Freedman DS, 2001, INT J OBESITY, V25, P543, DOI 10.1038/sj.ijo.0801581; Guo SS, 2000, INT J OBESITY, V24, P1628, DOI 10.1038/sj.ijo.0801461; Guo SS, 1997, INT J OBESITY, V21, P1167, DOI 10.1038/sj.ijo.0800531; Kaplowitz PB, 2008, PEDIATRICS, V121, pS208, DOI 10.1542/peds.2007-1813F; KARLBERG J, 1987, STAT MED, V6, P185, DOI 10.1002/sim.4780060210; Kindblom JM, 2006, DIABETES, V55, P3047, DOI 10.2337/db06-0192; Kindblom JM, 2006, J BONE MINER RES, V21, P790, DOI 10.1359/JBMR.020602; Lorentzon M, 2005, J BONE MINER RES, V20, P1334, DOI 10.1359/JBMR.050404; Lorentzon M, 2006, J BONE MINER RES, V21, P1871, DOI 10.1359/JBMR.060814; Mangrio E, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-891; Nader PR, 2006, PEDIATRICS, V118, pE594, DOI 10.1542/peds.2005-2801; Quinton ND, 1999, J CLIN ENDOCR METAB, V84, P2336, DOI 10.1210/jc.84.7.2336; Starck G, 2002, BRIT J RADIOL, V75, P140, DOI 10.1259/bjr.75.890.750140; Wadsworth M, 2005, DIABETOLOGIA, V48, P2505, DOI 10.1007/s00125-005-0007-4; Whitaker RC, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e5; Williams S, 1999, INT J OBESITY, V23, P348, DOI 10.1038/sj.ijo.0800824; Williams SM, 2009, OBESITY, V17, P335, DOI 10.1038/oby.2008.547; Williams SM, 2005, OBES RES, V13, P1123, DOI 10.1038/oby.2005.131	23	32	33	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49404	10.1371/journal.pone.0049404	http://dx.doi.org/10.1371/journal.pone.0049404			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166661	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900139
J	Shirai, H; Kamimura, M; Yamaguchi, J; Imanishi, S; Kojima, T; Fujiwara, H				Shirai, Hiroyuki; Kamimura, Manabu; Yamaguchi, Junichi; Imanishi, Shigeo; Kojima, Tetsuya; Fujiwara, Haruhiko			Two Adjacent cis-Regulatory Elements Are Required for Ecdysone Response of Ecdysone Receptor (EcR) B1 Transcription	PLOS ONE			English	Article							PUPAL WING DEVELOPMENT; RED FLOUR BEETLE; BOMBYX-MORI; NUCLEAR RECEPTORS; JUVENILE-HORMONE; DROSOPHILA-MELANOGASTER; TRIBOLIUM-CASTANEUM; CELL-DEATH; GENE; ISOFORMS	Three distinct classes of nuclear receptors, EcR, E75, and HR3, are key regulators in the ecdysone-inducible gene activation cascade in insects. The transcription of these genes is induced by ecdysone (20E) differently, although the detailed mechanisms underlying their responses to 20E are largely unknown. We identified ecdysone response elements (EcREs) present in the promoters of genes coding BmEcR-B1, BmE75-A, and BHR3-B isoforms from Bombyx mori employing luciferase reporter assays in an ecdysteroid-responsive cultured cell line, NIAS-Bm-aff3 (aff3). The EcRE of BmEcR-B1 at 22800 comprises of two adjacent elements separated by 5 bp, E1 (15 bp) and E2 (21 bp), both of which are required for the 20E response. Further analysis using electrophoretic mobility shift assays showed that E1 binds to the EcR/USP heterodimer and that E2 may bind to the E-box (CACGTG) binding factor such as bHLH protein. The unique E1+E2-type EcRE is also detected in the promoter upstream regions of EcR-B1 from seven lepidopteran species studied. In contrast, both a 20 bp EcRE identified in the promoter of BmE75-A and a 18 bp EcRE identified in the BHR3-B promoter, contained only E1-type EcR/USP binding element but the E2 type element was not in the promoter regions of these genes. The combination of presence of the E2 element or other cis-regulatory elements in promoter regions explains the different 20E response of each class of nuclear receptor genes. Furthermore, the E1+E2 structure for EcR-B1 can be involved in a possible cross-talk between ecdysteroid and other regulatory pathways.	[Shirai, Hiroyuki; Yamaguchi, Junichi; Kojima, Tetsuya; Fujiwara, Haruhiko] Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan	University of Tokyo	Shirai, H (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Kashiwa, Chiba, Japan.	haruh@k.u-tokyo.ac.jp	Kojima, Tetsuya/ABF-8388-2021	Kojima, Tetsuya/0000-0001-9949-1943				ANTONIEWSKI C, 1994, MOL CELL BIOL, V14, P4465, DOI 10.1128/MCB.14.7.4465; Antoniewski C, 1995, MOL GEN GENET, V249, P545, DOI 10.1007/BF00290580; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Bernardo TJ, 2009, J MOL BIOL, V387, P794, DOI 10.1016/j.jmb.2009.02.013; Bitra K, 2009, ARCH INSECT BIOCHEM, V70, P90, DOI 10.1002/arch.20281; Bitra K, 2010, J INSECT PHYSIOL, V56, P1481, DOI 10.1016/j.jinsphys.2010.03.005; Bitra K, 2009, GENE, V448, P74, DOI 10.1016/j.gene.2009.08.003; Cakouros D, 2004, J CELL BIOL, V165, P631, DOI 10.1083/jcb.200311057; Cheng D, 2008, INSECT BIOCHEM MOLEC, V38, P1130, DOI 10.1016/j.ibmb.2008.09.013; CHERBAS L, 1991, GENE DEV, V5, P120, DOI 10.1101/gad.5.1.120; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; DAVINO PP, 1995, MOL CELL ENDOCRINOL, V113, P1; Devarakonda S, 2003, EMBO J, V22, P5827, DOI 10.1093/emboj/cdg569; Fujiwara H, 2001, DEV GENES EVOL, V211, P118, DOI 10.1007/s004270000131; Gauhar Z, 2009, GENOME RES, V19, P1006, DOI 10.1101/gr.081349.108; Hiruma K, 2004, DEV BIOL, V272, P510, DOI 10.1016/j.ydbio.2004.04.028; HORNER MA, 1995, DEV BIOL, V168, P490, DOI 10.1006/dbio.1995.1097; HUET F, 1995, DEVELOPMENT, V121, P1195; Imanishi S, 2002, P 2002 C IN VITR BIO, V38, P16; Kamimura M, 1999, ARCH INSECT BIOCHEM, V41, P79, DOI 10.1002/(SICI)1520-6327(1999)41:2&lt;79::AID-ARCH4&gt;3.0.CO;2-7; Kamimura M, 1997, EUR J BIOCHEM, V248, P786, DOI 10.1111/j.1432-1033.1997.t01-1-00786.x; King-Jones K, 2005, NAT REV GENET, V6, P311, DOI 10.1038/nrg1581; Konig A, 2011, EMBO J, V30, P1549, DOI 10.1038/emboj.2011.73; KRAMINSKY GP, 1980, P NATL ACAD SCI-BIOL, V77, P4175, DOI 10.1073/pnas.77.7.4175; Lan Q, 1999, MOL CELL BIOL, V19, P4897; Lehmann M, 1997, MECH DEVELOP, V62, P15, DOI 10.1016/S0925-4773(96)00644-2; LEHMANN M, 1995, EMBO J, V14, P716, DOI 10.1002/j.1460-2075.1995.tb07050.x; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Lobbia S, 2007, ARCH INSECT BIOCHEM, V65, P152, DOI 10.1002/arch.20192; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Moore AW, 2000, P NATL ACAD SCI USA, V97, P10436, DOI 10.1073/pnas.170301897; Nakagawa Y, 2009, FEBS J, V276, P6128, DOI 10.1111/j.1742-4658.2009.07347.x; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; RIDDIHOUGH G, 1987, EMBO J, V6, P3729, DOI 10.1002/j.1460-2075.1987.tb02707.x; Shirai H, 2007, INSECT MOL BIOL, V16, P253, DOI 10.1111/j.1365-2583.2006.00722.x; SMAGGHE G, 2009, ECDYSONES STRUCTURES; Suzuki MG, 2008, MOL CELL BIOL, V28, P333, DOI 10.1128/MCB.01528-07; TALBOT WS, 1993, CELL, V73, P1323, DOI 10.1016/0092-8674(93)90359-X; Tan A, 2008, MOL CELL ENDOCRINOL, V291, P42, DOI 10.1016/j.mce.2008.05.006; Tan A, 2008, INSECT BIOCHEM MOLEC, V38, P430, DOI 10.1016/j.ibmb.2007.09.012; TRUMAN JW, 1994, DEVELOPMENT, V120, P219; Wang Y, 2007, DEV GENES EVOL, V217, P715, DOI 10.1007/s00427-007-0184-x; Zhang ZL, 2011, J BIOL CHEM, V286, P8437, DOI 10.1074/jbc.M110.191684	43	11	14	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49348	10.1371/journal.pone.0049348	http://dx.doi.org/10.1371/journal.pone.0049348			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166644	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900127
J	Terron-Exposito, R; Dudognon, B; Galindo, I; Quetglas, JI; Coll, JM; Escribano, JM; Gomez-Casado, E				Terron-Exposito, Raul; Dudognon, Benoit; Galindo, Inmaculada; Quetglas, Jose I.; Coll, Julio M.; Escribano, Jose M.; Gomez-Casado, Eduardo			Antibodies against Marinobacter algicola and Salmonella typhimurium Flagellins Do Not Cross-Neutralize TLR5 Activation	PLOS ONE			English	Article							RECOMBINANT FUSION PROTEIN; HIGH-AFFINITY INTERACTION; MUCOSAL IMMUNIZATION; IMMUNE-RESPONSE; CANCER CELLS; RECEPTOR 5; VACCINE; IMMUNOGENICITY; ADJUVANT; INNATE	Flagellins evoke strong innate and adaptive immune responses. These proteins may play a key role as radioprotectors, exert antitumoral activity in certain types of tumor and reduce graft-versus-host disease in allogeneic hematopoietic stem cell transplant recipients. Notwithstanding, flagellins are highly immunogenic, and repeated use leads to their neutralization by systemic antibodies. This neutralization is not prevented by using functional deleted flagellins. These observations led us to explore the possibility of preventing initial neutralization by means of another functional flagellin that does not belong to common pathogenic bacteria but that has the capacity to activate TLR5. Here we characterized the functional capacity of the two-phase Marinobacter algicola (MA)-derived flagellins (F and FR) as systemic and mucosal adjuvants and compared their performance with that of Salmonella typhimurium (STF) flagellins (FljB and FliC). We also report for the first time on the in vitro and in vivo capacity of various flagellins to trigger TLR5 activation in the presence of species-specific anti-flagellin antibodies, the cross-neutralization mediated by these antibodies, and the sequential use of these flagellins for TLR5 activation. Our results showed that MA flagellins behave in a similar way to STF ones, inducing pro-inflammatory cytokines (IL8, CCL20, CCL2) and evoking a strong in vivo antibody response against a model epitope. More importantly, MA flagellins were fully functional, in vitro or in vivo, in the presence of a high concentration of neutralizing anti-flagellin STF antibodies, and STF flagellin was not inhibited by neutralizing anti-flagellin MA antibodies. The use of active flagellins from distinct bacteria could be a useful approach to prevent systemic neutralization of this group of adjuvants and to facilitate the rational design of flagellin-based vaccines and/or other therapeutic treatments (against ischemia, acute renal failure, tumors, ionizing radiations and also to improve the outcome of bone marrow transplants).	[Terron-Exposito, Raul; Galindo, Inmaculada; Coll, Julio M.; Escribano, Jose M.; Gomez-Casado, Eduardo] INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Terron-Exposito, R (corresponding author), INIA, Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Biotechnol, Madrid, Spain.	casado@inia.es	Gomez-Casado, Eduardo/G-5502-2010; Galindo, inmaculada/Q-6603-2018; Coll, Julio M/G-4533-2010; Coll, julio/M-6071-2019	Gomez-Casado, Eduardo/0000-0001-6904-1300; Galindo, inmaculada/0000-0001-8257-9797; Coll, Julio M/0000-0001-8496-3493; Coll, julio/0000-0001-8496-3493				Alonso C, 2001, J VIROL, V75, P9819, DOI 10.1128/JVI.75.20.9819-9827.2001; Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Camacho AGA, 2011, MEM I OSWALDO CRUZ, V106, P167, DOI 10.1590/S0074-02762011000900021; Bargieri Daniel Y, 2011, J Parasitol Res, V2011, P965369, DOI 10.1155/2011/965369; Basset C, 2003, VACCINE, V21, pS12, DOI 10.1016/S0264-410X(03)00195-6; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Cai ZY, 2011, CANCER RES, V71, P2466, DOI 10.1158/0008-5472.CAN-10-1993; Chen YS, 2006, INFECT IMMUN, V74, P1699, DOI 10.1128/IAI.74.3.1699-1705.2006; Ciacci-Woolwine F, 1998, INFECT IMMUN, V66, P1127, DOI 10.1128/IAI.66.3.1127-1134.1998; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Fukuzawa N, 2011, J IMMUNOL, V187, P3831, DOI 10.4049/jimmunol.1003238; Garaude J, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002868; GAUTHIER MJ, 1992, INT J SYST BACTERIOL, V42, P568, DOI 10.1099/00207713-42-4-568; Gomez-Casado E, 2011, PROTEIN EXPRES PURIF, V79, P35, DOI 10.1016/j.pep.2011.03.007; Green DH, 2006, INT J SYST EVOL MICR, V56, P523, DOI 10.1099/ijs.0.63447-0; Grimaud R., 2010, HDB HYDROCARBON LIPI, P1290, DOI DOI 10.1007/978-3-540-77587-4_90; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; Hernaez B, 2010, J VIROL, V84, P10792, DOI 10.1128/JVI.01168-10; Honko AN, 2006, INFECT IMMUN, V74, P1113, DOI 10.1128/IAI.74.2.1113-1120.2006; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Hossain MS, 2011, J IMMUNOL, V187, P5130, DOI 10.4049/jimmunol.1101334; Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062; Jiao XD, 2010, VACCINE, V28, P5635, DOI 10.1016/j.vaccine.2010.06.022; Jones RM, 2011, GUT, V60, P648, DOI 10.1136/gut.2010.223891; Le Moigne V, 2008, MOL IMMUNOL, V45, P2499, DOI 10.1016/j.molimm.2008.01.005; Lee SE, 2006, INFECT IMMUN, V74, P694, DOI 10.1128/IAI.74.1.694-702.2006; Leng J, 2011, VACCINE, V29, P8147, DOI 10.1016/j.vaccine.2011.08.027; Li YM, 2012, HYBRIDOMA, V31, P60, DOI 10.1089/hyb.2011.0083; Liang HY, 2010, LETT APPL MICROBIOL, V50, P181, DOI 10.1111/j.1472-765X.2009.02768.x; Liang HY, 2010, FISH SHELLFISH IMMUN, V29, P343, DOI 10.1016/j.fsi.2010.04.003; Lien E, 2003, NAT IMMUNOL, V4, P1162, DOI 10.1038/ni1203-1162; Liu F, 2010, BIOCHEM BIOPH RES CO, V392, P582, DOI 10.1016/j.bbrc.2010.01.077; Liu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020928; Marciani DJ, 2003, DRUG DISCOV TODAY, V8, P934, DOI 10.1016/S1359-6446(03)02864-2; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; McDonald WF, 2007, J INFECT DIS, V195, P1607, DOI 10.1086/517613; McNeilly TN, 2008, INFECT IMMUN, V76, P2594, DOI 10.1128/IAI.01452-07; McNeilly TN, 2010, VACCINE, V28, P1412, DOI 10.1016/j.vaccine.2009.10.148; Mizel SB, 2010, J IMMUNOL, V185, P5677, DOI 10.4049/jimmunol.1002156; Munoz N, 2010, INFECT IMMUN, V78, P4226, DOI 10.1128/IAI.00224-10; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; NEWTON SMC, 1989, SCIENCE, V244, P70, DOI 10.1126/science.2468182; PIJPER A, 1948, NATURE, V161, P200, DOI 10.1038/161200b0; Rhee SH, 2008, GASTROENTEROLOGY, V135, P518, DOI 10.1053/j.gastro.2008.04.022; Rolli J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012687; Saha S, 2007, J IMMUNOL, V179, P1147, DOI 10.4049/jimmunol.179.2.1147; Saha S, 2006, VACCINE, V24, P6240, DOI 10.1016/j.vaccine.2006.05.077; Sanders CJ, 2009, EUR J IMMUNOL, V39, P359, DOI 10.1002/eji.200838804; Sfondrini L, 2006, J IMMUNOL, V176, P6624, DOI 10.4049/jimmunol.176.11.6624; Skountzou I, 2010, VACCINE, V28, P4103, DOI 10.1016/j.vaccine.2009.07.058; Smith K, 2003, POETRY REV, V93, P5; Song EJ, 2011, INT J MOL MED, V28, P115, DOI 10.3892/ijmm.2011.656; Strindelius L, 2004, VACCINE, V22, P3797, DOI 10.1016/j.vaccine.2003.12.035; Turley CB, 2011, VACCINE, V29, P5145, DOI 10.1016/j.vaccine.2011.05.041; Vijay-Kumar M, 2008, J IMMUNOL, V180, P8280, DOI 10.4049/jimmunol.180.12.8280; Weimer ET, 2009, VACCINE, V27, P6762, DOI 10.1016/j.vaccine.2009.08.080; Weimer ET, 2009, INFECT IMMUN, V77, P2356, DOI 10.1128/IAI.00054-09; Wu CK, 2007, PROTEIN EXPRES PURIF, V56, P8, DOI 10.1016/j.pep.2007.05.016; WU JY, 1989, P NATL ACAD SCI USA, V86, P4726, DOI 10.1073/pnas.86.12.4726; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	62	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48466	10.1371/journal.pone.0048466	http://dx.doi.org/10.1371/journal.pone.0048466			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155384	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900018
J	van Swelm, RPL; Laarakkers, CMM; van der Kuur, EC; Morava-Kozicz, E; Wevers, RA; Augustijn, KD; Touw, DJ; Sandel, MH; Masereeuw, R; Russel, FGM				van Swelm, Rachel P. L.; Laarakkers, Coby M. M.; van der Kuur, Ellen C.; Morava-Kozicz, Eva; Wevers, Ron A.; Augustijn, Kevin D.; Touw, Daan J.; Sandel, Maro H.; Masereeuw, Rosalinde; Russel, Frans G. M.			Identification of Novel Translational Urinary Biomarkers for Acetaminophen-Induced Acute Liver Injury Using Proteomic Profiling in Mice	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE; CARBON-TETRACHLORIDE; MASS-SPECTROMETRY; NITRIC-OXIDE; MOUSE-LIVER; HEPATOTOXICITY; PROTEINS; RAT; DISCOVERY; REGIOISOMER	Drug-induced liver injury (DILI) is the leading cause of acute liver failure. Currently, no adequate predictive biomarkers for DILI are available. This study describes a translational approach using proteomic profiling for the identification of urinary proteins related to acute liver injury induced by acetaminophen (APAP). Mice were given a single intraperitoneal dose of APAP (0-350 mg/kg bw) followed by 24 h urine collection. Doses of >= 275 mg/kg bw APAP resulted in hepatic centrilobular necrosis and significantly elevated plasma alanine aminotransferase (ALT) values (p<0.0001). Proteomic profiling resulted in the identification of 12 differentially excreted proteins in urine of mice with acute liver injury (p<0.001), including superoxide dismutase 1 (SOD1), carbonic anhydrase 3 (CA3) and calmodulin (CaM), as novel biomarkers for APAP-induced liver injury. Urinary levels of SOD1 and CA3 increased with rising plasma ALT levels, but urinary CaM was already present in mice treated with high dose of APAP without elevated plasma ALT levels. Importantly, we showed in human urine after APAP intoxication the presence of SOD1 and CA3, whereas both proteins were absent in control urine samples. Urinary concentrations of CaM were significantly increased and correlated well with plasma APAP concentrations (r = 0.97; p<0.0001) in human APAP intoxicants, who did not present with elevated plasma ALT levels. In conclusion, using this urinary proteomics approach we demonstrate CA3, SOD1 and, most importantly, CaM as potential human biomarkers for APAP-induced liver injury.	[van Swelm, Rachel P. L.; Masereeuw, Rosalinde; Russel, Frans G. M.] Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	van Swelm, RPL (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pharmacol & Toxicol, NL-6525 ED Nijmegen, Netherlands.	F.Russel@pharmtox.umcn.nl	Russel, Frans G.M./B-3184-2014; Wevers, Ron A./H-8116-2014; Masereeuw, Roos/N-3582-2014; van Swelm, Rachel PL/P-6063-2015; Masereeuw, Roos/I-5276-2016; Morava, E./L-4529-2015	Russel, Frans G.M./0000-0002-7959-2314; Wevers, Ron A./0000-0003-2278-9746; Masereeuw, Roos/0000-0002-1560-1074; Touw, Daniel/0000-0002-1429-4789				Abbas K, 2008, IMMUNOBIOLOGY, V213, P815, DOI 10.1016/j.imbio.2008.07.029; Abdelmegeed MA, 2010, BIOCHEM PHARMACOL, V79, P57, DOI 10.1016/j.bcp.2009.07.016; Agarwal R, 2012, J PHARMACOL EXP THER, V340, P134, DOI 10.1124/jpet.111.184192; BANKS AT, 1995, HEPATOLOGY, V22, P820, DOI 10.1016/0270-9139(95)90303-8; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Boleij A, 2011, INFECT IMMUN, V79, P4777, DOI 10.1128/IAI.05572-11; de Groot T, 2011, MOL CELL BIOL, V31, P2845, DOI 10.1128/MCB.01319-10; Delgado-Coello B, 2006, MOL CELL BIOCHEM, V285, P1, DOI 10.1007/s11010-005-9060-z; Fiedler GM, 2007, CLIN CHEM, V53, P421, DOI 10.1373/clinchem.2006.077834; Fountoulakis M, 2000, ELECTROPHORESIS, V21, P2148, DOI 10.1002/1522-2683(20000601)21:11<2148::AID-ELPS2148>3.0.CO;2-X; Handa S, 2009, BIOL PHARM BULL, V32, P1645, DOI 10.1248/bpb.32.1645; Hinson Jack A, 2010, Handb Exp Pharmacol, P369, DOI 10.1007/978-3-642-00663-0_12; Hiyoshi M, 2009, TOXICOLOGY, V255, P6, DOI 10.1016/j.tox.2008.09.016; Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025; Kentsis A, 2011, PEDIATR INT, V53, P1, DOI 10.1111/j.1442-200X.2010.03253.x; Marimuthu A, 2011, J PROTEOME RES, V10, P2734, DOI 10.1021/pr2003038; Merrick BA, 2006, J PHARMACOL EXP THER, V318, P792, DOI 10.1124/jpet.106.102681; NICOTERA P, 1989, P NATL ACAD SCI USA, V86, P453, DOI 10.1073/pnas.86.2.453; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Papale M, 2007, J CHROMATOGR B, V856, P205, DOI 10.1016/j.jchromb.2007.06.001; Raisanen SR, 1999, FASEB J, V13, P513, DOI 10.1096/fasebj.13.3.513; Ramachandran A, 2011, TOXICOL APPL PHARM, V251, P226, DOI 10.1016/j.taap.2011.01.004; RAY SD, 1990, TOXICOL APPL PHARM, V106, P346, DOI 10.1016/0041-008X(90)90254-R; Rofe AM, 1998, TOXICOLOGY, V125, P131, DOI 10.1016/S0300-483X(97)00172-8; RUMACK BH, 1975, PEDIATRICS, V55, P871; Smyth R, 2009, INT J EXP PATHOL, V90, P500, DOI 10.1111/j.1365-2613.2009.00666.x; Stevens JL, 2009, DRUG DISCOV TODAY, V14, P162, DOI 10.1016/j.drudis.2008.11.009; Stine JG, 2011, EXPERT OPIN DRUG MET, V7, P875, DOI 10.1517/17425255.2011.577415; Thongboonkerd V, 2008, MOL BIOSYST, V4, P810, DOI 10.1039/b802534g; TIRMENSTEIN MA, 1989, J BIOL CHEM, V264, P9814; Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22; Vanhoutte KJA, 2007, NEPHROL DIAL TRANSPL, V22, P2932, DOI 10.1093/ndt/gfm170; Visser K, 2009, CLIN EXP RHEUMATOL, V27, P1017; Watkins PB, 2008, HEPATOLOGY, V48, P1680, DOI 10.1002/hep.22633; Wessels HJCT, 2011, METHOD ENZYMOL, V486, P465, DOI [10.1016/S0076-6879(11)86021-0, 10.1016/B978-0-12-381294-0.00021-3]; Yamamoto Toshinori, 2007, J Toxicol Sci, V32, P205, DOI 10.2131/jts.32.205	36	10	11	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49524	10.1371/journal.pone.0049524	http://dx.doi.org/10.1371/journal.pone.0049524			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166697	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900155
J	Tablado, Z; Revilla, E				Tablado, Zulima; Revilla, Eloy			Contrasting Effects of Climate Change on Rabbit Populations through Reproduction	PLOS ONE			English	Article							ORYCTOLAGUS-CUNICULUS; LIFE-HISTORIES; MODEL; CONSERVATION; SIMULATIONS; VARIABILITY; SENSITIVITY; 21ST-CENTURY; DETERMINANTS; EXTINCTION	Background: Climate change is affecting many physical and biological processes worldwide. Anticipating its effects at the level of populations and species is imperative, especially for organisms of conservation or management concern. Previous studies have focused on estimating future species distributions and extinction probabilities directly from current climatic conditions within their geographical ranges. However, relationships between climate and population parameters may be so complex that to make these high-level predictions we need first to understand the underlying biological processes driving population size, as well as their individual response to climatic alterations. Therefore, the objective of this study is to investigate the influence that climate change may have on species population dynamics through altering breeding season. Methodology/Principal Findings: We used a mechanistic model based on drivers of rabbit reproductive physiology together with demographic simulations to show how future climate-driven changes in breeding season result in contrasting rabbit population trends across Europe. In the Iberian Peninsula, where rabbits are a native species of high ecological and economic value, breeding seasons will shorten and become more variable leading to population declines, higher extinction risk, and lower resilience to perturbations. Whereas towards north-eastern countries, rabbit numbers are expected to increase through longer and more stable reproductive periods, which augment the probability of new rabbit invasions in those areas. Conclusions/Significance: Our study reveals the type of mechanisms through which climate will cause alterations at the species level and emphasizes the need to focus on them in order to better foresee large-scale complex population trends. This is especially important in species like the European rabbit whose future responses may aggravate even further its dual keystone/pest problematic. Moreover, this approach allows us to predict not only distribution shifts but also future population status and growth, and to identify the demographic parameters on which to focus to mitigate global change effects.	[Tablado, Zulima; Revilla, Eloy] CSIC, Estn Biol Donana, E-41080 Seville, Spain; [Tablado, Zulima] CNRS, Lab Ecol Alpine, Bourget Du Lac, France; [Tablado, Zulima] No Inst Nat Res, Tromso, Norway	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Norwegian Institute Nature Research	Tablado, Z (corresponding author), Swiss Ornithol Inst, Sempach, Switzerland.	zutal@ebd.csic.es	Revilla, Eloy/B-5100-2008; Tablado, Zulima/AAN-7484-2020	Revilla, Eloy/0000-0001-5534-5581; 	Spanish Ministry of Education and Science (MEC) [CGL2004-00346]; Spanish Ministry of Science and Innovation; FEDER [CGL2009-07301/BOS, CGL2012-35931/BOS]; FPU grant from the MEC	Spanish Ministry of Education and Science (MEC)(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); FEDER(European Commission); FPU grant from the MEC(German Research Foundation (DFG)National Health and Medical Research Council (NHMRC) of Australia)	This research was part of the project CGL2004-00346 financed by the Spanish Ministry of Education and Science (MEC). Also financially supported by the Spanish Ministry of Science and Innovation (CGL2009-07301/BOS, CGL2012-35931/BOS both co-funded by FEDER). ZT was also partly supported by a FPU grant from the MEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fernandez EA, 2010, COMPUT METH PROG BIO, V99, P49, DOI 10.1016/j.cmpb.2009.11.001; Angulo E, 2004, BIOL CONSERV, V115, P291, DOI 10.1016/S0006-3207(03)00148-4; Both C, 2006, NATURE, V441, P81, DOI 10.1038/nature04539; Branco M, 2000, HEREDITY, V85, P307, DOI 10.1046/j.1365-2540.2000.00756.x; Christensen JH, 2005, PREDICTION REGIONAL; Delibes-Mateos M, 2008, CONSERV BIOL, V22, P1106, DOI 10.1111/j.1523-1739.2008.00993.x; Delibes-Mateos M, 2007, BIOL CONSERV, V137, P149, DOI 10.1016/j.biocon.2007.01.024; Deque M, 2007, CLIMATIC CHANGE, V81, P53, DOI 10.1007/s10584-006-9228-x; Dobson FS, 2007, ECOSCIENCE, V14, P292, DOI 10.2980/1195-6860(2007)14[292:FASLHO]2.0.CO;2; Doscher R, 2002, BOREAL ENVIRON RES, V7, P183; Ferrer M, 2004, CONSERV BIOL, V18, P344, DOI 10.1111/j.1523-1739.2004.00096.x; Fitzpatrick CK, 2011, J BIOMECH, V44, P13, DOI 10.1016/j.jbiomech.2010.08.016; Gibb JA, 1998, NEW ZEAL J ZOOL, V25, P231, DOI 10.1080/03014223.1998.9518153; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; Helmuth B, 2005, ANNU REV PHYSIOL, V67, P177, DOI 10.1146/annurev.physiol.67.040403.105027; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Holmgren M, 2000, J ARID ENVIRON, V44, P197, DOI 10.1006/jare.1999.0589; HUDSON R, 1990, J COMP PHYSIOL A, V167, P225, DOI 10.1007/BF00188115; IPCC, 2000, SPECIAL REPORT EMISS; Lees AC, 2008, MAMMAL REV, V38, P304, DOI 10.1111/j.1365-2907.2008.00116.x; Lenderink G, 2007, CLIM DYNAM, V29, P157, DOI 10.1007/s00382-007-0227-z; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Moleon M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002307; Oberguggenberger M, 2009, INT J APPROX REASON, V50, P680, DOI 10.1016/j.ijar.2008.09.004; Oli MK, 2003, AM NAT, V161, P422, DOI 10.1086/367591; OWEN AB, 1994, J AM STAT ASSOC, V89, P1517, DOI 10.2307/2291014; Palomares F, 2003, MAMM BIOL, V68, P224, DOI 10.1078/1616-5047-00088; Peterson AT, 2002, NATURE, V416, P626, DOI 10.1038/416626a; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; POOLE W. E., 1960, C S I R O WILDLIFE RES, V5, P21; Raisanen J, 2004, CLIM DYNAM, V22, P13, DOI 10.1007/s00382-003-0365-x; ROBSON DL, 1993, WILDLIFE RES, V20, P815, DOI 10.1071/WR9930815; Roeckner E, 1999, J CLIMATE, V12, P3004, DOI 10.1175/1520-0442(1999)012<3004:TCCSWA>2.0.CO;2; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Saltelli A, 2010, ENVIRON MODELL SOFTW, V25, P1508, DOI 10.1016/j.envsoft.2010.04.012; Soriguer R. C., 1981, DONANA ACTA VERTEBRA, V8, P1; Stevens WF, 1981, P WORLD LAG C GUELPH, P870; Tablado Z, 2012, J ANIM ECOL, V81, P150, DOI 10.1111/j.1365-2656.2011.01884.x; Tablado Z, 2009, ECOGRAPHY, V32, P310, DOI 10.1111/j.1600-0587.2008.05532.x; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thompson Harry V., 1994, P64; TYNDALE-BISCOE C. H., 1955, NEW ZEALAND JOUR SCI AND TECHNOL SER B, V36, P561; Villafuerte R, 1994, THESIS U CORDOBA COR; Virgos E, 2007, BIODIVERS CONSERV, V16, P3489, DOI 10.1007/s10531-006-9054-5; von Holst D, 1999, NATURWISSENSCHAFTEN, V86, P388, DOI 10.1007/s001140050638; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Williams K, 1995, MANAGING VERTEBRATE; Zhang YQ, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001822	48	7	7	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48988	10.1371/journal.pone.0048988	http://dx.doi.org/10.1371/journal.pone.0048988			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152836	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234600017
J	Sun, XC; Qu, L; Garrick, DJ; Dekkers, JCM; Fernando, RL				Sun, Xiaochen; Qu, Long; Garrick, Dorian J.; Dekkers, Jack C. M.; Fernando, Rohan L.			A Fast EM Algorithm for BayesA-Like Prediction of Genomic Breeding Values	PLOS ONE			English	Article							GENETIC-RELATIONSHIP INFORMATION; FULL PEDIGREE; SELECTION; ACCURACY; IMPACT; LIKELIHOOD; TRAITS; MODELS	Prediction accuracies of estimated breeding values for economically important traits are expected to benefit from genomic information. Single nucleotide polymorphism (SNP) panels used in genomic prediction are increasing in density, but the Markov Chain Monte Carlo (MCMC) estimation of SNP effects can be quite time consuming or slow to converge when a large number of SNPs are fitted simultaneously in a linear mixed model. Here we present an EM algorithm (termed "fastBayesA") without MCMC. This fastBayesA approach treats the variances of SNP effects as missing data and uses a joint posterior mode of effects compared to the commonly used BayesA which bases predictions on posterior means of effects. In each EM iteration, SNP effects are predicted as a linear combination of best linear unbiased predictions of breeding values from a mixed linear animal model that incorporates a weighted marker-based realized relationship matrix. Method fastBayesA converges after a few iterations to a joint posterior mode of SNP effects under the BayesA model. When applied to simulated quantitative traits with a range of genetic architectures, fastBayesA is shown to predict GEBV as accurately as BayesA but with less computing effort per SNP than BayesA. Method fastBayesA can be used as a computationally efficient substitute for BayesA, especially when an increasing number of markers bring unreasonable computational burden or slow convergence to MCMC approaches. Citation: Sun X, Qu L, Garrick DJ, Dekkers JCM, Fernando RL (2012) A Fast EM Algorithm for BayesA-Like Prediction of Genomic Breeding Values. PLoS ONE 7(11): e49157. doi: 10.1371/journal.pone.0049157	[Sun, Xiaochen; Qu, Long; Garrick, Dorian J.; Dekkers, Jack C. M.; Fernando, Rohan L.] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA; [Sun, Xiaochen; Qu, Long; Garrick, Dorian J.; Dekkers, Jack C. M.; Fernando, Rohan L.] Iowa State Univ, Ctr Integrated Anim Genom, Ames, IA USA; [Qu, Long] Iowa State Univ, Dept Stat, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Fernando, RL (corresponding author), Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA.	rohan@iastate.edu	Qu, Long/I-8528-2012; Garrick, Dorian/Q-3239-2019; Garrick, Dorian/P-9628-2019	Garrick, Dorian/0000-0001-8640-5372	United States Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) Competitive Grant from the National Institute of Food and Agriculture [2010-65205-20341]	United States Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) Competitive Grant from the National Institute of Food and Agriculture	Support for this research was provided by United States Department of Agriculture (USDA) Agriculture and Food Research Initiative (AFRI) Competitive Grant No. 2010-65205-20341 from the National Institute of Food and Agriculture. No extra funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Celeux G, 2000, J AM STAT ASSOC, V95, P957, DOI 10.2307/2669477; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Fernando RL, 1998, P 6 WORLD C GEN APPL, V26, P329; Fernando RL, 2010, ANIMAL BREEDING GENE; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Haldane JBS, 1919, J GENET, V8, P299; Hayashi Takeshi, 2010, BMC Genet, V11, P3, DOI 10.1186/1471-2156-11-3; Hayes BJ, 2009, GENET RES, V91, P47, DOI 10.1017/S0016672308009981; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Hayes BJ, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-51; Henderson C. R, 1984, APPL LINEAR MODELS A; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Luan T, 2009, GENETICS, V183, P1119, DOI 10.1534/genetics.109.107391; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-2; Misztal I, 2009, J DAIRY SCI, V92, P4648, DOI 10.3168/jds.2009-2064; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Shepherd RK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-529; Solberg TR, 2008, J ANIM SCI, V86, P2447, DOI 10.2527/jas.2007-0010; Stranden I, 2009, J DAIRY SCI, V92, P2971, DOI 10.3168/jds.2008-1929; Sun Xiaochen, 2011, BMC Proc, V5 Suppl 3, pS13, DOI 10.1186/1753-6561-5-S3-S13; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; VanRaden PM, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-10; Wolc A, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-5; Yi NJ, 2009, GENETICS, V181, P1101, DOI 10.1534/genetics.108.099556; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648	36	22	22	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49157	10.1371/journal.pone.0049157	http://dx.doi.org/10.1371/journal.pone.0049157			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152868	Green Submitted, Green Published, gold			2022-12-27	WOS:000312272600050
J	Veschi, V; Petroni, M; Cardinali, B; Dominici, C; Screpanti, I; Frati, L; Bartolazzi, A; Gulino, A; Giannini, G				Veschi, Veronica; Petroni, Marialaura; Cardinali, Beatrice; Dominici, Carlo; Screpanti, Isabella; Frati, Luigi; Bartolazzi, Armando; Gulino, Alberto; Giannini, Giuseppe			Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells	PLOS ONE			English	Article							DIRECT TRANSCRIPTIONAL TARGET; N-MYC; ANTIAPOPTOTIC MOLECULE; TUMOR SUPPRESSION; P53 RESTORATION; CYTOCHROME-C; EXPRESSION; CANCER; DRUG; NUCLEAR	MYCN amplification occurs in about 20-25% of human neuroblastomas and characterizes the majority of the high-risk cases, which display less than 50% prolonged survival rate despite intense multimodal treatment. Somehow paradoxically, MYCN also sensitizes neuroblastoma cells to apoptosis, understanding the molecular mechanisms of which might be relevant for the therapy of MYCN amplified neuroblastoma. We recently reported that the apoptosis-sensitive phenotype induced by MYCN is linked to stabilization of p53 and its proapoptotic kinase HIPK2. In MYCN primed neuroblastoma cells, further activation of both HIPK2 and p53 by Nutlin-3 leads to massive apoptosis in vitro and to tumor shrinkage and impairment of metastasis in xenograft models. Here we report that Galectin-3 impairs MYCN-primed and HIPK2-p53-dependent apoptosis in neuroblastoma cells. Galectin-3 is broadly expressed in human neuroblastoma cell lines and tumors and is repressed by MYCN to induce the apoptosis-sensitive phenotype. Despite its reduced levels, Galectin-3 can still exert residual antiapoptotic effects in MYCN amplified neuroblastoma cells, possibly due to its specific subcellular localization. Importantly, Nutlin-3 represses Galectin-3 expression, and this is required for its potent cell killing effect on MYCN amplified cell lines. Our data further characterize the apoptosis-sensitive phenotype induced by MYCN, expand our understanding of the activity of MDM2-p53 antagonists and highlight Galectin-3 as a potential biomarker for the tailored p53 reactivation therapy in patients with high-risk neuroblastomas. Citation: Veschi V, Petroni M, Cardinali B, Dominici C, Screpanti I, et al. (2012) Galectin-3 Impairment of MYCN-Dependent Apoptosis-Sensitive Phenotype Is Antagonized by Nutlin-3 in Neuroblastoma Cells. PLoS One 7(11): e49139. doi: 10.1371/journal.pone.0049139	[Petroni, Marialaura; Screpanti, Isabella; Gulino, Alberto; Giannini, Giuseppe] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy; [Veschi, Veronica; Frati, Luigi] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Cardinali, Beatrice] CNR, Inst Cell Biol & Neurobiol, Monterotondo, Italy; [Dominici, Carlo] Univ Roma La Sapienza, Dept Pediat, Rome, Italy; [Dominici, Carlo] Univ Liverpool, Sch Reprod & Dev Med, Liverpool L69 3BX, Merseyside, England; [Bartolazzi, Armando] S Andrea Hosp, Expt Pathol Lab, Rome, Italy; [Bartolazzi, Armando] Karolinska Hosp, CCK R8 04, S-10401 Stockholm, Sweden	Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); Sapienza University Rome; University of Liverpool; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Karolinska Institutet; Karolinska University Hospital	Giannini, G (corresponding author), Univ Roma La Sapienza, Dept Mol Med, Rome, Italy.	giuseppe.giannini@uniroma1.it	Veschi, Veronica/K-4143-2018; petroni, marialaura/AAB-8637-2019; Giannini, Giuseppe/B-5672-2013; Frati, Luigi/ABI-7437-2020; Cardinali, Beatrice/M-8862-2015; Bartolazzi, Armando/K-9708-2016	Veschi, Veronica/0000-0002-6379-7366; petroni, marialaura/0000-0002-6021-1657; Giannini, Giuseppe/0000-0003-0299-4056; Cardinali, Beatrice/0000-0002-3333-3384; Bartolazzi, Armando/0000-0001-7820-5127	Associazione Italiana per la Ricerca sul Cancro [IG12116]; Telethon grant [GGP07118]; National Research Council (CNR); MIUR FIRB; PRIN; Ministry of Health; Fondazione Roma; EU Healing grant; Italian Institute of Technology (IIT); Agenzia Spaziale Italiana (ASI); National Institutes of Health (NIH) [P41 RR011823]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Telethon grant(Fondazione Telethon); National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR)); MIUR FIRB(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministry of Health; Fondazione Roma(Fondazione RomaEuropean Commission); EU Healing grant; Italian Institute of Technology (IIT)(Istituto Italiano di Tecnologia - IIT); Agenzia Spaziale Italiana (ASI)(Agenzia Spaziale Italiana (ASI)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was partially supported by grants from Associazione Italiana per la Ricerca sul Cancro (IG12116), Telethon grant GGP07118, National Research Council (CNR), MIUR FIRB and PRIN, Ministry of Health, Fondazione Roma, EU Healing grant, Italian Institute of Technology (IIT), Agenzia Spaziale Italiana (ASI), National Institutes of Health (NIH) P41 RR011823. MP is a Teresa-Ariaudo fellow of the Pasteur Insitute/Cenci Bolognetti Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akahani S, 1997, CANCER RES, V57, P5272; Bagatell R, 2009, J CLIN ONCOL, V27, P365, DOI 10.1200/JCO.2008.17.9184; Bartolazzi A, 2001, LANCET, V357, P1644, DOI 10.1016/S0140-6736(00)04817-0; Bartolazzi A, 2008, LANCET ONCOL, V9, P543, DOI 10.1016/S1470-2045(08)70132-3; Bell E, 2006, CELL CYCLE, V5, P2639, DOI 10.4161/cc.5.22.3443; Burkhart CA, 2003, J NATL CANCER I, V95, P1394, DOI 10.1093/jnci/djg045; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Canesin G, 2010, TUMOR BIOL, V31, P277, DOI 10.1007/s13277-010-0033-9; Canete A, 2009, J CLIN ONCOL, V27, P1014, DOI 10.1200/JCO.2007.14.5839; Carr-Wilkinson J, 2010, CLIN CANCER RES, V16, P1108, DOI 10.1158/1078-0432.CCR-09-1865; Cecchinelli B, 2006, MOL CELL BIOL, V26, P4746, DOI 10.1128/MCB.00959-05; Cerignoli F, 2004, ANN NY ACAD SCI, V1028, P122, DOI 10.1196/annals.1322.013; Chen L, 2007, CELL CYCLE, V6, P2685, DOI 10.4161/cc.6.21.4853; Chen LD, 2010, CANCER RES, V70, P1377, DOI 10.1158/0008-5472.CAN-09-2598; Cheok CF, 2011, NAT REV CLIN ONCOL, V8, P25, DOI 10.1038/nrclinonc.2010.174; Chesler L, 2008, NEOPLASIA, V10, P1268, DOI 10.1593/neo.08778; Cohn SL, 2009, J CLIN ONCOL, V27, P289, DOI 10.1200/JCO.2008.16.6785; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; DOMINICI C, 1989, CLIN EXP METASTAS, V7, P201, DOI 10.1007/BF01787024; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Endo K, 2005, ANTICANCER RES, V25, P3117; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Fulda S, 1999, ONCOGENE, V18, P1479, DOI 10.1038/sj.onc.1202435; Gamble LD, 2012, ONCOGENE, V31, P752, DOI 10.1038/onc.2011.270; Giammarioli AM, 2012, INT J CANCER, V131, pE337, DOI 10.1002/ijc.26420; Giannini G, 2005, CANCER LETT, V228, P97, DOI 10.1016/j.canlet.2005.01.045; Giannini G, 2005, CANCER RES, V65, P8308, DOI 10.1158/0008-5472.CAN-05-0607; Giannini G, 1999, CANCER RES, V59, P2484; Giannini G, 2000, BRIT J CANCER, V83, P1503, DOI 10.1054/bjoc.2000.1494; Haudek KC, 2010, BBA-GEN SUBJECTS, V1800, P181, DOI 10.1016/j.bbagen.2009.07.005; Hopkins-Donaldson S, 2002, ONCOGENE, V21, P6132, DOI 10.1038/sj.onc.1205879; Idikio H, 1998, INT J ONCOL, V12, P1287; Judware R, 1995, ONCOGENE, V11, P2599; Keshelava N, 1998, CANCER RES, V58, P5396; Kim MK, 2011, INT J CLIN ONCOL, V16, P352, DOI 10.1007/s10147-011-0190-x; Kobayashi M, 2006, CELL TISSUE RES, V323, P81, DOI 10.1007/s00441-005-0011-5; Lavra L, 2008, J PATHOL; Lavra L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020665; Lutz W, 1996, ONCOGENE, V13, P803; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Mellone M, 2008, NEOPLASIA, V10, P773, DOI 10.1593/neo.08462; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nara K, 2007, INT J ONCOL, V30, P1189; Pacis RA, 2000, PROSTATE, V44, P118; Petroni M, 2011, MOL CANCER RES, V9, P67, DOI 10.1158/1541-7786.MCR-10-0227; Reynolds C P, 1988, Prog Clin Biol Res, V271, P291; Rinaldo C, 2009, CANCER RES, V69, P6241, DOI 10.1158/0008-5472.CAN-09-0337; Shimamura T, 2002, CLIN CANCER RES, V8, P2570; Slack A, 2005, P NATL ACAD SCI USA, V102, P731, DOI 10.1073/pnas.0405495102; Takenaka Y, 2004, MOL CELL BIOL, V24, P4395, DOI 10.1128/MCB.24.10.4395-4406.2004; Takenaka Y, 2003, CANCER LETT, V195, P111, DOI 10.1016/S0304-3835(03)00056-9; Tang XX, 2006, CANCER RES, V66, P2826, DOI 10.1158/0008-5472.CAN-05-0854; Thiele CJ, 1999, HUMAN CELL CULTURE, V1, P21; Tweddle DA, 2003, CANCER LETT, V197, P93, DOI 10.1016/S0304-3835(03)00088-0; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Van Maerken T, 2009, CELL DEATH DIFFER, V16, P1563, DOI 10.1038/cdd.2009.138; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Yoshii T, 2001, INT J ONCOL, V18, P787; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; ZORNIG M, 1995, ONCOGENE, V11, P2165	67	19	20	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49139	10.1371/journal.pone.0049139	http://dx.doi.org/10.1371/journal.pone.0049139			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152863	Green Submitted, gold, Green Published			2022-12-27	WOS:000312272600048
J	Alysandratos, KD; Asadi, S; Angelidou, A; Zhang, BD; Sismanopoulos, N; Yang, HL; Critchfield, A; Theoharides, TC				Alysandratos, Konstantinos-Dionysios; Asadi, Shahrzad; Angelidou, Asimenia; Zhang, Bodi; Sismanopoulos, Nikolaos; Yang, Hailing; Critchfield, Agatha; Theoharides, Theoharis C.			Neurotensin and CRH Interactions Augment Human Mast Cell Activation	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; ATOPIC-DERMATITIS; VASCULAR-PERMEABILITY; SUBSTANCE-P; HISTAMINE-RELEASE; G-PROTEINS; HUMAN SKIN; RECEPTOR; RAT; EXPRESSION	Stress affects immunity, but the mechanism is not known. Neurotensin (NT) and corticotropin-releasing hormone (CRH) are secreted under stress in various tissues, and have immunomodulatory actions. We had previously shown that NT augments the ability of CRH to increase mast cell-dependent skin vascular permeability in rodents. Here we show that NT triggered human mast cell degranulation and significantly augmented CRH-induced vascular endothelial growth factor (VEGF) release. Investigation of various signaling molecules indicated that only NF-kappa B activation was involved. These effects were blocked by pretreatment with the NTR antagonist SR48692. NT induced expression of CRH receptor-1 (CRHR-1), as shown by Western blot and FACS analysis. Interestingly, CRH also induced NTR gene and protein expression. These results indicate unique interactions among NT, CRH, and mast cells that may contribute to auto-immune and inflammatory diseases that worsen with stress.			Alysandratos, KD (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA.	theoharis.theoharides@tufts.edu	Zhang, Bodi/ABI-6738-2020	Critchfield, Agatha/0000-0003-1411-1150	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047652] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR047652, AR47652] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asadi S, 2012, J INVEST DE IN PRESS; Badertscher K, 2005, ARCH DERMATOL RES, V296, P503, DOI 10.1007/s00403-005-0542-3; Barrocas AM, 1999, IMMUNOPHARMACOLOGY, V41, P131, DOI 10.1016/S0162-3109(98)00064-2; Bieber T, 2008, NEW ENGL J MED, V358, P1483, DOI 10.1056/NEJMra074081; Bonness S, 2007, CURR OPIN ALLERGY CL, V7, P382, DOI 10.1097/ACI.0b013e3282a643c3; Cao J, 2005, J IMMUNOL, V174, P7665, DOI 10.4049/jimmunol.174.12.7665; CARRAWAY R, 1982, J PHYSIOL-LONDON, V323, P403, DOI 10.1113/jphysiol.1982.sp014080; CARRAWAY R, 1973, J BIOL CHEM, V248, P6854; Castagliuolo I, 1999, J CLIN INVEST, V103, P843, DOI 10.1172/JCI4217; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cochrane DE, 2011, INFLAMM RES, V60, P1139, DOI 10.1007/s00011-011-0378-6; COCHRANE DE, 1982, ANN NY ACAD SCI, V400, P396, DOI 10.1111/j.1749-6632.1982.tb31591.x; COCHRANE DE, 1986, INT ARCH ALLER A IMM, V80, P225, DOI 10.1159/000234057; COCHRANE DE, 1991, PEPTIDES, V12, P1187, DOI 10.1016/0196-9781(91)90193-S; Crompton R, 2003, J CLIN ENDOCR METAB, V88, P5427, DOI 10.1210/jc.2003-030377; Damsgaard TE, 1997, ARCH DERMATOL RES, V289, P256, DOI 10.1007/s004030050189; Donelan J, 2006, J INVEST DERMATOL, V126, P929, DOI 10.1038/sj.jid.5700153; Donelan J, 2006, P NATL ACAD SCI USA, V103, P7759, DOI 10.1073/pnas.0602210103; Feldberg RS, 1998, INFLAMM RES, V47, P245, DOI 10.1007/s000110050325; FOREMAN JC, 1982, BRIT J PHARMACOL, V77, P531, DOI 10.1111/j.1476-5381.1982.tb09328.x; Galli SJ, 1999, CURR OPIN IMMUNOL, V11, P53, DOI 10.1016/S0952-7915(99)80010-7; GAO GC, 1995, REGUL PEPTIDES, V58, P117, DOI 10.1016/0167-0115(95)00070-R; GRAHAM DT, 1953, J LAB CLIN MED, V42, P238; Groneberg DA, 2005, ALLERGY, V60, P90, DOI 10.1111/j.1398-9995.2004.00628.x; Grutzkau A, 1998, MOL BIOL CELL, V9, P875, DOI 10.1091/mbc.9.4.875; Ito N, 2010, J INVEST DERMATOL, V130, P995, DOI 10.1038/jid.2009.387; Jarvikallio A, 2003, ARCH DERMATOL RES, V295, P2, DOI 10.1007/s00403-002-0378-z; Karalis K, 1997, J NEUROIMMUNOL, V72, P131, DOI 10.1016/S0165-5728(96)00178-6; Katsarou-Katsari A, 1999, INT J IMMUNOPATH PH, V12, P7; Kempuraj D, 2004, ENDOCRINOLOGY, V145, P43, DOI 10.1210/en.2003-0805; Kempuraj D, 1999, BLOOD, V93, P3338, DOI 10.1182/blood.V93.10.3338.410k05_3338_3346; Kinet JP, 2007, IMMUNOL REV, V217, P5, DOI 10.1111/j.1600-065X.2007.00528.x; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; KRUGER PG, 1982, ACTA PHYSIOL SCAND, V114, P467, DOI 10.1111/j.1748-1716.1982.tb07011.x; Laham RJ, 2003, ANN VASC SURG, V17, P245, DOI 10.1007/s10016-001-0299-x; Li RCX, 2000, AM J PHYSIOL-HEART C, V279, pH1679, DOI 10.1152/ajpheart.2000.279.4.H1679; Linnet J, 2001, INT J DERMATOL, V40, P632, DOI 10.1046/j.1365-4362.2001.01272.x; Liu FT, 2011, CLIN REV ALLERGY IMM; Lytinas M, 2003, INT ARCH ALLERGY IMM, V130, P224, DOI 10.1159/000069516; Metz M, 2007, TRENDS IMMUNOL, V28, P234, DOI 10.1016/j.it.2007.03.003; Metz M, 2007, IMMUNOL REV, V217, P304, DOI 10.1111/j.1600-065X.2007.00520.x; Metz M, 2009, CURR OPIN IMMUNOL, V21, P687, DOI 10.1016/j.coi.2009.09.009; MOUSLI M, 1990, FEBS LETT, V259, P260, DOI 10.1016/0014-5793(90)80023-C; MOUSLI M, 1990, TRENDS PHARMACOL SCI, V11, P358, DOI 10.1016/0165-6147(90)90179-C; Mustain WC, 2011, CURR OPIN ENDOCRINOL, V18, P75, DOI 10.1097/MED.0b013e3283419052; Norton SK, 2008, J IMMUNOL, V180, P2848, DOI 10.4049/jimmunol.180.5.2848; O'Kane M, 2006, EXP DERMATOL, V15, P143; Oh SH, 2012, J ALLERGY CLIN IMMUN, V129, P151, DOI 10.1016/j.jaci.2011.09.008; Ostlere LS, 1995, CLIN EXP DERMATOL, V20, P462, DOI 10.1111/j.1365-2230.1995.tb01378.x; Paus R, 2006, TRENDS IMMUNOL, V27, P32, DOI 10.1016/j.it.2005.10.002; Piliponsky AM, 2008, NAT MED, V14, P392, DOI 10.1038/nm1738; Quevedo ME, 2001, IN VITRO CELL DEV-AN, V37, P50; Rahman S, 2011, INFLAMM ALLERGY DRUG; Ralph JA, 2007, AM J PATHOL, V170, P1121, DOI 10.2353/ajpath.2007.061000; Roloff B, 1998, FASEB J, V12, P287, DOI 10.1096/fasebj.12.3.287; Rozniecki JJ, 1999, BRAIN RES, V849, P1, DOI 10.1016/S0006-8993(99)01855-7; Seiffert K, 2005, DERMATOLOGY, V210, P286, DOI 10.1159/000084752; Singh LK, 1999, BRAIN BEHAV IMMUN, V13, P225, DOI 10.1006/brbi.1998.0541; Sismanopoulos N, 2012, PLOS ONE IN PRESS; Slattery MJ, 2005, IMMUNOL ALLERGY CLIN, V25, P407, DOI 10.1016/j.iac.2005.02.007; Slominski A, 2000, ENDOCR REV, V21, P457, DOI 10.1210/er.21.5.457; Slominski A, 1998, J CLIN ENDOCR METAB, V83, P1020, DOI 10.1210/jc.83.3.1020; Slominski A, 2009, BRIT J DERMATOL, V160, P229, DOI 10.1111/j.1365-2133.2008.08958.x; Slominski A, 2000, PHYSIOL REV, V80, P979, DOI 10.1152/physrev.2000.80.3.979; Slominski A, 2004, ENDOCRINOLOGY, V145, P941, DOI 10.1210/en.2003-0851; Slominski A, 2001, FASEB J, V15, P1678, DOI 10.1096/fj.00-0850rev; Stander S, 2002, EXP DERMATOL, V11, P12, DOI 10.1034/j.1600-0625.2002.110102.x; Stauder A, 2003, PSYCHOSOM MED, V65, P816, DOI 10.1097/01.PSY.0000088620.66211.B1; SUGIURA H, 1993, ACTA DERM-VENEREOL, V73, P296; SUGIURA H, 1989, ACTA DERM-VENEREOL, P115; SZEKERES PG, 1994, REGUL PEPTIDES, V54, P293, DOI 10.1016/0167-0115(94)90505-3; Theoharides TC, 2004, TRENDS PHARMACOL SCI, V25, P563, DOI 10.1016/j.tips.2004.09.007; Theoharides TC, 2004, J NEUROIMMUNOL, V146, P1, DOI 10.1016/j.jneuroim.2003.10.041; Theoharides TC, 1998, ENDOCRINOLOGY, V139, P403, DOI 10.1210/en.139.1.403; Theoharides TC, 2012, BBA-MOL BASIS DIS, V1822, P21, DOI 10.1016/j.bbadis.2010.12.014; Tyler-McMahon BM, 2000, REGUL PEPTIDES, V93, P125, DOI 10.1016/S0167-0115(00)00183-X; Vasiadi M, 2012, J ALLERGY CLIN IMMUN, V129, P1410, DOI 10.1016/j.jaci.2012.01.041; Wang BB, 2012, MOL ENDOCRINOL, V26, P1356, DOI 10.1210/me.2012-1035; Weidinger S, 2005, ALLERGY, V60, P1256, DOI 10.1111/j.1398-9995.2005.00879.x; Wright RJ, 2005, CURR OPIN ALLERGY CL, V5, P23, DOI 10.1097/00130832-200502000-00006; Zhao DZ, 2007, INT J CANCER, V120, P1652, DOI 10.1002/ijc.22407; Zhao DZ, 2011, J BIOL CHEM, V286, P6092, DOI 10.1074/jbc.M110.192534	82	64	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48934	10.1371/journal.pone.0048934	http://dx.doi.org/10.1371/journal.pone.0048934			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155429	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900064
J	Blauw, AN; Beninca, E; Laane, RWPM; Greenwood, N; Huisman, J				Blauw, Anouk N.; Beninca, Elisa; Laane, Remi W. P. M.; Greenwood, Naomi; Huisman, Jef			Dancing with the Tides: Fluctuations of Coastal Phytoplankton Orchestrated by Different Oscillatory Modes of the Tidal Cycle	PLOS ONE			English	Article							PREDATOR-PREY SYSTEM; SOUTHERN NORTH-SEA; TIME-SERIES; NATURAL PHYTOPLANKTON; PARTICLE AGGREGATION; WAVELET ANALYSIS; SPRING BLOOM; EMS ESTUARY; COMPETITION; LIGHT	Population fluctuations are often driven by an interplay between intrinsic population processes and extrinsic environmental forcing. To investigate this interplay, we analyzed fluctuations in coastal phytoplankton concentration in relation to the tidal cycle. Time series of chlorophyll fluorescence, suspended particulate matter (SPM), salinity and temperature were obtained from an automated measuring platform in the southern North Sea, covering 9 years of data at a resolution of 12 to 30 minutes. Wavelet analysis showed that chlorophyll fluctuations were dominated by periodicities of 6 hours 12 min, 12 hours 25 min, 24 hours and 15 days, which correspond to the typical periodicities of tidal current speeds, the semidiurnal tidal cycle, the day-night cycle, and the spring-neap tidal cycle, respectively. During most of the year, chlorophyll and SPM fluctuated in phase with tidal current speed, indicative of alternating periods of sinking and vertical mixing of algal cells and SPM driven by the tidal cycle. Spring blooms slowly built up over several spring-neap tidal cycles, and subsequently expanded in late spring when a strong decline of the SPM concentration during neap tide enabled a temporary "escape" of the chlorophyll concentration from the tidal mixing regime. Our results demonstrate that the tidal cycle is a major determinant of phytoplankton fluctuations at several different time scales. These findings imply that high-resolution monitoring programs are essential to capture the natural variability of phytoplankton in coastal waters.	[Blauw, Anouk N.; Beninca, Elisa; Laane, Remi W. P. M.; Huisman, Jef] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands	University of Amsterdam	Blauw, AN (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.	anouk.blauw@deltares.nl	Huisman, Jef/A-1089-2013; Greenwood, Naomi/B-1832-2012	Huisman, Jef/0000-0001-9598-3211; Greenwood, Naomi/0000-0001-7166-9455				ALLDREDGE AL, 1989, DEEP-SEA RES, V36, P159, DOI 10.1016/0198-0149(89)90131-3; Beninca E, 2008, NATURE, V451, P822, DOI 10.1038/nature06512; Beninca E, 2011, AM NAT, V178, pE85, DOI 10.1086/661902; Bjornstad ON, 2001, SCIENCE, V293, P638, DOI 10.1126/science.1062226; Blauw AN, 2010, J MARINE SYST, V83, P115, DOI 10.1016/j.jmarsys.2010.05.003; Brunet C, 2003, ESTUAR COAST SHELF S, V56, P833, DOI 10.1016/S0272-7714(02)00323-2; Burd AB, 2009, ANNU REV MAR SCI, V1, P65, DOI 10.1146/annurev.marine.010908.163904; Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2; Chen ZQ, 2010, ESTUAR COAST SHELF S, V89, P62, DOI 10.1016/j.ecss.2010.05.014; CLOERN JE, 1991, J MAR RES, V49, P203, DOI 10.1357/002224091784968611; Colijn F, 2003, J SEA RES, V49, P83, DOI 10.1016/S1385-1101(03)00002-9; CONNELL JH, 1978, SCIENCE, V199, P1302, DOI 10.1126/science.199.4335.1302; Dakos V, 2009, P ROY SOC B-BIOL SCI, V276, P2871, DOI 10.1098/rspb.2009.0584; de Brouwer JFC, 2000, CONT SHELF RES, V20, P1159, DOI 10.1016/S0278-4343(00)00017-0; DEJONGE VN, 1995, LIMNOL OCEANOGR, V40, P766; Elton CS, 1924, BR J EXP BIOL, V2, P119; Floder S, 1999, LIMNOL OCEANOGR, V44, P1114; Fussmann GF, 2000, SCIENCE, V290, P1358, DOI 10.1126/science.290.5495.1358; GAEDEKE A, 1986, OECOLOGIA, V71, P25, DOI 10.1007/BF00377315; Gause G. F., 1934, STRUGGLE EXISTENCE; GEIDER RJ, 1987, NEW PHYTOL, V106, P1, DOI 10.1111/j.1469-8137.1987.tb04788.x; Greenwood N, 2010, BIOGEOSCIENCES, V7, P1357, DOI 10.5194/bg-7-1357-2010; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; GROVER JP, 1991, AM NAT, V138, P811, DOI 10.1086/285254; Huisman J, 1999, ECOLOGY, V80, P211, DOI 10.1890/0012-9658(1999)080[0211:CFLBPS]2.0.CO;2; Huisman J, 2004, ECOLOGY, V85, P2960, DOI 10.1890/03-0763; Huisman J, 1999, NATURE, V402, P407, DOI 10.1038/46540; Huisman J, 2002, MAR ECOL PROG SER, V244, P39, DOI 10.3354/meps244039; Jago CF, 1998, CONT SHELF RES, V18, P1255, DOI 10.1016/S0278-4343(98)00043-0; KIEFER DA, 1973, MAR BIOL, V22, P263, DOI 10.1007/BF00389180; Koelle K, 2004, AM NAT, V163, P901, DOI 10.1086/420798; Kroger S, 2009, OCEAN SCI, V5, P523; Lauria ML, 1999, J MARINE SYST, V21, P189, DOI 10.1016/S0924-7963(99)00013-5; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Lucas CH, 2000, MAR ECOL PROG SER, V196, P59, DOI 10.3354/meps196059; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; May CL, 2003, MAR ECOL PROG SER, V254, P111, DOI 10.3354/meps254111; McCandliss RR, 2002, J SEA RES, V47, P285, DOI 10.1016/S1385-1101(02)00123-5; McCauley E, 1999, NATURE, V402, P653, DOI 10.1038/45223; MCKAYBALCH W, 1981, J EXP MAR BIOL ECOL, V55, P65, DOI 10.1016/0022-0981(81)90093-9; McQuoid MR, 2003, ESTUAR COAST SHELF S, V56, P339, DOI 10.1016/S0272-7714(02)00187-7; Mills DK, 2003, ELSEV OCEANOGR SERIE, V69, P311; Muylaert K, 1999, J MARINE SYST, V22, P133, DOI 10.1016/S0924-7963(99)00037-8; Nechad B, 2011, OCEAN DYNAM, V61, P1205, DOI 10.1007/s10236-011-0425-4; PADISAK J, 1993, DEV HYDROBIOLOGY, V81; Passarge J, 2006, ECOL MONOGR, V76, P57, DOI 10.1890/04-1824; Passow U, 2002, PROG OCEANOGR, V55, P287, DOI 10.1016/S0079-6611(02)00138-6; Pietrzak JD, 2011, CONT SHELF RES, V31, P594, DOI 10.1016/j.csr.2010.12.014; Pugh DT, 1996, JOHN; RIEBESELL U, 1991, MAR ECOL PROG SER, V69, P273, DOI 10.3354/meps069273; Roncarati F, 2008, MAR BIOL, V153, P965, DOI 10.1007/s00227-007-0868-9; Sharples J, 2008, J PLANKTON RES, V30, P183, DOI 10.1093/plankt/fbm088; Sharples J, 2007, LIMNOL OCEANOGR, V52, P1735, DOI 10.4319/lo.2007.52.5.1735; SHIFRIN NS, 1981, J PHYCOL, V17, P374, DOI 10.1111/j.0022-3646.1981.00374.x; SMAYDA TJ, 1971, MAR GEOL, V11, P105, DOI 10.1016/0025-3227(71)90070-3; Smayda TJ, 1998, ICES J MAR SCI, V55, P562, DOI 10.1006/jmsc.1998.0385; SMETACEK VS, 1985, MAR BIOL, V84, P239, DOI 10.1007/BF00392493; SOMMER U, 1985, LIMNOL OCEANOGR, V30, P335, DOI 10.4319/lo.1985.30.2.0335; Stomp M, 2008, AM NAT, V172, pE169, DOI 10.1086/591680; Sutherland TF, 1998, LIMNOL OCEANOGR, V43, P65, DOI 10.4319/lo.1998.43.1.0065; Tett P.B., 1987, P280; Thornton DCO, 2002, EUR J PHYCOL, V37, P149, DOI 10.1017/S0967026202003657; Tian T, 2009, J SEA RES, V62, P214, DOI 10.1016/j.seares.2009.04.001; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Utermohl H., 1931, Verhandlungen der Internationalen Vereinigung fuer Theoretische Limnologie Stuttgart, V5, P567; van der Woerd HJ, 2011, J SEA RES, V65, P195, DOI 10.1016/j.seares.2010.09.007; van Haren H, 1998, J MAR RES, V56, P655, DOI 10.1357/002224098765213621; van Leussen W, 2011, OCEAN DYNAM, V61, P387, DOI 10.1007/s10236-011-0384-9; Volterra V, 1926, NATURE, V118, P558, DOI 10.1038/118558a0; Weston K, 2008, J SEA RES, V60, P262, DOI 10.1016/j.seares.2008.09.003; Yoshida T, 2003, NATURE, V424, P303, DOI 10.1038/nature01767	71	54	61	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49319	10.1371/journal.pone.0049319	http://dx.doi.org/10.1371/journal.pone.0049319			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166639	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900122
J	Liu, YY; Ren, SC; Castellanos-Martin, A; Perez-Losada, J; Kwon, YW; Huang, YR; Wang, ZR; Abad, M; Cruz-Hernandez, JJ; Rodriguez, CA; Sun, YH; Mao, JH				Liu, Yueyong; Ren, Shancheng; Castellanos-Martin, Andres; Perez-Losada, Jesus; Kwon, Yong-Won; Huang, Yurong; Wang, Zeran; Abad, Mar; Cruz-Hernandez, Juan J.; Rodriguez, Cesar A.; Sun, Yinghao; Mao, Jian-Hua			Multiple Novel Alternative Splicing Forms of FBXW7 alpha Have a Translational Modulatory Function and Show Specific Alteration in Human Cancer	PLOS ONE			English	Article							FBW7 UBIQUITIN LIGASE; F-BOX PROTEIN; TUMOR-SUPPRESSOR; GENE-EXPRESSION; CYCLIN-E; C-MYC; AURORA-A; DEGRADATION; CHROMOSOME-4; INACTIVATION	FBXW7 acts as a tumor suppressor through ubiquitination and degradation of multiple oncoproteins. Loss of FBXW7 expression, which could be partially attributed by the genomic deletion or mutation of FBXW7 locus, is frequently observed in various human cancers. However, the mechanisms regulating FBXW7 expression still remain poorly understood. Here we examined the 59 region of FBXW7 gene to investigate the regulation of FBXW7 expression. We identified seven alternative splicing (AS) 5'-UTR forms of FBXW7 alpha that are composed of multiple novel non-coding exons. A significant difference in translational efficiency among these 5'-UTRs variants was observed by in vivo Luciferase reporter assay and Western blot. Furthermore, we found that the mRNA level of the AS form with high translational efficiency was specifically reduced in more than 80% of breast cancer cell lines and in more than 50% of human primary cancers from various tissues. In addition, we also identified mutations of FBXW7 in prostate cancers (5.6%), kidney cancers (16.7%), and bladder cancers (18.8%). Our results suggest that in addition to mutation, differential expression of FBXW7 alpha AS forms with different translational properties may serve as a novel mechanism for inactivation of FBXW7 in human cancer.	[Liu, Yueyong; Kwon, Yong-Won; Huang, Yurong; Wang, Zeran; Mao, Jian-Hua] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Ren, Shancheng; Sun, Yinghao] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Castellanos-Martin, Andres; Perez-Losada, Jesus] Inst Mixto Univ Salamanca CSIC, IBSAL, Inst Biol Mol & Celular Canc IBMCC, Salamanca, Spain; [Abad, Mar] Hosp Univ Salamanca, IBSAL, Dept Pathol, Salamanca, Spain; [Cruz-Hernandez, Juan J.; Rodriguez, Cesar A.] Hosp Univ Salamanca, IBSAL, Dept Med Oncol, Salamanca, Spain	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Naval Medical University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Liu, YY (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA.	sunyh@medmail.com.cn; JHMao@lbl.gov	Mao, Jian-Hua/EIZ-8595-2022; Castellanos, Andres/F-3302-2016; Pérez-Losada, Jesús/A-5883-2019	Mao, Jian-Hua/0000-0001-9320-6021; Castellanos, Andres/0000-0003-2864-7271; Pérez-Losada, Jesús/0000-0003-2400-624X; Cruz Hernandez, Juan Jesus/0000-0003-1980-2751	NATIONAL CANCER INSTITUTE [R01CA116481] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA116481] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akhoondi S, 2007, CANCER RES, V67, P9006, DOI 10.1158/0008-5472.CAN-07-1320; Akhoondi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2788; Cavatorta AL, 2011, FEBS J, V278, P2596, DOI 10.1111/j.1742-4658.2011.08188.x; Cenik C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r29; Cheng YB, 2012, CANCER METAST REV, V31, P75, DOI 10.1007/s10555-011-9330-z; Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; Goepfert TM, 2002, CANCER RES, V62, P4115; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Kemp Z, 2005, CANCER RES, V65, P11361, DOI 10.1158/0008-5472.CAN-05-2565; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Koh MS, 2006, CANCER BIOL THER, V5, P78, DOI 10.4161/cbt.5.1.2290; Kwon YW, 2012, MOL CANCER RES, V10, P834, DOI 10.1158/1541-7786.MCR-12-0025; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Meijer HA, 2002, BIOCHEM J, V367, P1, DOI 10.1042/BJ20011706; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Pershouse MA, 1997, ONCOGENE, V14, P369, DOI 10.1038/sj.onc.1200836; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Rumpel CA, 1999, AM J PATHOL, V154, P1329, DOI 10.1016/S0002-9440(10)65386-2; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Schwendel A, 1998, BRIT J CANCER, V78, P806, DOI 10.1038/bjc.1998.583; Sherwood JB, 2000, GYNECOL ONCOL, V79, P90, DOI 10.1006/gyno.2000.5922; Signori E, 2001, ONCOGENE, V20, P4596, DOI 10.1038/sj.onc.1204620; Smith L, 2008, BIOCHEM SOC T, V36, P708, DOI 10.1042/BST0360708; Smith L, 2010, J CELL MOL MED, V14, P2172, DOI 10.1111/j.1582-4934.2009.00867.x; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Taylor C, 1997, CURR TOP MICROBIOL, V224, P201; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	37	5	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49453	10.1371/journal.pone.0049453	http://dx.doi.org/10.1371/journal.pone.0049453			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166673	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900143
J	Lluveras-Tenorio, A; Mazurek, J; Restivo, A; Colombini, MP; Bonaduce, I				Lluveras-Tenorio, Anna; Mazurek, Joy; Restivo, Annalaura; Colombini, Maria Perla; Bonaduce, Ilaria			The Development of a New Analytical Model for the Identification of Saccharide Binders in Paint Samples	PLOS ONE			English	Article							MASS SPECTROMETRIC ANALYSIS; GC-MS ANALYSIS; BINDING MEDIA; PLANT GUMS; MUSEUM OBJECTS; CHROMATOGRAPHY; ART; POLYSACCHARIDES; MONOSACCHARIDES; HYDROLYSIS	This paper describes a method for reliably identifying saccharide materials in paintings. Since the 3rd millennium B.C., polysaccharide materials such as plant gums, sugar, flour, and honey were used as binding media and sizing agents in paintings, illuminated manuscripts, and polychrome objects. Although it has been reported that plant gums have a stable composition, their identification in paint samples is often doubtful and rarely discussed. Our research was carried out independently at two different laboratories: the Getty Conservation Institute in Los Angeles, USA (GCI) and the Department of Chemistry and Industrial Chemistry of the University of Pisa, Italy (DCCI). It was shown in a previous stage of this research that the two methods give highly comparable data when analysing both reference paint samples and paint layers from art objects, thus the combined data was used to build a large database. In this study, the simultaneous presence of proteinaceous binders and pigments in fresh and artificially aged paint replicas was investigated, and it highlighted how these can affect the sugar profile of arabic, tragacanth, and fruit tree gums. The environmental contamination due to sugars from various plant tissues is also discussed. The results allowed the development of a new model for the reliable identification of saccharide binders in paintings based on the evaluation of markers that are stable to ageing and unaffected by pigments. This new model was applied to the sugar profiles obtained from the analysis of a large number of samples from murals, easel paintings, manuscripts, and polychrome objects from different geographical areas and dating from the 13th century BC to the 20th century AD, thus demonstrating its reliability.	[Lluveras-Tenorio, Anna; Restivo, Annalaura; Colombini, Maria Perla; Bonaduce, Ilaria] Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy	University of Pisa	Lluveras-Tenorio, A (corresponding author), Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy.	ilariab@dcci.unipi.it	; BONADUCE, ILARIA/I-8801-2012	Lluveras-Tenorio, Anna/0000-0002-0600-5668; BONADUCE, ILARIA/0000-0003-0346-8373; colombini, maria perla/0000-0002-1666-8596				Andreotti Alessia, 2008, NEW TRENDS ANAL ENV, P389; Birstein VJ, 1975, STUDIES CONSERVATION, V20; BLETON J, 1996, STUD CONSERV, V41, P95, DOI 10.2307/1506520; Bonaduce I, 2007, J CHROMATOGR A, V1175, P275, DOI 10.1016/j.chroma.2007.10.056; Cennini C., 2003, LIBRO ARTE; Chiantore O, 2009, INT J MASS SPECTROM, V284, P35, DOI 10.1016/j.ijms.2008.07.031; Colombini MP, 2010, ACCOUNTS CHEM RES, V43, P715, DOI 10.1021/ar900185f; Cotte M, 2008, J ANAL ATOM SPECTROM, V23, P820, DOI 10.1039/b801358f; Daniels V, 1997, STUD CONSERV, V42, P17, DOI 10.2307/1506572; Doerner M., 1998, MAT PINTURA EMPLEO A; Kakoulli I., 2002, STUD CONSERV, V47, P56, DOI [10.1179/sic.2002.47.Supplement-1.56, DOI 10.1179/SIC.2002.47.SUPPLEMENT-1.56, DOI 10.1179/sic.2002.47.Supplement-1.56]; Khanjian H.P., 1996, P ICOM COMM CONS 11, P211; LIKENS GE, 1983, TELLUS B, V35, P16, DOI 10.1111/j.1600-0889.1983.tb00003.x; Liuveras A, 2010, ANAL CHEM, V82, P376, DOI 10.1021/ac902141m; Lluveras-Tenorio A, 2012, CHEM CENTRA IN PRESS; Mazurek J, 2008, ANTIBODY ASSAY CHARA, P678; Mejanelle P, 2002, J CHROMATOGR LIBR, V66, P845; Merrifield M. P., 1849, ORIGINAL TREATISES D; Mills J, 2000, ORGANIC CHEM OBJECTS; Nevin A, 2007, ANAL BIOANAL CHEM, V388, P1897, DOI 10.1007/s00216-007-1402-0; Ormsby BA, 2005, STUD CONSERV, V50, P45; Pitthard V, 2001, CHROMATOGRAPHIA, V53, pS317, DOI 10.1007/BF02490349; Pitthard V, 2006, MACROMOL SYMP, V238, P37, DOI 10.1002/masy.200650606; Riedo C, 2010, ANAL BIOANAL CHEM, V396, P1559, DOI 10.1007/s00216-009-3325-4; Scalarone D, 2008, J ANAL APPL PYROL, V83, P157, DOI 10.1016/j.jaap.2008.07.006; Schilling M.R., 2005, SCI EXAMINATION ART, P186, DOI [10.17226/11413, DOI 10.17226/11413]; Schneider U, 2001, FRESEN J ANAL CHEM, V371, P81, DOI 10.1007/s002160100938; Scott DA, 2004, STUD CONSERV, V49, P177; Scott DA, 2009, J ARCHAEOL SCI, V36, P923, DOI 10.1016/j.jas.2008.12.011; STEPHEN AM, 1990, METHODS PLANT BIOCH, V2, P483; TWILLEY JW, 1984, ADV CHEM SER, P357; Vallance SL, 1998, J AM INST CONSERV, V37, P294, DOI 10.2307/3179814; Vallance SL, 1997, ANALYST, V122, pR75, DOI 10.1039/a606219i; Willfor S, 2005, WOOD SCI TECHNOL, V39, P245, DOI 10.1007/s00226-004-0280-2; Willfor S, 2005, WOOD SCI TECHNOL, V39, P601, DOI 10.1007/s00226-005-0039-4; Willfor S, 2009, IND CROP PROD, V29, P571, DOI 10.1016/j.indcrop.2008.11.003	36	29	29	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49383	10.1371/journal.pone.0049383	http://dx.doi.org/10.1371/journal.pone.0049383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	038CD	23166654	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900134
J	Minten, C; Terry, R; Deffrasnes, C; King, NJC; Campbell, IL				Minten, Carsten; Terry, Rachael; Deffrasnes, Celine; King, Nicholas J. C.; Campbell, Iain L.			IFN Regulatory Factor 8 Is a Key Constitutive Determinant of the Morphological and Molecular Properties of Microglia in the CNS	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MYELOID CELLS; TARGET GENES; IRF8; FRACTALKINE; REVEALS; IDENTIFICATION; HETEROGENEITY; PHAGOCYTOSIS; ICSBP/IRF-8	IFN regulatory factor (IRF) 8 is a transcription factor that has a key role in the cellular response to IFN-gamma and is pivotal in myeloid cell differentiation. Whether IRF8 plays a role in the development and function of microglia, the tissue-resident myeloid cells of the brain, is unknown. Here, we show IRF8 is a constitutively produced nuclear factor in microglia, which suggested that IRF8 might also be a key homeostatic transcriptional determinant of the microglial cell phenotype. In support of this, in mice with a targeted disruption of the IRF8 gene, microglia were increased in number and showed gross alterations in morphology and surface area. In situ analysis of some key myeloid markers revealed that IRF8-deficient microglia had significantly reduced levels of Iba1, but increased levels of CD206 (mannose receptor) and F4/80 as well as increased tomato lectin binding. Analysis of microglia ex vivo revealed IRF8-deficient microglia had significantly increased levels of CD45, CD11b and F4/80, but significantly decreased levels of the chemokine receptors CCR2, CCR5 and CX3CR1. The known involvement of some of these molecular markers in membrane dynamics and phagocytosis led us to examine the phagocytic capacity of cultured IRF8-deficient microglia, however, this was found to be similar to wild type microglia. We conclude IRF8 is a constitutively produced nuclear factor in resident microglia of the CNS being a crucial transcriptional determinant of the phenotype of these cells in the healthy brain.	[Minten, Carsten; Campbell, Iain L.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia	University of Sydney	Minten, C (corresponding author), Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia.	iain.campbell@sydney.edu.au	Deffrasnes, Celine/H-5744-2013	Terry, Rachael/0000-0002-6260-7372; King, Nicholas Jonathan Cole/0000-0002-3877-9772; Deffrasnes, Celine/0000-0003-3878-4771				ACARIN L, 1994, J HISTOCHEM CYTOCHEM, V42, P1033, DOI 10.1177/42.8.8027523; Alliot F, 1999, DEV BRAIN RES, V117, P145, DOI 10.1016/S0165-3806(99)00113-3; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Consortium IMSG, 2011, PLOS ONE, V6; Dalmau I, 1998, HIPPOCAMPUS, V8, P458, DOI 10.1002/(SICI)1098-1063(1998)8:5<458::AID-HIPO6>3.0.CO;2-N; Dalmau I, 2003, J COMP NEUROL, V458, P144, DOI 10.1002/cne.10572; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Ellis SL, 2010, J IMMUNOL, V185, P1864, DOI 10.4049/jimmunol.1000900; Galea I, 2005, GLIA, V49, P375, DOI 10.1002/glia.20124; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Graeber MB, 1998, BRAIN RES, V813, P241, DOI 10.1016/S0006-8993(98)00859-2; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Horiuchi M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-8; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kubosaki A, 2010, MOL IMMUNOL, V47, P2295, DOI 10.1016/j.molimm.2010.05.289; LAWSON LJ, 1990, NEUROSCIENCE, V39, P151, DOI 10.1016/0306-4522(90)90229-W; Levi BZ, 2002, J INTERF CYTOK RES, V22, P153, DOI 10.1089/107999002753452764; MARODI L, 1991, J IMMUNOL, V146, P2783; Marquis JF, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002097; Ohsawa K, 2000, J CELL SCI, V113, P3073; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Rebenko-Moll NM, 2006, CURR OPIN IMMUNOL, V18, P683, DOI 10.1016/j.coi.2006.09.005; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Tamura T, 2005, BLOOD, V106, P1938, DOI 10.1182/blood-2005-01-0080; Tamura T, 2002, J INTERF CYTOK RES, V22, P145, DOI 10.1089/107999002753452755; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Turcotte K, 2007, J IMMUNOL, V179, P2467, DOI 10.4049/jimmunol.179.4.2467; UTANS U, 1995, J CLIN INVEST, V95, P2954, DOI 10.1172/JCI118003; Walton MR, 2000, J NEUROIMMUNOL, V104, P109, DOI 10.1016/S0165-5728(99)00262-3; Wang HS, 2009, IMMUNOL RES, V43, P109, DOI 10.1007/s12026-008-8055-8	41	62	62	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49851	10.1371/journal.pone.0049851	http://dx.doi.org/10.1371/journal.pone.0049851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166780	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900198
J	Saav, I; Stephansson, O; Gemzell-Danielsson, K				Saav, Ingrid; Stephansson, Olof; Gemzell-Danielsson, Kristina			Early versus Delayed Insertion of Intrauterine Contraception after Medical Abortion - A Randomized Controlled Trial	PLOS ONE			English	Article							NULLIPAROUS WOMEN; FOLLOW-UP; IMMEDIATE; DEVICE; ACCEPTABILITY; PREGNANCY	Background: Today, a large proportion of early abortions are medical terminations, in accordance to the woman's choice. Intrauterine contraceptives (IUC) provide highly effective, reversible, long-acting contraception. However, the effects of timing of IUC insertion after medical abortion are not known. Methods: Women undergoing medical abortion with mifepristone and misoprostol up to 63 days gestation and opting for IUC were randomised to early insertion (day 5-9 after mifepristone) or delayed (routine) insertion (at 3-4 weeks after mifepristone). The primary outcome was the rate of IUC expulsion at six months after IUC insertion. Results: A total of 129 women were randomized, and 116 women had a successful IUC insertion. There was no difference in expulsion rate between early (9.7%) vs. delayed (7.4%) IUC insertion (risk difference -9.2-13.4). Furthermore, 1.5% of women randomized to early and 11.5% to delayed insertion did not attend the follow up (proportion difference 10.0%, 95% CI: 1.8-20.6%, p = 0.015), and a higher proportion of women (41%) had had unprotected intercourse prior to returning for insertion in the delayed group compared with the early group (16%) (p = 0.015). Adverse events were rare and did not differ between the groups. Conclusions: Early insertion of IUC after medical abortion was safe and well tolerated with no increased incidence for expulsions or complications. Women were more likely to return for the IUC insertion if scheduled early after the abortion, and less likely to have had an unprotected intercourse prior to the IUC insertion. Early insertion should be offered as a routine for women undergoing first trimester medical abortion.	[Saav, Ingrid; Stephansson, Olof; Gemzell-Danielsson, Kristina] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynaecol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital	Saav, I (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Div Obstet & Gynaecol, Stockholm, Sweden.	kristina.gemzell@ki.se		Stephansson, Olof/0000-0003-1528-4563				Bednarek PH, 2011, NEW ENGL J MED, V364, P2208, DOI 10.1056/NEJMoa1011600; Betstadt SJ, 2011, CONTRACEPTION, V83, P517, DOI 10.1016/j.contraception.2010.10.006; Boesen HC, 2004, ACTA OBSTET GYN SCAN, V83, P1189, DOI 10.1111/j.0001-6349.2004.00494.x; Cameron ST, 2012, CONTRACEPTION, V86, P67, DOI 10.1016/j.contraception.2011.11.010; Fiala C, 2006, CONTRACEPTION, V74, P66, DOI 10.1016/j.contraception.2006.03.018; GILLETT PG, 1980, FERTIL STERIL, V34, P121; Goodman S, 2008, CONTRACEPTION, V78, P143, DOI 10.1016/j.contraception.2008.03.003; Grimes DA, 2010, COCHRANE DB SYST REV, V6; Grossman D, 2011, CONTRACEPTION, V83, P504, DOI 10.1016/j.contraception.2010.08.023; Heikinheimo O, 2008, CONTRACEPTION, V78, P149, DOI 10.1016/j.contraception.2008.03.013; Heikinheimo O, 2009, HUM REPROD, V24, P820, DOI 10.1093/humrep/den465; HEIKKILA M, 1982, CONTRACEPTION, V26, P245, DOI 10.1016/0010-7824(82)90073-7; HENSHAW RC, 1993, BRIT MED J, V307, P714, DOI 10.1136/bmj.307.6906.714; LAHTEENMAKI P, 1978, CLIN ENDOCRINOL, V8, P123, DOI 10.1111/j.1365-2265.1978.tb02160.x; Mansour D, 2011, CONTRACEPTION, V84, P465, DOI 10.1016/j.contraception.2011.04.002; Marions L, 2011, EUR J CONTRACEP REPR, V16, P126, DOI 10.3109/13625187.2011.558222; Pakarinen P, 2003, CONTRACEPTION, V68, P31, DOI 10.1016/S0010-7824(03)00104-5; Roberts H, 2010, CONTRACEPTION, V82, P260, DOI 10.1016/j.contraception.2010.03.003; RYBO G, 1993, ANN MED, V25, P143, DOI 10.3109/07853899309164158; Saav I, 2007, HUM REPROD, V22, P2647, DOI 10.1093/humrep/dem244; Schreiber CA, 2011, CONTRACEPTION, V84, P230, DOI 10.1016/j.contraception.2011.01.013; Shimoni N, 2011, OBSTET GYNECOL, V118, P623, DOI 10.1097/AOG.0b013e31822ade67; WINIKOFF B, 1995, FAM PLANN PERSPECT, V27, P142, DOI 10.2307/2136257; Winner B, 2012, NEW ENGL J MED, V366, P1998, DOI 10.1056/NEJMoa1110855	24	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48948	10.1371/journal.pone.0048948	http://dx.doi.org/10.1371/journal.pone.0048948			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155432	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900067
J	Wickenheisser, JK; Biegler, JM; Nelson-DeGrave, VL; Legro, RS; Strauss, JF; McAllister, JM				Wickenheisser, Jessica K.; Biegler, Jessica M.; Nelson-DeGrave, Velen L.; Legro, Richard S.; Strauss, Jerome F., III; McAllister, Jan M.			Cholesterol Side-Chain Cleavage Gene Expression in Theca Cells: Augmented Transcriptional Regulation and mRNA Stability in Polycystic Ovary Syndrome	PLOS ONE			English	Article							NUCLEAR FACTOR-I; STEROID 17-ALPHA-HYDROXYLASE/17,20 LYASE; CYTOCHROME-P450 17-ALPHA-HYDROXYLASE; HUMAN CYP11A1; DNA-REPLICATION; BINDING PROTEIN; WOMEN; BIOSYNTHESIS; ACTIVATION; RECEPTOR	Hyperandrogenism is characteristic of women with polycystic ovary syndrome (PCOS). Ovarian theca cells isolated from PCOS follicles and maintained in long-term culture produce elevated levels of progestins and androgens compared to normal theca cells. Augmented steroid production in PCOS theca cells is associated with changes in the expression of genes for several steroidogenic enzymes, including CYP11A1, which encodes cytochrome P450 cholesterol side-chain cleavage. Here, we further examined CYP11A1 gene expression, at both the transcriptional and post-transcriptional level in normal and PCOS theca cells propagated in long-term culture utilizing quantitative RT-PCR, functional promoter analyses, and mRNA degradation studies. The minimal element(s) that conferred increased basal and cAMP-dependent CYP11A1 promoter function were determined. CYP11A1 mRNA half-life in normal and PCOS theca cells was compared. Results of these cumulative studies showed that basal and forskolin stimulated steady state CYP11A1 mRNA abundance and CYP11A1 promoter activity were increased in PCOS theca cells. Deletion analysis of the CYP11A1 promoter demonstrated that augmented promoter function in PCOS theca cells results from increased basal regulation conferred by a minimal sequence between -160 and -90 bp of the transcriptional start site. The transcription factor, nuclear factor 1C2, was observed to regulate basal activity of this minimal CYP11A1 element. Examination of mRNA stability in normal and PCOS theca cells demonstrated that CYP11A1 mRNA half-life increased >2-fold, from approximately 9.22+/-1.62 h in normal cells, to 22.38+/-0.92 h in PCOS cells. Forskolin treatment did not prolong CYP11A1 mRNA stability in either normal or PCOS theca cells. The 5'-UTR of CYP11A1 mRNA confers increased basal mRNA stability in PCOS cells. In conclusion, these studies show that elevated steady state CYP11A1 mRNA abundance in PCOS cells results from increased transactivation of the CYP11A1 promoter and increased CYP11A1 mRNA stability.	[Wickenheisser, Jessica K.; Biegler, Jessica M.; Nelson-DeGrave, Velen L.; McAllister, Jan M.] Penn State Univ, Coll Med, Dept Pathol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park	Wickenheisser, JK (corresponding author), Penn State Univ, Coll Med, Dept Pathol, University Pk, PA 16802 USA.	jmcallister@psu.edu		Legro, Richard/0000-0001-9927-7584	NICHD NIH HHS [HD33852, HD34449, U54 HD034449, R01 HD033852] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD034449] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033852] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARBIERI RL, 1986, J CLIN ENDOCR METAB, V62, P904, DOI 10.1210/jcem-62-5-904; Barnes R, 1989, POLYCYSTIC OVARY SYN; BARNES RB, 1989, NEW ENGL J MED, V320, P559, DOI 10.1056/NEJM198903023200904; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Cheadle C, 2005, ANN NY ACAD SCI, V1058, P196, DOI 10.1196/annals.1359.026; Cheadle C, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-75; CHUNG B, 1986, P NATL ACAD SCI USA, V83, P8962, DOI 10.1073/pnas.83.23.8962; Daneshmand S, 2002, FERTIL STERIL, V77, P274, DOI 10.1016/S0015-0282(01)02999-5; ERICKSON GF, 1985, ENDOCR REV, V6, P371, DOI 10.1210/edrv-6-3-371; Franks S, 1997, HUM REPROD, V12, P2641, DOI 10.1093/humrep/12.12.2641; Franks Stephen, 2000, Hum Fertil (Camb), V3, P77, DOI 10.1080/1464727002000198731; GillingSmith C, 1997, CLIN ENDOCRINOL, V47, P93, DOI 10.1046/j.1365-2265.1997.2321049.x; GOLDZIEHER JW, 1981, FERTIL STERIL, V35, P371; GOLDZIEHER JW, 1962, J CLIN ENDOCR METAB, V22, P325, DOI 10.1210/jcem-22-3-325; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRONOSTAJSKI RM, 1985, MOL CELL BIOL, V5, P964, DOI 10.1128/MCB.5.5.964; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; GUO IC, 1994, J BIOL CHEM, V269, P6362; Guo IC, 2007, J BIOMED SCI, V14, P509, DOI 10.1007/s11373-007-9177-z; Guo IC, 2007, ENDOCRINOLOGY, V148, P1804, DOI 10.1210/en.2006-0938; Ho CKM, 2005, J CLIN ENDOCR METAB, V90, P6596, DOI 10.1210/jc.2005-0890; HUM DW, 1995, DNA CELL BIOL, V14, P451, DOI 10.1089/dna.1995.14.451; Ishmael FT, 2008, J IMMUNOL, V180, P8342, DOI 10.4049/jimmunol.180.12.8342; Jakubowicz DJ, 1997, J CLIN ENDOCR METAB, V82, P556, DOI 10.1210/jc.82.2.556; Kannius-Janson M, 2002, J BIOL CHEM, V277, P17589, DOI 10.1074/jbc.M105979200; Legro RS, 1998, P NATL ACAD SCI USA, V95, P14956, DOI 10.1073/pnas.95.25.14956; Lin CJ, 2001, MOL ENDOCRINOL, V15, P1277, DOI 10.1210/me.15.8.1277; MCALLISTER JM, 1995, ENDOCRINE, V3, P143, DOI 10.1007/BF02990066; MCALLISTER JM, 1989, ENDOCRINOLOGY, V125, P1959, DOI 10.1210/endo-125-4-1959; McAllister JM, 1993, HUMAN THECA INTERNA, P330; MCNATTY KP, 1979, J CLIN ENDOCR METAB, V49, P687, DOI 10.1210/jcem-49-5-687; Mukhopadhyay SS, 2001, MOL CELL BIOL, V21, P6859, DOI 10.1128/MCB.21.20.6859-6869.2001; NAGATA K, 1983, P NATL ACAD SCI-BIOL, V80, P6177, DOI 10.1073/pnas.80.20.6177; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925; Nelson-DeGrave VL, 2004, ENDOCRINOLOGY, V145, P799, DOI 10.1210/en.2003-0940; Nestler JE, 1998, J CLIN ENDOCR METAB, V83, P2001, DOI 10.1210/jc.83.6.2001; PELTZ SW, 1987, J BIOL CHEM, V262, P9382; PICADOLEONARD J, 1987, DNA-J MOLEC CELL BIO, V6, P439, DOI 10.1089/dna.1987.6.439; Poele RHT, 1999, ONCOGENE, V18, P5765, DOI 10.1038/sj.onc.1202961; SANTORO C, 1988, NATURE, V334, P218, DOI 10.1038/334218a0; Shih MCM, 2011, MOL CELL ENDOCRINOL, V336, P80, DOI 10.1016/j.mce.2010.12.017; Soccio RE, 2002, P NATL ACAD SCI USA, V99, P6943, DOI 10.1073/pnas.052143799; Spitz F, 1997, MOL CELL BIOL, V17, P656, DOI 10.1128/MCB.17.2.656; Strauss JF, 1999, RECENT PROG HORM RES, V54, P369; Strauss JF, 1999, RECENT PROG HORM RES, V54, P394; Voutilainen R, 1996, J CLIN ENDOCR METAB, V81, P1003, DOI 10.1210/jc.81.3.1003; Wickenheisser JK, 2005, J CLIN ENDOCR METAB, V90, P4858, DOI 10.1210/jc.2005-0330; Wickenheisser JK, 2005, J CLIN ENDOCR METAB, V90, P1720, DOI 10.1210/jc.2004-1860; Wickenheisser JK, 2004, MOL ENDOCRINOL, V18, P588, DOI 10.1210/me.2003-0090; Wickenheisser JK, 2000, J CLIN ENDOCR METAB, V85, P2304, DOI 10.1210/jc.85.6.2304; Zawadski JK, 1992, DIAGNOSTIC CRITERIA	52	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48963	10.1371/journal.pone.0048963	http://dx.doi.org/10.1371/journal.pone.0048963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155436	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900071
J	Cloke, T; Munder, M; Taylor, G; Muller, I; Kropf, P				Cloke, Thomas; Munder, Markus; Taylor, Graham; Mueller, Ingrid; Kropf, Pascale			Characterization of a Novel Population of Low-Density Granulocytes Associated with Disease Severity in HIV-1 Infection	PLOS ONE			English	Article							SUPPRESSOR-CELLS; ENDOTHELIAL-CELLS; ARGINASE-I; NEUTROPHIL; ADHERENCE; CD18	The mechanisms resulting in progressive immune dysfunction during the chronic phase of HIV infection are not fully understood. We have previously shown that arginase, an enzyme with potent immunosuppressive properties, is increased in HIV seropositive (HIV+) patients with low CD4(+) T cell counts. Here we show that the cells expressing arginase in peripheral blood mononuclear cells of HIV+ patients are low-density granulocytes (LDGs) and that whereas these cells have a similar morphology to normal-density granulocyte, they are phenotypically different. Importantly, our results reveal that increased frequencies of LDGs correlate with disease severity in HIV+ patients.	[Cloke, Thomas; Mueller, Ingrid] Univ London Imperial Coll Sci Technol & Med, Fac Med, Immunol Sect, Dept Med, London, England; [Munder, Markus] Univ Med Ctr Mainz, Dept Med Hematol Oncol & Pneumol 3, Mainz, Germany; [Taylor, Graham] Univ London Imperial Coll Sci Technol & Med, Dept Med, Infect Dis Sect, London, England; [Kropf, Pascale] London Sch Hyg & Trop Med, Immunol & Infect Dept, London WC1, England	Imperial College London; Johannes Gutenberg University of Mainz; Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Muller, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Immunol Sect, Dept Med, London, England.	i.muller@imperial.ac.uk; pascale.kropf@lshtm.ac.uk	Munder, Markus/K-6737-2013		Wellcome Trust [07664/Z/05/Z]; Imperial College London	Wellcome Trust(Wellcome Trust); Imperial College London(General Electric)	This work was supported by a grant from The Wellcome Trust (07664/Z/05/Z, PK). TC was a recipient of an Imperial College London MB/PhD fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appay V, 2008, J PATHOL, V214, P231, DOI 10.1002/path.2276; Brandau S, 2011, J LEUKOCYTE BIOL, V89, P311, DOI 10.1189/jlb.0310162; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; CLERICI M, 1989, J CLIN INVEST, V84, P1892, DOI 10.1172/JCI114376; Cloke TE, 2010, J INFECT DIS, V202, P374, DOI 10.1086/653736; Elghetany MT, 2002, BLOOD CELL MOL DIS, V28, P260, DOI 10.1006/bcmd.2002.0513; HAKKERT BC, 1991, BLOOD, V78, P2721, DOI 10.1182/blood.V78.10.2721.bloodjournal78102721; Haverkamp JM, 2011, EUR J IMMUNOL, V41, P749, DOI 10.1002/eji.201041069; Kropf P, 2005, FASEB J, V19, P1000, DOI 10.1096/fj.04-3416fje; KUIJPERS TW, 1991, J IMMUNOL, V147, P1369; KUIJPERS TW, 1991, BLOOD, V78, P1105; Levy JA, 2007, HIV AND THE PATHOGENESIS OF AIDS, 3RD EDITION, P1; Martin-Martin B, 2000, BLOOD, V96, P2574; Modolell M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000480; Muller I, 2009, TRENDS IMMUNOL, V30, P522, DOI 10.1016/j.it.2009.07.007; Munder M, 2005, BLOOD, V105, P2549, DOI 10.1182/blood-2004-07-2521; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Rodriguez PC, 2008, IMMUNOL REV, V222, P180, DOI 10.1111/j.1600-065X.2008.00608.x; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; SHEARER GM, 1991, AIDS, V5, P245, DOI 10.1097/00002030-199103000-00001; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895	23	83	86	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48939	10.1371/journal.pone.0048939	http://dx.doi.org/10.1371/journal.pone.0048939			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152825	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234600016
J	Li, GQ; Chen, XG; Wu, XP; Xie, JD; Liang, YJ; Zhao, XQ; Chen, WQ; Fu, LW				Li, Guang-quan; Chen, Xing-gui; Wu, Xing-ping; Xie, Jing-dun; Liang, Yong-ju; Zhao, Xiao-qin; Chen, Wei-qiang; Fu, Li-wu			Effect of Dicycloplatin, a Novel Platinum Chemotherapeutical Drug, on Inhibiting Cell Growth and Inducing Cell Apoptosis	PLOS ONE			English	Article							CISPLATIN-INDUCED APOPTOSIS; MITOCHONDRIAL DEATH PATHWAY; MEDIATED APOPTOSIS; OXIDATIVE STRESS; CARCINOMA-CELLS; DOWN-REGULATION; LEUKEMIA-CELLS; CANCER CELLS; HL-60 CELLS; INDUCTION	Dicycloplatin, a new supramolecular platinum-based antitumor drug, has been approved by the State Food and Administration (SFDA) of China. In this study, we investigated the anticancer activity of dicycloplatin in cancer cells and signaling pathways involved in dicycloplatin-induced apoptosis. Dicycloplatin inhibited the proliferation of cancer cells and increased the percentage of apoptosis in a concentration-dependent manner. Besides, some apoptosis related events were observed after treatment with dicycloplatin, including increase of reactive oxygen species (ROS), collapse of mitochondrial membrane potential (Delta psi m), release of cytochrome c from the mitochondria to the cytosol, upregulation of p53, which were accompanied by activation of caspase-9, caspase-3, caspase-8, and poly (ADP-ribose) polymerase cleavage in a concentration-dependent manner. The role of apoptosis in dicycloplatin-mediated cell death was further confirmed by the concomitant treatment with caspase-8 or caspase-9 inhibitors, which inhibited apoptosis and PARP cleavage. Intracellular glutathione (GSH) was also found to inhibit the cytotoxic effect of dicycloplatin. In conclusion, these findings suggest that dicycloplatin induces apoptosis through ROS stress-mediated death receptor pathway and mitochondrial pathway which is similar to carboplatin.	[Li, Guang-quan; Chen, Xing-gui; Chen, Wei-qiang] Guangdong Med Coll, Chen Xing Hai Hosital, Dept Gen Surg, Zhongshan, Peoples R China; [Li, Guang-quan; Wu, Xing-ping; Xie, Jing-dun; Liang, Yong-ju; Zhao, Xiao-qin; Fu, Li-wu] Sun Yat Sen Univ, State Key Lab Oncol So China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China	Guangdong Medical University; Sun Yat Sen University	Chen, WQ (corresponding author), Guangdong Med Coll, Chen Xing Hai Hosital, Dept Gen Surg, Zhongshan, Peoples R China.	cxhyy2010@163.com.cn; Fulw@mail.sysu.edu.cn	Fu, Liwu/AAE-8835-2020		China National Sciences Foundation [81072669]; 863 Project Foundation [2006AA02A404]	China National Sciences Foundation; 863 Project Foundation	The work was supported by grants from China National Sciences Foundation number 81072669 and 863 Project Foundation number 2006AA02A404. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barabas K, 2008, VET COMP ONCOL, V6, P1, DOI 10.1111/j.1476-5829.2007.00142.x; Blanc C, 2000, CANCER RES, V60, P4386; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Del Bello B, 2001, ONCOGENE, V20, P4591, DOI 10.1038/sj.onc.1204618; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Floros KV, 2004, BIOL CHEM, V385, P1099, DOI 10.1515/BC.2004.143; Giaccone G, 2000, DRUGS, V59, P9, DOI 10.2165/00003495-200059004-00002; Hasnain SE, 2003, J BIOSCIENCES, V28, P349, DOI 10.1007/BF02970153; Herr I, 2001, BLOOD, V98, P2603, DOI 10.1182/blood.V98.9.2603; Hou DX, 2003, INT J ONCOL, V23, P705; Hu SY, 2006, J TOXICOL ENV HEAL A, V69, P1261, DOI 10.1080/15287390500361875; Itoh M, 2000, ORAL ONCOL, V36, P277, DOI 10.1016/S1368-8375(00)00010-5; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; Kuwahara D, 2000, CANCER LETT, V148, P65, DOI 10.1016/S0304-3835(99)00315-8; Lavrik IN, 2006, BLOOD, V108, P559, DOI 10.1182/blood-2005-07-007096; Lee CS, 2010, EUR J PHARMACOL, V632, P7, DOI 10.1016/j.ejphar.2010.01.004; Li XQ, CANC LETT, V301, P212; Lin SG, 2003, ARCH BIOCHEM BIOPHYS, V418, P99, DOI 10.1016/j.abb.2003.08.004; Mese H, 2000, CANCER CHEMOTH PHARM, V46, P241, DOI 10.1007/s002800000145; Mishima K, 2003, INT J CANCER, V105, P593, DOI 10.1002/ijc.11133; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Pae HO, 2003, TOXICOL IN VITRO, V17, P49, DOI 10.1016/S0887-2333(02)00097-8; Pelli N, 2007, CLIN EXP IMMUNOL, V148, P85, DOI [10.1111/j.1365-2249.2006.03293.X, 10.1111/j.1365-2249.2006.03293.x]; PENG JWH, 2009, CHINESE J CLIN ONCOL, V12, P711; Piccart MJ, 2001, ANN ONCOL, V12, P1195, DOI 10.1023/A:1012259625746; Rubio S, 2006, EUR J PHARMACOL, V548, P9, DOI 10.1016/j.ejphar.2006.07.020; Seki K, 2000, CANCER CHEMOTH PHARM, V45, P199, DOI 10.1007/s002800050030; Sewell JM, 2005, EUR J CANCER, V41, P1637, DOI 10.1016/j.ejca.2005.04.015; Singh S, 2006, CANCER LETT, V236, P213, DOI 10.1016/j.canlet.2005.05.024; Tang PMK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-56; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Wang C., 2004, MED J LIAONING, V18, P273; WANG Chun YR, 2005, PRACTICAL ONCOLOGY J, V19, P21; Wang Tao, 2005, Zhonghua Jiehe He Huxi Zazhi, V28, P102; Wang Y, 2002, CANCER LETT, V188, P73, DOI 10.1016/S0304-3835(02)00493-7; Xia ZL, 1999, BIOCHEM PHARMACOL, V57, P1199, DOI 10.1016/S0006-2952(99)00009-X; [闫长会 YAN Changhui], 2005, [中国新药杂志, Chinese Journal New Drugs], V14, P1156; [颜冬梅 YAN Dongmei], 2007, [中国现代应用药学, Chinese Journal of Modern Applied Pharmacy], V24, P352; YAN DTL, 2009, J ONCOL, V15, P667; Yan YY, 2008, MOL CANCER THER, V7, P1688, DOI 10.1158/1535-7163.MCT-07-2362; Yang BF, 2007, CLIN EXP PHARMACOL P, V34, P1245, DOI 10.1111/j.1440-1681.2007.04711.x; [杨旭清 Yang Xuqing], 2010, [中国科学：化学, Scientia Sinica Chimica], V40, P485; Yin XM, 2006, GENE, V369, P7, DOI 10.1016/j.gene.2005.10.038; Zhang JY, 2007, CANCER BIOL THER, V6, P1413; Zhang R, 2008, APOPTOSIS, V13, P1465, DOI 10.1007/s10495-008-0278-6; Zhang Sen, 2005, Zhonghua Yi Xue Za Zhi, V85, P908; Zhuge J, 2006, FREE RADICAL BIO MED, V40, P63, DOI 10.1016/j.freeradbiomed.2005.08.012	47	14	14	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48994	10.1371/journal.pone.0048994	http://dx.doi.org/10.1371/journal.pone.0048994			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152837	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234000043
J	Numpacharoen, K; Atsawarungruangkit, A				Numpacharoen, Kawee; Atsawarungruangkit, Amporn			Generating Correlation Matrices Based on the Boundaries of Their Coefficients	PLOS ONE			English	Article								Correlation coefficients among multiple variables are commonly described in the form of matrices. Applications of such correlation matrices can be found in many fields, such as finance, engineering, statistics, and medicine. This article proposes an efficient way to sequentially obtain the theoretical bounds of correlation coefficients together with an algorithm to generate n x n correlation matrices using any bounded random variables. Interestingly, the correlation matrices generated by this method using uniform random variables as an example produce more extreme relationships among the variables than other methods, which might be useful for modeling complex biological systems where rare cases are very important.	[Numpacharoen, Kawee] Kasikorn Secur, Financial Prod Dev, Bangkok, Thailand; [Numpacharoen, Kawee] Mahidol Univ, Fac Sci, Dept Math, Bangkok 10400, Thailand; [Atsawarungruangkit, Amporn] Rangsit Univ, Coll Med, Bangkok, Thailand	Mahidol University; Rangsit University	Numpacharoen, K (corresponding author), Kasikorn Secur, Financial Prod Dev, Bangkok, Thailand.	kawee.num@student.mahidol.ac.th		Charoen, Amber/0000-0003-0622-6839				BENDEL RB, 1978, COMMUN STAT B-SIMUL, V7, P163, DOI 10.1080/03610917808812068; Budden M, 2008, APPL MATH E-NOTES, V8, P279; Chu JH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-55; Davies PI, 2000, BIT, V40, P640, DOI 10.1023/A:1022384216930; Dhillon IS, 2005, SIAM J MATRIX ANAL A, V27, P61, DOI 10.1137/S0895479803438183; Higham NJ, 2002, IMA J NUMER ANAL, V22, P329, DOI 10.1093/imanum/22.3.329; Hirschberger M, 2007, EUR J OPER RES, V177, P1610, DOI 10.1016/j.ejor.2005.10.014; HOLMES RB, 1991, SIAM J MATRIX ANAL A, V12, P239, DOI 10.1137/0612019; Li QN, 2010, J OPTIMIZ THEORY APP, V147, P546, DOI 10.1007/s10957-010-9738-6; MARSAGLIA G, 1984, SIAM J SCI STAT COMP, V5, P470, DOI 10.1137/0905034; Mittelbach M, 2012, IEEE T SIGNAL PROCES, V60, P2167, DOI 10.1109/TSP.2012.2186447; Numpachaoren K, 2012, INTUITIVELY VALID AL; Numpachaoren K, 2012, APPL MATH F IN PRESS; Rapisarda F., 2007, IMA Journal of Management Mathematics, V18, P55, DOI 10.1093/imaman/dp1010; Rebonat R, 2000, J RISK, V2, P17; Simonian J, 2010, APPL ECON LETT, V17, P1767, DOI 10.1080/13504850903299628; TUCKER LR, 1969, PSYCHOMETRIKA, V34, P421, DOI 10.1007/BF02290601; Zalesky A, 2012, NEUROIMAGE, V60, P2096, DOI 10.1016/j.neuroimage.2012.02.001	18	25	25	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48902	10.1371/journal.pone.0048902	http://dx.doi.org/10.1371/journal.pone.0048902			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152816	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000033
J	Phelan, D; Watson, C; Martos, R; Collier, P; Patle, A; Donnelly, S; Ledwidge, M; Baugh, J; McDonald, K				Phelan, Dermot; Watson, Chris; Martos, Ramon; Collier, Patrick; Patle, Anil; Donnelly, Seamas; Ledwidge, Mark; Baugh, John; McDonald, Ken			Modest Elevation in BNP in Asymptomatic Hypertensive Patients Reflects Sub-Clinical Cardiac Remodeling, Inflammation and Extracellular Matrix Changes	PLOS ONE			English	Article							BRAIN NATRIURETIC PEPTIDE; VENTRICULAR DIASTOLIC FUNCTION; SYSTOLIC HEART-FAILURE; MYOCARDIAL FIBROSIS; CARDIOVASCULAR EVENTS; CIRCULATING LEVELS; COLLAGEN TURNOVER; DYSFUNCTION; DISEASE; BETA	In asymptomatic subjects B-type natriuretic peptide (BNP) is associated with adverse cardiovascular outcomes even at levels well below contemporary thresholds used for the diagnosis of heart failure. The mechanisms behind these observations are unclear. We examined the hypothesis that in an asymptomatic hypertensive population BNP would be associated with subclinical evidence of cardiac remodeling, inflammation and extracellular matrix (ECM) alterations. We performed transthoracic echocardiography and sampled coronary sinus (CS) and peripheral serum from patients with low (n = 14) and high BNP (n = 27). Peripheral BNP was closely associated with CS levels (r = 0.92, p < 0.001). CS BNP correlated significantly with CS levels of markers of collagen type I and III turnover including: PINP (r = 0.44, p = 0.008), CITP (r = 0.35, p = 0.03) and PIIINP (r = 0.35, p = 0.001), and with CS levels of inflammatory cytokines including: TNF-alpha (r = 0.49, p = 0.002), IL-6 (r = 0.35, p = 0.04), and IL-8 (r = 0.54, p < 0.001). The high BNP group had greater CS expression of fibro-inflammatory biomarkers including: CITP (3.8 +/- 0.7 versus 5.1 +/- 1.9, p = 0.007), TNF-alpha (3.2 +/- 0.5 versus 3.7 +/- 1.1, p = 003), IL-6 (1.9 +/- 1.3 versus 3.4 +/- 2.7, p = 0.02) and hsCRP (1.2 +/- 1.1 versus 2.4 +/- 1.1, p = 0.04), and greater left ventricular mass index (97 +/- 20 versus 118 +/- 26 g/m(2), p = 0.03) and left atrial volume index (18 +/- 2 versus 21 +/- 4, p = 0.008). Our data provide insight into the mechanisms behind the observed negative prognostic impact of modest elevations in BNP and suggest that in an asymptomatic hypertensive cohort a peripheral BNP measurement may be a useful marker of an early, sub-clinical pathological process characterized by cardiac remodeling, inflammation and ECM alterations.	[Phelan, Dermot; Watson, Chris; Martos, Ramon; Donnelly, Seamas; Baugh, John; McDonald, Ken] Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst, Dublin 2, Ireland; [Phelan, Dermot; Martos, Ramon; Patle, Anil; Ledwidge, Mark; McDonald, Ken] St Vincents Univ Hosp, Heart Failure Unit, Dublin 4, Ireland	University College Dublin; University College Dublin; Saint Vincent's University Hospital	Baugh, J (corresponding author), Univ Coll Dublin, Sch Med & Med Sci, UCD Conway Inst, Dublin 2, Ireland.	John.Baugh@ucd.ie		Donnelly, Seamas/0000-0001-7145-1843; , The Heartbeat Trust/0000-0002-4020-6754; Ledwidge, Mark/0000-0001-7391-2949; McDonald, Kenneth/0000-0001-8011-3301	Irish Heart Foundation; Pfizer	Irish Heart Foundation; Pfizer(Pfizer)	Dr. Phelan received grant support from the Irish Heart Foundation (The Noel Hickey Bursary) sponsored by Pfizer. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Barasch E, 2011, CIRC-HEART FAIL, V4, P733, DOI 10.1161/CIRCHEARTFAILURE.111.962027; Bartholomeu JB, 2008, J MOL CELL CARDIOL, V45, P240, DOI 10.1016/j.yjmcc.2008.05.011; Berk BC, 2007, J CLIN INVEST, V117, P568, DOI 10.1172/JCI31044; Brilla CG, 2000, CIRCULATION, V102, P1388, DOI 10.1161/01.CIR.102.12.1388; Chatzis D, 2009, INT J CARDIOL; Cheng V, 2001, J AM COLL CARDIOL, V37, P386, DOI 10.1016/S0735-1097(00)01157-8; Chiurchiu V, 2008, REGUL PEPTIDES, V148, P26, DOI 10.1016/j.regpep.2008.02.009; Ciulla M, 1997, J AM SOC ECHOCARDIOG, V10, P657, DOI 10.1016/S0894-7317(97)70028-2; Collier P, 2011, EUR J HEART FAIL; DIEZ J, 1995, CIRCULATION, V91, P1450, DOI 10.1161/01.CIR.91.5.1450; Diez J, 2002, CIRCULATION, V105, P2512, DOI 10.1161/01.CIR.0000017264.66561.3D; Frangogiannis NG, 2004, INFLAMM RES, V53, P585, DOI 10.1007/s00011-004-1298-5; GRODECKI PV, 1993, ECHOCARDIOGR-J CARD, V10, P213, DOI 10.1111/j.1540-8175.1993.tb00032.x; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Kai H, 2005, HYPERTENS RES, V28, P483, DOI 10.1291/hypres.28.483; Kapoun AM, 2004, CIRC RES, V94, P453, DOI 10.1161/01.RES.0000117070.86556.9F; Kuwahara F, 2004, HYPERTENSION, V43, P739, DOI 10.1161/01.HYP.0000118584.33350.7d; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Levin ER, 1998, NEW ENGL J MED, V339, P321; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Lopez B, 2001, HYPERTENSION, V38, P1222, DOI 10.1161/hy1101.098549; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Martos R, 2007, CIRCULATION, V115, P888, DOI 10.1161/CIRCULATIONAHA.106.638569; Melendez GC, 2010, HYPERTENSION, V56, P225, DOI 10.1161/HYPERTENSIONAHA.109.148635; Montecucco F, 2011, J NEPHROL, V24, P23, DOI 10.5301/JN.2010.4729; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Nakatsu T, 2007, HYPERTENS RES, V30, P651, DOI 10.1291/hypres.30.651; Nishikimi T, 2006, CARDIOVASC RES, V69, P318, DOI 10.1016/j.cardiores.2005.10.001; Nishio M, 2008, EUR J HEART FAIL, V10, P446, DOI 10.1016/j.ejheart.2008.03.002; Oguzhan A, 2005, ECHOCARDIOGR-J CARD, V22, P320, DOI 10.1111/j.1540-8175.2005.03177.x; Ohtsuka T, 2001, J AM COLL CARDIOL, V37, P412, DOI 10.1016/S0735-1097(00)01121-9; Omland T, 2007, J AM COLL CARDIOL, V50, P205, DOI 10.1016/j.jacc.2007.03.038; Paget V, 2011, HYPERTENSION, V57, P702, DOI 10.1161/HYPERTENSIONAHA.110.163550; Plaksej R, 2009, J HYPERTENS, V27, P2483, DOI 10.1097/HJH.0b013e3283316c4d; Querejeta R, 2000, CIRCULATION, V101, P1729; Querejeta R, 2004, CIRCULATION, V110, P1263, DOI 10.1161/01.CIR.0000140973.60992.9A; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Rosenberg J, 2008, CARDIOVASC DRUG THER, V22, P305, DOI 10.1007/s10557-008-6099-6; Rossi MA, 1998, J HYPERTENS, V16, P1031, DOI 10.1097/00004872-199816070-00018; Shor R, 2006, EUR J INTERN MED, V17, P536, DOI 10.1016/j.ejim.2006.07.013; Sivasubramanian N, 2001, CIRCULATION, V104, P826, DOI 10.1161/hc3401.093154; Sun M, 2007, CIRCULATION, V115, P1398, DOI 10.1161/CIRCULATIONAHA.106.643585; Tamura N, 2000, P NATL ACAD SCI USA, V97, P4239, DOI 10.1073/pnas.070371497; TANAKA M, 1986, BRIT HEART J, V55, P575; Troughton RW, 2007, ANN MED, V39, P242, DOI 10.1080/07853890701232057; Tsuchida K, 2008, J CARDIOL, V52, P212, DOI 10.1016/j.jjcc.2008.07.007; Vesely DL, 2009, J INVEST MED, V57, P29, DOI 10.2310/JIM.0b013e3181948b37; Wang TJ, 2004, NEW ENGL J MED, V350, P655, DOI 10.1056/NEJMoa031994; Watanabe S, 2006, EUR HEART J, V27, P832, DOI 10.1093/eurheartj/ehi772	50	33	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49259	10.1371/journal.pone.0049259	http://dx.doi.org/10.1371/journal.pone.0049259			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152884	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234000057
J	Royer, DL				Royer, Dana L.			Leaf Shape Responds to Temperature but Not CO2 in Acer rubrum	PLOS ONE			English	Article							TOOTHED LEAVES; CLIMATE; PALEOCLIMATE; SIZE; MORPHOLOGY; FUTURE; FIELD	The degree of leaf dissection and the presence of leaf teeth, along with tooth size and abundance, inversely correlate with mean annual temperature (MAT) across many plant communities. These relationships form the core of several methods for reconstructing MAT from fossils, yet the direct selection of temperature on tooth morphology has not been demonstrated experimentally. It is also not known if atmospheric CO2 concentration affects leaf shape, limiting confidence in ancient climate reconstructions because CO2 has varied widely on geologic timescales. Here I report the results of growing Acer rubrum (red maple) in growth cabinets at contrasting temperature and CO2 conditions. The CO2 treatment imparted no significant differences in leaf size and shape, while plants grown at cooler temperatures tended to have more teeth and more highly dissected leaves. These results provide direct evidence for the selection of temperature on leaf shape in one species, and support a key link in many leaf-climate methods. More broadly, these results increase confidence for using leaf shape in fossils to reconstruct paleoclimate.	Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT USA	Wesleyan University	Royer, DL (corresponding author), Wesleyan Univ, Dept Earth & Environm Sci, Middletown, CT USA.	droyer@wesleyan.edu		Royer, Dana/0000-0003-0976-953X	Wesleyan University	Wesleyan University	This study was funded by Wesleyan University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Bailey IW, 1916, AM J BOT, V3, P24, DOI 10.2307/2435109; Bailey IW, 1915, SCIENCE, V41, P831, DOI 10.1126/science.41.1066.831; BakerBrosh KF, 1997, ECOLOGY, V78, P1250, DOI 10.2307/2265874; Beerling DJ, 1998, TRENDS ECOL EVOL, V13, P311, DOI 10.1016/S0169-5347(98)01334-2; BROWN VK, 1991, PHILOS T R SOC B, V333, P265, DOI 10.1098/rstb.1991.0076; Cramer MD, 2009, OECOLOGIA, V161, P15, DOI 10.1007/s00442-009-1364-3; Feild TS, 2005, PLANT CELL ENVIRON, V28, P1179, DOI 10.1111/j.1365-3040.2005.01354.x; Givnish T., 1979, Topics in plant population biology., P375; Givnish TJ., 1978, ACTA BIOTHEOR, V27, P83; Greenwood DR, 2005, NEW PHYTOL, V166, P355, DOI 10.1111/j.1469-8137.2005.01380.x; Gregory KM, 1996, PALAEOGEOGR PALAEOCL, V124, P39, DOI 10.1016/0031-0182(96)00015-6; Gregory-Wodzicki KM, 2000, PALEOBIOLOGY, V26, P668, DOI 10.1666/0094-8373(2000)026&lt;0668:RBLMAC&gt;2.0.CO;2; Halloy SRP, 1996, J ROY SOC NEW ZEAL, V26, P41, DOI 10.1080/03014223.1996.9517504; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huff PM, 2003, PALAIOS, V18, P266, DOI 10.1669/0883-1351(2003)018<0266:DFFPEF>2.0.CO;2; Lamont A, 1970, SCOTT J SCI, V1, P104; Little SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015161; Long SP, 2004, ANNU REV PLANT BIOL, V55, P591, DOI 10.1146/annurev.arplant.55.031903.141610; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; PERONI PA, 1995, FOREST SCI, V41, P378; RiveroLynch AP, 1996, PHILOS T R SOC B, V351, P1671, DOI 10.1098/rstb.1996.0149; Royer DL, 2008, NEW PHYTOL, V179, P808, DOI 10.1111/j.1469-8137.2008.02496.x; Royer DL, 2006, GEOCHIM COSMOCHIM AC, V70, P5665, DOI 10.1016/j.gca.2005.11.031; Royer DL, 2012, AM J BOT, V99, P915, DOI 10.3732/ajb.1100428; Royer DL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007653; Royer DL, 2006, INT J PLANT SCI, V167, P11, DOI 10.1086/497995; Royer DL, 2005, AM J BOT, V92, P1141, DOI 10.3732/ajb.92.7.1141; Stranks L, 1997, PALAEOGEOGR PALAEOCL, V131, P15, DOI 10.1016/S0031-0182(96)00147-2; Thomas SC, 1996, AM J BOT, V83, P106, DOI 10.2307/2445962; Wilf P, 1997, PALEOBIOLOGY, V23, P373, DOI 10.1017/S0094837300019746; Wing S.L., 2000, WARM CLIMATES EARTH, P197; WING SL, 1993, PHILOS T ROY SOC B, V341, P243, DOI 10.1098/rstb.1993.0109; Wolfe J., 1979, GEOLOGICAL PROFESSIO, V1106, P1; Wolfe J.A., 1993, US GEOLOGICAL SURVEY, V2040, P1, DOI DOI 10.3133/B2040	35	18	20	2	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49559	10.1371/journal.pone.0049559	http://dx.doi.org/10.1371/journal.pone.0049559			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152921	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000072
J	Peres, JF; Moreira-Almeida, A; Caixeta, L; Leao, F; Newberg, A				Peres, Julio Fernando; Moreira-Almeida, Alexander; Caixeta, Leonardo; Leao, Frederico; Newberg, Andrew			Neuroimaging during Trance State: A Contribution to the Study of Dissociation	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; ANTERIOR CINGULATE; TRAUMATIC MEMORIES; SCHIZOPHRENIA; PSYCHOTHERAPY; MEDITATION; BRAIN; PERFORMANCE; ACTIVATION; EXPERIENCE	Despite increasing interest in pathological and non-pathological dissociation, few researchers have focused on the spiritual experiences involving dissociative states such as mediumship, in which an individual (the medium) claims to be in communication with, or under the control of, the mind of a deceased person. Our preliminary study investigated psychography - in which allegedly "the spirit writes through the medium's hand" - for potential associations with specific alterations in cerebral activity. We examined ten healthy psychographers - five less expert mediums and five with substantial experience, ranging from 15 to 47 years of automatic writing and 2 to 18 psychographies per month - using single photon emission computed tomography to scan activity as subjects were writing, in both dissociative trance and non-trance states. The complexity of the original written content they produced was analyzed for each individual and for the sample as a whole. The experienced psychographers showed lower levels of activity in the left culmen, left hippocampus, left inferior occipital gyrus, left anterior cingulate, right superior temporal gyrus and right precentral gyrus during psychography compared to their normal (non-trance) writing. The average complexity scores for psychographed content were higher than those for control writing, for both the whole sample and for experienced mediums. The fact that subjects produced complex content in a trance dissociative state suggests they were not merely relaxed, and relaxation seems an unlikely explanation for the underactivation of brain areas specifically related to the cognitive processing being carried out. This finding deserves further investigation both in terms of replication and explanatory hypotheses.	[Peres, Julio Fernando; Newberg, Andrew] Univ Penn, Dept Radiol, Div Nucl Med, Philadelphia, PA 19104 USA; [Peres, Julio Fernando; Newberg, Andrew] Univ Penn, Ctr Spiritual & Mind, Philadelphia, PA 19104 USA; [Peres, Julio Fernando; Leao, Frederico] Univ Sao Paulo, PROSER Inst Psychiat, Sao Paulo, Brazil; [Moreira-Almeida, Alexander] Univ Fed Juiz de Fora, Sch Med, Res Ctr Spiritual & Hlth, Juiz De Fora, MG, Brazil; [Caixeta, Leonardo] Univ Fed Goias, Sch Med, Goiania, Go, Brazil; [Newberg, Andrew] Thomas Jefferson Univ, Myrna Brind Ctr Integrat Med, Philadelphia, PA 19107 USA	University of Pennsylvania; University of Pennsylvania; Universidade de Sao Paulo; Universidade Federal de Juiz de Fora; Universidade Federal de Goias; Jefferson University	Peres, JF (corresponding author), Univ Penn, Dept Radiol, Div Nucl Med, Philadelphia, PA 19104 USA.	julioperes@yahoo.com	Moreira-Almeida, Alexander/D-1419-2012	Moreira-Almeida, Alexander/0000-0002-9135-2532; Leao, Frederico/0000-0002-4400-5861; Newberg, Andrew/0000-0001-8230-1752				Abaurre MBM, 1993, VESTIBULAR UNICAMP R; Alvarado C.S., 2002, J TRAUMA DISSOCIATIO, V3, P29; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreasen NC, 2008, SCHIZOPHRENIA BULL, V34, P708, DOI 10.1093/schbul/sbn034; Awh E, 1999, NAT NEUROSCI, V2, P853, DOI 10.1038/13145; Beauregard M, 2006, NEUROSCI LETT, V405, P186, DOI 10.1016/j.neulet.2006.06.060; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bell V, 2011, J NEUROL NEUROSUR PS, V82, P332, DOI 10.1136/jnnp.2009.199158; Berkowitz AL, 2010, NEUROIMAGE, V49, P712, DOI 10.1016/j.neuroimage.2009.08.042; Bishop M, 2002, CONSCIOUS COGN, V11, P642, DOI 10.1016/S1053-8100(02)00023-5; Blakemore SJ, 2003, NEUROPSYCHOLOGIA, V41, P1058, DOI 10.1016/S0028-3932(02)00313-5; Capek CM, 2010, BRAIN LANG, V112, P129, DOI 10.1016/j.bandl.2009.10.004; Cardena E, 2008, HDB PSYCHIAT MEASURE; Cardena E., 2009, DISSOCIATION DISSOCI, P171; Chavez-Eakle RA, 2007, NEUROIMAGE, V38, P519, DOI 10.1016/j.neuroimage.2007.07.059; Cojan Y, 2009, NEURON, V62, P862, DOI 10.1016/j.neuron.2009.05.021; Crabtree A., 1993, MESMER FREUD MAGNETI; Davanger S, 2010, PERCEPT MOTOR SKILL, V111, P291, DOI 10.2466/02.04.22.PMS.111.4.291-306; de Ruiter Michiel B, 2006, J Trauma Dissociation, V7, P115, DOI 10.1300/J229v07n04_07; Erk S, 2011, ARCH GEN PSYCHIAT, V68, P845, DOI 10.1001/archgenpsychiatry.2011.80; Fincham JM, 2006, P NATL ACAD SCI USA, V103, P12941, DOI 10.1073/pnas.0605493103; Gauthier I, 2003, NAT NEUROSCI, V6, P428, DOI 10.1038/nn1029; Giesbrecht T, 2008, PSYCHOL BULL, V134, P617, DOI 10.1037/0033-2909.134.5.617; Han ZZ, 2009, BRAIN LANG, V110, P23, DOI 10.1016/j.bandl.2008.12.002; Hanakawa T, 2003, NEUROIMAGE, V19, P296, DOI 10.1016/S1053-8119(03)00050-8; Hillis AE, 2003, NAT NEUROSCI, V6, P19, DOI 10.1038/nn982; Holmes EA, 2005, CLIN PSYCHOL REV, V25, P1, DOI 10.1016/j.cpr.2004.08.006; Jarosz AF, 2012, CONSCIOUS COGN, V21, P487, DOI 10.1016/j.concog.2012.01.002; Kindermann SS, 2004, SCHIZOPHR RES, V68, P203, DOI 10.1016/j.schres.2003.08.010; Kircher TTJ, 2001, ARCH GEN PSYCHIAT, V58, P769, DOI 10.1001/archpsyc.58.8.769; Kozasa EH, 2012, NEUROIMAGE, V59, P745, DOI 10.1016/j.neuroimage.2011.06.088; Lancaster JL, 1997, HUM BRAIN MAPP, V5, P238, DOI 10.1002/(SICI)1097-0193(1997)5:4<238::AID-HBM6>3.0.CO;2-4; Lewis-Fernandez R., 1998, TRANSCULT PSYCHIATRY, V35, P387, DOI DOI 10.1177/136346159803500305; Limb CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001679; Lynn SJ, 2010, HDB CLIN HYPNOSIS DI; MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23; McClain CS, 2003, LANCET, V361, P1603, DOI 10.1016/S0140-6736(03)13310-7; McGeown WJ, 2009, CONSCIOUS COGN, V18, P848, DOI 10.1016/j.concog.2009.09.001; Mohr S, 2011, PSYCHIAT RES, V186, P177, DOI 10.1016/j.psychres.2010.08.012; Moreira-Almeida A, 2012, EXPLORING FRONTIERS; Moreira-Almeida A, 2011, REV BRAS PSIQUIATR, V33, P29; Moreira-Almeida A, 2008, J NERV MENT DIS, V196, P420, DOI 10.1097/NMD.0b013e31816ff3a1; Moreira-Almeida A, 2007, PSYCHOTHER PSYCHOSOM, V76, P57, DOI 10.1159/000096365; Moskal B. M., 2003, PRACTICAL ASSESSMENT, V8, P14; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg AB, 2006, PSYCHIAT RES-NEUROIM, V148, P67, DOI 10.1016/j.pscychresns.2006.07.001; Peres J, 2008, INT J PSYCHOL, V43, P943, DOI 10.1080/00207590701248487; Peres JFP, 2008, AUST NZ J PSYCHIAT, V42, P478, DOI 10.1080/00048670802050561; Peres JFP, 2007, PSYCHOL MED, V37, P1481, DOI 10.1017/S003329170700997X; Peres JFP, 2007, J RELIG HEALTH, V46, P343, DOI 10.1007/s10943-006-9103-0; Peres JFP, 2012, J NERV MENT DIS, V200, P174, DOI 10.1097/NMD.0b013e3182439836; Peres JFP, 2011, J PSYCHIATR RES, V45, P727, DOI 10.1016/j.jpsychires.2010.11.004; Peres JFP, 2009, CURR PAIN HEADACHE R, V13, P350, DOI 10.1007/s11916-009-0057-2; Pesenti M, 2001, NAT NEUROSCI, V4, P103, DOI 10.1038/82831; Playfair GL, 2010, CHICO XAVIER MEDIUM; Sabb FW, 2010, SCHIZOPHR RES, V116, P173, DOI 10.1016/j.schres.2009.09.042; Searle JR, 2000, ANNU REV NEUROSCI, V23, P557, DOI 10.1146/annurev.neuro.23.1.557; Severino PR, 1994, LIFES TRIUMPH; Smieskova R, 2010, NEUROSCI BIOBEHAV R, V34, P1207, DOI 10.1016/j.neubiorev.2010.01.016; Terhune DB, 2011, PSYCHOPHYSIOLOGY, V48, P1444, DOI 10.1111/j.1469-8986.2011.01211.x; van Lommel P, 2001, LANCET, V358, P2039, DOI 10.1016/S0140-6736(01)07100-8; Van Paesschen W, 2004, EPILEPSIA, V45, P35, DOI 10.1111/j.0013-9580.2004.04008.x; Wang DJJ, 2011, PSYCHIAT RES-NEUROIM, V191, P60, DOI 10.1016/j.pscychresns.2010.09.011; Wang JJ, 2005, P NATL ACAD SCI USA, V102, P17804, DOI 10.1073/pnas.0503082102; Wong YK, 2010, J COGNITIVE NEUROSCI, V22, P695, DOI 10.1162/jocn.2009.21229; World Health Organization SCAN, 1992, SCHED CLIN ASS NEUR; Xu YD, 2005, CEREB CORTEX, V15, P1234, DOI 10.1093/cercor/bhi006	68	36	37	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49360	10.1371/journal.pone.0049360	http://dx.doi.org/10.1371/journal.pone.0049360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	048BN	23166648	Green Published, Green Submitted, gold			2022-12-27	WOS:000311885300030
J	Sung, Y; Choi, W; Lue, N; Dasari, RR; Yaqoob, Z				Sung, Yongjin; Choi, Wonshik; Lue, Niyom; Dasari, Ramachandra R.; Yaqoob, Zahid			Stain-Free Quantification of Chromosomes in Live Cells Using Regularized Tomographic Phase Microscopy	PLOS ONE			English	Article							OPTICAL DIFFRACTION TOMOGRAPHY; REFRACTIVE-INDEX; LIGHT-SCATTERING; RETRIEVAL; MASS; EQUATION; GROWTH	Refractive index imaging is a label-free technique that enables long-term monitoring of the internal structures and molecular composition in living cells with minimal perturbation. Existing tomographic methods for the refractive index imaging lack 3-D resolution and result in artifacts that prevent accurate refractive index quantification. To overcome these limitations without compromising the capability to observe a sample in its most native condition, we have developed a regularized tomographic phase microscope (RTPM) enabling accurate refractive index imaging of organelles inside intact cells. With the enhanced accuracy, we quantify the mass of chromosomes in intact living cells, and differentiate two human colon cancer lines, HT-29 and T84 cells, solely based on the non-aqueous (dry) mass of chromosomes. In addition, we demonstrate chromosomal imaging using a dual-wavelength RTPM, which shows its potential to determine the molecular composition of cellular organelles in live cells.	[Sung, Yongjin; Lue, Niyom; Dasari, Ramachandra R.; Yaqoob, Zahid] MIT, GR Harrison Spect Lab, Cambridge, MA 02139 USA; [Choi, Wonshik] Korea Univ, Dept Phys, Seoul 136701, South Korea	Massachusetts Institute of Technology (MIT); Korea University	Sung, Y (corresponding author), MIT, GR Harrison Spect Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	ysung@mit.edu		Sung, Yongjin/0000-0001-6371-8771	National Institute of Biomedical Imaging and Bioengineering [9P41EB015871-26A1]; Hamamatsu Photonics, Japan; Kwanjeong Educational Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015871] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Hamamatsu Photonics, Japan; Kwanjeong Educational Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the National Institute of Biomedical Imaging and Bioengineering (9P41EB015871-26A1), and Hamamatsu Photonics, Japan. Y. Sung is grateful for the support by a fellowship from the Kwanjeong Educational Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, J BIOMED OPT, DOI [10.1117/1.2904580, DOI 10.1117/1.2904580]; Ayasso H, 2010, J MOD OPTIC, V57, P765, DOI 10.1080/09500340903564702; BARER R, 1957, J OPT SOC AM, V47, P545, DOI 10.1364/JOSA.47.000545; BARER R, 1954, NATURE, V173, P821, DOI 10.1038/173821b0; BARER R, 1952, NATURE, V169, P366, DOI 10.1038/169366b0; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chalut KJ, 2009, CANCER RES, V69, P1199, DOI 10.1158/0008-5472.CAN-08-3079; Charriere F, 2006, OPT LETT, V31, P178, DOI 10.1364/OL.31.000178; Chatterjee P, 2009, COMPUT J, V52, P80, DOI 10.1093/comjnl/bxm050; Choi W, 2007, NAT METHODS, V4, P717, DOI 10.1038/NMETH1078; Dixit R, 2003, PLANT J, V36, P280, DOI 10.1046/j.1365-313X.2003.01868.x; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; EASTY DM, 1956, BIOCHIM BIOPHYS ACTA, V20, P528, DOI 10.1016/0006-3002(56)90347-X; Fang-Yen C, 2007, OPT LETT, V32, P1572, DOI 10.1364/OL.32.001572; FIENUP JR, 1982, APPL OPTICS, V21, P2758, DOI 10.1364/AO.21.002758; Haeberle O, 2010, J MOD OPTIC, V57, P686, DOI 10.1080/09500340.2010.493622; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Ikeda T, 2005, OPT LETT, V30, P1165, DOI 10.1364/OL.30.001165; Isikman SO, 2011, P NATL ACAD SCI USA, V108, P7296, DOI 10.1073/pnas.1015638108; Iwai H, 2004, OPT LETT, V29, P2399, DOI 10.1364/OL.29.002399; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Kim M, 2011, OPT LETT, V36, P148, DOI 10.1364/OL.36.000148; Lauer V, 2002, J MICROSC-OXFORD, V205, P165, DOI 10.1046/j.0022-2720.2001.00980.x; Maire G, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213905; Miao J, 1998, J OPT SOC AM A, V15, P1662, DOI 10.1364/JOSAA.15.001662; Min Y, 2009, P NATL ACAD SCI USA, V106, P3154, DOI 10.1073/pnas.0813110106; Mir M, 2011, P NATL ACAD SCI USA, V108, P13124, DOI 10.1073/pnas.1100506108; PAUL JS, 1970, EXP CELL RES, V59, P227, DOI 10.1016/0014-4827(70)90595-1; Penzkofer A, 2007, CHEM PHYS, V342, P55, DOI 10.1016/j.chemphys.2007.09.014; Pierce MC, 2004, J INVEST DERMATOL, V123, P458, DOI 10.1111/j.0022-202X.2004.23404.x; Popescu G, 2008, AM J PHYSIOL-CELL PH, V295, pC538, DOI 10.1152/ajpcell.00121.2008; STREIBL N, 1984, OPT COMMUN, V49, P6, DOI 10.1016/0030-4018(84)90079-8; Subramanian H, 2008, P NATL ACAD SCI USA, V105, P20118, DOI 10.1073/pnas.0804723105; Sung YJ, 2011, J OPT SOC AM A, V28, P1554, DOI 10.1364/JOSAA.28.001554; Sung YJ, 2009, OPT EXPRESS, V17, P266, DOI 10.1364/OE.17.000266; TEAGUE MR, 1983, J OPT SOC AM, V73, P1434, DOI 10.1364/JOSA.73.001434; Vertu S, 2011, EUROPEAN J PHYS, P1; Wax A, 2003, CANCER RES, V63, P3556; Wolf E., 1969, Optics Communications, V1, P153, DOI 10.1016/0030-4018(69)90052-2; Zeskind BJ, 2007, NAT METHODS, V4, P567, DOI 10.1038/NMETH1053; Zhao HY, 2011, BIOPHYS J, V100, P2309, DOI 10.1016/j.bpj.2011.03.004	41	77	81	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49502	10.1371/journal.pone.0049502	http://dx.doi.org/10.1371/journal.pone.0049502			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166689	Green Submitted, Green Published, gold			2022-12-27	WOS:000311885300049
J	Wahlgren, J; Karlson, TD; Glader, P; Telemo, E; Valadi, H				Wahlgren, Jessica; Karlson, Tanya De L.; Glader, Pernilla; Telemo, Esbjorn; Valadi, Hadi			Activated Human T Cells Secrete Exosomes That Participate in IL-2 Mediated Immune Response Signaling	PLOS ONE			English	Article							COMPLEX CLASS-II; TRANSFERRIN RECEPTOR; MEMBRANE-VESICLES; ACCUMULATION; LYMPHOCYTES; MOLECULES; RELEASE; RANTES; IDENTIFICATION; INTERLEUKIN-2	It has previously been shown that nano-meter sized vesicles (30-100 nm), exosomes, secreted by antigen presenting cells can induce T cell responses thus showing the potential of exosomes to be used as immunological tools. Additionally, activated CD3(+) T cells can secrete exosomes that have the ability to modulate different immunological responses. Here, we investigated what effects exosomes originating from activated CD3(+) T cells have on resting CD3(+) T cells by studying T cell proliferation, cytokine production and by performing T cell and exosome phenotype characterization. Human exosomes were generated in vitro following CD3(+) T cell stimulation with anti-CD28, anti-CD3 and IL-2. Our results show that exosomes purified from stimulated CD3(+) T cells together with IL-2 were able to generate proliferation in autologous resting CD3(+) T cells. The CD3(+) T cells stimulated with exosomes together with IL-2 had a higher proportion of CD8(+) T cells and had a different cytokine profile compared to controls. These results indicate that activated CD3(+) T cells communicate with resting autologous T cells via exosomes.	[Wahlgren, Jessica; Karlson, Tanya De L.; Telemo, Esbjorn; Valadi, Hadi] Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden	University of Gothenburg	Valadi, H (corresponding author), Univ Gothenburg, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	hadi.valadi@gu.se	Valadi, Hadi/ABH-9766-2020	Valadi, Hadi/0000-0003-3482-2451	Swedish Research Council; Ake Wiberg Foundation; Assar Gabrielsson Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wiberg Foundation; Assar Gabrielsson Foundation	This work was supported by grants from the Swedish Research Council (www.vr.se), Ake Wiberg Foundation (www.ake-wiberg.com), Assar Gabrielsson Foundation (www.agfond.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admyre C, 2003, EUR RESPIR J, V22, P578, DOI 10.1183/09031936.03.00041703; Admyre C, 2007, J ALLERGY CLIN IMMUN, V120, P1418, DOI 10.1016/j.jaci.2007.06.040; Admyre C, 2007, J IMMUNOL, V179, P1969, DOI 10.4049/jimmunol.179.3.1969; Admyre C, 2006, EUR J IMMUNOL, V36, P1772, DOI 10.1002/eji.200535615; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Andre F, 2002, VACCINE, V20, pA28, DOI 10.1016/S0264-410X(02)00384-5; Appay V, 2000, INT IMMUNOL, V12, P1173, DOI 10.1093/intimm/12.8.1173; Blanchard N, 2002, J IMMUNOL, V168, P3235, DOI 10.4049/jimmunol.168.7.3235; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Catalfamo M, 2004, IMMUNITY, V20, P219, DOI 10.1016/S1074-7613(04)00027-5; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Eldh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015353; Fomina AF, 2003, EXP CELL RES, V291, P150, DOI 10.1016/S0014-4827(03)00372-0; HARDING C, 1983, J CELL BIOL, V97, P329, DOI 10.1083/jcb.97.2.329; Kamin-Lewis R, 2001, P NATL ACAD SCI USA, V98, P9283, DOI 10.1073/pnas.161298998; Karlsson M, 2001, EUR J IMMUNOL, V31, P2892, DOI 10.1002/1521-4141(2001010)31:10<2892::AID-IMMU2892>3.0.CO;2-I; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Liu CR, 2006, J IMMUNOL, V176, P1375, DOI 10.4049/jimmunol.176.3.1375; Martinez-Lorenzo MJ, 1999, J IMMUNOL, V163, P1274; Mears R, 2004, PROTEOMICS, V4, P4019, DOI 10.1002/pmic.200400876; Muntasell A, 2007, EMBO J, V26, P4263, DOI 10.1038/sj.emboj.7601842; Nolte-'t Hoen ENM, 2009, BLOOD, V113, P1977, DOI 10.1182/blood-2008-08-174094; Osinalde N, 2011, J PROTEOMICS, V75, P177, DOI 10.1016/j.jprot.2011.06.007; PAN BT, 1985, J CELL BIOL, V101, P942, DOI 10.1083/jcb.101.3.942; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 1997, MOL BIOL CELL, V8, P2631, DOI 10.1091/mbc.8.12.2631; Skokos D, 2001, J IMMUNOL, V166, P868, DOI 10.4049/jimmunol.166.2.868; Sprent J, 2005, BLOOD CELL MOL DIS, V35, P17, DOI 10.1016/j.bcmd.2005.04.004; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Tumne A, 2009, J VIROL, V83, P4354, DOI 10.1128/JVI.02629-08; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198; Wahlgren J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks463; Zakharova L, 2007, J CELL PHYSIOL, V212, P174, DOI 10.1002/jcp.21013; Zeelenberg IS, 2008, CANCER RES, V68, P1228, DOI 10.1158/0008-5472.CAN-07-3163; Zhu JF, 2010, CELL RES, V20, P4, DOI 10.1038/cr.2009.138; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	41	87	90	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49723	10.1371/journal.pone.0049723	http://dx.doi.org/10.1371/journal.pone.0049723			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166755	Green Published, gold, Green Submitted			2022-12-27	WOS:000311885300063
J	Garcia-Bermudez, M; Gonzalez-Juanatey, C; Lopez-Mejias, R; Teruel, M; Corrales, A; Miranda-Filloy, JA; Castaneda, S; Balsa, A; Fernandez-Gutierrez, B; Gonzalez-Alvaro, I; Gomez-Vaquero, C; Blanco, R; Llorca, J; Martin, J; Gonzalez-Gay, MA				Garcia-Bermudez, Mercedes; Gonzalez-Juanatey, Carlos; Lopez-Mejias, Raquel; Teruel, Maria; Corrales, Alfonso; Miranda-Filloy, Jose A.; Castaneda, Santos; Balsa, Alejandro; Fernandez-Gutierrez, Benjamin; Gonzalez-Alvaro, Isidoro; Gomez-Vaquero, Carmen; Blanco, Ricardo; Llorca, Javier; Martin, Javier; Gonzalez-Gay, Miguel A.			Study of Association of CD40-CD154 Gene Polymorphisms with Disease Susceptibility and Cardiovascular Risk in Spanish Rheumatoid Arthritis Patients	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; LIGAND INTERACTIONS; SHARED EPITOPE; CD154 GENE; CD40 GENE; ATHEROSCLEROSIS; MECHANISMS; EXPRESSION; EVENTS; EPIDEMIOLOGY	Objective: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased cardiovascular (CV) mortality. Since CD40-CD154 binding has direct consequences on inflammation process initiation, we aimed to replicate previous findings related to disease susceptibility in Spanish RA population. Furthermore, as the major complication in RA disease patients is the development of CV events due to accelerated atherosclerosis, and elevated levels of CD40L/CD154 are present in patients with acute myocardial infarction, we assessed the potential association of CD40 and CD154/CD40L gene variants with CV risk in Spanish RA patients. Methods: One thousand five hundred and seventy-five patients fulfilling the 1987 ACR classification criteria for RA and 1600 matched controls were genotyped for the CD40 rs1883832, rs4810485 and rs1535045 and CD154 rs3092952 and rs3092920 gene polymorphisms, using predesigned TaqMan single nucleotide polymorphism genotyping assays. Afterwards, we investigated the influence of CD40-CD154 gene variants in the development of CV events. Also, in a subgroup of 273 patients without history of CV events, we assessed the influence of these polymorphisms in the risk of subclinical atherosclerosis determined by carotid ultrasonography. Results: Nominally significant differences in the allele frequencies for the rs1883832 CD40 gene polymorphism between RA patients and controls were found (p = 0.038). Although we did not observe a significant association of CD40-CD154 gene variants with the development of CV events, an ANCOVA model adjusted for sex, age at the time of the ultrasonography assessment, follow-up time, traditional CV risk factors and anti-cyclic citrullinated peptide antibodies disclosed a significant association (p = 0.0047) between CD40 rs1535045 polymorphism and carotid intima media thickness, a surrogate marker of atherosclerosis. Conclusion: Data from our pilot study indicate a potential association of rs1883832 CD40 gene polymorphism with susceptibility to RA. Also, the CD40 rs1535045 gene variant may influence development of subclinical atherosclerosis in RA patients.	[Lopez-Mejias, Raquel; Corrales, Alfonso; Blanco, Ricardo; Gonzalez-Gay, Miguel A.] IFIMAV, Hosp Univ Marques de Valdecilla, Dept Rheumatol, Santander, Spain; [Garcia-Bermudez, Mercedes; Teruel, Maria; Martin, Javier] IPBLN CSIC, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Gonzalez-Juanatey, Carlos] Hosp Xeral Calde, Div Cardiol, Lugo, Spain; [Miranda-Filloy, Jose A.] Hosp Xeral Calde, Dept Rheumatol, Lugo, Spain; [Castaneda, Santos; Gonzalez-Alvaro, Isidoro] IIS Princesa, Hosp Univ La Princesa, Dept Rheumatol, Madrid, Spain; [Balsa, Alejandro] Hosp Univ La Paz, Rheumatol Unit, Madrid, Spain; [Fernandez-Gutierrez, Benjamin] Hosp Clin San Carlos, Dept Rheumatol, Madrid, Spain; [Gomez-Vaquero, Carmen] IDIBELL, Hosp Univ Bellvitge, Dept Rheumatol, Barcelona, Spain; [Llorca, Javier] Univ Cantabria, Sch Med, Dept Epidemiol & Computat Biol, E-39005 Santander, Spain; [Llorca, Javier] IFIMAV, CIBERESP, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario Lucus Augusti-Lugo; Hospital Universitario La Paz; Hospital Clinico San Carlos; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	Gonzalez-Gay, MA (corresponding author), IFIMAV, Hosp Univ Marques de Valdecilla, Dept Rheumatol, Santander, Spain.	miguelaggay@hotmail.com	Martin, Javier/B-8141-2008; blanco, ricardo/AAA-1248-2020; Martín, María/HDL-9512-2022; Fernandez-Gutierrez, Benjamin/AAM-9063-2020; García-Bermúdez, Mercedes/E-7708-2013; Martín, Javier/AAV-5209-2021; González-Gay, Miguel A./B-2306-2008; Balsa, Alejandro/ABF-6456-2020; Llorca, Javier/F-7371-2011	Martin, Javier/0000-0002-2202-0622; blanco, ricardo/0000-0003-2344-2285; García-Bermúdez, Mercedes/0000-0002-2643-5956; González-Gay, Miguel A./0000-0002-7924-7406; Llorca, Javier/0000-0001-8569-861X; Fernandez-Gutierrez, Benjamin/0000-0002-6126-8786	Fondo de Investigaciones Sanitarias (Spanish National Health System; Ministry of Science and Innovation, Spain Government) [PI06-0024, PS09/00748]; Instituto de Salud Carlos III (ISCIII) [RD08/0075 (RIER)]; National Health System (Spain) within the VI Programa Nacional de I+D+i (FEDER); European IMI BTCure Program; Fundacion Espanola de Reumatologia	Fondo de Investigaciones Sanitarias (Spanish National Health System; Ministry of Science and Innovation, Spain Government); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); National Health System (Spain) within the VI Programa Nacional de I+D+i (FEDER); European IMI BTCure Program; Fundacion Espanola de Reumatologia	This work was supported by two grants from Fondo de Investigaciones Sanitarias PI06-0024 and PS09/00748 (Spanish National Health System; Ministry of Science and Innovation, Spain Government) and by RETICS Program, RD08/0075 (RIER) from Instituto de Salud Carlos III (ISCIII), National Health System (Spain) within the VI Programa Nacional de I+D+i 2008-2011 (FEDER). This work was supported in part by grants from the European IMI BTCure Program. MGB is a beneficiary of a grant from Fundacion Espanola de Reumatologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlestig L, 2012, J RHEUMATOL, V39, P939, DOI 10.3899/jrheum.111336; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Bang SY, 2010, ARTHRITIS RHEUM-US, V62, P369, DOI 10.1002/art.27272; Bartoloni E, 2011, ARTHRIT CARE RES, V63, P178, DOI 10.1002/acr.20322; Bartoloni E, 2010, EXPERT REV CARDIOVAS, V8, P1309, DOI 10.1586/ERC.10.123; Blanco-Kelly F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011520; Burdon KP, 2006, AM HEART J, V151, P706, DOI 10.1016/j.ahj.2005.05.004; Carmona L, 2002, RHEUMATOLOGY, V41, P88, DOI 10.1093/rheumatology/41.1.88; Chadha S, 2005, EUR J HUM GENET, V13, P669, DOI 10.1038/sj.ejhg.5201367; Citores MJ, 2004, ANN RHEUM DIS, V63, P310, DOI 10.1136/ard.2003.006148; Gerdes N, 2011, THROMB HAEMOSTASIS, V106, P804, DOI 10.1160/TH11-09-0605; Gonzalez-Gay MA, 2005, SEMIN ARTHRITIS RHEU, V35, P8, DOI 10.1016/j.semarthrit.2005.03.004; Gonzalez-Gay MA, 2008, SEMIN ARTHRITIS RHEU, V38, P67, DOI 10.1016/j.semarthrit.2008.02.001; Gonzalez-Gay MA, 2007, ARTHRIT RHEUM-ARTHR, V57, P125, DOI 10.1002/art.22482; Gonzalez-Juanatey C, 2006, ARTHRIT RHEUM-ARTHR, V55, P150, DOI 10.1002/art.21707; Gonzalez-Juanatey C, 2009, SEMIN ARTHRITIS RHEU, V38, P366, DOI 10.1016/j.semarthrit.2008.01.012; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Hughes LB, 2010, ARTHRITIS RHEUM-US, V62, P3547, DOI 10.1002/art.27732; Innala L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3442; Jacobson EM, 2007, GENES IMMUN, V8, P205, DOI 10.1038/sj.gene.6364375; Jacobson EM, 2005, ENDOCRINOLOGY, V146, P2684, DOI 10.1210/en.2004-1617; Lopez-Longo FJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P419, DOI 10.1002/art.24390; Kawabe T, 2011, NAGOYA J MED SCI, V73, P69; Kayrak M, 2011, HEART VESSELS, V26, P131, DOI 10.1007/s00380-010-0036-x; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kozera L, 2011, RHEUMATOLOGY, V50, P1944, DOI 10.1093/rheumatology/ker232; Libby P, 2008, AM J MED, V121, P21, DOI 10.1016/j.amjmed.2008.06.014; Liu MF, 2001, AUTOIMMUNITY, V34, P107, DOI 10.3109/08916930109001958; Lopez-Mejias R, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3755; Lougaris V, 2005, IMMUNOL REV, V203, P48, DOI 10.1111/j.0105-2896.2005.00229.x; Malarstig A, 2006, ARTERIOSCL THROM VAS, V26, P1667, DOI 10.1161/01.ATV.0000222908.78873.36; Martin-Donaire T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2288; Montecucco F, 2009, RHEUMATOLOGY, V48, P11, DOI 10.1093/rheumatology/ken395; Orozco G, 2010, ANN RHEUM DIS, V69, P813, DOI 10.1136/ard.2009.109579; Palomino-Morales R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2989; Peters AL, 2009, SEMIN IMMUNOL, V21, P293, DOI 10.1016/j.smim.2009.05.012; Plant D, 2010, ANN RHEUM DIS, V69, P1548, DOI 10.1136/ard.2009.121020; Pollard KM, 2012, J AUTOIMMUN, V38, pJ177, DOI 10.1016/j.jaut.2011.11.007; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rizvi M, 2008, TRENDS MOL MED, V14, P530, DOI 10.1016/j.molmed.2008.09.006; Rodriguez-Rodriguez L, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3444; Rodriguez-Rodriguez L, 2010, J RHEUMATOL, V37, P2076, DOI 10.3899/jrheum.100362; Sherer Y, 2006, NAT CLIN PRACT RHEUM, V2, P99, DOI 10.1038/ncprheum0092; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Stolt P, 2003, ANN RHEUM DIS, V62, P835, DOI 10.1136/ard.62.9.835; Tamura N, 2001, J RHEUMATOL, V28, P2583; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; Tousoulis D, 2010, TRENDS CARDIOVAS MED, V20, P153, DOI 10.1016/j.tcm.2010.12.004; Vazgiourakis VM, 2011, ANN RHEUM DIS, V70, P2184, DOI 10.1136/ard.2010.146530; Zinger H, 2009, CLIN REV ALLERG IMMU, V37, P20, DOI 10.1007/s12016-008-8094-x	55	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49214	10.1371/journal.pone.0049214	http://dx.doi.org/10.1371/journal.pone.0049214			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166616	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300032
J	Ji, DL; Lin, H; Chi, W; Zhang, LX				Ji, Dai-Li; Lin, Hong; Chi, Wei; Zhang, Li-Xin			CpLEPA Is Critical for Chloroplast Protein Synthesis Under Suboptimal Conditions in Arabidopsis thaliana	PLOS ONE			English	Article							PHOTOSYSTEM-II; MESSENGER-RNA; ELONGATION-FACTOR; ESCHERICHIA-COLI; LEP OPERON; GENE; TRANSCRIPTION; SPECTROSCOPY; TRANSLATION; POLYMERASE	LEPA is one of the most conserved translation factors and is found from bacteria to higher plants. However, the physiological function of the chloroplast LEPA homolog in higher plants remains unknown. Herein, we demonstrate the physiological role of cpLEPA in enabling efficient photosynthesis in higher plants. The cplepa-1 mutant displays slightly high chlorophyll fluorescence and pale green phenotypes under normal growth conditions. The growth of the cplepa-1 mutant is reduced when grown on soil, and greater reduction is observed under intense light illumination. Photosynthetic activity is impaired in the cplepa-1 mutants, which is reflected in the decreased steady-state levels of chloroplast proteins. In vivo protein labeling experiments explained the decrease in the steady-state levels of chloroplast proteins. An abnormal association of the chloroplast-encoded mRNAs with ribosomes suggests that the protein synthesis deficiencies in cplepa-1 are due to defects in translation initiation in the chloroplasts. The cpLEPA protein appears to be an essential translation factor that promotes the efficiency of chloroplast protein synthesis.	[Ji, Dai-Li; Lin, Hong; Chi, Wei; Zhang, Li-Xin] Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Photosynthesis Res Ctr, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Zhang, LX (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Photobiol, Photosynthesis Res Ctr, Beijing, Peoples R China.	zhanglixin@ibcas.ac.cn			National Natural Science Foundation of China [13843A1001]; Major State Basic Research Development Program [2009CB118500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (no. 13843A1001) and the Major State Basic Research Development Program (no. 2009CB118500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronsson H, 2002, FEBS LETT, V529, P215, DOI 10.1016/S0014-5793(02)03342-2; Badu-Nkansah A, 2010, FEMS MICROBIOL LETT, V311, P147, DOI 10.1111/j.1574-6968.2010.02083.x; BARKAN A, 1988, EMBO J, V7, P2637, DOI 10.1002/j.1460-2075.1988.tb03116.x; BARKAN A, 1993, PLANT CELL, V5, P389, DOI 10.1105/tpc.5.4.389; Bauerschmitt H, 2008, J BIOL CHEM, V283, P17139, DOI 10.1074/jbc.M710037200; BENDICH AJ, 1987, BIOESSAYS, V6, P279, DOI 10.1002/bies.950060608; BOURNE HR, 1995, PHILOS T R SOC B, V349, P283, DOI 10.1098/rstb.1995.0114; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BURGESS RR, 1969, J BIOL CHEM, V244, P6168; Cai WH, 2010, PLANT PHYSIOL, V154, P109, DOI 10.1104/pp.110.159558; Cai WH, 2009, PLANT PHYSIOL, V150, P1260, DOI 10.1104/pp.109.136812; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; DIBB NJ, 1986, J BACTERIOL, V166, P83, DOI 10.1128/jb.166.1.83-87.1986; Evans RN, 2008, P NATL ACAD SCI USA, V105, P4673, DOI 10.1073/pnas.0801308105; KEEGSTRA K, 1986, METHOD ENZYMOL, V118, P316; KLAFF P, 1991, PLANT CELL, V3, P517, DOI 10.1105/tpc.3.5.517; Liu HQ, 2011, P NATL ACAD SCI USA, V108, P16223, DOI 10.1073/pnas.1103820108; Liu HQ, 2010, J MOL BIOL, V396, P1043, DOI 10.1016/j.jmb.2009.12.043; Ma JF, 2007, PLANT CELL, V19, P1980, DOI 10.1105/tpc.107.050526; MARCH PE, 1985, J BIOL CHEM, V260, P7206; Martinez-Garcia JF, 1999, PLANT J, V20, P251, DOI 10.1046/j.1365-313x.1999.00579.x; MATTOO AK, 1989, CELL, V56, P241, DOI 10.1016/0092-8674(89)90897-0; Meurer J, 1996, PLANTA, V198, P385, DOI 10.1007/BF00620055; Meurer J, 2002, PLANT CELL, V14, P3255, DOI 10.1105/tpc.006809; Motohashi R, 2007, PLANT MOL BIOL, V64, P481, DOI 10.1007/s11103-007-9166-7; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ouyang M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1278; Pech M, 2011, P NATL ACAD SCI USA, V108, P3199, DOI 10.1073/pnas.1012994108; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qin Y, 2006, CELL, V127, P721, DOI 10.1016/j.cell.2006.09.037; RAJASEKHAR VK, 1991, EUR J BIOCHEM, V195, P215, DOI 10.1111/j.1432-1033.1991.tb15697.x; RAPP JC, 1992, J BIOL CHEM, V267, P21404; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Schult K, 2007, PLANT CELL, V19, P1329, DOI 10.1105/tpc.106.042895; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; Sun XW, 2010, PLANT PHYSIOL, V152, P1263, DOI 10.1104/pp.109.150722	37	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49746	10.1371/journal.pone.0049746	http://dx.doi.org/10.1371/journal.pone.0049746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166764	Green Submitted, gold, Green Published			2022-12-27	WOS:000311272300069
J	Kiko, T; Nakagawa, K; Satoh, A; Tsuduki, T; Furukawa, K; Arai, H; Miyazawa, T				Kiko, Takehiro; Nakagawa, Kiyotaka; Satoh, Akira; Tsuduki, Tsuyoshi; Furukawa, Katsutoshi; Arai, Hiroyuki; Miyazawa, Teruo			Amyloid beta Levels in Human Red Blood Cells	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; VITAMIN-A; PLASMA; BRAIN; PEPTIDE; PROTEIN; CLEARANCE; AGE	Amyloid beta-peptide (A beta) is hypothesized to play a key role by oxidatively impairing the capacity of red blood cells (RBCs) to deliver oxygen to the brain. These processes are implicated in the pathogenesis of Alzheimer's disease (AD). Although plasma A beta has been investigated thoroughly, the presence and distribution of A beta in human RBCs are still unclear. In this study, we quantitated A beta 40 and A beta 42 in human RBCs with ELISA assays, and provided evidence that significant amounts of A beta could be detected in RBCs and that the RBC A beta levels increased with aging. The RBC A beta levels increased with aging. On the other hand, providing an antioxidant supplement (astaxanthin, a polar carotenoid) to humans was found to decrease RBC A beta as well as oxidative stress marker levels. These results suggest that plasma A beta 40 and A beta 42 bind to RBCs (possibly with aging), implying a pathogenic role of RBC A beta. Moreover, the data indicate that RBC A beta 40 and A beta 42 may constitute biomarkers of AD. As a preventive strategy, therapeutic application of astaxanthin as an A beta-lowering agent in RBCs could be considered as a possible anti-dementia agent.	[Kiko, Takehiro; Nakagawa, Kiyotaka; Miyazawa, Teruo] Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 980, Japan; [Satoh, Akira] Yamaha Motor Co Ltd, Inst Life Sci, Shizuoka, Japan; [Tsuduki, Tsuyoshi] Tohoku Univ, Grad Sch Agr Sci, Lab Food & Biomol Sci, Sendai, Miyagi 980, Japan; [Furukawa, Katsutoshi; Arai, Hiroyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Geriatr & Gerontol, Sendai, Miyagi 980, Japan	Tohoku University; Yamaha Motor Company; Tohoku University; Tohoku University	Miyazawa, T (corresponding author), Tohoku Univ, Grad Sch Agr Sci, Food & Biodynam Chem Lab, Sendai, Miyagi 980, Japan.	miyazawa@biochem.tohoku.ac.jp	Tsuduki, Tsuyoshi/T-2697-2019; Tsuduki, Tsuyoshi/C-2254-2016	Tsuduki, Tsuyoshi/0000-0001-7810-0528; 	KAKENHI (S) of the Japan Society for the Promotion of Science (JSPS), Japan [20228002]	KAKENHI (S) of the Japan Society for the Promotion of Science (JSPS), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	A part of this study was supported by KAKENHI (S) (20228002, to TM) of the Japan Society for the Promotion of Science (JSPS), Japan. http://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Butterfield DA, 2002, FREE RADICAL RES, V36, P1307, DOI 10.1080/1071576021000049890; CHEN M, 1995, BIOCHEM BIOPH RES CO, V213, P96, DOI 10.1006/bbrc.1995.2103; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Fukumoto H, 2003, ARCH NEUROL-CHICAGO, V60, P958, DOI 10.1001/archneur.60.7.958; GhersiEgea JF, 1996, J NEUROCHEM, V67, P880; Ghiso J, 2004, J BIOL CHEM, V279, P45897, DOI 10.1074/jbc.M407668200; Graff-Radford NR, 2007, ARCH NEUROL-CHICAGO, V64, P354, DOI 10.1001/archneur.64.3.354; Hone E, 2003, J ALZHEIMERS DIS, V5, P1, DOI 10.3233/JAD-2003-5101; Hosoda R, 1998, J NEUROPATH EXP NEUR, V57, P1089, DOI 10.1097/00005072-199811000-00012; Jayakumar R, 2003, BBA-GEN SUBJECTS, V1622, P20, DOI 10.1016/S0304-4165(03)00101-6; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kiko T, 2012, J ALZHEIMERS DIS, V28, P593, DOI 10.3233/JAD-2011-111493; Kuo YM, 2000, BIOCHEM BIOPH RES CO, V268, P750, DOI 10.1006/bbrc.2000.2222; Matsubara E, 1999, ANN NEUROL, V45, P537, DOI 10.1002/1531-8249(199904)45:4<537::AID-ANA20>3.0.CO;2-2; Mattson MP, 1997, BRAIN RES, V771, P147, DOI 10.1016/S0006-8993(97)00824-X; Mayeux R, 2003, NEUROLOGY, V61, P1185, DOI 10.1212/01.WNL.0000091890.32140.8F; Mehta PD, 2000, ARCH NEUROL-CHICAGO, V57, P100, DOI 10.1001/archneur.57.1.100; MIYAZAWA T, 1992, J LIPID RES, V33, P1051; Moghekar A, 2012, ARCH NEUROL-CHICAGO, V69, P246, DOI 10.1001/archneurol.2011.732; Mohanty JG, 2008, ADV EXP MED BIOL, V614, P29, DOI 10.1007/978-0-387-74911-2_4; Nakagawa K, 2008, ANAL BIOCHEM, V381, P129, DOI 10.1016/j.ab.2008.06.038; Nakagawa K, 2011, BRIT J NUTR, V105, P1563, DOI 10.1017/S0007114510005398; Nakagawa K, 2011, BIOSCI BIOTECH BIOCH, V75, P2030, DOI 10.1271/bbb.110318; Nakagawa K, 2011, FEBS LETT, V585, P1249, DOI 10.1016/j.febslet.2011.03.060; Nakagawa Kiyotaka, 2009, Br J Nutr, V102, P1280, DOI 10.1017/S0007114509990316; Ono K, 2004, EXP NEUROL, V189, P380, DOI 10.1016/j.expneurol.2004.05.035; Pillot T, 1996, J BIOL CHEM, V271, P28757, DOI 10.1074/jbc.271.46.28757; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takasaki J, 2011, J ALZHEIMERS DIS, V27, P271, DOI 10.3233/JAD-2011-110455; van Oijen M, 2006, LANCET NEUROL, V5, P655, DOI 10.1016/S1474-4422(06)70501-4; Varadarajan S, 1999, BRAIN RES BULL, V50, P133, DOI 10.1016/S0361-9230(99)00093-3; YOUNKIN SG, 1995, ANN NEUROL, V37, P287, DOI 10.1002/ana.410370303; Zlokovic BV, 2004, J NEUROCHEM, V89, P807, DOI 10.1111/j.1471-4159.2004.02385.x	37	58	59	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49620	10.1371/journal.pone.0049620	http://dx.doi.org/10.1371/journal.pone.0049620			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166730	gold, Green Submitted, Green Published			2022-12-27	WOS:000311272300058
J	Spathis, A; Kottaridi, C; Chranioti, A; Meristoudis, C; Chrelias, C; Panayiotides, IG; Paraskevaidis, E; Karakitsos, P				Spathis, Aris; Kottaridi, Christine; Chranioti, Aikaterini; Meristoudis, Christos; Chrelias, Charalambos; Panayiotides, Ioannis G.; Paraskevaidis, Evangelos; Karakitsos, Petros			mRNA and DNA Detection of Human Papillomaviruses in Women of All Ages Attending Two Colposcopy Clinics	PLOS ONE			English	Article							CARCINOGENIC HUMAN-PAPILLOMAVIRUS; NATURAL-HISTORY; CERVICAL PRECANCER; HPV INFECTION; EXPRESSION; ASSAY; E6; QUANTIFICATION; PERFORMANCE; TYPE-16	Objective: HPV infection is a common finding, especially in young women while the majority of infections are cleared within a short time interval. The aim of this study was to examine the efficacy of HPV DNA and mRNA testing in a population attending colposcopy units of two University hospitals. Methods: 1173 liquid based cervical samples from two colposcopy clinics were tested for HPV DNA positivity using a commercial typing kit and HPV E6/E7 mRNA positivity with a flow cytometry based commercial kit. Statistic measures were calculated for both molecular tests and morphological cytology and colposcopy diagnosis according to histology results. Results: HPV DNA, high-risk HPV DNA, HPV16 or 18 DNA and HPV mRNA was detected in 55.5%, 50.6%, 20.1% and 29.7% of the cervical smears respectively. Concordance between the DNA and the mRNA test was 71.6% with their differences being statistically significant. Both tests' positivity increased significantly as lesion grade progressed and both displayed higher positivity rates in samples from women under 30 years old. mRNA testing displayed similar NPV, slightly lower sensitivity but significantly higher specificity and PPV than DNA testing, except only when DNA positivity for either HPV16 or 18 was used. Conclusions: Overall mRNA testing displayed higher clinical efficacy than DNA testing, either when used as a reflex test or as an ancillary test combined with morphology. Due to enhanced specificity of mRNA testing and its comparable sensitivity in ages under 25 or 30 years old, induction of mRNA testing in young women could be feasible if a randomized trial verifies these results.	[Spathis, Aris; Kottaridi, Christine; Chranioti, Aikaterini; Meristoudis, Christos; Karakitsos, Petros] Natl & Kapodistrian Univ Athens, Sch Med, Univ Gen Hosp ATTIKON, Dept Cytopathol, Chaidari, Greece; [Chrelias, Charalambos] Natl & Kapodistrian Univ Athens, Sch Med, Univ Gen Hosp ATTIKON, Dept Obstet & Gynecol 3, Chaidari, Greece; [Panayiotides, Ioannis G.] Natl & Kapodistrian Univ Athens, Sch Med, Univ Gen Hosp ATTIKON, Dept Pathol 2, Chaidari, Greece; [Paraskevaidis, Evangelos] Univ Hosp Ioannina, Dept Obstet & Gynecol, Ioannina, Greece	National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens; University Hospital Attikon; National & Kapodistrian University of Athens; University Hospital Attikon; University Hospital Ioannina	Spathis, A (corresponding author), Natl & Kapodistrian Univ Athens, Sch Med, Univ Gen Hosp ATTIKON, Dept Cytopathol, Chaidari, Greece.	aspathis@med.uoa.gr	Paraskevaidis, Evangelos/ABH-4990-2020; Spathis, Aris T/A-2442-2015	Spathis, Aris T/0000-0001-8867-3661; Kottaridi, Christine/0000-0003-0979-3871	Special Account of Research Grants of the University of Athens [8702]; Greek Ministry of Development-GSRT [ATT95]	Special Account of Research Grants of the University of Athens; Greek Ministry of Development-GSRT(Greek Ministry of Development-GSRT)	This study was funded by the Special Account of Research Grants of the University of Athens, grant 8702 and from the Greek Ministry of Development-GSRT, Project AKAKOS (ATT95). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Boulet GAV, 2008, CANCER EPIDEM BIOMAR, V17, P810, DOI 10.1158/1055-9965.EPI-07-2865; Boulet GAV, 2010, J CLIN MICROBIOL, V48, P2524, DOI 10.1128/JCM.00173-10; Castle PE, 2007, CLIN CANCER RES, V13, P2599, DOI 10.1158/1078-0432.CCR-06-2881; Castle PE, 2011, LANCET ONCOL, V12, P880, DOI 10.1016/S1470-2045(11)70188-7; Clavel C, 2001, BRIT J CANCER, V84, P1616, DOI 10.1054/bjoc.2001.1845; Coquillard G, 2011, GYNECOL ONCOL, V120, P89, DOI 10.1016/j.ygyno.2010.09.013; Cox T, 2006, GYNECOL ONCOL, V103, P8, DOI 10.1016/j.ygyno.2006.07.030; Cuschieri KS, 2004, J MED VIROL, V6, P1; Duensing S, 2002, CANCER RES, V62, P7075; Duensing S, 2001, BBA-REV CANCER, V1471, pM81, DOI 10.1016/S0304-419X(00)00025-1; Dunne EF, 2007, JAMA-J AM MED ASSOC, V297, P813, DOI 10.1001/jama.297.8.813; Dunne EF, 2006, CLIN INFECT DIS, V43, P624, DOI 10.1086/505982; Gravitt PE, 2008, CANCER EPIDEM BIOMAR, V17, P1248, DOI 10.1158/1055-9965.EPI-07-2904; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Kottaridi C, 2011, ANAL QUANT CYTOL, V33, P305; Kraus I, 2006, J CLIN MICROBIOL, V44, P1310, DOI 10.1128/JCM.44.4.1310-1317.2006; Kraus I, 2004, BRIT J CANCER, V90, P1407, DOI 10.1038/sj.bjc.6601691; Molden T, 2006, GYNECOL ONCOL, V100, P95, DOI 10.1016/j.ygyno.2005.07.108; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; Narimatsu R, 2005, AM J CLIN PATHOL, V123, P716, DOI 10.1309/FE70AVNY75TDDJUH; Schlecht NF, 2001, JAMA-J AM MED ASSOC, V286, P3106, DOI 10.1001/jama.286.24.3106; Sellors JW, 2003, CAN MED ASSOC J, V168, P421; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Sorbye SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024083; Tarkowski TA, 2004, J INFECT DIS, V189, P46, DOI 10.1086/380466; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Woodman CBJ, 2001, LANCET, V357, P1831, DOI 10.1016/S0140-6736(00)04956-4; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050	30	14	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49205	10.1371/journal.pone.0049205	http://dx.doi.org/10.1371/journal.pone.0049205			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166611	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300027
J	Xie, AX; Sun, MY; Murphy, T; Lauderdale, K; Tiglao, E; Fiacco, TA				Xie, Alison X.; Sun, Min-Yu; Murphy, Thomas; Lauderdale, Kelli; Tiglao, Elizabeth; Fiacco, Todd A.			Bidirectional Scaling of Astrocytic Metabotropic Glutamate Receptor Signaling following Long-Term Changes in Neuronal Firing Rates	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; HIPPOCAMPAL ASTROCYTES; IN-SITU; CALCIUM OSCILLATIONS; SYNAPTIC FUNCTION; INVERSE AGONISM; EXPRESSION; PLASTICITY; RELEASE; FREQUENCY	Very little is known about the ability of astrocytic receptors to exhibit plasticity as a result of changes in neuronal activity. Here we provide evidence for bidirectional scaling of astrocytic group I metabotropic glutamate receptor signaling in acute mouse hippocampal slices following long-term changes in neuronal firing rates. Plasticity of astrocytic mGluRs was measured by recording spontaneous and evoked Ca2+ elevations in both astrocytic somata and processes. An exogenous astrocytic Gq G protein-coupled receptor was resistant to scaling, suggesting that the alterations in astrocyte Ca2+ signaling result from changes in activity of the surface mGluRs rather than a change in intracellular G protein signaling molecules. These findings suggest that astrocytes actively detect shifts in neuronal firing rates and adjust their receptor signaling accordingly. This type of long-term plasticity in astrocytes resembles neuronal homeostatic plasticity and might be important to ensure an optimal or expected level of input from neurons.	[Fiacco, Todd A.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Fiacco, Todd A.] Univ Calif Riverside, Ctr Glial Neuronal Interact, Riverside, CA 92521 USA; [Xie, Alison X.; Murphy, Thomas; Lauderdale, Kelli] Univ Calif Riverside, Grad Program Neurosci, Riverside, CA 92521 USA; [Sun, Min-Yu] Univ Calif Riverside, Grad Program Cellular Mol & Dev Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Fiacco, TA (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA.	todd.fiacco@ucr.edu		Murphy, Thomas/0000-0002-2168-0602	University of California Hellman Fellowship; University of California Riverside	University of California Hellman Fellowship; University of California Riverside(University of California System)	This work was supported by a University of California Hellman Fellowship and initial complement funds from the University of California Riverside. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Agulhon C, 2010, SCIENCE, V327, P1250, DOI 10.1126/science.1184821; Ango F, 2001, NATURE, V411, P962, DOI 10.1038/35082096; Araque A, 2002, J NEUROSCI, V22, P2443, DOI 10.1523/JNEUROSCI.22-07-02443.2002; Aronica E, 2003, EPILEPSIA, V44, P785, DOI 10.1046/j.1528-1157.2003.54802.x; Aronica E, 2003, EUR J NEUROSCI, V17, P2106, DOI 10.1046/j.1460-9568.2003.02657.x; Beattie EC, 2002, SCIENCE, V295, P2282, DOI 10.1126/science.1067859; Belair EL, 2010, J PHYSIOL-LONDON, V588, P1039, DOI 10.1113/jphysiol.2009.178988; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; Bond RA, 2006, TRENDS PHARMACOL SCI, V27, P92, DOI 10.1016/j.tips.2005.12.007; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carmignoto G, 1998, J NEUROSCI, V18, P4637; de Ligt RAF, 2000, BRIT J PHARMACOL, V130, P1, DOI 10.1038/sj.bjp.0703311; Desai NS, 2002, NAT NEUROSCI, V5, P783, DOI 10.1038/nn878; Di Castro MA, 2011, NAT NEUROSCI, V14, P1276, DOI 10.1038/nn.2929; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Fellin Tommaso, 2007, ScientificWorldJournal, V7, P89; Ferraguti F, 2001, EXP BRAIN RES, V137, P1, DOI 10.1007/s002210000633; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2006, GLIA, V54, P676, DOI 10.1002/glia.20396; Garaschuk O, 2006, NAT PROTOC, V1, P380, DOI 10.1038/nprot.2006.58; Gordon GRJ, 2008, NATURE, V456, P745, DOI 10.1038/nature07525; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Hermans E, 2001, BIOCHEM J, V359, P465, DOI 10.1042/0264-6021:3590465; Honsek SD, 2012, HIPPOCAMPUS, V22, P29, DOI 10.1002/hipo.20843; Hu QH, 1999, J BIOL CHEM, V274, P33995, DOI 10.1074/jbc.274.48.33995; Li WH, 1998, NATURE, V392, P936, DOI 10.1038/31965; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Milligan G, 2003, MOL PHARMACOL, V64, P1271, DOI 10.1124/mol.64.6.1271; Mudo G, 2007, BRAIN RES, V1149, P1, DOI 10.1016/j.brainres.2007.02.041; Nett WJ, 2002, J NEUROPHYSIOL, V87, P528, DOI 10.1152/jn.00268.2001; Newcombe J, 2008, BRAIN PATHOL, V18, P52, DOI 10.1111/j.1750-3639.2007.00101.x; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Ostasov P, 2008, CELL BIOCHEM FUNCT, V26, P264, DOI 10.1002/cbf.1453; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Porter JT, 1997, PROG NEUROBIOL, V51, P439, DOI 10.1016/S0301-0082(96)00068-8; Porter JT, 1996, J NEUROSCI, V16, P5073; Prezeau L, 1996, MOL PHARMACOL, V49, P422; Rae MG, 2004, NEUROPHARMACOLOGY, V46, P1057, DOI 10.1016/j.neuropharm.2004.02.002; Reeves AMB, 2011, J NEUROSCI, V31, P9353, DOI 10.1523/JNEUROSCI.0127-11.2011; Rusakov DA, 2011, NEUROSCIENTIST, V17, P513, DOI 10.1177/1073858410387304; Santello M, 2011, NEURON, V69, P988, DOI 10.1016/j.neuron.2011.02.003; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; SHAO Y, 1995, CELL CALCIUM, V17, P187, DOI 10.1016/0143-4160(95)90033-0; SHAO YP, 1993, MOL PHARMACOL, V44, P247; Shelton MK, 1999, GLIA, V26, P1, DOI 10.1002/(SICI)1098-1136(199903)26:1<1::AID-GLIA1>3.0.CO;2-Z; Shelton MK, 2000, J NEUROCHEM, V74, P555, DOI 10.1046/j.1471-4159.2000.740555.x; Simard M, 2003, J NEUROSCI, V23, P9254; Sullivan MR, 2005, J NEUROPHYSIOL, V94, P1636, DOI 10.1152/jn.01013.2004; Sutton MA, 2004, SCIENCE, V304, P1979, DOI 10.1126/science.1096202; Sutton MA, 2006, CELL, V125, P785, DOI 10.1016/j.cell.2006.03.040; Sweger EJ, 2007, J NEUROSCI, V27, P2309, DOI 10.1523/JNEUROSCI.4565-06.2007; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Tian GF, 2006, ADV DRUG DELIVER REV, V58, P773, DOI 10.1016/j.addr.2006.07.001; Tyler WJ, 2007, J NEUROSCI, V27, P9427, DOI 10.1523/JNEUROSCI.0664-07.2007; Ulas J, 2000, GLIA, V30, P352, DOI 10.1002/(SICI)1098-1136(200006)30:4<352::AID-GLIA40>3.0.CO;2-6; Ullian EM, 2004, GLIA, V47, P209, DOI 10.1002/glia.20082; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Vermeiren C, 2005, J NEUROCHEM, V94, P405, DOI 10.1111/j.1471-4159.2005.03216.x; WANG SSH, 1994, CELL CALCIUM, V15, P483, DOI 10.1016/0143-4160(94)90112-0; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Whiting B, 2009, NEUROSCIENCE, V163, P1264, DOI 10.1016/j.neuroscience.2009.07.049; WILSON DA, 1995, J NEUROSCI, V15, P5574; Witcher MR, 2007, GLIA, V55, P13, DOI 10.1002/glia.20415; Witcher MR, 2010, GLIA, V58, P572, DOI 10.1002/glia.20946; Zonta M, 2003, NAT NEUROSCI, V6, P43, DOI 10.1038/nn980; Zur Nieden R, 2006, CEREB CORTEX, V16, P676, DOI 10.1093/cercor/bhj013	70	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49637	10.1371/journal.pone.0049637	http://dx.doi.org/10.1371/journal.pone.0049637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166735	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300060
J	Akmatov, MK; Gatzemeier, A; Schughart, K; Pessler, F				Akmatov, Manas K.; Gatzemeier, Anja; Schughart, Klaus; Pessler, Frank			Equivalence of Self- and Staff-Collected Nasal Swabs for the Detection of Viral Respiratory Pathogens	PLOS ONE			English	Article							INFECTION; VIRUS; VALIDATION; TOOL	Background: The need for the timely collection of diagnostic biosamples during symptomatic episodes represents a major obstacle to large-scale studies on acute respiratory infection (ARI) epidemiology. This may be circumvented by having the participants collect their own nasal swabs. We compared self- and staff-collected swabs in terms of swabbing quality and detection of viral respiratory pathogens. Methodology/Principal Findings: We conducted a prospective study among employees of our institution during the ARI season 2010/2011 (December-March). Weekly emails were sent to the participants (n = 84), reminding them to come to the study center in case of new symptoms. The participants self-collected an anterior nasal swab from one nostril, and trained study personnel collected one from the other nostril. The participants self-collected another two swabs (one from each nostril) on a subsequent day. Human beta-actin DNA concentration was determined in the swabs as a quality control. Viral respiratory pathogens were detected by multiplex RT-PCR (Seeplex RV15 kit, Seegene, Eschborn, Germany). Of 84 participants, 56 (67%) reported at least one ARI episode, 18 participants two, and one participant three. Self-swabbing was highly accepted by the participants. The amount of beta-actin DNA per swab was higher in the self-than in the staff-collected swabs (p = 0.008). beta-actin concentration was lower in the self-swabs collected on day 1 than in those collected on a subsequent day (p < 0.0001). A respiratory viral pathogen was detected in 31% (23/75) of staff- and in 35% (26/75) of self-collected swabs (p = 0.36). With both approaches, the most frequently identified pathogens were human rhinoviruses A/B/C (12/75 swabs, 16%) and human coronavirus OC43 (4/75 swabs, 5%). There was almost perfect agreement between self- and staff-collected swabs in terms of pathogen detection (agreement = 93%, kappa = 0.85, p < 0.0001). Conclusions/Significance: Nasal self-swabbing for identification of viral ARI pathogens proved to be equivalent to staff-swabbing in this population in terms of acceptance and pathogen detection.	[Akmatov, Manas K.; Gatzemeier, Anja; Pessler, Frank] Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany	Helmholtz Association; Helmholtz-Center for Infection Research	Akmatov, MK (corresponding author), Helmholtz Ctr Infect Res, Dept Epidemiol, Braunschweig, Germany.	manas.akmatov@helmholtz-hzi.de	Stangel, Martin/AAH-5345-2020	Schughart, Klaus/0000-0002-6824-7523				Akmatov MK, 2011, INT J INFECT DIS, V15, pE589, DOI 10.1016/j.ijid.2011.04.009; Akmatov MK, 2011, INT J INFECT DIS, V15, pE799, DOI 10.1016/j.ijid.2011.07.005; Esposito S, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-85; Ip DKM, 2012, J INFECT DIS, V205, P631, DOI 10.1093/infdis/jir803; Jobin C, 1997, J IMMUNOL, V158, P226; Lambert SB, 2008, VACCINE, V26, P1826, DOI 10.1016/j.vaccine.2008.01.055; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Larios OE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021335; Luinstra K, 2011, J CLIN MICROBIOL, V49, P2138, DOI 10.1128/JCM.00327-11; Smieja M, 2010, J CLIN MICROBIOL, V48, P3340, DOI 10.1128/JCM.02235-09	10	50	50	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48508	10.1371/journal.pone.0048508	http://dx.doi.org/10.1371/journal.pone.0048508			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155387	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900021
J	Ambrosi, C; Pompili, M; Scribano, D; Zagaglia, C; Ripa, S; Nicoletti, M				Ambrosi, Cecilia; Pompili, Monica; Scribano, Daniela; Zagaglia, Carlo; Ripa, Sandro; Nicoletti, Mauro			Outer Membrane Protein A (OmpA): A New Player in Shigella flexneri Protrusion Formation and Inter-Cellular Spreading	PLOS ONE			English	Article							ACTIN-BASED MOTILITY; ESCHERICHIA-COLI; INTERCELLULAR SPREAD; AUTOTRANSPORTER ICSA; SURFACE PRESENTATION; VIRULENCE GENE; HELA-CELLS; PLASMID; IDENTIFICATION; LOCALIZATION	Outer membrane protein A (OmpA) is a multifaceted predominant outer membrane protein of Escherichia coli and other Enterobacteriaceae whose role in the pathogenesis of various bacterial infections has recently been recognized. Here, the role of OmpA on the virulence of Shigella flexneri has been investigated. An ompA mutant of wild-type S. flexneri 5a strain M90T was constructed (strain HND92) and it was shown to be severely impaired in cell-to-cell spreading since it failed to plaque on HeLa cell monolayers. The lack of OmpA significantly reduced the levels of IcsA while the levels of cell associated and released IcsP-cleaved 95 kDa amino-terminal portion of the mature protein were similar. Nevertheless, the ompA mutant displayed IcsA exposed across the entire bacterial surface. Surprisingly, the ompA mutant produced proper F-actin comet tails, indicating that the aberrant IcsA exposition at bacterial lateral surface did not affect proper activation of actin-nucleating proteins, suggesting that the absence of OmpA likely unmasks mature or cell associated IcsA at bacterial lateral surface. Moreover, the ompA mutant was able to invade and to multiply within HeLa cell monolayers, although internalized bacteria were found to be entrapped within the host cell cytoplasm. We found that the ompA mutant produced significantly less protrusions than the wild-type strain, indicating that this defect could be responsible of its inability to plaque. Although we could not definitely rule out that the ompA mutation might exert pleiotropic effects on other S. flexneri genes, complementation of the ompA mutation with a recombinant plasmid carrying the S. flexneri ompA gene clearly indicated that a functional OmpA protein is required and sufficient for proper IcsA exposition, plaque and protrusion formation. Moreover, an independent ompA mutant was generated. Since we found that both mutants displayed identical virulence profile, these results further supported the findings presented in this study.	[Ambrosi, Cecilia; Nicoletti, Mauro] Univ G DAnnunzio, Dip Sci Sperimentali & Clin, Chieti, Italy	G d'Annunzio University of Chieti-Pescara	Ambrosi, C (corresponding author), Univ G DAnnunzio, Dip Sci Sperimentali & Clin, Chieti, Italy.	mauro.nicoletti@uniroma1.it	ambrosi, cecilia/AAM-3939-2020; Scribano, Daniela/AAY-1714-2021; Nicoletti, Mauro/AAI-7702-2020	ambrosi, cecilia/0000-0003-2163-1613; SCRIBANO, Daniela/0000-0002-2901-265X				Bahrani FK, 1997, INFECT IMMUN, V65, P4005, DOI 10.1128/IAI.65.10.4005-4010.1997; BEHER MG, 1980, J BACTERIOL, V143, P906, DOI 10.1128/JB.143.2.906-913.1980; BERNARDINI ML, 1989, P NATL ACAD SCI USA, V86, P3867, DOI 10.1073/pnas.86.10.3867; Brandon LD, 2003, MOL MICROBIOL, V50, P45, DOI 10.1046/j.1365-2958.2003.03674.x; CHAI TJ, 1977, BIOCHIM BIOPHYS ACTA, V493, P210, DOI 10.1016/0005-2795(77)90274-4; Charles M, 2001, P NATL ACAD SCI USA, V98, P9871, DOI 10.1073/pnas.171310498; Tran CN, 2011, NUCLEIC ACIDS RES, V39, P8122, DOI 10.1093/nar/gkr521; CLERC P, 1987, INFECT IMMUN, V55, P2681, DOI 10.1128/IAI.55.11.2681-2688.1987; Cossart P, 2004, DEV CELL, V6, P314, DOI 10.1016/S1534-5807(04)00072-3; Cossart P, 2000, CELL MICROBIOL, V2, P195, DOI 10.1046/j.1462-5822.2000.00053.x; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; deCock H, 1996, J BIOL CHEM, V271, P12885, DOI 10.1074/jbc.271.22.12885; DHAUTEVILLE H, 1992, MOL MICROBIOL, V6, P833, DOI 10.1111/j.1365-2958.1992.tb01534.x; Egile C, 1997, MOL MICROBIOL, V23, P1063, DOI 10.1046/j.1365-2958.1997.2871652.x; FUKUDA I, 1995, J BACTERIOL, V177, P1719, DOI 10.1128/jb.177.7.1719-1726.1995; GOLDBERG MB, 1994, INFECT IMMUN, V62, P5664, DOI 10.1128/IAI.62.12.5664-5668.1994; GOLDBERG MB, 1993, J BACTERIOL, V175, P2189, DOI 10.1128/JB.175.8.2189-2196.1993; Goldberg MB, 2001, MICROBIOL MOL BIOL R, V65, P595, DOI 10.1128/MMBR.65.4.595-626.2001; Haglund CM, 2011, J CELL BIOL, V195, P7, DOI 10.1083/jcb.201103148; HALE TL, 1981, INFECT IMMUN, V32, P137, DOI 10.1128/IAI.32.1.137-144.1981; Haugland R., 1996, HDB FLUORESCENT PROB; Heindl JE, 2010, INFECT IMMUN, V78, P193, DOI 10.1128/IAI.00252-09; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; HOFSTRA H, 1980, J GEN MICROBIOL, V119, P123; HOFSTRA H, 1980, J BACTERIOL, V143, P328, DOI 10.1128/JB.143.1.328-337.1980; Hong M, 1997, MOL MICROBIOL, V24, P779, DOI 10.1046/j.1365-2958.1997.3731744.x; KADURUGAMUWA JL, 1991, INFECT IMMUN, V59, P3463, DOI 10.1128/IAI.59.10.3463-3471.1991; Kandzari D E, 1996, Subcell Biochem, V26, P97; Krishnan S, 2012, FEBS J, V279, P919, DOI 10.1111/j.1742-4658.2012.08482.x; LABREC EH, 1964, J BACTERIOL, V88, P1503, DOI 10.1128/JB.88.5.1503-1518.1964; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAKINO S, 1986, CELL, V46, P551, DOI 10.1016/0092-8674(86)90880-9; Maruvada R, 2011, J INFECT DIS, V203, P131, DOI 10.1093/infdis/jiq009; May KL, 2008, J BACTERIOL, V190, P4666, DOI 10.1128/JB.00093-08; Monack DM, 2001, CELL MICROBIOL, V3, P633, DOI 10.1046/j.1462-5822.2001.00143.x; Morona R, 2003, FEMS MICROBIOL LETT, V221, P173, DOI 10.1016/S0378-1097(03)00210-6; Morona R, 2003, MICROBIOL-SGM, V149, P925, DOI 10.1099/mic.0.26141-0; OAKS EV, 1985, INFECT IMMUN, V48, P124, DOI 10.1128/IAI.48.1.124-129.1985; Pore D, 2012, J BIOL CHEM, V287, P12589, DOI 10.1074/jbc.M111.335554; Pore D, 2009, VACCINE, V27, P5855, DOI 10.1016/j.vaccine.2009.07.054; Prasadarao NV, 1996, INFECT IMMUN, V64, P146, DOI 10.1128/IAI.64.1.146-153.1996; Purdy GE, 2007, J BACTERIOL, V189, P5566, DOI 10.1128/JB.00483-07; Rasband W., 2006, IMAGEJ; Rathman M, 2000, MOL MICROBIOL, V35, P974, DOI 10.1046/j.1365-2958.2000.01770.x; Reusch RN, 2012, FEBS J, V279, P894, DOI 10.1111/j.1742-4658.2012.08484.x; Robbins JR, 2001, MOL MICROBIOL, V41, P861, DOI 10.1046/j.1365-2958.2001.02552.x; Sambrook J., 2001, MOL CLONING LAB MANU; SANSONETTI PJ, 1986, INFECT IMMUN, V51, P461, DOI 10.1128/IAI.51.2.461-469.1986; SANSONETTI PJ, 1982, INFECT IMMUN, V35, P852, DOI 10.1128/IAI.35.3.852-860.1982; SANSONETTI PJ, 2001, PRINCIPLES BACTERIAL, P335; Santapaola D, 2006, J BACTERIOL, V188, P1620, DOI 10.1128/JB.188.4.1620-1627.2006; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Steinhauer J, 1999, MOL MICROBIOL, V32, P367, DOI 10.1046/j.1365-2958.1999.01356.x; Sugawara E, 1996, J BACTERIOL, V178, P6067, DOI 10.1128/jb.178.20.6067-6069.1996; SUZUKI T, 1994, MOL MICROBIOL, V11, P31, DOI 10.1111/j.1365-2958.1994.tb00287.x; Suzuki T, 1998, EMBO J, V17, P2767, DOI 10.1093/emboj/17.10.2767; TANJI K, 1992, J PHARM PHARMACOL, V44, P1036; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Van Den Bosch L, 2003, MICROB PATHOGENESIS, V35, P11, DOI 10.1016/S0882-4010(03)00064-0; Wagner JK, 2009, J BACTERIOL, V191, P815, DOI 10.1128/JB.00989-08; Wang Y, 2002, BIOCHEM BIOPH RES CO, V292, P396, DOI 10.1006/bbrc.2002.6657; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	62	28	28	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49625	10.1371/journal.pone.0049625	http://dx.doi.org/10.1371/journal.pone.0049625			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166731	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900175
J	Godfroy, JI; Roostan, M; Moroz, YS; Korendovych, IV; Yin, H				Godfroy, James I., III; Roostan, Mohammad; Moroz, Yurii S.; Korendovych, Ivan V.; Yin, Hang			Isolated Toll-like Receptor Transmembrane Domains Are Capable of Oligomerization	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; PATTERN-RECOGNITION; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; STRUCTURAL BASIS; INNATE IMMUNITY; DIMERIZATION; MEMBRANE; SYSTEM; TOXR	Toll-like receptors (TLRs) act as the first line of defense against bacterial and viral pathogens by initiating critical defense signals upon dimer activation. The contribution of the transmembrane domain in the dimerization and signaling process has heretofore been overlooked in favor of the extracellular and intracellular domains. As mounting evidence suggests that the transmembrane domain is a critical region in several protein families, we hypothesized that this was also the case for Toll-like receptors. Using a combined biochemical and biophysical approach, we investigated the ability of isolated Toll-like receptor transmembrane domains to interact independently of extracellular domain dimerization. Our results showed that the transmembrane domains had a preference for the native dimer partners in bacterial membranes for the entire receptor family. All TLR transmembrane domains showed strong homotypic interaction potential. The TLR2 transmembrane domain demonstrated strong heterotypic interactions in bacterial membranes with its known interaction partners, TLR1 and TLR6, as well as with a proposed interaction partner, TLR10, but not with TLR4, TLR5, or unrelated transmembrane receptors providing evidence for the specificity of TLR2 transmembrane domain interactions. Peptides for the transmembrane domains of TLR1, TLR2, and TLR6 were synthesized to further study this subfamily of receptors. These peptides validated the heterotypic interactions seen in bacterial membranes and demonstrated that the TLR2 transmembrane domain had moderately strong interactions with both TLR1 and TLR6. Combined, these results suggest a role for the transmembrane domain in Toll-like receptor oligomerization and as such, may be a novel target for further investigation of new therapeutic treatments of Toll-like receptor mediated diseases.	[Godfroy, James I., III] Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Godfroy, JI (corresponding author), Univ Colorado, Dept Chem & Biol Engn, Boulder, CO 80309 USA.	hubert.yin@colorado.edu	YIN, HANG/O-2097-2014	YIN, HANG/0000-0002-9762-4818; Moroz, Yurii/0000-0001-6073-002X	Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32 GM065103, T32 GM-065103] Funding Source: Medline	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anbazhagan V, 2010, BBA-BIOMEMBRANES, V1798, P1899, DOI 10.1016/j.bbamem.2010.06.027; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brosig B, 1998, PROTEIN SCI, V7, P1052; Caputo GA, 2008, BIOCHEMISTRY-US, V47, P8600, DOI 10.1021/bi800687h; Chen L, 2010, SCI SIGNAL, V3, P1; Chin CN, 2005, FEBS LETT, V579, P3855, DOI 10.1016/j.febslet.2005.05.071; Cohen T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001085; Cook DN, 2004, NAT IMMUNOL, V5, P975, DOI 10.1038/ni1116; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Daugherty DL, 1999, J AM CHEM SOC, V121, P4325, DOI 10.1021/ja990178p; DeGrado WF, 2003, PROTEIN SCI, V12, P647, DOI 10.1110/ps.0236503; Duong MT, 2007, J MOL BIOL, V371, P422, DOI 10.1016/j.jmb.2007.05.026; DUPLAY P, 1987, J MOL BIOL, V194, P663, DOI 10.1016/0022-2836(87)90243-9; Ebie AZ, 2007, J MOL BIOL, V366, P517, DOI 10.1016/j.jmb.2006.11.035; Finger C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000547; Fink A, 2012, BBA-BIOMEMBRANES, V1818, P974, DOI 10.1016/j.bbamem.2011.11.029; Ghirlanda G, 2009, CURR OPIN CHEM BIOL, V13, P643, DOI 10.1016/j.cbpa.2009.09.017; Goh FG, 2011, RHEUMATOLOGY, P1; Guan Y, 2010, J IMMUNOL, V184, P5094, DOI 10.4049/jimmunol.0901888; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Hasan UA, 2004, BIOCHEM BIOPH RES CO, V321, P124, DOI 10.1016/j.bbrc.2004.06.134; Hennecke F, 2005, PROTEIN ENG DES SEL, V18, P477, DOI 10.1093/protein/gzi053; Herrmann JR, 2009, J MOL BIOL, V385, P912, DOI 10.1016/j.jmb.2008.10.058; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kang JY, 2011, ANNU REV BIOCHEM, V80, P917, DOI 10.1146/annurev-biochem-052909-141507; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Kanzler H, 2007, NAT MED, V13, P552, DOI 10.1038/nm1589; Kawai T, 2006, CELL DEATH DIFFER, V13, P816, DOI 10.1038/sj.cdd.4401850; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KOLMAR H, 1995, EMBO J, V14, P3895, DOI 10.1002/j.1460-2075.1995.tb00061.x; Krishnan J, 2009, ARCH PHARM RES, V32, P1485, DOI 10.1007/s12272-009-2100-6; Kruithof EKO, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-148; Langosch D, 1996, J MOL BIOL, V263, P525, DOI 10.1006/jmbi.1996.0595; Langosch D, 2009, PROTEIN SCI, V18, P1343, DOI 10.1002/pro.154; Latz E, 2007, NAT IMMUNOL, V8, P772, DOI 10.1038/ni1479; Leonard JN, 2007, PNAS, V105, P258; Li E, 2005, BIOCHEMISTRY-US, V44, P352, DOI 10.1021/bi048480k; Li RH, 2004, J BIOL CHEM, V279, P26666, DOI 10.1074/jbc.M314168200; Lien E, 2009, CURR MOL MED, V9, P52, DOI 10.2174/156652409787314453; Lindner E, 2006, PROTEINS, V65, P803, DOI 10.1002/prot.21226; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Merzlyakov M, 2007, J MEMBRANE BIOL, V215, P93, DOI 10.1007/s00232-007-9009-0; Vega MTM, 2009, ALLERGOL IMMUNOPATH, V37, P252, DOI 10.1016/j.aller.2009.04.004; Moore DT, 2008, STRUCTURE, V16, P991, DOI 10.1016/j.str.2008.05.007; Nemoto W, 2006, CURR PROTEIN PEPT SC, V7, P561, DOI 10.2174/138920306779025657; O'Neill LAJ, 2009, PHARMACOL REV, V61, P177, DOI 10.1124/pr.109.001073; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Panter G, 2011, J BIOL CHEM, V286, P23334, DOI 10.1074/jbc.M110.205419; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Sal-Man N, 2005, BIOCHEM J, V385, P29, DOI 10.1042/BJ20041022; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Schneider D, 2004, J BIOL CHEM, V279, P9840, DOI 10.1074/jbc.M312749200; Schneider D, 2003, J BIOL CHEM, V278, P3105, DOI 10.1074/jbc.M206287200; SHERMAN WR, 1968, ANAL CHEM, V40, P803, DOI 10.1021/ac60260a045; Slivka PF, 2008, ACS CHEM BIOL, V3, P402, DOI 10.1021/cb800049w; Soong R, 2009, J MEMBRANE BIOL, V230, P49, DOI 10.1007/s00232-009-9185-1; Takagi M, 2011, J CLIN EXP HEMATOP, V51, P77, DOI 10.3960/jslrt.51.77; Treeby M, 2009, BIOCHEM BIOPH RES CO, V381, P65, DOI 10.1016/j.bbrc.2009.02.017; Van Arnam EB, 2011, ACS CHEM BIOL, V6, P1063, DOI 10.1021/cb200153g; Yin H, 2007, SCIENCE, V315, P1817, DOI 10.1126/science.1136782; Zhang HF, 2002, FEBS LETT, V532, P171, DOI 10.1016/S0014-5793(02)03669-4; Zhu H, 2010, J MOL BIOL, V401, P882, DOI 10.1016/j.jmb.2010.06.062	64	54	56	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48875	10.1371/journal.pone.0048875	http://dx.doi.org/10.1371/journal.pone.0048875			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155421	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900056
J	Fejerskov, B; Zelikin, AN				Fejerskov, Betina; Zelikin, Alexander N.			Substrate Mediated Enzyme Prodrug Therapy	PLOS ONE			English	Article							ALCOHOL) PHYSICAL HYDROGELS; BETA-GLUCURONIDASE; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; CONTROLLED-RELEASE; FUSION PROTEIN; CELLS; ACTIVATION; ANTIBODY; DESIGN	In this report, we detail Substrate Mediated Enzyme Prodrug Therapy (SMEPT) as a novel approach in drug delivery which relies on enzyme-functionalized cell culture substrates to achieve a localized conversion of benign prodrug(s) into active therapeutics with subsequent delivery to adhering cells or adjacent tissues. For proof-of-concept SMEPT, we use surface adhered micro-structured physical hydrogels based on poly(vinyl alcohol), beta-glucuronidase enzyme and glucuronide prodrugs. We demonstrate enzymatic activity mediated by the assembled hydrogel samples and illustrate arms of control over rate of release of model fluorescent cargo. SMEPT was not impaired by adhering cells and afforded facile time - and dose - dependent uptake of the in situ generated fluorescent cargo by hepatic cells, HepG2. With the use of a glucuronide derivative of an anticancer drug, SN-38, SMEPT afforded a decrease in cell viability to a level similar to that achieved using parent drug. Finally, dose response was achieved using SMEPT and administration of judiciously chosen concentration of SN-38 glucuronide prodrug thus revealing external control over drug delivery using drug eluting surface. We believe that this highly adaptable concept will find use in diverse biomedical applications, specifically surface mediated drug delivery and tissue engineering.	[Fejerskov, Betina; Zelikin, Alexander N.] Aarhus Univ, Dept Chem, DK-8000 Aarhus, Denmark; [Zelikin, Alexander N.] Aarhus Univ, iNano Interdisciplinary Nanosci Ctr, Aarhus, Denmark	Aarhus University; Aarhus University	Zelikin, AN (corresponding author), Aarhus Univ, Dept Chem, Langelandsgade 140, DK-8000 Aarhus, Denmark.	zelikin@chem.au.dk	Zelikin, Alexander/J-3659-2012	Zelikin, Alexander/0000-0002-9864-321X	Lundbeck Foundation; Danish Council for Independent Research, Technology and Production Sciences, Denmark (ANZ)	Lundbeck Foundation(Lundbeckfonden); Danish Council for Independent Research, Technology and Production Sciences, Denmark (ANZ)	This work was supported by grant from the Lundbeck Foundation and Sapere Aude Starting Grant from the Danish Council for Independent Research, Technology and Production Sciences, Denmark (ANZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JW, 2003, BIOTECHNOL BIOENG, V82, P253, DOI 10.1002/bit.10569; Alves MH, 2011, MACROMOL BIOSCI, V11, P1293, DOI 10.1002/mabi.201100145; Bakina E, 1997, J MED CHEM, V40, P4013, DOI 10.1021/jm970066d; Bhatia SN, 1999, FASEB J, V13, P1883, DOI 10.1096/fasebj.13.14.1883; Bichara DA, 2010, J SURG RES, V163, P331, DOI 10.1016/j.jss.2010.03.070; BOSSLET K, 1994, CANCER RES, V54, P2151; Cao L, 2007, ADV DRUG DELIVER REV, V59, P1340, DOI 10.1016/j.addr.2007.08.012; Chen KC, 2007, CANCER GENE THER, V14, P187, DOI 10.1038/sj.cgt.7700999; Czichocki G, 2001, BIOTECHNOL LETT, V23, P1303, DOI 10.1023/A:1010569322537; de Graaf M, 2002, CURR PHARM DESIGN, V8, P1391; DEAN RT, 1974, BIOCHEM J, V138, P395, DOI 10.1042/bj1380395; Fejerskov B, 2012, ACS APPL MATER INTER, V4, P4981, DOI 10.1021/am3013467; Fukuda J, 2006, BIOMATERIALS, V27, P1479, DOI 10.1016/j.biomaterials.2005.09.015; Groger H, 2001, ORG LETT, V3, P1969, DOI 10.1021/ol015920g; Gulsen D, 2005, CURR EYE RES, V30, P1071, DOI 10.1080/02713680500346633; Haisma HJ, 1998, BLOOD, V92, P184, DOI 10.1182/blood.V92.1.184.413k26_184_190; Hassan CM, 2000, ADV POLYM SCI, V153, P37; Hoare TR, 2008, POLYMER, V49, P1993, DOI 10.1016/j.polymer.2008.01.027; Hosta-Rigau L, 2012, ADV HEALTHC MATER, V1, P791, DOI 10.1002/adhm.201200092; Jensen BEB, 2012, SOFT MATTER, V8, P4625, DOI 10.1039/c2sm07075h; Jensen BEB, 2011, LANGMUIR, V27, P10216, DOI 10.1021/la201595e; Khademhosseini A, 2007, BIOMATERIALS, V28, P5087, DOI 10.1016/j.biomaterials.2007.07.021; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Koutsopoulos S, 2009, P NATL ACAD SCI USA, V106, P4623, DOI 10.1073/pnas.0807506106; Kratz F, 2008, CHEMMEDCHEM, V3, P20, DOI 10.1002/cmdc.200700159; Ladewig K, 2011, EXPERT OPIN DRUG DEL, V8, P1175, DOI 10.1517/17425247.2011.588698; Levental I, 2007, SOFT MATTER, V3, P299, DOI 10.1039/b610522j; Li YL, 2012, CHEM SOC REV, V41, P2193, DOI 10.1039/c1cs15203c; Lin CC, 2006, ADV DRUG DELIVER REV, V58, P1379, DOI 10.1016/j.addr.2006.09.004; Lin CC, 2009, PHARM RES-DORDR, V26, P631, DOI 10.1007/s11095-008-9801-2; Liu SQ, 2010, SOFT MATTER, V6, P67, DOI 10.1039/b916705f; Lo CM, 2000, BIOPHYS J, V79, P144, DOI 10.1016/S0006-3495(00)76279-5; Lozinsky VI, 2003, TRENDS BIOTECHNOL, V21, P445, DOI 10.1016/j.tibtech.2003.08.002; Lozinsky VI, 1997, ENZYME MICROB TECH, V20, P182, DOI 10.1016/S0141-0229(96)00110-X; Mertz D, 2009, NAT MATER, V8, P731, DOI [10.1038/NMAT2504, 10.1038/nmat2504]; NiculescuDuvaz I, 1997, ADV DRUG DELIVER REV, V26, P151, DOI 10.1016/S0169-409X(97)00032-X; Saltzman WM, 2002, NAT REV DRUG DISCOV, V1, P177, DOI 10.1038/nrd744; Seliktar D, 2012, SCIENCE, V336, P1124, DOI 10.1126/science.1214804; Slaughter BV, 2009, ADV MATER, V21, P3307, DOI 10.1002/adma.200802106; Smith AAA, 2012, POLYM CHEM-UK, V3, P85, DOI 10.1039/c1py00429h; Starkey DE, 2001, J CHROMATOGR B, V762, P33, DOI 10.1016/S0378-4347(01)00313-9; Tietze LF, 2009, CHEM BIOL DRUG DES, V74, P205, DOI 10.1111/j.1747-0285.2009.00856.x; Uhrich KE, 1999, CHEM REV, V99, P3181, DOI 10.1021/cr940351u; Vogt C, 2012, ACS MACRO LETT, V1, P797, DOI 10.1021/mz3000896; Wang NX, 2011, MACROMOL BIOSCI, V11, P321, DOI 10.1002/mabi.201000206; Zelikin AN, 2010, ACS NANO, V4, P2494, DOI 10.1021/nn100634r; Zinchenko YS, 2006, TISSUE ENG, V12, P751, DOI 10.1089/ten.2006.12.751; Zustiak SP, 2011, BIOTECHNOL BIOENG, V108, P197, DOI 10.1002/bit.22911	48	20	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49619	10.1371/journal.pone.0049619	http://dx.doi.org/10.1371/journal.pone.0049619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152927	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600050
J	Masumoto, M; Ohde, T; Shiomi, K; Yaginuma, T; Niimi, T				Masumoto, Mika; Ohde, Takahiro; Shiomi, Kunihiro; Yaginuma, Toshinobu; Niimi, Teruyuki			A Baculovirus Immediate-Early Gene, ie1, Promoter Drives Efficient Expression of a Transgene in Both Drosophila melanogaster and Bombyx mori	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; GERM-LINE TRANSFORMATION; PIGGYBAC TRANSPOSABLE ELEMENT; NEUROSECRETORY-CELLS; FRUIT-FLY; VECTOR; MARKER; GFP; SYSTEM; DIFFERENTIATION	Many promoters have been used to drive expression of heterologous transgenes in insects. One major obstacle in the study of non-model insects is the dearth of useful promoters for analysis of gene function. Here, we investigated whether the promoter of the immediate-early gene, ie1, from the Bombyx mori nucleopolyhedrovirus (BmNPV) could be used to drive efficient transgene expression in a wide variety of insects. We used a piggyBac-based vector with a 3xP3-DsRed transformation marker to generate a reporter construct; this construct was used to determine the expression patterns driven by the BmNPV ie1 promoter; we performed a detailed investigation of the promoter in transgene expression pattern in Drosophila melanogaster and in B. mori. Drosophila and Bombyx belong to different insect orders (Diptera and Lepidoptera, respectively); however, and to our surprise, ie1 promoter-driven expression was evident in several tissues (e.g., prothoracic gland, midgut, and tracheole) in both insects. Furthermore, in both species, the ie1 promoter drove expression of the reporter gene from a relatively early embryonic stage, and strong ubiquitous ie1 promoter-driven expression continued throughout the larval, pupal, and adult stages by surface observation. Therefore, we suggest that the ie1 promoter can be used as an efficient expression driver in a diverse range of insect species.	[Masumoto, Mika; Ohde, Takahiro; Yaginuma, Toshinobu; Niimi, Teruyuki] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Masumoto, Mika] Kitasato Univ, Div Biol, Coll Liberal Arts & Sci, Sagamihara, Kanagawa 228, Japan; [Shiomi, Kunihiro] Shinshu Univ, Fac Text Sci & Technol, Ueda, Nagano 386, Japan	Nagoya University; Kitasato University; Shinshu University	Niimi, T (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	niimi@agr.nagoya-u.ac.jp		Niimi, Teruyuki/0000-0003-3981-0177; Ohde, Takahiro/0000-0002-0870-9175	Japan Society for the Promotion of Science [21380041-01]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, grant number 21380041-01 (http://www.jsps.go.jp/english/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Friesen PD, 1997, BACULOVIRUSES, P141; Gehring WJ, 2011, GENOME BIOL EVOL, V3, P1053, DOI 10.1093/gbe/evr061; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; Gonzalez-Estevez C, 2003, P NATL ACAD SCI USA, V100, P14046, DOI 10.1073/pnas.2335980100; Grossman GL, 2001, INSECT MOL BIOL, V10, P597, DOI 10.1046/j.0962-1075.2001.00299.x; GUARINO LA, 1986, J VIROL, V57, P563, DOI 10.1128/JVI.57.2.563-571.1986; Handler AM, 1999, INSECT MOL BIOL, V8, P449, DOI 10.1046/j.1365-2583.1999.00139.x; Handler AM, 2001, INSECT BIOCHEM MOLEC, V31, P199, DOI 10.1016/S0965-1748(00)00119-3; Hara Kimiko, 2008, Journal of Insect Biotechnology and Sericology, V77, P159; Heinrich JC, 2002, INSECT MOL BIOL, V11, P1, DOI 10.1046/j.0962-1075.2001.00301.x; Herniou EA, 2003, ANNU REV ENTOMOL, V48, P211, DOI 10.1146/annurev.ento.48.091801.112756; Horn C, 2002, INSECT BIOCHEM MOLEC, V32, P1221, DOI 10.1016/S0965-1748(02)00085-1; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; HUYBRECHTS R, 1992, BIOCHIM BIOPHYS ACTA, V1129, P328, DOI 10.1016/0167-4781(92)90511-W; Imamura M, 2006, INSECT BIOCHEM MOLEC, V36, P429, DOI 10.1016/j.ibmb.2006.03.002; JARVIS DL, 1990, BIO-TECHNOL, V8, P950, DOI 10.1038/nbt1090-950; Jehle JA, 2006, ARCH VIROL, V151, P1257, DOI 10.1007/s00705-006-0763-6; Kojima K, 2007, VIRUS RES, V130, P202, DOI 10.1016/j.virusres.2007.06.012; KOVACS GR, 1991, J VIROL, V65, P5281, DOI 10.1128/JVI.65.10.5281-5288.1991; Kuwayama H, 2006, INSECT MOL BIOL, V15, P507, DOI 10.1111/j.1365-2583.2006.00665.x; Liu Y, 2006, BIOCHEM BIOPH RES CO, V342, P273, DOI 10.1016/j.bbrc.2006.01.140; LU A, 1997, BACULOVIRUSES, P171; Masumoto M, 2009, DEV GENES EVOL, V219, P437, DOI 10.1007/s00427-009-0305-9; MITSIALIS SA, 1985, NATURE, V317, P453, DOI 10.1038/317453a0; Morita A, 2003, J INSECT PHYSIOL, V49, P1093, DOI 10.1016/j.jinsphys.2003.08.009; Nakamura T, 2010, CURR BIOL, V20, P1641, DOI 10.1016/j.cub.2010.07.044; Ohtsuki Y., 1979, GEN TXB SERICULTURE, P156; Pathakamuri JA, 2002, J VIROL, V76, P5598, DOI 10.1128/JVI.76.11.5598-5604.2002; Peloquin JJ, 2000, INSECT MOL BIOL, V9, P323, DOI 10.1046/j.1365-2583.2000.00194.x; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; REICHHART JM, 1998, DROS INFO SERV, V81, P201; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Sezutsu Hideki, 2009, Journal of Insect Biotechnology and Sericology, V78, P1; Sheng GJ, 1997, GENE DEV, V11, P1122, DOI 10.1101/gad.11.9.1122; Shotkoski F, 1996, FEBS LETT, V380, P257, DOI 10.1016/0014-5793(96)00025-7; Siebert KS, 2008, INSECT BIOCHEM MOLEC, V38, P749, DOI 10.1016/j.ibmb.2008.04.007; Sumitani M, 2003, INSECT BIOCHEM MOLEC, V33, P449, DOI 10.1016/S0965-1748(03)00009-2; Suzuki MG, 2005, EVOL DEV, V7, P58, DOI 10.1111/j.1525-142X.2005.05007.x; Suzuki MG, 2003, DEV GENES EVOL, V213, P345, DOI 10.1007/s00427-003-0334-8; Tamura T, 2000, NAT BIOTECHNOL, V18, P81, DOI 10.1038/71978; Thomas JL, 2002, INSECT BIOCHEM MOLEC, V32, P247, DOI 10.1016/S0965-1748(01)00150-3; Uhlirova M, 2002, DEV GENES EVOL, V212, P145, DOI 10.1007/s00427-002-0221-8; Yamagata T, 2008, ZOOL SCI, V25, P509, DOI 10.2108/zsj.25.509; YOO SH, 1994, VIROLOGY, V202, P746, DOI 10.1006/viro.1994.1396; Zhang HJ, 2002, DEV GROWTH DIFFER, V44, P409, DOI 10.1046/j.1440-169X.2002.00654.x; Zhou YJ, 2002, BIOSCI BIOTECH BIOCH, V66, P1488, DOI 10.1271/bbb.66.1488	47	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49323	10.1371/journal.pone.0049323	http://dx.doi.org/10.1371/journal.pone.0049323			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152896	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600035
J	Stringhini, S; Spencer, B; Marques-Vidal, P; Waeber, G; Vollenweider, P; Paccaud, F; Bovet, P				Stringhini, Silvia; Spencer, Brenda; Marques-Vidal, Pedro; Waeber, Gerard; Vollenweider, Peter; Paccaud, Fred; Bovet, Pascal			Age and Gender Differences in the Social Patterning of Cardiovascular Risk Factors in Switzerland: The CoLaus Study	PLOS ONE			English	Article							HEALTH-RELATED BEHAVIORS; SOCIOECONOMIC INEQUALITIES; EDUCATIONAL INEQUALITIES; EUROPEAN COUNTRIES; PHYSICAL-ACTIVITY; LIFE-STYLE; DISEASE MORTALITY; SWISS POPULATION; NORTHERN-IRELAND; HEART-DISEASE	Objectives: We examined the social distribution of a comprehensive range of cardiovascular risk factors (CVRF) in a Swiss population and assessed whether socioeconomic differences varied by age and gender. Methods: Participants were 2960 men and 3343 women aged 35-75 years from a population-based survey conducted in Lausanne, Switzerland (CoLaus study). Educational level was the indicator of socioeconomic status used in this study. Analyses were stratified by gender and age group (35-54 years; 55-75 years). Results: There were large educational differences in the prevalence of CVRF such as current smoking (Delta = absolute difference in prevalence between highest and lowest educational group: 15.1%/12.6% in men/women aged 35-54 years), physical inactivity (Delta = 25.3%/22.7% in men/women aged 35-54 years), overweight and obesity (Delta = 14.6%/14.8% in men/women aged 55-75 years for obesity), hypertension (Delta = 16.7%/11.4% in men/women aged 55-75 years), dyslipidemia (Delta = 2.8%/6.2% in men/women aged 35-54 years for high LDL-cholesterol) and diabetes (Delta = 6.0%/2.6% in men/women aged 55-75 years). Educational inequalities in the distribution of CVRF were larger in women than in men for alcohol consumption, obesity, hypertension and dyslipidemia (p<0.05). Relative educational inequalities in CVRF tended to be greater among the younger (35-54 years) than among the older age group (55-75 years), particularly for behavioral CVRF and abdominal obesity among men and for physiological CVRF among women (p<0.05). Conclusion: Large absolute differences in the prevalence of CVRF according to education categories were observed in this Swiss population. The socioeconomic gradient in CVRF tended to be larger in women and in younger persons.	[Stringhini, Silvia; Spencer, Brenda; Marques-Vidal, Pedro; Paccaud, Fred; Bovet, Pascal] Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] CHU Vaudois, Dept Med, Lausanne, Switzerland; [Waeber, Gerard; Vollenweider, Peter] Fac Biol & Med, Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Stringhini, S (corresponding author), Univ Lausanne Hosp, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland.	silvia.stringhini@chuv.ch	Stringhini, Silvia/B-4899-2013; paccaud, fred/M-7516-2019; Colaus, PsyColaus/K-6607-2013; Marques-Vidal, Pedro M/C-9449-2009; Bovet, Pascal/F-4477-2011	Marques-Vidal, Pedro M/0000-0002-4548-8500; Bovet, Pascal/0000-0002-0242-4259; Waeber, Gerard/0000-0003-4193-788X	Swiss School of Public Health (SSPH+); GlaxoSmithKline; University Hospital Center; Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss National Science Foundation [33CSCO-122661]; GSK	Swiss School of Public Health (SSPH+); GlaxoSmithKline(GlaxoSmithKline); University Hospital Center; Faculty of Biology and Medicine of Lausanne, Switzerland; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); GSK(GlaxoSmithKline)	SS is supported by a post-doctoral fellowship awarded by the Swiss School of Public Health (SSPH+). PV and GW received an unrestricted grant for GSK to build the CoLaus study. The CoLaus study was supported by research grants from GlaxoSmithKline, the University Hospital Center, the Faculty of Biology and Medicine of Lausanne, Switzerland and the Swiss National Science Foundation (grant no: 33CSCO-122661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GSK provided grants for the CoLaus study. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Bartley M, 2000, J EPIDEMIOL COMMUN H, V54, P806, DOI 10.1136/jech.54.11.806; Borrell C, 2000, J EPIDEMIOL COMMUN H, V54, P24, DOI 10.1136/jech.54.1.24; Cavelaars A E, 1997, J Health Psychol, V2, P353, DOI 10.1177/135910539700200306; Chen WQ, 2008, J OCCUP HEALTH, V50, P262, DOI 10.1539/joh.L7149; Curtin F, 1997, PREV MED, V26, P658, DOI 10.1006/pmed.1997.0187; Danon-Hersch N, 2009, EUR J CARDIOV PREV R, V16, P66, DOI 10.1097/HJR.0b013e32831e9511; De Vogli R, 2005, SOZ PRAVENTIV MED, V50, P197, DOI [10.1007/s00038-004-4025-2, 10.1007/s00038-005-4025-2]; Espelt A, 2008, DIABETOLOGIA, V51, P1971, DOI 10.1007/s00125-008-1146-1; Estoppey D, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-114; Faeh D, 2011, OBES REV, V12, P151, DOI 10.1111/j.1467-789X.2010.00793.x; Faeh D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-567; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; Galobardes B, 2003, AM J PUBLIC HEALTH, V93, P1302, DOI 10.2105/AJPH.93.8.1302; Gaolbardes B, 2003, ANN EPIDEMIOL, V13, P537, DOI 10.1016/S1047-2797(03)00055-3; Graham H, 1996, SOC SCI MED, V43, P243, DOI 10.1016/0277-9536(95)00369-X; HATZIANDREU EJ, 1989, AM J PUBLIC HEALTH, V79, P1020, DOI 10.2105/AJPH.79.8.1020; Huisman M, 2005, TOB CONTROL, V14, P106, DOI 10.1136/tc.2004.008573; IfS UNESCO, 2011, INT STAND CLASS ED; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; KAPLAN GA, 1993, CIRCULATION, V88, P1973, DOI 10.1161/01.CIR.88.4.1973; Khang YH, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-66; Kivimaki M, 2008, LANCET, V372, P1648, DOI 10.1016/S0140-6736(08)61688-8; Lopez AD, 1994, TOB CONTROL, V3, P242, DOI [DOI 10.1136/TC.3.3.242, 10.1136/tc.3.3.242]; Mackenbach JP, 2008, NEW ENGL J MED, V358, P2468, DOI 10.1056/NEJMsa0707519; Mackenbach JP, 2000, EUR HEART J, V21, P1141, DOI 10.1053/euhj.1999.1990; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; MARMOT MG, 1978, BMJ-BRIT MED J, V2, P1109, DOI 10.1136/bmj.2.6145.1109; Marques-Vidal P, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-246; Marques-Vidal P, 2011, J EPIDEMIOL COMMUN H, V65, P281, DOI 10.1136/jech.2009.099424; Marques-Vidal P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-87; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Morabia A, 2005, AM J PUBLIC HEALTH, V95, P632, DOI 10.2105/2004.047877; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; Nedeltchev K, 2005, J NEUROL, V252, P1210, DOI 10.1007/s00415-005-0838-4; OSLER M, 1993, PUBLIC HEALTH, V107, P251, DOI 10.1016/S0033-3506(05)80504-9; Pell JP, 2000, BRIT MED J, V320, P15, DOI 10.1136/bmj.320.7226.15; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Ramsay SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019742; Roos G, 2001, PUBLIC HEALTH NUTR, V4, P35, DOI 10.1079/PHN200048; Roskam AJR, 2010, INT J EPIDEMIOL, V39, P392, DOI 10.1093/ije/dyp329; Schroder H, 2004, EUR J NUTR, V43, P77, DOI 10.1007/s00394-004-0443-9; Sergeant JC, 2006, BIOSTATISTICS, V7, P213, DOI 10.1093/biostatistics/kxj002; Stringhini S, 2010, J AM MED ASS; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; van Lenthe FJ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-125; Wagner A, 2003, EUR J EPIDEMIOL, V18, P321, DOI 10.1023/A:1023625110856; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; WHO Regional Office for Europe, 2007, CHALLENGE OBESITY WH, DOI [10.1186/1479-5868-4-11, DOI 10.1186/1479-5868-4-11]; WILKINSON RG, 1994, DAEDALUS, V123, P61; Woodside JV, 2012, PREV MED, V54, P247, DOI 10.1016/j.ypmed.2012.01.017; World Bank, 2022, WORLD DEV IND; Zimmermann-Sloutskis D, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-2; Zins M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026531	54	35	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49443	10.1371/journal.pone.0049443	http://dx.doi.org/10.1371/journal.pone.0049443			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039HF	23152909	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234600040
J	da Costa, DCF; Casanova, FA; Quarti, J; Malheiros, MS; Sanches, D; dos Santos, PS; Fialho, E; Silva, JL				Ferraz da Costa, Danielly Cristiny; Casanova, Fabiana Alves; Quarti, Julia; Malheiros, Maite Santos; Sanches, Daniel; dos Santos, Patricia Souza; Fialho, Eliane; Silva, Jerson L.			Transient Transfection of a Wild-Type p53 Gene Triggers Resveratrol-Induced Apoptosis in Cancer Cells	PLOS ONE			English	Article							MOLECULAR-MECHANISM; MUTANT P53; PROLIFERATION; INHIBITOR; EXPRESSION; GROWTH; MCF-7; PHOSPHORYLATION; CHEMOPREVENTION; ANGIOGENESIS	Resveratrol is a promising chemopreventive agent that mediates many cellular targets involved in cancer signaling pathways. p53 has been suggested to play a role in the anticancer properties of resveratrol. We investigated resveratrol-induced cytotoxicity in H1299 cells, which are non-small lung cancer cells that have a partial deletion of the gene that encodes the p53 protein. The results for H1299 cells were compared with those for three cell lines that constitutively express wild-type p53: breast cancer MCF-7, adenocarcinomic alveolar basal epithelia A549 and non-small lung cancer H460. Cell viability assays revealed that resveratrol reduced the viability of all four of these cell lines in a dose- and time-dependent manner. MCF-7, A549 and H460 cells were more sensitive to resveratrol than were H1299 cells when exposed to the drug for 24 h at concentrations above 100 mu M. Resveratrol also increased the p53 protein levels in MCF-7 cells without altering the p53 mRNA levels, suggesting a post-translational modulation of the protein. The resveratrol-induced cytotoxicity in these cells was partially mediated by p53 and involved the activation of caspases 9 and 7 and the cleavage of PARP. In H1299 cells, resveratrol-induced cytotoxicity was less pronounced and (in contrast to MCF-7 cells) cell death was not accompanied by caspase activation. These findings are consistent with the observation that MCF-7 cells were positively labeled by TUNEL following exposure to 100 mu M resveratrol whereas H1299 cells under similar conditions were not labeled by TUNEL. The transient transfection of a wild-type p53-GFP gene caused H1299 cells to become more responsive to the pro-apoptotic properties of resveratrol, similarly to findings in the p53-positive MCF-7 cells. Our results suggest a possible therapeutic strategy based on the use of resveratrol for the treatment of tumors that are typically unresponsive to conventional therapies because of the loss of normal p53 function.	[Ferraz da Costa, Danielly Cristiny; Casanova, Fabiana Alves; Malheiros, Maite Santos; Sanches, Daniel; dos Santos, Patricia Souza; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil; [Ferraz da Costa, Danielly Cristiny; Malheiros, Maite Santos; Sanches, Daniel; dos Santos, Patricia Souza; Silva, Jerson L.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Casanova, Fabiana Alves; Quarti, Julia; Fialho, Eliane] Univ Fed Rio de Janeiro, Inst Nutr Josue de Castro, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Silva, JL (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Rio De Janeiro, Brazil.	jerson@bioqmed.ufrj.br	Silva, Jerson/J-8984-2014; Fialho, Eliane/AAF-8856-2019; SILVA, JERSON Lima/GRF-1442-2022	Silva, Jerson/0000-0001-9523-9441; SILVA, JERSON Lima/0000-0001-9523-9441	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ); Fundacao do Cancer of Brazil	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao do Cancer of Brazil	This work was funded by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa Carlos Chagas Filho do Estado do Rio de Janeiro (FAPERJ); and Fundacao do Cancer of Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bom APDA, 2010, J BIOL CHEM, V285, P2857, DOI 10.1074/jbc.M109.075861; Baarine M, 2011, GENES NUTR, V6, P161, DOI 10.1007/s12263-011-0232-z; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Bielawski K, 2006, BIOCHEM PHARMACOL, V72, P320, DOI 10.1016/j.bcp.2006.04.028; Bom APDA, 2012, J BIOL CHEM, V287, P28152, DOI 10.1074/jbc.M112.340638; Brown CJ, 2009, NAT REV CANCER, V9, P862, DOI 10.1038/nrc2763; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Casanova F, 2012, J CELL BIOCHEM, V113, P2586, DOI 10.1002/jcb.24134; Davis CD, 2010, SEMIN ONCOL, V37, P243, DOI 10.1053/j.seminoncol.2010.05.001; De Amicis F, 2011, FASEB J, V25, P3695, DOI 10.1096/fj.10-178871; Dong ZG, 2003, MUTAT RES-FUND MOL M, V523, P145, DOI 10.1016/S0027-5107(02)00330-5; Fimia GM, 2011, PLOS ONE, V6; Fujimoto A, 2009, BASIC CLIN PHARMACOL, V104, P455, DOI 10.1111/j.1742-7843.2009.00386.x; Garvin S, 2006, CANCER LETT, V231, P113, DOI 10.1016/j.canlet.2005.01.031; Gatz SA, 2008, CARCINOGENESIS, V29, P519, DOI 10.1093/carcin/bgm283; Gogada R, 2011, J BIOL CHEM, V286, P28749, DOI 10.1074/jbc.M110.202440; Hong WK, 1997, SCIENCE, V278, P1073, DOI 10.1126/science.278.5340.1073; Hsieh TC, 2005, BIOCHEM BIOPH RES CO, V334, P223, DOI 10.1016/j.bbrc.2005.06.073; Huang CS, 1999, CARCINOGENESIS, V20, P237, DOI 10.1093/carcin/20.2.237; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Joe AK, 2002, CLIN CANCER RES, V8, P893; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Kundu JK, 2008, CANCER LETT, V269, P243, DOI 10.1016/j.canlet.2008.03.057; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; Lang FF, 2003, J CLIN ONCOL, V21, P2508, DOI 10.1200/JCO.2003.21.13.2508; Li GW, 2011, PHYTOMEDICINE, V18, P704, DOI 10.1016/j.phymed.2010.11.015; Li Y, 2009, EUR J PHARMACOL, V609, P13, DOI 10.1016/j.ejphar.2009.03.004; Lin HY, 2006, FASEB J, V20, P1742, DOI 10.1096/fj.06-5743fje; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahyar-Roemer M, 2001, ONCOGENE, V20, P3387, DOI 10.1038/sj.onc.1204440; Mahyar-Roemer M, 2001, INT J CANCER, V94, P615, DOI 10.1002/ijc.1516; Mann JR, 2005, NAT CLIN PRACT ONCOL, V2, P202, DOI 10.1038/ncponc0140; Marcellus RC, 1996, CELL GROWTH DIFFER, V7, P1643; Marcsek ZL, 2007, CELL BIOL INT, V31, P1214, DOI 10.1016/j.cellbi.2007.01.039; Niles RM, 2003, CANCER LETT, V190, P157, DOI 10.1016/S0304-3835(02)00676-6; Pan MH, 2010, J AGR FOOD CHEM, V58, P226, DOI 10.1021/jf903067g; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Pezzuto JM, 2008, PHARM BIOL, V46, P443, DOI 10.1080/13880200802116610; Pozo-Guisado E, 2002, BIOCHEM PHARMACOL, V64, P1375, DOI 10.1016/S0006-2952(02)01296-0; Reagan-Shaw S, 2008, PHOTOCHEM PHOTOBIOL, V84, P415, DOI 10.1111/j.1751-1097.2007.00279.x; Saiko P, 2008, MUTAT RES-REV MUTAT, V658, P68, DOI 10.1016/j.mrrev.2007.08.004; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; She QB, 2001, CANCER RES, V61, P1604; Shih A, 2002, J CLIN ENDOCR METAB, V87, P1223, DOI 10.1210/jc.87.3.1223; Shih A, 2001, BIOCHEMISTRY-US, V40, P2870, DOI 10.1021/bi001978b; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Silva JL, 2010, ACCOUNTS CHEM RES, V43, P271, DOI 10.1021/ar900179t; Soussi T, 2005, BIOCHEM BIOPH RES CO, V331, P834, DOI 10.1016/j.bbrc.2005.03.190; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Thomasset SC, 2007, INT J CANCER, V120, P451, DOI 10.1002/ijc.22419; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Weng CJ, 2010, J AGR FOOD CHEM, V58, P2886, DOI 10.1021/jf904182y; Zahid M, 2008, FREE RADICAL BIO MED, V45, P136, DOI 10.1016/j.freeradbiomed.2008.03.017	54	26	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48746	10.1371/journal.pone.0048746	http://dx.doi.org/10.1371/journal.pone.0048746			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152798	Green Submitted, gold, Green Published			2022-12-27	WOS:000311234000027
J	Briesemeister, S; Rahnenfuhrer, J; Kohlbacher, O				Briesemeister, Sebastian; Rahnenfuehrer, Joerg; Kohlbacher, Oliver			No Longer Confidential: Estimating the Confidence of Individual Regression Predictions	PLOS ONE			English	Article							APPLICABILITY DOMAIN; TRAINING SET; RELIABILITY; QSAR; MOLECULES	Quantitative predictions in computational life sciences are often based on regression models. The advent of machine learning has led to highly accurate regression models that have gained widespread acceptance. While there are statistical methods available to estimate the global performance of regression models on a test or training dataset, it is often not clear how well this performance transfers to other datasets or how reliable an individual prediction is-a fact that often reduces a user's trust into a computational method. In analogy to the concept of an experimental error, we sketch how estimators for individual prediction errors can be used to provide confidence intervals for individual predictions. Two novel statistical methods, named CONFINE and CONFIVE, can estimate the reliability of an individual prediction based on the local properties of nearby training data. The methods can be applied equally to linear and non-linear regression methods with very little computational overhead. We compare our confidence estimators with other existing confidence and applicability domain estimators on two biologically relevant problems (MHC-peptide binding prediction and quantitative structure-activity relationship (QSAR)). Our results suggest that the proposed confidence estimators perform comparable to or better than previously proposed estimation methods. Given a sufficient amount of training data, the estimators exhibit error estimates of high quality. In addition, we observed that the quality of estimated confidence intervals is predictable. We discuss how confidence estimation is influenced by noise, the number of features, and the dataset size. Estimating the confidence in individual prediction in terms of error intervals represents an important step from plain, non-informative predictions towards transparent and interpretable predictions that will help to improve the acceptance of computational methods in the biological community.	[Briesemeister, Sebastian; Kohlbacher, Oliver] Univ Tubingen, Appl Bioinformat Grp, Ctr Bioinformat, Dept Comp Sci, D-72074 Tubingen, Germany; [Rahnenfuehrer, Joerg] TU Dortmund, Dept Stat, Dortmund, Germany	Eberhard Karls University of Tubingen; Dortmund University of Technology	Briesemeister, S (corresponding author), Univ Tubingen, Appl Bioinformat Grp, Ctr Bioinformat, Dept Comp Sci, D-72074 Tubingen, Germany.	briese@informatik.uni-tuebingen.de	Kohlbacher, Oliver/AAF-3297-2021; Kohlbacher, Oliver/B-7310-2008	Kohlbacher, Oliver/0000-0003-1739-4598; Kohlbacher, Oliver/0000-0003-1739-4598; Rahnenfuhrer, Jorg/0000-0002-8947-440X	LGFG Promotionsverbund "Pflanzliche Sensorhistidinkinasen"; Deutsche Forschungsgemeinschaft [SPP 1335]	LGFG Promotionsverbund "Pflanzliche Sensorhistidinkinasen"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	SB gratefully acknowledges financial support from LGFG Promotionsverbund "Pflanzliche Sensorhistidinkinasen" and Deutsche Forschungsgemeinschaft (SPP 1335). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosnic Z, 2008, APPL INTELL, V29, P187, DOI 10.1007/s10489-007-0084-9; Bosnic Z, 2010, KNOWL ENG REV, V25, P27, DOI 10.1017/S0269888909990154; Bosnic Z, 2008, DATA KNOWL ENG, V67, P504, DOI 10.1016/j.datak.2008.08.001; Bosnic Z, 2009, INTELL DATA ANAL, V13, P385, DOI 10.3233/IDA-2009-0371; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Briesemeister S, 2010, BIOINFORMATICS, V26, P1232, DOI 10.1093/bioinformatics/btq115; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimitrov S, 2005, J CHEM INF MODEL, V45, P839, DOI 10.1021/ci0500381; FRIEDMAN JH, 1991, ANN STAT, V19, P1, DOI 10.1214/aos/1176347963; Heskes T, 1997, ADV NEUR IN, V9, P176; Horvath D, 2009, J CHEM INF MODEL, V49, P1762, DOI 10.1021/ci9000579; Jaworska J, 2005, ATLA-ALTERN LAB ANIM, V33, P445, DOI 10.1177/026119290503300508; Obozinski G, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s6; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Sheridan RP, 2004, J CHEM INF COMP SCI, V44, P1912, DOI 10.1021/ci049782w; Sutherland JJ, 2004, J MED CHEM, V47, P5541, DOI 10.1021/jm0497141; Talete srl, 2007, DRAGONX 1 4 MOL DESC	17	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48723	10.1371/journal.pone.0048723	http://dx.doi.org/10.1371/journal.pone.0048723			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166592	gold, Green Submitted, Green Published			2022-12-27	WOS:000311272300013
J	Spinozzi, F; Mariani, P; Micetic, I; Ferrero, C; Pontoni, D; Beltramini, M				Spinozzi, Francesco; Mariani, Paolo; Micetic, Ivan; Ferrero, Claudio; Pontoni, Diego; Beltramini, Mariano			Quaternary Structure Heterogeneity of Oligomeric Proteins: A SAXS and SANS Study of the Dissociation Products of Octopus vulgaris Hemocyanin	PLOS ONE			English	Article							X-RAY-SCATTERING; RAPANA-VENOSA HEMOCYANIN; CONFORMATIONAL TRANSITIONS; FUNCTIONAL UNITS; LIGHT-SCATTERING; MOLECULAR-MODEL; STABILITY; OXYGEN; SUBUNITS; MICROSCOPY	Octopus vulgaris hemocyanin shows a particular self-assembling pattern, characterized by a hierarchical organization of monomers. The highest molecular weight aggregate is a decamer, the stability of which in solution depends on several parameters. Different pH values, buffer compositions, H2O/D2O ratios and Hofmeister's salts result in modifications of the aggregation state of Octopus vulgaris hemocyanin. The new QUAFIT method, recently applied to derive the structure of the decameric and the monomeric assembly from small-angle scattering data, is used here to model the polydisperse system that results from changing the solution conditions. A dataset of small-angle X-rays and neutron scattering curves is analysed by QUAFIT to derive structure, composition and concentration of different assemblies present in solution. According to the hierarchy of the association/dissociation processes and the possible number of different aggregation products in solution, each sample has been considered as a heterogeneous mixture composed of the entire decamer, the dissociated "loose" monomer and all the intermediate dissociation products. Scattering curves corresponding to given experimental conditions are well fitted by using a linear combination of single particle form factors. QUAFIT has proved to be a method of general validity to describe solutions of proteins that, even after purification processes, result to be intrinsically heterogeneous.	[Spinozzi, Francesco; Mariani, Paolo] Marche Polytech Univ, Dept Life & Environm Sci, Ancona, Italy; [Spinozzi, Francesco; Mariani, Paolo] CNISM, Ancona, Italy; [Micetic, Ivan; Beltramini, Mariano] Univ Padua, Dept Biol, Padua, Italy; [Ferrero, Claudio; Pontoni, Diego] European Synchrotron Radiat Facil, F-38043 Grenoble, France	Marche Polytechnic University; University of Padua; European Synchrotron Radiation Facility (ESRF)	Spinozzi, F (corresponding author), Marche Polytech Univ, Dept Life & Environm Sci, Ancona, Italy.	f.spinozzi@univpm.it; mariano.beltramini@unipd.it	Mariani, Paolo/F-4090-2015; Mičetić, Ivan/A-7146-2015; Mariani, Paolo/R-2210-2019; Spinozzi, Francesco/P-2991-2015	Mariani, Paolo/0000-0003-4293-1009; Mičetić, Ivan/0000-0003-1691-8425; Mariani, Paolo/0000-0003-4293-1009; Spinozzi, Francesco/0000-0002-0693-5582				BROUWER M, 1981, BIOCHEMISTRY-US, V20, P1842, DOI 10.1021/bi00510a020; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; Decker H, 2007, INTEGR COMP BIOL, V47, P631, DOI 10.1093/icb/icm063; Dolashka P, 1996, BIOCHEM J, V315, P139, DOI 10.1042/bj3150139; Dolashka-Angelova P, 2003, BBA-PROTEINS PROTEOM, V1646, P77, DOI 10.1016/S1570-9639(02)00549-6; Dolashki A, 2008, BBA-PROTEINS PROTEOM, V1784, P1617, DOI 10.1016/j.bbapap.2008.06.004; Favilla R, 1998, BBA-PROTEIN STRUCT M, V1385, P115, DOI 10.1016/S0167-4838(98)00037-5; FETLER L, 1995, J MOL BIOL, V251, P243, DOI 10.1006/jmbi.1995.0432; Gatsogiannis C, 2007, J MOL BIOL, V374, P465, DOI 10.1016/j.jmb.2007.09.036; Gatsogiannis C, 2009, J MOL BIOL, V385, P963, DOI 10.1016/j.jmb.2008.10.080; Georgieva D, 2005, BIOPHYS J, V88, P1276, DOI 10.1529/biophysj.104.048066; Hartmann H, 2004, METHOD ENZYMOL, V379, P81; Hartmann H, 2004, J BIOL CHEM, V279, P2841, DOI 10.1074/jbc.M308959200; Hartmann H, 2002, BBA-PROTEINS PROTEOM, V1601, P132, DOI 10.1016/S1570-9639(02)00459-4; Hartmann H, 2001, J BIOL CHEM, V276, P19954, DOI 10.1074/jbc.M010435200; HERSKOVITS TT, 1988, COMP BIOCHEM PHYS B, V91, P597, DOI 10.1016/0305-0491(88)90179-4; Hirota S, 2010, J BIOL CHEM, V285, P19338, DOI 10.1074/jbc.M109.076067; HLang W, 1991, PNAS, V88, P244; Hura GL, 2009, NAT METHODS, V6, P606, DOI 10.1038/nmeth.1353; Jasnin M, 2008, EUR BIOPHYS J BIOPHY, V37, P613, DOI 10.1007/s00249-008-0281-4; Jensen MH, 2010, J SYNCHROTRON RADIAT, V17, P769, DOI 10.1107/S0909049510030372; Lafleur JP, 2011, J APPL CRYSTALLOGR, V44, P1090, DOI 10.1107/S0021889811030068; LAMBRIGHT DG, 1991, CHEM PHYS, V158, P249, DOI 10.1016/0301-0104(91)87069-8; Levy ED, 2006, PLOS COMPUT BIOL, V2, P1395, DOI 10.1371/journal.pcbi.0020155; Lieb B, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-14; MAKHATADZE GI, 1995, NAT STRUCT BIOL, V2, P852, DOI 10.1038/nsb1095-852; Meissner U, 2007, MICRON, V38, P754, DOI 10.1016/j.micron.2006.11.005; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; Press WH, 1994, NUMERICAL RECIPIES A; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Spinozzi F, 2005, ARCH BIOCHEM BIOPHYS, V439, P42, DOI 10.1016/j.abb.2005.05.005; Spinozzi F, 2012, BIOPHYS J, V103, P511, DOI 10.1016/j.bpj.2012.06.037; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; van Holde K.E., 1992, Advances in Comparative and Environmental Physiology, V13, P257; VANHOLDE KE, 1991, J MOL BIOL, V217, P307, DOI 10.1016/0022-2836(91)90545-H; vanHolde KE, 1995, ADV PROTEIN CHEM, V47, P1, DOI 10.1016/S0065-3233(08)60545-8	36	13	13	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49644	10.1371/journal.pone.0049644	http://dx.doi.org/10.1371/journal.pone.0049644			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166737	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300061
J	Lentini, PE; Gibbons, P; Fischer, J; Law, B; Hanspach, J; Martin, TG				Lentini, Pia E.; Gibbons, Philip; Fischer, Joern; Law, Brad; Hanspach, Jan; Martin, Tara G.			Bats in a Farming Landscape Benefit from Linear Remnants and Unimproved Pastures	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; NEW-SOUTH-WALES; LONG-EARED BAT; NYCTOPHILUS-GEOFFROYI; CHALINOLOBUS-GOULDII; INSECTIVOROUS BATS; POPULATION ECOLOGY; CONSERVATION; HABITAT; AUSTRALIA	Schemes designed to make farming landscapes less hostile to wildlife have been questioned because target taxa do not always respond in the expected manner. Microbats are often overlooked in this process, yet persist in agricultural landscapes and exert top-down control of crop pests. We investigated the relationship between microbats and measures commonly incorporated into agri-environment schemes, to derive management recommendations for their ongoing conservation. We used acoustic detectors to quantify bat species richness, activity, and feeding in 32 linear remnants and adjacent fields across an agricultural region of New South Wales, Australia. Nocturnal arthropods were simultaneously trapped using black-light traps. We recorded 91,969 bat calls, 17,277 of which could be attributed to one of the 13 taxa recorded, and 491 calls contained feeding buzzes. The linear remnants supported higher bat activity than the fields, but species richness and feeding activity did not significantly differ. We trapped a mean 87.6 g (+/- 17.6 g SE) of arthropods per night, but found no differences in biomass between land uses. Wider linear remnants with intact native vegetation supported more bat species, as did those adjacent to unsealed, as opposed to sealed roads. Fields of unimproved native pastures, with more retained scattered trees and associated hollows and logs, supported the greatest bat species richness and activity. We conclude that the juxtaposition of linear remnants of intact vegetation and scattered trees in fields, coupled with less-intensive land uses such as unimproved pastures will benefit bat communities in agricultural landscapes, and should be incorporated into agri-environment schemes. In contrast, sealed roads may act as a deterrent. The "wildlife friendly farming'' vs "land sparing'' debate has so far primarily focussed on birds, but here we have found evidence that the integration of both approaches could particularly benefit bats.	[Lentini, Pia E.; Gibbons, Philip] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia	Australian National University	Lentini, PE (corresponding author), Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia.	pia.lentini@unimelb.edu.au	Gibbons, Philip/I-8248-2012; Martin, Tara/M-1897-2016; Lentini, Pia/H-3254-2019; Fischer, Joern/C-6625-2012; Fischer, Joern/W-5380-2019	Martin, Tara/0000-0001-7165-9812; Fischer, Joern/0000-0003-3187-8978; Hanspach, Jan/0000-0002-6638-8699; Law, Bradley/0000-0002-3991-3865; Lentini, Pia/0000-0002-3520-3460				Adams MD, 2010, ACTA CHIROPTEROL, V12, P231, DOI 10.3161/150811010X504725; Adams MD, 2005, WILDLIFE RES, V32, P173, DOI 10.1071/WR04060; Brigham RM, 1997, CAN J ZOOL, V75, P131, DOI 10.1139/z97-017; Downs NC, 2006, ACTA CHIROPTEROL, V8, P169, DOI 10.3161/1733-5329(2006)8[169:TUBBOH]2.0.CO;2; Fischer J, 2010, P NATL ACAD SCI USA, V107, P19597, DOI 10.1073/pnas.1008476107; Fischer J, 2010, BIOL CONSERV, V143, P1564, DOI 10.1016/j.biocon.2010.03.030; Fuentes-Montemayor E, 2011, BIOL CONSERV, V144, P2233, DOI 10.1016/j.biocon.2011.05.015; Gibson M., 2003, AUSTRALASIAN BAT SOC, V20, P24; Green RE, 2005, SCIENCE, V307, P550, DOI 10.1126/science.1106049; Hanspach J, 2012, J APPL ECOL, V49, P842, DOI 10.1111/j.1365-2664.2012.02159.x; Kalka MB, 2008, SCIENCE, V320, P71, DOI 10.1126/science.1153352; Kerth G., 2009, BIOL CONSERV, V142, P270, DOI DOI 10.1016/j.biocon.2008.10.022; Kleijn D, 2003, J APPL ECOL, V40, P947, DOI 10.1111/j.1365-2664.2003.00868.x; Kleijn D, 2001, NATURE, V413, P723, DOI 10.1038/35099540; Landsberg J., 1990, Proceedings of the Ecological Society of Australia, V16, P149; Larson DJ, 2000, ACTA CHIROPTEROL, V2, P209; Law BS, 2006, BIOL CONSERV, V133, P236, DOI 10.1016/j.biocon.2006.06.016; Law BS, 2011, WILDLIFE RES, V38, P173, DOI 10.1071/WR10204; Law BS, 2000, AUSTRAL ECOL, V25, P352, DOI 10.1046/j.1442-9993.2000.01046.x; Lee YF, 2005, J MAMMAL, V86, P67, DOI 10.1644/1545-1542(2005)086&lt;0067:DVOBFB&gt;2.0.CO;2; Lentini Pia, 2011, Ecological Management & Restoration, V12, P148, DOI 10.1111/j.1442-8903.2011.00585.x; Lentini Pia E., 2011, Ecological Management & Restoration, V12, P119, DOI 10.1111/j.1442-8903.2011.00591.x; Leon MC, 2006, AGROFOREST SYST, V68, P15, DOI 10.1007/s10457-005-5831-5; Lumsden LF, 2005, BIOL CONSERV, V122, P205, DOI 10.1016/j.biocon.2004.07.006; Lumsden LF, 2002, BIOL CONSERV, V106, P237, DOI 10.1016/S0006-3207(01)00250-6; Lumsden LF, 2002, J ZOOL, V257, P207, DOI 10.1017/S095283690200081X; Lundy M, 2010, EUR J WILDLIFE RES, V56, P385, DOI 10.1007/s10344-009-0330-z; LUNNEY D, 1988, AUST WILDLIFE RES, V15, P375; Martin TG, 2006, BIOL CONSERV, V127, P201, DOI 10.1016/j.biocon.2005.08.014; Mortelliti A, 2010, OECOLOGIA, V163, P535, DOI 10.1007/s00442-010-1623-3; Murray SW, 2004, J ZOOL, V262, P197, DOI 10.1017/S0952836903004503; Ozolins Amanda, 2001, Pacific Conservation Biology, V7, P195; Phalan B, 2011, SCIENCE, V333, P1289, DOI 10.1126/science.1208742; Pressey RL, 2000, BIOL CONSERV, V96, P55, DOI 10.1016/S0006-3207(00)00050-1; Rainho A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019227; Ransome R., 1990, NATURAL HIST HIBERNA; Rayner L, 2008, VARIATION TREE HOLLO; Russ JM, 2002, BIOL CONSERV, V108, P49, DOI 10.1016/S0006-3207(02)00089-7; Russo D, 2002, BIOL CONSERV, V107, P71, DOI 10.1016/S0006-3207(02)00047-2; Saikia U, 2007, RESONANCE, V12, P63, DOI 10.1007/s12045-007-0115-1; Threlfall CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038800; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; TUTTLE MD, 1976, ECOLOGY, V57, P587, DOI 10.2307/1936443; van der Ree R, 2002, WILDLIFE RES, V29, P329, DOI 10.1071/WR01095; Vickery JA, 2004, BIOL CONSERV, V119, P19, DOI 10.1016/j.biocon.2003.06.004; Webala PW, 2011, J APPL ECOL, V48, P398, DOI 10.1111/j.1365-2664.2010.01934.x; Weinberg A, 2011, BIOL CONSERV, V144, P227, DOI 10.1016/j.biocon.2010.08.020; Wickramasinghe LP, 2003, J APPL ECOL, V40, P984, DOI 10.1111/j.1365-2664.2003.00856.x; Zuur Alain F., 2009, P1	49	48	49	2	128	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48201	10.1371/journal.pone.0048201	http://dx.doi.org/10.1371/journal.pone.0048201			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155378	gold, Green Published			2022-12-27	WOS:000311151900012
J	Li, T; Du, J; Yu, SY; Jiang, HF; Fu, YM; Wang, DX; Sun, HM; Chen, HH; Zhao, M				Li, Ting; Du, Jiang; Yu, Shunying; Jiang, Haifeng; Fu, Yingmei; Wang, Dongxiang; Sun, Haiming; Chen, Hanhui; Zhao, Min			Pathways to Age of Onset of Heroin Use: A Structural Model Approach Exploring the Relationship of the COMT Gene, Impulsivity and Childhood Trauma	PLOS ONE			English	Article							SUBSTANCE USE; SEXUAL-ABUSE; 11TH VERSION; SCALE; RISK; OUTCOMES	Background: The interaction of the association of dopamine genes, impulsivity and childhood trauma with substance abuse remains unclear. Objectives: To clarify the impacts and the interactions of the Catechol -O-methyltransferase (COMT) gene, impulsivity and childhood trauma on the age of onset of heroin use among heroin dependent patients in China. Methods: 202 male and 248 female inpatients who meet DSM-IV criteria of heroin dependence were enrolled. Impulsivity and childhood trauma were measured using BIS-11 (Barratt Impulsiveness Scale-11) and ETISR-SF (Early Trauma Inventory Self Report-Short Form). The single nucleotide polymorphism (SNP) rs737866 on the COMT gene-which has previously been associated with heroin abuse, was genotyped using a DNA sequence detection system. Structural equations model was used to assess the interaction paths between these factors and the age of onset of heroin use. Principal Findings: Chi-square test indicated the individuals with TT allele have earlier age of onset of heroin use than those with CT or CC allele. In the correlation analysis, the severity of childhood trauma was positively correlated to impulsive score, but both of them were negatively related to the age of onset of heroin use. In structure equation model, both the COMT gene and childhood trauma had impacts on the age of onset of heroin use directly or via impulsive personality. Conclusions: Our findings indicated that the COMT gene, impulsive personality traits and childhood trauma experience were interacted to impact the age of onset of heroin use, which play a critical role in the development of heroin dependence. The impact of environmental factor was greater than the COMT gene in the development of heroin dependence.	[Li, Ting; Du, Jiang; Yu, Shunying; Jiang, Haifeng; Fu, Yingmei; Wang, Dongxiang; Sun, Haiming; Chen, Hanhui; Zhao, Min] Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Li, T (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Mental Hlth Ctr, Shanghai 200030, Peoples R China.	drminzhao@gmail.com	Fu, Yingmei/AAN-1675-2021	Li, Ting/0000-0002-8408-2482	FIC NIH HHS [R01 TW007279, R01TW007279] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R01TW007279] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Babovic D, 2007, BEHAV BRAIN RES, V183, P236, DOI 10.1016/j.bbr.2007.07.006; Bayle FJ, 2000, CAN J PSYCHIAT, V45, P156, DOI 10.1177/070674370004500206; Berke JD, 2000, NEURON, V25, P515, DOI 10.1016/S0896-6273(00)81056-9; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Bremner JD, 2007, J NERV MENT DIS, V195, P211, DOI 10.1097/01.nmd.0000243824.84651.6c; Bremner JD, 2000, DEPRESS ANXIETY, V12, P1, DOI 10.1002/1520-6394(2000)12:1<1::AID-DA1>3.0.CO;2-W; Dube SR, 2003, PEDIATRICS, V111, P564, DOI 10.1542/peds.111.3.564; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; Kollins SH, 2003, ADDICT BEHAV, V28, P1167, DOI 10.1016/S0306-4603(02)00220-4; Kreek MJ, 2005, NAT NEUROSCI, V8, P1450, DOI 10.1038/nn1583; Moeller FG, 2002, DRUG ALCOHOL DEPEN, V68, P105; Narvaez JCM, 2012, COMPR PSYCHIAT, V53, P238, DOI 10.1016/j.comppsych.2011.04.058; Patkar AA, 2004, J ADDICT DIS, V23, P93, DOI 10.1300/J069v23n01_08; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Peltan JR, 2011, J SUBST ABUSE TREAT, V41, P215, DOI 10.1016/j.jsat.2011.03.004; Perroud N, 2010, GENES BRAIN BEHAV, V9, P193, DOI 10.1111/j.1601-183X.2009.00547.x; Read J, 2005, ACTA PSYCHIAT SCAND, V112, P330, DOI 10.1111/j.1600-0447.2005.00634.x; Sansone Randy A, 2002, Violence Vict, V17, P49, DOI 10.1891/vivi.17.1.49.33636; Savitz J, 2010, BEHAV GENET, V40, P415, DOI 10.1007/s10519-009-9323-7; Silberg J, 2003, J CHILD PSYCHOL PSYC, V44, P664, DOI 10.1111/1469-7610.00153; Someya T, 2001, PSYCHIAT CLIN NEUROS, V55, P111, DOI 10.1046/j.1440-1819.2001.00796.x; Tarter RE, 2003, AM J PSYCHIAT, V160, P1078, DOI 10.1176/appi.ajp.160.6.1078; Ting L, 2011, PLOS ONE, V6; Tyler KA, 2003, J RES ADOLESCENCE, V13, P457, DOI 10.1046/j.1532-7795.2003.01304003.x; Tyler KA, 2002, AGGRESS VIOLENT BEH, V7, P567, DOI 10.1016/S1359-1789(01)00047-7; Wall A. M, 2000, ALCOHOLISM TREATMENT, V18, P49, DOI [10.1300/J020v18n03_05, DOI 10.1300/J020V18N03_05]; [王振 WANG Zhen], 2008, [中国行为医学科学, Chinese Journal of Behavioral Medical Science], V17, P956; Wanger S, 2010, ACTA PSYCHIAT SCAND, V122, P110; Yao SQ, 2007, PERCEPT MOTOR SKILL, V104, P1169, DOI 10.2466/PMS.104.4.1169-1182	29	22	24	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48735	10.1371/journal.pone.0048735	http://dx.doi.org/10.1371/journal.pone.0048735			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155402	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900036
J	Moodley, A; Espinosa-Gongora, C; Nielsen, SS; McCarthy, AJ; Lindsay, JA; Guardabassi, L				Moodley, Arshnee; Espinosa-Gongora, Carmen; Nielsen, Soren S.; McCarthy, Alex J.; Lindsay, Jodi A.; Guardabassi, Luca			Comparative Host Specificity of Human- and Pig-Associated Staphylococcus aureus Clonal Lineages	PLOS ONE			English	Article							FELINE CORNEOCYTES; GENETIC-VARIATION; VETERINARY STAFF; STRAINS; ADHERENCE; CANINE; ADAPTATION; CARRIAGE; ADHESION; INSIGHTS	Bacterial adhesion is a crucial step in colonization of the skin. In this study, we investigated the differential adherence to human and pig corneocytes of six Staphylococcus aureus strains belonging to three human-associated [ST8 (CC8), ST22 (CC22) and ST36(CC30)] and two pig-associated [ST398 (CC398) and ST433(CC30)] clonal lineages, and their colonization potential in the pig host was assessed by in vivo competition experiments. Corneocytes were collected from 11 humans and 21 pigs using D-squame (R) adhesive discs, and bacterial adherence to corneocytes was quantified by a standardized light microscopy assay. A previously described porcine colonization model was used to assess the potential of the six strains to colonize the pig host. Three pregnant, S. aureus-free sows were inoculated intravaginally shortly before farrowing with different strain mixes [mix 1) human and porcine ST398; mix 2) human ST36 and porcine ST433; and mix 3) human ST8, ST22, ST36 and porcine ST398] and the ability of individual strains to colonize the nasal cavity of newborn piglets was evaluated for 28 days after birth by strain-specific antibiotic selective culture. In the corneocyte assay, the pig-associated ST433 strain and the human-associated ST22 and ST36 strains showed significantly greater adhesion to porcine and human corneocytes, respectively (p, 0.0001). In contrast, ST8 and ST398 did not display preferential host binding patterns. In the in vivo competition experiment, ST8 was a better colonizer compared to ST22, ST36, and ST433 prevailed over ST36 in colonizing the newborn piglets. These results are partly in agreement with previous genetic and epidemiological studies indicating the host specificity of ST22, ST36 and ST433 and the broad-host range of ST398. However, our in vitro and in vivo experiments revealed an unexpected ability of ST8 to adhere to porcine corneocytes and persist in the nasal cavity of pigs.	[Moodley, Arshnee; Espinosa-Gongora, Carmen; Guardabassi, Luca] Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark	University of Copenhagen	Moodley, A (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Vet Dis Biol, Frederiksberg, Denmark.	asm@life.ku.dk	Lindsay, Jodi/B-9565-2008; Lindsay, Jodi/ABH-8205-2020	Lindsay, Jodi/0000-0002-5219-1625; Lindsay, Jodi/0000-0002-5219-1625; Espinosa-Gongora, Carmen/0000-0002-9536-0548; McCarthy, Alex/0000-0002-4105-3737; Guardabassi, Luca/0000-0002-2389-5084; Nielsen, Soren/0000-0003-2417-0787; Moodley, Arshnee/0000-0002-6469-3948				Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Arriola CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028529; Ben Zakour NL, 2008, FEMS MICROBIOL LETT, V289, P1, DOI 10.1111/j.1574-6968.2008.01384.x; Christensen RV, 2007, J VET MED A, V54, P491, DOI 10.1111/j.1439-0442.2007.00952.x; Deurenberg RH, 2009, CURR MOL MED, V9, P100, DOI 10.2174/156652409787581637; DEVRIESE LA, 1984, J APPL BACTERIOL, V56, P215, DOI 10.1111/j.1365-2672.1984.tb01341.x; DEVRIESE LA, 1976, RES VET SCI, V21, P284, DOI 10.1016/S0034-5288(18)33337-X; DIMITRACOPOULOS G, 1977, APPL ENVIRON MICROB, V34, P461, DOI 10.1128/AEM.34.5.461-464.1977; Feil EJ, 2003, J BACTERIOL, V185, P3307, DOI 10.1128/JB.185.11.3307-3316.2003; Forsythe PJ, 2002, VET DERMATOL, V13, P29, DOI 10.1046/j.0959-4493.2001.00269.x; Giotis ES, 2012, J APPL MICROBIOL, V113, P992, DOI 10.1111/j.1365-2672.2012.05397.x; Guinane CM, 2010, GENOME BIOL EVOL, V2, P454, DOI 10.1093/gbe/evq031; Hasman H, 2010, VET MICROBIOL, V141, P326, DOI 10.1016/j.vetmic.2009.09.025; Herron-Olson L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001120; Jorgensen HJ, 2005, APPL ENVIRON MICROB, V71, P8352, DOI 10.1128/AEM.71.12.8352-8361.2005; Liljegren CH, 2003, APMIS, V111, P531, DOI 10.1034/j.1600-0463.2003.1110501.x; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Lindsay JA, 2010, METHODS MOL BIOL, V642, P3, DOI 10.1007/978-1-60327-279-7_1; Loeffler A, 2010, J HOSP INFECT, V74, P282, DOI 10.1016/j.jhin.2009.09.020; Lowder BV, 2009, P NATL ACAD SCI USA, V106, P19545, DOI 10.1073/pnas.0909285106; Lu YF, 2007, VET DERMATOL, V18, P29, DOI 10.1111/j.1365-3164.2007.00567.x; McCarthy AJ, 2012, VET DERMATOL, V23, P267, DOI 10.1111/j.1365-3164.2012.01072.x; McCarthy AJ, 2011, GENOME BIOL EVOL, V3, P1164, DOI 10.1093/gbe/evr092; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Monnet DL, 2010, EMERG INFECT DIS, V17, P502; Moodley A, 2011, EPIDEMIOL INFECT, V139, P1594, DOI 10.1017/S0950268810002888; Moodley A, 2006, J ANTIMICROB CHEMOTH, V58, P1118, DOI 10.1093/jac/dkl394; Nouwen J, 2004, INFECT IMMUN, V72, P6685, DOI 10.1128/IAI.72.11.6685-6688.2004; O'Mahony R, 2005, VET MICROBIOL, V109, P285, DOI 10.1016/j.vetmic.2005.06.003; Odofin LU, 2 ASM ESCMID C METH; Peacock SJ, 2000, J INFECTION, V41, P23, DOI 10.1053/jinf.2000.0657; Pohlmann-Dietze P, 2000, INFECT IMMUN, V68, P4865, DOI 10.1128/IAI.68.9.4865-4871.2000; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rabello RF, 2007, J MED MICROBIOL, V56, P1505, DOI 10.1099/jmm.0.47357-0; Ruimy R, 2010, J INFECT DIS, V202, P924, DOI 10.1086/655901; Simou C, 2005, VET DERMATOL, V16, P156, DOI 10.1111/j.1365-3164.2005.00452.x; Smyth DS, 2009, J MED MICROBIOL, V58, P1343, DOI 10.1099/jmm.0.009837-0; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; Strommenger B, 2006, J ANTIMICROB CHEMOTH, V57, P461, DOI 10.1093/jac/dki471; Szabo I, 2012, APPL ENVIRON MICROB, V78, P541, DOI 10.1128/AEM.05327-11; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; van Leeuwen WB, 2005, J BACTERIOL, V187, P4584, DOI 10.1128/JB.187.13.4584-4591.2005; Walther B, 2009, J CLIN MICROBIOL, V47, P704, DOI 10.1128/JCM.01626-08; Woolley KL, 2008, VET DERMATOL, V19, P1, DOI 10.1111/j.1365-3164.2007.00649.x	44	13	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49344	10.1371/journal.pone.0049344	http://dx.doi.org/10.1371/journal.pone.0049344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166643	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000311151900126
J	Moulis, G; Sommet, A; Bene, J; Montastruc, F; Sailler, L; Montastruc, JL; Lapeyre-Mestre, M				Moulis, Guillaume; Sommet, Agnes; Bene, Johana; Montastruc, Francois; Sailler, Laurent; Montastruc, Jean-Louis; Lapeyre-Mestre, Maryse			Cancer Risk of Anti-TNF-alpha at Recommended Doses in Adult Rheumatoid Arthritis: A Meta-Analysis with Intention to Treat and per Protocol Analyses	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; MALIGNANCIES; THERAPY; CRITERIA; TRIALS	Background: The risk of malignancies on TNF-alpha antagonists is controversial. The aim of this survey was to assess cancer risk on TNF-alpha antagonists in adult rheumatoid arthritis patients, including the five marketed drugs (infliximab, etanercept, adalimumab, golimumab and certolizumab) used in line with the New Drug Application. Furthermore, the relative interest of modified intention to treat or per protocol analyses to assess such sparse events remains unknown. Methodology/Principal Findings: Data sources were MEDLINE, CENTRAL, ISI Web of Science, ACR and EULAR meeting abstracts, scientific evaluation of the drugs leading to their marketing approval, and clinicaltrials. gov, until 31 December 2012. We selected double-blind randomized controlled trials in adult rheumatoid arthritis patients, including at least one treatment arm in line with New Drug Application. We performed random effect meta-analysis, with modified intention to treat and per protocol analyses. Thirty-three trials were included. There was no excess risk of malignancies on anti-TNF-alpha administered in line with New Drug Application in the per protocol model (OR, 0.93 95% CI[0.59-1.44]), as well as in the modified intention to treat model (OR, 1.27 95% CI[0.82-1.98]). There was a non-significant tendency for an excess non-melanoma skin cancer risk in both models (respectively, 1.37 [0.71-2.66] and 1.90 [0.98-3.67]). With fixed effect Peto model restricting to trials during at least 52 weeks, the overall cancer risk was respectively 1.60 [0.97-2.64] and 1.22 [0.72-2.08]. Whatever the model, modified intention to treat analysis led to higher estimations than per protocol analysis. The later may underestimate the treatment effect when assessing very sparse events and when many patients dropped out in placebo arms. In metaregression, there was no differential risk among the five drugs. Conclusions/Significance: This study did not find any evidence for an excess cancer risk on TNF-alpha antagonists in adult rheumatoid arthritis patients, but an excess cancer risk after several years of exposure cannot be ruled out. Both modified intention to treat and per protocol analyses should be presented in such safety analyses.	[Moulis, Guillaume; Sailler, Laurent] CHU Toulouse, Serv Med Interne, Toulouse, France	CHU de Toulouse	Moulis, G (corresponding author), CHU Toulouse, Serv Med Interne, Toulouse, France.	guillaume.moulis@univ-tlse3.fr	Lapeyre-Mestre, Maryse/C-8710-2012; Montastruc, François/ABE-9903-2020	Lapeyre-Mestre, Maryse/0000-0002-5494-5873; Montastruc, François/0000-0001-7056-8126				Alonso-Ruiz A, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-52; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Askling J, 2011, PHARMACOEPIDEM DR S, V20, P119, DOI 10.1002/pds.2046; Balkwill F, 2009, NAT REV CANCER, V9, P361, DOI 10.1038/nrc2628; Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275, DOI 10.1001/jama.295.19.2275; Bongartz T, 2009, ANN RHEUM DIS, V68, P1177, DOI 10.1136/ard.2008.094904; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huang HY, 2011, PHARMACOEPIDEM DR S, V20, P1014, DOI 10.1002/pds.2208; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Keystone E, 2008, ARTHRITIS RHEUM, V58, P3319, DOI 10.1002/art.23964; Leombruno JP, 2009, ANN RHEUM DIS, V68, P1136, DOI 10.1136/ard.2008.091025; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Mariette X, 2011, ANN RHEUM DIS, V70, P1895, DOI 10.1136/ard.2010.149419; Nuesch E, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3244; Singh JA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008794.pub2; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; Thompson AE, 2011, ARTHRITIS RHEUM-US, V63, P1479, DOI 10.1002/art.30310; Verhagen AP, 1998, J CLIN EPIDEMIOL, V51, P1235, DOI 10.1016/S0895-4356(98)00131-0	19	61	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48991	10.1371/journal.pone.0048991	http://dx.doi.org/10.1371/journal.pone.0048991			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155441	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900076
J	Shimada, H; Okada, Y; Ibata, K; Ebise, H; Ota, S; Tomioka, I; Nomura, T; Maeda, T; Kohda, K; Yuzaki, M; Sasaki, E; Nakamura, M; Okano, H				Shimada, Hiroko; Okada, Yohei; Ibata, Keiji; Ebise, Hayao; Ota, Shin-ichi; Tomioka, Ikuo; Nomura, Toshihiro; Maeda, Takuji; Kohda, Kazuhisa; Yuzaki, Michisuke; Sasaki, Erika; Nakamura, Masaya; Okano, Hideyuki			Efficient Derivation of Multipotent Neural Stem/Progenitor Cells from Non-Human Primate Embryonic Stem Cells	PLOS ONE			English	Article							SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; HUMAN OLIGODENDROCYTES; DIFFERENTIATION; TRANSPLANTATION; ESTABLISHMENT; GENERATION; NEURONS; LINES	The common marmoset (Callithrix jacchus) is a small New World primate that has been used as a non-human primate model for various biomedical studies. We previously demonstrated that transplantation of neural stem/progenitor cells (NS/PCs) derived from mouse and human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) promote functional locomotor recovery of mouse spinal cord injury models. However, for the clinical application of such a therapeutic approach, we need to evaluate the efficacy and safety of pluripotent stem cell-derived NS/PCs not only by xenotransplantation, but also allotransplantation using non-human primate models to assess immunological rejection and tumorigenicity. In the present study, we established a culture method to efficiently derive NS/PCs as neurospheres from common marmoset ESCs. Marmoset ESC-derived neurospheres could be passaged repeatedly and showed sequential generation of neurons and astrocytes, similar to that of mouse ESC-derived NS/PCs, and gave rise to functional neurons as indicated by calcium imaging. Although marmoset ESC-derived NS/PCs could not differentiate into oligodendrocytes under default culture conditions, these cells could abundantly generate oligodendrocytes by incorporating additional signals that recapitulate in vivo neural development. Moreover, principal component analysis of microarray data demonstrated that marmoset ESC-derived NS/PCs acquired similar gene expression profiles to those of fetal brain-derived NS/PCs by repeated passaging. Therefore, marmoset ESC-derived NS/PCs may be useful not only for accurate evaluation by allotransplantation of NS/PCs into non-human primate models, but are also applicable to analysis of iPSCs established from transgenic disease model marmosets.	[Shimada, Hiroko; Nakamura, Masaya] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan	Keio University	Shimada, H (corresponding author), Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo, Japan.	yohei@a6.keio.jp; hidokano@a2.keio.jp	Kohda, Kazuhisa/L-4731-2013; Ibata, Keiji/L-5802-2013; Yuzaki, Michisuke/K-5328-2013; Okano, Hideyuki/I-7584-2019; Nakamura, Masaya/K-4111-2013; Nomura, Toshihiro/AAD-3088-2022; Okada, Yohei/L-1662-2013	Yuzaki, Michisuke/0000-0002-5750-3544; Nomura, Toshihiro/0000-0001-8786-831X; Tomioka, Ikuo/0000-0002-1471-6419				Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Hu BY, 2009, NAT PROTOC, V4, P1614, DOI 10.1038/nprot.2009.186; Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447; Iwanami A, 2005, J NEUROSCI RES, V80, P182, DOI 10.1002/jnr.20436; Kawasaki H, 2002, P NATL ACAD SCI USA, V99, P1580, DOI 10.1073/pnas.032662199; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kuai XL, 2009, DIFFERENTIATION, V77, P229, DOI 10.1016/j.diff.2008.10.014; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Lemon RN, 2004, PROG BRAIN RES, V143, P263, DOI 10.1016/S0079-6123(03)43026-4; Liu S, 2000, P NATL ACAD SCI USA, V97, P6126, DOI 10.1073/pnas.97.11.6126; Liu Y, 2011, NAT PROTOC, V6, P640, DOI 10.1038/nprot.2011.310; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Nakamura Y, 2003, LAB INVEST, V83, P479, DOI 10.1097/01.LAB.0000063930.75913.B3; NATHAN PW, 1994, BRAIN, V117, P337, DOI 10.1093/brain/117.2.337; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ogawa D, 2009, J NEUROSCI RES, V87, P307, DOI 10.1002/jnr.21843; Ogawa Y, 2002, J NEUROSCI RES, V69, P925, DOI 10.1002/jnr.10341; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; QIU Y, 1991, J NEUROL SCI, V102, P137, DOI 10.1016/0022-510X(91)90061-B; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Suemori H, 2001, DEV DYNAM, V222, P273, DOI 10.1002/dvdy.1191; Temple S, 2001, NATURE, V414, P112, DOI 10.1038/35102174; Tomioka I, 2010, GENES CELLS, V15, P959, DOI 10.1111/j.1365-2443.2010.01437.x; Tsuji O, 2010, P NATL ACAD SCI USA, V107, P12704, DOI 10.1073/pnas.0910106107; Wada T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006722; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54	32	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49469	10.1371/journal.pone.0049469	http://dx.doi.org/10.1371/journal.pone.0049469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166679	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900148
J	Tenan, S; Adrover, J; Navarro, AM; Sergio, F; Tavecchia, G				Tenan, Simone; Adrover, Jaume; Munoz Navarro, Antoni; Sergio, Fabrizio; Tavecchia, Giacomo			Demographic Consequences of Poison-Related Mortality in a Threatened Bird of Prey	PLOS ONE			English	Article							POPULATION VIABILITY ANALYSIS; BEARDED VULTURE; RECOVERY; RAPTOR; DENSITY; BYCATCH; MODELS; EXTINCTION; ABUNDANCE; ACCURACY	Evidence for decline or threat of wild populations typically comes from multiple sources and methods that allow optimal integration of the available information, representing a major advance in planning management actions. We used integrated population modelling and perturbation analyses to assess the demographic consequences of the illegal use of poison for an insular population of Red Kites, Milvus milvus. We first pooled into a single statistical framework the annual census of breeding pairs, the available individual-based data, the average productivity and the number of birds admitted annually to the local rehabilitation centre. By combining these four types of information we were able to increase estimate precision and to obtain an estimate of the proportion of breeding adults, an important parameter that was not directly measured in the field and that is often difficult to assess. Subsequently, we used perturbation analyses to measure the expected change in the population growth rate due to a change in poison-related mortality. We found that poison accounted for 0.43 to 0.76 of the total mortality, for yearlings and older birds, respectively. Results from the deterministic population model indicated that this mortality suppressed the population growth rate by 20%. Despite this, the population was estimated to increase, albeit slowly. This positive trend was likely maintained by a very high productivity (1.83 fledglings per breeding pair) possibly promoted by supplementary feeding, a situation which is likely to be common to many large obligate or facultative European scavengers. Under this hypothetical scenario of double societal costs (poisoning of a threatened species and feeding programs), increasing poison control would help to lower the public cost of maintaining supplementary feeding stations.	[Tenan, Simone; Tavecchia, Giacomo] Univ Balearic Isl, Consejo Super Invest Cient, Mediterranean Inst Adv Studies, Populat Ecol Grp, Esporles, Mallorca, Spain; [Tenan, Simone] Museo Sci, Sez Zool Vertebrati, Trento, Italy; [Tenan, Simone] Univ Pavia, Dipartimento Sci Terra & Ambiente, I-27100 Pavia, Italy; [Adrover, Jaume; Munoz Navarro, Antoni] Grp Ornitol Balear & Def Nat, Palma De Mallorca, Mallora, Spain; [Sergio, Fabrizio] CSIC, Estn Biol Donana, Dept Conservat Biol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Mediterraneo de Estudios Avanzados (IMEDEA); Universitat de les Illes Balears; University of Pavia; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Tenan, S (corresponding author), Univ Balearic Isl, Consejo Super Invest Cient, Mediterranean Inst Adv Studies, Populat Ecol Grp, Esporles, Mallorca, Spain.	simone.tenan@mtsn.tn.it	Tenan, Simone/N-5246-2014; Sergio, Fabrizio/B-3952-2015; Tavecchia, Giacomo/N-3961-2014	Tenan, Simone/0000-0001-5055-9193; Sergio, Fabrizio/0000-0002-8024-1773; Tavecchia, Giacomo/0000-0001-5435-2691				Abadi F, 2010, ECOLOGY, V91, P7, DOI 10.1890/08-2235.1; Abadi F, 2010, J APPL ECOL, V47, P393, DOI 10.1111/j.1365-2664.2010.01789.x; Adrover Jaume, 2002, Anuari Ornitologic de les Balears, V17, P41; Beissinger S. R., 2002, POPULATION VIABILITY; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Belda EJ, 2001, BIOL CONSERV, V98, P357, DOI 10.1016/S0006-3207(00)00178-6; Besbeas P, 2002, BIOMETRICS, V58, P540, DOI 10.1111/j.0006-341X.2002.00540.x; Besbeas P, 2003, J ROY STAT SOC C-APP, V52, P95, DOI 10.1111/1467-9876.00391; Brook BW, 2000, NATURE, V404, P385, DOI 10.1038/35006050; Brooks S. P., 2004, Animal Biodiversity and Conservation, V27, P515; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Butchart SHM, 2004, PLOS BIOL, V2, P2294, DOI 10.1371/journal.pbio.0020383; Calix M., 2018, EUROPEAN RED LIST SA; Cardona M, 2009, LECT NOTES COMPUT SC, V5391, P137; Carrete M, 2006, ECOL APPL, V16, P1674, DOI 10.1890/1051-0761(2006)016[1674:DPDIPB]2.0.CO;2; Caswell, 2000, MATRIX POPULATION MO; Cave VM, 2010, J AGR BIOL ENVIR ST, V15, P119, DOI 10.1007/s13253-009-0001-2; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Coulson T, 2001, TRENDS ECOL EVOL, V16, P219, DOI 10.1016/S0169-5347(01)02137-1; DEL HOYO J., 1996, HDB BIRDS WORLD, V3; Garcia-Fernandez A., 2006, REV TOXICOLOGIA, V23, P44; Gimenez O, 2007, ECOL MODEL, V206, P431, DOI 10.1016/j.ecolmodel.2007.03.040; Gonzalez LM, 2007, ORYX, V41, P495, DOI 10.1017/S0030605307414119; Guitart R, 2010, VET J, V183, P260, DOI 10.1016/j.tvjl.2009.03.033; Hernandez M, 2009, EUR J WILDLIFE RES, V55, P415, DOI 10.1007/s10344-009-0255-6; Kenward RE, 2000, OIKOS, V91, P271, DOI 10.1034/j.1600-0706.2000.910207.x; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Laneri K, 2010, MAR ECOL PROG SER, V420, P241, DOI 10.3354/meps08847; Lebreton JD, 1999, BIRD STUDY, V46, P39; Lehman RN, 2007, BIOL CONSERV, V136, P159, DOI 10.1016/j.biocon.2006.09.015; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Igual JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004826; Margalida A, 2008, BIRD CONSERV INT, V18, P1, DOI 10.1017/S0959270908000026; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020248; Gonzalez L, 2006, BIOL CONSERV, V129, P477, DOI 10.1016/j.biocon.2005.11.014; Martinez-Abrain A, 2012, J APPL ECOL, V49, P109, DOI 10.1111/j.1365-2664.2011.02080.x; Maunder MN, 2004, ACTA OECOL, V26, P85, DOI 10.1016/j.actao.2003.11.008; McCrea RS, 2010, J AGR BIOL ENVIR ST, V15, P539, DOI 10.1007/s13253-010-0027-5; Mougeot F, 2006, IBIS, V148, P436, DOI 10.1111/j.1474-919X.2006.00558.x; Oro D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004084; Ortega E, 2009, ORYX, V43, P113, DOI 10.1017/S0030605307991048; Pradel R, 2009, ENVIRON ECOL STAT SE, V3, P781, DOI 10.1007/978-0-387-78151-8_36; Pullin AS, 2004, BIOL CONSERV, V119, P245, DOI 10.1016/j.biocon.2003.11.007; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Robb GN, 2008, FRONT ECOL ENVIRON, V6, P476, DOI 10.1890/060152; Sanz-Aguilar A, 2010, J ORNITHOL, V151, P133, DOI 10.1007/s10336-009-0435-x; Sarrazin F, 2000, CONSERV BIOL, V14, P488, DOI 10.1046/j.1523-1739.2000.97305.x; Schaub M, 2004, ECOLOGY, V85, P930, DOI 10.1890/03-0012; Schaub M, 2011, OECOLOGIA, P1; Schaub M, 2007, CONSERV BIOL, V21, P945, DOI 10.1111/j.1523-1739.2007.00743.x; Schaub M, 2011, J ORNITHOL, V152, P227, DOI 10.1007/s10336-010-0632-7; Schaub M, 2010, BIOL CONSERV, V143, P1911, DOI 10.1016/j.biocon.2010.04.047; Sergio F, 2005, BIOL CONSERV, V125, P11, DOI 10.1016/j.biocon.2005.03.002; Sergio F, 2004, J APPL ECOL, V41, P836, DOI 10.1111/j.0021-8901.2004.00946.x; Smart J, 2010, BIOL CONSERV, V143, P1278, DOI 10.1016/j.biocon.2010.03.002; SOULE ME, 1985, BIOSCIENCE, V35, P727, DOI 10.2307/1310054; Spiegelhalter D., 2007, WINBUGS USER MANUAL; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Tavecchia G, 2008, ECOLOGY, V89, P77, DOI 10.1890/06-0326.1; Tavecchia G, 2012, J APPL ECOL, V49, P297, DOI 10.1111/j.1365-2664.2011.02074.x; Tavecchia G, 2009, AM NAT, V173, P722, DOI 10.1086/598499; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Whitfield DP, 2003, BIOL CONSERV, V114, P157, DOI 10.1016/S0006-3207(03)00019-3	64	31	33	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49187	10.1371/journal.pone.0049187	http://dx.doi.org/10.1371/journal.pone.0049187			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155464	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900099
J	Loo, AEK; Wong, YT; Ho, RJ; Wasser, M; Du, TH; Ng, WT; Halliwell, B				Loo, Alvin Eng Kiat; Wong, Yee Ting; Ho, Rongjian; Wasser, Martin; Du, Tiehua; Wee Thong Ng; Halliwell, Barry			Effects of Hydrogen Peroxide on Wound Healing in Mice in Relation to Oxidative Damage	PLOS ONE			English	Article							IN-VIVO; MATRIX METALLOPROTEINASE-8; TISSUE INHIBITOR; NEUTROPHIL; INFLAMMATION; COLLAGENASE; DEPLETION; STRESS; CELLS; FORMS	It has been established that low concentrations of hydrogen peroxide (H2O2) are produced in wounds and is required for optimal healing. Yet at the same time, there is evidence that excessive oxidative damage is correlated with poor-healing wounds. In this paper, we seek to determine whether topical application of H2O2 can modulate wound healing and if its effects are related to oxidative damage. Using a C57BL/6 mice excision wound model, H2O2 was found to enhance angiogenesis and wound closure at 10 mM but retarded wound closure at 166 mM. The delay in closure was also associated with decreased connective tissue formation, increased MMP-8 and persistent neutrophil infiltration. Wounding was found to increase oxidative lipid damage, as measured by F-2-isoprostanes, and nitrative protein damage, as measured by 3-nitrotyrosine. However H2O2 treatment did not significantly increase oxidative and nitrative damage even at concentrations that delay wound healing. Hence the detrimental effects of H2O2 may not involve oxidative damage to the target molecules studied.	[Loo, Alvin Eng Kiat; Wong, Yee Ting; Ho, Rongjian; Halliwell, Barry] Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore; [Loo, Alvin Eng Kiat; Halliwell, Barry] Natl Univ Singapore, Grad Sch Integrat Sci & Engn, Singapore 117548, Singapore; [Wasser, Martin; Wee Thong Ng] ASTAR, Imaging Informat Div, Live Cell Imaging & Automat Image Anal Grp, Bioinformat Inst BII, Singapore, Singapore; [Wasser, Martin] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Du, Tiehua] Nanyang Polytech, Sch Engn, Singapore, Singapore	National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Nanyang Polytechnic	Halliwell, B (corresponding author), Natl Univ Singapore, Dept Biochem, Singapore 117548, Singapore.	barry_halliwell@nuhs.edu.sg	Halliwell, Barry/C-8318-2009	Halliwell, Barry/0000-0002-3560-7123	Singapore National Medical Research Council [NMRC 1205/2009]; Tan Chin Tuan Centennial Professorship	Singapore National Medical Research Council(National Medical Research Council, Singapore); Tan Chin Tuan Centennial Professorship	This work was funded by the Singapore National Medical Research Council (NMRC 1205/2009, http://www.nmrc.gov.sg/) and the Tan Chin Tuan Centennial Professorship (http://www.tanfoundation.com.sg). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaiby AD, 1999, J ANAT, V195, P531, DOI 10.1046/j.1469-7580.1999.19540531.x; Arul V, 2011, J BIOMATER APPL; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Benhanifia MB, 2011, RECENT PATENTS INFLA, V5, P81, DOI 10.2174/187221311794474847; Bennett LL, 2001, PLAST RECONSTR SURG, V108, P675, DOI 10.1097/00006534-200109010-00011; Brubaker Aleah L, 2011, Expert Rev Dermatol, V6, P5, DOI 10.1586/edm.10.66; Danielsen PL, 2011, SURGERY, V150, P897, DOI 10.1016/j.surg.2011.06.016; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Fang Y, 2010, BRIT J DERMATOL, V162, P478, DOI 10.1111/j.1365-2133.2009.09528.x; GOLDNER JACQUES, 1938, AMER JOUR PATH, V14, P237; Goren I, 2003, DIABETES, V52, P2821, DOI 10.2337/diabetes.52.11.2821; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Halliwell B., 2007, FREE RADICALS BIOL M; Halliwell B, 2010, ANTIOXID REDOX SIGN, V13, P145, DOI 10.1089/ars.2009.2934; Hanemaaijer R, 1997, J BIOL CHEM, V272, P31504, DOI 10.1074/jbc.272.50.31504; HASTY KA, 1986, J BIOL CHEM, V261, P5645; Jenner A, 2007, FREE RADICAL BIO MED, V42, P559, DOI 10.1016/j.freeradbiomed.2006.11.024; KIRK TZ, 1995, J BIOL CHEM, V270, P3423, DOI 10.1074/jbc.270.7.3423; Kumin A, 2007, J CELL BIOL, V179, P747, DOI 10.1083/jcb.200706090; Kwakman PHS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017709; Kyriakides TR, 2009, MATRIX BIOL, V28, P65, DOI 10.1016/j.matbio.2009.01.001; Lee CYJ, 2008, FREE RADICAL BIO MED, V44, P1314, DOI 10.1016/j.freeradbiomed.2007.12.026; Lobmann R, 2002, DIABETOLOGIA, V45, P1011, DOI 10.1007/s00125-002-0868-8; Loo AEK, 2012, BIOCHEM BIOPH RES CO, V423, P253, DOI 10.1016/j.bbrc.2012.05.100; Loo AEK, 2011, FREE RADICAL BIO MED, V51, P884, DOI 10.1016/j.freeradbiomed.2011.06.001; MILLER EJ, 1976, BIOCHEMISTRY-US, V15, P787, DOI 10.1021/bi00649a009; MORROW JD, 1990, P NATL ACAD SCI USA, V87, P9383, DOI 10.1073/pnas.87.23.9383; Moseley R, 2004, WOUND REPAIR REGEN, V12, P419, DOI 10.1111/j.1067-1927.2004.12406.x; MURPHY G, 1985, BIOCHIM BIOPHYS ACTA, V831, P49, DOI 10.1016/0167-4838(85)90148-7; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nishio N, 2008, AGE, V30, P11, DOI 10.1007/s11357-007-9043-y; Nomura T, 2007, WOUND REPAIR REGEN, V15, P833, DOI 10.1111/j.1524-475X.2007.00289.x; Nwomeh BC, 1999, J SURG RES, V81, P189, DOI 10.1006/jsre.1998.5495; Ojha N, 2008, FREE RADICAL BIO MED, V44, P682, DOI 10.1016/j.freeradbiomed.2007.10.056; Prince LR, 2011, CURR OPIN PHARMACOL, V11, P397, DOI 10.1016/j.coph.2011.06.007; Rasik AM, 2000, INT J EXP PATHOL, V81, P257, DOI 10.1046/j.1365-2613.2000.00158.x; Reiss MJ, 2010, SURGERY, V147, P295, DOI 10.1016/j.surg.2009.10.016; Rieger S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000621; Roy S, 2006, MOL THER, V13, P211, DOI 10.1016/j.ymthe.2005.07.684; Schafer M, 2008, PHARMACOL RES, V58, P165, DOI 10.1016/j.phrs.2008.06.004; Schreml S, 2011, EXP DERMATOL, V20, P229, DOI 10.1111/j.1600-0625.2010.01195.x; Shukla A, 1997, FREE RADICAL RES, V26, P93, DOI 10.3109/10715769709097788; Suzuki YJ, 2010, ANTIOXID REDOX SIGN, V12, P323, DOI 10.1089/ars.2009.2887; Tang DL, 2007, J LEUKOCYTE BIOL, V81, P741, DOI 10.1189/jlb.0806540; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Trengove NJ, 1999, WOUND REPAIR REGEN, V7, P442, DOI 10.1046/j.1524-475X.1999.00442.x; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; Yeoh-Ellerton S, 2003, J INVEST DERMATOL, V121, P918, DOI 10.1046/j.1523-1747.2003.12471.x; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632	50	123	125	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49215	10.1371/journal.pone.0049215	http://dx.doi.org/10.1371/journal.pone.0049215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152875	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234600030
J	Pehlic, M; Vrkic, D; Skrabic, V; Jeroncic, A; Stipancic, G; Urojic, AS; Marjanac, I; Jaksic, J; Kacic, Z; Boraska, V; Zemunik, T				Pehlic, Marina; Vrkic, Dina; Skrabic, Veselin; Jeroncic, Ana; Stipancic, Gordana; Urojic, Anita Spehar; Marjanac, Igor; Jaksic, Jasminka; Kacic, Zrinka; Boraska, Vesna; Zemunik, Tatijana			IL12RB2 Gene Is Associated with the Age of Type 1 Diabetes Onset in Croatian Family Trios	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY; EPIDEMIOLOGY; VARIANTS; INSIGHTS; RISK	Background: Common complex diseases are influenced by both genetic and environmental factors. Many genetic factors overlap between various autoimmune diseases. The aim of the present study is to determine whether four genetic variants known to be risk variants for several autoimmune diseases could be associated with an increased susceptibility to type 1 diabetes mellitus. Methods and Findings: We genotyped four genetic variants (rs2358817, rs1049550, rs6679356, rs9865818) within VTCN1, ANXA11, IL12RB2 and LPP genes respectively, in 265 T1DM family trios in Croatian population. We did not detect association of these polymorphisms with T1DM. However, quantitative transmission disequilibrium test (QTDT, orthogonal model) revealed a significant association between the age of onset of T1DM and IL12RB2 rs6679356 variant. An earlier onset of T1DM was associated with the rs6679356 minor dominant allele C (p = 0.005). The association remained significant even after the Bonferroni correction for multiple testing and permutation. Conclusions: Variants originally associated with juvenile idiopathic arthritis (VTCN1 gene), sarcoidosis (ANXA11 gene), primary biliary cirrhosis (IL12RB2 gene) and celiac disease (LPP gene) were not associated with type 1 diabetes in our dataset. Nevertheless, association of IL12RB2 rs6679356 polymorphism with the age of T1DM onset suggests that this gene plays a role in defining the time of disease onset.	[Pehlic, Marina; Vrkic, Dina; Boraska, Vesna; Zemunik, Tatijana] Univ Split, Sch Med, Dept Med Biol, Split, Croatia; [Pehlic, Marina; Boraska, Vesna; Zemunik, Tatijana] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split, Croatia; [Skrabic, Veselin] Univ Hosp Ctr Split, Dept Pediat, Split, Croatia; [Jeroncic, Ana] Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia; [Stipancic, Gordana] Univ Hosp Sestre Milosrdnice Zagreb, Dept Pediat, Zagreb, Croatia; [Urojic, Anita Spehar] Univ Hosp Ctr Rebro, Dept Pediat, Zagreb, Croatia; [Marjanac, Igor] Univ Hosp Ctr Osijek, Dept Pediat, Osijek, Croatia; [Jaksic, Jasminka] Gen Hosp, Dept Pediat, Shibenik, Croatia; [Kacic, Zrinka] Gen Hosp Dubrovnik, Dept Pediat, Dubrovnik, Croatia	University of Split; University of Split; University of Split; University of Split	Pehlic, M (corresponding author), Univ Split, Sch Med, Dept Med Biol, Split, Croatia.	marina.pehlic@mefst.hr	škrabić, veselin/D-5564-2017; Zemunik, Tatijana/D-8584-2017; Perica, Vesna Boraska/D-8230-2017; Jerončić, Ana/D-6191-2017	škrabić, veselin/0000-0003-2995-8733; Zemunik, Tatijana/0000-0001-8120-2891; Perica, Vesna Boraska/0000-0003-3999-1529; Jerončić, Ana/0000-0003-1621-1956; Skrabic, Veselin/0000-0001-9434-5306	Croatian Ministry of Science, Education and Sports [216-1080315-0293]	Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia)	This study was supported by the Croatian Ministry of Science, Education and Sports (project number 216-1080315-0293). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, EUR J HUM GENET, V8, P545, DOI 10.1038/sj.ejhg.5200494; Amador-Patarroyo MJ, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/251730; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bitti MLM, 2011, J PEDIATR ENDOCR MET, V24, P437, DOI 10.1515/JPEM.2011.058; Eleftherohorinou H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008068; Espino-Paisan L, 2011, IMMUNOGENETICS, V63, P255, DOI 10.1007/s00251-010-0500-x; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Garner CP, 2009, HUM MOL GENET, V18, P4219, DOI 10.1093/hmg/ddp364; Gauderman WJ, 2003, GENET EPIDEMIOL, V25, P327, DOI 10.1002/gepi.10262; Hakonarson H, 2009, SEMIN IMMUNOL, V21, P355, DOI 10.1016/j.smim.2009.06.001; Hemminki K, 2009, DIABETOLOGIA, V52, P1820, DOI 10.1007/s00125-009-1427-3; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hofmann S, 2008, NAT GENET, V40, P1103, DOI 10.1038/ng.198; Huber A, 2008, ENDOCR REV, V29, P697, DOI 10.1210/er.2008-0015; Lee HS, 2008, ANN NY ACAD SCI, V1150, P93, DOI 10.1196/annals.1447.013; Lehne B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020133; Lettre G, 2008, HUM MOL GENET, V17, pR116, DOI 10.1093/hmg/ddn246; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Pociot F, 2010, DIABETES, V59, P1561, DOI 10.2337/db10-0076; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Sica GL, 2003, IMMUNITY, V18, P849, DOI 10.1016/S1074-7613(03)00152-3; Smyth DJ, 2008, NEW ENGL J MED, V359, P2767, DOI 10.1056/NEJMoa0807917; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Vehik K, 2011, DIABETES-METAB RES, V27, P3, DOI 10.1002/dmrr.1141	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49133	10.1371/journal.pone.0049133	http://dx.doi.org/10.1371/journal.pone.0049133			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152861	Green Published, gold			2022-12-27	WOS:000311234600023
J	Izban, MG; Nowicki, BJ; Nowicki, S				Izban, Michael G.; Nowicki, Bogdan J.; Nowicki, Stella			1,25-Dihydroxyvitamin D3 Promotes a Sustained LPS-Induced NF-kappa B-Dependent Expression of CD55 in Human Monocytic THP-1 Cells	PLOS ONE			English	Article							DECAY-ACCELERATING FACTOR; VITAMIN-D; PHOSPHATIDYLINOSITOL 3-KINASE; TRANSCRIPTIONAL REGULATION; MACROPHAGE ACTIVATION; COMPLEMENT RECEPTOR-3; BLOOD LEUKOCYTES; CD14; LIPOPOLYSACCHARIDE; DIFFERENTIATION	The vitamin D3 system imposes immunosuppressive effects on monocytic cells, in part, by inhibiting NF-kappa B-dependent expression of proinflammatory mediators. CD55, a cell surface complement regulatory protein that promotes protective and anti-inflammatory properties, is reportedly an NF-kappa B target gene transiently induced in monocytic cells by the bacterial endotoxin LPS. CD55 is elevated on white cells in women experiencing preterm labor (a pathophysiology commonly associated with bacterial infection) and failure to maintain CD55 was associated with subsequent preterm delivery. We examined the influence of vitamin D3 signaling on LPS-induced expression of CD55 in human monocytic THP-1 cells using quantitative PCR, immunoblot, immunohistochemistry, and NF-kappa B activation pathway inhibitors. Non-NF-kappa B targets CD14 and CD11b, which modulate bacterial surveillance and eradication, respectively, were also examined. LPS produced a rapid transient 1.6-fold increase in CD55 mRNA. 1,25-D3 alone did not affect CD55 mRNA expression within the first 48 h. However, in 1,25-D3 pretreated cells, LPS produced a >4-fold immediate and sustained increase in CD55 mRNA and protein expression, which was blocked by NF-kappa B inhibitors. Our results unexpectedly suggest that vitamin D3 signaling may promote an anti-inflammatory response through an NF-kappa B-dependent increase in CD55 expression. As expected, LPS or 1,25-D3 alone led to sustained increases in CD14 and CD11b expression. In 1,25-D3 pretreated cells, LPS differentially regulated protein expression-CD14 (21-fold increase) and CD11b (a transient 2-fold decrease)-principally at the posttranscriptional level. The coordinated temporal expression of CD55, CD14 and CD11b would contribute to an anti-inflammatory response by providing protection against complement-mediated cell lysis during pathogen recognition and eradication. Overall, the vitamin D3 system may play a role coordinating an anti-inflammatory response pattern of the host complement immune system. This may be particularly important when considering the high rates of preterm births in blacks, a population that exhibits reduced circulating vitamin D3 levels.	[Izban, Michael G.; Nowicki, Bogdan J.; Nowicki, Stella] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Nowicki, Bogdan J.] Meharry Med Coll, Dept Obstet & Gynecol, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College	Izban, MG (corresponding author), Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA.	mizban@mmc.edu			Public Health Service grant [HD055648, HD041687, U54 RR026140]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD041687, R01HD055648] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR026140] Funding Source: NIH RePORTER	Public Health Service grant(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by Public Health Service grant HD055648 (to SN), HD041687 (to BJN and SN) and U54 RR026140 (to SN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androulidaki A, 2009, IMMUNITY, V31, P220, DOI 10.1016/j.immuni.2009.06.024; Bodnar LM, 2007, J CLIN ENDOCR METAB, V92, P3517, DOI 10.1210/jc.2007-0718; Bodnar LM, 2010, J NUTR, V140, P999, DOI 10.3945/jn.109.119636; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Campbell FC, 2010, BIOCHEM PHARMACOL, V79, P1, DOI 10.1016/j.bcp.2009.09.005; Chen M, 2010, J AUTOIMMUN, V34, pJ276, DOI 10.1016/j.jaut.2009.11.014; Christmas SE, 2006, IMMUNOLOGY, V119, P522, DOI 10.1111/j.1365-2567.2006.02467.x; Cohen-Lahav M, 2006, NEPHROL DIAL TRANSPL, V21, P889, DOI 10.1093/ndt/gfi254; Davis LM, 2010, J PEDIATR ADOL GYNEC, V23, P45, DOI 10.1016/j.jpag.2009.05.005; Dobrovolskaia MA, 2002, MICROBES INFECT, V4, P903, DOI 10.1016/S1286-4579(02)01613-1; Ehlers MRW, 2000, MICROBES INFECT, V2, P289, DOI 10.1016/S1286-4579(00)00299-9; El Gazzar M, 2011, J LEUKOCYTE BIOL, V90, P509, DOI 10.1189/jlb.0211074; Evans KN, 2004, J SOC GYNECOL INVEST, V11, P263, DOI 10.1016/j.jsgi.2004.02.002; Friedman AD, 2002, ONCOGENE, V21, P3377, DOI 10.1038/sj.onc.1205324; Gangloff SC, 2005, J IMMUNOL, V175, P3940, DOI 10.4049/jimmunol.175.6.3940; Garcia LA, 2011, ENDOCRINOLOGY, V152, P2976, DOI 10.1210/en.2011-0159; Girardi G, 2006, MOL IMMUNOL, V43, P68, DOI 10.1016/j.molimm.2005.06.017; Griffin MD, 2007, ARCH BIOCHEM BIOPHYS, V460, P218, DOI 10.1016/j.abb.2007.01.034; Hawley KL, 2012, P NATL ACAD SCI USA, V109, P1228, DOI 10.1073/pnas.1112078109; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hmama Z, 1999, J EXP MED, V190, P1583, DOI 10.1084/jem.190.11.1583; Holers VM, 2008, IMMUNOL REV, V223, P300, DOI 10.1111/j.1600-065X.2008.00641.x; Holla VR, 2005, J BIOL CHEM, V280, P476, DOI 10.1074/jbc.M407403200; Hughes PJ, 2010, LEUKEMIA RES, V34, P553, DOI 10.1016/j.leukres.2009.09.010; Klos A, 2009, MOL IMMUNOL, V46, P2753, DOI 10.1016/j.molimm.2009.04.027; Klug M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-6-r63; Kohl J, 2001, MOL IMMUNOL, V38, P175, DOI 10.1016/S0161-5890(01)00041-4; Kovacs CS, 1997, ENDOCR REV, V18, P832, DOI 10.1210/er.18.6.832; Kwok BHB, 2001, CHEM BIOL, V8, P759, DOI 10.1016/S1074-5521(01)00049-7; Lawrence DW, 2003, J EXP MED, V198, P999, DOI 10.1084/jem.20030380; Le Cabec V, 2000, INFECT IMMUN, V68, P4736, DOI 10.1128/IAI.68.8.4736-4745.2000; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li K, 2012, IMMUNOBIOLOGY, V217, P65, DOI 10.1016/j.imbio.2011.07.033; Li K, 2011, MOL IMMUNOL, V48, P1121, DOI 10.1016/j.molimm.2011.02.003; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Lublin D M, 2005, Immunohematology, V21, P39; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mason JC, 2004, J BIOL CHEM, V279, P41611, DOI 10.1074/jbc.M407981200; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Moeenrezakhanlou A, 2008, J LEUKOCYTE BIOL, V84, P519, DOI 10.1189/jlb.1207833; Moeenrezakhanlou A, 2007, J LEUKOCYTE BIOL, V81, P1311, DOI 10.1189/jlb.1106681; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Nowicki S, 2009, AM J REPROD IMMUNOL, V61, P360, DOI 10.1111/j.1600-0897.2009.00702.x; Pacheco LD, 2011, AM J PERINAT, V28, P565, DOI 10.1055/s-0031-1274510; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Rachez C, 2000, GENE, V246, P9, DOI 10.1016/S0378-1119(00)00052-4; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Saha P, 2009, CURR OPIN PHARMACOL, V9, P109, DOI 10.1016/j.coph.2008.12.017; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Schwende H, 1996, J LEUKOCYTE BIOL, V59, P555, DOI 10.1002/jlb.59.4.555; Sendide K, 2005, J IMMUNOL, V174, P4210, DOI 10.4049/jimmunol.174.7.4210; Sharif O, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-1; Shibata M, 2011, J BONE MINER METAB, V29, P615, DOI 10.1007/s00774-011-0264-x; Szeles L, 2009, J IMMUNOL, V182, P2074, DOI 10.4049/jimmunol.0803345; Triantafilou M, 2008, EUR J IMMUNOL, V38, P192, DOI 10.1002/eji.200636821; Verstuyf A, 2010, KIDNEY INT, V78, P140, DOI 10.1038/ki.2010.17; Wang TT, 2005, MOL ENDOCRINOL, V19, P2685, DOI 10.1210/me.2005-0106; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wuding Z, 2012, IMMUNOBIOLOGY, V217, P225; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; ZHANG DE, 1994, J IMMUNOL, V153, P3276	63	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49318	10.1371/journal.pone.0049318	http://dx.doi.org/10.1371/journal.pone.0049318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152895	Green Submitted, gold, Green Published			2022-12-27	WOS:000311234000063
J	Capitan, A; Allais-Bonnet, A; Pinton, A; Marquant-Le Guienne, B; Le Bourhis, D; Grohs, C; Bouet, S; Clement, L; Salas-Cortes, L; Venot, E; Chaffaux, S; Weiss, B; Delpeuch, A; Noe, G; Rossignol, MN; Barbey, S; Dozias, D; Cobo, E; Barasc, H; Auguste, A; Pannetier, M; Deloche, MC; Lhuilier, E; Bouchez, O; Esquerre, D; Salin, G; Klopp, C; Donnadieu, C; Chantry-Darmon, C; Hayes, H; Gallard, Y; Ponsart, C; Boichard, D; Pailhoux, E				Capitan, Aurelien; Allais-Bonnet, Aurelie; Pinton, Alain; Marquant-Le Guienne, Brigitte; Le Bourhis, Daniel; Grohs, Cecile; Bouet, Stephan; Clement, Laetitia; Salas-Cortes, Laura; Venot, Eric; Chaffaux, Stephane; Weiss, Bernard; Delpeuch, Arnaud; Noe, Guy; Rossignol, Marie-Noelle; Barbey, Sarah; Dozias, Dominique; Cobo, Emilie; Barasc, Harmonie; Auguste, Aurelie; Pannetier, Maelle; Deloche, Marie-Christine; Lhuilier, Emeline; Bouchez, Olivier; Esquerre, Diane; Salin, Gerald; Klopp, Christophe; Donnadieu, Cecile; Chantry-Darmon, Celine; Hayes, Helene; Gallard, Yves; Ponsart, Claire; Boichard, Didier; Pailhoux, Eric			A 3.7 Mb Deletion Encompassing ZEB2 Causes a Novel Polled and Multisystemic Syndrome in the Progeny of a Somatic Mosaic Bull	PLOS ONE			English	Article							MOWAT-WILSON-SYNDROME; EPITHELIAL-MESENCHYMAL TRANSITIONS; IN-SITU HYBRIDIZATION; GENE; EXPRESSION; CATTLE; EVOLUTION; DISEASE; HORN; IDENTIFICATION	Polled and Multisystemic Syndrome (PMS) is a novel developmental disorder occurring in the progeny of a single bull. Its clinical spectrum includes polledness (complete agenesis of horns), facial dysmorphism, growth delay, chronic diarrhea, premature ovarian failure, and variable neurological and cardiac anomalies. PMS is also characterized by a deviation of the sex-ratio, suggesting male lethality during pregnancy. Using Mendelian error mapping and whole-genome sequencing, we identified a 3.7 Mb deletion on the paternal bovine chromosome 2 encompassing ARHGAP15, GTDC1 and ZEB2 genes. We then produced control and affected 90-day old fetuses to characterize this syndrome by histological and expression analyses. Compared to wild type individuals, affected animals showed a decreased expression of the three deleted genes. Based on a comparison with human Mowat-Wilson syndrome, we suggest that deletion of ZEB2, is responsible for most of the effects of the mutation. Finally sperm-FISH, embryo genotyping and analysis of reproduction records confirmed somatic mosaicism in the founder bull and male-specific lethality during the first third of gestation. In conclusion, we identified a novel locus involved in bovid horn ontogenesis and suggest that epithelial-to-mesenchymal transition plays a critical role in horn bud differentiation. We also provide new insights into the pathogenicity of ZEB2 loss of heterozygosity in bovine and humans and describe the first case of male-specific lethality associated with an autosomal locus in a non-murine mammalian species. This result sets PMS as a unique model to study sex-specific gene expression/regulation. Citation: Capitan A, Allais- Bonnet A, Pinton A, Marquant-Le Guienne B, Le Bourhis D, et al. (2012) A 3.7 Mb Deletion Encompassing ZEB2 Causes a Novel Polled and Multisystemic Syndrome in the Progeny of a Somatic Mosaic Bull. PLoS ONE 7(11): e49084. doi:10.1371/journal.pone.0049084	[Capitan, Aurelien; Grohs, Cecile; Bouet, Stephan; Venot, Eric; Chaffaux, Stephane; Weiss, Bernard; Hayes, Helene; Boichard, Didier] INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France; [Capitan, Aurelien] UNCEIA, Serv Genet, Paris, France; [Allais-Bonnet, Aurelie; Le Bourhis, Daniel; Auguste, Aurelie; Pannetier, Maelle; Pailhoux, Eric] INRA, UMR Biol Dev & Reprod 1198, Jouy En Josas, France; [Pinton, Alain; Barasc, Harmonie] INRA ENVT, UMR Genet Cellulaire 444, Toulouse, France; [Marquant-Le Guienne, Brigitte; Le Bourhis, Daniel; Clement, Laetitia; Salas-Cortes, Laura; Deloche, Marie-Christine; Ponsart, Claire] UNCEIA, Dept Rech & Dev, Maisons Alfort, France; [Delpeuch, Arnaud] Inst Elevage, Dept Genet Identificat Phenotypes & Syst Informat, Limoges, France; [Noe, Guy; Rossignol, Marie-Noelle; Chantry-Darmon, Celine] Labogena, Jouy En Josas, France; [Barbey, Sarah; Dozias, Dominique; Cobo, Emilie; Gallard, Yves] INRA, Domaine Expt Pin Au Haras UE0326, Exmes, France; [Lhuilier, Emeline; Bouchez, Olivier; Esquerre, Diane; Salin, Gerald; Donnadieu, Cecile] INRA, Genet Cellulaire UMR444, Castanet Tolosan, France; [Klopp, Christophe] INRA, Biometr & Intelligence Artificielle UR875, Castanet Tolosan, France; [Lhuilier, Emeline; Bouchez, Olivier; Esquerre, Diane; Salin, Gerald; Donnadieu, Cecile] GeT PlaGe, Genotoul, Castanet Tolosan, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE; INRAE; INRAE	Capitan, A (corresponding author), INRA, Genet Anim & Biol Integrat UMR1313, Jouy En Josas, France.	aurelien.capitan@jouy.inra.fr	Emilie, Cobo/AAM-9178-2021; Boichard, Didier/AAD-8675-2020; Pinton, Alain/AAQ-1648-2020; Klopp, Christophe/J-3164-2019; Barasc, Harmonie/AAS-9519-2020; Pannetier, Maëlle/AAQ-1626-2020; Capitan, Aurélien/M-3732-2015	Emilie, Cobo/0000-0003-2902-5730; Boichard, Didier/0000-0003-0361-2961; Pinton, Alain/0000-0002-0809-7180; Klopp, Christophe/0000-0001-7126-5477; Barasc, Harmonie/0000-0002-1644-4701; Pannetier, Maelle/0000-0002-5826-619X; Ponsart, Claire/0000-0002-9633-4464; CHANTRY DARMON, Celine/0000-0002-1313-7650; ROSSIGNOL, Marie-Noelle/0000-0003-1673-5258; Auguste, Aurelie/0000-0001-5115-0218	Apis Gene "Hornout" grant; INRA-DGA "Hornaseq" grant	Apis Gene "Hornout" grant; INRA-DGA "Hornaseq" grant	This project was funded by Apis Gene "Hornout" and INRA-DGA "Hornaseq" grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Adam MP, 2006, AM J MED GENET A, V140A, P2730, DOI 10.1002/ajmg.a.31530; Adam MP, 2011, GENEREVIEWS; Allanson, 2010, MANAGEMENT GENETIC S; Barone R, 2001, SPLANCHNOLOGIE 2 APP; BECHTOL KB, 1982, GENET RES, V39, P79, DOI 10.1017/S0016672300020759; Beltran M, 2008, GENE DEV, V22, P756, DOI 10.1101/gad.455708; Bubenik GA., 1990, HORNS PRONGHORNS ANT; Capitan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022242; Costa C, 2011, BLOOD, V118, P1099, DOI 10.1182/blood-2010-12-324756; Davis EB, 2011, P ROY SOC B-BIOL SCI, V278, P2857, DOI 10.1098/rspb.2011.0938; Ducos A, 2000, GENET SEL EVOL, V32, P589, DOI 10.1051/gse:2000139; Eggen A, 2001, GENET SEL EVOL, V33, P543, DOI 10.1051/gse:2001132; El-Kasti MM, 2012, HUM MOL GENET; Engenheiro E, 2008, CLIN GENET, V73, P579, DOI 10.1111/j.1399-0004.2008.00997.x; Garavelli L, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-42; GEIST V, 1966, BEHAVIOUR, V27, P175, DOI 10.1163/156853966X00155; Hamblet NS, 2002, DEVELOPMENT, V129, P5827, DOI 10.1242/dev.00164; Hassanane M, 1999, MOL REPROD DEV, V53, P407, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;407::AID-MRD6&gt;3.0.CO;2-O; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; JANIS C, 1982, BIOL REV, V57, P261, DOI 10.1111/j.1469-185X.1982.tb00370.x; Johnston SE, 2011, MOL ECOL, V20, P2555, DOI 10.1111/j.1365-294X.2011.05076.x; LEITER EH, 1981, DIABETES, V30, P30, DOI 10.2337/diabetes.30.1.30; Leong M, 2010, PEDIATR DEVEL PATHOL, V13, P415, DOI 10.2350/09-09-0715-CR.1; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LONG CR, 1978, J HERED, V69, P395, DOI 10.1093/oxfordjournals.jhered.a108980; Mainardi PC, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.009548; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; MARQUANTLEGUIEN.B, 2011, REPROD FERT DEVELOP, V24, P198; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Mialon MM, 1999, ANN ZOOTECH, V48, P413, DOI 10.1051/animres:19990601; Mitchell G., 2003, Transactions of the Royal Society of South Africa, V58, P51; Montazer-Torbati F, 2010, DEV DYNAM, V239, P3324, DOI 10.1002/dvdy.22452; Moore LA, 1998, DEVELOPMENT, V125, P667; Mowat DR, 1998, J MED GENET, V35, P617, DOI 10.1136/jmg.35.8.617; Myers M, 2010, WIRES SYST BIOL MED, V2, P117, DOI 10.1002/wsbm.21; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pannetier M, 2005, GENOMICS, V85, P715, DOI 10.1016/j.ygeno.2005.02.011; Perez-Pomares JM, 2002, ANAT RECORD, V268, P343, DOI 10.1002/ar.10165; Persani L, 2011, J ENDOCRINOL INVEST, V34, P244, DOI [10.1007/BF03347073, 10.3275/7502]; Pinton A, 2004, GENET SEL EVOL, V36, P123, DOI 10.1051/gse:2003055; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Seichter D, 2012, ANIM GENET, V43, P595, DOI 10.1111/j.1365-2052.2011.02302.x; Shimono N, 2011, BIOSCI BIOTECH BIOCH, V75, P1451, DOI 10.1271/bbb.110124; Sollars VE, 2002, HUM MOL GENET, V11, P2777, DOI 10.1093/hmg/11.22.2777; VIGIER B, 1976, ARCH ANAT MICROSC MO, V65, P77; Wetzel E, 1951, TIERAERZTL UMSCHAU, V6, P209; White WT, 1936, J GENET, V32, P33, DOI 10.1007/BF02982500; Wijchers PJ, 2011, TRENDS GENET, V27, P132, DOI 10.1016/j.tig.2011.01.004; Wijchers PJ, 2010, DEV CELL, V19, P477, DOI 10.1016/j.devcel.2010.08.005; Yang Yang, 2011, BMC Genomics, V12, P13, DOI 10.1186/1471-2164-12-13; YERLE M, 1994, MAMM GENOME, V5, P34, DOI 10.1007/BF00360565; Zhao EP, 2004, DNA CELL BIOL, V23, P183, DOI 10.1089/104454904322964788; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42; Zweier C, 2005, EUR J MED GENET, V48, P97, DOI 10.1016/j.ejmg.2005.01.003; Zweier C, 2003, J MED GENET, V40, P601, DOI 10.1136/jmg.40.8.601	57	21	22	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49084	10.1371/journal.pone.0049084	http://dx.doi.org/10.1371/journal.pone.0049084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152852	Green Published, gold, Green Submitted			2022-12-27	WOS:000312272600041
J	Hargrove, J; Eastwood, H; Mahiane, G; van Schalkwyk, C				Hargrove, John; Eastwood, Hayden; Mahiane, Guy; van Schalkwyk, Cari			How Should We Best Estimate the Mean Recency Duration for the BED Method?	PLOS ONE			English	Article							HIV INCIDENCE	BED estimates of HIV incidence from cross-sectional surveys are obtained by restricting, to fixed time T, the period over which incidence is estimated. The appropriate mean recency duration (Omega(T)) then refers to the time where BED optical density (OD) is less than a pre-set cut-off C, given the patient has been HIV positive for at most time T. Five methods, tested using data for postpartum women in Zimbabwe, provided similar estimates of Omega(T) for C = 0.8: i) The ratio (r/s) of the number of BED-recent infections to all seroconversions over T = 365 days: 192 days [95% CI 168-216]. ii) Linear mixed modeling (LMM): 191 days [95% CI 174-208]. iii) Non-linear mixed modeling (NLMM): 196 days [95% CrI 188-204]. iv) Survival analysis (SA): 192 days [95% CI 168-216]. Graphical analysis: 193 days. NLMM estimates of Omega(T) - based on a biologically more appropriate functional relationship than LMM - resulted in best fits to OD data, the smallest variance in estimates of Omega(T), and best correspondence between BED and follow-up estimates of HIV incidence, for the same subjects over the same time period. SA and NLMM produced very similar estimates of Omega(T) but the coefficient of variation of the former was >3 times as high. The r/s method requires uniformly distributed seroconversion events but is useful if data are available only from a single follow-up. The graphical method produces the most variable results, involves unsound methodology and should not be used to provide estimates of Omega(T). False-recent rates increased as a quadratic function of C: for incidence estimation C should thus be chosen as small as possible, consistent with an adequate resultant number of recent cases, and accurate estimation of Omega(T). Inaccuracies in the estimation of Omega(T) should not now provide an impediment to incidence estimation.	[Hargrove, John; Eastwood, Hayden; Mahiane, Guy; van Schalkwyk, Cari] Univ Stellenbosch, S African Dept Sci & Technol, Natl Res Fdn, Ctr Excellence Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa	National Research Foundation - South Africa; Stellenbosch University	Hargrove, J (corresponding author), Univ Stellenbosch, S African Dept Sci & Technol, Natl Res Fdn, Ctr Excellence Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa.	jhargrove@sun.ac.za		van Schalkwyk, Cari/0000-0001-5154-1390	Canadian International Development Agency (CIDA) [A033749]	Canadian International Development Agency (CIDA)	This work was supported by funding from the Canadian International Development Agency (CIDA; Project A033749). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brookmeyer R, 2009, AIDS, V23, P2066, DOI 10.1097/QAD.0b013e32832f3dbb; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Hargrove J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029736; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Humphrey JH, 2006, AIDS, V20, P1437, DOI 10.1097/01.aids.0000233578.72091.09; Humphrey JH, 2006, J INFECT DIS, V193, P960; Kassanjee R, 2012, EPIDEMIOLOGY, V23, P721, DOI 10.1097/EDE.0b013e3182576c07; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Sweeting MJ, 2010, STAT MED, V29, P3194, DOI 10.1002/sim.3941; Team R. D. C, 2011, R LANG ENV STAT COMP; TURNBULL BW, 1976, J R STAT SOC B, V38, P290	12	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49661	10.1371/journal.pone.0049661	http://dx.doi.org/10.1371/journal.pone.0049661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166743	gold, Green Published			2022-12-27	WOS:000311885300058
J	Sharp, LZ; Shinoda, K; Ohno, H; Scheel, DW; Tomoda, E; Ruiz, L; Hu, HC; Wang, L; Pavlova, Z; Gilsanz, V; Kajimura, S				Sharp, Louis Z.; Shinoda, Kosaku; Ohno, Haruya; Scheel, David W.; Tomoda, Emi; Ruiz, Lauren; Hu, Houchun; Wang, Larry; Pavlova, Zdena; Gilsanz, Vicente; Kajimura, Shingo			Human BAT Possesses Molecular Signatures That Resemble Beige/Brite Cells	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; WHITE FAT; GENE-EXPRESSION; ADIPOCYTES; OBESITY; IDENTIFICATION; INDUCTION; PROTEIN; MOUSE; MICE	Brown adipose tissue (BAT) dissipates chemical energy and generates heat to protect animals from cold and obesity. Rodents possess two types of UCP-1 positive brown adipocytes arising from distinct developmental lineages: "classical" brown adipocytes develop during the prenatal stage whereas "beige" or "brite" cells that reside in white adipose tissue (WAT) develop during the postnatal stage in response to chronic cold or PPAR gamma agonists. Beige cells' inducible characteristics make them a promising therapeutic target for obesity treatment, however, the relevance of this cell type in humans remains unknown. In the present study, we determined the gene signatures that were unique to classical brown adipocytes and to beige cells induced by a specific PPAR gamma agonist rosiglitazone in mice. Subsequently we applied the transcriptional data to humans and examined the molecular signatures of human BAT isolated from multiple adipose depots. To our surprise, nearly all the human BAT abundantly expressed beige cell-selective genes, but the expression of classical brown fat-selective genes were nearly undetectable. Interestingly, expression of known brown fat-selective genes such as PRDM16 was strongly correlated with that of the newly identified beige cell-selective genes, but not with that of classical brown fat-selective genes. Furthermore, histological analyses showed that a new beige cell marker, CITED1, was selectively expressed in the UCP1-positive beige cells as well as in human BAT. These data indicate that human BAT may be primary composed of beige/brite cells.	[Sharp, Louis Z.; Shinoda, Kosaku; Ohno, Haruya; Scheel, David W.; Tomoda, Emi; Ruiz, Lauren; Kajimura, Shingo] Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA; [Sharp, Louis Z.; Shinoda, Kosaku; Ohno, Haruya; Scheel, David W.; Tomoda, Emi; Ruiz, Lauren; Kajimura, Shingo] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Hu, Houchun; Gilsanz, Vicente] Univ So Calif, Childrens Hosp Los Angeles, Dept Radiol, Los Angeles, CA USA; [Wang, Larry; Pavlova, Zdena] Univ So Calif, Childrens Hosp Los Angeles, Dept Pathol, Los Angeles, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Children's Hospital Los Angeles; University of Southern California; Children's Hospital Los Angeles; University of Southern California	Kajimura, S (corresponding author), Univ Calif San Francisco, UCSF Diabet Ctr, San Francisco, CA 94143 USA.	skajimura@diabetes.ucsf.edu	Shinoda, Kosaku/V-1698-2019; Kajimura, Shingo/AAC-5090-2019	Shinoda, Kosaku/0000-0002-1928-0749; Kajimura, Shingo/0000-0003-0672-5910; Ohno, Haruya/0000-0001-5400-1162	National Institutes of Health [R00DK087853, R21DK090778, K25DK087931]; UCSF Program for Breakthrough Biomedical Research (PBBR); Asubio Pharma Co.; CIRM Bridges fellowship [TB1-01197]; Manpei Suzuki Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK087931, R21DK090778, R01DK097441, R00DK087853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Program for Breakthrough Biomedical Research (PBBR); Asubio Pharma Co.; CIRM Bridges fellowship; Manpei Suzuki Diabetes Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health to SK (R00DK087853) and to VG (R21DK090778 and K25DK087931). This work was also supported by grants from UCSF Program for Breakthrough Biomedical Research (PBBR) and from Asubio Pharma Co. to SK. LZS is supported by CIRM Bridges fellowship (TB1-01197). HO is supported by Manpei Suzuki Diabetes Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldred MA, 2004, J CLIN ONCOL, V22, P3531, DOI 10.1200/JCO.2004.08.127; Arch JRS, 2002, EUR J PHARMACOL, V440, P99, DOI 10.1016/S0014-2999(02)01421-8; Barbatelli G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1244, DOI 10.1152/ajpendo.00600.2009; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3; Coulter AA, 2003, PHYSIOL GENOMICS, V14, P139, DOI 10.1152/physiolgenomics.00057.2003; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Enerback S, 2010, CELL METAB, V11, P248, DOI 10.1016/j.cmet.2010.03.008; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Forner F, 2009, CELL METAB, V10, P324, DOI 10.1016/j.cmet.2009.08.014; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Gilsanz V, 2012, J PEDIATR-US, V160, P604, DOI 10.1016/j.jpeds.2011.09.035; Hu Houchun H, 2011, Front Endocrinol (Lausanne), V2, P33, DOI 10.3389/fendo.2011.00033; Hu HCH, 2012, J MAGN RESON IMAGING, V35, P938, DOI 10.1002/jmri.23531; Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Koncarevic A, 2012, ENDOCRINOLOGY, V153, P3133, DOI 10.1210/en.2012-1016; Lee P, 2010, AM J PHYSIOL-ENDOC M, V299, pE601, DOI 10.1152/ajpendo.00298.2010; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Madsen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011391; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Nishikata I, 2003, BLOOD, V102, P3323, DOI 10.1182/blood-2002-12-3944; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Prasad ML, 2004, THYROID, V14, P169, DOI 10.1089/105072504773297830; Rheinwald JG, 2002, MOL CELL BIOL, V22, P5157, DOI 10.1128/MCB.22.14.5157-5172.2002; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shioda T, 1996, P NATL ACAD SCI USA, V93, P12298, DOI 10.1073/pnas.93.22.12298; Svensson PA, 2011, INT J MOL MED, V27, P227, DOI 10.3892/ijmm.2010.566; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Vegiopoulos A, 2010, SCIENCE, V328, P1158, DOI 10.1126/science.1186034; Vernochet C, 2009, MOL CELL BIOL, V29, P4714, DOI 10.1128/MCB.01899-08; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Walden TB, 2012, AM J PHYSIOL-ENDOC M, V302, pE19, DOI 10.1152/ajpendo.00249.2011; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xue BZ, 2007, J LIPID RES, V48, P41, DOI 10.1194/jlr.M600287-JLR200; Xue BZ, 2005, MOL CELL BIOL, V25, P8311, DOI 10.1128/MCB.25.18.8311-8322.2005; Yadav H, 2011, CELL METAB, V14, P67, DOI 10.1016/j.cmet.2011.04.013; Yahata T, 2001, GENE DEV, V15, P2598, DOI 10.1101/gad.906301; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	53	468	487	1	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49452	10.1371/journal.pone.0049452	http://dx.doi.org/10.1371/journal.pone.0049452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166672	Green Published, gold			2022-12-27	WOS:000311885300043
J	Collins, S; Waickman, A; Basson, A; Kupfer, A; Licht, JD; Horton, MR; Powell, JD				Collins, Sam; Waickman, Adam; Basson, Albert; Kupfer, Abraham; Licht, Jonathan D.; Horton, Maureen R.; Powell, Jonathan D.			Regulation of CD4(+) and CD8(+) Effector Responses by Sprouty-1	PLOS ONE			English	Article							T-CELL ANERGY; E3 UBIQUITIN LIGASE; ACTIVATION; INDUCTION; PROTEINS; EGR-2; TOLERANCE; SPRED-1	TCR-induced NF-AT activation leads to the expression of both activating and inhibitory proteins. Previously, we had identified Egr-2 and Egr-3 as NF-AT-induced transcription factors which promote the inhibition of T cell activation. In this report we identify Sprouty1 as a downstream target of Egr-3. CD4(+) T cells lacking Spry1 demonstrate enhanced proliferation and cytokine production. Likewise, Spry1(Flox/Flox) Lck Cre CD8(+) T cells display increased cytolytic activity. Mechanistically, Spry1 acts at the level of PLC-gamma promoting the inhibition of both Ca++ induced NF-AT activation and MAP-kinase induced AP-1 activation while sparing NF-kappa B signaling. In vivo, mice in which Spry1 is selectively deleted in T cells demonstrate enhanced responses to a tumor vaccine and subsequently reject tumors more robustly than Wt mice. These findings suggest that targeting Spry1 might prove to be a novel means of enhancing tumor immunotherapy.	[Waickman, Adam; Powell, Jonathan D.] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA; [Collins, Sam; Horton, Maureen R.] Johns Hopkins Univ, Sch Med, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA; [Kupfer, Abraham] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD USA; [Basson, Albert] Kings Coll London, Dept Craniofacial Dev & Stem Cell Biol, London WC2R 2LS, England; [Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; University of London; King's College London; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center	Powell, JD (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21218 USA.	poweljo@jhmi.edu	Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019; Waickman, Adam/AHB-5028-2022	Licht, Jonathan/0000-0002-3942-1369; Waickman, Adam/0000-0002-4536-6714; Basson, M. Albert/0000-0001-9834-7528	National Institutes of Health [RO1 CA 59998, PO1 AI072677]; NATIONAL CANCER INSTITUTE [R01CA059998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI072677, T32AI007247] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health grants RO1 CA 59998 and PO1 AI072677. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbulut S, 2010, MOL BIOL CELL, V21, P3487, DOI 10.1091/mbc.E10-02-0123; Choi H, 2006, J IMMUNOL, V176, P6034, DOI 10.4049/jimmunol.176.10.6034; Collins S, 2008, EUR J IMMUNOL, V38, P528, DOI 10.1002/eji.200737157; Frank MJ, 2009, BLOOD, V113, P2478, DOI 10.1182/blood-2008-05-156943; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; Inoue H, 2005, J EXP MED, V201, P73, DOI 10.1084/jem.20040616; Jeon MS, 2004, IMMUNITY, V21, P167, DOI 10.1016/j.immuni.2004.07.013; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Lee JS, 2009, J IMMUNOL, V183, P7178, DOI 10.4049/jimmunol.0803799; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Nonami A, 2005, GENES CELLS, V10, P887, DOI 10.1111/j.1365-2443.2005.00886.x; Okamura T, 2009, P NATL ACAD SCI USA, V106, P13974, DOI 10.1073/pnas.0906872106; Olenchock BA, 2006, NAT IMMUNOL, V7, P1174, DOI 10.1038/ni1400; Reilly R Todd, 2002, Methods Mol Med, V69, P233; Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193; Seroogy CM, 2004, J IMMUNOL, V173, P79, DOI 10.4049/jimmunol.173.1.79; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394; Zhu B, 2008, J EXP MED, V205, P2295, DOI 10.1084/jem.20080187	19	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49801	10.1371/journal.pone.0049801	http://dx.doi.org/10.1371/journal.pone.0049801			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166773	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300070
J	Lin, J; Yoon, KC; Zhang, LL; Su, ZT; Lu, R; Ma, P; De Paiva, CS; Pflugfelder, SC; Li, DQ				Lin, Jing; Yoon, Kyung-Chul; Zhang, Lili; Su, Zhitao; Lu, Rong; Ma, Ping; De Paiva, Cintia S.; Pflugfelder, Stephen C.; Li, De-Quan			A Native-Like Corneal Construct Using Donor Corneal Stroma for Tissue Engineering	PLOS ONE			English	Article							LIMBAL EPITHELIAL-CELLS; HUMAN AMNIOTIC MEMBRANE; STEM-CELLS; SURFACE RECONSTRUCTION; GROWTH-FACTOR; EX-VIVO; TRANSPLANTATION; POPULATION; PHENOTYPE; MARKERS	Tissue engineering holds great promise for corneal transplantation to treat blinding diseases. This study was to explore the use of natural corneal stroma as an optimal substrate to construct a native like corneal equivalent. Human corneal epithelium was cultivated from donor limbal explants on corneal stromal discs prepared by FDA approved Horizon Epikeratome system. The morphology, phenotype, regenerative capacity and transplantation potential were evaluated by hematoxylin eosin and immunofluorescent staining, a wound healing model, and the xeno-transplantation of the corneal constructs to nude mice. An optically transparent and stratified epithelium was rapidly generated on donor corneal stromal substrate and displayed native-like morphology and structure. The cells were polygonal in the basal layer and became flattened in superficial layers. The epithelium displayed a phenotype similar to human corneal epithelium in vivo. The differentiation markers, keratin 3, involucrin and connexin 43, were expressed in full or superficial layers. Interestingly, certain basal cells were immunopositive to antibodies against limbal stem/progenitor cell markers ABCG2 and p63, which are usually negative in corneal epithelium in vivo. It suggests that this bioengineered corneal epithelium shared some characteristics of human limbal epithelium in vivo. This engineered epithelium was able to regenerate in 4 days following from a 4mm-diameter wound created by a filter paper soaked with 1 N NaOH. This corneal construct survived well after xeno-transplantation to the back of a nude mouse. The transplanted epithelium remained multilayer and became thicker with a phenotype similar to human corneal epithelium. Our findings demonstrate that natural corneal stroma is an optimal substrate for tissue bioengineering, and a native-like corneal construct has been created with epithelium containing limbal stem cells. This construct may have great potential for clinical use in corneal reconstruction.	[Lin, Jing; Yoon, Kyung-Chul; Zhang, Lili; Su, Zhitao; Lu, Rong; Ma, Ping; De Paiva, Cintia S.; Pflugfelder, Stephen C.; Li, De-Quan] Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA; [Lin, Jing; Zhang, Lili] Qingdao Univ, Coll Med, Affiliated Hosp, Dept Ophthalmol, Qingdao 266071, Peoples R China; [Yoon, Kyung-Chul] Chonnam Natl Univ, Med Sch & Hosp, Dept Ophthalmol, Kwangju, South Korea	Baylor College of Medicine; Qingdao University; Chonnam National University	Li, DQ (corresponding author), Baylor Coll Med, Cullen Eye Inst, Dept Ophthalmol, Ocular Surface Ctr, Houston, TX 77030 USA.	dequanl@bcm.tmc.edu	De Paiva, Cintia/AAH-8354-2021	De Paiva, Cintia/0000-0002-9057-5494	Department of Defense CDMRP PRMRP [FY06 PR064719]; National Institutes of Health [EY11915]; Lions Foundation for Sight; Research to Prevent Blindness; Oshman Foundation; William Stamps Farish Fund; NATIONAL EYE INSTITUTE [R01EY011915] Funding Source: NIH RePORTER	Department of Defense CDMRP PRMRP; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lions Foundation for Sight; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Oshman Foundation; William Stamps Farish Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by Department of Defense CDMRP PRMRP FY06 PR064719 (DQL), National Institutes of Health Grant EY11915 (SCP), Lions Foundation for Sight, Research to Prevent Blindness, Oshman Foundation, and William Stamps Farish Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Budak MT, 2005, J CELL SCI, V118, P1715, DOI 10.1242/jcs.02279; Chen B, 2012, SOFT MATTER, V8, P8379, DOI 10.1039/c2sm26175h; Chen B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013192; Chen Z, 2004, STEM CELLS, V22, P355, DOI 10.1634/stemcells.22-3-355; Chen Z, 2006, MOL VIS, V12, P983; Chen Z, 2006, STEM CELLS, V24, P1265, DOI 10.1634/stemcells.2005-0363; De Paiva CS, 2006, STEM CELLS, V24, P368, DOI 10.1634/stemcells.2005-0148; De Paiva CS, 2005, STEM CELLS, V23, P63, DOI 10.1634/stemcells.2004-0093; Doillon CJ, 2003, INT J ARTIF ORGANS, V26, P764, DOI 10.1177/039139880302600810; DONOHUE DJ, 1995, J OPT SOC AM A, V12, P1425, DOI 10.1364/JOSAA.12.001425; Dua H S, 2000, Indian J Ophthalmol, V48, P83; Germain L, 2000, PROG RETIN EYE RES, V19, P497, DOI 10.1016/S1350-9462(00)00005-7; Gil ES, 2010, BIOMATERIALS, V31, P8953, DOI 10.1016/j.biomaterials.2010.08.017; GIPSON IK, 1989, INVEST OPHTH VIS SCI, V30, P425; Jones RR, 2012, STEM CELL RES, V8, P403, DOI 10.1016/j.scr.2012.01.001; Kim HS, 2004, EXP EYE RES, V79, P41, DOI 10.1016/j.exer.2004.02.015; KIM JC, 1995, CORNEA, V14, P473; Koizumi N, 2000, INVEST OPHTH VIS SCI, V41, P2506; Koizumi N, 2001, OPHTHALMOLOGY, V108, P1569, DOI 10.1016/S0161-6420(01)00694-7; Li DQ, 2005, EXP EYE RES, V80, P581, DOI 10.1016/j.exer.2004.11.011; Lu R, 2012, STEM CELLS, V30, P753, DOI 10.1002/stem.1032; Nishida K, 2003, CORNEA, V22, pS28, DOI 10.1097/00003226-200310001-00005; Pajoohesh-Ganji A, 2005, BIOL CELL, V97, P265, DOI 10.1042/BC20040114; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Qi H, 2008, EXP EYE RES, V86, P34, DOI 10.1016/j.exer.2007.09.003; Qi H, 2008, EXP EYE RES, V87, P580, DOI 10.1016/j.exer.2008.09.012; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Schlotzer-Schrehardt U, 2005, EXP EYE RES, V81, P247, DOI 10.1016/j.exer.2005.02.016; Schwab IR, 2000, CORNEA, V19, P421, DOI 10.1097/00003226-200007000-00003; Selvam S, 2006, OCUL SURF, V4, P120, DOI 10.1016/S1542-0124(12)70039-3; Suzuki K, 2003, PROG RETIN EYE RES, V22, P113, DOI 10.1016/S1350-9462(02)00042-3; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P1938, DOI 10.1167/iovs.05-1129; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202	34	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49571	10.1371/journal.pone.0049571	http://dx.doi.org/10.1371/journal.pone.0049571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166715	gold, Green Published, Green Submitted			2022-12-27	WOS:000311272300055
J	Mades, A; Gotthardt, K; Awe, K; Stieler, J; Doring, T; Fuser, S; Prange, R				Mades, Andreas; Gotthardt, Katherina; Awe, Karin; Stieler, Jens; Doering, Tatjana; Fueser, Sabine; Prange, Reinhild			Role of Human Sec63 in Modulating the Steady-State Levels of Multi-Spanning Membrane Proteins	PLOS ONE			English	Article							LARGE ENVELOPE PROTEIN; ENDOPLASMIC-RETICULUM MEMBRANE; B SURFACE-ANTIGEN; ER MEMBRANE; TRANSMEMBRANE TOPOLOGY; TRANSLOCATIONAL REGULATION; CONDUCTING CHANNEL; POLYCYSTIC KIDNEY; TRANSLOCON; TRANSPORT	The Sec61 translocon of the endoplasmic reticulum (ER) membrane forms an aqueous pore, allowing polypeptides to be transferred across or integrated into membranes. Protein translocation into the ER can occur co- and posttranslationally. In yeast, posttranslational translocation involves the heptameric translocase complex including its Sec62p and Sec63p subunits. The mammalian ER membrane contains orthologs of yeast Sec62p and Sec63p, but their function is poorly understood. Here, we analyzed the effects of excess and deficit Sec63 on various ER cargoes using human cell culture systems. The overexpression of Sec63 reduces the steady-state levels of viral and cellular multi-spanning membrane proteins in a cotranslational mode, while soluble and single-spanning ER reporters are not affected. Consistent with this, the knock-down of Sec63 increases the steady-state pools of polytopic ER proteins, suggesting a substrate-specific and regulatory function of Sec63 in ER import. Overexpressed Sec63 exerts its down-regulating activity on polytopic protein levels independent of its Sec62-interacting motif, indicating that it may not act in conjunction with Sec62 in human cells. The specific action of Sec63 is further sustained by our observations that the up-regulation of either Sec62 or two other ER proteins with lumenal J domains, like ERdj1 and ERdj4, does not compromise the steady-state level of a multi-spanning membrane reporter. A J domain-specific mutation of Sec63, proposed to weaken its interaction with the ER resident BiP chaperone, reduces the down-regulating capacity of excess Sec63, suggesting an involvement of BiP in this process. Together, these results suggest that Sec63 may perform a substrate-selective quantity control function during cotranslational ER import.	[Gotthardt, Katherina; Awe, Karin; Stieler, Jens; Doering, Tatjana; Fueser, Sabine; Prange, Reinhild] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Microbiol & Hyg, Mainz, Germany; [Mades, Andreas] Johannes Gutenberg Univ Mainz, Sch Med, Dept Med Hematol & Oncol 3, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Prange, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Microbiol & Hyg, Mainz, Germany.	prange@uni-mainz.de	Stieler, Jens T/A-5111-2017	Stieler, Jens T/0000-0002-3770-3258; Prange, Reinhild/0000-0001-8312-4970	Deutsche Forschungsgemeinschaft [PR305/1-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by grants to RP from the Deutsche Forschungsgemeinschaft (PR305/1-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abell BM, 2003, J BIOL CHEM, V278, P5669, DOI 10.1074/jbc.M209968200; Awe K, 2008, FEBS LETT, V582, P3179, DOI 10.1016/j.febslet.2008.07.062; Bakeberg JL, 2011, J AM SOC NEPHROL, V22, P2266, DOI 10.1681/ASN.2010111173; BRODSKY JL, 1995, P NATL ACAD SCI USA, V92, P9643, DOI 10.1073/pnas.92.21.9643; BRUSS V, 1994, EMBO J, V13, P2273, DOI 10.1002/j.1460-2075.1994.tb06509.x; Bruss V, 2007, WORLD J GASTROENTERO, V13, P65, DOI 10.3748/wjg.v13.i1.65; Chevalier M, 2000, J BIOL CHEM, V275, P19620, DOI 10.1074/jbc.M001333200; Corsi AK, 1997, J CELL BIOL, V137, P1483, DOI 10.1083/jcb.137.7.1483; Davila S, 2004, NAT GENET, V36, P575, DOI 10.1038/ng1357; Del-Val M, 2002, MOL IMMUNOL, V39, P235, DOI 10.1016/S0161-5890(02)00104-9; Dudek J, 2005, NAT STRUCT MOL BIOL, V12, P1008, DOI 10.1038/nsmb1007; EBLE BE, 1986, MOL CELL BIOL, V6, P1454, DOI 10.1128/MCB.6.5.1454; Fedeles SV, 2011, NAT GENET, V43, P639, DOI 10.1038/ng.860; Fons RD, 2003, J CELL BIOL, V160, P529, DOI 10.1083/jcb.200210095; Goldshmidt H, 2008, J BIOL CHEM, V283, P32085, DOI 10.1074/jbc.M801499200; GORLICH D, 1992, NATURE, V357, P47, DOI 10.1038/357047a0; GORLICH D, 1993, CELL, V75, P615, DOI 10.1016/0092-8674(93)90483-7; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; Harada Y, 2011, J BIOL CHEM, V286, P2956, DOI 10.1074/jbc.M110.159517; Hartmann-Stuhler C, 2001, J VIROL, V75, P5343, DOI 10.1128/JVI.75.11.5343-5351.2001; Hegde RS, 2008, J CELL BIOL, V182, P225, DOI 10.1083/jcb.200804157; Heinrich SU, 2000, CELL, V102, P233, DOI 10.1016/S0092-8674(00)00028-3; Hendershot LM, 2004, MT SINAI J MED, V71, P289; HUOVILA APJ, 1992, J CELL BIOL, V118, P1305, DOI 10.1083/jcb.118.6.1305; Junne T, 2010, MOL BIOL CELL, V21, P1662, DOI 10.1091/mbc.E10-01-0060; Kalies KU, 1998, J CELL BIOL, V141, P887, DOI 10.1083/jcb.141.4.887; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kida Y, 2007, J CELL BIOL, V179, P1441, DOI 10.1083/jcb.200707050; Lai CW, 2012, J BIOL CHEM, V287, P7969, DOI 10.1074/jbc.M111.311290; Lambert C, 2003, P NATL ACAD SCI USA, V100, P5199, DOI 10.1073/pnas.0930813100; Lambert C, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-45; Lang S, 2012, J CELL SCI, V125, P1958, DOI 10.1242/jcs.096727; Lazar C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034169; LOCKER JK, 1992, J BIOL CHEM, V267, P21911; MACHAMER CE, 1985, MOL CELL BIOL, V5, P3074, DOI 10.1128/MCB.5.11.3074; MARTOGLIO B, 1995, CELL, V81, P207, DOI 10.1016/0092-8674(95)90330-5; McCormick PJ, 2003, MOL CELL, V12, P329, DOI 10.1016/S1097-2765(03)00304-6; Meacock SL, 2002, MOL BIOL CELL, V13, P4114, DOI 10.1091/mbc.E02-04-0198; Meyer HA, 2000, J BIOL CHEM, V275, P14550, DOI 10.1074/jbc.275.19.14550; Misselwitz E, 1999, J BIOL CHEM, V274, P20110, DOI 10.1074/jbc.274.29.20110; Mochizuki T, 1996, SCIENCE, V272, P1339, DOI 10.1126/science.272.5266.1339; Muller L, 2010, MOL BIOL CELL, V21, P691, DOI 10.1091/mbc.E09-08-0730; OSTAPCHUK P, 1994, EMBO J, V13, P1048, DOI 10.1002/j.1460-2075.1994.tb06353.x; Ota K, 1998, MOL CELL, V2, P495, DOI 10.1016/S1097-2765(00)80149-5; Otero JH, 2010, SEMIN CELL DEV BIOL, V21, P472, DOI 10.1016/j.semcdb.2009.12.008; Pitonzo D, 2009, MOL BIOL CELL, V20, P685, DOI 10.1091/mbc.E08-09-0902; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; PRANGE R, 1992, J VIROL, V66, P5832, DOI 10.1128/JVI.66.10.5832-5841.1992; PRANGE R, 1995, EMBO J, V14, P247, DOI 10.1002/j.1460-2075.1995.tb06998.x; Rapoport TA, 2007, NATURE, V450, P663, DOI 10.1038/nature06384; Rost M, 2006, J BIOL CHEM, V281, P29297, DOI 10.1074/jbc.M603517200; Sadlish H, 2005, NAT STRUCT MOL BIOL, V12, P870, DOI 10.1038/nsmb994; Schnell DJ, 2003, CELL, V112, P491, DOI 10.1016/S0092-8674(03)00110-7; Swift S, 2001, CURR PROTOC IMMUNOL; Tolosano E, 2002, DNA CELL BIOL, V21, P297, DOI 10.1089/104454902753759717; Tyedmers J, 2000, P NATL ACAD SCI USA, V97, P7214, DOI 10.1073/pnas.97.13.7214; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van Niel G, 2011, DEV CELL, V21, P708, DOI 10.1016/j.devcel.2011.08.019; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Voigt S, 1996, J CELL BIOL, V134, P25, DOI 10.1083/jcb.134.1.25; Zimmermann R, 2006, TRENDS MOL MED, V12, P567, DOI 10.1016/j.molmed.2006.10.004	61	12	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49243	10.1371/journal.pone.0049243	http://dx.doi.org/10.1371/journal.pone.0049243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166619	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300035
J	Gleason, MX; Mdzinarishvili, T; Sherman, S				Gleason, Michael X.; Mdzinarishvili, Tengiz; Sherman, Simon			Breast Cancer Incidence in Black and White Women Stratified by Estrogen and Progesterone Receptor Statuses	PLOS ONE			English	Article							AGE DISTRIBUTION; INCIDENCE RATES; FEMALE BREAST; MODEL; RISK; MENOPAUSE; BIRTH	Background: There is increasing evidence that breast cancer is a heterogeneous disease presented by different phenotypes and that white women have a higher breast cancer incidence rate, whereas black women have a higher mortality rate. It is also well known that white women have lower incidence rates than black women until approximately age 40, when rate curves cross over and white women have higher rates. The goal of this study was to validate the risk of white and black women to breast cancer phenotypes, stratified by statuses of the estrogen (ER) and progesterone (PR) receptors. Methodology/Principal Findings: SEER17 data were fractioned by receptor status into [ER+, PR+], [ER2, PR2], [ER+, PR2], and [ER2, PR+] phenotypes. It was shown that in black women compared to white women, cumulative age-specific incidence rates are: (i) smaller for the [ER+, PR+] phenotype; (ii) larger for the [ER2, PR2] and [ER2, PR+] phenotypes; and (iii) almost equal for the [ER+, PR2] phenotype. Clemmesen's Hook, an undulation unique to women's breast cancer age-specific incidence rate curves, is shown here to exist in both races only for the [ER+, PR+] phenotype. It was also shown that for all phenotypes, rate curves have additional undulations and that age-specific incidence rates are nearly proportional in all age intervals. Conclusions/Significance: For black and white women, risk for the [ER+, PR+], [ER2, PR2] and [ER2, PR+] phenotypes are race dependent, while risk for the [ER+, PR2] phenotype is almost independent of race. The processes of carcinogenesis in aging, leading to the development of each of the considered breast cancer phenotypes, are similar in these racial groups. Undulations exhibited on the curves of age-specific incidence rates of the considered breast cancer phenotypes point to the presence of several subtypes (to be determined) of each of these phenotypes.	[Gleason, Michael X.; Mdzinarishvili, Tengiz; Sherman, Simon] Univ Nebraska Med Ctr, Eppley Canc Inst, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center	Gleason, MX (corresponding author), Univ Nebraska Med Ctr, Eppley Canc Inst, Omaha, NE USA.	ssherm@unmc.edu		Gleason, Michael/0000-0003-3845-1870				Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; American Cancer Society, 2010, CANC FACTS FIG 2010; ANDERSON E, 1950, CANCER-AM CANCER SOC, V3, P410, DOI 10.1002/1097-0142(1950)3:3<410::AID-CNCR2820030303>3.0.CO;2-H; Anderson WF, 2006, JNCI-J NATL CANCER I, V98, P948, DOI 10.1093/jnci/djj295; Anderson WF, 2008, JNCI-J NATL CANCER I, V100, P1804, DOI 10.1093/jnci/djn411; [Anonymous], 2008, SURVEILLANCE EPIDEMI; [Anonymous], 2011, SURV EP END RES SEER; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Beral V, 2002, LANCET, V360, P187, DOI 10.1016/S0140-6736(02)09454-0; Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0; Brinton LA, 1997, INT J CANCER, V73, P349, DOI 10.1002/(SICI)1097-0215(19971104)73:3<349::AID-IJC8>3.0.CO;2-#; BYRNE C, 1995, J NATL CANCER I, V87, P1622, DOI 10.1093/jnci/87.21.1622; Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5; CLEMMESEN J, 1948, BRIT J RADIOL, V21, P583, DOI 10.1259/0007-1285-21-252-583; CLEMMESEN J, 1951, J NATL CANCER I, V12, P1; Colditz GA, 2000, AM J EPIDEMIOL, V152, P950, DOI 10.1093/aje/152.10.950; COOK PJ, 1969, INT J CANCER, V4, P93, DOI 10.1002/ijc.2910040113; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; De Maeyer L, 2008, J CLIN ONCOL, V26, P335, DOI 10.1200/JCO.2007.14.8411; DEWAARD F, 1960, BRIT J CANCER, V14, P437, DOI 10.1038/bjc.1960.47; Ettinger B, 2003, OBSTET GYNECOL, V102, P1225, DOI 10.1016/j.obstetgynecol.2003.08.007; Forshee Richard A., 2003, Cancer, V97, P280, DOI 10.1002/cncr.11020; GRAY GE, 1980, J NATL CANCER I, V64, P461; Hankey B F, 1994, J Natl Cancer Inst Monogr, P7; Holli K, 2009, J CLIN ONCOL, V27, P927, DOI 10.1200/JCO.2008.19.7129; HORWITZ KB, 1978, J BIOL CHEM, V253, P2223; KNIGHT WA, 1977, CANCER RES, V37, P4669; Kravchenko J, 2011, BREAST CANCER RES TR, V128, P483, DOI 10.1007/s10549-011-1347-z; LILIENFELD AM, 1955, CANCER, V8, P875, DOI 10.1002/1097-0142(1955)8:5<875::AID-CNCR2820080504>3.0.CO;2-Z; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; MACMAHON B, 1970, B WORLD HEALTH ORGAN, V43, P209; MANTON KG, 1980, J NATL CANCER I, V64, P9; Mdzinarishvili T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034362; MOOLGAVKAR SH, 1981, J NATL CANCER I, V66, P1037, DOI 10.1093/jnci/66.6.1037; Newman LA, 2005, ONCOLOGIST, V10, P1, DOI 10.1634/theoncologist.10-1-1; Olopade Olufunmilayo I., 2003, Cancer, V97, P236, DOI 10.1002/cncr.11019; Palmer JR, 2003, J NATL CANCER I, V95, P478, DOI 10.1093/jnci/95.6.478; Parkin DM, 2001, EUR J CANCER, V37, pS4, DOI 10.1016/S0959-8049(01)00267-2; Pathak DR, 2000, CANCER-AM CANCER SOC, V88, P1230, DOI 10.1002/(SICI)1097-0142(20000301)88:5+<1230::AID-CNCR9>3.0.CO;2-F; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pompei F, 2001, HUM ECOL RISK ASSESS, V7, P1619, DOI 10.1080/20018091095267; Ries LAG, 2007, SEER SURVIVAL MONOGR; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; SAINSBURY JRC, 1987, LANCET, V1, P1398; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; STEVENS RG, 1982, AM J EPIDEMIOL, V115, P759, DOI 10.1093/oxfordjournals.aje.a113358; TRICHOPOULOS D, 1983, INT J CANCER, V31, P701, DOI 10.1002/ijc.2910310604; Turnbull L, 2010, LANCET, V375, P563, DOI 10.1016/S0140-6736(09)62070-5; Velentgas P, 1994, J Natl Cancer Inst Monogr, P15; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Whelan TJ, 2010, NEW ENGL J MED, V362, P513, DOI 10.1056/NEJMoa0906260; Wiseman M, 2008, P NUTR SOC, V67, P253, DOI 10.1017/S002966510800712X	52	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49359	10.1371/journal.pone.0049359	http://dx.doi.org/10.1371/journal.pone.0049359			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166647	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900130
J	Gosu, V; Basith, S; Durai, P; Choi, S				Gosu, Vijayakumar; Basith, Shaherin; Durai, Prasannavenkatesh; Choi, Sangdun			Molecular Evolution and Structural Features of IRAK Family Members	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; TOLL-LIKE; INTERLEUKIN-1 RECEPTOR; DEATH DOMAIN; SIGNALING PATHWAYS; ADAPTER MOLECULE; MICE LACKING; PROTEIN; KINASE; COMPLEX	The interleukin-1 receptor-associated kinase (IRAK) family comprises critical signaling mediators of the TLR/IL-1R signaling pathways. IRAKs are Ser/Thr kinases. There are 4 members in the vertebrate genome (IRAK1, IRAK2, IRAKM, and IRAK4) and an IRAK homolog, Pelle, in insects. IRAK family members are highly conserved in vertebrates, but the evolutionary relationship between IRAKs in vertebrates and insects is not clear. To investigate the evolutionary history and functional divergence of IRAK members, we performed extensive bioinformatics analysis. The phylogenetic relationship between IRAK sequences suggests that gene duplication events occurred in the evolutionary lineage, leading to early vertebrates. A comparative phylogenetic analysis with insect homologs of IRAKs suggests that the Tube protein is a homolog of IRAK4, unlike the anticipated protein, Pelle. Furthermore, the analysis supports that an IRAK4-like kinase is an ancestral protein in the metazoan lineage of the IRAK family. Through functional analysis, several potentially diverged sites were identified in the common death domain and kinase domain. These sites have been constrained during evolution by strong purifying selection, suggesting their functional importance within IRAKs. In summary, our study highlighted the molecular evolution of the IRAK family, predicted the amino acids that contributed to functional divergence, and identified structural variations among the IRAK paralogs that may provide a starting point for further experimental investigations.	[Gosu, Vijayakumar; Basith, Shaherin; Durai, Prasannavenkatesh; Choi, Sangdun] Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea	Ajou University	Gosu, V (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 441749, South Korea.	sangdunchoi@ajou.ac.kr	Durai, Prasannavenkatesh/AAU-4782-2021	Gosu, Vijayakumar/0000-0001-6038-4104; Durai, Prasannavenkatesh/0000-0002-1538-8349				Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Basith S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023989; Benson DA, 2004, NUCLEIC ACIDS RES, V32, pD23, DOI 10.1093/nar/gkh045; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Beutler B, 2003, SCAND J INFECT DIS, V35, P563, DOI 10.1080/00365540310016295; Brikos C, 2007, MOL CELL PROTEOMICS, V6, P1551, DOI 10.1074/mcp.M600455-MCP200; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; CROSTON GE, 1995, J BIOL CHEM, V270, P16514, DOI 10.1074/jbc.270.28.16514; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Edwards DN, 1997, DEVELOPMENT, V124, P3855; Escriva H, 2006, PLOS GENET, V2, P955, DOI 10.1371/journal.pgen.0020102; FEINSTEIN E, 1995, TRENDS BIOCHEM SCI, V20, P342, DOI 10.1016/S0968-0004(00)89070-2; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Flannery S, 2010, BIOCHEM PHARMACOL, V80, P1981, DOI 10.1016/j.bcp.2010.06.020; Gauthier MEA, 2010, EVOL DEV, V12, P519, DOI 10.1111/j.1525-142X.2010.00436.x; Gottipati S, 2008, CELL SIGNAL, V20, P269, DOI 10.1016/j.cellsig.2007.08.009; Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Gu X, 2001, MOL BIOL EVOL, V18, P453, DOI 10.1093/oxfordjournals.molbev.a003824; Holland LZ, 2004, CELL MOL LIFE SCI, V61, P2290, DOI 10.1007/s00018-004-4075-2; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kanakaraj P, 1998, J EXP MED, V187, P2073, DOI 10.1084/jem.187.12.2073; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Kollewe C, 2004, J BIOL CHEM, V279, P5227, DOI 10.1074/jbc.M309251200; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krishnan J, 2007, EXP MOL MED, V39, P421, DOI 10.1038/emm.2007.47; Kuglstatter A, 2007, J IMMUNOL, V178, P2641, DOI 10.4049/jimmunol.178.5.2641; LETSOU A, 1993, EMBO J, V12, P3449, DOI 10.1002/j.1460-2075.1993.tb06019.x; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lin SC, 2010, NATURE, V465, P885, DOI 10.1038/nature09121; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Manuel M, 2000, J MOL EVOL, V51, P378, DOI 10.1007/s002390010100; MARTIN M, 1994, EUR J IMMUNOL, V24, P1566, DOI 10.1002/eji.1830240717; Martin M.U., 2001, SIGNAL TRANSDUCT, V1, P37; Martin MU, 2002, BBA-MOL CELL RES, V1592, P265, DOI 10.1016/S0167-4889(02)00320-8; McDowall J, 2011, METHODS MOL BIOL, V694, P37, DOI 10.1007/978-1-60761-977-2_3; Medzhitov R, 1998, MOL CELL, V2, P253, DOI 10.1016/S1097-2765(00)80136-7; Meylan E, 2008, NAT IMMUNOL, V9, P581, DOI 10.1038/ni0608-581; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Neumann D, 2008, J LEUKOCYTE BIOL, V84, P807, DOI 10.1189/jlb.0507290; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Oshiumi H, 2003, NAT IMMUNOL, V4, P161, DOI 10.1038/ni886; Pawlowski M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-403; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosati O, 2002, BIOCHEM BIOPH RES CO, V293, P1472, DOI 10.1016/S0006-291X(02)00411-4; Russo AA, 1996, NAT STRUCT BIOL, V3, P696, DOI 10.1038/nsb0896-696; SHELTON CA, 1993, CELL, V72, P515, DOI 10.1016/0092-8674(93)90071-W; Silverman N, 2001, GENE DEV, V15, P2321, DOI 10.1101/gad.909001; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Sun HY, 2002, P NATL ACAD SCI USA, V99, P12871, DOI 10.1073/pnas.202396399; Suzuki N, 2002, NATURE, V416, P750, DOI 10.1038/nature736; Swantek JL, 2000, J IMMUNOL, V164, P4301, DOI 10.4049/jimmunol.164.8.4301; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thomas JA, 1999, J IMMUNOL, V163, P978; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Towb P, 2009, J INNATE IMMUN, V1, P309, DOI 10.1159/000200773; Van de Peer Y, 2004, NAT REV GENET, V5, P752, DOI 10.1038/nrg1449; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Wang ZL, 2006, STRUCTURE, V14, P1835, DOI 10.1016/j.str.2006.11.001; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Wesche H, 1999, J BIOL CHEM, V274, P19403, DOI 10.1074/jbc.274.27.19403; Xiao T, 1999, CELL, V99, P545, DOI 10.1016/S0092-8674(00)81542-1; Yang J, 1997, P NATL ACAD SCI USA, V94, P14524, DOI 10.1073/pnas.94.26.14524; Ye H, 2002, NATURE, V418, P443, DOI 10.1038/nature00888	79	31	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49771	10.1371/journal.pone.0049771	http://dx.doi.org/10.1371/journal.pone.0049771			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166766	Green Published, gold			2022-12-27	WOS:000311151900190
J	Hakulinen, R; Puranen, S; Lehtonen, JV; Johnson, MS; Corander, J				Hakulinen, Riku; Puranen, Santeri; Lehtonen, Jukka V.; Johnson, Mark S.; Corander, Jukka			Probabilistic Prediction of Contacts in Protein-Ligand Complexes	PLOS ONE			English	Article							HYDROGEN-BOND	We introduce a statistical method for evaluating atomic level 3D interaction patterns of protein-ligand contacts. Such patterns can be used for fast separation of likely ligand and ligand binding site combinations out of all those that are geometrically possible. The practical purpose of this probabilistic method is for molecular docking and scoring, as an essential part of a scoring function. Probabilities of interaction patterns are calculated conditional on structural x-ray data and predefined chemical classification of molecular fragment types. Spatial coordinates of atoms are modeled using a Bayesian statistical framework with parametric 3D probability densities. The parameters are given distributions a priori, which provides the possibility to update the densities of model parameters with new structural data and use the parameter estimates to create a contact hierarchy. The contact preferences can be defined for any spatial area around a specified type of fragment. We compared calculated contact point hierarchies with the number of contact atoms found near the contact point in a reference set of x-ray data, and found that these were in general in a close agreement. Additionally, using substrate binding site in cathechol-O-methyltransferase and 27 small potential binder molecules, it was demonstrated that these probabilities together with auxiliary parameters separate well ligands from decoys (true positive rate 0.75, false positive rate 0). A particularly useful feature of the proposed Bayesian framework is that it also characterizes predictive uncertainty in terms of probabilities, which have an intuitive interpretation from the applied perspective.	[Hakulinen, Riku] Abo Akad Univ, Dept Nat Sci Math & Stat, Turku, Finland	Abo Akademi University	Hakulinen, R (corresponding author), Abo Akad Univ, Dept Nat Sci Math & Stat, Turku, Finland.	riku.hakulinen@abo.fi		Lehtonen, Jukka V./0000-0003-0385-0636				Acharya KR, 2005, TRENDS PHARMACOL SCI, V26, P10, DOI 10.1016/j.tips.2004.10.011; Auffinger P, 2001, P NATL ACAD SCI USA, V101, P16789; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernardo JM, 1994, BAYESIAN THEORY; Bewick V, 2005, CRIT CARE; Bonifacio MJ, 2002, MOL PHARMACOL, V62, P795, DOI 10.1124/mol.62.4.795; Desiraju GR, 1996, ACCOUNTS CHEM RES, V29, P441, DOI 10.1021/ar950135n; DIMITROPOULOS D, 2006, CURRENT PROTOCOLS BI; Drinkwater N, 2009, BIOCHEM J, V422, P463, DOI 10.1042/BJ20090702; Egan J.P., 1975, SIGNAL DETECTION THE; Finkelstein A. V., 2002, PROTEIN PHYS COURSE; Gautschi Walter, 1972, HDB MATH FUNCTIONS, P295; Geisser S., 2017, PREDICTIVE INFERENCE; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gilson MK, 2007, ANNU REV BIOPH BIOM, V36, P21, DOI 10.1146/annurev.biophys.36.040306.132550; Grimme S, 2008, ANGEW CHEM INT EDIT, V47, P3430, DOI 10.1002/anie.200705157; GUTTORP P, 1988, J AM STAT ASSOC, V83, P322, DOI 10.2307/2288846; Howard JAK, 1996, TETRAHEDRON, V52, P12613, DOI 10.1016/0040-4020(96)00749-1; Huang N, 2006, J MED CHEM, V49, P6789, DOI 10.1021/jm0608356; Huang SY, 2010, PHYS CHEM CHEM PHYS, V12, P12899, DOI 10.1039/c0cp00151a; Huang SY, 2010, INT J MOL SCI, V11, P3016, DOI 10.3390/ijms11083016; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549; Kortemme T, 2003, J MOL BIOL, V326, P1239, DOI 10.1016/S0022-2836(03)00021-4; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Mandl F, 1988, STAT PHYS; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Mardia K.V., 1999, DIRECTIONAL STAT, DOI [10.1002/9780470316979, DOI 10.1002/9780470316979]; Morozov AV, 2004, P NATL ACAD SCI USA, V101, P6946, DOI 10.1073/pnas.0307578101; Nicholls A, 2008, J COMPUT AID MOL DES, V22, P239, DOI 10.1007/s10822-008-9170-2; Nunez- Antonio G, 2005, COMMUN STAT-SIMUL C, V34, P989, DOI 10.1080/03610910500308495; PARR RG, 1983, J AM CHEM SOC, V105, P7512, DOI 10.1021/ja00364a005; Rantanen Ville-Veikko, 2005, Journal of Bioinformatics and Computational Biology, V3, P861, DOI 10.1142/S0219720005001417; Rantanen VV, 2003, J COMPUT AID MOL DES, V17, P435, DOI 10.1023/A:1027371810547; Rantanen VV, 2001, J MOL BIOL, V313, P197, DOI 10.1006/jmbi.2001.5023; Scapin G, 2006, CURR PHARM DESIGN, V12, P2087, DOI 10.2174/138161206777585201; Scheiner S, 2001, J BIOL CHEM, V276, P9832, DOI 10.1074/jbc.M010770200; Strombergsson H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S6-S13	38	3	3	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49216	10.1371/journal.pone.0049216	http://dx.doi.org/10.1371/journal.pone.0049216			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155467	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900102
J	Moussa, L; Bezirard, V; Salvador-Cartier, C; Bacquie, V; Lencina, C; Leveque, M; Braniste, V; Menard, S; Theodorou, V; Houdeau, E				Moussa, Lara; Bezirard, Valerie; Salvador-Cartier, Christel; Bacquie, Valerie; Lencina, Corinne; Leveque, Mathilde; Braniste, Viorica; Menard, Sandrine; Theodorou, Vassilia; Houdeau, Eric			A Low Dose of Fermented Soy Germ Alleviates Gut Barrier Injury, Hyperalgesia and Faecal Protease Activity in a Rat Model of Inflammatory Bowel Disease	PLOS ONE			English	Article							MIGRATION-INHIBITORY FACTOR; DEXTRAN SULFATE SODIUM; BOWMAN-BIRK INHIBITOR; NECROSIS-FACTOR-ALPHA; ULCERATIVE-COLITIS; COLONIC INFLAMMATION; FACTOR ANTIBODY; CROHNS-DISEASE; ESTROGEN; INTERLEUKIN-10	Pro-inflammatory cytokines like macrophage migration inhibitory factor (MIF), IL-1 beta and TNF-alpha predominate in inflammatory bowel diseases (IBD) and TNBS colitis. Increased levels of serine proteases activating protease-activated receptor 2 (PAR-2) are found in the lumen and colonic tissue of IBD patients. PAR-2 activity and pro-inflammatory cytokines impair epithelial barrier, facilitating the uptake of luminal aggressors that perpetuate inflammation and visceral pain. Soy extracts contain phytoestrogens (isoflavones) and serine protease inhibitors namely Bowman-Birk Inhibitors (BBI). Since estrogens exhibit anti-inflammatory and epithelial barrier enhancing properties, and that a BBI concentrate improves ulcerative colitis, we aimed to evaluate if a fermented soy germ extract (FSG) with standardized isoflavone profile and stable BBI content exert cumulative or synergistic protection based on protease inhibition and estrogen receptor (ER)-ligand activity in colitic rats. Female rats received orally for 15 d either vehicle or FSG with or without an ER antagonist ICI 182.780 before TNBS intracolonic instillation. Macroscopic and microscopic damages, myeloperoxidase activity, cytokine levels, intestinal paracellular permeability, visceral sensitivity, faecal proteolytic activity and PAR-2 expression were assessed 24 h, 3 d and 5 d post-TNBS. FSG treatment improved the severity of colitis, by decreasing the TNBS-induced rise in gut permeability, visceral sensitivity, faecal proteolytic activity and PAR-2 expression at all post-TNBS points. All FSG effects were reversed by the ICI 182.780 except the decrease in faecal proteolytic activity and PAR-2 expression. In conclusion, the anti-inflammatory properties of FSG treatment result from two distinct but synergic pathways i.e an ER-ligand and a PAR-2 mediated pathway, providing rationale for potential use as adjuvant therapy in IBD.	[Moussa, Lara; Bezirard, Valerie; Salvador-Cartier, Christel; Bacquie, Valerie; Lencina, Corinne; Leveque, Mathilde; Braniste, Viorica; Menard, Sandrine; Theodorou, Vassilia; Houdeau, Eric] INRA INPT UPS, Inst Natl Rech Agron, Toxalim UMR1331, Toulouse, France	INRAE; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National Polytechnique de Toulouse	Moussa, L (corresponding author), INRA INPT UPS, Inst Natl Rech Agron, Toxalim UMR1331, Toulouse, France.	Eric.Houdeau@toulouse.inra.fr	Menard, Sandrine/ABF-8935-2021	Menard, Sandrine/0000-0001-8867-199X; Braniste, Viorica/0000-0003-1992-3609; Leveque, Mathilde/0000-0003-1253-3798				ADAMS RB, 1993, J IMMUNOL, V150, P2356; Alzoghaibi Mohammed Abdullah, 2005, Saudi J Gastroenterol, V11, P63; APPLEYARD CB, 1995, AM J PHYSIOL-GASTR L, V269, pG119, DOI 10.1152/ajpgi.1995.269.1.G119; Arai Y, 1998, CYTOKINE, V10, P890, DOI 10.1006/cyto.1998.0355; Baumgart DC, 2007, LANCET, V369, P1641, DOI 10.1016/S0140-6736(07)60751-X; BIRK Y, 1985, INT J PEPT PROT RES, V25, P113, DOI 10.1111/j.1399-3011.1985.tb02155.x; Braniste V, 2009, J PHYSIOL-LONDON, V587, P3317, DOI 10.1113/jphysiol.2009.169300; Brown AC, 2011, EXPERT REV GASTROENT, V5, P411, DOI [10.1586/EGH.11.29, 10.1586/egh.11.29]; Bueno L, 2000, AM J PHYSIOL-GASTR L, V278, pG670, DOI 10.1152/ajpgi.2000.278.5.G670; Cattaruzza F, 2011, GASTROENTEROLOGY, V141, P1864, DOI 10.1053/j.gastro.2011.07.035; Cenac N, 2003, J IMMUNOL, V170, P4296, DOI 10.4049/jimmunol.170.8.4296; de Jong YP, 2001, NAT IMMUNOL, V2, P1061, DOI 10.1038/ni720; Drewes AM, 2006, INFLAMM BOWEL DIS, V12, P294, DOI 10.1097/01.MIB.0000209365.09189.04; Eijkelkamp N, 2009, BRAIN BEHAV IMMUN, V23, P18, DOI 10.1016/j.bbi.2008.07.006; FABIA R, 1993, DIGESTION, V54, P248, DOI 10.1159/000201045; Filipe P, 2005, PHOTOCH PHOTOBIO SCI, V4, P420, DOI 10.1039/b416811a; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; HACHET T, 1993, GASTROEN CLIN BIOL, V17, P347; Harnish DC, 2004, AM J PHYSIOL-GASTR L, V286, pG118, DOI 10.1152/ajpgi.00024.2003; Hawkins JV, 1997, DIGEST DIS SCI, V42, P1969, DOI 10.1023/A:1018887832465; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Houdeau E, 2007, GASTROENTEROLOGY, V132, P982, DOI 10.1053/j.gastro.2006.12.028; Hubert J, 2008, FOOD CHEM, V109, P709, DOI 10.1016/j.foodchem.2007.12.081; Hyun E, 2008, GUT, V57, P1222, DOI 10.1136/gut.2008.150722; Ji YP, 2005, PAIN, V117, P433, DOI 10.1016/j.pain.2005.07.011; Kim JA, 2003, INFLAMM BOWEL DIS, V9, P224, DOI 10.1097/00054725-200307000-00002; Konstantinopoulos PA, 2003, EUR J CANCER, V39, P1251, DOI 10.1016/S0959-8049(03)00239-9; Kruidenier L, 2003, FREE RADICAL BIO MED, V34, P753, DOI 10.1016/S0891-5849(02)01426-0; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Lichtenstein GR, 2008, DIGEST DIS SCI, V53, P175, DOI 10.1007/s10620-007-9840-2; Madsen KL, 1999, INFLAMM BOWEL DIS, V5, P262, DOI 10.1097/00054725-199911000-00004; Makita H, 1998, AM J RESP CRIT CARE, V158, P573, DOI 10.1164/ajrccm.158.2.9707086; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Morimoto M, 2009, J GASTROENTEROL HEPA; MORTEAU O, 1994, DIGEST DIS SCI, V39, P1239, DOI 10.1007/BF02093789; Moussa L, 2013, CLIN NUTR, V32, P51, DOI 10.1016/j.clnu.2012.05.021; Murakami H, 2002, CLIN EXP IMMUNOL, V128, P504, DOI 10.1046/j.1365-2249.2002.01838.x; Ohkawara T, 2002, GASTROENTEROLOGY, V123, P256, DOI 10.1053/gast.2002.34236; Paul G, 2012, EUR J CLIN INVEST, V42, P95, DOI 10.1111/j.1365-2362.2011.02552.x; Raithel H, 2001, SCAND J GASTROENTERO, V36, P174, DOI 10.1080/003655201750065933; REINECKER HC, 1993, CLIN EXP IMMUNOL, V94, P174; Roka R, 2007, CLIN GASTROENTEROL H, V5, P550, DOI 10.1016/j.cgh.2006.12.004; Seibel J, 2009, EUR J NUTR; Setchell KDR, 2002, AM J CLIN NUTR, V76, P447, DOI 10.1093/ajcn/76.2.447; Shih DQ, 2008, WORLD J GASTROENTERO, V14, P390, DOI 10.3748/wjg.14.390; Soderholm JD, 2004, GUT, V53, P1817, DOI 10.1136/gut.2004.041426; Suzuki T, 2011, J NUTR BIOCHEM, V22, P401, DOI 10.1016/j.jnutbio.2010.08.001; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Verdu EF, 2002, AM J PHYSIOL-GASTR L, V283, pG27, DOI 10.1152/ajpgi.00460.2001; WALLACE JL, 1992, GASTROENTEROLOGY, V102, P1176; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Weber CR, 2007, GUT, V56, P6, DOI 10.1136/gut.2006.104182; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Young D, 2012, J NUTR, V142, P363, DOI 10.3945/jn.111.149104	54	45	45	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49547	10.1371/journal.pone.0049547	http://dx.doi.org/10.1371/journal.pone.0049547			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166707	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900161
J	Mulder, C; Harting, J; Jansen, N; Borgdorff, MW; van Leth, F				Mulder, Christiaan; Harting, Janneke; Jansen, Niesje; Borgdorff, Martien W.; van Leth, Frank			Adherence by Dutch Public Health Nurses to the National Guidelines for Tuberculosis Contact Investigation	PLOS ONE			English	Article							TRANSMISSION	Objectives: To assess whether public health nurses adhered to Dutch guidelines for tuberculosis contact investigations and to explore which factors influenced the process of identifying contacts, prioritizing contacts for testing and scaling up a contact investigation. Methods: A multiple-case study (2010-2012) compared the contact investigation guidelines as recommended with their use in practice. We interviewed twice 14 public health nurses of seven Public Health Services while they conducted a contact investigation. Results: We found more individuals to be identified as contacts than recommended, owing to a desire to gain insight into the infectiousness of the index case and prevent anxiety among potential contacts. Because some public health nurses did not believe the recommendations for prioritizing contacts fully encompassed daily practice, they preferred their own regular routine. In scaling up a contact investigation, they hardly applied the stone-in-the-pond principle. They neither regularly compared the infection prevalence in the contact investigation with the background prevalence in the community, especially not in immigrant populations. Nonadherence was related to ambiguity of the recommendations and a tendency to act from an individual health-care position rather than a population health perspective. Conclusions: The adherence to the contact investigation guidelines was limited, restraining the effectiveness, efficiency and uniformity of tuberculosis control. Adherence could be optimized by specifying guideline recommendations, actively involving the TB workforce, and training public health nurses.	[Mulder, Christiaan; Jansen, Niesje; van Leth, Frank] KNCV TB Fdn, The Hague, Netherlands	KNCV Tuberculosis Foundation	Mulder, C (corresponding author), KNCV TB Fdn, The Hague, Netherlands.	mulderc@kncvtbc.nl	Harting, Janneke/E-9377-2017	Harting, Janneke/0000-0002-2811-9551; van Leth, Frank/0000-0002-5490-8968				Arah OA, 2009, MED HEALTH CARE PHIL, V12, P235, DOI 10.1007/s11019-008-9173-8; Bailey WC, 2002, JAMA-J AM MED ASSOC, V287, P996, DOI 10.1001/jama.287.8.996; Erkens CGM, 2010, EUR RESPIR J, V36, P925, DOI 10.1183/09031936.00201609; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Gerald LB, 2003, INT J TUBERC LUNG D, V7, pS369; Grol R, 2001, MED CARE, V39, pII46; Jensen Paul A., 2005, Morbidity and Mortality Weekly Report, V54, P1; Lambert H, 2006, SOC SCI MED, V62, P2633, DOI 10.1016/j.socscimed.2005.11.023; Landry J, 2008, INT J TUBERC LUNG D, V12, P1352; LIIPPO KK, 1993, AM REV RESPIR DIS, V148, P235, DOI 10.1164/ajrccm/148.1.235; MacIntyre CR, 1998, PREV MED, V27, P830, DOI 10.1006/pmed.1998.0366; Madhi F, 2002, PEDIATR PULM, V34, P159, DOI 10.1002/ppul.10153; Marks SM, 2000, AM J RESP CRIT CARE, V162, P2033, DOI 10.1164/ajrccm.162.6.2004022; Mulder C, 2011, INT J TUBERC LUNG D, V15, P1630, DOI 10.5588/ijtld.11.0027; Mulder C, 2012, EUR RESP J IN PRESS; Ormerod P, 2000, THORAX, V55, P887; Reichler MR, 2002, JAMA-J AM MED ASSOC, V287, P991, DOI 10.1001/jama.287.8.991; Roethlisberger F. J., 1939, MANAGEMENT WORKER; Sprinson JE, 2003, INT J TUBERC LUNG D, V7, pS363; Styblo K, 1997, PROGR REPORT HAGUE; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; Timmermans S, 1997, SOC STUD SCI, V27, P273, DOI 10.1177/030631297027002003; van Leth F, 2009, EUR J PUBLIC HEALTH, V19, P424, DOI 10.1093/eurpub/ckp042; VEEN J, 1992, TUBERCLE LUNG DIS, V73, P73, DOI 10.1016/0962-8479(92)90058-R; Wilce Maureen, 2002, J Public Health Manag Pract, V8, P69; Yin R.K., 2017, APPL CASE STUDY RES	27	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49649	10.1371/journal.pone.0049649	http://dx.doi.org/10.1371/journal.pone.0049649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166738	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900179
J	Wu, L; Chai, DG; Fraser, ME; Zimmerly, S				Wu, Li; Chai, Dinggeng; Fraser, Marie E.; Zimmerly, Steven			Structural Variation and Uniformity among Tetraloop-Receptor Interactions and Other Loop-Helix Interactions in RNA Crystal Structures	PLOS ONE			English	Article							TERTIARY INTERACTION; RIBOSOMAL-SUBUNIT; SEQUENCE; MOTIF; CLASSIFICATION; ARCHITECTURE; RECOGNITION; HAIRPINS; FEATURES; INTRONS	Tetraloop-receptor interactions are prevalent structural units in RNAs, and include the GAAA/11-nt and GNRA-minor groove interactions. In this study, we have compiled a set of 78 nonredundant loop-helix interactions from X-ray crystal structures, and examined them for the extent of their sequence and structural variation. Of the 78 interactions in the set, only four were classical GAAA/11-nt motifs, while over half (48) were GNRA-minor groove interactions. The GNRA-minor groove interactions were not a homogeneous set, but were divided into five subclasses. The most predominant subclass is characterized by two triple base pair interactions in the minor groove, flanked by two ribose zipper contacts. This geometry may be considered the "standard'' GNRA-minor groove interaction, while the other four subclasses are alternative ways to form interfaces between a minor groove and tetraloop. The remaining 26 structures in the set of 78 have loops interacting with mostly idiosyncratic receptors. Among the entire set, a number of sequence-structure correlations can be identified, which may be used as initial hypotheses in predicting three-dimensional structures from primary sequences. Conversely, other sequence patterns are not predictive; for example, GAAA loop sequences and GG/CC receptors bind to each other with three distinct geometries. Finally, we observe an example of structural evolution in group II introns, in which loop-receptor motifs are substituted for each other while maintaining the larger three-dimensional geometry. Overall, the study gives a more complete view of RNA loop-helix interactions that exist in nature.	[Wu, Li; Chai, Dinggeng; Fraser, Marie E.; Zimmerly, Steven] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	University of Calgary	Zimmerly, S (corresponding author), Univ Calgary, Dept Biol Sci, 2500 Univ Dr 1 NW, Calgary, AB T2N 1N4, Canada.	zimmerly@ucalgary.ca		Fraser, Marie/0000-0001-8501-1494	Natural Sciences and Engineering Research Council (NSERC) [203717-02, RGPIN/222915-2008]	Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by Natural Sciences and Engineering Research Council (NSERC) grants to SZ (203717-02) and MF (RGPIN/222915-2008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Clemons WM, 2001, J MOL BIOL, V310, P827, DOI 10.1006/jmbi.2001.4778; Correll CC, 1997, CELL, V91, P705, DOI 10.1016/S0092-8674(00)80457-2; COSTA M, 1995, EMBO J, V14, P1276, DOI 10.1002/j.1460-2075.1995.tb07111.x; Costa M, 1997, EMBO J, V16, P3289, DOI 10.1093/emboj/16.11.3289; Duarte CM, 2003, NUCLEIC ACIDS RES, V31, P4755, DOI 10.1093/nar/gkg682; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Duszczyk MM, 2011, RNA, V17, P1973, DOI 10.1261/rna.2747411; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ferre-D'Amare AR, 1998, J MOL BIOL, V279, P621, DOI 10.1006/jmbi.1998.1789; Gate JH, 1996, SCIENCE, V273, P1696, DOI 10.1126/science.273.5282.1696; Geary C, 2008, NUCLEIC ACIDS RES, V36, P1138, DOI 10.1093/nar/gkm1048; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Huang HC, 2005, RNA, V11, P412, DOI 10.1261/rna.7104605; Ikawa Y, 2001, J BIOCHEM, V130, P251; Jossinet F, 2005, BIOINFORMATICS, V21, P3320, DOI 10.1093/bioinformatics/bti504; Keating KS, 2008, J MOL BIOL, V383, P475, DOI 10.1016/j.jmb.2008.08.043; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Klosterman PS, 2004, NUCLEIC ACIDS RES, V32, P2342, DOI 10.1093/nar/gkh537; Lemieux S, 2006, NUCLEIC ACIDS RES, V34, P2340, DOI 10.1093/nar/gkl120; Leontis NB, 2001, RNA, V7, P499, DOI 10.1017/S1355838201002515; Leontis NB, 2003, CURR OPIN STRUC BIOL, V13, P300, DOI 10.1016/S0959-440X(03)00076-9; Leontis NB, 2006, CURR OPIN STRUC BIOL, V16, P279, DOI 10.1016/j.sbi.2006.05.009; Massire C, 1997, RNA, V3, P553; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MOLINARO M, 1995, NUCLEIC ACIDS RES, V23, P3056, DOI 10.1093/nar/23.15.3056; Nissen P, 2001, P NATL ACAD SCI USA, V98, P4899, DOI 10.1073/pnas.081082398; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PLEY HW, 1994, NATURE, V372, P111, DOI 10.1038/372111a0; Shen Y, 2011, BIOINFORMATICS, V27, P2828, DOI 10.1093/bioinformatics/btr495; Simon DM, 2008, RNA, V14, P1704, DOI 10.1261/rna.1056108; Tamura M, 2002, J MOL BIOL, V320, P455, DOI 10.1016/S0022-2836(02)00515-6; Toor N, 2001, RNA, V7, P1142, DOI 10.1017/S1355838201010251; Torres-Larios A, 2005, NATURE, V437, P584, DOI 10.1038/nature04074; TUERK C, 1988, P NATL ACAD SCI USA, V85, P1364, DOI 10.1073/pnas.85.5.1364; Waldsich C, 2007, NAT STRUCT MOL BIOL, V14, P37, DOI 10.1038/nsmb1181; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOESE CR, 1990, P NATL ACAD SCI USA, V87, P8467, DOI 10.1073/pnas.87.21.8467; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275; Zhong CC, 2012, NUCLEIC ACIDS RES, V40, P1307, DOI 10.1093/nar/gkr804; Zhou J, 2012, RNA, V18, P230, DOI 10.1261/rna.031187.111	43	23	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49225	10.1371/journal.pone.0049225	http://dx.doi.org/10.1371/journal.pone.0049225			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152878	Green Published, Green Submitted, gold			2022-12-27	WOS:000312272600052
J	Magalhaes, RJS; Zhou, XY; Jia, BB; Guo, FS; Pfeiffer, DU; Martin, V				Magalhaes, Ricardo J. Soares; Zhou, Xiaoyan; Jia, Beibei; Guo, Fusheng; Pfeiffer, Dirk U.; Martin, Vincent			Live Poultry Trade in Southern China Provinces and HPAIV H5N1 Infection in Humans and Poultry: The Role of Chinese New Year Festivities	PLOS ONE			English	Article							PATHOGENIC AVIAN INFLUENZA; BIRD MARKETS; NETWORK ANALYSIS; VIRUS-INFECTION; RISK-FACTORS; HONG-KONG; SURVEILLANCE; VIETNAM	Background: The number of outbreaks of highly pathogenic avian influenza virus of the H5N1 subtype (HPAIV H5N1) over the past 5 years has been drastically reduced in China but sporadic infections in poultry and humans are still occurring. In this study, we aimed to investigate seasonal patterns in the association between the movement of live poultry originating from southern China and HPAIV H5N1 infection history in humans and poultry in China. Methodology/Principal Findings: During January to April 2010, longitudinal questionnaire surveys were carried out monthly in four wholesale live bird markets (LBMs) in Hunan and Guangxi provinces of South China. Using social network analysis, we found an increase in the number of observed links and degree centrality between LBMs and poultry sources in February and March compared to the months of January and April. The association of some live poultry traders (LPT's) with a limited set of counties (within the catchment area of LBMs) in the months of February and March may support HPAIV H5N1 transmission and contribute to perpetuating HPAIV H5N1 virus circulation among certain groups of counties. The connectivity among counties experiencing human infection was significantly higher compared to counties without human infection for the months of January, March and April. Conversely, counties with poultry infections were found to be significantly less connected than counties without poultry infection for the month of February. Conclusions/Significance: Our results show that temporal variation in live poultry trade in Southern China around the Chinese New Year festivities is associated with higher HPAIV H5N1 infection risk in humans and poultry. This study has shown that capturing the dynamic nature of poultry trade networks in Southern China improves our ability to explain the spatiotemporal dissemination in avian influenza viruses in China.	[Magalhaes, Ricardo J. Soares] Univ Queensland, Sch Populat Hlth, Infect Dis Epidemiol Unit, Brisbane, Qld, Australia; [Zhou, Xiaoyan; Jia, Beibei; Guo, Fusheng; Martin, Vincent] Food & Agr Org United Nations, FAO HPAI Programme China H5N1, Beijing, Peoples R China; [Jia, Beibei] Univ Prince Edward Isl, Atlantic Vet Coll, Dept Hlth Management, Charlottetown, PE C1A 4P3, Canada; [Pfeiffer, Dirk U.] Univ London, Royal Vet Coll, Dept Vet Clin Sci, Vet Epidemiol & Publ Hlth Grp, London, England	University of Queensland; Food & Agriculture Organization of the United Nations (FAO); University of Prince Edward Island; University of London; University of London Royal Veterinary College	Magalhaes, RJS (corresponding author), Univ Queensland, Sch Populat Hlth, Infect Dis Epidemiol Unit, Brisbane, Qld, Australia.	r.magalhaes@sph.uq.edu.au	Pfeiffer, Dirk U/C-5002-2009; Magalhaes, Ricardo J. Soares/A-5316-2010	Pfeiffer, Dirk U/0000-0001-7000-0530; Magalhaes, Ricardo J. Soares/0000-0001-9157-8470	Food and Agriculture Organization; United Nations; United States Agency for International Development (USAID) through the Emergency Center for Transboundary Animal diseases (ECTAD) office in China [OSRO/RAS/604/USA]; UQ Postdoctoral Research Fellowship	Food and Agriculture Organization; United Nations; United States Agency for International Development (USAID) through the Emergency Center for Transboundary Animal diseases (ECTAD) office in China(United States Agency for International Development (USAID)); UQ Postdoctoral Research Fellowship	This study was supported by the Food and Agriculture Organization and funded by the United Nations and the United States Agency for International Development (USAID) through the Emergency Center for Transboundary Animal diseases (ECTAD) office in China [project code OSRO/RAS/604/USA (Phases III and IV)]. RJSM is supported by a UQ Postdoctoral Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingsheng K, 2008, POULTRY SECTOR IN CH; Bulaga LL, 2003, AVIAN DIS, V47, P996, DOI 10.1637/0005-2086-47.s3.996; Choi YK, 2005, VIROLOGY, V332, P529, DOI 10.1016/j.virol.2004.12.002; Christley RM, 2005, AM J EPIDEMIOL, V162, P1024, DOI 10.1093/aje/kwi308; Gilbert M, 2006, EMERG INFECT DIS, V12, P227, DOI 10.3201/eid1202.050640; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Hanneman R. A., 2005, INTRODUCTION TO SOCI; Klovdahl AS, 2001, SOC SCI MED, V52, P681, DOI 10.1016/S0277-9536(00)00170-2; Leibler JH, 2009, ECOHEALTH, V6, P58, DOI 10.1007/s10393-009-0226-0; Liu M, 2003, VIROLOGY, V305, P267, DOI 10.1006/viro.2002.1762; Martin V, 2011, PREV VET MED, V102, P196, DOI 10.1016/j.prevetmed.2011.07.007; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; Mounts AW, 1999, J INFECT DIS, V180, P505, DOI 10.1086/314903; Nguyen DC, 2005, J VIROL, V79, P4201, DOI 10.1128/JVI.79.7.4201-4212.2005; OIE, 2011, HIGHLY PATHOGENIC AV; Panigrahy B, 2002, AVIAN DIS, V46, P298, DOI 10.1637/0005-2086(2002)046[0298:AIVSIA]2.0.CO;2; Pfeiffer DU, 2007, VET J, V174, P302, DOI 10.1016/j.tvjl.2007.05.010; Pfeiffer DU, 2011, VET J, V190, P309, DOI 10.1016/j.tvjl.2010.12.022; Rothenberg RB, 1998, AIDS, V12, P1529, DOI 10.1097/00002030-199812000-00016; Scott J., 2000, SOCIAL STRUCTURE, V2nd; Shortridge KF, 2003, J APPL MICROBIOL, V94, p70S; Soares Magalhaes RJ, 2010, BMC VET RES, V6, DOI [10.1186/1746-6148-1186-1110, DOI 10.1186/1746-6148-1186-1110]; Van Kerkhove MD, 2009, VACCINE, V27, P6345, DOI 10.1016/j.vaccine.2009.05.004; Wan XF, 2011, J VIROL, V85, P13432, DOI 10.1128/JVI.05266-11; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Wasserman S., 1994, SOCIAL NETWORK ANALY; WHO, 2012, SITUATION UPDATES AV; Zhou L, 2009, J INFECT DIS, V199, P1726, DOI 10.1086/599206	28	33	33	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49712	10.1371/journal.pone.0049712	http://dx.doi.org/10.1371/journal.pone.0049712			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166751	gold, Green Published, Green Submitted			2022-12-27	WOS:000311885300060
J	Zhao, HM; Ma, HL; Yu, L; Wang, X; Zhao, J				Zhao, Heming; Ma, Haoli; Yu, Li; Wang, Xin; Zhao, Jie			Genome-Wide Survey and Expression Analysis of Amino Acid Transporter Gene Family in Rice (Oryza sativa L.)	PLOS ONE			English	Article							HIGH-AFFINITY TRANSPORTER; COMPATIBLE SOLUTE TRANSPORTERS; PROLINE TRANSPORTER; SEED DEVELOPMENT; FUNCTIONAL-CHARACTERIZATION; SUBSTRATE-SPECIFICITY; PROFILE ANALYSIS; AUXIN PERMEASE; ARABIDOPSIS; CLASSIFICATION	Background: Amino acid transporters (AATs) that transport amino acids across cellular membranes are essential for plant growth and development. To date, a genome-wide overview of the AAT gene family in rice is not yet available. Methodology/Principal Findings: In this study, a total of 85 AAT genes were identified in rice genome and were classified into eleven distinct subfamilies based upon their sequence composition and phylogenetic relationship. A large number of OsAAT genes were expanded via gene duplication, 23 and 24 OsAAT genes were tandemly and segmentally duplicated, respectively. Comprehensive analyses were performed to investigate the expression profiles of OsAAT genes in various stages of vegetative and reproductive development by using data from EST, Microarrays, MPSS and Real-time PCR. Many OsAAT genes exhibited abundant and tissue-specific expression patterns. Moreover, 21 OsAAT genes were found to be differentially expressed under the treatments of abiotic stresses. Comparative analysis indicates that 26 AAT genes with close evolutionary relationships between rice and Arabidopsis exhibited similar expression patterns. Conclusions/Significance: This study will facilitate further studies on OsAAT family and provide useful clues for functional validation of OsAATs.	[Zhao, Heming; Ma, Haoli; Yu, Li; Wang, Xin; Zhao, Jie] Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China	Wuhan University	Zhao, J (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Hybrid Rice, Wuhan 430072, Peoples R China.	jzhao@whu.edu.cn			National Basic Research Program of China (973 Program) [2012CB944801]; Special Doctorial Program Funds of the Ministry of Education of China [20090141110035]; National Natural Science Foundation of China [31170171]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Special Doctorial Program Funds of the Ministry of Education of China(Ministry of Education, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China (973 Program) (2012CB944801, http://www.most.gov.cn/cxfw/index.htm), the Special Doctorial Program Funds of the Ministry of Education of China (20090141110035, http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm), and the National Natural Science Foundation of China (31170171, http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett MJ, 1996, SCIENCE, V273, P948, DOI 10.1126/science.273.5277.948; Chen LS, 2001, PLANT PHYSIOL, V125, P1813, DOI 10.1104/pp.125.4.1813; Chen LS, 1997, PLANT PHYSIOL, V115, P1127, DOI 10.1104/pp.115.3.1127; Cooper B, 2003, P NATL ACAD SCI USA, V100, P4945, DOI 10.1073/pnas.0737574100; Couturier J, 2010, J EXP BOT, V61, P1671, DOI 10.1093/jxb/erq036; Dundar E, 2009, PLANTA, V229, P1047, DOI 10.1007/s00425-009-0892-8; Fischer WN, 1998, TRENDS PLANT SCI, V3, P188, DOI 10.1016/S1360-1385(98)01231-X; Fischer WN, 2002, PLANT J, V29, P717, DOI 10.1046/j.1365-313X.2002.01248.x; FISCHER WN, 1995, J BIOL CHEM, V270, P16315, DOI 10.1074/jbc.270.27.16315; Frommer WB, 1995, P NATL ACAD SCI USA, V92, P12036, DOI 10.1073/pnas.92.26.12036; Grallath S, 2005, PLANT PHYSIOL, V137, P117, DOI 10.1104/pp.104.055079; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; Hirner B, 1998, PLANT J, V14, P535, DOI 10.1046/j.1365-313X.1998.00151.x; Hoyerova K, 2008, PLANT PHYSIOL, V146, P1128, DOI 10.1104/pp.107.109371; Hunt E, 2010, J EXP BOT, V61, P55, DOI 10.1093/jxb/erp274; Igarashi Y, 2000, PLANT CELL PHYSIOL, V41, P750, DOI 10.1093/pcp/41.6.750; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jain M, 2006, BIOCHEM BIOPH RES CO, V345, P646, DOI 10.1016/j.bbrc.2006.04.140; Koch W, 2003, PLANT J, V33, P211, DOI 10.1046/j.1365-313X.2003.01618.x; Komatsu K, 2003, P NATL ACAD SCI USA, V100, P11765, DOI 10.1073/pnas.1932414100; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; Lee YH, 2007, PLANT J, V50, P305, DOI 10.1111/j.1365-313X.2007.03045.x; Lehmann S, 2011, J EXP BOT, V62, P787, DOI 10.1093/jxb/erq320; Lehmann S, 2010, AMINO ACIDS, V39, P949, DOI 10.1007/s00726-010-0525-3; Liu F, 2011, MOL PLANT, V4, P1105, DOI 10.1093/mp/ssr058; Liu X, 2006, AMINO ACIDS, V30, P113, DOI 10.1007/s00726-005-0248-z; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Ma HL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025184; Ma HL, 2010, J EXP BOT, V61, P2647, DOI 10.1093/jxb/erq104; Marchant A, 1999, EMBO J, V18, P2066, DOI 10.1093/emboj/18.8.2066; Marchant A, 2002, PLANT CELL, V14, P589, DOI 10.1105/tpc.010354; Meyer A, 2006, J BIOL CHEM, V281, P7197, DOI 10.1074/jbc.M510766200; Michaeli S, 2011, PLANT J, V67, P485, DOI 10.1111/j.1365-313X.2011.04612.x; Miranda M, 2001, PLANT J, V28, P61, DOI 10.1046/j.1365-313X.2001.01129.x; Okumoto S, 2004, J EXP BOT, V55, P2155, DOI 10.1093/jxb/erh233; Okumoto S, 2002, J BIOL CHEM, V277, P45338, DOI 10.1074/jbc.M207730200; Okumoto S, 2011, MOL PLANT, V4, P453, DOI 10.1093/mp/ssr003; Ortiz-Lopez A, 2000, BBA-BIOMEMBRANES, V1465, P275, DOI 10.1016/S0005-2736(00)00144-9; Popova OV, 2003, PLANT MOL BIOL, V52, P569, DOI 10.1023/A:1024802101057; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Qi YH, 2012, NEW PHYTOL, V193, P109, DOI 10.1111/j.1469-8137.2011.03910.x; Rentsch D, 1996, PLANT CELL, V8, P1437, DOI 10.1105/tpc.8.8.1437; Rentsch D, 2007, FEBS LETT, V581, P2281, DOI 10.1016/j.febslet.2007.04.013; Saier MH, 2009, NUCLEIC ACIDS RES, V37, pD274, DOI 10.1093/nar/gkn862; Sanders A, 2009, PLANT J, V59, P540, DOI 10.1111/j.1365-313X.2009.03890.x; Schmidt R, 2007, PLANTA, V226, P805, DOI 10.1007/s00425-007-0527-x; Schwacke R, 1999, PLANT CELL, V11, P377, DOI 10.1105/tpc.11.3.377; Shen CJ, 2010, FEBS J, V277, P2954, DOI 10.1111/j.1742-4658.2010.07706.x; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Su YH, 2004, PLANT PHYSIOL, V136, P3104, DOI 10.1104/pp.104.045278; Svennerstam H, 2011, NEW PHYTOL, V183, P1; Svennerstam H, 2008, NEW PHYTOL, V180, P620, DOI 10.1111/j.1469-8137.2008.02589.x; Svennerstam H, 2007, PLANT PHYSIOL, V143, P1853, DOI 10.1104/pp.106.092205; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Swarup R, 2004, PLANT CELL, V16, P3069, DOI 10.1105/tpc.104.024737; Tabuchi H, 2011, PLANT CELL, V23, P3276, DOI 10.1105/tpc.111.088765; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tan QM, 2008, PLANT SCI, V174, P348, DOI 10.1016/j.plantsci.2007.12.008; Tegeder M, 2000, PLANT PHYSIOL, V122, P319, DOI 10.1104/pp.122.2.319; Tegeder M, 2012, CURR OPIN PLANT BIOL, V15, P315, DOI 10.1016/j.pbi.2012.02.001; Tegeder M, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00021; Ueda A, 2001, PLANT CELL PHYSIOL, V42, P1282, DOI 10.1093/pcp/pce166; Ueda A, 2008, PLANTA, V227, P277, DOI 10.1007/s00425-007-0615-y; Ugartechea-Chirino Y, 2010, ANN BOT-LONDON, V105, P277, DOI 10.1093/aob/mcp287; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wipf D, 2002, TRENDS BIOCHEM SCI, V27, P139, DOI 10.1016/S0968-0004(01)02054-0; Yang YD, 2006, CURR BIOL, V16, P1123, DOI 10.1016/j.cub.2006.04.029; Zhao XB, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-92	69	102	113	8	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49210	10.1371/journal.pone.0049210	http://dx.doi.org/10.1371/journal.pone.0049210			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166615	gold, Green Published, Green Submitted			2022-12-27	WOS:000311272300031
J	Baumer, P; Weiler, M; Ruetters, M; Staub, F; Dombert, T; Heiland, S; Bendszus, M; Pham, M				Baeumer, Philipp; Weiler, Markus; Ruetters, Maurice; Staub, Frank; Dombert, Thomas; Heiland, Sabine; Bendszus, Martin; Pham, Mirko			MR Neurography in Ulnar Neuropathy as Surrogate Parameter for the Presence of Disseminated Neuropathy	PLOS ONE			English	Article							MAGNETIC-RESONANCE NEUROGRAPHY; TARSAL TUNNEL-SYNDROME; PERIPHERAL-NERVE; ELBOW; SCHWANNOMA	Purpose: Patients with ulnar neuropathy of unclear etiology occasionally present with lesion extension from elbow to upper arm level on MRI. This study investigated whether MRI thereby distinguishes multifocal neuropathy from focal-compressive neuropathy at the elbow. Methods: This prospective study was approved by the institutional ethics committee and written informed consent was obtained from all participants. 122 patients with ulnar mononeuropathy of undetermined localization and etiology by clinical and electrophysiological examination were assessed by MRI at upper arm and elbow level using T2-weighted fat-saturated sequences at 3T. Twenty-one patients were identified with proximal ulnar nerve lesions and evaluated for findings suggestive of disseminated neuropathy (i) subclinical lesions in other nerves, (ii) unfavorable outcome after previous decompressive elbow surgery, and (iii) subsequent diagnosis of inflammatory or other disseminated neuropathy. Two groups served as controls for quantitative analysis of nerve-to-muscle signal intensity ratios: 20 subjects with typical focal ulnar neuropathy at the elbow and 20 healthy subjects. Results: In the group of 21 patients with proximal ulnar nerve lesion extension, T2-w ulnar nerve signal was significantly (p<0.001) higher at upper arm level than in both control groups. A cut-off value of 1.92 for maximum nerve-to-muscle signal intensity ratio was found to be sensitive (86%) and specific (100%) to discriminate this group. Ten patients (48%) exhibited additional T2-w lesions in the median and/or radial nerve. Another ten (48%) had previously undergone elbow surgery without satisfying outcome. Clinical follow-up was available in 15 (71%) and revealed definitive diagnoses of multifocal neuropathy of various etiologies in four patients. In another eight, diagnoses could not yet be considered definitive but were consistent with multifocal neuropathy. Conclusion: Proximal ulnar nerve T2 lesions at upper arm level are detected by MRI and indicate the presence of a non-focal disseminated neuropathy instead of a focal compressive neuropathy.	[Baeumer, Philipp; Ruetters, Maurice; Bendszus, Martin; Pham, Mirko] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Baumer, P (corresponding author), Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany.	philipp.baeumer@med.uni-heidelberg.de	Pham, Mirko/AAI-8713-2020					Baumer P, 2011, RADIOLOGY, V260, P199, DOI 10.1148/radiol.11102357; Bartels RHMA, 1998, J NEUROSURG, V89, P722, DOI 10.3171/jns.1998.89.5.0722; Baumer P, 2012, J NEUROL; Beekman R, 2004, NEUROLOGY, V63, P1675, DOI 10.1212/01.WNL.0000142535.24626.90; Bendszus M, 2005, NAT CLIN PRACT NEURO, V1, P45, DOI 10.1038/ncpneuro0017; Bradshaw DY, 1999, NEUROL CLIN, V17, P447, DOI 10.1016/S0733-8619(05)70147-X; BRITZ GW, 1995, NEUROSURGERY, V37, P1097, DOI 10.1227/00006123-199512000-00009; Campbell WW, 2000, MUSCLE NERVE, V23, P450, DOI 10.1002/(SICI)1097-4598(200004)23:4<450::AID-MUS2>3.3.CO;2-R; Dejerine J, 1915, PRESSE MED, P321; Du R, 2010, J NEUROSURG, V112, P362, DOI 10.3171/2009.7.JNS09414; DYCK PJ, 1981, ANN NEUROL, V10, P222, DOI 10.1002/ana.410100304; England JD, 2004, LANCET, V363, P2151, DOI 10.1016/S0140-6736(04)16508-2; Filler AG, 1996, J NEUROSURG, V85, P299, DOI 10.3171/jns.1996.85.2.0299; Gominak SC, 1998, MUSCLE NERVE, V21, P528, DOI 10.1002/(SICI)1097-4598(199804)21:4<528::AID-MUS12>3.0.CO;2-T; Kastel T, 2011, AM J NEURORADIOL, V32, P821, DOI 10.3174/ajnr.A2402; Kollmer J, 2012, PLOS ONE IN PRESS; Lubec D, 1999, POSTGRAD MED J, V75, P723, DOI 10.1136/pgmj.75.890.723; OSBORNE G, 1959, Postgrad Med J, V35, P392; PERSING JA, 1988, ANN PLAS SURG, V20, P252, DOI 10.1097/00000637-198803000-00012; Pham M, 2011, DIABETES CARE, V34, P721, DOI 10.2337/dc10-1491; Pham M, 2011, J NEUROL, V258, P1120, DOI 10.1007/s00415-010-5895-7; Staff NP, 2010, BRAIN, V133, P2866, DOI 10.1093/brain/awq252; Stewart JD, 2003, MUSCLE NERVE, V28, P525, DOI 10.1002/mus.10454; STEWART JD, 1987, J NEUROL NEUROSUR PS, V50, P252, DOI 10.1136/jnnp.50.3.252; WOLOCK BS, 1989, J BONE JOINT SURG AM, V71A, P932, DOI 10.2106/00004623-198971060-00020	25	23	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49742	10.1371/journal.pone.0049742	http://dx.doi.org/10.1371/journal.pone.0049742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166762	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900188
J	Edelman, S; Shalev, I; Uzefovsky, F; Israel, S; Knafo, A; Kremer, I; Mankuta, D; Kaitz, M; Ebstein, RP				Edelman, Shany; Shalev, Idan; Uzefovsky, Florina; Israel, Salomon; Knafo, Ariel; Kremer, Ilana; Mankuta, David; Kaitz, Marsha; Ebstein, Richard P.			Epigenetic and Genetic Factors Predict Women's Salivary Cortisol following a Threat to the Social Self	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; ESTROGEN-RECEPTOR-ALPHA; SEROTONIN TRANSPORTER GENE; MEDIAL PREOPTIC AREA; GLUCOCORTICOID-RECEPTOR; PSYCHOSOCIAL STRESS; PSYCHIATRIC-DISORDERS; PROMOTER POLYMORPHISM; MATERNAL-CARE; 5-HTT GENE	Evidence suggests that the reactivity of the Hypothalamus-Pituitary-Adrenal axis (HPAA) is modulated by both genetic and environmental variables. Of special interest are the underlying molecular mechanisms driving gender differences to psychosocial stressors. Epigenetic mechanisms that sculpt the genome are ideal candidates for mediating the effects of signals on the HPAA. In the current study, we analyzed by pyrosequencing, bisulfite-treated buccal DNA from male and female university students who participated in the Trier Social Stress Test (TSST). A linear regression model was used to ascertain the effects of sex, CpG methylation and genes on stress response. Total cortisol output (area under the curve, AUC) was significantly predicted by glucocorticoid receptor (NR3C1) exon 1F methylation (averaged across 39 CpG sites) solely in female subjects. A single CpG site located in the exon 1F noncanonical nerve growth factor-inducible protein A (NGFI-A) transcription factor was a highly significant predictor of AUC in female subjects. Additionally, variations in the estrogen receptor alpha (ESR1) and the serotonin transporter promoter (5-HTTLPR) genes were independent additive predictors of AUC. The full model accounted for half of the variance (50.06%) in total cortisol output. Notably, this is the first demonstration that epigenetic changes at the GR exon 1F correlate with HPAA reactivity. These findings have important implications for understanding the molecular mechanisms underlying gender differences in stress-related disorders and underscore the unique value of modeling both epigenetic and genetic information in conferring vulnerability to stress.	[Edelman, Shany; Shalev, Idan; Ebstein, Richard P.] Hadassah Hebrew Univ, Med Ctr, Dept Neurobiol, Jerusalem, Israel	Hebrew University of Jerusalem; Hadassah University Medical Center	Edelman, S (corresponding author), Hadassah Hebrew Univ, Med Ctr, Dept Neurobiol, Jerusalem, Israel.	rpebstein@gmail.com	Knafo-Noam, Ariel/E-8067-2011; Shalev, Idan/H-1943-2011	Knafo-Noam, Ariel/0000-0003-0613-1960; Ebstein, Richard/0000-0002-3626-541X; Uzefovsky, Florina/0000-0003-4571-2514; Israel, Salomon/0000-0003-3629-2466				Alt SR, 2010, PSYCHONEUROENDOCRINO, V35, P544, DOI 10.1016/j.psyneuen.2009.09.001; Bartels M, 2003, PSYCHONEUROENDOCRINO, V28, P121, DOI 10.1016/S0306-4530(02)00003-3; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Bornstein SR, 2008, TRENDS ENDOCRIN MET, V19, P175, DOI 10.1016/j.tem.2008.01.009; Canli T, 2007, NAT NEUROSCI, V10, P1103, DOI 10.1038/nn1964; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Champagne FA, 2003, ENDOCRINOLOGY, V144, P4720, DOI 10.1210/en.2003-0564; Champagne FA, 2006, ENDOCRINOLOGY, V147, P2909, DOI 10.1210/en.2005-1119; Chida Y, 2008, PSYCHOL BULL, V134, P829, DOI 10.1037/a0013342; Chrousos GP, 2009, ANN NY ACAD SCI, V1179, P153, DOI 10.1111/j.1749-6632.2009.04988.x; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Dinan TG, 1996, LIFE SCI, V58, P1683, DOI 10.1016/0024-3205(96)00066-5; Federenko IS, 2004, J CLIN ENDOCR METAB, V89, P6244, DOI 10.1210/jc.2004-0981; Gladkevich A, 2004, PROG NEURO-PSYCHOPH, V28, P559, DOI 10.1016/j.pnpbp.2004.01.009; Gotlib IH, 2007, BIOL PSYCHIAT; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Kaminsky ZA, 2009, NAT GENET; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Klein Laura Cousino, 2002, Curr Psychiatry Rep, V4, P441, DOI 10.1007/s11920-002-0072-z; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kudielka BM, 2009, PSYCHONEUROENDOCRINO, V34, P2, DOI 10.1016/j.psyneuen.2008.10.004; Kumsta R, 2008, BIOL PSYCHOL; Kumsta R, 2009, AM J MED GENET B, V150B, P476, DOI 10.1002/ajmg.b.30837; Laplante P, 2002, DEV BRAIN RES, V139, P199, DOI 10.1016/S0165-3806(02)00550-3; LEFEBVRE H, 1992, NEUROSCIENCE, V47, P999, DOI 10.1016/0306-4522(92)90047-6; Lewis DA, 2002, NEUROPSYCHOPHARMACOL, V26, P143, DOI 10.1016/S0893-133X(01)00393-1; Lovallo WR, 2006, PHARMACOL BIOCHEM BE, V83, P441, DOI 10.1016/j.pbb.2006.03.005; McEwen BS, 2008, EUR J PHARM; McGowan PO, 2009, NAT NEUROSCI, V12, P342, DOI 10.1038/nn.2270; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Miller G, 2009, ANNU REV PSYCHOL, V60, P501, DOI 10.1146/annurev.psych.60.110707.163551; Miller GE, 2009, P NATL ACAD SCI USA, V106, P14716, DOI 10.1073/pnas.0902971106; Miller WJS, 2004, J NEUROSCI, V24, P10628, DOI 10.1523/JNEUROSCI.5540-03.2004; MITCHELL JB, 1990, DEV BRAIN RES, V55, P231, DOI 10.1016/0165-3806(90)90204-C; Moser D, 2007, WORLD J BIOL PSYCHIA, V8, P262, DOI 10.1080/15622970701429862; Moser U, 2010, NEUROSCI LETT, V476, P161, DOI 10.1016/j.neulet.2010.04.020; MUNAFO MR, 2008, BIOL PSYCHIAT; Nicolson N, 1997, J GERONTOL A-BIOL, V52, pM68, DOI 10.1093/gerona/52A.2.M68; Oakley Robert H., 1993, Critical Reviews in Eukaryotic Gene Expression, V3, P63; Oberlander TF, 2008, EPIGENETICS-US, V3, P97, DOI 10.4161/epi.3.2.6034; PAN L, 1992, NEUROENDOCRINOLOGY, V56, P797, DOI 10.1159/000126332; PATCHEV VK, 1995, FASEB J, V9, P419, DOI 10.1096/fasebj.9.5.7896013; Patchev VK, 1998, MOL NEUROBIOL, V16, P63, DOI 10.1007/BF02740603; Philibert R, 2007, AM J MED GENET B, V144B, P101, DOI 10.1002/ajmg.b.30414; Philibert RA, 2008, AM J MED GENET B, V147B, P543, DOI 10.1002/ajmg.b.30657; Risch N, 2009, JAMA-J AM MED ASSOC, V301, P2462, DOI 10.1001/jama.2009.878; Rollins B, 2010, AM J MED GENET B, V153B, P919, DOI 10.1002/ajmg.b.31062; Seale JV, 2005, J PHYSIOL-LONDON, V563, P265, DOI 10.1113/jphysiol.2004.078212; Seale JV, 2004, J NEUROENDOCRINOL, V16, P989, DOI 10.1111/j.1365-2826.2004.01258.x; Shalev I, 2009, PSYCHONEUROENDOCRINO, V34, P382, DOI 10.1016/j.psyneuen.2008.09.017; Shansky RM, 2009, EXPERT REV NEUROTHER, V9, P967, DOI [10.1586/ern.09.46, 10.1586/ERN.09.46]; Sher L, 2005, QJM-INT J MED, V98, P323, DOI 10.1093/qjmed/hci064; Solomon MB, 2009, PHYSL BEHAV; Steptoe A, 1996, J PSYCHOSOM RES, V41, P171, DOI 10.1016/0022-3999(96)00095-5; Steptoe A, 2009, J PERS, V77, P1747, DOI 10.1111/j.1467-6494.2009.00599.x; Sundermann EE, 2010, MENOPAUSE, V17, P874, DOI 10.1097/gme.0b013e3181df4a19; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Turner JD, 2005, J MOL ENDOCRINOL, V35, P283, DOI 10.1677/jme.1.01822; Turner JD, 2010, BIOCH PHARM; Uher R, 2010, MOL PSYCHIATR, V15, P18, DOI 10.1038/mp.2009.123; VAMVAKOPOULOS NC, 1993, J CLIN INVEST, V92, P1896, DOI 10.1172/JCI116782; Van IMH, BIOL PSYCHIAT, V68, P405; Walker JJ, 2010, P ROY SOC B-BIOL SCI, V277, P1627, DOI 10.1098/rspb.2009.2148; Way BM, 2010, BIOL PSYCHIAT, V67, P487, DOI 10.1016/j.biopsych.2009.10.021; Way BM, 2010, PSYCHOSOM MED, V72, P107, DOI 10.1097/PSY.0b013e3181ce6a7d; Weaver ICG, 2007, J NEUROSCI, V27, P1756, DOI 10.1523/JNEUROSCI.4164-06.2007; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Weidner G, 2003, AM J PUBLIC HEALTH, V93, P768, DOI 10.2105/AJPH.93.5.768; Weiser MJ, 2009, NEUROSCIENCE, V159, P883, DOI 10.1016/j.neuroscience.2008.12.058; Weiss LA, 2006, NAT GENET, V38, P218, DOI 10.1038/ng1726; Westberg L, 2003, MOL PSYCHIATR, V8, P118, DOI 10.1038/sj.mp.4001192; Wust S, 2009, PSYCHONEUROENDOCRINO, V34, P972, DOI 10.1016/j.psyneuen.2009.01.011; Wust S, 2004, J CLIN ENDOCR METAB, V89, P565, DOI 10.1210/jc.2003-031148; Young EA, 1995, CRIT REV NEUROBIOL, V9, P371	77	45	46	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48597	10.1371/journal.pone.0048597	http://dx.doi.org/10.1371/journal.pone.0048597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155396	Green Published, gold			2022-12-27	WOS:000311151900030
J	Ferrara, F; Naranjo, LA; Kumar, S; Gaiotto, T; Mukundan, H; Swanson, B; Bradbury, ARM				Ferrara, Fortunato; Naranjo, Leslie A.; Kumar, Sandeep; Gaiotto, Tiziano; Mukundan, Harshini; Swanson, Basil; Bradbury, Andrew R. M.			Using Phage and Yeast Display to Select Hundreds of Monoclonal Antibodies: Application to Antigen 85, a Tuberculosis Biomarker	PLOS ONE			English	Article							SURFACE DISPLAY; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; POLYPEPTIDE LIBRARIES; DIRECTED EVOLUTION; AFFINITY; PROTEIN; REPERTOIRE; DIAGNOSIS; SERODIAGNOSIS	Background: Current diagnostic methods for tuberculosis (TB), a major global health challenge that kills nearly two million people annually, are time-consuming and inadequate. During infection a number of bacterial molecules that play a role in the infective process are released and have been proposed as biomarkers for early TB diagnosis. Antigen 85 (Ag85) is the most abundant secreted TB protein, and a potential target for this diagnostic approach. One of the bottlenecks in the direct detection of such bacterial targets is the availability of robust, sensitive, specific antibodies. Methods: Using Ag85 as a model, we describe a method to select antibodies against any potential target using a novel combination of phage and yeast display that exploits the advantage of each approach. Results: The efficiency of this approach was attested to by the 111 specific antibodies identified in initial screens. These were assessed for binding to the different Ag85 subunits, affinity, and activity in sandwich assays. Conclusions: The novelty of this approach lies in the possibility of screening the entire output of a phage antibody selection in a single experiment by yeast display. This can be considered analogous to carrying out a million ELISAs. The monoclonal antibodies (mAbs) identified in this way show high binding affinity and selectivity for the antigens and offer an advantage over traditional mAbs produced by relatively expensive and time consuming techniques. This approach has wide applicability, and the affinity of selected antibodies can be significantly improved, if required.	[Ferrara, Fortunato; Naranjo, Leslie A.; Kumar, Sandeep; Gaiotto, Tiziano; Swanson, Basil; Bradbury, Andrew R. M.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA	United States Department of Energy (DOE); Los Alamos National Laboratory	Ferrara, F (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM USA.	amb@lanl.gov	Ferrara, Fortunato/AAD-5947-2019; KUMAR, SANDEEP/GZA-7182-2022	Bradbury, Andrew/0000-0002-5567-8172; Ferrara, Fortunato/0000-0002-4615-035X				Bentley-Hibbert SI, 1999, INFECT IMMUN, V67, P581, DOI 10.1128/IAI.67.2.581-588.1999; Bera Swati, 2006, Indian Journal of Pediatrics, V73, P675, DOI 10.1007/BF02898442; Boder ET, 1998, BIOTECHNOL PROGR, V14, P55, DOI 10.1021/bp970144q; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Boder ET, 2000, P NATL ACAD SCI USA, V97, P10701, DOI 10.1073/pnas.170297297; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791; Butler JE, 1997, IMMUNOL INVEST, V26, P39, DOI 10.3109/08820139709048914; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Cho YK, 2010, PROTEIN ENG DES SEL, V23, P567, DOI 10.1093/protein/gzq029; de Bruin R, 1999, NAT BIOTECHNOL, V17, P397, DOI 10.1038/7959; Di Niro R, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq052; Edwards BM, 2003, J MOL BIOL, V334, P103, DOI 10.1016/j.jmb.2003.09.054; Flores LL, 2011, CLIN VACCINE IMMUNOL, V18, P1616, DOI 10.1128/CVI.05205-11; Ford C, 2012, TUBERCULOSIS, V92, P194, DOI 10.1016/j.tube.2011.11.003; FUKUI Y, 1965, BIKEN J, V8, P189; Gai SA, 2007, CURR OPIN STRUC BIOL, V17, P467, DOI 10.1016/j.sbi.2007.08.012; Garcia-Rodriguez C, 2007, NAT BIOTECHNOL, V25, P107, DOI 10.1038/nbt1269; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; GRIFFITHS AD, 1994, EMBO J, V13, P3245, DOI 10.1002/j.1460-2075.1994.tb06626.x; Ivanyi J, 2012, TUBERCULOSIS, V92, P31, DOI 10.1016/j.tube.2011.09.001; Kashyap RS, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-74; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Landowski CP, 2001, J CLIN MICROBIOL, V39, P2418, DOI 10.1128/JCM.39.7.2418-2424.2001; Madhi SA, 2000, INT J TUBERC LUNG D, V4, P448; Marks James D, 2004, Methods Mol Biol, V248, P161; MARKS JD, 1991, J MOL BIOL, V222, P581, DOI 10.1016/0022-2836(91)90498-U; MARKS JD, 1993, BIO-TECHNOL, V11, P1145, DOI 10.1038/nbt1093-1145; ORRWEAVER TL, 1983, P NATL ACAD SCI-BIOL, V80, P4417, DOI 10.1073/pnas.80.14.4417; PERELSON AS, 1979, J THEOR BIOL, V81, P645, DOI 10.1016/0022-5193(79)90275-3; Powers DB, 2001, J IMMUNOL METHODS, V251, P123, DOI 10.1016/S0022-1759(00)00290-8; Raja A, 2008, DIAGN MICR INFEC DIS, V60, P361, DOI 10.1016/j.diagmicrobio.2007.11.006; Ravn U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq789; Richman SA, 2006, PROTEIN ENG DES SEL, V19, P255, DOI 10.1093/protein/gzl008; Sblattero D, 2000, NAT BIOTECHNOL, V18, P75, DOI 10.1038/71958; Sheets MD, 1998, P NATL ACAD SCI USA, V95, P6157, DOI 10.1073/pnas.95.11.6157; Shusta EV, 1999, J MOL BIOL, V292, P949, DOI 10.1006/jmbi.1999.3130; Siegel RW, 2004, J IMMUNOL METHODS, V286, P141, DOI 10.1016/j.jim.2004.01.005; Siegel RW, 2003, NAT BIOTECHNOL; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; Tong M, 2005, J IMMUNOL METHODS, V301, P154, DOI 10.1016/j.jim.2005.04.004; Vaughan TJ, 1996, NAT BIOTECHNOL, V14, P309, DOI 10.1038/nbt0396-309; Velayati AA, 2009, CHEST, V136, P420, DOI 10.1378/chest.08-2427; Wallis RS, 2009, LANCET INFECT DIS, V9, P162, DOI 10.1016/S1473-3099(09)70042-8; Wang XX, 2007, NAT METHODS, V4, P143, DOI 10.1038/nmeth993; WIKER HG, 1992, SCAND J IMMUNOL, V36, P307, DOI 10.1111/j.1365-3083.1992.tb03104.x; Woods GL, 2001, ARCH PATHOL LAB MED, V125, P122; World Health Organization, 1997, WHO WHO TUB DIAGN WO; World Health Organization, 2009, GLOB TUB CONTR EP ST; Wu XQ, 2010, CLIN CHIM ACTA, V411, P1520, DOI 10.1016/j.cca.2010.06.014; YANG WP, 1995, J MOL BIOL, V254, P392, DOI 10.1006/jmbi.1995.0626	53	52	57	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49535	10.1371/journal.pone.0049535	http://dx.doi.org/10.1371/journal.pone.0049535			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166701	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900158
J	Kague, E; Gallagher, M; Burke, S; Parsons, M; Franz-Odendaal, T; Fisher, S				Kague, Erika; Gallagher, Michael; Burke, Sally; Parsons, Michael; Franz-Odendaal, Tamara; Fisher, Shannon			Skeletogenic Fate of Zebrafish Cranial and Trunk Neural Crest	PLOS ONE			English	Article							REGULATED TRANSGENIC ZEBRAFISH; BRANCHIAL ARCH MUTANTS; DANIO-RERIO; SKULL VAULT; HEART REGENERATION; PLASTRON BONES; TISSUE ORIGINS; PAIRED FINS; CELLS; MODEL	The neural crest (NC) is a major contributor to the vertebrate craniofacial skeleton, detailed in model organisms through embryological and genetic approaches, most notably in chick and mouse. Despite many similarities between these rather distant species, there are also distinct differences in the contribution of the NC, particularly to the calvariae of the skull. Lack of information about other vertebrate groups precludes an understanding of the evolutionary significance of these differences. Study of zebrafish craniofacial development has contributed substantially to understanding of cartilage and bone formation in teleosts, but there is currently little information on NC contribution to the zebrafish skeleton. Here, we employ a two-transgene system based on Cre recombinase to genetically label NC in the zebrafish. We demonstrate NC contribution to cells in the cranial ganglia and peripheral nervous system known to be NC-derived, as well as to a subset of myocardial cells. The indelible labeling also enables us to determine NC contribution to late-forming bones, including the calvariae. We confirm suspected NC origin of cartilage and bones of the viscerocranium, including cartilages such as the hyosymplectic and its replacement bones (hymandibula and symplectic) and membranous bones such as the opercle. The cleithrum develops at the border of NC and mesoderm, and as an ancestral component of the pectoral girdle was predicted to be a hybrid bone composed of both NC and mesoderm tissues. However, we find no evidence of a NC contribution to the cleithrum. Similarly, in the vault of the skull, the parietal bones and the caudal portion of the frontal bones show no evidence of NC contribution. We also determine a NC origin for caudal fin lepidotrichia; the presumption is that these are derived from trunk NC, demonstrating that these cells have the ability to form bone during normal vertebrate development.	[Kague, Erika; Gallagher, Michael; Fisher, Shannon] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Kague, E (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	sfisher4@upenn.edu	Gallagher, Michael Dane/G-7113-2015	Gallagher, Michael Dane/0000-0002-2109-1293; Franz-Odendaal, Tamara/0000-0003-4883-2677; Kague, Erika/0000-0002-0266-9424	NIDCR NIH HHS [R21DE021509-01, R21 DE021509] Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021509] Funding Source: NIH RePORTER	NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Ahlberg PE, 2006, EVOL DEV, V8, P116, DOI 10.1111/j.1525-142X.2006.00082.x; Andreeva V, 2011, GENESIS, V49, P360, DOI 10.1002/dvg.20712; Antonellis A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000174; Arduini BL, 2009, DEVELOPMENT, V136, P1987, DOI 10.1242/dev.033209; Brown AM, 2009, DEV DYNAM, V238, P2922, DOI 10.1002/dvdy.22114; Cebra-Thomas JA, 2007, EVOL DEV, V9, P267, DOI 10.1111/j.1525-142X.2007.00159.x; Chai Y, 2000, DEVELOPMENT, V127, P1671; Clark K, 2001, GENESIS, V31, P111, DOI 10.1002/gene.10012; COLLAZO A, 1994, SCIENCE, V264, P426, DOI 10.1126/science.8153631; COULY GF, 1993, DEVELOPMENT, V117, P409; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Culbertson MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024443; Evans DJR, 2006, DEV DYNAM, V235, P1310, DOI 10.1002/dvdy.20663; Feng H, 2007, BRIT J HAEMATOL, V138, P169, DOI 10.1111/j.1365-2141.2007.06625.x; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; Fisher S, 2006, SCIENCE, V312, P276, DOI 10.1126/science.1124070; Fisher S, 2003, DEV BIOL, V264, P64, DOI 10.1016/S0012-1606(03)00399-3; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Gagan Jeffrey R., 2007, Birth Defects Research, V81, P297, DOI 10.1002/bdrc.20104; Gilbert SF, 2007, INTEGR COMP BIOL, V47, P401, DOI 10.1093/icb/icm020; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Gross JB, 2005, J EXP ZOOL PART B, V304B, P169, DOI 10.1002/jez.b.21028; Gross JB, 2004, DEV DYNAM, V230, P100, DOI 10.1002/dvdy.20036; Gross JB, 2008, DEV BIOL, V317, P389, DOI 10.1016/j.ydbio.2008.02.046; Hansen A, 2002, DEV DYNAM, V223, P483, DOI 10.1002/dvdy.10074; Harris MP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000206; Hesselson D, 2009, P NATL ACAD SCI USA, V106, P14896, DOI 10.1073/pnas.0906348106; Hutson MR, 2007, SEMIN CELL DEV BIOL, V18, P101, DOI 10.1016/j.semcdb.2006.12.004; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Jopling C, 2010, NATURE, V464, P606, DOI 10.1038/nature08899; Kague E, 2010, DEV BIOL, V337, P496, DOI 10.1016/j.ydbio.2009.10.028; Kelsh RN, 2000, DEVELOPMENT, V127, P515; Kikuchi K, 2010, NATURE, V464, P601, DOI 10.1038/nature08804; Knopf F, 2011, DEV CELL, V20, P713, DOI 10.1016/j.devcel.2011.04.014; Langenau DM, 2005, P NATL ACAD SCI USA, V102, P6068, DOI 10.1073/pnas.0408708102; Li YX, 2003, DEV DYNAM, V226, P540, DOI 10.1002/dvdy.10264; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; McBratney-Owen B, 2008, DEV BIOL, V322, P121, DOI 10.1016/j.ydbio.2008.07.016; McGonnell IM, 2002, CURR BIOL, V12, P767, DOI 10.1016/S0960-9822(02)00818-7; Morriss-Kay GM, 2005, J ANAT, V207, P637, DOI 10.1111/j.1469-7580.2005.00475.x; NAKAMURA H, 1982, J EMBRYOL EXP MORPH, V70, P1; Neuhauss SCF, 1996, DEVELOPMENT, V123, P357; Nguyen CT, 2010, DEV BIOL, V341, P167, DOI 10.1016/j.ydbio.2010.02.020; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Parichy DM, 2009, DEV DYNAM, V238, P2975, DOI 10.1002/dvdy.22113; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Quarto N, 2005, CELLS TISSUES ORGANS, V181, P109, DOI 10.1159/000091100; RAIBLE DW, 1994, DEVELOPMENT, V120, P495; Sanchez-Villagra MR, 2006, EVOL DEV, V8, P113, DOI 10.1111/j.1525-142X.2006.00081.x; Sato M, 2003, DEV BIOL, V257, P127, DOI 10.1016/S0012-1606(03)00037-X; Schilling TF, 1996, DEVELOPMENT, V123, P329; SCHILLING TF, 1994, DEVELOPMENT, V120, P483; Schneider RA, 1999, DEV BIOL, V208, P441, DOI 10.1006/dbio.1999.9213; Seok SH, 2010, CANCER SCI, V101, P149, DOI 10.1111/j.1349-7006.2009.01393.x; Shepherd I, 2011, METHOD CELL BIOL, V101, P143, DOI 10.1016/B978-0-12-387036-0.00006-2; SMITH M, 1994, P ROY SOC B-BIOL SCI, V256, P137, DOI 10.1098/rspb.1994.0061; Staab KL, 2010, J MORPHOL, V271, P814, DOI 10.1002/jmor.10836; Stine ZE, 2009, GENESIS, V47, P765, DOI 10.1002/dvg.20559; Wada N, 2005, DEVELOPMENT, V132, P3977, DOI 10.1242/dev.01943; Wang YY, 2011, DEVELOPMENT, V138, P609, DOI 10.1242/dev.059097; Westerfield M, 1995, ZEBRAFISH BOOK; Yoshida T, 2008, MECH DEVELOP, V125, P797, DOI 10.1016/j.mod.2008.06.007	62	129	130	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e47394	10.1371/journal.pone.0047394	http://dx.doi.org/10.1371/journal.pone.0047394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155370	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900004
J	Takemoto, Y; Li, TS; Kubo, M; Ohshima, M; Kurazumi, H; Ueda, K; Enoki, T; Murata, T; Hamano, K				Takemoto, Yoshihiro; Li, Tao-Sheng; Kubo, Masayuki; Ohshima, Mako; Kurazumi, Hiroshi; Ueda, Kazuhiro; Enoki, Tadahiko; Murata, Tomoaki; Hamano, Kimikazu			The Mobilization and Recruitment of C-Kit plus Cells Contribute to Wound Healing after Surgery	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; SURGICAL-SITE INFECTIONS; TUMOR-GROWTH; LUNG GROWTH; INHIBITION; INJURY; ANGIOGENESIS; MORTALITY; MICE	Delayed wound healing is a serious clinical problem in patients after surgery. A recent study has demonstrated that bone marrow-derived c-kit-positive (c-kit(+)) cells play important roles in repairing and regenerating various tissues and organs. To examine the hypothesis that surgical injury induces the mobilization and recruitment of c-kit+ cells to accelerate wound healing. Mice were subjected to a left pneumonectomy. The mobilization of c-kit+ cells was monitored after surgery. Using green fluorescent protein (GFP(+)) bone marrow-transplanted chimera mice, we investigated further whether the mobilized c-kit+ cells were recruited to effect wound healing in a skin puncture model. The group with left pneumonectomies increased the c-kit(+) and CD34(+) stem cells in peripheral blood 24 h after surgery. At 3 days after surgery, the skin wound size was observed to be significantly smaller, and the number of bone marrow-derived GFP(+) cells and GFP(+)/c-kit+ cells in the wound tissue was significantly greater in mice that had received pneumonectomies, as compared with those that had received a sham operation. Furthermore, some of these GFP(+) cells were positively expressed specific markers of macrophages (F4/80), endothelial cells (CD31), and myofibroblasts (alpha SMA). The administration of AMD3100, an antagonist of a stromal-cell derived factor (SDF)-1/CXCR4 signaling pathway, reduced the number of GFP(+) cells in wound tissue and completely negated the accelerated wound healing. Surgical injury induces the mobilization and recruitment of c-kit+ cells to contribute to wound healing. Regulating c-kit+ cells may provide a new approach that accelerates wound healing after surgery.	[Takemoto, Yoshihiro; Kubo, Masayuki; Ohshima, Mako; Kurazumi, Hiroshi; Ueda, Kazuhiro; Enoki, Tadahiko; Hamano, Kimikazu] Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan	Yamaguchi University	Takemoto, Y (corresponding author), Yamaguchi Univ, Grad Sch Med, Dept Surg & Clin Sci, Ube, Yamaguchi 755, Japan.	litaoshe@nagasaki-u.ac.jp		Li, Tao-Sheng/0000-0002-7653-8873				Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Astagneau P, 2001, J HOSP INFECT, V48, P267, DOI 10.1053/jhin.2001.1003; Barisic-Dujmovic T, 2010, J CELL PHYSIOL, V222, P703, DOI 10.1002/jcp.21997; Condon ET, 2004, SURGERY, V135, P657, DOI 10.1016/j.surg.2003.10.012; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Gaynes RP, 2001, CLIN INFECT DIS, V33, pS69, DOI 10.1086/321860; Hirbe AC, 2007, P NATL ACAD SCI USA, V104, P14062, DOI 10.1073/pnas.0705203104; Kamota T, 2009, J AM COLL CARDIOL, V53, P1814, DOI 10.1016/j.jacc.2009.02.015; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Li TS, 2010, J THORAC CARDIOV SUR, V139, P459, DOI 10.1016/j.jtcvs.2009.07.053; Li TS, 2009, CIRCULATION, V120, pS255, DOI 10.1161/CIRCULATIONAHA.108.837039; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Martone WJ, 2001, CLIN INFECT DIS, V33, pS67, DOI 10.1086/321859; Matsusue R, 2009, ANN SURG ONCOL, V16, P2645, DOI 10.1245/s10434-009-0599-x; Murakami J, 2009, INT J CANCER, V124, P1685, DOI 10.1002/ijc.24085; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Redjal N, 2006, CLIN CANCER RES, V12, P6765, DOI 10.1158/1078-0432.CCR-06-1372; Reynolds LE, 2005, NAT MED, V11, P167, DOI 10.1038/nm1165; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sakamaki Y, 2002, AM J RESP CELL MOL, V26, P525, DOI 10.1165/ajrcmb.26.5.4714; Schillaci G, 2009, INT J IMMUNOPATH PH, V22, P1035, DOI 10.1177/039463200902200419; Schurmann C, 2010, BRIT J SURG, V97, P1437, DOI 10.1002/bjs.7123; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Smith RL, 2004, ANN SURG, V239, P599, DOI 10.1097/01.sla.0000124292.21605.99; Takemoto Y, 2011, SURGERY, V149, P792, DOI 10.1016/j.surg.2011.02.005; Tanaka T, 2001, ANN THORAC SURG, V72, P1173, DOI 10.1016/S0003-4975(01)03054-5; Towfigh S, 2011, ARCH SURG-CHICAGO, V146, P448, DOI 10.1001/archsurg.2011.61; Voswinckel R, 2004, EUR RESPIR J, V24, P524, DOI 10.1183/09031936.04.10004904; WEKSLER B, 1994, J APPL PHYSIOL, V76, P1823, DOI 10.1152/jappl.1994.76.4.1823; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420	31	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48052	10.1371/journal.pone.0048052	http://dx.doi.org/10.1371/journal.pone.0048052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155375	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900009
J	Wang, DT; Wang, Y; Argyriou, C; Carriere, A; Malo, D; Hekimi, S				Wang, Dantong; Wang, Ying; Argyriou, Catherine; Carriere, Audrey; Malo, Danielle; Hekimi, Siegfried			An Enhanced Immune Response of Mclk1(+/-) Mutant Mice Is Associated with Partial Protection from Fibrosis, Cancer and the Development of Biomarkers of Aging	PLOS ONE			English	Article							OXIDATIVE DAMAGE; IFN-GAMMA; LIFE-SPAN; IDENTIFICATION; INFLAMMATION; RESISTANCE; LONGEVITY; INFECTION; SYSTEM; CELLS	The immune response is essential for survival by destroying microorganisms and pre-cancerous cells. However, inflammation, one aspect of this response, can result in short-and long-term deleterious side-effects. Mclk1(+/-) mutant mice can be long-lived despite displaying a hair-trigger inflammatory response and chronically activated macrophages as a result of high mitochondrial ROS generation. Here we ask whether this phenotype is beneficial or simply tolerated. We used models of infection by Salmonella serovars and found that Mclk1(+/-) mutants mount a stronger immune response, control bacterial proliferation better, and are resistant to cell and tissue damage resulting from the response, including fibrosis and types of oxidative damage that are considered to be biomarkers of aging. Moreover, these same types of tissue damage were found to be low in untreated 23 months-old mutants. We also examined the initiation of tumour growth after transplantation of mouse LLC1 carcinoma cells into Mclk1(+/-) mutants, as well as during spontaneous tumorigenesis in Mclk1(+/-) Trp53(+/-) double mutants. Tumour latency was increased by the Mclk1(+/-) genotype in both models. Furthermore, we used the transplantation model to show that splenic CD8+ T lymphocytes from Mclk1(+/-) graft recipients show enhanced cytotoxicity against LLC1 cells in vitro. Mclk1(+/-) mutants thus display an association of an enhanced immune response with partial protection from age-dependent processes and from pathologies similar to those that are found with increased frequency during the aging process. This suggests that the immune phenotype of these mutants might contribute to their longevity. We discuss how these findings suggest a broader view of how the immune response might impact the aging process.	[Wang, Dantong; Wang, Ying; Argyriou, Catherine; Carriere, Audrey; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Wang, DT (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	siegfried.hekimi@mcgill.ca	Wang, Ying/AAI-6756-2020	Wang, Ying/0000-0003-1339-9017; Carriere, Audrey/0000-0002-4277-7905; Wang, Dantong/0000-0003-2379-8222; Malo, Danielle/0000-0003-3980-6610	CIHR [15461-4, MOP-97869] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Andziak B, 2006, AGING CELL, V5, P525, DOI 10.1111/j.1474-9726.2006.00246.x; Andziak B, 2006, AGING CELL, V5, P463, DOI 10.1111/j.1474-9726.2006.00237.x; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Bokov AF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026891; Caron J, 2002, GENES IMMUN, V3, P196, DOI 10.1038/sj.gene.6363850; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Dai DF, 2009, CIRCULATION, V119, P2789, DOI 10.1161/CIRCULATIONAHA.108.822403; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; Finch CE, 2004, SCIENCE, V305, P1736, DOI 10.1126/science.1092556; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gagliano N, 2002, MECH AGEING DEV, V123, P413, DOI 10.1016/S0047-6374(01)00398-0; Green RM, 2002, GASTROENTEROLOGY, V123, P1367, DOI 10.1053/gast.2002.36061; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanssen SA, 2004, P ROY SOC B-BIOL SCI, V271, P925, DOI 10.1098/rspb.2004.2678; HARVEY M, 1993, NAT GENET, V5, P225, DOI 10.1038/ng1193-225; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Kim R, 2007, IMMUNOLOGY, V121, P1, DOI 10.1111/j.1365-2567.2007.02587.x; Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200; Lapointe J, 2012, J CELL BIOL, V199, P215, DOI 10.1083/jcb.201203090; Lapointe J, 2010, CELL MOL LIFE SCI, V67, P1, DOI 10.1007/s00018-009-0138-8; Lapointe J, 2009, J BIOL CHEM, V284, P20364, DOI 10.1074/jbc.M109.006569; Larbi A, 2008, PHYSIOLOGY, V23, P64, DOI 10.1152/physiol.00040.2007; Levavasseur F, 2001, J BIOL CHEM, V276, P46160, DOI 10.1074/jbc.M108980200; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; McElhaney JE, 2009, CURR OPIN IMMUNOL, V21, P418, DOI 10.1016/j.coi.2009.05.023; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Shanley DP, 2009, TRENDS IMMUNOL, V30, P374, DOI 10.1016/j.it.2009.05.001; Sharma S, 1999, J IMMUNOL, V163, P5020; Shi FD, 2000, J IMMUNOL, V165, P3099, DOI 10.4049/jimmunol.165.6.3099; Strindhall J, 2007, EXP GERONTOL, V42, P753, DOI 10.1016/j.exger.2007.05.001; Tabas I, 2010, NAT REV IMMUNOL, V10, P36, DOI 10.1038/nri2675; Teng MWL, 2008, J LEUKOCYTE BIOL, V84, P988, DOI 10.1189/jlb.1107774; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; VIDAL S, 1995, J EXP MED, V182, P655, DOI 10.1084/jem.182.3.655; Wang DT, 2010, J IMMUNOL, V184, P582, DOI 10.4049/jimmunol.0902352; Williams MD, 1998, J BIOL CHEM, V273, P28510, DOI 10.1074/jbc.273.43.28510	41	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49606	10.1371/journal.pone.0049606	http://dx.doi.org/10.1371/journal.pone.0049606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166727	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900172
J	Kuck, P; Greve, C; Misof, B; Gimnich, F				Kueck, Patrick; Greve, Carola; Misof, Bernhard; Gimnich, France			Automated Masking of AFLP Markers Improves Reliability of Phylogenetic Analyses	PLOS ONE			English	Article							GENOME SCAN; GENETIC-VARIATION; DATA SETS; SELECTION; ADAPTATION; ACCURACY; PLANT; DIFFERENTIATION; DIVERGENCE; PARAMETERS	The amplified fragment length polymorphisms (AFLP) method has become an attractive tool in phylogenetics due to the ease with which large numbers of characters can be generated. In contrast to sequence-based phylogenetic approaches, AFLP data consist of anonymous multilocus markers. However, potential artificial amplifications or amplification failures of fragments contained in the AFLP data set will reduce AFLP reliability especially in phylogenetic inferences. In the present study, we introduce a new automated scoring approach, called "AMARE" (AFLP MAtrix REduction). The approach is based on replicates and makes marker selection dependent on marker reproducibility to control for scoring errors. To demonstrate the effectiveness of our approach we record error rate estimations, resolution scores, PCoA and stemminess calculations. As in general the true tree (i.e. the species phylogeny) is not known, we tested AMARE with empirical, already published AFLP data sets, and compared tree topologies of different AMARE generated character matrices to existing phylogenetic trees and/or other independent sources such as morphological and geographical data. It turns out that the selection of masked character matrices with highest resolution scores gave similar or even better phylogenetic results than the original AFLP data sets. Citation: Kuck P, Greve C, Misof B, Gimnich F (2012) Automated Masking of AFLP Markers Improves Reliability of Phylogenetic Analyses. PLoS ONE 7(11): e49119. doi: 10.1371/journal.pone.0049119	[Kueck, Patrick; Greve, Carola; Misof, Bernhard; Gimnich, France] Zool Forsch Museum Alexander Koenig, Bonn, Germany	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK)	Greve, C (corresponding author), Zool Forsch Museum Alexander Koenig, Bonn, Germany.	c.greve@uni-bonn.de			Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was financially supported by grants from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrigo N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-33; Arthofer W, 2010, MOL ECOL RESOUR, V10, P385, DOI 10.1111/j.1755-0998.2009.02751.x; Bonin A, 2007, MOL ECOL, V16, P3737, DOI 10.1111/j.1365-294X.2007.03435.x; Bonin A, 2006, MOL BIOL EVOL, V23, P773, DOI 10.1093/molbev/msj087; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Buys MH, 2008, BIOCHEM SYST ECOL, V36, P92, DOI 10.1016/j.bse.2007.08.003; Dasmahapatra KK, 2009, HEREDITY, V103, P168, DOI 10.1038/hdy.2009.25; Egan SP, 2008, EVOLUTION, V62, P1162, DOI 10.1111/j.1558-5646.2008.00352.x; FIALA KI, 1985, EVOLUTION, V39, P609, DOI 10.1111/j.1558-5646.1985.tb00398.x; Geiger MF, 2010, MOL PHYLOGENET EVOL, V56, P1011, DOI 10.1016/j.ympev.2010.05.015; Gort G, 2010, THEOR APPL GENET, V121, P337, DOI 10.1007/s00122-010-1313-x; Hadfield JD, 2006, MOL ECOL, V15, P3715, DOI 10.1111/j.1365-294X.2006.03050.x; Herder F, 2006, P R SOC B, V273, P2209, DOI 10.1098/rspb.2006.3558; Herrmann D, 2010, GENOME, V53, P302, DOI [10.1139/G10-006, 10.1139/g10-006]; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Holland BR, 2008, SYST BIOL, V57, P347, DOI 10.1080/10635150802044037; Garcia-Pereira MJ, 2010, MOL BIOL EVOL, V27, P988, DOI 10.1093/molbev/msp315; Kingston SE, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-245; Koblmuller S, 2010, MOL PHYLOGENET EVOL, V55, P318, DOI 10.1016/j.ympev.2009.09.032; Koopman WJM, 2005, SYST BIOL, V54, P197, DOI 10.1080/10635150590924181; Lazaruk K, 1998, ELECTROPHORESIS, V19, P86, DOI 10.1002/elps.1150190116; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Manel S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-288; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Meudt HM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-111; Mila B, 2010, MOL ECOL, V19, P108, DOI 10.1111/j.1365-294X.2009.04441.x; Minder AM, 2008, MOL ECOL, V17, P1552, DOI 10.1111/j.1365-294X.2008.03709.x; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nosil P, 2008, EVOLUTION, V62, P316, DOI 10.1111/j.1558-5646.2007.00299.x; Paris M, 2010, MOL ECOL, V19, P325, DOI 10.1111/j.1365-294X.2009.04437.x; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schluter PM, 2006, MOL ECOL NOTES, V6, P569, DOI 10.1111/j.1471-8286.2006.01225.x; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taylor DJ, 2004, MOL BIOL EVOL, V21, P1534, DOI 10.1093/molbev/msh156; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Whitlock R, 2008, MOL ECOL RESOUR, V8, P725, DOI 10.1111/j.1755-0998.2007.02073.x; Zieritz A, 2010, EVOL ECOL, V24, P923, DOI 10.1007/s10682-009-9350-0	38	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49119	10.1371/journal.pone.0049119	http://dx.doi.org/10.1371/journal.pone.0049119			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152859	Green Submitted, Green Published, gold			2022-12-27	WOS:000312272600046
J	Springer, MS; Meredith, RW; Gatesy, J; Emerling, CA; Park, J; Rabosky, DL; Stadler, T; Steiner, C; Ryder, OA; Janecka, JE; Fisher, CA; Murphy, WJ				Springer, Mark S.; Meredith, Robert W.; Gatesy, John; Emerling, Christopher A.; Park, Jong; Rabosky, Daniel L.; Stadler, Tanja; Steiner, Cynthia; Ryder, Oliver A.; Janecka, Jan E.; Fisher, Colleen A.; Murphy, William J.			Macroevolutionary Dynamics and Historical Biogeography of Primate Diversification Inferred from a Species Supermatrix	PLOS ONE			English	Article							WORLD MONKEYS PLATYRRHINI; EVOLUTIONARY HISTORY; MOLECULAR PHYLOGENIES; DIVERGENCE TIMES; MIDDLE EOCENE; MOUSE LEMURS; GEOGRAPHIC RANGE; ASIAN COLOBINES; MITOCHONDRIAL; DIVERSITY	Phylogenetic relationships, divergence times, and patterns of biogeographic descent among primate species are both complex and contentious. Here, we generate a robust molecular phylogeny for 70 primate genera and 367 primate species based on a concatenation of 69 nuclear gene segments and ten mitochondrial gene sequences, most of which were extracted from GenBank. Relaxed clock analyses of divergence times with 14 fossil-calibrated nodes suggest that living Primates last shared a common ancestor 71-63 Ma, and that divergences within both Strepsirrhini and Haplorhini are entirely post-Cretaceous. These results are consistent with the hypothesis that the Cretaceous-Paleogene mass extinction of non-avian dinosaurs played an important role in the diversification of placental mammals. Previous queries into primate historical biogeography have suggested Africa, Asia, Europe, or North America as the ancestral area of crown primates, but were based on methods that were coopted from phylogeny reconstruction. By contrast, we analyzed our molecular phylogeny with two methods that were developed explicitly for ancestral area reconstruction, and find support for the hypothesis that the most recent common ancestor of living Primates resided in Asia. Analyses of primate macroevolutionary dynamics provide support for a diversification rate increase in the late Miocene, possibly in response to elevated global mean temperatures, and are consistent with the fossil record. By contrast, diversification analyses failed to detect evidence for rate-shift changes near the Eocene-Oligocene boundary even though the fossil record provides clear evidence for a major turnover event ("Grande Coupure'') at this time. Our results highlight the power and limitations of inferring diversification dynamics from molecular phylogenies, as well as the sensitivity of diversification analyses to different species concepts.	[Springer, Mark S.; Meredith, Robert W.; Gatesy, John; Emerling, Christopher A.; Park, Jong] Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA; [Meredith, Robert W.] Montclair State Univ, Dept Biol & Mol Biol, Montclair, NJ USA; [Park, Jong] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Rabosky, Daniel L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Rabosky, Daniel L.] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Stadler, Tanja] ETH, Inst Integrat Biol, Zurich, Switzerland; [Steiner, Cynthia; Ryder, Oliver A.] San Diego Zoo Global, San Diego Zoo Inst Conservat Res, San Diego, CA USA; [Janecka, Jan E.; Fisher, Colleen A.; Murphy, William J.] Texas A&M Univ, Dept Vet Integrat Biosci, College Stn, TX USA	University of California System; University of California Riverside; Montclair State University; University of Washington; University of Washington Seattle; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; Swiss Federal Institutes of Technology Domain; ETH Zurich; Zoological Society of San Diego; Texas A&M University System; Texas A&M University College Station	Springer, MS (corresponding author), Univ Calif Riverside, Dept Biol, Riverside, CA 92521 USA.	mark.springer@ucr.edu; wmurphy@cvm.tamu.edu	Stadler, Tanja/J-4742-2013; Rabosky, Daniel L/G-4530-2015	Stadler, Tanja/0000-0001-6431-535X; Emerling, Christopher/0000-0002-7722-7305	NSF [EF0629860, EF0629849]	NSF(National Science Foundation (NSF))	This work was supported by NSF (EF0629860 to MSS and JG; EF0629849 to WJM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews P, 1987, PRIMATE EVOLUTION HU, P194; Andriaholinirina N, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-17; Andriantompohavana Rambinintsoa, 2006, Occasional Papers Museum of Texas Tech University, V259, P1; Anthony NM, 2007, P NATL ACAD SCI USA, V104, P20432, DOI 10.1073/pnas.0704816105; Arnason U, 2002, P NATL ACAD SCI USA, V99, P8151, DOI 10.1073/pnas.102164299; Bajpai S, 2008, P NATL ACAD SCI USA, V105, P11093, DOI 10.1073/pnas.0804159105; Beard K. Christopher, 1998, Bulletin of Carnegie Museum of Natural History, V34, P5; Beard KC, 2002, CAM S BIO EVOL ANTHR, V33, P133; BEARD KC, 1994, NATURE, V368, P604, DOI 10.1038/368604a0; Begun DR, 2010, ANNU REV ANTHROPOL, V39, P67, DOI 10.1146/annurev.anthro.012809.105047; Bloch JI, 2007, P NATL ACAD SCI USA, V104, P1159, DOI 10.1073/pnas.0610579104; Bonvicino CR, 2003, AM J PRIMATOL, V61, P123, DOI 10.1002/ajp.10115; Bonvicino CR, 2001, CHROMOSOMA, V110, P241, DOI 10.1007/s004120000128; Boubli JP, 2008, INT J PRIMATOL, V29, P723, DOI 10.1007/s10764-008-9248-7; Cartmill Matt, 2010, P10; Chaimanee Y, 2012, P NATL ACAD SCI USA, V109, P10293, DOI 10.1073/pnas.1200644109; Chakraborty D, 2007, MOL PHYLOGENET EVOL, V44, P838, DOI 10.1016/j.ympev.2007.04.007; Chan YC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014419; Chatterjee HJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-259; Cortes-Ortiz L, 2003, MOL PHYLOGENET EVOL, V26, P64, DOI 10.1016/S1055-7903(02)00308-1; Costa E, 2011, PALAEOGEOGR PALAEOCL, V301, P97, DOI 10.1016/j.palaeo.2011.01.005; Cracraft J., 1983, Current Ornithology, V1, P159; Craul M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-83; Crowley TJ, 2000, WARM CLIMATES EARTH, P50, DOI DOI 10.1017/CBO9780511564512.004; de Queiroz K, 1998, ENDLESS FORMS, P57; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Edwards CJ, 2011, CURR BIOL, V21, P1251, DOI 10.1016/j.cub.2011.05.058; Elango N, 2006, P NATL ACAD SCI USA, V103, P1370, DOI 10.1073/pnas.0510716103; Fabre PH, 2009, MOL PHYLOGENET EVOL, V53, P808, DOI 10.1016/j.ympev.2009.08.004; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Folinsbee KE, 2007, J BIOGEOGR, V34, P383, DOI 10.1111/j.1365-2699.2006.01641.x; Galeotti S, 2010, GEOLOGY, V38, P419, DOI 10.1130/G30629.1; Gathorne-Hardy FJ, 2002, BIOL J LINN SOC, V75, P453, DOI 10.1046/j.1095-8312.2002.00031.x; Geissmann T, 2011, AM J PRIMATOL, V73, P96, DOI 10.1002/ajp.20894; Gligor M, 2009, MOL ECOL, V18, P520, DOI 10.1111/j.1365-294X.2008.04040.x; GRADSTEIN FM, 2009, TIMETREE LIFE, P26; Groeneveld LF, 2010, MOL PHYLOGENET EVOL, V55, P833, DOI 10.1016/j.ympev.2010.03.004; Groves C.P., 2005, MAMMAL SPECIES WORLD, P111; Groves C.P., 2001, PRIMATE TAXONOMY; Groves C, 2010, INT J PRIMATOL, V31, P1071, DOI 10.1007/s10764-010-9443-1; Groves Colin P., 1993, P243; Hartwig WC, 2002, PRIMATE FOSSIL RECOR; Hill J. E, 1991, WORLD LIST MAMMALIAN; Hodgson JA, 2009, P NATL ACAD SCI USA, V106, P5534, DOI 10.1073/pnas.0810346106; Hooker JJ, 2004, J GEOL SOC LONDON, V161, P161, DOI 10.1144/0016-764903-091; Horvath JE, 2008, GENOME RES, V18, P489, DOI 10.1101/gr.7265208; Jablonski NG, 2002, CAM S BIO EVOL ANTHR, V33, P255; Jaeger JJ, 2005, SCIENCE, V310, P244, DOI 10.1126/science.1118124; Jaeger JJ, 1999, SCIENCE, V286, P528, DOI 10.1126/science.286.5439.528; Kappeler P.M., 2005, Primate Report, V71, P3; Kappelman J, 2003, NATURE, V426, P549, DOI 10.1038/nature02102; Karanth KP, 2010, J GENET, V89, P393, DOI 10.1007/s12041-010-0057-3; Kay RF, 1997, SCIENCE, V275, P797, DOI 10.1126/science.275.5301.797; Kay RF, 2012, P NATL ACAD SCI USA, V109, P10132, DOI 10.1073/pnas.1207933109; Kjer KM, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-8; Kraatz BP, 2010, GEOLOGY, V38, P111, DOI 10.1130/G30619.1; LI WH, 1987, NATURE, V326, P93, DOI 10.1038/326093a0; Louis Edward E. Jr, 2006, Texas Tech University Museum Special Publications, V49, P1; Louis Edward E. Jr, 2008, Primate Conservation, V23, P19, DOI 10.1896/052.023.0103; Matauschek C, 2011, AM J PHYS ANTHROPOL, V144, P564, DOI 10.1002/ajpa.21445; McGowan AJ, 2008, PALEOBIOLOGY, V34, P80, DOI 10.1666/07019.1; McInnes L, 2011, P ROY SOC B-BIOL SCI, V278, P3294, DOI 10.1098/rspb.2011.0241; Mckay BD, 2010, MOL PHYLOGENET EVOL, V54, P647, DOI 10.1016/j.ympev.2009.08.024; McLain AT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044035; Menezes AN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-248; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Meredith RW, 2010, J MAMM EVOL, V17, P75, DOI 10.1007/s10914-010-9129-7; Merker S, 2010, INT J PRIMATOL, V31, P1107, DOI 10.1007/s10764-010-9452-0; Merker S, 2009, P NATL ACAD SCI USA, V106, P8459, DOI 10.1073/pnas.0900319106; Meyer D, 2011, MOL PHYLOGENET EVOL, V59, P311, DOI 10.1016/j.ympev.2011.02.015; Miller M.A., 2010, P GAT COMP ENV WORKS; Mittermeier R, 2008, INT J PRIMATOL, V29, P1607, DOI 10.1007/s10764-008-9317-y; Morlon H, 2011, P NATL ACAD SCI USA, V108, P16327, DOI 10.1073/pnas.1102543108; Moya-Sola S, 1999, CURR BIOL, V9, pR547, DOI 10.1016/S0960-9822(99)80350-9; NEE S, 1994, PHILOS T ROY SOC B, V344, P305, DOI 10.1098/rstb.1994.0068; Olivieri G, 2007, MOL PHYLOGENET EVOL, V43, P309, DOI 10.1016/j.ympev.2006.10.026; Opazo JC, 2006, MOL PHYLOGENET EVOL, V40, P274, DOI 10.1016/j.ympev.2005.11.015; Osterholz M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-58; Pastorini J, 2003, P NATL ACAD SCI USA, V100, P5879, DOI 10.1073/pnas.1031673100; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Poux C, 2006, SYST BIOL, V55, P228, DOI 10.1080/10635150500481390; Poux C, 2004, AM J PHYS ANTHROPOL, V124, P1, DOI 10.1002/ajpa.10322; PURVIS A, 1995, PHILOS T ROY SOC B, V348, P405, DOI 10.1098/rstb.1995.0078; Rabosky DL, 2009, SYST BIOL, V58, P629, DOI 10.1093/sysbio/syp069; Radespiel U, 2008, AM J PRIMATOL, V70, P1033, DOI 10.1002/ajp.20592; Radespiel U, 2012, PRIMATES, V53, P157, DOI 10.1007/s10329-011-0290-2; Rambaut A., 1996, SEQUENCE ALIGNMENT E; Rannala B, 2007, SYST BIOL, V56, P453, DOI 10.1080/10635150701420643; RAUP D M, 1976, Paleobiology, V2, P289; Ray N., 2001, INTERNET ARCHAEOLOGY, V11, P1, DOI [DOI 10.11141/IA.11.2, 10.11141/ia.11.2]; Ree RH, 2005, EVOLUTION, V59, P2299; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Reed KE, 2004, YEARB PHYS ANTHROPOL, V47, P2, DOI 10.1002/ajpa.20153; Reeder DeeAnn M., 2007, Occasional Papers Museum of Texas Tech University, V269, P1; Riley EP, 2010, EVOL ANTHROPOL, V19, P22, DOI 10.1002/evan.20246; Roca AL, 2005, NAT GENET, V37, P96, DOI 10.1038/ng1485; Roos C, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-77; Roos Christian, 2006, Primate Conservation, V21, P51, DOI 10.1896/0898-6207.21.1.51; Rosenberger AL, 2002, CAM S BIO EVOL ANTHR, V33, P151; Ruiz-Garcia M, 2010, FOLIA PRIMATOL, V81, P109, DOI 10.1159/000315070; Rull V, 2011, TRENDS ECOL EVOL, V26, P508, DOI 10.1016/j.tree.2011.05.011; Rumpler Y, 2011, CHROMOSOME RES, V19, P209, DOI 10.1007/s10577-011-9188-5; Rylands Anthony B., 2009, P23, DOI 10.1007/978-0-387-78705-3_2; Sanchez-Gracia A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030239; Schneider H, 1996, AM J PHYS ANTHROPOL, V100, P153, DOI 10.1002/(SICI)1096-8644(199606)100:2<153::AID-AJPA1>3.0.CO;2-Z; SCHNEIDER H, 1993, MOL PHYLOGENET EVOL, V2, P225, DOI 10.1006/mpev.1993.1022; Schneider I, 2004, GENET MOL BIOL, V27, P505, DOI 10.1590/S1415-47572004000400007; Seiffert ER, 2005, SCIENCE, V310, P300, DOI 10.1126/science.1116569; Seiffert ER, 2001, J HUM EVOL, V41, P577, DOI 10.1006/jhev.2001.0508; Seiffert ER, 2010, P NATL ACAD SCI USA, V107, P9712, DOI 10.1073/pnas.1001393107; Shekelle M, 2010, INT J PRIMATOL, V31, P1083, DOI 10.1007/s10764-010-9457-8; Silcox Mary T., 2008, P199, DOI 10.1007/978-1-4020-6997-0_10; Smith AB, 2002, ANNU REV EARTH PL SC, V30, P65, DOI 10.1146/annurev.earth.30.091201.140057; SOLA SM, 1993, NATURE, V365, P543, DOI 10.1038/365543a0; Soligo Christophe, 2007, P29, DOI 10.1007/978-0-387-33507-0_2; SOMURA H, 2012, ISRN ZOOL, V2012, DOI DOI 10.5402/2012/498731; Springer MS, 2011, PHILOS T R SOC B, V366, P2478, DOI 10.1098/rstb.2011.0023; Springer MS, 2004, MOL PHYLOGENET EVOL, V30, P883, DOI 10.1016/j.ympev.2003.09.019; Stadler T, 2011, P NATL ACAD SCI USA, V108, P16145, DOI 10.1073/pnas.1113242108; Stadler T, 2011, P NATL ACAD SCI USA, V108, P6187, DOI 10.1073/pnas.1016876108; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Steiper ME, 2004, P NATL ACAD SCI USA, V101, P17021, DOI 10.1073/pnas.0407270101; Steiper ME, 2006, MOL PHYLOGENET EVOL, V41, P384, DOI 10.1016/j.ympev.2006.05.021; Steiper ME, 2012, P NATL ACAD SCI USA, V109, P6006, DOI 10.1073/pnas.1119506109; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Takacs Z, 2005, MOL PHYLOGENET EVOL, V36, P456, DOI 10.1016/j.ympev.2005.03.032; Tavare S, 2002, NATURE, V416, P726, DOI 10.1038/416726a; Thinh VN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-74; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Ting N, 2008, MOL PHYLOGENET EVOL, V46, P466, DOI 10.1016/j.ympev.2007.11.008; Toews DPL, 2012, MOL ECOL, V21, P3907, DOI 10.1111/j.1365-294X.2012.05664.x; Tosi AJ, 2000, MOL PHYLOGENET EVOL, V17, P133, DOI 10.1006/mpev.2000.0834; Tosi AJ, 2005, MOL PHYLOGENET EVOL, V36, P58, DOI 10.1016/j.ympev.2005.01.009; Tosi AJ, 2003, EVOLUTION, V57, P1419; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Wang XG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0051667, 10.1371/journal.pone.0029469, 10.1371/journal.pone.0047703, 10.1371/journal.pone.0036274, 10.1371/journal.pone.0048069, 10.1371/journal.pone.0032405]; Weisrock DW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009883; Wiens JJ, 2006, J BIOMED INFORM, V39, P34, DOI 10.1016/j.jbi.2005.04.001; Wilkinson RD, 2011, SYST BIOL, V60, P16, DOI 10.1093/sysbio/syq054; Williams BA, 2010, P NATL ACAD SCI USA, V107, P4797, DOI 10.1073/pnas.0908320107; Xing J, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-5; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yoder AD, 2004, MOL ECOL, V13, P757, DOI 10.1046/j.1365-294X.2004.02106.x; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801; Zalmout IS, 2010, NATURE, V466, P360, DOI 10.1038/nature09094; Zinner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004859	148	265	269	3	144	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49521	10.1371/journal.pone.0049521	http://dx.doi.org/10.1371/journal.pone.0049521			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166696	Green Published, Green Submitted, gold			2022-12-27	WOS:000311885300051
J	Barac, YD; Bar-Am, O; Liani, E; Amit, T; Frolov, L; Ovcharenko, E; Angel, I; Youdim, MBH; Binah, O				Barac, Yaron D.; Bar-Am, Orit; Liani, Esti; Amit, Tamar; Frolov, Luba; Ovcharenko, Elena; Angel, Itzchak; Youdim, Moussa B. H.; Binah, Ofer			I-1 Imidazoline Receptor: Novel Potential Cytoprotective Target of TVP1022, the S-Enantiomer of Rasagiline	PLOS ONE			English	Article							RAT VENTRICULAR MYOCYTES; MONOAMINE-OXIDASE; I-1-IMIDAZOLINE RECEPTORS; PHOSPHOLIPASE-C; PC12 CELLS; ACTIVATION; NEUROPROTECTION; PROPARGYLAMINE; INHIBITOR; MECHANISM	TVP1022, the S-enantiomer of rasagiline (Azilect (R)) (N-propargyl-1R-aminoindan), exerts cyto/cardio-protective effects in a variety of experimental cardiac and neuronal models. Previous studies have demonstrated that the protective activity of TVP1022 and other propargyl derivatives involve the activation of p42/44 mitogen-activated protein kinase (MAPK) signaling pathway. In the current study, we further investigated the molecular mechanism of action and signaling pathways of TVP1022 which may account for the cyto/cardio-protective efficacy of the drug. Using specific receptor binding and enzyme assays, we demonstrated that the imidazoline 1 and 2 binding sites (I-1 & I-2) are potential targets for TVP1022 (IC50 = 9.5E-08 M and IC50 = 1.4E-07 M, respectively). Western blotting analysis showed that TVP1022 (1-20 mu M) dose-dependently increased the immunoreactivity of phosphorylated p42 and p44 MAPK in rat pheochromocytoma PC12 cells and in neonatal rat ventricular myocytes (NRVM). This effect of TVP1022 was significantly attenuated by efaroxan, a selective I-1 imidazoline receptor antagonist. In addition, the cytoprotective effect of TVP1022 demonstrated in NRVM against serum deprivation-induced toxicity was markedly inhibited by efaroxan, thus suggesting the importance of I(1)imidazoline receptor in mediating the cardioprotective activity of the drug. Our findings suggest that the I(1)imidazoline receptor represents a novel site of action for the cyto/cardio-protective efficacy of TVP1022.	[Barac, Yaron D.; Liani, Esti; Frolov, Luba; Ovcharenko, Elena; Binah, Ofer] Technion Israel Inst Technol, Fac Med, Dept Physiol & Biophys, Haifa, Israel; [Bar-Am, Orit; Amit, Tamar; Youdim, Moussa B. H.] Technion Israel Inst Technol, Eve Topf & Natl Parkinson Fdn, Ctr Neurodegenerat Dis Res, Haifa, Israel; [Bar-Am, Orit; Amit, Tamar; Youdim, Moussa B. H.] Technion Israel Inst Technol, Dept Pharmacol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel; [Angel, Itzchak] APCT Ltd, Ness Ziona, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Binah, O (corresponding author), Technion Israel Inst Technol, Fac Med, Dept Physiol & Biophys, Haifa, Israel.	binah@tx.technion.ac.il		Binah, Ofer/0000-0002-0468-8530; barac, yaron/0000-0002-4688-2358				Bar-Am O, 2010, J ALZHEIMERS DIS, V21, P361, DOI 10.3233/JAD-2010-100150; Berdichevski A, 2010, J PHARMACOL EXP THER, V332, P413, DOI 10.1124/jpet.109.161158; Black SC, 2000, J PHARMACOL TOXICOL, V43, P153, DOI 10.1016/S1056-8719(00)00102-7; BROWN CM, 1990, BRIT J PHARMACOL, V99, P803, DOI 10.1111/j.1476-5381.1990.tb13010.x; Downey JM, 2009, CIRC J, V73, P1171, DOI 10.1253/circj.CJ-09-0338; Dupuy L, 2004, CELL DEATH DIFFER, V11, P1049, DOI 10.1038/sj.cdd.4401447; Edwards L, 2003, BRAIN RES, V980, P71, DOI 10.1016/S0006-8993(03)02893-2; Edwards L, 2001, J NEUROCHEM, V79, P931, DOI 10.1046/j.1471-4159.2001.00632.x; Ernsberger P, 1999, ANN NY ACAD SCI, V881, P35, DOI 10.1111/j.1749-6632.1999.tb09339.x; Ertracht O, 2011, BRIT J PHARMACOL, V163, P755, DOI 10.1111/j.1476-5381.2011.01274.x; Huang W, 1999, EUR J PHARMACOL, V366, P127, DOI 10.1016/S0014-2999(98)00929-7; Kleiner Y, 2008, J CARDIOVASC PHARM, V52, P268, DOI 10.1097/FJC.0b013e3181862441; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Mandel S, 2005, BRAIN RES REV, V48, P379, DOI 10.1016/j.brainresrev.2004.12.027; Molderings GJ, 2007, NEUROCHEM INT, V51, P476, DOI 10.1016/j.neuint.2007.04.022; MOLDERINGS GJ, 1993, N-S ARCH PHARMACOL, V348, P70, DOI 10.1007/BF00168539; Molderings GJ, 2002, NEUROCHEM INT, V40, P157, DOI 10.1016/S0197-0186(01)00076-6; Musgrave IF, 1999, ANN NY ACAD SCI, V881, P301, DOI 10.1111/j.1749-6632.1999.tb09375.x; Naoi M, 2009, EXPERT REV NEUROTHER, V9, P1233, DOI [10.1586/ern.09.68, 10.1586/ERN.09.68]; Separovic D, 1997, BRAIN RES, V749, P335, DOI 10.1016/S0006-8993(96)01372-8; Separovic D, 1996, MOL PHARMACOL, V49, P668; Stabile AM, 2011, LIFE SCI, V88, P493, DOI 10.1016/j.lfs.2011.01.008; Sugiyama A, 2000, JPN J PHARMACOL, V82, P338, DOI 10.1254/jjp.82.338; Tiyyagura SR, 2006, MT SINAI J MED, V73, P840; Weinreb O, 2004, FASEB J, V18, P1471, DOI 10.1096/fj.04-1916fje; Weinreb O, 2010, PROG NEUROBIOL, V92, P330, DOI 10.1016/j.pneurobio.2010.06.008; Youdim MBH, 2005, J NEUROSCI RES, V79, P172, DOI 10.1002/jnr.20350; Youdim MBH, 2001, BRIT J PHARMACOL, V132, P500, DOI 10.1038/sj.bjp.0703826; Zhang J, 2001, EUR J PHARMACOL, V415, P117, DOI 10.1016/S0014-2999(01)00834-2	29	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e47890	10.1371/journal.pone.0047890	http://dx.doi.org/10.1371/journal.pone.0047890			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166584	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300005
J	Kobayashi, S; Tsugama, D; Liu, SK; Takano, T				Kobayashi, Shio; Tsugama, Daisuke; Liu, Shenkui; Takano, Tetsuo			A U-Box E3 Ubiquitin Ligase, PUB20, Interacts with the Arabidopsis G-Protein beta Subunit, AGB1	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; ABSCISIC-ACID REGULATION; PUCCINELLIA-TENUIFLORA; THALIANA; RICE; EXPRESSION; K+	An Arabidopsis U-box E3 ubiquitin ligase Plant U-box 20 (PUB20; alternatively called AtCMPG1) was identified as a possible interactor of the Arabidopsis G-protein beta subunit, AGB1, by yeast two-hybrid screening. A bimolecular fluorescence complementation (BiFC) assay showed that PUB20 interacted with AGB1 in the nuclei and the cytosol. The expression levels of PUB20 and its closest homolog, PUB21 were stable under many conditions. GUS driven by the PUB20 promoter was active in anthers, pollen, premature seeds and receptacles and GUS driven by the PUB21 promoter was active in anthers and funiculi. PUB20 was found to have autoubiquitination activity in vitro.	[Kobayashi, Shio; Tsugama, Daisuke; Takano, Tetsuo] Univ Tokyo, ANESC, Tokyo, Japan; [Liu, Shenkui] NE Forestry Univ, ASNESC, Harbin, Peoples R China	University of Tokyo; Northeast Forestry University - China	Takano, T (corresponding author), Univ Tokyo, ANESC, Tokyo, Japan.	takano@anesc.u-tokyo.ac.jp	Liu, Shenkui/AAC-5405-2019; Tsugama, Daisuke/N-6054-2014	Liu, Shenkui/0000-0001-5294-4765; Tsugama, Daisuke/0000-0002-4946-678X	 [21380002]		This work was supported by Grant-in-aid for Scientific Research (21380002) (http://www.jsps.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DJ, 2007, PLANT CELL REP, V26, P1469, DOI 10.1007/s00299-007-0356-1; Ardie SW, 2011, MOL BIOTECHNOL, V48, P76, DOI 10.1007/s12033-010-9349-3; Chang-Qing Z, 2008, BMB REP, V41, P448, DOI 10.5483/BMBRep.2008.41.6.448; Chen JG, 2004, PLANT PHYSIOL, V135, P907, DOI 10.1104/pp.104.038992; Drechsel G, 2011, J EXP BOT, V62, P775, DOI 10.1093/jxb/erq313; Fan LM, 2008, P NATL ACAD SCI USA, V105, P8476, DOI 10.1073/pnas.0800980105; Heise A, 2002, P NATL ACAD SCI USA, V99, P9049, DOI 10.1073/pnas.132277699; Lease KA, 2001, PLANT CELL, V13, P2631, DOI 10.1105/tpc.13.12.2631; Lee JH, 2008, PLANT CELL, V20, P152, DOI 10.1105/tpc.107.055418; Mason MG, 2000, P NATL ACAD SCI USA, V97, P14784, DOI 10.1073/pnas.97.26.14784; Mudgil Y, 2004, PLANT PHYSIOL, V134, P59, DOI 10.1104/pp.103.029553; Pandey S, 2006, PLANT PHYSIOL, V141, P243, DOI 10.1104/pp.106.079038; Temple BRS, 2007, ANNU REV PLANT BIOL, V58, P249, DOI 10.1146/annurev.arplant.58.032806.103827; Thung L, 2012, J PLANT PHYSIOL, V169, P542, DOI 10.1016/j.jplph.2011.11.010; Trusov Y, 2009, PLANT J, V58, P69, DOI 10.1111/j.1365-313X.2008.03755.x; Tsugama D, 2012, FEBS LETT, V586, P693, DOI 10.1016/j.febslet.2012.02.019; Tsugama D, 2011, PLANT METHODS, V7, DOI 10.1186/1746-4811-7-22; Ullah H, 2003, PLANT CELL, V15, P393, DOI 10.1105/tpc.006148; Xie Q, 2002, NATURE, V187, P184; Yee D, 2009, J EXP BOT, V60, P1109, DOI 10.1093/jxb/ern369; Zhang LG, 2008, DEV BIOL, V324, P68, DOI 10.1016/j.ydbio.2008.09.008	21	15	18	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49207	10.1371/journal.pone.0049207	http://dx.doi.org/10.1371/journal.pone.0049207			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166612	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300028
J	Durant, KT; McCray, AT; Safran, C				Durant, Kathleen T.; McCray, Alexa T.; Safran, Charles			Identifying Gender-Preferred Communication Styles within Online Cancer Communities: A Retrospective, Longitudinal Analysis	PLOS ONE			English	Article							COMPUTER-MEDIATED COMMUNICATION; RANDOMIZED CONTROLLED-TRIAL; SHORT-MESSAGE SERVICE; SUPPORT GROUPS; PEER INTERACTIONS; SEX-DIFFERENCES; BREAST-CANCER/; INTERNET; CHILDHOOD; REMINDERS	Background: The goal of this research is to determine if different gender-preferred social styles can be observed within the user interactions at an online cancer community. To achieve this goal, we identify and measure variables that pertain to each gender-specific social style. Methods and Findings: We perform social network and statistical analysis on the communication flow of 8,388 members at six different cancer forums over eight years. Kruskal-Wallis tests were conducted to measure the difference between the number of intimate (and highly intimate) dyads, relationship length, and number of communications. We determine that two patients are more likely to form an intimate bond on a gender-specific cancer forum (ovarian P = <0.0001, breast P = 0.0089, prostate P = 0.0021). Two female patients are more likely to form a highly intimate bond on a female-specific cancer forum (Ovarian P < 0.0001, Breast P < 0.01). Typically a male patient communicates with more members than a female patient (Ovarian forum P = 0.0406, Breast forum P = 0.0013). A relationship between two patients is longer on the gender-specific cancer forums than a connection between two members not identified as patients (ovarian forum P = 0.00406, breast forum P = 0.00013, prostate forum P = .0.0003). Conclusion: : The high level of interconnectedness among the prostate patients supports the hypothesis that men prefer to socialize in large, interconnected, less-intimate groups. A female patient is more likely to form a highly intimate connection with another female patient; this finding is consistent with the hypothesis that woman prefer fewer, more intimate connections. The relationships of same-gender cancer patients last longer than other relationships; this finding demonstrates homophily within these online communities. Our findings regarding online communication preferences are in agreement with research findings from person-to-person communication preference studies. These findings should be considered when designing online communities as well as designing and evaluating psychosocial and educational interventions for cancer patients.	[Durant, Kathleen T.] Silverlink Commun, Boston, MA USA		Durant, KT (corresponding author), Silverlink Commun, Boston, MA USA.	Kathleen.durant@post.harvard.edu			NLM NIH HHS [T15-RFA-LM-06-001] Funding Source: Medline; NATIONAL LIBRARY OF MEDICINE [P41LM006001] Funding Source: NIH RePORTER	NLM NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Altekruse S. F., 2007, SEER CANC STAT REV 1; Andronico MP, 1997, MEN GROUPS INSIGHTS; Andronico MP, 1997, MEN GROUPS INSIGHTS; [Anonymous], 2008, HDB LANGUAGE GENDER; Armstrong AW, 2009, ARCH DERMATOL, V145, P1230, DOI 10.1001/archdermatol.2009.269; Bauer S, 2010, PATIENT EDUC COUNS, V79, P315, DOI 10.1016/j.pec.2010.03.014; BAUM A, 2001, PSYCHOSOCIAL INTERVE; Baumeister RF, 1997, PSYCHOL BULL, V122, P38, DOI 10.1037/0033-2909.122.1.38; Becket JV, 1997, MEN GROUPS INSIGHTS; Benenson J. F., 1990, J EARLY ADOLESC, V10, P472, DOI DOI 10.1177/0272431690104004; Benenson JF, 1997, DEV PSYCHOL, V33, P538, DOI 10.1037/0012-1649.33.3.538; Benenson JF, 2003, CHILD DEV, V74, P1123, DOI 10.1111/1467-8624.00596; BENENSON JF, 1993, CHILD DEV, V64, P544, DOI 10.2307/1131268; Benenson JF, 2008, ANIM BEHAV, V76, P497, DOI 10.1016/j.anbehav.2008.01.027; Benenson JF, 2009, PSYCHOL SCI, V20, P184, DOI 10.1111/j.1467-9280.2009.02269.x; Blank TO, 2007, COMPUT HUM BEHAV, V23, P1249, DOI 10.1016/j.chb.2004.12.003; Buhrmester D., 1995, DISCLOSURE PROCESSES, P10, DOI DOI 10.1017/CBO9780511527746.002; Calamari JE, 1997, MEN GROUPS INSIGHTS, P305; Catherall DR, 1997, MEN GROUPS INSIGHTS; Coomes CM, 2012, AIDS CARE, V24, P348, DOI 10.1080/09540121.2011.608421; Davidson L, 1999, CLIN PSYCHOL-SCI PR, V6, P165, DOI 10.1093/clipsy/6.2.165; Durant KT, 2010, P 2010 AMIA CLIN RES; EDELSKY C, 1981, LANG SOC, V10, P383, DOI 10.1017/S004740450000885X; Eysenbach G, 2001, BRIT MED J, V323, P1103, DOI 10.1136/bmj.323.7321.1103; Ferrer-Roca O, 2004, J TELEMED TELECARE, V10, P282, DOI 10.1258/1357633042026341; Fjeldsoe BS, 2009, AM J PREV MED, V36, P165, DOI 10.1016/j.amepre.2008.09.040; Fox Susannah, 2011, SOCIAL LIFE HLTH INF; Friedman H, 2007, FDN HLTH PSYCHOL; Ginossar T, 2008, HEALTH COMMUN, V23, P1, DOI 10.1080/10410230701697100; Goodwin PJ, 2001, NEW ENGL J MED, V345, P1719, DOI 10.1056/NEJMoa011871; Guo L, 2008, P 15 ACM SIGKDD INT, P369; Hanauer DA, 2009, DIABETES TECHNOL THE, V11, P99, DOI 10.1089/dia.2008.0022; Hansen DL, 2011, ANALYZING SOCIAL MEDIA NETWORKS WITH NODEXL: INSIGHTS FROM A CONNECTED WORLD, P1; Harrison JB, 1997, MEN GROUPS INSIGHTS; Harway M, 1997, MEN GROUPS INSIGHTS; Herring Elizabeth, 2012, 9 ANN GRADUATE STUDE; Hussein WI, 2011, DIABETES RES CLIN PR, V94, pE24, DOI 10.1016/j.diabres.2011.07.025; Hutson Thomas E, 2005, Proc (Bayl Univ Med Cent), V18, P337; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Kiss A, 2001, BMJ-BRIT MED J, V323, P1055, DOI 10.1136/bmj.323.7320.1055; Klemm P, 1999, COMPUT NURS, V17, P65; Lakkis NA, 2011, PREV MED, V53, P325, DOI 10.1016/j.ypmed.2011.08.013; Lakoff Robin, 1975, LANGUAGE WOMANS PLAC; Lieberman MA, 2003, CANCER, V97, P920, DOI 10.1002/cncr.11145; Lieberman MA, 2004, INT J SELF HELP, V2, P219, DOI [10.2190/GE85-J31W-XJV7-LB9L, DOI 10.2190/GE85-J31W-XJV7-LB9L]; Lieberman MA, 2008, J CANCER EDUC, V23, P167, DOI 10.1080/08858190802039185; Maccoby E. E., 1998, 2 SEXES GROWING APAR; MACCOBY EE, 1990, AM PSYCHOL, V45, P513, DOI 10.1037/0003-066X.45.4.513; MACCOBY EE, 1988, DEV PSYCHOL, V24, P755, DOI 10.1037/0012-1649.24.6.755; MACCOBY EE, 1987, ADV CHILD DEV BEHAV, V20, P239, DOI 10.1016/S0065-2407(08)60404-8; Maccoby EE, 1994, CHILDHOOD GENDER SEG, P87; Markovits H, 2001, CHILD DEV, V72, P879, DOI 10.1111/1467-8624.00321; Martin CL, 2001, DEV PSYCHOL, V37, P431, DOI 10.1037//0012-1649.37.3.431; Mbuagbaw L, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-5; Mead S, 2006, INT J PSYCHOSOCIAL R, V10, P29, DOI DOI 10.1016/J.JSAT.2012.11.005; Meric F, 2002, BMJ-BRIT MED J, V324, P577, DOI 10.1136/bmj.324.7337.577; Mo PKH, 2009, PATIENT EDUC COUNS, V75, P16, DOI 10.1016/j.pec.2008.08.029; NOOY WD, 2005, EXPLORATORY SOCIAL N; Norton TR, 2004, J CLIN ONCOL, V22, P919, DOI 10.1200/JCO.2004.07.028; Oswald DL, 2004, J SOC CLIN PSYCHOL, V23, P413, DOI 10.1521/jscp.23.3.413.35460; Owen JE, 2004, J BEHAV MED, V27, P491, DOI 10.1023/B:JOBM.0000047612.81370.f7; Owen JE, 2004, CANCER, V109, P2580; Paolillo J. C., 2001, J SOCIOLING, V5, P180, DOI DOI 10.1111/1467-9481.00147; Savicki V, 2000, CYBERPSYCHOL BEHAV, V3, P817, DOI 10.1089/10949310050191791; Solomon P, 2004, PSYCHIATR REHABIL J, V27, P392, DOI 10.2975/27.2004.392.401; Sullivan CF, 2003, J HEALTH PSYCHOL, V8, P83, DOI 10.1177/1359105303008001446; Twombly R, 2004, J NATL CANCER I, V96, P1414, DOI 10.1093/jnci/96.19.1414; Vigil JM, 2007, HUM NATURE-INT BIOS, V18, P143, DOI 10.1007/s12110-007-9003-3; Wangberg SC, 2006, J TELEMED TELECARE, V12, P55, DOI 10.1258/135763306777978515; Wilson C., 2009, P ACM EUROSYS; Winzelberg AJ, 2003, CANCER, V98, P1164; Wood J.T., 1993, J APPLIED COMMUNICAT, V21, P279, DOI [10.1080/00909889309365372, DOI 10.1080/00909889309365372]; Woolford SJ, 2010, J TELEMED TELECARE, V16, P458, DOI 10.1258/jtt.2010.100207	74	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49169	10.1371/journal.pone.0049169	http://dx.doi.org/10.1371/journal.pone.0049169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155460	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900095
J	Haugland, GT; Jordal, AEO; Wergeland, HI				Haugland, Gyri T.; Jordal, Ann-Elise O.; Wergeland, Heidrun I.			Characterization of Small, Mononuclear Blood Cells from Salmon Having High Phagocytic Capacity and Ability to Differentiate into Dendritic like Cells	PLOS ONE			English	Article							PERIPHERAL LYMPHOID ORGANS; ATLANTIC SALMON; MONOCLONAL-ANTIBODIES; IDENTIFICATION; THROMBOCYTES; EXPRESSION; SURFACE; MOUSE; MICE; CD83	Phagocytes are the principal component of the innate immune system, playing a key role in the clearance of foreign particles that include potential pathogens. In vertebrates, both neutrophils and mononuclear cells like monocytes, macrophages and dendritic cells are all professional phagocytes. In teleosts, B-lymphocytes also have potent phagocytic ability. We have isolated a population of small (<5 mu m), mononuclear blood cells from Atlantic salmon (Salmo salar L.) not previously characterized. In order to identify them, we have performed morphological, gene expression, flow cytometry, cytochemical, ultrastructural and functional analyses. Interestingly, they highly express the gene encoding CD83, the most characteristic cell surface marker for dendritic cells in mammals, and MHC class II limited to professional antigen presenting cells. They did not express genes nor did they have cell markers for B-cells, T-cells, monocytes/macrophages or neutrophils as shown by qRT-PCR, flow cytometry and immunoblotting. A remarkable feature of these cells is their potent phagocytic capacity. Their oxygen-independent killing mechanism, as shown by intense acid phosphatase staining, is supported by lack of respiratory burst and myeloperoxidase activity and the acid phosphatase's sensitivity to tartrate. They show a high level of morphological plasticity, as, upon stimulation with mitogens, they change morphology and obtain branching protrusions similarly to dendritic cells. We suggest, based on our findings, that the small, round cells described here are progenitor cells with potential to differentiate into dendritic like cells, although we can not exclude the possibility that they represent a novel cell type.	[Haugland, Gyri T.; Jordal, Ann-Elise O.; Wergeland, Heidrun I.] Univ Bergen, Bergen High Technol Ctr, Dept Biol, Bergen, Norway	University of Bergen	Haugland, GT (corresponding author), Univ Bergen, Bergen High Technol Ctr, Dept Biol, Bergen, Norway.	Gyri.Haugland@bio.uib.no						Aghaallaei N, 2010, P NATL ACAD SCI USA, V107, P18079, DOI 10.1073/pnas.1000467107; Amigo JD, 2009, BLOOD, V114, P4654, DOI 10.1182/blood-2008-12-189910; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Bassity E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033196; Breloer M, 2008, TRENDS IMMUNOL, V29, P186, DOI 10.1016/j.it.2008.01.009; Cao WP, 2005, BIOCHEM J, V385, P85, DOI 10.1042/BJ20040741; Carradice D, 2008, BLOOD, V111, P3331, DOI 10.1182/blood-2007-10-052761; Chow A, 2011, NAT REV IMMUNOL, V11, P788, DOI 10.1038/nri3087; Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Donate C, 2007, FISH SHELLFISH IMMUN, V23, P877, DOI 10.1016/j.fsi.2007.03.016; Dore LC, 2008, P NATL ACAD SCI USA, V105, P3333, DOI 10.1073/pnas.0712312105; Esteban MA, 2000, ANAT REC, V258, P80, DOI 10.1002/(SICI)1097-0185(20000101)258:1<80::AID-AR9>3.0.CO;2-I; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Goetz FW, 2004, MOL IMMUNOL, V41, P1199, DOI 10.1016/j.molimm.2004.06.005; Haugarvoll E, 2006, PIGM CELL RES, V19, P214, DOI 10.1111/j.1600-0749.2006.00297.x; Haugland GT, 2010, J IMMUNOL METHODS, V362, P10, DOI 10.1016/j.jim.2010.07.008; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Hume DA, 2008, J IMMUNOL, V181, P5829, DOI 10.4049/jimmunol.181.9.5829; Ingerslev HC, 2006, MOL IMMUNOL, V43, P1194, DOI 10.1016/j.molimm.2005.07.009; Kalgraff CA, 2011, FISH SHELLFISH IMMUN; Kollner B, 2004, DEV COMP IMMUNOL, V28, P1049, DOI 10.1016/j.dci.2004.03.004; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Liu K, 2010, EUR J IMMUNOL, V40, P2099, DOI 10.1002/eji.201040501; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu Y, 2008, CHARACTERIZATION CD3; Lovy J, 2006, DEV COMP IMMUNOL, V30, P259, DOI 10.1016/j.dci.2005.06.003; Lovy J, 2008, ANAT REC, V291, P456, DOI 10.1002/ar.20674; Lovy J, 2009, FISH SHELLFISH IMMUN, V27, P365, DOI 10.1016/j.fsi.2009.01.006; LU L, 1994, J EXP MED, V179, P1823, DOI 10.1084/jem.179.6.1823; Lugo-Villarino G, 2010, P NATL ACAD SCI USA, V107, P15850, DOI 10.1073/pnas.1000494107; Mahnke K, 1996, J LEUKOCYTE BIOL, V60, P465, DOI 10.1002/jlb.60.4.465; Martin SAM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-150; McNagny KM, 1997, J CELL BIOL, V138, P1395, DOI 10.1083/jcb.138.6.1395; Meseguer J, 2002, MICROSC RES TECHNIQ, V57, P491, DOI 10.1002/jemt.10102; Moore LJ, 2005, MOL IMMUNOL, V42, P1225, DOI 10.1016/j.molimm.2004.11.017; Naik SH, 2008, IMMUNOL CELL BIOL, V86, P439, DOI 10.1038/icb.2008.28; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Ohashi K, 2010, IMMUNOGENETICS, V62, P543, DOI 10.1007/s00251-010-0460-1; Olsvik PA, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-21; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Overland HS, 2010, FISH SHELLFISH IMMUN, V28, P193, DOI 10.1016/j.fsi.2009.10.021; Pettersen EF, 2000, FISH SHELLFISH IMMUN, V10, P695, DOI 10.1006/fsim.2000.0284; Pettersen EF, 2008, FISH SHELLFISH IMMUN, V25, P809, DOI 10.1016/j.fsi.2008.08.014; ROMANI N, 1994, J EXP MED, V180, P83, DOI 10.1084/jem.180.1.83; Rombout JHWM, 2005, FISH SHELLFISH IMMUN, V19, P441, DOI 10.1016/j.fsi.2005.03.007; Rowley A.F., 1988, P19; Schlitzer A, 2012, BLOOD; Shigdar S, 2009, FISH SHELLFISH IMMUN, V26, P731, DOI 10.1016/j.fsi.2009.03.010; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Song HD, 2004, P NATL ACAD SCI USA, V101, P16240, DOI 10.1073/pnas.0407241101; Steinman RM, 2012, ANNU REV IMMUNOL, V30, P1, DOI 10.1146/annurev-immunol-100311-102839; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; STEINMAN RM, 1974, J EXP MED, V139, P1431, DOI 10.1084/jem.139.6.1431; STEINMAN RM, 1975, J EXP MED, V141, P804; STEINMAN RM, 1974, J EXP MED, V139, P380, DOI 10.1084/jem.139.2.380; STEINMAN RM, 1979, J EXP MED, V149, P1, DOI 10.1084/jem.149.1.1; Stosik M, 2002, VET MED-CZECH, V47, P21, DOI 10.17221/5798-VETMED; Tadiso TM, 2011, VET IMMUNOL IMMUNOP, V139, P17, DOI 10.1016/j.vetimm.2010.07.024; Wittamer V, 2011, BLOOD, V117, P7126, DOI 10.1182/blood-2010-11-321448; ZHOU LJ, 1992, J IMMUNOL, V149, P735	64	38	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49260	10.1371/journal.pone.0049260	http://dx.doi.org/10.1371/journal.pone.0049260			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166624	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900113
J	He, BS; Pan, YQ; Cho, WC; Xu, YQ; Gu, L; Nie, ZL; Chen, LP; Song, GQ; Gao, TY; Li, R; Wang, SK				He, Bangshun; Pan, Yuqin; Cho, William C.; Xu, Yeqiong; Gu, Ling; Nie, Zhenglin; Chen, Liping; Song, Guoqi; Gao, Tianyi; Li, Rui; Wang, Shukui			The Association between Four Genetic Variants in MicroRNAs (rs11614913, rs2910164, rs3746444, rs2292832) and Cancer Risk: Evidence from Published Studies	PLOS ONE			English	Article							NORTH INDIAN POPULATION; PRE-MICRORNAS; HEPATOCELLULAR-CARCINOMA; CHINESE POPULATION; FUNCTIONAL POLYMORPHISM; CELL CARCINOMA; GASTRIC-CANCER; SUSCEPTIBILITY; METAANALYSIS; PRE-MIR-146A	MicroRNAs (miRNAs) participate in diverse biological pathways and may act as either tumor suppressor genes or oncogenes. Single nucleotide polymorphisms (SNPs) in miRNA may contribute to cancer development with changes in the microRNA's properties and/or maturation. Polymorphisms in miRNAs have been suggested in predisposition to cancer risk; however, accumulated studies have shown inconsistent conslusionss. To further validate determine whether there is any potential association between the four common SNPs (miR-196a2C>T, rs11614913; miR-146aG>C, rs2910164; miR-499A>G, rs3746444; miR-149C>T, rs2292832) and the risk for developing risk, a meta-analysis was performed according to the 40 published case-control studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the extent of the association. The results demonstrated that the rs11614913TT genotype was significantly associated with a decreased cancer risk, in particular with a decreased risk for colorectal cancer and lung cancer, or for Asian population subgroup. In addition, the rs2910164C allele was associated with decreased risk for esophageal cancer, cervical cancer, prostate cancer, and hepatocellular carcinoma (HCC), in particular in Asian population subgroup. Similarly, the rs3746444G allele was observed as a risk factor for cancers in the Asian population. It is concluded that two SNPs prsent in miRNAs(rs11614913TT, and rs2910164C) may protect against the pathogenesis of some cancers, and that the rs3746444 may increase risk for cancer.	[He, Bangshun; Pan, Yuqin; Xu, Yeqiong; Gu, Ling; Nie, Zhenglin; Chen, Liping; Song, Guoqi; Gao, Tianyi; Li, Rui; Wang, Shukui] Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	He, BS (corresponding author), Nanjing Med Univ, Nanjing Hosp 1, Cent Lab, Nanjing, Jiangsu, Peoples R China.	shukwang@163.com						Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cho WCS, 2010, EXPERT REV MOL DIAGN, V10, P699, DOI [10.1586/erm.10.64, 10.1586/ERM.10.64]; Cho WCS, 2010, INT J BIOCHEM CELL B, V42, P1273, DOI 10.1016/j.biocel.2009.12.014; Christensen BC, 2010, CLIN CANCER RES, V16, P3713, DOI 10.1158/1078-0432.CCR-10-0657; Chu HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018108; Dou TH, 2010, J CANCER RES CLIN, V136, P1853, DOI 10.1007/s00432-010-0844-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; George GP, 2011, MOL BIOL REP, V38, P1609, DOI 10.1007/s11033-010-0270-4; Handoll HH, 2006, ARCH PHYS MED REHAB, V87, P875, DOI 10.1016/j.apmr.2006.04.006; Hoffman AE, 2009, CANCER RES, V69, P5970, DOI 10.1158/0008-5472.CAN-09-0236; Horikawa Y, 2008, CLIN CANCER RES, V14, P7956, DOI 10.1158/1078-0432.CCR-08-1199; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Li XD, 2010, PATHOLOGY, V42, P669, DOI 10.3109/00313025.2010.522175; MIDGETTE AS, 1994, MED DECIS MAKING, V14, P108, DOI 10.1177/0272989X9401400203; Mittal RD, 2011, DNA CELL BIOL, V30, P401, DOI 10.1089/dna.2010.1159; Okubo M, 2010, HELICOBACTER, V15, P524, DOI 10.1111/j.1523-5378.2010.00806.x; Qi P, 2010, HUM IMMUNOL, V71, P621, DOI 10.1016/j.humimm.2010.02.017; Qiu LX, 2011, CYTOKINE, V56, P589, DOI 10.1016/j.cyto.2011.08.019; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Srivastava K, 2010, J HUM GENET, V55, P495, DOI 10.1038/jhg.2010.54; Tano K, 2010, FEBS LETT, V584, P4575, DOI 10.1016/j.febslet.2010.10.008; Wang F, 2012, MOL BIOL REP, V39, P269, DOI 10.1007/s11033-011-0735-0; Xiang Y, 2012, MOL BIOL REP, V39, P7019, DOI 10.1007/s11033-012-1532-0; Xu T, 2008, CARCINOGENESIS, V29, P2126, DOI 10.1093/carcin/bgn195; Xu W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020471; Zhan JF, 2011, ARCH MED RES, V42, P144, DOI 10.1016/j.arcmed.2011.04.001; Zhou B, 2011, MOL CARCINOGEN, V50, P499, DOI 10.1002/mc.20740; Zhou FY, 2012, DNA CELL BIOL, V31, P1290, DOI 10.1089/dna.2011.1596	31	60	63	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49032	10.1371/journal.pone.0049032	http://dx.doi.org/10.1371/journal.pone.0049032			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155448	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900083
J	Lerner, AM; Ariza, ME; Williams, M; Jason, L; Beqaj, S; Fitzgerald, JT; Lemeshow, S; Glaser, R				Lerner, A. Martin; Ariza, Maria E.; Williams, Marshall; Jason, Leonard; Beqaj, Safedin; Fitzgerald, James T.; Lemeshow, Stanley; Glaser, Ronald			Antibody to Epstein-Barr Virus Deoxyuridine Triphosphate Nucleotidohydrolase and Deoxyribonucleotide Polymerase in a Chronic Fatigue Syndrome Subset	PLOS ONE			English	Article							NF-KAPPA-B; NASOPHARYNGEAL CARCINOMA; DNA-POLYMERASE; THYMIDINE KINASE; INFECTED CELLS; EXPRESSION; EBV; REPLICATION; TITERS; CYTOMEGALOVIRUS	Background: A defined diagnostic panel differentiated patients who had been diagnosed with chronic fatigue syndrome (CFS), based upon Fukuda/Carruthers criteria. This diagnostic panel identified an Epstein-Barr virus (EBV) subset of patients (6), excluding for the first time other similar "clinical" conditions such as cytomegalovirus (CMV), human herpesvirus 6 (HHV6), babesiosis, ehrlichiosis, borreliosis, Mycoplasma pneumoniae, Chlamydia pneumoniae, and adult rheumatic fever, which may be mistakenly called CFS. CFS patients were treated with valacyclovir (14.3 mg/kg q6h) for >= 12 months. Each patient improved, based upon the Functional Activity Appraisal: Energy Index Score Healthcare Worker Assessment (EIPS), which is a validated (FSS-9), item scale with high degree of internal consistency measured by Cronbach's alpha. Methods: Antibody to EBV viral capsid antigen (VCA) IgM, EBV Diffuse Early Antigen EA(D), and neutralizing antibodies against EBV-encoded DNA polymerase and EBV-encoded dUTPase were assayed serially approximately every three months for 13-16 months from sera obtained from patients with CFS (6) and from sera obtained from twenty patients who had no history of CFS. Results: Antibodies to EBV EA(D) and neutralizing antibodies against the encoded-proteins EBV DNA polymerase and deoxyuridine triphosphate nucleotidohydrolase (dUTPase) were present in the EBV subset CFS patients. Of the sera samples obtained from patients with CFS 93.9% were positive for EA(D), while 31.6% of the control patients were positive for EBV EA(D). Serum samples were positive for neutralizing antibodies against the EBV-encoded dUTPase (23/52; 44.2%) and DNA polymerase (41/52; 78.8%) in EBV subset CFS patients, but negative in sera of controls. Conclusions: There is prolonged elevated antibody level against the encoded proteins EBV dUTPase and EBV DNA polymerase in a subset of CFS patients, suggesting that this antibody panel could be used to identify these patients, if these preliminary findings are corroborated by studies with a larger number of EBV subset CFS patients.	[Lerner, A. Martin] Oakland Univ, William Beaumont Sch Med, Dept Med, Rochester, MI 48063 USA	Oakland University	Lerner, AM (corresponding author), Oakland Univ, William Beaumont Sch Med, Dept Med, Rochester, MI 48063 USA.	amartinlerner@yahoo.com	Glaser, Ronald/E-3124-2011		NIAID NIH HHS [AI084898, R01 AI084898] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI084898] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ariza ME, 2009, J IMMUNOL, V182, P851, DOI 10.4049/jimmunol.182.2.851; BAER R, 1984, NATURE, V310, P207, DOI 10.1038/310207a0; Beqaj SH, 2008, J CLIN PATHOL, V61, P623, DOI 10.1136/jcp.2007.050633; Capuron L, 2003, BRAIN BEHAV IMMUN, V17, pS119; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Chang CM, 2012, CANCER-AM CANCER SOC, V118, P5929, DOI 10.1002/cncr.27612; CHENG YC, 1980, P NATL ACAD SCI-BIOL, V77, P6162, DOI 10.1073/pnas.77.10.6162; CHENG YC, 1980, VIROLOGY, V100, P334, DOI 10.1016/0042-6822(80)90524-3; D'Addario M, 2000, J MOL BIOL, V298, P765, DOI 10.1006/jmbi.2000.3717; Deng JH, 2004, J VIROL, V78, P11108, DOI 10.1128/JVI.78.20.11108-11120.2004; DETURENNETESSIER M, 1989, INT J CANCER, V43, P45, DOI 10.1002/ijc.2910430111; Dukers DF, 2000, J IMMUNOL, V165, P663, DOI 10.4049/jimmunol.165.2.663; Fluge O, 2011, PLOS, V6, P1; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Glaser R, 2006, VIROLOGY, V346, P205, DOI 10.1016/j.virol.2005.10.034; Glaser R, 2005, BRAIN BEHAV IMMUN, V19, P91, DOI 10.1016/j.bbi.2004.09.001; GLASER R, 1973, P SOC EXP BIOL MED, V142, P1059; GLASER R, 1987, B I PASTEUR, V85, P189; HENLE G, 1971, INT J CANCER, V8, P272, DOI 10.1002/ijc.2910080212; HENLE W, 1973, JNCI-J NATL CANCER I, V51, P361; HENRY BE, 1978, VIROLOGY, V89, P262, DOI 10.1016/0042-6822(78)90058-2; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Jason LA, 1999, ARCH INTERN MED, V159, P2129, DOI 10.1001/archinte.159.18.2129; Jason Leonard A, 2008, Dyn Med, V7, P6, DOI 10.1186/1476-5918-7-6; JONES JF, 1988, ARCH INTERN MED, V148, P1957, DOI 10.1001/archinte.148.9.1957; KLEMOLA E, 1965, BMJ-BRIT MED J, V2, P1099, DOI 10.1136/bmj.2.5470.1099; Klimas Nancy G, 2007, Curr Rheumatol Rep, V9, P482, DOI 10.1007/s11926-007-0078-y; Kogelnik AM, 2006, J CLIN VIROL, V37, pS33, DOI 10.1016/S1386-6532(06)70009-9; Lerner A.M., 2011, VIRUS ADAPT TREAT, V3, P19, DOI [10.2147/VAAT.S15105, DOI 10.2147/VAAT.S15105]; Lerner AM, 2008, IN VIVO, V22, P799; Lerner AM, 2004, IN VIVO, V18, P101; Lerner AM, 2010, VIRUS ADAPTATION TRE, V2, P135; Lerner AM., 2010, VIRUS ADAPT TREAT, V2, P47; Levine P.H., 2000, J CHRONIC FATIGUE SY, V7, P29, DOI [10.1300/J092v07n01_04, DOI 10.1300/J092V07N01_04]; LIU MY, 1989, J MED VIROL, V28, P101, DOI 10.1002/jmv.1890280209; MATHES LE, 1979, CANCER RES, V39, P950; MILLER RL, 1977, VIROLOGY, V76, P494, DOI 10.1016/0042-6822(77)90232-X; NATELSON BH, 1994, J MED VIROL, V42, P42, DOI 10.1002/jmv.1890420109; Padgett DA, 2004, J MED VIROL, V74, P442, DOI 10.1002/jmv.20196; Sommer P, 1996, J GEN VIROL, V77, P2795, DOI 10.1099/0022-1317-77-11-2795; Strayer DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031334; Watkins LR, 2005, J INTERN MED, V257, P139, DOI 10.1111/j.1365-2796.2004.01443.x; WILLIAMS MV, 1985, VIROLOGY, V142, P326, DOI 10.1016/0042-6822(85)90341-1	43	30	32	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e47891	10.1371/journal.pone.0047891	http://dx.doi.org/10.1371/journal.pone.0047891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155374	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900008
J	Li, C; Jin, L; Bai, Y; Chen, QM; Fu, LJ; Yang, MJ; Xiao, HS; Zhao, GP; Wang, SY				Li, Chong; Jin, Lei; Bai, Yun; Chen, Qimin; Fu, Lijun; Yang, Minjun; Xiao, Huasheng; Zhao, Guoping; Wang, Shengyue			Genome-Wide Expression Analysis in Down Syndrome: Insight into Immunodeficiency	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; TRANSCRIPTION FACTOR PAX5; GENE-EXPRESSION; CELL DIFFERENTIATION; ACQUIRED MUTATIONS; OVER-EXPRESSION; SYNDROME BRAIN; IMMUNE-SYSTEM; CHILDREN; ADHESION	Down syndrome (DS) is caused by triplication of Human chromosome 21 (Hsa21) and associated with an array of deleterious phenotypes, including mental retardation, heart defects and immunodeficiency. Genome-wide expression patterns of uncultured peripheral blood cells are useful to understanding of DS-associated immune dysfunction. We used a Human Exon microarray to characterize gene expression in uncultured peripheral blood cells derived from DS individuals and age-matched controls from two age groups: neonate (N) and child (C). A total of 174 transcript clusters (gene-level) with eight located on Hsa21 in N group and 383 transcript clusters including 56 on Hsa21 in C group were significantly dysregulated in DS individuals. Microarray data were validated by quantitative polymerase chain reaction. Functional analysis revealed that the dysregulated genes in DS were significantly enriched in two and six KEGG pathways in N and C group, respectively. These pathways included leukocyte trans-endothelial migration, B cell receptor signaling pathway and primary immunodeficiency, etc., which causally implicated dysfunctional immunity in DS. Our results provided a comprehensive picture of gene expression patterns in DS at the two developmental stages and pointed towards candidate genes and molecular pathways potentially associated with the immune dysfunction in DS.	[Li, Chong; Zhao, Guoping; Wang, Shengyue] Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China	Fudan University	Li, C (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 200433, Peoples R China.	wangsy@chgc.sh.cn	Yang, Minjun/AGJ-3201-2022	Zhao, Guo-Ping/0000-0002-7621-6620; Yang, Minjun/0000-0002-3324-1498				Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; Alford KA, 2011, BLOOD, V118, P2222, DOI 10.1182/blood-2011-03-342774; Arora PD, 2008, AM J PHYSIOL-CELL PH, V295, pC130, DOI 10.1152/ajpcell.00168.2008; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bittles AH, 2007, EUR J PUBLIC HEALTH, V17, P221, DOI 10.1093/eurpub/ckl103; Bloemers BLP, 2010, MICROBES INFECT, V12, P799, DOI 10.1016/j.micinf.2010.05.007; Bloemers BLP, 2010, J PEDIATR-US, V156, P804, DOI 10.1016/j.jpeds.2009.12.006; Broers CJM, 2012, ACTA PAEDIATR, V101, P862, DOI 10.1111/j.1651-2227.2012.02696.x; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Cesano A, 2003, SEMIN ONCOL, V30, P253, DOI 10.1053/sonc.2003.50057; Conti A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-268; COSSARIZZA A, 1991, BLOOD, V77, P1263; Costa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018493; De Hingh YCM, 2005, J PEDIATR-US, V147, P744, DOI 10.1016/j.jpeds.2005.07.022; EPSTEIN CJ, 1991, AM J HUM GENET, V49, P207; FitzPatrick DR, 2005, TRENDS GENET, V21, P249, DOI 10.1016/j.tig.2005.02.012; Ghai R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-348; GIANNONE S, 2004, GENE, V68, P546, DOI DOI 10.1046/J.1529-8817.2003.00123.X; Groet J, 2003, LANCET, V361, P1617, DOI 10.1016/S0140-6736(03)13266-7; Guazzarotti L, 2009, AJIDD-AM J INTELLECT, V114, P100, DOI 10.1352/2009.114.100-109; Henderson YC, 2007, PLACENTA, V28, P152, DOI 10.1016/j.placenta.2006.03.008; Hitzler JK, 2005, NAT REV CANCER, V5, P11, DOI 10.1038/nrc1525; Huber-Keener KJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041333; Kahlem P, 2004, GENOME RES, V14, P1258, DOI 10.1101/gr.1951304; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Khatri P, 2004, NUCLEIC ACIDS RES, V32, pW449, DOI 10.1093/nar/gkh409; KISH S, 1989, J NEUROCHEM, V52, P1183, DOI 10.1111/j.1471-4159.1989.tb01864.x; Kusters MAA, 2009, CLIN EXP IMMUNOL, V156, P189, DOI 10.1111/j.1365-2249.2009.03890.x; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Li CM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-24; Lintas C, 2012, NEUROBIOL DIS, V45, P57, DOI 10.1016/j.nbd.2010.11.010; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; Lubec B, 2001, J NEURAL TRANSM-SUPP, P303; Mammoto A, 2009, CURR OPIN CELL BIOL, V21, P864, DOI 10.1016/j.ceb.2009.08.001; Mao R, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r107; MONTAGNA D, 1988, EUR J PEDIATR, V148, P53, DOI 10.1007/BF00441815; Montoya MC, 2002, IMMUNOL REV, V186, P68, DOI 10.1034/j.1600-065X.2002.18607.x; Nagarajan UM, 2002, J IMMUNOL, V168, P1780, DOI 10.4049/jimmunol.168.4.1780; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pine SR, 2007, BLOOD, V110, P2128, DOI 10.1182/blood-2007-01-069542; Prandini P, 2007, AM J HUM GENET, V81, P252, DOI 10.1086/519248; Pridans C, 2008, J IMMUNOL, V180, P1719, DOI 10.4049/jimmunol.180.3.1719; Ram G, 2011, CLIN EXP IMMUNOL, V164, P9, DOI 10.1111/j.1365-2249.2011.04335.x; Roper RJ, 2006, PLOS GENET, V2, P231, DOI 10.1371/journal.pgen.0020050; Roper RJ, 2006, P NATL ACAD SCI USA, V103, P1452, DOI 10.1073/pnas.0510750103; Rozen S, 2000, Methods Mol Biol, V132, P365; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Slonim DK, 2009, P NATL ACAD SCI USA, V106, P9425, DOI 10.1073/pnas.0903909106; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tang Y, 2004, ANN NEUROL, V56, P808, DOI 10.1002/ana.20291; TAYLOR GM, 1988, IMMUNOLOGY, V64, P451; Tedder TF, 1997, ANNU REV IMMUNOL, V15, P481, DOI 10.1146/annurev.immunol.15.1.481; van Buul JD, 2004, ARTERIOSCL THROM VAS, V24, P824, DOI 10.1161/01.ATV.0000122854.76267.5c; Visan I, 2003, EUR J IMMUNOL, V33, P1163, DOI 10.1002/eji.200323747; Vyas P, 2007, CURR OPIN PEDIATR, V19, P9, DOI 10.1097/MOP.0b013e328013e7b2; Wechsler J, 2002, NAT GENET, V32, P148, DOI 10.1038/ng955; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yahya-Graison EA, 2007, AM J HUM GENET, V81, P475, DOI 10.1086/520000; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	61	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49130	10.1371/journal.pone.0049130	http://dx.doi.org/10.1371/journal.pone.0049130			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155455	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900090
J	Orosz, F				Orosz, Ferenc			A New Protein Superfamily: TPPP-Like Proteins	PLOS ONE			English	Article							BRAIN-SPECIFIC PROTEIN; EUKARYOTE TREE; UNSTRUCTURED PROTEIN; ENERGY CONTENT; RAT-BRAIN; TUBULIN; DATABASE; FAMILY; DOUBLECORTIN; PREDICTION	The introduction of the term 'Tubulin Polymerization Promoting Protein (TPPP)-like proteins' is suggested. They constitute a eukaryotic protein superfamily, characterized by the presence of the p25alpha domain (Pfam05517, IPR008907), and named after the first identified member, TPPP/p25, exhibiting microtubule stabilizing function. TPPP-like proteins can be grouped on the basis of two characteristics: the length of their p25alpha domain, which can be long, short, truncated or partial, and the presence or absence of additional domain(s). TPPPs, in the strict sense, contain no other domains but one long or short p25alpha one (long-and short-type TPPPs, respectively). Proteins possessing truncated p25alpha domain are first described in this paper. They evolved from the long-type TPPPs and can be considered as arthropod-specific paralogs of long-type TPPPs. Phylogenetic analysis shows that the two groups (long-type and truncated TPPPs) split in the common ancestor of arthropods. Incomplete p25alpha domains can be found in multidomain TPPP-like proteins as well. The various subfamilies occur with a characteristic phyletic distribution: e.g., animal genomes/proteomes contain almost without exception long-type TPPPs; the multidomain apicortins occur almost exclusively in apicomplexan parasites. There are no data about the physiological function of these proteins except two human long-type TPPP paralogs which are involved in developmental processes of the brain and the musculoskeletal system, respectively. I predict that the superfamily members containing long or partial p25alpha domain are often intrinsically disordered proteins, while those with short or truncated domain(s) are structurally ordered. Interestingly, members of this superfamily connected or maybe connected to diseases are intrinsically disordered proteins.	Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Orosz, F (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.	orosz@enzim.hu						Adl SM, 2005, J EUKARYOT MICROBIOL, V52, P399, DOI 10.1111/j.1550-7408.2005.00053.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aramini J.M., 2007, SOLUTION NMR STRUCTU; Bishop M.J., 1987, P123; Bork P, 1998, J MOL BIOL, V283, P707, DOI 10.1006/jmbi.1998.2144; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Cavalier-Smith T, 2010, PROTIST, V161, P549, DOI 10.1016/j.protis.2010.04.002; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dosztanyi Z, 2010, BRIEF BIOINFORM, V11, P225, DOI 10.1093/bib/bbp061; Felsenstein J, 2008, PHYLIP PHYLOGENY INF; Ferenc O, 2011, INFECT GENET EVOL, V11, P1037, DOI 10.1016/j.meegid.2011.03.023; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hirose S, 2007, BIOINFORMATICS, V23, P2046, DOI 10.1093/bioinformatics/btm302; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kim MH, 2003, NAT STRUCT BIOL, V10, P324, DOI 10.1038/nsb918; KOBAYASHI N, 2005, SOLUTION STRUCTURE M; Kovacs GG, 2004, NEUROBIOL DIS, V17, P155, DOI 10.1016/j.nbd.2004.06.006; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lehotzky A, 2008, PHILOS T R SOC A, V366, P3599, DOI 10.1098/rsta.2008.0106; Lehotzky A, 2004, J CELL SCI, V117, P6249, DOI 10.1242/jcs.01550; Lehotzky A, 2010, GLIA, V58, P157, DOI 10.1002/glia.20909; Logan-Klumpler FJ, 2010, NUCLEIC ACIDS RES, V40, pD98; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Monleon D, 2004, J BIOMOL NMR, V28, P91, DOI 10.1023/B:JNMR.0000012832.71049.bf; O'Brien EA, 2007, NUCLEIC ACIDS RES, V35, pD445, DOI 10.1093/nar/gkl770; Orosz F, 2004, BIOL CELL, V96, P701, DOI 10.1016/j.biolcel.2004.08.002; Orosz F, 2012, J MOL EVOL, V75, P55, DOI 10.1007/s00239-012-9521-4; Orosz F, 2011, BIOINFORMATICS, V27, P1449, DOI 10.1093/bioinformatics/btr175; Orosz F, 2009, INFECT GENET EVOL, V9, P1275, DOI 10.1016/j.meegid.2009.09.001; Orosz Ferenc, 2009, V7, P225, DOI 10.1007/978-1-4020-9434-7_10; Orosz F, 2008, FEBS LETT, V582, P3757, DOI 10.1016/j.febslet.2008.10.011; Ovadi J, 2009, BIOESSAYS, V31, P676, DOI 10.1002/bies.200900008; Reiner O, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-188; Roger AJ, 2009, CURR BIOL, V19, pR165, DOI 10.1016/j.cub.2008.12.032; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Ruiz-Trillo I, 2007, TRENDS GENET, V23, P113, DOI 10.1016/j.tig.2007.01.005; Sapir T, 2000, HUM MOL GENET, V9, P703, DOI 10.1093/hmg/9.5.703; Skjoerringe T, 2006, J NEUROCHEM, V99, P333, DOI 10.1111/j.1471-4159.2006.04073.x; Sonnhammer ELL, 2002, TRENDS GENET, V18, P619, DOI 10.1016/S0168-9525(02)02793-2; Staverosky JA, 2009, DEV DYNAM, V238, P685, DOI 10.1002/dvdy.21865; Stechmann A, 2003, CURR BIOL, V13, pR665, DOI 10.1016/S0960-9822(03)00602-X; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stifanic M, 2011, BIOLOGIA, V66, P111, DOI 10.2478/s11756-010-0147-y; TAKAHASHI M, 1993, J NEUROCHEM, V60, P228, DOI 10.1111/j.1471-4159.1993.tb05842.x; TAKAHASHI M, 1991, FEBS LETT, V289, P37, DOI 10.1016/0014-5793(91)80903-G; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Zhou RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023079; Zotter A, 2011, BIOCHEMISTRY-US, V50, P9568, DOI 10.1021/bi201447w; Zotter A, 2011, FEBS LETT, V585, P803, DOI 10.1016/j.febslet.2011.02.006	57	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49276	10.1371/journal.pone.0049276	http://dx.doi.org/10.1371/journal.pone.0049276			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166627	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000311151900115
J	Deng, K; Lin, SR; Zhou, LY; Li, Y; Chen, M; Wang, YC; Li, YW				Deng, Kai; Lin, Sanren; Zhou, Liya; Li, Yuan; Chen, Mo; Wang, Yingchun; Li, Yuwen			High Levels of Aromatic Amino Acids in Gastric Juice during the Early Stages of Gastric Cancer Progression	PLOS ONE			English	Article							CELL LUNG-CANCER; ENDOGASTRIC CAPSULE; RAMAN-SPECTROSCOPY; DIAGNOSTIC-TOOL; KRUSKAL-WALLIS; TUMOR-MARKERS; CARCINOMA; TRANSPORTER-1; EXPRESSION; LAT1	Background: Early-stage gastric cancer is mostly asymptomatic and can easily be missed easily by conventional gastroscopy. Currently, there are no useful biomarkers for the early detection of gastric cancer, and their identification of biomarkers is urgently needed. Methods: Gastric juice was obtained from 185 subjects that were divided into three groups: non-neoplastic gastric disease (NGD), advanced gastric cancer and early gastric cancer (EGC). The levels of aromatic amino acids in the gastric juice were quantitated using high-performance liquid chromatography. Results: The median values (25th to 75th percentile) of tyrosine, phenylalanine and tryptophan in the gastric juice were 3.8 (1.7-7.5) mu g/ml, 5.3 (2.3-9.9) mu g/ml and 1.0 (0.4-2.8) mu g/ml in NGD; 19.4 (5.8-72.4) mu g/ml, 24.6 (11.5-73.7) mu g/ml and 8.3 (2.1-28.0) mu g/ml in EGC. Higher levels of tyrosine, phenylalanine and tryptophan in the gastric juice were observed in individuals of EGC groups compared those of the NGD group (NGD vs. EGC, P<0.0001). For the detection of EGC, the areas under the receiver operating characteristic curves (AUCs) of each biomarker were as follows: tyrosine, 0.790 [95% confidence interval (CI), 0.703-0.877]; phenylalanine, 0.831 (95% CI, 0.750-0.911); and tryptophan, 0.819 (95% CI, 0.739-0.900). The sensitivity and specificity of phenylalanine were 75.5% and 81.4%, respectively, for detection of EGC. A multiple logistic regression analysis showed that high levels of aromatic amino acids in the gastric juice were associated with gastric cancer (adjusted beta coefficients ranged from 1.801 to 4.414, P<0.001). Conclusion: Increased levels of tyrosine, phenylalanine and tryptophan in the gastric juice samples were detected in the early phase of gastric carcinogenesis. Thus, tyrosine, phenylalanine and tryptophan in gastric juice could be used as biomarkers for the early detection of gastric cancer. A gastric juice analysis is an efficient, economical and convenient method for screening early gastric cancer development in the general population.	[Deng, Kai; Lin, Sanren; Zhou, Liya; Li, Yuan; Chen, Mo; Wang, Yingchun; Li, Yuwen] Peking Univ, Dept Gastroenterol, Hosp 3, Beijing 100871, Peoples R China	Peking University	Zhou, LY (corresponding author), Peking Univ, Dept Gastroenterol, Hosp 3, Beijing 100871, Peoples R China.	liyazhou@medmail.com.cn	Zhou, Li/GSE-4531-2022; Li, yu/HHZ-5236-2022; li, yuwen/HGU-6435-2022		National Natural Science Foundation of China [3097415]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Science Foundation of China [Grant number: 3097415](URL: http://www.nsfc.gov.cn/e_nsfc/desktop/zn/0101.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin A, 2002, J ROY COLL SURG EDIN, V47, P681; ARVANITAKIS C, 1992, HEPATO-GASTROENTEROL, V39, P355; Axon A, 2006, BEST PRACT RES CL GA, V20, P697, DOI 10.1016/j.bpg.2006.03.015; Cai M, 2002, CLIN CANCER RES, V8, P1152; CASCINO A, 1995, ANTICANCER RES, V15, P507; Cunningham SC, 2005, J GASTROINTEST SURG, V9, P718, DOI 10.1016/j.gassur.2004.12.002; Deng K, 2011, ANAL CHIM ACTA, V694, P100, DOI 10.1016/j.aca.2011.03.053; Draga ROP, 2010, ANAL CHEM, V82, P5993, DOI 10.1021/ac100448p; Duraker N, 2002, EUR J SURG ONCOL, V28, P844, DOI 10.1053/ejso.2002.1295; Fan CP, 2011, BIOMETRICS, V67, P213, DOI 10.1111/j.1541-0420.2010.01407.x; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Ganapathy V, 2009, PHARMACOL THERAPEUT, V121, P29, DOI 10.1016/j.pharmthera.2008.09.005; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Huang ZW, 2003, INT J CANCER, V107, P1047, DOI 10.1002/ijc.11500; ITOH H, 1989, AM J SURG, V158, P14, DOI 10.1016/0002-9610(89)90305-X; Kaira K, 2008, BRIT J CANCER, V98, P742, DOI 10.1038/sj.bjc.6604235; Kobayashi H, 2005, J SURG ONCOL, V90, P233, DOI 10.1002/jso.20257; Kobayashi K, 2008, NEUROSURGERY, V62, P493, DOI 10.1227/01.neu.0000316018.51292.19; LACHENBRUCH PA, 1991, COMMUN STAT THEORY, V20, P107, DOI 10.1080/03610929108830486; LANSDOWN M, 1990, GUT, V31, P977, DOI 10.1136/gut.31.9.977; Laviano A, 2003, ADV EXP MED BIOL, V527, P363; LI Y, 2003, CHIN J DIG, P11; Lian W, 2012, J DIGEST DIS, V13, P100, DOI 10.1111/j.1751-2980.2011.00559.x; MCDERMOTT EWM, 1990, BRIT J SURG, V77, P1179, DOI 10.1002/bjs.1800771029; Miki K, 2003, AM J GASTROENTEROL, V98, P735, DOI 10.1016/S0002-9270(03)00128-X; Miki Kazumasa, 2006, Gastric Cancer, V9, P245, DOI 10.1007/s10120-006-0397-0; Muretto P, 2008, ANN ONCOL, V19, P516, DOI 10.1093/annonc/mdm493; Muretto P, 2003, ANN ONCOL, V14, P105, DOI 10.1093/annonc/mdg027; Muscaritoli M, 1999, NUTRITION, V15, P195, DOI 10.1016/S0899-9007(98)00179-8; Nakanishi K, 2007, VIRCHOWS ARCH, V451, P681, DOI 10.1007/s00428-007-0457-9; Nawashiro H, 2006, INT J CANCER, V119, P484, DOI 10.1002/ijc.21866; Nosho K, 2004, CLIN CANCER RES, V10, P7950, DOI 10.1158/1078-0432.CCR-04-0875; Pathirana A, 2001, EUR J SURG ONCOL, V27, P9, DOI 10.1053/ejso.2000.1041; Rudolph-Owen LA, 1998, CANCER RES, V58, P5500; Sakata T, 2009, PATHOL INT, V59, P7, DOI 10.1111/j.1440-1827.2008.02319.x; Shein-Chung Chowm, 2008, SAMPLE SIZE CALCULAT; Sier CFM, 2000, CLIN CANCER RES, V6, P2333; SUN XN, 2004, CHIN J DIG, P10; Talvensaari-Mattila A, 1999, GYNECOL ONCOL, V72, P306, DOI 10.1006/gyno.1998.5157; Wang RT, 1991, J BEIJING MED U, V23, P9; Yalamarthi S, 2004, ENDOSCOPY, V36, P874, DOI 10.1055/s-2004-825853; Yoon JH, 2004, CANCER LETT, V205, P215, DOI 10.1016/j.canlet.2003.10.009; Zhou LY, 2011, J DIGEST DIS, V12, P279, DOI 10.1111/j.1751-2980.2011.00507.x	43	31	35	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49434	10.1371/journal.pone.0049434	http://dx.doi.org/10.1371/journal.pone.0049434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152906	Green Submitted, gold, Green Published			2022-12-27	WOS:000311234600039
J	Albaladejo, RG; Guzman, B; Gonzalez-Martinez, SC; Aparicio, A				Albaladejo, Rafael G.; Guzman, Beatriz; Gonzalez-Martinez, Santiago C.; Aparicio, Abelardo			Extensive Pollen Flow but Few Pollen Donors and High Reproductive Variance in an Extremely Fragmented Landscape	PLOS ONE			English	Article							SPATIAL GENETIC-STRUCTURE; TORMINALIS L. CRANTZ; WILDSERVICE TREE; MATING SYSTEM; HABITAT FRAGMENTATION; FOREST FRAGMENTATION; PATERNITY ANALYSIS; DISPERSAL; SOFTWARE; CONSEQUENCES	Analysing pollen movement is a key to understanding the reproductive system of plant species and how it is influenced by the spatial distribution of potential mating partners in fragmented populations. Here we infer parameters related to levels of pollen movement and diversity of the effective pollen cloud for the wind-pollinated shrub Pistacia lentiscus across a highly disturbed landscape using microsatellite loci. Paternity analysis and the indirect KinDist and Mixed Effect Mating models were used to assess mating patterns, the pollen dispersal kernel, the effective number of males (N-ep) and their relative individual fertility, as well as the existence of fine-scale spatial genetic structure in adult plants. All methods showed extensive pollen movement, with high rates of pollen flow from outside the study site (up to 73-93%), fat-tailed dispersal kernels and large average pollination distances (delta = 229-412 m). However, they also agreed in detecting very few pollen donors (N-ep = 4.3-10.2) and a large variance in their reproductive success: 70% of males did not sire any offspring among the studied female plants and 5.5% of males were responsible for 50% of pollinations. Although we did not find reduced levels of genetic diversity, the adult population showed high levels of biparental inbreeding (14%) and strong spatial genetic structure (S-p = 0.012), probably due to restricted seed dispersal and scarce safe sites for recruitment. Overall, limited seed dispersal and the scarcity of successful pollen donors can be contributing to generate local pedigrees and to increase inbreeding, the prelude of genetic impoverishment.	[Albaladejo, Rafael G.; Guzman, Beatriz; Aparicio, Abelardo] Univ Seville, Dept Plant Biol & Ecol, Sch Pharm, Seville, Spain; [Gonzalez-Martinez, Santiago C.] CIFOR INIA, Dept Forest Ecol & Genet, Madrid, Spain	University of Sevilla; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA)	Albaladejo, RG (corresponding author), Univ Seville, Dept Plant Biol & Ecol, Sch Pharm, Seville, Spain.	albaladejo@us.es	Albaladejo, Rafael G/K-2204-2014; Gonzalez-Martinez, Santiago C/H-2014-2012; Aparicio Martinez, Abelardo/E-3027-2010	Albaladejo, Rafael G/0000-0003-2101-5204; Gonzalez-Martinez, Santiago C/0000-0002-4534-3766; Aparicio Martinez, Abelardo/0000-0001-7122-4421	'Junta de Andalucia' (Proyecto de Excelencia) [P06-RNM-01499]; Spanish Ministerio de Ciencia e Innovacion [CGL2008-00938]	'Junta de Andalucia' (Proyecto de Excelencia)(Junta de Andalucia); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This study has been funded by grants of the 'Junta de Andalucia' (Proyecto de Excelencia P06-RNM-01499) and the Spanish Ministerio de Ciencia e Innovacion (CGL2008-00938) to AA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaladejo RG, 2008, MOL ECOL RESOUR, V8, P904, DOI 10.1111/j.1755-0998.2008.02110.x; Albaladejo RG, 2009, MOL ECOL, V18, P5195, DOI 10.1111/j.1365-294X.2009.04415.x; [Anonymous], [No title captured]; Aparicio A, 2008, BIODIVERS CONSERV, V17, P2219, DOI 10.1007/s10531-007-9295-y; Aparicio A, 2012, DIVERS DISTRIB, V18, P226, DOI 10.1111/j.1472-4642.2011.00823.x; Ashley MV, 2010, CRIT REV PLANT SCI, V29, P148, DOI 10.1080/07352689.2010.481167; Austerlitz F, 2007, HEREDITY, V99, P193, DOI 10.1038/sj.hdy.6800983; Bacles CFE, 2008, HEREDITY, V101, P368, DOI 10.1038/hdy.2008.66; Bacles CFE, 2011, TRENDS PLANT SCI, V16, P13, DOI 10.1016/j.tplants.2010.10.002; Cheptou PO, 2001, EVOL ECOL, V15, P1, DOI 10.1023/A:1011961905525; Clark JS, 1998, ECOL MONOGR, V68, P213, DOI 10.1890/0012-9615(1998)068[0213:SASSOR]2.0.CO;2; De-Lucas AI, 2008, HEREDITY, V100, P390, DOI 10.1038/sj.hdy.6801090; Dow BD, 1998, NEW FOREST, V15, P161, DOI 10.1023/A:1006557904751; FORE SA, 1992, CAN J BOT, V70, P1659, DOI 10.1139/b92-205; Franceschinelli EV, 2000, HEREDITY, V84, P116, DOI 10.1046/j.1365-2540.2000.00636.x; Garcia C, 2009, J ECOL, V97, P1424, DOI 10.1111/j.1365-2745.2009.01577.x; Gerber S, 2003, MOL ECOL NOTES, V3, P479, DOI 10.1046/j.1471-8286.2003.00439.x; Hall P, 1996, CONSERV BIOL, V10, P757, DOI 10.1046/j.1523-1739.1996.10030757.x; Hamrick JL, 2004, FOREST ECOL MANAG, V197, P323, DOI 10.1016/j.foreco.2004.05.023; Hardy OJ, 2004, GENETICS, V168, P1601, DOI 10.1534/genetics.104.027714; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Jordano P, 2010, HEREDITY, V105, P329, DOI 10.1038/hdy.2010.28; JORDANO P, 1989, OIKOS, V55, P375, DOI 10.2307/3565598; Jump AS, 2006, P NATL ACAD SCI USA, V103, P8096, DOI 10.1073/pnas.0510127103; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Klein EK, 2008, MOL ECOL, V17, P3323, DOI 10.1111/j.1365-294X.2008.03809.x; Kramer AT, 2008, CONSERV BIOL, V22, P878, DOI 10.1111/j.1523-1739.2008.00944.x; Lander TA, 2010, BIOL CONSERV, V143, P2583, DOI 10.1016/j.biocon.2010.06.028; LOISELLE BA, 1995, AM J BOT, V82, P1420, DOI 10.2307/2445869; Lund U., 2007, CIRCULAR CIRCULAR ST; McIntyre S, 1999, CONSERV BIOL, V13, P1282, DOI 10.1046/j.1523-1739.1999.97509.x; Oddou-Muratorio S, 2005, MOL ECOL, V14, P4441, DOI 10.1111/j.1365-294X.2005.02720.x; Oddou-Muratorio S, 2003, MOL ECOL, V12, P3427, DOI 10.1046/j.1365-294X.2003.01989.x; OKUBO A, 1989, ECOLOGY, V70, P329, DOI 10.2307/1937537; Petit RJ, 2006, ANNU REV ECOL EVOL S, V37, P187, DOI 10.1146/annurev.ecolsys.37.091305.110215; Pluess AR, 2009, FOREST ECOL MANAG, V258, P735, DOI 10.1016/j.foreco.2009.05.014; Ritland K, 2002, HEREDITY, V88, P221, DOI 10.1038/sj.hdy.6800029; Robledo-Arnuncio JJ, 2007, MOL ECOL NOTES, V7, P763, DOI 10.1111/j.1471-8286.2007.01706.x; Robledo-Arnuncio JJ, 2006, AM NAT, V168, P500, DOI 10.1086/507881; Robledo-Arnuncio JJ, 2006, GENETICS, V173, P1033, DOI 10.1534/genetics.105.052035; Rousset F, 2004, GENETIC STRUCTURE SE, P288; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sork VL, 2005, AM J BOT, V92, P262, DOI 10.3732/ajb.92.2.262; Vekemans X, 2004, MOL ECOL, V13, P921, DOI 10.1046/j.1365-294X.2004.02076.x; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8	45	21	21	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49012	10.1371/journal.pone.0049012	http://dx.doi.org/10.1371/journal.pone.0049012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152842	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234000045
J	Nicholson, TL; Conover, MS; Deora, R				Nicholson, Tracy L.; Conover, Matt S.; Deora, Rajendar			Transcriptome Profiling Reveals Stage-Specific Production and Requirement of Flagella during Biofilm Development in Bordetella bronchiseptica	PLOS ONE			English	Article							VIRULENCE CONTROL-SYSTEM; PSEUDOMONAS-AERUGINOSA; BPS POLYSACCHARIDE; RESPIRATORY-INFECTION; SIGNAL-TRANSDUCTION; BACTERIAL BIOFILMS; ATROPHIC RHINITIS; PERTUSSIS; EXPRESSION; LOCUS	We have used microarray analysis to study the transcriptome of the bacterial pathogen Bordetella bronchiseptica over the course of five time points representing distinct stages of biofilm development. The results suggest that B. bronchiseptica undergoes a coordinately regulated gene expression program similar to a bacterial developmental process. Expression and subsequent production of the genes encoding flagella, a classical Bvg(-) phase phenotype, occurs and is under tight regulatory control during B. bronchiseptica biofilm development. Using mutational analysis, we demonstrate that flagella production at the appropriate stage of biofilm development, i.e. production early subsequently followed by repression, is required for robust biofilm formation and maturation. We also demonstrate that flagella are necessary and enhance the initial cell-surface interactions, thereby providing mechanistic information on the initial stages of biofilm development for B. bronchiseptica. Biofilm formation by B. bronchiseptica involves the production of both Bvg- activated and Bvg- repressed factors followed by the repression of factors that inhibit formation of mature biofilms.	[Nicholson, Tracy L.] USDA, Natl Anim Dis Ctr, Agr Res Serv, Ames, IA 50010 USA; [Conover, Matt S.; Deora, Rajendar] Wake Forest Univ Hlth Sci, Program Mol Genet, Winston Salem, NC USA; [Deora, Rajendar] Wake Forest Univ Hlth Sci, Dept Microbiol & Immunol, Winston Salem, NC USA	United States Department of Agriculture (USDA); Wake Forest University; Wake Forest University School of Medicine; Wake Forest University; Wake Forest University School of Medicine	Nicholson, TL (corresponding author), USDA, Natl Anim Dis Ctr, Agr Res Serv, Ames, IA 50010 USA.	tracy.nicholson@ars.usda.gov; rdeora@wakehealth.edu			National Institutes of Health (NIH) [1R01AI075081]; NIH [T32 AI07401]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075081, T32AI007401] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in the laboratory of R.D. is supported National Institutes of Health (NIH) grant 1R01AI075081. M.C. was supported by an NIH predoctoral training grant (T32 AI07401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERLEY BJ, 1993, J BACTERIOL, V175, P3468, DOI 10.1128/jb.175.11.3468-3479.1993; AKERLEY BJ, 1995, CELL, V80, P611, DOI 10.1016/0092-8674(95)90515-4; AKERLEY BJ, 1992, J BACTERIOL, V174, P980, DOI 10.1128/jb.174.3.980-990.1992; AMANN E, 1985, GENE, V40, P183, DOI 10.1016/0378-1119(85)90041-1; Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; BEMIS DA, 1992, VET CLIN N AM-SMALL, V22, P1173, DOI 10.1016/S0195-5616(92)50308-4; Buboltz AM, 2008, J BACTERIOL, V190, P5502, DOI 10.1128/JB.00226-08; Buboltz AM, 2009, INFECT IMMUN, V77, P3969, DOI 10.1128/IAI.01362-08; Conover MS, 2012, J BACTERIOL, V194, P233, DOI 10.1128/JB.06020-11; Conover MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016861; Conover MS, 2010, MOL MICROBIOL, V77, P1439, DOI 10.1111/j.1365-2958.2010.07297.x; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cotter PA, 1997, MOL MICROBIOL, V24, P671, DOI 10.1046/j.1365-2958.1997.3821741.x; Cotter PA, 2003, TRENDS MICROBIOL, V11, P367, DOI 10.1016/S0966-842X(03)00156-2; Cotter PA, 1998, INFECT IMMUN, V66, P5921, DOI 10.1128/IAI.66.12.5921-5929.1998; COTTER PA, 1994, INFECT IMMUN, V62, P3381, DOI 10.1128/IAI.62.8.3381-3390.1994; de Tejada GM, 1998, INFECT IMMUN, V66, P2762, DOI 10.1128/IAI.66.6.2762-2768.1998; Deora R, 2002, J BACTERIOL, V184, P6942, DOI 10.1128/JB.184.24.6942-6951.2002; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; GILES CJ, 1980, VET REC, V106, P25, DOI 10.1136/vr.106.2.25; Guerrero RJ, 1990, RESP DIS IMPORTANT G; Harvill ET, 1999, INFECT IMMUN, V67, P6109, DOI 10.1128/IAI.67.11.6109-6118.1999; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Irie Y, 2004, J BACTERIOL, V186, P5692, DOI 10.1128/JB.186.17.5692-5698.2004; Jesaitis AJ, 2003, J IMMUNOL, V171, P4329, DOI 10.4049/jimmunol.171.8.4329; Jurcisek J, 2005, INFECT IMMUN, V73, P3210, DOI 10.1128/IAI.73.6.3210-3218.2005; Kirimanjeswara GS, 2003, INFECT IMMUN, V71, P1719, DOI 10.1128/IAI.71.4.1719-1724.2003; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144; Macnab R., 1996, ESCHERICHIA COLI SAL, V2nd ed, P119; Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2; McMillan DJ, 1996, MICROB PATHOGENESIS, V21, P379, DOI 10.1006/mpat.1996.0069; Merkel TJ, 1998, INFECT IMMUN, V66, P4367; Mishra M, 2005, J BACTERIOL, V187, P1474, DOI 10.1128/JB.187.4.1474-1484.2005; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Moorthy S, 2005, MOL MICROBIOL, V57, P1623, DOI 10.1111/j.1365-2958.2005.04797.x; Moorthy S, 2004, MOL MICROBIOL, V52, P573, DOI 10.1111/j.1365-2958.2004.04000.x; Nicholson TL, 2009, INFECT IMMUN; Nicholson TL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-220; Nicholson TL, 2009, INFECT IMMUN, V77, P4221, DOI 10.1128/IAI.00136-09; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Ouahrani-Bettache S, 1999, BIOTECHNIQUES, V26, P620, DOI 10.2144/99264bm05; Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06; Petrova OE, 2012, J BACTERIOLOGY; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; PORTER JF, 1993, FEMS MICROBIOL LETT, V110, P33, DOI 10.1111/j.1574-6968.1993.tb06291.x; Rath BA, 2008, CLIN INFECT DIS, V46, P905, DOI 10.1086/528858; Register KB, 2012, ZOONOSES PUBLIC HLTH; RUTTER JM, 1981, VET REC, V108, P451, DOI 10.1136/vr.108.21.451; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sauer K, 2002, J BACTERIOL, V184, P1140, DOI 10.1128/jb.184.4.1140-1154.2002; Savelkoul PHM, 1996, INFECT IMMUN, V64, P5098, DOI 10.1128/IAI.64.12.5098-5105.1996; Serra D, 2007, ANAL BIOANAL CHEM, V387, P1759, DOI 10.1007/s00216-006-1079-9; Serra DO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028811; Sloan GP, 2007, J BACTERIOL, V189, P8270, DOI 10.1128/JB.00785-07; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Tolker-Nielsen T, 2000, J BACTERIOL, V182, P6482, DOI 10.1128/JB.182.22.6482-6489.2000; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; United States DoA, 2008, SWIN 2006 3; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200	61	24	25	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49166	10.1371/journal.pone.0049166	http://dx.doi.org/10.1371/journal.pone.0049166			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152870	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234000053
J	Nadal-Nicolas, FM; Jimenez-Lopez, M; Salinas-Navarro, M; Sobrado-Calvo, P; Alburquerque-Bejar, JJ; Vidal-Sanz, M; Agudo-Barriuso, M				Nadal-Nicolas, Francisco M.; Jimenez-Lopez, Manuel; Salinas-Navarro, Manuel; Sobrado-Calvo, Paloma; Alburquerque-Bejar, Juan J.; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta			Whole Number, Distribution and Co-Expression of Brn3 Transcription Factors in Retinal Ganglion Cells of Adult Albino and Pigmented Rats	PLOS ONE			English	Article							OPTIC-NERVE TRANSECTION; GENE-EXPRESSION; COMPUTERIZED ANALYSIS; OCULAR HYPERTENSION; MICROGLIAL CELLS; DOWN-REGULATION; TIME-COURSE; IN-VIVO; BRN-3A; PROJECTIONS	The three members of the Pou4f family of transcription factors: Pou4f1, Pou4f2, Pou4f3 (Brn3a, Brn3b and Brn3c, respectively) play, during development, essential roles in the differentiation and survival of sensory neurons. The purpose of this work is to study the expression of the three Brn3 factors in the albino and pigmented adult rat. Animals were divided into these groups: i) untouched; ii) fluorogold (FG) tracing from both superior colliculli; iii) FG-tracing from one superior colliculus; iv) intraorbital optic nerve transection or crush. All retinas were dissected as flat-mounts and subjected to single, double or triple immunohistofluorescence The total number of FG-traced, Brn3a, Brn3b, Brn3c or Brn3 expressing RGCs was automatically quantified and their spatial distribution assessed using specific routines. Brn3 factors were studied in the general RGC population, and in the intrinsically photosensitive (ip-RGCs) and ipsilateral RGC sub-populations. Our results show that: i) 70% of RGCs co-express two or three Brn3s and the remaining 30% express only Brn3a (26%) or Brn3b; ii) the most abundant Brn3 member is Brn3a followed by Brn3b and finally Brn3c; iii) Brn3 a-, b- or c-expressing RGCs are similarly distributed in the retina; iv) The vast majority of ip-RGCs do not express Brn3; v) The main difference between both rat strains was found in the population of ipsilateral-RGCs, which accounts for 4.2% and 2.5% of the total RGC population in the pigmented and albino strain, respectively. However, more ipsilateral-RGCs express Brn3 factors in the albino than in the pigmented rat; vi) RGCs that express only Brn3b and RGCs that co-express the three Brn3 members have the biggest nuclei; vii) After axonal injury the level of Brn3a expression in the surviving RGCs decreases compared to control retinas. Finally, this work strengthens the validity of Brn3a as a marker to identify and quantify rat RGCs.	[Nadal-Nicolas, Francisco M.; Agudo-Barriuso, Marta] Fdn Formac & Invest Sanitarias Reg Murcia, IMIB, Hosp Univ Virgen de la Arrixaca, Unidad Invest, Murcia, Spain; [Nadal-Nicolas, Francisco M.; Jimenez-Lopez, Manuel; Salinas-Navarro, Manuel; Sobrado-Calvo, Paloma; Alburquerque-Bejar, Juan J.; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta] Univ Murcia, Fac Med, Dept Oftalmol, IMIB, Murcia, Spain	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia	Agudo-Barriuso, M (corresponding author), Fdn Formac & Invest Sanitarias Reg Murcia, IMIB, Hosp Univ Virgen de la Arrixaca, Unidad Invest, Murcia, Spain.	martabar@um.es	Agudo-Barriuso, Marta/B-7100-2016; Vidal-Sanz, Manuel/J-6989-2016; Alburquerque-Bejar, Juan/AAA-7666-2020	Agudo-Barriuso, Marta/0000-0002-8566-9277; Vidal-Sanz, Manuel/0000-0002-9216-1615; Nadal-Nicolas, Francisco M./0000-0003-4121-514X; Jimenez Lopez, Manuel/0000-0002-8768-9968; Alburquerque Bejar, Juan Jose/0000-0002-9022-124X	Spanish Ministry of Economy and Competitiviness; ISCIII-FEDER [PI10/00187]; Fundacion Seneca [04446/GERM/07]; Spanish Ministry of Education and Science [SAF-22010-10385]; Red Tematica de Investigacion Cooperativa en Oftalmologia [RD07/0062/0001]	Spanish Ministry of Economy and Competitiviness(Spanish Government); ISCIII-FEDER(Spanish Government); Fundacion Seneca(Fundacion Seneca); Spanish Ministry of Education and Science(Spanish Government); Red Tematica de Investigacion Cooperativa en Oftalmologia	Spanish Ministry of Economy and Competitiviness and ISCIII-FEDER "Una manera de hacer Europa": PI10/00187, http://www.mineco.gob.es/, http://www.isciii.es/, Fundacion Seneca 04446/GERM/07; http://www.f-seneca.org Spanish Ministry of Education and Science SAF-22010-10385 http://www.educacion.gob.es/, and Red Tematica de Investigacion Cooperativa en Oftalmologia RD07/0062/0001 http://www.oftared.com/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agudo M, 2009, INVEST OPHTH VIS SCI, V50, P424, DOI 10.1167/iovs.08-2404; Agudo M, 2008, MOL VIS, V14, P1050; Badea TC, 2009, NEURON, V61, P852, DOI 10.1016/j.neuron.2009.01.020; Badea TC, 2012, J NEUROSCI, V32, P995, DOI 10.1523/JNEUROSCI.4755-11.2012; Badea TC, 2011, VISION RES, V51, P269, DOI 10.1016/j.visres.2010.08.039; BALKEMA GW, 1991, VISUAL NEUROSCI, V6, P577, DOI 10.1017/S095252380000256X; BALKEMA GW, 1981, J NEUROSCI, V1, P1320; BALKEMA GW, 1990, VISUAL NEUROSCI, V4, P595, DOI 10.1017/S0952523800005794; BARNSTABLE CJ, 1984, NEUROSCIENCE, V11, P847, DOI 10.1016/0306-4522(84)90195-7; Bernstein SL, 2006, MOL VIS, V12, P147; Bouaita A, 2012, BRAIN, V135, P35, DOI 10.1093/brain/awr290; Buckingham BP, 2008, J NEUROSCI, V28, P2735, DOI 10.1523/JNEUROSCI.4443-07.2008; Budhram-Mahadeo V, 2002, NEUROSCI LETT, V334, P1, DOI 10.1016/S0304-3940(02)00813-3; Calissano M, 2010, MOL CELL NEUROSCI, V45, P317, DOI 10.1016/j.mcn.2010.06.015; Casson RJ, 2004, INVEST OPHTH VIS SCI, V45, P685, DOI 10.1167/iovs.03-0674; Chen SK, 2011, NATURE, V476, P92, DOI 10.1038/nature10206; COWEY A, 1979, EXP BRAIN RES, V35, P457; DRAGER UC, 1980, J COMP NEUROL, V191, P383, DOI 10.1002/cne.901910306; DRAGER UC, 1987, NEUROSCI RES, pS75, DOI 10.1016/0921-8696(87)90009-0; DRAGER UC, 1985, PROC R SOC SER B-BIO, V224, P57, DOI 10.1098/rspb.1985.0021; DRAGER UC, 1981, INVEST OPHTH VIS SCI, V20, P285; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; Ecker JL, 2010, NEURON, V67, P49, DOI 10.1016/j.neuron.2010.05.023; Eng SR, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-3; Eng SR, 2004, DEVELOPMENT, V131, P3859, DOI 10.1242/dev.01260; Ensor E, 2001, J BIOL CHEM, V276, P5204, DOI 10.1074/jbc.M007068200; Farooqui-Kabir SR, 2004, CELL DEATH DIFFER, V11, P1242, DOI 10.1038/sj.cdd.4401478; Faulkes DJ, 2004, NEUROREPORT, V15, P1421, DOI 10.1097/01.wnr.0000129371.81377.05; FUKUDA Y, 1977, BRAIN RES, V119, P327, DOI 10.1016/0006-8993(77)90314-6; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Gan L, 1996, P NATL ACAD SCI USA, V93, P3920, DOI 10.1073/pnas.93.9.3920; Ganesh BS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018305; Garcia-Ayuso D, 2011, MOL VIS, V17, P1716; Garcia-Ayuso D, 2010, EXP EYE RES, V91, P800, DOI 10.1016/j.exer.2010.10.003; HOFBAUER A, 1985, J COMP NEUROL, V234, P465, DOI 10.1002/cne.902340405; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Hudson CD, 2005, J BIOL CHEM, V280, P11851, DOI 10.1074/jbc.M408679200; Ichikawa H, 2005, BRAIN RES, V1053, P203, DOI 10.1016/j.brainres.2005.06.026; Isenmann S, 2003, PROG RETIN EYE RES, V22, P483, DOI 10.1016/S1350-9462(03)00027-2; Jain V, 2012, J COMP NEUROL, V520, P742, DOI 10.1002/cne.22765; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Kim IJ, 2008, NATURE, V452, P478, DOI 10.1038/nature06739; Kiyama T, 2011, VISION RES, V51, P251, DOI 10.1016/j.visres.2010.10.016; Latchman DS, 1999, J CELL PHYSIOL, V179, P126; Leahy KM, 2004, EXP EYE RES, V79, P131, DOI 10.1016/j.exer.2004.02.007; Li CZ, 2012, INVEST OPHTH VIS SCI, V53, P3241, DOI 10.1167/iovs.11-8406; Li RS, 2006, INVEST OPHTH VIS SCI, V47, P2951, DOI 10.1167/iovs.05-1295; Li SY, 2008, CELL MOL NEUROBIOL, V28, P1095, DOI 10.1007/s10571-008-9286-x; LILLYCROP KA, 1992, NUCLEIC ACIDS RES, V20, P5093, DOI 10.1093/nar/20.19.5093; LINDEN R, 1983, BRAIN RES, V272, P145, DOI 10.1016/0006-8993(83)90371-2; Lindqvist N, 2004, EXP NEUROL, V187, P487, DOI 10.1016/j.expneurol.2004.02.002; Liu W, 2000, DEVELOPMENT, V127, P3237; LUND JS, 1976, BRAIN RES, V116, P83, DOI 10.1016/0006-8993(76)90250-X; LUND RD, 1965, SCIENCE, V149, P1506, DOI 10.1126/science.149.3691.1506; LUND RD, 1980, J COMP NEUROL, V189, P711, DOI 10.1002/cne.901890407; MARTIN PR, 1983, NEUROSCI LETT, V41, P219, DOI 10.1016/0304-3940(83)90454-8; Mu XQ, 2004, SEMIN CELL DEV BIOL, V15, P115, DOI 10.1016/j.semcdb.2003.09.009; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; NINKINA NN, 1993, NUCLEIC ACIDS RES, V21, P3175, DOI 10.1093/nar/21.14.3175; Ortin-Martinez A, 2010, INVEST OPHTH VIS SCI, V51, P3171, DOI 10.1167/iovs.09-4861; Pan L, 2005, DEVELOPMENT, V132, P703, DOI 10.1242/dev.01646; Parrilla-Reverter G, 2009, VISION RES, V49, P2808, DOI 10.1016/j.visres.2009.08.020; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Provencio I, 2002, NATURE, V415, P493, DOI 10.1038/415493a; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Prusky GT, 2002, BEHAV BRAIN RES, V136, P339, DOI 10.1016/S0166-4328(02)00126-2; Qiu F, 2008, J NEUROSCI, V28, P3392, DOI 10.1523/JNEUROSCI.0043-08.2008; Quina LA, 2005, J NEUROSCI, V25, P11595, DOI 10.1523/JNEUROSCI.2837-05.2005; REESE BE, 1986, J COMP NEUROL, V250, P8, DOI 10.1002/cne.902500103; REESE BE, 1986, EXP BRAIN RES, V61, P375; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Salinas-Navarro M, 2010, EXP EYE RES, V90, P168, DOI 10.1016/j.exer.2009.10.003; Salvador-Silva M, 2000, J COMP NEUROL, V417, P431, DOI 10.1002/(SICI)1096-9861(20000221)417:4<431::AID-CNE4>3.0.CO;2-G; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Sefton A.J., 2004, RAT NERVOUS SYSTEM, P1083; Smith MD, 2001, MOL CELL NEUROSCI, V17, P460, DOI 10.1006/mcne.2000.0927; Smith MDP, 2001, NEUROREPORT, V12, P3183, DOI 10.1097/00001756-200110290-00008; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008; Surgucheva I, 2008, MOL VIS, V14, P1540; THANOS S, 1991, NEUROSCI LETT, V127, P108, DOI 10.1016/0304-3940(91)90906-A; THANOS S, 1992, EXP EYE RES, V55, P101, DOI 10.1016/0014-4835(92)90098-D; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; VILLEGASPEREZ MP, 1993, J NEUROBIOL, V24, P23, DOI 10.1002/neu.480240103; Voyatzis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031105; Wang S, 2003, CURR EYE RES, V27, P183, DOI 10.1076/ceyr.27.3.183.16053; Wang SW, 2002, DEVELOPMENT, V129, P467; Weishaupt JH, 2005, J MOL NEUROSCI, V26, P17, DOI 10.1385/JMN:26:1:017; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; Xiang M, 1997, COLD SPRING HARB SYM, V62, P325; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Xiang MQ, 1996, P NATL ACAD SCI USA, V93, P596, DOI 10.1073/pnas.93.2.596; Young MJ, 1998, BRAIN RES, V787, P191, DOI 10.1016/S0006-8993(97)01473-X; Zhang PP, 2012, NEUROSCIENCE, V220, P62, DOI 10.1016/j.neuroscience.2012.06.032; Zou M, 2012, DEV BIOL, V364, P114, DOI 10.1016/j.ydbio.2012.01.021	100	116	116	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49830	10.1371/journal.pone.0049830	http://dx.doi.org/10.1371/journal.pone.0049830			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166779	Green Submitted, Green Published, gold			2022-12-27	WOS:000311885300071
J	Raran-Kurussi, S; Waugh, DS				Raran-Kurussi, Sreejith; Waugh, David S.			The Ability to Enhance the Solubility of Its Fusion Partners Is an Intrinsic Property of Maltose-Binding Protein but Their Folding Is Either Spontaneous or Chaperone-Mediated	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAIN; ETCH VIRUS PROTEASE; HPV E6 ONCOPROTEIN; IN-VIVO; DIHYDROFOLATE-REDUCTASE; RECOMBINANT PROTEINS; MOLECULAR CHAPERONE; DISULFIDE BONDS; HIGH-AFFINITY; PURIFICATION	Escherichia coli maltose binding protein (MBP) is commonly used to promote the solubility of its fusion partners. To investigate the mechanism of solubility enhancement by MBP, we compared the properties of MBP fusion proteins refolded in vitro with those of the corresponding fusion proteins purified under native conditions. We fused five aggregation-prone passenger proteins to 3 different N-terminal tags: His(6)-MBP, His(6)-GST and His(6). After purifying the 15 fusion proteins under denaturing conditions and refolding them by rapid dilution, we recovered far more of the soluble MBP fusion proteins than their GST- or His-tagged counterparts. Hence, we can reproduce the solubilizing activity of MBP in a simple in vitro system, indicating that no additional factors are required to mediate this effect. We assayed both the soluble fusion proteins and their TEV protease digestion products (i.e., with the N-terminal tag removed) for biological activity. Little or no activity was detected for some fusion proteins whereas others were quite active. When the MBP fusions proteins were purified from E. coli under native conditions they were all substantially active. These results indicate that the ability of MBP to promote the solubility of its fusion partners in vitro sometimes, but not always, results in their proper folding. We show that the folding of some passenger proteins is mediated by endogenous chaperones in vivo. Hence, MBP serves as a passive participant in the folding process; passenger proteins either fold spontaneously or with the assistance of chaperones.	[Raran-Kurussi, Sreejith; Waugh, David S.] Frederick Natl Lab Canc Res, Ctr Canc Res, Prot Engn Sect, Macromol Crystallog Lab, Frederick, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Waugh, DS (corresponding author), Frederick Natl Lab Canc Res, Ctr Canc Res, Prot Engn Sect, Macromol Crystallog Lab, Frederick, MD USA.	waughd@mail.nih.gov		RARAN-KURUSSI, SREEJITH/0000-0001-7738-9606	Center for Cancer Research, National Cancer Institute; Frederick National Laboratory for Cancer Research; National Institutes of Health; NATIONAL CANCER INSTITUTE [ZIABC010780] Funding Source: NIH RePORTER	Center for Cancer Research, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Frederick National Laboratory for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the intramural research program of the Center for Cancer Research, National Cancer Institute, Frederick National Laboratory for Cancer Research, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JY, 2005, NUCLEIC ACIDS RES, V33, P3751, DOI 10.1093/nar/gki692; Austin BP, 2012, PROTEIN EXPRES PURIF, V82, P116, DOI 10.1016/j.pep.2011.11.015; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bach H, 2001, J MOL BIOL, V312, P79, DOI 10.1006/jmbi.2001.4914; Braun P, 2002, P NATL ACAD SCI USA, V99, P2654, DOI 10.1073/pnas.042684199; CAI H, 1994, J BIOL CHEM, V269, P24550; Chaudhuri TK, 2001, CELL, V107, P235, DOI 10.1016/S0092-8674(01)00523-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Douette P, 2005, BIOCHEM BIOPH RES CO, V333, P686, DOI 10.1016/j.bbrc.2005.05.164; Ellis RJ, 2006, NATURE, V442, P360, DOI 10.1038/442360a; Fox JD, 2003, FEBS LETT, V537, P53, DOI 10.1016/S0014-5793(03)00070-X; Fox JD, 2001, PROTEIN SCI, V10, P622, DOI 10.1110/ps.45201; Fujiwara K, 2010, EMBO J, V29, P1552, DOI 10.1038/emboj.2010.52; Hammarstrom M, 2002, PROTEIN SCI, V11, P313, DOI 10.1110/ps.22102; Hewitt SN, 2011, ACTA CRYSTALLOGR F, V67, P1006, DOI 10.1107/S1744309111022159; Horst R, 2007, P NATL ACAD SCI USA, V104, P20788, DOI 10.1073/pnas.0710042105; Inbar E, 1997, BIOCHEMISTRY-US, V36, P12276, DOI 10.1021/bi9714870; Kapust RB, 1999, PROTEIN SCI, V8, P1668, DOI 10.1110/ps.8.8.1668; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Keresztessy Z, 1996, BIOCHEM J, V314, P41, DOI 10.1042/bj3140041; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Kim CW, 2007, PROTEIN SCI, V16, P635, DOI 10.1110/ps.062330907; Korf U, 2005, PROTEOMICS, V5, P3571, DOI 10.1002/pmic.200401195; Lountos GT, 2009, ACTA CRYSTALLOGR D, V65, P1013, DOI 10.1107/S0907444909023762; Lountos GT, 2009, PROTEIN SCI, V18, P92, DOI 10.1002/pro.16; Mark JK, 2007, PROTEIN EXPRES PURIF, V54, P253, DOI 10.1016/j.pep.2007.03.004; MISSET O, 1984, EUR J BIOCHEM, V144, P475, DOI 10.1111/j.1432-1033.1984.tb08490.x; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Nallamsetty S, 2004, PROTEIN EXPRES PURIF, V38, P108, DOI 10.1016/j.pep.2004.08.016; Nallamsetty S, 2007, BIOCHEM BIOPH RES CO, V364, P639, DOI 10.1016/j.bbrc.2007.10.060; Nomine Y, 2001, PROTEIN EXPRES PURIF, V23, P22, DOI 10.1006/prep.2001.1451; Nomine Y, 2001, PROTEIN ENG, V14, P297, DOI 10.1093/protein/14.4.297; Quaite-Randall E, 2000, METH MOL B, V140, P41; Quaite-Randall E, 2000, METH MOL B, V140, P29; Sachdev D, 1998, BIOCHEM BIOPH RES CO, V244, P933, DOI 10.1006/bbrc.1998.8365; Shaki-Loewenstein S, 2005, J IMMUNOL METHODS, V303, P19, DOI 10.1016/j.jim.2005.05.004; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Shih YP, 2002, PROTEIN SCI, V11, P1714, DOI 10.1110/ps.0205202; Sun P, 2011, METHODS MOL BIOL, V705, P259, DOI 10.1007/978-1-61737-967-3_16; Telmer PG, 2003, J BIOL CHEM, V278, P34555, DOI 10.1074/jbc.M301004200; Tropea JE, 2006, PROTEIN EXPRES PURIF, V50, P31, DOI 10.1016/j.pep.2006.05.007; Tyagi NK, 2011, FEBS LETT, V585, P1969, DOI 10.1016/j.febslet.2011.05.031; VIITANEN PV, 1991, BIOCHEMISTRY-US, V30, P9716, DOI 10.1021/bi00104a021; Wang JD, 2002, CELL, V111, P1027, DOI 10.1016/S0092-8674(02)01198-4; Waugh DS, 2005, TRENDS BIOTECHNOL, V23, P316, DOI 10.1016/j.tibtech.2005.03.012; Zhang YB, 2004, PROTEIN EXPRES PURIF, V36, P207, DOI 10.1016/j.pep.2004.04.020	47	76	79	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49589	10.1371/journal.pone.0049589	http://dx.doi.org/10.1371/journal.pone.0049589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166722	Green Published, Green Submitted, gold			2022-12-27	WOS:000311885300055
J	Ajbani, K; Nikam, C; Kazi, M; Gray, C; Boehme, C; Balan, K; Shetty, A; Rodrigues, C				Ajbani, Kanchan; Nikam, Chaitali; Kazi, Mubin; Gray, Christen; Boehme, Catharina; Balan, Kavita; Shetty, Anjali; Rodrigues, Camilla			Evaluation of Genotype MTBDRsl Assay to Detect Drug Resistance Associated with Fluoroquinolones, Aminoglycosides and Ethambutol on Clinical Sediments	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS STRAINS; DIAGNOSIS; 2ND-LINE; AMIKACIN; SYSTEM	Background: The emergence of resistant tuberculosis (TB) is a major setback to the global control of the disease as the treatment of such resistance is complex and expensive. Use of direct detection of mutations by molecular methods could facilitate rapid diagnosis of resistance to offset diagnostic delays. We evaluated the performance of the Genotype MTBDRsl (Hain Life Sciences) for the detection of second line resistant TB directly from stored smear positive sputum sediments. Methodology/Principal Findings: The assay showed a diverse range of sensitivity and specificity, 91.26% [95% CI, 84-96] and 95.5% [95% CI, 87-99] for FQ (PPV similar to 97% & NPV similar to 87.67%), 56.19% [95% CI, 46-66] and 81% [95% CI, 66-91] for EMB (PPV similar to 88.06% & NPV similar to 43.21%) and 100% for SLD. Diagnostic accuracy for FQ, SLD and EMB was 94%, 100% and 63.51%, respectively. 1.17% (2/170) were heteroresistance strains, where the heteroresistance was linked to rrs gene. A varying rate of validity was observed 100% (170/170) for FQ, 94.11% (160/170) for EMB, 88.23% (150/170) for SLD. Conclusions/Significance: Genotype MTBDRsl is simple, rapid, economical assay that can be used to detect commonly known resistance associated with Fluoroquinolone, second line injectable drugs and ethambutol. The assay detects the targeted resistance in less time as compared to phenotypic DST. But due to low NPV to FQ (88%) and EMB (43.21%), the assay results must be interpreted in coordination with the phenotypic DST.	[Ajbani, Kanchan; Nikam, Chaitali; Kazi, Mubin; Balan, Kavita; Shetty, Anjali; Rodrigues, Camilla] PD Hinduja Hosp & Med Res Ctr, Dept Microbiol, Mumbai, Maharashtra, India; [Gray, Christen; Boehme, Catharina] FIND, Geneva, Switzerland	Foundation For Innovative New Diagnostics	Rodrigues, C (corresponding author), PD Hinduja Hosp & Med Res Ctr, Dept Microbiol, Veer Sarvarkar Marg, Mumbai, Maharashtra, India.	dr_crodrigues@hindujahospital.com		Gray, Christen/0000-0002-9723-3032; Nikam, Chaitali/0000-0002-3834-3936	Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland	Foundation for Innovative New Diagnostics (FIND), Geneva, Switzerland	The study was co-funded by the Foundation for Innovative New Diagnostics (FIND), 16 Avenue de Bude, 1202 Geneva, Switzerland. Dr. Boehme is employed by FIND and participated in study design and manuscript preparation. FIND had no role in data collection, analysis or decision to publish.	Ajbani K, 2011, J CLIN MICROBIOL, V49, P2546, DOI 10.1128/JCM.02511-10; Alangaden GJ, 1998, ANTIMICROB AGENTS CH, V42, P1295, DOI 10.1128/AAC.42.5.1295; Brossier F, 2010, J CLIN MICROBIOL, V48, P1683, DOI 10.1128/JCM.01947-09; Chakravorty S, 2011, J CLIN MICROBIOL, V49, P932, DOI 10.1128/JCM.02271-10; Hillemann D, 2009, J CLIN MICROBIOL, V47, P1767, DOI 10.1128/JCM.00081-09; Huang WL, 2011, J CLIN MICROBIOL, V49, P2502, DOI 10.1128/JCM.00197-11; Ignatyeva O, 2012, J CLIN MICR IN PRESS; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Johnson R, 2006, INT J TUBERC LUNG D, V10, P68; Johnson R, 2006, CURR ISSUES MOL BIOL, V8, P97; Jugheli L, 2009, ANTIMICROB AGENTS CH, V53, P5064, DOI 10.1128/AAC.00851-09; Lacoma A, 2012, J CLIN MICROBIOL, V50, P30, DOI 10.1128/JCM.05274-11; Maruri F, 2012, J ANTIMICROB CHEMOTH, V67, P819, DOI 10.1093/jac/dkr566; Miotto P, 2012, EUROPEAN RE IN PRESS; Mistry NF, 2002, J CLIN MICROBIOL, V40, P2677, DOI 10.1128/JCM.40.7.2677-2680.2002; Parsons LM, 2011, CLIN MICROBIOL REV, V24, P314, DOI 10.1128/CMR.00059-10; Piersimoni C, 2006, J CLIN MICROBIOL, V44, P20, DOI 10.1128/JCM.44.1.20-28.2006; Plinke C, 2009, TUBERCULOSIS, V89, P448, DOI 10.1016/j.tube.2009.09.001; Rodrigues C, 2007, Indian J Med Microbiol, V25, P4; Rodrigues C, 2008, INT J TUBERC LUNG D, V12, P1449; Shen GH, 2012, INT J ANTIMICROB AG, V39, P201, DOI 10.1016/j.ijantimicag.2011.11.014; Srivastava S, 2006, CURR MICROBIOL, V53, P401, DOI 10.1007/s00284-006-0135-1; Vadwai V, 2012, TUBERCULOSI IN PRESS; Vasanthi N, 2010, INT J MICROBIOLOGICA, V1, P14; Vo SK, 2010, J CLIN MICROBIOL, V48, P2934, DOI 10.1128/JCM.00201-10; World Health Organization, 1997, WHOTB97220; World Health organization, 2008, POL GUID DRUG SUSC T; World Health Orginisation, 2008, POL GUID MOL LIN PRO; Zhang Y, 2009, INT J TUBERC LUNG D, V13, P1320	29	37	41	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49433	10.1371/journal.pone.0049433	http://dx.doi.org/10.1371/journal.pone.0049433			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166667	gold, Green Published, Green Submitted			2022-12-27	WOS:000311272300043
J	Chen, YC; Fu, K; Feng, C; Tang, LH; Zhang, J; Huan, Y; Cui, JL; Mu, YF; Qi, S; Xiong, LZ; Ma, C; Wang, HH; Tan, QR; Yin, H				Chen, Yunchun; Fu, Kuang; Feng, Chen; Tang, Lihua; Zhang, Jian; Huan, Yi; Cui, Jinli; Mu, Yunfeng; Qi, Shun; Xiong, Lize; Ma, Cheng; Wang, Huaihai; Tan, Qingrong; Yin, Hong			Different Regional Gray Matter Loss in Recent Onset PTSD and Non PTSD after a Single Prolonged Trauma Exposure	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MEDIAL PREFRONTAL CORTEX; VOXEL-BASED MORPHOMETRY; HIPPOCAMPAL VOLUME; CINGULATE CORTEX; SEXUAL-ABUSE; MRI REVEALS; EXTINCTION; FEAR; SURVIVORS	Objective-Gray matter loss in the limbic structures was found in recent onset post traumatic stress disorder (PTSD) patients. present study, we measured regional gray matter volume in trauma survivors to verify the hypothesis that stress may cause different regional gray matter loss in trauma survivors with and without recent onset PTSD. Method: High resolution T1-weighted magnetic resonance imaging (MRI) were obtained from coal mine flood disaster survivors with (n = 10) and without (n = 10) recent onset PTSD and 20 no trauma exposed normal controls. The voxel-based morphometry (VBM) method was used to measure the regional gray matter volume in three groups, the correlations of PTSD symptom severities with the gray matter volume in trauma survivors were also analyzed by multiple regression. Results: Compared with normal controls, recent onset PTSD patients had smaller gray matter volume in left dorsal anterior cingulate cortex (ACC), and non PTSD subjects had smaller gray matter volume in the right pulvinar and left pallidum. The gray matter volume of the trauma survivors correlated negatively with CAPS scores in the right frontal lobe, left anterior and middle cingulate cortex, bilateral cuneus cortex, right middle occipital lobe, while in the recent onset PTSD, the gray matter volume correlated negatively with CAPS scores in bilateral superior medial frontal lobe and right ACC. Conclusion: The present study identified gray matter loss in different regions in recent onset PTSD and non PTSD after a single prolonged trauma exposure. The gray matter volume of left dorsal ACC associated with the development of PTSD, while the gray matter volume of right pulvinar and left pallidum associated with the response to the severe stress. The atrophy of the frontal and limbic cortices predicts the symptom severities of the PTSD.	[Chen, Yunchun; Wang, Huaihai; Tan, Qingrong] Fourth Mil Med Univ, Xijing Hosp, Dept Psychiat, Xian 710032, Shaanxi, Peoples R China	Air Force Military Medical University	Chen, YC (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Psychiat, Xian 710032, Shaanxi, Peoples R China.	tanqingrong@gmail.com; yinhong@fmmu.edu.cn	Yin, Hong/AAC-5784-2020; Yin, Hong/G-3877-2014	Yin, Hong/0000-0002-5215-1455				Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; [Anonymous], 1994, Am J Psychiatry, V151, P797; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bonne O, 2008, J CLIN PSYCHIAT, V69, P1087, DOI 10.4088/JCP.v69n0707; Bouton ME, 2006, BIOL PSYCHIAT, V60, P352, DOI 10.1016/j.biopsych.2005.12.015; Bremner JD, 1999, AM J PSYCHIAT, V156, P1787; Bremner JD, 1997, BIOL PSYCHIAT, V41, P23, DOI 10.1016/S0006-3223(96)00162-X; Chen SL, 2006, PSYCHIAT RES-NEUROIM, V146, P65, DOI 10.1016/j.pscychresns.2005.09.006; Corbo V, 2005, BIOL PSYCHIAT, V58, P119, DOI 10.1016/j.biopsych.2005.02.032; Filipovic BR, 2010, CEN EUR NEUROSURG; Ganzel BL, 2008, NEUROIMAGE, V40, P788, DOI 10.1016/j.neuroimage.2007.12.010; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; Grillon C, 1999, J ABNORM PSYCHOL, V108, P134, DOI 10.1037/0021-843X.108.1.134; Gurvits TV, 1996, BIOL PSYCHIAT, V40, P1091, DOI 10.1016/S0006-3223(96)00229-6; Gurvits TV, 2000, ARCH GEN PSYCHIAT, V57, P181, DOI 10.1001/archpsyc.57.2.181; Hadjikhani N, 2008, BRAIN COGNITION, V68, P1, DOI 10.1016/j.bandc.2008.01.008; Herry C, 2004, EUR J NEUROSCI, V20, P781, DOI 10.1111/j.1460-9568.2004.03542.x; Herry C, 2002, J NEUROSCI, V22, P577, DOI 10.1523/JNEUROSCI.22-02-00577.2002; Jones E G, 1981, Int Rev Physiol, V25, P173; Karl A, 2006, NEUROSCI BIOBEHAV R, V30, P1004, DOI 10.1016/j.neubiorev.2006.03.004; Kaysen D, 2010, J INTERPERS VIOLENCE, V25, P63, DOI 10.1177/0886260508329131; Kitayama IT, 2008, ANN NY ACAD SCI, V1148, P95, DOI 10.1196/annals.1410.059; KRETTEK JE, 1977, J COMP NEUROL, V172, P687, DOI 10.1002/cne.901720408; Lui S, 2009, P NATL ACAD SCI USA, V106, P15412, DOI 10.1073/pnas.0812751106; Macklin ML, 1998, J CONSULT CLIN PSYCH, V66, P323, DOI 10.1037/0022-006X.66.2.323; Maddock RJ, 2003, NEUROREPORT, V14, P325, DOI 10.1097/01.wnr.0000059776.23521.25; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Maffei C, 1997, J PERS DISORD, V11, P279, DOI 10.1521/pedi.1997.11.3.279; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; Matsuda H, 2012, AM J NEURORADIOL, V33, P1109, DOI 10.3174/ajnr.A2935; Milad MR, 2005, P NATL ACAD SCI USA, V102, P10706, DOI 10.1073/pnas.0502441102; Milad MR, 2002, NATURE, V420, P70, DOI 10.1038/nature01138; MORGAN MA, 1993, NEUROSCI LETT, V163, P109, DOI 10.1016/0304-3940(93)90241-C; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nardo D, 2010, J PSYCHIATR RES, V44, P477, DOI 10.1016/j.jpsychires.2009.10.014; Nutt DJ, 2004, J CLIN PSYCHIAT, V65, P11; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Rauch SL, 2003, NEUROREPORT, V14, P913, DOI 10.1097/01.wnr.0000071767.24455.10; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Sewards TV, 2002, COMP BIOCHEM PHYS A, V132, P861, DOI 10.1016/S1095-6433(02)00119-8; Shapira NA, 2006, J NEUROL NEUROSUR PS, V77, P410, DOI 10.1136/jnnp.2005.069906; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Talalaenko A N, 2008, Neurosci Behav Physiol, V38, P115, DOI 10.1007/s11055-008-0016-0; Villarreal G, 2001, Semin Clin Neuropsychiatry, V6, P131, DOI 10.1053/scnp.2001.21840; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; Wang HH, 2010, J PSYCHIATR RES, V44, P385, DOI 10.1016/j.jpsychires.2009.10.001; Wang Z, 2010, ARCH GEN PSYCHIAT, V67, P296, DOI 10.1001/archgenpsychiatry.2009.205; Wignall EL, 2004, BIOL PSYCHIAT, V56, P832, DOI 10.1016/j.biopsych.2004.09.015; Williams LM, 2006, NEUROIMAGE, V29, P347, DOI 10.1016/j.neuroimage.2005.03.047; Winter H, 2004, AM J PSYCHIAT, V161, P2194, DOI 10.1176/appi.ajp.161.12.2194; Woodward SH, 2006, BIOL PSYCHIAT, V59, P582, DOI 10.1016/j.biopsych.2005.07.033; Yamasue H, 2003, P NATL ACAD SCI USA, V100, P9039, DOI 10.1073/pnas.1530467100; Zhang J, 2011, PSYCHIAT RES-NEUROIM, V192, P84, DOI 10.1016/j.pscychresns.2010.09.001	56	44	46	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48298	10.1371/journal.pone.0048298	http://dx.doi.org/10.1371/journal.pone.0048298			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155380	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900014
J	Fainberg, HP; Bodley, K; Bacardit, J; Li, DF; Wessely, F; Mongan, NP; Symonds, ME; Clarke, L; Mostyn, A				Fainberg, Hernan P.; Bodley, Katherine; Bacardit, Jaume; Li, Dongfang; Wessely, Frank; Mongan, Nigel P.; Symonds, Michael E.; Clarke, Lynne; Mostyn, Alison			Reduced Neonatal Mortality in Meishan Piglets: A Role for Hepatic Fatty Acids?	PLOS ONE			English	Article							ADIPOSE-TISSUE; ARACHIDONIC-ACID; BODY-COMPOSITION; COLOSTRUM INTAKE; LINOLEIC ACIDS; LATE GESTATION; NEWBORN; OXIDATION; GROWTH; IMPACT	The Meishan pig breed exhibits increased prolificacy and reduced neonatal mortality compared to commercial breeds, such as the Large White, prompting breeders to introduce the Meishan genotype into commercial herds. Commercial piglets are highly susceptible to hypoglycemia, hypothermia, and death, potentially due to limited lipid stores and/or delayed hepatic metabolic ability. We therefore hypothesized that variation in hepatic development and lipid metabolism could contribute to the differences in neonatal mortality between breeds. Liver samples were obtained from piglets of each breed on days 0, 7, and 21 of postnatal age and subjected to molecular and biochemical analysis. At birth, both breeds exhibited similar hepatic glycogen contents, despite Meishan piglets having significantly lower body weight. The livers from newborn Meishan piglets exhibited increased C18:1n9C and C20:1n9 but lower C18:0, C20:4n6, and C22:6n3 fatty acid content. Furthermore, by using an unsupervised machine learning approach, we detected an interaction between C18:1n9C and glycogen content in newborn Meishan piglets. Bioinformatic analysis could identify unique age-based clusters from the lipid profiles in Meishan piglets that were not apparent in the commercial offspring. Examination of the fatty acid signature during the neonatal period provides novel insights into the body composition of Meishan piglets that may facilitate liver responses that prevent hypoglycaemia and reduce offspring mortality.	[Fainberg, Hernan P.; Bodley, Katherine; Wessely, Frank; Mongan, Nigel P.; Mostyn, Alison] Univ Nottingham, Sch Vet Med & Sci, Nottingham, Leics, England	University of Nottingham	Fainberg, HP (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Nottingham, Leics, England.	alison.mostyn@nottingham.ac.uk	Mostyn, Alison/B-9126-2008; Mongan, Nigel/B-7410-2011; Bacardit, Jaume/F-9293-2014	Bacardit, Jaume/0000-0002-2692-7205; Fainberg, Hernan Pablo/0000-0001-9330-9047; Wessely, Frank/0000-0001-8137-647X; Symonds, Michael/0000-0001-9649-8963; Mongan, Nigel/0000-0001-5438-1126	Biotechnology and Biological Sciences Research Council [S15331] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alston-Mills B, 2000, LIVEST PROD SCI, V63, P85, DOI 10.1016/S0301-6226(99)00114-1; Amusquivar E, 2008, LIPIDS, V43, P713, DOI 10.1007/s11745-008-3180-7; ANDERSON LH, 1993, J ANIM SCI, V71, P1566, DOI 10.2527/1993.7161566x; Bacardit J., 2009, MEMET COMPUT, V1, P55, DOI DOI 10.1007/S12293-008-0005-4; Bassel GW, 2011, PLANT CELL, V23, P3101, DOI 10.1105/tpc.111.088153; BAZER FW, 1991, REPROD FERT DEVELOP, V3, P51, DOI 10.1071/RD9910051; BIEBER LL, 1973, BIOCHIM BIOPHYS ACTA, V326, P145, DOI 10.1016/0005-2760(73)90240-3; Biensen NJ, 1998, J ANIM SCI, V76, P2169; BOYD RD, 1982, J ANIM SCI, V55, P95, DOI 10.2527/jas1982.55195x; BOYD RD, 1985, J ANIM SCI, V60, P659, DOI 10.2527/jas1985.603659x; Campbell FM, 1998, LIFE SCI, V63, P235, DOI 10.1016/S0024-3205(98)00267-7; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Cheng D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017299; Chouinard PY, 1999, J DAIRY SCI, V82, P2737, DOI 10.3168/jds.S0022-0302(99)75530-X; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Dalrymple R. H., 1973, Journal of Food Technology, V8, P439; DUEE PH, 1994, BIOCHEM J, V298, P207, DOI 10.1042/bj2980207; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORD SP, 1993, J REPROD FERTIL, P271; GARG ML, 1990, J LIPID RES, V31, P271; GIRARD J, 1986, BIOL NEONATE, V50, P237, DOI 10.1159/000242605; Giuffra E, 2000, GENETICS, V154, P1785; Glaab E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039932; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; GOODWIN RFW, 1957, J PHYSIOL-LONDON, V136, P208, DOI 10.1113/jphysiol.1957.sp005753; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; HALEY CS, 1993, J REPROD FERTIL, P247; HERPIN P, 1993, J ANIM SCI, V71, P2645, DOI 10.2527/1993.71102645x; LEDIVIDICH J, 1994, J ANIM SCI, V72, P2082, DOI 10.2527/1994.7282082x; LeDividich J, 1997, J ANIM SCI, V75, P707; LEDIVIDICH J, 1991, J ANIM SCI, V69, P2480; LEPINE AJ, 1989, DOMEST ANIM ENDOCRIN, V6, P231, DOI 10.1016/0739-7240(89)90017-9; MANNERS MJ, 1963, BRIT J NUTR, V17, P495, DOI 10.1079/BJN19630053; MERSMANN HJ, 1974, J ANIM SCI, V38, P1022, DOI 10.2527/jas1974.3851022x; Mostyn A, 2004, J ENDOCRINOL, V183, P121, DOI 10.1677/joe.1.05448; Mostyn A, 2006, J ENDOCRINOL, V190, P631, DOI 10.1677/joe.1.06731; NEWCOMB MD, 1991, J ANIM SCI, V69, P230; Ntambi JM, 2004, PROG LIPID RES, V43, P91, DOI 10.1016/S0163-7827(03)00039-0; PEGORIER JP, 1983, BIOCHEM J, V212, P93, DOI 10.1042/bj2120093; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RODEMANN HP, 1982, J BIOL CHEM, V257, P1632; Sampath H, 2005, LIPIDS, V40, P1187, DOI 10.1007/s11745-005-1484-z; Sharkey D, 2009, HYPERTENSION, V53, P925, DOI 10.1161/HYPERTENSIONAHA.108.122812; Sinha RA, 2009, INT J DEV NEUROSCI, V27, P377, DOI 10.1016/j.ijdevneu.2009.02.003; SWIATEK KR, 1968, AM J PHYSIOL, V214, P400, DOI 10.1152/ajplegacy.1968.214.2.400; THULIN AJ, 1989, J ANIM SCI, V67, P738; WHITE BR, 1995, J ANIM SCI, V73, P738; Wilson ME, 1998, BIOL REPROD, V58, P905, DOI 10.1095/biolreprod58.4.905; WOLFE RG, 1977, J NUTR, V107, P2100, DOI 10.1093/jn/107.12.2100; WOLFE RG, 1978, J NUTR, V108, P1621, DOI 10.1093/jn/108.10.1621; Xu YJ, 2009, J ANIM SCI, V87, P2519, DOI 10.2527/jas.2008-1708	51	14	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49101	10.1371/journal.pone.0049101	http://dx.doi.org/10.1371/journal.pone.0049101			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155453	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900088
J	Martinez, AM; Gama, LT; Canon, J; Ginja, C; Delgado, JV; Dunner, S; Landi, V; Martin-Burriel, I; Penedo, MCT; Rodellar, C; Vega-Pla, JL; Acosta, A; Alvarez, LA; Camacho, E; Cortes, O; Marques, JR; Martinez, R; Martinez, RD; Melucci, L; Martinez-Velazquez, G; Munoz, JE; Postiglioni, A; Quiroz, J; Sponenberg, P; Uffo, O; Villalobos, A; Zambrano, D; Zaragoza, P				Martinez, Amparo M.; Gama, Luis T.; Canon, Javier; Ginja, Catarina; Delgado, Juan V.; Dunner, Susana; Landi, Vincenzo; Martin-Burriel, Inmaculada; Penedo, M. Cecilia T.; Rodellar, Clementina; Luis Vega-Pla, Jose; Acosta, Atzel; Alvarez, Luz A.; Camacho, Esperanza; Cortes, Oscar; Marques, Jose R.; Martinez, Roberto; Martinez, Ruben D.; Melucci, Lilia; Martinez-Velazquez, Guillermo; Munoz, Jaime E.; Postiglioni, Alicia; Quiroz, Jorge; Sponenberg, Philip; Uffo, Odalys; Villalobos, Axel; Zambrano, Delsito; Zaragoza, Pilar			Genetic Footprints of Iberian Cattle in America 500 Years after the Arrival of Columbus	PLOS ONE			English	Article							CREOLE CATTLE; ANCESTRAL ADMIXTURE; EUROPEAN CATTLE; BEEF-CATTLE; BOS-TAURUS; DIVERSITY; BREEDS; POPULATION; AFRICAN; MITOCHONDRIAL	Background: American Creole cattle presumably descend from animals imported from the Iberian Peninsula during the period of colonization and settlement, through different migration routes, and may have also suffered the influence of cattle directly imported from Africa. The introduction of European cattle, which began in the 18th century, and later of Zebu from India, has threatened the survival of Creole populations, some of which have nearly disappeared or were admixed with exotic breeds. Assessment of the genetic status of Creole cattle is essential for the establishment of conservation programs of these historical resources. Methodology/Principal Findings: We sampled 27 Creole populations, 39 Iberian, 9 European and 6 Zebu breeds. We used microsatellite markers to assess the origins of Creole cattle, and to investigate the influence of different breeds on their genetic make-up. The major ancestral contributions are from breeds of southern Spain and Portugal, in agreement with the historical ports of departure of ships sailing towards the Western Hemisphere. This Iberian contribution to Creoles may also include some African influence, given the influential role that African cattle have had in the development of Iberian breeds, but the possibility of a direct influence on Creoles of African cattle imported to America can not be discarded. In addition to the Iberian influence, the admixture with other European breeds was minor. The Creoles from tropical areas, especially those from the Caribbean, show clear signs of admixture with Zebu. Conclusions/Significance: Nearly five centuries since cattle were first brought to the Americas, Creoles still show a strong and predominant signature of their Iberian ancestors. Creole breeds differ widely from each other, both in genetic structure and influences from other breeds. Efforts are needed to avoid their extinction or further genetic erosion, which would compromise centuries of selective adaptation to a wide range of environmental conditions.	[Martinez, Amparo M.; Delgado, Juan V.; Landi, Vincenzo] Univ Cordoba, Dept Genet, Cordoba, Spain	Universidad de Cordoba	Martinez, AM (corresponding author), Univ Cordoba, Dept Genet, Cordoba, Spain.	jvegpla@oc.mde.es	Martin-Burriel, Inmaculada/K-3724-2014; zaragoza, pilar/AAN-9479-2021; Bermejo, Juan Vicente Delgado/Z-6119-2019; Dunner, Susana/H-3124-2015; Landi, Vincenzo/T-7484-2017; Rodellar, Clementina/E-9987-2018; Vega-Pla, Jose Luis/ABB-5125-2020; Abad, Atzel Candido Acosta/U-8994-2019; Villalobos-Cortes, Axel I/E-2476-2017; Martinez, Amparo/ABE-6085-2020; Gama, Luis T/N-4172-2018; Cortes Gardyn, Oscar/K-7545-2014; Canon Ferreras, Francisco Javier/M-5704-2018	Martin-Burriel, Inmaculada/0000-0001-6016-4726; Bermejo, Juan Vicente Delgado/0000-0003-1657-8838; Landi, Vincenzo/0000-0003-1385-8439; Abad, Atzel Candido Acosta/0000-0002-8271-7923; Villalobos-Cortes, Axel I/0000-0003-4223-0560; Martinez, Amparo/0000-0002-6944-0501; Gama, Luis T/0000-0003-3894-3488; /0000-0003-3289-2675; Cortes Gardyn, Oscar/0000-0001-7685-3980; MUNOZ FLOREZ, JAIME EDUARDO/0000-0002-8237-0499; Martinez Lopez, Oscar Roberto/0000-0003-2882-6675; Canon Ferreras, Francisco Javier/0000-0003-1137-0958; Vega-Pla, Jose Luis/0000-0003-0916-9876; Ginja, Catarina/0000-0003-2278-7089; Uffo, Odalys/0000-0002-1006-9015				Achilli A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005753; Beja-Pereira A, 2006, P NATL ACAD SCI USA, V103, P8113, DOI 10.1073/pnas.0509210103; Belkhir K, 2004, 5000 CNRS UMR; Canon J, 2001, GENET SEL EVOL, V33, P311, DOI 10.1051/gse:2001121; Carvajal-Carmona LG, 2003, GENETICS, V165, P1457; Crosby A. W., 1973, COLUMBIAN EXCHANGE B; Dani MAC, 2008, GENET MOL RES, V7, P1127, DOI 10.4238/vol7-4gmr499; De Alba J., 1987, ANIMAL GENETIC RESOU; Delgado JV, 2012, ANIM GENET, V43, P2, DOI 10.1111/j.1365-2052.2011.02207.x; Edwards CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015922; Egito AA, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-83; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FAO, 2004, SEC GUID DEV NAT FAR; Garcia D, 2006, MEAT SCI, V72, P560, DOI 10.1016/j.meatsci.2005.09.005; Gautier M, 2010, PLOS ONE, V5; Gautier M, 2011, MOL ECOL, V20, P3128, DOI 10.1111/j.1365-294X.2011.05163.x; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Ginja C, 2010, ANIM GENET, V41, P128, DOI 10.1111/j.1365-2052.2009.01976.x; Ginja C, 2010, J HERED, V101, P201, DOI 10.1093/jhered/esp104; Giovambattista G, 2000, ANIM GENET, V31, P302, DOI 10.1046/j.1365-2052.2000.00658.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Langella O, 1999, POPULATIONS 1 2 31 C; Lara M. A. C., 2005, Archivos de Zootecnia, V54, P295; Lebart L., 1984, MULTIVARIATE DESCRIP; Lenstra JA, 2006, ANIM GENET, V37, P475, DOI [10.1111/j.1365-20052.2006.01511.x., 10.1111/j.1365-2052.2006.01511.x]; Lewis J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018007; Li MH, 2010, ANIM GENET, V41, P150, DOI 10.1111/j.1365-2052.2009.01980.x; Liron JP, 2006, ANIM GENET, V37, P379, DOI 10.1111/j.1365-2052.2006.01452.x; Lush, 1943, ANIMAL BREEDING PLAN; MacHugh DE, 1997, GENETICS, V146, P1071; Magee DA, 2002, J HERED, V93, P429, DOI 10.1093/jhered/93.6.429; Martin-Burriel I, 2011, J ANIM SCI, V89, P893, DOI 10.2527/jas.2010-3338; Martin-Burriel I, 1999, ANIM GENET, V30, P177, DOI 10.1046/j.1365-2052.1999.00437.x; Martin-Burriel I, 2007, J HERED, V98, P687, DOI 10.1093/jhered/esm096; Martinez A. M., 2005, Archivos de Zootecnia, V54, P357; Martinez A. M., 2009, ARCH ZOOTEC, V58, P121; Martinez AM, 2000, ANIM GENET, V31, P295, DOI 10.1046/j.1365-2052.2000.00645.x; Martinez AM, 2007, 8 S IB CONS UT REC Z; Martinez-Correal G, 2009, 10 S IB CONS UT REC; Mateus JC, 2004, ANIM GENET, V35, P106, DOI 10.1111/j.1365-2052.2004.01089.x; Miretti MM, 2004, J HERED, V95, P450, DOI 10.1093/jhered/esh070; Mirol PM, 2003, HEREDITY, V91, P248, DOI 10.1038/sj.hdy.6800312; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Park SDE, 2001, THESIS U DUBLIN; Primo, 2004, AMERICA CONQUISTA CO; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; REYNOLDS J, 1983, GENETICS, V105, P767; Rischkowsky B., 2007, STATE WORLDS ANIMAL; Rodero A., 1992, Archivos de Zootecnia, V41, P383; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rouse JE., 1977, CRIOLLO SPANISH CATT; Santiago A.A., 1978, ZEBU J, V1, P6; Stahl PW, 2008, HANDBOOK OF SOUTH AMERICAN ARCHAEOLOGY, P121, DOI 10.1007/978-0-387-74907-5_8; Tapio I, 2006, CONSERV BIOL, V20, P1768, DOI 10.1111/j.1523-1739.2006.00488.x; UFFO O, 2006, AGRI, V39, P15; Ulloa-Arvizu R, 2008, J ANIM BREED GENET, V125, P351, DOI 10.1111/j.1439-0388.2008.00735.x; Cortes AIV, 2010, LIVEST SCI, V131, P45, DOI 10.1016/j.livsci.2010.02.024; Villalobos Cortes A. I, 2009, Archivos de Zootecnia, V58, P485; Wang JL, 2003, GENETICS, V164, P747; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WILLHAM RL, 1982, J ANIM SCI, V54, P659, DOI 10.2527/jas1982.543659x; Yeh Francis C., 1997, Belgian Journal of Botany, V129, P157	66	49	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49066	10.1371/journal.pone.0049066	http://dx.doi.org/10.1371/journal.pone.0049066			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155451	Green Published, gold			2022-12-27	WOS:000311151900086
J	Yan, XX; Cai, Y; Shelton, J; Deng, SH; Luo, XG; Oddo, S; LaFerla, FM; Cai, HB; Rose, GM; Patrylo, PR				Yan, Xiao-Xin; Cai, Yan; Shelton, Jarod; Deng, Si-Hao; Luo, Xue-Gang; Oddo, Salvatore; LaFerla, Frank M.; Cai, Huaibin; Rose, Gregory M.; Patrylo, Peter R.			Chronic Temporal Lobe Epilepsy Is Associated with Enhanced Alzheimer-Like Neuropathology in 36 x Tg-AD Mice	PLOS ONE			English	Article							INDUCED STATUS-EPILEPTICUS; AMYLOID PLAQUE PATHOGENESIS; MEDIAL ENTORHINAL CORTEX; MOUSE PILOCARPINE MODEL; BETA-SECRETASE; DENTATE GYRUS; IN-VIVO; BETA-SECRETASE-1 ELEVATION; AXON REORGANIZATION; PROTEIN EXPRESSION	The comorbidity between epilepsy and Alzheimer's disease (AD) is a topic of growing interest. Senile plaques and tauopathy are found in epileptic human temporal lobe structures, and individuals with AD have an increased incidence of spontaneous seizures. However, why and how epilepsy is associated with enhanced AD-like pathology remains unknown. We have recently shown beta-secretase-1 (BACE1) elevation associated with aberrant limbic axonal sprouting in epileptic CD1 mice. Here we sought to explore whether BACE1 upregulation affected the development of Alzheimer-type neuropathology in mice expressing mutant human APP, presenilin and tau proteins, the triple transgenic model of AD (36 x Tg-AD). 36 x Tg-AD mice were treated with pilocarpine or saline (i.p.) at 6-8 months of age. Immunoreactivity (IR) for BACE1, beta-amyloid (A beta) and phosphorylated tau (p-tau) was subsequently examined at 9, 11 or 14 months of age. Recurrent convulsive seizures, as well as mossy fiber sprouting and neuronal death in the hippocampus and limbic cortex, were observed in all epileptic mice. Neuritic plaques composed of BACE1-labeled swollen/sprouting axons and extracellular A beta IR were seen in the hippocampal formation, amygdala and piriform cortices of 9 month-old epileptic, but not control, 36 x Tg-AD mice. Densities of plaque-associated BACE1 and A beta IR were elevated in epileptic versus control mice at 11 and 14 months of age. p-Tau IR was increased in dentate granule cells and mossy fibers in epileptic mice relative to controls at all time points examined. Thus, pilocarpine-induced chronic epilepsy was associated with accelerated and enhanced neuritic plaque formation and altered intraneuronal p-tau expression in temporal lobe structures in 36 x Tg-AD mice, with these pathologies occurring in regions showing neuronal death and axonal dystrophy.	[Yan, Xiao-Xin; Cai, Yan; Deng, Si-Hao; Luo, Xue-Gang] Cent S Univ Xiangya Sch Med, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China		Yan, XX (corresponding author), Cent S Univ Xiangya Sch Med, Dept Anat & Neurobiol, Changsha, Hunan, Peoples R China.	yanxiaoxin@csu.edu.cn; grose@siumed.edu; ppatrylo@siu.edu	Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108; Oddo, Salvatore/0000-0001-7304-7430; Shelton, Jarod/0000-0002-8590-4986	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS056371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000959] Funding Source: NIH RePORTER; NINDS NIH HHS [1R21NS056371, R21 NS056371] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ackermann R F, 1986, Adv Neurol, V44, P921; Akman CI, 2010, EPILEPSY BEHAV, V17, P373, DOI 10.1016/j.yebeh.2009.12.007; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bero AW, 2011, NAT NEUROSCI, V14, P750, DOI 10.1038/nn.2801; Blizzard CA, 2011, CEREB CORTEX, V21, P281, DOI 10.1093/cercor/bhq091; Blumcke I, 1999, J COMP NEUROL, V414, P437, DOI 10.1002/(SICI)1096-9861(19991129)414:4<437::AID-CNE2>3.0.CO;2-3; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Buckmaster PS, 2002, J NEUROSCI, V22, P6650; Buda O, 2009, NEUROLOGY, V72, P88, DOI 10.1212/01.wnl.0000338626.93425.74; Bullmann T, 2009, INT J DEV NEUROSCI, V27, P591, DOI 10.1016/j.ijdevneu.2009.06.001; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Cai Y, 2012, NEUROSCIENCE, V215, P160, DOI 10.1016/j.neuroscience.2012.04.043; Cai Y, 2012, NEUROTOX RES, V21, P160, DOI 10.1007/s12640-011-9256-9; Cai Y, 2010, EUR J NEUROSCI, V32, P1223, DOI 10.1111/j.1460-9568.2010.07376.x; Cao LX, 2012, SCI REP-UK, V2, DOI 10.1038/srep00231; Castellani RJ, 2010, DM-DIS MON, V56, P484, DOI 10.1016/j.disamonth.2010.06.001; Cavazos JE, 2003, J COMP NEUROL, V458, P272, DOI 10.1002/cne.10581; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; COOK MJ, 1992, BRAIN, V115, P1001, DOI 10.1093/brain/115.4.1001; Covolan L, 2006, BRAZ J MED BIOL RES, V39, P915, DOI 10.1590/S0100-879X2006000700010; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Deller T, 2006, ADV EXP MED BIOL, V557, P101; DU F, 1995, J NEUROSCI, V15, P6301; DUONG T, 1994, ACTA NEUROPATHOL, V87, P493, DOI 10.1007/BF00294176; Duyckaerts C, 2009, ACTA NEUROPATHOL, V118, P5, DOI 10.1007/s00401-009-0532-1; ENGEL J, 1982, SCIENCE, V218, P64, DOI 10.1126/science.6981843; Fabene PF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001105; FAZEKAS F, 1989, J NUCL MED, V30, P1607; Fiala JC, 2007, ACTA NEUROPATHOL, V114, P551, DOI 10.1007/s00401-007-0284-8; HENRY TR, 1993, ARCH NEUROL-CHICAGO, V50, P582, DOI 10.1001/archneur.1993.00540060022011; Houser C R, 1999, Adv Neurol, V79, P743; KUHL DE, 1980, ANN NEUROL, V8, P348, DOI 10.1002/ana.410080403; Kumar SS, 2007, J NEUROSCI, V27, P1239, DOI 10.1523/JNEUROSCI.3182-06.2007; Laird FM, 2005, J NEUROSCI, V25, P11693, DOI 10.1523/JNEUROSCI.2766-05.2005; Larner AJ, 2010, NEUROMOL MED, V12, P71, DOI 10.1007/s12017-009-8076-z; Llorens-Martin M, 2012, J ALZHEIMERS DIS, V29, P921, DOI 10.3233/JAD-2012-112057; MACKENZIE IRA, 1994, ACTA NEUROPATHOL, V87, P504; MASLIAH E, 1993, MED HYPOTHESES, V41, P334, DOI 10.1016/0306-9877(93)90078-5; Mastrangelo MA, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-81; Miyazaki H, 2007, BIOCHEM BIOPH RES CO, V361, P43, DOI 10.1016/j.bbrc.2007.06.170; Nagaishi M, 2011, NEUROPATHOLOGY, V31, P468, DOI 10.1111/j.1440-1789.2010.01188.x; Noebels J, 2011, EPILEPSIA, V52, P39, DOI 10.1111/j.1528-1167.2010.02909.x; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; POLLARD H, 1994, NEUROSCIENCE, V61, P773, DOI 10.1016/0306-4522(94)90401-4; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Rao SC, 2009, EPILEPSY BEHAV, V14, P118, DOI 10.1016/j.yebeh.2008.08.012; Scarmeas N, 2009, ARCH NEUROL-CHICAGO, V66, P992, DOI 10.1001/archneurol.2009.130; Scharfman HE, 2003, J NEUROPHYSIOL, V90, P2536, DOI 10.1152/jn.00251.2003; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; SHENG JG, 1994, J NEUROCHEM, V63, P1872; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Stieler JT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014530; Stoothoff WH, 2005, BBA-MOL BASIS DIS, V1739, P280, DOI 10.1016/j.bbadis.2004.06.017; Struble RG, 2010, J ALZHEIMERS DIS, V22, P393, DOI 10.3233/JAD-2010-100846; Terry RD, 1970, ALZHEIMERS DISEASE R, P145; Tian FF, 2010, CLIN LAB, V56, P127; Wang L, 2008, BRAIN RES, V1241, P157, DOI 10.1016/j.brainres.2008.07.097; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wieloch T, 2006, CURR OPIN NEUROBIOL, V16, P258, DOI 10.1016/j.conb.2006.05.011; Winton MJ, 2011, J NEUROSCI, V31, P7691, DOI 10.1523/JNEUROSCI.6637-10.2011; Xiong K, 2007, EXP BRAIN RES, V181, P435, DOI 10.1007/s00221-007-0943-y; Yan XX, 2007, J COMP NEUROL, V501, P52, DOI 10.1002/cne.21239; Yan XX, 2012, EXP NEUROL, V235, P228, DOI 10.1016/j.expneurol.2012.01.003; Zhang S, 2009, J NEUROSCI RES, V87, P1135, DOI 10.1002/jnr.21941; Zhang XM, 2010, EUR J NEUROSCI, V31, P710, DOI 10.1111/j.1460-9568.2010.07103.x; Zhang XM, 2009, EUR J NEUROSCI, V30, P2271, DOI 10.1111/j.1460-9568.2009.07017.x; Ziyatdinova S, 2011, EPILEPSY RES, V94, P75, DOI 10.1016/j.eplepsyres.2011.01.003	71	40	40	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48782	10.1371/journal.pone.0048782	http://dx.doi.org/10.1371/journal.pone.0048782			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155407	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900041
J	Farhadi, M; Ismail, R; Fooladi, M				Farhadi, Maryam; Ismail, Rahmah; Fooladi, Masood			Information and Communication Technology Use and Economic Growth	PLOS ONE			English	Article							PRODUCTIVITY GROWTH; OUTPUT GROWTH; ICT; TELECOMMUNICATIONS; IMPACT; LEVEL; 1990S	In recent years, progress in information and communication technology (ICT) has caused many structural changes such as reorganizing of economics, globalization, and trade extension, which leads to capital flows and enhancing information availability. Moreover, ICT plays a significant role in development of each economic sector, especially during liberalization process. Growth economists predict that economic growth is driven by investments in ICT. However, empirical studies on this issue have produced mixed results, regarding to different research methodology and geographical configuration of the study. This paper examines the impact of Information and Communication Technology (ICT) use on economic growth using the Generalized Method of Moments (GMM) estimator within the framework of a dynamic panel data approach and applies it to 159 countries over the period 2000 to 2009. The results indicate that there is a positive relationship between growth rate of real GDP per capita and ICT use index (as measured by the number of internet users, fixed broadband internet subscribers and the number of mobile subscription per 100 inhabitants). We also find that the effect of ICT use on economic growth is higher in high income group rather than other groups. This implies that if these countries seek to enhance their economic growth, they need to implement specific policies that facilitate ICT use.	[Farhadi, Maryam; Fooladi, Masood] Islamic Azad Univ, Mobarakeh Branch, Dept Accounting, Esfahan, Iran; [Ismail, Rahmah] Univ Kebangsaan Malaysia, Fac Econ & Management, Sch Econ, Ukm Bangi, Selangor, Malaysia	Islamic Azad University; Universiti Kebangsaan Malaysia	Farhadi, M (corresponding author), Islamic Azad Univ, Mobarakeh Branch, Dept Accounting, Esfahan, Iran.	farhadim58@gmail.com	fooladi, masood/AAP-2526-2020; farhadi, maryam/G-1925-2011	farhadi, maryam/0000-0002-8663-9213				[Anonymous], DIFFUSION ADV TELECO; [Anonymous], 2011, WORLD DEV INDICATOR; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Baum CF, 2003, INSTRUMENTAL VARIABL, P545; Brynjolfsson E, 1996, COMPUTERS, P179; Chakraborty C., 2003, COMMUNICATIONS AND S, V52, P31; Colecchia A, 2002, REV ECON DYNAM, V5, P408, DOI 10.1006/redy.2002.0170; Colecchia A, 2001, IMPACT INFORM COMMUN; Daveri F, 2002, OXFORD REV ECON POL, V18, P345, DOI 10.1093/oxrep/18.3.345; Daveri F, 2000, 168 IGIER; Dedrick J, 2003, ACM COMPUT SURV, V35, P1, DOI 10.1145/641865.641866; Dewan S, 2000, MANAGE SCI, V46, P548, DOI 10.1287/mnsc.46.4.548.12057; Edquist H, 2005, INF ECON POLICY, V17, P275, DOI 10.1016/j.infoecopol.2004.06.004; Granville B, 2000, TOK CLUB M MUN GERM, P19; Gruber H., 2010, 52 EC POL PAN M EIN; Gujarati D. N., 2009, BASIC ECONOMETRICS; HANSEN LP, 1982, ECONOMETRICA, V50, P1029, DOI 10.2307/1912775; HOLTZEAKIN D, 1988, ECONOMETRICA, V56, P1371, DOI 10.2307/1913103; Hwan-Joo Seo, 2006, Information Technology for Development, V12, P159, DOI 10.1002/itdj.20021; Im KS, 2003, J ECONOMETRICS, V115, P53, DOI 10.1016/S0304-4076(03)00092-7; International Telecommunications Union, 2010, MEAS INF SOC ICT DEV; ITU, 2009, MEASURING INFORM SOC; Jacobsen K.F.L., 2003, R200313 CHR MICH I; Jalava J, 2002, INF ECON POLICY, V14, P189, DOI 10.1016/S0167-6245(01)00066-X; Jorgenson D., 2003, WORLD ECON, V4, P139; Jorgenson DW, 2007, GER ECON REV, V8, P125, DOI 10.1111/j.1468-0475.2007.00401.x; Jorgenson DW, 2005, J JPN INT ECON, V19, P460, DOI 10.1016/j.jjie.2005.05.001; Jorgenson DW, 2001, AM ECON REV, V91, P1, DOI 10.1257/aer.91.1.1; Jorgenson DW, 2000, BROOKINGS PAP ECO AC, P125; Kiley MT, 1999, 199936 FED RES BOARD; Kooshki M., 2011, P 2 INT C BUS EC RES, P1282; Koutroumpis P, 2009, TELECOMMUN POLICY, V33, P471, DOI 10.1016/j.telpol.2009.07.004; Kraemer KL, 2001, INFORM TECHNOLOGY PR, P257, DOI DOI 10.1093/ACPROF:OSO/9780199243983.003.0012; Lam PL, 2010, TELECOMMUN POLICY, V34, P185, DOI 10.1016/j.telpol.2009.12.001; Lee SYT, 2005, INFORM MANAGE-AMSTER, V42, P1009, DOI 10.1016/j.im.2004.11.005; Madden G., 1998, Information Economics and Policy, V10, P173, DOI 10.1016/S0167-6245(97)00020-6; Motohashi K, 1997, STI REV, V20, P13; NICKELL S, 1981, ECONOMETRICA, V49, P1417, DOI 10.2307/1911408; Noll RG, 2000, EC POLICY REFORM 2 S; O'Mahony M, 2005, ECONOMICA, V72, P615, DOI 10.1111/j.1468-0335.2005.0435.x; Oliner SD, 2000, J ECON PERSPECT, V14, P3, DOI 10.1257/jep.14.4.3; OLINER SD, 1994, BROOKINGS PAP ECO AC, P273; Oulton N, 2002, OXFORD REV ECON POL, V18, P363, DOI 10.1093/oxrep/18.3.363; PESARAN MH, 1995, J ECONOMETRICS, V68, P79, DOI 10.1016/0304-4076(94)01644-F; Pesaran MH, 1999, J AM STAT ASSOC, V94, P621, DOI 10.2307/2670182; Pilat D, 2002, OECD EC STUDIES, V35, P47; Pohjola M, 2002, INF ECON POLICY, V14, P133, DOI 10.1016/S0167-6245(01)00063-4; Roller LH, 2001, AM ECON REV, V91, P909, DOI 10.1257/aer.91.4.909; ROMER PM, 1990, J POLIT ECON, V98, pS71, DOI 10.1086/261725; Schreyer P, 2000, 20002 OECD; Seo HJ, 2009, TELECOMMUN POLICY, V33, P422, DOI 10.1016/j.telpol.2009.04.001; Shiu A, 2008, REG STUD, V42, P705, DOI 10.1080/00343400701543314; Sichel D.E., 1997, COMPUTER REVOLUTION; Stiroh K.J., 2005, ANN EC STAT, P529; Timmer M, 2003, GD67 GRON GROWTH DEV GD67 GRON GROWTH DEV; Timmer MP, 2005, OXFORD ECON PAP, V57, P693, DOI 10.1093/oep/gpi032; Waverman L., 2005, VODAFONE POLICY PAPE, V2, P10; Ypma, 2002, ICT INVESTMENT GROWT	58	79	79	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48903	10.1371/journal.pone.0048903	http://dx.doi.org/10.1371/journal.pone.0048903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039HA	23152817	gold, Green Published			2022-12-27	WOS:000311234000034
J	Wang, G; Gao, F; Zhang, WM; Chen, J; Wang, T; Zhang, GX; Shen, LZ				Wang, Gang; Gao, Fei; Zhang, Weiming; Chen, Jia; Wang, Tao; Zhang, Guoxin; Shen, Lizong			Involvement of Aquaporin 3 in Helicobacter pylori-Related Gastric Diseases	PLOS ONE			English	Article							FOLLOW-UP; INFECTION; CANCER; PREVALENCE; CARCINOMA; MIGRATION; PROLIFERATION; CELLS; RISK; SEROPOSITIVITY	Background: Gastric cancer is one of the most common and lethal malignant cancers worldwide, and numerous epidemiological studies have demonstrated that Helicobacter pylori (H. pylori) infection plays a key role in the development of gastric carcinomas. Our previous studies showed that aquaporin 3 (AQP3) is overexpressed in gastric carcinoma and promotes the migration and proliferation of human gastric carcinoma cells, suggesting that AQP3 may be a potentially important determinant of gastric carcinoma. However, the role of AQP3 in H. pylori carcinogenesis is unknown. Methods: The AQP3 protein and H. pylori were detected in human gastric tissues by immunohistochemistry and modified Giemsa staining respectively. AQP3 knockdown was obtained by small interfering (si) RNA. Western blot assays and RT-PCR were used to evaluate the change of AQP3 in the human gastric cancer AGS and SGC7901 cell lines after co-culture with H. pylori. Sprague Dawley rats were orally inoculated with H. pylori to establish a rat model colonized by H. pylori. Results: The present study found that AQP3 expression correlated with H. pylori infection status in gastric cancer tissues and corresponding normal mucosa, and H. pylori co-culture upregulated AQP3 expression in human gastric adenocarcinoma cells in vitro via the extracellular signal-regulated kinase signaling pathway. H. pylori infection also increased AQP3 expression in gastric mucosa colonized by H. pylori in a Sprague Dawley rat model. Conclusions: These findings provide further information to understand the mechanism of H. pylori carcinogenesis and a potential strategy for the treatment of H. pylori-associated gastric carcinoma. Citation: Wang G, Gao F, Zhang W, Chen J, Wang T, et al. (2012) Involvement of Aquaporin 3 in Helicobacter pylori-Related Gastric Diseases. PLoS ONE 7(11): e49104. doi:10.1371/journal.pone.0049104	[Wang, Gang; Gao, Fei; Chen, Jia; Wang, Tao; Shen, Lizong] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Div Gastrointestinal Surg, Nanjing, Jiangsu, Peoples R China; [Zhang, Weiming] Nanjing Med Univ, Affiliated Hosp 1, Dept Pathol, Nanjing, Jiangsu, Peoples R China; [Zhang, Guoxin] Nanjing Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Shen, LZ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Div Gastrointestinal Surg, Nanjing, Jiangsu, Peoples R China.	shenlz@163.com			Qing Lan Project, 7th "Six Talent-Person-Peak Program" of Jiangsu Province; Key Medical Talent Program of Jiangsu Province	Qing Lan Project, 7th "Six Talent-Person-Peak Program" of Jiangsu Province; Key Medical Talent Program of Jiangsu Province	This work was funded by the Qing Lan Project, 7th "Six Talent-Person-Peak Program" of Jiangsu Province, and Key Medical Talent Program of Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agre Peter, 2006, Proc Am Thorac Soc, V3, P5, DOI 10.1513/pats.200510-109JH; Asim M, 2010, J BIOL CHEM, V285, P20343, DOI 10.1074/jbc.M110.116988; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Chen J, 2007, HELICOBACTER, V12, P164, DOI 10.1111/j.1523-5378.2007.00487.x; de Paulis A, 2009, J IMMUNOL, V183, P3761, DOI 10.4049/jimmunol.0900863; Elitsur Y, 2002, HUM PATHOL, V33, P1133, DOI 10.1053/hupa.2002.129201; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Hatakeyama M, 2009, J GASTROENTEROL, V44, P239, DOI 10.1007/s00535-009-0014-1; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; Huang YM, 2010, CANCER BIOL THER, V9, P1000, DOI 10.4161/cbt.9.12.11705; Jang S, 2010, J CLIN MICROBIOL, V48, P559, DOI 10.1128/JCM.01501-09; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kamangar F, 2007, BRIT J CANCER, V96, P172, DOI 10.1038/sj.bjc.6603517; Kang SY, 2012, INT J CANCER, V130, P948, DOI 10.1002/ijc.26081; Kawakami Elisabete, 2008, Arq. Gastroenterol., V45, P147, DOI 10.1590/S0004-28032008000200011; Konturek PC, 2009, J PHYSIOL PHARMACOL, V60, P3; Li ZS, 2011, CANCER LETT, V313, P192, DOI 10.1016/j.canlet.2011.09.007; Limburg PJ, 2001, JNCI-J NATL CANCER I, V93, P226, DOI 10.1093/jnci/93.3.226; Lin CS, 2010, BIOCHEM BIOPH RES CO, V392, P183, DOI 10.1016/j.bbrc.2010.01.010; Lin YS, 2011, WORLD J GASTROENTERO, V17, P4421, DOI 10.3748/wjg.v17.i39.4421; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Machado AMD, 2010, BBA-REV CANCER, V1806, P58, DOI 10.1016/j.bbcan.2010.01.007; Magni F, 2006, PROTEOMICS, V6, P5637, DOI 10.1002/pmic.200600212; Parkin DM, 2006, INT J CANCER, V118, P3030, DOI 10.1002/ijc.21731; Shen LZ, 2010, BIOMED PHARMACOTHER, V64, P313, DOI 10.1016/j.biopha.2009.12.003; Shi RH, 2008, HELICOBACTER, V13, P157, DOI 10.1111/j.1523-5378.2008.00586.x; Shin CM., 2010, J CLIN GASTROENTEROL, V44, pe34, DOI [DOI 10.1097/MCG.0B013E3181A159C4, 10.1097/MCG.0b013e3181a159c4]; Suzuki H, 2004, WOUND REPAIR REGEN, V12, P93, DOI 10.1111/j.1067-1927.2004.012116.x; Tkachenko MA, 2007, J PEDIATR GASTR NUTR, V45, P428, DOI 10.1097/MPG.0b013e318064589f; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wang JP, 2012, CANCER LETT, V319, P109, DOI 10.1016/j.canlet.2011.12.040; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Wu IC, 2009, WORLD J GASTROENTERO, V15, P5465, DOI 10.3748/wjg.15.5465; Xu H, 2009, GASTROEN CLIN BIOL, V33, P72, DOI 10.1016/j.gcb.2008.07.010; Xu H, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-86; Xue FB, 2001, WORLD J GASTROENTERO, V7, P801, DOI 10.3748/wjg.v7.i6.801; Yang ZM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033030; You WC, 2006, JNCI-J NATL CANCER I, V98, P974, DOI 10.1093/jnci/djj264; Yuan JM, 1999, CANCER EPIDEM BIOMAR, V8, P621; Zhang DH, 2009, CHINESE MED J-PEKING, V122, P1759, DOI 10.3760/cma.j.issn.0366-6999.2009.15.008; Zhao DP, 2010, J MED MICROBIOL, V59, P259, DOI 10.1099/jmm.0.014704-0	41	46	48	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49104	10.1371/journal.pone.0049104	http://dx.doi.org/10.1371/journal.pone.0049104			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152856	Green Published, gold, Green Submitted			2022-12-27	WOS:000312272600044
J	You, YB; Bai, LJ; Dai, RW; Zhong, CG; Xue, T; Wang, H; Liu, ZY; Wei, WJ; Tian, J				You, Youbo; Bai, Lijun; Dai, Ruwei; Zhong, Chongguang; Xue, Ting; Wang, Hu; Liu, Zhenyu; Wei, Wenjuan; Tian, Jie			Acupuncture Induces Divergent Alterations of Functional Connectivity within Conventional Frequency Bands: Evidence from MEG Recordings	PLOS ONE			English	Article							FALSE DISCOVERY RATE; PARKINSONS-DISEASE; HUMAN BRAIN; PHASE SYNCHRONIZATION; STIMULATION; ELECTROACUPUNCTURE; MODULATION; CORTEX; FMRI; EEG	As an ancient Chinese healing modality which has gained increasing popularity in modern society, acupuncture involves stimulation with fine needles inserted into acupoints. Both traditional literature and clinical data indicated that modulation effects largely depend on specific designated acupoints. However, scientific representations of acupoint specificity remain controversial. In the present study, considering the new findings on the sustained effects of acupuncture and its time-varied temporal characteristics, we employed an electrophysiological imaging modality namely magnetoencephalography with a temporal resolution on the order of milliseconds. Taken into account the differential band-limited signal modulations induced by acupuncture, we sought to explore whether or not stimulation at Stomach Meridian 36 (ST36) and a nearby non-meridian point (NAP) would evoke divergent functional connectivity alterations within delta, theta, alpha, beta and gamma bands. Whole-head scanning was performed on 28 healthy participants during an eyes-closed no-task condition both preceding and following acupuncture. Data analysis involved calculation of band-limited power (BLP) followed by pair-wise BLP correlations. Further averaging was conducted to obtain local and remote connectivity. Statistical analyses revealed the increased connection degree of the left temporal cortex within delta (0.5-4 Hz), beta (13-30 Hz) and gamma (30-48 Hz) bands following verum acupuncture. Moreover, we not only validated the closer linkage of the left temporal cortex with the prefrontal and frontal cortices, but further pinpointed that such patterns were more extensively distributed in the ST36 group in the delta and beta bands compared to the restriction only to the delta band for NAP. Psychophysical results for significant pain threshold elevation further confirmed the analgesic effect of acupuncture at ST36. In conclusion, our findings may provide a new perspective to lend support for the specificity of neural expression underlying acupuncture.	[You, Youbo; Bai, Lijun; Dai, Ruwei; Zhong, Chongguang; Wang, Hu; Liu, Zhenyu; Wei, Wenjuan; Tian, Jie] Chinese Acad Sci, Intelligent Med Res Ctr, Inst Automat, Beijing, Peoples R China; [Xue, Ting; Tian, Jie] Xidian Univ, Sch Elect Engn, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China	Chinese Academy of Sciences; Institute of Automation, CAS; Xidian University	Tian, J (corresponding author), Chinese Acad Sci, Intelligent Med Res Ctr, Inst Automat, Beijing, Peoples R China.	tian@ieee.org	tian, jie/M-6336-2013; Tian, Jie/H-1190-2011; Bai, Lijun/C-5119-2015; Liu, Zhenyu/G-8444-2018	Tian, Jie/0000-0003-0498-0432; Bai, Lijun/0000-0001-8790-5424; Liu, Zhenyu/0000-0001-7559-8519	Knowledge Innovation Program of the Chinese Academy of Sciences [KGCX2-YW-129]; National Natural Science Foundation of China [30873462, 30970769, 30970771, 60910006, 81071217, 81171314]; Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao funder [31028010]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2010T2G36]; Fundamental Research Funds for the Central University, Beijing Nova program [Z111101054511116]; National Basic Research Program of China (973 Program) [2011CB707700]	Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao funder; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists; Fundamental Research Funds for the Central University, Beijing Nova program; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This paper is supported by the Knowledge Innovation Program of the Chinese Academy of Sciences under Grant No. KGCX2-YW-129, the National Natural Science Foundation of China under Grant Nos. 30873462, 30970769, 30970771, 60910006, 81071217, 81171314, the Joint Research Fund for Overseas Chinese Scholars and Scholars in Hong Kong and Macao funder Grant No. 31028010, the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists under Grant No. 2010T2G36, the Fundamental Research Funds for the Central University, Beijing Nova program under Grant No. Z111101054511116, and the National Basic Research Program of China (973 Program) under Grant No. 2011CB707700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LJ, 2009, HUM BRAIN MAPP, V30, P3445, DOI 10.1002/hbm.20769; Beijing S., 1980, NANJING COLL TRADITI; Benjamini Y, 2001, ANN STAT, V29, P1165; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benjamini Y, 2010, J R STAT SOC B, V72, P405, DOI 10.1111/j.1467-9868.2010.00746.x; Beyens F, 1993, ACUPUNCT MED, V11, P105; Bosboom JLW, 2009, J NEURAL TRANSM, V116, P193, DOI 10.1007/s00702-008-0132-6; Breakspear M, 2004, J COMPUT NEUROSCI, V16, P49, DOI 10.1023/B:JCNS.0000004841.66897.7d; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Chen L, 1998, ANESTH ANALG, V87, P1129, DOI 10.1097/00000539-199811000-00028; Cho ZH, 1998, P NATL ACAD SCI USA, V95, P2670, DOI 10.1073/pnas.95.5.2670; COHEN D, 1972, SCIENCE, V175, P664, DOI 10.1126/science.175.4022.664; Douw L, 2011, NEUROSCIENCE, V175, P169, DOI 10.1016/j.neuroscience.2010.11.039; Feng YY, 2011, MAGN RESON IMAGING, V29, P958, DOI 10.1016/j.mri.2011.04.009; Fermaglich J., 1982, J AMER MED ASSOC, V247, P1879, DOI DOI 10.1001/JAMA.1982.03320380071046; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Guevara R, 2005, NEUROINFORMATICS, V3, P301, DOI 10.1385/NI:3:4:301; Hadjipapas A, 2005, CLIN NEUROPHYSIOL, V116, P1300, DOI 10.1016/j.clinph.2005.01.014; Hampson M, 2002, HUM BRAIN MAPP, V15, P247, DOI 10.1002/hbm.10022; Han JS, 2011, PAIN, V152, pS41, DOI 10.1016/j.pain.2010.10.012; Hari R, 2000, TRENDS COGN SCI, V4, P455, DOI 10.1016/S1364-6613(00)01549-7; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Johnson MH, 2012, EUR J PAIN, V16, P767, DOI 10.1002/j.1532-2149.2011.00059.x; Kaptchuk TJ, 2002, ANN INTERN MED, V136, P374, DOI 10.7326/0003-4819-136-5-200203050-00010; Kiebel SJ, 2005, HUM BRAIN MAPP, V26, P170, DOI 10.1002/hbm.20153; Kim MS, 2008, AM J CHINESE MED, V36, P481, DOI 10.1142/S0192415X08005928; Kong J, 2007, J ALTERN COMPLEM MED, V13, P1059, DOI 10.1089/acm.2007.0524; Kong J, 2009, HUM BRAIN MAPP, V30, P38, DOI 10.1002/hbm.20481; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Leopold DA, 2003, CEREB CORTEX, V13, P422, DOI 10.1093/cercor/13.4.422; Li G, 2003, NEUROREPORT, V14, P669, DOI 10.1097/00001756-200304150-00002; Liu JX, 2011, J MAGN RESON IMAGING, V33, P33, DOI 10.1002/jmri.22393; Liu ZM, 2010, NEUROIMAGE, V51, P102, DOI 10.1016/j.neuroimage.2010.01.092; Mayor DF, 2007, ACUPUNCT MED, V25, P204; NAHIN RL, 2009, COSTS COMPLEMENTARY; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; OGAWA S, 1992, P NATL ACAD SCI USA, V89, P5951, DOI 10.1073/pnas.89.13.5951; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; RICHARDSON PH, 1986, PAIN, V24, P15, DOI 10.1016/0304-3959(86)90023-0; Stam CJ, 2006, NEUROIMAGE, V32, P1335, DOI 10.1016/j.neuroimage.2006.05.033; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2003, HUM BRAIN MAPP, V19, P63, DOI 10.1002/hbm.10106; Stoffers D, 2008, NEUROIMAGE, V41, P212, DOI 10.1016/j.neuroimage.2008.02.027; Stoffers D, 2007, BRAIN, V130, P1847, DOI 10.1093/brain/awm034; Stoffers D, 2008, EXP NEUROL, V213, P191, DOI 10.1016/j.expneurol.2008.05.021; Tass PA, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.088101; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; VOUDOURIS NJ, 1990, PAIN, V43, P121, DOI 10.1016/0304-3959(90)90057-K; VOUDOURIS NJ, 1989, PAIN, V38, P109, DOI 10.1016/0304-3959(89)90080-8; Wesolowski T, 2009, NEUROREPORT, V20, P116, DOI 10.1097/WNR.0b013e328321004d; Wheaton LA, 2005, CLIN NEUROPHYSIOL, V116, P1382, DOI 10.1016/j.clinph.2005.01.008; Witt CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032399; Witzel T, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-73; Yoo SS, 2004, NEUROIMAGE, V22, P932, DOI 10.1016/j.neuroimage.2004.02.017; You Y, 2011, ENG MED BIOL SOC EMB, DOI [10.1109/IEMBS.2011.6091794, DOI 10.1109/IEMBS.2011.6091794]; You YB, 2011, PROC SPIE, V7965, DOI 10.1117/12.877981; Zhang Hongwei, 2010, Chin Med, V5, P1, DOI 10.1186/1749-8546-5-1	61	8	8	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49250	10.1371/journal.pone.0049250	http://dx.doi.org/10.1371/journal.pone.0049250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152881	Green Submitted, Green Published			2022-12-27	WOS:000312272600054
J	Crevel, G; Vo, N; Crevel, I; Hamid, S; Hoa, L; Miyata, S; Cotterill, S				Crevel, Gilles; Vo, Nicole; Crevel, Isabelle; Hamid, Sana; Hoa, Lily; Miyata, Seiji; Cotterill, Sue			Drosophila RecQ4 Is Directly Involved in Both DNA Replication and the Response to UV Damage in S2 Cells	PLOS ONE			English	Article							ROTHMUND-THOMSON-SYNDROME; GENOTOXIC AGENTS; GENE-PRODUCT; PROTEINS; REPAIR; SENSITIVITY; INITIATION; LOCALIZES; REQUIRES; COMPLEX	The RecQ4 protein shows homology to both the S. cerevisiae DNA replication protein Sld2 and the DNA repair related RecQ helicases. Experimental data also suggest replication and repair functions for RecQ4, but the precise details of its involvement remain to be clarified. Here we show that depletion of DmRecQ4 by dsRNA interference in S2 cells causes defects consistent with a replication function for the protein. The cells show reduced proliferation associated with an S phase block, reduced BrdU incorporation, and an increase in cells with a subG1 DNA content. At the molecular level we observe reduced chromatin association of DNA polymerase-alpha and PCNA. We also observe increased chromatin association of phosphorylated H2AvD - consistent with the presence of DNA damage and increased apoptosis. Analysis of DmRecQ4 repair function suggests a direct role in NER, as the protein shows rapid but transient nuclear localisation after UV treatment. Re-localisation is not observed after etoposide or H2O2 treatment, indicating that the involvement of DmRecQ4 in repair is likely to be pathway specific. Deletion analysis of DmRecQ4 suggests that the SLD2 domain was essential, but not sufficient, for replication function. In addition a DmRecQ4 N-terminal deletion could efficiently re-localise on UV treatment, suggesting that the determinants for this response are contained in the C terminus of the protein. Finally several deletions show differential rescue of dsRNA generated replication and proliferation phenotypes. These will be useful for a molecular analysis of the specific role of DmRecQ4 in different cellular pathways.	[Crevel, Gilles; Vo, Nicole; Crevel, Isabelle; Hamid, Sana; Hoa, Lily; Miyata, Seiji; Cotterill, Sue] St Georges Univ London, Dept Basic Med Sci, London, England; [Miyata, Seiji] Kyoto Inst Technol, Dept Appl Biol, Kyoto 606, Japan	St Georges University London; Kyoto Institute of Technology	Cotterill, S (corresponding author), St Georges Univ London, Dept Basic Med Sci, Cranmer Terrace, London, England.	s.cotterill@sgul.ac.uk	Hamid, Sana/GQI-2602-2022		St. Georges University of London; C. H. Foundation; MRC [G0601107] Funding Source: UKRI; Medical Research Council [G0601107] Funding Source: researchfish	St. Georges University of London; C. H. Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This research was supported by internal St. Georges University of London consumable budgets for BSc (SH) and MRes students (NT and LH), and an MSc support grant from the C. H. Foundation (NT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, BBA-MOL CELL RES, V1813, P473, DOI 10.1016/j.bbamcr.2011.01.001; Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4; Cabral REC, 2008, MUTAT RES-FUND MOL M, V643, P41, DOI 10.1016/j.mrfmmm.2008.06.002; Crevel G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000833; Crevel I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027101; Daigaku Y, 2010, NATURE, V465, P951, DOI 10.1038/nature09097; Fan W, 2008, J BIOL CHEM, V283, P29037, DOI 10.1074/jbc.M801928200; Ichikawa Koji, 2002, Nihon Yakurigaku Zasshi, V119, P219; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jin WD, 2008, HUM GENET, V123, P643, DOI 10.1007/s00439-008-0518-4; Kohzaki M, 2012, CARCINOGENESIS, V33, P1203, DOI 10.1093/carcin/bgs149; Kumata Y, 2007, BBA-MOL CELL RES, V1773, P556, DOI 10.1016/j.bbamcr.2007.01.005; Larizza L, 2006, CANCER LETT, V232, P107, DOI 10.1016/j.canlet.2005.07.042; Maiato Helder, 2003, Biological Procedures Online, V5, P153, DOI 10.1251/bpo57; Mann MB, 2005, HUM MOL GENET, V14, P813, DOI 10.1093/hmg/ddi075; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; MELOV S, 1992, J CELL SCI, V102, P847; Park SJ, 2006, DNA CELL BIOL, V25, P696, DOI 10.1089/dna.2006.25.696; Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Schurman SH, 2009, HUM MOL GENET, V18, P3470, DOI 10.1093/hmg/ddp291; Werner SR, 2006, BIOCHEM BIOPH RES CO, V345, P403, DOI 10.1016/j.bbrc.2006.04.093; Woo LL, 2006, EXP CELL RES, V312, P3443, DOI 10.1016/j.yexcr.2006.07.023; Wu JH, 2008, DEV BIOL, V323, P130, DOI 10.1016/j.ydbio.2008.08.006; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Xu YJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006107	26	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49505	10.1371/journal.pone.0049505	http://dx.doi.org/10.1371/journal.pone.0049505			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166690	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000311885300050
J	Ross, BE; Hooten, MB; Koons, DN				Ross, Beth E.; Hooten, Mevin B.; Koons, David N.			An Accessible Method for Implementing Hierarchical Models with Spatio-Temporal Abundance Data	PLOS ONE			English	Article							SPRING CONDITION HYPOTHESIS; SCAUP AYTHYA-AFFINIS; LESSER SCAUP; DENSITY-DEPENDENCE; POPULATION-DYNAMICS; OBSERVATION ERROR; PROCESS NOISE; YUKON FLATS; SURVIVAL; ECOLOGY	A common goal in ecology and wildlife management is to determine the causes of variation in population dynamics over long periods of time and across large spatial scales. Many assumptions must nevertheless be overcome to make appropriate inference about spatio-temporal variation in population dynamics, such as autocorrelation among data points, excess zeros, and observation error in count data. To address these issues, many scientists and statisticians have recommended the use of Bayesian hierarchical models. Unfortunately, hierarchical statistical models remain somewhat difficult to use because of the necessary quantitative background needed to implement them, or because of the computational demands of using Markov Chain Monte Carlo algorithms to estimate parameters. Fortunately, new tools have recently been developed that make it more feasible for wildlife biologists to fit sophisticated hierarchical Bayesian models (i.e., Integrated Nested Laplace Approximation, 'INLA'). We present a case study using two important game species in North America, the lesser and greater scaup, to demonstrate how INLA can be used to estimate the parameters in a hierarchical model that decouples observation error from process variation, and accounts for unknown sources of excess zeros as well as spatial and temporal dependence in the data. Ultimately, our goal was to make unbiased inference about spatial variation in population trends over time.	[Ross, Beth E.; Koons, David N.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Hooten, Mevin B.] US Geol Survey, Colorado Cooperat Fish & Wildlife Res Unit, Ft Collins, CO USA; [Hooten, Mevin B.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Hooten, Mevin B.] Colorado State Univ, Dept Stat, Ft Collins, CO 80523 USA; [Koons, David N.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University; United States Department of the Interior; United States Geological Survey; Colorado State University; Colorado State University; Utah System of Higher Education; Utah State University	Ross, BE (corresponding author), Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA.	beth.ross@aggiemail.usu.edu			Delta Waterfowl; Ecology Center and Wildland Resources Department at Utah State University	Delta Waterfowl; Ecology Center and Wildland Resources Department at Utah State University	Delta Waterfowl (www.deltawaterfowl.org) and the Ecology Center and Wildland Resources Department at Utah State University provided funding for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afton AD, 2001, J WILDLIFE MANAGE, V65, P781, DOI 10.2307/3803028; Afton Alan D., 1993, Prairie Naturalist, V25, P227; Anteau MJ, 2008, WATERBIRDS, V31, P97, DOI 10.1675/1524-4695(2008)31[97:DOLSDS]2.0.CO;2; Anteau MJ, 2006, CAN J ZOOL, V84, P779, DOI 10.1139/Z06-047; Anteau MJ, 2004, AUK, V121, P917, DOI 10.1642/0004-8038(2004)121[0917:NROLSA]2.0.CO;2; Austin JE, 1998, BIRDS N AM; Austin JE, 2006, CONS REP 2 SCAUP WOR; Banerjee S., 2004, HIERARCHICAL MODELIN; Berliner LM, 1996, FUND THEOR, V79, P15; BESAG J, 1974, J ROY STAT SOC B MET, V36, P192; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Boomer G. S., 2007, PROPOSED ASSESSMENT; Brady CM, 2009, THESIS U W ONTARIO; BROOK D, 1964, BIOMETRIKA, V51, P481; Calder C, 2003, ECOLOGY, V84, P1395, DOI 10.1890/0012-9658(2003)084[1395:IMSOSI]2.0.CO;2; Clark JS, 2004, ECOLOGY, V85, P3140, DOI 10.1890/03-0520; Colchero F, 2009, J ANIM ECOL, V78, P666, DOI 10.1111/j.1365-2656.2009.01528.x; Corcoran RM, 2007, J WILDLIFE MANAGE, V71, P127, DOI 10.2193/2005-534; Cressie N., 2011, STAT SPATIO TEMPORAL; Cressie N. A. C., 2011, STAT SPATIO TEMPORAL; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Davies B., 2002, INTEGRAL TRANSFORMS; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; DeVink JM, 2008, AUK, V125, P291, DOI 10.1525/auk.2008.06171; Drever MC, 2012, GLOBAL CHANGE BIOL, V18, P480, DOI 10.1111/j.1365-2486.2011.02541.x; du Toit JT, 2010, ANIM CONSERV, V13, P229, DOI 10.1111/j.1469-1795.2010.00355.x; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; Folk TH, 2007, POPUL ECOL, V49, P211, DOI 10.1007/s10144-007-0037-5; Fox GA, 2005, CONDOR, V107, P50, DOI 10.1650/7626; Gardner B, 2007, MODELING SPATI UNPUB; HEINZ GH, 1989, J WILDLIFE MANAGE, V53, P418, DOI 10.2307/3801145; Hobson KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007915; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hooten M.B., 2012, DESIGN ANAL LONG TER, P443; Humbert JY, 2009, OIKOS, V118, P1940, DOI 10.1111/j.1600-0706.2009.17839.x; JOHNSON DH, 1988, WILDLIFE MONOGRAPHS, V100; Jonzen N, 2006, SCIENCE, V312, P1959, DOI 10.1126/science.1126119; Knape J, 2012, ECOL LETT, V15, P17, DOI 10.1111/j.1461-0248.2011.01702.x; Koons DN, 2006, AVIAN CONSERV ECOL, V1; KRAMER W, 1987, J AM STAT ASSOC, V82, P577, DOI 10.2307/2289467; Marsh DM, 2008, CONSERV BIOL, V22, P647, DOI 10.1111/j.1523-1739.2008.00927.x; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; MATZ AC, 2007, CONDOR, V109, P852; O'Hara RB, 2010, METHODS ECOL EVOL, V1, P118, DOI 10.1111/j.2041-210X.2010.00021.x; Ponciano JM, 2009, ECOLOGY, V90, P356, DOI 10.1890/08-0967.1; R Development Core Team, 2012, R LANG ENV STAT COMP; Ricklefs R.E., 2008, EC NATURE; Royle J. A., 2008, HIERARCHICAL MODELIN; Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x; SMITH GW, 1995, 5 US DEP INT NAT BIO; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Stephens SE, 2005, ECOL APPL, V15, P2137, DOI 10.1890/04-1162; Thogmartin WE, 2004, ECOL APPL, V14, P1766, DOI 10.1890/03-5247; Viljugrein H, 2005, ECOLOGY, V86, P245, DOI 10.1890/04-0467; Walker J, 2005, J WILDLIFE MANAGE, V69, P592, DOI 10.2193/0022-541X(2005)069[0592:SOSDIT]2.0.CO;2; Wilson TL, 2010, J APPL ECOL, V47, P401, DOI 10.1111/j.1365-2664.2009.01766.x; Zimpfer NL, 2012, TECHNICAL REPORT	58	26	26	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49395	10.1371/journal.pone.0049395	http://dx.doi.org/10.1371/journal.pone.0049395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166658	gold, Green Published			2022-12-27	WOS:000311885300035
J	Sauvanet, C; Duvezin-Caubet, S; Salin, B; David, C; Massoni-Laporte, A; di Rago, JP; Rojo, M				Sauvanet, Cecile; Duvezin-Caubet, Stephane; Salin, Benedicte; David, Claudine; Massoni-Laporte, Aurelie; di Rago, Jean-Paul; Rojo, Manuel			Mitochondrial DNA Mutations Provoke Dominant Inhibition of Mitochondrial Inner Membrane Fusion	PLOS ONE			English	Article							DYNAMIN-RELATED GTPASE; SACCHAROMYCES-CEREVISIAE; ATP SYNTHASE; MORPHOLOGY; GENE; CELLS; OPA1; MAINTENANCE; PROTEINS; REQUIRES	Mitochondria are highly dynamic organelles that continuously move, fuse and divide. Mitochondrial dynamics modulate overall mitochondrial morphology and are essential for the proper function, maintenance and transmission of mitochondria and mitochondrial DNA (mtDNA). We have investigated mitochondrial fusion in yeast cells with severe defects in oxidative phosphorylation (OXPHOS) due to removal or various specific mutations of mtDNA. We find that, under fermentative conditions, OXPHOS deficient cells maintain normal levels of cellular ATP and ADP but display a reduced mitochondrial inner membrane potential. We demonstrate that, despite metabolic compensation by glycolysis, OXPHOS defects are associated to a selective inhibition of inner but not outer membrane fusion. Fusion inhibition was dominant and hampered the fusion of mutant mitochondria with wild-type mitochondria. Inhibition of inner membrane fusion was not systematically associated to changes of mitochondrial distribution and morphology, nor to changes in the isoform pattern of Mgm1, the major fusion factor of the inner membrane. However, inhibition of inner membrane fusion correlated with specific alterations of mitochondrial ultrastructure, notably with the presence of aligned and unfused inner membranes that are connected to two mitochondrial boundaries. The fusion inhibition observed upon deletion of OXPHOS related genes or upon removal of the entire mtDNA was similar to that observed upon introduction of point mutations in the mitochondrial ATP6 gene that are associated to neurogenic ataxia and retinitis pigmentosa (NARP) or to maternally inherited Leigh Syndrome (MILS) in humans. Our findings indicate that the consequences of mtDNA mutations may not be limited to OXPHOS defects but may also include alterations in mitochondrial fusion. Our results further imply that, in healthy cells, the dominant inhibition of fusion could mediate the exclusion of OXPHOS-deficient mitochondria from the network of functional, fusogenic mitochondria.	[Sauvanet, Cecile; Duvezin-Caubet, Stephane; Salin, Benedicte; David, Claudine; Massoni-Laporte, Aurelie; di Rago, Jean-Paul; Rojo, Manuel] CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, Bordeaux, France; [Sauvanet, Cecile; Duvezin-Caubet, Stephane; Salin, Benedicte; David, Claudine; Massoni-Laporte, Aurelie; di Rago, Jean-Paul; Rojo, Manuel] Univ Bordeaux Segalen, Inst Biochim & Genet Cellulaires, UMR 5095, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Rojo, M (corresponding author), CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, Bordeaux, France.	manuel.rojo@ibgc.cnrs.fr	Rojo, Manuel/AAM-7352-2021	Rojo, Manuel/0000-0002-9680-9263; Duvezin-Caubet, Stephane/0000-0002-0243-2697	Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux Segalen; Conseil Regional d'Aquitaine (CRA); Association Francaise contre les Myopathies (AFM); Fondation pour la Recherche Medicale (FRM)	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Bordeaux Segalen; Conseil Regional d'Aquitaine (CRA)(Region Nouvelle-Aquitaine); Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by Centre National de la Recherche Scientifique (CNRS), Universite Bordeaux Segalen, Conseil Regional d'Aquitaine (CRA), Association Francaise contre les Myopathies (AFM) and Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEAUVOIT B, 1993, EUR J BIOCHEM, V214, P163, DOI 10.1111/j.1432-1033.1993.tb17909.x; Bonnefoy N, 2000, MOL GEN GENET, V262, P1036, DOI 10.1007/PL00008646; BOWMAN S, 1991, J BIOL CHEM, V266, P7517; Celotto AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025823; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Dimmer KS, 2002, MOL BIOL CELL, V13, P847, DOI 10.1091/mbc.01-12-0588; Duvezin-Caubet S, 2006, J BIOL CHEM, V281, P37972, DOI 10.1074/jbc.M606059200; Gajewski CD, 2003, MOL BIOL CELL, V14, P3628, DOI 10.1091/mbc.E02-12-0796; Guillery O, 2008, BIOL CELL, V100, P315, DOI 10.1042/BC20070110; Herlan M, 2004, J CELL BIOL, V165, P167, DOI 10.1083/jcb.200403022; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Hyde BB, 2010, SEMIN CELL DEV BIOL, V21, P575, DOI 10.1016/j.semcdb.2010.01.003; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Kucharczyk R, 2009, HUM MOL GENET, V18, P2889, DOI 10.1093/hmg/ddp226; Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200; Legros F, 2002, MOL BIOL CELL, V13, P4343, DOI 10.1091/mbc.E02-06-0330; Liu XG, 2009, EMBO J, V28, P3074, DOI 10.1038/emboj.2009.255; Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335; Malka F, 2005, EMBO REP, V6, P853, DOI 10.1038/sj.embor.7400488; Meeusen S, 2004, SCIENCE, V305, P1747, DOI 10.1126/science.1100612; Meeusen S, 2006, CELL, V127, P383, DOI 10.1016/j.cell.2006.09.021; Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613; Pallotti F, 2004, BIOCHEM J, V384, P287, DOI 10.1042/BJ20040561; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Priault M, 2002, EUR J BIOCHEM, V269, P5440, DOI 10.1046/j.1432-1033.2002.03234.x; Rak M, 2007, MODELISATION CHEZ LE; Rak M, 2007, J BIOL CHEM, V282, P34039, DOI 10.1074/jbc.M703053200; Rak M, 2007, J BIOL CHEM, V282, P10853, DOI 10.1074/jbc.M608692200; Rinaldi T, 2008, MOL BIOL CELL, V19, P1022, DOI 10.1091/mbc.E07-07-0717; Sauvanet C, 2010, SEMIN CELL DEV BIOL, V21, P558, DOI 10.1016/j.semcdb.2009.12.006; Sesaki H, 2003, MOL BIOL CELL, V14, P2342, DOI 10.1091/mbc.E02-12-0788; Soto IC, 2009, BBA-MOL CELL RES, V1793, P1776, DOI 10.1016/j.bbamcr.2009.09.002; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Westermann B, 2000, YEAST, V16, P1421, DOI 10.1002/1097-0061(200011)16:15<1421::AID-YEA624>3.3.CO;2-L; Westermann B., 2012, BIOCH BIOPHYS ACTA, DOI 10.1016/j.bbabio.2012.02.033; Zick M, 2009, FEBS LETT, V583, P2237, DOI 10.1016/j.febslet.2009.05.053	38	14	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49639	10.1371/journal.pone.0049639	http://dx.doi.org/10.1371/journal.pone.0049639			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166736	Green Published, gold, Green Submitted			2022-12-27	WOS:000311885300057
J	Hukezalie, KR; Thumati, NR; Cote, HCF; Wong, JMY				Hukezalie, Kyle R.; Thumati, Naresh R.; Cote, Helene C. F.; Wong, Judy M. Y.			In Vitro and Ex Vivo Inhibition of Human Telomerase by Anti-HIV Nucleoside Reverse Transcriptase Inhibitors (NRTIs) but Not by Non-NRTIs	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; ANALOG INHIBITORS; CELLS; GENOTOXICITY; ACTIVATION; ZIDOVUDINE; INFECTION; MECHANISM; APOPTOSIS; ROLES	Telomerase is a specialized reverse transcriptase responsible for the de novo synthesis of telomeric DNA repeats. In addition to its established reverse transcriptase and terminal transferase activities, recent reports have revealed unexpected cellular activities of telomerase, including RNA-dependent RNA polymerization. This telomerase characteristic, distinct from other reverse transcriptases, indicates that clinically relevant reverse transcriptase inhibitors might have unexpected telomerase inhibition profiles. This is particularly important for the newer generation of RT inhibitors designed for anti-HIV therapy, which have reported higher safety margins than older agents. Using an in vitro primer extension assay, we tested the effects of clinically relevant HIV reverse transcriptase inhibitors on cellular telomerase activity. We observed that all commonly used nucleoside reverse transcriptase inhibitors (NRTIs), including zidovudine, stavudine, tenofovir, didanosine and abacavir, inhibit telomerase effectively in vitro. Truncated telomere synthesis was consistent with the expected mode of inhibition by all tested NRTIs. Through dose-response experiments, we established relative inhibitory potencies of NRTIs on in vitro telomerase activity as compared to the inhibitory potencies of the corresponding dideoxynucleotide triphosphates. In contrast to NRTIs, the non-nucleoside reverse transcriptase inhibitors (NNRTIs) nevirapine and efavirenz did not inhibit the primer extension activity of telomerase, even at millimolar concentrations. Long-term, continuous treatment of human HT29 cells with select NRTIs resulted in an accelerated loss of telomere repeats. All tested NRTIs exhibited the same rank order of inhibitory potencies on telomerase and HIV RT, which, according to published data, were orders-of-magnitude more sensitive than other DNA polymerases, including the susceptible mitochondria-specific DNA polymerase gamma. We concluded that telomerase activity could be inhibited by common NRTIs, including currently recommended RTI agents tenofovir and abacavir, which warrants large-scale clinical and epidemiological investigation of the off-target effects of long-term highly active antiretroviral therapy (HAART) with these agents.	[Hukezalie, Kyle R.; Cote, Helene C. F.; Wong, Judy M. Y.] Univ British Columbia, Grad Program Genet, Vancouver, BC V5Z 1M9, Canada; [Hukezalie, Kyle R.; Thumati, Naresh R.; Wong, Judy M. Y.] Univ British Columbia, Fac Pharmaceut Sci, Vancouver, BC V5Z 1M9, Canada; [Cote, Helene C. F.] Univ British Columbia, Dept Pathol & Lab Med HCFC, Vancouver, BC V5Z 1M9, Canada	University of British Columbia; University of British Columbia; University of British Columbia	Wong, JMY (corresponding author), Univ British Columbia, Grad Program Genet, Vancouver, BC V5Z 1M9, Canada.	judy.wong@ubc.ca	Wong, Judy/AAG-1868-2021; Cote, Helene/K-7896-2012	Wong, Judy/0000-0001-5572-4143; 	Emerging team grant in HIV therapy and aging (CARMA) from the Canadian Institutes of Health Research [FRN85515]; Michael Smith Foundation for Health Research career development program	Emerging team grant in HIV therapy and aging (CARMA) from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research career development program	Financial support to NRT for this work and for KRH was provided by an Emerging team grant in HIV therapy and aging (CARMA) from the Canadian Institutes of Health Research [GRANT # FRN85515]. HCFC is a CIHR new investigator. JMYW is supported by the Michael Smith Foundation for Health Research career development program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey CM, 2009, ANTIMICROB AGENTS CH, V53, P2610, DOI 10.1128/AAC.01659-08; Belfort M, 2011, P NATL ACAD SCI USA, V108, P20304, DOI 10.1073/pnas.1100269109; Blackburn EH, 2011, COLD SPRING HARB PER, V3; Brown JA, 2011, ANTIMICROB AGENTS CH, V55, P276, DOI 10.1128/AAC.01229-10; Brown T, 2003, ANN SURG ONCOL, V10, P910, DOI 10.1245/ASO.2003.03.032; Capeau J, 2011, CLIN INFECT DIS, V53, P1127, DOI 10.1093/cid/cir628; Chen LY, 2012, NATURE, V488, P540, DOI 10.1038/nature11269; Cihlar T, 2002, ANTIVIR RES, V54, P37, DOI 10.1016/S0166-3542(01)00210-8; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Eckert B, 2012, J BIOL CHEM, V287, P12805, DOI 10.1074/jbc.M112.339853; Effros RB, 2008, CLIN INFECT DIS, V47, P542, DOI 10.1086/590150; Fang JL, 2009, TOXICOL SCI, V111, P120, DOI 10.1093/toxsci/kfp136; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Gomez DE, 1998, BIOCHEM BIOPH RES CO, V246, P107, DOI 10.1006/bbrc.1998.8555; Gordon DM, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/390791; Haendeler J, 2009, ARTERIOSCL THROM VAS, V29, P929, DOI 10.1161/ATVBAHA.109.185546; Ji HJ, 2005, BREAST CANCER RES TR, V93, P227, DOI 10.1007/s10549-005-5156-0; Kewn S, 1999, AIDS RES HUM RETROV, V15, P793, DOI 10.1089/088922299310692; Kopera HC, 2011, P NATL ACAD SCI USA, V108, P20345, DOI 10.1073/pnas.1100275108; Kovalenko OA, 2010, AGING CELL, V9, P203, DOI 10.1111/j.1474-9726.2010.00551.x; Liu XH, 2007, NUCLEIC ACIDS RES, V35, P7140, DOI 10.1093/nar/gkm859; Lue NF, 2005, P NATL ACAD SCI USA, V102, P9778, DOI 10.1073/pnas.0502252102; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Majerska J, 2011, MOL BIOSYST, V7, P1013, DOI 10.1039/c0mb00268b; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; Meng QX, 2000, P NATL ACAD SCI USA, V97, P12667, DOI 10.1073/pnas.220203197; Mondello C, 2004, BIOCHEM CELL BIOL, V82, P498, DOI 10.1139/O04-048; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Olivero OA, 1997, J NATL CANCER I, V89, P1602, DOI 10.1093/jnci/89.21.1602; Olivero OA, 2008, TOXICOL APPL PHARM, V228, P158, DOI 10.1016/j.taap.2007.12.005; Olivero OA, 2007, ENVIRON MOL MUTAGEN, V48, P215, DOI 10.1002/em.20195; Painter GR, 2004, CURR TOP MED CHEM, V4, P1035, DOI 10.2174/1568026043388358; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Prescott JC, 2000, MOL CELL BIOL, V20, P2941, DOI 10.1128/MCB.20.8.2941-2948.2000; Ray Adrian S., 2007, Antiviral Chemistry & Chemotherapy, V18, P25; Ray AS, 2002, BIOCHEMISTRY-US, V41, P5150, DOI 10.1021/bi0121858; Rosenbluh J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026270; Rossi A, 2009, INT J CANCER, V125, P235, DOI 10.1002/ijc.24331; Saretzki G, 2009, EXP GERONTOL, V44, P485, DOI 10.1016/j.exger.2009.05.004; Sluis-Cremer N, 2004, CURR HIV RES, V2, P323, DOI 10.2174/1570162043351093; Strahl C, 1996, MOL CELL BIOL, V16, P53; Tamakawa RA, 2010, CANCER RES, V70, P8684, DOI 10.1158/0008-5472.CAN-10-2227; Tendian SW, 2000, MOL PHARMACOL, V57, P695, DOI 10.1124/mol.57.4.695; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004; VINCE R, 1988, BIOCHEM BIOPH RES CO, V156, P1046, DOI 10.1016/S0006-291X(88)80950-1; Wood E, 2012, CURR OPIN HIV AIDS, V7, P151, DOI 10.1097/COH.0b013e32834f9927; Yang GW, 2008, ANTIMICROB AGENTS CH, V52, P2035, DOI 10.1128/AAC.00083-08; Zeng XL, 2012, HUM MOL GENET, V21, P721, DOI 10.1093/hmg/ddr504	48	57	61	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e47505	10.1371/journal.pone.0047505	http://dx.doi.org/10.1371/journal.pone.0047505			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166583	gold, Green Published, Green Submitted			2022-12-27	WOS:000311272300003
J	Pouyanfard, S; Bamdad, T; Hashemi, H; Bandehpour, M; Kazemi, B				Pouyanfard, Somayeh; Bamdad, Taravat; Hashemi, Hamidreza; Bandehpour, Mojgan; Kazemi, Bahram			Induction of Protective Anti-CTL Epitope Responses against HER-2-Positive Breast Cancer Based on Multivalent T7 Phage Nanoparticles	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; FILAMENTOUS BACTERIOPHAGE-FD; MONOCLONAL-ANTIBODIES; DELIVERY-SYSTEMS; TUMOR-GROWTH; VACCINES; VACCINATION; PEPTIDE; PROTEIN; SUPPRESSION	We report here the development of multivalent T7 bacteriophage nanoparticles displaying an immunodominant H-2k(d)-restricted CTL epitope derived from the rat HER2/neu oncoprotein. The immunotherapeutic potential of the chimeric T7 nanoparticles as anti-cancer vaccine was investigated in BALB/c mice in an implantable breast tumor model. The results showed that T7 phage nanoparticles confer a high immunogenicity to the HER-2-derived minimal CTL epitope, as shown by inducing robust CTL responses. Furthermore, the chimeric nanoparticles protected mice against HER-2-positive tumor challenge in both prophylactic and therapeutic setting. In conclusion, these results suggest that CTL epitope-carrying T7 phage nanoparticles might be a promising approach for development of T cell epitope-based cancer vaccines.	[Pouyanfard, Somayeh; Bamdad, Taravat] Tarbiat Modares Univ, Fac Med Sci, Dept Virol, Tehran, Iran; [Hashemi, Hamidreza] Univ Tehran Med Sci, Sch Publ Hlth, Dept Med Virol, Tehran, Iran; [Bandehpour, Mojgan; Kazemi, Bahram] Shahid Beheshti Univ Med Sci, Sch Med, Dept Biotechnol, Tehran, Iran; [Bandehpour, Mojgan; Kazemi, Bahram] Shahid Beheshti Univ Med Sci, Sch Med, CMRC, Tehran, Iran	Tarbiat Modares University; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences	Bamdad, T (corresponding author), Tarbiat Modares Univ, Fac Med Sci, Dept Virol, Tehran, Iran.	Bamdad_T@modares.ac.ir; kazemi@sbmu.ac.ir	Kazemi, Bahram/GRR-9838-2022; Kazemi, Bahram/F-2785-2016; bandehpour, mojgan/O-9744-2019	Kazemi, Bahram/0000-0002-3072-8831; bandehpour, mojgan/0000-0002-5479-2846; bamdad, Taravat/0000-0003-3620-0701	Tarbiat Modares University; Shahid Beheshti University of Medical Sciences	Tarbiat Modares University; Shahid Beheshti University of Medical Sciences	This study was part of a PhD thesis supported by Tarbiat Modares University and Shahid Beheshti University of Medical Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Aly HA, 2012, J IMMUNOL METHODS; Andreasson K, 2009, INT J CANCER, V124, P150, DOI 10.1002/ijc.23920; Bergmann CC, 1996, J IMMUNOL, V157, P3242; Billiau A, 2001, J LEUKOCYTE BIOL, V70, P849; Bramwell VW, 2005, CRIT REV THER DRUG, V22, P151, DOI 10.1615/CritRevTherDrugCarrierSyst.v22.i2.20; De Berardinis P, 2000, NAT BIOTECHNOL, V18, P873, DOI 10.1038/78490; De Temmerman ML, 2011, DRUG DISCOV TODAY, V16, P569, DOI 10.1016/j.drudis.2011.04.006; DELVAL M, 1991, CELL, V66, P1145, DOI 10.1016/0092-8674(91)90037-Y; Disis ML, 1996, J IMMUNOL, V156, P3151; Fang JB, 2005, VACCINE, V23, P4860, DOI 10.1016/j.vaccine.2005.05.024; Franke ED, 1997, J IMMUNOL, V159, P3424; GORCZYNSKI RM, 1982, DEV COMP IMMUNOL, V6, P199, DOI 10.1016/S0145-305X(82)80003-7; Herrmann S, 2007, J VIROL METHODS, V141, P133, DOI 10.1016/j.jviromet.2006.11.041; Hubbell JA, 2009, NATURE, V462, P449, DOI 10.1038/nature08604; HURWITZ E, 1995, P NATL ACAD SCI USA, V92, P3353, DOI 10.1073/pnas.92.8.3353; Jalali SA, 2012, NANOMED-NANOTECHNOL, V8, P692, DOI 10.1016/j.nano.2011.09.010; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; KOVACSOVICSBANKOWSKI M, 1993, P NATL ACAD SCI USA, V90, P4942, DOI 10.1073/pnas.90.11.4942; Launois P, 1999, MICROBES INFECT, V1, P59, DOI 10.1016/S1286-4579(99)80015-X; Layton GT, 1996, IMMUNOLOGY, V87, P171, DOI 10.1046/j.1365-2567.1996.464539.x; Nava-Parada P, 2007, CANCER RES, V67, P1326, DOI 10.1158/0008-5472.CAN-06-3290; O'Hagan DT, 2004, DRUG DISCOV TODAY, V9, P846, DOI 10.1016/S1359-6446(04)03234-9; Plummer EM, 2010, WILEY INTERDISCIP RE; Prisco A, 2012, INT J MOL SCI, V13, P5179, DOI 10.3390/ijms13045179; Ren SX, 2011, VACCINE, V29, P5802, DOI 10.1016/j.vaccine.2011.03.051; Rosenberg A, 1996, NBER REPORTER    WIN, P1; Rovero S, 2000, J IMMUNOL, V165, P5133, DOI 10.4049/jimmunol.165.9.5133; Rueda P, 2004, J GEN VIROL, V85, P563, DOI 10.1099/vir.0.19525-0; Sartorius R, 2008, J IMMUNOL, V180, P3719, DOI 10.4049/jimmunol.180.6.3719; SCHUTZE MP, 1985, J IMMUNOL, V135, P2319; Shadidi M, 2008, INT J ONCOL, V32, P241; Shibaki A, 2002, EXP DERMATOL, V11, P126, DOI 10.1034/j.1600-0625.2002.110204.x; STANCOVSKI I, 1991, P NATL ACAD SCI USA, V88, P8691, DOI 10.1073/pnas.88.19.8691; Storni T, 2005, ADV DRUG DELIVER REV, V57, P333, DOI 10.1016/j.addr.2004.09.008; Tan GH, 2005, J MED VIROL, V77, P475, DOI 10.1002/jmv.20479; Tegerstedt K, 2005, CANCER RES, V65, P5953, DOI 10.1158/0008-5472.CAN-05-0335; Thomas BS, 2012, VACCINE, V30, P998, DOI 10.1016/j.vaccine.2011.12.070; van der Bruggen P, 2002, IMMUNOL REV, V188, P51, DOI 10.1034/j.1600-065X.2002.18806.x; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073	41	17	17	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49539	10.1371/journal.pone.0049539	http://dx.doi.org/10.1371/journal.pone.0049539			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166703	gold, Green Published, Green Submitted			2022-12-27	WOS:000311272300050
J	Runge, F; Ndambi, B; Thines, M				Runge, Fabian; Ndambi, Beninweck; Thines, Marco			Which Morphological Characteristics Are Most Influenced by the Host Matrix in Downy Mildews? A Case Study in Pseudoperonospora cubensis	PLOS ONE			English	Article							WHITE BLISTER RUSTS; CAUSAL AGENT; PERONOSPORA; CUCURBITACEAE; CUCUMBERS; DIFFERENTIATION; CLASSIFICATION; TEMPERATURE; PATHOTYPES; PHYLOGENY	Before the advent of molecular phylogenetics, species concepts in the downy mildews, an economically important group of obligate biotrophic oomycete pathogens, have mostly been based upon host range and morphology. While molecular phylogenetic studies have confirmed a narrow host range for many downy mildew species, others, like Pseudoperonospora cubensis affect even different genera. Although often morphological differences were found for new, phylogenetically distinct species, uncertainty prevails regarding their host ranges, especially regarding related plants that have been reported as downy mildew hosts, but were not included in the phylogenetic studies. In these cases, the basis for deciding if the divergence in some morphological characters can be deemed sufficient for designation as separate species is uncertain, as observed morphological divergence could be due to different host matrices colonised. The broad host range of P. cubensis (ca. 60 host species) renders this pathogen an ideal model organism for the investigation of morphological variations in relation to the host matrix and to evaluate which characteristics are best indicators for conspecificity or distinctiveness. On the basis of twelve morphological characterisitcs and a set of twelve cucurbits from five different Cucurbitaceae tribes, including the two species, Cyclanthera pedata and Thladiantha dubia, hitherto not reported as hosts of P. cubensis, a significant influence of the host matrix on pathogen morphology was found. Given the high intraspecific variation of some characteristics, also their plasticity has to be taken into account. The implications for morphological species determination and the confidence limits of morphological characteristics are discussed. For species delimitations in Pseudoperonospora it is shown that the ratio of the height of the first ramification to the sporangiophore length, ratio of the longer to the shorter ultimate branchlet, and especially the length and width of sporangia, as well as, with some reservations, their ratio, are the most suitable characteristics for species delimitation.	[Thines, Marco] Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany; [Runge, Fabian; Ndambi, Beninweck] Univ Hohenheim, Inst Bot, D-7000 Stuttgart, Germany; [Ndambi, Beninweck] Univ Hohenheim, Inst Plant Prod & Agroecol Trop & Subtrop, D-7000 Stuttgart, Germany; [Thines, Marco] Senckenberg Gesell Nat Forsch, Frankfurt, Germany; [Thines, Marco] Goethe Univ Frankfurt, Dept Biol Sci, Inst Ecol Evolut & Divers, Frankfurt, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University Hohenheim; University Hohenheim; Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt	Thines, M (corresponding author), Biodivers & Climate Res Ctr BiK F, Frankfurt, Germany.	marco.thines@senckenberg.de			Ministry of Science, Education and the Arts of Baden-Wurttemberg; "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts	Ministry of Science, Education and the Arts of Baden-Wurttemberg; "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts	This study was supported by a grant from the Ministry of Science, Education and the Arts of Baden-Wurttemberg awarded to FR and by the research funding programme "LOEWE - Landes-Offensive zur Entwicklung Wissenschaftlich okonomischer Exzellenz" of Hesse's Ministry of Higher Education, Research, and the Arts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAINS SS, 1978, PLANT SOIL, V49, P85, DOI 10.1007/BF02149910; Bedlan G, 1989, PFLANZENSCHUTZBERICH, V3, P119; Choi YJ, 2008, PLANT PATHOL, V57, P371, DOI 10.1111/j.1365-3059.2007.01628.x; Choi YJ, 2005, MYCOL RES, V109, P841, DOI 10.1017/S0953756205002534; Choi YJ, 2008, MYCOPATHOLOGIA, V165, P155, DOI 10.1007/s11046-007-9087-7; Choi YJ, 2007, FUNGAL DIVERS, V27, P11; Choi YJ, 2007, NOVA HEDWIGIA, V85, P93, DOI 10.1127/0029-5035/2007/0085-0093; Choi YJ, 2011, MYCOPATHOLOGIA, V171, P151, DOI 10.1007/s11046-010-9340-3; Choi YJ, 2011, FUNGAL BIOL-UK, V115, P102, DOI 10.1016/j.funbio.2010.10.010; Choi YJ, 2009, MYCOL PROG, V8, P329, DOI 10.1007/s11557-009-0604-6; Choi YJ, 2009, MYCOL RES, V113, P1340, DOI 10.1016/j.mycres.2009.08.010; Choi YJ, 2009, MYCOL RES, V113, P1127, DOI 10.1016/j.mycres.2009.07.010; Choi YJ, 2008, MYCOL RES, V112, P1327, DOI 10.1016/j.mycres.2008.04.015; Cohen Y, 2011, PLANT DIS, V95, P874, DOI 10.1094/PDIS-02-11-0127; COHEN Y, 1977, CAN J BOT, V55, P1478, DOI 10.1139/b77-174; COHEN Y, 1977, PHYSIOL PLANT PATHOL, V10, P93, DOI 10.1016/0048-4059(77)90013-3; DELANOE D, 1972, CETIOM INFORM TECHNI, V26, P1; DUDKA IO, 2007, ADV DOWNY MILDEW RES, V3, P39; Garcia-Blazquez G, 2008, MYCOL RES, V112, P502, DOI 10.1016/j.mycres.2007.10.007; GAUMANN E, 1923, BEITR KRYPTOGAMENFL, V5, P1; Gaumann E, 1918, FRIES BEITR BOT ZENT, V35, P395; Goker M, 2007, FUNGAL GENET BIOL, V44, P105, DOI 10.1016/j.fgb.2006.07.005; Goker M, 2009, MYCOL RES, V113, P308, DOI 10.1016/j.mycres.2008.11.006; Hoerner GR, 1940, J AGRIC RES, V61, P0331; IWATA Y, 1953, B FACULTY AGR MIE U, V1, P30; Iwata Yosito, 1942, ANN PHYTOPATH SOC JAPAN, V11, P172; Ko Y, 2008, PLANT DIS, V92, P1706, DOI 10.1094/PDIS-92-12-1706C; Kocyan A, 2007, MOL PHYLOGENET EVOL, V44, P553, DOI 10.1016/j.ympev.2006.12.022; Kulkarni S., 2009, Helia, V32, P85, DOI 10.2298/HEL0950085K; Lebeda A, 2004, DEV PLANT PATHOL, V16, P203; Lebeda A, 2003, Z PFLANZENK PFLANZEN, V110, P337; LEBEDA A, 1992, PHYTOPARASITICA, V20, P203, DOI 10.1007/BF02980842; Lebeda A., 1999, Acta Horticulturae, P363; LEBEDA A, 1991, SCI HORTIC-AMSTERDAM, V45, P255, DOI 10.1016/0304-4238(91)90071-6; LEBEDA A, 2007, GENETIC RESOURCES CH, V3, P273; Lebeda A, 2011, EUR J PLANT PATHOL, V129, P129, DOI 10.1007/s10658-010-9709-7; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Miyabe K, 1906, T SAPPORO NATURAL HI, V1, P149; PALTI J, 1980, PHYTOPARASITICA, V8, P109, DOI 10.1007/BF02994506; PALTI J, 1975, CMI DESCIRPTIONS PAT, V682, P1; Ploch S, 2010, MOL PHYLOGENET EVOL, V57, P812, DOI 10.1016/j.ympev.2010.06.026; Runge F, 2009, THESIS U HOHENHEIM S; Runge F, 2011, IMA FUNGUS, V2, P163, DOI 10.5598/imafungus.2011.02.02.07; Runge F, 2012, PLANT DIS, V96, P55, DOI 10.1094/PDIS-01-11-0035; Runge F, 2011, EUR J PLANT PATHOL, V129, P147, DOI 10.1007/s10658-010-9650-9; Runge F, 2011, EUR J PLANT PATHOL, V129, P135, DOI 10.1007/s10658-010-9714-x; Runge F, 2009, EUR J PLANT PATHOL, V123, P483, DOI 10.1007/s10658-008-9382-2; Salati M, 2010, AFR J BIOTECHNOL, V9, P4897; SAWADA K, 1931, REPORT GOVT RES I DE, V51, P76; Schaefer H, 2011, TAXON, V60, P122, DOI 10.1002/tax.601011; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Thines M, 2009, PERSOONIA, V22, P123, DOI 10.3767/003158509X457931; Thines M, 2009, OOMYCETE GENETICS GE, DOI [10.1002/9780470475898.ch3, DOI 10.1002/9780470475898.CH3]; THINES M, 2009, OOMYCETE GENETICS GE, P77, DOI DOI 10.1002/9780470475898.CH4; Thines M, 2011, MYCOL PROG, V10, P415, DOI 10.1007/s11557-010-0712-3; Thines Marco, 2010, Polish Botanical Journal, V55, P259; Thines M, 2010, EUR J PLANT PATHOL, V128, P81, DOI 10.1007/s10658-010-9632-y; Thines M, 2009, MYCOL RES, V113, P532, DOI 10.1016/j.mycres.2008.12.005; Voglmayr H, 2008, EUR J PLANT PATHOL, V122, P3, DOI 10.1007/s10658-008-9341-y; Voglmayr H, 2011, MYCOL PROG, V10, P283, DOI 10.1007/s11557-010-0699-9; WAITE MB, 1892, J MYCOLOGY, V7, P105; Waterhouse GM, 1981, MYCOL PAP, V148, P1; YERKES WD, 1959, PHYTOPATHOLOGY, V49, P499	63	19	21	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e44863	10.1371/journal.pone.0044863	http://dx.doi.org/10.1371/journal.pone.0044863			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166582	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300002
J	Chen, BR; Cheng, HH; Lin, WC; Wang, KH; Liou, JY; Chen, PF; Wu, KK				Chen, Bo-Rui; Cheng, Huei-Hsuan; Lin, Wei-Chung; Wang, Kai-Hsuan; Liou, Jun-Yang; Chen, Pei-Feng; Wu, Kenneth K.			Quiescent Fibroblasts Are More Active in Mounting Robust Inflammatory Responses Than Proliferative Fibroblasts	PLOS ONE			English	Article							CYCLOOXYGENASE-2 PROMOTER ACTIVATION; STREPTAVIDIN-AGAROSE PULLDOWN; SACCHAROMYCES-CEREVISIAE; STATIONARY-PHASE; BINDING; EXPRESSION; CANCER; MYOFIBROBLASTS; MEDIATORS; APOPTOSIS	Quiescent cells are considered to be dormant. However, recent studies suggest that quiescent fibroblasts possess active metabolic profile and certain functional characteristics. We previously observed that serum-starved quiescent fibroblasts respond to proinflammatory stimuli by robust expression of cyclooxygenase-2 (COX-2), which declines after the quiescent fibroblasts are driven to proliferation. In this study, we elucidated the underlying signaling and transcriptional mechanism and identified by microarray genes with similar differential expression. By using pharmacological inhibitors coupled with gene silencing, we uncovered the key role of protein kinase C delta (PKC delta) and extracellular signal regulated protein kinase 1/2 (ERK1/2) signaling in mediating COX-2 expression in quiescent cells. Surprisingly, COX-2 expression in proliferative cells was not blocked by PKC delta or ERK1/2 inhibitors due to intrinsic inhibition of PKC delta and ERK1/2 in proliferative cells. Restrained COX-2 transcription in proliferative cells was attributable to reduced NF-kappa B binding. Microarray analysis identified 35 genes whose expressions were more robust in quiescent than in proliferative cells. A majority of those genes belong to proinflammatory cytokines, chemokines, adhesive molecules and metalloproteinases, which require NF-kappa B for transcription. Quiescent fibroblasts had a higher migratory activity than proliferative fibroblasts as determined by the transwell assay. Selective COX-2 inhibition reduced migration which was restored by prostaglandin E-2. As COX-2 and inflammatory mediators induce DNA oxidation, we measured 8-hydroxydeoxyguanosine (8-OHdG) in quiescent vs. proliferative fibroblasts. PMA-induced 8-OHdG accumulation was significantly higher in quiescent than in proliferative fibroblasts. These findings indicate that quiescent fibroblasts (and probably other quiescent cells) are at the forefront in mounting inflammatory responses through expression of an array of proinflammatory genes via the PKC delta/ERK1/2 signaling pathway.	[Chen, Bo-Rui; Cheng, Huei-Hsuan; Lin, Wei-Chung; Wang, Kai-Hsuan; Liou, Jun-Yang; Chen, Pei-Feng; Wu, Kenneth K.] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli, Taiwan	National Health Research Institutes - Taiwan	Chen, BR (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Miaoli, Taiwan.	kkgo@nhri.org.tw	Wu, Kenneth Kun-Yu/B-1070-2010; Liou, Jun-Yang/B-1065-2010					Bielas JH, 2000, P NATL ACAD SCI USA, V97, P11391, DOI 10.1073/pnas.190330997; Coller HA, 2006, PLOS BIOL, V4, P329, DOI 10.1371/journal.pbio.0040083; Deng WG, 2004, BLOOD, V103, P2135, DOI 10.1182/blood-2003-09-3131; Deng WG, 2003, ANAL BIOCHEM, V323, P12, DOI 10.1016/j.ab.2003.08.007; Deng WG, 2003, J BIOL CHEM, V278, P4770, DOI 10.1074/jbc.M209286200; Deng WG, 2002, FASEB J, V16, P1286, DOI 10.1096/fj.01-0844fje; FUGE EK, 1994, J BACTERIOL, V176, P5802, DOI 10.1128/JB.176.18.5802-5813.1994; Gilroy DW, 2001, FASEB J, V15, P288; Iyer VR, 1999, SCIENCE, V283, P83, DOI 10.1126/science.283.5398.83; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Lemons JMS, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000514; Liou JY, 2008, MOL PHARMACOL, V74, P1399, DOI 10.1124/mol.108.049569; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nikolic D, 2001, CHEM RES TOXICOL, V14, P351, DOI 10.1021/tx010004x; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Pollina EA, 2008, CELL CYCLE, V7, P2056, DOI 10.4161/cc.7.13.6240; Sartore S, 2001, CIRC RES, V89, P1111, DOI 10.1161/hh2401.100844; Schroer K, 2002, CIRCULATION, V105, P2760, DOI 10.1161/01.CIR.0000018127.10968.34; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Sova H, 2010, BRIT J CANCER, V102, P1018, DOI 10.1038/sj.bjc.6605565; Tardieu D, 2000, CARCINOGENESIS, V21, P973, DOI 10.1093/carcin/21.5.973; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Tsujii M, 1997, P NATL ACAD SCI USA, V94, P3336, DOI 10.1073/pnas.94.7.3336; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Wu K K, 1995, Adv Pharmacol, V33, P179, DOI 10.1016/S1054-3589(08)60669-9; Wu Kenneth K., 2006, V338, P281; Zalewski A, 1997, ARTERIOSCL THROM VAS, V17, P417, DOI 10.1161/01.ATV.17.3.417; Zhu Y, 2002, J BIOL CHEM, V277, P6923, DOI 10.1074/jbc.M108075200	30	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49232	10.1371/journal.pone.0049232	http://dx.doi.org/10.1371/journal.pone.0049232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155470	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900105
J	Correa-Costa, M; Azevedo, H; Amano, MT; Goncalves, GM; Hyane, MI; Cenedeze, MA; Renesto, PG; Pacheco-Silva, A; Moreira, CA; Camara, NOS				Correa-Costa, Matheus; Azevedo, Hatylas; Amano, Mariane Tami; Goncalves, Giselle Martins; Hyane, Meire Ioshie; Cenedeze, Marcos Antonio; Renesto, Paulo Guilherme; Pacheco-Silva, Alvaro; Moreira-Filho, Carlos Alberto; Saraiva Camara, Niels Olsen			Transcriptome Analysis of Renal Ischemia/Reperfusion Injury and Its Modulation by Ischemic Pre-Conditioning or Hemin Treatment	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; TUBULAR EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; REPERFUSION INJURY; GENE-EXPRESSION; ANGIOTENSIN-II; OXYGENASE-1 INDUCTION; MICROARRAY ANALYSIS; KINASE ACTIVATION; INDUCED APOPTOSIS	Ischemia/reperfusion injury (IRI) is a leading cause of acute renal failure. The definition of the molecular mechanisms involved in renal IRI and counter protection promoted by ischemic pre-conditioning (IPC) or Hemin treatment is an important milestone that needs to be accomplished in this research area. We examined, through an oligonucleotide microarray protocol, the renal differential transcriptome profiles of mice submitted to IRI, IPC and Hemin treatment. After identifying the profiles of differentially expressed genes observed for each comparison, we carried out functional enrichment analysis to reveal transcripts putatively involved in potential relevant biological processes and signaling pathways. The most relevant processes found in these comparisons were stress, apoptosis, cell differentiation, angiogenesis, focal adhesion, ECM-receptor interaction, ion transport, angiogenesis, mitosis and cell cycle, inflammatory response, olfactory transduction and regulation of actin cytoskeleton. In addition, the most important overrepresented pathways were MAPK, ErbB, JAK/STAT, Toll and Nod like receptors, Angiotensin II, Arachidonic acid metabolism, Wnt and coagulation cascade. Also, new insights were gained about the underlying protection mechanisms against renal IRI promoted by IPC and Hemin treatment. Venn diagram analysis allowed us to uncover common and exclusively differentially expressed genes between these two protective maneuvers, underscoring potential common and exclusive biological functions regulated in each case. In summary, IPC exclusively regulated the expression of genes belonging to stress, protein modification and apoptosis, highlighting the role of IPC in controlling exacerbated stress response. Treatment with the Hmox1 inducer Hemin, in turn, exclusively regulated the expression of genes associated with cell differentiation, metabolic pathways, cell cycle, mitosis, development, regulation of actin cytoskeleton and arachidonic acid metabolism, suggesting a pleiotropic effect for Hemin. These findings improve the biological understanding of how the kidney behaves after IRI. They also illustrate some possible underlying molecular mechanisms involved in kidney protection observed with IPC or Hemin treatment maneuvers.	[Correa-Costa, Matheus; Amano, Mariane Tami; Goncalves, Giselle Martins; Hyane, Meire Ioshie; Renesto, Paulo Guilherme; Saraiva Camara, Niels Olsen] Univ Sao Paulo, Inst Ciencias Biomed, Dept Immunol, Lab Transplantat Immunobiol, BR-05508 Sao Paulo, Brazil	Universidade de Sao Paulo	Correa-Costa, M (corresponding author), Univ Sao Paulo, Inst Ciencias Biomed, Dept Immunol, Lab Transplantat Immunobiol, BR-05508 Sao Paulo, Brazil.	carlos.moreira@hc.fm.usp.br; niels@icb.usp.br	moreira-filho, carlos alberto/J-2551-2014; Pacheco-Silva, Alvaro/K-3583-2013; Complexos, INCT Fluidos/H-9172-2013; Correa-Costa, Matheus/B-2006-2014; Azevedo, Hatylas FZ/M-5332-2013; AMANO, MARIANE TAMI/D-1361-2012; camara, niels olsen saraiva/AAX-3269-2020; Camara, Niels OS/G-8336-2011	moreira-filho, carlos alberto/0000-0003-3433-4714; Azevedo, Hatylas FZ/0000-0001-9233-0696; AMANO, MARIANE TAMI/0000-0003-4321-3375; camara, niels olsen saraiva/0000-0001-5436-1248; Camara, Niels OS/0000-0001-5436-1248				Alderliesten M, 2007, AM J PATHOL, V171, P452, DOI 10.2353/ajpath.2007.060805; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Atkinson SJ, 2004, J BIOL CHEM, V279, P5194, DOI 10.1074/jbc.M306973200; Barandon L, 2005, CIRC RES, V96, P1299, DOI 10.1161/01.RES.0000171895.06914.2c; Basile DP, 2005, AM J PHYSIOL-RENAL, V288, pF953, DOI 10.1152/ajprenal.00329.2004; Benardete EA, 2009, BRAIN RES, V1292, P107, DOI 10.1016/j.brainres.2009.07.027; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Botros FT, 2012, INT J HYPERTENS, V2012, DOI 10.1155/2012/189512; Braga TT, 2012, MOL MED; BREZIS M, 1993, ANNU REV MED, V44, P27, DOI 10.1146/annurev.me.44.020193.000331; Castoldi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037584; Chen JC, 2006, J AM SOC NEPHROL, V17, P1615, DOI 10.1681/ASN.2005111163; Chen JC, 2012, KIDNEY INT, V82, P45, DOI 10.1038/ki.2012.43; Chok Mohammed Koussai, 2009, Inflammation & Allergy Drug Targets, V8, P252; Correa-Costa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029004; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Dallas PB, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-59; Decleves AE, 2006, INT J MOL MED, V18, P83; Desbuards N, 2009, NEPHRON EXP NEPHROL, V113, pE35, DOI 10.1159/000228081; Devarajan P, 2003, MOL GENET METAB, V80, P365, DOI 10.1016/j.ymgme.2003.09.012; Di Mari JF, 1999, AM J PHYSIOL-RENAL, V277, pF195, DOI 10.1152/ajprenal.1999.277.2.F195; Git A, 2010, RNA, V16, P991, DOI 10.1261/rna.1947110; Goncalves GM, 2006, KIDNEY INT, V70, P1742, DOI 10.1038/sj.ki.5001893; Goncalves GM, 2011, SCAND J IMMUNOL, V73, P428, DOI 10.1111/j.1365-3083.2011.02523.x; Hauser P, 2002, WIEN KLIN WOCHENSCHR, V114, P671; Holzen JP, 2008, J SURG RES, V148, P126, DOI 10.1016/j.jss.2007.10.007; Hwang I, 2009, ARCH PHARM RES, V32, P1653, DOI 10.1007/s12272-009-2200-3; Jancso G, 2007, ANN NY ACAD SCI, V1095, P251, DOI 10.1196/annals.1397.029; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; Jones AW, 2010, J PHARMACOL EXP THER, V335, P85, DOI 10.1124/jpet.110.169755; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P128, DOI 10.1097/01.ASN.0000040596.23073.01; Kentrup D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026419; Kieran NE, 2003, KIDNEY INT, V64, P480, DOI 10.1046/j.1523-1755.2003.00106.x; Kim JH, 2006, J AM SOC NEPHROL, V17, P1373, DOI 10.1681/ASN.2005091001; Kinsey GR, 2010, KIDNEY INT, V77, P771, DOI 10.1038/ki.2010.12; Kirkby KA, 2006, AM J PHYSIOL-RENAL, V290, pF563, DOI 10.1152/ajprenal.00220.2005; Kurella M, 2001, J AM SOC NEPHROL, V12, P1072, DOI 10.1681/ASN.V1251072; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Lautrette A, 2005, NAT MED, V11, P867, DOI 10.1038/nm1275; Li A, 2012, MOL BIOL REP, V39, P3773, DOI 10.1007/s11033-011-1154-y; Li Kai-long, 2007, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V23, P6; Li SD, 2011, TRANSPL P, V43, P1980, DOI 10.1016/j.transproceed.2011.03.032; Liano F, 1996, KIDNEY INT, V50, P811, DOI 10.1038/ki.1996.380; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Vinas JL, 2010, AM J PHYSIOL-RENAL, V299, pF234, DOI 10.1152/ajprenal.00687.2009; Mallick IH, 2010, AM J SURG, V199, P223, DOI 10.1016/j.amjsurg.2009.01.011; Mehta A, 2002, MOL CELL BIOCHEM, V240, P19, DOI 10.1023/A:1020675721351; Molina A, 2005, J AM SOC NEPHROL, V16, P374, DOI 10.1681/ASN.2004070528; Molitoris BA, 2009, J AM SOC NEPHROL, V20, P1754, DOI 10.1681/ASN.2008111204; Montie HL, 2005, BBA-MOL BASIS DIS, V1741, P314, DOI 10.1016/j.bbadis.2005.04.007; Napoli C, 2000, P NATL ACAD SCI USA, V97, P3678, DOI 10.1073/pnas.97.7.3678; Napoli C, 2002, AM J PHYSIOL-HEART C, V282, pH2004, DOI 10.1152/ajpheart.00909.2001; Ndisang JF, 2010, ENDOCRINOLOGY, V151, P549, DOI 10.1210/en.2009-0471; Nelson PJ, 2011, EXPERT OPIN THER TAR, V15, P1073, DOI 10.1517/14728222.2011.588210; Park KM, 2001, J BIOL CHEM, V276, P11870, DOI 10.1074/jbc.M007518200; Pasupathy S, 2005, EUR J VASC ENDOVASC, V29, P106, DOI 10.1016/j.ejvs.2004.11.005; Peng TC, 2011, J SURG RES, V167, pE245, DOI 10.1016/j.jss.2010.06.010; Pirooznia M, 2007, BIOINFORMATION, V1, P420, DOI 10.6026/97320630001420; Prifti E, 2008, BIOINFORMATICS, V24, P2636, DOI 10.1093/bioinformatics/btn492; Pulskens WP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003596; Rouschop KMA, 2006, KIDNEY INT, V70, P1127, DOI 10.1038/sj.ki.5001711; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeki I, 2011, PEDIATR SURG INT, V27, P857, DOI 10.1007/s00383-010-2810-3; Saenz-Morales D, 2009, CELL PHYSIOL BIOCHEM, V23, P285, DOI 10.1159/000218175; Salojin K, 2007, J LEUKOCYTE BIOL, V81, P860, DOI 10.1189/jlb.1006639; Salom MG, 2007, AM J PHYSIOL-HEART C, V293, pH3542, DOI 10.1152/ajpheart.00977.2007; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schuster H, 2006, SCAND J GASTROENTERO, V41, P1342, DOI 10.1080/00365520600682039; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sheridan AM, 2000, CURR OPIN NEPHROL HY, V9, P427, DOI 10.1097/00041552-200007000-00015; Shigeoka AA, 2010, J IMMUNOL, V184, P2297, DOI 10.4049/jimmunol.0903065; Stroo I, 2010, INT IMMUNOL, V22, P433, DOI 10.1093/intimm/dxq025; Suen JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013809; Supavekin S, 2003, KIDNEY INT, V63, P1714, DOI 10.1046/j.1523-1755.2003.00928.x; Sutton TA, 1998, SEMIN NEPHROL, V18, P490; Sutton TA, 2008, AM J PHYSIOL-RENAL, V295, pF1666, DOI 10.1152/ajprenal.90304.2008; TRUONG LD, 1994, KIDNEY INT, V45, P201, DOI 10.1038/ki.1994.24; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; Vigneron F, 2011, CARDIOVASC RES, V90, P49, DOI 10.1093/cvr/cvr002; von Toerne C, 2009, AM J TRANSPLANT, V9, P2223, DOI 10.1111/j.1600-6143.2009.02762.x; Wagner M, 2003, KIDNEY INT, V63, P1564, DOI 10.1046/j.1523-1755.2003.00897.x; Wang PHM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003050; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Weidekamm C, 2002, WIEN KLIN WOCHENSCHR, V114, P725; Wen XY, 2010, CONTRIB NEPHROL, V165, P39, DOI 10.1159/000313743; Wu QQ, 2011, AM J PHYSIOL-RENAL, V300, pF1180, DOI 10.1152/ajprenal.00353.2010; Xia ZY, 2009, CHIN J TRAUMATOL, V12, P162, DOI 10.3760/cma.j.issn.1008-1275.2009.03.008; Yang CW, 2003, TRANSPLANTATION, V75, P20, DOI 10.1097/01.TP.0000040002.12912.65; Yang NS, 2008, NEPHROL DIAL TRANSPL, V23, P91, DOI 10.1093/ndt/gfm509; Yoshida T, 2002, KIDNEY INT, V61, P1646, DOI 10.1046/j.1523-1755.2002.00341.x; Yoshida T, 2008, J AM SOC NEPHROL, V19, P217, DOI 10.1681/ASN.2005111155; Yu Bo, 2004, Sichuan Da Xue Xue Bao Yi Xue Ban, V35, P350; Yuen PST, 2006, PHYSIOL GENOMICS, V25, P375, DOI 10.1152/physiolgenomics.00223.2005; Yun N, 2012, J PHYSIOL SCI, V62, P199, DOI 10.1007/s12576-012-0199-6; Zeynalov E, 2009, NEUROBIOL DIS, V35, P264, DOI 10.1016/j.nbd.2009.05.010	98	41	42	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49569	10.1371/journal.pone.0049569	http://dx.doi.org/10.1371/journal.pone.0049569			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166714	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900166
J	Hau, A; Ceppi, P; Peter, ME				Hau, Annika; Ceppi, Paolo; Peter, Marcus E.			CD95 Is Part of a Let-7/p53/miR-34 Regulatory Network	PLOS ONE			English	Article							CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; NEGATIVE FEEDBACK LOOP; DEATH RECEPTORS; DOWN-REGULATION; MIR-34 FAMILY; FAS; P53; ACTIVATION; APOPTOSIS	The death receptor CD95 (APO-1/Fas) mediates apoptosis induction upon ligation by its cognate ligand CD95L. Two types of CD95 signaling pathways have been identified, which are characterized by the absence (Type I) or presence (Type II) of mitochondrial involvement. Micro(mi)RNAs are small noncoding RNAs that negatively regulate gene expression. They are important regulators of differentiation processes and are found frequently deregulated in many human cancers. We recently showed that Type I cells express less of the differentiation marker miRNA let-7 and, hence, likely represent more advanced tumor cells than the let-7 high expressing Type II cells. We have now identified miR-34a as a selective marker for cells that are sensitive to CD95-mediated apoptosis. Both CD95 and miR-34a are p53 target genes, and consequently, both the sensitivity of cancer cells to CD95-mediated apoptosis and the ability to respond to p53 mediated DNA genotoxic stress are linked. Interestingly, while miR-34a was found to positively correlate with the ability of cells to respond to genotoxic stress, let-7 was negatively correlated. The expression level of CD95 inversely correlated with the expression of let-7 suggesting regulation of let-7 expression by CD95. To test a link between p53 and miR-34a, we altered the expression of CD95. This affected the ability of cells to activate p53 and to regulate miR-34a. Our data point to a novel regulatory network comprising p53, CD95, let-7, and miR-34a that affects cancer cell survival, differentiation, and sensitivity to apoptotic signals. The possible relevance of this regulatory network for cancer stem cells is discussed.	[Hau, Annika; Ceppi, Paolo; Peter, Marcus E.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Hau, A (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA.	m-peter@northwestern.edu	Ceppi, Paolo/GPS-8668-2022; Hau, Annika/Q-2131-2015	Hau, Annika/0000-0002-3388-3394; Ceppi, Paolo/0000-0002-3632-8476; Peter, Marcus Ernst/0000-0003-3216-036X	NATIONAL CANCER INSTITUTE [R01CA095319] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA095319] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Algeciras-Schimnich A, 2003, P NATL ACAD SCI USA, V100, P11445, DOI 10.1073/pnas.2034995100; Barnhart BC, 2003, SEMIN IMMUNOL, V15, P185, DOI 10.1016/S1044-5323(03)00031-9; Beier CP, 2009, CELL STEM CELL, V5, P128, DOI 10.1016/j.stem.2009.07.008; Bennett M, 1998, SCIENCE, V282, P290, DOI 10.1126/science.282.5387.290; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Boyerinas B, 2010, ENDOCR-RELAT CANCER, V17, pF19, DOI 10.1677/ERC-09-0184; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang CJ, 2011, NAT CELL BIOL, V13, P317, DOI 10.1038/ncb2173; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Choi YJ, 2011, NAT CELL BIOL, V13, P1353, DOI 10.1038/ncb2366; Christoffersen NR, 2010, CELL DEATH DIFFER, V17, P236, DOI 10.1038/cdd.2009.109; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; Corney DC, 2010, CLIN CANCER RES, V16, P1119, DOI 10.1158/1078-0432.CCR-09-2642; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Del-Rey M, 2006, BLOOD, V108, P1306, DOI 10.1182/blood-2006-04-015776; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gaur A, 2007, CANCER RES, V67, P2456, DOI 10.1158/0008-5472.CAN-06-2698; Geng L, 2011, BIOCHEM BIOPH RES CO, V408, P494, DOI 10.1016/j.bbrc.2011.04.074; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grande SM, 2007, IMMUNOL REV, V218, P214, DOI 10.1111/j.1600-065X.2007.00535.x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; Hong YL, 2004, P NATL ACAD SCI USA, V101, P14443, DOI 10.1073/pnas.0401346101; Hua YJ, MIRCONNECT 2 0 UNPUB; Hua YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026521; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Kim T, 2011, J EXP MED, V208, P875, DOI 10.1084/jem.20110235; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Knight JC, 2010, J NEUROSCI RES, V88, P746, DOI 10.1002/jnr.22253; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Lotze M.T., 2003, CYTOKINE HDB, V4th; Maecker HL, 2000, CANCER RES, V60, P4638; Medema JP, 1998, J BIOL CHEM, V273, P3388, DOI 10.1074/jbc.273.6.3388; Meng XW, 2011, J BIOL CHEM, V286, P35823, DOI 10.1074/jbc.M111.240432; Mielgo A, 2006, CELL DEATH DIFFER, V13, P465, DOI 10.1038/sj.cdd.4401763; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Munsch D, 2000, J BIOL CHEM, V275, P3867, DOI 10.1074/jbc.275.6.3867; Nalls D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024099; OConnor PM, 1997, CANCER RES, V57, P4285; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Papenfuss K, 2008, J CELL MOL MED, V12, P2566, DOI 10.1111/j.1582-4934.2008.00514.x; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; PAULL KD, 1989, J NATL CANCER I, V81, P1088, DOI 10.1093/jnci/81.14.1088; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Peter ME, 2005, BBA-REV CANCER, V1755, P25, DOI 10.1016/j.bbcan.2005.01.001; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Saleh AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024429; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Schilling T, 2009, BIOCHEM BIOPH RES CO, V387, P399, DOI 10.1016/j.bbrc.2009.07.063; Semont A, 2004, ONCOGENE, V23, P8497, DOI 10.1038/sj.onc.1207821; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Shi M, 2010, BBA-REV CANCER, V1805, P218, DOI 10.1016/j.bbcan.2009.12.001; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Siemens H, 2011, CELL CYCLE, V10, P4256, DOI 10.4161/cc.10.24.18552; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang S, 2011, GENES IMMUN, V12, P149, DOI 10.1038/gene.2010.53; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zou CB, 2007, NAT MED, V13, P1078, DOI 10.1038/nm1625; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	77	23	27	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49636	10.1371/journal.pone.0049636	http://dx.doi.org/10.1371/journal.pone.0049636			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166734	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900177
J	Wang, C; Lv, XM; Jiang, C; Cordes, CM; Fu, L; Lele, SM; Davis, JS				Wang, Cheng; Lv, Xiangmin; Jiang, Chao; Cordes, Crystal M.; Fu, Lan; Lele, Subodh M.; Davis, John S.			Transforming Growth Factor Alpha (TGF alpha) Regulates Granulosa Cell Tumor (GCT) Cell Proliferation and Migration through Activation of Multiple Pathways	PLOS ONE			Unspecified	Article							FINE-NEEDLE-ASPIRATION; DEOXYRIBONUCLEIC-ACID SYNTHESIS; HUMAN OVARIAN TISSUE; FACTOR RECEPTOR; MOLECULAR PATHOGENESIS; FOLLICULAR-GROWTH; FACTOR-BETA; CYCLIN D1; METASTASIS; EXPRESSION	Granulosa cell tumors (GCTs) are the most common ovarian estrogen producing tumors, leading to symptoms of excessive estrogen such as endometrial hyperplasia and endometrial adenocarcinoma. These tumors have malignant potential and often recur. The etiology of GCT is unknown. TGF alpha is a potent mitogen for many different cells. However, its function in GCT initiation, progression and metastasis has not been determined. The present study aims to determine whether TGF alpha plays a role in the growth of GCT cells. KGN cells, which are derived from an invasive GCT and have many features of normal granulosa cells, were used as the cellular model. Immunohistochemistry, Western blot and RT-PCR results showed that the ErbB family of receptors is expressed in human GCT tissues and GCT cell lines. RT-PCR results also indicated that TGF alpha and EGF are expressed in the human granulosa cells and the GCT cell lines, suggesting that TGF alpha might regulate GCT cell function in an autocrine/paracrine manner. TGF alpha stimulated KGN cell DNA synthesis, cell proliferation, cell viability, cell cycle progression, and cell migration. TGF alpha rapidly activated EGFR/PI3K/Akt and mTOR pathways, as indicated by rapid phosphorylation of Akt, TSC2, Rictor, mTOR, P70S6K and S6 proteins following TGF alpha treatment. TGF alpha also rapidly activated the EGFR/MEK/ERK pathway, and P38 MAPK pathways, as indicated by the rapid phosphorylation of EGFR, MEK, ERK1/2, P38, and CREB after TGF alpha treatment. Whereas TGF alpha triggered a transient activation of Akt, it induced a sustained activation of ERK1/2 in KGN cells. Long-term treatment of KGN cells with TGF alpha resulted in a significant increase in cyclin D2 and a decrease in p27/Kip1, two critical regulators of granulosa cell proliferation and granulosa cell tumorigenesis. In conclusion, TGF alpha, via multiple signaling pathways, regulates KGN cell proliferation and migration and may play an important role in the growth and metastasis of GCTs.	[Wang, Cheng; Lv, Xiangmin; Jiang, Chao; Cordes, Crystal M.; Fu, Lan; Davis, John S.] Univ Nebraska Med Ctr, Coll Med, Olson Ctr Womens Hlth, Dept Obstet, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Wang, C (corresponding author), Univ Nebraska Med Ctr, Coll Med, Olson Ctr Womens Hlth, Dept Obstet, Omaha, NE 68198 USA.	chengwang@unmc.edu; jsdavis@unmc.edu	Davis, John S/C-3234-2014; Lv, Xiangmin/I-7106-2019	Lv, Xiangmin/0000-0001-8338-6014; Davis, John/0000-0003-3468-4079; Krause, Crystal/0000-0001-9523-4798	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R00HD059985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG029531] Funding Source: NIH RePORTER; NIA NIH HHS [1P01 AG029531-01A2, P01 AG029531] Funding Source: Medline; NICHD NIH HHS [R00 HD059985] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abadeer RA, 2010, ANN DIAGN PATHOL, V14, P457, DOI 10.1016/j.anndiagpath.2009.10.010; Al-Agha OM, 2011, AM J SURG PATHOL, V35, P484, DOI 10.1097/PAS.0b013e31820a406c; ARTEAGA CL, 1988, CANCER RES, V48, P5023; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Boerboom D, 2005, CANCER RES, V65, P9206, DOI 10.1158/0008-5472.CAN-05-1024; Burns KH, 2003, MOL ENDOCRINOL, V17, P2053, DOI 10.1210/me.2003-0038; Cipriano SC, 2001, MOL ENDOCRINOL, V15, P985, DOI 10.1210/me.15.6.985; COFFEY RJ, 1987, NATURE, V328, P817, DOI 10.1038/328817a0; Colombo N, 2007, J CLIN ONCOL, V25, DOI 10.1200/JCO.2007.11.1005; Conti M, 2006, MOL ENDOCRINOL, V20, P715, DOI 10.1210/me.2005-0185; COOPER GJ, 1991, RESP MED, V85, P327, DOI 10.1016/S0954-6111(06)80106-X; Craig J, 2007, FRONT BIOSCI-LANDMRK, V12, P3628, DOI 10.2741/2339; Crew KD, 2005, GYNECOL ONCOL, V96, P235, DOI 10.1016/j.ygyno.2004.09.023; D'Antonio A, 2002, INT J ONCOL, V21, P941; DERYNCK R, 1990, MOL REPROD DEV, V27, P3, DOI 10.1002/mrd.1080270104; DERYNCK R, 1987, CANCER RES, V47, P707; Donate-Moreno MJ, 2007, EUR J GYNAECOL ONCOL, V28, P487; Dubuc-Lissoir J, 2001, GYNECOL ONCOL, V83, P400, DOI 10.1006/gyno.2001.6367; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fan QW, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000014; FLEMMING P, 1995, AM J SURG PATHOL, V19, P927, DOI 10.1097/00000478-199508000-00008; Fuller PJ, 2004, TRENDS ENDOCRIN MET, V15, P122, DOI 10.1016/j.tem.2004.02.005; Furger C, 1998, CANCER RES, V58, P1773; HAMMOND JM, 1987, ENDOCRINOLOGY, V120, P1039, DOI 10.1210/endo-120-3-1039; Hanauske AR, 1998, CANCER, V61, P1832; Havelock JC, 2004, MOL CELL ENDOCRINOL, V228, P67, DOI 10.1016/j.mce.2004.04.018; HSUEH AJW, 1994, ENDOCR REV, V15, P707, DOI 10.1210/er.15.6.707; Imai M, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-319; Ismi O, 2009, TUMORI J, V95, P254; Jamieson S, 2012, ENDOCR REV, V33, P109, DOI 10.1210/er.2011-0014; KOBRIN MS, 1986, J BIOL CHEM, V261, P4414; Kurachi H, 1996, CANCER, V78, P1049, DOI 10.1002/(SICI)1097-0142(19960901)78:5<1049::AID-CNCR15>3.0.CO;2-2; Lafky JM, 2008, BBA-REV CANCER, V1785, P232, DOI 10.1016/j.bbcan.2008.01.001; Leibl S, 2006, GYNECOL ONCOL, V101, P18, DOI 10.1016/j.ygyno.2005.10.009; LI SW, 1994, ENDOCR J, V41, P693, DOI 10.1507/endocrj.41.693; Liu K, 1997, DIAGN CYTOPATHOL, V16, P341, DOI 10.1002/(SICI)1097-0339(199704)16:4<341::AID-DC7>3.0.CO;2-G; LOBB DK, 1989, BIOL REPROD, V40, P1087, DOI 10.1095/biolreprod40.5.1087; Mabuchi S, 2011, CURR MED CHEM, V18, P2960, DOI 10.2174/092986711796150450; MADTES DK, 1988, CELL, V53, P285, DOI 10.1016/0092-8674(88)90390-X; MARGOLIN KA, 1985, CANCER, V56, P691, DOI 10.1002/1097-0142(19850801)56:3<691::AID-CNCR2820560342>3.0.CO;2-Q; MARUO T, 1993, ENDOCRINOLOGY, V132, P924, DOI 10.1210/en.132.2.924; MATZUK MM, 1992, NATURE, V360, P313, DOI 10.1038/360313a0; Miyazawa M, 2010, J OBSTET GYNAECOL RE, V36, P448, DOI 10.1111/j.1447-0756.2009.01127.x; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Qu JP, 2000, FERTIL STERIL, V74, P113, DOI 10.1016/S0015-0282(00)00549-5; Reeka N, 1998, HUM REPROD, V13, P2199, DOI 10.1093/humrep/13.8.2199; Richards JS, 2012, ONCOGENE, V31, P1504, DOI 10.1038/onc.2011.341; Robker RL, 1998, MOL ENDOCRINOL, V12, P924, DOI 10.1210/me.12.7.924; ROY SK, 1994, MOL ENDOCRINOL, V8, P1175, DOI 10.1210/me.8.9.1175; ROY SK, 1993, BIOL REPROD, V48, P552, DOI 10.1095/biolreprod48.3.552; Schumer ST, 2003, J CLIN ONCOL, V21, P1180, DOI 10.1200/JCO.2003.10.019; Sheng Q, 2011, BRIT J CANCER, V104, P1241, DOI 10.1038/bjc.2011.62; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Singh AB, 2005, CELL SIGNAL, V17, P1183, DOI 10.1016/j.cellsig.2005.03.026; SKINNER MK, 1988, ENDOCRINOLOGY, V123, P2632, DOI 10.1210/endo-123-6-2632; Smith ER, 2008, LANCET ONCOL, V9, P1108, DOI 10.1016/S1470-2045(08)70281-X; STERN PH, 1985, J CLIN INVEST, V76, P2016, DOI 10.1172/JCI112202; TAMURA M, 1995, HUM REPROD, V10, P1891, DOI 10.1093/oxfordjournals.humrep.a136203; Thirumala SD, 1998, DIAGN CYTOPATHOL, V19, P375, DOI 10.1002/(SICI)1097-0339(199811)19:5<375::AID-DC13>3.0.CO;2-O; TRAVERSE S, 1994, CURR BIOL, V4, P694, DOI 10.1016/S0960-9822(00)00154-8; Trinh XB, 2009, EXPERT OPIN INV DRUG, V18, P1885, DOI 10.1517/13543780903321508; Villella J, 2007, INT J GYNECOL PATHOL, V26, P154, DOI 10.1097/01.pgp.0000228143.52054.46; Watson RH, 1997, GYNECOL ONCOL, V65, P387, DOI 10.1006/gyno.1997.4682; Weber JD, 1997, BIOCHEM J, V326, P61, DOI 10.1042/bj3260061; WILCOX JN, 1988, J NEUROSCI, V8, P1901; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Williams RJ, 2001, EUR J CARDIO-THORAC, V19, P516, DOI 10.1016/S1010-7940(01)00605-4; Wilson KJ, 2012, GROWTH FACTORS, V30, P107, DOI 10.3109/08977194.2011.649918; Wong Alice S T, 2002, Cancer Treat Res, V107, P161; Ylagan LR, 2002, DIAGN CYTOPATHOL, V27, P38, DOI 10.1002/dc.10134; Zeineldin R, 2010, J ONCOL, V2010, DOI 10.1155/2010/414676; Zhang Y, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-61	72	36	37	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48299	10.1371/journal.pone.0048299	http://dx.doi.org/10.1371/journal.pone.0048299			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155381	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900015
J	Hendricks, JM; Hoffman, C; Pascual, DW; Hardy, ME				Hendricks, Jay M.; Hoffman, Carol; Pascual, David W.; Hardy, Michele E.			18 beta-Glycyrrhetinic Acid Delivered Orally Induces Isolated Lymphoid Follicle Maturation at the Intestinal Mucosa and Attenuates Rotavirus Shedding	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; SUFFICIENT B-LYMPHOCYTES; GLYCYRRHIZIN TREATMENT; LUNG INJURY; RECEPTOR; GUT; ACTIVATION; INDUCTION; RESPONSES; LICORICE	Glycyrrhizin, an abundant bioactive component of the medicinal licorice root is rapidly metabolized by gut commensal bacteria into 18 beta-glycyrrhetinic acid (GRA). Either or both of these compounds have been shown to have antiviral, anti-hepatotoxic, anti-ulcerative, anti-tumor, anti-allergenic and anti-inflammatory activity in vitro or in vivo. In this study, the ability of GRA to modulate immune responses at the small intestinal mucosa when delivered orally was investigated. Analysis of cytokine transcription in duodenal and ileal tissue in response to GRA treatment revealed a pattern of chemokine and chemokine receptor gene expression predictive of B cell recruitment to the gut. Consistent with this finding, GRA induced increases in CD19(+) B cells in the lamina propria and B220(+) B cell aggregates framed by CD11c(+) dendritic cells in structures resembling isolated lymphoid follicles (ILF). Using a mouse model of rotavirus infection, GRA reduced the duration of viral antigen shedding, and endpoint serum antibody titers were higher in GRA-treated animals. Together the data suggest GRA delivered orally augments lymphocyte recruitment to the intestinal mucosa and induces maturation of B cell-rich ILF independently of ectopic antigenic stimulus. These results provide further support a role for dietary ligands in modulation of dynamic intestinal lymphoid tissue.	[Hendricks, Jay M.; Hoffman, Carol; Pascual, David W.; Hardy, Michele E.] Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman	Hardy, ME (corresponding author), Montana State Univ, Dept Immunol & Infect Dis, Bozeman, MT 59717 USA.	mhardy@montana.edu	Pascual, David/AAC-2248-2022		PHS grant [NCCAM AT004986]; National Center for Research Resources (NCRR) [RR020185-09]; National Institute of General Medical Sciences (NIGMS) [GM103500-09]; Montana Agriculture Experiment Station; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004986] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103500] Funding Source: NIH RePORTER	PHS grant; National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Montana Agriculture Experiment Station; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by PHS grant NCCAM AT004986. Additional support was provided by National Center for Research Resources (NCRR) grant RR020185-09, National Institute of General Medical Sciences (NIGMS) grant GM103500-09, equipment from the Murdock Charitable Trust, and the Montana Agriculture Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arase Y, 1997, CANCER, V79, P1494, DOI 10.1002/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B; Armanini D, 2002, EXP CLIN ENDOCR DIAB, V110, P257, DOI 10.1055/s-2002-34587; Asl MN, 2008, PHYTOTHER RES, V22, P709, DOI 10.1002/ptr.2362; Barouki Robert, 2012, Drug Metabolism and Drug Interactions, V27, P3, DOI 10.1515/dmdi-2011-0035; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; BURNS JW, 1995, VIROLOGY, V207, P143, DOI 10.1006/viro.1995.1060; Cerutti A, 2011, TRENDS IMMUNOL, V32, P202, DOI 10.1016/j.it.2011.02.004; Csencsits KL, 2001, J IMMUNOL, V167, P2441, DOI 10.4049/jimmunol.167.5.2441; Di Paola R, 2009, INTENS CARE MED, V35, P687, DOI 10.1007/s00134-008-1334-y; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fiore C, 2008, PHYTOTHER RES, V22, P141, DOI 10.1002/ptr.2295; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hardy ME, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-96; HATTORI M, 1983, PLANTA MED, V48, P38, DOI 10.1055/s-2007-969875; Ikeda K, 2006, DIGEST DIS SCI, V51, P603, DOI 10.1007/s10620-006-3177-0; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Knoop KA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00084; Li HE, 2012, FITOTERAPIA, V83, P241, DOI 10.1016/j.fitote.2011.10.018; Long DRM, 2012, ANTIMICROB IN PRESS; Lorenz RG, 2003, J IMMUNOL, V170, P5475, DOI 10.4049/jimmunol.170.11.5475; Marchesi F, 2009, MUCOSAL IMMUNOL, V2, P486, DOI 10.1038/mi.2009.113; McDonald KG, 2005, J IMMUNOL, V174, P5720, DOI 10.4049/jimmunol.174.9.5720; Menegazzi M, 2008, PHARMACOL RES, V58, P22, DOI 10.1016/j.phrs.2008.05.012; Ni YF, 2011, J SURG RES, V165, pE29, DOI 10.1016/j.jss.2010.10.004; ONeal CM, 1997, J VIROL, V71, P8707, DOI 10.1128/JVI.71.11.8707-8717.1997; Orlent H, 2006, J HEPATOL, V45, P539, DOI 10.1016/j.jhep.2006.05.015; Pabst O, 2005, EUR J IMMUNOL, V35, P98, DOI 10.1002/eji.200425432; Rose J, 1999, ADV VIRUS RES, V51, P203; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schrofelbauer B, 2009, BIOCHEM J, V421, P473, DOI 10.1042/BJ20082416; Shaneyfelt ME, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-68; Shin YW, 2007, PLANTA MED, V73, P257, DOI 10.1055/s-2007-967126; Sun Y, 2009, INT IMMUNOPHARMACOL, V9, P1437, DOI 10.1016/j.intimp.2009.08.017; Suzuki K, 2008, TRENDS IMMUNOL, V29, P523, DOI 10.1016/j.it.2008.08.001; Ukil A, 2005, J IMMUNOL, V175, P1161, DOI 10.4049/jimmunol.175.2.1161; Utsunomiya T, 1997, ANTIMICROB AGENTS CH, V41, P551, DOI 10.1128/AAC.41.3.551; Van Rossum TGJ, 1998, ALIMENT PHARM THER, V12, P199; Velaga S, 2009, J IMMUNOL, V182, P2610, DOI 10.4049/jimmunol.0801141; Wolkerstorfer A, 2009, ANTIVIR RES, V83, P171, DOI 10.1016/j.antiviral.2009.04.012	40	17	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49491	10.1371/journal.pone.0049491	http://dx.doi.org/10.1371/journal.pone.0049491			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152913	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600042
J	Troost, T; Klein, T				Troost, Tobias; Klein, Thomas			Sequential Notch Signalling at the Boundary of Fringe Expressing and Non-Expressing Cells	PLOS ONE			English	Article							DORSAL-VENTRAL BOUNDARY; ORGAN PRECURSOR CELL; DORSOVENTRAL BOUNDARY; COMPARTMENT BOUNDARY; WING DEVELOPMENT; GENE-EXPRESSION; DISTINCT ROLES; MIND BOMB; DROSOPHILA; SERRATE	Wing development in Drosophila requires the activation of Wingless (Wg) in a small stripe along the boundary of Fringe (Fng) expressing and non-expressing cells (FB), which coincides with the dorso-ventral (D/V) boundary of the wing imaginal disc. The expression of Wg is induced by interactions between dorsal and ventral cells mediated by the Notch signalling pathway. It appears that mutual signalling from dorsal to ventral and ventral to dorsal cells by the Notch ligands Serrate (Ser) and Delta (Dl) respectively establishes a symmetric domain of Wg that straddles the D/V boundary. The directional signalling of these ligands requires the modification of Notch in dorsal cells by the glycosyltransferase Fng and is based on the restricted expression of the ligands with Ser expression to the dorsal and that of Dl to the ventral side of the wing anlage. In order to further investigate the mechanism of Notch signalling at the FB, we analysed the function of Fng, Ser and Dl during wing development at an ectopic FB and at the D/V boundary. We find that Notch signalling is initiated in an asymmetric fashion on only one side of the FB. During this initial asymmetric phase, only one ligand is required, with Ser initiating Notch-signalling at the D/V and Dl at the ectopic FB. Furthermore, our analysis suggests that Fng has also a positive effect on Ser signalling. Because of these additional properties, differential expression of the ligands, which has been a prerequisite to restrict Notch activation to the FB in the current model, is not required to restrict Notch signalling to the FB.	[Troost, Tobias; Klein, Thomas] Univ Dusseldorf, Inst Genet, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Klein, T (corresponding author), Univ Dusseldorf, Inst Genet, Univ Str 1, D-40225 Dusseldorf, Germany.	Thomas.Klein@uni-duesseldorf.de			Deutsche Forschungs Gemeinschaft (DFG), through Sachbeihilfe [KL 1028-3-1]	Deutsche Forschungs Gemeinschaft (DFG), through Sachbeihilfe(German Research Foundation (DFG))	The work was supported by the Deutsche Forschungs Gemeinschaft (DFG), through Sachbeihilfe KL 1028-3-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bachmann A, 1998, DEV GENES EVOL, V208, P346, DOI 10.1007/s004270050190; Bachmann A, 1998, MECH DEVELOP, V76, P67, DOI 10.1016/S0925-4773(98)00114-2; Bang AG, 1995, DEV BIOL, V172, P479, DOI 10.1006/dbio.1995.8033; Barolo S, 2002, GENE DEV, V16, P1964, DOI 10.1101/gad.987402; Blair SS, 2000, CURR BIOL, V10, pR608, DOI 10.1016/S0960-9822(00)00633-3; COHEN B, 1992, GENE DEV, V6, P715, DOI 10.1101/gad.6.5.715; Couso JP, 1995, CURR BIOL, V5, P1437, DOI 10.1016/S0960-9822(95)00281-8; Dahmann C, 1999, TRENDS GENET, V15, P320, DOI 10.1016/S0168-9525(99)01774-6; De Strooper B, 1999, NATURE, V398, P518, DOI 10.1038/19083; deCelis JF, 1996, DEVELOPMENT, V122, P359; deCelis JF, 1997, DEVELOPMENT, V124, P3241; DiazBenjumea FJ, 1995, DEVELOPMENT, V121, P4215; Doherty D, 1996, GENE DEV, V10, P421, DOI 10.1101/gad.10.4.421; Duffy JB, 1998, DEVELOPMENT, V125, P2263; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; Furriols M, 2000, DEV BIOL, V227, P520, DOI 10.1006/dbio.2000.9923; Grammont M, 2001, DEVELOPMENT, V128, P2243; Greco V, 2001, CELL, V106, P633, DOI 10.1016/S0092-8674(01)00484-6; Gridley T, 2003, HUM MOL GENET, V12, pR9, DOI 10.1093/hmg/ddg052; Irvine KD, 1999, CURR OPIN GENET DEV, V9, P434, DOI 10.1016/S0959-437X(99)80066-5; Irvine KD, 2001, ANNU REV CELL DEV BI, V17, P189, DOI 10.1146/annurev.cellbio.17.1.189; IRVINE KD, 1994, CELL, V79, P595, DOI 10.1016/0092-8674(94)90545-2; Kim J, 1997, COLD SPRING HARB SYM, V62, P283; KIM J, 1995, CELL, V82, P795, DOI 10.1016/0092-8674(95)90476-X; Klein T, 1997, DEV BIOL, V189, P123, DOI 10.1006/dbio.1997.8564; Klein T, 1998, DEV BIOL, V194, P196, DOI 10.1006/dbio.1997.8829; Klein T, 1998, DEVELOPMENT, V125, P2951; Klein T, 2001, CURR OPIN GENET DEV, V11, P470, DOI 10.1016/S0959-437X(00)00219-7; Klein T, 2000, DEVELOPMENT, V127, P3553; Koelzer S, 2006, DEV BIOL, V289, P77, DOI 10.1016/j.ydbio.2005.10.008; Koelzer S, 2003, DEVELOPMENT, V130, P1973, DOI 10.1242/dev.00426; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Lai EC, 2002, EMBO REP, V3, P840, DOI 10.1093/embo-reports/kvf170; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; LECOURTOIS M, 1995, GENE DEV, V9, P2598, DOI 10.1101/gad.9.21.2598; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Lei L, 2003, DEVELOPMENT, V130, P6411, DOI 10.1242/dev.00883; Micchelli CA, 1999, NATURE, V401, P473, DOI 10.1038/46779; Micchelli CA, 1997, DEVELOPMENT, V124, P1485; Moloney DJ, 2000, NATURE, V406, P369, DOI 10.1038/35019000; Munro S, 2000, CURR BIOL, V10, P813, DOI 10.1016/S0960-9822(00)00578-9; Panin VM, 1997, NATURE, V387, P908, DOI 10.1038/43191; Radtke F, 2005, BIOESSAYS, V27, P1117, DOI 10.1002/bies.20315; Rauskolb C, 1999, NATURE, V401, P476, DOI 10.1038/46786; SPEICHER SA, 1994, DEVELOPMENT, V120, P535; Struhl G, 1999, NATURE, V398, P522, DOI 10.1038/19091; THOMAS U, 1991, DEVELOPMENT, V111, P749; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; WILLIAMS JA, 1994, NATURE, V368, P299, DOI 10.1038/368299a0; Yaron A, 2012, TRENDS NEUROSCI, V35, P230, DOI 10.1016/j.tins.2011.12.003; Ye YH, 1999, NATURE, V398, P525, DOI 10.1038/19096; YEH E, 1995, P NATL ACAD SCI USA, V92, P7036, DOI 10.1073/pnas.92.15.7036	53	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49007	10.1371/journal.pone.0049007	http://dx.doi.org/10.1371/journal.pone.0049007			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152840	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000044
J	Joseph, S; Desai, P; Ji, YM; Cummings, CA; Shih, R; Degoricija, L; Rico, A; Brzoska, P; Hamby, SE; Masood, N; Hariri, S; Sonbol, H; Chuzhanova, N; McClelland, M; Furtado, MR; Forsythe, SJ				Joseph, Susan; Desai, Prerak; Ji, Yongmei; Cummings, Craig A.; Shih, Rita; Degoricija, Lovorka; Rico, Alain; Brzoska, Pius; Hamby, Stephen E.; Masood, Naqash; Hariri, Sumyya; Sonbol, Hana; Chuzhanova, Nadia; McClelland, Michael; Furtado, Manohar R.; Forsythe, Stephen J.			Comparative Analysis of Genome Sequences Covering the Seven Cronobacter Species	PLOS ONE			English	Article							ENTEROBACTER-SAKAZAKII INFECTIONS; ANTIGEN GENE CLUSTERS; INTENSIVE-CARE-UNIT; O-ANTIGEN; ENDOTHELIAL-CELLS; INFANT FORMULA; SP-NOV.; FOOD; IDENTIFICATION; VIRULENCE	Background: Species of Cronobacter are widespread in the environment and are occasional food-borne pathogens associated with serious neonatal diseases, including bacteraemia, meningitis, and necrotising enterocolitis. The genus is composed of seven species: C. sakazakii, C. malonaticus, C. turicensis, C. dublinensis, C. muytjensii, C. universalis, and C. condimenti. Clinical cases are associated with three species, C. malonaticus, C. turicensis and, in particular, with C. sakazakii multilocus sequence type 4. Thus, it is plausible that virulence determinants have evolved in certain lineages. Methodology/Principal Findings: We generated high quality sequence drafts for eleven Cronobacter genomes representing the seven Cronobacter species, including an ST4 strain of C. sakazakii. Comparative analysis of these genomes together with the two publicly available genomes revealed Cronobacter has over 6,000 genes in one or more strains and over 2,000 genes shared by all Cronobacter. Considerable variation in the presence of traits such as type six secretion systems, metal resistance (tellurite, copper and silver), and adhesins were found. C. sakazakii is unique in the Cronobacter genus in encoding genes enabling the utilization of exogenous sialic acid which may have clinical significance. The C. sakazakii ST4 strain 701 contained additional genes as compared to other C. sakazakii but none of them were known specific virulence-related genes. Conclusions/Significance: Genome comparison revealed that pair-wise DNA sequence identity varies between 89 and 97% in the seven Cronobacter species, and also suggested various degrees of divergence. Sets of universal core genes and accessory genes unique to each strain were identified. These gene sequences can be used for designing genus/species specific detection assays. Genes encoding adhesins, T6SS, and metal resistance genes as well as prophages are found in only subsets of genomes and have contributed considerably to the variation of genomic content. Differences in gene content likely contribute to differences in the clinical and environmental distribution of species and sequence types.	[Desai, Prerak; McClelland, Michael] Vaccine Res Inst San Diego, San Diego, CA USA; [Joseph, Susan; Masood, Naqash; Hariri, Sumyya; Sonbol, Hana; Forsythe, Stephen J.] Nottingham Trent Univ, Pathogen Res Grp, Sch Sci & Technol, Nottingham, England; [Ji, Yongmei; Cummings, Craig A.; Shih, Rita; Degoricija, Lovorka; Brzoska, Pius; Furtado, Manohar R.] Life Technol Corp, Foster City, CA USA; [Rico, Alain] Life Technol Corp, Darmstadt, Germany; [Hamby, Stephen E.; Chuzhanova, Nadia] Nottingham Trent Univ, Bioinformat & Biomath Grp, Sch Sci & Technol, Nottingham, England; [McClelland, Michael] Univ Calif Irvine, Dept Pathol & Lab Med, Irvine, CA USA	Nottingham Trent University; Thermo Fisher Scientific; Thermo Fisher Scientific; Nottingham Trent University; University of California System; University of California Irvine	McClelland, M (corresponding author), Vaccine Res Inst San Diego, San Diego, CA USA.	mmcclelland@sdibr.org; stephen.forsythe@ntu.ac.uk	Desai, Prerak/ABF-8529-2020; Joseph, Susan/I-8936-2019	Joseph, Susan/0000-0002-0297-5405; Chuzhanova, Nadia/0000-0002-4655-3618; Furtado, Manohar/0000-0001-6016-1357; Forsythe, Stephen/0000-0002-6709-0712; McClelland, Michael/0000-0003-1788-9347	Life Technologies; United States National Institutes of Health [AI039557 AI052237, AI073971, AI075093, AI077645, AI083646]; USDA [2009-03579, 2011-67017-30127]; Binational Agricultural Research and Development Fund; CDMRP BCRP [W81XWH-08-1-0720]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039557, R01AI075093, R56AI077645, R01AI073971, R21AI039557, R01AI052237, R01AI083646] Funding Source: NIH RePORTER	Life Technologies; United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); Binational Agricultural Research and Development Fund; CDMRP BCRP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Life Technologies funded and performed the genome sequencing. The authors thank Alain Rico for the sequencing of strains using the C. sakazakii 680, C. dublinensis 1210 and C. condimenti 1330 using the Ion Torrent PGMTM. MM and PD were supported in part by United States National Institutes of Health grants AI039557 AI052237, AI073971, AI075093, AI077645, AI083646, USDA grants 2009-03579 and 2011-67017-30127, the Binational Agricultural Research and Development Fund, and CDMRP BCRP W81XWH-08-1-0720. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison GE, 2000, TRENDS MICROBIOL, V8, P17, DOI 10.1016/S0966-842X(99)01646-7; Almagro-Moreno S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-118; Arbatsky NP, 2012, CARBOHYD RES, V355, P50, DOI 10.1016/j.carres.2012.02.031; Asakura H, 2007, MICROBIOL IMMUNOL, V51, P671, DOI 10.1111/j.1348-0421.2007.tb03955.x; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baldwin A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-223; BARDOWSKI J, 1994, J BACTERIOL, V176, P5681, DOI 10.1128/JB.176.18.5681-5685.1994; Barron JC, 2007, J FOOD PROTECT, V70, P2111, DOI 10.4315/0362-028X-70.9.2111; BIERING G, 1989, J CLIN MICROBIOL, V27, P2054, DOI 10.1128/JCM.27.9.2054-2056.1989; Burdette JH, 2000, PEDIATR RADIOL, V30, P33, DOI 10.1007/s002470050009; Caubilla-Barron J, 2007, J CLIN MICROBIOL, V45, P3979, DOI 10.1128/JCM.01075-07; Chen Y, 2011, J BACTERIOL, V193, P5861, DOI 10.1128/JB.05913-11; Cruz A, 2011, CYTOKINE, V56, P95, DOI 10.1016/j.cyto.2011.07.280; Cruz A, 2011, CAN J MICROBIOL, V57, P735, DOI [10.1139/W11-063, 10.1139/w11-063]; Czerwicka M, 2010, CARBOHYD RES, V345, P908, DOI 10.1016/j.carres.2010.01.020; den Bakker HC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-688; Didelot X, 2007, GENETICS, V175, P1251, DOI 10.1534/genetics.106.063305; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FAO/WHO, 2008, MICR RISK ASS SER, V15; FARMER JJ, 1980, INT J SYST BACTERIOL, V30, P569, DOI 10.1099/00207713-30-3-569; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Franco AA, 2011, APPL ENVIRON MICROB, V77, P3255, DOI 10.1128/AEM.03023-10; Friedemann M, 2007, INT J FOOD MICROBIOL, V116, P1, DOI 10.1016/j.ijfoodmicro.2006.12.018; Gajdosova J, 2011, ANTON LEEUW INT J G, V100, P279, DOI 10.1007/s10482-011-9585-y; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilmour MW, 2004, PLASMID, V52, P182, DOI 10.1016/j.plasmid.2004.06.006; Hamby SE, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-204; Hariri S, 2012, EMERG INFEC IN PRESS; Himelright I, 2002, JAMA-J AM MED ASSOC, V287, P2204; Hurrell E, 2009, INT J FOOD MICROBIOL, V136, P227, DOI 10.1016/j.ijfoodmicro.2009.08.007; Hurrell E, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-146; Iversen C, 2004, J CLIN MICROBIOL, V42, P5368, DOI 10.1128/JCM.42.11.5368-5370.2004; Iversen C, 2004, INT J FOOD MICROBIOL, V96, P133, DOI 10.1016/j.ijfoodmicro.2004.01.024; Iversen C, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-64; Jarvis KG, 2011, APPL ENVIRON MICROB, V77, P4017, DOI 10.1128/AEM.00162-11; Joseph S, 2012, J CLIN MICROBIOL, V50, P3031, DOI 10.1128/JCM.00905-12; Joseph S, 2012, INT J SYST EVOL MICR, V62, P1277, DOI 10.1099/ijs.0.032292-0; Joseph S, 2011, EMERG INFECT DIS, V17, P1713, DOI 10.3201/eid1709.110260; Kandhai MC, 2004, LANCET, V363, P39, DOI 10.1016/S0140-6736(03)15169-0; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim KP, 2008, INFECT IMMUN, V76, P562, DOI 10.1128/IAI.00937-07; Kim K, 2010, APPL ENVIRON MICROB, V76, P5188, DOI 10.1128/AEM.02498-09; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KORBER B, 2000, COMPUTATIONAL ANAL H, P55, DOI DOI 10.1007/B112102; Kothary MH, 2007, APPL ENVIRON MICROB, V73, P4142, DOI 10.1128/AEM.02729-06; Kucerova E, 2011, QUAL ASSUR SAF CROP, V3, P104, DOI 10.1111/j.1757-837X.2011.00104.x; Kucerova E, 2010, PLOS ONE, V5, pA51, DOI 10.1371/journal.pone.0009556; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lai KK, 2001, MEDICINE, V80, P113, DOI 10.1097/00005792-200103000-00004; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lima-Mendez G, 2008, BIOINFORMATICS, V24, P863, DOI 10.1093/bioinformatics/btn043; MacLean LL, 2009, BIOCHEM CELL BIOL, V87, P927, DOI 10.1139/O09-059; MacLean LL, 2009, BIOCHEM CELL BIOL, V87, P459, DOI 10.1139/O09-004; MacLean LL, 2009, CARBOHYD RES, V344, P667, DOI 10.1016/j.carres.2009.01.020; Mattick JS, 2002, ANNU REV MICROBIOL, V56, P289, DOI 10.1146/annurev.micro.56.012302.160938; Mullane N, 2008, APPL ENVIRON MICROB, V74, P3783, DOI 10.1128/AEM.02302-07; Nuccio SP, 2007, MICROBIOL MOL BIOL R, V71, P551, DOI 10.1128/MMBR.00014-07; Osaili T, 2009, INT J FOOD MICROBIOL, V136, P214, DOI 10.1016/j.ijfoodmicro.2009.08.006; Pagotto FJ, 2003, J FOOD PROTECT, V66, P370, DOI 10.4315/0362-028X-66.3.370; Snipen L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-385; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stephan R, 2011, J BACTERIOL, V193, P309, DOI 10.1128/JB.01162-10; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun YM, 2012, APPL ENVIRON MICROB, V78, P3966, DOI 10.1128/AEM.07825-11; Sun YM, 2011, APPL ENVIRON MICROB, V77, P2209, DOI 10.1128/AEM.02229-10; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Teng CH, 2005, INFECT IMMUN, V73, P2923, DOI 10.1128/IAI.73.5.2923-2931.2005; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Townsend S, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-64; Townsend SM, 2007, MICROBIOL-SGM, V153, P3538, DOI 10.1099/mic.0.2007/009316-0; Van Acker J, 2001, J CLIN MICROBIOL, V39, P293, DOI 10.1128/JCM.39.1.293-297.2001; Williams TL, 2005, PROTEOMICS, V5, P4161, DOI 10.1002/pmic.200401263; WILLIS J, 1988, PEDIATR INFECT DIS J, V7, P196, DOI 10.1097/00006454-198803000-00012; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou Y, 2012, INFECT IMMUN, V80, P1243, DOI 10.1128/IAI.05994-11	78	88	92	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49455	10.1371/journal.pone.0049455	http://dx.doi.org/10.1371/journal.pone.0049455			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166675	Green Published, gold, Green Accepted			2022-12-27	WOS:000311885300044
J	Pham, MHT; Bonello, GB; Castiblanco, J; Le, T; Sigala, J; He, WJ; Mummidi, S				Pham, Minh-Hieu T.; Bonello, Gregory B.; Castiblanco, John; Le, Tuan; Sigala, Jose; He, Weijing; Mummidi, Srinivas			The rs1024611 Regulatory Region Polymorphism Is Associated with CCL2 Allelic Expression Imbalance	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; SINGLE-NUCLEOTIDE POLYMORPHISMS; MCP-1 GENE POLYMORPHISM; FUNCTIONAL PROMOTER POLYMORPHISM; TYPE-2 DIABETES-MELLITUS; INTIMA-MEDIA THICKNESS; PULMONARY TUBERCULOSIS; MYOCARDIAL-INFARCTION; PLASMA-CONCENTRATIONS; CHEMOKINE-RECEPTORS	CC chemokine ligand 2 (CCL2) is the most potent monocyte chemoattractant and inter-individual differences in its expression level have been associated with genetic variants mapping to the cis-regulatory regions of the gene. An A to G polymorphism in the CCL2 enhancer region at position -2578 (rs1024611; A>G), was found in most studies to be associated with higher serum CCL2 levels and increased susceptibility to a variety of diseases such as HIV-1 associated neurological disorders, tuberculosis, and atherosclerosis. However, the precise mechanism by which rs1024611influences CCL2 expression is not known. To address this knowledge gap, we tested the hypothesis that rs1024611G polymorphism is associated with allelic expression imbalance (AEI) of CCL2. We used haplotype analysis and identified a transcribed SNP in the 3'UTR (rs13900; C>T) can serve as a proxy for the rs1024611 and demonstrated that the rs1024611G allele displayed a perfect linkage disequilibrium with rs13900T allele. Allele-specific transcript quantification in lipopolysaccharide treated PBMCs obtained from heterozygous donors showed that rs13900T allele were expressed at higher levels when compared to rs13900C allele in all the donors examined suggesting that CCL2 is subjected to AEI and that that the allele containing rs1024611G is preferentially transcribed. We also found that AEI of CCL2 is a stable trait and could be detected in newly synthesized RNA. In contrast to these in vivo findings, in vitro assays with haplotype-specific reporter constructs indicated that the haplotype bearing rs1024611G had a lower or similar transcriptional activity when compared to the haplotype containing rs1024611A. This discordance between the in vivo and in vitro expression studies suggests that the CCL2 regulatory region polymorphisms may be functioning in a complex and context-dependent manner. In summary, our studies provide strong functional evidence and a rational explanation for the phenotypic effects of the CCL2 rs1024611G allele.	[Pham, Minh-Hieu T.; Bonello, Gregory B.; Castiblanco, John; Le, Tuan; Sigala, Jose; He, Weijing; Mummidi, Srinivas] S Texas Vet Hlth Care Syst, Ctr Personalized Med, San Antonio, TX 78229 USA; [Pham, Minh-Hieu T.; Bonello, Gregory B.; Castiblanco, John; Le, Tuan; Sigala, Jose; He, Weijing; Mummidi, Srinivas] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas Health San Antonio	Mummidi, S (corresponding author), S Texas Vet Hlth Care Syst, Ctr Personalized Med, San Antonio, TX 78229 USA.	mummidi@uthscsa.edu	CASTIBLANCO, JOHN/B-6599-2009; Mummidi, Srinivas/C-1004-2008; Mummidi, Srinivas/H-3335-2017	CASTIBLANCO, JOHN/0000-0002-7965-9822; Mummidi, Srinivas/0000-0002-4068-6380; Mummidi, Srinivas/0000-0002-4068-6380; CASTIBLANCO, JOHN/0000-0003-2556-3697	Veterans Affairs Office of Research and Development-Biomedical Laboratory Research and Development Service Award [I01BX000975]; Department of Veterans Affairs Career Development Award-2 [1IK2BX001276-01A1]; National Institutes of Health (NIMH and NINDS); NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH059724, U01MH083545, U01MH083501, U01MH083507, U01MH083500] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R24NS038841] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000975] Funding Source: NIH RePORTER	Veterans Affairs Office of Research and Development-Biomedical Laboratory Research and Development Service Award; Department of Veterans Affairs Career Development Award-2(US Department of Veterans Affairs); National Institutes of Health (NIMH and NINDS); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs)	This work is supported by the Veterans Affairs Office of Research and Development-Biomedical Laboratory Research and Development Service Award (I01BX000975) to SM. TL is supported by a Department of Veterans Affairs Career Development Award-2 (1IK2BX001276-01A1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The brain samples for examining the CCL2 AEI were obtained from National Neurological AIDS bank (5U01MH083500, NS38841), The Manhattan HIV Brain Bank (U01MH083501, R24MH59724), and the Texas Repository for AIDS Neuropathogenesis Research (U01MH083507, R24 NS 38841) that are part of the National NeuroAIDS Tissue Consortium that is funded by the National Institutes of Health (NIMH and NINDS).	Abraham S, 2005, J NEUROIMMUNOL, V160, P219, DOI 10.1016/j.jneuroim.2004.11.009; Aguilar F, 2001, TISSUE ANTIGENS, V58, P335, DOI 10.1034/j.1399-0039.2001.580508.x; Ahluwalia TS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005168; Alagarasu K, 2009, INDIAN J MED RES, V130, P444; Alioglu E, 2009, CAN J CARDIOL, V25, pE1, DOI 10.1016/S0828-282X(09)70022-4; Alonso-Villaverde C, 2004, CIRCULATION, V110, P2204, DOI 10.1161/01.CIR.0000143835.95029.7D; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Berrahmoune H, 2007, ATHEROSCLEROSIS, V192, P348, DOI 10.1016/j.atherosclerosis.2006.05.015; Bjarnadottir K, 2006, ATHEROSCLEROSIS, V188, P341, DOI 10.1016/j.atherosclerosis.2005.11.014; Boger CA, 2005, ATHEROSCLEROSIS, V183, P121, DOI 10.1016/j.atherosclerosis.2005.03.006; Bonello GB, 2011, J IMMUNOL, V186, P7025, DOI 10.4049/jimmunol.0900643; Brenner D, 2006, STROKE, V37, P1691, DOI 10.1161/01.STR.0000226565.76113.6c; Brown KS, 2007, J RHEUMATOL, V34, P740; Buckland PR, 2006, BBA-MOL BASIS DIS, V1762, P17, DOI 10.1016/j.bbadis.2005.10.004; Buijtels PCAM, 2008, INT J TUBERC LUNG D, V12, P1485; Carter KW, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-60; Carulli MT, 2008, J RHEUMATOL, V35, P839; Cavestro GM, 2010, AM J GASTROENTEROL, V105, P199, DOI 10.1038/ajg.2009.611; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Chelbi H, 2008, GENES IMMUN, V9, P575, DOI 10.1038/gene.2008.50; Cho ML, 2004, AUTOIMMUNITY, V37, P77, DOI 10.1080/08916930310001609446; Chu SF, 2007, GENES IMMUN, V8, P475, DOI 10.1038/sj.gene.6364412; Cirulli ET, 2007, HUM MOL GENET, V16, P1931, DOI 10.1093/hmg/ddm140; Combarros O, 2004, NEUROSCI LETT, V360, P25, DOI 10.1016/j.neulet.2004.01.035; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dhillon NK, 2008, FRONT BIOSCI, V13, P3913, DOI 10.2741/2979; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Feng WX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014652; Fenoglio C, 2004, NEUROBIOL AGING, V25, P1169, DOI 10.1016/j.neurobiolaging.2003.11.008; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Ganachari M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008881; Ghilardi G, 2005, CLIN CHEM, V51, P452, DOI 10.1373/clinchem.2004.041657; Glas J, 2004, GASTROENTEROLOGY, V126, P1930, DOI 10.1053/j.gastro.2004.04.039; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Gonzalez-Enriquez GV, 2008, ARCH MED RES, V39, P753, DOI 10.1016/j.arcmed.2008.07.007; Gonzalez-Scarano F, 2005, NAT REV IMMUNOL, V5, P69, DOI 10.1038/nri1527; Huerta  C, 2004, NEUROSCI LETT, V370, P151, DOI 10.1016/j.neulet.2004.08.016; Intemann CD, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-34; Iwai N, 2006, CIRC J, V70, P805, DOI 10.1253/circj.70.805; Iwamoto T, 2008, FEBS J, V275, P4448, DOI 10.1111/j.1742-4658.2008.06580.x; Johnson AD, 2008, PHARMACOGENET GENOM, V18, P781, DOI 10.1097/FPC.0b013e3283050107; Joven J, 2006, CLIN CHIM ACTA, V368, P114, DOI 10.1016/j.cca.2005.12.014; Karrer S, 2005, J INVEST DERMATOL, V124, P92, DOI 10.1111/j.0022-202X.2004.23512.x; Kaur S, 2009, METAB SYNDR RELAT D, V7, P193, DOI 10.1089/met.2008.0064; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim HL, 2002, AM J KIDNEY DIS, V40, P1146, DOI 10.1053/ajkd.2002.36858; Kim MP, 2007, ATHEROSCLEROSIS, V193, P366, DOI 10.1016/j.atherosclerosis.2006.06.029; Kozma GT, 2002, ALLERGY, V57, P160, DOI 10.1034/j.1398-9995.2002.1s3361.x; Kurreeman FAS, 2004, HUM MOL GENET, V13, P1755, DOI 10.1093/hmg/ddh187; Lee YH, 2010, MOL BIOL REP, V37, P3421, DOI 10.1007/s11033-009-9932-5; Letendre S, 2004, J NEUROIMMUNOL, V157, P193, DOI 10.1016/j.jneuroim.2004.08.028; Lim SP, 2000, J VIROL, V74, P1632, DOI 10.1128/JVI.74.4.1632-1640.2000; Malafronte P, 2010, J RHEUMATOL, V37, P776, DOI 10.3899/jrheum.090681; Marsh CB, 1997, J IMMUNOL, V158, P1078; McDermott DH, 2005, CIRCULATION, V112, P1113, DOI 10.1161/CIRCULATIONAHA.105.543579; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Melzer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000072; Moller M, 2009, TUBERCULOSIS, V89, P189, DOI 10.1016/j.tube.2008.10.001; Muhlbauer M, 2003, GASTROENTEROLOGY, V125, P1085, DOI 10.1016/S0016-5085(03)01213-7; Mummidi S, 2009, GENES IMMUN, V10, P197, DOI 10.1038/gene.2008.75; Nakashima H, 2004, LUPUS, V13, P165, DOI 10.1191/0961203304lu523oa; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Nica AC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002003; Nyquist P, 2010, CEREBROVASC DIS, V29, P242, DOI 10.1159/000267849; Nyquist PA, 2009, CEREBROVASC DIS, V28, P124, DOI 10.1159/000223437; Page SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022052; Palmieri O, 2010, AM J GASTROENTEROL, V105, P1586, DOI 10.1038/ajg.2010.4; Pola R, 2004, EXP GERONTOL, V39, P1249, DOI 10.1016/j.exger.2004.05.001; Radstake TRDJ, 2009, HUM IMMUNOL, V70, P130, DOI 10.1016/j.humimm.2008.10.012; Ragin AB, 2010, PROTEOM CLIN APPL, V4, P295, DOI 10.1002/prca.200900083; Rosenbloom KR, 2010, NUCLEIC ACIDS RES, V38, pD620, DOI 10.1093/nar/gkp961; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Sanchez E, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-48; Schnabel RB, 2010, BLOOD, V115, P5289, DOI 10.1182/blood-2009-05-221382; Szalai C, 2001, J ALLERGY CLIN IMMUN, V108, P375, DOI 10.1067/mai.2001.117930; Szalai C, 2001, ATHEROSCLEROSIS, V158, P233, DOI 10.1016/S0021-9150(01)00423-3; Tabara Y, 2003, HYPERTENS RES, V26, P677, DOI 10.1291/hypres.26.677; Teferedegne B, 2006, MOL CELL BIOL, V26, P5759, DOI 10.1128/MCB.00271-06; Thye T, 2009, HUM MOL GENET, V18, P381, DOI 10.1093/hmg/ddn352; Tucci M, 2004, ARTHRITIS RHEUM-US, V50, P1842, DOI 10.1002/art.20266; van Wijk DF, 2010, ARTERIOSCL THROM VAS, V30, P1460, DOI 10.1161/ATVBAHA.110.205526; Vilades C, 2007, JAIDS-J ACQ IMM DEF, V44, P132, DOI 10.1097/QAI.0b013e31802b3147; Wang DX, 2006, AAPS J, V8, pE515, DOI 10.1208/aapsj080361; Wang Hua, 2007, V373, P157; Wang L, 2008, INT J IMMUNOGENET, V35, P45, DOI 10.1111/j.1744-313X.2007.00734.x; Wright EK, 2008, GENES IMMUN, V9, P419, DOI 10.1038/gene.2008.33; Yadav A, 2010, CLIN CHIM ACTA, V411, P1570, DOI 10.1016/j.cca.2010.07.006; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yao TC, 2004, ALLERGY, V59, P436, DOI 10.1111/j.1398-9995.2003.00438.x; Yuasa S, 2009, DIABETES RES CLIN PR, V86, P193, DOI 10.1016/j.diabres.2009.09.001; Zhou X, 2011, NAT METHODS, V8, P989, DOI 10.1038/nmeth.1772; Zhou ZHL, 1998, J IMMUNOL, V160, P3908; Zietz B, 2005, DIABETES OBES METAB, V7, P570, DOI 10.1111/j.1463-1326.2004.00436.x	96	36	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49498	10.1371/journal.pone.0049498	http://dx.doi.org/10.1371/journal.pone.0049498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166687	gold, Green Published, Green Submitted			2022-12-27	WOS:000311885300048
J	Werry, JM; Lee, SY; Lemckert, CJ; Otway, NM				Werry, Jonathan M.; Lee, Shing Y.; Lemckert, Charles J.; Otway, Nicholas M.			Natural or Artificial? Habitat-Use by the Bull Shark, Carcharhinus leucas	PLOS ONE			English	Article							MOVEMENT PATTERNS; NEGAPRION-BREVIROSTRIS; ENVIRONMENTAL IMPACTS; CANAL DEVELOPMENTS; FISH ASSEMBLAGES; ATLANTIC SALMON; LEMON SHARKS; SOUTH-AFRICA; SHORT-TERM; FLORIDA	Background: Despite accelerated global population declines due to targeted and illegal fishing pressure for many top-level shark species, the impacts of coastal habitat modification have been largely overlooked. We present the first direct comparison of the use of natural versus artificial habitats for the bull shark, Carcharhinus leucas, an IUCN 'Near-threatened' species - one of the few truly euryhaline sharks that utilises natural rivers and estuaries as nursery grounds before migrating offshore as adults. Understanding the value of alternate artificial coastal habitats to the lifecycle of the bull shark is crucial for determining the impact of coastal development on this threatened but potentially dangerous species. Methodology/Findings: We used longline surveys and long-term passive acoustic tracking of neonate and juvenile bull sharks to determine the ontogenetic value of natural and artificial habitats to bull sharks associated with the Nerang River and adjoining canals on the Gold Coast, Australia. Long-term movements of tagged sharks suggested a preference for the natural river over artificial habitat (canals). Neonates and juveniles spent the majority of their time in the upper tidal reaches of the Nerang River and undertook excursions into adjoining canals. Larger bull sharks ranged further and frequented the canals closer to the river mouth. Conclusions/Significance: Our work suggests with increased destruction of natural habitats, artificial coastal habitat may become increasingly important to large juvenile bull sharks with associated risk of attack on humans. In this system, neonate and juvenile bull sharks utilised the natural and artificial habitats, but the latter was not the preferred habitat of neonates. The upper reaches of tidal rivers, often under significant modification pressure, serve as nursery sites for neonates. Analogous studies are needed in similar systems elsewhere to assess the spatial and temporal generality of this research.	[Werry, Jonathan M.; Lee, Shing Y.] Griffith Univ, Australian Rivers Inst, Gold Coast, Qld, Australia; [Werry, Jonathan M.; Lee, Shing Y.] Griffith Univ, Sch Environm, Gold Coast, Qld, Australia; [Werry, Jonathan M.] Ocean & Coast Res, Gold Coast, Qld, Australia; [Lemckert, Charles J.] Griffith Univ, Griffith Sch Engn, Gold Coast, Qld, Australia; [Otway, Nicholas M.] Port Stephens Fisheries Inst, New S Wales Dept Primary Ind, Taylors Beach, NSW, Australia	Griffith University; Griffith University; Griffith University; NSW Department of Primary Industries	Werry, JM (corresponding author), Griffith Univ, Australian Rivers Inst, Gold Coast, Qld, Australia.	jwerry@oc-research.com	Lee, Joe S. Y./B-9185-2008	Lee, Joe S. Y./0000-0001-9336-2323; Lemckert, Charles/0000-0002-1811-858X	Sea World Research and Rescue Foundation Inc.; Queensland Fisheries	Sea World Research and Rescue Foundation Inc.; Queensland Fisheries	Funding was provided by the Sea World Research and Rescue Foundation Inc. http://www.seaworld.com.au/research-and-rescue.aspx and Queensland Fisheries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2010, J COASTAL RES, V26, P436, DOI 10.2112/08-1118.1; Baum JK, 2004, ECOL LETT, V7, P135, DOI 10.1111/j.1461-0248.2003.00564.x; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Beder S., 1993, NATURE SUSTAINABLE D; Benfer NP, 2010, J WATERW PORT COAST, V136, P91, DOI 10.1061/(ASCE)WW.1943-5460.0000029; BRES M, 1993, REV FISH BIOL FISHER, V3, P133, DOI 10.1007/BF00045229; Brunnschweiler JM, 2010, J FISH BIOL, V77, P1343, DOI 10.1111/j.1095-8649.2010.02757.x; Carlisle AB, 2009, MAR ECOL PROG SER, V380, P213, DOI 10.3354/meps07907; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Cavanagh R, 2003, AUSTR OC REG RED LIS; CHESSON J, 1978, ECOLOGY, V59, P211, DOI 10.2307/1936364; Clarke S, 2007, MAR RESOUR ECON, V22, P305, DOI 10.1086/mre.22.3.42629561; CLIFF G, 1991, S AFR J MARINE SCI, V10, P253; CLIFF G, 1984, COMP BIOCHEM PHYS A, V78, P167, DOI 10.1016/0300-9629(84)90111-7; Compagno Leonard J.V., 1995, Chondros, V6, P7; Connolly RM, 2003, ESTUAR COAST SHELF S, V58, P929, DOI 10.1016/j.ecss.2003.06.003; Conrath CL, 2010, MAR FRESHWATER RES, V61, P223, DOI 10.1071/MF09078; Cortes Enric, 2000, Reviews in Fisheries Science, V8, P299, DOI 10.1080/10641260008951115; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Ehrlich A.H., 1973, HUMAN ECOLOGY PROBLE; FAIRWEATHER PG, 1991, AUST J MAR FRESH RES, V42, P555, DOI 10.1071/MF9910555; FAO, 2007, FISHST CAPT PROD 195; Farrugia TJ, 2011, MAR FRESHWATER RES, V62, P648, DOI 10.1071/MF10173; Field IC, 2009, FISH FISH, V10, P323, DOI 10.1111/j.1467-2979.2009.00325.x; Froeschke J, 2010, MAR ECOL PROG SER, V407, P279, DOI 10.3354/meps08546; Froeschke JT, 2010, AQUAT BIOL, V11, P65, DOI 10.3354/ab00290; George RH, 2004, P N AM VET C, V18, P1249; GRUBER SH, 1988, B MAR SCI, V43, P61; Hammerschlag N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045958; Heithaus MR, 2009, LIMNOL OCEANOGR, V54, P472, DOI 10.4319/lo.2009.54.2.0472; Heupel MR, 2008, LIMNOL OCEANOGR-METH, V6, P327, DOI 10.4319/lom.2008.6.327; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Heupel MR, 2004, ENVIRON BIOL FISH, V71, P135, DOI 10.1023/B:EBFI.0000045710.18997.f7; Heupel MR, 2002, MAR FRESHWATER RES, V53, P543, DOI 10.1071/MF01132; Hoenig JM, 1990, ELASMOBRANCHS LIVING; HOLLAND KN, 1993, COPEIA, P495, DOI 10.2307/1447150; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; IUCN, 2008, TECH REP; Jennings DE, 2008, ENVIRON BIOL FISH, V83, P369, DOI 10.1007/s10641-008-9357-3; Jensen N.H., 1976, P539; Karl SA, 2011, CONSERV GENET, V12, P371, DOI 10.1007/s10592-010-0145-1; Knip DM, 2011, MAR ECOL PROG SER, V425, P233, DOI 10.3354/meps09006; Lacroix GL, 1996, J FISH BIOL, V49, P1086; Lacroix GL, 2000, ADV FISH TELEMETRY, P37; Last PR, 2006, SHARKS RAYS AUSTR; Lee SY, 2006, AUSTRAL ECOL, V31, P149, DOI 10.1111/j.1442-9993.2006.01581.x; Ley JA, 2002, MAR ECOL PROG SER, V245, P223, DOI 10.3354/meps245223; Manire C, 2001, T AM FISH SOC, V130, P1038, DOI 10.1577/1548-8659(2001)130&lt;1038:SCAWGN&gt;2.0.CO;2; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1049, DOI 10.1017/S0025315405012105; McCord ME, 2009, AFR J MAR SCI, V31, P107, DOI 10.2989/AJMS.2009.31.1.11.782; Micheli F, 1997, ECOL MONOGR, V67, P203, DOI 10.1890/0012-9615(1997)067[0203:EOPFBO]2.0.CO;2; Mirfenderesk H, 2009, J COASTAL RES, V25, P969, DOI 10.2112/06-0741.1; Mizuhara, 2003, J FOR RES, V8, P235, DOI DOI 10.1007/S10310-003-0032-4; Mollet HF, 2002, MAR FRESHWATER RES, V53, P503, DOI 10.1071/MF01083; MONTOYA RV, 1982, ENVIRON BIOL FISH, V7, P341, DOI 10.1007/BF00005568; Moreau S, 2008, J FISH BIOL, V72, P205, DOI 10.1111/j.1095-8649.2007.01705.x; MORTON RM, 1992, AUST J MAR FRESH RES, V43, P1359, DOI 10.1071/MF9921359; MORTON RM, 1989, ESTUAR COAST SHELF S, V28, P43, DOI 10.1016/0272-7714(89)90040-1; Moyle P., 1992, CONSERVATION BIOL; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Mylniczenko ND, 2006, AM J VET RES, V67, P1861, DOI 10.2460/ajvr.67.11.1861; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; O'Connell MT, 2007, ESTUAR COAST, V30, P567, DOI 10.1007/BF02841954; Otway NM, 2011, MAR FRESHWATER RES, V62, P607, DOI 10.1071/MF10139; Otway NM, 2011, VET CLIN PATH, V40, P361, DOI 10.1111/j.1939-165X.2011.00330.x; Papastamatiou YP, 2010, J EXP MAR BIOL ECOL, V386, P94, DOI 10.1016/j.jembe.2010.02.009; Pillans RD, 2006, J EXP MAR BIOL ECOL, V331, P145, DOI 10.1016/j.jembe.2005.10.013; Pillans RD, 2004, COMP BIOCHEM PHYS A, V138, P363, DOI 10.1016/j.cbpb.2004.05.006; Rangeley RW, 1998, ECOLOGY, V79, P943; Rasalato E, 2010, ENVIRON CONSERV, V37, P90, DOI 10.1017/S0376892910000317; Simpfendorfer CA, 2005, ESTUARIES, V28, P78, DOI 10.1007/BF02732755; Simpfendorfer CA, 2008, CAN J FISH AQUAT SCI, V65, P482, DOI 10.1139/F07-180; Skomal GB, 2007, FISHERIES MANAG ECOL, V14, P81, DOI 10.1111/j.1365-2400.2007.00528.x; Skomal G, 2010, CRC MAR BIOL SER, P459; SMITH MFL, 1992, AUST J MAR FRESH RES, V43, P325, DOI 10.1071/MF9920325; SNELSON FF, 1984, B MAR SCI, V34, P71; STAPLES DJ, 1985, MAR ECOL PROG SER, V23, P15, DOI 10.3354/meps023015; STOSKOPF M K, 1990, Journal of Aquariculture and Aquatic Sciences, V5, P33; Stoskopf Michael K., 1993, P809; STOSKOPF MK, 1984, J ZOO ANIM MED, V15, P116, DOI 10.2307/20094702; Thomson J. M., 1957, Proceedings of the Royal Society of Queensland, V68, P17; Thomson J.M., 1978, Proceedings of the Royal Society of Queensland, V89, P121; THORSON TB, 1973, PHYSIOL ZOOL, V46, P29, DOI 10.1086/physzool.46.1.30152514; THORSON TB, 1971, COPEIA, P336, DOI 10.2307/1442846; Tillett BJ, 2011, MAR FRESHWATER RES, V62, P850, DOI 10.1071/MF10271; Tillett J, 2012, J FISH BIOL, V80, P2140, DOI 10.1111/j.1095-8649.2012.03228.x; Turner RE, 1997, ESTUARIES, V20, P1, DOI 10.2307/1352716; Ubeda AJ, 2009, ENVIRON BIOL FISH, V84, P293, DOI 10.1007/s10641-008-9436-5; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; UNDERWOOD AJ, 1993, AUST J ECOL, V18, P99, DOI 10.1111/j.1442-9993.1993.tb00437.x; Voegeli FA, 1998, HYDROBIOLOGIA, V372, P35, DOI 10.1023/A:1017014903313; Vorenberg M. M., 1962, Copeia, V1962, P455, DOI 10.2307/1440934; Waltham NJ, 2007, J FISH BIOL, V71, P1613, DOI 10.1111/j.1095-8649.2007.01629.x; Waltham NJ, 2011, ESTUAR COAST SHELF S, V94, P192, DOI 10.1016/j.ecss.2011.06.003; Waltham NJ, 2006, MAR BIOL, V148, P1135, DOI 10.1007/s00227-005-0154-7; WATSKY MA, 1990, FISH PHYSIOL BIOCHEM, V8, P207, DOI 10.1007/BF00004459; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136; Werry JM, 2010, THESIS GRIFFITH U GO; Wetherbee BM, 2007, MAR ECOL PROG SER, V343, P283, DOI 10.3354/meps06920; Wiley TR, 2007, B MAR SCI, V80, P171; YAPP GA, 1986, COAST MANAGE, V14, P47, DOI 10.1080/08920758609361994; Yeiser BG, 2008, MAR FRESHWATER RES, V59, P489, DOI 10.1071/MF07181; Zeller BM, 1999, BULL SHARK CARCHARHI; Zigic S, 2005, ESTUAR COAST SHELF S, V63, P33, DOI 10.1016/j.ecss.2004.11.001; [No title captured]	110	38	39	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49796	10.1371/journal.pone.0049796	http://dx.doi.org/10.1371/journal.pone.0049796			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166772	Green Published, gold			2022-12-27	WOS:000311885300068
J	Onishi, Y; Kawamoto, T; Ueha, T; Kishimoto, K; Hara, H; Fukase, N; Toda, M; Harada, R; Minoda, M; Sakai, Y; Miwa, M; Kurosaka, M; Akisue, T				Onishi, Yasuo; Kawamoto, Teruya; Ueha, Takeshi; Kishimoto, Kenta; Hara, Hitomi; Fukase, Naomasa; Toda, Mitsunori; Harada, Risa; Minoda, Masaya; Sakai, Yoshitada; Miwa, Masahiko; Kurosaka, Masahiro; Akisue, Toshihiro			Transcutaneous Application of Carbon Dioxide (CO2) Induces Mitochondrial Apoptosis in Human Malignant Fibrous Histiocytoma In Vivo	PLOS ONE			English	Article							SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR; TUMOR-GROWTH; COPY NUMBER; PGC-1-ALPHA; CELLS; PNEUMOPERITONEUM; EXERCISE; ACTIVATION; MODEL	Mitochondria play an essential role in cellular energy metabolism and apoptosis. Previous studies have demonstrated that decreased mitochondrial biogenesis is associated with cancer progression. In mitochondrial biogenesis, peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) regulates the activities of multiple nuclear receptors and transcription factors involved in mitochondrial proliferation. Previously, we showed that overexpression of PGC-1 alpha leads to mitochondrial proliferation and induces apoptosis in human malignant fibrous histiocytoma (MFH) cells in vitro. We also demonstrated that transcutaneous application of carbon dioxide (CO2) to rat skeletal muscle induces PGC-1 alpha expression and causes an increase in mitochondrial proliferation. In this study, we utilized a murine model of human MFH to determine the effect of transcutaneous CO2 exposure on PGC-1 alpha expression, mitochondrial proliferation and cellular apoptosis. PGC-1 alpha expression was evaluated by quantitative real-time PCR, while mitochondrial proliferation was assessed by immunofluorescence staining and the relative copy number of mitochondrial DNA (mtDNA) was assessed by real-time PCR. Immunofluorescence staining and DNA fragmentation assays were used to examine mitochondrial apoptosis. We also evaluated the expression of mitochondrial apoptosis related proteins, such as caspases, cytochorome c and Bax, by immunoblot analysis. We show that transcutaneous application of CO2 induces PGC-1 alpha expression, and increases mitochondrial proliferation and apoptosis of tumor cells, significantly reducing tumor volume. Proteins involved in the mitochondrial apoptotic cascade, including caspase 3 and caspase 9, were elevated in CO2 treated tumors compared to control. We also observed an enrichment of cytochrome c in the cytoplasmic fraction and Bax protein in the mitochondrial fraction of CO2 treated tumors, highlighting the involvement of mitochondria in apoptosis. These data indicate that transcutaneous application of CO2 may represent a novel therapeutic tool in the treatment of human MFH.	[Onishi, Yasuo; Kawamoto, Teruya; Kishimoto, Kenta; Hara, Hitomi; Fukase, Naomasa; Toda, Mitsunori; Harada, Risa; Minoda, Masaya; Miwa, Masahiko; Kurosaka, Masahiro; Akisue, Toshihiro] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo 657, Japan; [Ueha, Takeshi] NeoChemir Inc, Chuo Ku, Kobe, Hyogo, Japan; [Sakai, Yoshitada] Himeji Dokkyo Univ, Fac Hlth Care Sci, Himeji, Hyogo, Japan	Kobe University; Himeji Dokkyo University	Kawamoto, T (corresponding author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kusunoki Cho, Kobe, Hyogo 657, Japan.	trykwmt@med.kobe-u.ac.jp	Akisue, Toshihiro/V-6187-2019	Akisue, Toshihiro/0000-0003-3708-4095; Kawamoto, Teruya/0000-0003-1845-7482	NeoChemir Inc.	NeoChemir Inc.	This study was supported by NeoChemir Inc. through the employment of Takeshi Ueha who conceived, designed and performed the experiments, and analyzed the data for this study. The hydro-gel used in this study was a gift from NeoChemir Inc. and is patented by Neochemir Inc. (publication number WO2004/002393; publication date January 8, 2004). There are no other patents, products in development or other marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Akimoto T, 2004, AM J PHYSIOL-CELL PH, V287, pC790, DOI 10.1152/ajpcell.00425.2003; Amuthan G, 2001, EMBO J, V20, P1910, DOI 10.1093/emboj/20.8.1910; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Are C, 2005, J LAPAROENDOSC ADV A, V15, P38, DOI 10.1089/lap.2005.15.38; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Chandel NS, 1999, FEBS LETT, V454, P173, DOI 10.1016/S0014-5793(99)00783-8; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Ekstrand MI, 2004, HUM MOL GENET, V13, P935, DOI 10.1093/hmg/ddh109; Gutt C N, 1998, Langenbecks Arch Chir Suppl Kongressbd, V115, P535; Hao YX, 2009, CLIN EXP MED, V9, P139, DOI 10.1007/s10238-008-0023-z; Hartmann BR, 1997, ANGIOLOGY, V48, P337, DOI 10.1177/000331979704800406; Higuchi M, 1997, J CLIN INVEST, V99, P1751, DOI 10.1172/JCI119339; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Irrcher I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003614; Iwabu M, 2010, NATURE, V464, P1313, DOI 10.1038/nature08991; Jacobi CA, 1998, DIGEST SURG, V15, P110, DOI 10.1159/000018603; Kiyozuka Y, 2001, CANCER GENET CYTOGEN, V127, P7, DOI 10.1016/S0165-4608(00)00413-1; Kluza J, 2004, ONCOGENE, V23, P7018, DOI 10.1038/sj.onc.1207936; LeDoussal V, 1996, CANCER-AM CANCER SOC, V77, P1823; Lee SW, 1999, DIS COLON RECTUM, V42, P477, DOI 10.1007/BF02234171; Lira VA, 2010, AM J PHYSIOL-ENDOC M, V299, pE145, DOI 10.1152/ajpendo.00755.2009; Mathew G, 1997, AUST NZ J SURG, V67, P289, DOI 10.1111/j.1445-2197.1997.tb01965.x; Moro L, 2008, CELL ONCOL, V30, P307, DOI 10.3233/CLO-2008-0427; Neuhaus SJ, 2004, SURG ENDOSC, V18, P1316, DOI 10.1007/s00464-003-8238-2; Oe K, 2011, BIOCHEM BIOPH RES CO, V407, P148, DOI 10.1016/j.bbrc.2011.02.128; Ojuka EO, 2003, FASEB J, V17, P675, DOI 10.1096/fj.02-0951com; Okada Y, 2010, ANTICANCER RES, V30, P3391; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Resch K L, 1994, Wien Med Wochenschr, V144, P45; RIGGS A, 1960, J GEN PHYSIOL, V43, P737, DOI 10.1085/jgp.43.4.737; Summers BA, 2002, J NEUROPHYSIOL, V88, P604, DOI 10.1152/jn.2002.88.2.604; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Takiguchi S, 2000, SURG ENDOSC-ULTRAS, V14, P41, DOI 10.1007/s004649900008; Vadasz I, 2008, J CLIN INVEST, V118, P752, DOI 10.1172/JCI29723; Verma Mukesh, 2007, Cancer Res, V67, P437, DOI 10.1158/0008-5472.CAN-06-4119; Wu H, 2002, SCIENCE, V296, P349, DOI 10.1126/science.1071163; Yamada S, 2006, EJSO-EUR J SURG ONC, V32, P303, DOI 10.1016/j.ejso.2006.01.002; Yu M, 2010, CLIN CHIM ACTA, V411, P679, DOI 10.1016/j.cca.2010.01.035	39	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49189	10.1371/journal.pone.0049189	http://dx.doi.org/10.1371/journal.pone.0049189			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166610	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300026
J	Bouslama-Oueghlani, L; Wehrle, R; Doulazmi, M; Chen, XR; Jaudon, F; Lemaigre-Dubreuil, Y; Rivals, I; Sotelo, C; Dusart, I				Bouslama-Oueghlani, Lamia; Wehrle, Rosine; Doulazmi, Mohamed; Chen, Xiao Ru; Jaudon, Fanny; Lemaigre-Dubreuil, Yolande; Rivals, Isabelle; Sotelo, Constantino; Dusart, Isabelle			Purkinje Cell Maturation Participates in the Control of Oligodendrocyte Differentiation: Role of Sonic Hedgehog and Vitronectin	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MOUSE CEREBELLUM; SPINAL-CORD; AXONAL REGENERATION; VENTRAL FOREBRAIN; ACTION-POTENTIALS; TRANSGENIC MICE; SLICE CULTURES; IN-VITRO; MYELINATION	Oligodendrocyte differentiation is temporally regulated during development by multiple factors. Here, we investigated whether the timing of oligodendrocyte differentiation might be controlled by neuronal differentiation in cerebellar organotypic cultures. In these cultures, the slices taken from newborn mice show very few oligodendrocytes during the first week of culture (immature slices) whereas their number increases importantly during the second week (mature slices). First, we showed that mature cerebellar slices or their conditioned media stimulated oligodendrocyte differentiation in immature slices thus demonstrating the existence of diffusible factors controlling oligodendrocyte differentiation. Using conditioned media from different models of slice culture in which the number of Purkinje cells varies drastically, we showed that the effects of these differentiating factors were proportional to the number of Purkinje cells. To identify these diffusible factors, we first performed a transcriptome analysis with an Affymetrix array for cerebellar cortex and then real-time quantitative PCR on mRNAs extracted from fluorescent flow cytometry sorted (FACS) Purkinje cells of L7-GFP transgenic mice at different ages. These analyses revealed that during postnatal maturation, Purkinje cells down-regulate Sonic Hedgehog and up-regulate vitronectin. Then, we showed that Sonic Hedgehog stimulates the proliferation of oligodendrocyte precursor cells and inhibits their differentiation. In contrast, vitronectin stimulates oligodendrocyte differentiation, whereas its inhibition with blocking antibodies abolishes the conditioned media effects. Altogether, these results suggest that Purkinje cells participate in controlling the timing of oligodendrocyte differentiation in the cerebellum through the developmentally regulated expression of diffusible molecules such as Sonic Hedgehog and vitronectin.	[Bouslama-Oueghlani, Lamia; Wehrle, Rosine; Doulazmi, Mohamed; Chen, Xiao Ru; Lemaigre-Dubreuil, Yolande; Sotelo, Constantino; Dusart, Isabelle] Univ Paris 06, Paris, France	UDICE-French Research Universities; Sorbonne Universite	Bouslama-Oueghlani, L (corresponding author), Univ Paris 06, Paris, France.	isabelle.dusart@upmc.fr	Sotelo, Constantino/G-3397-2015; Jaudon, Fanny/AAB-8695-2022; Rivals, Isabelle/AAE-7971-2022	Jaudon, Fanny/0000-0001-7648-0977; Rivals, Isabelle/0000-0002-8736-7010; Sotelo, Constantino/0000-0001-8051-2492; Doulazmi, Mohamed/0000-0002-0313-1490; Dusart, Isabelle/0000-0002-3211-4323				Alberta JA, 2001, MOL CELL NEUROSCI, V18, P434, DOI 10.1006/mcne.2001.1026; BARRES BA, 1993, CURR BIOL, V3, P489, DOI 10.1016/0960-9822(93)90039-Q; BARRES BA, 1994, DEVELOPMENT, V120, P1097; BARTLETT WP, 1991, DEV BIOL, V147, P239, DOI 10.1016/S0012-1606(05)80021-1; Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhat RV, 1996, GLIA, V17, P169; Blaschuk KL, 2000, DEVELOPMENT, V127, P1961; Boukhtouche F, 2006, J NEUROSCI, V26, P1531, DOI 10.1523/JNEUROSCI.4636-05.2006; Bouslama-Oueghlani L, 2005, DEV BIOL, V285, P409, DOI 10.1016/j.ydbio.2005.07.003; Bouslama-Oueghlani L, 2003, J NEUROSCI, V23, P8318; Burne JF, 1996, J NEUROSCI, V16, P2064; Buttery PC, 1999, MOL CELL NEUROSCI, V14, P199, DOI 10.1006/mcne.1999.0781; Casella GTB, 2004, J NEUROSCI METH, V139, P1, DOI 10.1016/j.jneumeth.2004.04.008; Charles P, 2000, P NATL ACAD SCI USA, V97, P7585, DOI 10.1073/pnas.100076197; Chojnacki A, 2004, J NEUROSCI, V24, P10888, DOI 10.1523/JNEUROSCI.3302-04.2004; COLE JS, 1994, J NEUROSCI, V14, P6956; CONSTAM DB, 1994, EUR J NEUROSCI, V6, P766, DOI 10.1111/j.1460-9568.1994.tb00988.x; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Dahmane N, 1999, DEVELOPMENT, V126, P3089; Danesin C, 2006, J NEUROSCI, V26, P5037, DOI 10.1523/JNEUROSCI.0715-06.2006; Demerens C, 1996, P NATL ACAD SCI USA, V93, P9887, DOI 10.1073/pnas.93.18.9887; Draper Smith, 1981, APPL REGRESSION ANAL; DUBOISDALCQ M, 1986, J CELL BIOL, V102, P384, DOI 10.1083/jcb.102.2.384; Durand B, 2000, BIOESSAYS, V22, P64; Dusart I, 1997, J NEUROSCI, V17, P3710; Emery B, 2010, SCIENCE, V330, P779, DOI 10.1126/science.1190927; FRIEDE RL, 1982, BRAIN RES, V235, P335, DOI 10.1016/0006-8993(82)91012-5; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Ghoumari AM, 2003, P NATL ACAD SCI USA, V100, P7953, DOI 10.1073/pnas.1332667100; Ghoumari AM, 2002, J NEUROSCI, V22, P3531; Gil JE, 2009, FEBS LETT, V583, P561, DOI 10.1016/j.febslet.2008.12.061; Gupta SK, 2010, J NEUROSCI, V30, P2755, DOI 10.1523/JNEUROSCI.4218-09.2010; HSIEH ST, 1994, J NEUROSCI, V14, P6392; Kapfhammer JP, 2004, PROG HISTOCHEM CYTO, V39, P131, DOI 10.1016/j.proghi.2004.07.002; Laursen LS, 2007, NEURON GLIA BIOL, V3, P367, DOI 10.1017/S1740925X08000161; Lelievre V, 2006, REGUL PEPTIDES, V137, P58, DOI 10.1016/j.regpep.2006.04.024; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; LOUIS JC, 1992, GLIA, V6, P30, DOI 10.1002/glia.440060105; Loulier K, 2006, J NEUROCHEM, V98, P530, DOI 10.1111/j.1471-4159.2006.03896.x; Lutfalla G, 2006, METHOD ENZYMOL, V410, P386, DOI 10.1016/S0076-6879(06)10019-1; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mastronardi FG, 2003, MULT SCLER, V9, P362, DOI 10.1191/1352458503ms924oa; MCKINNON RD, 1993, J CELL BIOL, V121, P1397, DOI 10.1083/jcb.121.6.1397; Merchan P, 2007, MOL CELL NEUROSCI, V36, P355, DOI 10.1016/j.mcn.2007.07.012; Nash B, 2011, J NEUROSCI, V31, P13028, DOI 10.1523/JNEUROSCI.1449-11.2011; Poncet C, 1996, MECH DEVELOP, V60, P13, DOI 10.1016/S0925-4773(96)00595-3; Pons S, 2000, DEVELOPMENT, V127, P333; Pons S, 2001, DEVELOPMENT, V128, P1481; Poulain FE, 2008, J NEUROSCI, V28, P7387, DOI 10.1523/JNEUROSCI.1942-08.2008; Rosenberg SS, 2008, P NATL ACAD SCI USA, V105, P14662, DOI 10.1073/pnas.0805640105; SARLIEVE LL, 1980, BRAIN RES, V189, P79, DOI 10.1016/0006-8993(80)90008-6; Schnadelbach O, 2001, MOL CELL NEUROSCI, V17, P1084, DOI 10.1006/mcne.2001.0961; Sherrard RM, 1997, DEV BRAIN RES, V98, P102, DOI 10.1016/S0165-3806(96)00174-5; SOBEL RA, 1995, J NEUROPATH EXP NEUR, V54, P202, DOI 10.1097/00005072-199503000-00007; SOLBACH S, 1991, ANAT EMBRYOL, V184, P103, DOI 10.1007/BF00942742; Sotelo C, 2008, J COMP NEUROL, V506, P240, DOI 10.1002/cne.21501; Soula C, 2001, DEVELOPMENT, V128, P1369; Spassky N, 2001, DEVELOPMENT, V128, P4993; Stevens B, 2002, NEURON, V36, P855, DOI 10.1016/S0896-6273(02)01067-X; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Tekki-Kessaris N, 2001, DEVELOPMENT, V128, P2545; Tomomura M, 2001, EUR J NEUROSCI, V14, P57, DOI 10.1046/j.0953-816x.2001.01624.x; Traiffort E, 1999, EUR J NEUROSCI, V11, P3199, DOI 10.1046/j.1460-9568.1999.00777.x; Trapp BD, 1997, J CELL BIOL, V137, P459, DOI 10.1083/jcb.137.2.459; Tsutsui K, 2006, CEREBELLUM, V5, P89, DOI 10.1080/14734220600697211; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wallace VA, 1999, CURR BIOL, V9, P445, DOI 10.1016/S0960-9822(99)80195-X; Wang SL, 1998, NEURON, V21, P63, DOI 10.1016/S0896-6273(00)80515-2; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Wechsler-Reya RJ, 2001, TRENDS NEUROSCI, V24, P680, DOI 10.1016/S0166-2236(00)02058-0; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	76	21	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49015	10.1371/journal.pone.0049015	http://dx.doi.org/10.1371/journal.pone.0049015			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155445	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900080
J	Chai, SL; Healey, JR; Tanner, EVJ				Chai, Shauna-Lee; Healey, John R.; Tanner, Edmund V. J.			Evaluation of Forest Recovery over Time and Space Using Permanent Plots Monitored over 30 Years in a Jamaican Montane Rain Forest	PLOS ONE			English	Article						Doubt in authoritycard instructions; HSL	SPECIES COMPOSITION; HURRICANE DISTURBANCE; BLUE MOUNTAINS; SECONDARY FORESTS; LAND-USE; GROWTH; SUCCESSION; CHRONOSEQUENCE; FLORISTICS; MANAGEMENT	Conservation of tropical forest biodiversity increasingly depends on its recovery following severe human disturbance. Our ability to measure recovery using current similarity indices suffers from two limitations: different sized individuals are treated as equal, and the indices are proportionate (a community with twice the individuals of every species as compared with the reference community would be assessed as identical). We define an alternative recovery index for trees - the Tanner index, as the mean of the quantitative Bray-Curtis similarity indices of species composition for stem density and for basal area. We used the new index to compare the original (pre-gap) and post-gap composition of five experimental gap plots (each 90-100 m(2)) and four control plots over 24-35 years in the Blue Mountains of Jamaica. After 24-35 years, these small gaps surrounded by undisturbed forest had recovered 68% of the sum of per species stem density and 29% of the sum of per species basal area, a recovery index of 47%. Four endemic species were especially reduced in density and basal area. With the incorporation of basal area and stem density, our index reduces over-estimations of forest recovery obtained using existing similarity indices (by 24%-41%), and thus yields more accurate estimates of forest conservation status. Finally, our study indicates that the two kinds of comparisons: 1) over time between pre-gap and post-gap composition and 2) over space between gap plots and spatial controls (space-for-time substitution) yield broadly similar results, which supports the value of using space-for-time substitutions in studying forest recovery, at least in this tropical montane forest.	[Chai, Shauna-Lee; Tanner, Edmund V. J.] Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England; [Chai, Shauna-Lee] Alberta Innovates Technol Futures, Ecosyst Management Unit, Vegreville, AB, Canada; [Healey, John R.] Bangor Univ, Sch Environm Nat Resources & Geog, Bangor LL57 2UW, Gwynedd, Wales	University of Cambridge; Alberta Innovates; Bangor University	Chai, SL (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge CB2 3EA, England.	schai@cantab.net	Healey, John R/J-3719-2016	Healey, John R/0000-0002-5398-2293				Adams, 1972, FLOWERING PLANTS JAM; Aide TM, 2000, RESTOR ECOL, V8, P328, DOI 10.1046/j.1526-100x.2000.80048.x; Aide TM, 1994, RESTOR ECOL, V2, P219, DOI [10.1111/j.1526-100X.1994.tb00054.x, DOI 10.1111/J.1526-100X.1994.TB00054.X]; Baker TR, 2010, J APPL ECOL, V47, P1159, DOI 10.1111/j.1365-2664.2010.01885.x; BELLINGHAM PJ, 1995, ECOLOGY, V76, P2562, DOI 10.2307/2265828; Bellingham PJ, 2000, BIOTROPICA, V32, P378, DOI 10.1111/j.1744-7429.2000.tb00484.x; Bellingham PJ, 2005, J VEG SCI, V16, P675; BROWN ND, 1992, PHILOS T R SOC B, V335, P369, DOI 10.1098/rstb.1992.0028; Chai SL, 2011, J ECOL, V99, P113, DOI 10.1111/j.1365-2745.2010.01742.x; Chai SL, 2009, BIOL CONSERV, V142, P2484, DOI 10.1016/j.biocon.2009.05.020; Chao A, 2005, ECOL LETT, V8, P148, DOI 10.1111/j.1461-0248.2004.00707.x; Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727; Chazdon RL, 2007, PHILOS T R SOC B, V362, P273, DOI 10.1098/rstb.2006.1990; Clark MR, 2011, ECOL SOC, V16; Colwell RK, 2013, ESTIMATES STAT ESTIM; DALLING JW, 1994, BIOTROPICA, V26, P392, DOI 10.2307/2389233; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; EWEL J, 1980, BIOTROPICA, V12, P2, DOI 10.2307/2388149; Feldpausch TR, 2007, GLOBAL CHANGE BIOL, V13, P967, DOI 10.1111/j.1365-2486.2007.01344.x; Flynn DFB, 2010, BIOTROPICA, V42, P149, DOI 10.1111/j.1744-7429.2009.00581.x; Goodland T., 1996, INVASION JAMAICAN MO; Goodland T, 1998, WOODY PLANT SPECIES; Grimm V, 1997, OECOLOGIA, V109, P323, DOI 10.1007/s004420050090; GRUBB PJ, 1976, J ARNOLD ARBORETUM, V57, P313; GRUBB PJ, 1977, ANNU REV ECOL SYST, V8, P83, DOI 10.1146/annurev.es.08.110177.000503; Guariguata MR, 1997, PLANT ECOL, V132, P107, DOI 10.1023/A:1009726421352; Harrison ME, 2012, TROP CONSERV SCI, V5, P1; HEALEY JR, 1990, THESIS U CAMBRIDGE C; Holz S, 2009, FOREST ECOL MANAG, V258, P1629, DOI 10.1016/j.foreco.2009.07.023; Hooper E, 2005, J APPL ECOL, V42, P1165, DOI 10.1111/j.1365-2664.2005.01106.x; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Johnson EA, 2008, ECOL LETT, V11, P419, DOI 10.1111/j.1461-0248.2008.01173.x; Letcher SG, 2009, BIOTROPICA, V41, P608, DOI 10.1111/j.1744-7429.2009.00517.x; Martin PH, 2004, BIOTROPICA, V36, P297; McDonald MA, 2003, FOREST ECOL MANAG, V175, P379, DOI 10.1016/S0378-1127(02)00132-9; McDonald MA, 2000, FOREST ECOL MANAG, V139, P257, DOI 10.1016/S0378-1127(00)00442-4; Norden N, 2009, ECOL LETT, V12, P385, DOI 10.1111/j.1461-0248.2009.01292.x; Okansen J, 2005, VEGAN COMMUNITY ECOL; Pena-Claros M, 2003, BIOTROPICA, V35, P450, DOI 10.1111/j.1744-7429.2003.tb00602.x; PETERSON CJ, 1995, ECOLOGY, V76, P763, DOI 10.2307/1939342; SALDARRIAGA JG, 1988, J ECOL, V76, P938, DOI 10.2307/2260625; Sommerville MM, 2011, BIOL CONSERV, V144, P2832, DOI 10.1016/j.biocon.2011.07.036; Sugden A. M., 1985, J TROP ECOL, V1, P329; SWAINE MD, 1988, VEGETATIO, V75, P81, DOI 10.1007/BF00044629; Tanner EVJ, 2006, J ECOL, V94, P1003, DOI 10.1111/j.1365-2745.2006.01149.x; TANNER EVJ, 1980, J ECOL, V68, P573, DOI 10.2307/2259423; TANNER EVJ, 1977, J ECOL, V65, P883, DOI 10.2307/2259385; TANNER EVJ, 1991, BIOTROPICA, V23, P513, DOI 10.2307/2388274; Team RDC, 2019, R LANG ENV STAT COMP; Toledo M, 2006, BIOTROPICA, V38, P161, DOI 10.1111/j.1744-7429.2006.00120.x; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; UHL C, 1988, J ECOL, V76, P663, DOI 10.2307/2260566; Uriarte M, 2009, ECOL MONOGR, V79, P423, DOI 10.1890/08-0707.1; Whitmore TC, 1996, PHILOS T R SOC B, V351, P1195, DOI 10.1098/rstb.1996.0102; Wright SJ, 2005, TRENDS ECOL EVOL, V20, P553, DOI 10.1016/j.tree.2005.07.009	55	11	12	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48859	10.1371/journal.pone.0048859	http://dx.doi.org/10.1371/journal.pone.0048859			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155417	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900051
J	Chen, YH; Wei, J; Wang, MZ; Shi, ZB; Gong, WM; Zhang, M				Chen, Yuhong; Wei, Jia; Wang, Mingzhu; Shi, Zhubing; Gong, Weimin; Zhang, Min			The Crystal Structure of Arabidopsis VSP1 Reveals the Plant Class C-Like Phosphatase Structure of the DDDD Superfamily of Phosphohydrolases	PLOS ONE			English	Article							VEGETATIVE STORAGE PROTEIN; ACID-PHOSPHATASE; JASMONATE; CRYSTALLOGRAPHY; BACTERIAL; SYSTEM	Arabidopsis thaliana vegetative storage proteins, VSP1 and VSP2, are acid phosphatases and belong to the haloacid dehalogenase (HAD) superfamily. In addition to their potential nutrient storage function, they were thought to be involved in plant defense and flower development. To gain insights into the architecture of the protein and obtain clues about its function, we have tested their substrate specificity and solved the structure of VSP1. The acid phosphatase activities of these two enzymes require divalent metal such as magnesium ion. Conversely, the activity of these two enzymes is inhibited by vanadate and molybdate, but is resistant to inorganic phosphate. Both VSP1 and VSP2 did not exhibit remarkable activities to any physiological substrates tested. In the current study, we presented the crystal structure of recombinant VSP1 at 1.8 angstrom resolution via the selenomethionine single-wavelength anomalous diffraction (SAD). Specifically, an alpha-helical cap domain on the top of the alpha/beta core domain is found to be involved in dimerization. In addition, despite of the low sequence similarity between VSP1 and other HAD enzymes, the core domain of VSP1 containing conserved active site and catalytic machinery displays a classic haloacid dehalogenase fold. Furthermore, we found that VSP1 is distinguished from bacterial class C acid phosphatase P4 by several structural features. To our knowledge, this is the first study to reveal the crystal structure of plant vegetative storage proteins.	[Chen, Yuhong; Zhang, Min] Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China	Anhui University	Chen, YH (corresponding author), Anhui Univ, Sch Life Sci, Hefei 230039, Anhui, Peoples R China.	wgong@sun5.ibp.ac.cn; zhmin07@ustc.edu	Wei, Jia/N-6628-2019; Shi, Zhubing/F-9490-2010	Wei, Jia/0000-0002-7301-3297; Shi, Zhubing/0000-0002-9624-4960				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Allen KN, 2009, CURR OPIN STRUC BIOL, V19, P658, DOI 10.1016/j.sbi.2009.09.008; Allen KN, 2004, TRENDS BIOCHEM SCI, V29, P495, DOI 10.1016/j.tibs.2004.07.008; BERGER S, 1995, PLANT MOL BIOL, V27, P933, DOI 10.1007/BF00037021; Berger S, 2002, PHYSIOL PLANTARUM, V114, P85, DOI 10.1046/j.0031-9317.2001.1140112.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Calderone V, 2004, J MOL BIOL, V335, P761, DOI 10.1016/j.jmb.2003.10.050; DEWALD DB, 1992, J BIOL CHEM, V267, P15958; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Ellis C, 2001, PLANT CELL, V13, P1025, DOI 10.1105/tpc.13.5.1025; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felts RL, 2007, BIOCHEMISTRY-US, V46, P11110, DOI 10.1021/bi701016m; Gamboa A, 2001, BIOCHEM BIOPH RES CO, V288, P1018, DOI 10.1006/bbrc.2001.5875; Gerlach G, 2006, J BACTERIOL, V188, P6719, DOI 10.1128/JB.00432-06; Guerineau F, 2003, J EXP BOT, V54, P1153, DOI 10.1093/jxb/erg123; Kemmer G, 2001, J BACTERIOL, V183, P3974, DOI 10.1128/JB.183.13.3974-3981.2001; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Liu YL, 2005, PLANT PHYSIOL, V139, P1545, DOI 10.1104/pp.105.066837; Ljusberg J, 1999, BIOCHEM J, V343, P63, DOI 10.1042/0264-6021:3430063; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Penheiter AR, 1997, PLANT PHYSIOL, V114, P597, DOI 10.1104/pp.114.2.597; Shi ZB, 2010, ACTA CRYSTALLOGR F, V66, P201, DOI 10.1107/S1744309109053688; Singh H, 2010, J MOL BIOL, V404, P639, DOI 10.1016/j.jmb.2010.09.065; STASWICK PE, 1994, ANNU REV PLANT PHYS, V45, P303, DOI 10.1146/annurev.pp.45.060194.001511; Thaller MC, 1998, PROTEIN SCI, V7, P1647, DOI 10.1002/pro.5560070722; WILLIAMSON VM, 1991, PLANT PHYSIOL, V97, P139, DOI 10.1104/pp.97.1.139; Zhong PY, 1997, PLANT PHYSIOL, V113, P479, DOI 10.1104/pp.113.2.479	30	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49421	10.1371/journal.pone.0049421	http://dx.doi.org/10.1371/journal.pone.0049421			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166664	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900141
J	Deaner, RO; Geary, DC; Puts, DA; Ham, SA; Kruger, J; Fles, E; Winegard, B; Grandis, T				Deaner, Robert O.; Geary, David C.; Puts, David A.; Ham, Sandra A.; Kruger, Judy; Fles, Elizabeth; Winegard, Bo; Grandis, Terry			A Sex Difference in the Predisposition for Physical Competition: Males Play Sports Much More than Females Even in the Contemporary US	PLOS ONE			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; CROSS-CULTURAL-ANALYSIS; HIGH-SCHOOL SPORTS; GENDER-DIFFERENCES; EVOLUTIONARY PERSPECTIVE; PERSONALITY-TRAITS; ADOLESCENTS SPEND; CHILDRENS PLAY; TITLE-IX; PARTICIPATION	Much evidence indicates that men experienced an evolutionary history of physical competition, both one-on-one and in coalitions. We thus hypothesized that, compared to girls and women, boys and men will possess a greater motivational predisposition to be interested in sports, especially team sports. According to most scholars, advocacy groups, and the United States courts, however, this hypothesis is challenged by modest sex differences in organized school sports participation in the contemporary U.S., where females comprise 42% of high school participants and 43% of intercollegiate participants. We conducted three studies to test whether organized school sports participation data underestimate the actual sex difference in sports participation. Study 1 analyzed the American Time Use Survey, which interviewed 112,000 individuals regarding their activities during one day. Females accounted for 51% of exercise (i.e., non-competitive) participations, 24% of total sports participations, and 20% of team sports participations. These sex differences were similar for older and younger age groups. Study 2 was based on systematic observations of sports and exercise at 41 public parks in four states. Females accounted for 37% of exercise participations, 19% of individual sports participations, and 10% of team sports participations. Study 3 involved surveying colleges and universities about intramural sports, which primarily consist of undergraduate participation in team sports. Across 34 institutions, females accounted for 26% of registrations. Nine institutions provided historical data, and these did not indicate that the sex difference is diminishing. Therefore, although efforts to ensure more equitable access to sports in the U.S. (i.e., Title IX) have produced many benefits, patterns of sports participation do not challenge the hypothesis of a large sex difference in interest and participation in physical competition.	[Deaner, Robert O.; Fles, Elizabeth] Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA	Grand Valley State University	Deaner, RO (corresponding author), Grand Valley State Univ, Dept Psychol, Allendale, MI 49401 USA.	deanerr@gvsu.edu	Puts, David A/E-5453-2011	Ham, Sandra/0000-0002-1966-2413; Puts, David/0000-0002-6478-1980				Abe T, 2003, BRIT J SPORT MED, V37, P436, DOI 10.1136/bjsm.37.5.436; Adams DB, 1983, BEHAV SCI RES, V18, P196, DOI [10.1177/106939718301800302, DOI 10.1177/106939718301800302]; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Archer J, 2009, BEHAV BRAIN SCI, V32, P249, DOI 10.1017/S0140525X09990951; Benenson JF, 2009, PSYCHOL SCI, V20, P184, DOI 10.1111/j.1467-9280.2009.02269.x; BERENBAUM SA, 1995, DEV PSYCHOL, V31, P31, DOI 10.1037/0012-1649.31.1.31; Berenbaum SA, 1999, HORM BEHAV, V35, P102, DOI 10.1006/hbeh.1998.1503; Berenbaum SA, 2011, FRONT NEUROENDOCRIN, V32, P183, DOI 10.1016/j.yfrne.2011.03.001; BLINDE EM, 1992, SOCIOL QUART, V33, P521, DOI 10.1111/j.1533-8525.1992.tb00141.x; Brake Deborah., 2010, GETTING GAME TITLE 9; Brewer G, 2012, PERS INDIV DIFFER, V53, P640, DOI 10.1016/j.paid.2012.05.010; Brown D. E., 1991, HUMAN UNIVERSALS; Bureau of Labor Statistics (n.d.), AM TIM US SURV ACT L; BUSS DM, 1993, PSYCHOL REV, V100, P204, DOI 10.1037/0033-295X.100.2.204; Campbell A, 1999, BEHAV BRAIN SCI, V22, P203, DOI 10.1017/S0140525X99001818; Carroll DM, 2000, INTERDISCIPLINARY ST; Cashdan Elizabeth, 1996, Evolutionary Anthropology, V5, P134, DOI 10.1002/(SICI)1520-6505(1996)5:4<134::AID-EVAN3>3.0.CO;2-G; Chick G E, 1984, Exerc Sport Sci Rev, V12, P307; Chick Garry, 1997, CROSS-CULT RES, V31, P249, DOI DOI 10.1177/106939719703100304; Chick Garry, 1998, CROSS-CULT RES, V32, P185, DOI [10.1177/106939719803200204, DOI 10.1177/106939719803200204]; Craig S, 2002, SPORTS GAMES ANCIENT; De Block A, 2009, PERSPECT BIOL MED, V52, P1, DOI 10.1353/pbm.0.0063; Deaner R. O., 2011, Journal of Sport Behavior, V34, P325; Deaner RO, 2006, EVOL HUM BEHAV, V27, P63, DOI 10.1016/j.evolhumbehav.2005.04.005; Deaner RO, 2012, ARCH SEX BE IN PRESS; Deaner RO, 2011, EVOL PSYCHOL-US, V9, P600; Deaner Robert O., 2012, SEX DIFFERENCES SPOR; Dietz-Uhler B., 2000, Journal of Sport Behavior, V23, P219; DIPIETRO JA, 1981, DEV PSYCHOL, V17, P50, DOI 10.1037/0012-1649.17.1.50; Eccles JS, 2003, J SOC ISSUES, V59, P865, DOI 10.1046/j.0022-4537.2003.00095.x; Edwards CP, 2000, CROSS-CULT RES, V34, P318, DOI 10.1177/106939710003400402; Ekelund U, 2011, BRIT J SPORT MED, V45, P859, DOI 10.1136/bjsports-2011-090190; Ellis L., 2008, SEX DIFFERENCES SUMM; Evans EM, 2002, SEX ROLES, V47, P153, DOI 10.1023/A:1021047122532; Faurie C, 2004, EVOL HUM BEHAV, V25, P1, DOI 10.1016/S1090-5138(03)00064-3; Ferrar KE, 2012, HLTH ED BEH IN PRESS; Frederick JA, 1995, TIME GOES TIME USE C; Fredricks JA, 2005, J SPORT EXERCISE PSY, V27, P3, DOI 10.1123/jsep.27.1.3; Frisen L, 2009, J CLIN ENDOCR METAB, V94, P3432, DOI 10.1210/jc.2009-0636; Gangestad SW, 2006, PSYCHOL INQ, V17, P75, DOI 10.1207/s15327965pli1702_1; Ganz W, 1991, J BROADCAST ELECTRON, V35, P233; Gat Azar, 2006, WAR HUMAN CIVILIZATI; Gavora J., 2001, TILTING PLAYING FIEL; Geary D.C., 2010, MALE FEMALE EVOLUTIO; Geary DC, 2003, DEV REV, V23, P444, DOI 10.1016/j.dr.2003.08.001; George BG, 2010, YALE J LAW FEMINISM, P22; GILL DL, 1986, SEX ROLES, V15, P233, DOI 10.1007/BF00288314; GILL DL, 1988, INT J SPORT PSYCHOL, V19, P145; Gneezy U, 2009, ECONOMETRICA, V77, P1637, DOI 10.3982/ECTA6690; Guttman A., 1991, WOMENS SPORTS HIST; Guttman Allen, 2004, SPORTS 1 5 MILLENNIA; Ham SA, 2009, J PHYS ACT HEALTH, V6, P6, DOI 10.1123/jpah.6.1.6; HARRIS JR, 1995, PSYCHOL REV, V102, P458, DOI 10.1037/0033-295X.102.3.458; Hogshead-Makar N, 2007, EQUAL PLAY TITLE 9 S, P218; Jacobs JE, 2002, CHILD DEV, V73, P509, DOI 10.1111/1467-8624.00421; James J. D., 2002, J SPORT BEHAV, V25, P260; Kane M. J., 1989, Arena Review, V13, P77; Keeley LH., 1996, WAR CIVILIZATION; Kimmel M., 1990, SPORT MEN GENDER ORD, P55; KIRSHNIT CE, 1989, J YOUTH ADOLESCENCE, V18, P601, DOI 10.1007/BF02139076; Koivula N., 1999, Journal of Sport Behavior, V22, P360; Larson RW, 1999, PSYCHOL BULL, V125, P701, DOI 10.1037/0033-2909.125.6.701; Larson RW, 2001, AM J COMMUN PSYCHOL, V29, P565, DOI 10.1023/A:1010422017731; Lassek WD, 2009, EVOL HUM BEHAV, V30, P322, DOI 10.1016/j.evolhumbehav.2009.04.002; LEVER J, 1978, AM SOCIOL REV, V43, P471, DOI 10.2307/2094773; Lieber Steeg J, 2007, NEW OWNERS STAKE CLA; Lippa RA, 2010, ARCH SEX BEHAV, V39, P619, DOI 10.1007/s10508-008-9380-7; Llaurens V, 2009, J EVOLUTION BIOL, V22, P1854, DOI 10.1111/j.1420-9101.2009.01793.x; Lombardo MP, 2012, EVOL PSYCHOL-US, V10, P1; LOW BS, 1989, J COMP PSYCHOL, V103, P311, DOI 10.1037/0735-7036.103.4.311; Lunn PD, 2010, SOC SCI MED, V70, P711, DOI 10.1016/j.socscimed.2009.11.006; MACCOBY EE, 1988, DEV PSYCHOL, V24, P755, DOI 10.1037/0012-1649.24.6.755; Marlowe FW, 2007, CROSS-CULT RES, V41, P170, DOI 10.1177/1069397106297529; MASTERS KS, 1993, RES Q EXERCISE SPORT, V64, P134, DOI 10.1080/02701367.1993.10608790; MAYHEW JL, 1990, EUR J APPL PHYSIOL, V60, P133, DOI 10.1007/BF00846033; McDonald MM, 2012, PHILOS T R SOC B, V367, P670, DOI 10.1098/rstb.2011.0301; Media Life, 2002, MEDIA LIFE; Messner M., 2002, TAKING FIELD WOMEN M; Messner M.A., 1992, POWER PLAY SPORTS PR; Messner MA, 2003, J SPORT SOC ISSUES, V27, P38, DOI 10.1177/0193732502239583; Messner MA, 1996, SOCIOL INQ, V66, P422, DOI 10.1111/j.1475-682X.1996.tb01185.x; Miller, 2000, MATING MIND SEXUAL C; MURDOCK GP, 1973, ETHNOLOGY, V12, P203, DOI 10.2307/3773347; National Center for Education Statistics, 2012, COLL NAV; National Federation of State High School Associations. (NFHS; 2010), 2009, 2009 10 HIGH SCH ATH; NCAA Research, 2010, NCAA SPORTS SPONS PA; Neave N, 2008, PERS INDIV DIFFER, V45, P373, DOI 10.1016/j.paid.2008.05.007; Nielsen G, 2011, EUR PHYS EDUC REV, V17, P69, DOI 10.1177/1356336X11402267; Ogles B. M., 2003, Journal of Sport Behavior, V26, P69; Puts DA, 2012, J SEX RES, V49, P227, DOI 10.1080/00224499.2012.658924; Puts DA, 2010, EVOL HUM BEHAV, V31, P157, DOI 10.1016/j.evolhumbehav.2010.02.005; Rees DI, 2010, ECON EDUC REV, V29, P751, DOI 10.1016/j.econedurev.2010.04.008; Rhoads S. E., 2004, TAKING SEX DIFFERENC; ROBERTS JM, 1959, AM ANTHROPOL, V61, P597, DOI 10.1525/aa.1959.61.4.02a00050; Rose AJ, 2006, PSYCHOL BULL, V132, P98, DOI 10.1037/0033-2909.132.1.98; Sabo D, 2007, EQUAL PLAY TITLE 9 S, P276; SANDBERG DE, 1994, ARCH SEX BEHAV, V23, P645, DOI 10.1007/BF01541817; Sax LJ., 2008, GENDER GAP COLL MAXI; Schlegel A, 1989, ADOLESCENTS PLAY CON, P33; Schmitt DP, 2008, J PERS SOC PSYCHOL, V94, P168, DOI 10.1037/0022-3514.94.1.168; Schulte-Hostedde AI, 2008, EVOL PSYCHOL-US, V6, P113; Seiler S, 2007, MED SCI SPORT EXER, V39, P534, DOI 10.1249/01.mss.0000247005.17342.2b; Shakib S, 2003, AM BEHAV SCI, V46, P1405, DOI 10.1177/0002764203046010008; Sheaffer L, 2005, IDENTITY CRISIS WHY; SIPES RG, 1973, AM ANTHROPOL, V75, P64, DOI 10.1525/aa.1973.75.1.02a00040; Stamatakis E, 2008, BRIT J SPORT MED, V42, P901, DOI 10.1136/bjsm.2008.048082; Stevenson B, 2007, CONTEMP ECON POLICY, V25, P486, DOI 10.1111/j.1465-7287.2007.00080.x; Stevenson B, 2010, REV ECON STAT, V92, P284, DOI 10.1162/rest.2010.11623; Suggs W, 2005, PLACE ON THE TEAM: THE TRIUMPH AND TRAGEDY OF TITLE IX, P1; TANNEHILL D, 1994, J TEACH PHYS EDUC, V13, P406, DOI 10.1123/jtpe.13.4.406; U.S. Department of Labor, 2011, 2003 10 ATUS MULT MI; U.S. Department of Labor (n.d.) Bureau of Labor Statistics and US Department of Commerce US Census Bureau, 63RV US DEP LAB US C; U.S. Department of Labor U.S. Bureau of Labor Statistics, 2011, AM TIM US SURV US GU; United States Deparment of Education, 2003, OP ALL TITL 9 30; Van Tuyckom C, 2010, J SPORT SCI, V28, P1077, DOI 10.1080/02640414.2010.492229; Vilhjalmsson R, 2003, SOC SCI MED, V56, P363, DOI 10.1016/S0277-9536(02)00042-4; Walker PL, 2001, ANNU REV ANTHROPOL, V30, P573, DOI 10.1146/annurev.anthro.30.1.573; WHITING B, 1973, J SOC PSYCHOL, V91, P171, DOI 10.1080/00224545.1973.9923040; Whiting B. B., 1988, CHILDREN DIFFERENT W; Wigfield A, 1997, J EDUC PSYCHOL, V89, P451, DOI 10.1037/0022-0663.89.3.451; Wilson Margo, 1988, HOMICIDE; Winegard B, 2010, EVOL PSYCHOL-US, V8, P432; Wolff SE, 2010, BEHAV ECOL SOCIOBIOL, V64, P1673, DOI 10.1007/s00265-010-0981-5; Women's Sports Foundation: Title IX Myth-Fact, TITL 9 MYTH FACT; Zimbalist AS., 2007, EQUAL PLAY TITLE 9 S	125	90	91	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49168	10.1371/journal.pone.0049168	http://dx.doi.org/10.1371/journal.pone.0049168			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155459	Green Published, gold			2022-12-27	WOS:000311151900094
J	James, TC; Bond, U				James, Tharappel C.; Bond, Ursula			Molecular Mimics of the Tumour Antigen MUC1	PLOS ONE			English	Article							ABERRANTLY GLYCOSYLATED MUC1; INTERNAL IMAGE; CANCER-IMMUNOTHERAPY; DENDRITIC CELLS; BREAST-CANCER; T-CELLS; VACCINE; ANTIBODY; MICE; IDENTIFICATION	A key requirement for the development of cancer immunotherapy is the identification of tumour-associated antigens that are differentially or exclusively expressed on the tumour and recognized by the host immune system. However, immune responses to such antigens are often muted or lacking due to the antigens being recognized as "self'', and further complicated by the tumour environment and regulation of immune cells within. In an effort to circumvent the lack of immune responses to tumour antigens, we have devised a strategy to develop potential synthetic immunogens. The strategy, termed mirror image phage display, is based on the concept of molecular mimicry as demonstrated by the idiotype/anti-idiotype paradigm in the immune system. Here as 'proof of principle' we have selected molecular mimics of the well-characterised tumour associated antigen, the human mucin1 protein (MUC1) from two different peptide phage display libraries. The putative mimics were compared in structure and function to that of the native antigen. Our results demonstrate that several of the mimic peptides display T-cell stimulation activity in vitro when presented by matured dendritic cells. The mimic peptides and the native MUC1 antigenic epitopes can cross-stimulate T-cells. The data also indicate that sequence homology and/or chemical properties to the original epitope are not the sole determining factors for the observed immunostimulatory activity of the mimic peptides.	[James, Tharappel C.; Bond, Ursula] Univ Dublin Trinity Coll, Sch Genet & Microbiol, Moyne Inst Prevent Med, Dublin 2, Ireland	Trinity College Dublin	James, TC (corresponding author), Univ Dublin Trinity Coll, Sch Genet & Microbiol, Moyne Inst Prevent Med, Dublin 2, Ireland.	ubond@tcd.ie	Bond, Ursula/CAF-3974-2022	Bond, Ursula/0000-0003-2877-6460				Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Arnaiz Blanca, 2006, J Immune Based Ther Vaccines, V4, P2, DOI 10.1186/1476-8518-4-2; Baldus SE, 2004, CLIN CANCER RES, V10, P2790, DOI 10.1158/1078-0432.CCR-03-0163; Blixt O, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2841; Bray SM, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/249281; Caux C, 2012, TARGET ONCOL, V7, P1, DOI 10.1007/s11523-012-0211-3; Cheever MA, 2009, CLIN CANCER RES, V15, P5323, DOI 10.1158/1078-0432.CCR-09-0737; Elaine D, 1985, European Patent Organisation, Patent No. [EP0141783 (A2)_1985-05-15, 0141783]; Fleischer K, 2004, J IMMUNOL, V172, P162, DOI 10.4049/jimmunol.172.1.162; Graves CRL, 2005, J PEPT RES, V66, P357, DOI 10.1111/j.1399-3011.2005.00297.x; Hammerstrom AE, 2011, PHARMACOTHERAPY, V31, P813, DOI 10.1592/phco.31.8.813; HERLYN D, 1986, SCIENCE, V232, P100, DOI 10.1126/science.3952496; Heukamp LC, 2001, INT J CANCER, V91, P385, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1051>3.0.CO;2-Z; Hiltbold EM, 2000, J IMMUNOL, V165, P3730, DOI 10.4049/jimmunol.165.7.3730; Hurwitz AA, 2012, CANCER IMMUNOL IMMUN, V61, P289, DOI 10.1007/s00262-011-1181-5; Kaiser A, 2009, ANGEW CHEM INT EDIT, V48, P7551, DOI 10.1002/anie.200902564; KENNEDY R C, 1985, Biotechniques, V3, P404; KENNEDY RC, 1986, VIROLOGY, V148, P369, DOI 10.1016/0042-6822(86)90333-8; Lacunza E, 2010, CANCER GENET CYTOGEN, V201, P102, DOI 10.1016/j.cancergencyto.2010.05.015; Lakshminarayanan V, 2012, P NATL ACAD SCI USA, V109, P261, DOI 10.1073/pnas.1115166109; Luo D, 2000, J BIOCHEM-TOKYO, V128, P345, DOI 10.1093/oxfordjournals.jbchem.a022759; Mellman I, 2011, NATURE, V480, P480, DOI 10.1038/nature10673; Mitchell Malcolm S, 2002, Curr Opin Investig Drugs, V3, P150; NISONOFF A, 1981, CLIN IMMUNOL IMMUNOP, V21, P397, DOI 10.1016/0090-1229(81)90228-2; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; Quinlin IS, 2007, ONCOL REP, V17, P453; RAYCHAUDHURI S, 1986, J IMMUNOL, V137, P1743; Raychaudhuri S, 1986, WIPO Patent Application, Patent No. [WO/1989/005309, 1989005309]; Renkvist N, 2001, CANCER IMMUNOL IMMUN, V50, P3, DOI 10.1007/s002620000169; Rong Y, 2011, CLIN EXP MED; Ryan SO, 2010, CANCER RES, V70, P5788, DOI 10.1158/0008-5472.CAN-09-4519; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Shirakura Y, 2012, CANCER SCI, V103, P17, DOI 10.1111/j.1349-7006.2011.02111.x; Siebke C, 2012, CELL STRESS CHAPERON, V17, P145, DOI 10.1007/s12192-011-0295-1; Singh AP, 2007, CANCER RES, V67, P433, DOI 10.1158/0008-5472.CAN-06-3114; Sorensen AL, 2006, GLYCOBIOLOGY, V16, P96, DOI 10.1093/glycob/cwj044; Tang CK, 2008, EXPERT REV VACCINES, V7, P963, DOI 10.1586/14760584.7.7.963; Thie H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015921; Tsang KY, 2004, CLIN CANCER RES, V10, P2139, DOI 10.1158/1078-0432.CCR-1011-03; Westerlind U, 2011, CHIMIA, V65, P30, DOI 10.2533/chimia.2011.30; Whiteside TL, 2012, CANCER IMMUNOL IMMUN, V61, P283, DOI 10.1007/s00262-011-1171-7; Wicherek L, 2011, AM J REPROD IMMUNOL, V66, P444, DOI 10.1111/j.1600-0897.2011.01024.x; Wilkinson RW, 2000, BRIT J CANCER, V83, P1202, DOI 10.1054/bjoc.2000.1431; Yuan W, 2012, MOL MED REP, V5, P388, DOI 10.3892/mmr.2011.643	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49728	10.1371/journal.pone.0049728	http://dx.doi.org/10.1371/journal.pone.0049728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166757	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900185
J	Jiang, S; Wang, W; Miner, J; Fromm, M				Jiang, Shan; Wang, Wei; Miner, Jess; Fromm, Michael			Cross Regulation of Sirtuin 1, AMPK, and PPAR gamma in Conjugated Linoleic Acid Treated Adipocytes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; WHITE ADIPOSE-TISSUE; LIPID-METABOLISM; BODY-COMPOSITION; TRANS-10; CELL; ISOMER; FAT; DELIPIDATION; INFLAMMATION	Trans-10, cis-12 conjugated linoleic acid (t10c12 CLA) reduces triglyceride (TG) levels in adipocytes through multiple pathways, with AMP-activated protein kinase (AMPK) generally facilitating, and peroxisome proliferator-activated receptor c (PPAR gamma) generally opposing these reductions. Sirtuin 1 (SIRT1), a histone/protein deacetylase that affects energy homeostasis, often functions coordinately with AMPK, and is capable of binding to PPAR gamma, thereby inhibiting its activity. This study investigated the role of SIRT1 in the response of 3T3-L1 adipocytes to t10c12 CLA by testing the following hypotheses: 1) SIRT1 is functionally required for robust TG reduction; and 2) SIRT1, AMPK, and PPAR gamma cross regulate each other. These experiments were performed by using activators, inhibitors, or siRNA knockdowns that affected these pathways in t10c12 CLA-treated 3T3-L1 adipocytes. Inhibition of SIRT1 amounts or activity using siRNA, sirtinol, nicotinamide, or etomoxir attenuated the amount of TG loss, while SIRT1 activator SRT1720 increased the TG loss. SRT1720 increased AMPK activity while sirtuin-specific inhibitors decreased AMPK activity. Reciprocally, an AMPK inhibitor reduced SIRT1 activity. Treatment with t10c12 CLA increased PPAR gamma phosphorylation in an AMPK-dependent manner and increased the amount of PPAR gamma bound to SIRT1. Reciprocally, a PPAR gamma agonist attenuated AMPK and SIRT1 activity levels. These results indicated SIRT1 increased TG loss and that cross regulation between SIRT1, AMPK, and PPAR gamma occurred in 3T3-L1 adipocytes treated with t10c12 CLA.	[Jiang, Shan] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Jiang, S (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA.	Mfromm2@unl.edu						Beekum O., 2009, OBESITY SILVER SPRIN, V17, P213, DOI DOI 10.1038/OBY.2008.47319169221; Brown JM, 2003, J LIPID RES, V44, P1287, DOI 10.1194/jlr.M300001-JLR200; Buerki C, 2008, NUCLEIC ACIDS RES, V36, P1665, DOI 10.1093/nar/gkn003; Burgermeister E, 2007, CELL CYCLE, V6, P1539, DOI 10.4161/cc.6.13.4453; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chung SK, 2005, J BIOL CHEM, V280, P38445, DOI 10.1074/jbc.M508159200; Chung SY, 2005, J LIPID RES, V46, P885, DOI 10.1194/jlr.M400476-JLR200; Daval M, 2006, J PHYSIOL-LONDON, V574, P55, DOI 10.1113/jphysiol.2006.111484; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; El-Mir MY, 2000, J BIOL CHEM, V275, P223, DOI 10.1074/jbc.275.1.223; Evans M, 2002, J NUTR, V132, P450, DOI 10.1093/jn/132.3.450; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164; Gaidhu MP, 2009, J LIPID RES, V50, P704, DOI 10.1194/jlr.M800480-JLR200; Gondai T, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1043; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Grozinger CM, 2002, CHEM BIOL, V9, P3, DOI 10.1016/S1074-5521(02)00092-3; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064; Hargrave-Barnes KM, 2008, OBESITY, V16, P2245, DOI 10.1038/oby.2008.338; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; House RL, 2005, OBES REV, V6, P247, DOI 10.1111/j.1467-789X.2005.00198.x; House RL, 2005, PHYSIOL GENOMICS, V21, P351, DOI 10.1152/physiolgenomics.00244.2004; Jiang S, 2011, J NUTR BIOCHEM, V22, P656, DOI 10.1016/j.jnutbio.2010.05.005; Jiang S, 2009, J NUTR, V139, P2244, DOI 10.3945/jn.109.112417; Kennedy A, 2008, J NUTR, V138, P455, DOI 10.1093/jn/138.3.455; Kennedy A, 2010, J NUTR BIOCHEM, V21, P171, DOI 10.1016/j.jnutbio.2009.08.003; Kennedy A, 2009, J LIPID RES, V50, P225, DOI 10.1194/jlr.M800258-JLR200; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; Knight JRP, 2012, CURR OPIN ONCOL, V24, P68, DOI 10.1097/CCO.0b013e32834d813b; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; LaRosa PC, 2007, PHYSIOL GENOMICS, V31, P544, DOI 10.1152/physiolgenomics.00156.2007; LaRosa PC, 2006, PHYSIOL GENOMICS, V27, P282, DOI 10.1152/physiolgenomics.00076.2006; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luconi M, 2009, STEROIDS, DOI [10.1016/j.steroids.2009.1010.1012., DOI 10.1016/J.STEROIDS.2009.1010.1012]; Mai A, 2005, J MED CHEM, V48, P7789, DOI 10.1021/jm050100l; Miller JR, 2008, J LIPID RES, V49, P550, DOI 10.1194/jlr.M700275-JLR200; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Obsen T, 2012, J NUTR BIOCHEM, V23, P580, DOI 10.1016/j.jnutbio.2011.02.014; Ou LH, 2008, J LIPID RES, V49, P985, DOI 10.1194/jlr.M700465-JLR200; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; Park Y, 1997, LIPIDS, V32, P853, DOI 10.1007/s11745-997-0109-x; Park Y, 1999, LIPIDS, V34, P235, DOI 10.1007/s11745-999-0358-8; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Poirier H, 2006, DIABETES, V55, P1634, DOI 10.2337/db06-0036; Ruderman NB, AM J PHYSL ENDOCRINO, V298, pE751; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Vaquero A, 2009, GENE DEV, V23, P1849, DOI 10.1101/gad.1807009; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Wendel AA, 2009, LIPIDS, V44, P975, DOI 10.1007/s11745-009-3348-9; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zhang L, 2007, AM J PHYSIOL-HEART C, V293, pH457, DOI 10.1152/ajpheart.00002.2007; ZHAO S, SCIENCE, V327, P1000	59	31	34	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48874	10.1371/journal.pone.0048874	http://dx.doi.org/10.1371/journal.pone.0048874			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155420	gold, Green Published			2022-12-27	WOS:000311151900055
J	Lewis, SJ; Zuccolo, L; Smith, GD; Macleod, J; Rodriguez, S; Draper, ES; Barrow, M; Alati, R; Sayal, K; Ring, S; Golding, J; Gray, R				Lewis, Sarah J.; Zuccolo, Luisa; Smith, George Davey; Macleod, John; Rodriguez, Santiago; Draper, Elizabeth S.; Barrow, Margaret; Alati, Rosa; Sayal, Kapil; Ring, Susan; Golding, Jean; Gray, Ron			Fetal Alcohol Exposure and IQ at Age 8: Evidence from a Population-Based Birth-Cohort Study	PLOS ONE			English	Article							MENDELIAN RANDOMIZATION; COGNITIVE DEFICITS; LIGHT DRINKING; CHILDHOOD IQ; RISK-FACTORS; ALDH2 GENE; MIDDLE-AGE; DEHYDROGENASE; PREGNANCY; ADH	Background: Observational studies have generated conflicting evidence on the effects of moderate maternal alcohol consumption during pregnancy on offspring cognition mainly reflecting problems of confounding. Among mothers who drink during pregnancy fetal alcohol exposure is influenced not only by mother's intake but also by genetic variants carried by both the mother and the fetus. Associations between children's cognitive function and both maternal and child genotype at these loci can shed light on the effects of maternal alcohol consumption on offspring cognitive development. Methods: We used a large population based study of women recruited during pregnancy to determine whether genetic variants in alcohol metabolising genes in this cohort of women and their children were related to the child's cognitive score (measured by the Weschler Intelligence Scale) at age 8. Findings: We found that four genetic variants in alcohol metabolising genes in 4167 children were strongly related to lower IQ at age 8, as was a risk allele score based on these 4 variants. This effect was only seen amongst the offspring of mothers who were moderate drinkers (1-6 units alcohol per week during pregnancy (per allele effect estimates were -1.80 (95% CI = -2.63 to -0.97) p = 0.00002, with no effect among children whose mothers abstained during pregnancy (0.16 (95% CI = -1.05 to 1.36) p = 0.80), p-value for interaction = 0.009). A further genetic variant associated with alcohol metabolism in mothers was associated with their child's IQ, but again only among mothers who drank during pregnancy.	[Lewis, Sarah J.; Zuccolo, Luisa; Macleod, John; Rodriguez, Santiago; Ring, Susan; Golding, Jean] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England	University of Bristol	Lewis, SJ (corresponding author), Univ Bristol, Sch Social & Community Med, Bristol, Avon, England.	s.j.lewis@bristol.ac.uk	Draper, Elizabeth/S-6874-2019; Davey Smith, George/A-7407-2013; Alati, Rosa/A-2335-2014; Alati, Rosa/G-2523-2010	Draper, Elizabeth/0000-0001-9340-8176; Davey Smith, George/0000-0002-1407-8314; Alati, Rosa/0000-0002-9240-3450; Lewis, Sarah/0000-0003-4311-6890; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Sayal, Kapil/0000-0002-2050-4316; Rodriguez, Santiago/0000-0001-6551-932X; Golding, Jean/0000-0003-2826-3307; Macleod, John/0000-0001-8202-1144; s, hema/0000-0002-3440-9475; Zuccolo, Luisa/0000-0002-7049-3037	MRC [G0902144, G0600705] Funding Source: UKRI; Medical Research Council [G9815508, G0902144, G0600705, 74882] Funding Source: Medline; Wellcome Trust [083506, 076467, 092731] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alati R, 2005, ADDICTION, V100, P643, DOI 10.1111/j.1360-0443.2005.01063.x; Alati R, 2008, PEDIATR RES, V64, P659, DOI 10.1203/PDR.0b013e318187cc31; Badger TM, 2005, LIFE SCI, V77, P2111, DOI 10.1016/j.lfs.2005.02.019; BARRETT JC, 2005, BIOINFORMATICS; Batty GD, 2009, AM J EPIDEMIOL, V169, P606, DOI 10.1093/aje/kwn381; Birley AJ, 2008, HUM MOL GENET, V17, P179, DOI 10.1093/hmg/ddm295; Birley AJ, 2009, HUM MOL GENET, V18, P1533, DOI 10.1093/hmg/ddp060; BONTHIUS DJ, 1988, ALCOHOL, V5, P209, DOI 10.1016/0741-8329(88)90054-7; CLARREN SK, 1990, ALCOHOL CLIN EXP RES, V14, P674, DOI 10.1111/j.1530-0277.1990.tb01226.x; DITLOW CC, 1984, BIOCHEMISTRY-US, V23, P6363, DOI 10.1021/bi00321a012; Edenberg HJ, 2006, HUM MOL GENET, V15, P1539, DOI 10.1093/hmg/ddl073; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Green RF, 2007, AM J OBSTET GYNECOL, V197, P12, DOI 10.1016/j.ajog.2007.02.028; Henderson J, 2007, BJOG-INT J OBSTET GY, V114, P243, DOI 10.1111/j.1471-0528.2006.01163.x; Jacobson SW, 2006, J PEDIATR-US, V148, P30, DOI 10.1016/j.jpeds.2005.08.023; Joinson C, 2007, PEDIATRICS, V120, pE308, DOI 10.1542/peds.2006-2891; JONES A W, 1984, Alcohol, V1, P385, DOI 10.1016/0741-8329(84)90008-9; JONES KL, 1973, LANCET, V2, P999; Kelly Y, 2009, INT J EPIDEMIOL, V38, P129, DOI 10.1093/ije/dyn230; Kelly YJ, 2012, J EPIDEMIOL COMMUN H, V66, P41, DOI 10.1136/jech.2009.103002; Kuo PH, 2008, ALCOHOL CLIN EXP RES, V32, P785, DOI 10.1111/j.1530-0277.2008.00642.x; Luo XG, 2006, AM J HUM GENET, V78, P973, DOI 10.1086/504113; Macgregor S, 2009, HUM MOL GENET, V18, P580, DOI 10.1093/hmg/ddn372; May PA, 2008, ALCOHOL CLIN EXP RES, V32, P738, DOI 10.1111/j.1530-0277.2008.00634.x; McCarver DG, 1997, J PHARMACOL EXP THER, V283, P1095; McCarver DG, 2001, DRUG METAB DISPOS, V29, P562; O'Callaghan FV, 2007, EARLY HUM DEV, V83, P115, DOI 10.1016/j.earlhumdev.2006.05.011; Osier MV, 2004, AM J MED GENET B, V126B, P19, DOI 10.1002/ajmg.b.20136; Osier MV, 2002, AM J HUM GENET, V71, P84, DOI 10.1086/341290; Pearce MS, 2006, PUBLIC HEALTH, V120, P1020, DOI 10.1016/j.puhe.2006.06.015; Sayal K, 2007, PEDIATRICS, V119, pE426, DOI 10.1542/peds.2006-1840; Shipley BA, 2008, J PSYCHOSOM RES, V65, P143, DOI 10.1016/j.jpsychores.2008.02.017; Smith GD, 2004, INT J EPIDEMIOL, V33, P30, DOI 10.1093/ije/dyh132; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Smith GD, 2007, PLOS MED, V4, P1985, DOI 10.1371/journal.pmed.0040352; Smith GD, 2008, BASIC CLIN PHARMACOL, V102, P245, DOI 10.1111/j.1742-7843.2007.00191.x; Smith GD, 2011, GENES NUTR, V6, P27, DOI 10.1007/s12263-010-0181-y; SMITH M, 1973, ANN HUM GENET, V36, P401, DOI 10.1111/j.1469-1809.1973.tb00604.x; SMITH M, 1971, ANN HUM GENET, V34, P251, DOI 10.1111/j.1469-1809.1971.tb00238.x; Stoler JM, 2002, J PEDIATR-US, V141, P780, DOI 10.1067/mpd.2002.128112; Swallow DM, 2003, ANNU REV GENET, V37, P197, DOI 10.1146/annurev.genet.37.110801.143820; Timpson N, 2007, SCIENCE, V317, DOI 10.1126/science.1141705; Timpson NJ, 2005, AM J CLIN NUTR, V81, P1005; Viljoen DL, 2001, ALCOHOL CLIN EXP RES, V25, P1719; Wechsler D., 1992, WESCHLER INTELLIGENC, V3rd ed; ZGOMBICKNIGHT M, 1995, J BIOL CHEM, V270, P4305, DOI 10.1074/jbc.270.9.4305; Zuccolo L, 2009, HUM MOL GENET, V18, P4457, DOI 10.1093/hmg/ddp388	48	50	52	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49407	10.1371/journal.pone.0049407	http://dx.doi.org/10.1371/journal.pone.0049407			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166662	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900140
J	Lu, J; Wu, D; Yang, H; Luo, C; Li, CY; Yao, DZ				Lu, Jing; Wu, Dan; Yang, Hua; Luo, Cheng; Li, Chaoyi; Yao, Dezhong			Scale-Free Brain-Wave Music from Simultaneously EEG and fMRI Recordings	PLOS ONE			English	Article							SONIFICATION	In the past years, a few methods have been developed to translate human EEG to music. In 2009, PloS One 4 e5915, we developed a method to generate scale-free brainwave music where the amplitude of EEG was translated to music pitch according to the power law followed by both of them, the period of an EEG waveform is translated directly to the duration of a note, and the logarithm of the average power change of EEG is translated to music intensity according to the Fechner's law. In this work, we proposed to adopt simultaneously-recorded fMRI signal to control the intensity of the EEG music, thus an EEG-fMRI music is generated by combining two different and simultaneous brain signals. And most importantly, this approach further realized power law for music intensity as fMRI signal follows it. Thus the EEG-fMRI music makes a step ahead in reflecting the physiological process of the scale-free brain.	[Lu, Jing; Wu, Dan; Yang, Hua; Luo, Cheng; Li, Chaoyi; Yao, Dezhong] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China	University of Electronic Science & Technology of China	Lu, J (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab NeuroInformat, Chengdu 610054, Peoples R China.	dyao@uestc.edu.cn	Luo, Cheng/A-4647-2015	Luo, Cheng/0000-0003-0524-5886; Yao, Dezhong/0000-0002-8042-879X; Lu, Jing/0000-0002-3519-3055				Adrian ED, 1934, BRAIN, V57, P355, DOI 10.1093/brain/57.4.355; Arslan B, 2005, ENTERFACE 05; Baier G, 2007, CLIN NEUROPHYSIOL, V118, P1377, DOI 10.1016/j.clinph.2007.01.025; Bucci W, 2001, PSYCHOANAL INQ, V21, P40, DOI 10.1080/07351692109348923; Collins DL, 1998, IEEE T MED IMAGING, V17, P463, DOI 10.1109/42.712135; Dunn J, 1999, LEONARDO, V32, P25, DOI 10.1162/002409499552966; Fang GZ, 2010, PHYSIOL MEAS, V31, P795, DOI 10.1088/0967-3334/31/6/005; He BYJ, 2010, NEURON, V66, P353, DOI 10.1016/j.neuron.2010.04.020; Hwa RC, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.021901; Lei X, 2010, NEUROIMAGE, V52, P1123, DOI 10.1016/j.neuroimage.2010.01.024; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Miranda ER, 2005, LEONARDO, V38, P331, DOI 10.1162/0024094054762133; Patel Aniruddh D, 2010, MUSIC LANGUAGE BRAIN; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; PENN AI, 1997, MED IMAGING IEEE T, V16, P930; Qin Y, 2010, CLIN NEUROPHYSIOL, V121, P1981, DOI 10.1016/j.clinph.2010.03.056; Rosenboom D, 1990, EXTENDED MUSICAL INT; Sanchez Sousa Aurora, 2005, Revista Iberoamericana de Micologia, V22, P242; Teich MC, 1997, J OPT SOC AM A, V14, P529, DOI 10.1364/JOSAA.14.000529; Ting-Ting Gao, 2007, Journal of Electronic Science and Technology of China, V5, P272; VOSS RF, 1975, NATURE, V258, P317, DOI 10.1038/258317a0; Wu Dan, 2010, Comput Intell Neurosci, P267671, DOI 10.1155/2010/267671; Wu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005915; Yao DZ, 2000, IEEE T BIO-MED ENG, V47, P964, DOI 10.1109/10.846691; Yao DZ, 2001, PHYSIOL MEAS, V22, P693, DOI 10.1088/0967-3334/22/4/305	25	19	21	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49773	10.1371/journal.pone.0049773	http://dx.doi.org/10.1371/journal.pone.0049773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166768	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900192
J	Ohshima, K; Mogi, M; Jing, F; Iwanami, J; Tsukuda, K; Min, LJ; Ogimoto, A; Dahlof, B; Steckelings, UM; Unger, T; Higaki, J; Horiuchi, M				Ohshima, Kousei; Mogi, Masaki; Jing, Fei; Iwanami, Jun; Tsukuda, Kana; Min, Li-Juan; Ogimoto, Akiyoshi; Dahlof, Bjorn; Steckelings, Ulrike M.; Unger, Tomas; Higaki, Jitsuo; Horiuchi, Masatsugu			Direct Angiotensin II Type 2 Receptor Stimulation Ameliorates Insulin Resistance in Type 2 Diabetes Mice with PPAR gamma Activation	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SMOOTH-MUSCLE-CELLS; ADIPOSE-TISSUE; ADIPOCYTE DIFFERENTIATION; GLUCOSE-TOLERANCE; SKELETAL-MUSCLE; TNF-ALPHA; HIGH-RISK; SYSTEM; OBESITY	Objectives: The role of angiotensin II type 2 (AT(2)) receptor stimulation in the pathogenesis of insulin resistance is still unclear. Therefore we examined the possibility that direct AT(2) receptor stimulation by compound 21 (C21) might contribute to possible insulin-sensitizing/anti-diabetic effects in type 2 diabetes (T2DM) with PPAR gamma activation, mainly focusing on adipose tissue. Methods: T2DM mice, KK-Ay, were subjected to intraperitoneal injection of C21 and/or a PPAR gamma antagonist, GW9662 in drinking water for 2 weeks. Insulin resistance was evaluated by oral glucose tolerance test, insulin tolerance test, and uptake of 2-[H-3] deoxy-D-glucose in white adipose tissue. Morphological changes of adipose tissues as well as adipocyte differentiation and inflammatory response were examined. Results: Treatment with C21 ameliorated insulin resistance in KK-Ay mice without influencing blood pressure, at least partially through effects on the PPAR gamma pathway. C21 treatment increased serum adiponectin concentration and decreased TNF-alpha concentration; however, these effects were attenuated by PPAR gamma blockade by co-treatment with GW9662. Moreover, we observed that administration of C21 enhanced adipocyte differentiation and PPAR gamma DNA-binding activity, with a decrease in inflammation in white adipose tissue, whereas these effects of C21 were attenuated by co-treatment with GW9662. We also observed that administration of C21 restored beta cell damage in diabetic pancreatic tissue. Conclusion: The present study demonstrated that direct AT(2) receptor stimulation by C21 accompanied with PPAR gamma activation ameliorated insulin resistance in T2DM mice, at least partially due to improvement of adipocyte dysfunction and protection of pancreatic beta cells.	[Ohshima, Kousei; Mogi, Masaki; Jing, Fei; Iwanami, Jun; Tsukuda, Kana; Min, Li-Juan; Horiuchi, Masatsugu] Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan	Ehime University	Ohshima, K (corresponding author), Ehime Univ, Grad Sch Med, Dept Mol Cardiovasc Biol & Pharmacol, Tohon, Ehime, Japan.	horiuchi@m.ehime-u.ac.jp		Steckelings, Ulrike Muscha/0000-0002-5430-4275				Abadir PM, 2011, P NATL ACAD SCI USA, V108, P14849, DOI 10.1073/pnas.1101507108; Cawthorn WP, 2007, CELL DEATH DIFFER, V14, P1361, DOI 10.1038/sj.cdd.4402127; Chu KY, 2006, DIABETES, V55, P367, DOI 10.2337/diabetes.55.02.06.db05-1022; Cole BK, 2010, HYPERTENSION, V55, P715, DOI 10.1161/HYPERTENSIONAHA.109.148049; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; DARIMONT C, 1994, ENDOCRINOLOGY, V135, P2030, DOI 10.1210/en.135.5.2030; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Gupta D, 2010, DIABETES OBES METAB, V12, P1036, DOI 10.1111/j.1463-1326.2010.01299.x; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Iwai M, 2009, AM J HYPERTENS, V22, P784, DOI 10.1038/ajh.2009.85; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kaschina E, 2008, CIRCULATION, V118, P2523, DOI 10.1161/CIRCULATIONAHA.108.784868; Kjeldsen SE, 2006, J HYPERTENS, V24, P1405, DOI 10.1097/01.hjh.0000234122.55895.5b; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Leung PS, 2007, J PHYSIOL-LONDON, V580, P31, DOI 10.1113/jphysiol.2006.126193; MACARI D, 1993, EUR J PHARMACOL, V249, P85, DOI 10.1016/0014-2999(93)90665-5; Mathews ST, 2006, BIOCHEM BIOPH RES CO, V350, P437, DOI 10.1016/j.bbrc.2006.09.071; Miles PDG, 2000, J CLIN INVEST, V105, P287, DOI 10.1172/JCI8538; Mitsuishi M, 2009, DIABETES, V58, P710, DOI 10.2337/db08-0949; Nissen SE, 2008, JAMA-J AM MED ASSOC, V299, P1561, DOI 10.1001/jama.299.13.1561; Ohshima K, 2012, HYPERTENSION, V59, P493, DOI 10.1161/HYPERTENSIONAHA.111.183178; Olivares-Reyes JA, 2009, MOL CELL ENDOCRINOL, V302, P128, DOI 10.1016/j.mce.2008.12.011; Olsen MH, 2005, J HYPERTENS, V23, P891, DOI 10.1097/01.hjh.0000163160.60234.15; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Rieusset J, 2002, MOL ENDOCRINOL, V16, P2628, DOI 10.1210/me.2002-0036; Saint-Marc P, 2001, ENDOCRINOLOGY, V142, P487, DOI 10.1210/en.142.1.487; Shiuchi T, 2001, ENDOCRINOLOGY, V142, P608, DOI 10.1210/en.142.2.608; Shiuchi T, 2004, HYPERTENSION, V43, P1003, DOI 10.1161/01.HYP.0000125142.41703.64; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Steckelings UM, 2010, J HYPERTENS, V28, pS50, DOI 10.1097/01.hjh.0000388495.66330.63; Stephens LA, 1999, ENDOCRINOLOGY, V140, P3219, DOI 10.1210/en.140.7.3219; SUDO M, 1991, AM J PHYSIOL, V261, pE298, DOI 10.1152/ajpendo.1991.261.3.E298; Sugawara A, 2001, ENDOCRINOLOGY, V142, P3125, DOI 10.1210/en.142.7.3125; Takeda K, 2000, CIRCULATION, V102, P1834; Takeda K, 2001, J BIOL CHEM, V276, P48950, DOI 10.1074/jbc.M108722200; Tham DM, 2002, PHYSIOL GENOMICS, V11, P21, DOI 10.1152/physiolgenomics.00062.2002; Tikellis C, 2004, DIABETES, V53, P989, DOI 10.2337/diabetes.53.4.989; Tomono Y, 2008, AM J HYPERTENS, V21, P206, DOI 10.1038/ajh.2007.50; Tsiotra PC, 2001, INT J OBESITY, V25, P1018, DOI 10.1038/sj.ijo.0801657; Unger T, 2010, J RENIN-ANGIO-ALDO S, V11, P75, DOI 10.1177/1470320309347792; Wan YQ, 2004, J MED CHEM, V47, P5995, DOI 10.1021/jm049715t; Widdop RE, 2003, BRIT J PHARMACOL, V140, P809, DOI 10.1038/sj.bjp.0705448; Wu XY, 2006, J MED CHEM, V49, P7160, DOI 10.1021/jm0606185; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Yvan-Charvet L, 2005, DIABETES, V54, P991, DOI 10.2337/diabetes.54.4.991; Yvan-Charvet L, 2009, ENDOCRINOLOGY, V150, P1421, DOI 10.1210/en.2008-1120; Zhao Y, 2005, J NEUROCHEM, V94, P1395, DOI 10.1111/j.1471-4159.2005.03275.x	50	53	56	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48387	10.1371/journal.pone.0048387	http://dx.doi.org/10.1371/journal.pone.0048387			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155382	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900016
J	Paulose, JK; Rucker, EB; Cassone, VM				Paulose, Jiffin K.; Rucker, Edmund B., III; Cassone, Vincent M.			Toward the Beginning of Time: Circadian Rhythms in Metabolism Precede Rhythms in Clock Gene Expression in Mouse Embryonic Stem Cells	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; C-14-LABELED DEOXYGLUCOSE; IN-VITRO; RAT; DIFFERENTIATION; OSCILLATORS; RECEPTORS; LESIONS; PINEAL	The appearance, progression, and potential role for circadian rhythms during early development have previously focused mainly on the suprachiasmatic nucleus (SCN) and peri- and postnatal expression of canonical clock genes. More recently, gene expression studies in embryonic stem cells have shown that some clock genes are expressed in undifferentiated cells; however rhythmicity was only established when cells are directed toward a neural fate. These studies also concluded that a functional clock is not present in ESCs, based solely on their gene expression. The null hypothesis underlying the present study is that embryonic stem cells become rhythmic in both clock gene expression and glucose utilization only when allowed to spontaneously differentiate. Undifferentiated stem cells (ESCs, n = 6 cultures/timepoint for all experiments) were either maintained in their pluripotent state or released into differentiation (dESCs, n = 6 cultures/timepoint for all experiments). Glucose utilization was assayed through 2-deoxyglucose uptake measurement, and clock gene and glucose transporter expression was assayed every 4 hours for 2 days in ESCs and dESCs by quantitative PCR (qPCR) in the same cell lysates. Undifferentiated stem cells expressed a self-sustained rhythm in glucose uptake that was not coincident with rhythmic expression of clock genes. This physiological rhythm was paralleled by glucose transporter mRNA expression. Upon differentiation, circadian patterns of some but not all clock genes were expressed, and the amplitude of the glucose utilization rhythm was enhanced in dESCs. These data provide the earliest evidence of a functional circadian clock, in addition to further challenging the idea that rhythmic transcription of clock genes are necessary for rhythmic physiological output and suggest a role for a clock-controlled physiology in the earliest stages of development.	[Paulose, Jiffin K.] Texas A&M Univ, Dept Biol, Ctr Res Biol Clocks, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Paulose, JK (corresponding author), Texas A&M Univ, Dept Biol, Ctr Res Biol Clocks, College Stn, TX 77843 USA.	Vincent.Cassone@uky.edu	Paulose, Jiffin/AAA-9296-2020; Cassone, Vincent/AAD-5191-2022	Paulose, Jiffin/0000-0002-0061-7786; 	NINDS NIH HHS [P01 NS35846] Funding Source: Medline	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Challet E, 1999, AM J PHYSIOL-REG I, V276, pR1063, DOI 10.1152/ajpregu.1999.276.4.R1063; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Earnest DJ, 1999, SCIENCE, V283, P693, DOI 10.1126/science.283.5402.693; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Heilig C, 2003, AM J PATHOL, V163, P1873, DOI 10.1016/S0002-9440(10)63546-8; Johnson Martin H, 2002, Reprod Biomed Online, V4, P140; Karaganis SP, 2009, GEN COMP ENDOCR, V161, P179, DOI 10.1016/j.ygcen.2008.12.015; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Kowalska E, 2010, J BIOL RHYTHM, V25, P442, DOI 10.1177/0748730410385281; KRIEGLSTEIN J, 1982, NEUROCHEM RES, V7, P737, DOI 10.1007/BF00965526; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Paulose JK, 2009, J PINEAL RES, V46, P286, DOI 10.1111/j.1600-079X.2008.00659.x; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; RALPH MR, 1991, TRENDS NEUROSCI, V14, P362, DOI 10.1016/0166-2236(91)90164-P; REPPERT SM, 1984, J NEUROSCI, V4, P1677; Saitoh Y, 1987, Acta Neurochir Suppl (Wien), V41, P41; Saxena MT, 2007, MOL IMAGING, V6, P68, DOI 10.2310/7290.2007.00003; SCHWARTZ WJ, 1977, SCIENCE, V197, P1089, DOI 10.1126/science.887940; Seron-Ferre Maria, 2007, Birth Defects Research, V81, P204, DOI 10.1002/bdrc.20101; Sladek M, 2004, P NATL ACAD SCI USA, V101, P6231, DOI 10.1073/pnas.0401149101; Sladek M, 2007, AM J PHYSIOL-REG I, V292, pR1224, DOI 10.1152/ajpregu.00184.2006; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Swanson RA, 1996, DEV NEUROSCI-BASEL, V18, P515, DOI 10.1159/000111448; Teboul M, 2009, J APPL PHYSIOL, V107, P1965, DOI 10.1152/japplphysiol.00515.2009; Tonack S, 2006, DIFFERENTIATION, V74, P499, DOI 10.1111/j.1432-0436.2006.00091.x; WARREN WS, 1994, PHYSIOL BEHAV, V55, P1091, DOI 10.1016/0031-9384(94)90392-1; Wong RCB, 2008, STEM CELL REV, V4, P283, DOI 10.1007/s12015-008-9038-9; Yagita K, 2010, P NATL ACAD SCI USA, V107, P3846, DOI 10.1073/pnas.0913256107	32	37	37	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49555	10.1371/journal.pone.0049555	http://dx.doi.org/10.1371/journal.pone.0049555			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155474	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900163
J	Pechey, R; Halligan, P				Pechey, Rachel; Halligan, Peter			Using Co-Occurrence to Evaluate Belief Coherence in a Large Non Clinical Sample	PLOS ONE			English	Article							RIGHT-HEMISPHERE STROKE; DELUSIONS; SYSTEMS; SCHIZOPHRENIA; SCHIZOTYPY; INTERVIEW; IDEATION	Much of the recent neuropsychological literature on false beliefs (delusions) has tended to focus on individual or single beliefs, with few studies actually investigating the relationship or co-occurrence between different types of co-existing beliefs. Quine and Ullian proposed the hypothesis that our beliefs form an interconnected web in which the beliefs that make up that system must somehow "cohere'' with one another and avoid cognitive dissonance. As such beliefs are unlikely to be encapsulated (i.e., exist in isolation from other beliefs). The aim of this preliminary study was to empirically evaluate the probability of belief co-occurrence as one indicator of coherence in a large sample of subjects involving three different thematic sets of beliefs (delusion-like, paranormal & religious, and societal/cultural). Results showed that the degree of belief co-endorsement between beliefs within thematic groupings was greater than random occurrence, lending support to Quine and Ullian's coherentist account. Some associations, however, were relatively weak, providing for well-established examples of cognitive dissonance.	[Pechey, Rachel; Halligan, Peter] Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales	Cardiff University	Pechey, R (corresponding author), Cardiff Univ, Sch Psychol, Cardiff, S Glam, Wales.	halliganpw@cf.ac.uk	Halligan, Peter W/A-1669-2010	Halligan, Peter W/0000-0003-2784-6690; Pechey, Rachel/0000-0002-6558-388X				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BEBBINGTON P, 1995, INT J METHOD PSYCH, V5, P11; Bell V, 2006, POWER BELIEF, P3; Bell V, 2006, TRENDS COGN SCI, V10, P219, DOI 10.1016/j.tics.2006.03.004; Bonjour L., 1985, STRUCTURE EMPIRICAL; Coltheart M, 2007, SCHIZOPHRENIA BULL, V33, P642, DOI 10.1093/schbul/sbm017; Coltheart M, 2011, ANNU REV PSYCHOL, V62, P271, DOI 10.1146/annurev.psych.121208.131622; Davidson D., 1973, DIALECTICA, V27, P314, DOI DOI 10.1111/J.1746-8361.1973.TB00623.X; Davidson Donald, 1984, INQUIRIES TRUTH INTE; Davies M, 2000, MIND LANG, V15, P1, DOI 10.1111/1468-0017.00122; Delin, 1993, J SOC PSYCHICAL RES, V59, P172; Douven I, 2007, SYNTHESE, V156, P405, DOI 10.1007/s11229-006-9131-z; Eagly A. H., 1993, PSYCHOL ATTITUDES; ECKBLAD M, 1983, J CONSULT CLIN PSYCH, V51, P215, DOI 10.1037/0022-006X.51.2.215; ELLIS HD, 1990, BRIT J PSYCHIAT, V157, P239, DOI 10.1192/bjp.157.2.239; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FODOR JA, 1978, MONIST, V61, P501, DOI 10.5840/monist197861444; Gallup G. H., 1991, SKEPTICAL INQUIRER, V15, P137; GILBERT DT, 1991, AM PSYCHOL, V46, P107, DOI 10.1037/0003-066X.46.2.107; HALLIGAN PW, 1995, CORTEX, V31, P173, DOI 10.1016/S0010-9452(13)80115-3; Halligan PW, 2001, NAT REV NEUROSCI, V2, P209, DOI 10.1038/35058586; HALLIGAN PW, 1993, J NEUROL NEUROSUR PS, V56, P159, DOI 10.1136/jnnp.56.2.159; Houran J, 2001, PERS INDIV DIFFER, V31, P371, DOI 10.1016/S0191-8869(00)00143-4; Jervis R, 2006, POLIT PSYCHOL, V27, P641, DOI 10.1111/j.1467-9221.2006.00527.x; Kaliuzhna M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034771; McCreery C, 2002, PERS INDIV DIFFER, V32, P141, DOI 10.1016/S0191-8869(01)00013-7; Pechey R, 2011, PSYCHOPATHOLOGY, V44, P106, DOI 10.1159/000319788; Peters E, 2004, SCHIZOPHRENIA BULL, V30, P1005, DOI 10.1093/oxfordjournals.schbul.a007116; Quine Willard, 1970, WEB BELIEF; Renshon J, 2008, J CONFLICT RESOLUT, V52, P820, DOI 10.1177/0022002708323669; Rescher N., 1973, COHERENCE THEORY TRU; Rice TW, 2003, J SCI STUD RELIG, V42, P95, DOI 10.1111/1468-5906.00163; ROBINS LN, 1988, ARCH GEN PSYCHIAT, V45, P1069; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Taylor H., 2003, RELIG OTHER BELIEFS; Thagard Paul, 2000, COHERENCE THOUGHT AC; THALBOURNE MA, 1994, BRIT J CLIN PSYCHOL, V33, P78, DOI 10.1111/j.2044-8260.1994.tb01097.x; TOBACYK J, 1983, J PERS SOC PSYCHOL, V44, P1029, DOI 10.1037/0022-3514.44.5.1029; Tullett AM, 2012, PSYCHOL MEA IN PRESS; [No title captured]	40	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48446	10.1371/journal.pone.0048446	http://dx.doi.org/10.1371/journal.pone.0048446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155383	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000311151900017
J	Pfeifer, A; Martin, B; Kamper, J; Basse, CW				Pfeifer, Anja; Martin, Bettina; Kaemper, Joerg; Basse, Christoph W.			The Mitochondrial LSU rRNA Group II Intron of Ustilago maydis Encodes an Active Homing Endonuclease Likely Involved in Intron Mobility	PLOS ONE			English	Article							DNA CLEAVAGE; HO ENDONUCLEASE; GENES; RECOGNITION; SITE; SCEI; IDENTIFICATION; RECOMBINATION; INHERITANCE; PROTEIN	Background: The a2 mating type locus gene lga2 is critical for uniparental mitochondrial DNA inheritance during sexual development of Ustilago maydis. Specifically, the absence of lga2 results in biparental inheritance, along with efficient transfer of intronic regions in the large subunit rRNA gene between parental molecules. However, the underlying role of the predicted LAGLIDADG homing endonuclease gene I-UmaI located within the group II intron LRII1 has remained unresolved. Methodology/Principal Findings: We have investigated the enzymatic activity of I-UmaI in vitro based on expression of a tagged full-length and a naturally occurring mutant derivative, which harbors only the N-terminal LAGLIDADG domain. This confirmed Mg2+-dependent endonuclease activity and cleavage at the LRII1 insertion site to generate four base pair extensions with 3' overhangs. Specifically, I-UmaI recognizes an asymmetric DNA sequence with a minimum length of 14 base pairs 5'-GACGGGAAGACCCT-3') and tolerates subtle base pair substitutions within the homing site. Enzymatic analysis of the mutant variant indicated a correlation between the activity in vitro and intron homing. Bioinformatic analyses revealed that putatively functional or former functional I-UmaI homologs are confined to a few members within the Ustilaginales and Agaricales, including the phylogenetically distant species Lentinula edodes, and are linked to group II introns inserted into homologous positions in the LSU rDNA. Conclusions/Significance: The present data provide strong evidence that intron homing efficiently operates under conditions of biparental inheritance in U. maydis. Conversely, uniparental inheritance may be critical to restrict the transmission of mobile introns. Bioinformatic analyses suggest that I-UmaI-associated introns have been acquired independently in distant taxa and are more widespread than anticipated from available genomic data.			Pfeifer, A (corresponding author), Univ Nice Sophia, Nice, France.	christoph.basse@kit.edu						Bakhrat A, 2004, GENETICS, V166, P721, DOI 10.1534/genetics.166.2.721; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Basse CW, 2010, CURR OPIN MICROBIOL, V13, P712, DOI 10.1016/j.mib.2010.09.003; Basse CW, 2000, MOL CELL BIOL, V20, P329, DOI 10.1128/MCB.20.1.329-339.2000; Belfort M, 2003, GENE DEV, V17, P2860, DOI 10.1101/gad.1162503; Belfort M, 1997, NUCLEIC ACIDS RES, V25, P3379, DOI 10.1093/nar/25.17.3379; Bonen L, 2001, TRENDS GENET, V17, P322, DOI 10.1016/S0168-9525(01)02324-1; Bonocora RP, 2001, MOL MICROBIOL, V39, P1299, DOI 10.1111/j.1365-2958.2001.02318.x; Bortfeld M, 2004, PLANT CELL, V16, P2233, DOI 10.1105/tpc.104.022657; Burt A, 2004, CURR OPIN GENET DEV, V14, P609, DOI 10.1016/j.gde.2004.09.010; Chevalier B, 2004, BIOCHEMISTRY-US, V43, P14015, DOI 10.1021/bi048970c; Chevalier BS, 2001, NUCLEIC ACIDS RES, V29, P3757, DOI 10.1093/nar/29.18.3757; Christ F, 1999, EMBO J, V18, P6908, DOI 10.1093/emboj/18.24.6908; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; Eskes R, 2000, MOL CELL BIOL, V20, P8432, DOI 10.1128/MCB.20.22.8432-8446.2000; Fedler M, 2009, GENETICS, V181, P847, DOI 10.1534/genetics.108.096859; Gimble FS, 2003, J MOL BIOL, V334, P993, DOI 10.1016/j.jmb.2003.10.013; Goddard MR, 1999, P NATL ACAD SCI USA, V96, P13880, DOI 10.1073/pnas.96.24.13880; Haugen P, 2005, TRENDS GENET, V21, P111, DOI 10.1016/j.tig.2004.12.007; Haugen P, 2004, NUCLEIC ACIDS RES, V32, P2049, DOI 10.1093/nar/gkh520; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; JACQUIER A, 1985, CELL, V41, P383, DOI 10.1016/S0092-8674(85)80011-8; Jin YJ, 1997, J BIOL CHEM, V272, P7352, DOI 10.1074/jbc.272.11.7352; LAMBOWITZ AM, 1993, ANNU REV BIOCHEM, V62, P587, DOI 10.1146/annurev.bi.62.070193.003103; Lang BF, 2007, TRENDS GENET, V23, P119, DOI 10.1016/j.tig.2007.01.006; LAZOWSKA J, 1994, EMBO J, V13, P4963, DOI 10.1002/j.1460-2075.1994.tb06823.x; Lowery R., 1992, PROMEGA NOTES, V38, P8; Monteilhet C, 2000, NUCLEIC ACIDS RES, V28, P1245, DOI 10.1093/nar/28.5.1245; Moure CM, 2008, NUCLEIC ACIDS RES, V36, P3287, DOI 10.1093/nar/gkn178; Mullineux ST, 2010, RNA, V16, P1818, DOI 10.1261/rna.2184010; NETTER P, 1974, GENETICS, V78, P1063; Nieto-Jacobo F, 2012, EUKARYOT CELL, V11, P1154, DOI 10.1128/EC.00115-12; PERRIN A, 1993, EMBO J, V12, P2939, DOI 10.1002/j.1460-2075.1993.tb05956.x; Roberts RJ, 2003, NUCLEIC ACIDS RES, V31, P1805, DOI 10.1093/nar/gkg274; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scalley-Kim M, 2007, J MOL BIOL, V372, P1305, DOI 10.1016/j.jmb.2007.07.052; Seligman LM, 1997, GENETICS, V147, P1653; Silva GH, 1999, J MOL BIOL, V286, P1123, DOI 10.1006/jmbi.1998.2519; Stoddard BL, 2011, STRUCTURE, V19, P7, DOI 10.1016/j.str.2010.12.003; Stoddard BL, 2005, Q REV BIOPHYS, V38, P49, DOI 10.1017/S0033583505004063; Toor N, 2002, RNA, V8, P1373, DOI 10.1017/S1355838202023087; Urban M, 1996, MOL GEN GENET, V251, P31; Zhao L, 2007, EMBO J, V26, P2432, DOI 10.1038/sj.emboj.7601672	43	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49551	10.1371/journal.pone.0049551	http://dx.doi.org/10.1371/journal.pone.0049551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166709	Green Published, gold			2022-12-27	WOS:000311151900162
J	Rhodes, G; Addison, B; Jeffery, L; Ewbank, M; Calder, AJ				Rhodes, Gillian; Addison, Brooke; Jeffery, Linda; Ewbank, Michael; Calder, Andrew J.			Facial Expressions of Threat Influence Perceived Gaze Direction in 8 Year-Olds	PLOS ONE			English	Article							EMOTIONAL EXPRESSION; EYE GAZE; DEVELOPMENTAL-CHANGES; FACE; RECOGNITION; CHILDHOOD; SENSITIVITY; PERCEPTION	Adults show reciprocal influences between the perception of gaze direction and emotional expression. These facilitate the understanding of facial signals, because the meaning of one cue can vary considerably depending on the value of the other. Here we ask whether children show similar reciprocal influences in the perception of gaze and expression. A previous study has demonstrated that gaze direction affects the perception of emotional expression in children. Here we demonstrate the opposite direction of influence, showing that expression affects the perception of gaze direction. Specifically, we show that the cone of gaze, i.e., range of gaze deviations perceived as direct, is larger for angry than neutral or fearful faces in 8 year-old children. Therefore, we conclude that children, like adults, show reciprocal influences in the perception of gaze and expression. An unexpected finding was that, compared with adults, children showed larger effects of expression on gaze perception. This finding raises the possibility that it is the ability to process cues independently, rather than sensitivity to combinations, that matures during development. Alternatively, children may be particularly sensitive to anger in adult faces.	[Rhodes, Gillian; Addison, Brooke; Jeffery, Linda; Calder, Andrew J.] Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Disorders, Crawley, WA, Australia	University of Western Australia	Rhodes, G (corresponding author), Univ Western Australia, Sch Psychol, ARC Ctr Excellence Cognit & Disorders, Crawley, WA, Australia.	gillian.rhodes@uwa.edu.au	Jeffery, Linda/H-5127-2014	Jeffery, Linda/0000-0002-3980-5864; Rhodes, Gillian/0000-0002-3631-8518; Ewbank, Michael/0000-0002-0097-5057	Medical Research Council [MC_U105579214, MC-A060-5PQ50] Funding Source: Medline; MRC [MC_U105579214] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adams RB, 2005, EMOTION, V5, P3, DOI 10.1037/1528-3542.5.1.3; Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Adams RB, 2009, MOTIV EMOTION, V33, P106, DOI 10.1007/s11031-009-9121-9; Akechi H, 2009, CHILD DEV, V80, P1134, DOI 10.1111/j.1467-8624.2009.01321.x; Bindemann M, 2008, VIS COGN, V16, P708, DOI 10.1080/13506280701269318; Bruce V, 2000, BRIT J DEV PSYCHOL, V18, P319, DOI 10.1348/026151000165715; CHAPMAN M, 1981, J EXP CHILD PSYCHOL, V31, P332, DOI 10.1016/0022-0965(81)90022-9; CHUNG MS, 1995, BRIT J PSYCHOL, V86, P55, DOI 10.1111/j.2044-8295.1995.tb02546.x; Crookes K, 2009, COGNITION, V111, P219, DOI 10.1016/j.cognition.2009.02.004; DIAMOND R, 1977, J EXP CHILD PSYCHOL, V23, P1, DOI 10.1016/0022-0965(77)90069-8; ELLIS HD, 1992, PHILOS T R SOC B, V335, P105, DOI 10.1098/rstb.1992.0013; Ewbank MP, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00056; Ewbank MP, 2009, J VISION, V9, DOI 10.1167/9.12.16; Gao XQ, 2010, J EXP CHILD PSYCHOL, V107, P67, DOI 10.1016/j.jecp.2010.05.003; Graham R, 2007, EMOTION, V7, P296, DOI 10.1037/1528-3542.7.2.296; Graham R, 2012, NEUROPSYCHOLOGIA, V50, P553, DOI 10.1016/j.neuropsychologia.2012.01.019; Herba C, 2004, J CHILD PSYCHOL PSYC, V45, P1185, DOI 10.1111/j.1469-7610.2004.00316.x; Hess U, 2007, MOTIV EMOTION, V31, P137, DOI 10.1007/s11031-007-9057-x; Hoehl S, 2010, DEVELOPMENTAL SCI, V13, P813, DOI 10.1111/j.1467-7687.2009.00944.x; Hoehl S, 2008, CHILD DEV, V79, P1752, DOI 10.1111/j.1467-8624.2008.01223.x; Leat SJ., 2009, J OPTOM, V2(1), P19, DOI DOI 10.3921/JOPTOM.2009.19; Lobmaier JS, 2008, EMOTION, V8, P573, DOI 10.1037/1528-3542.8.4.573; Milders M, 2011, EMOTION, V11, P1456, DOI 10.1037/a0022901; Mondloch CJ, 2003, J EXP CHILD PSYCHOL, V86, P67, DOI 10.1016/S0022-0965(03)00102-4; Mondloch CJ, 2002, PERCEPTION, V31, P553, DOI 10.1068/p3339; Mondloch CJ, 2004, J EXP CHILD PSYCHOL, V89, P159, DOI 10.1016/j.jecp.2004.07.002; Rigato S, 2010, SOC COGN AFFECT NEUR, V5, P88, DOI 10.1093/scan/nsp037; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Sander D, 2007, EUR J COGN PSYCHOL, V19, P470, DOI 10.1080/09541440600757426; Spangler SM, 2010, J EXP CHILD PSYCHOL, V105, P1, DOI 10.1016/j.jecp.2009.09.003; Thomas LA, 2007, DEVELOPMENTAL SCI, V10, P547, DOI 10.1111/j.1467-7687.2007.00614.x; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; Vida M, 2011, J VISION, V11, P449; Vida MD, 2012, J EXP CHILD PSYCHOL, V112, P243, DOI 10.1016/j.jecp.2012.02.002	34	14	15	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49317	10.1371/journal.pone.0049317	http://dx.doi.org/10.1371/journal.pone.0049317			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166638	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900121
J	Teychenne, M; Ball, K; Salmon, J				Teychenne, Megan; Ball, Kylie; Salmon, Jo			Promoting Physical Activity and Reducing Sedentary Behavior in Disadvantaged Neighborhoods: A Qualitative Study of What Women Want	PLOS ONE			English	Article							SOCIOECONOMIC-STATUS; ACTIVITY INTERVENTION; BARRIERS; ADULTS; POPULATIONS; INDICATORS; NUTRITION; INTERNET; OUTCOMES; SAFETY	Since women living in socioeconomically disadvantaged neighborhoods are more likely to be physically inactive and engage in higher levels of sedentary behavior than women living in more advantaged neighborhoods, it is important to develop and test the feasibility of strategies aimed to promote physical activity and reduce sedentary behavior amongst this high-risk target group. Thirty-seven women (aged 19-85) living in a disadvantaged neighborhood, and five key stakeholders, received a suite of potential intervention materials and completed a qualitative questionnaire assessing the perceived feasibility of strategies aimed to increase physical activity and reduce sedentary behavior. Thematic analyses were performed. Women perceived the use of a locally-relevant information booklet as a feasible strategy to increase physical activity and reduce sedentary behavior. Including weight-loss information was suggested to motivate women to be active. Half the women felt the best delivery method was mailed leaflets. Other suggestions included reference books and websites. Many women mentioned that an online activity calendar was motivational but too time-consuming to commit to. Most women preferred the information booklet as a strategy to increase physical activity/reduce sedentary behavior, yet several suggested that using the booklet together with the online calendar may be more effective. These findings make an important contribution to research informing the development of intervention strategies to increase physical activity and reduce sedentary behavior amongst women living in disadvantaged neighborhoods.	[Teychenne, Megan; Ball, Kylie; Salmon, Jo] Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Burwood, Vic, Australia	Deakin University	Teychenne, M (corresponding author), Deakin Univ, Ctr Phys Act & Nutr Res, Sch Exercise & Nutr Sci, Burwood, Vic, Australia.	mteych@deakin.edu.au	Ball, Kylie/B-5866-2015; Salmon, Jo/X-2630-2019; Salmon, Jo/C-1226-2009	Ball, Kylie/0000-0003-2893-8415; Salmon, Jo/0000-0002-4734-6354; Salmon, Jo/0000-0002-4734-6354; Teychenne, Megan/0000-0002-7293-8255				Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Altpeter M, 2011, ARTHRIT CARE RES, V63, P927, DOI 10.1002/acr.20474; [Anonymous], 1978, MAIL TELEPHONE SURVE; Armstrong T., 2000, P 6 QUEENSL WEED S C, P25; Australian Bureau of Statistics, 2003, CRIT FACT SUCC R D I, P1; Baum F, 1999, HEALTH PROMOT J AUST, V9, P171; Bauman A E, 2004, J Sci Med Sport, V7, P6, DOI 10.1016/S1440-2440(04)80273-1; Bensenor I, 1999, LIFESTYLE MED, P343; Booth ML, 1997, PREV MED, V26, P131, DOI 10.1006/pmed.1996.9982; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown W, 2002, MEASUREMENT PHYS ACT; Caperchione C, 2010, HEALTH PROMOT PRACT, V11, P637, DOI 10.1177/1524839908328996; Caperchoine C, 2009, J PHYS ACT HEALTH, V6, P589, DOI 10.1123/jpah.6.5.589; Chen A H, 1998, Womens Health, V4, P19; Craft LL, 2007, J WOMENS HEALTH, V16, P1499, DOI 10.1089/jwh.2007.0483; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; De Cocker KA, 2008, PREV MED, V47, P179, DOI 10.1016/j.ypmed.2008.05.012; Dinger MK, 2005, AM J HEALTH PROMOT, V20, P2, DOI 10.4278/0890-1171-20.1.2; Dunton GF, 2008, PREV MED, V47, P605, DOI 10.1016/j.ypmed.2008.10.004; Foster JA, 2006, AM J HEALTH BEHAV, V30, P3, DOI 10.5993/AJHB.30.1.1; Galobardes B, 2006, J EPIDEMIOL COMMUN H, V60, P95, DOI 10.1136/jech.2004.028092; HILLSDON M, 1995, J EPIDEMIOL COMMUN H, V49, P448, DOI 10.1136/jech.49.5.448; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Kavanagh AM, 2005, J EPIDEMIOL COMMUN H, V59, P934, DOI 10.1136/jech.2005.035931; Marcus BH, 2007, ARCH INTERN MED, V167, P944, DOI 10.1001/archinte.167.9.944; Marcus BH, 2006, CIRCULATION, V114, P2739, DOI 10.1161/CIRCULATIONAHA.106.179683; Marcus BH, 1998, WOMEN HEALTH ISS, V8, P104, DOI 10.1016/S1049-3867(97)00102-3; Marshall AL, 2003, AM J PREV MED, V25, P88, DOI 10.1016/S0749-3797(03)00111-9; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Muller-Riemenschneider F, 2008, PREV MED, V47, P354, DOI 10.1016/j.ypmed.2008.07.006; Norman GJ, 2007, AM J PREV MED, V33, P336, DOI 10.1016/j.amepre.2007.05.007; Otten JJ, 2009, ARCH INTERN MED, V169, P2109, DOI 10.1001/archinternmed.2009.430; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Plotnikoff RC, 2005, AM J HEALTH PROMOT, V19, P422, DOI 10.4278/0890-1171-19.6.422; Proper KI, 2011, AM J PREV MED, V40, P174, DOI 10.1016/j.amepre.2010.10.015; Ross CE, 2000, J HEALTH SOC BEHAV, V41, P177, DOI 10.2307/2676304; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Salmon J, 2003, HEALTH PSYCHOL, V22, P178, DOI 10.1037/0278-6133.22.2.178; Signorello LB, 2005, J NATL MED ASSOC, V97, P972; Stamatakis E, 2009, J EPIDEMIOL COMMUN H, V63, P734, DOI 10.1136/jech.2008.085902; Stokols D, 1996, AM J HEALTH PROMOT, V10, P282, DOI 10.4278/0890-1171-10.4.282; Sugiyama T, 2007, AM J PREV MED, V33, P444, DOI 10.1016/j.amepre.2007.07.035; Teychenne M, 2011, MENT HEALTH PHYS ACT, V4, P95, DOI DOI 10.1016/J.MHPA.2011.05.001; van Lenthe FJ, 2005, SOC SCI MED, V60, P763, DOI 10.1016/j.socscimed.2004.06.013; Wilson DK, 2004, ANN BEHAV MED, V28, P20, DOI 10.1207/s15324796abm2801_4; Wylie-Rosett J, 2001, J AM DIET ASSOC, V101, P1155, DOI 10.1016/S0002-8223(01)00284-X; Yancey AK, 2006, AM J PREV MED, V31, pS82, DOI 10.1016/j.amepre.2006.06.020	47	13	13	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49583	10.1371/journal.pone.0049583	http://dx.doi.org/10.1371/journal.pone.0049583			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166718	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900168
J	van de Wetering, FT; Scholten, RJPM; Haring, T; Clarke, M; Hooft, L				van de Wetering, Fleur T.; Scholten, Rob J. P. M.; Haring, Tamara; Clarke, Michael; Hooft, Lotty			Trial Registration Numbers Are Underreported in Biomedical Publications	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; MEDICAL-JOURNAL-EDITORS; INTERNATIONAL-COMMITTEE; CLINICAL-TRIALS; STATEMENT	Context: Since September 2005, the International Committee of Medical Journal Editors (ICMJE) has required that randomised controlled trials (RCTs) are prospectively registered in a publicly accessible database. After registration, a trial registration number (TRN) is assigned to each RCT, which should make it easier to identify future publications and cross-check published results with associated registry entries, as long as the unique identification number is reported in the article. Objective: Our primary objective was to evaluate the reporting of trial registration numbers in biomedical publications. Secondary objectives were to evaluate how many published RCTs had been registered and how many registered RCTs had resulted in a publication, using a sample of trials from the Netherlands Trials Register (NTR). Design, Setting: Two different samples of RCTs were examined: 1) RCTs published in November 2010 in core clinical journals identified in MEDLINE; 2) RCTs registered in the NTR with a latest expected end date of 31 August 2008. Results: Fifty-five percent (166/302) of the reports of RCTs found in MEDLINE and 60% (186/312) of the published reports of RCTs from the NTR cohort contained a TRN. In both samples, reporting of a TRN was more likely in RCTs published in ICMJE member journals as compared to non-ICMJE member journals (MEDLINE 58% vs. 45%; NTR: 70% vs. 49%). Thirty-nine percent of published RCTs in the MEDLINE sample appear not to have been registered, and 48% of RCTs registered in the NTR seemed not to have been published at least two years after the expected date for study completion. Conclusion: Our results show that further promotion and implementation of trial registration and accurate reporting of TRN is still needed. This might be helped by inclusion of the TRN as an item on the CONSORT checklist.	[van de Wetering, Fleur T.; Scholten, Rob J. P. M.; Haring, Tamara; Hooft, Lotty] Univ Amsterdam, Acad Med Ctr, Dutch Cochrane Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	van de Wetering, FT (corresponding author), Univ Amsterdam, Acad Med Ctr, Dutch Cochrane Ctr, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	f.t.vandewetering@amc.uva.nl						Anders ME, 2010, RESP CARE, V55, P578; Antes G, 2003, LANCET, V361, P978, DOI 10.1016/S0140-6736(03)12838-3; Chan AW, 2004, JAMA-J AM MED ASSOC, V291, P2457, DOI 10.1001/jama.291.20.2457; De Angelis CD, 2005, JAMA-J AM MED ASSOC, V293, P2927, DOI 10.1001/jama.293.23.jed50037; DeAngelis CD, 2004, JAMA-J AM MED ASSOC, V292, P1363, DOI 10.1001/jama.292.11.1363; Faure H, 2011, J EVID BASED MED, DOI [10.1111/j.1756-5391., DOI 10.1111/J.1756-5391]; Ghersi D, 2008, B WORLD HEALTH ORGAN, V86, P492, DOI 10.2471/BLT.08.053769; Ghersi Davina, 2009, J Evid Based Med, V2, P1, DOI 10.1111/j.1756-5391.2009.01014.x; Glanville JM, 2006, J MED LIBR ASSOC, V94, P130; Grobler L, 2008, LANCET, V372, P1201, DOI 10.1016/S0140-6736(08)61498-1; Gulmezoglu AM, 2005, LANCET, V365, P1829, DOI 10.1016/S0140-6736(05)66589-0; Laine C, 2007, JAMA-J AM MED ASSOC, V298, P93, DOI 10.1001/jama.298.1.jed70037; McGee RG, 2011, TRANSPLANTATION, V92, P1094, DOI 10.1097/TP.0b013e318232baf2; Ross JS, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000144; Wager E, 2004, CURR MED RES OPIN, V20, P203, DOI 10.1185/030079903125002883	15	49	49	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49599	10.1371/journal.pone.0049599	http://dx.doi.org/10.1371/journal.pone.0049599			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166724	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900169
J	Velders, FP; De Wit, JE; Jansen, PW; Jaddoe, VWV; Hofman, A; Verhulst, FC; Tiemeier, H				Velders, Fleur P.; De Wit, Jolanda E.; Jansen, Pauline W.; Jaddoe, Vincent W. V.; Hofman, Albert; Verhulst, Frank C.; Tiemeier, Henning			FTO at rs9939609, Food Responsiveness, Emotional Control and Symptoms of ADHD in Preschool Children	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EATING BEHAVIOR QUESTIONNAIRE; GENE VARIANT; FAT MASS; OBESITY; OVERWEIGHT; CHILDHOOD; ADOLESCENTS; ADIPOSITY; PARENTS	The FTO minor allele at rs9939609 has been associated with body mass index (BMI: weight (kg)/height (m)(2)) in children from 5 years onwards, food intake, and eating behaviour. The high expression of FTO in the brain suggests that this gene may also be associated with behavioural phenotypes, such as impulsivity and control. We examined the effect of the FTO minor allele (A) at rs9939609 on eating behaviour, impulsivity and control in young children, thus before the BMI effect becomes apparent. This study was embedded in the Generation R Study, a population-based cohort from fetal life onwards. 1,718 children of European descent were genotyped for FTO at rs9939609. With logistic regression assuming an additive genetic model, we examined the association between the FTO minor allele and eating behaviour, impulsivity and control in preschool children. There was no relation between FTO at rs9939609 and child BMI at this age. The A allele at rs9939609 was associated with increased food responsiveness (OR 1.21, p = 0.03). Also, children with the A allele were less likely to have symptoms of ADHD (OR 0.74, p = 0.01) and showed more emotional control (OR 0.64, p = 0.01) compared to children without the A allele. Our findings suggest that before the association between FTO and BMI becomes apparent, the FTO minor allele at rs9939609 leads to increased food responsiveness, a decreased risk for symptoms of ADHD and better emotional control. Future studies are needed to investigate whether these findings represent one single mechanism or reflect pleiotropic effects of FTO.	[Velders, Fleur P.; De Wit, Jolanda E.; Jansen, Pauline W.; Verhulst, Frank C.; Tiemeier, Henning] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Velders, FP (corresponding author), Sophia Childrens Univ Hosp, Erasmus Med Ctr, Dept Child & Adolescent Psychiat, Rotterdam, Netherlands.	h.tiemeier@erasmusmc.nl	Tiemeier, Henning/H-6534-2019	Tiemeier, Henning/0000-0002-4395-1397; Jansen, Pauline/0000-0001-7747-5803				Achenbach T. M., 2000, MANUAL ASEBA PRESCHO; Carnell S, 2007, APPETITE, V48, P104, DOI 10.1016/j.appet.2006.07.075; Cecil JE, 2008, NEW ENGL J MED, V359, P2558, DOI 10.1056/NEJMoa0803839; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Cortese S, 2008, CRIT REV FOOD SCI, V48, P524, DOI 10.1080/10408390701540124; Davis Caroline, 2006, Eat Behav, V7, P266, DOI 10.1016/j.eatbeh.2005.09.006; del Campo N, 2011, BIOL PSYCHIAT, V69, pE145, DOI 10.1016/j.biopsych.2011.02.036; Dick DM, 2005, J ABNORM CHILD PSYCH, V33, P219, DOI 10.1007/s10802-005-1829-8; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Fredriksson R, 2008, ENDOCRINOLOGY, V149, P2062, DOI 10.1210/en.2007-1457; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Gioia G.A.., 2003, BEHAV RATING INVENTO; Ho AJ, 2010, P NATL ACAD SCI USA, V107, P8404, DOI 10.1073/pnas.0910878107; Jaddoe VWV, 2007, EUR J EPIDEMIOL, V22, P917, DOI 10.1007/s10654-007-9209-z; Jaddoe VWV, 2010, EUR J EPIDEMIOL, V25, P823, DOI 10.1007/s10654-010-9516-7; Kivimaki M, 2011, AM J EPIDEMIOL, V173, P421, DOI 10.1093/aje/kwq444; Lawlor DA, 2011, J INTERN MED, V269, P525, DOI 10.1111/j.1365-2796.2011.02343.x; Puder JJ, 2010, INT J OBESITY, V34, pS37, DOI 10.1038/ijo.2010.238; Rolland-Cachera MF, 2006, INT J OBESITY, V30, pS11, DOI 10.1038/sj.ijo.0803514; Ruiz JR, 2010, ARCH PEDIAT ADOL MED, V164, P328, DOI 10.1001/archpediatrics.2010.29; Sherman EMS, 2010, CHILD NEUROPSYCHOL, V16, P503, DOI 10.1080/09297041003679344; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; SPSS, 2008, PASW STAT 17 0 WIND; Stearns FW, 2010, GENETICS, V186, P767, DOI 10.1534/genetics.110.122549; Tanofsky-Kraff M, 2009, AM J CLIN NUTR, V90, P1483, DOI 10.3945/ajcn.2009.28439; Terracciano A, 2009, PSYCHOSOM MED, V71, P682, DOI 10.1097/PSY.0b013e3181a2925b; Timpson NJ, 2008, AM J CLIN NUTR, V88, P971, DOI 10.1093/ajcn/88.4.971; Tung YCL, 2011, ANN NY ACAD SCI, V1220, P162, DOI 10.1111/j.1749-6632.2010.05903.x; Van Engeland H., 2008, RUTTERS CHILD ADOLES, P759; Velders FP, 2011, EUR CHILD ADOLES PSY, V20, P341, DOI 10.1007/s00787-011-0178-0; Wardle J, 2009, INT J OBESITY, V33, P42, DOI 10.1038/ijo.2008.174; Wardle J, 2001, J CHILD PSYCHOL PSYC, V42, P963, DOI 10.1111/1469-7610.00792; Wardle J, 2008, J CLIN ENDOCR METAB, V93, P3640, DOI 10.1210/jc.2008-0472; Waring ME, 2008, PEDIATRICS, V122, pE1, DOI 10.1542/peds.2007-1955; Zimmermann E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004428	37	51	51	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49131	10.1371/journal.pone.0049131	http://dx.doi.org/10.1371/journal.pone.0049131			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155456	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900091
J	Cheng, RH; Li, M; Zhang, H; Guo, YF; Chen, XL; Tao, JF; Jiang, AF; Gan, JC; Qi, HS; Yu, H; Liao, WQ; Yao, ZR				Cheng, Ruhong; Li, Ming; Zhang, Hui; Guo, Yifeng; Chen, Xilan; Tao, Jianfeng; Jiang, Aifang; Gan, Jiecheng; Qi, Huaishan; Yu, Hong; Liao, Wanqing; Yao, Zhirong			Common FLG Mutation K4671X Not Associated with Atopic Dermatitis in Han Chinese in a Family Association Study	PLOS ONE			English	Article							FILAGGRIN-NULL MUTATIONS; ICHTHYOSIS VULGARIS; GENE; POPULATIONS; ECZEMA	Background: Filaggrin gene (FLG) mutations have been identified as the cause of ichthyosis vulgaris (IV) and major predisposing factors for atopic dermatitis (AD). The relationship among AD, IV and FLG mutations has not been clarified yet. Mutations 3321delA and K4671X, two of the most common mutations in Chinese patients, were both statistically associated with AD in case-control studies. Materials and Methods: A group of 100 family trios (a total of 300 members with one affected AD proband and both parents) were recruited and screened for three filaggrin null mutations (3222del4, 3321delA and K4671X). The subjects' manifestations of AD and IV were assessed by two experienced dermatologists and recorded in detail. The relationship of common mutations to AD were assessed using both case-control and family-based tests of association. Filaggrin expression was measured in skin of 3 subjects with K4671X heterozygote and the normal control using quantitative real-time RT-PCR and immunohistochemistry. Results: Of 100 probands for AD, 22 were carriers for common FLG mutations and only 2 of them were from 40 none-IV family trios (5.00%), consistent with that of the healthy control group (3.99%, P>0.05). Significant statistical associations were revealed between AD and 3321delA (P<0.001, odds ratio 12.28, 95% confidence interval 3.35-44.98) as well as K4671X (P = 0.002, odds ratio 4.53, 95% confidence interval 1.77-11.60). The family-based approach revealed that 3321delA was over-transmitted to AD offspring from parents (T:U = 12: 1, P = 0.003) but failed to demonstrate transmission disequilibrium between K4671X and AD (T: U = 10: 8, P = 0.815). Moreover, compared to the normal control, filaggrin expression at both mRNA and protein levels in epidermis of subjects with K4671X(heter) was not reduced. Conclusions: AD patients from none-IV family trios have low probability of carrying FLG mutations. The present family samples confirmed the susceptibility of mutation 3321delA to AD in Han Chinese. K4671X was not a pathogenic mutation.	[Liao, Wanqing] Second Mil Med Univ, Changzheng Hosp, Dept Dermatol, Shanghai, Peoples R China; [Cheng, Ruhong; Li, Ming; Zhang, Hui; Guo, Yifeng; Chen, Xilan; Tao, Jianfeng; Jiang, Aifang; Gan, Jiecheng; Qi, Huaishan; Yu, Hong; Yao, Zhirong] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Dermatol, Shanghai 200030, Peoples R China	Naval Medical University; Shanghai Jiao Tong University	Liao, WQ (corresponding author), Second Mil Med Univ, Changzheng Hosp, Dept Dermatol, Shanghai, Peoples R China.	Liaowanqing@sohu.com; dermatology.yao@sohu.com			Science and Technology Commission of Shanghai Municipality [11jc1408400]; National Nature Science Foundation of China [81171544]	Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by Science and Technology Commission of Shanghai Municipality (11jc1408400) and National Nature Science Foundation of China (81171544). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bremmer SE, 2008, J AM ACAD DERMATOL, V59, P72, DOI 10.1016/j.jaad.2008.03.029; Brown S, 2008, TLS-TIMES LIT SUPPL, P27; Chen H, 2011, BRIT J DERMATOL, V165, P106, DOI 10.1111/j.1365-2133.2011.10331.x; Ching GK, 2009, INT J IMMUNOGENET, V36, P251, DOI 10.1111/j.1744-313X.2009.00859.x; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Hsu CK, 2009, BRIT J DERMATOL, V161, P448, DOI 10.1111/j.1365-2133.2009.09112.x; Li M, 2013, J EUR ACAD DERMATOL, V27, P169, DOI 10.1111/j.1468-3083.2011.04435.x; Nemoto-Hasebe I, 2009, BRIT J DERMATOL, V161, P1387, DOI 10.1111/j.1365-2133.2009.09406.x; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Rogers AJ, 2007, J ALLERGY CLIN IMMUN, V120, P1332, DOI 10.1016/j.jaci.2007.09.037; Sandilands A, 2007, NAT GENET, V39, P650, DOI 10.1038/ng2020; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; Zhang H, 2011, ALLERGY, V66, P1253, DOI 10.1111/j.1398-9995.2011.02597.x; Zhang H, 2011, ALLERGY, V66, P420, DOI 10.1111/j.1398-9995.2010.02493.x; Zhang X, 2010, BRIT J DERMATOL, V163, P63, DOI 10.1111/j.1365-2133.2010.09740.x; 1993, DERMATOLOGY, V186, P23	19	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49158	10.1371/journal.pone.0049158	http://dx.doi.org/10.1371/journal.pone.0049158			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152869	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600026
J	Crespo, JA; Ortuno-Ortin, I; Ruiz-Castillo, J				Crespo, Juan A.; Ortuno-Ortin, Ignacio; Ruiz-Castillo, Javier			The Citation Merit of Scientific Publications	PLOS ONE			English	Article							IMPACT FACTORS; INDICATORS	We propose a new method to assess the merit of any set of scientific papers in a given field based on the citations they receive. Given a field and a citation impact indicator, such as the mean citation or the h-index, the merit of a given set of n articles is identified with the probability that a randomly drawn set of n articles from a given pool of articles in that field has a lower citation impact according to the indicator in question. The method allows for comparisons between sets of articles of different sizes and fields. Using a dataset acquired from Thomson Scientific that contains the articles published in the periodical literature in the period 1998-2007, we show that the novel approach yields rankings of research units different from those obtained by a direct application of the mean citation or the h-index.	[Crespo, Juan A.] Univ Autonoma Madrid, Dept Econ Cuantitat, Madrid, Spain; [Ortuno-Ortin, Ignacio; Ruiz-Castillo, Javier] Univ Carlos III Madrid, Dept Econ, Madrid, Spain	Autonomous University of Madrid; Universidad Carlos III de Madrid	Crespo, JA (corresponding author), Univ Autonoma Madrid, Dept Econ Cuantitat, Madrid, Spain.	juan.crespo@uam.es	Ruiz-Castillo, Javier/O-8180-2019; Crespo, Juan/A-2444-2011; ORTUNO, IGNACIO ISIDRO/Y-5541-2018	CRESPO FERNANDEZ, JUAN ALFONSO/0000-0001-6696-621X; ORTUNO, IGNACIO ISIDRO/0000-0001-6721-5901	Santander Universities Global Division of Banco Santander; Spanish MEC (Ministerio de Educacion) [SEJ2007-67436, ECO2010-19596]; European Commission [SSH7-CT-2008-217436]	Santander Universities Global Division of Banco Santander; Spanish MEC (Ministerio de Educacion)(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre)	The authors acknowledge financial support from the Santander Universities Global Division of Banco Santander. JR-C also acknowledges financial help from the Spanish MEC (Ministerio de Educacion) through grant SEJ2007-67436. JAC and IO-O also acknowledge financial help from the Spanish MEC through grant ECO2010-19596. This paper is produced as part of the project Science, Innovation, Firms and markets in a Globalised World (SCIFI-GLOW), a Collaborative Project funded by the European Commission's Seventh Research Framework Programme, Contract number SSH7-CT-2008-217436. Any opinions expressed here are those of the author(s) and not those of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aksnes DW, 2012, J INFORMETR, V6, P36, DOI 10.1016/j.joi.2011.08.002; Albarran P, 2011, SCIENTOMETRICS, V88, P385, DOI 10.1007/s11192-011-0407-9; Albarran P, 2011, J AM SOC INF SCI TEC, V62, P40, DOI 10.1002/asi.21448; Albarran P, 2011, J INFORMETR, V5, P122, DOI 10.1016/j.joi.2010.10.001; Albarran P, 2010, SCIENTOMETRICS, V85, P329, DOI 10.1007/s11192-010-0223-7; Bornmann L., J AM SOC IN IN PRESS; Bouyssou D, 2011, J AM SOC INF SCI TEC, V62, P1761, DOI 10.1002/asi.21544; Bouyssou D, 2011, J INFORMETR, V5, P75, DOI 10.1016/j.joi.2010.09.001; Braun WG, 1985, SCIENTOMETRICS INDIC; Fortunato S, 2008, PNAS, V105, P17268; Glanzel W, 2007, J INFORMETR, V1, P92, DOI 10.1016/j.joi.2006.10.001; Glanzel W, 2002, SCIENTOMETRICS, V55, P335, DOI 10.1023/A:1020406627944; Glanzel W., 1983, P 1 NAT C INT PART S; Herranz N, 2012, J AM SOC IN IN PRESS; Hirsch JE, 2005, P NATL ACAD SCI USA, V102, P16569, DOI 10.1073/pnas.0507655102; King DA, 2004, NATURE, V430, P311, DOI 10.1038/430311a; Kinney AL, 2007, P NATL ACAD SCI USA, V104, P17943, DOI 10.1073/pnas.0704416104; Leydesdorff L, 2011, J AM SOC INF SCI TEC, V62, P2133, DOI 10.1002/asi.21609; Leydesdorff L, 2011, J AM SOC INF SCI TEC, V62, P1370, DOI 10.1002/asi.21534; May RM, 1997, SCIENCE, V275, P793, DOI 10.1126/science.275.5301.793; MOED HF, 1985, RES POLICY, V14, P131, DOI 10.1016/0048-7333(85)90012-5; MOED HF, 1995, SCIENTOMETRICS, V33, P381, DOI 10.1007/BF02017338; Molinari JF, 2008, SCIENTOMETRICS, V75, P163, DOI 10.1007/s11192-007-1853-2; Ravallion M, 2011, SCIENTOMETRICS, V88, P321, DOI 10.1007/s11192-011-0375-0; Rousseau R, 2012, J AM SOC INF SCI TEC, V63, P416, DOI 10.1002/asi.21684; SCHUBERT A, 1987, SCIENTOMETRICS, V12, P267, DOI 10.1007/BF02016664; SCHUBERT A, 1986, SCIENTOMETRICS, V9, P281, DOI 10.1007/BF02017249; Seglen P, 2004, J AM SOC INFORM SCI, V43, P628; van Raan AFJ, 2004, HANDBOOK OF QUANTITATIVE SCIENCE AND TECHNOLOGY RESEARCH: THE USE OF PUBLICATION AND PATENT STATISTICS IN STUDIES OF S&T SYSTEMS, P19; Vinkler P, 2003, SCIENTOMETRICS, V58, P687, DOI 10.1023/B:SCIE.0000006888.69146.24; VINKLER P, 1986, SCIENTOMETRICS, V10, P157, DOI 10.1007/BF02026039; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P406, DOI 10.1002/asi.21678	32	14	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49156	10.1371/journal.pone.0049156	http://dx.doi.org/10.1371/journal.pone.0049156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039HF	23152867	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600025
J	Knox, J; Uhlemann, AC; Miller, M; Hafer, C; Vasquez, G; Vavagiakis, P; Shi, QH; Lowy, FD				Knox, Justin; Uhlemann, Anne-Catrin; Miller, Maureen; Hafer, Cory; Vasquez, Glenny; Vavagiakis, Peter; Shi, Qiuhu; Lowy, Franklin D.			Environmental Contamination as a Risk Factor for Intra-Household Staphylococcus aureus Transmission	PLOS ONE			English	Article							HOUSEHOLD CONTACTS; FAMILIAL TRANSMISSION; RANDOMIZED-TRIAL; NASAL CARRIAGE; PCR STRATEGY; COLONIZATION; INFECTION; PREVALENCE; MULTIPLEX; SETTINGS	Background: The household is a recognized community reservoir for Staphylococcus aureus. This study investigated potential risk factors for intra-household S. aureus transmission, including the contribution of environmental contamination. Methods: We investigated intra-household S. aureus transmission using a sample of multiple member households from a community-based case-control study examining risk factors for CA-MRSA infection conducted in Northern Manhattan. During a home visit, index subjects completed a questionnaire. All consenting household members were swabbed, as were standardized environmental household items. Swabs were cultured for S. aureus. Positive isolates underwent further molecular characterization. Intra-household transmission was defined as having identical strains among two or more household members. Multiple logistic regression was used to identify independent risk factors for transmission. Results: We enrolled 291 households: 146 index cases, 145 index controls and 687 of their household contacts. The majority of indexes were Hispanic (85%), low income (74%), and female (67%), with a mean age of 31 (range 1-79). The average size of case and control households was 4 people. S. aureus colonized individuals in 62% of households and contaminated the environment in 54% of households. USA300 was the predominant clinical infection, colonizing and environmental strain. Eighty-one households had evidence of intra-household transmission: 55 (38%) case and 26 (18%) control households (P<.01). Environmental contamination with a colonizing or clinical infection strain (aOR: 5.4 [2.9-10.3] P<.01) and the presence of a child under 5 (aOR: 2.3 [1.2-4.5] P = .02) were independently associated with transmission. In separate multivariable models, environmental contamination was associated with transmission among case (aOR 3.3, p<.01) and control households (aOR 27.2, p<.01). Conclusions: Environmental contamination with a colonizing or clinical infection strain was significantly and independently associated with transmission in a large community-based sample. Environmental contamination should be considered when treating S. aureus infections, particularly among households with multiple infected members.	[Knox, Justin; Uhlemann, Anne-Catrin; Hafer, Cory; Vasquez, Glenny; Lowy, Franklin D.] Columbia Univ, Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10027 USA; [Miller, Maureen] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Vavagiakis, Peter] Panna Technol Inc, New York, NY USA; [Shi, Qiuhu] New York Med Coll, Sch Hlth Sci & Practice, Dept Epidemiol & Community Hlth, New York, NY USA; [Lowy, Franklin D.] Columbia Univ, Coll Phys & Surg, Dept Pathol, New York, NY USA	Columbia University; Columbia University; New York Medical College; Columbia University	Knox, J (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Med, Div Infect Dis, New York, NY 10027 USA.	jrk2115@columbia.edu	Knox, Justin/AAA-1729-2021	Knox, Justin/0000-0001-6771-8138	National Institutes of Health [AI077690, AI090013]; Paul A. Marks scholarship by Columbia University Medical Center Institutional grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI090013, R01AI077690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul A. Marks scholarship by Columbia University Medical Center Institutional grants; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health [AI077690 to FL and AI090013 to ACU) and the Paul A. Marks scholarship (to ACU) by Columbia University Medical Center Institutional grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Busato, 1998, Braz J Infect Dis, V2, P78; Calfee DP, 2003, INFECT CONT HOSP EP, V24, P422, DOI 10.1086/502225; Cook HA, 2007, CLIN INFECT DIS, V44, P410, DOI 10.1086/510681; Dancer SJ, 2009, J HOSP INFECT, V73, P378, DOI 10.1016/j.jhin.2009.03.030; Fritz SA, 2012, CLIN INFECT DIS, V54, P743, DOI 10.1093/cid/cir919; Fritz SA, 2011, INFECT CONT HOSP EP, V32, P872, DOI 10.1086/661285; Gwizdala RA, 2011, AM J PUBLIC HEALTH, V101, P1268, DOI 10.2105/AJPH.2010.300028; Harbarth S, 2000, CLIN INFECT DIS, V31, P1380, DOI 10.1086/317484; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ho PL, 2007, DIAGN MICR INFEC DIS, V57, P145, DOI 10.1016/j.diagmicrobio.2006.08.003; Huang YC, 2007, PEDIATR INFECT DIS J, V26, P1066, DOI 10.1097/INF.0b013e31813429e8; Huijsdens XW, 2006, J CLIN MICROBIOL, V44, P2994, DOI 10.1128/JCM.00846-06; Johansson PJH, 2007, SCAND J INFECT DIS, V39, P764, DOI 10.1080/00365540701302501; Jones TF, 2006, CLIN INFECT DIS, V42, pE76, DOI 10.1086/503265; L'Heriteau F, 1999, JAMA-J AM MED ASSOC, V282, P1038, DOI 10.1001/jama.282.11.1038; Latkin C, 1996, J ACQ IMMUN DEF SYND, V13, P273, DOI 10.1097/00042560-199611010-00010; Lautenbach E, 2010, EPIDEMIOL INFECT, V138, P683, DOI 10.1017/S0950268810000099; Lee CJ, 2011, CLIN INFECT DIS, V52, P775, DOI 10.1093/cid/cir026; Lucet JC, 2009, ARCH INTERN MED, V169, P1372, DOI 10.1001/archinternmed.2009.217; Milheirico C, 2007, ANTIMICROB AGENTS CH, V51, P3374, DOI 10.1128/AAC.00275-07; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Miller LG, 2012, CLIN INFECT DIS, V54, P1523, DOI 10.1093/cid/cis213; Miller M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006708; Mollema FPN, 2010, J CLIN MICROBIOL, V48, P202, DOI 10.1128/JCM.01499-09; Nerby JM, 2011, PEDIATR INFECT DIS J, V30, P927, DOI 10.1097/INF.0b013e31822256c3; Shopsin B, 1999, J CLIN MICROBIOL, V37, P3556, DOI 10.1128/JCM.37.11.3556-3563.1999; Uhlemann AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022407; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wagenvoort JHT, 1997, EUR J CLIN MICROBIOL, V16, P399, DOI 10.1007/BF01726373; Zafar U, 2007, INFECT CONT HOSP EP, V28, P966, DOI 10.1086/518965	31	41	43	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49900	10.1371/journal.pone.0049900	http://dx.doi.org/10.1371/journal.pone.0049900			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152934	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600054
J	Weimer, K; Schulte, J; Maichle, A; Muth, ER; Scisco, JL; Horing, B; Enck, P; Klosterhalfen, S				Weimer, Katja; Schulte, Joerg; Maichle, Annamaria; Muth, Eric R.; Scisco, Jenna L.; Horing, Bjoern; Enck, Paul; Klosterhalfen, Sibylle			Effects of Ginger and Expectations on Symptoms of Nausea in a Balanced Placebo Design	PLOS ONE			English	Article							MOTION SICKNESS; CONDITIONED NAUSEA; CANCER-PATIENTS; RESPONSES; EXPECTANCY; DRUG	Objective: Ginger effects on (experimental) nausea have been described, but also strong placebo effects and sex differences when nausea is involved. The "balanced placebo design'' has been proposed to allow better separation of drug and placebo effects. Methods: Sixty-four healthy participants (32 women) were randomly assigned to receive an antiemetic ginger preparation or placebo, and half of each group was told to have received drug or placebo. They were exposed to 5x2 min body rotations to induce nausea. Subjective symptoms and behavioral (rotation tolerance, head movements) and physiological measures (electrogastrogram, cortisol) were recorded. Groups were balanced for sex of participants and experimenters. Results: Ginger and the information given did not affect any outcome measure, and previous sex differences could not be confirmed. Adding the experimenters revealed a significant four-factorial interaction on behavioral but not on subjective or physiological measures Men who received placebo responded to placebo information when provided by the male experimenter, and to ginger information when provided by the female experimenter. This effect was not significant in women. Conclusion: The effects of an antiemetic drug and provided information interact with psychosocial variables of participants and experimenters in reports of nausea.	[Weimer, Katja; Schulte, Joerg; Maichle, Annamaria; Horing, Bjoern; Enck, Paul; Klosterhalfen, Sibylle] Univ Tubingen Hosp, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany; [Muth, Eric R.; Scisco, Jenna L.] Clemson Univ, Dept Psychol, Clemson, SC 29634 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Clemson University	Enck, P (corresponding author), Univ Tubingen Hosp, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany.	paul.enck@uni-tuebingen.de		Weimer, Katja/0000-0001-8656-607X	Volkswagen Foundation, Germany [I/83 805]; Deutsche Forschungsgemeinschaft (DFG) [En 50/30-1]	Volkswagen Foundation, Germany(Volkswagen); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This study was supported by grants from the Volkswagen Foundation, Germany (I/83 805) (http://www.volkswagenstiftung.de) and the Deutsche Forschungsgemeinschaft (DFG, En 50/30-1) (http://www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslaksen PM, 2008, PSYCHOSOM MED, V70, P811, DOI 10.1097/PSY.0b013e31818105ed; Aslaksen PM, 2007, PAIN, V129, P260, DOI 10.1016/j.pain.2006.10.011; Aslaksen PM, 2011, PSYCHOSOM MED, V73, P193, DOI 10.1097/PSY.0b013e3182080d73; BOVBJERG DH, 1992, PSYCHOSOM MED, V54, P623, DOI 10.1097/00006842-199211000-00001; Butcher BE, 2012, EUR J PAIN, V16, P1005, DOI 10.1002/j.1532-2149.2011.00104.x; Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030; Enck P, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-90; Flaten MA, 2006, J PSYCHOSOM RES, V61, P81, DOI 10.1016/j.jpsychores.2005.12.004; Frass M, 2012, OCHSNER J, V12, P45; Golding JF, 1998, BRAIN RES BULL, V47, P507, DOI 10.1016/S0361-9230(98)00091-4; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Juliano LM, 2011, EXP CLIN PSYCHOPHARM, V19, P105, DOI 10.1037/a0022937; Kallai I, 2004, PAIN, V112, P142, DOI 10.1016/j.pain.2004.08.008; KIRSCH I, 1988, BEHAV NEUROSCI, V102, P319, DOI 10.1037/0735-7044.102.2.319; Kirsch I, 2000, BIOL PSYCHIAT, V47, P733, DOI 10.1016/S0006-3223(00)00832-5; Klosterhalfen S, 2005, PSYCHOSOM MED, V67, P335, DOI 10.1097/01.psy.0000156930.00201.e0; Klosterhalfen S, 2000, PSYCHOSOM MED, V62, P671, DOI 10.1097/00006842-200009000-00011; Klosterhalfen Sibylle, 2006, Gend Med, V3, P236, DOI 10.1016/S1550-8579(06)80211-1; Klosterhalfen S, 2009, J PSYCHOSOM RES, V66, P323, DOI 10.1016/j.jpsychores.2008.09.019; Lee A, 2009, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD003281.PUB3; Levine ME, 2006, PSYCHOSOM MED, V68, P478, DOI 10.1097/01.psy.0000221377.52036.50; Lien HC, 2003, AM J PHYSIOL-GASTR L, V284, pG481, DOI 10.1152/ajpgi.00164.2002; Matthews A, 2010, COCHRANE DB SYST REV, V9; Meissner K, 2009, PHYSIOL BEHAV, V97, P102, DOI 10.1016/j.physbeh.2009.02.007; Miller FG, 2005, PLOS MED, V2, P853, DOI 10.1371/journal.pmed.0020262; Miller KE, 2004, AVIAT SPACE ENVIR MD, V 75, P227; Myers CD, 2003, CLIN J PAIN, V19, P225, DOI 10.1097/00002508-200307000-00005; Pillai AK, 2011, PEDIATR BLOOD CANCER, V56, P234, DOI 10.1002/pbc.22778; Probst T, 1998, J PSYCHOPHYSIOL, V12, P34; Rohleder N, 2006, PSYCHONEUROENDOCRINO, V31, P226, DOI 10.1016/j.psyneuen.2005.07.004; ROHSENOW DJ, 1981, ADDICT BEHAV, V6, P107, DOI 10.1016/0306-4603(81)90003-4; Stem RM, 1985, AVIAT SPACE ENV MED, V56, P1074; Stern RM, 1987, GASTROENTEROLOGY, V92, P92, DOI 10.1016/0016-5085(87)90843-2; Stockhorst U, 2000, BRAIN BEHAV IMMUN, V14, P198, DOI 10.1006/brbi.1999.0581; Stockhorst U, 1998, PHYSIOL BEHAV, V64, P743, DOI 10.1016/S0031-9384(98)00135-8; Valussi M, 2012, INT J FOOD SCI NUTR, V63, P82, DOI 10.3109/09637486.2011.627841; Weimer K., 2010, Z MED PSYCHOL, V19, P146; White B, 2007, AM FAM PHYSICIAN, V75, P1689; Zhang ZY, 2008, MED HYPOTHESES, V70, P551, DOI 10.1016/j.mehy.2007.06.029	39	18	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49031	10.1371/journal.pone.0049031	http://dx.doi.org/10.1371/journal.pone.0049031			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152846	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600019
J	Yamaguchi, A; Kitajo, K				Yamaguchi, Atsushi; Kitajo, Keiko			The Effect of PRMT1-Mediated Arginine Methylation on the Subcellular Localization, Stress Granules, and Detergent-Insoluble Aggregates of FUS/TLS	PLOS ONE			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; PRO-ONCOPROTEIN TLS/FUS; RNA-BINDING PROTEIN; FUS; TDP-43; ALS; IDENTIFICATION; EXPRESSION; MUTATIONS; PRMT1	Fused in sarcoma/translocated in liposarcoma (FUS/TLS) is one of causative genes for familial amyotrophic lateral sclerosis (ALS). In order to identify binding partners for FUS/TLS, we performed a yeast two-hybrid screening and found that protein arginine methyltransferase 1 (PRMT1) is one of binding partners primarily in the nucleus. In vitro and in vivo methylation assays showed that FUS/TLS could be methylated by PRMT1. The modulation of arginine methylation levels by a general methyltransferase inhibitor or conditional over-expression of PRMT1 altered slightly the nucleus-cytoplasmic ratio of FUS/TLS in cell fractionation assays. Although co-localized primarily in the nucleus in normal condition, FUS/TLS and PRMT1 were partially recruited to the cytoplasmic granules under oxidative stress, which were merged with stress granules (SGs) markers in SH-SY5Y cell. C-terminal truncated form of FUS/TLS (FUS-dC), which lacks C-terminal nuclear localization signal (NLS), formed cytoplasmic inclusions like ALS-linked FUS mutants and was partially co-localized with PRMT1. Furthermore, conditional over-expression of PRMT1 reduced the FUS-dC-mediated SGs formation and the detergent-insoluble aggregates in HEK293 cells. These findings indicate that PRMT1-mediated arginine methylation could be implicated in the nucleus-cytoplasmic shuttling of FUS/TLS and in the SGs formation and the detergent-insoluble inclusions of ALS-linked FUS/TLS mutants.	[Yamaguchi, Atsushi; Kitajo, Keiko] Chiba Univ, Grad Sch Med, Dept Neurobiol, Chiba, Japan	Chiba University	Yamaguchi, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Neurobiol, Chiba, Japan.	atsyama@restaff.chiba-u.jp			Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22591578] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by research grants from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson MK, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-37; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; Basso M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008130; Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bertrand P, 1999, ONCOGENE, V18, P4515, DOI 10.1038/sj.onc.1203048; Blackwell E, 2010, HUM MOL GENET, V19, P1314, DOI 10.1093/hmg/ddq007; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Cairns NJ, 2007, AM J PATHOL, V171, P227, DOI 10.2353/ajpath.2007.070182; Chen DH, 2004, J BIOCHEM, V136, P371, DOI 10.1093/jb/mvh131; Colombrita C, 2011, ARCH ITAL BIOL, V149, P83, DOI 10.4449/aib.v149i1.1261; Cote J, 2003, MOL BIOL CELL, V14, P274, DOI 10.1091/mbc.E02-08-0484; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Dewey CM, 2011, MOL CELL BIOL, V31, P1098, DOI 10.1128/MCB.01279-10; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Dormann D, 2012, EMBO J, DOI [10.1038/emboj.2012.261, DOI 10.1038/EMB0J.2012.261.[]; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Du K, 2011, BIOCHEM BIOPH RES CO, V404, P991, DOI 10.1016/j.bbrc.2010.12.097; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Forloni G, 2001, FEBS LETT, V487, P404, DOI 10.1016/S0014-5793(00)02380-2; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Fujita Y, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-6; Gal J, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.06.010; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Goulet I, 2007, J BIOL CHEM, V282, P33009, DOI 10.1074/jbc.M704349200; Herrmann F, 2004, J BIOL CHEM, V279, P48774, DOI 10.1074/jbc.M407332200; Hung CJ, 2009, PROTEIN J, V28, P139, DOI 10.1007/s10930-009-9174-3; Ivanov PA, 2006, MOL BIOL+, V40, P844, DOI 10.1134/S0026893306060021; Ju SL, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001052; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kim S, 1997, BIOCHEMISTRY-US, V36, P5185, DOI 10.1021/bi9625509; Koga S, 2012, BRAIN RES, V1436, P137, DOI 10.1016/j.brainres.2011.12.004; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2010, HUM MOL GENET, V19, pR46, DOI 10.1093/hmg/ddq137; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lee HW, 1997, BIOCHEMISTRY-US, V16, P78; Lei NZ, 2009, NUCLEIC ACIDS RES, V37, P832, DOI 10.1093/nar/gkn941; Liu-Yesucevitz L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013250; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, BRAIN, V132, P2922, DOI 10.1093/brain/awp214; Nichols RC, 2000, EXP CELL RES, V256, P522, DOI 10.1006/excr.2000.4827; Nicholson TB, 2009, PHARMACOL RES, V60, P466, DOI 10.1016/j.phrs.2009.07.006; Ohn T, 2010, WIRES RNA, V1, P486, DOI 10.1002/wrna.23; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Pahlich S, 2008, PROTEINS, V72, P1125, DOI 10.1002/prot.22004; PRASAD DDK, 1994, ONCOGENE, V9, P3717; Sebastiao MP, 2000, BIOCHEM J, V351, P273, DOI 10.1042/0264-6021:3510273; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Tradewell ML, 2012, HUM MOL GENET, V21, P136, DOI 10.1093/hmg/ddr448; Udan M, 2011, PRION, V5, P1, DOI 10.4161/pri.5.1.14265; Van Langenhove T, 2010, NEUROLOGY, V74, P366, DOI 10.1212/WNL.0b013e3181ccc732; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wada K, 2002, BBA-MOL CELL RES, V1591, P1, DOI 10.1016/S0167-4889(02)00202-1; Xie W, 2011, MOL BIOL INT, V2011, P1; Xu C, 2004, MOL CELL BIOL, V24, P10742, DOI 10.1128/MCB.24.24.10742-10756.2004; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761	59	66	67	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49267	10.1371/journal.pone.0049267	http://dx.doi.org/10.1371/journal.pone.0049267			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152885	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600033
J	Bengtsson, L; Lu, X; Nguyen, QC; Camitz, M; Hoang, NL; Nguyen, TA; Liljeros, F; Thorson, A				Bengtsson, Linus; Lu, Xin; Quoc Cuong Nguyen; Camitz, Martin; Nguyen Le Hoang; Tuan Anh Nguyen; Liljeros, Fredrik; Thorson, Anna			Implementation of Web-Based Respondent-Driven Sampling among Men Who Have Sex with Men in Vietnam	PLOS ONE			English	Article							HARD-TO-REACH; HIDDEN POPULATIONS; HIV; RISK; SURVEILLANCE; PREVALENCE; ONLINE; VARIANCE; HIV/AIDS; NETWORKS	Objective: Lack of representative data about hidden groups, like men who have sex with men (MSM), hinders an evidence-based response to the HIV epidemics. Respondent-driven sampling (RDS) was developed to overcome sampling challenges in studies of populations like MSM for which sampling frames are absent. Internet-based RDS (webRDS) can potentially circumvent limitations of the original RDS method. We aimed to implement and evaluate webRDS among a hidden population. Methods and Design: criteria were men, aged 18 and above, who had ever had sex with another man and were living in Vietnam. Participants were invited by an MSM friend, logged in, and answered a survey. Participants could recruit up to four MSM friends. We evaluated the system by its success in generating sustained recruitment and the degree to which the sample compositions stabilized with increasing sample size. Results: Twenty starting participants generated 676 participants over 24 recruitment waves. Analyses did not show evidence of bias due to ineligible participation. Estimated mean age was 22 years and 82% came from the two large metropolitan areas. 32 out of 63 provinces were represented. The median number of sexual partners during the last six months was two. The sample composition stabilized well for 16 out of 17 variables. Conclusion: Results indicate that webRDS could be implemented at a low cost among Internet-using MSM in Vietnam. WebRDS may be a promising method for sampling of Internet-using MSM and other hidden groups.	[Bengtsson, Linus; Lu, Xin; Camitz, Martin; Thorson, Anna] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Lu, Xin; Liljeros, Fredrik] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Quoc Cuong Nguyen] Family Heath Int, Hanoi, Vietnam; [Nguyen Le Hoang] iSEE, Hanoi, Vietnam; [Tuan Anh Nguyen] Hanoi Med Univ, Hanoi, Vietnam	Karolinska Institutet; Stockholm University; Hanoi Medical University	Bengtsson, L (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	bengtssonlinus@gmail.com	Liljeros, Fredrik G I/I-2667-2018; lu, xin/C-1940-2009	Liljeros, Fredrik G I/0000-0001-8642-6624; lu, xin/0000-0002-3547-6493; Thorson, Anna/0000-0002-8703-6561; Nguyen, Anh Tuan/0000-0003-4726-8162	Swedish International Development Agency (Sida)	Swedish International Development Agency (Sida)	Funding was provided by the Swedish International Development Agency (Sida). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, US CENS BUR INT DAT; [Anonymous], 2011, HIV AIDS SURVEY DATA; Bank World, 2010, OP DAT URB POP; Baral S, 2007, PLOS MED, V4, P1901, DOI 10.1371/journal.pmed.0040339; Bauermeister JA, 2012, FIELD METHOD, V24, P272, DOI 10.1177/1525822X12443097; Bauermeister JA, 2012, J STUD ALCOHOL DRUGS, V73, P834, DOI 10.15288/jsad.2012.73.834; Bengtsson L, 2010, AIDS, V24, P2301, DOI 10.1097/QAD.0b013e32833d207d; BERK RA, 1983, AM SOCIOL REV, V48, P386, DOI 10.2307/2095230; Cimigo, 2010, URB VIETN INT PEN HI; Colby D, 2008, SEX TRANSM INFECT, V84, P439, DOI 10.1136/sti.2008.031294; Commision on AIDS in Asia, 2008, RED AIDS AS CRAFT EF; Frost SDW, 2006, J URBAN HEALTH, V83, pI83, DOI 10.1007/s11524-006-9104-z; General Statistics Office of Viet Nam, 2009, 2009 VIETN POP HOUS; General Statistics Office of Vietnam, 2010, RES VIETN HOUS LIV S; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Goel S, 2009, STAT MED, V28, P2202, DOI 10.1002/sim.3613; GOODMAN LA, 1961, ANN MATH STAT, V32, P148, DOI 10.1214/aoms/1177705148; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Heckathorn DD, 2002, AIDS BEHAV, V6, P55; Iguchi MY, 2009, J URBAN HEALTH, V86, pS5, DOI 10.1007/s11524-009-9365-4; Jakopanec I, 2010, BMC INFECT DIS, V10; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Johnston LG, 2010, AIDS CARE, V22, P784, DOI 10.1080/09540120903373557; Konstan JA, 2005, J COMPUT-MEDIAT COMM, V10; Liljeros F, 2009, ENCY COMPLEXITY SYST; Lu X, 2012, ARXIV12051971V1; Lu X, 2012, ARXIV12011927V2; Lu X, 2012, J R STAT SOC A STAT, V175, P191, DOI 10.1111/j.1467-985X.2011.00711.x; Ma XY, 2007, JAIDS-J ACQ IMM DEF, V45, P581, DOI 10.1097/QAI.0b013e31811eadbc; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Ministry of Health Vietnam, 2009, INT BIOL BEH SURV; Mumtaz G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000444; Ngo DA, 2009, AIDS EDUC PREV, V21, P251, DOI 10.1521/aeap.2009.21.3.251; Nguyen QC, 2010, SEXUAL RISK BEHAV ME; Salganik MJ, 2006, J URBAN HEALTH, V83, pI98, DOI 10.1007/s11524-006-9106-x; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Smith AD, 2009, LANCET, V374, P416, DOI 10.1016/S0140-6736(09)61118-1; Volz E, 2008, J OFF STAT, V24, P79; Vu ML, 2009, MSM VIETNAM SOCIAL S; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wejnert C, 2011, SAGE HDB INNOVATION; Wejnert C, 2008, SOCIOL METHOD RES, V37, P105, DOI 10.1177/0049124108318333; Wejnert C, 2009, SOCIOL METHODOL, V39, P73, DOI 10.1111/j.1467-9531.2009.01216.x; Zhang D, 2007, SEX TRANSM INFECT, V83, P571, DOI 10.1136/sti.2007.026138	45	40	40	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49417	10.1371/journal.pone.0049417	http://dx.doi.org/10.1371/journal.pone.0049417			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039HA	23152902	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000067
J	Loy, RE; Lueck, JD; Mostajo-Radji, MA; Carrell, EM; Dirksen, RT				Loy, Ryan E.; Lueck, John D.; Mostajo-Radji, Mohammed A.; Carrell, Ellie M.; Dirksen, Robert T.			Allele-Specific Gene Silencing in Two Mouse Models of Autosomal Dominant Skeletal Myopathy	PLOS ONE			English	Article							TYPE-1 RYANODINE RECEPTOR; KNOCK-IN MICE; CA2+ RELEASE; MUSCULAR-DYSTROPHY; RNA INTERFERENCE; CURRENT PROGRESS; SUDDEN-DEATH; MUSCLE; THERAPEUTICS; SIRNA	We explored the potential of mutant allele-specific gene silencing (ASGS) in providing therapeutic benefit in two established mouse models of the autosomal dominantly-inherited muscle disorders, Malignant Hyperthermia (MH) and Central Core Disease (CCD). Candidate ASGS siRNAs were designed and validated for efficacy and specificity on ryanodine receptor (RyR1) cDNA mini-constructs expressed in HEK293 cells using RT-PCR- and confocal microscopy-based assays. In vivo delivery of the most efficacious identified siRNAs into flexor digitorum brevis (FDB) muscles was achieved by injection/electroporation of footpads of 4-6 month old heterozygous Ryr1(Y524S/+) (YS/+) and Ryr1(I4895T/+) (IT/+) knock-in mice, established mouse models of MH with cores and CCD, respectively. Treatment of IT/+ mice resulted in a modest rescue of deficits in the maximum rate (similar to 38% rescue) and magnitude (similar to 78%) of ligand-induced Ca2+ release that occurred in the absence of a change in the magnitude of electrically-evoked Ca2+ release. Compared to the difference between the caffeine sensitivity of Ca2+ release in FDB fibers from YS/+ and WT mice treated with SCR siRNA (EC50: 1.1 mM versus 4.4 mM, respectively), caffeine sensitivity was normalized in FDB fibers from YS/+ mice following 2 (EC50: 2.8 mM) and 4 week (EC50: 6.6 mM) treatment with YS allele-specific siRNA. Moreover, the temperature-dependent increase in resting Ca2+ observed in FDB fibers from YS/+ mice was normalized to WT levels after 2 weeks of treatment with YS allele-specific siRNA. As determined by quantitative real time PCR, the degree of functional rescue in YS/+ and IT/+ mice correlated well with the relative increase in fractional WT allele expression.	[Loy, Ryan E.; Lueck, John D.; Mostajo-Radji, Mohammed A.; Carrell, Ellie M.; Dirksen, Robert T.] Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA	University of Rochester	Dirksen, RT (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, Rochester, NY 14627 USA.	Robert_Dirksen@URMC.Rochester.edu		Lueck, John/0000-0002-1820-711X	National Institutes of Health [AR044657, AR053349]; National Institutes of Health Dental and Craniofacial Training Grant; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044657, R29AR044657, R01AR053349] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Dental and Craniofacial Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by research grants from the National Institutes of Health (AR044657 and AR053349 to RTD) and a National Institutes of Health Dental and Craniofacial Training Grant (to REL and JDL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andronache Z, 2009, P NATL ACAD SCI USA, V106, P4531, DOI 10.1073/pnas.0812661106; BEAM KG, 1988, J GEN PHYSIOL, V91, P781, DOI 10.1085/jgp.91.6.781; Boncompagni S, 2009, P NATL ACAD SCI US; Boncompagni S, 2010, AGING CELL, V9, P958, DOI 10.1111/j.1474-9726.2010.00623.x; Burnett JC, 2012, CHEM BIOL, V19, P60, DOI 10.1016/j.chembiol.2011.12.008; Burnett JC, 2011, BIOTECHNOL J, V6, P1130, DOI 10.1002/biot.201100054; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; DiFranco M, 2006, PROTEIN EXPRES PURIF, V47, P281, DOI 10.1016/j.pep.2005.10.018; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; Goemans NM, 2011, NEW ENGL J MED, V364, P1513, DOI 10.1056/NEJMoa1011367; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Huang HY, 2009, CURR OPIN MOL THER, V11, P652; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Loy RE, 2011, J GEN PHYSIOL, V137, P43, DOI 10.1085/jgp.201010523; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Oestreich EA, 2009, J BIOL CHEM, V284, P1514, DOI 10.1074/jbc.M806994200; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Suzuki M, 2009, CRIT REV IMMUNOL, V29, P443, DOI 10.1615/CritRevImmunol.v29.i6.10; TAKESHIMA H, 1995, EMBO J, V14, P2999, DOI 10.1002/j.1460-2075.1995.tb07302.x; Tiemann K, 2009, EMBO MOL MED, V1, P142, DOI 10.1002/emmm.200900023; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Wheeler TM, 2009, SCIENCE, V325, P336, DOI 10.1126/science.1173110; Zvaritch E, 2009, P NATL ACAD SCI US; Zvaritch E, 2007, P NATL ACAD SCI USA, V104, P18537, DOI 10.1073/pnas.0709312104	27	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49757	10.1371/journal.pone.0049757	http://dx.doi.org/10.1371/journal.pone.0049757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152933	Green Submitted, gold, Green Published			2022-12-27	WOS:000311234000077
J	Samaille, T; Fillon, L; Cuingnet, R; Jouvent, E; Chabriat, H; Dormont, D; Colliot, O; Chupin, M				Samaille, Thomas; Fillon, Ludovic; Cuingnet, Remi; Jouvent, Eric; Chabriat, Hugues; Dormont, Didier; Colliot, Olivier; Chupin, Marie			Contrast-Based Fully Automatic Segmentation of White Matter Hyperintensities: Method and Validation	PLOS ONE			English	Article							SURFACE-BASED ANALYSIS; MR-IMAGES; ANISOTROPIC DIFFUSION; BRAIN MRI; AGREEMENT; LESIONS; CADASIL; STROKE; VOLUME; SCALE	White matter hyperintensities (WMH) on T2 or FLAIR sequences have been commonly observed on MR images of elderly people. They have been associated with various disorders and have been shown to be a strong risk factor for stroke and dementia. WMH studies usually required visual evaluation of WMH load or time-consuming manual delineation. This paper introduced WHASA (White matter Hyperintensities Automated Segmentation Algorithm), a new method for automatically segmenting WMH from FLAIR and T1 images in multicentre studies. Contrary to previous approaches that were based on intensities, this method relied on contrast: non linear diffusion filtering alternated with watershed segmentation to obtain piecewise constant images with increased contrast between WMH and surroundings tissues. WMH were then selected based on subject dependant automatically computed threshold and anatomical information. WHASA was evaluated on 67 patients from two studies, acquired on six different MRI scanners and displaying a wide range of lesion load. Accuracy of the segmentation was assessed through volume and spatial agreement measures with respect to manual segmentation; an intraclass correlation coefficient (ICC) of 0.96 and a mean similarity index (SI) of 0.72 were obtained. WHASA was compared to four other approaches: Freesurfer and a thresholding approach as unsupervised methods; k-nearest neighbours (kNN) and support vector machines (SVM) as supervised ones. For these latter, influence of the training set was also investigated. WHASA clearly outperformed both unsupervised methods, while performing at least as good as supervised approaches (ICC range: 0.87-0.91 for kNN; 0.89-0.94 for SVM. Mean SI: 0.63-0.71 for kNN, 0.67-0.72 for SVM), and did not need any training set.	[Samaille, Thomas; Fillon, Ludovic; Cuingnet, Remi; Dormont, Didier; Colliot, Olivier; Chupin, Marie] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France; [Samaille, Thomas; Fillon, Ludovic; Cuingnet, Remi; Dormont, Didier; Colliot, Olivier; Chupin, Marie] INSERM, U975, Paris, France; [Samaille, Thomas; Fillon, Ludovic; Cuingnet, Remi; Dormont, Didier; Colliot, Olivier; Chupin, Marie] CNRS, UMR 7225, Paris, France; [Samaille, Thomas; Fillon, Ludovic; Cuingnet, Remi; Dormont, Didier; Colliot, Olivier; Chupin, Marie] ICM Inst Cerveau & Moelle Epiniere, Paris, France; [Dormont, Didier] Pitie Salpetriere Univ Hosp, AP HP, Dept Neuroradiol, Paris, France; [Jouvent, Eric; Chabriat, Hugues] Lariboisiere Univ Hosp, AP HP, Dept Neurol, Paris, France; [Chabriat, Hugues] INSERM, UMR 740, Paris, France; [Chabriat, Hugues] DHU NeuroVasc Sorbonne Paris Cite, Paris, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm)	Samaille, T (corresponding author), Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, UMR S975, Paris, France.	thomas.samaille@gmail.com	Jouvent, Eric/B-4320-2014; Chabriat, Hugues/G-5699-2010	Jouvent, Eric/0000-0001-7797-2236; Cuingnet, Remi/0000-0002-9104-2446; Chabriat, Hugues/0000-0001-8436-6074	French Ministry of Higher Education and Research; ANR [ANR-09-EMER-006]; PHRC [AOR 02-001]	French Ministry of Higher Education and Research; ANR(French National Research Agency (ANR)); PHRC	This work was partially supported by a PhD fellowship from the French Ministry of Higher Education and Research and by a grant from ANR (project HM-TC, number ANR-09-EMER-006). Data collection for CADASIL patients was supported by PHRC grant AOR 02-001 (DRC/APHP) and performed with the help of ARNEVA (Association de Recherche en NEurologie VAsculaire). Data collection for MCI patients was funded by Eisai as part of the "Hippocampus'' study. Eisai authorized the submission of the present paper but had no role in the design and analysis of the present study nor in the preparation of the manucript. Other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Admiraal-Behloul F, 2005, NEUROIMAGE, V28, P607, DOI 10.1016/j.neuroimage.2005.06.061; Anbeek P, 2004, NEUROIMAGE, V21, P1037, DOI 10.1016/j.neuroimage.2003.10.012; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Au R, 2006, ARCH NEUROL-CHICAGO, V63, P246, DOI 10.1001/archneur.63.2.246; Black MJ, 1998, IEEE T IMAGE PROCESS, V7, P421, DOI 10.1109/83.661192; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brickman AM, 2011, PSYCHIAT RES-NEUROIM, V193, P101, DOI 10.1016/j.pscychresns.2011.03.007; Chabriat H, 2009, LANCET NEUROL, V8, P643, DOI 10.1016/S1474-4422(09)70127-9; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; de Boer R, 2009, NEUROIMAGE, V45, P1151, DOI 10.1016/j.neuroimage.2009.01.011; Debette S, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c3666; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Dubois B., 2009, EFFECTS DONEPEZIL ST; Duering M, 2011, BRAIN; Durgerian S, 2011, WHITE MATTER DIFFUSI; Dyrby TB, 2008, NEUROIMAGE, V41, P335, DOI 10.1016/j.neuroimage.2008.02.024; Eckerstrom C, 2011, DEMENT GERIATR COGN, V31, P132, DOI 10.1159/000323014; FAZEKAS F, 1993, NEUROLOGY, V43, P1683, DOI 10.1212/WNL.43.9.1683; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Gibson E, 2010, J MAGN RESON IMAGING, V31, P1311, DOI 10.1002/jmri.22004; Guttmann CRG, 2000, NEUROLOGY, V54, P1277, DOI 10.1212/WNL.54.6.1277; Herrmann LL, 2008, J NEUROL NEUROSUR PS, V79, P619, DOI 10.1136/jnnp.2007.124651; Hirono N, 2000, STROKE, V31, P2182, DOI 10.1161/01.STR.31.9.2182; Ikram MA, 2010, NEUROBIOL AGING, V31, P378, DOI 10.1016/j.neurobiolaging.2008.04.008; Jack CR, 2001, J MAGN RESON IMAGING, V14, P668, DOI 10.1002/jmri.10011; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Kloppel S, 2011, NEUROIMAGE, V57, P416, DOI 10.1016/j.neuroimage.2011.04.053; Kuller LH, 2004, STROKE, V35, P1821, DOI 10.1161/01.STR.0000132193.35955.69; Lao ZQ, 2008, ACAD RADIOL, V15, P300, DOI 10.1016/j.acra.2007.10.012; Longstreth WT, 1996, STROKE, V27, P1274, DOI 10.1161/01.STR.27.8.1274; Maillard P, 2008, NEURORADIOLOGY, V50, P31, DOI 10.1007/s00234-007-0312-3; Mantyla R, 1997, STROKE, V28, P1614, DOI 10.1161/01.STR.28.8.1614; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PERONA P, 1990, IEEE T PATTERN ANAL, V12, P629, DOI 10.1109/34.56205; Raniga P, 2011, I S BIOMED IMAGING, P2057, DOI 10.1109/ISBI.2011.5872817; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Smith EE, 2011, NEUROLOGY, V76, P1492, DOI 10.1212/WNL.0b013e318217e7c8; van den Heuvel DMJ, 2006, AM J NEURORADIOL, V27, P875; Vapnik V., 2013, NATURE STAT LAERNING; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wen W, 2004, NEUROIMAGE, V22, P144, DOI 10.1016/j.neuroimage.2003.12.027; Wu MJ, 2006, PSYCHIAT RES-NEUROIM, V148, P133, DOI 10.1016/j.pscychresns.2006.09.003; Zijdenbos AP, 2002, IEEE T MED IMAGING, V21, P1280, DOI 10.1109/TMI.2002.806283	46	38	38	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48953	10.1371/journal.pone.0048953	http://dx.doi.org/10.1371/journal.pone.0048953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152828	Green Published, gold			2022-12-27	WOS:000311234000037
J	Berges, R; Balzeau, J; Takahashi, M; Prevost, C; Eyer, J				Berges, Raphael; Balzeau, Julien; Takahashi, Masayuki; Prevost, Chantal; Eyer, Joel			Structure-Function Analysis of the Glioma Targeting NFL-TBS.40-63 Peptide Corresponding to the Tubulin-Binding Site on the Light Neurofilament Subunit	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CELL-PENETRATING PEPTIDES; A PHOSPHORYLATION SITE; TERMINAL HEAD DOMAIN; DE-NOVO PEPTIDE; STRUCTURE PREDICTION; CIRCULAR-DICHROISM; MASS-SPECTROMETRY; AXONAL-TRANSPORT; QUICK-FREEZE	We previously reported that a 24 amino acid peptide (NFL-TBS.40-63) corresponding to the tubulin-binding site located on the light neurofilament subunit, selectively enters in glioblastoma cells where it disrupts their microtubule network and inhibits their proliferation. Here, we analyzed the structure-function relationships using an alanine-scanning strategy, in order to identify residues essential for these biological activities. We showed that the majority of modified peptides present a decreased or total loss to penetrate in these cells, or to alter microtubules. Correspondingly, circular dichroism measurements showed that this peptide forms either beta-sheet or alpha-helix structures according to the solvent and that alanine substitution modified or destabilized the structure, in relation with changes in the biological activities. Moreover, substitution of serine residues by phosphoserine or aspartic acid concomitantly decreased the cell penetrating activity and the structure stability. These results indicate the importance of structure for the activities, including selectivity to glioblastoma cells of this peptide, and its regulation by phosphorylation.	[Berges, Raphael; Balzeau, Julien; Takahashi, Masayuki; Prevost, Chantal; Eyer, Joel] Ctr Hosp Univ, INSERM, UPRES EA 3143, Lab Neurobiol & Transgenese, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Eyer, J (corresponding author), Ctr Hosp Univ, INSERM, UPRES EA 3143, Lab Neurobiol & Transgenese, Angers, France.	joel.eyer@inserm.fr	Eyer, Joel/V-8679-2019; Takahashi, Masayuki/AAM-7033-2021; Eyer, Joel/K-4265-2015	Eyer, Joel/0000-0001-6301-7465; Eyer, Joel/0000-0001-6301-7465; Chantal, Prevost/0000-0003-3516-6687	Association pour la Recherche sur le Cancer (ARC); Association Francaise sur la Myopathie (AFM); Fonds Europeen de Developement Regional (FEDER); Institut National du Cancer (INCA); Region des Pays de la Loire	Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association Francaise sur la Myopathie (AFM); Fonds Europeen de Developement Regional (FEDER); Institut National du Cancer (INCA)(Institut National du Cancer (INCA) France); Region des Pays de la Loire(Region Pays de la Loire)	This investigation was supported by grants to J. Eyer from the Association pour la Recherche sur le Cancer (ARC), Association Francaise sur la Myopathie (AFM), Fonds Europeen de Developement Regional (FEDER) and Institut National du Cancer (INCA), and grants to J. Eyer and M. Takahashi from the Region des Pays de la Loire (CIMAT and CIMATH-2). R. Berges and J. Balzeau were supported by the Region des Pays de la Loire (CIMATH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellet-Amalric E, 2000, BBA-BIOMEMBRANES, V1467, P131, DOI 10.1016/S0005-2736(00)00218-2; Berges R, 2012, MOL THER, V20, P1367, DOI 10.1038/mt.2012.45; Bocquet A, 2009, J NEUROSCI, V29, P11043, DOI 10.1523/JNEUROSCI.1924-09.2009; CARDEN MJ, 1987, J NEUROSCI, V7, P3489; Chen J, 2011, J PEPT SCI, V17, P163, DOI 10.1002/psc.1299; Cleverley KE, 1998, BIOCHEMISTRY-US, V37, P3917, DOI 10.1021/bi9724523; DEWAEGH SM, 1992, CELL, V68, P451, DOI 10.1016/0092-8674(92)90183-D; Duvignaud JB, 2010, BIOCHEM CELL BIOL, V88, P315, DOI [10.1139/O09-155, 10.1139/o09-155]; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; EYER J, 1988, BIOCHEM J, V252, P655, DOI 10.1042/bj2520655; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; Foerg C, 2008, J PHARM SCI-US, V97, P144, DOI 10.1002/jps.21117; Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200; Giasson BI, 1998, J NEUROCHEM, V70, P1869; Guerrini R, 2010, MED RES REV, V30, P751, DOI 10.1002/med.20180; Hashimoto R, 2000, NEUROREPORT, V11, P2739, DOI 10.1097/00001756-200008210-00026; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HIROKAWA N, 1988, J NEUROSCI, V8, P2769; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; HISANAGA S, 1990, CELL REGUL, V1, P237, DOI 10.1091/mbc.1.2.237; HISANAGA S, 1990, J BIOL CHEM, V265, P21852; HISANAGA S, 1991, J BIOL CHEM, V266, P21798; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JOHNSON WC, 1990, PROTEINS, V7, P205, DOI 10.1002/prot.340070302; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JULIEN JP, 1982, J BIOL CHEM, V257, P467; Kaminski GA, 2001, J PHYS CHEM B, V105, P6474, DOI 10.1021/jp003919d; Kawaguchi A, 2010, BIOCHEM BIOPH RES CO, V398, P778, DOI 10.1016/j.bbrc.2010.07.028; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Maupetit J, 2007, PROTEINS, V69, P394, DOI 10.1002/prot.21505; Maupetit J, 2010, J COMPUT CHEM, V31, P726, DOI 10.1002/jcc.21365; Maupetit J, 2009, NUCLEIC ACIDS RES, V37, pW498, DOI 10.1093/nar/gkp323; MIYASAKA H, 1993, J BIOL CHEM, V268, P22695; Mukai H, 1996, J BIOL CHEM, V271, P9816, DOI 10.1074/jbc.271.16.9816; Norden B, 2010, LINEAR DICHROISM AND CIRCULAR DICHROISM: A TEXTBOOK ON POLARIZED LIGHT SPECTROSCOPY, P1; Oehlke J, 1997, FEBS LETT, V415, P196, DOI 10.1016/S0014-5793(97)01123-X; OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387; Perrot R, 2008, MOL NEUROBIOL, V38, P27, DOI 10.1007/s12035-008-8033-0; Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355; SIHAG RK, 1991, J BIOL CHEM, V266, P18861; Sihag RK, 1999, J NEUROCHEM, V72, P491, DOI 10.1046/j.1471-4159.1999.0720491.x; Steckbeck JD, 2011, J BIOL CHEM, V286, P27156, DOI 10.1074/jbc.M111.258855; Trimpin S, 2004, BIOCHEMISTRY-US, V43, P2091, DOI 10.1021/bi030196q; VENYAMINOV SY, 1993, ANAL BIOCHEM, V214, P17, DOI 10.1006/abio.1993.1450; WATERHOUS DV, 1994, BIOCHEMISTRY-US, V33, P2121, DOI 10.1021/bi00174a019; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Yates DM, 2009, EUR J CELL BIOL, V88, P193, DOI 10.1016/j.ejcb.2008.11.004; Zhu QZ, 1997, EXP NEUROL, V148, P299, DOI 10.1006/exnr.1997.6654; Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010	49	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49436	10.1371/journal.pone.0049436	http://dx.doi.org/10.1371/journal.pone.0049436			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152907	Green Published, gold, Green Submitted			2022-12-27	WOS:000312272600060
J	Pinato, DJ; Stavraka, C; Tanner, M; Esson, A; Jacobson, EW; Wilkins, MR; Libri, V				Pinato, David J.; Stavraka, Chara; Tanner, Mark; Esson, Audrey; Jacobson, Eric W.; Wilkins, Martin R.; Libri, Vincenzo			Clinical, Ethical and Financial Implications of Incidental Imaging Findings: Experience from a Phase I Trial in Healthy Elderly Volunteers	PLOS ONE			English	Article							SINGLE-CENTER; BIOMARKERS; MRI; PHARMACOKINETICS; RECOMMENDATIONS; GUIDELINES	Background: The detection of incidental findings (IF) in magnetic resonance imaging (MRI) studies is common and increases as a function of age. Responsible handling of IF is required, with implications for the conduct of research and the provision of good clinical care. Aim: To investigate the prevalence and clinical significance of IF in a prospective cohort of healthy elderly volunteers who underwent MRI of the torso as a baseline investigation for a phase I trial. We assessed the follow-up pathway with consequent cost implications and impact on trial outcomes. Methods: A total of 29 elderly healthy volunteers (mean age 67, range 61-77, 59% female) were eligible at screening and underwent MRI for assessment of visceral and subcutaneous fat. Results: IF were detected in 19 subjects (66%). Suspected IF of high and low clinical significance were found in 14% and 52% of participants, respectively. Follow up of IF was conducted in 18 individuals, confirming abnormalities in 13 subjects, 3 of whom were recommended for deferred clinical re-evaluation. The remaining 5 subjects had false positive IF based on second line imaging tests. Costs of follow-up medical care were considerable. Conclusion: MRI abnormalities are common in elderly individuals, as a result of age and non-diagnostic quality of research scans. In the presence of IF in the context of clinical trials, immediate referrals and follow up assessments may be required to rule out suspected pathology prior to exposing trial participants to investigational medicine products (IMP). Unanticipated costs, ethical implication and the possible impact of IF on trial outcomes need to be taken into account when designing and conducting trials with an IMP.	[Pinato, David J.; Stavraka, Chara; Esson, Audrey; Wilkins, Martin R.; Libri, Vincenzo] Univ London Imperial Coll Sci Technol & Med, Natl Inst Hlth Res, Wellcome Trust Imperial Coll Clin Res Facil, Imperial Ctr Translat & Expt Med, London, England; [Tanner, Mark] Imanova Ctr Imaging Sci, London, England; [Jacobson, Eric W.] Sirtris Pharmaceut Inc, Cambridge, MA USA	Imperial College London	Libri, V (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Inst Hlth Res, Wellcome Trust Imperial Coll Clin Res Facil, Imperial Ctr Translat & Expt Med, Hammersmith Hosp Campus, London, England.	v.libri@imperial.ac.uk	Pinato, David James/ABB-3719-2020; Stavraka, Chara/F-8385-2013	Pinato, David James/0000-0002-3529-0103; Stavraka, Chara/0000-0001-7623-299X				Booth TC, 2012, BRIT J RADIOL, V85, P11, DOI 10.1259/bjr/73283917; Booth TC, 2010, BRIT J RADIOL, V83, P456, DOI 10.1259/bjr/15877332; *CIOMS, 2002, INT ETH GUID BIOM RE; Curtis L., 2009, UNIT COSTS HLTH SOCI; Dancey JE, 2010, CLIN CANCER RES, V16, P1745, DOI 10.1158/1078-0432.CCR-09-2167; Ding A, 2011, RADIOL CLIN N AM, V49, P257, DOI 10.1016/j.rcl.2010.11.004; Filippi M, 2010, J MAGN RESON IMAGING, V31, P770, DOI 10.1002/jmri.22102; FRIES JF, 1988, PERSPECT BIOL MED, V31, P407; Furtado CD, 2005, RADIOLOGY, V237, P385, DOI 10.1148/radiol.2372041741; GLOVER GH, 1991, JMRI-J MAGN RESON IM, V1, P521, DOI 10.1002/jmri.1880010504; Grundman M, 2002, J MOL NEUROSCI, V18, P283, DOI 10.1385/JMN:18:3:283; Hartwigsen G, 2010, J COMPUT ASSIST TOMO, V34, P596, DOI 10.1097/RCT.0b013e3181d9c2bb; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Macaluso M, 2011, J PSYCHIATR PRACT, V17, P200, DOI 10.1097/01.pra.0000398413.44244.f8; Mangoni AA, 2004, BRIT J CLIN PHARMACO, V57, P6, DOI 10.1046/j.1365-2125.2003.02007.x; Morin SHX, 2009, EUR J RADIOL, V72, P529, DOI 10.1016/j.ejrad.2008.08.006; Nunes T, 2011, CLIN THER, V33, P776, DOI 10.1016/j.clinthera.2011.05.048; Pasqualetti G, 2010, EUR J CLIN PHARMACOL, V66, P647, DOI 10.1007/s00228-010-0827-0; Pich EM, 2011, CURR OPIN PHARMACOL, V11, P557, DOI 10.1016/j.coph.2011.06.010; Pickard JD, 2005, NATURE, V435, P17, DOI 10.1038/435017a; Pien HH, 2005, DRUG DISCOV TODAY, V10, P259, DOI 10.1016/S1359-6446(04)03334-3; Rajaram V, 2004, AM J CARDIOL, V93, p32C, DOI 10.1016/j.amjcard.2004.02.004; Reneman L, 2012, AJNR AM J NEURORADIO; Rofsky NM, 1999, RADIOLOGY, V212, P876, DOI 10.1148/radiology.212.3.r99se34876; Ross K, 2005, EMBO REP, V6, P1116, DOI 10.1038/sj.embor.7400579; Ross R, 2000, ANN NY ACAD SCI, V904, P12; Royal JM, 2008, J LAW MED ETHICS, V36, P305, DOI 10.1111/j.1748-720X.2008.00274.x; Sharma R, 2011, BRIT J PHARMACOL, V163, P1565, DOI 10.1111/j.1476-5381.2010.01160.x; Tootell A, 2012, NUCL MED COMMUN, V33, P1122, DOI 10.1097/MNM.0b013e3283571b35; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x	32	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49814	10.1371/journal.pone.0049814	http://dx.doi.org/10.1371/journal.pone.0049814			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166776	gold, Green Published, Green Submitted			2022-12-27	WOS:000311885300069
J	Rialland, P; Authier, S; Guillot, M; del Castillo, JRE; Veilleux-Lemieux, D; Frank, D; Gauvin, D; Troncy, E				Rialland, Pascale; Authier, Simon; Guillot, Martin; del Castillo, Jerome R. E.; Veilleux-Lemieux, Daphnee; Frank, Diane; Gauvin, Dominique; Troncy, Eric			Validation of Orthopedic Postoperative Pain Assessment Methods for Dogs: A Prospective, Blinded, Randomized, Placebo-Controlled Study	PLOS ONE			English	Article							GENERALIZED ESTIMATING EQUATIONS; TOTAL KNEE REPLACEMENT; INDUCED SYNOVITIS; GAIT ANALYSIS; KINETIC GAIT; CARPROFEN; ANALGESIA; MORPHINE; SURGERY; MODEL	In the context of translational research, there is growing interest in studying surgical orthopedic pain management approaches that are common to humans and dogs. The validity of postoperative pain assessment methods is uncertain with regards to responsiveness and the potential interference of analgesia. The hypothesis was that video analysis (as a reference), electrodermal activity, and two subjective pain scales (VAS and 4A-VET) would detect different levels of pain intensity in dogs after a standardized trochleoplasty procedure. In this prospective, blinded, randomized study, postoperative pain was assessed in 25 healthy dogs during a 48-hour time frame (T). Pain was managed with placebo (Group 1, n = 10), preemptive and multimodal analgesia (Group 2, n = 5), or preemptive analgesia consisting in oral tramadol (Group 3, n = 10). Changes over time among groups were analyzed using generalized estimating equations. Multivariate regression tested the significance of relationships between pain scales and video analysis. Video analysis identified that one orthopedic behavior, namely 'Walking with full weight bearing' of the operated leg, decreased more in Group 1 at T24 (indicative of pain), whereas three behaviors indicative of sedation decreased in Group 2 at T24 (all p<0.004). Electrodermal activity was higher in Group 1 than in Groups 2 and 3 until T1 (p<0.0003). The VAS was not responsive. 4A-VET showed divergent results as its orthopedic component (4A-VETleg) detected lower pain in Group 2 until T12 (p<0.0009), but its interactive component (4A-VETbeh) was increased in Group 2 from T12 to T48 (p<0.001). Concurrent validity established that 4A-VETleg scores the painful orthopedic condition accurately and that pain assessment through 4A-VETbeh and VAS was severely biased by the sedative side-effect of the analgesics. Finally, the video analysis offered a concise template for assessment in dogs with acute orthopedic pain. However, subjective pain quantification methods and electrodermal activity need further investigation.	[Rialland, Pascale; Authier, Simon; Guillot, Martin; del Castillo, Jerome R. E.; Veilleux-Lemieux, Daphnee; Gauvin, Dominique; Troncy, Eric] Univ Montreal, Fac Vet Med, Dept Biomed Sci, Grp Rech Pharmacol Anim Quebec GREPAQ, St Hyacinthe, PQ J2S 7C6, Canada; [Authier, Simon] CiToxLAB N Amer, Laval, PQ, Canada; [Frank, Diane] Univ Montreal, Fac Vet Med, Dept Clin Sci, St Hyacinthe, PQ J2S 7C6, Canada	Universite de Montreal; Universite de Montreal	Troncy, E (corresponding author), Univ Montreal, Fac Vet Med, Dept Biomed Sci, Grp Rech Pharmacol Anim Quebec GREPAQ, St Hyacinthe, PQ J2S 7C6, Canada.	eric.troncy@umontreal.ca	Troncy, Eric/J-6650-2013; del Castillo, Jérôme RE/J-6976-2013; del Castillo, Jerome/AAM-9409-2020	Troncy, Eric/0000-0003-0209-5261; del Castillo, Jérôme RE/0000-0001-5046-7926; del Castillo, Jerome/0000-0001-5046-7926	Vetoquinol Laboratories, Lure, France; Canada Foundation for Innovation [9483]; Natural Sciences and Engineering Research Council of Canada [327158-2008]; Vetoquinol Laboratories	Vetoquinol Laboratories, Lure, France; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Vetoquinol Laboratories	This study was supported in part by a grant from Vetoquinol Laboratories, Lure, France (http://www.vetoquinol.fr/); an ongoing New Opportunities Fund grant from the Canada Foundation for Innovation (#9483) for the pain/function equipment (http://www.innovation.ca); a Discovery grant from the Natural Sciences and Engineering Research Council of Canada (#327158-2008) as operating fund for pain biomarkers (http://www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors received funding for this work from a commercial source (Vetoquinol Laboratories) and with regards to their agreement with this company, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. Moreover, the authors contracted the realization of the experiments in a Contract Research Organization, named CiToxLAB North America, and one author, Simon Authier at the time a Ph.D. student under supervision and actually Head of Veterinary Services at this company, participated actively in the study's realization as well as edition of the manuscript. For this reason, this does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	BERK RA, 1979, AM J MENT DEF, V83, P460; Borer LR, 2003, AM J VET RES, V64, P1429, DOI 10.2460/ajvr.2003.64.1429; BRENNAN P, 1992, BMJ-BRIT MED J, V304, P1491, DOI 10.1136/bmj.304.6840.1491; Brennan Timothy J, 2005, Anesthesiol Clin North Am, V23, P1, DOI 10.1016/j.atc.2004.11.009; Budsberg SC, 2011, AM J VET RES, V72, P757, DOI 10.2460/ajvr.72.6.757; Buvanendran A, 2008, ANESTH ANALG, V107, P300, DOI 10.1213/ane.0b013e3181732f21; Cohen LL, 2008, J PEDIATR PSYCHOL, V33, P911, DOI 10.1093/jpepsy/jsj115; Critchley HD, 2002, NEUROSCIENTIST, V8, P132, DOI 10.1177/107385840200800209; Dzikiti TB, 2006, J S AFR VET ASSOC, V77, P120; Firth AM, 1999, J AM VET MED ASSOC, V214, P651; Fox SM, 2000, RES VET SCI, V68, P265, DOI 10.1053/rvsc.2000.0375; Gruet P, 2011, AM J VET RES, V72, P184, DOI 10.2460/ajvr.72.2.184; Guedes AGP, 2007, J VET PHARMACOL THER, V30, P224, DOI 10.1111/j.1365-2885.2007.00849.x; Guillot M, 2011, J VET INTERN MED, V25, P1050, DOI 10.1111/j.1939-1676.2011.00786.x; Hadjistavropoulos T, 2002, BEHAV RES THER, V40, P551, DOI 10.1016/S0005-7967(01)00072-9; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hansen BD, 2003, ILAR J, V44, P197, DOI 10.1093/ilar.44.3.197; Hazewinkel HAW, 2003, VET REC, V152, P11, DOI 10.1136/vr.152.1.11; Hazewinkel HAW, 2008, RES VET SCI, V84, P74, DOI 10.1016/j.rvsc.2007.02.005; Hoelzler MG, 2004, VET SURG, V33, P146, DOI 10.1111/j.1532-950X.2004.04022.x; Holton L, 2001, VET REC, V148, P525, DOI 10.1136/vr.148.17.525; Horstman CL, 2004, VET SURG, V33, P286, DOI 10.1111/j.1532-950X.2004.04042.x; HOSMER DW, 1989, APPL LOGISTIC REGRES; Hugonnard M, 2004, VET ANAESTH ANALG, V31, P154, DOI 10.1111/j.1467-2987.2004.00175.x; Ji ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030505; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Kona-Boun JJ, 2006, JAVMA-J AM VET MED A, V229, P1103, DOI 10.2460/javma.229.7.1103; Kyles AE, 1998, RES VET SCI, V65, P245, DOI 10.1016/S0034-5288(98)90151-5; Laboissiere B, 2006, THESIS ECOLE NATL VE; Lafuente MP, 2005, JAVMA-J AM VET MED A, V227, P1768, DOI 10.2460/javma.2005.227.1768; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Langford DJ, 2010, NAT METHODS, V7, P447, DOI [10.1038/NMETH.1455, 10.1038/nmeth.1455]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lipscomb VJ, 2002, VET REC, V150, P684, DOI 10.1136/vr.150.22.684; Liska WD, 2009, VET SURG, V38, P568, DOI 10.1111/j.1532-950X.2009.00531.x; Mann KA, 2012, VET COMP ORTHOPAED, V25, P1, DOI 10.3415/VCOT-11-01-0014; Marucio RL, 2008, AM J VET RES, V69, P854, DOI 10.2460/ajvr.69.7.854; MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971; Moreau M, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3373; Oosterlinck M, 2011, AM J VET RES, V72, P820, DOI 10.2460/ajvr.72.6.820; Pacharinsak C, 2003, J VET PHARMACOL THER, V26, P71, DOI 10.1046/j.1365-2885.2003.00452.x; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Punke JP, 2007, AM J VET RES, V68, P704, DOI 10.2460/ajvr.68.7.704; Quessy SN, 2010, J PAIN, V11, P698, DOI 10.1016/j.jpain.2010.05.001; Quinn MM, 2007, VET SURG, V36, P360, DOI 10.1111/j.1532-950X.2007.00276.x; Reid J, 2007, ANIM WELFARE, V16, P97; Richardson CA, 2007, LAB ANIM-UK, V41, P46, DOI 10.1258/002367707779399455; Roughan JV, 2006, APPL ANIM BEHAV SCI, V96, P327, DOI 10.1016/j.applanim.2005.06.012; SCHUMACHER HR, 1974, J RHEUMATOL, V1, P102; Shih AC, 2008, VET ANAESTH ANALG, V35, P69, DOI 10.1111/j.1467-2995.2007.00352.x; Stokes ME, 2000, CATEGORICAL DATA ANA; Storm H, 2008, CURR OPIN ANESTHESIO, V21, P796, DOI 10.1097/ACO.0b013e3283183fe4; Streiner D. L., 2003, HLTH MEASUREMENT SCA; Vaisanen MAM, 2008, J SMALL ANIM PRACT, V49, P626, DOI 10.1111/j.1748-5827.2008.00626.x; Valtolina C, 2009, VET ANAESTH ANALG, V36, P369, DOI 10.1111/j.1467-2995.2009.00461.x; Vettorato E, 2010, VET J, V183, P310, DOI 10.1016/j.tvjl.2008.11.002; Waxman AS, 2008, VET SURG, V37, P241, DOI 10.1111/j.1532-950X.2008.00372.x; Williams VM, 2005, NEW ZEAL VET J, V53, P193, DOI 10.1080/00480169.2005.36504; Xu J, 2009, PAIN, V144, P329, DOI 10.1016/j.pain.2009.05.019; Ziegler A, 1998, BIOMETRICAL J, V40, P115, DOI 10.1002/(SICI)1521-4036(199806)40:2<115::AID-BIMJ115>3.0.CO;2-6; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	61	34	34	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49480	10.1371/journal.pone.0049480	http://dx.doi.org/10.1371/journal.pone.0049480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166681	Green Published, gold, Green Submitted			2022-12-27	WOS:000311885300045
J	Alshurafa, M; Briel, M; Akl, EA; Haines, T; Moayyedi, P; Gentles, SJ; Rios, L; Tran, C; Bhatnagar, N; Lamontagne, F; Walter, SD; Guyatt, GH				Alshurafa, Mohamad; Briel, Matthias; Akl, Elie A.; Haines, Ted; Moayyedi, Paul; Gentles, Stephen J.; Rios, Lorena; Tran, Chau; Bhatnagar, Neera; Lamontagne, Francois; Walter, Stephen D.; Guyatt, Gordon H.			Inconsistent Definitions for Intention-To-Treat in Relation to Missing Outcome Data: Systematic Review of the Methods Literature	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIALS; FOLLOW-UP; LOST-IT; INFORMATION; STATEMENT; PROTOCOL	Background: Authors of randomized trial reports seem to hold a variety of views regarding the relationship between missing outcome data (MOD) and intention to treat (ITT). The objectives of this study were to systematically investigate how authors of methodology articles define ITT in the presence of MOD, how they recommend handling MOD under ITT, and to make a proposal for potential improvement in the definition and use of ITT in relation to MOD. Methods and Findings: We systematically searched MEDLINE in February 2009 for methodological articles written in English that devoted at least one paragraph to ITT and two other paragraphs to either ITT or MOD. We excluded original trial reports, observational studies, and clinical systematic reviews. Working in teams of two, we independently extracted relevant information from each eligible article. Of 1007 titles and abstracts reviewed, 66 articles met eligibility criteria. Five (8%) did not provide a definition of ITT; 25 (38%) mentioned MOD but did not discuss its relationship to ITT; and 36 (55%) discussed the relationship of MOD with ITT. These 36 articles described one or more of three statements: complete follow-up is required for ITT (58%); ITT and MOD are separate issues (17%); and ITT requires a specific strategy for handling MOD (78%); 17 (47%) endorsed more than one relationship. The most frequently mentioned strategies for handling MOD within ITT were: using the last outcome carried forward (50%); sensitivity analysis (50%); and use of available data to impute missing data (46%). Conclusion: We found that there is no consensus on the definition of ITT in relation to MOD. For conceptual clarity, we suggest that both reports of randomized trials and systematic reviews separately consider and describe how they deal with participants with complete data and those with MOD.	[Alshurafa, Mohamad; Briel, Matthias; Akl, Elie A.; Haines, Ted; Moayyedi, Paul; Gentles, Stephen J.; Rios, Lorena; Bhatnagar, Neera; Walter, Stephen D.; Guyatt, Gordon H.] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Briel, Matthias] Univ Basel Hosp, Basel Inst Clin Epidemiol & Biostat, CH-4031 Basel, Switzerland; [Akl, Elie A.] SUNY Buffalo, Dept Med, Buffalo, NY 14260 USA; [Akl, Elie A.] SUNY Buffalo, Dept Family Med, Buffalo, NY 14260 USA; [Moayyedi, Paul; Guyatt, Gordon H.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Tran, Chau] Chau Tran Consulting, Toronto, ON, Canada; [Lamontagne, Francois] Univ Sherbrooke, Ctr Rech Clin Etienne Le Bel, Sherbrooke, PQ J1K 2R1, Canada	McMaster University; University of Basel; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; McMaster University; University of Sherbrooke	Briel, M (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	brielm@uhbs.ch	Walter, Stephen/AAB-5548-2022; Moayyedi, Paul/M-6178-2014; Gentles, Stephen/AAO-4561-2021; Briel, Matthias/AAT-9284-2021; Tran, Chau/GRX-4633-2022; Bhatnagar, Neera/B-8004-2013; Akl, Elie A/R-2079-2016; Akl, Elie/K-5269-2019	Walter, Stephen/0000-0003-4157-8928; Moayyedi, Paul/0000-0002-3616-9292; Bhatnagar, Neera/0000-0002-5060-5257; Akl, Elie A/0000-0002-3444-8618; Alshurafa, Mohamad/0000-0002-2817-0410; Briel, Matthias/0000-0002-2070-5230; Gentles, Stephen/0000-0003-2004-1451	Santesuisse, Solothurn, Switzerland; Gottfried and Julia Bangerter-Rhyner-Foundation, Berne, Switzerland; Canadian Institutes for Health Research	Santesuisse, Solothurn, Switzerland; Gottfried and Julia Bangerter-Rhyner-Foundation, Berne, Switzerland; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	None specific to the project. MB is supported by Santesuisse, Solothurn, Switzerland, and the Gottfried and Julia Bangerter-Rhyner-Foundation, Berne, Switzerland. FL is supported by a Canadian Institutes for Health Research RCT Mentoring Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akl EA, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2809; Akl EA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-40; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Fisher L.D., 1990, STAT ISSUES DRUG RES, P331, DOI DOI 10.1201/9780203738610; [Food and Drug Administration Department of Health and Human Services], 1988, GUID FORM CONT CLIN; Gravel J, 2007, CLIN TRIALS, V4, P350, DOI 10.1177/1740774507081223; Guyatt GH, 2008, USERS GUIDES MED LIT, P167; Higgins JP, 2009, COCHRANE HDB; Hollis S, 1999, BRIT MED J, V319, P670, DOI 10.1136/bmj.319.7211.670; Kruse RL, 2002, J FAM PRACTICE, V51, P969; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Montori VM, 2001, CAN MED ASSOC J, V165, P1339; Nordic Council on Medicine, 1989, NLN PUBL; Panel on Handling Missing Data in Clinical Trials National Research Council, 2010, PREV TREATM MISS DAT; Porta N, 2007, J CLIN EPIDEMIOL, V60, P663, DOI 10.1016/j.jclinepi.2006.09.013; Ruiz-Canela M, 2000, BMJ-BRIT MED J, V320, P1007, DOI 10.1136/bmj.320.7240.1007; Sandelowski M, 2000, RES NURS HEALTH, V23, P334, DOI 10.1002/1098-240X(200008)23:4<334::AID-NUR9>3.0.CO;2-G; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Soares Isabel, 2002, Rev Port Cardiol, V21, P1191; Unnebrink K, 2001, STAT MED, V20, P3931, DOI 10.1002/sim.1149; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40	23	90	91	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49163	10.1371/journal.pone.0049163	http://dx.doi.org/10.1371/journal.pone.0049163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166608	gold, Green Submitted, Green Published			2022-12-27	WOS:000311272300024
J	Cossu, F; Milani, M; Vachette, P; Malvezzi, F; Grassi, S; Lecis, D; Delia, D; Drago, C; Seneci, P; Bolognesi, M; Mastrangelo, E				Cossu, Federica; Milani, Mario; Vachette, Patrice; Malvezzi, Francesca; Grassi, Serena; Lecis, Daniele; Delia, Domenico; Drago, Carmelo; Seneci, Pierfausto; Bolognesi, Martino; Mastrangelo, Eloise			Structural Insight into Inhibitor of Apoptosis Proteins Recognition by a Potent Divalent Smac-Mimetic	PLOS ONE			English	Article							X-LINKED INHIBITOR; SCATTERING; DESIGN; ANTAGONISTS; VALIDATION; PEPTIDES; PROGRAM; DOMAIN; CIAP1; XIAP	Genetic alterations enhancing cell survival and suppressing apoptosis are hallmarks of cancer that significantly reduce the efficacy of chemotherapy or radiotherapy. The Inhibitor of Apoptosis Protein (IAP) family hosts conserved proteins in the apoptotic pathway whose over-expression, frequently found in tumours, potentiates survival and resistance to anticancer agents. In humans, IAPs comprise eight members hosting one or more structural Baculoviral IAP Repeat (BIR) domains. Cellular IAPs (cIAP1 and 2) indirectly inhibit caspase-8 activation, and regulate both the canonical and the non-canonical NFkB signaling pathways. In contrast to cIAPs, XIAP (X chromosome-linked Inhibitor of Apoptosis Protein) inhibits directly the effector caspases-3 and -7 through its BIR2 domain, and initiator caspase-9 through its BIR3 domain; molecular docking studies suggested that Smac/DIABLO antagonizes XIAP by simultaneously targeting both BIR2 and BIR3 domains. Here we report analytical gel filtration, crystallographic and SAXS experiments on cIAP1-BIR3, XIAP-BIR3 and XIAP-BIR2BIR3 domains, alone and in the presence of compound 9a, a divalent homodimeric Smac mimetic. 9a is shown to bind two BIR domains inter-(in the case of two BIR3) and intra-molecularly (in the case of XIAP-BIR2BIR3), with higher affinity for cIAP1-BIR3, relative to XIAP-BIR3. Despite the different crystal lattice packing, 9a maintains a right handed helical conformation in both cIAP1-BIR3 and XIAP-BIR3 crystals, that is likely conserved in solution as shown by SAXS data. Our structural results demonstrate that the 9a linker length, its conformational degrees of freedom and its hydrophobicity, warrant an overall compact structure with optimal solvent exposure of its two active moieties for IAPs binding. Our results show that 9a is a good candidate for pre-clinical and clinical studies, worth of further investigations in the field of cancer therapy.	[Cossu, Federica; Milani, Mario; Malvezzi, Francesca; Grassi, Serena; Bolognesi, Martino; Mastrangelo, Eloise] Univ Milan, Dept Biosci, Milan, Italy; [Milani, Mario; Bolognesi, Martino; Mastrangelo, Eloise] Univ Milan, CNR, Ist Biofis, Milan, Italy; [Vachette, Patrice] Univ Paris 11, CNRS, IFR115, Inst Biochim & Biophys Mol & Cellulaire,UMR8619, F-91405 Orsay, France; [Lecis, Daniele; Delia, Domenico] Ist Nazl Tumori, I-20133 Milan, Italy; [Drago, Carmelo; Seneci, Pierfausto] Univ Milan, Ctr Interdisciplinare Studi Biomol & Applicaz Ind, Milan, Italy; [Seneci, Pierfausto] Univ Milan, Dept Organ & Ind Chem, Milan, Italy	University of Milan; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Milan; University of Milan	Mastrangelo, E (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.	eloise.mastrangelo@unimi.it	Lecis, Daniele/C-2113-2017; Seneci, Pierfausto/A-5951-2017; Bolognesi, Martino/B-7924-2017; Milani, Mario/B-6446-2015; Cossu, Federica/ABF-9268-2020; Cossu, Federica/P-4240-2018; Mastrangelo, Eloise/AAX-1385-2020	Lecis, Daniele/0000-0002-0564-0563; Seneci, Pierfausto/0000-0001-9709-7344; Bolognesi, Martino/0000-0002-9253-5170; Milani, Mario/0000-0001-6098-3991; Cossu, Federica/0000-0001-9753-3572; Cossu, Federica/0000-0001-9753-3572; Mastrangelo, Eloise/0000-0002-5968-8386	CARIPLO Foundation [2009-2534]; Progetto NEPENTE - Regione Lombardia [15-03-3002010-3]	CARIPLO Foundation(Fondazione Cariplo); Progetto NEPENTE - Regione Lombardia(Regione Lombardia)	This work was supported by the CARIPLO Foundation Project "Inhibitors of Apoptosis Proteins (IAPs) as anticancer therapeutic targets" (2010-2012; No. 2009-2534) to DD, MB and PS, which is gratefully acknowledged. FC, MB and PS are grateful to Progetto NEPENTE (15-03-3002010-3) - Regione Lombardia for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bricogne G BE, 2011, BUSTER VERSION XYZ; Cossu F, 2010, PROTEIN SCI, V19, P2418, DOI 10.1002/pro.523; Cossu F, 2009, J MOL BIOL, V392, P630, DOI 10.1016/j.jmb.2009.04.033; Cossu F, 2009, BIOCHEM BIOPH RES CO, V378, P162, DOI 10.1016/j.bbrc.2008.10.139; David G, 2009, J APPL CRYSTALLOGR, V42, P892, DOI 10.1107/S0021889809029288; Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feltham R, 2011, J BIOL CHEM, V286, P17015, DOI 10.1074/jbc.M111.222919; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Kleywegt GJ, 1997, J MOL BIOL, V273, P371, DOI 10.1006/jmbi.1997.1309; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulathila R, 2009, ACTA CRYSTALLOGR D, V65, P58, DOI 10.1107/S0907444908039243; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lecis D, 2010, BRIT J CANCER, V102, P1707, DOI 10.1038/sj.bjc.6605687; Lecis D, 2012, DIMERIC SMAR MIMET 2; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Lu JF, 2008, CANCER RES, V68, P9384, DOI 10.1158/0008-5472.CAN-08-2655; Manzoni L, 2012, HOMO HETEROD 1 UNPUB; Mastrangelo E, 2008, J MOL BIOL, V384, P673, DOI 10.1016/j.jmb.2008.09.064; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Maupetit J, 2006, NUCLEIC ACIDS RES, V34, pW147, DOI 10.1093/nar/gkl289; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nikolovska-Coleska Z, 2008, ANAL BIOCHEM, V374, P87, DOI 10.1016/j.ab.2007.10.032; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Seneci P, 2009, BIOORGAN MED CHEM, V17, P5834, DOI 10.1016/j.bmc.2009.07.009; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; Steller I, 1997, J APPL CRYSTALLOGR, V30, P1036, DOI 10.1107/S0021889897008777; Sun HY, 2008, J MED CHEM, V51, P7169, DOI 10.1021/jm8006849; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Wu G, 2000, NATURE, V408, P1008, DOI 10.1038/35050012	43	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49527	10.1371/journal.pone.0049527	http://dx.doi.org/10.1371/journal.pone.0049527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166698	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300049
J	Mattison, HA; Hayashi, T; Barria, A				Mattison, Hayley A.; Hayashi, Takashi; Barria, Andres			Palmitoylation at Two Cysteine Clusters on the C-Terminus of GluN2A and GluN2B Differentially Control Synaptic Targeting of NMDA Receptors	PLOS ONE			English	Article							SUBUNIT COMPOSITION; TRAFFICKING; PLASTICITY; SYNAPSES; PHOSPHORYLATION; PERMEABILITY; NEURONS; CAMKII; NR2B	Palmitoylation of NMDARs occurs at two distinct cysteine clusters in the carboxyl-terminus of GluN2A and GluN2B subunits that differentially regulates retention in the Golgi apparatus and surface expression of NMDARs. Mutations of palmitoylatable cysteine residues in the membrane-proximal cluster to non-palmitoylatable serines leads to a reduction in the surface expression of recombinant NMDARs via enhanced internalization of the receptors. Mutations in a cluster of cysteines in the middle of the carboxyl-terminus of GluN2A and GluN2B, leads to an increase in the surface expression of NMDARs via an increase in post-Golgi trafficking. Using a quantitative electrophysiological assay, we investigated whether palmitoylation of GluN2 subunits and the differential regulation of surface expression affect functional synaptic incorporation of NMDARs. We show that a reduction in surface expression due to mutations in the membrane-proximal cluster translates to a reduction in synaptic expression of NMDARs. However, increased surface expression induced by mutations in the cluster of cysteines that regulates post-Golgi trafficking of NMDARs does not increase the synaptic pool of NMDA receptors, indicating that the number of synaptic receptors is tightly regulated.	[Mattison, Hayley A.; Barria, Andres] Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Hayashi, Takashi] Univ Tokyo, Grad Sch Med, Dept Mol Neurobiol & Pharmacol, Tokyo, Japan	University of Washington; University of Washington Seattle; University of Tokyo	Barria, A (corresponding author), Univ Washington, Sch Med, Dept Physiol & Biophys, Seattle, WA 98195 USA.	barria@u.washington.edu		Hayashi, Takashi/0000-0003-3591-2109	National Institutes of Health-National Institute of Neurological Disorders and Stroke [R01NS060756]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060756] Funding Source: NIH RePORTER	National Institutes of Health-National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health-National Institute of Neurological Disorders and Stroke Grant R01NS060756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007; Barria A, 2002, NEURON, V35, P345, DOI 10.1016/S0896-6273(02)00776-6; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035; Bijlmakers MJ, 2003, TRENDS CELL BIOL, V13, P32, DOI 10.1016/S0962-8924(02)00008-9; BURNASHEV N, 1992, NEURON, V8, P189, DOI 10.1016/0896-6273(92)90120-3; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Chen BS, 2007, NEUROPHARMACOLOGY, V53, P362, DOI 10.1016/j.neuropharm.2007.05.018; Cline H, 2008, J PHYSIOL-LONDON, V586, P1509, DOI 10.1113/jphysiol.2007.150029; Derkach V, 1999, P NATL ACAD SCI USA, V96, P3269, DOI 10.1073/pnas.96.6.3269; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Gambrill AC, 2011, P NATL ACAD SCI USA, V108, P5855, DOI 10.1073/pnas.1012676108; Gambrill AC, 2011, J NEUROPHYSIOL, V105, P162, DOI 10.1152/jn.00457.2010; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Groc L, 2006, P NATL ACAD SCI USA, V103, P18769, DOI 10.1073/pnas.0605238103; Hayashi T, 2005, NEURON, V47, P709, DOI 10.1016/j.neuron.2005.06.035; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hayashi Y, 2000, SCIENCE, V287, P2262, DOI 10.1126/science.287.5461.2262; Jeyifous O, 2009, NAT NEUROSCI, V12, P1011, DOI 10.1038/nn.2362; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; Lan JY, 2001, NAT NEUROSCI, V4, P382, DOI 10.1038/86028; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758; Opitz-Araya X, 2011, J VIS EXP, V48, pe2462; Philpot BD, 2001, NEUROPHARMACOLOGY, V41, P762, DOI 10.1016/S0028-3908(01)00136-8; Sanchez JT, 2012, J PHYSL; Sanz-Clemente A, 2010, NEURON, V67, P984, DOI 10.1016/j.neuron.2010.08.011; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Single FN, 2000, J NEUROSCI, V20, P2558; Stocca G, 1998, J PHYSIOL-LONDON, V507, P13, DOI 10.1111/j.1469-7793.1998.013bu.x; Storey GP, 2011, J NEUROSCI, V31, P6311, DOI 10.1523/JNEUROSCI.5553-10.2011; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Wenthold RJ, 2003, ANNU REV PHARMACOL, V43, P335, DOI 10.1146/annurev.pharmtox.43.100901.135803; WOODS G, 2008, JOVE-J VIS EXP, V12, pE675, DOI DOI 10.3791/675	35	24	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49089	10.1371/journal.pone.0049089	http://dx.doi.org/10.1371/journal.pone.0049089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166606	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300023
J	Liang, G; He, H; Yu, DQ				Liang, Gang; He, Hua; Yu, Diqiu			Identification of Nitrogen Starvation-Responsive MicroRNAs in Arabidopsis thaliana	PLOS ONE			English	Article							SULFATE ASSIMILATION; SECONDARY METABOLISM; DOWN-REGULATION; SMALL RNAS; PLANT; GENES; EXPRESSION; TARGETS; NITRATE; MIRNA	microRNAs (miRNAs) are a class of negative regulators that take part in many processes such as growth and development, stress responses, and metabolism in plants. Recently, miRNAs were shown to function in plant nutrient metabolism. Moreover, several miRNAs were identified in the response to nitrogen (N) deficiency. To investigate the functions of other miRNAs in N deficiency, deep sequencing technology was used to detect the expression of small RNAs under N-sufficient and -deficient conditions. The results showed that members from the same miRNA families displayed differential expression in response to N deficiency. Upon N starvation, the expression of miR169, miR171, miR395, miR397, miR398, miR399, miR408, miR827, and miR857 was repressed, whereas those of miR160, miR780, miR826, miR842, and miR846 were induced. miR826, a newly identified N-starvation-induced miRNA, was found to target the AOP2 gene. Among these N-starvation-responsive miRNAs, several were involved in cross-talk among responses to different nutrient (N, P, S, Cu) deficiencies. miR160, miR167, and miR171 could be responsible for the development of Arabidopsis root systems under N-starvation conditions. In addition, twenty novel miRNAs were identified and nine of them were significantly responsive to N-starvation. This study represents comprehensive expression profiling of N-starvation-responsive miRNAs and advances our understanding of the regulation of N homeostasis mediated by miRNAs.	[Liang, Gang; He, Hua; Yu, Diqiu] Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China	Chinese Academy of Sciences; Xishuangbanna Tropical Botanical Garden, CAS	Liang, G (corresponding author), Chinese Acad Sci, Xishuangbanna Trop Bot Garden, Key Lab Trop Forest Ecol, Kunming, Yunnan, Peoples R China.	ydq@xtbg.ac.cn	yu, diqiu/D-2011-2009; 何, 华/GQA-7692-2022	Liang, Gang/0000-0002-0622-4043				Abdel-Ghany SE, 2008, J BIOL CHEM, V283, P15932, DOI 10.1074/jbc.M801406200; Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Arteaga-Vazquez M, 2006, PLANT CELL, V18, P3355, DOI 10.1105/tpc.106.044420; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Buhtz A, 2008, PLANT J, V53, P739, DOI 10.1111/j.1365-313X.2007.03368.x; Buhtz A, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-64; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Chiou TJ, 2006, PLANT CELL, V18, P412, DOI 10.1105/tpc.105.038943; Combier JP, 2006, GENE DEV, V20, P3084, DOI 10.1101/gad.402806; Dong Z, 2008, P NATL ACAD SCI USA, V105, P9970, DOI 10.1073/pnas.0803356105; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Forde BG, 2002, ANNU REV PLANT BIOL, V53, P203, DOI 10.1146/annurev.arplant.53.100301.135256; Gandikota M, 2007, PLANT J, V49, P683, DOI 10.1111/j.1365-313X.2006.02983.x; German MA, 2008, NAT BIOTECHNOL, V26, P941, DOI 10.1038/nbt1417; Gifford ML, 2008, P NATL ACAD SCI USA, V105, P803, DOI 10.1073/pnas.0709559105; Gutierrez L, 2009, PLANT CELL, V21, P3119, DOI 10.1105/tpc.108.064758; Hirota A, 2007, PLANT CELL, V19, P2156, DOI 10.1105/tpc.107.050674; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Khan GA, 2011, PLANT MOL BIOL, V77, P47, DOI 10.1007/s11103-011-9793-x; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Krapp A, 2011, PLANT PHYSIOL, V157, P1255, DOI 10.1104/pp.111.179838; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Li XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039650; Li YF, 2010, PLANT J, V62, P742, DOI 10.1111/j.1365-313X.2010.04187.x; Liang G, 2010, PLANT J, V62, P1046, DOI 10.1111/j.1365-313X.2010.04216.x; Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Merchan F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r136; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; NEUENSCHWANDER U, 1991, PLANT PHYSIOL, V97, P253, DOI 10.1104/pp.97.1.253; Ossowski S., 2010, COMMUNICATION; Pant BD, 2008, PLANT J, V53, P731, DOI 10.1111/j.1365-313X.2007.03363.x; Pant BD, 2009, PLANT PHYSIOL, V150, P1541, DOI 10.1104/pp.109.139139; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; REUVENY Z, 1980, P NATL ACAD SCI-BIOL, V77, P6670, DOI 10.1073/pnas.77.11.6670; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Schachtman DP, 2007, ANNU REV PLANT BIOL, V58, P47, DOI 10.1146/annurev.arplant.58.032806.103750; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Sunkar R, 2006, PLANT CELL, V18, P2051, DOI 10.1105/tpc.106.041673; Trevisan S, 2012, PLANT CELL ENVIRON, V35, P1137, DOI 10.1111/j.1365-3040.2011.02478.x; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Vidal EA, 2010, P NATL ACAD SCI USA, V107, P4477, DOI 10.1073/pnas.0909571107; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wang L, 2010, MOL PLANT, V3, P794, DOI 10.1093/mp/ssq042; Wang RC, 2000, PLANT CELL, V12, P1491, DOI 10.1105/tpc.12.8.1491; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Yamasaki H, 2007, J BIOL CHEM, V282, P16369, DOI 10.1074/jbc.M700138200; Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130; Zhao M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029669; Zhao M, 2011, NEW PHYTOL, V190, P906, DOI 10.1111/j.1469-8137.2011.03647.x	62	177	191	6	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48951	10.1371/journal.pone.0048951	http://dx.doi.org/10.1371/journal.pone.0048951			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155433	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900068
J	Stoeger, AS; Heilmann, G; Zeppelzauer, M; Ganswindt, A; Hensman, S; Charlton, BD				Stoeger, Angela S.; Heilmann, Gunnar; Zeppelzauer, Matthias; Ganswindt, Andre; Hensman, Sean; Charlton, Benjamin D.			Visualizing Sound Emission of Elephant Vocalizations: Evidence for Two Rumble Production Types	PLOS ONE			English	Article							VOCAL COMMUNICATION; AFRICAN ELEPHANTS; LONG-DISTANCE; ACOUSTIC CUES; INFORMATION; SIZE; FORMANTS; IDENTITY; ROARS; CALLS	Recent comparative data reveal that formant frequencies are cues to body size in animals, due to a close relationship between formant frequency spacing, vocal tract length and overall body size. Accordingly, intriguing morphological adaptations to elongate the vocal tract in order to lower formants occur in several species, with the size exaggeration hypothesis being proposed to justify most of these observations. While the elephant trunk is strongly implicated to account for the low formants of elephant rumbles, it is unknown whether elephants emit these vocalizations exclusively through the trunk, or whether the mouth is also involved in rumble production. In this study we used a sound visualization method (an acoustic camera) to record rumbles of five captive African elephants during spatial separation and subsequent bonding situations. Our results showed that the female elephants in our analysis produced two distinct types of rumble vocalizations based on vocal path differences: a nasally- and an orally-emitted rumble. Interestingly, nasal rumbles predominated during contact calling, whereas oral rumbles were mainly produced in bonding situations. In addition, nasal and oral rumbles varied considerably in their acoustic structure. In particular, the values of the first two formants reflected the estimated lengths of the vocal paths, corresponding to a vocal tract length of around 2 meters for nasal, and around 0.7 meters for oral rumbles. These results suggest that African elephants may be switching vocal paths to actively vary vocal tract length (with considerable variation in formants) according to context, and call for further research investigating the function of formant modulation in elephant vocalizations. Furthermore, by confirming the use of the elephant trunk in long distance rumble production, our findings provide an explanation for the extremely low formants in these calls, and may also indicate that formant lowering functions to increase call propagation distances in this species'.	[Stoeger, Angela S.] Univ Vienna, Dept Cognit Biol, Vienna, Austria	University of Vienna	Stoeger, AS (corresponding author), Univ Vienna, Dept Cognit Biol, Vienna, Austria.	angela.stoeger-horwath@univie.ac.at	Ganswindt, Andre/G-9856-2014	Ganswindt, Andre/0000-0002-1474-7602; Charlton, Benjamin/0000-0002-0218-7177; Zeppelzauer, Matthias/0000-0003-0413-4746; Stoeger, Angela S/0000-0002-6714-8291	Austrian Science Fund (FWF) [P 23099] Funding Source: researchfish; Austrian Science Fund FWF [P 23099] Funding Source: Medline	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund FWF(Austrian Science Fund (FWF))		ANDREW RJ, 1976, ANN NY ACAD SCI, V280, P673, DOI 10.1111/j.1749-6632.1976.tb25530.x; Boersma P, 2021, PRAAT DOING PHONETIC; Brudzynski SM, 2009, HDB MAMMALIAN VOCALI, P215; Charlton BD, 2007, BIOL LETTERS, V3, P382, DOI 10.1098/rsbl.2007.0244; Charlton BD, 2012, ANIM COGN, V15, P999, DOI 10.1007/s10071-012-0527-5; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Charlton BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021066; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Fitch WT, 2000, PHONETICA, V57, P205; Fitch WT, 1999, J ZOOL, V248, P31, DOI 10.1017/S095283699900504X; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669, DOI 10.1098/rspb.2001.1704; Fitch WT, 2006, PHONETICA, P115; Garstang M, 2004, J COMP PHYSIOL A, V190, P791, DOI 10.1007/s00359-004-0553-0; Harris TR, 2006, ETHOLOGY, V112, P911, DOI 10.1111/j.1439-0310.2006.01247.x; HEFFNER R, 1980, SCIENCE, V208, P518, DOI 10.1126/science.7367876; Heinz G. K., 1994, Systems Analysis and Modelling Simulation, V15, P151; Herbst CT, 2012, SCIENCE, V337, P595, DOI 10.1126/science.1219712; Hollister-Smith JA, 2007, ANIM BEHAV, V74, P287, DOI 10.1016/j.anbehav.2006.12.008; Jonson DH, 1992, ARRAY SIGNAL PROCESS; King LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010346; Laws R.M., 1975, ELEPHANTS THEIR HABI; Lieberman P., 1988, SPEECH PHYSL SPEECH; McComb K, 2003, ANIM BEHAV, V65, P317, DOI 10.1006/anbe.2003.2047; Ohms VR, 2010, P ROY SOC B-BIOL SCI, V277, P1003, DOI 10.1098/rspb.2009.1788; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Poole Joyce H., 2011, P125; Poole Joyce H., 2011, P109; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; RICHMAN B, 1976, J ACOUST SOC AM, V60, P718, DOI 10.1121/1.381144; Riede T, 1999, J EXP BIOL, V202, P2859; Riede T, 2003, J ACOUST SOC AM, V114, P1132, DOI 10.1121/1.1580812; Sanvito S, 2007, ANIM BEHAV, V73, P287, DOI 10.1016/j.anbehav.2006.08.005; Schehka S, 2009, BEHAV BRAIN RES, V203, P223, DOI 10.1016/j.bbr.2009.05.007; SEYFARTH RM, 1984, J ACOUST SOC AM, V75, P1623, DOI 10.1121/1.390872; Sikes S.K, 1971, NATURAL HIST AFRICAN; Soltis J, 2005, ANIM BEHAV, V70, P589, DOI 10.1016/j.anbehav.2004.11.016; Soltis J, 2010, ZOO BIOL, V29, P192, DOI 10.1002/zoo.20251; Soltis J, 2009, J COMP PSYCHOL, V123, P222, DOI 10.1037/a0015223; SOMMERS MS, 1992, J ACOUST SOC AM, V91, P3499, DOI 10.1121/1.402839; Stoeger AS, 2011, J ACOUST SOC AM, V130, P1700, DOI 10.1121/1.3605538; Stoeger-Horwath AS, 2007, J ACOUST SOC AM, V121, P3922, DOI 10.1121/1.2722216; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Taylor AM, 2008, J ACOUST SOC AM, V123, P2903, DOI 10.1121/1.2896962; Titze IR, 1994, PRINCIPLES VOCAL PRO; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; Venables WN., 2002, MODERN APPL STAT S 4; Volodin IA, 2011, ETHOLOGY, V117, P294, DOI 10.1111/j.1439-0310.2011.01874.x; Weissengruber GE, 2002, J ANAT, V201, P195, DOI 10.1046/j.1469-7580.2002.00088.x; WILEY RH, 1978, BEHAV ECOL SOCIOBIOL, V3, P69, DOI 10.1007/BF00300047	54	43	43	2	78	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48907	10.1371/journal.pone.0048907	http://dx.doi.org/10.1371/journal.pone.0048907			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155427	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000311151900062
J	Verweij, KJH; Burri, AV; Zietsch, BP				Verweij, Karin J. H.; Burri, Andrea V.; Zietsch, Brendan P.			Evidence for Genetic Variation in Human Mate Preferences for Sexually Dimorphic Physical Traits	PLOS ONE			English	Article							EQUAL ENVIRONMENTS ASSUMPTION; QUANTITATIVE GENETICS; MATING PREFERENCES; REPRODUCTIVE SUCCESS; FIELD CRICKET; CHOICE; TWIN; SELECTION; ATTRACTIVENESS; HERITABILITY	Intersexual selection has been proposed as an important force in shaping a number of morphological traits that differ between human populations and/or between the sexes. Important to these accounts is the source of mate preferences for such traits, but this has not been investigated. In a large sample of twins, we assess forced-choice, dichotomous mate preferences for height, skin colour, hair colour and length, chest hair, facial hair, and breast size. Across the traits, identical twins reported more similar preferences than nonidentical twins, suggesting genetic effects. However, the relative magnitude of estimated genetic and environmental effects differed greatly and significantly between different trait preferences, with heritability estimates ranging from zero to 57%.	[Verweij, Karin J. H.; Zietsch, Brendan P.] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia	University of Queensland	Verweij, KJH (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	Brendan.Zietsch@qimr.edu.au	Zietsch, Brendan/F-7497-2016	Zietsch, Brendan/0000-0003-0274-6140; Burri, Andrea/0000-0002-4705-3551	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Andrew T, 2001, Twin Res, V4, P464, DOI 10.1375/1369052012803; Aoki K, 2002, ANN HUM BIOL, V29, P589, DOI 10.1080/0301446021000019144; Borkenau P, 2002, PERS INDIV DIFFER, V33, P261, DOI 10.1016/S0191-8869(01)00150-7; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; Brooks R, 2001, EVOLUTION, V55, P1644, DOI 10.1111/j.0014-3820.2001.tb00684.x; Cannon TD, 2006, ANNU REV CLIN PSYCHO, V2, P267, DOI 10.1146/annurev.clinpsy.2.022305.095232; COLLINS RD, 1989, J CHEM ECOL, V15, P2647, DOI 10.1007/BF01014723; Courtiol A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013010; Courtiol A, 2010, EVOLUTION, V64, P2189, DOI 10.1111/j.1558-5646.2010.00985.x; Darwin C., 1871, P423; Delcourt M, 2010, EVOLUTION, V64, P2758, DOI 10.1111/j.1558-5646.2010.01031.x; Dixson BJ, 2010, ARCH SEX BEHAV, P1; Eaves L, 2003, TWIN RES, V6, P486, DOI 10.1375/twin.6.6.486; FEINMAN S, 1978, J SOC PSYCHOL, V105, P43, DOI 10.1080/00224545.1978.9924089; Fisher RA, 1930, GENETICAL THEORY NAT; Frost P, 2006, EVOL HUM BEHAV, V27, P85, DOI 10.1016/j.evolhumbehav.2005.07.002; FROST P, 1994, PERCEPT MOTOR SKILL, V79, P507, DOI 10.2466/pms.1994.79.1.507; Fuller RC, 2005, AM NAT, V166, P437, DOI 10.1086/444443; Gray DA, 1999, EVOLUTION, V53, P848, DOI [10.2307/2640724, 10.1111/j.1558-5646.1999.tb05378.x]; Hall M, 2004, BMC EVOLUTIONARY BIO, P4; Hill WG, 2008, PLOS GENET, P4; Irwin DE, 1999, HEREDITY, V82, P347, DOI 10.1038/sj.hdy.6885270; Iyengar VK, 2002, NATURE, V419, P830, DOI 10.1038/nature01027; Jang YW, 2000, HEREDITY, V84, P73, DOI 10.1046/j.1365-2540.2000.00631.x; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Keller MC, 2010, BEHAV GENET, V40, P377, DOI 10.1007/s10519-009-9320-x; Keller MC, 2005, TWIN RES HUM GENET, V8, P201, DOI 10.1375/twin.8.3.201; Kendler KS, 2000, AM J PSYCHIAT, V157, P1843, DOI 10.1176/appi.ajp.157.11.1843; Kendrick KM, 1998, NATURE, V395, P229, DOI 10.1038/26129; Lewis MB, 2011, PERS INDIV DIFFER, V50, P159, DOI 10.1016/j.paid.2010.09.018; Lie HC, 2010, EVOL HUM BEHAV, V31, P48, DOI 10.1016/j.evolhumbehav.2009.07.001; McEvoy BP, 2009, ECON HUM BIOL, V7, P294, DOI 10.1016/j.ehb.2009.09.005; McGuigan K, 2011, TRENDS ECOL EVOL, V26, P22, DOI 10.1016/j.tree.2010.10.008; Mesko N, 2004, HUM NATURE-INT BIOS, V15, P251, DOI 10.1007/s12110-004-1008-6; MOLLER AP, 1995, ETHOL SOCIOBIOL, V16, P207, DOI 10.1016/0162-3095(95)00002-3; Neale M. C., 2006, MX STAT MODELING, V7th; Neale MC, 1992, METHODOLOGY GENETIC; Neave N, 2008, PERS INDIV DIFFER, V45, P373, DOI 10.1016/j.paid.2008.05.007; Pawlowski B, 2000, NATURE, V403, P156, DOI 10.1038/35003107; PLOMIN R, 1976, BEHAV GENET, V6, P43, DOI 10.1007/BF01065677; Posthuma D, 2003, TWIN RES, V6, P361, DOI 10.1375/twin.6.5.361; Rantala MJ, 2011, BEHAV ECOL SOCIOBIOL, V65, P859, DOI 10.1007/s00265-011-1145-y; Roberts SC, 2005, BIOL LETT-UK, V1, P400, DOI 10.1098/rsbl.2005.0343; Roberts T, 2010, EXP BIOL MED, V235, P1277, DOI 10.1258/ebm.2010.010112; Schielzeth H, 2010, EVOLUTION, V64, P998, DOI 10.1111/j.1558-5646.2009.00890.x; Sesardic N., 2005, MAKING SENSE HERITAB; Simmons LW, 2004, ANIM BEHAV, V68, P313, DOI 10.1016/j.anbehav.2003.12.004; Spector TD, 2006, TWIN RES HUM GENET, V9, P899, DOI 10.1375/twin.9.6.899; Whitehead RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032988; Zietsch BP, 2012, EVOLUTION, V66, P1762, DOI 10.1111/j.1558-5646.2011.01546.x; Zietsch BP, 2011, AM NAT, V177, P605, DOI 10.1086/659629	51	9	10	1	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49294	10.1371/journal.pone.0049294	http://dx.doi.org/10.1371/journal.pone.0049294			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166631	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900117
J	Visser, R; Landman, EBM; Goeman, J; Wit, JM; Karperien, M				Visser, Remco; Landman, Ellie B. M.; Goeman, Jelle; Wit, Jan M.; Karperien, Marcel			Sotos Syndrome Is Associated with Deregulation of the MAPK/ERK-Signaling Pathway	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; HUMAN GENETIC-DISEASE; BONE-DEVELOPMENT; PROBE LEVEL; SET DOMAIN; NSD1; ACTIVATION; METHYLATION; EXPRESSION; PHENOTYPE	Sotos syndrome (SoS) is characterized by tall stature, characteristic craniofacial features and mental retardation. It is caused by haploinsufficiency of the NSD1 gene. In this study, our objective was to identify downstream effectors of NSD1 and to map these effectors in signaling pathways associated with growth. Genome-wide expression studies were performed on dermal fibroblasts from SoS patients with a confirmed NSD1 abnormality. To substantiate those results, phosphorylation, siRNA and transfection experiments were performed. A significant association was demonstrated with the MitogenActivated Protein Kinase (MAPK) pathway. Members of the fibroblast growth factor family such as FGF4 and FGF13 contributed strongly to the differential expression in this pathway. In addition, a diminished activity state of the MAPK/ERK pathway was demonstrated in SoS. The Ras Interacting Protein 1 (RASIP1) was identified to exhibit upregulated expression in SoS. It was shown that RASIP1 dose-dependently potentiated bFGF induced expression of the MAPK responsive SBE reporter providing further support for a link between NSD1 and the MAPK/ERK signaling pathway. Additionally, we demonstrated NSD1 expression in the terminally differentiated hypertrophic chondrocytes of normal human epiphyseal growth plates. In short stature syndromes such as hypochondroplasia and Noonan syndrome, the activation level of the FGF-MAPK/ERK-pathway in epiphyseal growth plates is a determining factor for statural growth. In analogy, we propose that deregulation of the MAPK/ERK pathway in SoS results in altered hypertrophic differentiation of NSD1 expressing chondrocytes and may be a determining factor in statural overgrowth and accelerated skeletal maturation in SoS.	[Visser, Remco; Wit, Jan M.] Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Visser, R (corresponding author), Leiden Univ, Dept Pediat, Med Ctr, Leiden, Netherlands.	r.visser@lumc.nl	Goeman, Jelle/AAT-1300-2020; Karperien, Marcel/R-3270-2018	Goeman, Jelle/0000-0003-4283-0259; Karperien, Marcel/0000-0003-0751-0604; /0000-0002-5839-4626				Bake S, 2008, ENDOCRINOLOGY, V149, P3881, DOI 10.1210/en.2008-0288; Bentires-Alj M, 2006, NAT MED, V12, P283, DOI 10.1038/nm0306-283; Berdasco M, 2009, P NATL ACAD SCI USA, V106, P21830, DOI 10.1073/pnas.0906831106; Chergui F, 2009, CLIN CHEM, V55, P1327, DOI 10.1373/clinchem.2008.116632; Colvin JS, 1996, NAT GENET, V12, P390, DOI 10.1038/ng0496-390; de Boer L, 2004, HORM RES, V62, P197, DOI 10.1159/000081063; de Boer L, 2004, EUR J ENDOCRINOL, V151, P333, DOI 10.1530/eje.0.1510333; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; Duno M, 2007, ANN HUM GENET, V71, P713, DOI 10.1111/j.1469-1809.2007.00376.x; Emons J, 2009, PEDIATR RES, V66, P654, DOI 10.1203/PDR.0b013e3181beaa8c; Fang P, 2009, J CLIN ENDOCR METAB, V94, P1740, DOI 10.1210/jc.2008-1903; Filzmoser P, 2008, COMPUT STAT DATA AN, V52, P1694, DOI 10.1016/j.csda.2007.05.018; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Goeman JJ, 2004, BIOINFORMATICS, V20, P93, DOI 10.1093/bioinformatics/btg382; Huang NW, 1998, EMBO J, V17, P3398, DOI 10.1093/emboj/17.12.3398; Hwa V, 2006, J CLIN ENDOCR METAB, V91, P1826, DOI 10.1210/jc.2005-2842; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kamp GA, 2002, CLIN ENDOCRINOL, V56, P439, DOI 10.1046/j.1365-2265.2002.01492.x; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu T, 2010, P NATL ACAD SCI USA, V107, P46, DOI 10.1073/pnas.0912493107; Lucio-Eterovic AK, 2010, P NATL ACAD SCI USA, V107, P16952, DOI 10.1073/pnas.1002653107; Mitin NY, 2004, J BIOL CHEM, V279, P22353, DOI 10.1074/jbc.M312867200; Mor A, 2006, ANNU REV IMMUNOL, V24, P771, DOI 10.1146/annurev.immunol.24.021605.090723; Murakami S, 2004, GENE DEV, V18, P290, DOI 10.1101/gad.1179104; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Qiao Q, 2011, J BIOL CHEM, V286, P8361, DOI 10.1074/jbc.M110.204115; Quatela SE, 2006, CURR OPIN CELL BIOL, V18, P162, DOI 10.1016/j.ceb.2006.02.004; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Tatton-Brown K, 2005, AM J HUM GENET, V77, P193, DOI 10.1086/432082; Tsai CA, 2005, BIOINFORMATICS, V21, P1502, DOI 10.1093/bioinformatics/bti162; van der Eerden BCJ, 2003, ENDOCR REV, V24, P782, DOI 10.1210/er.2002-0033; Vidarsdottir S, 2006, J CLIN ENDOCR METAB, V91, P3482, DOI 10.1210/jc.2006-0368; Voth DE, 2009, INFECT IMMUN, V77, P205, DOI 10.1128/IAI.01124-08; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Wang YC, 1999, P NATL ACAD SCI USA, V96, P4455, DOI 10.1073/pnas.96.8.4455	40	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49229	10.1371/journal.pone.0049229	http://dx.doi.org/10.1371/journal.pone.0049229			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155469	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900104
J	Yeatman, JD; Dougherty, RF; Myall, NJ; Wandell, BA; Feldman, HM				Yeatman, Jason D.; Dougherty, Robert F.; Myall, Nathaniel J.; Wandell, Brian A.; Feldman, Heidi M.			Tract Profiles of White Matter Properties: Automating Fiber-Tract Quantification	PLOS ONE			English	Article							HUMAN BRAIN; LONGITUDINAL FASCICULUS; AXONAL PROJECTIONS; DIFFUSION; TRACTOGRAPHY; MATURATION; PATHWAYS; TRACKING; LANGUAGE; SPECTRUM	Tractography based on diffusion weighted imaging (DWI) data is a method for identifying the major white matter fascicles (tracts) in the living human brain. The health of these tracts is an important factor underlying many cognitive and neurological disorders. In vivo, tissue properties may vary systematically along each tract for several reasons: different populations of axons enter and exit the tract, and disease can strike at local positions within the tract. Hence quantifying and understanding diffusion measures along each fiber tract (Tract Profile) may reveal new insights into white matter development, function, and disease that are not obvious from mean measures of that tract. We demonstrate several novel findings related to Tract Profiles in the brains of typically developing children and children at risk for white matter injury secondary to preterm birth. First, fractional anisotropy (FA) values vary substantially within a tract but the Tract FA Profile is consistent across subjects. Thus, Tract Profiles contain far more information than mean diffusion measures. Second, developmental changes in FA occur at specific positions within the Tract Profile, rather than along the entire tract. Third, Tract Profiles can be used to compare white matter properties of individual patients to standardized Tract Profiles of a healthy population to elucidate unique features of that patient's clinical condition. Fourth, Tract Profiles can be used to evaluate the association between white matter properties and behavioral outcomes. Specifically, in the preterm group reading ability is positively correlated with FA measured at specific locations on the left arcuate and left superior longitudinal fasciculus and the magnitude of the correlation varies significantly along the Tract Profiles. We introduce open source software for automated fiber-tract quantification (AFQ) that measures Tract Profiles of MRI parameters for 18 white matter tracts. With further validation, AFQ Tract Profiles have potential for informing clinical management and decisionmaking.	[Yeatman, Jason D.; Wandell, Brian A.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA	Stanford University	Yeatman, JD (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	jyeatman@stanford.edu	Jovicich, Jorge/D-2293-2010	Feldman, Heidi/0000-0002-4435-0913	NCATS NIH HHS [UL1 TR001085] Funding Source: Medline; NCRR NIH HHS [1UL1 RR025744, UL1 RR025744] Funding Source: Medline; NEI NIH HHS [R01-EY15000, R01 EY015000] Funding Source: Medline; NICHD NIH HHS [R01 HD046500, R01 HD069162, R01-HD46500] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069162] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046500] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015000] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; Andrews JS, 2010, DEV MED CHILD NEUROL, V52, pE94, DOI 10.1111/j.1469-8749.2009.03456.x; Back SA, 2007, STROKE, V38, P724, DOI 10.1161/01.STR.0000254729.27386.05; Back SA, 2006, MENT RETARD DEV D R, V12, P129, DOI 10.1002/mrdd.20107; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI [10.1006/jmrb.1996.0086, 10.1016/j.jmr.2011.09.022]; Ben-Shachar M, 2007, CURR OPIN NEUROBIOL, V17, P258, DOI 10.1016/j.conb.2007.03.006; Berman JI, 2005, NEUROIMAGE, V27, P862, DOI 10.1016/j.neuroimage.2005.05.018; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Colby JB, 2012, NEUROIMAGE, V59, P3227, DOI 10.1016/j.neuroimage.2011.11.004; Colby JB, 2011, NEUROIMAGE, V54, P25, DOI 10.1016/j.neuroimage.2010.08.014; Concha L, 2012, NEUROLOGY, V79, P455, DOI 10.1212/WNL.0b013e31826170b6; Davis SW, 2009, NEUROIMAGE, V46, P530, DOI 10.1016/j.neuroimage.2009.01.068; Dubois J, 2008, J NEUROSCI, V28, P1943, DOI 10.1523/JNEUROSCI.5145-07.2008; Duffau H, 2009, J NEUROL, V256, P382, DOI 10.1007/s00415-009-0053-9; Edden RA, 2011, J NEUROSCI METH, V201, P213, DOI 10.1016/j.jneumeth.2011.07.025; Feldman HM, 2010, J DEV BEHAV PEDIATR, V31, P346, DOI 10.1097/DBP.0b013e3181dcaa8b; Feldman HM, NEUROPSYCHO IN PRESS; Frey S, 2008, J NEUROSCI, V28, P11435, DOI 10.1523/JNEUROSCI.2388-08.2008; Friston KJ, 2004, NEUROIMAGE, V23, P21, DOI 10.1016/j.neuroimage.2004.04.021; Frye RE, 2010, DEV MED CHILD NEUROL, V52, P760, DOI 10.1111/j.1469-8749.2010.03633.x; Fuster JM, 2002, J NEUROCYTOL, V31, P373, DOI 10.1023/A:1024190429920; Geng XJ, 2012, NEUROIMAGE, V61, P542, DOI 10.1016/j.neuroimage.2012.03.057; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Leclercq D, 2010, J NEUROSURG, V112, P503, DOI 10.3171/2009.8.JNS09558; Lee ES, 2011, NEUROPSYCHOLOGIA, V49, P906, DOI 10.1016/j.neuropsychologia.2010.12.038; Leipsic P. F. O., 1901, LANCET, V158, P1027, DOI [10.1016/S0140-6736(01)01429-5, DOI 10.1016/S0140-6736(01)01429-5]; Lim KO, 2002, NMR BIOMED, V15, P587, DOI 10.1002/nbm.789; Lin FC, 2006, NEUROIMAGE, V33, P154, DOI 10.1016/j.neuroimage.2006.03.055; Mandonnet E, 2007, BRAIN, V130, P623, DOI 10.1093/brain/awl361; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Myall N, J CHILD NEU IN PRESS; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Nimsky C, 2005, NEUROSURGERY, V56, P130, DOI 10.1227/01.NEU.0000144842.18771.30; Nimsky C, 2007, NEUROSURGERY, V61, P306, DOI [10.1227/01.neu.0000279224.83998.7d, 10.1227/01.NEU.0000204726.00088.6D]; O'Donnell LJ, 2009, NEUROIMAGE, V45, P832, DOI 10.1016/j.neuroimage.2008.12.023; Parker GJM, 2002, NEUROIMAGE, V15, P797, DOI 10.1006/nimg.2001.0994; Rauschecker AM, 2009, NEUROPSYCHOLOGIA, V47, P180, DOI 10.1016/j.neuropsychologia.2008.08.011; Rohde GK, 2004, MAGN RESON MED, V51, P103, DOI 10.1002/mrm.10677; Rolheiser T, 2011, J NEUROSCI, V31, P16949, DOI 10.1523/JNEUROSCI.2725-11.2011; Schmahmann JD, 2007, BRAIN, V130, P630, DOI 10.1093/brain/awl359; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tsang JM, 2009, P NATL ACAD SCI USA, V106, P22546, DOI 10.1073/pnas.0906094106; Tsang JM, 2010, TRACT ALIGNMENT ERRO; Volpe JJ, 2001, PEDIATR RES, V50, P553, DOI 10.1203/00006450-200111000-00003; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wandell BA, 2012, ANNU REV PSYCHOL, V63, P31, DOI 10.1146/annurev-psych-120710-100434; Wassermann D., 2012, INF PROCESS MED IMAG, V22, P320; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Yeatman JD, 2011, J COGNITIVE NEUROSCI, V23, P3304, DOI 10.1162/jocn_a_00061; Yeatman JD, 2009, J CHILD NEUROL, V24, P795, DOI 10.1177/0883073808331080; Yeatman JD, 2012, BRAIN LANGUAGE; Yeatman JD, 2012, CORTEX; Yendiki Anastasia, 2011, Front Neuroinform, V5, P23, DOI 10.3389/fninf.2011.00023; Zhang WH, 2008, NEUROIMAGE, V42, P771, DOI 10.1016/j.neuroimage.2008.04.241	60	443	453	11	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49790	10.1371/journal.pone.0049790	http://dx.doi.org/10.1371/journal.pone.0049790			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166771	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900195
J	Alfonso-Pecchio, A; Garcia, M; Leonardi, R; Jackowski, S				Alfonso-Pecchio, Adolfo; Garcia, Matthew; Leonardi, Roberta; Jackowski, Suzanne			Compartmentalization of Mammalian Pantothenate Kinases	PLOS ONE			English	Article							HALLERVORDEN-SPATZ-SYNDROME; COENZYME-A SYNTHESIS; FLUORESCENT PROTEINS; MITOCHONDRIAL LOCALIZATION; FEEDBACK-REGULATION; IRON ACCUMULATION; ESCHERICHIA-COLI; NUCLEAR EXPORT; NEURODEGENERATION; GENE	The pantothenate kinases (PanK) catalyze the first and the rate-limiting step in coenzyme A (CoA) biosynthesis and regulate the amount of CoA in tissues by differential isoform expression and allosteric interaction with metabolic ligands. The four human and mouse PanK proteins share a homologous carboxy-terminal catalytic domain, but differ in their amino-termini. These unique termini direct the isoforms to different subcellular compartments. PanK1 alpha isoforms were exclusively nuclear, with preferential association with the granular component of the nucleolus during interphase. PanK1a also associated with the perichromosomal region in condensing chromosomes during mitosis. The PanK1 beta and PanK3 isoforms were cytosolic, with a portion of PanK1 beta associated with clathrin-associated vesicles and recycling endosomes. Human PanK2, known to associate with mitochondria, was specifically localized to the intermembrane space. Human PanK2 was also detected in the nucleus, and functional nuclear localization and export signals were identified and experimentally confirmed. Nuclear PanK2 trafficked from the nucleus to the mitochondria, but not in the other direction, and was absent from the nucleus during G2 phase of the cell cycle. The localization of human PanK2 in these two compartments was in sharp contrast to mouse PanK2, which was exclusively cytosolic. These data demonstrate that PanK isoforms are differentially compartmentalized allowing them to sense CoA homeostasis in different cellular compartments and enable interaction with regulatory ligands produced in these same locations.	[Alfonso-Pecchio, Adolfo; Garcia, Matthew; Leonardi, Roberta; Jackowski, Suzanne] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Jackowski, S (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	suzanne.jackowski@stjude.org	Jackowski, Suzanne/N-8168-2018	Jackowski, Suzanne/0000-0002-6855-1429	National Institutes of Health [GM062896]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM062896 (S.J.) and the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ba ANN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-202; Badugu R, 2008, J BIOL CHEM, V283, P3409, DOI 10.1074/jbc.M706851200; Bell P, 2007, J HISTOCHEM CYTOCHEM, V55, P931, DOI 10.1369/jhc.7A7180.2007; Bosveld F, 2008, HUM MOL GENET, V17, P2058, DOI 10.1093/hmg/ddn105; EHRICH M, 1995, CLIN EXP PHARMACOL P, V22, P291, DOI 10.1111/j.1440-1681.1995.tb01998.x; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Hayflick SJ, 2003, NEW ENGL J MED, V348, P33, DOI 10.1056/NEJMoa020817; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; Hortnagel K, 2003, HUM MOL GENET, V12, P321, DOI 10.1093/hmg/ddg026; Jackman J, 2001, Curr Protoc Cell Biol, VChapter 8, DOI 10.1002/0471143030.cb0803s00; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Johnson MA, 2004, ANN NY ACAD SCI, V1012, P282, DOI 10.1196/annals.1306.023; Kotzbauer PT, 2005, J NEUROSCI, V25, P689, DOI 10.1523/JNEUROSCI.4265-04.2005; Kruger T, 2007, J CELL BIOL, V177, P573, DOI 10.1083/jcb.200612048; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kuo YM, 2005, HUM MOL GENET, V14, P49, DOI 10.1093/hmg/ddi005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Leonardi R, 2007, FEBS LETT, V581, P4639, DOI 10.1016/j.febslet.2007.08.056; Leonardi R, 2007, P NATL ACAD SCI USA, V104, P1494, DOI 10.1073/pnas.0607621104; Leonardi R, 2010, CHEM BIOL, V17, P892, DOI 10.1016/j.chembiol.2010.06.006; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Mattaj IW, 1998, ANNU REV BIOCHEM, V67, P265, DOI 10.1146/annurev.biochem.67.1.265; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; PAHLMAN S, 1990, ACTA PHYSIOL SCAND, V140, P25; Ramaswamy G, 2004, J LIPID RES, V45, P17, DOI 10.1194/jlr.M300279-JLR200; Richards B, 2002, CYTOMETRY, V48, P106, DOI 10.1002/cyto.10117; ROBISHAW JD, 1982, J BIOL CHEM, V257, P967; ROBISHAW JD, 1984, AM J PHYSIOL, V246, pH532, DOI 10.1152/ajpheart.1984.246.4.H532; Rock CO, 2002, GENE, V291, P35, DOI 10.1016/S0378-1119(02)00564-4; Rock CO, 2000, J BIOL CHEM, V275, P1377, DOI 10.1074/jbc.275.2.1377; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SONG WJ, 1992, J BACTERIOL, V174, P6411, DOI 10.1128/JB.174.20.6411-6417.1992; Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01; Uji T, 2010, MAR BIOTECHNOL, V12, P150, DOI 10.1007/s10126-009-9210-5; Van Hooser AA, 2005, CHROMOSOMA, V114, P377, DOI 10.1007/s00412-005-0021-9; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yun M, 2000, J BIOL CHEM, V275, P28093; Zhang YM, 2006, J BIOL CHEM, V281, P107, DOI 10.1074/jbc.M508825200; Zhang YM, 2005, J BIOL CHEM, V280, P32594, DOI 10.1074/jbc.M506275200; Zhang YM, 2007, CHEM BIOL, V14, P291, DOI 10.1016/j.chembiol.2007.01.013; Zhou B, 2001, NAT GENET, V28, P345, DOI 10.1038/ng572	45	47	48	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49509	10.1371/journal.pone.0049509	http://dx.doi.org/10.1371/journal.pone.0049509			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152917	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600045
J	Low, KH; Chen, WF; Yildirim, E; Edery, I				Low, Kwang Huei; Chen, Wen-Feng; Yildirim, Evrim; Edery, Isaac			Natural Variation in the Drosophila melanogaster Clock Gene Period Modulates Splicing of Its 3 '-Terminal Intron and Mid-Day Siesta	PLOS ONE			English	Article							CIRCADIAN CLOCK; PHOSPHOLIPASE-C; DARK CYCLES; BEHAVIOR; LIGHT; TEMPERATURE; MUTANTS; PROTEIN; RHYTHMS	Drosophila melanogaster exhibits circadian (congruent to 24 hr) regulated morning and evening bouts of activity that are separated by a mid-day siesta. Increases in daily ambient temperature are accompanied by a progressively longer mid-day siesta and delayed evening activity. Presumably, this behavioral plasticity reflects an adaptive response that endows D. melanogaster with the ability to temporally optimize daily activity levels over a wide range of physiologically relevant temperatures. For example, the shift in activity towards the cooler nighttime hours on hot days might minimize the risks associated with exposure to mid-day heat, whereas on cold days activity is favored during the warmer daytime hours. These temperature-induced shifts in the distribution of daily activity are partly based on the thermal sensitive splicing of an intron found in the 3' untranslated region (UTR) of the circadian clock gene termed period (per). As temperature decreases, splicing of this 3'-terminal intron (termed dmpi8) is gradually increased, which is causally linked to a shorter mid-day siesta. Herein we identify several natural polymorphisms in the per 3' UTR from wild-caught populations of flies originating along the east coast of the United States. Two non-intronic closely spaced single nucleotide polymorphisms (SNPs) modulate dmpi8 splicing efficiency, with the least efficiently spliced version associated with a longer mid-day siesta, especially at lower temperatures. Although these SNPs modulate the splicing efficiency of dmpi8 they have little to no effect on its thermal responsiveness, consistent with the notion that the suboptimal 5' and 3' splice sites of the dmpi8 intron are the primary cis-acting elements mediating temperature regulation. Our results demonstrate that natural variations in the per gene can modulate the splicing efficiency of the dmpi8 intron and the daily distribution of activity, providing natural examples for the involvement of dmpi8 splicing in the thermal adaptation of behavioral programs in D. melanogaster.	[Edery, Isaac] Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Edery, I (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Dept Mol Biol & Biochem, Piscataway, NJ 08854 USA.	edery@cabm.rutgers.edu			NIH [R01 NS042088]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042088] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by NIH grant R01 NS042088 (I.E.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chiu Joanna C, 2010, J Vis Exp, DOI 10.3791/2157; CITRI Y, 1987, NATURE, V326, P42, DOI 10.1038/326042a0; Collins BH, 2004, P NATL ACAD SCI USA, V101, P1945, DOI 10.1073/pnas.0308240100; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; HAMBLENCOYLE MJ, 1992, J INSECT BEHAV, V5, P417, DOI 10.1007/BF01058189; Kim EY, 2007, MOL CELL BIOL, V27, P5014, DOI 10.1128/MCB.02339-06; Lee CG, 1998, NEURON, V21, P857, DOI 10.1016/S0896-6273(00)80601-7; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Majercak J, 2004, MOL CELL BIOL, V24, P3359, DOI 10.1128/MCB.24.8.3359-3372.2004; Padgett RA, 2012, TRENDS GENET, V28, P147, DOI 10.1016/j.tig.2012.01.001; PETERSEN G, 1988, EMBO J, V7, P3939, DOI 10.1002/j.1460-2075.1988.tb03280.x; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Sawyer LA, 1997, SCIENCE, V278, P2117, DOI 10.1126/science.278.5346.2117; Tomioka K, 1998, J INSECT PHYSIOL, V44, P587, DOI 10.1016/S0022-1910(98)00046-8; Vanin S, 2012, NATURE, V484, P371, DOI 10.1038/nature10991; Verrelli BC, 2001, GENETICS, V157, P1649; WHEELER DA, 1993, J BIOL RHYTHM, V8, P67, DOI 10.1177/074873049300800106; WHEELER DA, 1991, SCIENCE, V251, P1082, DOI 10.1126/science.1900131	19	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49536	10.1371/journal.pone.0049536	http://dx.doi.org/10.1371/journal.pone.0049536			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152918	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234600046
J	Mikell, I; Stamatatos, L				Mikell, Iliyana; Stamatatos, Leonidas			Evolution of Cross-Neutralizing Antibody Specificities to the CD4-BS and the Carbohydrate Cloak of the HIV Env in an HIV-1-Infected Subject	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; BINDING-SITE; CONFORMATIONAL EPITOPE; BROAD NEUTRALIZATION; STRUCTURAL BASIS; ENVELOPE; POTENT; GLYCOSYLATION; RESPONSES; MACAQUES	Broadly neutralizing antibodies are considered an important part of a successful HIV vaccine. A better understanding of the factors underlying their development during infection and of the epitopes they target is needed to elicit similar antibody responses by vaccination. We and others reported that, on average, it takes 2 to 3 years for cross-reactive neutralizing antibodies to become detectable in the sera of HIV-1-infected subjects and that they target a limited number of epitopes on the HIV Envelope. Here we investigated the emergence and evolution of the earliest cross-reactive neutralizing antibody specificities in one HIV-1-infected individual, AC053. We defined two distinct epitopes on Env that are targeted by the broadly neutralizing antibody responses developed by AC053. The first specificity became evident at 3 years post infection and targeted the CD4-binding site of Env. Antibodies responsible for that specificity neutralized most, but not all, viruses susceptible to neutralization by the plasma antibodies of AC053. The second specificity became apparent approximately a year later. It was due to PG9-like antibodies, which were able to neutralize those viruses not susceptible to the anti-CD4-BS antibodies in AC053. These findings improve our understanding of the co-development of broadly neutralizing antibodies that target more than one epitope during natural HIV-1-infection in selected HIV+ subjects. They support the hypothesis that developing broadly neutralizing antibody responses targeting distinct epitopes by immunization could be feasible.	[Mikell, Iliyana; Stamatatos, Leonidas] Seattle BioMed, Seattle, WA USA; [Mikell, Iliyana; Stamatatos, Leonidas] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Stamatatos, L (corresponding author), Seattle BioMed, Seattle, WA USA.	leo.stamatatos@seattlebiomed.org			National Institutes of Health (NIH) [R01AI081625, P30 AI027757]; University of Washington Center for AIDS Research (CFAR); J.B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757, R01AI081625] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington Center for AIDS Research (CFAR); J.B. Pendleton Charitable Trust; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by National Institutes of Health (NIH) grant R01AI081625. Partial support was also received by the University of Washington Center for AIDS Research (CFAR), an NIH funded program (P30 AI027757), and the J.B. Pendleton Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasa-Chapman MMI, 2004, AIDS, V18, P371, DOI 10.1097/00002030-200402200-00002; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bonsignori M, 2012, J VIROL, V86, P4688, DOI 10.1128/JVI.07163-11; Bonsignori M, 2011, J VIROL, V85, P9998, DOI 10.1128/JVI.05045-11; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Ching L, 2010, J VIROL, V84, P9932, DOI 10.1128/JVI.00868-10; Derby NR, 2006, J VIROL, V80, P8745, DOI 10.1128/JVI.00956-06; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Doores KJ, 2010, J VIROL, V84, P10510, DOI 10.1128/JVI.00552-10; Doores KJ, 2010, P NATL ACAD SCI USA, V107, P13800, DOI 10.1073/pnas.1006498107; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Euler Z, 2012, J VIROL, V86, P2045, DOI 10.1128/JVI.06091-11; Euler Z, 2010, J INFECT DIS, V201, P1045, DOI 10.1086/651144; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Gray ES, 2007, J VIROL, V81, P6187, DOI 10.1128/JVI.00239-07; Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Huang KHG, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1100; Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423; Lavine CL, 2012, J VIROL, V86, P2153, DOI 10.1128/JVI.06201-11; Li B, 2006, J VIROL, V80, P5211, DOI 10.1128/JVI.00201-06; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Long EM, 2002, AIDS RES HUM RETROV, V18, P567, DOI 10.1089/088922202753747914; Ly A, 2000, J VIROL, V74, P6769, DOI 10.1128/JVI.74.15.6769-6776.2000; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; McCaffrey RA, 2004, J VIROL, V78, P3279, DOI 10.1128/JVI.78.7.3279-3295.2004; McElrath MJ, 2010, IMMUNITY, V33, P542, DOI 10.1016/j.immuni.2010.09.011; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Mikell I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001251; Moore PL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000598; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Pejchal R, 2011, SCIENCE, V334, P1097, DOI 10.1126/science.1213256; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Robinson J, 2010, J VIROL; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; Scanlan CN, 2002, J VIROL, V76, P7306, DOI 10.1128/JVI.76.14.7306-7321.2002; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 1998, J VIROL, V72, P7840, DOI 10.1128/JVI.72.10.7840-7845.1998; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; van Gils MJ, 2009, AIDS, V23, P2405, DOI 10.1097/QAD.0b013e32833243e7; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; West AP, 2012, P NATL ACAD SCI US; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2011, J VIROL, V85, P4578, DOI 10.1128/JVI.02585-10; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	64	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49610	10.1371/journal.pone.0049610	http://dx.doi.org/10.1371/journal.pone.0049610			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152926	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600049
J	Rosengauer, E; Hartwich, H; Hartmann, AM; Rudnicki, A; Satheesh, SV; Avraham, KB; Nothwang, HG				Rosengauer, Elena; Hartwich, Heiner; Hartmann, Anna Maria; Rudnicki, Anya; Satheesh, Somisetty Venkata; Avraham, Karen B.; Nothwang, Hans Gerd			Egr2::Cre Mediated Conditional Ablation of Dicer Disrupts Histogenesis of Mammalian Central Auditory Nuclei	PLOS ONE			English	Article							SUPERIOR OLIVARY COMPLEX; BRAIN-STEM; INNER-EAR; DEVELOPMENTAL-CHANGES; COCHLEAR NUCLEUS; NONCODING RNAS; GRANULE CELLS; NEURAL CREST; ENZYME DICER; EXPRESSION	Histogenesis of the auditory system requires extensive molecular orchestration. Recently, Dicer1, an essential gene for generation of microRNAs, and miR-96 were shown to be important for development of the peripheral auditory system. Here, we investigated their role for the formation of the auditory brainstem. Egr2::Cre-mediated early embryonic ablation of Dicer1 caused severe disruption of auditory brainstem structures. In adult animals, the volume of the cochlear nucleus complex (CNC) was reduced by 73.5%. This decrease is in part attributed to the lack of the microneuronal shell. In contrast, fusiform cells, which similar to the granular cells of the microneural shell are derived from Egr2 positive cells, were still present. The volume reduction of the CNC was already present at birth (67.2% decrease). The superior olivary complex was also drastically affected in these mice. Nissl staining as well as Vglut1 and Calbindin 1 immunolabeling revealed that principal SOC nuclei such as the medial nucleus of the trapezoid body and the lateral superior olive were absent. Only choline acetyltransferase positive neurons of the olivocochlear bundle were observed as a densely packed cell group in the ventrolateral area of the SOC. Mid-embryonic ablation of Dicer1 in the ventral cochlear nucleus by Atoh7::Cre-mediated recombination resulted in normal formation of the cochlear nucleus complex, indicating an early embryonic requirement of Dicer1. Quantitative RT-PCR analysis of miR-96 demonstrated low expression in the embryonic brainstem and up-regulation thereafter, suggesting that other microRNAs are required for proper histogenesis of the auditory brainstem. Together our data identify a critical role of Dicer activity during embryonic development of the auditory brainstem.	[Rosengauer, Elena; Hartwich, Heiner; Hartmann, Anna Maria; Satheesh, Somisetty Venkata; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, D-2900 Oldenburg, Germany; [Rudnicki, Anya; Avraham, Karen B.] Tel Aviv Univ, Sackler Fac Med, Dept Human Mol Genet & Biochem, IL-69978 Tel Aviv, Israel; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Ctr Neurosci, D-2900 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Tel Aviv University; Sackler Faculty of Medicine; Carl von Ossietzky Universitat Oldenburg	Nothwang, HG (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Neurogenet, D-2900 Oldenburg, Germany.	hans.g.nothwang@uni-oldenburg.de		Nothwang, Hans Gerd/0000-0001-7695-6437; Avraham, Karen B/0000-0002-4913-251X	DFG [428/5-1]; Israel Science Foundation [1320/11]; PhD program Hearing of the State of Lower Saxony	DFG(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation); PhD program Hearing of the State of Lower Saxony	This work was supported by the DFG grant NO 428/5-1 and the Israel Science Foundation (grant no. 1320/11). H.H. was supported by a stipend from the PhD program Hearing of the State of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andl T, 2006, CURR BIOL, V16, P1041, DOI 10.1016/j.cub.2006.04.005; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berdnik D, 2008, CURR BIOL, V18, P1754, DOI 10.1016/j.cub.2008.09.045; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Blaesse P, 2005, CELL TISSUE RES, V320, P33, DOI 10.1007/s00441-004-1054-8; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cayirlioglu P, 2008, SCIENCE, V319, P1256, DOI 10.1126/science.1149483; Champagnat J, 2009, PHILOS T R SOC B, V364, P2469, DOI 10.1098/rstb.2009.0090; Champagnat J, 2011, RESP PHYSIOL NEUROBI, V178, P146, DOI 10.1016/j.resp.2011.04.013; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Farago AF, 2006, NEURON, V50, P205, DOI 10.1016/j.neuron.2006.03.014; Fineberg SK, 2009, NEURON, V64, P303, DOI 10.1016/j.neuron.2009.10.020; FRIAUF E, 1993, J COMP NEUROL, V334, P59, DOI 10.1002/cne.903340105; Friauf E, 2004, SPR HDB AUD, V23, P49; Friedland DR, 2006, NEUROSCIENCE, V142, P753, DOI 10.1016/j.neuroscience.2006.06.060; Friedman LM, 2009, P NATL ACAD SCI USA, V106, P7915, DOI 10.1073/pnas.0812446106; Georgi SA, 2010, J NEUROSCI, V30, P4048, DOI 10.1523/JNEUROSCI.4982-09.2010; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Grothe B, 2010, PHYSIOL REV, V90, P983, DOI 10.1152/physrev.00026.2009; Guinan J.J., 1996, COCHLEA EDITED, P435; HAMILTON DL, 1984, J MOL BIOL, V178, P481, DOI 10.1016/0022-2836(84)90154-2; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Harris JA, 2008, J NEUROSCI, V28, P10990, DOI 10.1523/JNEUROSCI.2697-08.2008; Hashimi ST, 2009, BLOOD, V114, P404, DOI 10.1182/blood-2008-09-179150; Helfert RH, 1991, NEUROBIOLOGY HEARING, P1; Herzog E, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-22-j0001.2001; Hoffpauir BK, 2010, J PHYSIOL-LONDON, V588, P4365, DOI 10.1113/jphysiol.2010.198564; Huang TW, 2010, J MOL CELL BIOL, V2, P152, DOI 10.1093/jmcb/mjq008; Irvine DRF, 1986, PROGR SENSORY PHYSL; Johnston J, 2010, J PHYSIOL-LONDON, V588, P3187, DOI 10.1113/jphysiol.2010.191973; Johnston RJ, 2005, P NATL ACAD SCI USA, V102, P12449, DOI 10.1073/pnas.0505530102; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kapsimali M, 2011, DEVELOPMENT, V138, P3473, DOI 10.1242/dev.058669; Karis A, 2001, J COMP NEUROL, V429, P615, DOI 10.1002/1096-9861(20010122)429:4<615::AID-CNE8>3.0.CO;2-F; Kersigo J, 2011, GENESIS, V49, P326, DOI 10.1002/dvg.20714; Koehl A, 2004, EUR J NEUROSCI, V20, P3244, DOI 10.1111/j.1460-9568.2004.03791.x; Kuhn S, 2011, P NATL ACAD SCI USA, V108, P2355, DOI 10.1073/pnas.1016646108; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Lewis MA, 2009, NAT GENET, V41, P614, DOI 10.1038/ng.369; Li XK, 2010, NAT REV NEUROSCI, V11, P329, DOI 10.1038/nrn2739; Liu QP, 2009, FUNCT INTEGR GENOMIC, V9, P277, DOI 10.1007/s10142-009-0111-5; MACK A, 1992, NUCLEIC ACIDS RES, V20, P4451, DOI 10.1093/nar/20.17.4451; Maiorano NA, 2012, INT J MOL SCI, V13, P558, DOI 10.3390/ijms13010558; Malmierca MS, 2004, RAT NERVOUS SYSTEM, P997, DOI DOI 10.1016/B978-0-12-547638-6.X5000-7; Maricich SM, 2009, J NEUROSCI, V29, P11123, DOI 10.1523/JNEUROSCI.2232-09.2009; MARTIN MR, 1981, J COMP NEUROL, V197, P169, DOI 10.1002/cne.901970113; Mencia A, 2009, NAT GENET, V41, P609, DOI 10.1038/ng.355; Millimaki BB, 2007, DEVELOPMENT, V134, P295, DOI 10.1242/dev.02734; MUGNAINI E, 1980, J NEUROCYTOL, V9, P537, DOI 10.1007/BF01204841; MUGNAINI E, 1980, J COMP NEUROL, V191, P581, DOI 10.1002/cne.901910406; Nakamura T, 2008, J PHYSIOL-LONDON, V586, P2253, DOI 10.1113/jphysiol.2007.142521; Nakayashiki H, 2006, J MOL EVOL, V63, P127, DOI 10.1007/s00239-005-0257-2; Nothwang HG, 2003, MOL BRAIN RES, V116, P59, DOI 10.1016/S0169-328X(03)00234-1; Oertel D, 1991, Curr Opin Neurobiol, V1, P221, DOI 10.1016/0959-4388(91)90082-I; Oertel D, 1997, NEURON, V19, P959, DOI 10.1016/S0896-6273(00)80388-8; Pierce E T, 1973, Prog Brain Res, V40, P53; Pinter R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010021; Ryugo DK, 2003, EXP BRAIN RES, V153, P477, DOI 10.1007/s00221-003-1605-3; Satheesh SV, 2012, HUM MOL GENET, V21, P3896, DOI 10.1093/hmg/dds217; Saul SM, 2008, MOL CELL NEUROSCI, V37, P153, DOI 10.1016/j.mcn.2007.09.006; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schratt G, 2009, NAT REV NEUROSCI, V10, P842, DOI 10.1038/nrn2763; Shi YH, 2010, J NEUROSCI, V30, P14931, DOI 10.1523/JNEUROSCI.4280-10.2010; Simmons DD, 2002, J NEUROBIOL, V53, P228, DOI 10.1002/neu.10130; Simmons D, 2011, SPRINGER HANDB AUDIT, V38, P187, DOI 10.1007/978-1-4419-7070-1_7; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Soukup GA, 2009, DEV BIOL, V328, P328, DOI 10.1016/j.ydbio.2009.01.037; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; TRUNE DR, 1982, J COMP NEUROL, V209, P409, DOI 10.1002/cne.902090410; Tumpel S, 2009, CURR TOP DEV BIOL, V88, P103, DOI 10.1016/S0070-2153(09)88004-6; Voiculescu O, 2000, GENESIS, V26, P123, DOI 10.1002/(SICI)1526-968X(200002)26:2<123::AID-GENE7>3.0.CO;2-O; Voiculescu O, 2001, DEVELOPMENT, V128, P4967; Wang VY, 2005, NEURON, V48, P31, DOI 10.1016/j.neuron.2005.08.024; Weston MD, 2011, DEV DYNAM, V240, P808, DOI 10.1002/dvdy.22591; WHITE JS, 1983, J COMP NEUROL, V219, P203, DOI 10.1002/cne.902190206; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Yang ZY, 2003, DEV BIOL, V264, P240, DOI 10.1016/j.ydbio.2003.08.005; Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039; Zhan S, 2011, CELL, V147, P1171, DOI 10.1016/j.cell.2011.09.052; Zhao J, 2010, J NEUROSCI, V30, P10860, DOI 10.1523/JNEUROSCI.1980-10.2010; Zhou JX, 2007, J COMP NEUROL, V500, P777, DOI 10.1002/cne.21208	89	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49503	10.1371/journal.pone.0049503	http://dx.doi.org/10.1371/journal.pone.0049503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152916	Green Published, gold			2022-12-27	WOS:000311234000069
J	Chuzeville, S; Puymege, A; Madec, JY; Haenni, M; Payot, S				Chuzeville, Sarah; Puymege, Aurore; Madec, Jean-Yves; Haenni, Marisa; Payot, Sophie			Characterization of a New CAMP Factor Carried by an Integrative and Conjugative Element in Streptococcus agalactiae and Spreading in Streptococci	PLOS ONE			English	Article							GROUP-B STREPTOCOCCUS; HORIZONTAL GENE-TRANSFER; PRESUMPTIVE IDENTIFICATION; PROPIONIBACTERIUM-ACNES; ESCHERICHIA-COLI; GENOME; EXPRESSION; VIRULENCE; EVOLUTION; TRANSFORMATION	Genetic exchanges between Streptococci occur frequently and contribute to their genome diversification. Most of sequenced streptococcal genomes carry multiple mobile genetic elements including Integrative and Conjugative Elements (ICEs) that play a major role in these horizontal gene transfers. In addition to genes involved in their mobility and regulation, ICEs also carry genes that can confer selective advantages to bacteria. Numerous elements have been described in S. agalactiae especially those integrated at the 3' end of a tRNA(Lys) encoding gene. In strain 515 of S. agalactiae, an invasive neonate human pathogen, the ICE (called 515_tRNA(Lys)) is functional and carries different putative virulence genes including one encoding a putative new CAMP factor in addition to the one previously described. This work demonstrated the functionality of this CAMP factor (CAMP factor II) in Lactococcus lactis but also in pathogenic strains of veterinary origin. The search for co-hemolytic factors in a collection of field strains revealed their presence in S. uberis, S. dysgalactiae, but also for the first time in S. equisimilis and S. bovis. Sequencing of these genes revealed the prevalence of a species-specific factor in S. uberis strains (Uberis factor) and the presence of a CAMP factor II encoding gene in S. bovis and S. equisimilis. Furthermore, most of the CAMP factor II positive strains also carried an element integrated in the tRNA(Lys) gene. This work thus describes a CAMP factor that is carried by a mobile genetic element and has spread to different streptococcal species. Citation: Chuzeville S, Puymege A, Madec J-Y, Haenni M, Payot S (2012) Characterization of a New CAMP Factor Carried by an Integrative and Conjugative Element in Streptococcus agalactiae and Spreading in Streptococci. PLoS ONE 7(11): e48918. doi:10.1371/journal.pone.0048918	[Chuzeville, Sarah; Puymege, Aurore; Payot, Sophie] INRA, Genet & Microbiol UMR1128, Fac Sci & Technol, Vandoeuvre Les Nancy, France; [Chuzeville, Sarah; Madec, Jean-Yves; Haenni, Marisa] Anses Lyon, Unite Antibioresistance & Virulence Bacteriennes, Lyon, France; [Chuzeville, Sarah; Puymege, Aurore; Payot, Sophie] Univ Lorraine, Fac Sci & Technol, Genet & Microbiol UMR1128, Vandoeuvre Les Nancy, France	INRAE; Universite de Lorraine; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Universite de Lorraine	Payot, S (corresponding author), INRA, Genet & Microbiol UMR1128, Fac Sci & Technol, Bd Aiguillettes,BP70239, Vandoeuvre Les Nancy, France.	sophie.payot@nancy.inra.fr	Haenni, Marisa/AAF-5545-2020; Payot, Sophie/J-6215-2019	Payot, Sophie/0000-0001-7266-3071	Institut National de la Recherche Agronomique (INRA); Agence Nationale de la Securite Sanitaire de l'alimentation, de l'Environnement et du travail (ANSES)	Institut National de la Recherche Agronomique (INRA); Agence Nationale de la Securite Sanitaire de l'alimentation, de l'Environnement et du travail (ANSES)(French National Research Agency (ANR))	SC was supported by the Institut National de la Recherche Agronomique (INRA, www.inra.fr) and by the Agence Nationale de la Securite Sanitaire de l'alimentation, de l'Environnement et du travail (ANSES, www.anses.fr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bellanger X, 2009, J BACTERIOL, V191, P2764, DOI 10.1128/JB.01412-08; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; Beres SB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000800; Brochet M, 2008, J BACTERIOL, V190, P6913, DOI 10.1128/JB.00824-08; Buckley ND, 1999, APPL ENVIRON MICROB, V65, P3800; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Burrus V, 2002, MOL MICROBIOL, V46, P601, DOI 10.1046/j.1365-2958.2002.03191.x; Carraro N, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-238; Christie R. N. E. Atkins, 1944, AUSTRALIAN JOUR EXP BIOL AND MED SCI, V22, P197; Collins MD, 2000, INT J SYST EVOL MICR, V50, P1173, DOI 10.1099/00207713-50-3-1173; Cordoba-Lopez A, 2002, ENFERM INFEC MICR CL, V20, P478, DOI 10.1016/S0213-005X(02)72848-6; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Davies MR, 2009, J BACTERIOL, V191, P2257, DOI 10.1128/JB.01624-08; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Doolittle WF, 1999, TRENDS CELL BIOL, V9, pM5, DOI 10.1016/S0962-8924(99)01664-5; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Framson PE, 1997, APPL ENVIRON MICROB, V63, P3539, DOI 10.1128/AEM.63.9.3539-3547.1997; FUCHS PC, 1978, J CLIN MICROBIOL, V7, P232; Gase K, 1999, INFECT IMMUN, V67, P4725, DOI 10.1128/IAI.67.9.4725-4731.1999; Glaser P, 2002, MOL MICROBIOL, V45, P1499, DOI 10.1046/j.1365-2958.2002.03126.x; GUBASH SM, 1978, J CLIN MICROBIOL, V8, P480; Gurturk K, 1990, FEMS Microbiol Immunol, V2, P97; Haenni M, 2010, APPL ENVIRON MICROB, V76, P7957, DOI 10.1128/AEM.00805-10; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hassan AA, 2000, CAN J MICROBIOL, V46, P946, DOI 10.1139/cjm-46-10-946; Hensler ME, 2008, MICROB PATHOGENESIS, V44, P84, DOI 10.1016/j.micpath.2007.08.005; Holden MTG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006072; Jiang M, 1996, MICROB PATHOGENESIS, V20, P297, DOI 10.1006/mpat.1996.0028; JURGENS D, 1987, J EXP MED, V165, P720, DOI 10.1084/jem.165.3.720; Ke DB, 2000, CLIN CHEM, V46, P324; Keefe GP, 1997, CAN VET J, V38, P429; Kurland CG, 2000, EMBO REP, V1, P92, DOI 10.1093/embo-reports/kvd042; LAMMLER C, 1987, BERL MUNCH TIERARZTL, V100, P95; LAMMLER C, 1987, J VET MED B, V34, P395; Lang SH, 2003, J BIOL CHEM, V278, P38167, DOI 10.1074/jbc.M303544200; Lang SH, 2007, MED MICROBIOL IMMUN, V196, P1, DOI 10.1007/s00430-006-0021-2; Lawrence JG, 1998, P NATL ACAD SCI USA, V95, P9413, DOI 10.1073/pnas.95.16.9413; Letort C, 2001, J APPL MICROBIOL, V91, P1023, DOI 10.1046/j.1365-2672.2001.01469.x; LOPES MF, 1995, FEMS IMMUNOL MED MIC, V12, P205, DOI 10.1016/0928-8244(95)00070-8; MAGUIN E, 1992, J BACTERIOL, V174, P5633, DOI 10.1128/JB.174.17.5633-5638.1992; Maisey Heather C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000811; Manning SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008795; Martins ER, 2007, J CLIN MICROBIOL, V45, P3850, DOI 10.1128/JCM.01358-07; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; PHILLIPS EA, 1980, J CLIN MICROBIOL, V12, P135, DOI 10.1128/JCM.12.2.135-137.1980; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; Rajagopal L, 2009, FUTURE MICROBIOL, V4, P201, DOI 10.2217/17460913.4.2.201; RATNER HB, 1986, J CLIN MICROBIOL, V24, P296, DOI 10.1128/JCM.24.2.296-297.1986; Richards VP, 2011, INFECT GENET EVOL, V11, P1263, DOI 10.1016/j.meegid.2011.04.019; Rodi PM, 2006, BIOPHYS CHEM, V122, P114, DOI 10.1016/j.bpc.2006.03.005; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sitkiewicz I, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-65; SKALKA B, 1981, ZBL BAKT-INT J MED M, V249, P190; Soedarmanto I, 1996, J VET MED B, V43, P513, DOI 10.1111/j.1439-0450.1996.tb00349.x; Sorensen M, 2010, J MICROBIOL METH, V83, P211, DOI 10.1016/j.mimet.2010.09.008; Suzuki H, 2011, GENOME BIOL EVOL, V3, P168, DOI 10.1093/gbe/evr006; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thal E, 1969, Berl Munch Tierarztl Wochenschr, V82, P126; TITBALL RW, 1993, MICROBIOL REV, V57, P347, DOI 10.1128/MMBR.57.2.347-366.1993; Valanne S, 2005, MICROBIOL-SGM, V151, P1369, DOI 10.1099/mic.0.27788-0; Ward PN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-54; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382; Yamamoto Y, 2005, MOL MICROBIOL, V56, P525, DOI 10.1111/j.1365-2958.2005.04555.x; Zhang S, 2006, INFECT IMMUN, V74, P4200, DOI 10.1128/IAI.00493-06	64	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48918	10.1371/journal.pone.0048918	http://dx.doi.org/10.1371/journal.pone.0048918			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152820	Green Published, gold, Green Submitted			2022-12-27	WOS:000312272600028
J	Chakraborty, S; Asgeirsson, B; Rao, BJ				Chakraborty, Sandeep; Asgeirsson, Bjarni; Rao, Basuthkar J.			A Measure of the Broad Substrate Specificity of Enzymes Based on 'Duplicate' Catalytic Residues	PLOS ONE			English	Article							PLATELET-ACTIVATING-FACTOR; CRYSTAL-STRUCTURE; BETA-LACTAMASE; COMPUTATIONAL DESIGN; DIRECTED EVOLUTION; STRUCTURAL BASIS; CONFORMATIONAL PLASTICITY; SATURATION MUTAGENESIS; ALKALINE-PHOSPHATASE; MOLECULAR EVOLUTION	The ability of an enzyme to select and act upon a specific class of compounds with unerring precision and efficiency is an essential feature of life. Simultaneously, these enzymes often catalyze the reaction of a range of similar substrates of the same class, and also have promiscuous activities on unrelated substrates. Previously, we have established a methodology to quantify promiscuous activities in a wide range of proteins. In the current work, we quantitatively characterize the active site for the ability to catalyze distinct, yet related, substrates (BRASS). A protein with known structure and active site residues provides the framework for computing 'duplicate' residues, each of which results in slightly modified replicas of the active site scaffold. Such spatial congruence is supplemented by Finite difference Poisson Boltzmann analysis which filters out electrostatically unfavorable configurations. The congruent configurations are used to compute an index (BrassIndex), which reflects the broad substrate profile of the active site. We identify an acetylhydrolase and a methyltransferase as having the lowest and highest BrassIndex, respectively, from a set of non-homologous proteins extracted from the Catalytic Site Atlas. The acetylhydrolase, a regulatory enzyme, is known to be highly specific for platelet-activating factor. In the methyltransferase (PDB: 1QAM), various combinations of glycine (Gly38/40/42), asparagine (Asn101/11) and glutamic acid (Glu59/36) residues having similar spatial and electrostatic profiles with the specified scaffold (Gly38, Asn101 and Glu59) exemplifies the broad substrate profile such an active site may provide. 'Duplicate' residues identified by relaxing the spatial and/or electrostatic constraints can be the target of directed evolution methodologies, like saturation mutagenesis, for modulating the substrate specificity of proteins.	[Chakraborty, Sandeep; Rao, Basuthkar J.] Tata Inst Fundamental Res, Dept Biol Sci, Mumbai 400005, Maharashtra, India; [Asgeirsson, Bjarni] Univ Iceland, Inst Sci, Dept Biochem, IS-107 Reykjavik, Iceland	Tata Institute of Fundamental Research (TIFR); University of Iceland	Chakraborty, S (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Mumbai 400005, Maharashtra, India.	sandeepchak@tifr.res.in	Ásgeirsson, Bjarni/E-3747-2015	Ásgeirsson, Bjarni/0000-0002-4275-2732	Tata Institute of Fundamental Research (Department of Atomic Energy); Department of Science and Technology; Icelandic National Research Council (RANNIS); University of Iceland Research Found	Tata Institute of Fundamental Research (Department of Atomic Energy); Department of Science and Technology(Department of Science & Technology (India)); Icelandic National Research Council (RANNIS); University of Iceland Research Found	This work was funded by the Tata Institute of Fundamental Research (Department of Atomic Energy), and the Department of Science and Technology (JC Bose Award Grant). BA extends gratitude to the Icelandic National Research Council (RANNIS) and the University of Iceland Research Found for supporting the project financially. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028018; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bellizzi JJ, 2000, P NATL ACAD SCI USA, V97, P4573, DOI 10.1073/pnas.080508097; Berger I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026794; Bolon DN, 2001, P NATL ACAD SCI USA, V98, P14274, DOI 10.1073/pnas.251555398; BONE R, 1989, NATURE, V339, P191, DOI 10.1038/339191a0; Calero G, 2003, J BIOL CHEM, V278, P37957, DOI 10.1074/jbc.M301225200; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040408; Chakraborty S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032011; Chakraborty S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028470; CHAO W, 1993, BIOCHEM J, V292, P617, DOI 10.1042/bj2920617; Cirino Patrick C, 2003, Methods Mol Biol, V231, P3; CLIMIE S, 1990, J BIOL CHEM, V265, P18776; Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Das C, 2006, P NATL ACAD SCI USA, V103, P4675, DOI 10.1073/pnas.0510403103; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Doucet N, 2004, J BIOL CHEM, V279, P46295, DOI 10.1074/jbc.M407606200; Drolet AM, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/913802; Faiella M, 2009, NAT CHEM BIOL, V5, P882, DOI 10.1038/nchembio.257; Fragel-Madeira L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016058; Georgiev I, 2008, J COMPUT CHEM, V29, P1527, DOI 10.1002/jcc.20909; Gherardini PF, 2007, J MOL BIOL, V372, P817, DOI 10.1016/j.jmb.2007.06.017; GHUYSEN JM, 1991, ANNU REV MICROBIOL, V45, P37, DOI 10.1146/annurev.mi.45.100191.000345; Helland R, 2009, BBA-PROTEINS PROTEOM, V1794, P297, DOI 10.1016/j.bbapap.2008.09.020; Ho YS, 1999, PROTEIN ENG, V12, P693, DOI 10.1093/protein/12.8.693; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Ibuka AS, 2003, BIOCHEMISTRY-US, V42, P10634, DOI 10.1021/bi0342822; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; JENSEN RA, 1976, ANNU REV MICROBIOL, V30, P409, DOI 10.1146/annurev.mi.30.100176.002205; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Kaup BA, 2007, APPL MICROBIOL BIOT, V73, P1087, DOI 10.1007/s00253-006-0559-3; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kleywegt GJ, 1999, J MOL BIOL, V285, P1887, DOI 10.1006/jmbi.1998.2393; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; Koutsioulis D, 2010, PROTEIN SCI, V19, P75, DOI 10.1002/pro.284; Lim D, 2002, NAT STRUCT BIOL, V9, P870, DOI 10.1038/nsb858; Linder ME, 2003, BIOCHEMISTRY-US, V42, P4311, DOI 10.1021/bi034159a; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Malisi C, 2009, PROTEINS, V77, P74, DOI 10.1002/prot.22418; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Matagne A, 1999, NAT PROD REP, V16, P1, DOI 10.1039/a705983c; McIntyre TM, 2009, J LIPID RES, V50, pS255, DOI 10.1194/jlr.R800024-JLR200; Nath A, 2008, BIOCHEMISTRY-US, V47, P157, DOI 10.1021/bi701448p; Nelson D. L., 2008, LEHNINGERS PRINCIPLE; NUKAGA M, 1995, J BIOL CHEM, V270, P5729, DOI 10.1074/jbc.270.11.5729; Park C, 2003, BIOCHEMISTRY-US, V42, P3509, DOI 10.1021/bi026076k; Park H, 2005, J AM CHEM SOC, V127, P13634, DOI 10.1021/ja053809q; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Porter CT, 2004, NUCLEIC ACIDS RES, V32, pD129, DOI 10.1093/nar/gkh028; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2006, CHEM-EUR J, V12, P6031, DOI 10.1002/chem.200600459; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Samuelson JC, 2002, J MOL BIOL, V319, P673, DOI 10.1016/S0022-2836(02)00343-1; Sauvage E, 2006, ANTIMICROB AGENTS CH, V50, P2516, DOI 10.1128/AAC.01226-05; Schluckebier G, 1999, J MOL BIOL, V289, P277, DOI 10.1006/jmbi.1999.2788; Siegel JB, 2010, SCIENCE, V329, P309, DOI 10.1126/science.1190239; Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; Tsutsumi R, 2008, PFLUG ARCH EUR J PHY, V456, P1199, DOI 10.1007/s00424-008-0465-x; VALLEE BL, 1993, ACCOUNTS CHEM RES, V26, P543, DOI 10.1021/ar00034a005; van Loo B, 2010, P NATL ACAD SCI USA, V107, P2740, DOI 10.1073/pnas.0903951107; Vester B, 1998, J MOL BIOL, V282, P255, DOI 10.1006/jmbi.1998.2024; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P577, DOI 10.1128/AAC.39.3.577; Wu RB, 2009, J PHYS CHEM A, V113, P11595, DOI 10.1021/jp901093g; Zanghellini A, 2006, PROTEIN SCI, V15, P2785, DOI 10.1110/ps.062353106; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258	73	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49313	10.1371/journal.pone.0049313	http://dx.doi.org/10.1371/journal.pone.0049313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166637	gold, Green Submitted, Green Published			2022-12-27	WOS:000311885300027
J	Dakin, SG; Dudhia, J; Werling, NJ; Werling, D; Abayasekara, DRE; Smith, RKW				Dakin, Stephanie Georgina; Dudhia, Jayesh; Werling, Natalie Jayne; Werling, Dirk; Abayasekara, Dilkush Robert Ephrem; Smith, Roger Kenneth Whealands			Inflamm-Aging and Arachadonic Acid Metabolite Differences with Stage of Tendon Disease	PLOS ONE			English	Article							DIGITAL FLEXOR TENDINITIS; HUMAN ACHILLES-TENDON; TIME RT-PCR; PROSTAGLANDIN DEHYDROGENASE; ANTIINFLAMMATORY DRUGS; REPETITIVE MOTION; ARACHIDONIC-ACID; FIBROBLASTS; EXPRESSION; RUPTURE	The contribution of inflammation to the pathogenesis of tendinopathy and high prevalence of re-injury is not well established, although recent evidence suggests involvement of prostaglandins. We investigated the roles of prostaglandins and inflammation-resolving mediators in naturally occurring equine tendon injury with disease stage and age. Levels of prostaglandins E-2 (PGE(2)), F-2 alpha (PGF(2 alpha)), lipoxin A(4) (LXA(4)) and its receptor FPR2/ALX were analysed in extracts of normal, sub-acute and chronic injured tendons. To assess whether potential changes were associated with altered PGE(2) metabolism, microsomal prostaglandin E synthase-1 (mPGES-1), prostaglandin dehydrogenase (PGDH), COX-2 and EP4 receptor expression were investigated. The ability of tendons to resolve inflammation was determined by assessing FPR2/ALX expression in natural injury and IL-1 beta stimulated tendon explants. Alterations in the profile of lipid mediators during subacute injury included low PGE(2) and elevated LXA(4) levels compared to normal and chronic injuries. In contrast, PGF(2 alpha) levels remained unchanged and were three-fold lower than PGE(2). The synthetic capacity of PGE(2) as measured by the ratio of mPGES-1: PGDH was elevated in sub-acute injury, suggesting aberrations in tendon prostaglandin metabolism, whilst COX-2 and EP4 receptor were unchanged. Paradoxically low tendon PGE(2) levels in early injury may be attributed to increased local clearance via PGDH or the class switching of lipid mediators from the prostaglandin to the lipoxin axis. PGE(2) is therefore implicated in the development of tendon inflammation and its ensuing resolution. Whilst there was no relationship between age and tendon LXA(4) levels, there was an age-associated decline in FPR2/ALX receptor expression with concurrent increased PGE(2) levels in injury. Furthermore, uninjured tendon explants from younger (< 10 years) but not older horses (>= 10 years) treated with IL-1 beta responded by increasing FPR2/ALX suggesting aged individuals exhibit a reduced capacity to resolve inflammation via FPR2/ALX, which may present a potential mechanism for development of chronic tendinopathy and re-injury.	[Dakin, Stephanie Georgina; Dudhia, Jayesh; Smith, Roger Kenneth Whealands] Univ London, Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England	University of London; University of London Royal Veterinary College	Dakin, SG (corresponding author), Univ London, Royal Vet Coll, Dept Vet Clin Sci, Hatfield, Herts, England.	sdakin@rvc.ac.uk	Werling, Dirk/F-5555-2013	Werling, Dirk/0000-0001-5411-4044; Dudhia, Jayesh/0000-0002-2503-697X; Dakin, Stephanie Georgina/0000-0003-2470-1031; Werling, Natalie/0000-0001-5813-6128	Biotechnology and Biological Sciences Research Council [BB/F018258/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alfredson H, 2002, CURR DRUG TARGETS, V3, P43, DOI 10.2174/1389450023348028; ALMEKINDERS LC, 1993, MED SCI SPORT EXER, V25, P603; Almekinders LC, 1998, MED SCI SPORT EXER, V30, P1183, DOI 10.1097/00005768-199808000-00001; ALMEKINDERS LC, 1995, AM J SPORT MED, V23, P119, DOI 10.1177/036354659502300120; Almekinders LC, 1999, AM J SPORT MED, V27, P417, DOI 10.1177/03635465990270040301; Attur M, 2008, J IMMUNOL, V181, P5082, DOI 10.4049/jimmunol.181.7.5082; Avella CS, 2009, EQUINE VET J, V41, P449, DOI 10.2746/042516409X391042; Birch HL, 1998, EQUINE VET J, V30, P534, DOI 10.1111/j.2042-3306.1998.tb04530.x; BLACKWELL GJ, 1975, BRIT J PHARMACOL, V55, P233, DOI 10.1111/j.1476-5381.1975.tb07633.x; Cheng Z, 2001, J ENDOCRINOL, V171, P463, DOI 10.1677/joe.0.1710463; Chiang N, 2006, PHARMACOL REV, V58, P463, DOI 10.1124/pr.58.3.4; Crevier-Denoix N, 1997, Equine Vet J Suppl, P23; Dakin SG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032333; Desai A, J LEUKOC BIOL, V87, P1001; Dowling BA, 2000, EQUINE VET J, V32, P369, DOI 10.2746/042516400777591138; Dudhia J, 2007, AGING CELL, V6, P547, DOI 10.1111/j.1474-9726.2007.00307.x; DUNN M, 1987, DRUGS, V33, P56, DOI 10.2165/00003495-198700331-00009; Dyson SJ, 2004, EQUINE VET J, V36, P415, DOI 10.2746/0425164044868422; FINCHAM N, 1983, BIOCHEM J, V212, P129, DOI 10.1042/bj2120129; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6; Graham S, 2009, EXPERT OPIN INV DRUG, V18, P749, DOI [10.1517/13543780902893051 , 10.1517/13543780902893051]; Hahn EL, 2000, J TRAUMA, V49, P1147, DOI 10.1097/00005373-200012000-00033; Jarvinen Tero A H, 2005, Foot Ankle Clin, V10, P255, DOI 10.1016/j.fcl.2005.01.013; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; KANNUS P, 1991, J BONE JOINT SURG AM, V73A, P1507, DOI 10.2106/00004623-199173100-00009; Kasashima Y, 2004, EQUINE VET J, V36, P346, DOI 10.2746/0425164044890580; Ker RF, 2000, J EXP BIOL, V203, P1317; Khan MH, 2005, CLIN J SPORT MED, V15, P27, DOI 10.1097/00042752-200501000-00006; KNUDSEN PJ, 1986, J IMMUNOL, V137, P3189; Kujala UM, 2005, CLIN J SPORT MED, V15, P133, DOI 10.1097/01.jsm.0000165347.55638.23; Langberg H, 1999, J PHYSIOL-LONDON, V515, P919, DOI 10.1111/j.1469-7793.1999.919ab.x; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Maffulli N, 1999, CLIN J SPORT MED, V9, P157, DOI 10.1097/00042752-199907000-00007; Moller A, 1996, ACTA ORTHOP SCAND, V67, P479, DOI 10.3109/17453679608996672; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Plowden J, 2004, AGING CELL, V3, P161, DOI 10.1111/j.1474-9728.2004.00102.x; RIEMERSMA DJ, 1985, RES VET SCI, V39, P263, DOI 10.1016/S0034-5288(18)31711-9; Romijn HJ, 1999, J HISTOCHEM CYTOCHEM, V47, P229, DOI 10.1177/002215549904700211; Ruwanpura SMPM, 2004, J DENT RES, V83, P260, DOI 10.1177/154405910408300315; Sayasith K, 2007, REPRODUCTION, V133, P455, DOI 10.1530/REP-06-0210; Serhan Charles N, 2002, ScientificWorldJournal, V2, P169; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Serhan CN, 2000, AM J RESP CRIT CARE, V161, pS95, DOI 10.1164/ajrccm.161.supplement_1.ltta-19; Stanley RL, 2007, J ANAT, V211, P325, DOI 10.1111/j.1469-7580.2007.00781.x; STEPHENS PR, 1989, AM J VET RES, V50, P1089; STROCCHI R, 1991, FOOT ANKLE, V12, P100, DOI 10.1177/107110079101200207; Stromberg B, 1973, Equine Vet J, V5, P156, DOI 10.1111/j.2042-3306.1973.tb03217.x; Takano T, 1997, J EXP MED, V185, P1693, DOI 10.1084/jem.185.9.1693; Thampatty BP, 2007, GENE, V386, P154, DOI 10.1016/j.gene.2006.08.027; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Wang JHC, 2004, CLIN ORTHOP RELAT R, P243, DOI 10.1097/01.blo.0000126337.65685.e4; Wilson AM, 2001, NATURE, V414, P895, DOI 10.1038/414895a; Yang GG, 2005, GENE, V363, P166, DOI 10.1016/j.gene.2005.08.006; Young NJ, 2006, J VIROL METHODS, V138, P218, DOI 10.1016/j.jviromet.2006.08.008; Young NJ, 2009, MATRIX BIOL, V28, P311, DOI 10.1016/j.matbio.2009.05.002; Zhang JY, 2010, J ORTHOP RES, V28, P198, DOI 10.1002/jor.20962	58	46	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48978	10.1371/journal.pone.0048978	http://dx.doi.org/10.1371/journal.pone.0048978			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155437	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900072
J	Ferro, F; Spelat, R; Beltrami, AP; Cesselli, D; Curcio, F				Ferro, Federico; Spelat, Renza; Beltrami, Antonio Paolo; Cesselli, Daniela; Curcio, Francesco			Isolation and Characterization of Human Dental Pulp Derived Stem Cells by Using Media Containing Low Human Serum Percentage as Clinical Grade Substitutes for Bovine Serum	PLOS ONE			English	Article							CULTURE	Adult stem cells have been proposed as an alternative to embryonic stem cells to study multilineage differentiation in vitro and to use in therapy. Current culture media for isolation and expansion of adult stem cells require the use of large amounts of animal sera, but animal-derived culture reagents give rise to some questions due to the real possibility of infections and severe immune reactions. For these reasons a clinical grade substitute to animal sera is needed. We tested the isolation, proliferation, morphology, stemness related marker expression, and osteoblastic differentiation potential of Dental Pulp Stem Cells (DPSC) in a chemically defined medium containing a low percentage of human serum, 1.25%, in comparison to a medium containing 10% Fetal Bovine Serum (FBS). DPSCs cultured in presence of our isolation/proliferation medium added with low HS percentage were obtained without immune-selection methods and showed high uniformity in the expression of stem cell markers, proliferated at higher rate, and demonstrated comparable osteoblastic potential with respect to DPSCs cultured in 10% FBS. In this study we demonstrated that a chemically defined medium added with low HS percentage, derived from autologous and heterologous sources, could be a valid substitute to FBS-containing media and should be helpful for adult stem cells clinical application.	[Ferro, Federico; Spelat, Renza; Beltrami, Antonio Paolo; Cesselli, Daniela; Curcio, Francesco] Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy	University of Udine	Ferro, F (corresponding author), Univ Udine, Dept Med & Biol Sci, I-33100 Udine, Italy.	ferro.federico@libero.it	Ferro, Federico/GPK-8383-2022; Beltrami, Antonio/C-5291-2008; Curcio, Francesco/K-4669-2014; CESSELLI, DANIELA/C-7052-2008; Spelat, Renza/AAZ-2980-2021	Beltrami, Antonio/0000-0002-0679-2710; Spelat, Renza/0000-0001-5794-8976; Ferro, Federico/0000-0002-6023-8227; CURCIO, Francesco/0000-0002-9070-4807; Cesselli, Daniela/0000-0002-0562-7852				Asher D M, 1999, Dev Biol Stand, V99, P41; CURCIO F, 1994, P NATL ACAD SCI USA, V91, P9004, DOI 10.1073/pnas.91.19.9004; Denker HW, 2006, J MED ETHICS, V32, P665, DOI 10.1136/jme.2005.014738; Eloit M, 1999, Dev Biol Stand, V99, P9; Ferro F, 2010, TISSUE ENG PT A, V16, P3657, DOI 10.1089/ten.TEA.2009.0750; Ferro F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041774; Ferro F, 2011, AM J PATHOL, V178, P2299, DOI 10.1016/j.ajpath.2011.01.055; Gallagher MF, 2009, J OVARIAN RES, V16, P2; Liedtke S, 2008, BIOL CHEM, V389, P845, DOI 10.1515/BC.2008.098; Mohamet L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012921; ROBEY PG, 1985, CALCIFIED TISSUE INT, V37, P453, DOI 10.1007/BF02557826; Shah G, 1999, Dev Biol Stand, V99, P17; Ulloa-Montoya F, 2005, J BIOSCI BIOENG, V100, P12, DOI 10.1263/jbb.100.12; van der Valk J, 2004, TOXICOL IN VITRO, V18, P1, DOI 10.1016/j.tiv.2003.08.009; Wessman S J, 1999, Dev Biol Stand, V99, P3	15	51	54	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48945	10.1371/journal.pone.0048945	http://dx.doi.org/10.1371/journal.pone.0048945			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155430	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900065
J	Flajollet, S; Tian, TV; Huot, L; Tomavo, N; Flourens, A; Holder-Espinasse, M; Le Jeune, M; Dumont, P; Hot, D; Mallein-Gerin, F; Duterque-Coquillaud, M				Flajollet, Sebastien; Tian, Tian V.; Huot, Ludovic; Tomavo, Nathalie; Flourens, Anne; Holder-Espinasse, Muriel; Le Jeune, Marion; Dumont, Patrick; Hot, David; Mallein-Gerin, Frederic; Duterque-Coquillaud, Martine			Increased Adipogenesis in Cultured Embryonic Chondrocytes and in Adult Bone Marrow of Dominant Negative Erg Transgenic Mice	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTION FACTOR ERG; ETS-DOMAIN; CARTILAGE; CELL; DIFFERENTIATION; MECHANISMS; ADIPOCYTES; GROWTH; EXPRESSION	In monolayer culture, primary articular chondrocytes have an intrinsic tendency to lose their phenotype during expansion. The molecular events underlying this chondrocyte dedifferentiation are still largely unknown. Several transcription factors are important for chondrocyte differentiation. The Ets transcription factor family may be involved in skeletal development. One family member, the Erg gene, is mainly expressed during cartilage formation. To further investigate the potential role of Erg in the maintenance of the chondrocyte phenotype, we isolated and cultured chondrocytes from the rib cartilage of embryos of transgenic mice that express a dominant negative form of Erg (DN-Erg) during cartilage formation. DN-Erg expression in chondrocytes cultured for up to 20 days did not affect the early dedifferentiation usually observed in cultured chondrocytes. However, lipid droplets accumulated in DN-Erg chondrocytes, suggesting adipocyte emergence. Transcriptomic analysis using a DNA microarray, validated by quantitative RT-PCR, revealed strong differential gene expression, with a decrease in chondrogenesis-related markers and an increase in adipogenesis-related gene expression in cultured DN-Erg chondrocytes. These results indicate that Erg is involved in either maintaining the chondrogenic phenotype in vitro or in cell fate orientation. Along with the in vitro studies, we compared adipocyte presence in wild-type and transgenic mice skeletons. Histological investigations revealed an increase in the number of adipocytes in the bone marrow of adult DN-Erg mice even though no adipocytes were detected in embryonic cartilage or bone. These findings suggest that the Ets transcription factor family may contribute to the homeostatic balance in skeleton cell plasticity.	[Flajollet, Sebastien; Tian, Tian V.; Tomavo, Nathalie; Flourens, Anne; Holder-Espinasse, Muriel; Le Jeune, Marion; Dumont, Patrick; Duterque-Coquillaud, Martine] Univ Lille Nord France, Inst Pasteur Lille IFR142, Inst Biol Lille, CNRS UMR 8161, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille	Flajollet, S (corresponding author), Univ Lille Nord France, Inst Pasteur Lille IFR142, Inst Biol Lille, CNRS UMR 8161, Lille, France.	martine.duterque@ibl.fr	TIAN, TIAN/O-1726-2015; Hot, David/M-6775-2016	TIAN, TIAN/0000-0002-9906-0980; Hot, David/0000-0002-2361-0616; Duterque-Coquillaud, Martine/0000-0003-3943-5629				Akiyama H, 2008, MOD RHEUMATOL, V18, P213, DOI 10.1007/s10165-008-0048-x; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Appleton CTG, 2007, ARTHRITIS RHEUM-US, V56, P1854, DOI 10.1002/art.22711; Aubin JE, 1998, BIOCHEM CELL BIOL, V76, P899, DOI 10.1139/bcb-76-6-899; Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bi WM, 2001, P NATL ACAD SCI USA, V98, P6698, DOI 10.1073/pnas.111092198; Bordji K, 2000, J BIOL CHEM, V275, P12243, DOI 10.1074/jbc.275.16.12243; Casteilla L, 2007, PPAR RES, V2007, DOI 10.1155/2007/68202; Clabaut A, 2010, DIFFERENTIATION, V80, P40, DOI 10.1016/j.diff.2010.04.004; Corre J, 2004, BRIT J HAEMATOL, V127, P344, DOI 10.1111/j.1365-2141.2004.05198.x; de Crombrugghe B, 2000, MATRIX BIOL, V19, P389, DOI 10.1016/S0945-053X(00)00094-9; DHORDAIN P, 1995, MECH DEVELOP, V50, P17, DOI 10.1016/0925-4773(94)00322-E; Duque G, 2008, CURR OPIN RHEUMATOL, V20, P429, DOI 10.1097/BOR.0b013e3283025e9c; Enomoto H, 2003, J BIOL CHEM, V278, P23971, DOI 10.1074/jbc.M302457200; Fahmi H, 2011, MOD RHEUMATOL, V21, P1, DOI 10.1007/s10165-010-0347-x; Frith J, 2008, TRANSFUS MED HEMOTH, V35, P216, DOI [10.1159/000127448, 000127448]; Ganan Y, 1996, DEVELOPMENT, V122, P2349; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gevers EF, 2002, ENDOCRINOLOGY, V143, P4065, DOI 10.1210/en.2002-220428; Gimble JM, 2006, J CELL BIOCHEM, V98, P251, DOI 10.1002/jcb.20777; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; GRIGORIADIS AE, 1988, J CELL BIOL, V106, P2139, DOI 10.1083/jcb.106.6.2139; HALL BK, 1992, ANAT EMBRYOL, V186, P107; Hanks BC, 2010, AM J VET RES, V71, P1142, DOI 10.2460/ajvr.71.10.1142; Hattori T, 2010, DEVELOPMENT, V137, P901, DOI 10.1242/dev.045203; HEERMEIER K, 1994, DIFFERENTIATION, V56, P45, DOI 10.1046/j.1432-0436.1994.56120045.x; Ishizeki K, 2002, CELL TISSUE RES, V309, P251, DOI 10.1007/s00441-002-0541-z; Iwamoto M, 2000, J CELL BIOL, V150, P27, DOI 10.1083/jcb.150.1.27; Iwamoto M, 2007, DEV BIOL, V305, P40, DOI 10.1016/j.ydbio.2007.01.037; KARIM FD, 1990, GENE DEV, V4, P1451, DOI 10.1101/gad.4.9.1451; Karsenty G, 2008, ANNU REV GENOM HUM G, V9, P183, DOI 10.1146/annurev.genom.9.081307.164437; Kawato Y, 2011, BIOCHEM BIOPH RES CO, V416, P205, DOI 10.1016/j.bbrc.2011.11.026; Komori T, 2002, J CELL BIOCHEM, V87, P1, DOI 10.1002/jcb.10276; Koo KH, 1998, RADIOLOGY, V206, P745, DOI 10.1148/radiology.206.3.9494495; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Liu FC, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3127; Majka SM, 2011, STEM CELLS, V29, P1034, DOI 10.1002/stem.653; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; Maroulakou IG, 2000, ONCOGENE, V19, P6432, DOI 10.1038/sj.onc.1204039; Monemdjou R, 2012, ARTHRITIS RHEUM-US, V64, P1551, DOI 10.1002/art.33490; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nishimura R, 2008, J BONE MINER METAB, V26, P203, DOI 10.1007/s00774-007-0824-2; Nuttall ME, 2000, BONE, V27, P177, DOI 10.1016/S8756-3282(00)00317-3; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; POLIARD A, 1995, J CELL BIOL, V130, P1461, DOI 10.1083/jcb.130.6.1461; Provot S, 2005, BIOCHEM BIOPH RES CO, V328, P658, DOI 10.1016/j.bbrc.2004.11.068; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; Schulze-Tanzil G, 2009, ANN ANAT, V191, P325, DOI 10.1016/j.aanat.2009.05.003; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Shum L, 2002, ARTHRITIS RES, V4, P94, DOI 10.1186/ar396; Soldani G, 2002, J MICROSC-OXFORD, V206, P139, DOI 10.1046/j.1365-2818.2002.01021.x; Song L, 2004, FASEB J, V18, P980, DOI 10.1096/fj.03-1100fje; Song L, 2006, STEM CELLS, V24, P1707, DOI 10.1634/stemcells.2005-0604; Stanton LA, 2010, J CELL MOL MED, V14, P242, DOI 10.1111/j.1582-4934.2008.00396.x; Ueta C, 2001, J CELL BIOL, V153, P87, DOI 10.1083/jcb.153.1.87; Uusitalo H, 2001, OSTEOARTHR CARTILAGE, V9, pS174, DOI 10.1053/joca.2001.0459; Valcourt U, 2003, FEBS LETT, V545, P115, DOI 10.1016/S0014-5793(03)00510-6; Vlaeminck-Guillem V, 2000, MECH DEVELOP, V91, P331, DOI 10.1016/S0925-4773(99)00272-5; Wang L, 2006, PPAR RES, V2006, DOI 10.1155/PPAR/2006/67297; Wei L, 2010, DEV BIOL, V341, P236, DOI 10.1016/j.ydbio.2010.02.033	61	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48656	10.1371/journal.pone.0048656	http://dx.doi.org/10.1371/journal.pone.0048656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155398	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900032
J	Flatt, JW; Fox, TL; Makarova, N; Blackwell, JL; Dmitriev, IP; Kashentseva, EA; Curiel, DT; Stewart, PL				Flatt, Justin W.; Fox, Tara L.; Makarova, Natalia; Blackwell, Jerry L.; Dmitriev, Igor P.; Kashentseva, Elena A.; Curiel, David T.; Stewart, Phoebe L.			CryoEM Visualization of an Adenovirus Capsid-Incorporated HIV Antigen	PLOS ONE			English	Article							ECTODOMAIN REGION; PROTEIN SECONDARY; EPITOPE; ANTIBODY; GP41; REFINEMENT; PREDICTION; POSITION; HEXON	Adenoviral (Ad) vectors show promise as platforms for vaccine applications against infectious diseases including HIV. However, the requirements for eliciting protective neutralizing antibody and cellular immune responses against HIV remain a major challenge. In a novel approach to generate 2F5- and 4E10-like antibodies, we engineered an Ad vector with the HIV membrane proximal ectodomain region (MPER) epitope displayed on the hypervariable region 2 (HVR2) of the viral hexon capsid, instead of expressed as a transgene. The structure and flexibility of MPER epitopes, and the structural context of these epitopes within viral vectors, play important roles in the induced host immune responses. In this regard, understanding the critical factors for epitope presentation would facilitate optimization strategies for developing viral vaccine vectors. Therefore we undertook a cryoEM structural study of this Ad vector, which was previously shown to elicit MPER-specific humoral immune responses. A subnanometer resolution cryoEM structure was analyzed with guided molecular dynamics simulations. Due to the arrangement of hexons within the Ad capsid, there are twelve unique environments for the inserted peptide that lead to a variety of conformations for MPER, including individual a-helices, interacting a-helices, and partially extended forms. This finding is consistent with the known conformational flexibility of MPER. The presence of an extended form, or an induced extended form, is supported by interaction of this vector with the human HIV monoclonal antibody 2F5, which recognizes 14 extended amino acids within MPER. These results demonstrate that the Ad capsid influences epitope structure, flexibility and accessibility, all of which affect the host immune response. In summary, this cryoEM structural study provided a means to visualize an epitope presented on an engineered viral vector and suggested modifications for the next generation of Ad vectors with capsid-incorporated HIV epitopes.	[Flatt, Justin W.; Fox, Tara L.; Stewart, Phoebe L.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Case Western Reserve University	Flatt, JW (corresponding author), Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.	pls47@case.edu		Flatt, Justin/0000-0001-5406-8156; Flatt, Justin/0000-0003-2985-0386; Flatt, Justin/0000-0003-3227-8763	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI076096, R21AI076096] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008320] Funding Source: NIH RePORTER; NIAID NIH HHS [AI076096] Funding Source: Medline; NIGMS NIH HHS [T32 GM008320] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cardoso RMF, 2007, J MOL BIOL, V365, P1533, DOI 10.1016/j.jmb.2006.10.088; CLARKE BE, 1987, NATURE, V330, P381, DOI 10.1038/330381a0; Dai GX, 2001, J BIOL CHEM, V276, P41913, DOI 10.1074/jbc.M106018200; Grigorieff N, 2007, J STRUCT BIOL, V157, P117, DOI 10.1016/j.jsb.2006.05.004; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hicks MJ, 2011, MOL THER, V19, P612, DOI 10.1038/mt.2010.280; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kratz PA, 1999, P NATL ACAD SCI USA, V96, P1915, DOI 10.1073/pnas.96.5.1915; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Liu J, 2009, BIOCHEMISTRY-US, V48, P2915, DOI 10.1021/bi802303b; Manayani DJ, 2007, PLOS PATHOG, V3, P1422, DOI 10.1371/journal.ppat.0030142; Matthews QL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011815; Matthews QL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-98; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mirano-Bascos D, 2008, EUR J IMMUNOL, V38, P1231, DOI 10.1002/eji.200738011; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Ofek G, 2010, P NATL ACAD SCI USA, V107, P17880, DOI 10.1073/pnas.1004728107; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Plummer EM, 2011, WIRES NANOMED NANOBI, V3, P174, DOI 10.1002/wnan.119; PURTSCHER M, 1994, AIDS RES HUM RETROV, V10, P1651, DOI 10.1089/aid.1994.10.1651; Reddy VS, 2010, SCIENCE, V329, P1071, DOI 10.1126/science.1187292; Roberts DM, 2006, NATURE, V441, P239, DOI 10.1038/nature04721; Saban SD, 2006, J VIROL, V80, P12049, DOI 10.1128/JVI.01652-06; SCHODEL F, 1992, J VIROL, V66, P106; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Trabuco LG, 2008, STRUCTURE, V16, P673, DOI 10.1016/j.str.2008.03.005; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wu HJ, 2005, J VIROL, V79, P3382, DOI 10.1128/JVI.79.6.3382-3390.2005	34	3	3	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49607	10.1371/journal.pone.0049607	http://dx.doi.org/10.1371/journal.pone.0049607			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166728	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900173
J	Giovannetti, E; van der Velde, A; Funel, N; Vasile, E; Perrone, V; Leon, LG; De Lio, N; Avan, A; Caponi, S; Pollina, LE; Galla, V; Sudo, H; Falcone, A; Campani, D; Boggi, U; Peters, GJ				Giovannetti, Elisa; van der Velde, Arjan; Funel, Niccola; Vasile, Enrico; Perrone, Vittorio; Leon, Leticia G.; De Lio, Nelide; Avan, Amir; Caponi, Sara; Pollina, Luca E.; Galla, Valentina; Sudo, Hiroko; Falcone, Alfredo; Campani, Daniela; Boggi, Ugo; Peters, Godefridus J.			High-Throughput MicroRNA (miRNAs) Arrays Unravel the Prognostic Role of MiR-211 in Pancreatic Cancer	PLOS ONE			English	Article							LASER MICRODISSECTION; POOR-PROGNOSIS; EXPRESSION; ADENOCARCINOMA; SURVIVAL; THERAPY; CELLS; BIOMARKERS; DIAGNOSIS; MELANOMA	Background: Only a subset of radically resected pancreatic ductal adenocarcinoma (PDAC) patients benefit from chemotherapy, and identification of prognostic factors is warranted. Recently miRNAs emerged as diagnostic biomarkers and innovative therapeutic targets, while high-throughput arrays are opening new opportunities to evaluate whether they can predict clinical outcome. The present study evaluated whether comprehensive miRNA expression profiling correlated with overall survival (OS) in resected PDAC patients. Methodology/Principal Findings: High-resolution miRNA profiles were obtained with the Toray's 3D-Gene (TM)-miRNA-chip, detecting more than 1200 human miRNAs. RNA was successfully isolated from paraffin-embedded primary tumors of 19 out of 26 stage-pT3N1 homogeneously treated patients (adjuvant gemcitabine 1000 mg/m(2)/day, days-1/8/15, every 28days), carefully selected according to their outcome (OS<12 (N = 13) vs. OS>30 months (N = 6), i.e. short/long-OS). Highly stringent statistics included t-test, distance matrix with Spearman-ranked correlation, and iterative approaches. Unsupervised hierarchical analysis revealed that PDACs clustered according to their short/long-OS classification, while the feature selection algorithm RELIEF identified the top 4 discriminating miRNAs between the two groups. These miRNAs target more than 1500 transcripts, including 169 targeted by two or more. MiR-211 emerged as the best discriminating miRNA, with significantly higher expression in long-vs. short-OS patients. The expression of this miRNA was subsequently assessed by quantitative-PCR in an independent cohort of laser-microdissected PDACs from 60 resected patients treated with the same gemcitabine regimen. Patients with low miR-211 expression according to median value had a significantly shorter median OS (14.8, 95% CI = 13.1-16.5, vs. 25.7 months, 95% CI = 16.2-35.1, log-rank- P = 0.004). Multivariate analysis demonstrated that low miR-211 expression was an independent factor of poor prognosis (hazard ratio 2.3, P = 0.03) after adjusting for all the factors influencing outcome. Conclusions/Significance: Through comprehensive microarray analysis and PCR validation we identified miR-211 as a prognostic factor in resected PDAC. These results prompt further prospective studies and research on the biological role of miR-211 in PDAC.	[Giovannetti, Elisa; Avan, Amir; Galla, Valentina; Peters, Godefridus J.] Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Giovannetti, E (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Oncol, Amsterdam, Netherlands.	elisa.giovannetti@gmail.com	Falcone, Alfredo/G-5217-2013; giovannetti, elisa/F-4261-2011; Peters, Godefridus J/C-7562-2013	giovannetti, elisa/0000-0002-7565-7504; Falcone, Alfredo/0000-0001-5840-2529; Funel, Niccola/0000-0002-5028-2363; Peters, Godefridus J/0000-0002-5447-2877; CAMPANI, DANIELA/0000-0001-5987-734X; naseri, shahrokh/0000-0001-8974-2120; van der Velde, Arjan/0000-0003-1086-0859				Abbruzzese JL, 2008, JAMA-J AM MED ASSOC, V299, P1066, DOI 10.1001/jama.299.9.1066; Bhatti I, 2011, J GASTROINTEST SURG, V15, P199, DOI 10.1007/s11605-010-1381-x; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Boggi U, 2009, SURGERY, V146, P869, DOI 10.1016/j.surg.2009.04.029; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; Cai CX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029750; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carpelan-Holmstrom M, 2005, GUT, V54, P385, DOI 10.1136/gut.2004.047191; Chang KW, 2008, J DENT RES, V87, P1063, DOI 10.1177/154405910808701116; Chen MY, 2012, ONCOL REP, V27, P265, DOI 10.3892/or.2011.1475; Dillhoff M, 2008, J GASTROINTEST SURG, V12, P2171, DOI 10.1007/s11605-008-0584-x; Donahue TR, 2012, CLIN CANCER RES, V18, P1352, DOI 10.1158/1078-0432.CCR-11-1539; Duxbury MS, 2004, ONCOGENE, V23, P1539, DOI 10.1038/sj.onc.1207272; Ferretti E, 2008, EMBO J, V27, P2616, DOI 10.1038/emboj.2008.172; Ferrone CR, 2008, J GASTROINTEST SURG, V12, P701, DOI 10.1007/s11605-007-0384-8; Funel N, 2008, LAB INVEST, V88, P773, DOI 10.1038/labinvest.2008.40; Funel N, 2011, EXPERT REV MOL DIAGN, V11, P695, DOI [10.1586/erm.11.62, 10.1586/ERM.11.62]; Giovannetti E, 2006, CANCER RES, V66, P3928, DOI 10.1158/0008-5472.CAN-05-4203; Giovannetti E, 2012, CRIT REV ONCOL HEMAT, V81, P103, DOI 10.1016/j.critrevonc.2011.03.010; Giovannetti E, 2010, CANCER RES, V70, P4528, DOI 10.1158/0008-5472.CAN-09-4467; Goff LA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007192; Gordon AD, 1999, CLASSIFICATION; Hamada S, 2012, MOL CANCER RES, V10, P3, DOI 10.1158/1541-7786.MCR-11-0272; Hao J, 2011, FEBS LETT, V585, P207, DOI 10.1016/j.febslet.2010.11.039; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Hwang JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010630; Jamieson NB, 2012, CLIN CANCER RES, V18, P534, DOI 10.1158/1078-0432.CCR-11-0679; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jiao LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032068; Jimeno A, 2006, MOL CANCER THER, V5, P787, DOI 10.1158/1535-7163.MCT-06-0005; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kefas B, 2009, J NEUROSCI, V29, P15161, DOI 10.1523/JNEUROSCI.4966-09.2009; KIRA K, 1992, AAAI-92 PROCEEDINGS : TENTH NATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, P129; Kononenko I, 1997, APPL INTELL, V7, P39, DOI 10.1023/A:1008280620621; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Lee JH, 2012, CLIN CANCER RES, V18, P524, DOI 10.1158/1078-0432.CCR-11-1903; Levy C, 2010, MOL CELL, V40, P841, DOI 10.1016/j.molcel.2010.11.020; Liang Zhongxing, 2010, Biochem Pharmacol, V79, P817, DOI 10.1016/j.bcp.2009.10.017; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mardin W, 2009, ANN SURG ONCOL, V16, P3183, DOI 10.1245/s10434-009-0623-1; Mazar J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013779; McQuitty LL, 1966, SIMILARITY ANAL RECI, V26, P825; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Moriyama T, 2009, MOL CANCER THER, V8, P1067, DOI 10.1158/1535-7163.MCT-08-0592; Munding JB, 2012, INT J CANCER, V131, pE86, DOI 10.1002/ijc.26466; Murtagh F., 1985, MULTIDIMENSIONAL CLU; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; Ohuchida K, 2011, ANN SURG ONCOL, V18, P2381, DOI 10.1245/s10434-011-1602-x; Park JK, 2009, PANCREAS, V38, pE190, DOI 10.1097/MPA.0b013e3181ba82e1; Piepoli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033663; Saif MW, 2007, J PANCREAS, V8, P545; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Sato F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005540; Schnelldorfer T, 2008, ANN SURG, V247, P456, DOI 10.1097/SLA.0b013e3181613142; Stratford JK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000307; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Wang J, 2011, J BIOSCIENCES, V36, P481, DOI 10.1007/s12038-011-9083-4; Xu Y, 2012, BRIT J CANCER, V106, P553, DOI 10.1038/bjc.2011.568; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0	63	59	62	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49145	10.1371/journal.pone.0049145	http://dx.doi.org/10.1371/journal.pone.0049145			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155457	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900092
J	Ruan, K; Ye, F; Li, CY; Liou, YC; Lin, SC; Lin, SY				Ruan, Ka; Ye, Fan; Li, Chenyu; Liou, Yih-Cherng; Lin, Sheng-Cai; Lin, Shu-Yong			PLK1 Interacts and Phosphorylates Axin That Is Essential for Proper Centrosome Formation	PLOS ONE			English	Article							CHROMOSOMAL INSTABILITY; POLO-LIKE-KINASE-1 PLK1; AMPLIFICATION; CANCER; REDUPLICATION; TUMORIGENESIS; DUPLICATION; ACTIVATION; ANEUPLOIDY; LOCALIZES	Abnormal amplification of centrosomes could lead to improper chromosome segregation and aneuploidy and is implicated in cancer development. Here, we demonstrate that Axin, a scaffolding protein in Wnt signaling, is phosphorylated by PLK1 during mitosis. Phosphorylation of Axin Ser-157 by PLK1 abolished Axin association with gamma-tubulin, while substitution of Ser-157 with alanine exhibited sustained interaction with gamma-tubulin. In addition, overexpression of Axin-S157A significantly increased the number of cells with multi-centrosomes. These results suggest that the phosphorylation status of Axin, mediated by PLK1, dynamically regulates its association with gamma-tubulin and centrosome formation and segregation.	[Ruan, Ka; Lin, Sheng-Cai; Lin, Shu-Yong] Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen, Fujian, Peoples R China	Xiamen University	Ruan, K (corresponding author), Xiamen Univ, State Key Lab Cellular Stress Biol, Sch Life Sci, Xiamen, Fujian, Peoples R China.	linsy@xmu.edu.cn	Ye, Fan/K-1620-2015; Lin, Shu-Yong/B-7726-2012; Lin, SC/G-4666-2010	Ye, Fan/0000-0002-5777-001X; Lin, Shu-Yong/0000-0002-4419-1713; 				Alexandrova EM, 2010, DEV DYNAM, V239, P261, DOI 10.1002/dvdy.22125; Alvarado-Kristensson M, 2009, NAT CELL BIOL, V11, P1081, DOI 10.1038/ncb1921; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Doxsey S, 2002, MOL CELL, V10, P439, DOI 10.1016/S1097-2765(02)00654-8; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Fumoto K, 2009, EMBO REP, V10, P606, DOI 10.1038/embor.2009.45; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Goto H, 2006, NAT CELL BIOL, V8, P180, DOI 10.1038/ncb1350; Hadjihannas MV, 2006, P NATL ACAD SCI USA, V103, P10747, DOI 10.1073/pnas.0604206103; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Kikuchi K, 2010, EMBO J, V29, P3470, DOI 10.1038/emboj.2010.221; Kim SM, 2009, EXP CELL RES, V315, P943, DOI 10.1016/j.yexcr.2009.01.013; Kim SM, 2005, EXP CELL RES, V308, P18, DOI 10.1016/j.yexcr.2005.04.002; Li QX, 2009, NAT CELL BIOL, V11, P1128, DOI 10.1038/ncb1927; Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999; Liu XQ, 2002, P NATL ACAD SCI USA, V99, P8672, DOI 10.1073/pnas.132269599; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; Swami M, 2010, NAT REV CANCER, V10, P737, DOI 10.1038/nrc2952; Takahashi T, 2003, CANCER SCI, V94, P148, DOI 10.1111/j.1349-7006.2003.tb01411.x; Toyoshima-Morimoto F, 2002, EMBO REP, V3, P341, DOI 10.1093/embo-reports/kvf069; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Zhang Y, 1999, J BIOL CHEM, V274, P35247, DOI 10.1074/jbc.274.49.35247	27	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49184	10.1371/journal.pone.0049184	http://dx.doi.org/10.1371/journal.pone.0049184			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155463	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900098
J	Salathe, R; Tognazzo, M; Schmid-Hempel, R; Schmid-Hempel, P				Salathe, Rahel; Tognazzo, Martina; Schmid-Hempel, Regula; Schmid-Hempel, Paul			Probing Mixed-Genotype Infections I: Extraction and Cloning of Infections from Hosts of the Trypanosomatid Crithidia bombi	PLOS ONE			English	Article							DIVISION-OF-LABOR; MULTIPLE INFECTIONS; PLASMODIUM-CHABAUDI; PARASITE; TRANSMISSION; COMPETITION; TERRESTRIS; EXPRESSION; VIRULENCE; PATHOGEN	We here present an efficient, precise and reliable method to isolate and cultivate healthy and viable single Crithidia bombi cells from bumblebee faeces using flow cytometry. We report a precision of>99% in obtaining single trypanosomatid cells for further culture and analysis ("cloning''). In the study, we have investigated the use of different liquid media to cultivate C. bombi and present an optimal medium for obtaining viable clones from all tested, infected host donors. We show that this method can be applied to genotype a collection of clones from natural infections. Furthermore, we show how to cryo-preserve C. bombi cells to be revived to become infective clones after at least 4 years of storage. Considering the high prevalence of infections in natural populations, our method provides a powerful tool in studying the level and diversity of these infections, and thus enriches the current methodology for the studies of complex host-parasite interactions.			Salathe, R (corresponding author), Penn State Univ, CIDD, University Pk, PA 16802 USA.	rahel.salathe@gmail.com; psh@env.ethz.ch			European Research Council [268853] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Antia R, 1996, P NATL ACAD SCI USA, V93, P985, DOI 10.1073/pnas.93.3.985; Balmer O, 2008, ACTA TROP, V107, P275, DOI 10.1016/j.actatropica.2008.06.006; Balmer O, 2011, LANCET INFECT DIS, V11, P868, DOI 10.1016/S1473-3099(11)70241-9; Balmer O, 2009, ECOLOGY, V90, P3367, DOI 10.1890/08-2291.1; Ben-Ami F, 2008, EVOLUTION, V62, P1700, DOI 10.1111/j.1558-5646.2008.00391.x; Bingham RA, 1998, NATURE, V391, P238, DOI 10.1038/34564; Bouquet C, 2003, THESIS U BASEL; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; BRUN R, 1979, ACTA TROP, V36, P289; BRUNE A, 1995, APPL ENVIRON MICROB, V61, P2681, DOI 10.1128/AEM.61.7.2681-2687.1995; CHANG CS, 1985, MOL BIOCHEM PARASIT, V16, P267, DOI 10.1016/0166-6851(85)90069-6; CRAILSHEIM K, 1990, APIDOLOGIE, V21, P417, DOI 10.1051/apido:19900504; CUNNINGHAM I, 1977, J PROTOZOOL, V24, P325, DOI 10.1111/j.1550-7408.1977.tb00987.x; Davies CM, 2002, PARASITOLOGY, V124, P31, DOI 10.1017/S0031182001008873; de Roode JC, 2005, AM NAT, V166, P531, DOI 10.1086/491659; De Roode JC, 2003, PARASITOLOGY, V127, P411, DOI 10.1017/S0031182003004001; de Souza W, 1999, FEMS MICROBIOL LETT, V173, P1, DOI 10.1111/j.1574-6968.1999.tb13477.x; Dettner K., 1999, LEHRBUCH ENTOMOLOGIE; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; FRANK SA, 1992, P ROY SOC B-BIOL SCI, V250, P195, DOI 10.1098/rspb.1992.0149; Funk CR, 2006, MOL ECOL NOTES, V6, P83, DOI 10.1111/j.1471-8286.2005.01147.x; Gardner KE, 2007, BEHAV ECOL SOCIOBIOL, V61, P783, DOI 10.1007/s00265-006-0309-7; GOULSON D, 2003, BUMBLEBEES THEIR BEH; GRACE TDC, 1962, NATURE, V195, P788, DOI 10.1038/195788a0; Heinrich B., 1979, BUMBLEBEE EC; Hodgson DJ, 2004, J EVOLUTION BIOL, V17, P1018, DOI 10.1111/j.1420-9101.2004.00750.x; Honisch C, 2007, P NATL ACAD SCI USA, V104, P10649, DOI 10.1073/pnas.0704152104; Hu YW, 2000, J CLIN MICROBIOL, V38, P2807, DOI 10.1128/JCM.38.8.2807-2813.2000; Imhoof B, 1998, PARASITOLOGY, V117, P331, DOI 10.1017/S0031182098003138; Koch H, 2011, MICROB ECOL, V62, P121, DOI 10.1007/s00248-011-9854-3; Koskella B, 2006, AM NAT, V168, P121, DOI 10.1086/505770; Langridge D. F., 1967, Journal of Protozoology, V14, P485; Lindstrom I, 2008, PARASITOLOGY, V135, P39, DOI 10.1017/S0031182007003654; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; Maina NWN, 2006, ACTA TROP, V98, P207, DOI 10.1016/j.actatropica.2005.11.011; Martinson VG, 2011, MOL ECOL, V20, P619, DOI 10.1111/j.1365-294X.2010.04959.x; Massey RC, 2004, P ROY SOC B-BIOL SCI, V271, P785, DOI 10.1098/rspb.2004.2676; MOTTA MCM, 1991, CAN J ZOOL, V69, P571, DOI 10.1139/z91-086; MUNDIM MH, 1974, J PROTOZOOL, V21, P518, DOI 10.1111/j.1550-7408.1974.tb03691.x; Podlipaev SA, 2004, J EUKARYOT MICROBIOL, V51, P283, DOI 10.1111/j.1550-7408.2004.tb00568.x; Popp M, 2011, J EUKARYOT MICROBIOL, V58, P7, DOI 10.1111/j.1550-7408.2010.00514.x; Read AF, 2001, SCIENCE, V292, P1099, DOI 10.1126/science.1059410; Ruiz-Gonzalez MX, 2012, EVOLUTION, V66, P3053, DOI 10.1111/j.1558-5646.2012.01655.x; Salathe RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022054; Schluns H, 2010, DEV COMP IMMUNOL, V34, P705, DOI 10.1016/j.dci.2010.02.002; Schmid-Hempel P, 1999, EVOLUTION, V53, P426, DOI 10.1111/j.1558-5646.1999.tb03778.x; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schmid-Hempel P, 2004, PARASITOLOGY, V129, P147, DOI 10.1017/S0031182004005542; Schmid-Hempel R, 2011, INFECT GENET EVOL, V11, P564, DOI 10.1016/j.meegid.2011.01.002; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; SCHMIDHEMPEL P, 1993, BEHAV ECOL SOCIOBIOL, V33, P319, DOI 10.1007/BF00172930; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; Tavares KCS, 2011, RES VET SCI, V90, P257, DOI 10.1016/j.rvsc.2010.05.021; Sinigalliano CD, 2009, PHYCOLOGIA, V48, P249, DOI 10.2216/08-51.1; SOARES M J, 1989, Microbios Letters, V41, P137; Sreekumar C, 2005, INT J PARASITOL, V35, P991, DOI 10.1016/j.ijpara.2005.03.017; Taylor LH, 1997, PARASITOLOGY, V115, P121, DOI 10.1017/S0031182097001145; Taylor LH, 1997, P ROY SOC B-BIOL SCI, V264, P927, DOI 10.1098/rspb.1997.0128; Tetaud E, 2002, MOL BIOCHEM PARASIT, V120, P195, DOI 10.1016/S0166-6851(02)00002-6; Tognazzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049137; Ulrich Y, 2011, J EVOLUTION BIOL, V24, P354, DOI 10.1111/j.1420-9101.2010.02172.x; Ulrich Y, 2012, P ROY SOC B-BIOL SCI, V279, P2982, DOI 10.1098/rspb.2012.0474; Veldhuis MJW, 2000, SCI MAR, V64, P121, DOI 10.3989/scimar.2000.64n2121; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Vizoso DB, 2005, OECOLOGIA, V143, P157, DOI 10.1007/s00442-004-1771-4; Wu W, 1994, THESIS U BASEL; Wu Wen-Jie, 1997, Acta Zoologica Sinica, V43, P103; Yourth CP, 2006, P ROY SOC B-BIOL SCI, V273, P655, DOI 10.1098/rspb.2005.3371	70	36	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49046	10.1371/journal.pone.0049046	http://dx.doi.org/10.1371/journal.pone.0049046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155449	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900084
J	Swami, V				Swami, Viren			Mental Health Literacy of Depression: Gender Differences and Attitudinal Antecedents in a Representative British Sample	PLOS ONE			English	Article							PROFESSIONAL PSYCHOLOGICAL HELP; PUBLIC BELIEFS; ILLNESS; RECOGNITION; DISORDERS; PEOPLE; SEEKING; MASCULINITY; BEYONDBLUE; KNOWLEDGE	Background: Poor mental health literacy and negative attitudes toward individuals with mental health disorders may impede optimal help-seeking for symptoms of mental ill-health. The present study examined the ability to recognize cases of depression as a function of respondent and target gender, as well as individual psychological differences in attitudes toward persons with depression. Methods: In a representative British general population survey, the ability to correctly recognize vignettes of depression was assessed among 1,218 adults. Respondents also rated the vignettes along a number of attitudinal dimensions and completed measures of attitudes toward seeking psychological help, psychiatric skepticism, and anti-scientific attitudes. Results: There were significant differences in the ability to correctly identify cases of depression as a function of respondent and target gender. Respondents were more likely to indicate that a male vignette did not suffer from a mental health disorder compared to a female vignette, and women were more likely than men to indicate that the male vignette suffered from a mental health disorder. Attitudes toward persons with depression were associated with attitudes toward seeking psychological help, psychiatric skepticism, and anti-scientific attitudes. Conclusion: Initiatives that consider the impact of gender stereotypes as well as individual differences may enhance mental health literacy, which in turn is associated with improved help-seeking behaviors for symptoms of mental ill-health.	Univ Westminster, Dept Psychol, London W1R 8AL, England	University of Westminster	Swami, V (corresponding author), Univ Westminster, Dept Psychol, London W1R 8AL, England.	v.swami@westminster.ac.uk						Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Alonso J, 2007, BRIT J PSYCHIAT, V190, P299, DOI 10.1192/bjp.bp.106.022004; Angermeyer MC, 2006, ACTA PSYCHIAT SCAND, V113, P163, DOI 10.1111/j.1600-0447.2005.00699.x; Angermeyer MC, 1999, SOC PSYCH PSYCH EPID, V34, P202, DOI 10.1007/s001270050134; Clarke M, 2006, BRIT J PSYCHIAT, V189, P235, DOI 10.1192/bjp.bp.105.014068; Connell RW, 2005, GENDER SOC, V19, P829, DOI 10.1177/0891243205278639; Courtenay WH, 2000, SOC SCI MED, V50, P1385, DOI 10.1016/S0277-9536(99)00390-1; Courtenay WH, 1999, SOC PSYCHOL STUDY ME, V4, P10; Cuijpers P, 2007, ACTA PSYCHIAT SCAND, V115, P229, DOI 10.1111/j.1600-0447.2006.00851.x; FISCHER EH, 1995, J COLL STUDENT DEV, V36, P368; Herran A, 1999, BRIT MED J, V318, P1558, DOI 10.1136/bmj.318.7197.1558; Jorm AF, 1997, MED J AUSTRALIA, V166, P182, DOI 10.5694/j.1326-5377.1997.tb140071.x; Jorm AF, 2006, AUST NZ J PSYCHIAT, V40, P42, DOI 10.1111/j.1440-1614.2006.01739.x; Jorm AF, 2006, AUST NZ J PSYCHIAT, V40, P36, DOI 10.1080/j.1440-1614.2006.01738.x; Jorm AF, 2005, AUST NZ J PSYCHIAT, V39, P248, DOI 10.1080/j.1440-1614.2005.01561.x; Jorm AF, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-12; Jorm AF, 2012, AM PSYCHOL, V67, P231, DOI 10.1037/a0025957; Kessler D, 1999, BRIT MED J, V318, P436, DOI 10.1136/bmj.318.7181.436; Lauber C, 2003, EUR ARCH PSY CLIN N, V253, P248, DOI 10.1007/s00406-003-0439-0; Link BG, 1999, AM J PUBLIC HEALTH, V89, P1328, DOI 10.2105/AJPH.89.9.1328; Men's Health Forum, 2002, GETT IT SORT NEW POL; Payne S, 2008, J MENS HEALTH, V5, P23, DOI 10.1016/j.jomh.2007.11.002; Popay J, 1998, SOCIOL HEALTH ILL, V20, P619, DOI 10.1111/1467-9566.00122; Rose D, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-97; Rusch N, 2011, PSYCHIAT SERV, V62, P675, DOI [10.1176/appi.ps.62.6.675, 10.1176/ps.62.6.pss6206_0675]; Sobocki P, 2007, EUR PSYCHIAT, V22, P146, DOI 10.1016/j.eurpsy.2006.10.006; Soorkia R, 2011, MENT HEALTH RELIG CU, V14, P613, DOI 10.1080/13674676.2010.494176; Sue WS, 2003, COUNSELLING CULTURAL; Swami V, 2011, SCAND J PSYCHOL, V52, P399, DOI 10.1111/j.1467-9450.2011.00881.x; Swami V, 2011, BRIT J PSYCHOL, V102, P662, DOI 10.1111/j.2044-8295.2011.02036.x; Swami V, 2011, SOC PSYCH PSYCH EPID, V46, P181, DOI 10.1007/s00127-010-0193-3; Swami V, 2010, INT J SOC PSYCHIATR, V56, P480, DOI 10.1177/0020764008101639; Swami V, 2009, BRIT J HEALTH PSYCH, V14, P519, DOI 10.1348/135910708X370781; ten Have M, 2010, SOC PSYCH PSYCH EPID, V45, P153, DOI 10.1007/s00127-009-0050-4; US Department of Health and Human Services Substance Abuse and Mental Health Services Administration Center for Mental Health Services, 2001, MENT HLTH CULT RAC E; Van Voorhees BW, 2006, SOC PSYCH PSYCH EPID, V41, P746, DOI 10.1007/s00127-006-0091-x; Wright A, 2007, SOC PSYCH PSYCH EPID, V42, P244, DOI 10.1007/s00127-006-0156-x; Yates GCR, 2000, RES SCI EDUC, V30, P377, DOI [10.1007/BF02461557, DOI 10.1007/BF02461557]	38	81	84	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49779	10.1371/journal.pone.0049779	http://dx.doi.org/10.1371/journal.pone.0049779			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166769	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900193
J	Zhou, ZH; Yuan, GZ; Yao, JJ				Zhou, Zhenhe; Yuan, Guozhen; Yao, Jianjun			Cognitive Biases toward Internet Game-Related Pictures and Executive Deficits in Individuals with an Internet Game Addiction	PLOS ONE			English	Article							TASK	Background: The cue-brelated go/no-go switching task provides an experimental approach to study individual's flexibility in changing situations. Because Internet addiction disorder (IAD) belongs to the compulsive-impulsive spectrum of disorders, it should present cognitive bias and executive functioning deficit characteristics of some of these types of disorders. Until now, no studies have been reported on cognitive bias and executive function involving mental flexibility and response inhibition in IAD. Methodology/Principal Findings: A total of 46 subjects who met the criteria of the modified Young's Diagnostic Questionnaire for Internet addiction (YDQ) were recruited as an Internet game addiction (IGA) group, along with 46 healthy control individuals. All participants performed the Internet game-shifting task. Using hit rate, RT, d' and C as the dependent measures, a three-way ANOVA (group x target x condition) was performed. For hit rate, a significant effect of group, type of target and condition were found. The group-target interaction effect was significant. For RT, significant effects were revealed for group and type of target. The group-target interaction effect was significant. Comparisons of the means revealed that the slowing down of IGA relative to NIA was more pronounced when the target stimuli were neutral as opposed to Internet game-related pictures. In addition, the group-condition interaction effect was significant. For d', significant effects of group, type of target and condition were found. The group-target interaction effect was significant. For C, the type of target produced a significant effect. There was a positive correlation between the length of the addiction (number of years) and the severity of the cognitive bias. Conclusions: IGA present cognitive biases towards information related to Internet gaming. These biases, as well as poor executive functioning skills (lower mental flexibility and response inhibition), might be responsible for Internet game addiction. The assessment of cognitive biases in IGA might provide a methodology for evaluation of therapeutic effects.	[Zhou, Zhenhe; Yuan, Guozhen; Yao, Jianjun] Nanjing Med Univ, Wuxi Mental Hlth Ctr, Dept Psychol, Wuxi City, Jiangsu, Peoples R China	Nanjing Medical University	Zhou, ZH (corresponding author), Nanjing Med Univ, Wuxi Mental Hlth Ctr, Dept Psychol, Wuxi City, Jiangsu, Peoples R China.	Zhouzhenhe1970@gmail.com						ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Beard KW, 2005, CYBERPSYCHOL BEHAV, V8, P7, DOI 10.1089/cpb.2005.8.7; Beard KW, 2001, CYBERPSYCHOL BEHAV, V4, P377, DOI 10.1089/109493101300210286; Block JJ, 2008, AM J PSYCHIAT, V165, P306, DOI 10.1176/appi.ajp.2007.07101556; Byun S, 2009, CYBERPSYCHOL BEHAV, V12, P203, DOI 10.1089/cpb.2008.0102; Cheung LM, 2011, J SLEEP RES, V20, P311, DOI 10.1111/j.1365-2869.2010.00883.x; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; Dong GH, 2011, NEUROSCI LETT, V499, P114, DOI 10.1016/j.neulet.2011.05.047; Franken IHA, 2003, PROG NEURO-PSYCHOPH, V27, P563, DOI 10.1016/S0278-5846(03)00081-2; Joyce JF, 2008, ARCH PSYCHIATR NURS, V22, P59; Ko CH, 2009, J PSYCHIATR RES, V43, P739, DOI 10.1016/j.jpsychires.2008.09.012; Lauretti W J, 1996, J Manipulative Physiol Ther, V19, P273; Linnet J, 2011, J GAMBLING IN PRESS; McCusker CG, 1997, BRIT J CLIN PSYCHOL, V36, P543, DOI 10.1111/j.2044-8260.1997.tb01259.x; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Shaw M, 2008, CNS DRUGS, V22, P353, DOI 10.2165/00023210-200822050-00001; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Xavier N, 2005, ADDICTION, V100, P1302; Young K.S., 1998, CYBER PSYCHOL BEHAV, V1, P237, DOI [10.1089/cpb.1998.1.237, DOI 10.1089/CPB.1998.1.237]; Young KS., 1998, CYBERPSYCHOL BEHAV, V1, P25, DOI [10.1089/cpb.1998.1.25, DOI 10.1089/CPB.1998.1.25]; Zhou ZH, 2010, ACTA NEUROPSYCHIATR, V22, P228, DOI 10.1111/j.1601-5215.2010.00444.x	21	80	81	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48961	10.1371/journal.pone.0048961	http://dx.doi.org/10.1371/journal.pone.0048961			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155434	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900069
J	Raja, KRM; Kubiczkova, L; Rihova, L; Piskacek, M; Vsianska, P; Hezova, R; Pour, L; Hajek, R				Raja, Karthick Raja Muthu; Kubiczkova, Lenka; Rihova, Lucie; Piskacek, Martin; Vsianska, Pavla; Hezova, Renata; Pour, Ludek; Hajek, Roman			Functionally Suppressive CD8 T Regulatory Cells Are Increased in Patients with Multiple Myeloma: A Cause for Immune Impairment	PLOS ONE			English	Article							PERIPHERAL-BLOOD; DENDRITIC CELLS; RECRUITMENT; LYMPHOMA; SURVIVAL; CANCER	Background: Multiple myeloma (MM) is a plasma cell malignancy frequently associated with impaired immune cell numbers and functions. In MM, several studies have previously shown that CD4 regulatory T (Treg) cells hamper effector T cell functions and enhance immune dysfunction. In this study, we aimed to prove the presence of functionally suppressive Treg cells expressing CD8 phenotype (CD8 Treg cells) in MM. To the best of our knowledge, this has not been reported previously in MM. Methods: We analyzed CD8 Treg cells and their transcription factor FoxP3 from 64 newly diagnosed MM patients using flow cytometry and real time-polymerase chain reaction (RT-PCR). RNA profile of cytokines in CD8 Treg cells was also assessed using RT-PCR. CD8 Treg cells from 5 MM patients and 5 healthy donors were functionally evaluated using proliferation assays. Results: CD8 Treg cells (CD8+CD25hi+) were significantly elevated in MM patients (P < 0.0001), and their transcription factor FoxP3 expression was also higher in MM (P < 0.0001) compared to healthy donors which was evidenced by flow cytometry and RT-PCR analyses. CD8 Treg cells negatively correlated with total lymphocyte count (P = 0.016). Functional studies revealed that CD8 Treg cells isolated from MM patients and healthy donors inhibited proliferation of CD4 T cells in a concentration dependent manner. In the presence of CD8 Treg cells in proliferation assays, level of IFN-gamma was decreased but not IL-10. CD4 T cells from MM patients secreted abnormal level of IL-10 compared to healthy donors (P = 0.01) in proliferation assays without CD8 Treg cells. RNA profile of cytokines from CD8 Treg cells did not differ significantly between MM patients and healthy donors. Conclusions: These findings show the presence of increased number of functionally suppressive CD8 Treg cells in MM patients. We believe that these suppressive CD8 Treg cells might enhance immune impairment and disease progression in MM.	[Raja, Karthick Raja Muthu; Kubiczkova, Lenka; Rihova, Lucie; Piskacek, Martin; Hajek, Roman] Masaryk Univ, Babak Myeloma Grp, Dept Pathol Physiol, Fac Med, Brno, Czech Republic; [Raja, Karthick Raja Muthu; Vsianska, Pavla; Hajek, Roman] Masaryk Univ, Fac Sci, Dept Expt Biol, CS-61137 Brno, Czech Republic; [Rihova, Lucie; Vsianska, Pavla; Hajek, Roman] Univ Hosp, Dept Clin Hematol, Brno, Czech Republic; [Pour, Ludek; Hajek, Roman] Univ Hosp, Dept Internal Med, Brno, Czech Republic; [Hezova, Renata] Masaryk Univ, Cent European Inst Technol, Brno, Czech Republic	Masaryk University Brno; Masaryk University Brno; University Hospital Brno; University Hospital Brno; Masaryk University Brno	Raja, KRM (corresponding author), Masaryk Univ, Babak Myeloma Grp, Dept Pathol Physiol, Fac Med, Brno, Czech Republic.	rajakarthick594@gmail.com	Hajek, Roman/I-6639-2017; Piskacek, Martin/I-4280-2016	Hajek, Roman/0000-0001-6955-6267; Piskacek, Martin/0000-0002-6283-1542	Czech Ministry of Education, Youth and Sports [MSM0021622434]; Czech Ministry of Health: IGA [NT12130, NT12425, NT11154, NT13190]; Czech Science Foundation GACR [GAP304/10/1395]	Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic); Czech Ministry of Health: IGA(Ministry of Health, Czech Republic); Czech Science Foundation GACR(Grant Agency of the Czech Republic)	This work was supported by grants from Czech Ministry of Education, Youth and Sports MSM0021622434, Czech Ministry of Health: IGA NT12130, NT12425, NT11154 and NT13190, and Czech Science Foundation GACR GAP304/10/1395. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beyer M, 2006, BLOOD, V108, P804, DOI 10.1182/blood-2006-02-002774; Beyer M, 2006, BLOOD, V107, P3940, DOI 10.1182/blood-2005-09-3671; Brimnes MK, 2010, SCAND J IMMUNOL, V72, P540, DOI 10.1111/j.1365-3083.2010.02463.x; Chang CC, 2002, NAT IMMUNOL, V3, P237, DOI 10.1038/ni760; Chaput N, 2009, GUT, V58, P520, DOI 10.1136/gut.2008.158824; Cosmi L, 2003, BLOOD, V102, P4107, DOI 10.1182/blood-2003-04-1320; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Endharti AT, 2005, J IMMUNOL, V175, P7093, DOI 10.4049/jimmunol.175.11.7093; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Farinha P, 2010, BLOOD, V115, P289, DOI 10.1182/blood-2009-07-235598; Feyler S, 2009, BRIT J HAEMATOL, V144, P686, DOI 10.1111/j.1365-2141.2008.07530.x; Filaci G, 2007, J IMMUNOL, V179, P4323, DOI 10.4049/jimmunol.179.7.4323; Giannopoulos K, 2012, BR J CANC; Ishida T, 2006, CANCER RES, V66, P5716, DOI 10.1158/0008-5472.CAN-06-0261; Kiniwa Y, 2007, CLIN CANCER RES, V13, P6947, DOI 10.1158/1078-0432.CCR-07-0842; Li J, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-189; Meloni F, 2006, HUM IMMUNOL, V67, P1, DOI 10.1016/j.humimm.2005.11.005; Merlo A, 2009, J CLIN ONCOL, V27, P1746, DOI 10.1200/JCO.2008.17.9036; Parasa VRR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037448; Pratt G, 2007, BRIT J HAEMATOL, V138, P563, DOI 10.1111/j.1365-2141.2007.06705.x; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Tang XL, 2005, CELL MOL IMMUNOL, V2, P11; Yang ZZ, 2006, BLOOD, V107, P3639, DOI 10.1182/blood-2005-08-3376	23	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49446	10.1371/journal.pone.0049446	http://dx.doi.org/10.1371/journal.pone.0049446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152910	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600041
J	Patakas, A; Benson, RA; Withers, DR; Conigliaro, P; McInnes, IB; Brewer, JM; Garside, P				Patakas, Agapitos; Benson, Robert A.; Withers, David R.; Conigliaro, Paola; McInnes, Iain B.; Brewer, James M.; Garside, Paul			Th17 Effector Cells Support B Cell Responses Outside of Germinal Centres	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; FOLLICULAR HELPER-CELLS; HUMAN AIRWAY EPITHELIUM; T-CELLS; IN-VIVO; ANTIBODY-PRODUCTION; SELF-TOLERANCE; MEMORY CELLS; EXPRESSION; IL-17	Th17 cells are pro-inflammatory CD4(+)T cells, which are important in immune responses against fungal pathogens and extracellular bacteria and have also been implicated in various autoimmune syndromes. However, their role in supporting B cell responses in these scenarios remains unclear, representing a significant lapse in our understanding of the role Th17 play in vaccine responses and the regulation of autoimmunity. We employed T cell and B cell receptor transgenic mice specific for model antigens, and adoptive transfer approaches that allowed the tracking of cognate B and T cells in situ and ex vivo using immunological methods. We have found that T cells activated under Th17 polarising conditions have a greater capacity to provide cognate B cell help compared with Th1 polarised populations, supporting higher expansion of antigen specific B cells and enhanced antibody titres. This advantage is associated with the increased persistence of Th17 polarised cells in areas of the lymph nodes where they can provide help (i.e. the B cell follicles). Also the Th17 cells are characterised by their higher expression of ICOS, a costimulatory molecule important for B cell help. Surprisingly, contrary to published reports, Th17 cells were not detected inside germinal centres, although they were found in close proximity to cognate B cells in the follicle early in the genesis of the humoral immune response. These data indicate that, Th17 cells have a more significant role earlier in the initiation/development of the germinal centre response and/or germinal centre-independent events, consistent with their early effector status.	[Patakas, Agapitos; Benson, Robert A.; Conigliaro, Paola; McInnes, Iain B.; Brewer, James M.; Garside, Paul] Univ Glasgow, Glasgow Biomed Res Ctr, Inst Immunol Infect & Inflammat, Glasgow, Lanark, Scotland; [Withers, David R.] Univ Birmingham Sch Med, Inst Biomed Res, MRC Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England; [Conigliaro, Paola] Univ Roma Tor Vergata, Dept Internal Med, Rheumatol Unit, Rome, Italy	University of Glasgow; University of Birmingham; University of Rome Tor Vergata	Patakas, A (corresponding author), Univ Glasgow, Glasgow Biomed Res Ctr, Inst Immunol Infect & Inflammat, Glasgow, Lanark, Scotland.	Agapitos.Patakas@glasgow.ac.uk	Brewer, James/A-7186-2010; Withers, David/C-7055-2015	Brewer, James/0000-0001-7933-0915; Withers, David/0000-0003-3757-7594; McInnes, Iain/0000-0002-6462-4280; Benson, Robert/0000-0003-3687-0481; CONIGLIARO, PAOLA/0000-0001-7905-8413	Oliver Bird Rheumatism Programme	Oliver Bird Rheumatism Programme	This work was supported by the Oliver Bird Rheumatism Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Benson RA, 2010, J IMMUNOL, V184, P6378, DOI 10.4049/jimmunol.0903951; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Di Y, 2007, NATURE, V450, P299; Ferretti S, 2003, J IMMUNOL, V170, P2106, DOI 10.4049/jimmunol.170.4.2106; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Goodnow CC, 2010, NAT IMMUNOL, V11, P681, DOI 10.1038/ni.1900; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Janke M, 2010, EUR J IMMUNOL, V40, P1089, DOI 10.1002/eji.200939487; Kao CY, 2005, J IMMUNOL, V175, P6676, DOI 10.4049/jimmunol.175.10.6676; Kao CY, 2004, J IMMUNOL, V173, P3482, DOI 10.4049/jimmunol.173.5.3482; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; LIEBERMAN R, 1974, J EXP MED, V139, P983, DOI 10.1084/jem.139.4.983; LIU Y, 1990, Journal of Experimental Medicine, V172, P1735, DOI 10.1084/jem.172.6.1735; Lu Kristina T, 2011, IMMUNITY, V35, P622; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mitsdoerffer M, 2010, P NATL ACAD SCI USA, V107, P14292, DOI 10.1073/pnas.1009234107; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Platt AM, 2010, J IMMUNOL, V185, P1558, DOI 10.4049/jimmunol.1001311; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Romani L, 2004, NAT REV IMMUNOL, V4, P11, DOI 10.1038/nri1255; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Shi GP, 2009, J IMMUNOL, V183, P7547, DOI 10.4049/jimmunol.0900519; Smith KM, 2000, J IMMUNOL, V165, P3136, DOI 10.4049/jimmunol.165.6.3136; Smith KM, 2004, J IMMUNOL, V173, P1640, DOI 10.4049/jimmunol.173.3.1640; SNAPPER CM, 1988, J IMMUNOL, V140, P2121; Steinman L, 2010, NAT IMMUNOL, V11, P41, DOI 10.1038/ni.1803; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vinuesa CG, 2010, IMMUNOL REV, V237, P72, DOI 10.1111/j.1600-065X.2010.00937.x; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Yang JH, 2005, RHEUMATOLOGY, V44, P1245, DOI 10.1093/rheumatology/keh724; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001; Yusuf I, 2010, J IMMUNOL, V185, P190, DOI 10.4049/jimmunol.0903505; Zaheen A, 2009, BLOOD, V114, P547, DOI 10.1182/blood-2009-03-211763; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303	48	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49715	10.1371/journal.pone.0049715	http://dx.doi.org/10.1371/journal.pone.0049715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166752	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000311885300061
J	Jog, SP; Paul, S; Dansithong, W; Tring, S; Comai, L; Reddy, S				Jog, Sonali P.; Paul, Sharan; Dansithong, Warunee; Tring, Stephanie; Comai, Lucio; Reddy, Sita			RNA Splicing Is Responsive to MBNL1 Dose	PLOS ONE			English	Article							MYOTONIC-DYSTROPHY; MESSENGER-RNA; MOUSE MODELS; CTG REPEAT; TRANSCRIPT; PROTEINS; SEQUENCE	Myotonic dystrophy (DM1) is a highly variable, multi-system disorder resulting from the expansion of an untranslated CTG tract in DMPK. In DM1 expanded CUG repeat RNAs form hairpin secondary structures that bind and aberrantly sequester the RNA splice regulator, MBNL1. RNA splice defects resulting as a consequence of MBNL1 depletion have been shown to play a key role in the development of DM1 pathology. In patient populations, both the number and severity of DM1 symptoms increase broadly as a function of CTG tract length. However significant variability in the DM1 phenotype is observed in patients encoding similar CTG repeat numbers. Here we demonstrate that a gradual decrease in MBNL1 levels results both in the expansion of the repertoire of splice defects and an increase in the severity of the splice alterations. Thus, MBNL1 loss does not have an all or none outcome but rather shows a graded effect on the number and severity of the ensuing splice defects. Our results suggest that once a critical threshold is reached, relatively small dose variations of free MBNL1 levels, which may reflect modest changes in the size of the CUG tract or the extent of hairpin secondary structure formation, can significantly alter the number and severity of splice abnormalities and thus contribute to the phenotype variability observed in DM1 patients.	[Comai, Lucio] Univ So Calif, Dept Mol Microbiol & Immunol, Inst Med Genet, Los Angeles, CA 90089 USA; [Jog, Sonali P.; Paul, Sharan; Dansithong, Warunee; Tring, Stephanie; Reddy, Sita] Univ So Calif, Inst Med Genet, Dept Biochem & Mol Biol, Los Angeles, CA USA	University of Southern California; University of Southern California	Comai, L (corresponding author), Univ So Calif, Dept Mol Microbiol & Immunol, Inst Med Genet, Los Angeles, CA 90089 USA.	comai@usc.edu; sitaredd@usc.edu	Comai, Lucio/H-9524-2019; Comai, Lucio/L-5905-2019	Comai, Lucio/0000-0003-3109-1841	National Institutes of Health (NIH) [R01 NS50861-04, R01 NS060839-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050861, R01NS060839] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the National Institutes of Health (NIH) (R01 NS50861-04 & R01 NS060839-03) to SR and LC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Du HQ, 2010, NAT STRUCT MOL BIOL, V17, P187, DOI 10.1038/nsmb.1720; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; HARLEY HG, 1992, LANCET, V339, P1125, DOI 10.1016/0140-6736(92)90729-M; HARLEY HG, 1993, AM J HUM GENET, V52, P1164; Harper PS, 2001, MYOTONIC DYSTROPHY; Holt I, 2007, GENES CELLS, V12, P1035, DOI 10.1111/j.1365-2443.2007.01112.x; Kanadia RN, 2003, SCIENCE, V302, P1978, DOI 10.1126/science.1088583; Laurent FX, 2012, NUCLEIC ACIDS RES, V40, P3159, DOI 10.1093/nar/gkr1228; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Mankodi A, 2002, MOL CELL, V10, P35, DOI 10.1016/S1097-2765(02)00563-4; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Paul S, 2006, EMBO J, V25, P4271, DOI 10.1038/sj.emboj.7601296; Ranum LPW, 2006, ANNU REV NEUROSCI, V29, P259, DOI 10.1146/annurev.neuro.29.051605.113014; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; TANEJA KL, 1995, J CELL BIOL, V128, P995, DOI 10.1083/jcb.128.6.995; Tennyson CN, 1996, NUCLEIC ACIDS RES, V24, P3059, DOI 10.1093/nar/24.15.3059; Wheeler TM, 2007, J CLIN INVEST, V117, P3952, DOI 10.1172/JCI33355; Yan Y, 2008, AM J PATHOL, V173, P1013, DOI 10.2353/ajpath.2008.080339; Yuan Y, 2007, NUCLEIC ACIDS RES, V35, P5474, DOI 10.1093/nar/gkm601	23	27	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48825	10.1371/journal.pone.0048825	http://dx.doi.org/10.1371/journal.pone.0048825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166594	gold, Green Published, Green Submitted			2022-12-27	WOS:000311272300014
J	Komarova, NL; Levy, DN; Wodarz, D				Komarova, Natalia L.; Levy, David N.; Wodarz, Dominik			Effect of Synaptic Transmission on Viral Fitness in HIV Infection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TO-CELL SPREAD; VIROLOGICAL SYNAPSES; REPLICATION; DYNAMICS; IMMUNITY; TYPE-1; TRIM5-ALPHA; PROGRESSION; INHIBITION	HIV can spread through its target cell population either via cell-free transmission, or by cell-to-cell transmission, presumably through virological synapses. Synaptic transmission entails the transfer of tens to hundreds of viruses per synapse, a fraction of which successfully integrate into the target cell genome. It is currently not understood how synaptic transmission affects viral fitness. Using a mathematical model, we investigate how different synaptic transmission strategies, defined by the number of viruses passed per synapse, influence the basic reproductive ratio of the virus, R-0, and virus load. In the most basic scenario, the model suggests that R-0 is maximized if a single virus particle is transferred per synapse. R-0 decreases and the infection eventually cannot be maintained for larger numbers of transferred viruses, because multiple infection of the same cell wastes viruses that could otherwise enter uninfected cells. To explain the relatively large number of HIV copies transferred per synapse, we consider additional biological assumptions under which an intermediate number of viruses transferred per synapse could maximize R-0. These include an increased burst size in multiply infected cells, the saturation of anti-viral factors upon infection of cells, and rate limiting steps during the process of synapse formation.	[Komarova, Natalia L.; Wodarz, Dominik] Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA; [Komarova, Natalia L.; Wodarz, Dominik] Univ Calif Irvine, Dept Ecol & Evolut, Irvine, CA 92717 USA; [Levy, David N.] NYU, Coll Dent, Dept Basic Sci, New York, NY USA	University of California System; University of California Irvine; University of California System; University of California Irvine; New York University	Komarova, NL (corresponding author), Univ Calif Irvine, Dept Math, Irvine, CA 92717 USA.	komarova@uci.edu; dwodarz@uci.edu	sourisseau, marion/M-7542-2014		National Institutes of Health [1R01AI093998-01A1]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant 1R01AI093998-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; De Boer RJ, 1998, J THEOR BIOL, V190, P201, DOI 10.1006/jtbi.1997.0548; Del Portillo A, 2011, J VIROL, V85, P7169, DOI 10.1128/JVI.00231-11; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dixit NM, 2005, P NATL ACAD SCI USA, V102, P8198, DOI 10.1073/pnas.0407498102; Dixit NM, 2004, J VIROL, V78, P8942, DOI 10.1128/JVI.78.16.8942-8945.2004; Doceul V, 2010, SCIENCE, V327, P873, DOI 10.1126/science.1183173; Feldmann J, 2010, VIRUSES-BASEL, V2, P1666, DOI 10.3390/v2081666; Gelderblom HC, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-60; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; GUPTA P, 1989, J VIROL, V63, P2361, DOI 10.1128/JVI.63.5.2361-2365.1989; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Jolly C, 2011, VIROLOGY, V411, P251, DOI 10.1016/j.virol.2010.12.031; Josefsson L, 2011, P NATL ACAD SCI USA, V108, P11199, DOI 10.1073/pnas.1107729108; Jung A, 2002, NATURE, V418, P144, DOI 10.1038/418144a; Kimata JT, 1999, NAT MED, V5, P535, DOI 10.1038/8414; Lifson JD, 1997, J VIROL, V71, P9508, DOI 10.1128/JVI.71.12.9508-9514.1997; Martin N, 2010, J VIROL, V84, P3516, DOI 10.1128/JVI.02651-09; Martin N, 2009, CURR OPIN HIV AIDS, V4, P143, DOI 10.1097/COH.0b013e328322f94a; Massanella M, 2009, AIDS, V23, P183, DOI 10.1097/QAD.0b013e32831ef1a3; Nowak MA., 2000, VIRUS DYNAMICS MATH; PARKER GA, 1990, NATURE, V348, P27, DOI 10.1038/348027a0; Perelson AS, 2002, NAT REV IMMUNOL, V2, P28, DOI 10.1038/nri700; RUDENSEY LM, 1995, VIROLOGY, V207, P528, DOI 10.1006/viro.1995.1113; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Sakuma R, 2007, GENE THER, V14, P185, DOI 10.1038/sj.gt.3302852; Sattentau Q, 2008, NAT REV MICROBIOL, V6, P815, DOI 10.1038/nrmicro1972; Sattentau QJ, 2010, VIRUSES-BASEL, V2, P1306, DOI 10.3390/v2061306; Sigal A, 2011, NATURE, V477, P95, DOI 10.1038/nature10347; Sokolskaja E, 2006, CURR OPIN MICROBIOL, V9, P404, DOI 10.1016/j.mib.2006.06.011; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229	35	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48361	10.1371/journal.pone.0048361	http://dx.doi.org/10.1371/journal.pone.0048361			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166585	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300006
J	Kanitz, A; Imig, J; Dziunycz, PJ; Primorac, A; Galgano, A; Hofbauer, GFL; Gerber, AP; Detmar, M				Kanitz, Alexander; Imig, Jochen; Dziunycz, Piotr J.; Primorac, Adriana; Galgano, Alessia; Hofbauer, Guenther F. L.; Gerber, Andre P.; Detmar, Michael			The Expression Levels of MicroRNA-361-5p and Its Target VEGFA Are Inversely Correlated in Human Cutaneous Squamous Cell Carcinoma	PLOS ONE			English	Article							ENDOTHELIAL-GROWTH-FACTOR; FACTOR MESSENGER-RNA; BINDING-PROTEINS; IDENTIFICATION; ANGIOGENESIS; HYPOXIA; TRANSLATION; STABILITY; INVASION; STABILIZATION	Vascular endothelial growth factor A (VEGFA) plays a key role in the angiogenesis of human skin. Elevated levels of VEGFA are associated with several pathological conditions, including chronic inflammatory skin diseases and several types of skin cancer. In particular, squamous cell carcinoma (SCC) of the skin, the second most common skin cancer in the general population, is characterized by invasive growth, pronounced angiogenesis and elevated levels of VEGFA. The processing, turnover and production of VEGFA are extensively regulated at the post-transcriptional level, both by RNA-binding proteins and microRNAs (miRNAs). In the present study, we identified a new miRNA recognition element in a downstream conserved region of the VEGFA 3'-UTR. We confirmed the repressive effect of miR-361-5p on this element in vitro, identifying the first target for this miRNA. Importantly, we found that miR-361-5p levels are inversely correlated with VEGFA expression in SCC and in healthy skin, indicating that miR-361-5p could play a role in cancers.	[Kanitz, Alexander; Imig, Jochen; Primorac, Adriana; Galgano, Alessia; Gerber, Andre P.; Detmar, Michael] ETH, Inst Pharmaceut Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kanitz, A (corresponding author), ETH, Inst Pharmaceut Sci, Zurich, Switzerland.	a.gerber@surrey.ac.uk; michael.detmar@pharma.ethz.ch	Kanitz, Alexander/AAG-7842-2021; Hofbauer, Gunther/B-2671-2010	Kanitz, Alexander/0000-0002-3468-0652; Hofbauer, Gunther/0000-0003-0542-7989; Imig, Jochen/0000-0003-0385-1081	NCI NIH HHS [CA69184, R01 CA069184] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA069184] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Afanasyeva EA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-52; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Blower PE, 2007, MOL CANCER THER, V6, P1483, DOI 10.1158/1535-7163.MCT-07-0009; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bowden J, 2002, J CUTAN PATHOL, V29, P585, DOI 10.1034/j.1600-0560.2002.291003.x; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CAMERON JD, 1987, OPHTHALMOLOGY, V94, P187; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chamorro-Jorganes A, 2011, ARTERIOSCL THROM VAS, V31, P2595, DOI 10.1161/ATVBAHA.111.236521; Choi YC, 2011, MOL CELLS, V32, P77, DOI 10.1007/s10059-011-1042-2; Chuang TD, 2012, ENDOCR-RELAT CANCER, V19, P541, DOI 10.1530/ERC-12-0007; Ciais D, 2004, ONCOGENE, V23, P8673, DOI 10.1038/sj.onc.1207939; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Coles LS, 2004, EUR J BIOCHEM, V271, P648, DOI 10.1111/j.1432-1033.2003.03968.x; Colombrita C, 2012, J BIOL CHEM, V287, P15635, DOI 10.1074/jbc.M111.333450; DETMAR M, 1994, J EXP MED, V180, P1141, DOI 10.1084/jem.180.3.1141; Detmar M, 2000, AM J PATHOL, V156, P159, DOI 10.1016/S0002-9440(10)64715-3; DETMAR M, 1995, J INVEST DERMATOL, V105, P44, DOI 10.1111/1523-1747.ep12312542; Detmar M, 2000, J DERMATOL SCI, V24, pS78, DOI 10.1016/S0923-1811(00)00145-6; DETMAR M, 1992, J INVEST DERMATOL, V98, P147, DOI 10.1111/1523-1747.ep12555746; Detmar M, 1997, J INVEST DERMATOL, V108, P263, DOI 10.1111/1523-1747.ep12286453; Dibbens JA, 2001, BBA-GENE STRUCT EXPR, V1518, P57, DOI 10.1016/S0167-4781(01)00167-1; Dibbens JA, 1999, MOL BIOL CELL, V10, P907, DOI 10.1091/mbc.10.4.907; Dziunycz P, 2010, J INVEST DERMATOL, V130, P2686, DOI 10.1038/jid.2010.169; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; FRANK S, 1995, J BIOL CHEM, V270, P12607, DOI 10.1074/jbc.270.21.12607; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69; Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo XJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-97; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Hofbauer GFL, 2010, EXP DERMATOL, V19, P473, DOI 10.1111/j.1600-0625.2010.01086.x; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang DW, 2008, BIOINFORMATION, V2, P428; Huez I, 2001, MOL ENDOCRINOL, V15, P2197, DOI 10.1210/me.15.12.2197; Imig J, 2012, BIOMOL CONCEPTS; Jafarifar F, 2011, EMBO J, V30, P1324, DOI 10.1038/emboj.2011.38; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kanitz A, 2010, WIRES SYST BIOL MED, V2, P245, DOI 10.1002/wsbm.55; Karaa ZS, 2009, RNA, V15, P249, DOI 10.1261/rna.1301109; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Levy NS, 1997, BBA-GENE STRUCT EXPR, V1352, P167, DOI 10.1016/S0167-4781(97)00052-3; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Li PF, 2013, CLIN SCI, V124, P27, DOI 10.1042/CS20120121; Li ZY, 2011, MOL BIOSYST, V7, P871, DOI 10.1039/c0mb00230e; Liang YX, 2002, J BIOL CHEM, V277, P20087, DOI 10.1074/jbc.M201766200; Liu B, 2009, LUNG CANCER, V66, P169, DOI 10.1016/j.lungcan.2009.01.010; Liu HF, 2010, MOL CANCER THER, V9, P1080, DOI 10.1158/1535-7163.MCT-09-0965; Lohmann CM, 2001, ADV ANAT PATHOL, V8, P27, DOI 10.1097/00125480-200101000-00005; Long JY, 2010, J BIOL CHEM, V285, P23455, DOI 10.1074/jbc.M110.136168; Maragkakis M, 2009, NUCLEIC ACIDS RES, V37, pW273, DOI 10.1093/nar/gkp292; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Meola Nicola, 2009, Pathogenetics, V2, P7, DOI 10.1186/1755-8417-2-7; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Onesto C, 2004, J BIOL CHEM, V279, P34217, DOI 10.1074/jbc.M400219200; Panda H, 2012, REPROD SCI, V19, P786, DOI 10.1177/1933719112438448; Pinheiro I, 2011, BIOESSAYS, V33, P791, DOI 10.1002/bies.201100047; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Ray PS, 2007, EMBO J, V26, P3360, DOI 10.1038/sj.emboj.7601774; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Salven P, 1997, BRIT J CANCER, V76, P930, DOI 10.1038/bjc.1997.486; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sasahira T, 2012, BRIT J CANCER, V107, P700, DOI 10.1038/bjc.2012.330; Sauter ER, 1999, CLIN CANCER RES, V5, P775; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz RA, 2008, J EUR ACAD DERMATOL, V22, P606, DOI 10.1111/j.1468-3083.2008.02579.x; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shih SC, 1999, J BIOL CHEM, V274, P1359, DOI 10.1074/jbc.274.3.1359; Stark MS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009685; Strunnikova N, 2012, ADV EXP MED BIOL, V723, P381, DOI 10.1007/978-1-4614-0631-0_49; Szczyrba J, 2012, INT J CANC; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Toth T, 2000, HUM PATHOL, V31, P955; van Kouwenhove M, 2011, NAT REV CANCER, V11, P644, DOI 10.1038/nrc3107; Vumbaca F, 2008, MOL CELL BIOL, V28, P772, DOI 10.1128/MCB.02078-06; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu HL, 2009, CELL RES, V19, P439, DOI 10.1038/cr.2009.18; Xie T, 2011, PHYSIOL GENOMICS, V43, P479, DOI 10.1152/physiolgenomics.00222.2010; Xin H, 2012, MOL CANCER RES, V10, P108, DOI 10.1158/1541-7786.MCR-11-0435; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yue X, 2012, ONCOL REP, V27, P1200, DOI 10.3892/or.2011.1588; Zhou S, 2011, MOL CELL BIOL, V31, P4928, DOI 10.1128/MCB.06085-11; Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7	101	69	70	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49568	10.1371/journal.pone.0049568	http://dx.doi.org/10.1371/journal.pone.0049568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166713	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000311151900165
J	Maddams, JC; McCormick, MI				Maddams, Jessica Claire; McCormick, Mark Ian			Not All Offspring Are Created Equal: Variation in Larval Characteristics in a Serially Spawning Damselfish	PLOS ONE			English	Article							HADDOCK MELANOGRAMMUS-AEGLEFINUS; LIFE-HISTORY TRAITS; COD GADUS-MORHUA; EGG-SIZE; MATERNAL AGE; BODY-SIZE; CLUTCH SIZE; POMACENTRUS AMBOINENSIS; FITNESS CONSEQUENCES; FEMALE SIZE	The way organisms allocate their resources to growth and reproduction are key attributes differentiating life histories. Many organisms spawn multiple times in a breeding season, but few studies have investigated the impact of serial spawning on reproductive allocation. This study investigated whether resource allocation was influenced by parental characteristics and prior spawning history in a serial spawning tropical damselfish (Pomacentrus amboinensis). The offspring attributes of isolated parents of known characteristics were monitored over a 6-week breeding period in the field. Smaller females produced larvae of longer length and larger energy reserves at hatching. This finding is contrary to several other studies that found larger females produce offspring of greater quality. We found that resource allocation in the form of reproductive output was not influenced by the number of spawning events within the breeding season, with larger females producing the greatest number of offspring. Larval characteristics changed as spawning progressed. There was a general decline in length of larvae produced, with an increase in the size of the larval yolk-sac, for all females regardless of size as spawning progressed. This trend was accentuated by the smallest females. This change in larval characteristics may reflect a parental ability to forecast unfavourable conditions as the season progresses or a mechanism to ensure that some will survive no matter what conditions they encounter. This study highlights the importance of accounting for temporal changes in reproductive allocation in studies of reproductive trade-offs and investigations into the importance of parental effects.	[Maddams, Jessica Claire; McCormick, Mark Ian] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia	James Cook University	Maddams, JC (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld, Australia.	jessica.maddams@my.jcu.edu.au	McCormick, Mark I/J-8301-2014	McCormick, Mark I/0000-0001-9289-1645				Badyaev AV, 2009, PHILOS T R SOC B, V364, P1169, DOI 10.1098/rstb.2008.0302; BEACHAM TD, 1985, CAN J FISH AQUAT SCI, V42, P1755, DOI 10.1139/f85-220; Benton TG, 2008, J ANIM ECOL, V77, P1038, DOI 10.1111/j.1365-2656.2008.01434.x; Berkeley SA, 2004, ECOLOGY, V85, P1258, DOI 10.1890/03-0706; Bernardo J, 1996, AM ZOOL, V36, P216; Bernardo J, 1996, AM ZOOL, V36, P83; Blouin-Demers G, 2007, OIKOS, V116, P1759, DOI 10.1111/j.2007.0030-1299.15993.x; Bogdanova MI, 2006, FUNCT ECOL, V20, P132, DOI 10.1111/j.1365-2435.2006.01088.x; BOWEN WD, 1994, CAN J ZOOL, V72, P8, DOI 10.1139/z94-002; Bowen WD, 2001, CAN J ZOOL, V79, P1088, DOI 10.1139/cjz-79-6-1088; Bradford Michael J., 1997, Fish and Fisheries Series, V21, P469; Buckley LJ, 2000, J WORLD AQUACULT SOC, V31, P22, DOI 10.1111/j.1749-7345.2000.tb00694.x; CHAMBERS RC, 1989, FISH B-NOAA, V87, P515; Clemmesen C, 2003, J FISH BIOL, V62, P706, DOI 10.1046/j.1095-8649.2003.00060.x; Coltman DW, 1999, AM NAT, V154, P730, DOI 10.1086/303274; Crean AJ, 2009, PHILOS T R SOC B, V364, P1087, DOI 10.1098/rstb.2008.0237; CROXALL JP, 1992, IBIS, V134, P219, DOI 10.1111/j.1474-919X.1992.tb03803.x; DUARTE CM, 1989, OECOLOGIA, V80, P401, DOI 10.1007/BF00379043; Duckworth RA, 2009, PHILOS T R SOC B, V364, P1075, DOI 10.1098/rstb.2008.0294; Dunham A.E., 1988, Biology of Reptilia, V16, P441; Dziminski MA, 2006, J EVOLUTION BIOL, V19, P144, DOI 10.1111/j.1420-9101.2005.00978.x; Dziminski MA, 2005, OECOLOGIA, V146, P98, DOI 10.1007/s00442-005-0177-2; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; Fisher, 1958, GENETICAL THEORY NAT; Forsman A, 2001, OECOLOGIA, V129, P357, DOI 10.1007/s004420100743; FORTIER L, 1985, MAR ECOL PROG SER, V25, P245, DOI 10.3354/meps025245; FOWLER AJ, 1990, MAR ECOL PROG SER, V64, P25, DOI 10.3354/meps064025; Gagliano M, 2007, J ANIM ECOL, V76, P174, DOI 10.1111/j.1365-2656.2006.01187.x; Gagliano M, 2007, OECOLOGIA, V152, P219, DOI 10.1007/s00442-006-0647-1; Gagliano M, 2009, OECOLOGIA, V160, P657, DOI 10.1007/s00442-009-1335-8; GAILLARD JM, 1993, OECOLOGIA, V94, P57, DOI 10.1007/BF00317301; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; Hendry AP, 2003, EVOL ECOL RES, V5, P421; Hoey AS, 2004, OECOLOGIA, V139, P23, DOI 10.1007/s00442-004-1489-3; Hoey J, 2007, CORAL REEFS, V26, P603, DOI 10.1007/s00338-007-0246-6; Iverson J.B., 1992, HERPETOL MONOGR, V6, P25, DOI [10.2307/1466960, DOI 10.2307/1466960]; Jones GP, 2002, CORAL REEF FISHES DY; Jonsson N, 1999, J FISH BIOL, V55, P767, DOI 10.1111/j.1095-8649.1999.tb00716.x; Kamler E, 2005, REV FISH BIOL FISHER, V15, P399, DOI 10.1007/s11160-006-0002-y; Keech MA, 2000, J WILDLIFE MANAGE, V64, P450, DOI 10.2307/3803243; Kerrigan BA, 1997, MAR BIOL, V127, P395, DOI 10.1007/s002270050026; Kerrigan BA, 1996, MAR ECOL PROG SER, V135, P27, DOI 10.3354/meps135027; KJESBU OS, 1989, J FISH BIOL, V34, P195, DOI 10.1111/j.1095-8649.1989.tb03302.x; Kjesbu OS, 1996, CAN J FISH AQUAT SCI, V53, P610, DOI 10.1139/cjfas-53-3-610; Koops MA, 2004, FISH FISH, V5, P120, DOI 10.1111/j.1467-2979.2004.00149.x; KURAMOTO M, 1978, EVOLUTION, V32, P287, DOI 10.1111/j.1558-5646.1978.tb00644.x; Lambert Yvan, 2003, Journal of Northwest Atlantic Fishery Science, V33, P115, DOI 10.2960/J.v33.a7; LANDA K, 1992, EVOLUTION, V46, P1553, DOI 10.1111/j.1558-5646.1992.tb01145.x; LARSSON FK, 1989, DEUT ENTOMOL Z, V36, P329, DOI 10.1002/mmnd.19890360423; Marshall DJ, 2004, MAR ECOL PROG SER, V272, P301, DOI 10.3354/meps272301; Marteinsdottir G, 1998, J FISH BIOL, V52, P1241, DOI 10.1111/j.1095-8649.1998.tb00969.x; McCormick MI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010616; McCormick MI, 2009, OIKOS, V118, P744, DOI 10.1111/j.1600-0706.2008.17410.x; McCormick MI, 2002, J EXP ZOOL, V293, P456, DOI 10.1002/jez.10138; McCormick MI, 2003, OECOLOGIA, V136, P37, DOI 10.1007/s00442-003-1247-y; McCormick MI, 1998, ECOLOGY, V79, P1873, DOI 10.1890/0012-9658(1998)079[1873:BIMSIA]2.0.CO;2; McCormick MI, 2006, ECOLOGY, V87, P1104, DOI 10.1890/0012-9658(2006)87[1104:MMCLTS]2.0.CO;2; McCormick MI, 2004, CORAL REEFS, V23, P570, DOI 10.1007/s00338-004-0413-y; McCormick MI, 2008, P 11 INT COR REEF S; MCGURK MD, 1986, MAR ECOL PROG SER, V34, P227, DOI 10.3354/meps034227; Meekan MG, 2010, ANIM BEHAV, V79, P803, DOI 10.1016/j.anbehav.2009.12.002; Mousseau TA, 2009, PHILOS T R SOC B, V364, P1035, DOI 10.1098/rstb.2008.0303; NAKATSURU K, 1982, SCIENCE, V216, P753, DOI 10.1126/science.216.4547.753; Nemeth RS, 2005, REV BIOL TROP, V53, P155; OOZEKI Y, 1988, AQUACULTURE, V71, P265, DOI 10.1016/0044-8486(88)90264-5; PARICHY DM, 1992, OECOLOGIA, V91, P579, DOI 10.1007/BF00650334; PHILIPPI T, 1989, TRENDS ECOL EVOL, V4, P41, DOI 10.1016/0169-5347(89)90138-9; Plaistow SJ, 2009, PHILOS T R SOC B, V364, P1049, DOI 10.1098/rstb.2008.0251; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Roff Derek A., 1992; RONNESTAD I, 1992, MAR BIOL, V114, P517, DOI 10.1007/BF00357249; Rose KE, 1998, J ANIM ECOL, V67, P979, DOI 10.1046/j.1365-2656.1998.6760979.x; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Sale P.F., 1991, ECOLOGY FISHES CORAL; Samhouri JF, 2009, ECOLOGY, V90, P3478, DOI 10.1890/08-1732.1; SCHLUTER D, 1993, EVOLUTION, V47, P658, DOI 10.1111/j.1558-5646.1993.tb02119.x; Shanbhag BA, 2000, COPEIA, P1062; SINERVO B, 1990, EVOLUTION, V44, P279, DOI 10.1111/j.1558-5646.1990.tb05198.x; SPEAR L, 1994, J ANIM ECOL, V63, P283, DOI 10.2307/5547; Stearns S.C., 1992, pi; STEARNS SC, 1986, EVOLUTION, V40, P893, DOI 10.1111/j.1558-5646.1986.tb00560.x; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Tamada K, 2005, ENVIRON BIOL FISH, V73, P379, DOI 10.1007/s10641-005-2230-8; THESSING A, 1994, J EVOLUTION BIOL, V7, P713, DOI 10.1046/j.1420-9101.1994.7060713.x; Trippel EA, 1998, T AM FISH SOC, V127, P339, DOI 10.1577/1548-8659(1998)127&lt;0339:ESAVAS&gt;2.0.CO;2; Trippel EA, 2004, CAN J FISH AQUAT SCI, V61, P2097, DOI [10.1139/f04-125, 10.1139/F04-125]; Trippel EA, 1997, EARLY LIFE HIST RECR, P63; VANDIJK TS, 1994, ECOL ENTOMOL, V19, P263, DOI 10.1111/j.1365-2311.1994.tb00418.x; Wilkinson LR, 2005, COPEIA, P868, DOI 10.1643/0045-8511(2005)005[0868:PORACA]2.0.CO;2; Williams G. C., 1966, P307; Wilson DT, 2002, MAR ECOL PROG SER, V231, P247, DOI 10.3354/meps231247; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	92	15	15	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48525	10.1371/journal.pone.0048525	http://dx.doi.org/10.1371/journal.pone.0048525			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155389	Green Published, Green Accepted, gold			2022-12-27	WOS:000311151900023
J	Shephard, S; Gerritsen, H; Kaiser, MJ; Reid, DG				Shephard, Samuel; Gerritsen, Hans; Kaiser, Michel J.; Reid, David G.			Spatial Heterogeneity in Fishing Creates de facto Refugia for Endangered Celtic Sea Elasmobranchs	PLOS ONE			English	Article							MARINE PROTECTED AREAS; ATLANTIC SHELF SEAS; NORTH-SEA; DEMERSAL FISH; SPECIES COMPOSITION; COMMUNITY STRUCTURE; NURSERY AREAS; CONSERVATION; FISHERIES; PATTERNS	The life history characteristics of some elasmobranchs make them particularly vulnerable to fishing mortality; about a third of all species are listed by the IUCN as Threatened or Near Threatened. Marine Protected Areas (MPAs) have been suggested as a tool for conservation of elasmobranchs, but they are likely to be effective only if such populations respond to fishing impacts at spatial-scales corresponding to MPA size. Using the example of the Celtic Sea, we modelled elasmobranch biomass (kg h(-1)) in fisheries-independent survey hauls as a function of environmental variables and 'local' (within 20 km radius) fishing effort (h y(-1)) recorded from Vessel Monitoring Systems data. Model selection using AIC suggested strongest support for linear mixed effects models in which the variables (i) fishing effort, (ii) geographic location and (iii) demersal fish assemblage had approximately equal importance in explaining elasmobranch biomass. In the eastern Celtic Sea, sampling sites that occurred in the lowest 10% of the observed fishing effort range recorded 10 species of elasmobranch including the critically endangered Dipturus spp. The most intensely fished 10% of sites had only three elasmobranch species, with two IUCN listed as Least Concern. Our results suggest that stable spatial heterogeneity in fishing effort creates de facto refugia for elasmobranchs in the Celtic Sea. However, changes in the present fisheries management regime could impair the refuge effect by changing fisher's behaviour and displacing effort into these areas.	[Shephard, Samuel] Galway Mayo Inst Technol, Marine & Freshwater Res Ctr, Galway, Ireland	Galway Mayo Institute of Technology	Shephard, S (corresponding author), Galway Mayo Inst Technol, Marine & Freshwater Res Ctr, Galway, Ireland.	samuel.shephard@gmit.ie	Reid, David/ABC-5916-2021; Gerritsen, Hans/J-5245-2019	Gerritsen, Hans/0000-0003-3689-1020; Reid, Dave/0000-0002-8494-0918; Kaiser, Michel Josef/0000-0001-8782-3621				Babcock EA, 2005, ICES J MAR SCI, V62, P469, DOI 10.1016/j.icesjms.2005.01.010; Badalamenti F, 2000, ENVIRON CONSERV, V27, P110, DOI 10.1017/S0376892900000163; Blanchard JL, 2005, CAN J FISH AQUAT SCI, V62, P2001, DOI 10.1139/F05-109; Blyth-Skyrme RE, 2006, CONSERV BIOL, V20, P811, DOI 10.1111/j.1523-1739.2006.00345.x; BRANDER K, 1981, NATURE, V290, P48, DOI 10.1038/290048a0; Carter DW, 2003, OCEAN COAST MANAGE, V46, P439, DOI 10.1016/S0964-5691(03)00017-6; Clarke KR, 2008, J EXP MAR BIOL ECOL, V366, P56, DOI 10.1016/j.jembe.2008.07.009; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; DAAN N, 1990, NETH J SEA RES, V26, P343, DOI 10.1016/0077-7579(90)90096-Y; Dulvy NK, 2006, CAN J FISH AQUAT SCI, V63, P1267, DOI 10.1139/F06-035; Dulvy NK, 2003, FISH FISH, V4, P25, DOI 10.1046/j.1467-2979.2003.00105.x; Dulvy NK, 1997, P ROY SOC B-BIOL SCI, V264, P1309, DOI 10.1098/rspb.1997.0181; Ehrich S, 2009, FISH OCEANOGR, V18, P36, DOI 10.1111/j.1365-2419.2008.00495.x; Ellis JR, 2012, J FISH BIOL, V80, P1057, DOI 10.1111/j.1095-8649.2011.03211.x; Ellis J.R., 2005, J NW ATL FISH SCI, V37, P195, DOI [10.2960/J.v35.m485, DOI 10.2960/J.V35.M485]; Ellis JR, 2000, ESTUAR COAST SHELF S, V51, P299, DOI 10.1006/ecss.2000.0677; Farrow S, 1996, MAR POLICY, V20, P439, DOI 10.1016/S0308-597X(96)00034-6; Fraser HM, 2008, ICES J MAR SCI, V65, P531, DOI 10.1093/icesjms/fsn036; Freon P, 2005, ICES J MAR SCI, V62, P459, DOI 10.1016/j.icesjms.2004.12.010; Frisk MG, 2002, ICES J MAR SCI, V59, P576, DOI 10.1006/jmsc.2002.1177; Garla RC, 2006, MAR BIOL, V149, P189, DOI 10.1007/s00227-005-0201-4; Gerritsen H, 2011, ICES J MAR SCI, V68, P245, DOI 10.1093/icesjms/fsq137; Greenstreet SPR, 2011, ICES J MAR SCI, V68, P1, DOI 10.1093/icesjms/fsq156; Greenstreet SPR, 1999, FISH RES, V40, P153, DOI 10.1016/S0165-7836(98)00210-0; Haedrich RL, 1997, FISH RES, V31, P229, DOI 10.1016/S0165-7836(97)00023-4; Heupel MR, 2007, MAR ECOL PROG SER, V337, P287, DOI 10.3354/meps337287; Hilborn R, 2004, OCEAN COAST MANAGE, V47, P197, DOI 10.1016/j.ocecoaman.2004.04.001; Hinz H, 2003, J FISH BIOL, V63, P1219, DOI 10.1046/j.1095-8649.2003.00244.x; Hinz H, 2009, ECOL APPL, V19, P761, DOI 10.1890/08-0351.1; Hobday AJ, 2011, FISH RES, V108, P372, DOI 10.1016/j.fishres.2011.01.013; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; Kaiser MJ, 2005, CAN J FISH AQUAT SCI, V62, P1194, DOI 10.1139/F05-056; Kinney MJ, 2009, CONSERV LETT, V2, P53, DOI 10.1111/j.1755-263X.2008.00046.x; Klein CJ, 2008, CONSERV BIOL, V22, P691, DOI 10.1111/j.1523-1739.2008.00896.x; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Le Quesne WJF, 2009, ICES J MAR SCI, V66, P122, DOI 10.1093/icesjms/fsn202; Le Quesne WJF, 2012, J APPL ECOL, V49, P20, DOI 10.1111/j.1365-2664.2011.02087.x; Lester SE, 2009, MAR ECOL PROG SER, V384, P33, DOI 10.3354/meps08029; Maravelias CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035474; Martin CS, 2010, MAR ECOL PROG SER, V417, P211, DOI 10.3354/meps08802; Maunder MN, 2004, FISH RES, V70, P141, DOI 10.1016/j.fishres.2004.08.002; McCrea-Strub A, 2011, MAR POLICY, V35, P1, DOI 10.1016/j.marpol.2010.07.001; Nilsson P, 2007, AQUAT CONSERV, V17, P421, DOI 10.1002/aqc.792; Papastamatiou YP, 2012, J FISH BIOL, V80, P1342, DOI 10.1111/j.1095-8649.2012.03232.x; Persohn C, 2009, FISH OCEANOGR, V18, P268, DOI 10.1111/j.1365-2419.2009.00515.x; Philippart CJM, 1998, ICES J MAR SCI, V55, P342, DOI 10.1006/jmsc.1997.0321; Piet GJ, 2009, ICES J MAR SCI, V66, P1985, DOI 10.1093/icesjms/fsp162; Pinnegar JK, 2003, J FISH BIOL, V63, P197, DOI 10.1111/j.1095-8649.2003.00204.x; Rochet MJ, 2002, ICES J MAR SCI, V59, P538, DOI 10.1006/jmsc.2002.1182; Rodriguez-Cabello C, 2008, J MARINE SYST, V72, P418, DOI 10.1016/j.jmarsys.2007.09.010; Rogers SI, 1999, FISH RES, V40, P135, DOI 10.1016/S0165-7836(98)00209-4; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Shephard S, 2012, ICES J MAR SCI, V69, P223, DOI 10.1093/icesjms/fsr200; Shephard S, 2011, ICES J MAR SCI, V68, P2106, DOI 10.1093/icesjms/fsr137; Shepherd TD, 2005, ECOL LETT, V8, P1095, DOI 10.1111/j.1461-0248.2005.00807.x; Shin YJ, 2005, ICES J MAR SCI, V62, P384, DOI 10.1016/j.icesjms.2005.01.004; Silva JF, 2012, J FISH BIOL, V80, P1678, DOI 10.1111/j.1095-8649.2012.03247.x; Simpfendorfer CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016918; Stewart GB, 2009, CONSERV LETT, V2, P243, DOI 10.1111/j.1755-263X.2009.00074.x; Suuronen P, 2010, MAR POLICY, V34, P237, DOI 10.1016/j.marpol.2009.07.001; Trenkel VM, 2005, MAR ECOL PROG SER, V299, P257, DOI 10.3354/meps299257; Walker PA, 1996, ICES J MAR SCI, V53, P1085, DOI 10.1006/jmsc.1996.0135; Walker PA, 1998, ICES J MAR SCI, V55, P392, DOI 10.1006/jmsc.1997.0325; Ward-Paige CA, 2012, J FISH BIOL, V80, P1844, DOI 10.1111/j.1095-8649.2012.03246.x; Wearmouth VJ, 2009, J EXP MAR BIOL ECOL, V380, P77, DOI 10.1016/j.jembe.2009.07.035; Wells RJD, 2008, CAN J FISH AQUAT SCI, V65, P2399, DOI 10.1139/F08-145; Wiegand J, 2011, MAR FRESHWATER RES, V62, P722, DOI 10.1071/MF10141	67	26	26	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49307	10.1371/journal.pone.0049307	http://dx.doi.org/10.1371/journal.pone.0049307			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166635	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900120
J	Straney, LD; Lim, SS; Murray, CJL				Straney, Lahn D.; Lim, Stephen S.; Murray, Christopher J. L.			Disentangling the Effects of Risk Factors and Clinical Care on Subnational Variation in Early Neonatal Mortality in the United States	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; INTENSIVE-CARE; SINGLETON BIRTHS; PRETERM BIRTHS; INFANTS; LEVEL; DELIVERY; NEWBORN; IMPACT; US	Objective: Between 1990 and 2010, the U.S ranking in neonatal mortality slipped from 29th to 45th among countries globally. Substantial subnational variation in newborn mortality also exists. Our objective is to measure the extent to which trends and subnational variation in early neonatal mortality reflect differences in the prevalence of risk factors (gestational age and birth weight) compared to differences in clinical care. Methods: Observational study using linked birth and death data for all births in the United States between 1996 and 2006. We examined health service area (HSA) level variation in the expected early neonatal mortality rate, based on gestational age (GA) and birth-weight (BW), and GA-BW adjusted mortality as a proxy for clinical care. We analyzed the relationship between selected health system indicators and GA-BW-adjusted mortality. Results: The early neonatal death (ENND) rate declined 12% between 1996 and 2006 (2.39 to 2.10 per 1000 live births). This occurred despite increases in risk factor prevalence. There was significant HSA-level variation in the expected ENND rate (Rate Ratio: 0.73-1.47) and the GA-BW adjusted rate (Rate ratio: 0.63-1.68). Accounting for preterm volume (defined as <34 weeks), the number of neonatologist and NICU beds, 25.2% and 58.7% of the HSA-level variance in outcomes was explained among all births and very low birth weight babies, respectively. Conclusion: Improvements in mortality could be realized through the expansion or reallocation of clinical neonatal resources, particularly in HSAs with a high volume of preterm births; however, prevention of preterm births and low-birth weight babies has a greater potential to improve newborn survival in the United States.	[Straney, Lahn D.; Lim, Stephen S.; Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Dept Global Hlth, Seattle, WA 98195 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Straney, LD (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Dept Global Hlth, Seattle, WA 98195 USA.	lahn.straney@monash.edu		Straney, Lahn/0000-0002-2615-2366				American Medical Association, AMA PHYS MAST; [Anonymous], 2009, DEATHS FIN DAT 2006; BARKER DJP, 1990, BRIT MED J, V301, P1111, DOI 10.1136/bmj.301.6761.1111; Barros FC, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S3; Bettegowda VR, 2008, CLIN PERINATOL, V35, P309, DOI 10.1016/j.clp.2008.03.002; Blondel B, 2009, BJOG-INT J OBSTET GY, V116, P1364, DOI 10.1111/j.1471-0528.2009.02239.x; Chien LY, 2001, OBSTET GYNECOL, V98, P247, DOI 10.1016/S0029-7844(01)01438-7; Cifuentes J, 2002, PEDIATRICS, V109, P745, DOI 10.1542/peds.109.5.745; COLLINS J W JR, 1992, Ethnicity and Disease, V2, P18; Conde-Agudelo A, 2006, JAMA-J AM MED ASSOC, V295, P1809, DOI 10.1001/jama.295.15.1809; Dietz PM, 2010, AM J PREV MED, V39, P45, DOI 10.1016/j.amepre.2010.03.009; Duley L, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004659.pub2; Ehrenthal DB, 2011, MATERN CHILD HLTH J, V15, P42, DOI 10.1007/s10995-010-0566-y; Empana JP, 2003, ACTA PAEDIATR, V92, P346; Fuchs K, 2006, CLIN PERINATOL, V33, P793, DOI 10.1016/j.clp.2006.09.010; Goodman DC, 2002, NEW ENGL J MED, V346, P1538, DOI 10.1056/NEJMoa011921; GORTMAKER SL, 1979, AM J PUBLIC HEALTH, V69, P653, DOI 10.2105/AJPH.69.7.653; Health Resources and Services Administration. Area Resource File ( ARF), AR RES FIL ARF; Kesmodel U, 2000, EPIDEMIOLOGY, V11, P512, DOI 10.1097/00001648-200009000-00005; Kresch M J, 1998, J Perinatol, V18, P276; Kulkarni SC, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-16; LARROQUE B, 1992, International Journal of Epidemiology, V21, pS8, DOI 10.1093/ije/21.Supplement_1.S8; LEE KS, 1980, AM J PUBLIC HEALTH, V70, P15, DOI 10.2105/AJPH.70.1.15; Lozano R, 2011, LANCET, V378, P1139, DOI 10.1016/S0140-6736(11)61337-8; Murray CJL, 2006, PLOS MED, V3, P1513, DOI 10.1371/journal.pmed.0030260; PANETH N, 1987, AM J DIS CHILD, V141, P60, DOI 10.1001/archpedi.1987.04460010060024; PANETH N, 1982, NEW ENGL J MED, V307, P149, DOI 10.1056/NEJM198207153070303; Phibbs CS, 2007, NEW ENGL J MED, V356, P2165, DOI 10.1056/NEJMsa065029; Phibbs CS, 1996, JAMA-J AM MED ASSOC, V276, P1054, DOI 10.1001/jama.276.13.1054; Richardson D, 1999, Pediatrics, V103, P255; Richardson DK, 1998, PEDIATRICS, V102, P893, DOI 10.1542/peds.102.4.893; Rogowski JA, 2004, HEALTH AFFAIR, V23, P88, DOI 10.1377/hlthaff.23.5.88; Salihu Hamisu M, 2003, Matern Child Health J, V7, P219, DOI 10.1023/A:1027319517405; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Srebotnjak T, 2010, POPUL HEALTH METR, V8, DOI 10.1186/1478-7954-8-26; Surveillance Epidemiology and End Results (2008), 2008, HLTH SERV AR HSA SEE; Thompson LA, 2005, PEDIATRICS, V116, P1114, DOI 10.1542/peds.2004-1627; VERLOOVEVANHORICK SP, 1988, PEDIATRICS, V81, P404; Warner B, 2004, PEDIATRICS, V113, P35, DOI 10.1542/peds.113.1.35; WILSON AL, 1986, PEDIATRICS, V78, P850; Yeast JD, 1998, AM J OBSTET GYNECOL, V178, P131, DOI 10.1016/S0002-9378(98)70639-8	41	8	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49399	10.1371/journal.pone.0049399	http://dx.doi.org/10.1371/journal.pone.0049399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166659	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900137
J	Tanferna, A; Lopez-Jimenez, L; Blas, J; Hiraldo, F; Sergio, F				Tanferna, Alessandro; Lopez-Jimenez, Lidia; Blas, Julio; Hiraldo, Fernando; Sergio, Fabrizio			Different Location Sampling Frequencies by Satellite Tags Yield Different Estimates of Migration Performance: Pooling Data Requires a Common Protocol	PLOS ONE			English	Article							WINTERING SITES; ACCURACY; TRACKING; TELEMETRY; PATTERNS; OPPORTUNITIES; MOVEMENTS; BEHAVIOR; ECOLOGY; OSPREYS	Migration research is in rapid expansion and increasingly based on sophisticated satellite-tracking devices subject to constant technological refinement, but is still ripe with descriptive studies and in need of meta-analyses looking for emergent generalisations. In particular, coexistence of studies and devices with different frequency of location sampling and spatial accuracy generates doubts of data compatibility, potentially preventing meta-analyses. We used satellite-tracking data on a migratory raptor to: (1) test whether data based on different location sampling frequencies and on different position subsampling approaches are compatible, and (2) seek potential solutions that enhance compatibility and enable eventual meta-analyses. Methodology/Principal Findings: We used linear mixed models to analyse the differences in the speed and route length of the migration tracks of 36 Black kites (Milvus migrans) satellite-tagged with two different types of devices (Argos vs GPS tags), entailing different regimes of position sampling frequency. We show that different location sampling frequencies and data subsampling approaches generate large (up to 33%) differences in the estimates of route length and migration speed of this migratory bird. Conclusions/Significance: Our results show that the abundance of locations available for analysis affects the tortuosity and realism of the estimated migration path. To avoid flaws in future meta-analyses or unnecessary loss of data, we urge researchers to reach an agreement on a common protocol of data presentation, and to recognize that all transmitter-based studies are likely to underestimate the actual distance traveled by the marked animal. As ecological research becomes increasingly technological, new technologies should be matched with improvements in analytical capacity that guarantee data compatibility.	[Tanferna, Alessandro; Lopez-Jimenez, Lidia; Blas, Julio; Hiraldo, Fernando; Sergio, Fabrizio] CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Tanferna, A (corresponding author), CSIC, Dept Conservat Biol, Estn Biol Donana, E-41080 Seville, Spain.	a.tanferna@ebd.csic.es	Sergio, Fabrizio/B-3952-2015; Hiraldo, Fernando/AAA-8314-2019; Blas, Julio/A-2487-2012; Tanferna, Alessandro/L-6648-2015; López, Lidia/HGE-0751-2022	Sergio, Fabrizio/0000-0002-8024-1773; Blas, Julio/0000-0003-0589-3322; Tanferna, Alessandro/0000-0003-0799-301X; Lopez-Jimenez, Lidia/0000-0002-4109-3034				Alerstam T, 2006, ANIM BEHAV, V71, P555, DOI 10.1016/j.anbehav.2005.05.016; Alerstam T, 2000, EXPTL BIOL REV, P105; Argos, 2011, US MAN CLS SERV ARG; Argos System CLS, 2010, ARG LOC ITS BEST ARG; Beck MW, 1997, OIKOS, V78, P265, DOI 10.2307/3546293; Belovsky GE, 2004, BIOSCIENCE, V54, P345, DOI 10.1641/0006-3568(2004)054[0345:TSTSTS]2.0.CO;2; Bolger DT, 2008, ECOL LETT, V11, P63; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Cerling TE, 2006, P NATL ACAD SCI USA, V103, P371, DOI 10.1073/pnas.0509606102; Chevallier D, 2010, P ROY SOC B-BIOL SCI, V277, P2755, DOI 10.1098/rspb.2010.0422; Combreau O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020570; Cooke SJ, 2004, TRENDS ECOL EVOL, V19, P334, DOI 10.1016/j.tree.2004.04.003; Costa DP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008677; Crawley MJ, 2011, R BOOK; ESRI, 2002, ARCGIS 9 2; Fast PLF, 2011, J WILDLIFE MANAGE, V75, P1553, DOI 10.1002/jwmg.220; Freitas C, 2008, MAR MAMMAL SCI, V24, P315, DOI 10.1111/j.1748-7692.2007.00180.x; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; Guilford T, 2011, J EXP BIOL, V214, P3705, DOI 10.1242/jeb.051292; Hatch SA, 2011, J FIELD ORNITHOL, V82, P269, DOI 10.1111/j.1557-9263.2011.00330.x; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; Johnson CJ, 2002, ECOL APPL, V12, P1840, DOI 10.1890/1051-0761(2002)012[1840:AMBATU]2.0.CO;2; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kjellen N, 1997, J AVIAN BIOL, V28, P15, DOI 10.2307/3677089; Klaassen RHG, 2012, BEHAV ECOL, V23, P58, DOI 10.1093/beheco/arr150; LAUNDRE JW, 1987, J WILDLIFE MANAGE, V51, P937, DOI 10.2307/3801763; Liminana R, 2012, J ORNITHOL, V153, P85, DOI 10.1007/s10336-011-0698-x; Malarde J, 2011, IMPROVING ARGOS DOPP; Mandernack BA, 2012, J RAPTOR RES, V46, P258, DOI 10.3356/JRR-10-77.1; Martell MS, 2001, CONDOR, V103, P715, DOI 10.1650/0010-5422(2001)103[0715:FMRTAW]2.0.CO;2; Miller-Gulland EJ, 2011, ANIMAL MIGRATION SYN; Nelson AA, 2012, ECOL APPL IN PRESS; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Ngene SM, 2010, AFR J ECOL, V48, P386, DOI 10.1111/j.1365-2028.2009.01125.x; Patterson TA, 2010, ECOLOGY, V91, P273, DOI 10.1890/08-1480.1; Pepin D, 2004, J MAMMAL, V85, P774, DOI 10.1644/BER-022; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; R Core Team, 2018, R LANG ENV STAT COMP; REYNOLDS TD, 1990, J WILDLIFE MANAGE, V54, P316, DOI 10.2307/3809049; Rowcliffe JM, 2012, METHODS ECOL EVOL, V3, P653, DOI 10.1111/j.2041-210X.2012.00197.x; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Schwartz Charles C., 1999, Ursus, V11, P261; Sergio F, 2011, SCIENCE, V331, P327, DOI 10.1126/science.1199422; Sergio F, 2007, BEHAV ECOL, V18, P811, DOI 10.1093/beheco/arm052; Soutullo A, 2007, J WILDLIFE MANAGE, V71, P1010, DOI 10.2193/2006-042; Terraube J, 2012, DIVERS DISTRIB, V18, P401, DOI 10.1111/j.1472-4642.2011.00830.x; Thompson JN, 2001, BIOSCIENCE, V51, P15, DOI 10.1641/0006-3568(2001)051[0015:FOE]2.0.CO;2; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Yamaguchi NM, 2012, J ETHOL, V30, P1, DOI 10.1007/s10164-011-0301-1; Zerbini AN, 2006, MAR ECOL PROG SER, V313, P295, DOI 10.3354/meps313295	52	13	14	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49659	10.1371/journal.pone.0049659	http://dx.doi.org/10.1371/journal.pone.0049659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166742	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900181
J	van Egmond-Frohlich, AWA; Weghuber, D; de Zwaan, M				van Egmond-Froehlich, Andreas W. A.; Weghuber, Daniel; de Zwaan, Martina			Association of Symptoms of Attention-Deficit/Hyperactivity Disorder with Physical Activity, Media Time, and Food Intake in Children and Adolescents	PLOS ONE			English	Article							GERMAN HEALTH INTERVIEW; DEFICIT HYPERACTIVITY DISORDER; BODY-MASS INDEX; DIFFICULTIES QUESTIONNAIRE; TELEVISION EXPOSURE; BEHAVIOR CHECKLIST; US CHILDREN; OVERWEIGHT; KIGGS; OBESITY	Introduction: The aim of the study was to assess the association between attention deficit/hyperactivity disorder (ADHD) symptoms and potentially obesogenic behaviors. Methods: Data of 11,676 German children and adolescents (6-17 years) were analyzed. Television/video exposure, physical activity, food frequency and portion size were assessed using questionnaires. A dietary quality index, energy density and volumes of consumed food, and total energy intake were calculated. The parent-rated hyperactivity/inattention subscale of the Strengths and Difficulties Questionnaire (SDQ-HI) was used as a continuous measure of ADHD symptoms. Associations were analyzed with general linear models adjusting for sex, age, socioeconomic status, migrant status, parental BMI, and parental smoking. Results: SDQ-HI scores correlated positively with physical activity, average energy density of food, volume of beverages, total energy intake, and television exposure and negatively with the nutritional quality score (HuSKY) even after adjustment for parental variables (BMI, smoking, socioeconomic status, migrant status), age, sex, as well as the other SDQ subscales. The adjusted association of the SDQ-HI scores with the nutritional quality score was stronger in girls and the associations with food volume, food energy, and total energy intake was significant only in girls. Conclusions: Poor nutritional quality, high energy intake and television exposure appear to be independently associated with ADHD symptoms. The relationship between food energy intake and ADHD symptoms was especially pronounced in girls and this may help to explain the reported association of ADHD symptoms with overweight in adolescent girls.	[van Egmond-Froehlich, Andreas W. A.] SMZ Ost Donauspital, Dept Pediat, Vienna, Austria	Donauspital	van Egmond-Frohlich, AWA (corresponding author), SMZ Ost Donauspital, Dept Pediat, Vienna, Austria.	dezwaan.martina@mh-hannover.de	Weghuber, Daniel/AAN-1422-2020	Weghuber, Daniel/0000-0002-4389-0379				Agranat-Meged AN, 2005, INT J EAT DISORDER, V37, P357, DOI 10.1002/eat.20096; Allan JL, 2010, APPETITE, V54, P422, DOI 10.1016/j.appet.2010.01.009; Azadbakht L, 2012, NUTRITION, V28, P242, DOI 10.1016/j.nut.2011.05.018; Batada A, 2008, J AM DIET ASSOC, V108, P673, DOI 10.1016/j.jada.2008.01.015; Bauchner H, 2000, ARCH DIS CHILD, V83, P63; Braet C, 2007, EUR CHILD ADOLES PSY, V16, P473, DOI 10.1007/s00787-007-0623-2; Chen W, 2008, AM J MED GENET B, V147B, P1450, DOI 10.1002/ajmg.b.30672; Christakis DA, 2004, PEDIATRICS, V113, P708, DOI 10.1542/peds.113.4.708; Curtin Carol, 2005, BMC Pediatr, V5, P48, DOI 10.1186/1471-2431-5-48; Dixon HG, 2007, SOC SCI MED, V65, P1311, DOI 10.1016/j.socscimed.2007.05.011; Drukker M, 2009, INT J PEDIATR OBES, V4, P91, DOI 10.1080/17477160802395442; Erhart M, 2012, EUR CHILD ADOLES PSY, V21, P39, DOI 10.1007/s00787-011-0230-0; Goodman R, 2003, INT REV PSYCHIATR, V15, P173, DOI 10.1080/0954026021000046137; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Guerrieri R, 2008, INT J OBESITY, V32, P708, DOI 10.1038/sj.ijo.0803770; Guerrieri R, 2007, APPETITE, V49, P66, DOI 10.1016/j.appet.2006.11.008; Guerrieri R, 2007, APPETITE, V48, P119, DOI 10.1016/j.appet.2006.06.004; Holling H, 2007, BUNDESGESUNDHEITSBLA, V50, P784, DOI 10.1007/s00103-007-0241-7; Hoffmeister U, 2011, BUNDESGESUNDHEITSBLA, V54, P128, DOI 10.1007/s00103-010-1193-x; Holtkamp K, 2004, INT J OBESITY, V28, P685, DOI 10.1038/sj.ijo.0802623; Howard AL, 2011, J ATTEN DISORD, V15, P403, DOI 10.1177/1087054710365990; Hubel R, 2006, Eat Weight Disord, V11, P139; Jansen A, 2009, BEHAV RES THER, V47, P105, DOI 10.1016/j.brat.2008.10.016; Johnson JG, 2007, ARCH PEDIAT ADOL MED, V161, P480, DOI 10.1001/archpedi.161.5.480; Kersting M, 2005, J PEDIATR GASTR NUTR, V40, P301, DOI 10.1097/01.MPG.0000153887.19429.70; Kim J, 2011, PREV MED, V52, P218, DOI 10.1016/j.ypmed.2011.01.003; Kleiser C, 2009, BRIT J NUTR, V102, P610, DOI 10.1017/S0007114509222689; KOTZ K, 1994, J AM DIET ASSOC, V94, P1296, DOI 10.1016/0002-8223(94)92463-5; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Kurth BM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-196; Lam LT, 2007, INT J OBESITY, V31, P584, DOI 10.1038/sj.ijo.0803526; Lampert T, 2007, BUNDESGESUNDHEITSBLA, V50, P634, DOI 10.1007/s00103-007-0224-8; Landhuis CE, 2007, PEDIATRICS, V120, P532, DOI 10.1542/peds.2007-0978; Lange M, 2007, BUNDESGESUNDHEITSBLA, V50, P578, DOI 10.1007/s00103-007-0219-5; Levy F, 1997, J AM ACAD CHILD PSY, V36, P737, DOI 10.1097/00004583-199706000-00009; Lingineni RK, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-50; Matheson DM, 2004, AM J CLIN NUTR, V79, P1088; Mensink GBM, 2007, BUNDESGESUNDHEITSBLA, V50, P609, DOI 10.1007/s00103-007-0222-x; Miller CJ, 2007, J PEDIATR PSYCHOL, V32, P448, DOI 10.1093/jpepsy/jsl035; Morgenstern M, 2009, ARCH PEDIAT ADOL MED, V163, P731, DOI 10.1001/archpediatrics.2009.78; Nederkoorn C, 2007, BEHAV RES THER, V45, P1071, DOI 10.1016/j.brat.2006.05.009; Nederkoorn Chantal, 2006, Eat Behav, V7, P315, DOI 10.1016/j.eatbeh.2005.11.005; Ozmert E, 2002, ARCH PEDIAT ADOL MED, V156, P910; Pinto LP, 1996, BEHAV MODIF, V20, P243, DOI 10.1177/01454455960203001; PORRINO LJ, 1983, ARCH GEN PSYCHIAT, V40, P681; Ptacek R, 2009, NEUROENDOCRINOL LETT, V30, P377; Rojo L, 2006, INT J EAT DISORDER, V39, P519, DOI 10.1002/eat.20284; Schenk L, 2007, BUNDESGESUNDHEITSBLA, V50, P590, DOI 10.1007/s00103-007-0220-z; Stevens T, 2006, PEDIATRICS, V117, P665, DOI 10.1542/peds.2005-0863; Swing EL, 2010, PEDIATRICS, V126, P214, DOI 10.1542/peds.2009-1508; van Egmond-Frohlich AWA, 2012, INT J OBESITY, V36, P963, DOI 10.1038/ijo.2012.78; van Egmond-Froehlich A, 2013, INT J EAT DISORDER, V46, P39, DOI 10.1002/eat.22043; Waring ME, 2008, PEDIATRICS, V122, pE1, DOI 10.1542/peds.2007-1955; Widhalm K, 2012, OBES FACTS IN PRESS; Winkler J., 1999, GESUNDHEITSWESEN, V61, pS178; Wood AC, 2009, J AM ACAD CHILD PSY, V48, P1023, DOI 10.1097/CHI.0b013e3181b54612	58	40	40	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49781	10.1371/journal.pone.0049781	http://dx.doi.org/10.1371/journal.pone.0049781			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166770	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900194
J	Morrison, BJ; Steel, JC; Morris, JC				Morrison, Brian J.; Steel, Jason C.; Morris, John C.			Sphere Culture of Murine Lung Cancer Cell Lines Are Enriched with Cancer Initiating Cells	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; STEM-CELLS; SIDE-POPULATION; IN-VITRO; IDENTIFICATION; EXPRESSION; CARCINOMA; TRANSPLANTATION; ANGIOSTATIN; TRANSPORTER	Cancer initiating cells (CICs) represent a unique cell population essential for the maintenance and growth of tumors. Most in vivo studies of CICs utilize human tumor xenografts in immunodeficient mice. These models provide limited information on the interaction of CICs with the host immune system and are of limited value in assessing therapies targeting CICs, especially immune-based therapies. To assess this, a syngeneic cancer model is needed. We examined the sphere-forming capacity of thirteen murine lung cancer cell lines and identified TC-1 and a metastatic subclone of Lewis lung carcinoma (HM-LLC) as cell lines that readily formed and maintained spheres over multiple passages. TC-1 tumorspheres were not enriched for expression of CD133 or CD44, putative CIC markers, nor did they demonstrate Hoechst 33342 side population staining or Aldefluor activity compared to adherent TC-1 cells. However, in tumorsphere culture, these cells exhibited self-renewal and long-term symmetric division capacity and expressed more Oct-4 compared to adherent cells. HM-LLC sphere-derived cells exhibited increased Oct-4, CD133, and CD44 expression, demonstrated a Hoechst 33342 side population and Aldefluor activity compared to adherent cells or a low metastatic subclone of LLC (LM-LLC). In syngeneic mice, HM-LLC sphere-derived cells required fewer cells to initiate tumorigenesis compared to adherent or LM-LLC cells. Similarly TC-1 sphere-derived cells were more tumorigenic than adherent cells in syngeneic mice. In contrast, in immunocompromised mice, less than 500 sphere or adherent TC-1 cells and less than 1,000 sphere or adherent LLC cells were required to initiate a tumor. We suggest that no single phenotypic marker can identify CICs in murine lung cancer cell lines. Tumorsphere culture may provide an alternative approach to identify and enrich for murine lung CICs. Furthermore, we propose that assessing tumorigenicity of murine lung CICs in syngeneic mice better models the interaction of CICs with the host immune system.	[Morrison, Brian J.; Steel, Jason C.; Morris, John C.] Univ Cincinnati, Dept Med, Div Hematol Oncol, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Morris, JC (corresponding author), Univ Cincinnati, Dept Med, Div Hematol Oncol, Cincinnati, OH 45221 USA.	morri2j7@ucmail.uc.edu	Steel, Jason C./D-1805-2013	Steel, Jason C./0000-0003-3608-7542	Division of Hematology-Oncology, University of Cincinnati; University of Cincinnati, University Research Council, Postdoctoral Fellow Research Program grant; NATIONAL CANCER INSTITUTE [T32CA117846] Funding Source: NIH RePORTER	Division of Hematology-Oncology, University of Cincinnati; University of Cincinnati, University Research Council, Postdoctoral Fellow Research Program grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Division of Hematology-Oncology, University of Cincinnati. BJM was supported by a University of Cincinnati, University Research Council, Postdoctoral Fellow Research Program grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anyanwu AC, 2002, J THORAC CARDIOV SUR, V124, P1190, DOI 10.1067/mtc.2002.124885; Bertolini G, 2009, P NATL ACAD SCI USA, V106, P16281, DOI 10.1073/pnas.0905653106; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Collins LG, 2007, AM FAM PHYSICIAN, V75, P56; Deleyrolle LP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015844; Dong ZY, 1997, CELL, V88, P801, DOI 10.1016/S0092-8674(00)81926-1; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Gibbons DL, 2009, GENE DEV, V23, P2140, DOI 10.1101/gad.1820209; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hooker CM, 2012, ANN THORAC SURG, V93, P405, DOI 10.1016/j.athoracsur.2011.11.012; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Jothy S, 2003, CLIN EXP METASTAS, V20, P195, DOI 10.1023/A:1022931016285; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Leung ELH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014062; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Mancini R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021320; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Meng XJ, 2009, CANCER SCI, V100, P1040, DOI 10.1111/j.1349-7006.2009.01144.x; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; SUTHERLAND K, 2011, TLS TIMES LIT S 0422, P19; WIKENHEISER KA, 1993, P NATL ACAD SCI USA, V90, P11029, DOI 10.1073/pnas.90.23.11029; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	38	46	47	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49752	10.1371/journal.pone.0049752	http://dx.doi.org/10.1371/journal.pone.0049752			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152931	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600053
J	Panda, AK; Panda, M; Tripathy, R; Pattanaik, SS; Ravindran, B; Das, BK				Panda, Aditya K.; Panda, Madhumita; Tripathy, Rina; Pattanaik, Sarit S.; Ravindran, Balachandran; Das, Bidyut K.			Complement Receptor 1 Variants Confer Protection from Severe Malaria in Odisha, India	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; FRAGMENT-LENGTH-POLYMORPHISM; ERYTHROCYTE CR-1 EXPRESSION; ABO BLOOD-GROUP; CEREBRAL MALARIA; GENE POLYMORPHISMS; DISEASE; METAANALYSIS; ASSOCIATION; SARCOIDOSIS	Background: In Plasmodium falciparum infection, complement receptor-1 (CR1) on erythrocyte's surface and ABO blood group play important roles in formation of rosettes which are presumed to be contributory in the pathogenesis of severe malaria. Although several studies have attempted to determine the association of CR1 polymorphisms with severe malaria, observations remain inconsistent. Therefore, a case control study and meta-analysis was performed to address this issue. Methods: Common CR1 polymorphisms (intron 27 and exon 22) and blood group were typed in 353 cases of severe malaria (SM) [97 cerebral malaria (CM), 129 multi-organ dysfunction (MOD), 127 non-cerebral severe malaria (NCSM)], 141 uncomplicated malaria and 100 healthy controls from an endemic region of Odisha, India. Relevant publications for metaanalysis were searched from the database. Results: The homozygous polymorphisms of CR1 intron 27 and exon 22 (TT and GG) and alleles (T and G) that are associated with low expression of CR1 on red blood cells, conferred significant protection against CM, MOD and malaria deaths. Combined analysis showed significant association of blood group B/intron 27-AA/exon 22-AA with susceptibility to SM (CM and MOD). Meta-analysis revealed that the CR1 exon 22 low expression polymorphism is significantly associated with protection against severe malaria. Conclusions: The results of the present study demonstrate that common CR1 variants significantly protect against severe malaria in an endemic area.	[Panda, Aditya K.; Panda, Madhumita; Ravindran, Balachandran] Inst Life Sci, Infect Dis Biol Grp, Bhubaneswar, Odisha, India; [Tripathy, Rina] SCB Med Coll, Dept Biochem, Cuttack, Odisha, India; [Pattanaik, Sarit S.; Das, Bidyut K.] SCB Med Coll, Dept Med, Cuttack, Odisha, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Srirama Chandra Bhanja Medical College & Hospital; Srirama Chandra Bhanja Medical College & Hospital	Ravindran, B (corresponding author), Inst Life Sci, Infect Dis Biol Grp, Bhubaneswar, Odisha, India.	ravindran8@gmail.com; bidyutdas@hotmail.com	Panda, Aditya K/E-1267-2012	Panda, Aditya K/0000-0002-1192-1978; Pattanaik, Sarit Sekhar/0000-0001-5878-0837	Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	The work was funded by intra-mural grants from Department of Biotechnology, Govt. of India, to the Institute of Life Sciences, Bhubaneswar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boiocchi C, 2009, INT J MOL MED, V24, P181, DOI 10.3892/ijmm_00000221; Brown H, 1999, NEUROPATH APPL NEURO, V25, P331; Clark IA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-85; Clark IA, 2009, TRENDS PARASITOL, V25, P314, DOI 10.1016/j.pt.2009.04.003; Cockburn IA, 2004, P NATL ACAD SCI USA, V101, P272, DOI 10.1073/pnas.0305306101; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Herrera AH, 1998, CLIN IMMUNOL IMMUNOP, V87, P176, DOI 10.1006/clin.1998.4529; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Krych-Goldberg M, 2002, TRENDS MOL MED, V8, P531, DOI 10.1016/S1471-4914(02)02419-X; KUMAR A, 1995, IMMUNOL CELL BIOL, V73, P457, DOI 10.1038/icb.1995.71; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mrazek F, 2008, TISSUE ANTIGENS, V71, P77, DOI 10.1111/j.1399-0039.2007.00957.x; Nagayasu Eiji, 2001, American Journal of Tropical Medicine and Hygiene, V64, P1; NVBDCP, 2004, GOV IND REP; NVBDCP, 2010, GOV IND REP; Panda AK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-309; Pattanaik SS, 2012, ACTA TROP; RINGWALD P, 1993, INFECT IMMUN, V61, P5198, DOI 10.1128/IAI.61.12.5198-5204.1993; Roozendaal R, 2007, IMMUNOL REV, V219, P157, DOI 10.1111/j.1600-065X.2007.00556.x; Rout R, 2011, INFECT GENET EVOL, V11, P139, DOI 10.1016/j.meegid.2010.09.009; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 2007, P NATL ACAD SCI USA, V104, P17471, DOI 10.1073/pnas.0705390104; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Rowe JA, 2002, GENES IMMUN, V3, P497, DOI 10.1038/sj.gene.6363899; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Sinha S, 2009, HUM IMMUNOL, V70, P244, DOI 10.1016/j.humimm.2009.02.001; Srivastava A, 2009, SCAND J IMMUNOL, V70, P614, DOI 10.1111/j.1365-3083.2009.02329.x; Stoute JA, 2003, J INFECT DIS, V187, P522, DOI 10.1086/367712; Stoute JA, 2011, CELL MICROBIOL, V13, P1441, DOI 10.1111/j.1462-5822.2011.01648.x; Teeranaipong P, 2008, J INFECT DIS, V198, P1880, DOI 10.1086/593338; Uneke CJ, 2007, PARASITOL RES, V100, P759, DOI 10.1007/s00436-006-0342-5; VIK DP, 1993, J IMMUNOL, V151, P6214; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WILSON JG, 1986, J EXP MED, V164, P50, DOI 10.1084/jem.164.1.50; Xiang LB, 1999, J IMMUNOL, V163, P4939; Yuan Ya-dong, 2011, Zhonghua Jie He He Hu Xi Za Zhi, V34, P841; Zorzetto M, 2002, AM J RESP CELL MOL, V27, P17, DOI 10.1165/ajrcmb.27.1.4805	40	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49420	10.1371/journal.pone.0049420	http://dx.doi.org/10.1371/journal.pone.0049420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152904	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600037
J	Tamura, Y; Higashi, M; Kitamoto, S; Yokoyama, S; Osako, M; Horinouchi, M; Shimizu, T; Tabata, M; Batra, SK; Goto, M; Yonezawa, S				Tamura, Yukihiro; Higashi, Michiyo; Kitamoto, Sho; Yokoyama, Seiya; Osako, Masahiko; Horinouchi, Michiko; Shimizu, Takeshi; Tabata, Mineo; Batra, Surinder K.; Goto, Masamichi; Yonezawa, Suguru			MUC4 and MUC1 Expression in Adenocarcinoma of the Stomach Correlates with Vessel Invasion and Lymph Node Metastasis: An Immunohistochemical Study of Early Gastric Cancer	PLOS ONE			English	Article							HUMAN PANCREATIC ADENOCARCINOMA; GLAND MUCOEPIDERMOID CARCINOMA; PROGNOSTIC-SIGNIFICANCE; DIAGNOSTIC-SIGNIFICANCE; ABERRANT EXPRESSION; ERBB2 EXPRESSION; GENE-EXPRESSION; MEMBRANE MUCINS; HUMAN NEOPLASMS; POOR-PROGNOSIS	We have previously reported that MUC4 expression is a poor prognostic factor in various carcinomas. Our previous study also showed that MUC1 expression in gastric cancers, including the early and advanced stages is a poor prognostic factor. In the present study, the expression profiles of MUC4 and MUC1 were examined by immunohistochemistry (IHC) using two anti-MUC4 monoclonal antibodies (MAbs), 8G7 and 1G8, and anti-MUC1 MAb DF3 in 104 gastrectomy specimens of early gastric adenocarcinoma with submucosal invasion (pT1b2), including 197 histological subtype lesions. Before the IHC study of the human specimens, we evaluated the specificity of the two MAbs by Western blotting and IHC of two MUC4 mRNA expressing gastric cancer cell lines. MAb 8G7 reacted clearly, whereas MAb 1G8 did not show any reactivity, in either Western blotting or IHC. In the IHC of the gastric cancers, the expression rates of MUC4/8G7 detected by MAb 8G7, MUC4/1G8 detected by MAb 1G8 and MUC1/DF3 detected by MAb DF3 in well differentiated types (70%, 38/54; 67%, 36/54; 52%, 28/54) were significantly higher than those in poorly differentiated types (18%, 10/55; 36%, 20/55; 13%, 7/55) (P<0.0001; P = 0.0021; P<0.0001), respectively. The MUC4/8G7 expression was related with lymphatic invasion (r = 0.304, P = 0.033). On the other hand, the MUC4/1G8 expression was related with lymphatic invasion (r = 0.395, P = 0.001) and lymph node metastasis (r = 0.296, P = 0.045). The MUC1/DF3 expression was related with lymphatic invasion (r = 0.357, P = 0.032) and venous invasion (r = 0.377, P = 0.024). In conclusion, the expression of MUC4 as well as MUC1 in early gastric cancers is a useful marker to predict poor prognostic factors related with vessel invasion.	[Tamura, Yukihiro; Higashi, Michiyo; Kitamoto, Sho; Yokoyama, Seiya; Goto, Masamichi; Yonezawa, Suguru] Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oncol, Dept Human Pathol, Kagoshima 890, Japan; [Tamura, Yukihiro] Ohsumi Kanoya Hosp, Dept Internal Med, Kanoya, Kagoshima, Japan; [Osako, Masahiko; Tabata, Mineo] Kagoshima Shi Med Assoc Hosp, Dept Surg, Kagoshima, Japan; [Horinouchi, Michiko; Shimizu, Takeshi] Kagoshima Shi Med Assoc Hosp, Dept Pathol, Kagoshima, Japan; [Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Biochem, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Batra, Surinder K.] Univ Nebraska Med Ctr, Dept Mol Biol, Eppley Inst Res Canc & Allied Dis, Omaha, NE USA; [Goto, Masamichi] Natl Sanat Hoshizuka Keiaien, Kanoya, Kagoshima, Japan	Kagoshima University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Higashi, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Field Oncol, Dept Human Pathol, Kagoshima 890, Japan.	east@m2.kufm.kagoshima-u.ac.jp	Kitamoto, Sho/AAE-4549-2021	Kitamoto, Sho/0000-0003-3597-6647	Princes Takamatsu Cancer Research Fund; Ministry of Education, Science, Sports, Culture and Technology, Japan [23390085, 21590399, 24701008, 239349]; Pancreas Research Foundation of Japan; Kodama Memorial Foundation, Japan; National Institutes of Health [CA78590, CA163120, CA133944, CA111294]; NATIONAL CANCER INSTITUTE [U01CA111294, R01CA078590, R03CA133944, U54CA163120] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24701008] Funding Source: KAKEN	Princes Takamatsu Cancer Research Fund; Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Pancreas Research Foundation of Japan(Pancreas Research Foundation of Japan); Kodama Memorial Foundation, Japan; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by Princes Takamatsu Cancer Research Fund to S. Yonezawa; Grants-in-Aid for Scientific Research on Scientific Research (B) 23390085 to S. Yonezawa; Scientific Research (C) 21590399 to M. Higashi; Young Scientists (B) 24701008 to S. Yokoyama; Scientific Research on Priority Areas 239349 to S. Kitamoto (JSPS Fellowship) from the Ministry of Education, Science, Sports, Culture and Technology, Japan; a Pancreas Research Foundation of Japan to S. Yokoyama; and the Kodama Memorial Foundation, Japan to M. Higashi. S. Batra is supported in part by the National Institutes of Health grants (CA78590, CA163120, CA133944 and CA111294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alos L, 2005, AM J SURG PATHOL, V29, P806, DOI 10.1097/01.pas.0000155856.84553.c9; Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033; Baek SK, 2007, LARYNGOSCOPE, V117, P911, DOI 10.1097/MLG.0b013e31803d1720; Carraway KL, 2003, BIOESSAYS, V25, P66, DOI 10.1002/bies.10201; Chauhan SC, 2006, MODERN PATHOL, V19, P1386, DOI 10.1038/modpathol.3800646; Correa Pelayo, 2004, Gastric Cancer, V7, P9, DOI 10.1007/s10120-003-0265-0; Hamada T, 2012, INT J CANCER, V130, P1768, DOI 10.1002/ijc.26187; Handra-Luca A, 2005, AM J SURG PATHOL, V29, P881, DOI 10.1097/01.pas.0000159103.95360.e8; Isobe Y, 2011, GASTRIC CANCER, V14, P301, DOI 10.1007/s10120-011-0085-6; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P113, DOI 10.1007/s10120-011-0042-4; Jeon JM, 2010, KOREAN J PATHOL, V44, P397, DOI 10.4132/KorearnJPathol.2010.44.4.397; Khorrami AM, 2002, J BIOCHEM, V131, P21, DOI 10.1093/oxfordjournals.jbchem.a003073; Kwon KY, 2007, ARCH PATHOL LAB MED, V131, P593; Lauwers GY, 2010, WHO CLASSIFICATION T, P45; Moniaux N, 2004, J HISTOCHEM CYTOCHEM, V52, P253, DOI 10.1177/002215540405200213; Moniaux N, 1999, BIOCHEM J, V338, P325, DOI 10.1042/0264-6021:3380325; Nam KH, 2011, THYROID, V21, P745, DOI 10.1089/thy.2010.0339; PORCHET N, 1991, BIOCHEM BIOPH RES CO, V175, P414, DOI 10.1016/0006-291X(91)91580-6; Rakha EA, 2005, MODERN PATHOL, V18, P1295, DOI 10.1038/modpathol.3800445; Saitou M, 2005, J CLIN PATHOL, V58, P845, DOI 10.1136/jcp.2004.023572; Senapati S, 2008, BRIT J CANCER, V99, P949, DOI 10.1038/sj.bjc.6604632; Shanmugam C, 2010, CANCER-AM CANCER SOC, V116, P3577, DOI 10.1002/cncr.25095; Shibahara H, 2004, HEPATOLOGY, V39, P220, DOI 10.1002/hep.20031; Singh AP, 2006, PROSTATE, V66, P421, DOI 10.1002/pros.20372; Tamada S, 2006, CLIN CANCER RES, V12, P4257, DOI 10.1158/1078-0432.CCR-05-2814; Tsutsumida H, 2007, LUNG CANCER, V55, P195, DOI 10.1016/j.lungcan.2006.10.013; Utsunomiya T, 1998, CLIN CANCER RES, V4, P2605; Weed DT, 2004, LARYNGOSCOPE, V114, P1, DOI 10.1097/00005537-200408001-00001; Weed DT, 2004, HEAD NECK-J SCI SPEC, V26, P353, DOI 10.1002/hed.10387; Westgaard A, 2009, HISTOPATHOLOGY, V54, P337, DOI 10.1111/j.1365-2559.2009.03227.x; Yonezawa S, 2008, PROTEOMICS, V8, P3329, DOI 10.1002/pmic.200800040; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Zhang J, 2005, J CELL PHYSIOL, V204, P166, DOI 10.1002/jcp.20277	34	9	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49251	10.1371/journal.pone.0049251	http://dx.doi.org/10.1371/journal.pone.0049251			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152882	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600032
J	Amador, C; Toro, MA; Fernandez, J				Amador, Carmen; Angel Toro, Miguel; Fernandez, Jesus			Molecular Markers Allow to Remove Introgressed Genetic Background: A Simulation Study	PLOS ONE			English	Article							HYBRIDIZATION; DIVERSITY; WILD; CONSERVATION; POPULATIONS; CATTLE; HYBRIDS; DOG	The maintenance of genetically differentiated populations can be important for several reasons (whether for wild species or domestic breeds of economic interest). When those populations are introgressed by foreign individuals, methods to eliminate the exogenous alleles can be implemented to recover the native genetic background. This study used computer simulations to explore the usefulness of several molecular based diagnostic approaches to recover of a native population after suffering an introgression event where some exogenous alleles were admixed for a few generations. To remove the exogenous alleles, different types of molecular markers were used in order to decide which of the available individuals contributed descendants to next generation and their number of offspring. Recovery was most efficient using diagnostic markers (i.e., with private alleles) and least efficient when using alleles present in both native and exogenous populations at different frequencies. The increased inbreeding was a side-effect of the management strategy. Both values (% of native alleles and inbreeding) were largely dependent on the amount of exogenous individuals entering the population and the number of generations of admixture that occurred prior to management.	[Amador, Carmen; Fernandez, Jesus] INIA, Madrid, Spain; [Angel Toro, Miguel] UPM, ETSIA, Madrid, Spain	Universidad Politecnica de Madrid	Amador, C (corresponding author), INIA, Ctra De La Coruna Km 7-5, Madrid, Spain.	amador.carmen@inia.es	Amador, Carmen/E-3593-2013; Toro, Miguel Angel/AAA-1309-2019; Toro, Miguel Angel Angel/H-9370-2015; Amador, Carmen/B-9232-2014; Fernandez, Jesus/H-4894-2015	Amador, Carmen/0000-0002-8464-705X; Toro, Miguel Angel/0000-0001-7460-2483; Toro, Miguel Angel Angel/0000-0001-7460-2483; Amador, Carmen/0000-0002-8464-705X; Fernandez, Jesus/0000-0001-8269-1893	Nacional I+D+i (Spain) [CGL2009-13278-C02-02]; fondos FEDER; FPI-INIA Grant	Nacional I+D+i (Spain); fondos FEDER(European Commission); FPI-INIA Grant	This research was financed by Plan Nacional I+D+i (Spain) CGL2009-13278-C02-02, and fondos FEDER. C. Amador was supported by a FPI-INIA Grant. (http://www.inia.es/inia/; http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allendorf FW, 2001, TRENDS ECOL EVOL, V16, P613, DOI 10.1016/S0169-5347(01)02290-X; Amador C, 2011, CONSERV GENET, V12, P1565, DOI 10.1007/s10592-011-0255-4; Barilani M, 2005, BIOL CONSERV, V126, P445, DOI 10.1016/j.biocon.2005.06.027; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Caballero A, 2000, GENET RES, V75, P331, DOI 10.1017/S0016672399004449; Cabria MT, 2011, MOL ECOL, V20, P1176, DOI 10.1111/j.1365-294X.2010.04988.x; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Dalvit C, 2007, MEAT SCI, V77, P437, DOI 10.1016/j.meatsci.2007.05.027; Dantzig G. B., 1963, LINEAR PROGRAMMING E; Fernandez J, 1999, J ANIM BREED GENET, V116, P447, DOI 10.1046/j.1439-0388.1999.00196.x; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Goodman SJ, 1999, GENETICS, V152, P355; Groeneveld LF, 2010, ANIM GENET, V41, P6, DOI 10.1111/j.1365-2052.2010.02038.x; Kidd AG, 2009, MOL ECOL, V18, P1175, DOI 10.1111/j.1365-294X.2009.04100.x; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kullback S., 1997, INFORM THEORY STAT; MacHugh DE, 1997, GENETICS, V146, P1071; Maudet C, 2002, J ANIM SCI, V80, P942; Ministerio de Agricultura pesca y alimentacion (MAPA), 2003, EST CAR SECT EQ ESP; Negro JJ, 2001, BIOL CONSERV, V98, P19, DOI 10.1016/S0006-3207(00)00129-4; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nei M., 1987, MOL EVOLUTIONARY GEN; Oliveira R, 2008, CONSERV GENET, V9, P1, DOI 10.1007/s10592-007-9297-z; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; ROY MS, 1994, MOL BIOL EVOL, V11, P553; Simberloff D, 1996, WILDLIFE BIOL, V2, P143, DOI 10.2981/wlb.1996.012; Susnik S, 2004, HEREDITY, V93, P273, DOI 10.1038/sj.hdy.6800500; Taberlet P, 2008, MOL ECOL, V17, P275, DOI 10.1111/j.1365-294X.2007.03475.x; Vila C, 2003, HEREDITY, V90, P17, DOI 10.1038/sj.hdy.6800175; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494	31	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49409	10.1371/journal.pone.0049409	http://dx.doi.org/10.1371/journal.pone.0049409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152901	Green Submitted, Green Published, gold			2022-12-27	WOS:000312272600059
J	Wieters, EA; McQuaid, C; Palomo, G; Pappalardo, P; Navarrete, SA				Wieters, Evie A.; McQuaid, Christopher; Palomo, Gabriela; Pappalardo, Paula; Navarrete, Sergio A.			Biogeographical Boundaries, Functional Group Structure and Diversity of Rocky Shore Communities along the Argentinean Coast	PLOS ONE			English	Article							LATITUDINAL GRADIENT; GEOGRAPHIC-VARIATION; ECOSYSTEM FUNCTION; GENETIC-STRUCTURE; CLIMATE-CHANGE; BOTTOM-UP; BIODIVERSITY; ATLANTIC; VARIABILITY; PATTERNS	We investigate the extent to which functional structure and spatial variability of intertidal communities coincide with major biogeographical boundaries, areas where extensive compositional changes in the biota are observed over a limited geographic extension. We then investigate whether spatial variation in the biomass of functional groups, over geographic (109s km) and local (109s m) scales, could be associated to species diversity within and among these groups. Functional community structure expressed as abundance (density, cover and biomass) and composition of major functional groups was quantified through field surveys at 20 rocky intertidal shores spanning six degrees of latitude along the southwest Atlantic coast of Argentina and extending across the boundaries between the Argentinean and Magellanic Provinces. Patterns of abundance of individual functional groups were not uniformly matched with biogeographical regions. Only ephemeral algae showed an abrupt geographical discontinuity coincident with changes in biogeographic boundaries, and this was limited to the mid intertidal zone. We identified 3-4 main 'groups' of sites in terms of the total and relative abundance of the major functional groups, but these did not coincide with biogeographical boundaries, nor did they follow latitudinal arrangement. Thus, processes that determine the functional structure of these intertidal communities are insensitive to biogeographical boundaries. Over both geographical and local spatial scales, and for most functional groups and tidal levels, increases in species richness within the functional group was significantly associated to increased total biomass and reduced spatial variability of the group. These results suggest that species belonging to the same functional group are sufficiently uncorrelated over space (i.e. metres and site-to-site) to stabilize patterns of biomass variability and, in this manner, provide a buffer, or "insurance'', against spatial variability in environmental conditions.	[Wieters, Evie A.; McQuaid, Christopher] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa; [Wieters, Evie A.; Pappalardo, Paula; Navarrete, Sergio A.] Pontificia Univ Catolica Chile, Estn Costera Invest Marinas, Santiago, Chile; [Wieters, Evie A.; Pappalardo, Paula; Navarrete, Sergio A.] Pontificia Univ Catolica Chile, Ctr Marine Conservat, Santiago, Chile; [Palomo, Gabriela] Consejo Nacl Invest Cient & Tecn, Museo Argentino Ciencias Nat, RA-1033 Buenos Aires, DF, Argentina	Rhodes University; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN)	Wieters, EA (corresponding author), Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa.	ewieters@bio.puc.cl	McQuaid, Christopher/AAT-3725-2020; Pappalardo, Paula/AFK-4906-2022; Navarrete, Sergio/D-4645-2013	McQuaid, Christopher/0000-0002-3473-8308; Pappalardo, Paula/0000-0003-0853-7681; Palomo, Maria Gabriela/0000-0002-9102-1282	Rhodes University; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Andrew Mellon Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Conicet); Fondo de Financiamiento de Centros de Excelencia en Investigacion - Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondap-Fondecyt) [15001-001]; Comision Nacional de Investigacion Cientifica y Tecnologica doctoral scholarship; FONDECYT [1100920, 1070335]; Center of Marine Conservation Nucleo Milenio Initiative [P10-033F]	Rhodes University; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Andrew Mellon Foundation; Consejo Nacional de Investigaciones Cientificas y Tecnicas (Conicet)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fondo de Financiamiento de Centros de Excelencia en Investigacion - Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondap-Fondecyt)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYTCONICYT FONDAP); Comision Nacional de Investigacion Cientifica y Tecnologica doctoral scholarship; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Center of Marine Conservation Nucleo Milenio Initiative	E.A.W. appreciates support from a Rhodes University Postdoctoral Fellowship. Funding for this project was provided by the South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation to C. M., grants from the Andrew Mellon Foundation to C. M. and S.A.N., a Consejo Nacional de Investigaciones Cientificas y Tecnicas (Conicet) grant to G. P., and by Fondo de Financiamiento de Centros de Excelencia en Investigacion - Fondo Nacional de Desarrollo Cientifico y Tecnologico (Fondap-Fondecyt) 15001-001 to the Center for Advanced Studies in Ecology and Biodiversity to S.A.N. P. P. was supported by a Comision Nacional de Investigacion Cientifica y Tecnologica doctoral scholarship. The continuous support from the Andrew Mellon Foundation to conduct large-scale studies is deeply acknowledged. We acknowledge additional support by FONDECYT 1100920 to E. A. W., FONDECYT 1070335 to S. A. N., and the Center of Marine Conservation Nucleo Milenio Initiative P10-033F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison G, 2004, ECOL MONOGR, V74, P117, DOI 10.1890/02-0681; Astorga A, 2003, ECOL LETT, V6, P420, DOI 10.1046/j.1461-0248.2003.00445.x; AVISE JC, 1992, OIKOS, V63, P62, DOI 10.2307/3545516; Balech Enrique, 2009, Revista de Investigacion y Desarrollo Pesquero, V19, P45; Bazterrica MC, 2007, J EXP MAR BIOL ECOL, V353, P22, DOI 10.1016/j.jembe.2007.08.018; Bertness MD, 2006, ECOL MONOGR, V76, P439, DOI 10.1890/0012-9615(2006)076[0439:TCSOWA]2.0.CO;2; Bianchi AA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002488; Boschi Enrique E., 2000, Revista de Investigacion y Desarrollo Pesquero, V13, P7; Broitman BR, 2001, MAR ECOL PROG SER, V224, P21, DOI 10.3354/meps224021; Burton RS, 1998, EVOLUTION, V52, P734, DOI 10.1111/j.1558-5646.1998.tb03698.x; Bustamante RH, 1996, J BIOGEOGR, V23, P339, DOI 10.1046/j.1365-2699.1996.00026.x; Carcelles A. R., 1951, Revista del Instituto Nacional de Investigacion de las Ciencias Naturales y Museo Argentino Zool, V2, P225; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2011, NATURE, V472, P86, DOI 10.1038/nature09904; Carreto JI, 2007, MAR ARGENTINO SUS RE; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Connolly SR, 1998, AM NAT, V151, P311, DOI 10.1086/286121; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.1890/0012-9658(2001)082[1799:ALGIRO]2.0.CO;2; Dawson MN, 2001, J BIOGEOGR, V28, P723, DOI 10.1046/j.1365-2699.2001.00572.x; DUARTE CM, 1995, OPHELIA, V41, P87, DOI 10.1080/00785236.1995.10422039; Gagliardini Domingo A, 2004, Gayana (Concepc.), V68, P186; GLORIOSO PD, 1987, CONT SHELF RES, V7, P27, DOI 10.1016/0278-4343(87)90061-6; Gorny M, 1999, MAGALLAN ANTARTIC EC; Grime J. P., 2001, PLANT STRATEGIES VEG; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Helmuth B, 2002, SCIENCE, V298, P1015, DOI 10.1126/science.1076814; Hidalgo FJ, 2007, ESTUAR COAST, V30, P886, DOI 10.1007/BF02841342; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hooper DU, 2012, NATURE; Huston M. A., 1994, BIOL DIVERSITY; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Ives AR, 1999, SCIENCE, V286, P542, DOI 10.1126/science.286.5439.542; Jenkins SR, 2008, ECOLOGY, V89, pS3, DOI 10.1890/07-1155.1; Karez R, 2004, AQUATIC BOT, V78; Kelly RP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008594; Liuzzi MG, 2011, HYDROBIOLOGIA, V673, P205, DOI 10.1007/s10750-011-0780-7; Loreau M, 2003, ECOL LETT, V6, P673, DOI 10.1046/j.1461-0248.2003.00483.x; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Macaya EC, 2010, MAR ECOL PROG SER, V420, P103, DOI 10.3354/meps08893; McCann KS, 2000, NATURE, V405, P228, DOI 10.1038/35012234; Morrone J.J., 2009, EVOLUTIONARY BIOGEOG; Naeem S, 1996, OIKOS, V76, P259, DOI 10.2307/3546198; Navarrete SA, 2005, P NATL ACAD SCI USA, V102, P18046, DOI 10.1073/pnas.0509119102; Nielsen KJ, 2004, ECOL LETT, V7, P31, DOI 10.1046/j.1461-0248.2003.00542.x; Petchey OL, 2002, OIKOS, V99, P231, DOI 10.1034/j.1600-0706.2002.990203.x; RIVAS AL, 1990, OCEANOL ACTA, V13, P265; Rivas AL, 2006, CONT SHELF RES, V26, P703, DOI 10.1016/j.csr.2006.01.013; Romero SI, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003244; Rosenfeld JS, 2002, OIKOS, V98, P156, DOI 10.1034/j.1600-0706.2002.980116.x; Savoya V, 2010, J EXP MAR BIOL ECOL, V382, P125, DOI 10.1016/j.jembe.2009.10.012; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Schiel DR, 2011, J EXP MAR BIOL ECOL, V400, P33, DOI 10.1016/j.jembe.2011.02.026; Schwindt E, 2007, J MAR BIOL ASSOC UK, V87, P1219, DOI 10.1017/S0025315407056895; Staddon P, 2010, ECOL LETT, V13, P543, DOI 10.1111/j.1461-0248.2010.01450.x; Tellier F, 2009, MOL PHYLOGENET EVOL, V53, P679, DOI 10.1016/j.ympev.2009.07.030; Thiel M, 2007, OCEANOGR MAR BIOL, V45, P195; Tilman D, 1999, ECOLOGY, V80, P1455, DOI 10.1890/0012-9658(1999)080[1455:TECOCI]2.0.CO;2; Valiela I, 1997, LIMNOL OCEANOGR, V42, P1105, DOI 10.4319/lo.1997.42.5_part_2.1105; Wieters EA, 2005, MAR ECOL PROG SER, V301, P43, DOI 10.3354/meps301043; Wieters EA, 2009, LIMNOL OCEANOGR, V54, P1060, DOI 10.4319/lo.2009.54.4.1060; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Zakas C, 2009, MAR ECOL PROG SER, V394, P165, DOI 10.3354/meps08265	62	15	15	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49725	10.1371/journal.pone.0049725	http://dx.doi.org/10.1371/journal.pone.0049725			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166756	gold, Green Published, Green Submitted			2022-12-27	WOS:000311885300064
J	Lauzeral, C; Grenouillet, G; Brosse, S				Lauzeral, Christine; Grenouillet, Gael; Brosse, Sebastien			Dealing with Noisy Absences to Optimize Species Distribution Models: An Iterative Ensemble Modelling Approach	PLOS ONE			English	Article							CLIMATE-CHANGE; HABITAT-SUITABILITY; THRESHOLD CRITERIA; SIMULATED DATA; RANGE SHIFTS; NICHE SHIFTS; SAMPLE-SIZE; PERFORMANCE; PREDICTION; PREVALENCE	Species distribution models (SDMs) are widespread in ecology and conservation biology, but their accuracy can be lowered by non-environmental (noisy) absences that are common in species occurrence data. Here we propose an iterative ensemble modelling (IEM) method to deal with noisy absences and hence improve the predictive reliability of ensemble modelling of species distributions. In the IEM approach, outputs of a classical ensemble model (EM) were used to update the raw occurrence data. The revised data was then used as input for a new EM run. This process was iterated until the predictions stabilized. The outputs of the iterative method were compared to those of the classical EM using virtual species. The IEM process tended to converge rapidly. It increased the consensus between predictions provided by the different methods as well as between those provided by different learning data sets. Comparing IEM and EM showed that for high levels of non-environmental absences, iterations significantly increased prediction reliability measured by the Kappa and TSS indices, as well as the percentage of well-predicted sites. Compared to EM, IEM also reduced biases in estimates of species prevalence. Compared to the classical EM method, IEM improves the reliability of species predictions. It particularly deals with noisy absences that are replaced in the data matrices by simulated presences during the iterative modelling process. IEM thus constitutes a promising way to increase the accuracy of EM predictions of difficult-to-detect species, as well as of species that are not in equilibrium with their environment.	[Lauzeral, Christine; Grenouillet, Gael; Brosse, Sebastien] Univ Toulouse, UPS, ENFA, Lab Evolut & Divers Biol,UMR 5174, Toulouse, France; [Lauzeral, Christine; Grenouillet, Gael; Brosse, Sebastien] CNRS, EDB, UMR 5174, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Ecole Nationale Formation Agronomique (ENSFEA)	Lauzeral, C (corresponding author), Univ Toulouse, UPS, ENFA, Lab Evolut & Divers Biol,UMR 5174, Toulouse, France.	christine.lauzeral@univ-tlse3.fr	Grenouillet, Gael/E-6518-2019; Brosse, Sebastien/AAC-4689-2019	Brosse, Sebastien/0000-0002-3659-8177	BIOFRESH European project	BIOFRESH European project	This study was supported by the BIOFRESH European project (FP7-ENV-2008) (http://www.freshwaterbiodiversity.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; Araujo MB, 2005, GLOBAL ECOL BIOGEOGR, V14, P529, DOI 10.1111/j.1466-822x.2005.00182.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Beaumont LJ, 2009, DIVERS DISTRIB, V15, P409, DOI 10.1111/j.1472-4642.2008.00547.x; Blanchett S, 2009, P ROY SOC B-BIOL SCI, V276, P2385, DOI 10.1098/rspb.2009.0156; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; BROWN JH, 1984, AM NAT, V124, P225; Buisson L, 2010, GLOBAL CHANGE BIOL, V16, P1145, DOI 10.1111/j.1365-2486.2009.02000.x; Capinha C, 2011, ECOGRAPHY, V34, P448, DOI 10.1111/j.1600-0587.2010.06369.x; Chefaoui RM, 2008, ECOL MODEL, V210, P478, DOI 10.1016/j.ecolmodel.2007.08.010; Cianfrani C, 2010, J APPL ECOL, V47, P421, DOI 10.1111/j.1365-2664.2010.01781.x; Cubaynes S, 2010, CONSERV BIOL, V24, P621, DOI 10.1111/j.1523-1739.2009.01431.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Farber O, 2003, ECOL MODEL, V160, P115, DOI 10.1016/S0304-3800(02)00327-7; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Gallien L., 2012, GLOBAL ECOL BIOGEOGR; Gallien L, 2010, DIVERS DISTRIB, V16, P331, DOI 10.1111/j.1472-4642.2010.00652.x; Grenouillet G, 2011, ECOGRAPHY, V34, P9, DOI 10.1111/j.1600-0587.2010.06152.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Jimenez-Valverde A, 2011, BIOL INVASIONS, V13, P2785, DOI 10.1007/s10530-011-9963-4; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Kadmon R, 2003, ECOL APPL, V13, P853, DOI 10.1890/1051-0761(2003)013[0853:ASAOFA]2.0.CO;2; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Kery M, 2010, J BIOGEOGR, V37, P1851, DOI 10.1111/j.1365-2699.2010.02345.x; Lauzeral C, 2011, GLOBAL ECOL BIOGEOGR, V20, P407, DOI 10.1111/j.1466-8238.2010.00611.x; Leprieur F, 2008, PLOS BIOL, V6, P404, DOI 10.1371/journal.pbio.0060028; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Lobo Jorge M., 2008, Biodiversity Informatics, V5, P14; Lobo JM, 2011, J NAT CONSERV, V19, P1, DOI 10.1016/j.jnc.2010.03.002; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Manel S, 1999, ECOL MODEL, V120, P337, DOI 10.1016/S0304-3800(99)00113-1; Marini MA, 2009, CONSERV BIOL, V23, P1558, DOI 10.1111/j.1523-1739.2009.01258.x; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; Medley KA, 2010, GLOBAL ECOL BIOGEOGR, V19, P122, DOI 10.1111/j.1466-8238.2009.00497.x; Menke SB, 2009, GLOBAL ECOL BIOGEOGR, V18, P50, DOI 10.1111/j.1466-8238.2008.00420.x; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Mouton AM, 2009, ECOL MODEL, V220, P1776, DOI 10.1016/j.ecolmodel.2009.04.020; Olden JD, 2002, FRESHWATER BIOL, V47, P1976, DOI 10.1046/j.1365-2427.2002.00945.x; Olden JD, 2010, DIVERS DISTRIB, V16, P496, DOI 10.1111/j.1472-4642.2010.00655.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Rodder D, 2009, GLOBAL ECOL BIOGEOGR, V18, P674, DOI 10.1111/j.1466-8238.2009.00477.x; Rowe RJ, 2010, GLOBAL CHANGE BIOL, V16, P2930, DOI 10.1111/j.1365-2486.2009.02150.x; Santika T, 2011, GLOBAL ECOL BIOGEOGR, V20, P181, DOI 10.1111/j.1466-8238.2010.00581.x; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106; Stokland JN, 2011, ECOL MODEL, V222, P1800, DOI 10.1016/j.ecolmodel.2011.02.025; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2004, GLOBAL CHANGE BIOL, V10, P2020, DOI 10.1111/j.1365-2486.2004.00859.x; Vaclavik T, 2009, ECOL MODEL, V220, P3248, DOI 10.1016/j.ecolmodel.2009.08.013; Williams JN, 2009, DIVERS DISTRIB, V15, P565, DOI 10.1111/j.1472-4642.2009.00567.x; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wisz Mary S., 2009, BMC Ecology, V9, P8, DOI 10.1186/1472-6785-9-8; Zaniewski AE, 2002, ECOL MODEL, V157, P261, DOI 10.1016/S0304-3800(02)00199-0	62	12	13	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49508	10.1371/journal.pone.0049508	http://dx.doi.org/10.1371/journal.pone.0049508			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166691	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300046
J	Uddin, MJ; Khan, WA; Ismail, AI				Uddin, Mohammed J.; Khan, Waqar A.; Ismail, Ahmed I.			MHD Free Convective Boundary Layer Flow of a Nanofluid past a Flat Vertical Plate with Newtonian Heating Boundary Condition	PLOS ONE			English	Article							STAGNATION-POINT FLOW; NATURAL-CONVECTION; THERMAL-CONDUCTIVITY; SURFACE; VISCOSITY; ENCLOSURE; CONDUCTANCE; RADIATION	Steady two dimensional MHD laminar free convective boundary layer flows of an electrically conducting Newtonian nanofluid over a solid stationary vertical plate in a quiescent fluid taking into account the Newtonian heating boundary condition is investigated numerically. A magnetic field can be used to control the motion of an electrically conducting fluid in micro/nano scale systems used for transportation of fluid. The transport equations along with the boundary conditions are first converted into dimensionless form and then using linear group of transformations, the similarity governing equations are developed. The transformed equations are solved numerically using the Runge-Kutta-Fehlberg fourth-fifth order method with shooting technique. The effects of different controlling parameters, namely, Lewis number, Prandtl number, buoyancy ratio, thermophoresis, Brownian motion, magnetic field and Newtonian heating on the flow and heat transfer are investigated. The numerical results for the dimensionless axial velocity, temperature and nanoparticle volume fraction as well as the reduced Nusselt and Sherwood number have been presented graphically and discussed. It is found that the rate of heat and mass transfer increase as Newtonian heating parameter increases. The dimensionless velocity and temperature distributions increase with the increase of Newtonian heating parameter. The results of the reduced heat transfer rate is compared for convective heating boundary condition and found an excellent agreement.	[Khan, Waqar A.] Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan; [Uddin, Mohammed J.; Ismail, Ahmed I.] Univ Sains Malaysia, Sch Math Sci, George Town, Malaysia; [Uddin, Mohammed J.] Amer Int Univ Bangladesh, Dept Math, Dhaka, Bangladesh	National University of Sciences & Technology - Pakistan; Universiti Sains Malaysia; American International University Bangladesh (AIUB)	Khan, WA (corresponding author), Natl Univ Sci & Technol, PN Engn Coll, Dept Engn Sci, Karachi, Pakistan.	wkhan_2000@yahoo.com	Khan, Waqar/H-3886-2013	Khan, Waqar/0000-0002-8328-850X				Abu-Nada E, 2012, SUPERLATTICE MICROST, V51, P381, DOI 10.1016/j.spmi.2012.01.002; Abu-Nada E, 2010, INT J THERM SCI, V49, P2339, DOI 10.1016/j.ijthermalsci.2010.07.006; Abu-Nada E, 2010, INT J THERM SCI, V49, P479, DOI 10.1016/j.ijthermalsci.2009.09.002; Akbarinia A, 2011, APPL THERM ENG, V31, P556, DOI 10.1016/j.applthermaleng.2010.10.017; Ames W. F., 1972, NONLINEAR PARTIAL DI; Aminossadati SM, 2009, EUR J MECH B-FLUID, V28, P630, DOI 10.1016/j.euromechflu.2009.05.006; [Anonymous], [No title captured]; Avramenko AA, 2001, ACTA MECH, V151, P1, DOI 10.1007/BF01272521; Aziz A, 2012, HEAT TRANSF-ASIAN RE, V41, P241, DOI 10.1002/htj.20409; Aziz A, 2012, INT J THERM SCI, V52, P83, DOI 10.1016/j.ijthermalsci.2011.10.001; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Capretto L, 2011, TOP CURR CHEM, V304, P27, DOI 10.1007/128_2011_150; Chamkha AJ, 2011, CHEM ENG COMMUN, V198, P425, DOI 10.1080/00986445.2010.520232; Chaudhary RC, 2007, J ENG PHYS THERMOPH+, V80, P954, DOI 10.1007/s10891-007-0127-4; Choi SUS, 2009, J HEAT TRANS-T ASME, V131, DOI 10.1115/1.3056479; Choi SUS., 1995, DEV APPL NONNEWTONIA, V6, P99; Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9; Ghasemi B, 2010, INT J THERM SCI, V49, P931, DOI 10.1016/j.ijthermalsci.2009.12.017; Gorla R. S. R., 2011, J MODERN PHYS, V2, P62, DOI DOI 10.4236/JMP.2011.22011; Hamad MAA, 2012, NUCL ENG DES, V242, P194, DOI 10.1016/j.nucengdes.2011.09.005; Hansen A. G., 1964, SIMILARITY ANALYSES; Hassani M, 2011, INT J THERM SCI, V50, P2256, DOI 10.1016/j.ijthermalsci.2011.05.015; Ho CJ, 2008, INT J HEAT MASS TRAN, V51, P4506, DOI 10.1016/j.ijheatmasstransfer.2007.12.019; Hobson DW, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 3: INDUSTRIAL BIOTECHNOLOGY AND COMMODITY PRODUCTS, 2ND EDITION, P683; Keblinski P, 2008, J NANOPART RES, V10, P1089, DOI 10.1007/s11051-007-9352-1; Khan WA, 2011, INT J THERM SCI, V50, P1207, DOI 10.1016/j.ijthermalsci.2011.02.015; Khan WA, 2010, INT J HEAT MASS TRAN, V53, P2477, DOI 10.1016/j.ijheatmasstransfer.2010.01.032; Kleinstreuer C, 2008, INT J HEAT MASS TRAN, V51, P5590, DOI 10.1016/j.ijheatmasstransfer.2008.04.043; Kuznetsov AV, 2011, EUR J MECH B-FLUID, V30, P156, DOI 10.1016/j.euromechflu.2010.10.007; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Kuznetsov AV, 2004, INT J ENG SCI, V42, P557, DOI 10.1016/j.ijengsci.2003.08.004; Makinde OD, 2011, INT J THERM SCI, V50, P1326, DOI 10.1016/j.ijthermalsci.2011.02.019; Matin MH, 2012, J THERM SCI TECH-JPN, V7, P104, DOI 10.1299/jtst.7.104; Merkin JH, 2012, J ENG MATH, V74, P53, DOI 10.1007/s10665-011-9487-z; Murshed SMS, 2009, J NANOPART RES, V11, P511, DOI 10.1007/s11051-008-9553-2; Mustafa M, 2011, INT J HEAT MASS TRAN, V54, P5588, DOI 10.1016/j.ijheatmasstransfer.2011.07.021; Na T.Y, 1985, GROUP INVARIANCE ENG; Na T. Y., 1979, COMPUTATIONAL METHOD; Napoli M, 2010, LAB CHIP, V10, P957, DOI 10.1039/b917759k; Narahari M, 2012, CHEM ENG COMMUN, V199, P628, DOI 10.1080/00986445.2011.611058; Nasir A, 2010, CLIN DERMATOL, V28, P581, DOI 10.1016/j.clindermatol.2009.06.006; Niu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037274; Nourazar SS, 2011, J APPL MATH, DOI 10.1155/2011/876437; Ogut EB, 2009, INT J THERM SCI, V48, P2063, DOI 10.1016/j.ijthermalsci.2009.03.014; Salleh MZ, 2009, CHEM ENG COMMUN, V196, P987, DOI 10.1080/00986440902797840; Schaefer HE, 2010, NANOSCIENCE: SCIENCE OF THE SMALL IN PHYSICS, ENGINEERING, CHEMISTRY, BIOLOGY AND MEDICINE, P1, DOI 10.1007/978-3-642-10559-3; Murshed SMS, 2011, RENEW SUST ENERG REV, V15, P2342, DOI 10.1016/j.rser.2011.02.016; Yazdi MH, 2011, INT J HEAT MASS TRAN, V54, P3214, DOI 10.1016/j.ijheatmasstransfer.2011.04.009; Yu WH, 2008, HEAT TRANSFER ENG, V29, P432, DOI 10.1080/01457630701850851; Zeeshan A., 2012, INT J PHYS SCI, V7, P1353, DOI [10.5897/IJPS11.1739, DOI 10.5897/IJPS11.1739]	50	76	76	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49499	10.1371/journal.pone.0049499	http://dx.doi.org/10.1371/journal.pone.0049499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166688	gold, Green Published			2022-12-27	WOS:000311272300045
J	Yang, L; Dun, AR; Martin, KJ; Qiu, Z; Dunn, A; Lord, GJ; Lu, WP; Duncan, RR; Rickman, C				Yang, Lei; Dun, Alison R.; Martin, Kirsty J.; Qiu, Zhen; Dunn, Andrew; Lord, Gabriel J.; Lu, Weiping; Duncan, Rory R.; Rickman, Colin			Secretory Vesicles Are Preferentially Targeted to Areas of Low Molecular SNARE Density	PLOS ONE			English	Article							MEMBRANE-FUSION; LOCALIZATION MICROSCOPY; CHROMAFFIN CELLS; PLASMA-MEMBRANE; LIVE CELLS; PROTEINS; COMPLEX; EXOCYTOSIS; DOCKING; GRANULES	Intercellular communication is commonly mediated by the regulated fusion, or exocytosis, of vesicles with the cell surface. SNARE (soluble N-ethymaleimide sensitive factor attachment protein receptor) proteins are the catalytic core of the secretory machinery, driving vesicle and plasma membrane merger. Plasma membrane SNAREs (tSNAREs) are proposed to reside in dense clusters containing many molecules, thus providing a concentrated reservoir to promote membrane fusion. However, biophysical experiments suggest that a small number of SNAREs are sufficient to drive a single fusion event. Here we show, using molecular imaging, that the majority of tSNARE molecules are spatially separated from secretory vesicles. Furthermore, the motilities of the individual tSNAREs are constrained in membrane micro-domains, maintaining a non-random molecular distribution and limiting the maximum number of molecules encountered by secretory vesicles. Together our results provide a new model for the molecular mechanism of regulated exocytosis and demonstrate the exquisite organization of the plasma membrane at the level of individual molecular machines.	[Yang, Lei; Dun, Alison R.; Martin, Kirsty J.; Qiu, Zhen; Dunn, Andrew; Lu, Weiping; Duncan, Rory R.; Rickman, Colin] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Edinburgh, Midlothian, Scotland	Heriot Watt University	Rickman, C (corresponding author), Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Edinburgh, Midlothian, Scotland.	c.rickman@hw.ac.uk	Lord, Gabriel/AAS-5488-2021; Yang, Lei/H-9595-2014; Lu, Wei/AAE-2921-2022	Lord, Gabriel/0000-0003-2152-1553; Lu, Wei/0000-0002-4150-8674; qiu, zhen/0000-0002-0226-7855; Martin, Kirsty/0000-0003-2899-2841; Duncan, Rory/0000-0003-0693-910X; Rickman, Colin/0000-0001-8938-524X	Medical Research Council; Wellcome Trust; Royal Society; Robertson Trust; Engineering and Physical Sciences Research Council; MRC [G0901607] Funding Source: UKRI; Medical Research Council [G0901607] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Robertson Trust; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (to RRD and CR), the Wellcome Trust (to RRD and CR), the Royal Society (to CR), the Robertson Trust (to RRD and CR) and the Engineering and Physical Sciences Research Council (to WL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annibale P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022678; Barg S, 2010, P NATL ACAD SCI USA, V107, P20804, DOI 10.1073/pnas.1014823107; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Boiko T, 2003, DEV CELL, V5, P191, DOI 10.1016/S1534-5807(03)00240-5; Brunger AT, 2001, ANNU REV BIOPH BIOM, V30, P157, DOI 10.1146/annurev.biophys.30.1.157; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Degtyar VE, 2007, P NATL ACAD SCI USA, V104, P15929, DOI 10.1073/pnas.0705406104; Delgado-Martinez I, 2007, J NEUROSCI, V27, P9380, DOI 10.1523/JNEUROSCI.5092-06.2007; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Ellena JF, 2009, P NATL ACAD SCI USA, V106, P20306, DOI 10.1073/pnas.0908317106; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Hartman NC, 2011, CURR OPIN CELL BIOL, V23, P370, DOI 10.1016/j.ceb.2011.05.003; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Jahn R, 2003, CELL, V112, P519, DOI 10.1016/S0092-8674(03)00112-0; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jewell JL, 2010, AM J PHYSIOL-REG I, V298, pR517, DOI 10.1152/ajpregu.00597.2009; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Knowles MK, 2010, P NATL ACAD SCI USA, V107, P20810, DOI 10.1073/pnas.1014840107; Laage R, 2000, J BIOL CHEM, V275, P17481, DOI 10.1074/jbc.M910092199; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lam AD, 2008, MOL BIOL CELL, V19, P485, DOI 10.1091/mbc.E07-02-0148; Lang T, 2001, EMBO J, V20, P2202, DOI 10.1093/emboj/20.9.2202; Manley S, 2008, NAT METHODS, V5, P155, DOI 10.1038/NMETH.1176; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; McEvoy AL, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-106; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mohrmann R, 2012, J MOL NEUROSCI, V48, P387, DOI 10.1007/s12031-012-9744-2; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Ostenson CG, 2006, DIABETES, V55, P435, DOI 10.2337/diabetes.55.02.06.db04-1575; Rickman C, 2010, J BIOL CHEM, V285, P13535, DOI 10.1074/jbc.M109.091058; Rickman C, 2010, J BIOL CHEM, V285, P3965, DOI 10.1074/jbc.M109.040402; Schnell U, 2012, NAT METHODS, V9, P152, DOI [10.1038/nmeth.1855, 10.1038/NMETH.1855]; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; van de Linde S, 2011, NAT PROTOC, V6, P991, DOI 10.1038/nprot.2011.336; van den Bogaart G, 2011, NATURE, V479, P552, DOI 10.1038/nature10545; van den Bogaart G, 2011, NAT STRUCT MOL BIOL, V18, P805, DOI 10.1038/nsmb.2061; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Vereb G, 2003, P NATL ACAD SCI USA, V100, P8053, DOI 10.1073/pnas.1332550100; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yang L, 2012, IEEE T BIO-MED ENG, V59, P2040, DOI 10.1109/TBME.2012.2196798; Yang L, 2010, J STRUCT BIOL, V172, P233, DOI 10.1016/j.jsb.2010.06.019; Zilly FE, 2011, EMBO J, V30, P1209, DOI 10.1038/emboj.2011.53	51	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49514	10.1371/journal.pone.0049514	http://dx.doi.org/10.1371/journal.pone.0049514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166692	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300047
J	Gao, RM; Liu, P; Wong, SM				Gao, Ruimin; Liu, Peng; Wong, Sek-Man			Identification of a Plant Viral RNA Genome in the Nucleus	PLOS ONE			English	Article							CHLOROTIC RINGSPOT VIRUS; LARGE-T-ANTIGEN; LOCALIZATION SIGNALS; CRYSTALLOGRAPHIC ANALYSIS; ARABIDOPSIS-THALIANA; KARYOPHERIN ALPHA; ENCODED MICRORNAS; GENE-EXPRESSION; IMPORTIN-ALPHA; MESSENGER-RNAS	Viruses contain either DNA or RNA as genomes. DNA viruses replicate within nucleus, while most RNA viruses, especially (+)-sense single-stranded RNA, replicate and are present within cytoplasm. We proposed a new thought that is contrary to the common notion that (+)-sense single-stranded RNA viruses are present only in the cytoplasm. In this study, we question whether the genome of a plant RNA virus (non-retroviral) is present in the nucleus of infected cells? Hibiscus chlorotic ringspot virus (HCRSV) RNA was detected in the nucleus of infected cells, as shown by fluorescent in situ hybridization. Western blot using anti-histone 3 and anti-phosphoenolpyruvate carboxylase showed that nuclei were highly purified from mock and HCRSV-infected kenaf (Hibiscus cannabilis L.) leaves, respectively. The p23 and HCRSV coat protein (CP) coding regions were both amplified from total RNA extracted from isolated nuclei. Viral RNA in the nucleus may be used to generate viral microRNAs (vir-miRNAs), as five putative vir-miRNAs were predicted from HCRSV using the vir-miRNAs prediction database. The vir-miRNA (hcrsv-miR-H1-5p) was detected using TaqMan (R) stem-loop real-time PCR, and by northern blot using DIG-end labeled probe in HCRSV-infected kenaf leaves. Finally, a novel nuclear localization signal (NLS) was discovered in p23 of HCRSV. The NLS interacts with importin alpha and facilitates viral RNA genome to enter nucleus. We demonstrate the presence of a (+)-sense single-stranded viral RNA within nucleus.	[Gao, Ruimin; Wong, Sek-Man] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	National University of Singapore	Gao, RM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore.	dbswsm@nus.edu.sg	Wong, Sek-Man/I-2385-2012	Wong, Sek-Man/0000-0002-4620-3706				Ahlquist P, 2002, SCIENCE, V296, P1270, DOI 10.1126/science.1069132; Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bennasser Yamina, 2004, Retrovirology, V1, P43, DOI 10.1186/1742-4690-1-43; Bhuvanakantham R, 2009, BIOCHEM BIOPH RES CO, V389, P63, DOI 10.1016/j.bbrc.2009.08.108; Birbach A, 2004, J CELL SCI, V117, P3615, DOI 10.1242/jcs.01224; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Cai XZ, 2005, P NATL ACAD SCI USA, V102, P5570, DOI 10.1073/pnas.0408192102; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cherezova L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018920; Chiba S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002146; Cingolani G, 2002, MOL CELL, V10, P1345, DOI 10.1016/S1097-2765(02)00727-X; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; GOLDFARB DS, 1986, NATURE, V322, P641, DOI 10.1038/322641a0; Gonzalez I, 2010, MOL PLANT MICROBE IN, V23, P294, DOI 10.1094/MPMI-23-3-0294; Haas M, 2005, PLANT CELL, V17, P927, DOI 10.1105/tpc.104.029017; Hsieh JC, 1998, J CELL BIOCHEM, V70, P94, DOI 10.1002/(SICI)1097-4644(19980701)70:1<94::AID-JCB10>3.3.CO;2-Q; Huang M, 2000, J VIROL, V74, P3149, DOI 10.1128/JVI.74.7.3149-3155.2000; Irie Y, 2000, J BIOL CHEM, V275, P2647, DOI 10.1074/jbc.275.4.2647; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Kaufmann K, 2010, NAT PROTOC, V5, P457, DOI 10.1038/nprot.2009.244; Kidner CA, 2005, CURR OPIN PLANT BIOL, V8, P38, DOI 10.1016/j.pbi.2004.11.008; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Koonin EV, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-29; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; LANFORD RE, 1984, CELL, V37, P801, DOI 10.1016/0092-8674(84)90415-X; Li SC, 2008, NUCLEIC ACIDS RES, V36, pD184, DOI 10.1093/nar/gkm610; Li SC, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-164; Li Y, 2012, J GEN VIROL; Liang XZ, 2002, PLANT CELL REP, V20, P982, DOI 10.1007/s00299-002-0435-2; Liang XZ, 2002, J VIROL, V76, P12312, DOI 10.1128/JVI.76.23.12312-12319.2002; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Lu YD, 2008, PLANT CELL REP, V27, P1571, DOI 10.1007/s00299-008-0584-z; Ma H, 2002, NEUROSCIENCE, V112, P1; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Samols MA, 2007, PLOS PATHOG, V3, P611, DOI 10.1371/journal.ppat.0030065; Sullivan CS, 2005, NATURE, V435, P682, DOI 10.1038/nature03576; Sullivan CS, 2005, MOL CELL, V20, P3, DOI 10.1016/j.molcel.2005.09.012; Taliansky ME, 2010, ADV VIRUS RES, V77, P119, DOI 10.1016/S0065-3527(10)77005-6; Tang S, 2008, P NATL ACAD SCI USA, V105, P10931, DOI 10.1073/pnas.0801845105; Truant R, 1999, MOL CELL BIOL, V19, P1210; Tsang CK, 2003, EMBO J, V22, P6045, DOI 10.1093/emboj/cdg578; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Varble A, 2010, P NATL ACAD SCI US; Wu WWH, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-68; Zenklusen D, 2008, NAT STRUCT MOL BIOL, V15, P1263, DOI 10.1038/nsmb.1514; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhang YJ, 2011, VIRUS RES, V155, P307, DOI 10.1016/j.virusres.2010.10.029	57	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48736	10.1371/journal.pone.0048736	http://dx.doi.org/10.1371/journal.pone.0048736			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155403	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900037
J	Kaufmann, U; Diedrichs-Mohring, M; Wildner, G				Kaufmann, Ulrike; Diedrichs-Moehring, Maria; Wildner, Gerhild			Dynamics of Intraocular IFN-gamma, IL-17 and IL-10-Producing Cell Populations during Relapsing and Monophasic Rat Experimental Autoimmune Uveitis	PLOS ONE			English	Article							ENDOTOXIN-INDUCED UVEITIS; REGULATORY T-CELLS; RECEPTOR ANTAGONIST; IMMUNE PRIVILEGE; TGF-BETA; IN-VIVO; INTERLEUKIN-10; TH17; INFLAMMATION; PROTEIN	A major limitation of most animal models of autoimmune diseases is that they do not reproduce the chronic or relapsing-remitting pattern characteristic of many human autoimmune diseases. This problem has been overcome in our rat models of experimentally induced monophasic or relapsing-remitting autoimmune uveitis (EAU), which depend on the inducing antigen peptides from retinal S-Antigen (monophasic EAU) or interphotoreceptor retinoid-binding protein (relapsing EAU). These models enable us to compare autoreactive and regulatory T cell populations. Intraocular, but not peripheral T cells differ in their cytokine profiles (IFN-gamma, IL-17 and IL-10) at distinct time points during monophasic or relapsing EAU. Only intraocular T cells concomitantly produced IFN-gamma, IL-17 and/or IL-10. Monophasic EAU presented rising numbers of cells expressing IFN-gamma and IL-17 (Th1/Th17) and cells expressing IL-10 or Foxp3. During relapsing uveitis an increase of intraocular IFN-gamma+ cells and a concomitant decrease of IL-17+ cells was detected, while IL-10+ populations remained stable. Foxp3+ cells and cells expressing IL-10, even in combination with IFN-gamma or IL-17, increased during the resolution of monophasic EAU, suggesting a regulatory role for these T cells. In general, cells producing multiple cytokines increased in monophasic and decreased in relapsing EAU. The distinct appearance of certain intraocular populations with characteristics of regulatory cells points to a differential influence of the ocular environment on T cells that induce acute and monophasic or relapsing disease. Here we provide evidence that different autoantigens can elicit distinct and differently regulated immune responses. IFN-gamma, but not IL-17 seems to be the key player in relapsing-remitting uveitis, as shown by increased, synchronized relapses after intraocular application of IFN-gamma. We demonstrated dynamic changes of the cytokine pattern during monophasic and relapsing-remitting disease with strongly increasing IL-10 expression in intraocular T cells during monophasic uveitis.	[Kaufmann, Ulrike; Diedrichs-Moehring, Maria; Wildner, Gerhild] Klinikum Univ, Dept Ophthalmol, Immunobiol Sect, Munich, Germany	University of Munich	Kaufmann, U (corresponding author), Klinikum Univ, Dept Ophthalmol, Immunobiol Sect, Munich, Germany.	Gerhild.Wildner@med.uni-muenchen.de		Kaufmann, Ulrike/0000-0003-4317-5794				Agarwal RK, 2008, J IMMUNOL, V180, P5423, DOI 10.4049/jimmunol.180.8.5423; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Cope A, 2011, TRENDS IMMUNOL, V32, P278, DOI 10.1016/j.it.2011.03.010; Cox CA, 2008, J IMMUNOL, V180, P7414, DOI 10.4049/jimmunol.180.11.7414; DESMET MD, 1993, J AUTOIMMUN, V6, P587, DOI 10.1006/jaut.1993.1048; Diedrichs-Mohring M, 2008, INT IMMUNOL, V20, P365, DOI 10.1093/intimm/dxm148; Diedrichs-Mohring M, 2005, J NEUROIMMUNOL, V164, P22, DOI 10.1016/j.jneuroim.2005.02.023; Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Jankovic D, 2007, NAT IMMUNOL, V8, P1281, DOI 10.1038/ni1207-1281; Ke Y, 2008, INVEST OPHTH VIS SCI, V49, P3999, DOI 10.1167/iovs.07-1468; Ke Y, 2009, J IMMUNOL, V182, P3183, DOI 10.4049/jimmunol.0802487; Kurschus FC, 2010, EUR J IMMUNOL, V40, P3336, DOI 10.1002/eji.201040755; Lee YS, 2011, IMMUNOLOGY, V132, P492, DOI 10.1111/j.1365-2567.2010.03379.x; Maggi L, 2010, EUR J IMMUNOL, V40, P2174, DOI 10.1002/eji.200940257; Matsuoka T, 2001, J IMMUNOL, V166, P2202, DOI 10.4049/jimmunol.166.4.2202; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nian H, 2011, INVEST OPHTH VIS SCI, V52, P5920, DOI 10.1167/iovs.10-6758; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Ohta K, 2000, INVEST OPHTH VIS SCI, V41, P2591; Peng Y, 2007, INVEST OPHTH VIS SCI, V48, P4153, DOI 10.1167/iovs.07-0251; Piccinini AM, 2010, J BIOL CHEM, V285, P8782, DOI 10.1074/jbc.M109.043299; Rizzo LV, 1998, INT IMMUNOL, V10, P807, DOI 10.1093/intimm/10.6.807; Singh SP, 2008, J IMMUNOL, V180, P214, DOI 10.4049/jimmunol.180.1.214; Sonobe Y, 2005, BRAIN RES, V1040, P202, DOI 10.1016/j.brainres.2005.01.100; Stein-Streilein Joan, 2011, Current Immunology Reviews, V7, P336; Thurau SR, 2004, INT IMMUNOL, V16, P1573, DOI 10.1093/intimm/dxh158; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Trittibach P, 2008, GENE THER, V15, P1478, DOI 10.1038/gt.2008.109; Vollenhoven RF Van, 1988, AGING IMMUNOL INFECT, V1, P159; von Toerne C, 2010, MOL IMMUNOL, V48, P272, DOI 10.1016/j.molimm.2010.07.017; Weishaupt A, 2004, J NEUROIMMUNOL, V152, P11, DOI 10.1016/j.jneuroim.2004.03.012; Wildner G, 2003, INT IMMUNOL, V15, P927, DOI 10.1093/intimm/dxg090; Yanagawa Y, 2009, IMMUNOLOGY, V127, P345, DOI 10.1111/j.1365-2567.2008.02986.x; Yoshimura T, 2008, INT IMMUNOL, V20, P209, DOI 10.1093/intimm/dxm135	38	32	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49008	10.1371/journal.pone.0049008	http://dx.doi.org/10.1371/journal.pone.0049008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155443	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900078
J	Li, DX; Tsang, JYS; Peng, J; Ho, DHH; Chan, YK; Zhu, J; Lui, VCH; Xu, AM; Lamb, JR; Tam, PKH; Chen, Y				Li, Daxu; Tsang, Julia Y. S.; Peng, Jiao; Ho, Derek H. H.; Chan, Yee Kwan; Zhu, Jiang; Lui, Vincent C. H.; Xu, Aimin; Lamb, Jonathan R.; Tam, Paul K. H.; Chen, Yan			Adiponectin Mediated MHC Class II Mismatched Cardiac Graft Rejection in Mice Is IL-4 Dependent	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DEXTRAN SULFATE SODIUM; T-CELLS; ALLOGRAFT-REJECTION; TRANSPLANTATION; MACROPHAGES; TOLERANCE; OXIDATION; RESPONSES; COLITIS	Background: Adiponectin regulates glucose and fatty-acid metabolism but its role in chronic graft rejection mediated by Th2 cytokines remains ill-defined. Methodology/Principal Findings: Wild type and adiponectin-null mice were used as graft recipients in mouse MHC class II disparate cardiac transplantation (bm12 toB6) and the graft rejection was monitored. In adiponectin-null mice we observed that the cellular infiltrate of eosinophils, CD4(+) and CD8(+) T cells was reduced in grafts compared to the controls as was collagen deposition and vessel occlusion. A similar outcome was observed for skin transplants except that neutrophil infiltration was increased. Low levels of IL-4 were detected in the grafts and serum. The effect of adiponectin signaling on IL-4 expression was further investigated. Treatment with AMPK and p38 MAPK inhibitors blocked adiponectin enhanced T cell proliferation in mixed lymphocyte reactions. Inhibition of AMPK reduced eosinophil infiltration in skin grafts in wild type recipients and in contrast AMPK activation increased eosinophils in adiponectin-null recipients. The addition of adiponectin increased IL-4 production by the T cell line EL4 with augmented nuclear GATA-3 and phospho-STAT6 expression which were suppressed by knockdown of adiponectin receptor 1 and 2. Conclusions: Our results demonstrate a direct effect of adiponectin on IL-4 expression which contributes to Th2 cytokine mediated rejection in mouse MHC class II histoincompatible transplants. These results add to our understanding of the interrelationship of metabolism and immune regulation and raise the possibility that AMPK inhibitors may be beneficial in selected types of rejection.			Li, DX (corresponding author), Bur Hlth Ordos Municipal, Inner Mongolia, Peoples R China.	paultam@hku.hk; ychenc@hku.hk	Xu, Aimin/D-3291-2013; Chen, Yan/N-7489-2019; Chen, Yan/C-4228-2009; /C-4405-2009; /C-4359-2009	Xu, Aimin/0000-0002-0668-033X; Chen, Yan/0000-0002-2354-230X; Chen, Yan/0000-0002-2354-230X; /0000-0001-6231-3035; /0000-0002-1758-8854; Zhu, Joe/0000-0003-4416-7040				Buonocore S, 2003, TRANSPLANTATION, V75, P407, DOI 10.1097/01.TP.0000044172.19087.22; Chen Y, 2007, TRANSPLANTATION, V83, P1602, DOI 10.1097/01.tp.0000266994.39480.42; Chen Y, 2011, J HEART LUNG TRANSPL, V30, P698, DOI 10.1016/j.healun.2011.01.704; Fayad R, 2007, GASTROENTEROLOGY, V132, P601, DOI 10.1053/j.gastro.2006.11.026; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Gibson F, 2004, DIABETES, V53, P2977, DOI 10.2337/diabetes.53.11.2977; Goldman M, 2001, TRENDS IMMUNOL, V22, P247, DOI 10.1016/S1471-4906(01)01893-2; Kosuge H, 2006, CIRCULATION, V113, P2613, DOI 10.1161/CIRCULATIONAHA.105.594101; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; LaRosa DF, 2007, J IMMUNOL, V178, P7503, DOI 10.4049/jimmunol.178.12.7503; Ma K, 2002, J BIOL CHEM, V277, P34658, DOI 10.1074/jbc.C200362200; Mandal P, 2011, J BIOL CHEM, V286, P13460, DOI 10.1074/jbc.M110.204644; Mayer A, 2008, EUR J IMMUNOL, V38, P948, DOI 10.1002/eji.200738045; Nishihara T, 2006, GASTROENTEROLOGY, V131, P853, DOI 10.1053/j.gastro.2006.06.015; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Okamoto Y, 2009, TRANSPLANTATION, V88, P879, DOI 10.1097/TP.0b013e3181b6efbf; Park PH, 2008, J LEUKOCYTE BIOL, V83, P1258, DOI 10.1189/jlb.0907631; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Schafer PH, 1999, J IMMUNOL, V162, P7110; Schenk S, 2005, J IMMUNOL, V174, P3741, DOI 10.4049/jimmunol.174.6.3741; Shibata R, 2005, NAT MED, V11, P1096, DOI 10.1038/nm1295; Stevceva L, 2001, GENES IMMUN, V2, P309, DOI 10.1038/sj.gene.6363782; Tsang JYS, 2011, INT IMMUNOPHARMACOL, V11, P604, DOI 10.1016/j.intimp.2010.11.009; Tsang JYS, 2008, J CLIN INVEST, V118, P3619, DOI 10.1172/JCI33185; Wilk S, 2011, EUR J IMMUNOL, V41, P2323, DOI 10.1002/eji.201041349; Yang J, 2009, AM J TRANSPLANT, V9, P2837, DOI 10.1111/j.1600-6143.2009.02839.x; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322	28	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48893	10.1371/journal.pone.0048893	http://dx.doi.org/10.1371/journal.pone.0048893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155424	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900059
J	Nicolas, V; Herbreteau, V; Couloux, A; Keovichit, K; Douangboupha, B; Hugot, JP				Nicolas, Violaine; Herbreteau, Vincent; Couloux, Arnaud; Keovichit, Kham; Douangboupha, Bounneuang; Hugot, Jean-Pierre			A Remarkable Case of Micro-Endemism in Laonastes aenigmamus (Diatomyidae, Rodentia) Revealed by Nuclear and Mitochondrial DNA Sequence Data	PLOS ONE			English	Article							CONFLICTING PATTERNS; STATISTICAL-METHOD; POPULATION; INFERENCE; KARST; PHYLOGENIES; SPECIATION; DIVERSITY; MAMMALS; MTDNA	L. aenigmamus is endemic to the limestone formations of the Khammuan Province (Lao PDR), and is strongly specialized ecologically. From the survey of 137 individuals collected from 38 localities, we studied the phylogeography of this species using one mitochondrial (Cyt b) and two nuclear genes (BFIBR and GHR). Cyt b analyses reveal a strong mtDNA phylogeographical structure: 8 major geographical clades differing by 5-14% sequence divergence were identified, most of them corresponding to distinct karst areas. Nuclear markers display congruent results but with a less genetic structuring. Together, the data strongly suggest an inland insular model for Laonastes population structure. With 8 to 16 evolutionary significant units in a small area (about 200650 km) this represents an exceptional example of micro-endemism. Our results suggest that L. aenigmamus may represent a complex of species and/or sub-species. The common ancestor of all Laonastes may have been widely distributed within the limestone formations of the Khammuan Province at the end of Miocene/beginning of the Pliocene. Parallel events of karst fragmentation and population isolation would have occurred during the Pleistocene or/and the end of the Pliocene. The limited gene flow detected between populations from different karst blocks restrains the likelihood of survival of Laonastes. This work increases the necessity for a strict protection of this rare animal and its habitat and provides exclusive information, essential to the organization of its protection.	[Nicolas, Violaine; Hugot, Jean-Pierre] Museum Natl Hist Nat, Dept Systemat & Evolut, UMR CNRS 7205, F-75231 Paris, France; [Herbreteau, Vincent] IRD, UMR ESPACE DEV, Montpellier, France; [Couloux, Arnaud] Genoscope, Ctr Natl Sequencage, Evry, France; [Keovichit, Kham; Douangboupha, Bounneuang] Natl Agr & Forestry Res Inst NAFRI, Viangchan, Laos	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite des Antilles; University of La Reunion; UDICE-French Research Universities; Aix-Marseille Universite; CEA; UDICE-French Research Universities; Universite Paris Saclay	Nicolas, V (corresponding author), Museum Natl Hist Nat, Dept Systemat & Evolut, UMR CNRS 7205, F-75231 Paris, France.	vnicolas@mnhn.fr	Herbreteau, Vincent/L-4411-2013; Nicolas, Violaine/N-9991-2017	Herbreteau, Vincent/0000-0003-1762-6336; Nicolas, Violaine/0000-0001-5384-7529				Adkins RM, 2001, MOL BIOL EVOL, V18, P777, DOI 10.1093/oxfordjournals.molbev.a003860; [Anonymous], 2014, TRACER V1 6; Baker RJ, 2006, J MAMMAL, V87, P643, DOI 10.1644/06-MAMM-F-038R2.1; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bensch S, 2006, MOL ECOL, V15, P161, DOI 10.1111/j.1365-294X.2005.02766.x; Clements R, 2008, BIOL CONSERV, V141, P2751, DOI 10.1016/j.biocon.2008.08.011; Clements R, 2006, BIOSCIENCE, V56, P733, DOI 10.1641/0006-3568(2006)56[733:LKOSAI]2.0.CO;2; CROWTHER J, 1986, NEW DIRECTIONS KARST, P427; Dawson MR, 2006, SCIENCE, V311, P1456, DOI 10.1126/science.1124187; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ducroz J. F., 2001, Journal of Mammalian Evolution, V8, P173, DOI 10.1023/A:1012277012303; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Flot JF, 2010, MOL ECOL RESOUR, V10, P162, DOI 10.1111/j.1755-0998.2009.02732.x; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; FU YX, 1993, GENETICS, V133, P693; GALE SJ, 1986, NEW DIRECTIONS KARST, P443; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hamilton-Smith Elery, 2001, Natura Croatica, V10, P229; Huchon D, 2007, P NATL ACAD SCI USA, V104, P7495, DOI 10.1073/pnas.0701289104; Hudson RR, 2000, GENETICS, V155, P2011; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hurst GDD, 2005, P ROY SOC B-BIOL SCI, V272, P1525, DOI 10.1098/rspb.2005.3056; Irwin DE, 2009, BIOL J LINN SOC, V98, P422, DOI 10.1111/j.1095-8312.2009.01282.x; Jenkins Paulina D., 2002, Bulletin of the Natural History Museum Zoology Series, V68, P1; Jenkins PD, 2004, SYST BIODIVERS, V2, P419, DOI DOI 10.1017/S1477200004001549; Johns GC, 1998, MOL BIOL EVOL, V15, P1481, DOI 10.1093/oxfordjournals.molbev.a025875; Keovichit K, 2011, B ACAD VET FRANCE, V164, P143; Kiernan K, 2009, ACTA CARSOLOGICA, V38, P65; Latinne A, 2011, CONSERV GENET, V12, P1495, DOI 10.1007/s10592-011-0248-3; Lecompte E, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-199; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; MANTEL N, 1967, CANCER RES, V27, P209; Mouret C, 2004, ENCY CAVES KARST SCI, P100; Mouret C, 1998, SPELUNCA, V71, P7; Mouret C., 2001, SPELUNCA, V84, P7; Musser GG, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)497[0001:DOANGA]2.0.CO;2; Nicolas V, 2008, J BIOGEOGR, V35, P2074, DOI 10.1111/j.1365-2699.2008.01950.x; Nylander J. A. A., 2004, MRMODELTEST V2; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Prusak B, 2004, ACTA BIOCHIM POL, V51, P897; Rambaut A., 2009, FIGTREE VERSION 1 3; Rato C, 2011, MOL PHYLOGENET EVOL, V58, P365, DOI 10.1016/j.ympev.2010.12.004; Rato C, 2010, MOL PHYLOGENET EVOL, V56, P962, DOI 10.1016/j.ympev.2010.04.033; Riviere-Dobigny T, 2011, J MAMMAL, V92, P620, DOI 10.1644/10-MAMM-A-028.1; Robinson MF, 2003, ACTA CHIROPTEROL, V5, P31, DOI 10.3161/001.005.0103; Ronquist F., 2005, MRBAYES 3 1 MANUAL; Rundel P. W., 1999, FOREST HABITATS FLOR; Schilthuizen M, 2005, CONSERV BIOL, V19, P949; Seddon JM, 2001, MOL ECOL, V10, P2187, DOI 10.1046/j.0962-1083.2001.01357.x; Shaw KL, 2002, P NATL ACAD SCI USA, V99, P16122, DOI 10.1073/pnas.242585899; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Swofford D. L., 2011, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; Triant DA, 2007, J MAMMAL, V88, P908, DOI 10.1644/06-MAMM-A-204R1.1; Vermeulen J., 1999, BIODIVERSITY CULTURA; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Woxvold IA, 2009, FORKTAIL, P1	62	18	18	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48145	10.1371/journal.pone.0048145	http://dx.doi.org/10.1371/journal.pone.0048145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155377	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900011
J	Osaka, N; Ikeda, T; Osaka, M				Osaka, Naoyuki; Ikeda, Takashi; Osaka, Mariko			Effect of Intentional Bias on Agency Attribution of Animated Motion: An Event-Related fMRI Study	PLOS ONE			English	Article							MIND; PERCEPTION; BEHAVIOR; CHILDREN	Animated movements of simple geometric shapes can readily be interpreted as depicting social events in which animate agents are engaged in intentional activity. However, the brain regions associated with such intention have not been clearly elucidated. In this study, intentional bias was manipulated using shape and pattern animations while measuring associated brain activity using event-related functional magnetic resonance imaging (fMRI). Twenty-five higher-intention involved and twenty-five lower-intention involved animations were presented to participants. Behavioral results showed that the degree of agency attribution of the mental state increased as intentional involvement increased. fMRI results revealed that the posterior superior temporal sulcus (STS), inferior temporal gyrus (ITG), inferior frontal gyrus (IFG), premotor, temporal pole, supramarginal gyrus, and superior parietal lobule (SPL) were activated while participants viewed the high-intention animations. In contrast, occipital, lingual, and middle frontal gyri were activated while the participants viewed the low-intention animations. These findings suggest that as agent attribution increases, the visual brain changes its functional role to the intentional brain and becomes a flexible network for processing information about social interaction.	[Osaka, Naoyuki; Ikeda, Takashi] Kyoto Univ, Dept Psychol, Grad Sch Letters, Kyoto, Japan	Kyoto University	Osaka, N (corresponding author), Kyoto Univ, Dept Psychol, Grad Sch Letters, Kyoto, Japan.	nosaka@bun.kyoto-u.ac.jp						Abell F, 2000, COGNITIVE DEV, V15, P1, DOI 10.1016/S0885-2014(00)00014-9; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BARONCOHEN S, 1994, BRIT J PSYCHIAT, V165, P640, DOI 10.1192/bjp.165.5.640; Blakemore SJ, 2003, PSYCHOL MED, V33, P1433, DOI 10.1017/S0033291703008341; Bonini L, 2010, CEREB CORTEX, V20, P1372, DOI 10.1093/cercor/bhp200; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gao T, 2010, PSYCHOL SCI, V21, P1845, DOI 10.1177/0956797610388814; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Goldstein E.B., 1989, SENSATION PERCEPTION; Grossman ED, 2005, VISION RES, V45, P2847, DOI 10.1016/j.visres.2005.05.027; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Martin A, 2003, COGN NEUROPSYCHOL, V20, P575, DOI 10.1080/02643290342000005; Michotte A. E, 1963, PERCEPTION CAUSALITY; Ohnishi T, 2004, NEUROREPORT, V15, P1483, DOI 10.1097/01.wnr.0000127464.17770.1f; Pavlova M, 2010, CEREB CORTEX, V20, P2361, DOI 10.1093/cercor/bhp304; Rizzolatti G, 1996, EXP BRAIN RES, V111, P246; Saxe R, 2004, NEUROPSYCHOLOGIA, V42, P1435, DOI 10.1016/j.neuropsychologia.2004.04.015; Schultz J, 2005, NEURON, V45, P625, DOI 10.1016/j.neuron.2004.12.052; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789	21	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49053	10.1371/journal.pone.0049053	http://dx.doi.org/10.1371/journal.pone.0049053			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155450	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900085
J	Reser, DH; Witharanage, RW; Rosa, MGP; Dyer, AG				Reser, David H.; Witharanage, Randika Wijesekara; Rosa, Marcello G. P.; Dyer, Adrian G.			Honeybees (Apis mellifera) Learn Color Discriminations via Differential Conditioning Independent of Long Wavelength (Green) Photoreceptor Modulation	PLOS ONE			English	Article							SPECTRALLY VARIABLE ILLUMINATION; BUMBLEBEES BOMBUS-TERRESTRIS; ALTERNATIVE USE; VISUAL-SYSTEM; VISION; BEE; CONTRAST; STIMULI; FLOWERS; HYMENOPTERA	Background: Recent studies on colour discrimination suggest that experience is an important factor in how a visual system processes spectral signals. In insects it has been shown that differential conditioning is important for processing fine colour discriminations. However, the visual system of many insects, including the honeybee, has a complex set of neural pathways, in which input from the long wavelength sensitive ('green') photoreceptor may be processed either as an independent achromatic signal or as part of a trichromatic opponent-colour system. Thus, a potential confound of colour learning in insects is the possibility that modulation of the 'green' photoreceptor could underlie observations. Methodology/Principal Findings: We tested honeybee vision using light emitting diodes centered on 414 and 424 nm wavelengths, which limit activation to the short-wavelength-sensitive ('UV') and medium-wavelength-sensitive ('blue') photoreceptors. The absolute irradiance spectra of stimuli was measured and modelled at both receptor and colour processing levels, and stimuli were then presented to the bees in a Y-maze at a large visual angle (26 degrees), to ensure chromatic processing. Sixteen bees were trained over 50 trials, using either appetitive differential conditioning (N = 8), or aversive-appetitive differential conditioning (N = 8). In both cases the bees slowly learned to discriminate between the target and distractor with significantly better accuracy than would be expected by chance. Control experiments confirmed that changing stimulus intensity in transfers tests does not significantly affect bee performance, and it was possible to replicate previous findings that bees do not learn similar colour stimuli with absolute conditioning. Conclusion: Our data indicate that honeybee colour vision can be tuned to relatively small spectral differences, independent of 'green' photoreceptor contrast and brightness cues. We thus show that colour vision is at least partly experience dependent, and behavioural plasticity plays an important role in how bees exploit colour information.	[Reser, David H.; Witharanage, Randika Wijesekara; Rosa, Marcello G. P.; Dyer, Adrian G.] Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia	Monash University	Reser, DH (corresponding author), Monash Univ, Dept Physiol, Clayton, Vic 3168, Australia.	adrian.dyer@monash.edu	Rosa, Marcello G/D-9278-2013	Rosa, Marcello G/0000-0002-6620-6285; Reser, David/0000-0002-5130-1255				Avargues-Weber A, 2010, J EXP BIOL, V213, P593, DOI 10.1242/jeb.039263; Avargues-Weber A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015370; BACKHAUS W, 1987, BIOL CYBERN, V56, P293, DOI 10.1007/BF00319510; BACKHAUS W, 1991, VISION RES, V31, P1381, DOI 10.1016/0042-6989(91)90059-E; Brandt R, 1997, VISION RES, V37, P425, DOI 10.1016/S0042-6989(96)00195-2; Burns JG, 2008, CURR BIOL, V18, pR953, DOI 10.1016/j.cub.2008.08.028; Camlitepe Y, 2010, J EXP BIOL, V213, P72, DOI 10.1242/jeb.037853; Chiao CC, 2000, J OPT SOC AM A, V17, P218, DOI 10.1364/JOSAA.17.000218; CHITTKA L, 1992, J COMP PHYSIOL A, V171, P171, DOI 10.1007/BF00188925; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; CHITTKA L, 1992, J COMP PHYSIOL A, V170, P545; Chittka Lars, 2004, P165; DAUMER K, 1956, Z VERGL PHYSIOL, V38, P413; De Ibarra NH, 2000, J EXP BIOL, V203, P3289; De Ibarra NH, 2003, ANIM BEHAV, V66, P903, DOI 10.1006/anbe.2003.2269; de Ibarra NH, 2002, J COMP PHYSIOL A, V188, P503, DOI 10.1007/s00359-002-0322-x; de Ibarra NH, 2001, J COMP PHYSIOL A, V187, P215, DOI 10.1007/s003590100192; Dyer AG, 2008, J COMP PHYSIOL A, V194, P617, DOI 10.1007/s00359-008-0335-1; Dyer AG, 2007, ENTOMOL GEN, V30, P165; Dyer AG, 2012, P ROY SOC B-BIOL SCI, V279, P3606, DOI 10.1098/rspb.2012.0827; Dyer AG, 2011, P ROY SOC B-BIOL SCI, V278, P952, DOI 10.1098/rspb.2010.2412; Dyer AG, 2009, ISR J PLANT SCI, V57, P203, DOI 10.1560/IJPS.57.3.203; Dyer AG, 1999, J COMP PHYSIOL A, V185, P445, DOI 10.1007/s003590050405; Dyer AG, 2005, J COMP PHYSIOL A, V191, P547, DOI 10.1007/s00359-005-0622-z; Dyer AG, 2004, J COMP PHYSIOL A, V190, P759, DOI 10.1007/s00359-004-0547-y; Dyer AG, 2004, NATURWISSENSCHAFTEN, V91, P224, DOI 10.1007/s00114-004-0508-x; Dyer AG, 2004, J COMP PHYSIOL A, V190, P105, DOI 10.1007/s00359-003-0475-2; Dyer AG, 1998, J COMP PHYSIOL A, V183, P203, DOI 10.1007/s003590050248; Frisch K.v, 1914, ZOOLOGISCHE JB, V37, P1, DOI DOI 10.5962/BHL.TITLE.11736; Giurfa M, 1996, J COMP PHYSIOL A, V178, P699; Giurfa M, 2004, NATURWISSENSCHAFTEN, V91, P228, DOI 10.1007/s00114-004-0530-z; Giurfa M, 1997, J COMP PHYSIOL A, V180, P235, DOI 10.1007/s003590050044; Giurfa M, 2001, COGNITIVE ECOLOGY OF POLLINATION: ANIMAL BEHAVIOUR AND FLORAL EVOLUTION, P61, DOI 10.1017/CBO9780511542268.005; Heiling AM, 2003, NATURE, V421, P334, DOI 10.1038/421334a; HELVERSEN OV, 1972, J COMP PHYSIOL, V80, P439, DOI 10.1007/BF00696438; Jacobs GH, 2007, SCIENCE, V315, P1723, DOI 10.1126/science.1138838; KAISER W, 1974, J COMP PHYSIOL, V89, P391, DOI 10.1007/BF00695355; Kelber A, 1999, NATURWISSENSCHAFTEN, V86, P221, DOI 10.1007/s001140050601; Kelber A, 2005, P ROY SOC B-BIOL SCI, V272, P2143, DOI 10.1098/rspb.2005.3207; Kelber A, 2010, BEHAV ECOL, V21, P1093, DOI 10.1093/beheco/arq115; Kulikowski J.J., 1991, LIMITS VISION, P202; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; LEHRER M, 1995, NATURWISSENSCHAFTEN, V82, P145, DOI 10.1007/BF01177278; Lehrer M, 1999, J COMP PHYSIOL A, V184, P195, DOI 10.1007/s003590050318; Lehrer M, 1993, SENSORY SYSTEMS ARTH; Llandres AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017136; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Menzel R., 1974, P195; MENZEL R, 1974, J COMP PHYSIOL, V93, P337, DOI 10.1007/BF00606801; MENZEL R, 1967, Z VERGL PHYSIOL, V56, P22, DOI 10.1007/BF00333562; Menzel Randolf, 1991, P262; Morawetz L, 2012, J EXP BIOL, V215, P2515, DOI 10.1242/jeb.066399; Mota T, 2011, J NEUROSCI, V31, P11443, DOI 10.1523/JNEUROSCI.0995-11.2011; NEUMEYER C, 1980, J COMP PHYSIOL, V139, P165, DOI 10.1007/BF00657079; NEUMEYER C, 1981, J COMP PHYSIOL, V144, P543, DOI 10.1007/BF01326839; Niggebrugge C, 2003, J COMP PHYSIOL A, V189, P915, DOI 10.1007/s00359-003-0466-3; Paulk AC, 2008, ARTHROPOD STRUCT DEV, V37, P443, DOI 10.1016/j.asd.2008.03.002; Paulk AC, 2008, J NEUROSCI, V28, P6319, DOI 10.1523/JNEUROSCI.1196-08.2008; Paulk AC, 2009, J NEUROSCI, V29, P9987, DOI 10.1523/JNEUROSCI.1325-09.2009; Paulk AC, 2009, J COMP NEUROL, V513, P441, DOI 10.1002/cne.21993; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Ribi W.A., 1975, Quarterly Review of Biology, V50, P1; RIBI WA, 1981, CELL TISSUE RES, V221, P17, DOI 10.1007/BF00216567; RIBI WA, 1975, CELL TISSUE RES, V165, P103, DOI 10.1007/BF00222803; Spaethe J, 2006, J EXP BIOL, V209, P987, DOI 10.1242/jeb.02124; SRINIVASAN M, 1985, J COMP PHYSIOL A, V157, P579, DOI 10.1007/BF01351352; SRINIVASAN MV, 1984, J COMP PHYSIOL, V155, P297, DOI 10.1007/BF00610583; Stach S, 2004, NATURE, V429, P758, DOI 10.1038/nature02594; Stach S, 2005, BEHAV BRAIN RES, V161, P8, DOI 10.1016/j.bbr.2005.02.008; Stojcev M, 2011, VISUAL NEUROSCI, V28, P361, DOI 10.1017/S0952523811000101; von Frisch K., 1967, DANCE LANGUAGE ORIEN; Vorobyev M, 1997, ISRAEL J PLANT SCI, V45, P103, DOI 10.1080/07929978.1997.10676677; Whitney HM, 2009, SCIENCE, V323, P130, DOI 10.1126/science.1166256; Wyszecki G., 2000, COLOR SCI CONCEPTS M, V2nd ed., P117	74	36	37	1	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48577	10.1371/journal.pone.0048577	http://dx.doi.org/10.1371/journal.pone.0048577			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155394	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900028
J	Vempati, UD; Przydzial, MJ; Chung, C; Abeyruwan, S; Mir, A; Sakurai, K; Visser, U; Lemmon, VP; Schurer, SC				Vempati, Uma D.; Przydzial, Magdalena J.; Chung, Caty; Abeyruwan, Saminda; Mir, Ahsan; Sakurai, Kunie; Visser, Ubbo; Lemmon, Vance P.; Schuerer, Stephan C.			Formalization, Annotation and Analysis of Diverse Drug and Probe Screening Assay Datasets Using the BioAssay Ontology (BAO)	PLOS ONE			English	Article							KRUPPEL-LIKE FACTOR-5; HIGH-THROUGHPUT; GENE-ONTOLOGY; OBO FOUNDRY; PUBCHEM; WEB	Huge amounts of high-throughput screening (HTS) data for probe and drug development projects are being generated in the pharmaceutical industry and more recently in the public sector. The resulting experimental datasets are increasingly being disseminated via publically accessible repositories. However, existing repositories lack sufficient metadata to describe the experiments and are often difficult to navigate by non-experts. The lack of standardized descriptions and semantics of biological assays and screening results hinder targeted data retrieval, integration, aggregation, and analyses across different HTS datasets, for example to infer mechanisms of action of small molecule perturbagens. To address these limitations, we created the BioAssay Ontology (BAO). BAO has been developed with a focus on data integration and analysis enabling the classification of assays and screening results by concepts that relate to format, assay design, technology, target, and endpoint. Previously, we reported on the higher-level design of BAO and on the semantic querying capabilities offered by the ontology-indexed triple store of HTS data. Here, we report on our detailed design, annotation pipeline, substantially enlarged annotation knowledgebase, and analysis results. We used BAO to annotate assays from the largest public HTS data repository, PubChem, and demonstrate its utility to categorize and analyze diverse HTS results from numerous experiments. BAO is publically available from the NCBO BioPortal at http://bioportal.bioontology.org/ontologies/1533. BAO provides controlled terminology and uniform scope to report probe and drug discovery screening assays and results. BAO leverages description logic to formalize the domain knowledge and facilitate the semantic integration with diverse other resources. As a consequence, BAO offers the potential to infer new knowledge from a corpus of assay results, for example molecular mechanisms of action of perturbagens.	[Vempati, Uma D.; Przydzial, Magdalena J.; Chung, Caty; Mir, Ahsan; Sakurai, Kunie; Schuerer, Stephan C.] Univ Miami, Ctr Computat Sci, Miami, FL 33152 USA	University of Miami	Vempati, UD (corresponding author), Univ Miami, Ctr Computat Sci, Miami, FL 33152 USA.	sschurer@med.miami.edu	Lemmon, Vance/A-7410-2010	Lemmon, Vance/0000-0003-3550-7576	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL111561] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005668] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS080145] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abeyruwan S, 2010, 9 INT SEM WEB C ISWC; Adams JC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000474; [Anonymous], 2010, OWL 2 WEB ONTOLOGY L; [Anonymous], EUR INFR OP SCREEN P; [Anonymous], 2011, BAO CATEGORIZED COMM; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Baker CJO, 2007, SEMANTIC WEB REVOLUT; Berners-Lee T, 2001, SCI AM, V284, P34, DOI 10.1038/scientificamerican0501-34; Bialkowska A, 2011, MOL CANCER THER; Bizer C, 2009, IEEE INTELL SYST, V24, P87, DOI 10.1109/MIS.2009.102; Boeker M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-456; Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7; Coan KED, 2009, J MED CHEM, V52, P2067, DOI 10.1021/jm801605r; Du P, 2009, BIOINFORMATICS, V25, pI63, DOI 10.1093/bioinformatics/btp193; Falconer S, 2011, ONTOGRAF 0 0 3; Grau BC, 2008, J ARTIF INTELL RES, V31, P273, DOI 10.1613/jair.2375; GUARINO N., 2009, HDB ONTOLOGIES, DOI [DOI 10.1007/978-3-540-92673-3_0, 10.1007/978-3-540-92673-3]; Hertzberg RP, 2000, CURR OPIN CHEM BIOL, V4, P445, DOI 10.1016/S1367-5931(00)00110-1; Hohman M, 2009, DRUG DISCOV TODAY, V14, P261, DOI 10.1016/j.drudis.2008.11.015; Horridge M, 2004, OWLVIZ VISUALISATION; Horrocks I, 2006, 10 INT C KNOWL REPR, pKR; Inglese J, 2007, NAT CHEM BIOL, V3, P438, DOI 10.1038/nchembio0807-438; Jensen NH, 2008, COMB CHEM HIGH T SCR, V11, P420, DOI 10.2174/138620708784911483; Kool J, 2010, COMB CHEM HIGH T SCR, V13, P548, DOI 10.2174/138620710791515815; Li QL, 2010, DRUG DISCOV TODAY, V15, P1052, DOI 10.1016/j.drudis.2010.10.003; Mayr LM, 2009, CURR OPIN PHARMACOL, V9, P580, DOI 10.1016/j.coph.2009.08.004; Nandan MO, 2004, ONCOGENE, V23, P3404, DOI 10.1038/sj.onc.1207397; Noy Natalya F, 2003, AMIA Annu Symp Proc, P953; Palsson B, 2010, NAT CHEM BIOL, V6, P787, DOI 10.1038/nchembio.462; Qi D, 2010, J INTEGR BIOINFORM, V7; Rubin DL, 2006, OMICS, V10, P185, DOI 10.1089/omi.2006.10.185; Ruttenberg A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S3-S2; Sarntivijai S, 2011, P INT C BIOM ONT ICB, P25; Sarntivijai S, 2008, BIOINFORMATICS, V24, P2760, DOI 10.1093/bioinformatics/btn502; Schober D, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-125; Schurer SC, 2011, J BIOMOL SCREEN, V16, P415, DOI 10.1177/1087057111400191; Schurer S, 2011, BAO ASSAY ANNOTATION; Shearer R, 2008, 5 INT WORKSH OWL EXP, P10; Sirin E, 2006, P INT WORKSH DESCR L, V189; Smith B, 2010, METHOD INFORM MED, V49, P135, DOI 10.3414/ME9302; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Smith GK, 2002, ARCH BIOCHEM BIOPHYS, V399, P195, DOI 10.1006/abbi.2002.2757; Sun RG, 2001, J BIOL CHEM, V276, P6897, DOI 10.1074/jbc.C000870200; Swinney DC, 2011, NAT REV DRUG DISCOV, V10, P507, DOI 10.1038/nrd3480; Visser U, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-257; Wang YL, 2009, NUCLEIC ACIDS RES, V37, pW623, DOI 10.1093/nar/gkp456; Xiang Zuoshuang, 2010, BMC Res Notes, V3, P175, DOI 10.1186/1756-0500-3-175	50	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49198	10.1371/journal.pone.0049198	http://dx.doi.org/10.1371/journal.pone.0049198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155465	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900100
J	Wasik, R; Winska, P; Poznanski, J; Shugar, D				Wasik, Romualda; Winska, Patrycja; Poznanski, Jaroslaw; Shugar, David			Isomeric Mono-, Di-, and Tri-Bromobenzo-1H-Triazoles as Inhibitors of Human Protein Kinase CK2 alpha	PLOS ONE			English	Article							HALOGEN BONDS; SELECTIVE INHIBITORS; CK-II; BENZIMIDAZOLE; ANALOGS; BINDING; SITE; 4,5,6,7-TETRABROMOBENZIMIDAZOLE; TETRABROMOBENZOTRIAZOLE; DEHALOGENATION	To further clarify the role of the individual bromine atoms of 4,5,6,7-tetrabromotriazole (TBBt), a relatively selective inhibitor of protein kinase CK2, we have examined the inhibition (IC50) of human CK2 alpha by the two mono-, the four di-, and the two tri- bromobenzotriazoles relative to that of TBBt. Halogenation of the central vicinal C(5)/C(6) atoms proved to be a key factor in enhancing inhibitory activity, in that 5,6-di-Br(2)Bt and 4,5,6-Br(3)Bt were almost as effective inhibitors as TBBt, notwithstanding their marked differences in pK(a) for dissociation of the triazole proton. The decrease in pK(a) on halogenation of the peripheral C(4)/C(7) atoms virtually nullifies the gain due to hydrophobic interactions, and does not lead to a decrease in IC50. Molecular modeling of structures of complexes of the ligands with the enzyme, as well as QSAR analysis, pointed to a balance of hydrophobic and electrostatic interactions as a discriminator of inhibitory activity. The role of halogen bonding remains debatable, as originally noted for the crystal structure of TBBt with CK2 alpha (pdb1j91). Finally we direct attention to the promising applicability of our series of well-defined halogenated benzotriazoles to studies on inhibition of kinases other than CK2.	[Wasik, Romualda; Winska, Patrycja; Poznanski, Jaroslaw; Shugar, David] Inst Biochem & Biophys PAS, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Wasik, R (corresponding author), Inst Biochem & Biophys PAS, Warsaw, Poland.	jarek@ibb.waw.pl; shugar@ibb.waw.pl	poznanski, jarek/G-7064-2013; Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Winska, Patrycja/0000-0002-2122-1123				Ahn YB, 2003, APPL ENVIRON MICROB, V69, P4159, DOI 10.1128/AEM.69.7.4159-4166.2003; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Battistutta R, 2005, CHEM BIOL, V12, P1211, DOI 10.1016/j.chembiol.2005.08.015; Battistutta R, 2001, PROTEIN SCI, V10, P2200, DOI 10.1110/ps.19601; Battistutta R, 2007, CHEMBIOCHEM, V8, P1804, DOI 10.1002/cbic.200700307; Baumli S, 2010, CHEM BIOL, V17, P931, DOI 10.1016/j.chembiol.2010.07.012; Bednarek E, 2002, J CHEM SOC PERK T 2, P999, DOI 10.1039/b110435g; Borowski P, 2003, EUR J BIOCHEM, V270, P1645, DOI 10.1046/j.1432-1033.2003.03540.x; De Moliner E, 2003, EUR J BIOCHEM, V270, P3174, DOI 10.1046/j.1432-1033.2003.03697.x; DOBROWOLSKA G, 1991, BIOCHIM BIOPHYS ACTA, V1080, P221, DOI 10.1016/0167-4838(91)90005-K; Grant SK, 2011, CHEM BIOL, V18, P3, DOI 10.1016/j.chembiol.2011.01.003; Hwang JS, 2009, ANTIMICROB AGENTS CH, V53, P5095, DOI 10.1128/AAC.00809-09; Jesenska A, 2005, APPL ENVIRON MICROB, V71, P6736, DOI 10.1128/AEM.71.11.6736-6745.2005; Kalchenko O, 2005, J PHYS ORG CHEM, V18, P578, DOI 10.1002/poc.902; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lu YX, 2012, EXPERT OPIN DRUG DIS, V7, P375, DOI 10.1517/17460441.2012.678829; Lum K, 1999, J PHYS CHEM B, V103, P4570, DOI 10.1021/jp984327m; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Olsen BB, 2008, MOL CELL BIOCHEM, V316, P37, DOI 10.1007/s11010-008-9824-3; Pagano MA, 2004, J MED CHEM, V47, P6239, DOI 10.1021/jm049854a; Pagano MA, 2008, BIOCHEM J, V415, P353, DOI 10.1042/BJ20080309; Parisini E, 2011, CHEM SOC REV, V40, P2267, DOI 10.1039/c0cs00177e; Poznanski J, 2007, J PHYS CHEM A, V111, P6501, DOI 10.1021/jp071611h; Rendine S, 2011, PHYS CHEM CHEM PHYS, V13, P19508, DOI 10.1039/c1cp22436k; Sarno S, 2011, CURR TOP MED CHEM, V11, P1340, DOI 10.2174/156802611795589638; SCHENK T, 1989, J BACTERIOL, V171, P5487, DOI 10.1128/jb.171.10.5487-5491.1989; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; SZYSZKA R, 1995, BIOCHEM BIOPH RES CO, V208, P418, DOI 10.1006/bbrc.1995.1354; Szyszka R, 1996, ACTA BIOCHIM POL, V43, P389; Thomas SR, 2009, J BIOL CHEM, V284, P19659, DOI 10.1074/jbc.M109.013458; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Voth AR, 2007, CURR TOP MED CHEM, V7, P1336; Voth AR, 2009, NAT CHEM, V1, P74, DOI [10.1038/NCHEM.112, 10.1038/nchem.112]; Wasik R, 2012, J PHYS CHEM B, V116, P7259, DOI 10.1021/jp301561x; Wasik R, 2010, J PHYS CHEM B, V114, P10601, DOI 10.1021/jp102848y; Zien P, 2005, BBA-PROTEINS PROTEOM, V1754, P271, DOI 10.1016/j.bbapap.2005.07.039; Zien P, 2003, BIOCHEM BIOPH RES CO, V306, P129, DOI 10.1016/S0006-291X(03)00928-8	38	17	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48898	10.1371/journal.pone.0048898	http://dx.doi.org/10.1371/journal.pone.0048898			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155426	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900061
J	Zheng, C; Wang, MJ; Takemoto, K; Akutsu, T; Zhang, ZD; Song, JN				Zheng, Cheng; Wang, Mingjun; Takemoto, Kazuhiro; Akutsu, Tatsuya; Zhang, Ziding; Song, Jiangning			An Integrative Computational Framework Based on a Two-Step Random Forest Algorithm Improves Prediction of Zinc-Binding Sites in Proteins	PLOS ONE			English	Article							SEQUENCE-BASED PREDICTION; AMINO-ACID; DISULFIDE CONNECTIVITY; RESIDUE DEPTH; ACCURATE; RECOGNITION; INFORMATION; ENZYMES; SPHERE; ROBUST	Zinc-binding proteins are the most abundant metalloproteins in the Protein Data Bank where the zinc ions usually have catalytic, regulatory or structural roles critical for the function of the protein. Accurate prediction of zinc-binding sites is not only useful for the inference of protein function but also important for the prediction of 3D structure. Here, we present a new integrative framework that combines multiple sequence and structural properties and graph-theoretic network features, followed by an efficient feature selection to improve prediction of zinc-binding sites. We investigate what information can be retrieved from the sequence, structure and network levels that is relevant to zinc-binding site prediction. We perform a two-step feature selection using random forest to remove redundant features and quantify the relative importance of the retrieved features. Benchmarking on a high-quality structural dataset containing 1,103 protein chains and 484 zinc-binding residues, our method achieved >80% recall at a precision of 75% for the zinc-binding residues Cys, His, Glu and Asp on 5-fold cross-validation tests, which is a 10%-28% higher recall at the 75% equal precision compared to SitePredict and zincfinder at residue level using the same dataset. The independent test also indicates that our method has achieved recall of 0.790 and 0.759 at residue and protein levels, respectively, which is a performance better than the other two methods. Moreover, AUC (the Area Under the Curve) and AURPC (the Area Under the Recall-Precision Curve) by our method are also respectively better than those of the other two methods. Our method can not only be applied to large-scale identification of zinc-binding sites when structural information of the target is available, but also give valuable insights into important features arising from different levels that collectively characterize the zinc-binding sites. The scripts and datasets are available at http://protein.cau.edu.cn/zincidentifier/.	[Zheng, Cheng; Wang, Mingjun; Song, Jiangning] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China	Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS	Zheng, C (corresponding author), Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Natl Engn Lab Ind Enzymes, Tianjin, Peoples R China.	zidingzhang@cau.edu.cn; Jiangning.Song@monash.edu	Takemoto, Kazuhiro/H-2915-2019; , zidingzhang/E-9320-2011; Song, Jiangning/F-9787-2010; wang, mingjun/C-8042-2013	Takemoto, Kazuhiro/0000-0002-6355-1366; , zidingzhang/0000-0002-9296-571X; Song, Jiangning/0000-0001-8031-9086; Akutsu, Tatsuya/0000-0001-9763-797X				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Andreini C, 2009, ACCOUNTS CHEM RES, V42, P1471, DOI 10.1021/ar900015x; Auld DS, 2001, BIOMETALS, V14, P271, DOI 10.1023/A:1012976615056; Babor M, 2008, PROTEINS, V70, P208, DOI 10.1002/prot.21587; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Bordner AJ, 2008, BIOINFORMATICS, V24, P2865, DOI 10.1093/bioinformatics/btn543; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chakravarty S, 1999, STRUCT FOLD DES, V7, P723, DOI 10.1016/S0969-2126(99)80097-5; Chea E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-153; Chen K, 2007, BIOINFORMATICS, V23, P2843, DOI 10.1093/bioinformatics/btm475; Chen XW, 2009, BIOINFORMATICS, V25, P585, DOI 10.1093/bioinformatics/btp039; COLEMAN JE, 1992, ANNU REV BIOCHEM, V61, P897, DOI 10.1146/annurev.bi.61.070192.004341; Davis J, 2006, P 23 INT C MACH LEAR, P233, DOI [DOI 10.1145/1143844.1143874, 10.1145/1143844.1143874]; Ebert JC, 2008, PROTEIN SCI, V17, P54, DOI 10.1110/ps.073138508; Ebina T, 2011, BIOINFORMATICS, V27, P487, DOI 10.1093/bioinformatics/btq700; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Goyal K, 2008, PROTEINS, V70, P1206, DOI 10.1002/prot.21601; Hamelryck T, 2005, PROTEINS, V59, P38, DOI 10.1002/prot.20379; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Hubbard SJ, 1993, NACCESS COMPUTER PRO; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Li YZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016932; Li YZ, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-14; Li YQ, 2011, BIOINFORMATICS, V27, P3379, DOI 10.1093/bioinformatics/btr579; Lin CT, 2005, INT J NEURAL SYST, V15, P71, DOI 10.1142/S0129065705000116; Lin HH, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S13; Lippi M, 2008, BIOINFORMATICS, V24, P2094, DOI 10.1093/bioinformatics/btn371; Maetschke SR, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-341; Matthews JM, 2008, CURR OPIN STRUC BIOL, V18, P484, DOI 10.1016/j.sbi.2008.04.009; MCDONALD IK, 1994, J MOL BIOL, V238, P777, DOI 10.1006/jmbi.1994.1334; Menchetti S, 2006, LECT NOTES COMPUT SC, V3909, P309, DOI 10.1007/11732990_26; Mika S, 2003, NUCLEIC ACIDS RES, V31, P3789, DOI 10.1093/nar/gkg620; Mizianty MJ, 2011, BIOINFORMATICS, V27, pI24, DOI 10.1093/bioinformatics/btr229; Passerini A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-39; Passerini A, 2006, PROTEINS, V65, P305, DOI 10.1002/prot.21135; Passerini A, 2012, IEEE ACM T COMPUT BI, V9, P203, DOI 10.1109/TCBB.2011.94; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102; Shu NJ, 2008, BIOINFORMATICS, V24, P775, DOI 10.1093/bioinformatics/btm618; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sodhi JS, 2004, J MOL BIOL, V342, P307, DOI 10.1016/j.jmb.2004.07.019; Song JN, 2008, BIOINFORMATICS, V24, P1489, DOI 10.1093/bioinformatics/btn222; Song JN, 2007, BIOINFORMATICS, V23, P3147, DOI 10.1093/bioinformatics/btm505; Song JN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030361; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Song JN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007072; VALLEE BL, 1992, FARADAY DISCUSS, V93, P47, DOI 10.1039/fd9929300047; Wang M, 2012, PLOS ONE; Wang XF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026767; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wu JS, 2009, BIOINFORMATICS, V25, P30, DOI 10.1093/bioinformatics/btn583; Wu S, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-4; Zhang JP, 2004, FOURTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P571, DOI 10.1109/ICDM.2004.10015; Zhang T, 2008, BIOINFORMATICS, V24, P2329, DOI 10.1093/bioinformatics/btn433; Zhao W, 2011, BIOINFORMATICS, V27, P1262, DOI 10.1093/bioinformatics/btr133; Zhu L, 2010, J COMPUT CHEM, V31, P1478, DOI 10.1002/jcc.21433	58	16	16	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49716	10.1371/journal.pone.0049716	http://dx.doi.org/10.1371/journal.pone.0049716			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166753	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900184
J	Choi, KH; Le, T; McGuire, J; Coyner, J; Higgs, BW; Diglisic, S; Johnson, LR; Benedek, DM; Ursano, RJ				Choi, Kwang H.; Le, Thien; McGuire, Jennifer; Coyner, Jennifer; Higgs, Brandon W.; Diglisic, Suad; Johnson, Luke R.; Benedek, David M.; Ursano, Robert J.			Expression Profiles of Mitochondrial Genes in the Frontal Cortex and the Caudate Nucleus of Developing Humans and Mice Selectively Bred for High and Low Fear	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; PREFRONTAL CORTICAL DEVELOPMENT; ANXIETY-LIKE BEHAVIORS; BIPOLAR DISORDER; HUMAN BRAIN; BASAL GANGLIA; PSYCHIATRIC-DISORDERS; MOLECULAR EVIDENCE; POSTMORTEM BRAINS; SCHIZOPHRENIA	A growing body of evidence suggests that mitochondrial function may be important in brain development and psychiatric disorders. However, detailed expression profiles of those genes in human brain development and fear-related behavior remain unclear. Using microarray data available from the public domain and the Gene Ontology analysis, we identified the genes and the functional categories associated with chronological age in the prefrontal cortex (PFC) and the caudate nucleus (CN) of psychiatrically normal humans ranging in age from birth to 50 years. Among those, we found that a substantial number of genes in the PFC (115) and the CN (117) are associated with the GO term: mitochondrion (FDR qv<0.05). A greater number of the genes in the PFC (91%) than the genes in the CN (62%) showed a linear increase in expression during postnatal development. Using quantitative PCR, we validated the developmental expression pattern of four genes including monoamine oxidase B (MAOB), NADH dehydrogenase flavoprotein (NDUFV1), mitochondrial uncoupling protein 5 (SLC25A14) and tubulin beta-3 chain (TUBB3). In mice, overall developmental expression pattern of MAOB, SLC25A14 and TUBB3 in the PFC were comparable to the pattern observed in humans (p<0.05). However, mice selectively bred for high fear did not exhibit normal developmental changes of MAOB and TUBB3. These findings suggest that the genes associated with mitochondrial function in the PFC play a significant role in brain development and fear-related behavior.	[Choi, Kwang H.; Le, Thien; McGuire, Jennifer; Coyner, Jennifer; Johnson, Luke R.; Benedek, David M.; Ursano, Robert J.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, Bethesda, MD 20814 USA; [Higgs, Brandon W.] Elashoff Consulting, Redwood City, CA USA; [Diglisic, Suad] Stanley Med Res Inst, Rockville, MD USA	Uniformed Services University of the Health Sciences - USA	Choi, KH (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Psychiat, Ctr Study Traumat Stress, Bethesda, MD 20814 USA.	kwang.choi@usuhs.edu	Ursano, Robert J/ABE-6533-2020	Johnson PhD, Luke R/0000-0002-5088-1788; Higgs, Brandon/0000-0002-2951-0245; Ursano, Robert/0000-0002-1861-9173; McGuire, Jennifer/0000-0003-3058-5241	Center for the Study of Traumatic Stress; Stanley Medical Research Institute	Center for the Study of Traumatic Stress; Stanley Medical Research Institute	This study was partially supported by The Center for the Study of Traumatic Stress and the Stanley Medical Research Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ameli R, 2001, PSYCHOPHYSIOLOGY, V38, P383, DOI 10.1017/S0048577201981776; Beasley CL, 2006, PROTEOMICS, V6, P3414, DOI 10.1002/pmic.200500069; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Ben-Shachar D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003676; Ben-Shachar D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000817; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bortolato M, 2008, ADV DRUG DELIVER REV, V60, P1527, DOI 10.1016/j.addr.2008.06.002; BOWLING AC, 1993, J NEUROCHEM, V60, P1964, DOI 10.1111/j.1471-4159.1993.tb13430.x; Carrera N, 2009, AM J MED GENET B, V150B, P369, DOI 10.1002/ajmg.b.30823; Casey BJ, 2000, BIOL PSYCHOL, V54, P241, DOI 10.1016/S0301-0511(00)00058-2; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Choi K, 2012, J PSYCHIAT RES; Choi KH, 2011, BIOL PSYCHIAT, V69, P353, DOI 10.1016/j.biopsych.2010.09.042; Choi KH, 2009, J PSYCHIATR NEUROSCI, V34, P450; Cocchi M, 2010, ANN GEN PSYCHIATR, V9, DOI 10.1186/1744-859X-9-25; CORTOPASSI GA, 1992, P NATL ACAD SCI USA, V89, P7370, DOI 10.1073/pnas.89.16.7370; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Duncan J, 2012, DRUG DISCOV THER, V6, P112, DOI 10.5582/ddt.2012.v6.3.112; EBLEN F, 1995, J NEUROSCI, V15, P5999; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Einat H, 2005, BEHAV BRAIN RES, V165, P172, DOI 10.1016/j.bbr.2005.06.012; Finsterer J, 2010, DRUG CHEM TOXICOL, V33, P138, DOI 10.3109/01480540903207076; Gardner A, 2003, J AFFECT DISORDERS, V76, P55, DOI 10.1016/S0165-0327(02)00067-8; Gardner A, 2011, PROG NEURO-PSYCHOPH, V35, P730, DOI 10.1016/j.pnpbp.2010.07.030; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gigante AD, 2011, NEUROSCI LETT, V505, P47, DOI 10.1016/j.neulet.2011.09.064; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Harris LW, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-28; Hollerman JR, 2000, PROG BRAIN RES, V126, P193; HUTCHIN T, 1995, P NATL ACAD SCI USA, V92, P6892, DOI 10.1073/pnas.92.15.6892; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Iwamoto K, 2005, HUM MOL GENET, V14, P241, DOI 10.1093/hmg/ddi022; Jazin EE, 1996, P NATL ACAD SCI USA, V93, P12382, DOI 10.1073/pnas.93.22.12382; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Katsel P, 2005, SCHIZOPHR RES, V77, P241, DOI 10.1016/j.schres.2005.03.020; Katyare SS, 1995, COMP BIOCHEM PHYS C, V112, P353, DOI 10.1016/0742-8413(95)02031-4; Koene S, 2009, J AFFECT DISORDERS, V114, P327, DOI 10.1016/j.jad.2008.06.023; Konradi C, 2004, ARCH GEN PSYCHIAT, V61, P300, DOI 10.1001/archpsyc.61.3.300; Konradi C, 2011, NEUROBIOL DIS; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee CW, 2008, MOL BIOL CELL, V19, P150, DOI 10.1091/mbc.E07-05-0515; Levitt P, 1997, TRENDS NEUROSCI, V20, P269, DOI 10.1016/S0166-2236(96)01028-4; Lewis DA, 1997, NEUROPSYCHOPHARMACOL, V16, P385, DOI 10.1016/S0893-133X(96)00277-1; Lewis DA, 2006, ARCH NEUROL-CHICAGO, V63, P1372, DOI 10.1001/archneur.63.10.1372; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Mamah D, 2007, SCHIZOPHR RES, V89, P59, DOI 10.1016/j.schres.2006.08.031; MATTSON MP, 1991, NEUROBIOL AGING, V12, P343, DOI 10.1016/0197-4580(91)90016-D; McCormick CM, 2007, PHARMACOL BIOCHEM BE, V86, P220, DOI 10.1016/j.pbb.2006.07.012; Meaney M.J., 1985, BRAIN RES, V350, P159, DOI DOI 10.1016/0165-3806(85)90259-7; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; MEIER E, 1991, NEUROCHEM INT, V19, P1, DOI 10.1016/0197-0186(91)90113-R; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Myers-Schulz B., 2011, MOL PSYCHIAT; Nahon E, 2005, FEBS LETT, V579, P5105, DOI 10.1016/j.febslet.2005.08.020; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Norrholm SD, 2011, BIOL PSYCHIAT, V69, P556, DOI 10.1016/j.biopsych.2010.09.013; Parker CC, 2012, BEHAV GENET, V42, P437, DOI 10.1007/s10519-011-9524-8; Parker Clarissa C., 2011, Frontiers in Genetics, V2, P32, DOI 10.3389/fgene.2011.00032; Pieczenik SR, 2007, EXP MOL PATHOL, V83, P84, DOI 10.1016/j.yexmp.2006.09.008; Ponder CA, 2007, GENES BRAIN BEHAV, V6, P736, DOI 10.1111/j.1601-183X.2007.00306.x; Ponder CA, 2008, BEHAV GENET, V38, P277, DOI 10.1007/s10519-008-9203-6; Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913; RondiReig L, 1997, NEUROREPORT, V8, P2429, DOI 10.1097/00001756-199707280-00004; Ryan MM, 2006, MOL PSYCHIATR, V11, P965, DOI 10.1038/sj.mp.4001875; Santoro A, 2006, BBA-BIOENERGETICS, V1757, P1388, DOI 10.1016/j.bbabio.2006.05.040; Savitz J, 2009, NEUROSCI BIOBEHAV R, V33, P699, DOI 10.1016/j.neubiorev.2009.01.004; SELEMON LD, 1985, J NEUROSCI, V5, P776; Shao L, 2008, BIOL PSYCHIAT, V64, P89, DOI 10.1016/j.biopsych.2007.11.010; Shao L, 2008, ANN MED, V40, P281, DOI 10.1080/07853890801923753; Sherman BT, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-426; Sokolov BP, 2003, J NEUROSCI RES, V72, P756, DOI 10.1002/jnr.10631; Somel M, 2009, P NATL ACAD SCI USA, V106, P5743, DOI 10.1073/pnas.0900544106; SOONG NW, 1992, NAT GENET, V2, P318; SOUZA HEJ, 1994, BIOCHEM PHARMACOL, V48, P535, DOI 10.1016/0006-2952(94)90283-6; Su YA, 2008, INT J BIOL SCI, V4, P223; Sullivan RM, 2002, PSYCHONEUROENDOCRINO, V27, P99, DOI 10.1016/S0306-4530(01)00038-5; Tranah GJ, 2010, AGEING RES REV; Turnbull HE, 2010, BBA-MOL BASIS DIS, V1802, P111, DOI 10.1016/j.bbadis.2009.07.010; Vawter MP, 2006, MOL PSYCHIATR, V11, P663, DOI 10.1038/sj.mp.4001830; Webster MJ, 2011, INT J DEV NEUROSCI, V29, P225, DOI 10.1016/j.ijdevneu.2010.09.006; Weickert CS, 2009, MOL PSYCHIATR, V14, P558, DOI 10.1038/mp.2009.5; Weickert CS, 1998, SCHIZOPHRENIA BULL, V24, P303, DOI 10.1093/oxfordjournals.schbul.a033327; WEINBERGER DR, 1992, AM J PSYCHIAT, V149, P890; Woo TUW, 2005, SCHIZOPHR RES, V73, P193, DOI 10.1016/j.schres.2004.07.022; Wright LD, 2008, PSYCHONEUROENDOCRINO, V33, P130, DOI 10.1016/j.psyneuen.2007.10.009; Wright LD, 2012, DEV PSYCHOBIOL, V54, P47, DOI 10.1002/dev.20575; Zielke HR, 1996, J AUTISM DEV DISORD, V26, P227, DOI 10.1007/BF02172017	88	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49183	10.1371/journal.pone.0049183	http://dx.doi.org/10.1371/journal.pone.0049183			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152871	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234600027
J	Zheng, M; Kang, YM; Liu, W; Zang, WJ; Bao, CY; Qin, DN				Zheng, Min; Kang, Yu-Ming; Liu, Wei; Zang, Wei-Jin; Bao, Cui-Yu; Qin, Da-Nian			Inhibition of Cyclooxygenase-2 Reduces Hypothalamic Excitation in Rats with Adriamycin-Induced Heart Failure	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RATS; FACTOR-KAPPA-B; PARAVENTRICULAR NUCLEUS; ANGIOTENSIN-II; MYOCARDIAL-INFARCTION; BRAIN ANGIOTENSIN; OXIDATIVE STRESS; NERVE DISCHARGE; AT(1) RECEPTOR; ACTIVATION	Background: The paraventricular nucleus (PVN) of the hypothalamus plays an important role in the progression of heart failure (HF). We investigated whether cyclooxygenase-2 (COX-2) inhibition in the PVN attenuates the activities of sympathetic nervous system (SNS) and renin-angiotensin system (RAS) in rats with adriamycin-induced heart failure. Methodology/Principal Finding: Heart failure was induced by intraperitoneal injection of adriamycin over a period of 2 weeks (cumulative dose of 15 mg/kg). On day 19, rats received intragastric administration daily with either COX-2 inhibitor celecoxib (CLB) or normal saline. Treatment with CLB reduced mortality and attenuated both myocardial atrophy and pulmonary congestion in HF rats. Compared with the HF rats, ventricle to body weight (VW/BW) and lung to body weight (LW/BW) ratios, heart rate (HR), left ventricular end-diastolic pressure (LVEDP), left ventricular peak systolic pressure (LVPSP) and maximum rate of change in left ventricular pressure (LV +/- dp/dtmax) were improved in HF+CLB rats. Angiotensin II (ANG II), norepinephrine (NE), COX-2 and glutamate (Glu) in the PVN were increased in HF rats. HF rats had higher levels of ANG II and NE in plasma, higher level of ANG II in myocardium, and lower levels of ANP in plasma and myocardium. Treatment with CLB attenuated these HF-induced changes. HF rats had more COX-2-positive neurons and more corticotropin releasing hormone (CRH) positive neurons in the PVN than did control rats. Treatment with CLB decreased COX-2-positive neurons and CRH positive neurons in the PVN of HF rats. Conclusions: These results suggest that PVN COX-2 may be an intermediary step for PVN neuronal activation and excitatory neurotransmitter release, which further contributes to sympathoexcitation and RAS activation in adriamycin-induced heart failure. Treatment with COX-2 inhibitor attenuates sympathoexcitation and RAS activation in adriamycin-induced heart failure.	[Kang, Yu-Ming] Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Med, Cardiovasc Res Ctr, Xian 710049, Peoples R China; [Zheng, Min; Liu, Wei; Qin, Da-Nian] Shantou Univ, Dept Physiol, Coll Med, Shantou, Peoples R China; [Zheng, Min; Bao, Cui-Yu] Hubei Univ Sci & Techonol, Dept Biomed Engn, Xianning, Peoples R China; [Zang, Wei-Jin] Xi An Jiao Tong Univ, Dept Pharmacol, Sch Med, Xian 710049, Peoples R China	Xi'an Jiaotong University; Shantou University; Hubei University of Science & Technology; Xi'an Jiaotong University	Kang, YM (corresponding author), Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Med, Cardiovasc Res Ctr, Xian 710049, Peoples R China.	ykang@mail.xjtu.edu.cn; dnqin@stu.edu.cn			National Basic Research Program of China [2012CB517805]; National Natural Science Foundation of China [81170248, 81070199]; foundation of Hubei Provincial Department of Education [Z20092801]; Shantou University Medical College Grant	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); foundation of Hubei Provincial Department of Education; Shantou University Medical College Grant	This work was supported by National Basic Research Program of China (No. 2012CB517805), National Natural Science Foundation of China (Nos. 81170248, 81070199), foundation of Hubei Provincial Department of Education (No. Z20092801) and Shantou University Medical College Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONACCIO MJ, 1978, NEUROPHARMACOLOGY, V17, P783, DOI 10.1016/0028-3908(78)90065-5; Arabia AM, 2002, NEUROSCIENCE, V114, P591, DOI 10.1016/S0306-4522(02)00337-8; Aston-Jones G, 2004, J NEUROSCI, V24, P2313, DOI 10.1523/JNEUROSCI.5339-03.2004; Boudaba C, 1996, J NEUROSCI, V16, P7151; Braunwald E, 2000, CIRCULATION, V102, P14; BRENNAN TJ, 1983, LIFE SCI, V33, P701, DOI 10.1016/0024-3205(83)90774-9; CATT KJ, 1987, ADV BIOCHEM PSYCHOPH, V43, P51; Delgado RM, 2004, CIRCULATION, V109, P1428, DOI 10.1161/01.CIR.0000121354.34067.48; Dieterich H A, 2005, Fiziol Cheloveka, V31, P97; Ericsson A, 1997, J NEUROSCI, V17, P7166; Francis J, 2004, AM J PHYSIOL-HEART C, V287, pH2138, DOI 10.1152/ajpheart.00112.2004; Francis J, 2004, AM J PHYSIOL-HEART C, V287, pH791, DOI 10.1152/ajpheart.00099.2004; Helwig BG, 2007, AM J PHYSIOL-REG I, V292, pR1165, DOI 10.1152/ajpregu.00507.2006; HOFFMAN WE, 1979, J PHYSIOL-LONDON, V288, P159; Huang JH, 1999, BRAIN RES, V845, P77, DOI 10.1016/S0006-8993(99)01937-X; Jaimes EA, 2005, KIDNEY INT, V68, P2143, DOI 10.1111/j.1523-1755.2005.00670.x; Johnson AK, 1997, FRONT NEUROENDOCRIN, V18, P292, DOI 10.1006/frne.1997.0153; Kang YM, 2008, CARDIOVASC RES, V79, P671, DOI 10.1093/cvr/cvn119; Kang YM, 2008, AM J PHYSIOL-HEART C, V295, pH227, DOI 10.1152/ajpheart.01157.2007; Kang YM, 2006, CIRC RES, V99, P758, DOI 10.1161/01.RES.0000244092.95152.86; Kang YM, 2009, CARDIOVASC RES, V83, P737, DOI 10.1093/cvr/cvp160; Li TM, 2000, CIRCULATION, V102, P2105, DOI 10.1161/01.CIR.102.17.2105; Liang CS, 2007, ACTA PHARMACOL SIN, V28, P921, DOI 10.1111/j.1745-7254.2007.00585.x; Lindley TE, 2004, CIRC RES, V94, P402, DOI 10.1161/01.RES.0000112964.40701.93; McKinley MJ, 2001, JPN J PHYSIOL, V51, P281, DOI 10.2170/jjphysiol.51.281; McKinley MJ, 1996, CLIN EXP PHARMACOL P, V23, pS99, DOI 10.1111/j.1440-1681.1996.tb02821.x; MohanKumar SMJ, 1998, BRAIN RES BULL, V47, P29, DOI 10.1016/S0361-9230(98)00037-9; Oldfield BJ, 2001, J NEUROENDOCRINOL, V13, P139, DOI 10.1046/j.1365-2826.2001.00597.x; Ouyang CH, 2007, NEUROSCI LETT, V420, P174, DOI 10.1016/j.neulet.2007.05.004; Pacher P, 2003, CIRCULATION, V107, P896, DOI 10.1161/01.CIR.0000048192.52098.DD; Pieske B, 2000, Ther Umsch, V57, P284, DOI 10.1024/0040-5930.57.5.284; Raasch W, 2006, ENDOCRINOLOGY, V147, P3539, DOI 10.1210/en.2006-0198; Rabelo E, 2001, HYPERTENSION, V38, P576, DOI 10.1161/hy09t1.096185; Saavedra JM, 2005, REGUL PEPTIDES, V128, P227, DOI 10.1016/j.regpep.2004.12.015; SIVESKIILISKOVIC N, 1994, CIRCULATION, V89, P2829, DOI 10.1161/01.CIR.89.6.2829; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tan JH, 2004, AM J PHYSIOL-HEART C, V286, pH1665, DOI 10.1152/ajpheart.00858.2003; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; vanAcker SABE, 1996, CANCER CHEMOTH PHARM, V38, P95, DOI 10.1007/s002800050453; World Medical A. & American Physiological, 2002, AM J PHYSIOL-REG I, V283, pR281; Yu Y, 2007, HYPERTENSION, V49, P511, DOI 10.1161/01.HYP.0000257356.20527.c5; Zanzinger J, 2000, PFLUG ARCH EUR J PHY, V439, P489, DOI 10.1007/s004240050968; Zhang K, 2002, AM J PHYSIOL-REG I, V282, pR1006, DOI 10.1152/ajpregu.00241.2001; Zhang ZH, 2003, AM J PHYSIOL-REG I, V284, pR916, DOI 10.1152/ajpregu.00406.2002; Zucker IH, 2006, HYPERTENSION, V48, P1005, DOI 10.1161/01.HYP.0000246614.47231.25	45	23	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48771	10.1371/journal.pone.0048771	http://dx.doi.org/10.1371/journal.pone.0048771			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152801	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600011
J	Bilo, G; Revera, M; Bussotti, M; Bonacina, D; Styczkiewicz, K; Caldara, G; Giglio, A; Faini, A; Giuliano, A; Lombardi, C; Kawecka-Jaszcz, K; Mancia, G; Agostoni, P; Parati, G				Bilo, Grzegorz; Revera, Miriam; Bussotti, Maurizio; Bonacina, Daniele; Styczkiewicz, Katarzyna; Caldara, Gianluca; Giglio, Alessia; Faini, Andrea; Giuliano, Andrea; Lombardi, Carolina; Kawecka-Jaszcz, Kalina; Mancia, Giuseppe; Agostoni, Piergiuseppe; Parati, Gianfranco			Effects of Slow Deep Breathing at High Altitude on Oxygen Saturation, Pulmonary and Systemic Hemodynamics	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; ARTERIAL BAROREFLEX SENSITIVITY; LUNG DIFFUSING-CAPACITY; MOUNTAIN-SICKNESS; BLOOD-PRESSURE; EXERCISE; DEVICE; HYPERTENSION; EXPOSURE; EDEMA	Slow deep breathing improves blood oxygenation (Sp(O2)) and affects hemodynamics in hypoxic patients. We investigated the ventilatory and hemodynamic effects of slow deep breathing in normal subjects at high altitude. We collected data in healthy lowlanders staying either at 4559 m for 2-3 days (Study A; N = 39) or at 5400 m for 12-16 days (Study B; N = 28). Study variables, including Sp(O2) and systemic and pulmonary arterial pressure, were assessed before, during and after 15 minutes of breathing at 6 breaths/min. At the end of slow breathing, an increase in Sp(O2) (Study A: from 80.2 +/- 7.7% to 89.5 +/- 8.2%; Study B: from 81.0 +/- 4.2% to 88.6 +/- 4.5; both p<0.001) and significant reductions in systemic and pulmonary arterial pressure occurred. This was associated with increased tidal volume and no changes in minute ventilation or pulmonary CO diffusion. Slow deep breathing improves ventilation efficiency for oxygen as shown by blood oxygenation increase, and it reduces systemic and pulmonary blood pressure at high altitude but does not change pulmonary gas diffusion.	[Agostoni, Piergiuseppe] Univ Milan, IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Agostoni, Piergiuseppe] Univ Milan, Dept Cardiovasc Sci, Milan, Italy; [Bilo, Grzegorz; Revera, Miriam; Caldara, Gianluca; Giglio, Alessia; Faini, Andrea; Giuliano, Andrea; Lombardi, Carolina; Parati, Gianfranco] San Luca Hosp, Dept Cardiol, Ist Auxol Italiano, Milan, Italy; [Bussotti, Maurizio] IRCCS, Fdn Salvatore Maugeri, Milan, Italy; [Bonacina, Daniele; Giuliano, Andrea; Mancia, Giuseppe; Parati, Gianfranco] Univ Milano Bicocca, Dept Clin Med & Prevent, Milan, Italy; [Styczkiewicz, Katarzyna; Kawecka-Jaszcz, Kalina] Jagiellonian Univ, Coll Med, Dept Cardiol & Hypertens 1, Krakow, Poland	IRCCS Centro Cardiologico Monzino; University of Milan; University of Milan; IRCCS Istituto Auxologico Italiano; Istituti Clinici Scientifici Maugeri IRCCS; University of Milano-Bicocca; Jagiellonian University; Collegium Medicum Jagiellonian University	Agostoni, P (corresponding author), Univ Milan, IRCCS, Ctr Cardiol Monzino, Milan, Italy.	piergiuseppe.agostoni@unimi.it	Agostoni, Piergiuseppe/ABG-9556-2020; Styczkiewicz, Katarzyna/AAF-3885-2019; Corrà, Ugo/AAF-8322-2020; Bilo, Grzegorz/J-8694-2016; Faini, Andrea/E-1052-2018; Parati, Gianfranco/K-7151-2016; Lombardi, Carolina/I-9337-2019; Bussotti, Maurizio/AAB-9439-2020	Agostoni, Piergiuseppe/0000-0002-8345-6382; Styczkiewicz, Katarzyna/0000-0003-4036-8320; Corrà, Ugo/0000-0002-9229-3298; Bilo, Grzegorz/0000-0002-5104-9176; Faini, Andrea/0000-0002-8924-8234; Parati, Gianfranco/0000-0001-9402-7439; Bussotti, Maurizio/0000-0003-3520-249X; Revera, Miriam/0000-0002-3388-1858; Lombardi, Carolina/0000-0003-1033-6053	institutional funds of Istituto Auxologico Italiano; Boehringer-Ingelheim Germany; Banca Intesa San Paolo, Milan, Italy	institutional funds of Istituto Auxologico Italiano; Boehringer-Ingelheim Germany(Boehringer Ingelheim); Banca Intesa San Paolo, Milan, Italy	Study A was supported by institutional funds of Istituto Auxologico Italiano, while Study B was supported with an unrestricted grant from Boehringer-Ingelheim Germany and Banca Intesa San Paolo, Milan, Italy. Sapio Life Italy s.r.l., GE Healthcare, and Intercure Ltd. supplied the devices necessary for this study free of charge. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. Study B was supported with an unrestricted grant from Boehringer-Ingelheim Germany and Banca Intesa San Paolo, Milan, Italy. Sapio Life Italy s.r.l., GE Healthcare, and Intercure Ltd. supplied the devices necessary for this study free of charge. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Agostoni P, 2011, J APPL PHYSIOL, V110, P1564, DOI 10.1152/japplphysiol.01167.2010; Agostoni P, 2010, EUR HEART J, V31, P457, DOI 10.1093/eurheartj/ehp472; ANAND IS, 1990, LANCET, V335, P561, DOI 10.1016/0140-6736(90)90348-9; Bernardi L, 1998, LANCET, V351, P1308, DOI 10.1016/S0140-6736(97)10341-5; Bernardi L, 2002, CIRCULATION, V105, P143, DOI 10.1161/hc0202.103311; Bernardi L, 2001, BRIT MED J, V323, P1446, DOI 10.1136/bmj.323.7327.1446; Bilo G, 2011, J HYPERTENS, V29, P380, DOI 10.1097/HJH.0b013e3283409014; COTES JE, 1972, CLIN SCI, V42, P325, DOI 10.1042/cs0420325; Hayano J, 1996, CIRCULATION, V94, P842, DOI 10.1161/01.CIR.94.4.842; Joseph CN, 2005, HYPERTENSION, V46, P714, DOI 10.1161/01.HYP.0000179581.68566.7d; Keyl C, 2003, J APPL PHYSIOL, V94, P213, DOI 10.1152/japplphysiol.01258.2001; MacIntyre N, 2005, EUR RESPIR J, V26, P720, DOI 10.1183/09031936.05.00034905; Maggiorini M, 2003, EUR RESPIR J, V22, P1019, DOI 10.1183/09031936.03.00052403; Meles E, 2004, AM J HYPERTENS, V17, P370, DOI 10.1016/j.amjhyper.2003.12.009; Oneda B, 2010, HYPERTENS RES, V33, P708, DOI 10.1038/hr.2010.74; Parati G, 2007, J HYPERTENS, V25, P57, DOI 10.1097/HJH.0b013e328012bf0f; Parati G, 2008, CIRC-HEART FAIL, V1, P178, DOI 10.1161/CIRCHEARTFAILURE.108.772640; Piiper J, 1992, PHYSIOLOGICAL ADAPTA; Raupach T, 2008, EUR RESPIR J, V32, P387, DOI 10.1183/09031936.00109607; Rosenthal T, 2001, AM J HYPERTENS, V14, P74, DOI 10.1016/S0895-7061(00)01235-8; Schein MH, 2001, J HUM HYPERTENS, V15, P271, DOI 10.1038/sj.jhh.1001148; Spicuzza L, 2000, LANCET, V356, P1495, DOI 10.1016/S0140-6736(00)02881-6; STAUB NC, 1974, PHYSIOL REV, V54, P678, DOI 10.1152/physrev.1974.54.3.678; VOCK P, 1989, RADIOLOGY, V170, P661, DOI 10.1148/radiology.170.3.2916019; WASSERMAN K, 1978, NEW ENGL J MED, V298, P780, DOI 10.1056/NEJM197804062981408	25	35	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49074	10.1371/journal.pone.0049074	http://dx.doi.org/10.1371/journal.pone.0049074			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152851	Green Published, gold			2022-12-27	WOS:000311234000049
J	Lira-Silva, E; Santiago-Martinez, MG; Hernandez-Juarez, V; Garcia-Contreras, R; Moreno-Sanchez, R; Jasso-Chavez, R				Lira-Silva, Elizabeth; Geovanni Santiago-Martinez, M.; Hernandez-Juarez, Viridiana; Garcia-Contreras, Rodolfo; Moreno-Sanchez, Rafael; Jasso-Chavez, Ricardo			Activation of Methanogenesis by Cadmium in the Marine Archaeon Methanosarcina acetivorans	PLOS ONE			English	Article							ANAEROBIC GRANULAR SLUDGE; HEAVY-METALS; CARBONIC-ANHYDRASE; EUGLENA-GRACILIS; ACETATE KINASE; THERMOPHILA; TOXICITY; COBALT; PURIFICATION; INHIBITION	Methanosarcina acetivorans was cultured in the presence of CdCl2 to determine the metal effect on cell growth and biogas production. With methanol as substrate, cell growth and methane synthesis were not altered by cadmium, whereas with acetate, cadmium slightly increased both, growth and methane rate synthesis. In cultures metabolically active, incubations for short-term (minutes) with 10 mu M total cadmium increased the methanogenesis rate by 6 and 9 folds in methanol- and acetate-grown cells, respectively. Cobalt and zinc but not copper or iron also activated the methane production rate. Methanogenic carbonic anhydrase and acetate kinase were directly activated by cadmium. Indeed, cells cultured in 100 mu M total cadmium removed 41-69% of the heavy metal from the culture and accumulated 231-539 nmol Cd/mg cell protein. This is the first report showing that (i) Cd2+ has an activating effect on methanogenesis, a biotechnological relevant process in the bio-fuels field; and (ii) a methanogenic archaea is able to remove a heavy metal from aquatic environments.	[Lira-Silva, Elizabeth; Geovanni Santiago-Martinez, M.; Hernandez-Juarez, Viridiana; Garcia-Contreras, Rodolfo; Moreno-Sanchez, Rafael; Jasso-Chavez, Ricardo] Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico	National Institute of Cardiology - Mexico	Jasso-Chavez, R (corresponding author), Inst Nacl Cardiol, Dept Bioquim, Mexico City, DF, Mexico.	rjass_cardiol@yahoo.com.mx	Garcia-Contreras, Rodolfo/AAI-3548-2020; lira-silva, elizabeth/GQH-9313-2022; Moreno-Sanchez, Rafael/A-3158-2011	Lira-Silva, Elizabeth/0000-0001-8261-0010; Moreno-Sanchez, Rafael/0000-0002-9587-7184; Santiago Martinez, Michel Geovanni/0000-0002-9872-7894	CONACyT, Mexico [90619, 80534, 123636, 156969]; ICyTDF, Mexico [PICS08-5]	CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ICyTDF, Mexico	The funding of the grants described in the manuscript (90619, 80534, 123636 and 156969 from CONACyT and # PICS08-5 from ICyTDF, Mexico) were used for acquisition of lab materials, chemicals and small equipmnet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBANAT DR, 1990, J BACTERIOL, V172, P7145, DOI 10.1128/jb.172.12.7145-7150.1990; ACETI DJ, 1988, J BIOL CHEM, V263, P15444; ALBER BE, 1994, P NATL ACAD SCI USA, V91, P6909, DOI 10.1073/pnas.91.15.6909; Altas L, 2009, J HAZARD MATER, V162, P1551, DOI 10.1016/j.jhazmat.2008.06.048; [Anonymous], 1992, REV INT CONTAM AMB; Cesar A, 2009, ECOTOX ENVIRON SAFE, V72, P1832, DOI 10.1016/j.ecoenv.2008.12.001; Fermoso FG, 2010, BIORESOURCE TECHNOL, V101, P9429, DOI 10.1016/j.biortech.2010.07.053; Ferry JG, 2007, ARCHAEA MOL CELLULAR, P100; FLORENCIO L, 1994, APPL ENVIRON MICROB, V60, P227, DOI 10.1128/AEM.60.1.227-234.1994; Gillan DC, 2005, APPL ENVIRON MICROB, V71, P679, DOI 10.1128/AEM.71.2.679-690.2005; HICKEY RF, 1989, WATER RES, V23, P207, DOI 10.1016/0043-1354(89)90045-6; Ingram-Smith C, 2005, J BACTERIOL, V187, P2386, DOI 10.1128/JB.187.7.2386-2394.2005; Innocenti A, 2004, BIOORG MED CHEM LETT, V14, P3327, DOI 10.1016/j.bmcl.2004.03.101; JARRELL KF, 1987, CAN J MICROBIOL, V33, P551, DOI 10.1139/m87-093; Karri S, 2006, CHEMOSPHERE, V62, P121, DOI 10.1016/j.chemosphere.2005.04.016; Kim BK, 1996, APPL ENVIRON MICROB, V62, P2629, DOI 10.1128/AEM.62.7.2629-2635.1996; KING TE, 1967, METHOD ENZYMOL, V10, P634; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; Lira-Silva E, 2011, J HAZARD MATER, V193, P216, DOI 10.1016/j.jhazmat.2011.07.056; LUNDIE LL, 1989, J BIOL CHEM, V264, P18392; MacAuley SR, 2009, BIOCHEMISTRY-US, V48, P817, DOI 10.1021/bi802246s; Madoni P, 2006, ENVIRON POLLUT, V141, P1, DOI 10.1016/j.envpol.2005.08.025; Mendoza-Cozatl DG, 2006, FEBS J, V273, P5703, DOI 10.1111/j.1742-4658.2006.05558.x; Mori K, 2000, J BIOSCI BIOENG, V90, P260, DOI 10.1263/jbb.90.260; PEPI M, 1992, BIOMETALS, V5, P179, DOI 10.1007/BF01061326; Rohlin L, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-62; SCHOENMAKERS TJM, 1992, BIOTECHNIQUES, V12, P870; Sillen L, 1964, STABILITY CONSTANTS; SILVER S, 1989, BIOL TRACE ELEM RES, V21, P145, DOI 10.1007/BF02917247; SIMPSON W R, 1981, Progress in Oceanography, V10, P1, DOI 10.1016/0079-6611(81)90007-0; SOWERS KR, 1984, APPL ENVIRON MICROB, V47, P971, DOI 10.1128/AEM.47.5.971-978.1984; Sowers KR, 1995, ARCHAEA LAB MANUAL, P200; Toes ACM, 2008, ARCH ENVIRON CON TOX, V55, P372, DOI 10.1007/s00244-008-9135-4; Tripp BC, 2004, J BIOL CHEM, V279, P6683, DOI 10.1074/jbc.M311648200; Wang MJ, 2011, AQUAT TOXICOL, V101, P387, DOI 10.1016/j.aquatox.2010.11.012	36	13	13	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48779	10.1371/journal.pone.0048779	http://dx.doi.org/10.1371/journal.pone.0048779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152802	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234000029
J	van Beers, RJ				van Beers, Robert J.			How Does Our Motor System Determine Its Learning Rate?	PLOS ONE			English	Article							INTEGRATION; POSITION; UNCERTAINTY; NOISE; ADAPTATION; PRINCIPLES; DIRECTION; ERROR; TASK	Motor learning is driven by movement errors. The speed of learning can be quantified by the learning rate, which is the proportion of an error that is corrected for in the planning of the next movement. Previous studies have shown that the learning rate depends on the reliability of the error signal and on the uncertainty of the motor system's own state. These dependences are in agreement with the predictions of the Kalman filter, which is a state estimator that can be used to determine the optimal learning rate for each movement such that the expected movement error is minimized. Here we test whether not only the average behaviour is optimal, as the previous studies showed, but if the learning rate is chosen optimally in every individual movement. Subjects made repeated movements to visual targets with their unseen hand. They received visual feedback about their endpoint error immediately after each movement. The reliability of these error-signals was varied across three conditions. The results are inconsistent with the predictions of the Kalman filter because correction for large errors in the beginning of a series of movements to a fixed target was not as fast as predicted and the learning rates for the extent and the direction of the movements did not differ in the way predicted by the Kalman filter. Instead, a simpler model that uses the same learning rate for all movements with the same error-signal reliability can explain the data. We conclude that our brain does not apply state estimation to determine the optimal planning correction for every individual movement, but it employs a simpler strategy of using a fixed learning rate for all movements with the same level of error-signal reliability.	[van Beers, Robert J.] Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands; [van Beers, Robert J.] Univ Utrecht, Dept Phys Man, Helmholtz Inst, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Utrecht University	van Beers, RJ (corresponding author), Vrije Univ Amsterdam, Fac Human Movement Sci, MOVE Res Inst Amsterdam, Amsterdam, Netherlands.	r.j.van.beers@vu.nl	van Beers, Robert J/R-7248-2018	van Beers, Robert J/0000-0003-3847-8918	Netherlands Organisation for Scientific Research [453-08-004]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Netherlands Organisation for Scientific Research (http://www.nwo.nl/, NWO Grant 453-08-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley RJ, 2003, J NEUROSCI, V23, P3066; Bays PM, 2007, J PHYSIOL-LONDON, V578, P387, DOI 10.1113/jphysiol.2006.120121; Berniker M, 2008, NAT NEUROSCI, V11, P1454, DOI 10.1038/nn.2229; Bland JM, 1998, BRIT MED J, V316, P129; Brown LE, 2003, J NEUROPHYSIOL, V90, P3105, DOI 10.1152/jn.00013.2003; Burge J, 2008, J VISION, V8, DOI 10.1167/8.4.20; Cheng S, 2006, NEURAL COMPUT, V18, P760, DOI 10.1162/089976606775774651; Cheng S, 2007, J NEUROPHYSIOL, V97, P3057, DOI 10.1152/jn.00897.2006; Churchland MM, 2006, NEURON, V52, P1085, DOI 10.1016/j.neuron.2006.10.034; Diedrichsen J, 2010, TRENDS COGN SCI, V14, P31, DOI 10.1016/j.tics.2009.11.004; Faisal AA, 2008, NAT REV NEUROSCI, V9, P292, DOI 10.1038/nrn2258; GORDON J, 1994, EXP BRAIN RES, V99, P97, DOI 10.1007/BF00241415; Haggard P, 2000, PERCEPT PSYCHOPHYS, V62, P363, DOI 10.3758/BF03205556; Jones KE, 2002, J NEUROPHYSIOL, V88, P1533, DOI 10.1152/jn.2002.88.3.1533; Kalman RE., 1960, J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; KENDALL MG, 1954, BIOMETRIKA, V41, P403, DOI 10.1093/biomet/41.3-4.403; Kording KP, 2006, TRENDS COGN SCI, V10, P319, DOI 10.1016/j.tics.2006.05.003; Korenberg AT, 2002, CAH PSYCHOL COGN, V21, P537; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; MARRIOTT FHC, 1954, BIOMETRIKA, V41, P390; MARSHALL RJ, 1980, BIOMETRIKA, V67, P567; Pine ZM, 1996, NEUROREPORT, V7, P2357, DOI 10.1097/00001756-199610020-00016; Rincon-Gonzalez L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025214; Simani MC, 2007, J NEUROPHYSIOL, V98, P2827, DOI 10.1152/jn.00290.2007; Smeets JBJ, 2006, P NATL ACAD SCI USA, V103, P18781, DOI 10.1073/pnas.0607687103; Smith MA, 2006, PLOS BIOL, V4, P1035, DOI 10.1371/journal.pbio.0040179; Snijders HJ, 2007, NEUROPSYCHOLOGIA, V45, P496, DOI 10.1016/j.neuropsychologia.2006.01.003; Sober SJ, 2003, J NEUROSCI, V23, P6982, DOI 10.1523/JNEUROSCI.23-18-06982.2003; Todorov E, 2004, NAT NEUROSCI, V7, P907, DOI 10.1038/nn1309; Trommershauser J, 2008, TRENDS COGN SCI, V12, P291, DOI 10.1016/j.tics.2008.04.010; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; van Beers RJ, 2004, J NEUROPHYSIOL, V91, P1050, DOI 10.1152/jn.00652.2003; van Beers RJ, 2002, PHILOS T R SOC B, V357, P1137, DOI 10.1098/rstb.2002.1101; van Beers RJ, 1998, EXP BRAIN RES, V122, P367, DOI 10.1007/s002210050525; van Beers RJ, 2009, NEURON, V63, P406, DOI 10.1016/j.neuron.2009.06.025; Wei KL, 2010, J NEUROPHYSIOL, V104, P3053, DOI 10.1152/jn.01025.2009; Wei KL, 2010, FRONT COMPUT NEUROSC, V4, DOI 10.3389/fncom.2010.00011; Wei KL, 2009, J NEUROPHYSIOL, V101, P655, DOI 10.1152/jn.90545.2008; Wei WWS., 2006, TIME SERIES ANAL UNI, V2nd; Wolpert DM, 2007, HUM MOVEMENT SCI, V26, P511, DOI 10.1016/j.humov.2007.05.005	41	29	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49373	10.1371/journal.pone.0049373	http://dx.doi.org/10.1371/journal.pone.0049373			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152899	Green Published, gold			2022-12-27	WOS:000311234000065
J	Zhou, XC; Mao, JH; Ai, JM; Deng, YP; Roth, MR; Pound, C; Henegar, J; Welti, R; Bigler, SA				Zhou, Xinchun; Mao, Jinghe; Ai, Junmei; Deng, Youping; Roth, Mary R.; Pound, Charles; Henegar, Jeffrey; Welti, Ruth; Bigler, Steven A.			Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics	PLOS ONE			English	Article							LYSOPHOSPHATIDIC ACID; MASS-SPECTROMETRY; MEMBRANE-LIPIDS; ANTIGEN; CELL; EXPRESSION; REVEALS; TISSUE; SERUM; ADENOCARCINOMA	Background: Lipids have critical functions in cellular energy storage, structure and signaling. Many individual lipid molecules have been associated with the evolution of prostate cancer; however, none of them has been approved to be used as a biomarker. The aim of this study is to identify lipid molecules from hundreds plasma apparent lipid species as biomarkers for diagnosis of prostate cancer. Methodology/Principal Findings: Using lipidomics, lipid profiling of 390 individual apparent lipid species was performed on 141 plasma samples from 105 patients with prostate cancer and 36 male controls. High throughput data generated from lipidomics were analyzed using bioinformatic and statistical methods. From 390 apparent lipid species, 35 species were demonstrated to have potential in differentiation of prostate cancer. Within the 35 species, 12 were identified as individual plasma lipid biomarkers for diagnosis of prostate cancer with a sensitivity above 80%, specificity above 50% and accuracy above 80%. Using top 15 of 35 potential biomarkers together increased predictive power dramatically in diagnosis of prostate cancer with a sensitivity of 93.6%, specificity of 90.1% and accuracy of 97.3%. Principal component analysis (PCA) and hierarchical clustering analysis (HCA) demonstrated that patient and control populations were visually separated by identified lipid biomarkers. RandomForest and 10-fold cross validation analyses demonstrated that the identified lipid biomarkers were able to predict unknown populations accurately, and this was not influenced by patient's age and race. Three out of 13 lipid classes, phosphatidylethanolamine (PE), ether-linked phosphatidylethanolamine (ePE) and ether-linked phosphatidylcholine (ePC) could be considered as biomarkers in diagnosis of prostate cancer. Conclusions/Significance: Using lipidomics and bioinformatic and statistical methods, we have identified a few out of hundreds plasma apparent lipid molecular species as biomarkers for diagnosis of prostate cancer with a high sensitivity, specificity and accuracy.	[Zhou, Xinchun; Henegar, Jeffrey] Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA; [Mao, Jinghe] Tougaloo Coll, Dept Biol, Tougaloo, MS USA; [Ai, Junmei] Georgia State Univ, Dept Comp Sci, Atlanta, GA 30303 USA; [Deng, Youping] Rush Univ, Med Ctr, Dept Med, Chicago, IL 60612 USA; [Roth, Mary R.; Welti, Ruth] Kansas State Univ, Div Biol, Kansas Lipid Res Ctr, Manhattan, KS 66506 USA; [Pound, Charles] Univ Mississippi, Med Ctr, Dept Surg, Jackson, MS 39216 USA; [Bigler, Steven A.] Mississippi Baptist Med Ctr, Dept Pathol, Jackson, MS USA	University of Mississippi; University of Mississippi Medical Center; Tougaloo College; University System of Georgia; Georgia State University; Rush University; Kansas State University; University of Mississippi; University of Mississippi Medical Center	Zhou, XC (corresponding author), Univ Mississippi, Med Ctr, Dept Pathol, Jackson, MS 39216 USA.	xzhou@umc.edu		Welti, Ruth/0000-0003-4373-2538	University of Mississippi Medical Center [68599370412]; National Institutes of Health/MSINBRE grant [P20RR016476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	University of Mississippi Medical Center; National Institutes of Health/MSINBRE grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by an intramural grant from the University of Mississippi Medical Center (68599370412), and partially by a National Institutes of Health/MSINBRE grant (P20RR016476). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Balogh G, 2010, BBA-MOL CELL BIOL L, V1801, P1036, DOI 10.1016/j.bbalip.2010.04.011; Bartz R, 2007, J LIPID RES, V48, P837, DOI 10.1194/jlr.M600413-JLR200; Bravi F, 2007, INT J CANCER, V120, P681, DOI 10.1002/ijc.22225; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Crowe FL, 2008, AM J CLIN NUTR, V88, P1353, DOI 10.3945/ajcn.2008.26369; de Mello VDF, 2009, DIABETOLOGIA, V52, P2612, DOI 10.1007/s00125-009-1482-9; Devaiah SP, 2006, PHYTOCHEMISTRY, V67, P1907, DOI 10.1016/j.phytochem.2006.06.005; Ding J, 2008, J CHROMATOGR B, V871, P243, DOI 10.1016/j.jchromb.2008.04.040; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Ekroos K, 2010, CURR ATHEROSCLER REP; Elgamal AAA, 2000, SEMIN SURG ONCOL, V18, P10, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<10::AID-SSU3>3.3.CO;2-M; Etzioni R, 2002, J NATL CANCER I, V94, P981; Freeman VL, 2007, CANCER CAUSE CONTROL, V18, P211, DOI 10.1007/s10552-006-0095-6; Gibbs TC, 2009, PROSTATE, V69, P1493, DOI 10.1002/pros.20994; Gorke R, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-126; Graessler J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006261; Graff JR, 2000, J BIOL CHEM, V275, P24500, DOI 10.1074/jbc.M003145200; Hamilton RJ, 2009, JNCI-J NATL CANCER I, V101, P611, DOI 10.1093/jnci/djp043; Han XL, 2007, BIOCHEMISTRY-US, V46, P6417, DOI 10.1021/bi7004015; Han XL, 2003, J LIPID RES, V44, P1071, DOI 10.1194/jlr.R300004-JLR200; He H, 2007, ANAL CHEM, V79, P8423, DOI 10.1021/ac071413m; Keshari KR, 2011, NMR BIOMED, V24, P691, DOI 10.1002/nbm.1738; Kirby RS, 2009, BJU INT, V103, P441, DOI 10.1111/j.1464-410X.2008.08280.x; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; KURHANEWICZ J, 1991, MAGNET RESON MED, V22, P404, DOI 10.1002/mrm.1910220248; Landers KA, 2005, INT J CANCER, V114, P950, DOI 10.1002/ijc.20760; Lankinen M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005258; Liebisch G, 2004, BBA-MOL CELL BIOL L, V1686, P108, DOI 10.1016/j.bbalip.2004.09.003; Min HK, 2011, ANAL BIOANAL CHEM, V399, P823, DOI 10.1007/s00216-010-4290-7; Ollero M, 2011, J LIPID RES, V52, P1011, DOI 10.1194/jlr.P013722; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Pflug BR, 2003, PROSTATE, V57, P245, DOI 10.1002/pros.10297; Pietilainen KH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000218; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Ramirez ML, 2008, PROSTATE CANCER P D, V11, P216, DOI 10.1038/pcan.2008.2; Rogers CG, 2004, J UROLOGY, V172, P1501, DOI 10.1097/01.ju.0000137659.53129.14; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Swanson MG, 2008, MAGN RESON MED, V60, P33, DOI 10.1002/mrm.21647; Teichert F, 2008, PROSTATE, V68, P1035, DOI 10.1002/pros.20761; Thompson IM, 2007, CAN MED ASSOC J, V176, P1853, DOI 10.1503/cmaj.060955; Thompson IM, 2005, JAMA-J AM MED ASSOC, V294, P66, DOI 10.1001/jama.294.1.66; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; Xie YH, 2002, J BIOL CHEM, V277, P32516, DOI 10.1074/jbc.M203864200; Zeng Y, 2009, PROSTATE, V69, P283, DOI 10.1002/pros.20879; Zhou XC, 2012, EXP MOL PATHOL, V92, P105, DOI 10.1016/j.yexmp.2011.11.001; Zhuang LY, 2005, J CLIN INVEST, V115, P959	48	50	53	3	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48889	10.1371/journal.pone.0048889	http://dx.doi.org/10.1371/journal.pone.0048889			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152813	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000032
J	Fernandez, P; Solenthaler, M; Spertini, O; Quarroz, S; Rovo, A; Lovey, PY; Leoncini, L; Ruault-Jungblut, S; D'Asaro, M; Schaad, O; Docquier, M; Descombes, P; Matthes, T				Fernandez, Paula; Solenthaler, Max; Spertini, Olivier; Quarroz, Stephane; Rovo, Alicia; Lovey, Pierre-Yves; Leoncini, Leda; Ruault-Jungblut, Sylvie; D'Asaro, Mathilde; Schaad, Olivier; Docquier, Mylene; Descombes, Patrick; Matthes, Thomas		Swiss Cytometry Soc	Using Digital RNA Counting and Flow Cytometry to Compare mRNA with Protein Expression in Acute Leukemias	PLOS ONE			English	Article							GENE-EXPRESSION; ABUNDANCE; ANTIGENS	Background: The diagnosis of malignant hematologic diseases has become increasingly complex during the last decade. It is based on the interpretation of results from different laboratory analyses, which range from microscopy to gene expression profiling. Recently, a method for the analysis of RNA phenotypes has been developed, the nCounter technology (Nanostring (R) Technologies), which allows for simultaneous quantification of hundreds of RNA molecules in biological samples. We evaluated this technique in a Swiss multi-center study on eighty-six samples from acute leukemia patients. Methods: mRNA and protein profiles were established for normal peripheral blood and bone marrow samples. Signal intensities of the various tested antigens with surface expression were similar to those found in previously performed Affymetrix microarray analyses. Acute leukemia samples were analyzed for a set of twenty-two validated antigens and the Pearson Correlation Coefficient for nCounter and flow cytometry results was calculated. Results: Highly significant values between 0.40 and 0.97 were found for the twenty-two antigens tested. A second correlation analysis performed on a per sample basis resulted in concordant results between flow cytometry and nCounter in 44-100% of the antigens tested (mean = 76%), depending on the number of blasts present in a sample, the homogeneity of the blast population, and the type of leukemia (AML or ALL). Conclusions: The nCounter technology allows for fast and easy depiction of a mRNA profile from hematologic samples. This technology has the potential to become a valuable tool for the diagnosis of acute leukemias, in addition to multi-color flow cytometry. Citation: Fernandez P, Solenthaler M, Spertini O, Quarroz S, Rovo A, et al. (2012) Using Digital RNA Counting and Flow Cytometry to Compare mRNA with Protein Expression in Acute Leukemias. PLoS ONE 7(11): e49010. doi:10.1371/journal.pone.0049010	[Ruault-Jungblut, Sylvie; D'Asaro, Mathilde; Matthes, Thomas] Univ Hosp Geneva, Hematol Serv, Geneva, Switzerland; [Solenthaler, Max] Inselspital Bern, Univ Clin Hematol, CH-3010 Bern, Switzerland; [Solenthaler, Max] Inselspital Bern, Cent Hematol Lab, CH-3010 Bern, Switzerland; [Solenthaler, Max] Univ Bern, Bern, Switzerland; [Spertini, Olivier; Quarroz, Stephane] Univ Lausanne Hosp, CHUV, Hematol Serv, Lausanne, Switzerland; [Rovo, Alicia] Univ Basel Hosp, Dept Hematol, CH-4031 Basel, Switzerland; [Lovey, Pierre-Yves] Inst Cent Hop Valaisans, Hematol Serv, Sion, Switzerland; [Leoncini, Leda] Ist Oncol Svizzera Italiana, Hematol Serv, Bellinzona, Switzerland; [Schaad, Olivier; Docquier, Mylene; Descombes, Patrick] Univ Med Ctr, CMU, Geneva, Switzerland	University of Geneva; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Basel; Institute of Oncology Research (IOR); University of Geneva	Matthes, T (corresponding author), Univ Hosp Geneva, Hematol Serv, Geneva, Switzerland.	thomas.matthes@hcuge.ch		Fernandez, Paula Carolina/0000-0003-3237-6283	Swiss National Science foundation [320030_132926/1]; Fondation Dr. Dubois-Ferriere Dinu-Lipatti; Centre de recherche clinique; HUG Geneva	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission); Fondation Dr. Dubois-Ferriere Dinu-Lipatti; Centre de recherche clinique; HUG Geneva	Swiss National Science foundation (Nr: 320030_132926/1), Fondation Dr. Dubois-Ferriere Dinu-Lipatti, Centre de recherche clinique, HUG Geneva. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Barber N, 2009, FEBS LETT, V583, P1785, DOI 10.1016/j.febslet.2009.03.018; Beaume M, 2011, J MICROBIOL METH, V84, P327, DOI 10.1016/j.mimet.2010.12.025; Belov L, 2006, BRIT J HAEMATOL, V135, P184, DOI 10.1111/j.1365-2141.2006.06266.x; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Kern W, 2006, CANCER, V107, P2401, DOI 10.1002/cncr.22251; Kulkarni Meghana M, 2011, Curr Protoc Mol Biol, VChapter 25, DOI 10.1002/0471142727.mb25b10s94; Malkov Vladislav A, 2009, BMC Res Notes, V2, P80, DOI 10.1186/1756-0500-2-80; Ornatsky O, 2010, J IMMUNOL METHODS, V361, P1, DOI 10.1016/j.jim.2010.07.002; Payton JE, 2009, J CLIN INVEST, V119, P1714, DOI 10.1172/JCI38248; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034	13	13	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49010	10.1371/journal.pone.0049010	http://dx.doi.org/10.1371/journal.pone.0049010			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152841	Green Published, gold, Green Submitted			2022-12-27	WOS:000312272600037
J	Zakas, PM; Gangadharan, B; Almeida-Porada, G; Porada, CD; Spencer, HT; Doering, CB				Zakas, Philip M.; Gangadharan, Bagirath; Almeida-Porada, Graca; Porada, Christopher D.; Spencer, H. Trent; Doering, Christopher B.			Development and Characterization of Recombinant Ovine Coagulation Factor VIII	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; HEMOPHILIA-A MICE; GENE-THERAPY; SUBUNIT; TRANSPLANTATION; CELLS	Animal models of the bleeding disorder, hemophilia A, have been an integral component of the biopharmaceutical development process and have facilitated the development of recombinant coagulation factor VIII (fVIII) products capable of restoring median survival of persons with hemophilia A to that of the general population. However, there remain several limitations to recombinant fVIII as a biotherapeutic, including invasiveness of intravenous infusion, short half-life, immunogenicity, and lack of availability to the majority of the world's population. The recently described ovine model of hemophilia A is the largest and most accurate phenocopy. Affected sheep die prematurely due to bleeding-related pathogenesis and display robust adaptive humoral immunity to non-ovine fVIII. Herein, we describe the development and characterization of recombinant ovine fVIII (ofVIII) to support further the utility of the ovine hemophilia A model. Full-length and B-domain deleted (BDD) ofVIII cDNAs were generated and demonstrated to facilitate greater biosynthetic rates than their human fVIII counterparts while both BDD constructs showed greater expression rates than the same-species full-length versions. A top recombinant BDD ofVIII producing baby hamster kidney clone was identified and used to biosynthesize raw material for purification and biochemical characterization. Highly purified recombinant BDD ofVIII preparations possess a specific activity nearly 2-fold higher than recombinant BDD human fVIII and display a differential glycosylation pattern. However, binding to the carrier protein, von Willebrand factor, which is critical for stability of fVIII in circulation, is indistinguishable. Decay of thrombin-activated ofVIIIa is 2-fold slower than human fVIII indicating greater intrinsic stability. Furthermore, intravenous administration of ofVIII effectively reverses the bleeding phenotype in the murine model of hemophilia A. Recombinant ofVIII should facilitate the maintenance of the ovine hemophilia A herd and their utilization as a relevant large animal model for the research and development of novel nucleic acid and protein-based therapies for hemophilia A. Citation: Zakas PM, Gangadharan B, Almeida-Porada G, Porada CD, Spencer HT, et al. (2012) Development and Characterization of Recombinant Ovine Coagulation Factor VIII. PLoS ONE 7(11): e49481. doi: 10.1371/journal.pone.0049481	[Gangadharan, Bagirath; Spencer, H. Trent; Doering, Christopher B.] Emory Univ, Dept Pediat, Sch Med, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA; [Zakas, Philip M.] Emory Univ, Grad Program Mol & Syst Pharmacol, Atlanta, GA 30322 USA; [Almeida-Porada, Graca; Porada, Christopher D.] Wake Forest Inst Regenerat Med, Winston Salem, NC USA	Emory University; Emory University; Wake Forest University	Doering, CB (corresponding author), Emory Univ, Dept Pediat, Sch Med, Aflac Canc & Blood Disorders Ctr, Atlanta, GA 30322 USA.	cdoerin@emory.edu	Doering, Christopher/W-2064-2019	Almeida-Porada, Maria da Graca/0000-0002-6715-865X	National Institutes of Health, National Heart, Lung, and Blood Institute [HL092179]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092179] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from the National Institutes of Health, National Heart, Lung, and Blood Institute, HL092179. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bihoreau N, 1995, RAPID COMMUN MASS SP, V9, P1584, DOI 10.1002/rcm.1290091524; Brown HC, 2011, J BIOL CHEM, V286, P24451, DOI 10.1074/jbc.M111.238758; Chavez CL, 2012, HUM GENE THER, V23, P390, DOI 10.1089/hum.2011.110; Doering CB, 2004, J BIOL CHEM, V279, P6546, DOI 10.1074/jbc.M312451200; Doering CB, 2002, J BIOL CHEM, V277, P38345, DOI 10.1074/jbc.M206959200; Doering CB, 2002, THROMB HAEMOSTASIS, V88, P450; Doering CB, 2009, MOL THER, V17, P1145, DOI 10.1038/mt.2009.35; Dooriss KL, 2009, HUM GENE THER, V20, P465, DOI 10.1089/hum.2008.150; FAY PJ, 1991, J BIOL CHEM, V266, P8957; Gozal YM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-82; Ide LM, 2010, J GENE MED, V12, P333, DOI 10.1002/jgm.1442; Kumaran V, 2005, J THROMB HAEMOST, V3, P2022, DOI 10.1111/j.1538-7836.2005.01508.x; LIND P, 1995, EUR J BIOCHEM, V232, P19, DOI 10.1111/j.1432-1033.1995.tb20776.x; LITTLEWOOD JD, 1987, THROMB HAEMOSTASIS, V57, P314; LOLLAR P, 1990, J BIOL CHEM, V265, P1688; LOLLAR P, 1991, J BIOL CHEM, V266, P12481; LOLLAR P, 1992, J BIOL CHEM, V267, P23652; LYNCH CM, 1993, HUM GENE THER, V4, P259, DOI 10.1089/hum.1993.4.3-259; Miao HZ, 2004, BLOOD, V103, P3412, DOI 10.1182/blood-2003-10-3591; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Parker ET, 2006, J BIOL CHEM, V281, P13922, DOI 10.1074/jbc.M513124200; Parker ET, 2004, BLOOD, V104, P704, DOI 10.1182/blood-2003-11-3891; Pipe SW, 1999, BLOOD, V93, P176, DOI 10.1182/blood.V93.1.176.401k07_176_183; PITTMAN DD, 1994, J BIOL CHEM, V269, P17329; Porada CD, 2010, J THROMB HAEMOST, V8, P276, DOI 10.1111/j.1538-7836.2009.03697.x; Sabatino DE, 2009, BLOOD, V114, P4562, DOI 10.1182/blood-2009-05-220327; Seidah NG, 1997, CURR OPIN BIOTECH, V8, P602, DOI 10.1016/S0958-1669(97)80036-5; Selvaraj SR, 2012, J THROMB HAEMOST, V10, P107, DOI 10.1111/j.1538-7836.2011.04545.x; Spencer HT, 2011, MOL THER, V19, P302, DOI 10.1038/mt.2010.239; Vidal F, 2000, HUM HERED, V50, P266, DOI 10.1159/000022928; Ward NJ, 2011, BLOOD, V117, P798, DOI 10.1182/blood-2010-05-282707; Yadav N, 2012, STEM CELLS DEV, V21, P110, DOI 10.1089/scd.2010.0569	32	14	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49481	10.1371/journal.pone.0049481	http://dx.doi.org/10.1371/journal.pone.0049481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152911	gold, Green Published, Green Submitted			2022-12-27	WOS:000312272600062
J	Bachmann, A; Petter, M; Tilly, AK; Biller, L; Uliczka, KA; Duffy, MF; Tannich, E; Bruchhaus, I				Bachmann, Anna; Petter, Michaela; Tilly, Ann-Kathrin; Biller, Laura; Uliczka, Karin A.; Duffy, Michael F.; Tannich, Egbert; Bruchhaus, Iris			Temporal Expression and Localization Patterns of Variant Surface Antigens in Clinical Plasmodium falciparum Isolates during Erythrocyte Schizogony	PLOS ONE			English	Article							CHONDROITIN SULFATE-A; RED-BLOOD-CELLS; RIF MULTIGENE FAMILY; INFECTED ERYTHROCYTES; STEVOR PROTEINS; MAURERS CLEFTS; GENE FAMILY; LIFE-CYCLE; SUBCELLULAR-LOCALIZATION; PFMC-2TM SUPERFAMILIES	Avoidance of antibody-mediated immune recognition allows parasites to establish chronic infections and enhances opportunities for transmission. The human malaria parasite Plasmodium falciparum possesses a number of multi-copy gene families, including var, rif, stevor and pfmc-2tm, which encode variant antigens believed to be expressed on the surfaces of infected erythrocytes. However, most studies of these antigens are based on in vitro analyses of culture-adapted isolates, most commonly the laboratory strain 3D7, and thus may not be representative of the unique challenges encountered by P. falciparum in the human host. To investigate the expression of the var, rif-A, rif-B, stevor and pfmc-2tm family genes under conditions that mimic more closely the natural course of infection, ex vivo clinical P. falciparum isolates were analyzed using a novel quantitative real-time PCR approach. Expression patterns in the clinical isolates at various time points during the first intraerythrocytic developmental cycle in vitro were compared to those of strain 3D7. In the clinical isolates, in contrast to strain 3D7, there was a peak of expression of the multi-copy gene families rif-A, stevor and pfmc-2tm at the young ring stage, in addition to the already known expression peak in trophozoites. Furthermore, most of the variant surface antigen families were overexpressed in the clinical isolates relative to 3D7, with the exception of the pfmc-2tm family, expression of which was higher in 3D7 parasites. Immunofluorescence analyses performed in parallel revealed two stage-dependent localization patterns of RIFIN, STEVOR and PfMC-2TM. Proteins were exported into the infected erythrocyte at the young trophozoite stage, whereas they remained inside the parasite membrane during schizont stage and were subsequently observed in different compartments in the merozoite. These results reveal a complex pattern of expression of P. falciparum multi-copy gene families during clinical progression and are suggestive of diverse functional roles of the respective proteins.	[Bachmann, Anna; Tilly, Ann-Kathrin; Biller, Laura; Uliczka, Karin A.; Tannich, Egbert; Bruchhaus, Iris] Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, Hamburg, Germany; [Petter, Michaela; Duffy, Michael F.] Royal Melbourne Hosp, Dept Med, Parkville, Vic 3050, Australia	Bernhard Nocht Institut fur Tropenmedizin; Royal Melbourne Hospital	Bachmann, A (corresponding author), Bernhard Nocht Inst Trop Med, Dept Mol Parasitol, Hamburg, Germany.	bachmann@bni-hamburg.de	Petter, Michaela/N-9876-2017; Duffy, Michael/A-8618-2012; Bachmann, Anna/GRO-1087-2022	Petter, Michaela/0000-0002-1837-2756; Duffy, Michael/0000-0001-5635-4033; Bachmann, Anna/0000-0001-8397-7308	Bernhard Nocht Institute for Tropical Medicine	Bernhard Nocht Institute for Tropical Medicine	The work was funded by the Bernhard Nocht Institute for Tropical Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Latif MS, 2002, INFECT IMMUN, V70, P7013, DOI 10.1128/IAI.70.12.7013-7021.2002; Bachmann A, 2011, CELL MICROBIOL, V13, P1397, DOI 10.1111/j.1462-5822.2011.01629.x; Bachmann A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007459; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Baruch DI, 1999, BEST PRACT RES CL HA, V12, P747, DOI 10.1053/beha.1999.0051; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; Blomqvist K, 2010, MOL BIOCHEM PARASIT, V170, P74, DOI 10.1016/j.molbiopara.2009.12.002; Blythe JE, 2008, INFECT IMMUN, V76, P3329, DOI 10.1128/IAI.01460-07; Boyle MJ, 2010, P NATL ACAD SCI USA, V107, P14378, DOI 10.1073/pnas.1009198107; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Bultrini E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-445; Cabral FJ, 2009, MOL BIOCHEM PARASIT, V168, P186, DOI 10.1016/j.molbiopara.2009.08.002; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; Daily JP, 2005, J INFECT DIS, V191, P1196, DOI 10.1086/428289; Duffy MF, 2002, MOL MICROBIOL, V43, P1285, DOI 10.1046/j.1365-2958.2002.02822.x; Dzikowski R, 2009, CURR GENET, V55, P103, DOI 10.1007/s00294-009-0233-2; Fernandez V, 1999, J EXP MED, V190, P1393, DOI 10.1084/jem.190.10.1393; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Foth BJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006411; Frankland S, 2007, EUKARYOT CELL, V6, P1584, DOI 10.1128/EC.00063-07; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Garcia JE, 2005, PEPTIDES, V26, P1133, DOI 10.1016/j.peptides.2005.01.013; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; HELMBY H, 1993, INFECT IMMUN, V61, P284, DOI 10.1128/IAI.61.1.284-288.1993; HO M, 1990, J INFECT DIS, V161, P555, DOI 10.1093/infdis/161.3.555; Howitt CA, 2009, MOL MICROBIOL, V73, P1171, DOI 10.1111/j.1365-2958.2009.06846.x; Joannin N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-19; Joergensen L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001083; Kaviratne M, 2002, EUKARYOT CELL, V1, P926, DOI 10.1128/EC.1.6.926-935.2002; Khattab A, 2006, TRAFFIC, V7, P1654, DOI 10.1111/j.1600-0854.2006.00494.x; Khattab A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-58; Khattab A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-137; Kirk K, 2001, PHYSIOL REV, V81, P495, DOI 10.1152/physrev.2001.81.2.495; Kocken CHM, 1998, J BIOL CHEM, V273, P15119, DOI 10.1074/jbc.273.24.15119; Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 1999, P NATL ACAD SCI USA, V96, P9333, DOI 10.1073/pnas.96.16.9333; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lavazec C, 2007, MOL MICROBIOL, V64, P1621, DOI 10.1111/j.1365-2958.2007.05767.x; Lavazec C, 2006, NUCLEIC ACIDS RES, V34, P6696, DOI 10.1093/nar/gkl942; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lemieux JE, 2009, P NATL ACAD SCI USA, V106, P7559, DOI 10.1073/pnas.0811829106; Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517; LOOAREESUWAN S, 1987, NEW ENGL J MED, V317, P675, DOI 10.1056/NEJM198709103171105; Mackinnon MJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000644; McRobert L, 2004, INFECT IMMUN, V72, P6597, DOI 10.1128/IAI.72.11.6597-6602.2004; Niang M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000307; OCKENHOUSE CF, 1992, J EXP MED, V176, P1183, DOI 10.1084/jem.176.4.1183; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Peters JM, 2007, J INFECT DIS, V195, P748, DOI 10.1086/511436; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Petter M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003779; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Robert F, 1996, T ROY SOC TROP MED H, V90, P704, DOI 10.1016/S0035-9203(96)90446-0; ROGERSON SJ, 1995, J EXP MED, V182, P15, DOI 10.1084/jem.182.1.15; Rug M, 2004, INFECT IMMUN, V72, P6095, DOI 10.1128/IAI.72.10.6095-6105.2004; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; Schreiber N, 2008, PARASITOLOGY, V135, P155, DOI 10.1017/S0031182007003794; Taylor HM, 2000, MOL BIOCHEM PARASIT, V105, P13, DOI 10.1016/S0166-6851(99)00159-0; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Tsarukyanova I, 2009, PARASITOL RES, V104, P875, DOI 10.1007/s00436-008-1270-3; UDEINYA IJ, 1983, EXP PARASITOL, V56, P207, DOI 10.1016/0014-4894(83)90064-4; Udomsangpetch R, 1997, J IMMUNOL, V158, P4358; Wang CW, 2009, INT J PARASITOL, V39, P655, DOI 10.1016/j.ijpara.2008.11.014; Young JA, 2005, MOL BIOCHEM PARASIT, V143, P67, DOI 10.1016/j.molbiopara.2005.05.007	70	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49540	10.1371/journal.pone.0049540	http://dx.doi.org/10.1371/journal.pone.0049540			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166704	gold, Green Published			2022-12-27	WOS:000311272300051
J	Jarboui, MA; Bidoia, C; Woods, E; Roe, B; Wynne, K; Elia, G; Hall, WW; Gautier, VW				Jarboui, Mohamed Ali; Bidoia, Carlo; Woods, Elena; Roe, Barbara; Wynne, Kieran; Elia, Giuliano; Hall, William W.; Gautier, Virginie W.			Nucleolar Protein Trafficking in Response to HIV-1 Tat: Rewiring the Nucleolus	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; JURKAT T-CELLS; NUCLEAR EXPORT SIGNAL; ARGININE-RICH MOTIF; GENE-EXPRESSION; PROTEOMICS ANALYSIS; MATRIN 3; HOST INTERACTIONS; CDNA INTEGRATION; PATHWAY ANALYSIS	The trans-activator Tat protein is a viral regulatory protein essential for HIV-1 replication. Tat trafficks to the nucleoplasm and the nucleolus. The nucleolus, a highly dynamic and structured membrane-less sub-nuclear compartment, is the site of rRNA and ribosome biogenesis and is involved in numerous cellular functions including transcriptional regulation, cell cycle control and viral infection. Importantly, transient nucleolar trafficking of both Tat and HIV-1 viral transcripts are critical in HIV-1 replication, however, the role(s) of the nucleolus in HIV-1 replication remains unclear. To better understand how the interaction of Tat with the nucleolar machinery contributes to HIV-1 pathogenesis, we investigated the quantitative changes in the composition of the nucleolar proteome of Jurkat T-cells stably expressing HIV-1 Tat fused to a TAP tag. Using an organellar proteomic approach based on mass spectrometry, coupled with Stable Isotope Labelling in Cell culture (SILAC), we quantified 520 proteins, including 49 proteins showing significant changes in abundance in Jurkat T-cell nucleolus upon Tat expression. Numerous proteins exhibiting a fold change were well characterised Tat interactors and/or known to be critical for HIV-1 replication. This suggests that the spatial control and subcellular compartimentaliation of these cellular cofactors by Tat provide an additional layer of control for regulating cellular machinery involved in HIV-1 pathogenesis. Pathway analysis and network reconstruction revealed that Tat expression specifically resulted in the nucleolar enrichment of proteins collectively participating in ribosomal biogenesis, protein homeostasis, metabolic pathways including glycolytic, pentose phosphate, nucleotides and amino acids biosynthetic pathways, stress response, T-cell signaling pathways and genome integrity. We present here the first differential profiling of the nucleolar proteome of T-cells expressing HIV-1 Tat. We discuss how these proteins collectively participate in interconnected networks converging to adapt the nucleolus dynamic activities, which favor host biosynthetic activities and may contribute to create a cellular environment supporting robust HIV-1 production.	[Jarboui, Mohamed Ali; Bidoia, Carlo; Woods, Elena; Roe, Barbara; Hall, William W.; Gautier, Virginie W.] Univ Coll Dublin, SMMS, CRID, Dublin 2, Ireland; [Wynne, Kieran; Elia, Giuliano] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland	University College Dublin; University College Dublin	Gautier, VW (corresponding author), Univ Coll Dublin, SMMS, CRID, Dublin 2, Ireland.	virginie.gautier@ucd.ie	Elia, Giuliano/H-3438-2011; Gautier, virginie/K-4057-2012; Elia, Giuliano/P-4725-2019; Jarboui, Dr. Mohamed Ali/C-8496-2013	Elia, Giuliano/0000-0001-8216-9560; Gautier, virginie/0000-0003-1862-2644; Elia, Giuliano/0000-0002-7941-223X; Jarboui, Dr. Mohamed Ali/0000-0002-5203-235X; WYNNE, KIERAN/0000-0001-5759-5285	University College Dublin (UCD)-National Virus Reference Laboratory (NVRL)	University College Dublin (UCD)-National Virus Reference Laboratory (NVRL)	This work was funded by the University College Dublin (UCD)-National Virus Reference Laboratory (NVRL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham RT, 2004, NAT REV IMMUNOL, V4, P301, DOI 10.1038/nri1330; Ahmad Y, 2009, NUCLEIC ACIDS RES, V37, pD181, DOI 10.1093/nar/gkn804; Alcivar A, 2003, ONCOGENE, V22, P291, DOI 10.1038/sj.onc.1206099; Ammosova T, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-47; Ammosova T, 2005, J BIOL CHEM, V280, P36364, DOI 10.1074/jbc.M503673200; Ammosova T, 2003, J BIOL CHEM, V278, P32189, DOI 10.1074/jbc.M300521200; Ammosova T, 2011, J BIOL CHEM, V286, P3798, DOI 10.1074/jbc.M110.196493; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Ansari SA, 1999, J GEN VIROL, V80, P2629, DOI 10.1099/0022-1317-80-10-2629; Apcher GS, 2003, FEBS LETT, V553, P200, DOI 10.1016/S0014-5793(03)01025-1; Askjaer P, 1998, J BIOL CHEM, V273, P33414, DOI 10.1074/jbc.273.50.33414; Au-Yeung BB, 2009, IMMUNOL REV, V228, P41, DOI 10.1111/j.1600-065X.2008.00753.x; Baek JY, 2003, BIOCHEM J, V373, P191, DOI 10.1042/BJ20030144; Banski P, 2010, TRENDS BIOCHEM SCI, V35, P361, DOI 10.1016/j.tibs.2010.02.010; Banski P, 2010, J BIOL CHEM, V285, P21858, DOI 10.1074/jbc.M110.117291; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Bettaccini AA, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-20; Biggiogera M, 1996, EXP CELL RES, V229, P77, DOI 10.1006/excr.1996.0345; Boisvert FM, 2010, PROTEOMICS, V10, P4087, DOI 10.1002/pmic.201000213; Boisvert FM, 2010, MOL CELL PROTEOMICS, V9, P457, DOI 10.1074/mcp.M900429-MCP200; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; CAPUTO A, 1990, J ACQ IMMUN DEF SYND, V3, P372; Cardarelli F, 2008, TRAFFIC, V9, P528, DOI 10.1111/j.1600-0854.2007.00696.x; Cardarelli F, 2007, MOL THER, V15, P1313, DOI 10.1038/sj.mt.6300172; Carpentier M, 2005, BIOCHEMISTRY-US, V44, P5804, DOI 10.1021/bi047831s; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chan Eric Y., 2009, Journal of Biology (London), V8, P84, DOI 10.1186/jbiol183; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chinnam M, 2011, CURR TOP DEV BIOL, V94, P129, DOI 10.1016/B978-0-12-380916-2.00005-X; Chu A, 2001, FASEB J, V15, P1478, DOI 10.1096/fj.00-0680fje; Clerzius G, 2011, REV MED VIROL, V21, P42, DOI 10.1002/rmv.674; Clerzius G, 2009, J VIROL, V83, P10119, DOI 10.1128/JVI.02457-08; Coiras M, 2006, PROTEOMICS, V6, pS63, DOI 10.1002/pmic.200500437; Coiras M, 2010, AIDS REV, V12, P103; Colombrino E, 2004, EXP CELL RES, V295, P539, DOI 10.1016/j.yexcr.2004.01.018; Comai L, 1999, BRAZ J MED BIOL RES, V32, P1473, DOI 10.1590/S0100-879X1999001200004; Coute Y, 2006, MASS SPECTROM REV, V25, P215, DOI 10.1002/mas.20067; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dayton AI, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-62; de la Fuente C, 2002, BMC BIOCHEM, V3, DOI 10.1186/1472-2091-3-14; Debaisieux S, 2012, TRAFFIC, V13, P355, DOI 10.1111/j.1600-0854.2011.01286.x; Dickerson JE, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-80; Doria M, 2011, J GEN VIROL, V92, P1228, DOI 10.1099/vir.0.028043-0; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; DUBIEL W, 1993, FEBS LETT, V323, P276, DOI 10.1016/0014-5793(93)81356-5; Easley R, 2010, BBA-GENE REGUL MECH, V1799, P275, DOI 10.1016/j.bbagrm.2009.08.008; Efthymiadis A, 1998, J BIOL CHEM, V273, P1623, DOI 10.1074/jbc.273.3.1623; Emmott E, 2008, VIROLOGY, V380, P191, DOI 10.1016/j.virol.2008.05.032; Emmott E, 2010, PROTEOMICS, V10, P3558, DOI 10.1002/pmic.201000139; Emmott E, 2010, J PROTEOME RES, V9, P5335, DOI 10.1021/pr100593g; Emmott E, 2010, MOL CELL PROTEOMICS, V9, P1920, DOI 10.1074/mcp.M900345-MCP200; Endo S, 1989, Virus Genes, V3, P99; Espeseth AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017612; FANKHAUSER C, 1991, MOL CELL BIOL, V11, P2567, DOI 10.1128/MCB.11.5.2567; Farnet CM, 1997, CELL, V88, P483, DOI 10.1016/S0092-8674(00)81888-7; Faulkner NE, 2003, J VIROL, V77, P2276, DOI 10.1128/JVI.77.3.2276-2281.2003; Feng S, 2011, NAT STRUCT MOL BIOL, V18, P169, DOI 10.1038/nsmb.1962; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fu W, 2009, NUCLEIC ACIDS RES, V37, pD417, DOI 10.1093/nar/gkn708; Gautier VW, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-47; Gautier VW, 2005, P NATL ACAD SCI USA, V102, P16362, DOI 10.1073/pnas.0503519102; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Geiger T, 2011, NAT PROTOC, V6, P147, DOI 10.1038/nprot.2010.192; Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Gibellini D, 2005, J CELL PHYSIOL, V203, P547, DOI 10.1002/jcp.20252; Gibellini D, 2002, VIRUS RES, V90, P337, DOI 10.1016/S0168-1702(02)00253-8; Greco A, 2009, REV MED VIROL, V19, P201, DOI 10.1002/rmv.614; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; Guergnon J, 2011, BIOCH BIOPHYS ACTA; Heiden MGV, 2010, SCIENCE, V329, P1492, DOI 10.1126/science.1188015; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hill JA, 2010, J PROTEOME RES, V9, P2809, DOI 10.1021/pr1000972; Hisada-Ishii S, 2007, BIOCHEM BIOPH RES CO, V354, P72, DOI 10.1016/j.bbrc.2006.12.191; Hiscox JA, 2010, PROTEOMICS; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Huang XH, 2002, J MOL BIOL, V323, P771, DOI 10.1016/S0022-2836(02)00998-1; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Izmailova E, 2003, NAT MED, V9, P191, DOI 10.1038/nm822; Jarboui MA, 2011, MOL IMMUNOL, V49, P441, DOI 10.1016/j.molimm.2011.09.005; Jayapandian M, 2007, NUCLEIC ACIDS RES, V35, pD566, DOI 10.1093/nar/gkl859; Jeanson L, 2002, VIROLOGY, V300, P100, DOI 10.1006/viro.2002.1515; Jerome KR, 2008, J VIROL, V82, P4194, DOI 10.1128/JVI.00059-08; KACZMARSKI W, 1993, BIOCHEM BIOPH RES CO, V196, P935, DOI 10.1006/bbrc.1993.2339; Kar B, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-33; Kim N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001103; Kiss A, 2003, VIROLOGY, V314, P591, DOI 10.1016/S0042-6822(03)00531-2; Kodiha M, 2005, AM J PHYSIOL-CELL PH, V289, pC1034, DOI 10.1152/ajpcell.00590.2004; Kula A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-60; Kundu M, 1998, J BIOL CHEM, V273, P8130, DOI 10.1074/jbc.273.14.8130; Kuusisto HV, 2012, FASEB J, V26, P1181, DOI 10.1096/fj.11-191585; Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Langer T, 2003, CELL BIOL INT, V27, P47, DOI 10.1016/S1065-6995(02)00256-1; Lassot I, 2007, MOL CELL, V25, P369, DOI 10.1016/j.molcel.2006.12.020; Lee MJ, 2009, J MICROBIOL BIOTECHN, V19, P1103, DOI 10.4014/jmb.0903.03005; Leung AKL, 2006, NUCLEIC ACIDS RES, V34, pD218, DOI 10.1093/nar/gkj004; Li L, 2000, J VIROL, V74, P10965, DOI 10.1128/JVI.74.23.10965-10974.2000; Li L, 2001, EMBO J, V20, P3272, DOI 10.1093/emboj/20.12.3272; Li YP, 1997, J VIROL, V71, P4098, DOI 10.1128/JVI.71.5.4098-4102.1997; Lo SJ, 2006, CELL RES, V16, P530, DOI 10.1038/sj.cr.7310070; Lopez-Huertas MR, 2010, NUCLEIC ACIDS RES, V38, P3287, DOI 10.1093/nar/gkq037; Luo JH, 2011, WORLD J CLIN ONCOL, V2, P120, DOI 10.5306/wjco.v2.i2.120; Luo W, 2012, TRENDS ENDOCRINOLOGY; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; Maldarelli F, 1998, VIRUS RES, V53, P39, DOI 10.1016/S0168-1702(97)00130-5; MARASCO WA, 1994, ARCH VIROL, V139, P133, DOI 10.1007/BF01309460; Marban C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026894; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Michienzi A, 2002, P NATL ACAD SCI USA, V99, P14047, DOI 10.1073/pnas.212229599; Michienzi A, 2000, P NATL ACAD SCI USA, V97, P8955, DOI 10.1073/pnas.97.16.8955; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Moore HM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009241; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Munday DC, 2010, MOL CELL PROTEOMICS, V9, P2438, DOI 10.1074/mcp.M110.001859; Nalabothula Narasimharao, 2010, Mol Cell Pharmacol, V2, P203; Nekhai S, 2007, CURR HIV RES, V5, P3, DOI 10.2174/157016207779316279; NELBOCK P, 1990, SCIENCE, V248, P1650, DOI 10.1126/science.2194290; Park SE, 2007, J MICROBIOL BIOTECHN, V17, P154; Pederson T, 2009, J CELL BIOL, V184, P771, DOI 10.1083/jcb.200812014; Pemberton LF, 2005, TRAFFIC, V6, P187, DOI 10.1111/j.1600-0854.2005.00270.x; Pennarun B, 2010, BBA-REV CANCER, V1805, P123, DOI 10.1016/j.bbcan.2009.11.004; Phuphuakrat A, 2008, J VIROL, V82, P10864, DOI 10.1128/JVI.00238-08; Pinney JW, 2009, AIDS, V23, P549, DOI 10.1097/QAD.0b013e328325a495; Pocernich CB, 2005, MOL BRAIN RES, V133, P307, DOI 10.1016/j.molbrainres.2004.10.023; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Ponti D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-32; PRASAD MVVSV, 1993, BIOCHEM MOL BIOL INT, V29, P57; Ptak RG, 2008, AIDS RES HUM RETROV, V24, P1497, DOI 10.1089/aid.2008.0113; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Rohrmoser M, 2007, MOL CELL BIOL, V27, P3682, DOI 10.1128/MCB.00172-07; Romani B, 2010, J GEN VIROL, V91, P1, DOI 10.1099/vir.0.016303-0; RONAI Z, 1993, INT J BIOCHEM, V25, P1073, DOI 10.1016/0020-711X(93)90123-V; Sarek G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000818; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Seeger M, 1997, J BIOL CHEM, V272, P8145, DOI 10.1074/jbc.272.13.8145; Shakib K, 2005, PROTEOMICS, V5, P2819, DOI 10.1002/pmic.200401108; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shcherbik N, 2011, GENES CANC, V1, P681; SHIBUYA H, 1992, NATURE, V357, P700, DOI 10.1038/357700a0; SIOMI H, 1990, J VIROL, V64, P1803, DOI 10.1128/JVI.64.4.1803-1807.1990; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Skibbens RV, 2005, J CELL BIOL, V169, P841, DOI 10.1083/jcb.200503129; Sloan RD, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-52; Sobhian B, 2010, MOL CELL, V38, P439, DOI 10.1016/j.molcel.2010.04.012; Stauber RH, 1998, VIROLOGY, V252, P126, DOI 10.1006/viro.1998.9400; Su V, 2009, CELL MOL LIFE SCI, V66, P2819, DOI 10.1007/s00018-009-0048-9; Thacker J, 2004, DNA REPAIR, V3, P1081, DOI 10.1016/j.dnarep.2004.04.012; Trere D, 2004, J HISTOCHEM CYTOCHEM, V52, P1601, DOI 10.1369/jhc.4A6454.2004; Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001; Truant R, 1999, MOL CELL BIOL, V19, P1210; Urcuqui-Inchima S, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-83; Vallejos M, 2011, NUCLEIC ACIDS RES, V39, P6186, DOI 10.1093/nar/gkr189; Van Duyne R, 2008, EXPERT REV PROTEOMIC, V5, P507, DOI 10.1586/14789450.5.3.507; Van Duyne R, 2009, EXPERT REV PROTEOMIC, V6, P515, DOI 10.1586/EPR.09.73; Vardabasso C, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-8; Vinkemeier U, 2004, J CELL BIOL, V167, P197, DOI 10.1083/jcb.200407163; Vozzolo L, 2010, J BIOL CHEM, V285, P39314, DOI 10.1074/jbc.M110.155275; Waninger S, 2004, J VIROL, V78, P12829, DOI 10.1128/JVI.78.23.12829-12837.2004; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Weinberger LS, 2005, CELL, V122, P169, DOI 10.1016/j.cell.2005.06.006; Wu L, 2007, MOL CELL PROTEOMICS, V6, P1343, DOI 10.1074/mcp.M700017-MCP200; Yedavalli VSRK, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-61; Yedavalli VSRK, 2004, CELL, V119, P381, DOI 10.1016/j.cell.2004.09.029; Yeung ML, 2009, J BIOL CHEM, V284, P19463, DOI 10.1074/jbc.M109.010033; Zeng Y, 2007, J VIROL, V81, P2401, DOI 10.1128/JVI.02024-06; Zhou ZL, 2002, NATURE, V419, P182, DOI 10.1038/nature01031	171	41	42	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48702	10.1371/journal.pone.0048702	http://dx.doi.org/10.1371/journal.pone.0048702			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166591	gold, Green Published, Green Submitted			2022-12-27	WOS:000311272300012
J	Woodard, LE; Li, XH; Malani, N; Kaja, A; Hice, RH; Atkinson, PW; Bushman, FD; Craig, NL; Wilson, MH				Woodard, Lauren E.; Li, Xianghong; Malani, Nirav; Kaja, Aparna; Hice, Robert H.; Atkinson, Peter W.; Bushman, Frederic D.; Craig, Nancy L.; Wilson, Matthew H.			Comparative Analysis of the Recently Discovered hAT Transposon TcBuster in Human Cells	PLOS ONE			English	Article							INTEGRATION SITE SELECTION; CANCER GENE DISCOVERY; SLEEPING-BEAUTY; IN-VIVO; ELEMENT; GENOME; DNA; MUTAGENESIS; DROSOPHILA; THERAPY	Background: Transposons are useful tools for creating transgenic organisms, insertional mutagenesis, and genome engineering. TcBuster, a novel hAT-family transposon system derived from the red flour beetle Tribolium castaneum, was shown to be highly active in previous studies in insect embryoes. Methodology/Principal Findings: We tested TcBuster for its activity in human embryonic kidney 293 (HEK-293) cells. Excision footprints obtained from HEK-293 cells contained small insertions and deletions consistent with a hAT-type repair mechanism of hairpin formation and non-homologous end-joining. Genome-wide analysis of 23,417 piggyBac, 30,303 Sleeping Beauty, and 27,985 TcBuster integrations in HEK-293 cells revealed a uniquely different integration pattern when compared to other transposon systems with regards to genomic elements. TcBuster experimental conditions were optimized to assay TcBuster activity in HEK-293 cells by colony assay selection for a neomycin-containing transposon. Increasing transposon plasmid increased the number of colonies, whereas gene transfer activity dependent on codon-optimized transposase plasmid peaked at 100 ng with decreased colonies at the highest doses of transposase DNA. Expression of the related human proteins Buster1, Buster3, and SCAND3 in HEK-293 cells did not result in genomic integration of the TcBuster transposon. TcBuster, Tol2, and piggyBac were compared directly at different ratios of transposon to transposase and found to be approximately comparable while having their own ratio preferences. Conclusions/Significance: TcBuster was found to be highly active in mammalian HEK-293 cells and represents a promising tool for mammalian genome engineering.	[Woodard, Lauren E.; Kaja, Aparna; Wilson, Matthew H.] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA; [Hice, Robert H.; Atkinson, Peter W.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Hice, Robert H.; Atkinson, Peter W.] Univ Calif Riverside, Inst Integrat Genome Biol, Riverside, CA 92521 USA; [Li, Xianghong; Craig, Nancy L.] Johns Hopkins Sch Med, Dept Mol Biol & Genet, Howard Hughes Med Inst, Baltimore, MD USA; [Malani, Nirav; Bushman, Frederic D.] Univ Penn, Dept Microbiol, Perlman Sch Med, Philadelphia, PA 19104 USA; [Wilson, Matthew H.] Michael E DeBakey Vet Adm Med Ctr, Houston, TX USA	Baylor College of Medicine; University of California System; University of California Riverside; University of California System; University of California Riverside; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center	Wilson, MH (corresponding author), Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA.	mhwilson@bcm.edu	Wilson, Matthew H/K-3193-2013	Bushman, Frederic/0000-0003-4740-4056	Department of Veteran's Affairs; National Institutes of Health [AI45741, GM76425, AI52845, 5T32DK062706, R01 DK093660]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052845, R01AI045741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062706, R01DK093660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076425] Funding Source: NIH RePORTER	Department of Veteran's Affairs(US Department of Veterans Affairs); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the Department of Veteran's Affairs [MHW] and by grants from the National Institutes of Health [AI45741 to PWA and NLC, GM76425 to NLC, AI52845 to FDB, and 5T32DK062706 to LEW]. NLC is an Investigator of the Howard Hughes Medical Institute. This work was supported in part by National Institutes of Health R01 DK093660 to MHW and the generous support of Dr. and Mrs. Harold M. Selzman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arensburger P, 2011, GENETICS, V188, P45, DOI 10.1534/genetics.111.126813; ATKINSON PW, 1993, P NATL ACAD SCI USA, V90, P9693, DOI 10.1073/pnas.90.20.9693; Balciunas D, 2006, PLOS GENET, V2, P1715, DOI 10.1371/journal.pgen.0020169; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; BLACKMAN RK, 1989, EMBO J, V8, P211, DOI 10.1002/j.1460-2075.1989.tb03366.x; COEN ES, 1989, MOBILE DNA, P413; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Doherty JE, 2012, HUM GENE THER, V23, P311, DOI 10.1089/hum.2011.138; Emelyanov A, 2006, GENETICS, V174, P1095, DOI 10.1534/genetics.106.061184; Fedoroff N, 1989, MOBILE DNA, P377; Feschotte C, 2006, P NATL ACAD SCI USA, V103, P14981, DOI 10.1073/pnas.0607282103; Galvan DL, 2009, J IMMUNOTHER, V32, P837, DOI 10.1097/CJI.0b013e3181b2914c; Gangadharan S, 2010, P NATL ACAD SCI USA, V107, P21966, DOI 10.1073/pnas.1016382107; Hackett PB, 2007, MOL THER, V15, P10, DOI 10.1038/sj.mt.6300065; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2007, MOL THER, V15, P1137, DOI 10.1038/sj.mt.6300169; Kawakami K, 2004, GENETICS, V166, P895, DOI 10.1534/genetics.166.2.895; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Kempken F, 2001, CHROMOSOMA, V110, P1, DOI 10.1007/s004120000118; Keng VW, 2009, GENETICS, V183, P1565, DOI 10.1534/genetics.109.100768; Kettlun C, 2011, MOL THER, V19, P1636, DOI 10.1038/mt.2011.129; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Largaespada David A, 2003, Reprod Biol Endocrinol, V1, P80, DOI 10.1186/1477-7827-1-80; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li X, 2012, P NATL ACAD IN PRESS; MARTIN C, 1988, GENETICS, V119, P171; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; Miskey C, 2003, NUCLEIC ACIDS RES, V31, P6873, DOI 10.1093/nar/gkg910; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Smit AFA, 1996, P NATL ACAD SCI USA, V93, P1443, DOI 10.1073/pnas.93.4.1443; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Wilson MH, 2010, METHODS MOL BIOL, V649, P353, DOI 10.1007/978-1-60761-753-2_22; Yant SR, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm089; Zhou LQ, 2004, NATURE, V432, P995, DOI 10.1038/nature03157	37	23	25	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e42666	10.1371/journal.pone.0042666	http://dx.doi.org/10.1371/journal.pone.0042666			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166581	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300001
J	Yamaga, M; Tsuji, K; Miyatake, K; Yamada, J; Abula, K; Ju, YJ; Sekiya, I; Muneta, T				Yamaga, Mika; Tsuji, Kunikazu; Miyatake, Kazumasa; Yamada, Jun; Abula, Kahaer; Ju, Young-Jin; Sekiya, Ichiro; Muneta, Takeshi			Osteopontin Level in Synovial Fluid Is Associated with the Severity of Joint Pain and Cartilage Degradation after Anterior Cruciate Ligament Rupture	PLOS ONE			English	Article							THROMBIN-CLEAVED OSTEOPONTIN; OSTEOARTHRITIC CARTILAGE; KNEE OSTEOARTHRITIS; BACTERIAL-INFECTION; GENETIC-RESISTANCE; MATRIX; RECONSTRUCTION; EXPRESSION; INTEGRIN; IDENTIFICATION	Objective: To explore the molecular function of Osteopontin (OPN) in the pathogenesis of human OA, we compared the expression levels of OPN in synovial fluid with clinical parameters such as arthroscopic observation of cartilage damage and joint pain after joint injury. Methods: Synovial fluid was obtained from patients who underwent anterior cruciate ligament (ACL) reconstruction surgery from 2009 through 2011 in our university hospital. The amounts of intact OPN (OPN Full) and it's N-terminal fragment (OPN N-half) in synovial fluid from each patient were quantified by ELISA and compared with clinical parameters such as severity of articular cartilage damage (TMDU cartilage score) and severity of joint pain (Visual Analogue Scale and Lysholm score). Results: Within a month after ACL rupture, both OPN Full and N-half levels in patient synovial fluid were positively correlated with the severity of joint pain. In contrast, patients with ACL injuries greater than one month ago felt less pain if they had higher amounts of OPN N-half in synovial fluid. OPN Full levels were positively correlated with articular cartilage damage in lateral tibial plateau. Conclusion: Our data suggest that OPN Full and N-half have distinct functions in articular cartilage homeostasis and in human joint pain.	[Tsuji, Kunikazu; Muneta, Takeshi] Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Tokyo, Japan; [Yamaga, Mika; Miyatake, Kazumasa; Yamada, Jun; Abula, Kahaer; Ju, Young-Jin; Muneta, Takeshi] Tokyo Med & Dent Univ, Dept Joint Surg & Sports Med, Tokyo, Japan; [Sekiya, Ichiro] Tokyo Med & Dent Univ, Dept Cartilage Regenerat, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Tsuji, K (corresponding author), Tokyo Med & Dent Univ, Int Res Ctr Mol Sci Tooth & Bone Dis, Global Ctr Excellence Program, Tokyo, Japan.	ktsuji.gcoe@tmd.ac.jp	Tsuji, Kunikazu/HDM-9242-2022	Tsuji, Kunikazu/0000-0002-1013-8359; Muneta, Takeshi/0000-0003-1018-2939	Japan Society for the Promotion of Science [22570135, 22600002]; Global Center of Excellence (GCOE) Program; International Research Center for Molecular Science in Tooth and Bone Diseases; Realization of Regenerative Medicine from Japanese Government; Grants-in-Aid for Scientific Research [22570135] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence (GCOE) Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Research Center for Molecular Science in Tooth and Bone Diseases; Realization of Regenerative Medicine from Japanese Government; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Japan Society for the Promotion of Science (22570135 to K.T.; 22600002 to Y-J.J.), by the Global Center of Excellence (GCOE) Program; the International Research Center for Molecular Science in Tooth and Bone Diseases (to K. T. and T. M.), and by the Realization of Regenerative Medicine from Japanese Government (to I.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Asano H, 2004, ARTHROSCOPY, V20, P474, DOI 10.1016/j.arthro.2004.03.006; Attur MG, 2001, ARTHRITIS RHEUM-US, V44, P578, DOI 10.1002/1529-0131(200103)44:3<578::AID-ANR106>3.3.CO;2-Z; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P421; Courtney P, 2009, BEST PRACT RES CL RH, V23, P161, DOI 10.1016/j.berh.2009.01.003; Denhardt DT, 1998, J CELL BIOCHEM, P92, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<92::AID-JCB13>3.0.CO;2-A; Dunn WR, 2010, AM J SPORT MED, V38, P1778, DOI 10.1177/0363546510370279; FRANZEN A, 1985, BIOCHEM J, V232, P715, DOI 10.1042/bj2320715; Gao YA, 2004, MATRIX BIOL, V23, P457, DOI 10.1016/j.matbio.2004.09.003; Hasegawa M, 2011, J RHEUMATOL, V38, P129, DOI 10.3899/jrheum.100637; Hasegawa M, 2009, J RHEUMATOL, V36, P240, DOI 10.3899/jrheum.080753; Huh YH, 2009, GENE, V448, P7, DOI 10.1016/j.gene.2009.08.015; Jain S, 2006, CANCER RES, V66, P6638, DOI 10.1158/0008-5472.CAN-06-0661; Johansen JS, 1996, BRIT J RHEUMATOL, V35, P553; Knauper V, 1996, J BIOL CHEM, V271, P17124, DOI 10.1074/jbc.271.29.17124; Kon E, 2011, KNEE SURG SPORTS TRA; Li RT, 2011, AM J SPORT MED, V39, P2595, DOI 10.1177/0363546511424720; Louboutin H, 2009, KNEE, V16, P239, DOI 10.1016/j.knee.2008.11.004; Maeda K, 2001, LUNG, V179, P279, DOI 10.1007/s004080000068; Matsui Y, 2009, ARTHRITIS RHEUM-US, V60, P2362, DOI 10.1002/art.24705; Mitchell PG, 1996, J CLIN INVEST, V97, P761, DOI 10.1172/JCI118475; Mori N, 2007, MATRIX BIOL, V26, P42, DOI 10.1016/j.matbio.2006.09.002; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; O'Regan A, 2000, INT J EXP PATHOL, V81, P373, DOI 10.1046/j.1365-2613.2000.00163.x; PATARCA R, 1989, J EXP MED, V170, P145, DOI 10.1084/jem.170.1.145; PATARCA R, 1993, CRIT REV IMMUNOL, V13, P225; Pullig O, 2000, MATRIX BIOL, V19, P245, DOI 10.1016/S0945-053X(00)00068-8; Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636; RODAN GA, 1995, ANN NY ACAD SCI, V760, P1, DOI 10.1111/j.1749-6632.1995.tb44614.x; Senger DR, 1996, AM J PATHOL, V149, P293; Steck E, 2002, BIOCHEM BIOPH RES CO, V299, P109, DOI 10.1016/S0006-291X(02)02585-8; Toma CD, 1997, J BONE MINER RES, V12, P1626, DOI 10.1359/jbmr.1997.12.10.1626; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001; Xu GW, 2005, J RHEUMATOL, V32, P410; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Yumoto K, 2002, P NATL ACAD SCI USA, V99, P4556, DOI 10.1073/pnas.052523599	38	16	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49014	10.1371/journal.pone.0049014	http://dx.doi.org/10.1371/journal.pone.0049014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166604	gold, Green Published, Green Submitted			2022-12-27	WOS:000311272300021
J	Andres-Mateos, E; Mejias, R; Soleimani, A; Lin, BM; Burks, TN; Marx, R; Lin, B; Zellars, RC; Zhang, YG; Huso, DL; Marr, TG; Leinwand, LA; Merriman, DK; Cohn, RD				Andres-Mateos, Eva; Mejias, Rebeca; Soleimani, Arshia; Lin, Brian M.; Burks, Tyesha N.; Marx, Ruth; Lin, Benjamin; Zellars, Richard C.; Zhang, Yonggang; Huso, David L.; Marr, Tom G.; Leinwand, Leslie A.; Merriman, Dana K.; Cohn, Ronald D.			Impaired Skeletal Muscle Regeneration in the Absence of Fibrosis during Hibernation in 13-Lined Ground Squirrels	PLOS ONE			English	Article							SATELLITE CELL ACTIVATION; GROWTH-FACTOR-BETA; STEM-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; MYOBLAST PROLIFERATION; SPERMOPHILUS-LATERALIS; MUSCULAR-DYSTROPHY; SELF-RENEWAL; MICE LACKING; IN-VIVO	Skeletal muscle atrophy can occur as a consequence of immobilization and/or starvation in the majority of vertebrates studied. In contrast, hibernating mammals are protected against the loss of muscle mass despite long periods of inactivity and lack of food intake. Resident muscle-specific stem cells (satellite cells) are known to be activated by muscle injury and their activation contributes to the regeneration of muscle, but whether satellite cells play a role in hibernation is unknown. In the hibernating 13-lined ground squirrel we show that muscles ablated of satellite cells were still protected against atrophy, demonstrating that satellite cells are not involved in the maintenance of skeletal muscle during hibernation. Additionally, hibernating skeletal muscle showed extremely slow regeneration in response to injury, due to repression of satellite cell activation and myoblast differentiation caused by a fine-tuned interplay of p21, myostatin, MAPK, and Wnt signaling pathways. Interestingly, despite long periods of inflammation and lack of efficient regeneration, injured skeletal muscle from hibernating animals did not develop fibrosis and was capable of complete recovery when animals emerged naturally from hibernation. We propose that hibernating squirrels represent a new model system that permits evaluation of impaired skeletal muscle remodeling in the absence of formation of tissue fibrosis.	[Andres-Mateos, Eva; Mejias, Rebeca; Soleimani, Arshia; Lin, Brian M.; Burks, Tyesha N.; Marx, Ruth; Lin, Benjamin; Cohn, Ronald D.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA	Johns Hopkins University	Andres-Mateos, E (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA.	rcohn2@jhmi.edu	Mejias-Estevez, Rebeca M/B-4696-2008; Cohn, Ronald/AAC-5835-2021	Mejias-Estevez, Rebeca M/0000-0003-1936-7219; LEINWAND, LESLIE/0000-0003-1470-4810; Merriman, Dana/0000-0003-2780-0772	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119937] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, R01GM029090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS055879] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG021334] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD004515] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL119937] Funding Source: Medline; NIA NIH HHS [P30 AG021334, P30AG021334-08S1] Funding Source: Medline; NIGMS NIH HHS [R01 GM29090, R01 GM029090, T32 GM007814] Funding Source: Medline; NIH HHS [DP2 OD004515] Funding Source: Medline; NINDS NIH HHS [5K08NS055879, K08 NS055879] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AGOSTINI B, 1991, Z NATURFORSCH C, V46, P1109; Andres-Mateos E, 2012, EMBO MOL ME IN PRESS; BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Bernasconi P, 1999, NEUROMUSCULAR DISORD, V9, P28, DOI 10.1016/S0960-8966(98)00093-5; Bish LT, 2011, HUM GENE THER, V22, P1499, DOI 10.1089/hum.2011.102; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Boyer BB, 1999, BIOSCIENCE, V49, P713, DOI 10.2307/1313595; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008; Capetanaki Y, 1997, CELL STRUCT FUNCT, V22, P103, DOI 10.1247/csf.22.103; Chazaud B, 2009, EXERC SPORT SCI REV, V37, P18, DOI 10.1097/JES.0b013e318190ebdb; Cohn RD, 2002, CELL, V110, P639, DOI 10.1016/S0092-8674(02)00907-8; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Cooper RN, 1999, J CELL SCI, V112, P2895; Cotton CJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P551, DOI 10.1086/650471; DALBIS A, 1988, EUR J BIOCHEM, V174, P103, DOI 10.1111/j.1432-1033.1988.tb14068.x; Debigarte R, 2001, AM J RESP CRIT CARE, V164, P1712, DOI 10.1164/ajrccm.164.9.2104035; Degens H, 2006, INT J SPORTS MED, V27, P94, DOI 10.1055/s-2005-837571; Dumonceaux J, 2010, MOL THER, V18, P881, DOI 10.1038/mt.2009.322; Gao YF, 2012, COMP BIOCHEM PHYS A, V161, P296, DOI 10.1016/j.cbpa.2011.11.009; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Glass DJ, 2010, CURR OPIN CLIN NUTR, V13, P225, DOI 10.1097/MCO.0b013e32833862df; Goichberg P, 2001, J CELL SCI, V114, P1309; Hamrick MW, 2010, J TRAUMA, V69, P579, DOI 10.1097/TA.0b013e3181c451f4; Hawke TJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1019, DOI 10.1152/ajpcell.00055.2003; Hindle AG, 2011, AM J PHYSIOL-REG I, V301, pR1440, DOI 10.1152/ajpregu.00298.2011; Huh JE, 2011, INT IMMUNOPHARMACOL, V11, P46, DOI 10.1016/j.intimp.2010.10.003; Jackman RW, 2004, AM J PHYSIOL-CELL PH, V287, pC834, DOI 10.1152/ajpcell.00579.2003; Jarvinen TAHJ, 2005, AM J SPORT MED, V33, P745, DOI 10.1177/0363546505274714; Jin Y, 2000, ACTA NEUROPATHOL, V99, P619, DOI 10.1007/s004010051172; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kim KI, 2006, ARTERIOSCL THROM VAS, V26, P91, DOI 10.1161/01.ATV.0000193569.12490.4b; Kollias HD, 2008, J APPL PHYSIOL, V104, P579, DOI 10.1152/japplphysiol.01091.2007; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Lam AP, 2011, CURR OPIN RHEUMATOL, V23, P562, DOI 10.1097/BOR.0b013e32834b3309; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611; Le Grand F, 2007, DEVELOPMENT, V134, P3953, DOI 10.1242/dev.005934; Lee K, 2010, J CELL PHYSIOL, V222, P313, DOI 10.1002/jcp.21952; Li Y, 2004, AM J PATHOL, V164, P1007, DOI 10.1016/S0002-9440(10)63188-4; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC370, DOI 10.1152/ajpcell.00453.2002; Li ZB, 2008, J BIOL CHEM, V283, P19371, DOI 10.1074/jbc.M802585200; Lohuis TD, 2007, PHYSIOL BIOCHEM ZOOL, V80, P257, DOI 10.1086/513190; Malatesta M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-19; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; Miyake T, 2009, J BIOL CHEM, V284, P19679, DOI 10.1074/jbc.M109.017319; Otto A, 2008, J CELL SCI, V121, P2939, DOI 10.1242/jcs.026534; Pavlath GK, 2003, AM J PATHOL, V162, P1685, DOI 10.1016/S0002-9440(10)64303-9; Petropoulos H, 2002, J BIOL CHEM, V277, P15393, DOI 10.1074/jbc.M112141200; Rourke BC, 2004, PHYSIOL BIOCHEM ZOOL, V77, P582, DOI 10.1086/421753; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Seow J, 2012, J AM COLL CARDIOL, V59, pE1387, DOI 10.1016/S0735-1097(12)61388-6; Serrano AL, 2010, EXP CELL RES, V316, P3050, DOI 10.1016/j.yexcr.2010.05.035; Shefer G, 2001, J CELL PHYSIOL, V187, P73, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1053>3.0.CO;2-9; Shen W, 2008, J CELL PHYSIOL, V214, P405, DOI 10.1002/jcp.21212; Smythe GM, 2001, CELL TISSUE RES, V304, P287, DOI 10.1007/s004410100366; Stratos I, 2012, J PINEAL RES, V52, P62, DOI 10.1111/j.1600-079X.2011.00919.x; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; Tessier SN, 2010, MOL CELL BIOCHEM, V344, P151, DOI 10.1007/s11010-010-0538-y; Tidball JG, 2010, AM J PHYSIOL-REG I, V298, pR1173, DOI 10.1152/ajpregu.00735.2009; Vaughan DK, 2006, LAB ANIMAL, V35, P33, DOI 10.1038/laban0406-33; Vikhlyantsev IM, 2004, BIOFIZIKA+, V49, P995; Wang X, 2008, CELL MOL NEUROBIOL, V28, P113, DOI 10.1007/s10571-007-9247-9; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; WICKLER SJ, 1991, AM J PHYSIOL, V261, pR1214, DOI 10.1152/ajpregu.1991.261.5.R1214; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yablonka-Reuveni Z, 1999, DEV BIOL, V210, P440, DOI 10.1006/dbio.1999.9284; Yeow K, 2002, BIOCHEM BIOPH RES CO, V293, P112, DOI 10.1016/S0006-291X(02)00190-0; Zhu J, 2007, J BIOL CHEM, V282, P25852, DOI 10.1074/jbc.M704146200; Zhu JH, 2011, AM J PATHOL, V179, P915, DOI 10.1016/j.ajpath.2011.04.008	72	24	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48884	10.1371/journal.pone.0048884	http://dx.doi.org/10.1371/journal.pone.0048884			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155423	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900058
J	Archer, J; Weber, J; Henry, K; Winner, D; Gibson, R; Lee, L; Paxinos, E; Arts, EJ; Robertson, DL; Mimms, L; Quinones-Mateu, ME				Archer, John; Weber, Jan; Henry, Kenneth; Winner, Dane; Gibson, Richard; Lee, Lawrence; Paxinos, Ellen; Arts, Eric J.; Robertson, David L.; Mimms, Larry; Quinones-Mateu, Miguel E.			Use of Four Next-Generation Sequencing Platforms to Determine HIV-1 Coreceptor Tropism	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TREATMENT-EXPERIENCED PATIENTS; TREATMENT-NAIVE PATIENTS; REVERSE-TRANSCRIPTASE; VIROLOGICAL RESPONSE; GENOTYPIC PREDICTION; PHENOTYPIC ASSAY; MARAVIROC; USAGE; CCR5	HIV-1 coreceptor tropism assays are required to rule out the presence of CXCR4-tropic (non-R5) viruses prior treatment with CCR5 antagonists. Phenotypic (e.g., Trofile (TM), Monogram Biosciences) and genotypic (e.g., population sequencing linked to bioinformatic algorithms) assays are the most widely used. Although several next-generation sequencing (NGS) platforms are available, to date all published deep sequencing HIV-1 tropism studies have used the 454 (TM) Life Sciences/Roche platform. In this study, HIV-1 co-receptor usage was predicted for twelve patients scheduled to start a maraviroc-based antiretroviral regimen. The V3 region of the HIV-1 env gene was sequenced using four NGS platforms: 454 (TM), PacBio (R) RS (Pacific Biosciences), Illumina (R), and Ion Torrent (TM) (Life Technologies). Cross-platform variation was evaluated, including number of reads, read length and error rates. HIV-1 tropism was inferred using Geno2Pheno, Web PSSM, and the 11/24/25 rule and compared with Trofile (TM) and virologic response to antiretroviral therapy. Error rates related to insertions/deletions (indels) and nucleotide substitutions introduced by the four NGS platforms were low compared to the actual HIV-1 sequence variation. Each platform detected all major virus variants within the HIV-1 population with similar frequencies. Identification of non-R5 viruses was comparable among the four platforms, with minor differences attributable to the algorithms used to infer HIV-1 tropism. All NGS platforms showed similar concordance with virologic response to the maraviroc-based regimen (75% to 80% range depending on the algorithm used), compared to Trofile (80%) and population sequencing (70%). In conclusion, all four NGS platforms were able to detect minority non-R5 variants at comparable levels suggesting that any NGS-based method can be used to predict HIV-1 coreceptor usage.	[Archer, John; Robertson, David L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England	University of Manchester	Archer, J (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	meq@case.edu	Weber, Jan/B-5405-2013; Quinones-Mateu, Miguel/H-3846-2019; Paxinos, Ellen/AAG-2907-2019	Weber, Jan/0000-0002-2799-7352; Paxinos, Ellen/0000-0002-1710-8064; Archer, John/0000-0001-6212-0962; Quinones-Mateu, Miguel/0000-0001-9170-5601; Arts, Eric/0000-0002-4880-7968	Biotechnology and Biological Sciences Research Council [BB/H012419/1] Funding Source: Medline; Medical Research Council [G1001806] Funding Source: Medline; NIAID NIH HHS [R01 AI049170] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049170] Funding Source: NIH RePORTER; BBSRC [BB/H012419/1] Funding Source: UKRI; MRC [G1001806] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abbate I, 2011, AIDS, V25, P611, DOI 10.1097/QAD.0b013e328343489e; Adriaenssens EM, 2012, J VIROL, V86, P6369, DOI 10.1128/JVI.00641-12; Archer J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-47; Archer J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001022; Archer J, 2009, AIDS, V23, P1209, DOI 10.1097/QAD.0b013e32832b4399; Armenia D, 2012, J INFECT DIS, V205, P557, DOI 10.1093/infdis/jir821; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bunnik EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002106; Buzon MJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002314; Cardozo T, 2007, AIDS RES HUM RETROV, V23, P415, DOI 10.1089/aid.2006.0130; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; de Mendoza C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0b013e3181734f0e; DEJONG JJ, 1992, J VIROL, V66, P6777, DOI 10.1128/JVI.66.11.6777-6780.1992; Delobel P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dorr P, 2005, ANTIMICROB AGENTS CH, V49, P4721, DOI 10.1128/AAC.49.11.4721-4732.2005; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Droege M, 2008, J BIOTECHNOL, V136, P3, DOI 10.1016/j.jbiotec.2008.03.021; FOUCHIER RAM, 1995, J CLIN MICROBIOL, V33, P906, DOI 10.1128/JCM.33.4.906-911.1995; Gonzalez-Serna A, 2012, ANTIMICROB AGENTS CH, V56, P1202, DOI 10.1128/AAC.05857-11; Harrigan PR, 2009, MOTIVATE TROPISM STU; Howden BP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002359; Jensen MA, 2003, J VIROL, V77, P13376, DOI 10.1128/JVI.77.24.13376-13388.2003; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lin NH, 2009, CURR OPIN HIV AIDS, V4, P481, DOI 10.1097/COH.0b013e328331b929; Liu J, 2011, ANTIMICROB AGENTS CH, V55, P1114, DOI 10.1128/AAC.01492-10; Loman NJ, 2012, NATURE BIOTECHNOLOGY; Low AJ, 2007, AIDS, V21, pF19, DOI 10.1097/QAD.0b013e3282ef81ea; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Matsushita H, 2012, NATURE, V482, P400, DOI 10.1038/nature10755; Messiaen P, 2012, VIROLOGY, V426, P7, DOI 10.1016/j.virol.2012.01.002; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Moreno S, 2009, HIV CLIN TRIALS, V10, P394, DOI 10.1310/hct1006-394; Mukherjee R, 2011, AIDS, V25, P1951, DOI 10.1097/QAD.0b013e32834b34de; Palmer S, 2005, J CLIN MICROBIOL, V43, P406, DOI 10.1128/JCM.43.1.406-413.2005; Poinar HN, 2006, SCIENCE, V311, P392, DOI 10.1126/science.1123360; Poveda E, 2010, AIDS REV, V12, P135; Poveda E, 2009, J ANTIMICROB CHEMOTH, V63, P1006, DOI 10.1093/jac/dkp063; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Raymond S, 2011, J ANTIMICROB CHEMOTH, V66, P1972, DOI 10.1093/jac/dkr224; Raymond S, 2011, AIDS, V25, P1668, DOI 10.1097/QAD.0b013e3283498305; Raymond S, 2010, J CLIN VIROL, V47, P126, DOI 10.1016/j.jcv.2009.11.018; Recordon-Pinson P, 2010, ANTIMICROB AGENTS CH, V54, P3335, DOI 10.1128/AAC.00148-10; Reeves JD, 2009, J VIRAL ENTRY, V3, P94; Robinson BF, 1998, BEHAV RES METH INS C, V30, P731, DOI 10.3758/BF03209495; Rose JD, 2009, CURR OPIN HIV AIDS, V4, P136, DOI 10.1097/COH.0b013e328322f973; Rosen O, 2006, P NATL ACAD SCI USA, V103, P13950, DOI 10.1073/pnas.0606312103; Rothberg JM, 2011, NATURE, V475, P348, DOI 10.1038/nature10242; Saag M, 2009, J INFECT DIS, V199, P1638, DOI 10.1086/598965; Saliou A, 2011, ANTIMICROB AGENTS CH, V55, P2831, DOI 10.1128/AAC.00091-11; Scally A, 2012, NATURE, V483, P169, DOI 10.1038/nature10842; Seclen E, 2011, J CLIN MICROBIOL, V49, P3380, DOI 10.1128/JCM.00908-11; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simen BB, 2009, J INFECT DIS, V199, P693, DOI 10.1086/596736; Sing T, 2007, ANTIVIR THER, V12, P1097; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; Swenson LC, 2011, CLIN INFECT DIS, V53, P732, DOI 10.1093/cid/cir493; Swenson LC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017402; Swenson LC, 2011, J INFECT DIS, V203, P237, DOI 10.1093/infdis/jiq030; Swenson LC, 2010, JAIDS-J ACQ IMM DEF, V54, P506, DOI 10.1097/QAI.0b013e3181d0558f; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Team RDC, 2010, R LANG ENV STAT COMP; Tilton JC, 2010, ANTIVIR RES, V85, P91, DOI 10.1016/j.antiviral.2009.07.022; Trabaud MA, 2012, J MED VIROL, V84, P402, DOI 10.1002/jmv.23209; Tran B, 2012, J CLIN ONCOL, V30, P647, DOI 10.1200/JCO.2011.39.2316; Trouplin V, 2001, J VIROL, V75, P251, DOI 10.1128/JVI.75.1.251-259.2001; Vandenbroucke I, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-4; Varghese V, 2009, JAIDS-J ACQ IMM DEF, V52, P309, DOI 10.1097/QAI.0b013e3181bca669; Weber J, 2012, 28TH ANNUAL CLINICAL; Weber J, 2006, AIDS REV, V8, P60; Westby M, 2006, J VIROL, V80, P4909, DOI 10.1128/JVI.80.10.4909-4920.2006; Whitcomb JM, 2007, ANTIMICROB AGENTS CH, V51, P566, DOI 10.1128/AAC.00853-06; Yang Z, 2011, J VIROL, V85, P5897, DOI 10.1128/JVI.00428-11; Ye L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r31	76	67	71	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49602	10.1371/journal.pone.0049602	http://dx.doi.org/10.1371/journal.pone.0049602			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166726	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000311151900171
J	Jarv, O; Ahas, R; Saluveer, E; Derudder, B; Witlox, F				Jarv, Olle; Ahas, Rein; Saluveer, Erki; Derudder, Ben; Witlox, Frank			Mobile Phones in a Traffic Flow: A Geographical Perspective to Evening Rush Hour Traffic Analysis Using Call Detail Records	PLOS ONE			English	Article							TRAVEL BEHAVIOR; LAND-USE; EMPIRICAL-FINDINGS; METROPOLITAN-AREA; MODELING APPROACH; POSITIONING DATA; NONWORK TRAVEL; SELF-SELECTION; URBAN TRAVEL; TIME	Excessive land use and suburbanisation around densely populated urban areas has gone hand in hand with a growth in overall transportation and discussions about causality of traffic congestions. The objective of this paper is to gain new insight regarding the composition of traffic flows, and to reveal how and to what extent suburbanites' travelling affects rush hour traffic. We put forward an alternative methodological approach using call detail records of mobile phones to assess the composition of traffic flows during the evening rush hour in Tallinn, Estonia. We found that daily commuting and suburbanites influence transportation demand by amplifying the evening rush hour traffic, although daily commuting trips comprises only 31% of all movement at that time. The geography of the Friday evening rush hour is distinctive from other working days, presumably in connection with domestic tourism and leisure time activities. This suggests that the rise of the overall mobility of individuals due to societal changes may play a greater role in evening rush hour traffic conditions than does the impact of suburbanisation.	[Jarv, Olle; Ahas, Rein; Saluveer, Erki] Univ Tartu, Dept Geog, Ulikooli 18, EE-50090 Tartu, Estonia	University of Tartu	Jarv, O (corresponding author), Univ Tartu, Dept Geog, Ulikooli 18, EE-50090 Tartu, Estonia.	olle.jarv@ut.ee	Järv, Olle/L-3488-2016; Derudder, Ben/ABH-5648-2020; Derudder, Ben/A-1616-2008; Witlox, Frank/A-5143-2008; Järv, Olle/N-5312-2019	Järv, Olle/0000-0003-3446-1545; Witlox, Frank/0000-0002-8966-6823; Järv, Olle/0000-0003-3446-1545; Derudder, Ben/0000-0001-6195-8544; Saluveer, Erki/0000-0002-9759-1905				Ahas R, 2005, FUTURES, V37, P547, DOI 10.1016/j.futures.2004.10.012; Ahas R, 2010, MOBILE METHODS, P183; Ahas R, 2008, TOURISM MANAGE, V29, P469, DOI 10.1016/j.tourman.2007.05.014; Ahas R, 2010, J URBAN TECHNOL, V17, P3, DOI 10.1080/10630731003597306; [Anonymous], 2002, OJ L, V45, P37; Arnott R.J., 2005, ALLEVIATING URBAN TR; Asakura Y, 2004, TRANSPORT RES C-EMER, V12, P273, DOI 10.1016/j.trc.2004.07.010; Axhausen K.W., 2005, SOCIAL DIMENSIONS SU, P90; Badoe DA, 2000, TRANSPORT RES D-TR E, V5, P235, DOI 10.1016/S1361-9209(99)00036-X; Bagley MN, 2002, ANN REGIONAL SCI, V36, P279, DOI 10.1007/s001680200083; Bar-Gera H, 2007, TRANSPORT RES C-EMER, V15, P380, DOI 10.1016/j.trc.2007.06.003; Baron NS, 2010, NEW MEDIA SOC, V12, P3, DOI 10.1177/1461444809355109; Bhat C, 1999, TRANSPORT RES B-METH, V33, P495, DOI 10.1016/S0191-2615(99)00003-X; Boarnet MG, 1998, URBAN STUD, V35, P1155, DOI 10.1080/0042098984538; Bolin G, 2010, NEW MEDIA SOC, V12, P55, DOI 10.1177/1461444809355112; Boussauw K, 2012, TIJDSCHR ECON SOC GE, V103, P20, DOI 10.1111/j.1467-9663.2011.00669.x; Boussauw K, 2011, PAP REG SCI, V90, P47, DOI 10.1111/j.1435-5957.2010.00295.x; Calabrese F, 2011, IEEE T INTELL TRANSP, V12, P141, DOI 10.1109/TITS.2010.2074196; Candia J, 2008, J PHYS A-MATH THEOR, V41, DOI 10.1088/1751-8113/41/22/224015; Cao XY, 2009, TRANSPORT REV, V29, P359, DOI 10.1080/01441640802539195; Carrasco JA, 2006, TRANSPORTATION, V33, P463, DOI 10.1007/s11116-006-8074-z; Castells M., 2006, MOBILE COMMUNICATION; Crane R., 2000, J PLAN LIT, V15, P3, DOI DOI 10.1177/08854120022092890; Delespaul PAEG, 2004, SOC INDIC RES, V67, P129, DOI 10.1023/B:SOCI.0000007337.94184.e5; Doherty ST, 2006, TRANSPORTATION, V33, P517, DOI 10.1007/s11116-006-0001-9; Downs A., 2004, STILL STUCK TRAFFIC; Ewing R, 2001, TRANSPORT RES REC, P87, DOI 10.3141/1780-10; Ewing R, 1997, J AM PLANN ASSOC, V63, P107, DOI 10.1080/01944369708975728; Ewing R., 2007, GROWING COOLER EVIDE; Friedrich M, 2010, TRANSP RES RECORD, P93, DOI 10.3141/2196-10; Giddens A., 1979, CENTRAL PROBLEMS SOC; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Google, 2011, MOB MOV UND SMARTPH; Gordon P, 1997, J AM PLANN ASSOC, V63, P95, DOI 10.1080/01944369708975727; Graham S, 1998, PROG HUM GEOG, V22, P165, DOI 10.1191/030913298671334137; GSMA, 2011, EUR MOB IND OBS 2011; Hagerstraand T., 1970, PAPERS REGIONAL SCI, V24, P7, DOI [DOI 10.1111/J.1435-5597.1970.TB01464.X, 10.1007/BF01936872]; Handy S, 2005, INT REGIONAL SCI REV, V28, P146, DOI 10.1177/0160017604273626; Handy SL, 1996, J PLAN EDUC RES, V15, P183, DOI 10.1177/0739456X9601500303; Henderson J, 2009, ANTIPODE, V41, P70, DOI 10.1111/j.1467-8330.2008.00657.x; Huang WH, 2010, LECT NOTES ARTIF INT, V6440, P346, DOI 10.1007/978-3-642-17316-5_34; Hubers C, 2008, TIJDSCHR ECON SOC GE, V99, P528, DOI 10.1111/j.1467-9663.2008.00490.x; Kang J. H., 2004, P 2 ACM INT WORKSH W, P110, DOI DOI 10.1145/1024733.1024748; Kaufmann V, 2004, INT J URBAN REGIONAL, V28, P745, DOI 10.1111/j.0309-1317.2004.00549.x; Kim TK, 2005, HOUSING STUD, V20, P457, DOI 10.1080/02673030500062335; Kwan MP, 2007, PROF GEOGR, V59, P434, DOI 10.1111/j.1467-9272.2007.00633.x; Kwan MP, 2002, URBAN GEOGR, V23, P471, DOI 10.2747/0272-3638.23.5.471; Leduc G., 2008, WORKING PAPERS ENERG; Ling R., 2004, MOBILE CONNECTION CE; McCartt Anne T, 2006, Traffic Inj Prev, V7, P89, DOI 10.1080/15389580600651103; McGuckin N., 2005, CENS DAT TRANSP PLAN; Metsvahi T, 2011, LIIKLUSVOOGUDE MUUTU; Meyer MD, 1999, TRANSPORT RES A-POL, V33, P575, DOI 10.1016/S0965-8564(99)00008-7; Mokhtarian PL, 2006, TRANSPORTATION, V33, P263, DOI 10.1007/s11116-005-2305-6; Mokhtarian PL, 2001, TRANSPORT RES A-POL, V35, P695, DOI 10.1016/S0965-8564(00)00013-6; Novak J, 2007, GEOGR ANN B, V89B, P147, DOI 10.1111/j.1468-0467.2007.00245.x; Nurmi P, 2008, LECT NOTES COMPUT SC, V5013, P111, DOI 10.1007/978-3-540-79576-6_7; OECD, 2007, EUR C MIN TRANSP TRA; Parry IWH, 2002, J PUBLIC ECON, V85, P333, DOI 10.1016/S0047-2727(00)00163-8; PRED A, 1984, ANN ASSOC AM GEOGR, V74, P279, DOI 10.1111/j.1467-8306.1984.tb01453.x; RECKER WW, 1986, TRANSPORT RES A-POL, V20, P307, DOI 10.1016/0191-2607(86)90089-0; Saluveer E, 2008, INT WORKSH SPM2008 T; Sarzynski A, 2006, URBAN STUD, V43, P601, DOI 10.1080/00420980500452441; Schlich R, 2004, TRANSPORT REV, V24, P219, DOI 10.1080/0144164032000138742; Schlich R, 2003, TRANSPORTATION, V30, P13, DOI 10.1023/A:1021230507071; Schrank  D., 2009, 2009 URBAN MOBILITY; Schwanen T., 2001, J TRANSP GEOGR, V9, P173, DOI [DOI 10.1016/S0966-6923(01)00009-6, 10.1016/S0966-6923(01)00009-6]; Schwanen T., 2005, J TRANSP GEOGR, V13, P83; Sharma Chetan, 2012, US MOBILE DATA MARKE; Sheller M, 2006, ENVIRON PLANN A, V38, P207, DOI 10.1068/a37268; Silm S, 2010, ENVIRON PLANN A, V42, P2527, DOI 10.1068/a43139; Statistics Estonia, 2011, CC41 TEL SERV; Steg L, 2005, TRANSPORT RES A-POL, V39, P147, DOI 10.1016/j.tra.2004.07.001; Stern E, 2005, TRANSPORT REV, V25, P159, DOI 10.1080/0144164042000313638; Stigell E, 2011, J TRANSP GEOGR, V19, P563, DOI 10.1016/j.jtrangeo.2010.06.006; Storper M, 2004, J ECON GEOGR, V4, P351, DOI 10.1093/jnlecg/lbh027; Tammaru T, 2005, ENVIRON PLANN A, V37, P1669, DOI 10.1068/a37118; TNS EMOR, 2008, BIM TEL SURV CATI BU; Townsend AM, 2000, J URBAN TECHNOL, V7, P85, DOI 10.1080/713684114; Van Acker V, 2007, TRANSPORT PLAN TECHN, V30, P331, DOI 10.1080/03081060701461675; Van Acker V, 2010, TRANSPORT REV, V30, P219, DOI 10.1080/01441640902943453; Van de Weghe N, 2005, EXPERT SYST APPL, V29, P977, DOI 10.1016/j.eswa.2005.06.022; Van Nuffel N, 2007, REG STUD, V41, P509, DOI 10.1080/00343400701281808; van Wee B, 2009, TRANSPORT REV, V29, P279, DOI 10.1080/01441640902752961; Vandenbulcke G, 2009, J TRANSP GEOGR, V17, P39, DOI 10.1016/j.jtrangeo.2008.04.008; Vanoutrive T, 2010, EUR J TRANSP INFRAST, V10, P121; White KM, 2010, TRANSPORT RES F-TRAF, V13, P9, DOI 10.1016/j.trf.2009.09.004; Witlox F, 2007, J TRANSP GEOGR, V15, P172, DOI 10.1016/j.jtrangeo.2006.02.012; Yilin Zhao, 2000, IEEE Transactions on Intelligent Transportation Systems, V1, P55, DOI 10.1109/6979.869021; Zhou C, 2007, ACM T INFORM SYST, V25, DOI 10.1145/1247715.1247718	91	56	57	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49171	10.1371/journal.pone.0049171	http://dx.doi.org/10.1371/journal.pone.0049171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155461	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900096
J	Tessari, A; Ottoboni, G; Mazzatenta, A; Merla, A; Nicoletti, R				Tessari, Alessia; Ottoboni, Giovanni; Mazzatenta, Andrea; Merla, Arcangelo; Nicoletti, Roberto			Please Don't! The Automatic Extrapolation of Dangerous Intentions	PLOS ONE			English	Article							FACIAL EXPRESSIONS; FUNCTIONAL ASYMMETRY; NEURAL MECHANISMS; SPATIAL ATTENTION; PERCEPTION; GAZE; RECOGNITION; STIMULI; EMOTION; BRAIN	Facial emotions and emotional body postures can easily grab attention in social communication. In the context of faces, gaze has been shown as an important cue for orienting attention, but less is known for other important body parts such as hands. In the present study we investigated whether hands may orient attention due to the emotional features they convey. By implying motion in static photographs of hands, we aimed at furnishing observers with information about the intention to act and at testing if this interacted with the hand automatic coding. In this study, we compared neutral and frontal hands to emotionally threatening hands, rotated along their radial-ulnar axes in a Sidedness task (a Simon-like task based on automatic access to body representation). Results showed a Sidedness effect for both the palm and the back views with either neutral and emotional hands. More important, no difference was found between the two views for neutral hands, but it emerged in the case of the emotional hands: faster reaction times were found for the palm than the back view. The difference was ascribed to palm views' "offensive" pose: a source of threat that might have raised participants' arousal. This hypothesis was also supported by conscious evaluations of the dimensions of valence (pleasant-unpleasant) and arousal. Results are discussed in light of emotional feature coding.	[Tessari, Alessia; Ottoboni, Giovanni] Univ Bologna, Dept Psychol, Bologna, Italy	University of Bologna	Tessari, A (corresponding author), Univ Bologna, Dept Psychol, Bologna, Italy.	alessia.tessari@unibo.it	Tessari, Alessia/K-3457-2013; Mazzatenta, Andrea/C-5946-2014; MAZZATENTA, ANDREA/AAP-8511-2020; ottoboni, giovanni/E-3476-2010; YIN, HANG HUBERT/O-2097-2014	Tessari, Alessia/0000-0002-6616-2454; MAZZATENTA, ANDREA/0000-0001-5132-0029; ottoboni, giovanni/0000-0002-7649-6642; YIN, HANG HUBERT/0000-0002-9762-4818				Adams RB, 2003, PSYCHOL SCI, V14, P644, DOI 10.1046/j.0956-7976.2003.psci_1479.x; Armony JL, 2002, NEUROPSYCHOLOGIA, V40, P817, DOI 10.1016/S0028-3932(01)00178-6; Baron-Cohen S., 1995, MINDBLINDNESS ESSAY; BaronCohen S, 1996, VIS COGN, V3, P39, DOI 10.1080/713756728; Barresi J, 1996, BEHAV BRAIN SCI, V19, P107, DOI 10.1017/S0140525X00041790; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; BILLINGS LS, 1993, B PSYCHONOMIC SOC, V31, P317; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Blakemore SJ, 2003, PSYCHOL MED, V33, P1433, DOI 10.1017/S0033291703008341; BRADLEY MM, 1992, J EXP PSYCHOL LEARN, V18, P379, DOI 10.1037/0278-7393.18.2.379; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Buxbaum LJ, 2001, COGNITIVE NEUROPSYCH, V18, P289, DOI 10.1080/02643290126172; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; COOPER LA, 1975, J EXP PSYCHOL HUMAN, V104, P48, DOI 10.1037/0096-1523.1.1.48; Costa RM, 2008, INT J PSYCHOPHYSIOL, V67, P64, DOI 10.1016/j.ijpsycho.2007.10.005; Csibra G, 2007, SENSORIMOTOR FDN HIG, P435; Dawson M.E., 2000, HDB PSYCHOPHYSIOLOGY, V2, P200; de Gelder B, 2006, NAT REV NEUROSCI, V7, P242, DOI 10.1038/nrn1872; de Gelder B, 2004, P NATL ACAD SCI USA, V101, P16701, DOI 10.1073/pnas.0407042101; de Gelder B., 2007, SCHOLARPEDIA, V2, P3555, DOI DOI 10.4249/SCH0LARPEDIA.3555; de Gelder B, 2006, NEUROREPORT, V17, P583, DOI 10.1097/00001756-200604240-00006; Decety J, 2003, NEUROPSYCHOLOGIA, V41, P127, DOI 10.1016/S0028-3932(02)00143-4; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Ducci L., 1981, ITALIAN J PSYCHOL, V8, P183; Eastwood JD, 2001, PERCEPT PSYCHOPHYS, V63, P1004, DOI 10.3758/BF03194519; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; EKMAN P, 1979, ANNU REV PSYCHOL, V30, P527, DOI 10.1146/annurev.ps.30.020179.002523; Emery NJ, 2000, NEUROSCI BIOBEHAV R, V24, P581, DOI 10.1016/S0149-7634(00)00025-7; Flanagan JR, 2003, NATURE, V424, P769, DOI 10.1038/nature01861; Fox E, 2000, COGNITION EMOTION, V14, P61, DOI 10.1080/026999300378996; Fox E, 2007, EMOTION, V7, P691, DOI 10.1037/1528-3542.7.4.691; Fox E, 2006, EMOTION, V6, P534, DOI 10.1037/1528-3542.6.3.534; FREYD JJ, 1983, PERCEPT PSYCHOPHYS, V33, P575, DOI 10.3758/BF03202940; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Glascher J, 2003, J NEUROSCI, V23, P10274; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Grezes J, 2007, NEUROIMAGE, V35, P959, DOI 10.1016/j.neuroimage.2006.11.030; Grezes J., 2008, SOCIAL COGNITION DEV, P67; Grosbras MH, 2006, CEREB CORTEX, V16, P1087; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Holmes A, 2006, BRAIN COGNITION, V60, P282, DOI 10.1016/j.bandc.2005.05.002; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Kilner JM, 2004, NAT NEUROSCI, V7, P1299, DOI 10.1038/nn1355; KLEINKE CL, 1986, PSYCHOL BULL, V100, P78, DOI 10.1037/0033-2909.100.1.78; Knoblich G, 2001, J EXP PSYCHOL HUMAN, V27, P456, DOI 10.1037/0096-1523.27.2.456; Kourtzi Z, 2000, J COGNITIVE NEUROSCI, V12, P48, DOI 10.1162/08989290051137594; Lagton SRH, 2000, J EXP PSYCHOL HUMAN, V27, P747; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; Lang P.J., 1997, INT AFFECTIVE PICTUR; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Leppanen JM, 2003, J PSYCHOPHYSIOL, V17, P113, DOI 10.1027//0269-8803.17.3.113; Nummenmaa L, 2009, TRENDS COGN SCI, V13, P135, DOI 10.1016/j.tics.2008.12.006; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ottoboni G, 2005, J EXP PSYCHOL HUMAN, V31, P778, DOI 10.1037/0096-1523.31.4.778; Prinz W, 1997, EUR J COGN PSYCHOL, V9, P129, DOI 10.1080/713752551; Prinz W., 2002, IMITATIVE MIND DEV E, P143, DOI DOI 10.1017/CBO9780511489969.009; Prinz W, 2006, HUMAN BODY PERCEPTIO, P393; RIPPON G, 1990, INT J PSYCHOPHYSIOL, V8, P309, DOI 10.1016/0167-8760(90)90021-5; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Robinson MD, 1998, COGNITION EMOTION, V12, P667, DOI 10.1080/026999398379493; SEQUEIRA H, 1993, NATO ADV SCI INST SE, V249, P93; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; SIRIGU A, 1991, BRAIN, V114, P629, DOI 10.1093/brain/114.1.629; Snowdon CT, 2006, PHILOS T R SOC B, V361, P2079, DOI 10.1098/rstb.2006.1932; Tamietto M, 2007, J COGNITIVE NEUROSCI, V19, P445, DOI 10.1162/jocn.2007.19.3.445; Tamietto M, 2006, EXP BRAIN RES, V171, P389, DOI 10.1007/s00221-005-0279-4; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tessari A, 2012, EXP BRAIN RES, V218, P515, DOI 10.1007/s00221-012-3045-4; Tessari A, 2010, NEUROPSYCHOLOGIA, V48, P681, DOI 10.1016/j.neuropsychologia.2009.11.020; Urgesi C, 2006, J NEUROSCI, V26, P7942, DOI 10.1523/JNEUROSCI.1289-06.2006	72	9	9	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49011	10.1371/journal.pone.0049011	http://dx.doi.org/10.1371/journal.pone.0049011			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155444	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900079
J	van Blitterswijk, M; Vlam, L; van Es, MA; van der Pol, WL; Hennekam, EAM; Dooijes, D; Schelhaas, HJ; van der Kooi, AJ; de Visser, M; Veldink, JH; van den Berg, LH				van Blitterswijk, Marka; Vlam, Lotte; van Es, Michael A.; van der Pol, W-Ludo; Hennekam, Eric A. M.; Dooijes, Dennis; Schelhaas, Helenius J.; van der Kooi, Anneke J.; de Visser, Marianne; Veldink, Jan H.; van den Berg, Leonard H.			Genetic Overlap between Apparently Sporadic Motor Neuron Diseases	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PROGRESSIVE MUSCULAR-ATROPHY; FRONTOTEMPORAL LOBAR DEGENERATION; HEXANUCLEOTIDE REPEAT; CLINICAL-FEATURES; FUS MUTATIONS; SUPEROXIDE-DISMUTASE; TARDBP MUTATIONS; ALS PATIENTS; EL-ESCORIAL	Progressive muscular atrophy (PMA) and amyotrophic lateral sclerosis (ALS) are devastating motor neuron diseases (MNDs), which result in muscle weakness and/or spasticity. We compared mutation frequencies in genes known to be associated with MNDs between patients with apparently sporadic PMA and ALS. A total of 261 patients with adult-onset sporadic PMA, patients with sporadic ALS, and control subjects of Dutch descent were obtained at national referral centers for neuromuscular diseases in The Netherlands. Sanger sequencing was used to screen these subjects for mutations in the coding regions of superoxide dismutase-1 (SOD1), angiogenin (ANG), fused in sarcoma/translated in liposarcoma (FUS/TLS), TAR DNA-binding protein 43 (TARDBP), and multivesicular body protein 2B (CHMP2B). In our cohort of PMA patients we identified two SOD1 mutations (p.D90A, p.I113T), one ANG mutation (p.K17I), one FUS/TLS mutation (p.R521H), one TARDBP mutation (p.N352S), and one novel CHMP2B mutation (p.R69Q). The mutation frequency of these genes was similar in sporadic PMA (2.7%) and ALS (2.0%) patients, and therefore, our findings demonstrate a genetic overlap between apparently sporadic PMA and ALS.	[van Blitterswijk, Marka; Vlam, Lotte; van Es, Michael A.; van der Pol, W-Ludo; Veldink, Jan H.; van den Berg, Leonard H.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	van Blitterswijk, M (corresponding author), Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurol, Utrecht, Netherlands.	L.H.vandenBerg@umcutrecht.nl	van Blitterswijk, Marka/AAL-4126-2021; van Blitterswijk, Marka/H-7274-2012; van+Es, Michael/AAC-5772-2021	van Blitterswijk, Marka/0000-0002-3054-7053; van Blitterswijk, Marka/0000-0002-3054-7053; van Es, Michael/0000-0002-7709-5883; Veldink, Jan/0000-0001-5572-9657; van der Kooi, Anneke/0000-0002-5261-5512				Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; ANDERSEN PM, 1995, NAT GENET, V10, P61, DOI 10.1038/ng0595-61; Banci L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001677; Benajiba L, 2009, ANN NEUROL, V65, P470, DOI 10.1002/ana.21612; Blair IP, 2010, J NEUROL NEUROSUR PS, V81, P639, DOI 10.1136/jnnp.2009.194399; Borghero G, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.009; Borroni B, 2010, REJUV RES, V13, P509, DOI 10.1089/rej.2010.1017; Borroni B, 2009, HUM MUTAT, V30, pE974, DOI 10.1002/humu.21100; Brettschneider J, 2012, ACTA NEUROPATHOL, V123, P825, DOI 10.1007/s00401-012-0970-z; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Broustal O, 2010, J ALZHEIMERS DIS, V22, P765, DOI 10.3233/JAD-2010-100837; Camdessanche JP, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-4; Cervenakova L, 2000, J NEUROL SCI, V177, P124, DOI 10.1016/S0022-510X(00)00350-6; Cox LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009872; Cudkowicz ME, 1998, ANN NEUROL, V43, P703, DOI 10.1002/ana.410430604; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Eisen A, 2008, AMYOTROPH LATERAL SC, V9, P108, DOI 10.1080/17482960801900073; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Gellera C, 2008, NEUROGENETICS, V9, P33, DOI 10.1007/s10048-007-0111-3; Ghanim M, 2010, J NEUROL, V257, P2032, DOI 10.1007/s00415-010-5655-8; Groen EJN, 2010, ARCH NEUROL-CHICAGO, V67, P224, DOI 10.1001/archneurol.2009.329; Horii M, 2006, BIOCHEM J, V400, P23, DOI 10.1042/BJ20060897; Huisman MHB, 2011, J NEUROL NEUROSUR PS, V82, P1165, DOI 10.1136/jnnp.2011.244939; Iida A, 2012, NEUROBIOL AGING, V33, P786, DOI 10.1016/j.neurobiolaging.2010.06.017; Ince PG, 2003, NEUROLOGY, V60, P1252, DOI 10.1212/01.WNL.0000058901.75728.4E; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Kamada M, 2009, J NEUROL SCI, V284, P69, DOI 10.1016/j.jns.2009.04.017; Kim WK, 2009, NEUROLOGY, V73, P1686, DOI 10.1212/WNL.0b013e3181c1dea3; Kovacs GG, 2009, MOVEMENT DISORD, V24, P1843, DOI 10.1002/mds.22697; Kuehnlein P, 2008, ARCH NEUROL-CHICAGO, V65, P1185, DOI 10.1001/archneur.65.9.1185; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lopate G, 2010, AMYOTROPH LATERAL SC, V11, P232, DOI 10.3109/17482960902898069; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Majounie E, 2012, LANCET NEUROL, V11, P323, DOI 10.1016/S1474-4422(12)70043-1; Millecamps S, 2012, J MED GENET, V49, P258, DOI 10.1136/jmedgenet-2011-100699; Millecamps S, 2010, J MED GENET, V47, P554, DOI 10.1136/jmg.2010.077180; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Padhi AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032479; Parkinson N, 2006, NEUROLOGY, V67, P1074, DOI 10.1212/01.wnl.0000231510.89311.8b; Praline J, 2012, AMYOTROPH LATERAL SC, V13, P155, DOI 10.3109/17482968.2011.598168; Quadri M, 2011, NEUROGENETICS, V12, P203, DOI 10.1007/s10048-011-0288-3; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Restagno G, 2008, AMYOTROPH LATERAL SC, V9, P35, DOI 10.1080/17482960701788198; Robberecht W, 1996, NEUROLOGY, V47, P1336, DOI 10.1212/WNL.47.5.1336; Sebastia J, 2009, CELL DEATH DIFFER, V16, P1238, DOI 10.1038/cdd.2009.52; Skibinski G, 2005, NAT GENET, V37, P806, DOI 10.1038/ng1609; Stewart H, 2012, ACTA NEUROPATHOL, V123, P409, DOI 10.1007/s00401-011-0937-5; Suzuki M, 2008, J NEUROL SCI, V268, P140, DOI 10.1016/j.jns.2007.11.020; Swash M, 2012, J NEUROL NEUROSUR PS, V83, P659, DOI 10.1136/jnnp-2012-302315; Ticozzi N, 2009, NEUROLOGY, V73, P1180, DOI 10.1212/WNL.0b013e3181bbff05; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Valdmanis PN, 2008, NEUROLOGY, V70, P144, DOI 10.1212/01.wnl.0000296811.19811.db; van Blitterswijk M, 2012, HUM MOL GENET, V21, P3776, DOI 10.1093/hmg/dds199; Van den Berg-Vos RM, 2009, ARCH NEUROL-CHICAGO, V66, P751, DOI 10.1001/archneurol.2009.91; van Es MA, 2009, NEUROLOGY, V72, P287, DOI 10.1212/01.wnl.0000339487.84908.00; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; van Es MA, 2010, J NEUROL NEUROSUR PS, V81, P562, DOI 10.1136/jnnp.2009.181453; Van Langenhove T, 2010, NEUROLOGY, V74, P366, DOI 10.1212/WNL.0b013e3181ccc732; van Rheenen W, 2012, NEUROLOGY, V79, P878, DOI 10.1212/WNL.0b013e3182661d14; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Visser J, 2007, ARCH NEUROL-CHICAGO, V64, P522, DOI 10.1001/archneur.64.4.522; Vlam L, 2012, ARCH NEUROL-CHICAGO, V69, P790, DOI 10.1001/archneurol.2012.148; Wingo TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027985; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Wu D, 2007, ANN NEUROL, V62, P609, DOI 10.1002/ana.21221; Yan J, 2010, NEUROLOGY, V75, P807, DOI 10.1212/WNL.0b013e3181f07e0c	67	50	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48983	10.1371/journal.pone.0048983	http://dx.doi.org/10.1371/journal.pone.0048983			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155438	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900073
J	Yu, GX; Greninger, AL; Isa, P; Phan, TG; Martinez, MA; Sanchez, MD; Contreras, JF; Santos-Preciado, JI; Parsonnet, J; Miller, S; DeRisi, JL; Delwart, E; Arias, CF; Chiu, CY				Yu, Guixia; Greninger, Alexander L.; Isa, Pavel; Phan, Tung G.; Angel Martinez, Miguel; Sanchez, Maria de la Luz; Francisco Contreras, Juan; Ignacio Santos-Preciado, Jose; Parsonnet, Julie; Miller, Steve; DeRisi, Joseph L.; Delwart, Eric; Arias, Carlos F.; Chiu, Charles Y.			Discovery of a Novel Polyomavirus in Acute Diarrheal Samples from Children	PLOS ONE			English	Article							MERKEL CELL POLYOMAVIRUS; RESPIRATORY-TRACT INFECTION; NUCLEAR-LOCALIZATION SIGNAL; BK VIRUS; WU POLYOMAVIRUS; GENETIC DIVERSITY; KI; IDENTIFICATION; SIMIAN-VIRUS-40; CARCINOMA	Polyomaviruses are small circular DNA viruses associated with chronic infections and tumors in both human and animal hosts. Using an unbiased deep sequencing approach, we identified a novel, highly divergent polyomavirus, provisionally named MX polyomavirus (MXPyV), in stool samples from children. The similar to 5.0 kB viral genome exhibits little overall homology (<46% amino acid identity) to known polyomaviruses, and, due to phylogenetic variation among its individual proteins, cannot be placed in any existing taxonomic group. PCR-based screening detected MXPyV in 28 of 834 (3.4%) fecal samples collected from California, Mexico, and Chile, and 1 of 136 (0.74%) of respiratory samples from Mexico, but not in blood or urine samples from immunocompromised patients. By quantitative PCR, the measured titers of MXPyV in human stool at 10% (weight/volume) were as high as 15,075 copies. No association was found between the presence of MXPyV and diarrhea, although girls were more likely to shed MXPyV in the stool than boys (p = 0.012). In one child, viral shedding was observed in two stools obtained 91 days apart, raising the possibility of chronic infection by MXPyV. A multiple sequence alignment revealed that MXPyV is a closely related variant of the recently reported MWPyV and HPyV10 polyomaviruses. Further studies will be important to determine the association, if any, of MXPyV with disease in humans.	[Yu, Guixia; Miller, Steve; Chiu, Charles Y.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Yu, GX (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.	charles.chiu@ucsf.edu	Arias, Carlos/O-4036-2019; Isa, Pavel/GVU-8303-2022	Arias, Carlos/0000-0003-3130-4501; Phan, Tung/0000-0003-3517-3078; Parsonnet, Julie/0000-0001-7342-5366; Delwart, Eric/0000-0002-6296-4484; Martinez-Mercado, Miguel A./0000-0003-2429-8772; Greninger, Alexander/0000-0002-7443-0527; Chiu, Charles/0000-0003-2915-2094	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105770, R01HL105704] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007618] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL105770, R01-HL105770, R01-HL105704, R01 HL105704] Funding Source: Medline; NIAID NIH HHS [AI042801, R56-AI08953, R01 AI042801] Funding Source: Medline; NIGMS NIH HHS [T32 GM007618] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abed Y, 2007, EMERG INFECT DIS, V13, P1939, DOI 10.3201/eid1312.070909; Agelli M, 2010, CURR PROB CANCER, V34, P14, DOI 10.1016/j.currproblcancer.2010.01.001; Albores-Saavedra J, 2010, J CUTAN PATHOL, V37, P20, DOI 10.1111/j.1600-0560.2009.01370.x; Allander T, 2007, J VIROL, V81, P4130, DOI 10.1128/JVI.00028-07; Babakir-Mina M, 2011, NEW MICROBIOL, V34, P1; Babakir-Mina M, 2009, J MED VIROL, V81, P1668, DOI 10.1002/jmv.21559; BARRONROMERO BL, 1985, J CLIN MICROBIOL, V22, P116; Bialasiewicz S, 2008, J CLIN VIROL, V41, P63, DOI 10.1016/j.jcv.2007.11.001; Braun WE, 2003, CLEV CLIN J MED, V70, P1056, DOI 10.3949/ccjm.70.12.1056; Buck CB, 2012, J VIROL, V86, P10887, DOI 10.1128/JVI.01690-12; Chen EC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002155; Chen TT, 2011, J CLIN VIROL, V50, P125, DOI 10.1016/j.jcv.2010.10.015; Chen YP, 2004, J GEN VIROL, V85, P2651, DOI 10.1099/vir.0.79920-0; Chiu CY, 2010, J VIROL, V84, P4407, DOI 10.1128/JVI.02536-09; Chiu CY, 2008, P NATL ACAD SCI USA, V105, P14124, DOI 10.1073/pnas.0805968105; Chiu CY, 2006, CLIN INFECT DIS, V43, pE71, DOI 10.1086/507896; Crandall KA, 2006, ADV EXP MED BIOL, V577, P46; Delwart EL, 2007, REV MED VIROL, V17, P115, DOI 10.1002/rmv.532; Drummond A. J., 2010, GENEIOUS V5 5 6; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Easha S, 2006, CELL MOL LIFE SCI, V63, P865, DOI 10.1007/s00018-005-5454-z; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Frisque RJ, 2001, J NEUROVIROL, V7, P293, DOI 10.1080/13550280152537120; GARDNER SD, 1971, LANCET, V1, P1253; Gaynor AM, 2007, PLOS PATHOG, V3, P595, DOI 10.1371/journal.ppat.0030064; Gjoerup O, 2010, ADV CANCER RES, V106, P1, DOI 10.1016/S0065-230X(10)06001-X; Greninger AL, 2010, CLIN VACCINE IMMUNOL, V17, P1584, DOI 10.1128/CVI.00152-10; Greninger AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013381; Han TH, 2007, EMERG INFECT DIS, V13, P1766, DOI 10.3201/eid1311.070872; Hou J, 2000, J NEUROVIROL, V6, pS98; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Ishii N, 1996, J VIROL, V70, P1317, DOI 10.1128/JVI.70.2.1317-1322.1996; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kazem S, 2012, J CLIN VIROL, V53, P225, DOI 10.1016/j.jcv.2011.11.007; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Knowles WA, 2006, ADV EXP MED BIOL, V577, P19; Loyo M, 2010, INT J CANCER, V126, P2991, DOI 10.1002/ijc.24737; Mendez-Toss M, 2004, J CLIN MICROBIOL, V42, P151, DOI 10.1128/JCM.42.1.151-157.2004; MORELAND RB, 1985, P NATL ACAD SCI USA, V82, P6561, DOI 10.1073/pnas.82.19.6561; PADGETT BL, 1971, LANCET, V1, P1257; Randhawa P, 2006, ADV EXP MED BIOL, V577, P148; Ren LL, 2009, EMERG INFECT DIS, V15, P134, DOI 10.3201/eid1501.080693; Ren LL, 2008, J CLIN VIROL, V43, P330, DOI 10.1016/j.jcv.2008.08.003; Reploeg MD, 2001, CLIN INFECT DIS, V33, P191, DOI 10.1086/321813; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006; Scuda N, 2011, J VIROL, V85, P4586, DOI 10.1128/JVI.02602-10; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Siebrasse EA, 2012, J VIROL, V86, P10321, DOI 10.1128/JVI.01210-12; SPENCE SL, 1994, J VIROL, V68, P4227, DOI 10.1128/JVI.68.7.4227-4240.1994; Tang P, 2010, FUTURE MICROBIOL, V5, P177, DOI [10.2217/fmb.09.120, 10.2217/FMB.09.120]; van der Meijden E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001024; Vanchiere JA, 2005, J MED VIROL, V75, P447, DOI 10.1002/jmv.20287; Vanchiere JA, 2009, J CLIN MICROBIOL, V47, P2388, DOI 10.1128/JCM.02472-08; Wattier RL, 2008, EMERG INFECT DIS, V14, P1766, DOI 10.3201/eid1411.080394; Yuan XH, 2008, J CLIN MICROBIOL, V46, P3522, DOI 10.1128/JCM.01301-08	57	107	111	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49449	10.1371/journal.pone.0049449	http://dx.doi.org/10.1371/journal.pone.0049449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166671	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000311151900142
J	Zhou, KJ; Lin, N; Xiao, YT; Wang, Y; Wen, J; Zou, GM; Gu, XF; Cai, W				Zhou, Kejun; Lin, Na; Xiao, Yongtao; Wang, Yang; Wen, Jie; Zou, Gang-Ming; Gu, XueFan; Cai, Wei			Elevated Bile Acids in Newborns with Biliary Atresia (BA)	PLOS ONE			English	Article							IONIZATION-MASS SPECTROMETRY; NEONATAL JAUNDICE; KASAI OPERATION; LIVER-DISEASE; SERUM; AGE; DIAGNOSIS; OUTCOMES; INFANTS; IMPACT	Biliary Atresia (BA), a result from inflammatory destruction of the intrahepatic and extrahepatic bile ducts, is a severe hepatobiliary disorder unique to infancy. Early diagnosis and Kasai operation greatly improve the outcome of BA patients, which encourages the development of early screening methods. Using HPLC coupled tandem mass spectrometry, we detected primary bile acids content in dried blood spots obtained from 8 BA infants, 17 neonatal jaundice and 292 comparison infants at 3-4 days of life. Taurocholate (TC) was significantly elevated in biliary atresia infants (0.98 +/- 0.62 mu mol/L) compared to neonatal jaundice (0.47 +/- 0.30 mu mol/L) and comparison infants (0.43 +/- 0.40 mu mol/L), with p = 0.0231 and p = 0.0016 respectively. The area under receiver operating characteristic (ROC) curve for TC to discriminate BA and comparison infants was 0.82 (95% confidence interval: 0.72-0.92). A cutoff of 0.63 mu mol/L produced a sensitivity of 79.1% and specificity of 62.5%. The concentrations of total bile acids were also raised significantly in BA compared to comparison infants (6.62 +/- 3.89 mu mol/L vs 3.81 +/- 3.06 mu mol/L, p = 0.0162), with the area under ROC curve of 0.75 (95% confidence interval: 0.61-0.89). No significant difference was found between the bile acids of neonatal jaundice and that of comparison infants. The early increase of bile acids indicates the presentation of BA in the immediate newborn period and the possibility of TC as newborn screening marker.	[Zhou, Kejun; Xiao, Yongtao; Wang, Yang; Wen, Jie; Zou, Gang-Ming; Cai, Wei] Shanghai Jiao Tong Univ, Dept Pediat Surg, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Zhou, KJ (corresponding author), Shanghai Jiao Tong Univ, Dept Pediat Surg, Xin Hua Hosp, Sch Med, Shanghai 200030, Peoples R China.	caiw204@yahoo.com.cn	Wang, Yang/HCG-9543-2022; Zou, Gang-Ming/F-1085-2016	Zhou, Kejun/0000-0001-5765-293X				Bertini G, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.3.e41; CAREY JB, 1958, J CLIN INVEST, V37, P1494, DOI 10.1172/JCI103741; Haas D, 2012, WORLD J GASTROENTERO, V18, P1067, DOI 10.3748/wjg.v18.i10.1067; Hagio M, 2011, METHODS MOL BIOL, V708, P119, DOI 10.1007/978-1-61737-985-7_6; Harpavat S, 2011, PEDIATRICS, V128, pE1428, DOI 10.1542/peds.2011-1869; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Hsiao CH, 2008, HEPATOLOGY, V47, P1233, DOI 10.1002/hep.22182; Janzen N, 2010, J LIPID RES, V51, P1591, DOI 10.1194/jlr.D003814; Lien TH, 2011, HEPATOLOGY, V53, P202, DOI 10.1002/hep.24023; Mieli-Vergani G, 2009, SEMIN IMMUNOPATHOL, V31, P371, DOI 10.1007/s00281-009-0171-6; MIELIVERGANI G, 1989, LANCET, V1, P421; Mills KA, 1998, PEDIATR RES, V43, P361, DOI 10.1203/00006450-199803000-00009; Mushtaq I, 1999, BRIT MED J, V319, P471, DOI 10.1136/bmj.319.7208.471; Nio M, 2010, J PEDIATR SURG, V45, P2361, DOI 10.1016/j.jpedsurg.2010.08.032; Powell JE, 2003, J MED SCREEN, V10, P112, DOI 10.1258/096914103769010996; Ramm GA, 2009, HEPATOLOGY, V49, P533, DOI 10.1002/hep.22637; Schreiber Richard A., 2002, JPGN Journal of Pediatric Gastroenterology and Nutrition, V35, pS11, DOI 10.1097/00005176-200207001-00005; Serinet MO, 2009, PEDIATRICS, V123, P1280, DOI 10.1542/peds.2008-1949; Steiner C, 2010, J CHROMATOGR B, V878, P2870, DOI 10.1016/j.jchromb.2010.08.045; Suzuki M, 2011, PEDIATR INT, V53, P497, DOI 10.1111/j.1442-200X.2010.03268.x; Toubi A, 2010, EUR J PEDIATR SURG, V20, P128, DOI 10.1055/s-0029-1224193; Tribe RM, 2010, AM J GASTROENTEROL, V105, P585, DOI 10.1038/ajg.2009.633; Wadhwani SI, 2008, PEDIATRICS, V121, pE1438, DOI 10.1542/peds.2007-2709; Zhang YKJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016683	24	18	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49270	10.1371/journal.pone.0049270	http://dx.doi.org/10.1371/journal.pone.0049270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166626	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900114
J	Hellmich, KA; Levinsohn, JL; Fattah, R; Newman, ZL; Maier, N; Sastalla, I; Liu, SH; Leppla, SH; Moayeri, M				Hellmich, Kristina A.; Levinsohn, Jonathan L.; Fattah, Rasem; Newman, Zachary L.; Maier, Nolan; Sastalla, Inka; Liu, Shihui; Leppla, Stephen H.; Moayeri, Mahtab			Anthrax Lethal Factor Cleaves Mouse Nlrp1b in Both Toxin-Sensitive and Toxin-Resistant Macrophages	PLOS ONE			English	Article							SUSCEPTIBILITY; PROTEOLYSIS; KINASE	Anthrax lethal factor (LF) is the protease component of anthrax lethal toxin (LT). LT induces pyroptosis in macrophages of certain inbred mouse and rat strains, while macrophages from other inbred strains are resistant to the toxin. In rats, the sensitivity of macrophages to toxin-induced cell death is determined by the presence of an LF cleavage sequence in the inflammasome sensor Nlrp1. LF cleaves rat Nlrp1 of toxin-sensitive macrophages, activating caspase-1 and inducing cell death. Toxin-resistant macrophages, however, express Nlrp1 proteins which do not harbor the LF cleavage site. We report here that mouse Nlrp1b proteins are also cleaved by LF. In contrast to the situation in rats, sensitivity and resistance of Balb/cJ and NOD/LtJ macrophages does not correlate to the susceptibility of their Nlrp1b proteins to cleavage by LF, as both proteins are cleaved. Two LF cleavage sites, at residues 38 and 44, were identified in mouse Nlrp1b. Our results suggest that the resistance of NOD/LtJ macrophages to LT, and the inability of the Nlrp1b protein expressed in these cells to be activated by the toxin are likely due to polymorphisms other than those at the LF cleavage sites.	[Hellmich, Kristina A.; Levinsohn, Jonathan L.; Fattah, Rasem; Newman, Zachary L.; Maier, Nolan; Sastalla, Inka; Liu, Shihui; Leppla, Stephen H.; Moayeri, Mahtab] NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Moayeri, M (corresponding author), NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	mmoayeri@niaid.nih.gov		Sastalla, Inka/0000-0003-4128-0742; Moayeri, Mahtab/0000-0002-4448-8883; Liu, Shihui/0000-0003-3444-1069; /0000-0001-6103-6726	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001032] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIH, National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Frew BC, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002659; Horvath GL, 2011, IMMUNOL REV, V243, P119, DOI 10.1111/j.1600-065X.2011.01050.x; Levinsohn JL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002638; Moayeri M, 2009, MOL ASPECTS MED, V30, P439, DOI 10.1016/j.mam.2009.07.003; Newman ZL, 2010, BIOCHEM BIOPH RES CO, V398, P785, DOI 10.1016/j.bbrc.2010.07.039; Newman ZL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000906; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Turk BE, 2001, NAT BIOTECHNOL, V19, P661, DOI 10.1038/90273; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Wickliffe KE, 2008, CELL MICROBIOL, V10, P332, DOI 10.1111/j.1462-5822.2007.01044.x	13	90	91	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49741	10.1371/journal.pone.0049741	http://dx.doi.org/10.1371/journal.pone.0049741			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152930	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000075
J	Luzzo, KM; Wang, Q; Purcell, SH; Chi, M; Jimenez, PT; Grindler, N; Schedl, T; Moley, KH				Luzzo, Kerri M.; Wang, Qiang; Purcell, Scott H.; Chi, Maggie; Jimenez, Patricia T.; Grindler, Natalia; Schedl, Tim; Moley, Kelle H.			High Fat Diet Induced Developmental Defects in the Mouse: Oocyte Meiotic Aneuploidy and Fetal Growth Retardation/Brain Defects	PLOS ONE			English	Article							BODY-MASS INDEX; DIABETES-MELLITUS; OXIDATIVE STRESS; MATERNAL OBESITY; PREPREGNANCY; RISK; PREGNANCY; MITOCHONDRIA; DISORDERS; OCCURS	Background: Maternal obesity is associated with poor outcomes across the reproductive spectrum including infertility, increased time to pregnancy, early pregnancy loss, fetal loss, congenital abnormalities and neonatal conditions. Furthermore, the proportion of reproductive-aged woman that are obese in the population is increasing sharply. From current studies it is not clear if the origin of the reproductive complications is attributable to problems that arise in the oocyte or the uterine environment. Methodology/Principal Findings: We examined the developmental basis of the reproductive phenotypes in obese animals by employing a high fat diet mouse model of obesity. We analyzed very early embryonic and fetal phenotypes, which can be parsed into three abnormal developmental processes that occur in obese mothers. The first is oocyte meiotic aneuploidy that then leads to early embryonic loss. The second is an abnormal process distinct from meiotic aneuploidy that also leads to early embryonic loss. The third is fetal growth retardation and brain developmental abnormalities, which based on embryo transfer experiments are not due to the obese uterine environment but instead must be from a defect that arises prior to the blastocyst stage. Conclusions/Significance: Our results suggest that reproductive complications in obese females are, at least in part, from oocyte maternal effects. This conclusion is consistent with IVF studies where the increased pregnancy failure rate in obese women returns to the normal rate if donor oocytes are used instead of autologous oocytes. We postulate that preconceptional weight gain adversely affects pregnancy outcomes and fetal development. In light of our findings, preconceptional counseling may be indicated as the preferable, earlier target for intervention in obese women desiring pregnancy and healthy outcomes.	[Luzzo, Kerri M.; Purcell, Scott H.; Chi, Maggie; Jimenez, Patricia T.; Grindler, Natalia; Moley, Kelle H.] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA; [Wang, Qiang] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Schedl, Tim] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Nanjing Medical University; Washington University (WUSTL)	Moley, KH (corresponding author), Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.	moleyk@wustl.edu			National Institutes of Health [T32 HD040135, T32 HD049305, RO1 GM085150, HD40390]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD040135, T32HD049305, R01HD040390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020579] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085150] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants T32 HD040135 (to KML and PTJ) and T32 HD049305 (to SHP), and RO1 GM085150 (to TS) and HD40390 (to KHM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adastra KL, 2011, REPRODUCTION, V141, P607, DOI 10.1530/REP-10-0265; Blomberg MI, 2010, BIRTH DEFECTS RES A, V88, P35, DOI 10.1002/bdra.20620; Bodnar LM, 2007, EPIDEMIOLOGY, V18, P234, DOI 10.1097/01.ede.0000254119.99660.e7; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Chang AS, 2005, ENDOCRINOLOGY, V146, P2445, DOI 10.1210/en.2004-1472; Chi MMY, 2002, AM J PHYSIOL-ENDOC M, V283, pE226, DOI 10.1152/ajpendo.00046.2002; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Colton SA, 2002, BIOL REPROD, V67, P220, DOI 10.1095/biolreprod67.1.220; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; Desai M, 2011, SEMIN REPROD MED, V29, P237, DOI 10.1055/s-0031-1275517; DIAMOND MP, 1989, J REPROD FERTIL, V86, P1; Gualtieri R, 2009, FERTIL STERIL, V91, P1023, DOI 10.1016/j.fertnstert.2008.01.076; Heerwagen MJ, 2011, AM J PHYSIOL-REG I, V299, pR711; Hoeks J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027274; Hunt PA, 2008, TRENDS GENET, V24, P86, DOI 10.1016/j.tig.2007.11.010; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Institute of Medicine, 2009, WEIGHT GAIN PREGN RE; Jones KT, 2012, EXPT CELL RES; Jungheim ES, 2010, ENDOCRINOLOGY, V151, P4039, DOI 10.1210/en.2010-0098; Lashen H, 2004, HUM REPROD, V19, P1644, DOI 10.1093/humrep/deh277; Liu XY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021687; Luke B, 2011, FERTIL STERIL, V96, P820, DOI 10.1016/j.fertnstert.2011.07.1100; Minge CE, 2008, ENDOCRINOLOGY, V149, P2646, DOI 10.1210/en.2007-1570; Misra VK, 2011, OBESITY, V19, P1476, DOI 10.1038/oby.2011.43; MOLEY KH, 1991, J REPROD FERTIL, V93, P325; Muoio DM, 2012, CELL METAB, V15, P595, DOI 10.1016/j.cmet.2012.04.010; Neggers YH, 2003, ACTA OBSTET GYN SCAN, V82, P235, DOI 10.1034/j.1600-0412.2003.00090.x; Purcell SH, 2012, ENDOCRINOLOGY, V153, P2444, DOI 10.1210/en.2011-1974; Rajasingam D, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.10.047; Ratchford AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1198, DOI 10.1152/ajpendo.00097.2007; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Rodriguez A, 2008, INT J OBESITY, V32, P550, DOI 10.1038/sj.ijo.0803741; Rodriguez A, 2010, J CHILD PSYCHOL PSYC, V51, P134, DOI 10.1111/j.1469-7610.2009.02133.x; Rogers LK, 2011, LIFE SCI, V89, P417, DOI 10.1016/j.lfs.2011.07.017; Staten R, 2010, J CHILD ADOL PS NURS, V23, P118, DOI 10.1111/j.1744-6171.2010.00231.x; Stothard KJ, 2009, JAMA-J AM MED ASSOC, V301, P636, DOI 10.1001/jama.2009.113; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Suen DF, 2008, GENE DEV, V22, P1577, DOI 10.1101/gad.1658508; Van Lieshout RJ, 2011, OBES REV, V12, pe548, DOI 10.1111/j.1467-789X.2010.00850.x; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Wang Q, 2009, MOL ENDOCRINOL, V23, P1603, DOI 10.1210/me.2009-0033; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; Wyman A, 2008, ENDOCRINOLOGY, V149, P466, DOI 10.1210/en.2007-1273; Zhang CM, 2010, MOL BIOL REP, V37, P3177, DOI 10.1007/s11033-009-9898-3; Zhang X, 2006, CELL RES, V16, P841, DOI 10.1038/sj.cr.7310095	46	227	242	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49217	10.1371/journal.pone.0049217	http://dx.doi.org/10.1371/journal.pone.0049217			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152876	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234000054
J	Manthey, JD; Klicka, J; Spellman, GM				Manthey, Joseph D.; Klicka, John; Spellman, Garth M.			Is Gene Flow Promoting the Reversal of Pleistocene Divergence in the Mountain Chickadee (Poecile gambeli)?	PLOS ONE			English	Article							NUTHATCH SITTA-CAROLINENSIS; MULTILOCUS GENOTYPE DATA; POPULATION-GENETICS; ICE AGES; HAPLOTYPE RECONSTRUCTION; STATISTICAL-METHOD; DNA POLYMORPHISM; FLYING SQUIRRELS; CLIMATE-CHANGE; HALDANES RULE	The Pleistocene glacial cycles left a genetic legacy on taxa throughout the world; however, the persistence of genetic lineages that diverged during these cycles is dependent upon levels of gene flow and introgression. The consequences of secondary contact among taxa may reveal new insights into the history of the Pleistocene's genetic legacy. Here, we use phylogeographic methods, using 20 nuclear loci from regional populations, to infer the consequences of secondary contact following divergence in the Mountain Chickadee (Poecile gambeli). Analysis of nuclear data identified two geographically-structured genetic groups, largely concordant with results from a previous mitochondrial DNA ( mtDNA) study. Additionally, the estimated multilocus divergence times indicate a Pleistocene divergence, and are highly concordant with mtDNA. The previous mtDNA study showed a paucity of sympatry between clades, while nuclear patterns of gene flow show highly varied patterns between populations. The observed pattern of gene flow, from coalescent-based analyses, indicates southern populations in both clades exhibit little gene flow within or between clades, while northern populations are experiencing higher gene flow within and between clades. If this pattern were to persist, it is possible the historical legacy of Pleistocene divergence may be preserved in the southern populations only, and the northern populations would become a genetically diverse hybrid species.	[Manthey, Joseph D.; Spellman, Garth M.] Black Hills State Univ, Ctr Conservat Biol Resources, Dept Biol, Spearfish, SD 57799 USA; [Manthey, Joseph D.; Spellman, Garth M.] Black Hills State Univ, Integrat Genom Program, Spearfish, SD 57799 USA; [Klicka, John] Univ Nevada, Marjorie Barrick Museum Nat Hist, Las Vegas, NV 89154 USA	Black Hills State University; Black Hills State University; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas	Manthey, JD (corresponding author), Black Hills State Univ, Ctr Conservat Biol Resources, Dept Biol, Spearfish, SD 57799 USA.	jdmanthey@gmail.com	Manthey, Joseph/A-6826-2012	Manthey, Joseph/0000-0003-2765-7611	National Science Foundation [DEB 0814841, DEB 0815705]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [2 P20 RR016479]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016479] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was supported by National Science Foundation grants awarded to GMS (DEB 0814841) and JK (DEB 0815705). The project described was also supported in part by grant number 2 P20 RR016479 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbogast BS, 1999, J MAMMAL, V80, P142, DOI 10.2307/1383215; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P457, DOI 10.1098/rspb.1998.0317; AXELROD DI, 1958, BOT REV, V24, P433, DOI 10.1007/BF02872570; Barrowclough GF, 2004, MOL ECOL, V13, P1911, DOI 10.1111/j.1365-294X.2004.02215.x; BEHLE WILLIAM H., 1956, CONDOR, V58, P51, DOI 10.2307/1365046; Berg EC, 2009, MOL ECOL, V18, P3486, DOI 10.1111/j.1365-294X.2009.04284.x; Betancourt JL, 1990, MP MIDDENS LAST 40 0; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; Brelsford A, 2011, MOL ECOL, V20, P2380, DOI 10.1111/j.1365-294X.2011.05055.x; Brumfield RT, 2003, TRENDS ECOL EVOL, V18, P249, DOI 10.1016/S0169-5347(03)00018-1; Bulgarella M, 2012, MOL ECOL, V21, P350, DOI 10.1111/j.1365-294X.2011.05400.x; BURNS KJ, 2007, FESTSCHRIFT NK JOHNS, P96; Carling MD, 2008, EVOLUTION, V62, P2600, DOI 10.1111/j.1558-5646.2008.00477.x; Chesser RT, 2011, AUK, V128, P600, DOI 10.1525/auk.2011.128.3.600; Clarke AL, 1997, OIKOS, V79, P429, DOI 10.2307/3546885; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Cummings MP, 2008, EVOLUTION, V62, P2411, DOI 10.1111/j.1558-5646.2008.00442.x; Dmitriev D.A., 2008, INDELLIGENT V 1 2; Dmitriev DA, 2008, PLOS COMPUTATIONAL B, P4; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Funk WC, 2008, MOL PHYLOGENET EVOL, V49, P198, DOI 10.1016/j.ympev.2008.05.037; Garroway CJ, 2010, GLOBAL CHANGE BIOL, V16, P113, DOI 10.1111/j.1365-2486.2009.01948.x; Graham, 2010, LATE CRETACEOUS CENO; GRANT PR, 1992, SCIENCE, V256, P193, DOI 10.1126/science.256.5054.193; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hermansen JS, 2011, MOL ECOL, V20, P3812, DOI 10.1111/j.1365-294X.2011.05183.x; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Kearns AM, 2011, MOL ECOL, V20, P5042, DOI 10.1111/j.1365-294X.2011.05330.x; Klicka J, 1997, SCIENCE, V277, P1666, DOI 10.1126/science.277.5332.1666; Lee JY, 2008, EVOLUTION, V62, P3117, DOI 10.1111/j.1558-5646.2008.00543.x; Li MH, 2010, MOL ECOL, V19, P5281, DOI 10.1111/j.1365-294X.2010.04870.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; LYNCH M, 1995, AM NAT, V146, P489, DOI 10.1086/285812; Manthey JD, 2011, MOL ECOL, V20, P4371, DOI 10.1111/j.1365-294X.2011.05270.x; Manthey JD, 2011, MOL PHYLOGENET EVOL, V58, P502, DOI 10.1016/j.ympev.2010.12.003; Mayr E, 1970, PUBLICATION NUTTALL; McCallum DA, 1999, BIRDS N AM ONLINE, DOI [10.2173/bna.453, DOI 10.2173/BNA.453]; Mettler RD, 2009, MOL ECOL, V18, P3256, DOI 10.1111/j.1365-294X.2009.04217.x; Miller RG., 1966, SIMULTANEOUS STAT IN; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Morris-Pocock JA, 2011, MOL ECOL, V20, P2835, DOI 10.1111/j.1365-294X.2011.05132.x; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pritchard JK, 2000, GENETICS, V155, P945; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Saether SA, 2007, SCIENCE, V318, P95, DOI 10.1126/science.1141506; SCHOENER TW, 1968, ECOLOGY, V49, P704, DOI 10.2307/1935534; Schwenk K, 2008, PHILOS T R SOC B, V363, P2805, DOI 10.1098/rstb.2008.0055; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Smith BT, 2010, ECOGRAPHY, V33, P333, DOI 10.1111/j.1600-0587.2009.06335.x; Sousa VC, 2011, MOL ECOL, V20, P3956, DOI 10.1111/j.1365-294X.2011.05247.x; Spellman GM, 2007, MOL ECOL, V16, P1729, DOI 10.1111/j.1365-294X.2007.03237.x; Spellman GM, 2007, MOL ECOL, V16, P1055, DOI 10.1111/j.1365-294X.2007.03199.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Storchova R, 2010, EVOLUTION, V64, P456, DOI 10.1111/j.1558-5646.2009.00841.x; TAJIMA F, 1989, GENETICS, V123, P585; Vallender R, 2007, MOL ECOL, V16, P2017, DOI 10.1111/j.1365-294X.2007.03282.x; Walstrom VW, 2012, MOL ECOL, V21, P907, DOI 10.1111/j.1365-294X.2011.05384.x; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Weir JT, 2004, P ROY SOC B-BIOL SCI, V271, P1881, DOI 10.1098/rspb.2004.2803; Wu CI, 1996, TRENDS ECOL EVOL, V11, P281, DOI 10.1016/0169-5347(96)10033-1	74	9	9	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49218	10.1371/journal.pone.0049218	http://dx.doi.org/10.1371/journal.pone.0049218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152877	gold, Green Submitted, Green Published			2022-12-27	WOS:000311234000055
J	Hamano, T; Kimura, Y; Takeda, M; Yamasaki, M; Isomura, M; Nabika, T; Shiwaku, K				Hamano, Tsuyoshi; Kimura, Yoshinari; Takeda, Miwako; Yamasaki, Masayuki; Isomura, Minoru; Nabika, Toru; Shiwaku, Kuninori			Effect of Environmental and Lifestyle Factors on Hypertension: Shimane COHRE Study	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK	Background: In recent years there has been increasing evidence of an association between residential remoteness and hypertension (HTN); however, no study has examined the effects of residential remoteness-lifestyle associations on HTN. The objective of this study was to evaluate the effects of residential remoteness, as measured by road network distance and elevation, and lifestyle associations, including access to daily products as a measure of car use, on HTN in a rural region in Japan. Method: This is a cross-sectional population based study. We analyzed data from the Shimane COHRE study conducted from 2006 to 2009 in the rural mountainous regions of Japan. After excluding missing data, we conducted a logistic regression analysis of the data for 1,348 individuals and examined the effects of residential remoteness and lifestyle associations, including road network distance, elevation and access to daily products as a measure of car use, on the prevalence of HTN. Principal Findings: In participants without access to car use, the odds ratios for self-reported HTN (i.e. taking antihypertensive medication) were significantly increased in those living in moderate (odds ratio (OR): 2.21, 95% confidence interval (CI): 1.19-4.08) and far (OR: 2.55, 95% CI: 1.00-6.51) road distances, whereas there were no significant associations in participants with access to car use. There were no significant associations between elevation and HTN for participants either with or without access to car transportation. Conclusions: Our findings show that specific residential remoteness-hypertension associations vary according to access to daily products as a measure of car use in a rural mountainous area of Japan. These results advance the understanding and importance of considering residential environment, "where people live," in establishing health policy. Citation: Hamano T, Kimura Y, Takeda M, Yamasaki M, Isomura M, et al. (2012) Effect of Environmental and Lifestyle Factors on Hypertension: Shimane COHRE Study. PLoS ONE 7(11): e49122. doi: 10.1371/journal.pone.0049122	[Hamano, Tsuyoshi; Takeda, Miwako; Yamasaki, Masayuki; Isomura, Minoru; Nabika, Toru; Shiwaku, Kuninori] Shimane Univ, Org Promot Project Res, Ctr Community Based Hlth Res & Educ COHRE, Izumo, Shimane, Japan; [Hamano, Tsuyoshi; Takeda, Miwako; Yamasaki, Masayuki; Shiwaku, Kuninori] Shimane Univ, Sch Med, Dept Environm & Prevent Med, Izumo, Shimane, Japan; [Kimura, Yoshinari] Osaka City Univ, Dept Geog, Grad Sch Literature & Human Sci, Osaka 558, Japan; [Isomura, Minoru; Nabika, Toru] Shimane Univ, Sch Med, Dept Funct Pathol, Izumo, Shimane, Japan	Shimane University; Shimane University; Osaka Metropolitan University; Shimane University	Hamano, T (corresponding author), Shimane Univ, Org Promot Project Res, Ctr Community Based Hlth Res & Educ COHRE, Izumo, Shimane, Japan.	thamano@med.shimane-u.ac.jp		Hamano, Tsuyoshi/0000-0002-6755-9138	Ministry of Education, Culture, Sports, Science and Technology	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	Funding for this study was provided by the Ministry of Education, Culture, Sports, Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcury TA, 2005, J RURAL HEALTH, V21, P31, DOI 10.1111/j.1748-0361.2005.tb00059.x; Axon RN, 2010, AM J HYPERTENS, V23, P30, DOI 10.1038/ajh.2009.199; Chaix B, 2008, J HYPERTENS, V26, P1078, DOI 10.1097/HJH.0b013e3282fd991f; Chaix B, 2010, HYPERTENSION, V55, P769, DOI 10.1161/HYPERTENSIONAHA.109.143206; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Ehret GB, 2011, NATURE, V478, P103, DOI 10.1038/nature10405; Estes MG, 2009, ENVIRON HEALTH PERSP, V117, P1832, DOI 10.1289/ehp.0900871; Fiori G, 2000, ANN HUM BIOL, V27, P19, DOI 10.1080/030144600282343; Franks PW, 2009, J HUM HYPERTENS, V23, P227, DOI 10.1038/jhh.2008.134; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Hamano T, 2011, J RURAL MED, V60, P516, DOI DOI 10.2185/JJRM.60.516; Hamano T, 2012, AM J HYPERTENS, V25, P784, DOI 10.1038/ajh.2012.36; Hamano T, 2011, AM J HYPERTENS, V24, P643, DOI 10.1038/ajh.2011.37; Huang J, 2011, AM J HYPERTENS, V24, P335, DOI 10.1038/ajh.2010.237; KHALID MEM, 1994, J HUM HYPERTENS, V8, P765; McGrath JJ, 2006, SOC SCI MED, V63, P1442, DOI 10.1016/j.socscimed.2006.03.019; Mitsui T, 2010, J PHYSIOL ANTHROPOL, V29, P43, DOI 10.2114/jpa2.29.43; Powell LM, 2007, PREV MED, V44, P189, DOI 10.1016/j.ypmed.2006.08.008; RODGERS A, 2002, WORLD HLTH REPORT 20; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Taylor JY, 2010, BIOL RES NURS, V12, P149, DOI 10.1177/1099800410371225	21	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49122	10.1371/journal.pone.0049122	http://dx.doi.org/10.1371/journal.pone.0049122			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152860	Green Published, Green Submitted, gold			2022-12-27	WOS:000312272600047
J	Villarreal-Molina, T; Posadas-Romero, C; Romero-Hidalgo, S; Antunez-Arguelles, E; Bautista-Grande, A; Vargas-Alarcon, G; Kimura-Hayama, E; Canizales-Quinteros, S; Juarez-Rojas, JG; Posadas-Sanchez, R; Cardoso-Saldana, G; Medina-Urrutia, A; Gonzalez-Salazar, MD; Martinez-Alvarado, R; Jorge-Galarza, E; Carnevale, A				Villarreal-Molina, Teresa; Posadas-Romero, Carlos; Romero-Hidalgo, Sandra; Antunez-Argueelles, Erika; Bautista-Grande, Araceli; Vargas-Alarcon, Gilberto; Kimura-Hayama, Eric; Canizales-Quinteros, Samuel; Gabriel Juarez-Rojas, Juan; Posadas-Sanchez, Rosalinda; Cardoso-Saldana, Guillermo; Medina-Urrutia, Aida; del Carmen Gonzalez-Salazar, Maria; Martinez-Alvarado, Rocio; Jorge-Galarza, Esteban; Carnevale, Alessandra			The ABCA1 Gene R230C Variant Is Associated with Decreased Risk of Premature Coronary Artery Disease: The Genetics of Atherosclerotic Disease (GEA) Study	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; CASSETTE TRANSPORTER A1; LOW HDL-CHOLESTEROL; ADIPOSE-TISSUE VOLUMES; CARDIOVASCULAR-DISEASE; HEART-DISEASE; EXPRESSION; WOMEN; QUESTIONNAIRE; INFILTRATION	Background: ABCA1 genetic variation is known to play a role in HDL-C levels and various studies have also implicated ABCA1 variation in cardiovascular risk. The functional ABCA1/R230C variant is frequent in the Mexican population and has been consistently associated with low HDL-C concentrations. Although it has been associated with other cardiovascular risk factors such as obesity and type 2 diabetes mellitus, it is not known whether it is associated with coronary artery disease (CAD). Aim: The purpose of the study was to analyze whether the ABCA1/R230C variant is associated with premature CAD in a case-control association study (GEA or Genetics of Atherosclerotic Disease), and to explore whether BMI modulates the effect of the C230 allele on other metabolic traits using a population-based design. Results: The C230 allele was significantly associated with both lower HDL-C levels and a lower risk of premature CAD as compared to controls (OR = 0.566; P-add = 1.499 x 10(-5)). In addition, BMI modulated the effect of R230C on body fat distribution, as the correlation between BMI and visceral to subcutaneous adipose tissue (a metric of the propensity to store fat viscerally as compared to subcutaneously) was negative in RR homozygous individuals, but positive in premenopausal women bearing the C230 allele, with a statistically significant interaction (P = 0.005). BMI-R230C interaction was also significant for triglyceride levels in women regardless of their menopausal status (P = 0.036). Conclusion: This is the first study assessing the effect of the R230C/ABCA1 variant in remature CAD. C230 was associated with both decreased HDL-C levels and a lower risk of premature CAD, and gender-specific BMI-R230C interactions were observed for different metabolic traits. These interactions may help explain inconsistencies in associations, and underscore the need to further analyze interactions of this functional and frequent variant with diet, exercise and other environmental factors.	[Villarreal-Molina, Teresa; Antunez-Argueelles, Erika; Bautista-Grande, Araceli] Inst Nacl Med Genom INMEGEN, Lab Genom Enfermedades Cardiovasc, Mexico City, DF, Mexico; [Posadas-Romero, Carlos; Gabriel Juarez-Rojas, Juan; Posadas-Sanchez, Rosalinda; Cardoso-Saldana, Guillermo; Medina-Urrutia, Aida; del Carmen Gonzalez-Salazar, Maria; Martinez-Alvarado, Rocio; Jorge-Galarza, Esteban] Inst Nacl Cardiol Ignacio Chavez INCICH, Dept Endocrinol, Mexico City, DF, Mexico; [Romero-Hidalgo, Sandra] INMEGEN, Dept Genom Computac, Mexico City, DF, Mexico; [Vargas-Alarcon, Gilberto] INCICH, Dept Mol Biol, Mexico City, DF, Mexico; [Kimura-Hayama, Eric] INCICH, Dept Tomog Cardiaca, Mexico City, DF, Mexico; [Canizales-Quinteros, Samuel] Univ Nacl Autonoma Mexico, Fac Quim, Dept Biol, Mexico City 04510, DF, Mexico; [Canizales-Quinteros, Samuel] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Unidad Biol Mol & Med Genom, Mexico City, DF, Mexico; [Carnevale, Alessandra] INMEGEN, Direcc Invest, Mexico City, DF, Mexico	Instituto Nacional de Medicina Genomica; National Institute of Cardiology - Mexico; Instituto Nacional de Medicina Genomica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Instituto Nacional de Medicina Genomica	Villarreal-Molina, T (corresponding author), Inst Nacl Med Genom INMEGEN, Lab Genom Enfermedades Cardiovasc, Mexico City, DF, Mexico.	mvillareal@inmegen.gob.mx	Juárez-Rojas, Juan Gabriel/AAM-9486-2020; Jorge-Galarza, Esteban/AAF-6915-2020	Juárez-Rojas, Juan Gabriel/0000-0001-8864-2304; Vargas-Alarcon, Gilberto/0000-0001-7916-5163; Martinez, Maria del Rocio/0000-0003-3013-9436; Jorge-Galarza, Esteban/0000-0002-7748-4678; VILLARREAL MOLINA, TERESA/0000-0003-4450-7690; Romero-Hidalgo, Sandra/0000-0003-3077-7825; , Erika/0000-0002-4538-8905; Cardoso, Guillermo/0000-0001-9525-1731	Consejo Nacional de Ciencia y Tecnologia (CONACyT) [2009-01-112547, 221098]	Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This research was supported by grant number 2009-01-112547 from the Consejo Nacional de Ciencia y Tecnologia (CONACyT, http://www.conacyt.mx/Paginas/default.aspx). EAA is in the PhD program from Ciencias Biomedicas at Universidad Nacional Autonoma de Mexico (UNAM), and is recipient of the CONACyT scholarship number 221098. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.`	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Aguilar-Salinas CA, 2011, ATHEROSCLEROSIS, V216, P146, DOI 10.1016/j.atherosclerosis.2010.10.049; Almeida S, 2008, BRAZ J MED BIOL RES, V41, P872, DOI 10.1590/S0100-879X2008001000007; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; Darabi M, 2011, GYNECOL ENDOCRINOL, V27, P701, DOI 10.3109/09513590.2010.507826; DELONG DM, 1986, JAMA-J AM MED ASSOC, V256, P2372, DOI 10.1001/jama.256.17.2372; Flores-Dorantes T, 2010, CLIN CHIM ACTA, V411, P1214, DOI 10.1016/j.cca.2010.04.025; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Frikke-Schmidt R, 2008, JAMA-J AM MED ASSOC, V299, P2524, DOI 10.1001/jama.299.21.2524; Frikke-Schmidt R, 2008, ARTERIOSCL THROM VAS, V28, P180, DOI 10.1161/ATVBAHA.107.153858; Frikke-Schmidt R, 2011, ATHEROSCLEROSIS, V218, P281, DOI 10.1016/j.atherosclerosis.2011.04.010; Frikke-Schmidt R, 2010, ATHEROSCLEROSIS, V208, P305, DOI 10.1016/j.atherosclerosis.2009.06.005; Gavin JR, 1999, DIABETES CARE, V22, pS5; GORDON DJ, 1989, CIRCULATION, V79, P8, DOI 10.1161/01.CIR.79.1.8; Hernandez-Avila M, 1998, SALUD PUBLICA MEXICO, V40, P133, DOI 10.1590/S0036-36341998000200005; Ietta F, 2010, AM J PHYSIOL-ENDOC M, V298, pE411, DOI 10.1152/ajpendo.00522.2009; Kim S, 2011, DIABETES CARE, V34, P504, DOI 10.2337/dc10-1364; KVIST H, 1988, AM J CLIN NUTR, V48, P1351, DOI 10.1093/ajcn/48.6.1351; Li Y, 2012, MOL BIOL REP, V39, P1809, DOI 10.1007/s11033-011-0922-z; LONGO R, 1993, INVEST RADIOL, V28, P297, DOI 10.1097/00004424-199304000-00006; Ma XY, 2011, ATHEROSCLEROSIS, V215, P428, DOI 10.1016/j.atherosclerosis.2011.01.008; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MAUTNER GC, 1994, RADIOLOGY, V192, P619, DOI 10.1148/radiology.192.3.8058924; McKimmie RL, 2008, AM J GASTROENTEROL, V103, P3029, DOI 10.1111/j.1572-0241.2008.02188.x; Medina-Urrutia A, 2008, ATHEROSCLEROSIS, V201, P392, DOI 10.1016/j.atherosclerosis.2008.02.029; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Nofer JR, 2004, J BIOL CHEM, V279, P34032, DOI 10.1074/jbc.M405174200; Oram JF, 2003, ARTERIOSCL THROM VAS, V23, P720, DOI 10.1161/01.ATV.0000054662.44688.9A; Oram JF, 2005, PHYSIOL REV, V85, P1343, DOI 10.1152/physrev.00005.2005; Peloso GM, 2010, J LIPID RES, V51, P3524, DOI 10.1194/jlr.P008268; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Regieli JJ, 2011, ATHEROSCLEROSIS, V218, P457, DOI 10.1016/j.atherosclerosis.2011.07.008; Romero-Hidalgo S, 2012, J NUTR, V142, P278, DOI 10.3945/jn.111.152421; Schmitz G, 2006, PATHOPHYSIOL HAEMO T, V35, P166, DOI 10.1159/000093563; SERFATYLACROSNIERE C, 1994, ATHEROSCLEROSIS, V107, P85, DOI 10.1016/0021-9150(94)90144-9; Srivastava RAK, 2002, MOL CELL BIOCHEM, V240, P67, DOI 10.1023/A:1020604610873; Tang CR, 2009, J BIOL CHEM, V284, P32336, DOI 10.1074/jbc.M109.047472; Versmissen J, 2011, EUR HEART J, V32, P469, DOI 10.1093/eurheartj/ehq208; Villarreal-Molina MT, 2008, DIABETES, V57, P509, DOI 10.2337/db07-0484; Villarreal-Molina MT, 2007, DIABETES, V56, P1881, DOI 10.2337/db06-0905; Voight FJ, 2012, LANCET; Woodard GA, 2011, MENOPAUSE, V18, P376, DOI 10.1097/gme.0b013e3181f6480e; Yvan-Charvet L, 2008, CIRCULATION, V118, P1837, DOI 10.1161/CIRCULATIONAHA.108.793869	46	62	63	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49285	10.1371/journal.pone.0049285	http://dx.doi.org/10.1371/journal.pone.0049285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152888	Green Submitted, Green Published, gold			2022-12-27	WOS:000312272600056
J	Liu, Y; Bi, YH; Gu, JG; Li, LH; Zhou, ZG				Liu, Yu; Bi, YanHui; Gu, JunGang; Li, LiHua; Zhou, ZhiGang			Localization of a Female-Specific Marker on the Chromosomes of the Brown Seaweed Saccharina japonica Using Fluorescence In Situ Hybridization	PLOS ONE			English	Article							ENVIRONMENTAL-CONTROL; LAMINARIA-SACCHARINA; DNA; NUCLEAR; CULTURE; GENOME; FERTILIZATION; GAMETOGENESIS; GAMETOPHYTES; PHAEOPHYTA	Background: There is a heteromorphic alternative life in the brown seaweed, Saccharina japonica (Aresch.) C. E. Lane, C. Mayes et G. W. Saunders (=Laminaria japonica Aresch.), with macroscopic monoecious sporophytes and microscopic diecious gametophytes. Female gametophytes are genetically different from males. It is very difficult to identify the parent of a sporophyte using only routine cytological techniques due to homomorphic chromosomes. A sex-specific marker is one of the best ways to make this determination. Methodology/Principal Findings: To obtain clear images, chromosome preparation was improved using maceration enzymes and fluorochrome 4', 6-diamidino-2-phenylindole (DAPI). The chromosome number of both male and female haploid gametophytes was 31, and there were 62 chromosomes in diploid sporophytes. Although the female chromosomes ranged from 0.77 mu m to 2.61 mu m in size and were larger than the corresponding ones in the males (from 0.57 mu m to 2.16 mu m), there was not a very large X chromosome in the females. Based on the known female-related FRML-494 marker, co-electrophoresis and Southern blot profiles demonstrated that it was inheritable and specific to female gametophytes. Using modified fluorescence in situ hybridization (FISH), this marker could be localized on one unique chromosome of the female gametophytes as well as the sporophytes, whereas no hybridization signal was detected in the male gametophytes. Conclusions/Significance: Our data suggest that this marker was a female chromosome-specific DNA sequence. This is the first report of molecular marker localization on algal chromosomes. This research provides evidence for the benefit of using FISH for identifying molecular markers for sex identification, isolation of specific genes linked to this marker in the females, and sex determination of S. japonica gametophytes in the future.	[Liu, Yu; Bi, YanHui; Gu, JunGang; Li, LiHua; Zhou, ZhiGang] Shanghai Ocean Univ, Coll Aqualife Sci & Technol, Shanghai, Peoples R China	Shanghai Ocean University	Zhou, ZG (corresponding author), Shanghai Ocean Univ, Coll Aqualife Sci & Technol, Shanghai, Peoples R China.	zgzhou@shou.edu.cn	ZHOU, Zhi-Gang/V-9675-2019		National Natural Sciences Foundation of China [30471328, 31201992]; Natural Sciences Foundation of Shanghai [10ZR1413900]; National High Technology Research and Development Program of China [2012AA10A406]; Key Discipline of Shanghai Municipal Education Commission [J50701]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Sciences Foundation of Shanghai(Natural Science Foundation of Shanghai); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Key Discipline of Shanghai Municipal Education Commission	This research was supported by the National Natural Sciences Foundation of China (30471328 and 31201992), the Natural Sciences Foundation of Shanghai (10ZR1413900), the National High Technology Research and Development Program of China (2012AA10A406), and the Key Discipline of Shanghai Municipal Education Commission (J50701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 1939, SCI REP TOHOKU IMP U, V14, P327; Barbier M, 1998, BIOL CELL, V90, P63, DOI 10.1016/S0248-4900(98)80233-5; Bartsch I, 2008, EUR J PHYCOL, V43, P1, DOI 10.1080/09670260701711376; DANN O, 1971, LIEBIGS ANN CHEM, V749, P68; EVANS LV, 1963, NATURE, V198, P215, DOI 10.1038/198215a0; EVANS LV, 1965, ANN BOT-LONDON, V29, P541, DOI 10.1093/oxfordjournals.aob.a083971; FANG TC, 1978, SCI SINICA, V21, P401; FAO, 2011, 2009 FAO YB FISH AQ; GALL JG, 1969, P NATL ACAD SCI USA, V63, P378, DOI 10.1073/pnas.63.2.378; GARMAN GD, 1994, MAR BIOL, V121, P355, DOI 10.1007/BF00346745; GRIFFOR MC, 1991, PLANT MOL BIOL, V17, P101, DOI 10.1007/BF00036810; Heslop-Harrison JS, 2011, PLANT J, V66, P18, DOI 10.1111/j.1365-313X.2011.04544.x; HSIAO SIC, 1973, CAN J BOT, V51, P829, DOI 10.1139/b73-106; HSIAO SIC, 1971, CAN J BOTANY, V49, P1503, DOI 10.1139/b71-211; Hu YJ, 2001, J APPL PHYCOL, V13, P415, DOI 10.1023/A:1011920213639; IMAI I, 1989, MAR BIOL, V103, P235, DOI 10.1007/BF00543353; Jiang JM, 2006, GENOME, V49, P1057, DOI 10.1139/G06-076; Jiang JM, 1996, MOL GEN GENET, V252, P497, DOI 10.1007/BF02172395; JOHN HA, 1969, NATURE, V223, P582, DOI 10.1038/223582a0; Kapraun DF, 2005, ANN BOT-LONDON, V95, P7, DOI 10.1093/aob/mci002; KAPRAUN DF, 1994, J APPL PHYCOL, V6, P7, DOI 10.1007/BF02185897; Kapraun DF, 2007, ANN BOT-LONDON, V99, P677, DOI 10.1093/aob/mcl294; Khrustaleva LI, 2001, PLANT J, V25, P699, DOI 10.1046/j.1365-313X.2001.00995.x; Lavania UC, 1998, CURR SCI INDIA, V74, P126; Le HT, 1989, PLANT MOL BIO REP, V7, P150, DOI DOI 10.1007/BF02669631; Lewis RJ, 1996, PHYCOLOGIA, V35, P19, DOI 10.2216/i0031-8884-35-1-19.1; LEWIS RJ, 1993, J PHYCOL, V29, P363, DOI 10.1111/j.0022-3646.1993.00363.x; Li DP, 1999, HYDROBIOLOGIA, V399, P473, DOI 10.1023/A:1017090130586; LIMADEFARIA A, 1980, HEREDITAS, V93, P1; LIN MS, 1977, CHROMOSOMA, V60, P15, DOI 10.1007/BF00330407; Liu YS, 2009, J PHYCOL, V45, P894, DOI 10.1111/j.1529-8817.2009.00719.x; [陆广琴 LU Guang-qin], 2009, [中国水产科学, Journal of Fishery Sciences of China], V16, P221; MOTOMURA T, 1991, J PHYCOL, V27, P248, DOI 10.1111/j.0022-3646.1991.00248.x; MOTOMURA T, 1990, J PHYCOL, V26, P80, DOI 10.1111/j.0022-3646.1990.00080.x; NOVACZEK I, 1986, BRIT PHYCOL J, V21, P407, DOI 10.1080/00071618600650471; Patwary M.U., 1992, KOREAN J PHYCOL, V7, P281; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943, DOI 10.4319/lo.1980.25.5.0943; Siguan MAR, 2011, CRYPTOGAMIE ALGOL, V32, P205, DOI 10.7872/crya.v32.iss2.2011.205; RICHARD F, 1994, CYTOGENET CELL GENET, V65, P169, DOI 10.1159/000133624; Schreiber E, 1931, PLANTA, V12, P331; SCHWARZACHER T, 1989, ANN BOT-LONDON, V64, P315, DOI 10.1093/oxfordjournals.aob.a087847; Schwarzacher Trude, 2009, V478, P227, DOI 10.1007/978-1-59745-379-0_14; SCHWEIZER D, 1976, CHROMOSOMA, V58, P307, DOI 10.1007/BF00292840; SHEATH RG, 1995, PHYCOLOGIA, V34, P33, DOI 10.2216/i0031-8884-34-1-33.1; Shi XiZhi, 2005, Journal of Fisheries of China, V29, P666; SHIHIRAISHIKAWA I, 1984, PROTOPLASMA, V122, P27, DOI 10.1007/BF01279434; SoyerGobillard MO, 1996, BIOL CELL, V87, P17, DOI 10.1016/S0248-4900(97)89834-6; STARR RC, 1993, J PHYCOL, V29, P1, DOI 10.1111/j.0022-3646.1993.00001.x; Stebbins GL, 1971, CHROMOSAL EVOLUTION; Stephens JL, 2004, GENOME, V47, P179, DOI [10.1139/g03-084, 10.1139/G03-084]; Tai C. H., 1976, ACTA GENET SIN, V3, P32; Tai S.H., 1977, ACTA GENET SIN, V4, P325; TRASK BJ, 1991, AM J HUM GENET, V48, P1; Tseng CK, 2001, J APPL PHYCOL, V13, P375, DOI 10.1023/A:1017972812576; Wang CZ, 2011, NANOSCALE RES LETT, V6, P1, DOI 10.1186/1556-276X-6-579; YABU H, 1973, Bulletin of the Faculty of Fisheries Hokkaido University, V23, P171; YABU H, 1991, Japanese Journal of Phycology, V39, P185; Yabu H, 1964, MEM FAC FISH HOKKAID, V12, P1; YASUI H, 1992, NIPPON SUISAN GAKK, V58, P1385, DOI 10.2331/suisan.58.1385; Zhang Peng, 2009, P365, DOI 10.1007/978-3-540-70581-9_32; Zhou LR, 2004, HYDROBIOLOGIA, V512, P141, DOI 10.1023/B:HYDR.0000020319.36532.eb; Zhou Z.G, 1998, CHIN J BIOTECH, V14, P109, DOI DOI 10.13345/J.CJB.1998.01.020	63	20	26	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 7	2012	7	11							e48784	10.1371/journal.pone.0048784	http://dx.doi.org/10.1371/journal.pone.0048784			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048TK	23166593	gold, Green Published, Green Submitted			2022-12-27	WOS:000311935800131
J	Albrecht, P; Muller, AK; Ringelstein, M; Finis, D; Geerling, G; Cohn, E; Aktas, O; Hartung, HP; Hefter, H; Methner, A				Albrecht, Philipp; Mueller, Ann-Kristin; Ringelstein, Marius; Finis, David; Geerling, Gerd; Cohn, Eva; Aktas, Orhan; Hartung, Hans-Peter; Hefter, Harald; Methner, Axel			Retinal Neurodegeneration in Wilson's Disease Revealed by Spectral Domain Optical Coherence Tomography	PLOS ONE			English	Article							GANGLION-CELL LOSS; EVOKED-POTENTIALS; MULTIPLE-SCLEROSIS; VISUAL PATHWAY; OCT; THICKNESS; SEGMENTATION; PATHOLOGY; NEURITIS; UPDATE	Background/Objective: In addition to cirrhosis of the liver, Wilson's disease leads to copper accumulation and widespread degeneration of the nervous system. Delayed visual evoked potentials (VEPs) suggest changes to the visual system and potential structural changes of the retina. Methods: We used the latest generation of spectral domain optical coherence tomography to assess the retinal morphology of 42 patients with Wilson's disease and 76 age-and sex-matched controls. We measured peripapillary retinal nerve fiber layer (RNFL) thickness and total macular thickness and manually segmented all retinal layers in foveal scans of 42 patients with Wilson's disease and 76 age- and sex-matched controls. The results were compared with VEPs and clinical parameters. Results: The mean thickness of the RNFL, paramacular region, retinal ganglion cell/inner plexiform layer and inner nuclear layer was reduced in Wilson's disease. VEPs were altered with delayed N75 and P100 latencies, but the N140 latency and amplitude was unchanged. An analysis of the laboratory parameters indicated that the serum concentrations of copper and caeruloplasmin positively correlated with the thickness of the outer plexiform layer and with N75 and P100 VEP latencies. Conclusion: Neuronal degeneration in Wilson's disease involves the retina and changes can be quantified by optical coherence tomography. While the VEPs and the thickness of the outer plexiform layer appear to reflect the current copper metabolism, the thicknesses of the RNFL, ganglion cell/inner plexiform layer, inner nuclear layer and the total paramacular thickness may be the best indicators of chronic neuronal degeneration.	[Albrecht, Philipp; Mueller, Ann-Kristin; Ringelstein, Marius; Cohn, Eva; Aktas, Orhan; Hartung, Hans-Peter; Hefter, Harald; Methner, Axel] Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany; [Finis, David; Geerling, Gerd] Univ Dusseldorf, Dept Ophthalmol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Albrecht, P (corresponding author), Univ Dusseldorf, Dept Neurol, Fac Med, Dusseldorf, Germany.	phil.albrecht@gmail.com	Aktas, Orhan/B-7623-2009	Aktas, Orhan/0000-0002-2020-9210; Methner, Axel/0000-0002-8774-0057	Walter-and-Ilse-Rose-Stiftung; Deutsche Forschungsgemeinschaft [Sonderforschungsbereich 974]	Walter-and-Ilse-Rose-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The Department of Neurology, Heinrich-Heine-Universitat Dusseldorf, is supported in part by the Walter-and-Ilse-Rose-Stiftung (for OCT research, to OA and HPH) and in part by the "Deutsche Forschungsgemeinschaft" through Sonderforschungsbereich 974 "Kommunikation und Systemrelevanz bei Leberschadigung und Regeneration" (for research regarding CNS involvement upon liver damage, TP B7, to OA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Albrecht P, 2012, MULT SCLER J, V18, P1422, DOI 10.1177/1352458512439237; Albrecht P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034891; Arendt G, 1994, Electromyogr Clin Neurophysiol, V34, P137; BEARN AG, 1953, AM J MED, V15, P442, DOI 10.1016/0002-9343(53)90134-X; Brandt AU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038741; CUMINGS JN, 1948, BRAIN, V71, P410, DOI 10.1093/brain/71.4.410; Das M, 2007, EUR J NEUROL, V14, P498, DOI 10.1111/j.1468-1331.2006.01676.x; Das SK, 2006, NAT CLIN PRACT NEURO, V2, P482, DOI 10.1038/ncpneuro0291; de Bie P, 2007, J MED GENET, V44, P673, DOI 10.1136/jmg.2007.052746; DINGLE J, 1978, ANN OPHTHALMOL, V10, P1227; Galetta KM, 2011, NEUROTHERAPEUTICS, V8, P117, DOI 10.1007/s13311-010-0005-1; Gelfand JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036847; HEFTER H, 1993, ACTA NEUROL SCAND, V87, P133; Hsu YS, 2003, PEDIATR NEUROL, V29, P42, DOI 10.1016/S0887-8994(03)00026-2; Ilic Tihomir V, 2005, Srp Arh Celok Lek, V133, P331; Jindahra P, 2009, BRAIN, V132, P628, DOI 10.1093/brain/awp001; Klistorner A, 2009, DOC OPHTHALMOL, V118, P129, DOI 10.1007/s10633-008-9147-4; Mehta JS, 2005, AM J OPHTHALMOL, V140, P727, DOI 10.1016/j.ajo.2005.03.059; Mufti AR, 2006, MOL CELL, V21, P775, DOI 10.1016/j.molcel.2006.01.033; Nassif N, 2004, OPT LETT, V29, P480, DOI 10.1364/OL.29.000480; Riordan SM, 2001, J HEPATOL, V34, P165, DOI 10.1016/S0168-8278(00)00028-3; Roberts EA, 2008, HEPATOLOGY, V47, P2089, DOI 10.1002/hep.22261; Saidha S, 2011, BRAIN, V134, P518, DOI 10.1093/brain/awq346; SATISHCHANDRA P, 1989, ACTA NEUROL SCAND, V79, P108, DOI 10.1111/j.1600-0404.1989.tb03720.x; Satishchandra P, 2000, J NEUROL SCI, V176, P13, DOI 10.1016/S0022-510X(00)00280-X; Seigo M.A., 2012, J NEUROL; Singh P, 2011, J PEDIATR NEUROSCI, V6, P27, DOI 10.4103/1817-1745.84402; Sinha S, 2006, NEURORADIOLOGY, V48, P613, DOI 10.1007/s00234-006-0101-4; Song WK, 2010, INVEST OPHTH VIS SCI, V51, P3913, DOI 10.1167/iovs.09-4189; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Topcu M, 2002, BRAIN DEV-JPN, V24, P276, DOI 10.1016/S0387-7604(02)00055-4; Wagner-Schuman M, 2011, INVEST OPHTH VIS SCI, V52, P625, DOI 10.1167/iovs.10-5886; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032; Warner CV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022947; Wexler A, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-13; Yang Q, 2011, BIOMED OPT EXPRESS, V2, P2493, DOI 10.1364/BOE.2.002493	38	36	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49825	10.1371/journal.pone.0049825	http://dx.doi.org/10.1371/journal.pone.0049825			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166778	Green Published, Green Submitted, gold			2022-12-27	WOS:000311885300070
J	Henningsson, L; Eneljung, T; Jirholt, P; Tengvall, S; Lidberg, U; van den Berg, WB; van de Loo, FA; Gjertsson, I				Henningsson, Louise; Eneljung, Tove; Jirholt, Pernilla; Tengvall, Sara; Lidberg, Ulf; van den Berg, Wim B.; van de Loo, Fons A.; Gjertsson, Inger			Disease-Dependent Local IL-10 Production Ameliorates Collagen Induced Arthritis in Mice	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; B-CELLS; INTERLEUKIN-10 TREATMENT; GENE-THERAPY; IN-VIVO; EXPRESSION; DIFFERENTIATION; AUTOIMMUNITY; INFLAMMATION; SUPPRESSION	Rheumatoid arthritis (RA) is a chronic destructive autoimmune disease characterised by periods of flare and remission. Today's treatment is based on continuous immunosuppression irrespective of the patient's inflammatory status. When the disease is in remission the therapy is withdrawn but withdrawal attempts often results in inflammatory flares, and re-start of the therapy is commenced when the inflammation again is prominent which leads both to suffering and increased risk of tissue destruction. An attractive alternative treatment would provide a disease-regulated therapy that offers increased anti-inflammatory effect during flares and is inactive during periods of remission. To explore this concept we expressed the immunoregulatory cytokine interleukin (IL)-10 gene under the control of an inflammation dependent promoter in a mouse model of RA -collagen type II (CII) induced arthritis (CIA). Haematopoetic stem cells (HSCs) were transduced with lentiviral particles encoding the IL-10 gene (LNT-IL-10), or a green fluorescence protein (GFP) as control gene (LNT-GFP), driven by the inflammation-dependent IL-1/IL-6 promoter. Twelve weeks after transplantation of transduced HSCs into DBA/1 mice, CIA was induced. We found that LNT-IL-10 mice developed a reduced severity of arthritis compared to controls. The LNT-IL-10 mice exhibited both increased mRNA expression levels of IL-10 as well as increased amount of IL-10 produced by B cells and non-B APCs locally in the lymph nodes compared to controls. These findings were accompanied by increased mRNA expression of the IL-10 induced suppressor of cytokine signalling 1 (SOCS1) in lymph nodes and a decrease in the serum protein levels of IL-6. We also found a decrease in both frequency and number of B cells and serum levels of anti-CII antibodies. Thus, inflammation-dependent IL-10 therapy suppresses experimental autoimmune arthritis and is a promising candidate in the development of novel treatments for RA.	[Henningsson, Louise; Eneljung, Tove; Jirholt, Pernilla; Tengvall, Sara; Gjertsson, Inger] Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Lidberg, Ulf] Sahlgrens Univ Hosp, Sahlgrenska Ctr Cardiovasc & Metab Res, Wallenberg Lab, Gothenburg, Sweden; [van den Berg, Wim B.; van de Loo, Fons A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	University of Gothenburg; Sahlgrenska University Hospital; Radboud University Nijmegen	Gjertsson, I (corresponding author), Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	inger.gjertsson@rheuma.gu.se	van de Loo, Fons AJ/A-3425-2014; van den Berg, W.B./H-8010-2014	van de Loo, Fons AJ/0000-0002-5851-099X; Tengvall, Sara/0000-0001-6553-1951	Swedish Science Council [K2007-52X-20310-01-4, K2007-52P-20314-01-4]; Goteborgs Lakaresallskap (the Gothenburg Medical society); King Gustav V's 80 year Foundation; Reumatikerforbundet in Goteborg; Almlov's Foundation; Professor Nanna Svartz Foundation; Tholen and Kristler Foundation; IngaBritt and Arne Lundgren Foundation; Swedish Foundation for Strategic Research; EuropeanUnion [LSHM-CT-2005-01863, LSHM-CT-2005-018661]	Swedish Science Council; Goteborgs Lakaresallskap (the Gothenburg Medical society); King Gustav V's 80 year Foundation; Reumatikerforbundet in Goteborg; Almlov's Foundation; Professor Nanna Svartz Foundation; Tholen and Kristler Foundation; IngaBritt and Arne Lundgren Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); EuropeanUnion(European Commission)	This study was supported by grants from the Swedish Science Council (Project No K2007-52X-20310-01-4, K2007-52P-20314-01-4), Goteborgs Lakaresallskap (the Gothenburg Medical society), King Gustav V's 80 year Foundation, Reumatikerforbundet in Goteborg, Almlov's Foundation, Professor Nanna Svartz Foundation, Tholen and Kristler Foundation, IngaBritt and Arne Lundgren Foundation, the Swedish Foundation for Strategic Research, the 6th Framework Program of the EuropeanUnion, NeuroproMiSe, LSHM-CT-2005-01863, AUTOCURE, LSHM-CT-2005-018661. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apparailly F, 1998, J IMMUNOL, V160, P5213; Buch MH, 2011, ANN RHEUM DIS, V70, P909, DOI 10.1136/ard.2010.144998; Diehl S, 2000, IMMUNITY, V13, P805, DOI 10.1016/S1074-7613(00)00078-9; Ding YZ, 2003, J IMMUNOL, V170, P1383, DOI 10.4049/jimmunol.170.3.1383; Egan PJ, 2003, J CLIN INVEST, V111, P915, DOI 10.1172/JCI200316156; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Finnegan A, 2003, ARTHRITIS RES THER, V5, pR18, DOI 10.1186/ar601; Garaulet G, 2012, MOL THERAPY J AM SOC; Geurts J, 2007, GENE THER, V14, P1632, DOI 10.1038/sj.gt.3303022; Hashizume M, 2011, ARTHRITIS, DOI 10.1155/2011/765624; Joosten LAB, 1997, ARTHRITIS RHEUM, V40, P249, DOI 10.1002/art.1780400209; Jorgensen C, 1998, IMMUNOLOGY, V93, P518; KASAMA T, 1995, J CLIN INVEST, V95, P2868, DOI 10.1172/JCI117993; Kimura A, 2005, P NATL ACAD SCI USA, V102, P17089, DOI 10.1073/pnas.0508517102; Kuroda T, 2006, J RHEUMATOL, V33, P455; Luckheeram RV, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/925135; Mathisen PM, 1997, J EXP MED, V186, P159, DOI 10.1084/jem.186.1.159; Mauri C, 2003, J EXP MED, V197, P489, DOI 10.1084/jem.20021293; Mauri C, 2010, CURR OPIN IMMUNOL, V22, P761, DOI 10.1016/j.coi.2010.10.009; Miyata M, 2000, J RHEUMATOL, V27, P1601; Neidhart M, 2005, ARTHRITIS RHEUM-US, V52, P3315, DOI 10.1002/art.21274; Palmer DC, 2009, TRENDS IMMUNOL, V30, P592, DOI 10.1016/j.it.2009.09.009; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Prochazkova J, 2012, IMMUNOBIOLOGY, V217, P74, DOI 10.1016/j.imbio.2011.07.032; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; SHIMIZU S, 1988, BLOOD, V72, P1826; Tarner IH, 2003, ANN NY ACAD SCI, V998, P512, DOI 10.1196/annals.1254.067; tenWolde S, 1996, LANCET, V347, P347, DOI 10.1016/S0140-6736(96)90535-8; van de Loo FAJ, 2004, GENE THER, V11, P581, DOI 10.1038/sj.gt.3302182; Van Roon JAG, 2003, J RHEUMATOL, V30, P648; Veenbergen S, 2011, ANN RHEUM DIS, V70, P2167, DOI 10.1136/ard.2011.154815; Walmsley M, 1996, ARTHRITIS RHEUM-US, V39, P495, DOI 10.1002/art.1780390318; Wright HL, 2011, RHEUMATOLOGY; Yoshimura A, 2011, CURR TOP MICROBIOL, V350, P127, DOI 10.1007/82_2010_87	34	27	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49731	10.1371/journal.pone.0049731	http://dx.doi.org/10.1371/journal.pone.0049731			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166758	Green Published, gold, Green Submitted			2022-12-27	WOS:000311885300065
J	Sinigalia, E; Alvisi, G; Segre, CV; Mercorelli, B; Muratore, G; Winkler, M; Hsiao, HH; Urlaub, H; Ripalti, A; Chiocca, S; Palu, G; Loregian, A				Sinigalia, Elisa; Alvisi, Gualtiero; Segre, Chiara V.; Mercorelli, Beatrice; Muratore, Giulia; Winkler, Michael; Hsiao, He-Hsuan; Urlaub, Henning; Ripalti, Alessandro; Chiocca, Susanna; Palu, Giorgio; Loregian, Arianna			The Human Cytomegalovirus DNA Polymerase Processivity Factor UL44 Is Modified by SUMO in a DNA-Dependent Manner	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; UBIQUITIN-CONJUGATING ENZYME; ACCESSORY PROTEIN UL44; GTPASE-ACTIVATING PROTEIN; YEAST HO GENE; CATALYTIC SUBUNIT; REPLICATION COMPARTMENTS; LOCALIZATION SIGNAL; VIRAL REPLICATION; BINDING-PROTEIN	During the replication of human cytomegalovirus (HCMV) genome, the viral DNA polymerase subunit UL44 plays a key role, as by binding both DNA and the polymerase catalytic subunit it confers processivity to the holoenzyme. However, several lines of evidence suggest that UL44 might have additional roles during virus life cycle. To shed light on this, we searched for cellular partners of UL44 by yeast two-hybrid screenings. Intriguingly, we discovered the interaction of UL44 with Ubc9, an enzyme involved in the covalent conjugation of SUMO (Small Ubiquitin-related MOdifier) to cellular and viral proteins. We found that UL44 can be extensively sumoylated not only in a cell-free system and in transfected cells, but also in HCMV-infected cells, in which about 50% of the protein resulted to be modified at late times post-infection, when viral genome replication is accomplished. Mass spectrometry studies revealed that UL44 possesses multiple SUMO target sites, located throughout the protein. Remarkably, we observed that binding of UL44 to DNA greatly stimulates its sumoylation both in vitro and in vivo. In addition, we showed that overexpression of SUMO alters the intranuclear distribution of UL44 in HCMV-infected cells, and enhances both virus production and DNA replication, arguing for an important role for sumoylation in HCMV life cycle and UL44 function(s). These data report for the first time the sumoylation of a viral processivity factor and show that there is a functional interplay between the HCMV UL44 protein and the cellular sumoylation system.	[Sinigalia, Elisa; Alvisi, Gualtiero; Mercorelli, Beatrice; Muratore, Giulia; Palu, Giorgio; Loregian, Arianna] Univ Padua, Dept Mol Med, Padua, Italy; [Alvisi, Gualtiero] Univ Bologna, Dept Hematol & Med Oncol Seragnoli, Bologna, Italy; [Alvisi, Gualtiero] Univ Heidelberg, Dept Infect Dis, Heidelberg, Germany; [Segre, Chiara V.; Chiocca, Susanna] European Inst Oncol, Milan, Italy; [Winkler, Michael] Leibniz Inst Primatenforsch, Gottingen, Germany; [Hsiao, He-Hsuan; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr, Dept Clin Chem, Gottingen, Germany; [Ripalti, Alessandro] Azienda Osped Univ Bologna, Policlin S Orsola Malpighi, Bologna, Italy	University of Padua; University of Bologna; Ruprecht Karls University Heidelberg; IRCCS European Institute of Oncology (IEO); Max Planck Society; University of Gottingen; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Palu, G (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.	giorgio.palu@unipd.it; arianna.loregian@unipd.it	Chiocca, Susanna/K-5233-2016; Mercorelli, Beatrice/ABE-5652-2021; Chiocca, Susanna/AAC-8863-2019	Chiocca, Susanna/0000-0002-9721-0850; Winkler, Michael/0000-0002-6198-554X; LOREGIAN, ARIANNA/0000-0002-8900-861X; Alvisi, Gualtiero/0000-0002-8177-3616; MERCORELLI, BEATRICE/0000-0003-0654-8045	MURST; Progetto di Ricerca di Ateneo [CPDA074945]; PRIN [20085FF4J4]; Regione Veneto and Progetto Strategico di Ateneo; Associazione Italiana Ricerca sul Cancro; Fondazione Umberto Veronesi; Italian Ministry of Health	MURST(Ministry of Education, Universities and Research (MIUR)); Progetto di Ricerca di Ateneo; PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Regione Veneto and Progetto Strategico di Ateneo; Associazione Italiana Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by MURST EX60%, Progetto di Ricerca di Ateneo 2007 (grant n. CPDA074945), and PRIN 2008 (grant n. 20085FF4J4) to AL, by Regione Veneto and Progetto Strategico di Ateneo 2008 to GP, by Associazione Italiana Ricerca sul Cancro and Italian Ministry of Health to SC, and by Fondazione Umberto Veronesi to CVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AL, 2005, BIOCHEM BIOPH RES CO, V336, P22, DOI 10.1016/j.bbrc.2005.08.036; Ahn JH, 2000, VIROLOGY, V274, P39, DOI 10.1006/viro.2000.0448; Ahn JH, 1999, J VIROL, V73, P10458, DOI 10.1128/JVI.73.12.10458-10471.1999; Ahn JH, 2001, J VIROL, V75, P3859, DOI 10.1128/JVI.75.8.3859-3872.2001; ALBRECHT T, 1980, LAB INVEST, V42, P1; Alvisi G, 2005, TRAFFIC, V6, P1002, DOI 10.1111/j.1600-0854.2005.00331.x; Alvisi G, 2006, TRAFFIC, V7, P1322, DOI 10.1111/j.1600-0854.2006.00477.x; Alvisi G, 2006, BIOCHEMISTRY-US, V45, P6866, DOI 10.1021/bi060086u; Alvisi G, 2011, VIROLOGY, V417, P259, DOI 10.1016/j.virol.2011.06.015; Alvisi G, 2009, J VIROL, V83, P9567, DOI 10.1128/JVI.00669-09; Alvisi G, 2008, BIOCHEMISTRY-US, V47, P13764, DOI 10.1021/bi800869y; Appleton BA, 2006, J BIOL CHEM, V281, P5224, DOI 10.1074/jbc.M506900200; Appleton BA, 2004, MOL CELL, V15, P233, DOI 10.1016/j.molcel.2004.06.018; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; BREEDEN L, 1985, COLD SPRING HARB SYM, V50, P643, DOI 10.1101/SQB.1985.050.01.078; Camozzi D, 2008, J GEN VIROL, V89, P731, DOI 10.1099/vir.0.83377-0; Da Silva M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005479; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; ERTL PF, 1992, J VIROL, V66, P4126, DOI 10.1128/JVI.66.7.4126-4133.1992; Fan Z, 2006, J MED VIROL, V78, P1365, DOI 10.1002/jmv.20707; Fortunato EA, 1998, J VIROL, V72, P2033, DOI 10.1128/JVI.72.3.2033-2039.1998; Fulcher AJ, 2010, FASEB J, V24, P1454, DOI 10.1096/fj.09-136564; GEBALLE AP, 1986, J VIROL, V57, P864, DOI 10.1128/JVI.57.3.864-874.1986; GIBSON W, 1981, VIROLOGY, V111, P251, DOI 10.1016/0042-6822(81)90669-3; Gostissa M, 1999, EMBO J, V18, P6462, DOI 10.1093/emboj/18.22.6462; Hamirally S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000275; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hsiao HH, 2009, MOL CELL PROTEOMICS, V8, P2664, DOI 10.1074/mcp.M900087-MCP200; Isomura H, 2008, J VIROL, V82, P1638, DOI 10.1128/JVI.01917-07; Isomura H, 2007, J VIROL, V81, P6197, DOI 10.1128/JVI.00089-07; Jeruzalmi D, 2002, CURR OPIN STRUC BIOL, V12, P217, DOI 10.1016/S0959-440X(02)00313-5; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Kamitani T, 1998, J BIOL CHEM, V273, P11349, DOI 10.1074/jbc.273.18.11349; Komazin-Meredith G, 2008, STRUCTURE, V16, P1214, DOI 10.1016/j.str.2008.05.008; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; Lee GW, 1998, J BIOL CHEM, V273, P6503, DOI 10.1074/jbc.273.11.6503; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Loregian A, 2006, CHEM BIOL, V13, P191, DOI 10.1016/j.chembiol.2005.12.002; Loregian A, 2004, J VIROL, V78, P9084, DOI 10.1128/JVI.78.17.9084-9092.2004; Loregian A, 2004, J VIROL, V78, P158, DOI 10.1128/JVI.78.1.158-167.2004; Loregian A, 2007, NUCLEIC ACIDS RES, V35, P4779, DOI 10.1093/nar/gkm506; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Marschall M, 2003, VIROLOGY, V311, P60, DOI 10.1016/S0042-6822(03)00147-8; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Mengoli C, 2004, J MED VIROL, V74, P78, DOI 10.1002/jmv.20149; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257; Muratore G, 2012, P NATL ACAD SCI USA, V109, P6247, DOI 10.1073/pnas.1119817109; Naryzhny SN, 2004, J BIOL CHEM, V279, P20194, DOI 10.1074/jbc.M312850200; Panza Emanuele, 2008, Pathogenetics, V1, P5, DOI 10.1186/1755-8417-1-5; Parker JL, 2008, EMBO J, V27, P2422, DOI 10.1038/emboj.2008.162; Penfold MET, 1997, VIROLOGY, V239, P46, DOI 10.1006/viro.1997.8848; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Rodriguez MS, 1999, EMBO J, V18, P6455, DOI 10.1093/emboj/18.22.6455; Rose MD., 1990, METHODS YEAST GENETI; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Silva LA, 2010, J VIROL, V84, P11563, DOI 10.1128/JVI.01033-10; Sinigalia E, 2008, J VIROL, V82, P12574, DOI 10.1128/JVI.01193-08; STINSKI MF, 1978, J VIROL, V26, P686, DOI 10.1128/JVI.26.3.686-701.1978; Strang BL, 2009, J VIROL, V83, P7581, DOI 10.1128/JVI.00663-09; Swift S, 2001, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1017cs31; Tseng CH, 2010, J VIROL, V84, P918, DOI 10.1128/JVI.01034-09; Uchimura Y, 2004, ANAL BIOCHEM, V331, P204, DOI 10.1016/j.ab.2004.04.034; Wang SC, 2006, NAT CELL BIOL, V8, P1359, DOI 10.1038/ncb1501; WEILAND KL, 1994, VIRUS RES, V34, P191, DOI 10.1016/0168-1702(94)90124-4; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Xu YX, 2001, J VIROL, V75, P10683, DOI 10.1128/JVI.75.22.10683-10695.2001; Xu YY, 2002, J VIROL, V76, P8931, DOI 10.1128/JVI.76.17.8931-8938.2002	74	29	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49630	10.1371/journal.pone.0049630	http://dx.doi.org/10.1371/journal.pone.0049630			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166733	Green Published, gold			2022-12-27	WOS:000311272300059
J	Tarabichi, M; Detours, V; Konopka, T				Tarabichi, Maxime; Detours, Vincent; Konopka, Tomasz			Piecewise Polynomial Representations of Genomic Tracks	PLOS ONE			English	Article							ARRAY CGH DATA; MODELS; SEGMENTATION	Genomic data from micro-array and sequencing projects consist of associations of measured values to chromosomal coordinates. These associations can be thought of as functions in one dimension and can thus be stored, analyzed, and interpreted as piecewise-polynomial curves. We present a general framework for building piecewise polynomial representations of genome-scale signals and illustrate some of its applications via examples. We show that piecewise constant segmentation, a typical step in copy-number analyses, can be carried out within this framework for both array and (DNA) sequencing data offering advantages over existing methods in each case. Higher-order polynomial curves can be used, for example, to detect trends and/or discontinuities in transcription levels from RNA-seq data. We give a concrete application of piecewise linear functions to diagnose and quantify alignment quality at exon borders (splice sites). Our software (source and object code) for building piecewise polynomial models is available at http://sourceforge.net/projects/locsmoc/.	[Tarabichi, Maxime; Detours, Vincent; Konopka, Tomasz] Univ Libre Bruxelles, IRIBHM, Brussels, Belgium	Universite Libre de Bruxelles	Detours, V (corresponding author), Univ Libre Bruxelles, IRIBHM, Brussels, Belgium.	vdetours@ulb.ac.be	Tarabichi, Maxime/ABA-9246-2020	Tarabichi, Maxime/0000-0002-1635-2348; Konopka, Tomasz/0000-0003-3042-4712	F.R.I.A. of the Belgian Fonds de la Recherche Scientifique (FNRS)	F.R.I.A. of the Belgian Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	MT is supported by funding from F.R.I.A. of the Belgian Fonds de la Recherche Scientifique (FNRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bar-Joseph Z, 2003, J COMPUT BIOL, V10, P341, DOI 10.1089/10665270360688057; Dreszer TR, 2012, NUCLEIC ACIDS RES, V40, pD918, DOI 10.1093/nar/gkr1055; Fridlyand J, 2004, J MULTIVARIATE ANAL, V90, P132, DOI 10.1016/j.jmva.2004.02.008; Hansen MH, 2002, STAT SCI, V17, P2, DOI 10.1214/ss/1023798997; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Konopka T, 2011, BIOINFORMATICS, V27, P961, DOI 10.1093/bioinformatics/btr069; Kozanitis C, 2011, J COMPUT BIOL, V18, P401, DOI 10.1089/cmb.2010.0253; Lai WR, 2005, BIOINFORMATICS, V21, P3763, DOI 10.1093/bioinformatics/bti611; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee H, 2012, BIOINFORMATICS ADV A; Magi A, 2012, BIOINFORMATICS, V28, P470, DOI 10.1093/bioinformatics/btr707; Muggeo VMR, 2003, STAT MED, V22, P3055, DOI 10.1002/sim.1545; Picard F, 2011, BIOSTATISTICS, V12, P413, DOI 10.1093/biostatistics/kxq076; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Wallstrom G, 2008, J STAT SOFTWARE, V26; Wan R, 2012, BIOINFORMATICS, V28, P628, DOI 10.1093/bioinformatics/btr689; Willenbrock H, 2005, BIOINFORMATICS, V21, P4084, DOI 10.1093/bioinformatics/bti677; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109; Zheng W, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-290	22	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48941	10.1371/journal.pone.0048941	http://dx.doi.org/10.1371/journal.pone.0048941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166601	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300020
J	Zhang, Z; Liu, J; Li, M; Yang, H; Zhang, CY				Zhang, Zhao; Liu, Jun; Li, Meng; Yang, Hui; Zhang, Chiyu			Evolutionary Dynamics of the Interferon-Induced Transmembrane Gene Family in Vertebrates	PLOS ONE			English	Article							NONHUMAN PRIMATE MODEL; MARMOSETS CALLITHRIX-JACCHUS; RESTRICTION FACTOR SAMHD1; VIRUS-B INFECTION; WEST NILE VIRUS; IMMUNODEFICIENCY-VIRUS; PROCESSED PSEUDOGENES; EXPRESSION; IFITM3; PROTEINS	Vertebrate interferon-induced transmembrane (IFITM) genes have been demonstrated to have extensive and diverse functions, playing important roles in the evolution of vertebrates. Despite observance of their functionality, the evolutionary dynamics of this gene family are complex and currently unknown. Here, we performed detailed evolutionary analyses to unravel the evolutionary history of the vertebrate IFITM family. A total of 174 IFITM orthologous genes and 112 pseudogenes were identified from 27 vertebrate genome sequences. The vertebrate IFITM family can be divided into immunity-related IFITM (IR-IFITM), IFITM5 and IFITM10 sub-families in phylogeny, implying origins from three different progenitors. In general, vertebrate IFITM genes are located in two loci, one containing the IFITM10 gene, and the other locus containing IFITM5 and various numbers of IR-IFITM genes. Conservation of evolutionary synteny was observed in these IFITM genes. Significant functional divergence was detected among the three IFITM sub-families. No gene duplication or positive selection was found in IFITM5 sub-family, implying the functional conservation of IFITM5 in vertebrate evolution, which is involved in bone formation. No IFITM5 locus was identified in the marmoset genome, suggesting a potential association with the tiny size of this monkey. The IFITM10 sub-family was divided into two groups: aquatic and terrestrial types. Functional divergence was detected between the two groups, and five IFITM10-like genes from frog were dispersed into the two groups. Both gene duplication and positive selection were observed in aquatic vertebrate IFITM10-like genes, indicating that IFITM10 might be associated with the adaptation to aquatic environments. A large number of lineage-and species-specific gene duplications were observed in IR-IFITM sub-family and positive selection was detected in IR-IFITM of primates and rodents. Because primates have experienced a long history of viral infection, such rapid expansion and positive selection suggests that the evolution of primate IR-IFITM genes is associated with broad-spectrum antiviral activity.	[Zhang, Zhao; Yang, Hui] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Zhang, Zhao; Liu, Jun; Li, Meng; Zhang, Chiyu] Jiangsu Univ, Inst Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Zhao; Zhang, Chiyu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Pasteur Shanghai, Diagnost Ctr Pathogens, Shanghai, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Jiangsu University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP)	Yang, H (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China.	yanghui@mail.kiz.ac.cn; zhangcy1999@hotmail.com		Zhang, Chiyu/0000-0001-8735-9857; zhang, zhao/0000-0002-3757-8469	State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, CAS [GREKF10-08]; "Top-notch personnel" Project of Jiangsu University; National Natural Science Foundation of China [30900793, 81071391]; Natural Science Foundation of Jiangsu Province, China [BK2011474]; National Key Science & Technology Special Projects on Major Infectious Diseases [2012ZX10004-211]	State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, CAS; "Top-notch personnel" Project of Jiangsu University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); National Key Science & Technology Special Projects on Major Infectious Diseases	This work was supported by the Open Project of State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, CAS (GREKF10-08), the "Top-notch personnel" Project of Jiangsu University to CZ, and a grant from National Natural Science Foundation of China (No. 30900793) to HY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank three anonymous reviewers for their valuable comments and also Zhen Liu, Zhiqiang Ye, Dongming Xu and all members in the Laboratory of Evolutionary & Functional Genomics, Kunming Institute of Zoology, CAS for helpful discussions about this study. This work was supported by the Open Project of the State Key Laboratory of Genetic Resources and Evolution, Kunming Institute of Zoology, CAS (GREKF10-08), the National Natural Science Foundation of China (81071391, 30900793), the Natural Science Foundation of Jiangsu Province, China (BK2011474), and in part by the National Key Science & Technology Special Projects on Major Infectious Diseases (2012ZX10004-211).	Adams AP, 2008, J VIROL, V82, P9035, DOI 10.1128/JVI.00674-08; Ai HX, 2011, VET IMMUNOL IMMUNOP, V140, P329, DOI 10.1016/j.vetimm.2011.01.012; Almen MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031961; Andersson M, 2011, VET IMMUNOL IMMUNOP, V142, P72, DOI 10.1016/j.vetimm.2011.04.012; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Carrion R, 2007, J VIROL, V81, P6482, DOI 10.1128/JVI.02876-06; Carrion R, 2011, VIROLOGY, V420, P117, DOI 10.1016/j.virol.2011.08.022; CHEN YX, 1984, J IMMUNOL, V133, P2496; Crostarosa F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008060; Daniel-Carmi V, 2009, INT J CANCER, V125, P2810, DOI 10.1002/ijc.24669; Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337; Force A, 1999, GENETICS, V151, P1531; Gu X, 2002, NAT GENET, V31, P205, DOI 10.1038/ng902; Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta RK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000443; Han JH, 2011, ONCOL REP, V25, P531, DOI 10.3892/or.2010.1092; Hanagata N, 2007, J BIOMED MATER RES A, V83A, P362, DOI 10.1002/jbm.a.31240; Hanagata N, 2011, BIOCHEM BIOPH RES CO, V409, P378, DOI 10.1016/j.bbrc.2011.04.136; Hanagata N, 2011, J BONE MINER METAB, V29, P279, DOI 10.1007/s00774-010-0221-0; Hickford D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-155; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huthoff H, 2008, TRENDS MICROBIOL, V16, P612, DOI 10.1016/j.tim.2008.08.013; Jacob JR, 2004, J GEN VIROL, V85, P2525, DOI 10.1099/vir.0.80036-0; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Kramski M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010412; Kyuregyan KK, 2005, VIRUS RES, V114, P154, DOI 10.1016/j.virusres.2005.06.009; Laguette N, 2012, CELL HOST MICROBE, V11, P205, DOI 10.1016/j.chom.2012.01.007; Li DW, 2011, CLIN CANCER RES, V17, P3558, DOI 10.1158/1078-0432.CCR-10-2729; Lim ES, 2012, CELL HOST MICROBE, V11, P194, DOI 10.1016/j.chom.2012.01.004; Liu J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011904; Lu J, 2011, J VIROL, V85, P2126, DOI 10.1128/JVI.01531-10; Matz-Rensing K, 2012, J COMP PATHOL, V146, P230, DOI 10.1016/j.jcpa.2011.06.003; Martensen PM, 2004, J INTERF CYTOK RES, V24, P1, DOI 10.1089/107999004772719864; McNatt MW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000300; Miyoshi-Akiyama T, 2011, J INFECT DIS, V203, P1574, DOI 10.1093/infdis/jir084; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nei M, 1997, P NATL ACAD SCI USA, V94, P7799, DOI 10.1073/pnas.94.15.7799; Omatsu T, 2011, J GEN VIROL, V92, P2272, DOI 10.1099/vir.0.031229-0; Piontkivska H, 2003, MOL BIOL EVOL, V20, P601, DOI 10.1093/molbev/msg064; Pond SLK, 2011, MOL BIOL EVOL, V28, P3033, DOI 10.1093/molbev/msr125; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Saika S, 2002, J MED VIROL, V66, P115, DOI 10.1002/jmv.2119; Sakai H, 2007, GENE, V389, P196, DOI 10.1016/j.gene.2006.11.007; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Sawyer SL, 2004, PLOS BIOL, V2, P1278, DOI 10.1371/journal.pbio.0020275; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shi LY, 2008, ARCH VIROL, V153, P1715, DOI 10.1007/s00705-008-0184-9; Shi P, 2003, MOL BIOL EVOL, V20, P805, DOI 10.1093/molbev/msg083; Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112; Sreenivasa BP, 2006, VET RES COMMUN, V30, P103, DOI 10.1007/s11259-005-3200-5; Sun W, 2006, J INFECT DIS, V193, P1658, DOI 10.1086/503372; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanaka SS, 2004, DEV DYNAM, V230, P651, DOI 10.1002/dvdy.20085; Trott KA, 2011, J VIROL, V85, P11655, DOI 10.1128/JVI.05644-11; Weatherford T, 2009, J VIROL, V83, P5806, DOI 10.1128/JVI.00033-09; Weidner JM, 2010, J VIROL, V84, P12646, DOI 10.1128/JVI.01328-10; Wilgenbusch J.C., 2003, CURR PROTOC BIOINFOR, DOI 10.1002/0471250953.bi0604s00; Wong SK, 2009, J VIROL, V83, P8771, DOI 10.1128/JVI.00112-09; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yao L, 2011, J VIRAL HEPATITIS, V18, pE523, DOI 10.1111/j.1365-2893.2011.01452.x; Yount JS, 2010, NAT CHEM BIOL, V6, P610, DOI [10.1038/NCHEMBIO.405, 10.1038/nchembio.405]; Yue YJ, 2008, ADV VIRUS RES, V72, P207, DOI 10.1016/S0065-3527(08)00405-3; Zapata JC, 2011, ANTIVIR RES, V92, P125, DOI 10.1016/j.antiviral.2011.07.015; Zhang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037477; Zhang JZ, 2004, HUM MOL GENET, V13, P1785, DOI 10.1093/hmg/ddh183; Zhang Y, 2011, LAB INVEST, V91, P1337, DOI 10.1038/labinvest.2011.82; Zhang ZL, 2003, GENOME RES, V13, P2541, DOI 10.1101/gr.1429003	71	57	62	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49265	10.1371/journal.pone.0049265	http://dx.doi.org/10.1371/journal.pone.0049265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166625	Green Submitted, gold, Green Published			2022-12-27	WOS:000311272300036
J	Balestrieri, E; Arpino, C; Matteucci, C; Sorrentino, R; Pica, F; Alessandrelli, R; Coniglio, A; Curatolo, P; Rezza, G; Macciardi, F; Garaci, E; Gaudi, S; Sinibaldi-Vallebona, P				Balestrieri, Emanuela; Arpino, Carla; Matteucci, Claudia; Sorrentino, Roberta; Pica, Francesca; Alessandrelli, Riccardo; Coniglio, Antonella; Curatolo, Paolo; Rezza, Giovanni; Macciardi, Fabio; Garaci, Enrico; Gaudi, Simona; Sinibaldi-Vallebona, Paola			HERVs Expression in Autism Spectrum Disorders	PLOS ONE			English	Article							LYMPHOBLASTOID CELL-LINES; ENDOGENOUS RETROVIRUS EXPRESSION; HUMAN TISSUES; ASSOCIATION; GENOME; RETROTRANSPOSITION; IDENTIFICATION; SCHIZOPHRENIA; POLYMORPHISMS; ACTIVATION	Background: Autistic Spectrum Disorder (ASD) is a heterogeneous neurodevelopmental disorder, resulting from complex interactions among genetic, genomic and environmental factors. Here we have studied the expression of Human Endogenous Retroviruses (HERVs), non-coding DNA elements with potential regulatory functions, and have tested their possible implication in autism. Methods: The presence of retroviral mRNAs from four HERV families (E, H, K and W), widely implicated in complex diseases, was evaluated in peripheral blood mononuclear cells (PBMCs) from ASD patients and healthy controls (HCs) by qualitative RT-PCR. We also analyzed the expression of the env sequence from HERV-H, HERV-W and HERV-K families in PBMCs at the time of sampling and after stimulation in culture, in both ASD and HC groups, by quantitative Real-time PCR. Differences between groups were evaluated using statistical methods. Results: The percentage of HERV-H and HERV-W positive samples was higher among ASD patients compared to HCs, while HERV-K was similarly represented and HERV-E virtually absent in both groups. The quantitative evaluation shows that HERV-H and HERV-W are differentially expressed in the two groups, with HERV-H being more abundantly expressed and, conversely, HERV-W, having lower abundance, in PBMCs from ASDs compared to healthy controls. PMBCs from ASDs also showed an increased potential to up-regulate HERV-H expression upon stimulation in culture, unlike HCs. Furthermore we report a negative correlation between expression levels of HERV-H and age among ASD patients and a statistically significant higher expression in ASD patients with Severe score in Communication and Motor Psychoeducational Profile-3. Conclusions: Specific HERV families have a distinctive expression profile in ASD patients compared to HCs. We propose that HERV-H expression be explored in larger samples of individuals with autism spectrum in order to determine its utility as a novel biological trait of this complex disorder.	[Balestrieri, Emanuela; Matteucci, Claudia; Sorrentino, Roberta; Pica, Francesca; Garaci, Enrico; Sinibaldi-Vallebona, Paola] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy	University of Rome Tor Vergata	Balestrieri, E (corresponding author), Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00173 Rome, Italy.	Sinibaldi-Vallebona@med.uniroma2.it	rezza, giovanni/D-4393-2016; GARACI, ENRICO/AAB-3349-2021; PICA, FRANCESCA/HHY-9400-2022; Macciardi, Fabio/N-3768-2014	rezza, giovanni/0000-0003-0268-6790; PICA, FRANCESCA/0000-0002-7899-889X; Macciardi, Fabio/0000-0003-0537-4266; balestrieri, emanuela/0000-0001-5906-5907; SINIBALDI VALLEBONA, PAOLA/0000-0002-8186-9861; Gaudi, Simona/0000-0001-6079-6942; MATTEUCCI, CLAUDIA/0000-0002-6058-1092				Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Aldinger KA, 2011, NEURON, V72; Anagnostou E, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-4; Baillie JK, 2011, NATURE, V479, P534, DOI 10.1038/nature10531; Balada E, 2009, REV MED VIROL, V19, P273, DOI 10.1002/rmv.622; Bannert N, 2006, ANNU REV GENOM HUM G, V7, P149, DOI 10.1146/annurev.genom.7.080505.115700; Baron CA, 2006, J AUTISM DEV DISORD, V36, P973, DOI 10.1007/s10803-006-0134-x; Beaudet AL, 2007, NAT MED, V13, P534, DOI 10.1038/nm0507-534; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Benvenuto A, 2009, WORLD J PEDIATR, V5, P169, DOI 10.1007/s12519-009-0033-2; Bill BR, 2009, CURR OPIN GENET DEV, V19, P271, DOI 10.1016/j.gde.2009.04.004; Boeke J. D., 1997, P343; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; Diamond Adele, ANNU REV PSYCHOL, V64, P135, DOI [DOI 10.1146/annurev-clinpsy-032813-153724, 10.1146/annurev-psych-113011-143750, DOI 10.1146/ANNUREV-PSYCH-113011-143750]; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Forsman A, 2005, J VIROL METHODS, V129, P16, DOI 10.1016/j.jviromet.2005.04.016; Frank O, 2005, J VIROL, V79, P10890, DOI 10.1128/JVI.79.17.10890-10901.2005; Gunther T, 2011, OMICS, V15, P507, DOI 10.1089/omi.2010.0154; Hu VW, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-118; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Johnston JB, 2001, ANN NEUROL, V50, P434, DOI 10.1002/ana.1131; JORDE LB, 1991, AM J HUM GENET, V49, P932; Kurth R, 2010, INT J CANCER, V126, P306, DOI 10.1002/ijc.24902; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LaSalle JM, 2011, EPIGENETICS-US, V6, P862, DOI 10.4161/epi.6.7.16353; Li J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002692; Lupski JR, 2011, CELL, V147, P32, DOI 10.1016/j.cell.2011.09.008; Marguerat S, 2004, DIABETES, V53, P852, DOI 10.2337/diabetes.53.3.852; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nishimura Y, 2007, HUM MOL GENET, V16, P1682, DOI 10.1093/hmg/ddm116; Perron H, 2010, CLIN REV ALLERG IMMU, V39, P51, DOI 10.1007/s12016-009-8170-x; Rowe HM, 2011, VIROLOGY, V411, P273, DOI 10.1016/j.virol.2010.12.007; Ryan FP, 2009, J ROY SOC MED, V102, P474, DOI 10.1258/jrsm.2009.090289; Salyakina D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026049; Schanen NC, 2006, HUM MOL GENET, V15, pR138, DOI 10.1093/hmg/ddl213; Seifarth W, 2005, J VIROL, V79, P341, DOI 10.1128/JVI.79.1.341-352.2005; Serafino A, 2009, EXP CELL RES, V315, P849, DOI 10.1016/j.yexcr.2008.12.023; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Weis S, 2007, J NEURAL TRANSM, V114, P261, DOI 10.1007/s00702-006-0544-0; Yao Y, 2008, GENES BRAIN BEHAV, V7, P103, DOI 10.1111/j.1601-183X.2007.00334.x; Yi JM, 2006, CANCER LETT, V231, P228, DOI 10.1016/j.canlet.2005.02.001	43	49	48	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48831	10.1371/journal.pone.0048831	http://dx.doi.org/10.1371/journal.pone.0048831			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155411	Green Published, gold			2022-12-27	WOS:000311151900045
J	Bosco, G; Delle Monache, S; Lacquaniti, F				Bosco, Gianfranco; Delle Monache, Sergio; Lacquaniti, Francesco			Catching What We Can't See: Manual Interception of Occluded Fly-Ball Trajectories	PLOS ONE			English	Article							HITTING MOVING TARGETS; ACCELERATION CANCELLATION THEORY; VISUAL GRAVITATIONAL MOTION; INTERNAL-MODEL; PARIETAL CORTEX; TIME-COURSE; INFORMATION; HAND; MOVEMENT; VELOCITY	Control of interceptive actions may involve fine interplay between feedback-based and predictive mechanisms. These processes rely heavily on target motion information available when the target is visible. However, short-term visual memory signals as well as implicit knowledge about the environment may also contribute to elaborate a predictive representation of the target trajectory, especially when visual feedback is partially unavailable because other objects occlude the visual target. To determine how different processes and information sources are integrated in the control of the interceptive action, we manipulated a computer-generated visual environment representing a baseball game. Twenty-four subjects intercepted fly-ball trajectories by moving a mouse cursor and by indicating the interception with a button press. In two separate sessions, fly-ball trajectories were either fully visible or occluded for 750, 1000 or 1250 ms before ball landing. Natural ball motion was perturbed during the descending trajectory with effects of either weightlessness (0 g) or increased gravity (2 g) at times such that, for occluded trajectories, 500 ms of perturbed motion were visible before ball disappearance. To examine the contribution of previous visual experience with the perturbed trajectories to the interception of invisible targets, the order of visible and occluded sessions was permuted among subjects. Under these experimental conditions, we showed that, with fully visible targets, subjects combined servo-control and predictive strategies. Instead, when intercepting occluded targets, subjects relied mostly on predictive mechanisms based, however, on different type of information depending on previous visual experience. In fact, subjects without prior experience of the perturbed trajectories showed interceptive errors consistent with predictive estimates of the ball trajectory based on a-priori knowledge of gravity. Conversely, the interceptive responses of subjects previously exposed to fully visible trajectories were compatible with the fact that implicit knowledge of the perturbed motion was also taken into account for the extrapolation of occluded trajectories.	[Bosco, Gianfranco; Delle Monache, Sergio; Lacquaniti, Francesco] Univ Roma Tor Vergata, Dept Syst Med, Neurosci Sect, Rome, Italy	University of Rome Tor Vergata	Bosco, G (corresponding author), Univ Roma Tor Vergata, Dept Syst Med, Neurosci Sect, Rome, Italy.	bosco@med.uniroma2.it	Bosco, Gianfranco/AAA-1548-2019; Monache, Sergio Delle/M-7444-2019; Lacquaniti, Francesco/J-9842-2016	Bosco, Gianfranco/0000-0002-7080-0674; Monache, Sergio Delle/0000-0002-4210-2545; Lacquaniti, Francesco/0000-0003-0896-7315				ASSAD JA, 1995, NATURE, V373, P518, DOI 10.1038/373518a0; Barborica A, 2003, NAT NEUROSCI, V6, P66, DOI 10.1038/nn990; Battelli L, 2007, TRENDS COGN SCI, V11, P204, DOI 10.1016/j.tics.2007.03.001; Battellil L, 2008, CURR OPIN NEUROBIOL, V18, P120, DOI 10.1016/j.conb.2008.08.004; Baures R, 2007, VISION RES, V47, P2982, DOI 10.1016/j.visres.2007.07.024; Baures R, 2011, PERCEPTION, V40, P674, DOI 10.1068/p6945; Beek PJ, 2003, PHILOS T R SOC B, V358, P1511, DOI 10.1098/rstb.2003.1343; Beudel M, 2009, NEUROIMAGE, V44, P1032, DOI 10.1016/j.neuroimage.2008.09.028; Bootsma RJ, 1997, J EXP PSYCHOL HUMAN, V23, P1282; Bosco G, 2008, J NEUROSCI, V28, P12071, DOI 10.1523/JNEUROSCI.2869-08.2008; BRANCAZIO PJ, 1985, AM J PHYS, V53, P849, DOI 10.1119/1.14350; Brenner E, 1998, EXP BRAIN RES, V122, P467, DOI 10.1007/s002210050535; Brouwer AM, 2000, EXP BRAIN RES, V133, P242, DOI 10.1007/s002210000371; Brouwer AM, 2006, VISION RES, V46, P382, DOI 10.1016/j.visres.2005.09.002; Brouwer AM, 2003, EXP BRAIN RES, V152, P368, DOI 10.1007/s00221-003-1556-8; Brouwer AM, 2002, EXP BRAIN RES, V143, P198, DOI 10.1007/s00221-001-0980-x; Brouwer AM, 2002, PERCEPT PSYCHOPHYS, V64, P1160, DOI 10.3758/BF03194764; Campana G, 2002, CEREB CORTEX, V12, P663, DOI 10.1093/cercor/12.6.663; Campana G, 2008, NEUROPSYCHOLOGIA, V46, P393, DOI 10.1016/j.neuropsychologia.2007.07.019; Carnahan H, 1996, ACTA PSYCHOL, V92, P17, DOI 10.1016/0001-6918(95)00006-2; Carrozzo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015638; Cerminara NL, 2009, J PHYSIOL-LONDON, V587, P429, DOI 10.1113/jphysiol.2008.163337; CHAPMAN S, 1968, AM J PHYS, V36, P868, DOI 10.1119/1.1974297; de Hemptinne C, 2010, EXP BRAIN RES, V207, P173, DOI 10.1007/s00221-010-2437-6; de Lussanet MHE, 2004, EXP BRAIN RES, V157, P181, DOI 10.1007/s00221-004-1832-2; de Lussanet MHE, 2002, BEHAV BRAIN RES, V129, P51, DOI 10.1016/S0166-4328(01)00320-5; de Lussanet MHE, 2001, EXP BRAIN RES, V137, P246, DOI 10.1007/s002210000607; de Rugy A, 2012, J NEUROPHYSIOL, V107, P766, DOI 10.1152/jn.00854.2011; DeLucia PR, 1998, J EXP PSYCHOL HUMAN, V24, P901, DOI 10.1037/0096-1523.24.3.901; Dessing JC, 2005, J COGNITIVE NEUROSCI, V17, P668, DOI 10.1162/0898929053467604; Dessing JC, 2002, NEURAL NETWORKS, V15, P163, DOI 10.1016/S0893-6080(01)00136-8; Dessing JC, 2009, EXP BRAIN RES, V192, P669, DOI 10.1007/s00221-008-1588-1; Dubrowski A, 2000, ACTA PSYCHOL, V104, P103, DOI 10.1016/S0001-6918(99)00056-6; Eggert T, 2005, EXP BRAIN RES, V160, P433, DOI 10.1007/s00221-004-2028-5; Faisal AA, 2009, J NEUROPHYSIOL, V101, P1901, DOI 10.1152/jn.90974.2008; Fink PW, 2009, J VISION, V9, DOI 10.1167/9.13.14; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Gibson J.J., 1986, ECOLOGICAL APPROACH; Gray R, 1998, VISION RES, V38, P499, DOI 10.1016/S0042-6989(97)00230-7; Hesse C, 2010, VISION RES, V50, P2642, DOI 10.1016/j.visres.2010.07.026; Indovina I, 2005, SCIENCE, V308, P416, DOI 10.1126/science.1107961; Jacobs DM, 2006, J EXP PSYCHOL HUMAN, V32, P443, DOI 10.1037/0096-1523.32.2.443; Katsumata H, 2012, EXP BRAIN RES, V216, P499, DOI 10.1007/s00221-011-2954-y; Lacquaniti F., 1993, MULTISENSORY CONTROL, P379, DOI [10.1093/acprof:oso/9780198547853.003.0190, DOI 10.1093/ACPROF:OSO/9780198547853.003.0190]; Lee D, 1997, EXP BRAIN RES, V116, P421, DOI 10.1007/PL00005770; Lee D.N., 1985, BRAIN MECH SPATIAL V, P1, DOI 10.1007/978-94-009-5071-9_1; Lee DN, 1998, ECOL PSYCHOL, V10, P221, DOI 10.1207/s15326969eco103&4_4; LEE DN, 1976, PERCEPTION, V5, P437, DOI 10.1068/p050437; Lee DN, 2001, EXP BRAIN RES, V139, P151, DOI 10.1007/s002210100725; Levy BJ, 2002, TRENDS COGN SCI, V6, P299, DOI 10.1016/S1364-6613(02)01923-X; LYON DR, 1995, ACTA PSYCHOL, V89, P239, DOI 10.1016/0001-6918(95)98945-Z; Maffei V, 2010, J NEUROPHYSIOL, V103, P360, DOI 10.1152/jn.00892.2009; Magnussen S, 1999, PSYCHOL RES-PSYCH FO, V62, P81, DOI 10.1007/s004260050043; Magnussen S, 2000, TRENDS NEUROSCI, V23, P247, DOI 10.1016/S0166-2236(00)01569-1; Makin ADJ, 2008, VISION RES, V48, P1884, DOI 10.1016/j.visres.2008.05.023; Makin ADJ, 2009, EXP BRAIN RES, V193, P137, DOI 10.1007/s00221-008-1678-0; Marinovic W, 2008, EXP BRAIN RES, V188, P275, DOI 10.1007/s00221-008-1360-6; Marinovic W, 2010, ACTA PSYCHOL, V135, P30, DOI 10.1016/j.actpsy.2010.04.009; Marinovic W, 2009, EXP BRAIN RES, V197, P311, DOI 10.1007/s00221-009-1916-0; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; McLeod P, 2006, J EXP PSYCHOL HUMAN, V32, P139, DOI 10.1037/0096-1523.32.1.139; McLeod P, 2003, NATURE, V426, P244, DOI 10.1038/426244a; McLeod P, 2008, VISION RES, V48, P1479, DOI 10.1016/j.visres.2008.03.016; Michaels Claire F., 1992, Ecological Psychology, V4, P199, DOI 10.1207/s15326969eco0404_1; Miller WL, 2008, J NEUROPHYSIOL, V99, P1969, DOI 10.1152/jn.00889.2007; Montagne G, 1999, EXP BRAIN RES, V129, P87, DOI 10.1007/s002210050939; Mori R, 2002, 2002 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS, VOLS 1-3, PROCEEDINGS, P281, DOI 10.1109/IRDS.2002.1041402; Mrotek LA, 2004, EXP BRAIN RES, V156, P94, DOI 10.1007/s00221-003-1764-2; Mrotek LA, 2007, J NEUROSCI, V27, P7297, DOI 10.1523/JNEUROSCI.2046-07.2007; Mrotek LA, 2007, EXP BRAIN RES, V178, P99, DOI 10.1007/s00221-006-0717-y; O'Reilly JX, 2008, J NEUROSCI, V28, P2252, DOI 10.1523/JNEUROSCI.2742-07.2008; Ogawa K, 2007, J COGNITIVE NEUROSCI, V19, P1827, DOI 10.1162/jocn.2007.19.11.1827; Pasternak T, 2003, J NEUROPHYSIOL, V90, P2757, DOI 10.1152/jn.00422.2003; PEPER L, 1994, J EXP PSYCHOL HUMAN, V20, P591, DOI 10.1037/0096-1523.20.3.591; Port NL, 1997, EXP BRAIN RES, V116, P406, DOI 10.1007/PL00005769; Regan D, 2000, TRENDS COGN SCI, V4, P99, DOI 10.1016/S1364-6613(99)01442-4; REGAN D, 1995, VISION RES, V35, P1845, DOI 10.1016/0042-6989(94)00274-P; Rozendaal LA, 2003, BIOL CYBERN, V89, P415, DOI 10.1007/s00422-002-0393-3; SAVELSBERGH GJP, 1991, J EXP PSYCHOL HUMAN, V17, P315, DOI 10.1037/0096-1523.17.2.315; SAXBERG BVH, 1987, BIOL CYBERN, V56, P177, DOI 10.1007/BF00317992; Senot P, 2005, J NEUROPHYSIOL, V94, P4471, DOI 10.1152/jn.00527.2005; Senot P, 2012, J NEUROSCI, V32, P1969, DOI 10.1523/JNEUROSCI.3886-11.2012; SHARP RH, 1974, J MOTOR BEHAV, V6, P139, DOI 10.1080/00222895.1974.10734990; SMEETS JBJ, 1995, J EXP PSYCHOL HUMAN, V21, P19, DOI 10.1037/0096-1523.21.1.19; Soechting JF, 2008, J NEUROPHYSIOL, V99, P2956, DOI 10.1152/jn.90308.2008; Soechting JF, 2009, J NEUROPHYSIOL, V102, P1491, DOI 10.1152/jn.00398.2009; Tijtgat P, 2011, EXP BRAIN RES, V214, P483, DOI 10.1007/s00221-011-2846-1; Tijtgat P, 2010, EXP BRAIN RES, V201, P875, DOI 10.1007/s00221-009-2102-0; TRESILIAN JR, 1995, Q J EXP PSYCHOL-A, V48, P688, DOI 10.1080/14640749508401411; Tresilian JR, 1999, TRENDS COGN SCI, V3, P301, DOI 10.1016/S1364-6613(99)01352-2; TRESILIAN JR, 1994, J EXP PSYCHOL HUMAN, V20, P154, DOI 10.1037/0096-1523.20.1.154; VANDONKELAAR P, 1992, EXP BRAIN RES, V91, P151, DOI 10.1007/BF00230023; Wann JP, 1996, J EXP PSYCHOL HUMAN, V22, P1031, DOI 10.1037/0096-1523.22.4.1031; Watamaniuk SNJ, 2003, J VISION, V3, P698, DOI 10.1167/3.11.5; WERKHOVEN P, 1992, VISION RES, V32, P2313, DOI 10.1016/0042-6989(92)90095-Z; WHITING HTA, 1970, ERGONOMICS, V13, P265, DOI 10.1080/00140137008931141; Wiggs CL, 1998, CURR OPIN NEUROBIOL, V8, P227, DOI 10.1016/S0959-4388(98)80144-X; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Xiao Q, 2007, CEREB CORTEX, V17, P918, DOI 10.1093/cercor/bhl002; Zago M, 2005, J NEUROPHYSIOL, V94, P1346, DOI 10.1152/jn.00215.2005; Zago M, 2005, J NEUROPHYSIOL, V93, P1055, DOI 10.1152/jn.00833.2004; Zago M, 2004, J NEUROPHYSIOL, V91, P1620, DOI 10.1152/jn.00862.2003; Zago M, 2008, VISION RES, V48, P1532, DOI 10.1016/j.visres.2008.04.005; Zago M, 2010, EXP BRAIN RES, V201, P365, DOI 10.1007/s00221-009-2041-9; Zago M, 2009, EXP BRAIN RES, V192, P571, DOI 10.1007/s00221-008-1691-3; Zokaei N, 2011, J VISION, V11, DOI 10.1167/11.14.2	107	43	43	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49381	10.1371/journal.pone.0049381	http://dx.doi.org/10.1371/journal.pone.0049381			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166653	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900133
J	Bostrom, S; Ibitokou, S; Oesterholt, M; Schmiegelow, C; Persson, JO; Minja, D; Lusingu, J; Lemnge, M; Fievet, N; Deloron, P; Luty, AJF; Troye-Blomberg, M				Bostrom, Stephanie; Ibitokou, Samad; Oesterholt, Mayke; Schmiegelow, Christentze; Persson, Jan-Olov; Minja, Daniel; Lusingu, John; Lemnge, Martha; Fievet, Nadine; Deloron, Philippe; Luty, Adrian J. F.; Troye-Blomberg, Marita			Biomarkers of Plasmodium falciparum Infection during Pregnancy in Women Living in Northeastern Tanzania	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; LOW-BIRTH-WEIGHT; PLACENTAL MALARIA; FACTOR-ALPHA; TNF-ALPHA; CHILDREN; RECEPTOR; CHEMOKINES; CYTOKINES; BLOOD	In pregnant women, Plasmodium falciparum infections are an important cause of maternal morbidity as well as fetal and neonatal mortality. Erythrocytes infected by these malaria-causing parasites accumulate through adhesive interactions in placental intervillous spaces, thus evading detection in peripheral blood smears. Sequestered infected erythrocytes induce inflammation, offering the possibility of detecting inflammatory mediators in peripheral blood that could act as biomarkers of placental infection. In a longitudinal, prospective study in Tanzania, we quantified a range of different cytokines, chemokines and angiogenic factors in peripheral plasma samples, taken on multiple sequential occasions during pregnancy up to and including delivery, from P. falciparum-infected women and matched uninfected controls. The results show that during healthy, uninfected pregnancies the levels of most of the panel of molecules we measured were largely unchanged except at delivery. In women with P. falciparum, however, both comparative and longitudinal assessments consistently showed that the levels of IL-10 and IP-10 increased significantly whilst that of RANTES decreased significantly, regardless of gestational age at the time the infection was detected. ROC curve analysis indicated that a combination of increased IL-10 and IP-10 levels and decreased RANTES levels might be predictive of P. falciparum infections. In conclusion, our data suggest that host biomarkers in peripheral blood may represent useful diagnostic markers of P. falciparum infection during pregnancy, but placental histology results would need to be included to verify these findings.	[Bostrom, Stephanie; Troye-Blomberg, Marita] Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden	Stockholm University	Bostrom, S (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Immunol, S-10691 Stockholm, Sweden.	stephanie.bostrom@wgi.su.se	Troye-Blomberg, Marita/B-9210-2016; Lusingu, John P. A./GSJ-3228-2022; Luty, Adrian/CAH-2547-2022; Deloron, Philippe/G-6305-2010	Troye-Blomberg, Marita/0000-0002-2804-0325; Deloron, Philippe/0000-0003-4705-2484; Luty, Adrian John Frederick/0000-0001-8830-3425; Fievet, Nadine/0000-0003-2272-9794; shmiegelow, christentze/0000-0002-9360-9741; Lusingu, John P. A./0000-0002-9407-0602				Abrams ET, 2003, J IMMUNOL, V170, P2759, DOI 10.4049/jimmunol.170.5.2759; Huynh BT, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-72; Bodker R, 2003, J MED ENTOMOL, V40, P706, DOI 10.1603/0022-2585-40.5.706; Brabin BJ, 2005, J REPROD IMMUNOL, V65, P1, DOI 10.1016/j.jri.2004.09.006; Campanella GSV, 2008, P NATL ACAD SCI USA, V105, P4814, DOI 10.1073/pnas.0801544105; Chaisavaneeyakorn S, 2002, J INFECT DIS, V185, P127, DOI 10.1086/338013; Conroy AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028540; Crocker IP, 2004, PLACENTA, V25, P273, DOI 10.1016/j.placenta.2003.09.010; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Ellis M, 2005, BRIT J HAEMATOL, V128, P482, DOI 10.1111/j.1365-2141.2004.05350.x; Fievet N, 2001, J INFECT DIS, V183, P1530, DOI 10.1086/320201; Fried M, 1998, J IMMUNOL, V160, P2523; Fried M, 1996, SCIENCE, V272, P1502, DOI 10.1126/science.272.5267.1502; Gerardin P, 2002, AM J TROP MED HYG, V66, P686, DOI 10.4269/ajtmh.2002.66.686; Gotsch F, 2007, J MATERN-FETAL NEO M, V20, P777, DOI 10.1080/14767050701483298; Holmes VA, 2003, CYTOKINE, V21, P265, DOI 10.1016/S1043-4666(03)00097-8; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; John CC, 2006, J INFECT DIS, V194, P837, DOI 10.1086/506623; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; MALEFYT RD, 1991, J EXP MED, V174, P1209; Melgarejo E, 2009, INT J BIOCHEM CELL B, V41, P998, DOI 10.1016/j.biocel.2008.07.018; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Mmbando BP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-216; Moormann AM, 1999, J INFECT DIS, V180, P1987, DOI 10.1086/315135; Mshana R N, 1991, J Clin Lab Immunol, V34, P131; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; OPSJON SL, 1993, AM J OBSTET GYNECOL, V169, P397, DOI 10.1016/0002-9378(93)90096-2; Ordi J, 1998, AM J SURG PATHOL, V22, P1006, DOI 10.1097/00000478-199808000-00011; Ostrowski SR, 2007, PARASITE IMMUNOL, V29, P37, DOI 10.1111/j.1365-3024.2006.00916.x; Othoro C, 1999, J INFECT DIS, V179, P279, DOI 10.1086/314548; Perch M, 2004, PARASITE IMMUNOL, V26, P207, DOI 10.1111/j.0141-9838.2004.00695.x; Raghupathy R, 1997, IMMUNOL TODAY, V18, P478, DOI 10.1016/S0167-5699(97)01127-4; Rogerson SJ, 2003, INFECT IMMUN, V71, P267, DOI 10.1128/IAI.71.1.267-270.2003; Rogerson SJ, 2003, AM J TROP MED HYG, V68, P115, DOI 10.4269/ajtmh.2003.68.1.0680115; Sharma A, 2007, AM J REPROD IMMUNOL, V58, P21, DOI 10.1111/j.1600-0897.2007.00486.x; Silver KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024985; Silver KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009481; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Suguitan AL, 2003, J INFECT DIS, V188, P1074, DOI 10.1086/378500; Szarka A, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-59; Tan SO, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-209; Thevenon AD, 2010, J IMMUNOL, V185, P7115, DOI 10.4049/jimmunol.1002293; Umbers AJ, 2011, J INFECT DIS, V203, P561, DOI 10.1093/infdis/jiq080; WEGMANN TG, 1993, IMMUNOL TODAY, V14, P353, DOI 10.1016/0167-5699(93)90235-D; Were T, 2006, HAEMATOLOGICA, V91, P1396; Wilhelm OG, 1999, J CELL PHYSIOL, V180, P225, DOI 10.1002/(SICI)1097-4652(199908)180:2<225::AID-JCP10>3.0.CO;2-2; Wilson NO, 2010, INFECT DIS OBSTET GY, V2010	47	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48763	10.1371/journal.pone.0048763	http://dx.doi.org/10.1371/journal.pone.0048763			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155405	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900039
J	Chiang, YJ; Difilippantonio, MJ; Tessarollo, L; Morse, HC; Hodes, RJ				Chiang, Y. Jeffrey; Difilippantonio, Michael J.; Tessarollo, Lino; Morse, Herbert C.; Hodes, Richard J.			Exon 1 Disruption Alters Tissue-Specific Expression of Mouse p53 and Results in Selective Development of B Cell Lymphomas	PLOS ONE			English	Article							MICE; SUPPRESSION; CROSSROADS; LEUKEMIA; SPECTRUM; DELETION; REPAIR; LOCUS	p53 is a tumor suppressor gene mutated in >50% of human cancers, while p53 deficiency in mice results in cancers and accelerated mortality. Thymic T cell lymphoma is the most common malignancy in p53-deficient mice, making it difficult to study the role of p53 in other malignancies. To overcome this limitation, we attempted to generate mice with a reversible p53 knockout (p53(rev/rev)) by inserting a floxed transcriptional stop into the first exon of p53, anticipating that this would allow tissue-specific Cre-mediated expression of p53. Contrary to expectations, functional p53 protein was expressed in the thymus and multiple other tissues of p53(rev/rev) mice in the absence of Cre, whereas B cells expressed p53 protein only in the presence of B cell-specific CD19-Cre. In the absence of Cre, 76% of p53(rev/rev) mice developed splenic marginal zone B cell lymphomas, indicating sensitivity of this B cell subset to transformation caused by p53 deficiency. 5'-RACE identified p53 mRNA transcribed from a novel start site utilized in thymocytes but not normal B cells or B cell lymphomas from p53(rev/rev) mice. The p53(rev/rev) mouse thus demonstrates an effect of p53 deficiency in development of splenic marginal zone lymphomas and provides a model for study of p53-deficient human B cell lymphomas.			Chiang, YJ (corresponding author), NCI, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA.	chiangj@mail.nih.gov	Difilippantonio, Michael/AAF-2839-2021	Difilippantonio, Michael/0000-0002-4676-7034; Morse, Herbert/0000-0002-9331-3705	Intramural NIH HHS [Z99 CA999999] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZICBC011265, ZIABC009405] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000858] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Bassing CH, 2003, P NATL ACAD SCI USA, V100, P2598, DOI 10.1073/pnas.0437943100; Belyi VA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001198; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Broz DK, 2010, CARCINOGENESIS, V31, P1311, DOI 10.1093/carcin/bgp331; Celeste A, 2003, CELL, V114, P371, DOI 10.1016/S0092-8674(03)00567-1; Chiang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018542; Chiang YJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002639; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DONEHOWER LA, 1995, GENE DEV, V9, P882, DOI 10.1101/gad.9.7.882; Feng ZH, 2008, CELL CYCLE, V7, P842, DOI 10.4161/cc.7.7.5657; Gladdy RA, 2003, CANCER CELL, V3, P37, DOI 10.1016/S1535-6108(02)00236-2; Gruszka-Westwood AM, 2001, BLOOD, V97, P3552, DOI 10.1182/blood.V97.11.3552; HARVEY M, 1993, FASEB J, V7, P938, DOI 10.1096/fasebj.7.10.8344491; Hussain S. Perwez, 2006, Journal of Nippon Medical School, V73, P54; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Miletic AV, 2010, J EXP MED, V207, P2407, DOI 10.1084/jem.20091962; Morse Herbert C. III, 2002, Blood, V100, P246; MOTHERSILL C, 1994, RADIAT RES, V137, P317, DOI 10.2307/3578705; Ogawa Y, 2000, INT J MOL MED, V5, P139; Padilla-Nash HM, 2006, NAT PROTOC, V1, P3129, DOI 10.1038/nprot.2006.358; Raveche ES, 2007, BLOOD, V109, P5079, DOI 10.1182/blood-2007-02-071225; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Robles AI, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001016; Rowh MAW, 2011, ONCOGENE, V30, P4757, DOI 10.1038/onc.2011.191; Rui LX, 2006, CURR MOL MED, V6, P291, DOI 10.2174/156652406776894563; Salido M, 2010, BLOOD, V116, P1479, DOI 10.1182/blood-2010-02-267476; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Southon Eileen, 2009, V530, P165, DOI 10.1007/978-1-59745-471-1_9; Ward JM, 1999, LAB INVEST, V79, P3; Watkins AJ, 2010, J PATHOL, V220, P461, DOI 10.1002/path.2665	34	7	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49305	10.1371/journal.pone.0049305	http://dx.doi.org/10.1371/journal.pone.0049305			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166633	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900119
J	de Camargo, NF; de Oliveira, HFM				de Camargo, Nicholas F.; de Oliveira, Hernani F. M.			Sexual Dimorphism in Sturnira lilium (Chiroptera, Phyllostomidae): Can Pregnancy and Pup Carrying Be Responsible for Differences in Wing Shape?	PLOS ONE			English	Article							COMBINING GEOMETRIC MORPHOMETRICS; PATTERN-RECOGNITION; MORPHOLOGY; BATS; FLIGHT; SIZE	Competition is one of the most cited mechanisms to explain secondary sexual dimorphism in animals. Nonetheless, it has been proposed that sexual dimorphism in bat wings is also a result of adaptive pressures to compensate additional weight caused by fetus or pup carrying during the reproductive period of females. The main objective of this study is to verify the existence of sexual dimorphism in Sturnira lilium wings. We employed geometric morphometrics techniques using anatomical landmarks superimposition to obtain size (Centroid Size) and shape variables of wings, which were reduced by Linear Discriminant Analysis (LDA). We also employed classical morphometrics using wing length measurements to compare efficiency between these two morphometric approaches and make comparisons using wing area measurements. LDA indicated significant differences between wing shapes of males and females, with 91% (stepwise classification) and 80% (leave-one-out cross validation) of correct classification. However, the size variable obtained did not contribute to such classifications. We have observed larger areas in female wings, but we found no differences in wing length measurements and no allometric effects in wing length, shape and area measurements. Interestingly, our study has provided evidences of morphological differences where classical morphometrics have failed. LDA and area measurements analyses revealed that females have a different area distribution in distinct portions of the wing, with wider dactylopatagia and plagiopatagia, and wingtips more triangular than males. No differences in body length or relative wing length were observed between the sexes, but pregnant females have more body weight than non-pregnant females and males. Our findings suggest that sexual dimorphism in the wing shape of S. lilium is probably related to the increase in flight efficiency of females during reproductive period. It decreases wing loading in specific portions of the wing and reduces energy cost to maintain a faster and maneuverable flight.	[de Camargo, Nicholas F.] Univ Brasilia, Inst Ciencias Biol, Dept Ecol, Programa Posgrad Ecol,Lab Ecol Vertebrados, BR-70910900 Brasilia, DF, Brazil	Universidade de Brasilia	de Camargo, NF (corresponding author), Univ Brasilia, Inst Ciencias Biol, Dept Ecol, Programa Posgrad Ecol,Lab Ecol Vertebrados, BR-70910900 Brasilia, DF, Brazil.	camargonf@gmail.com	Camargo, Nícholas/Q-2039-2019; Camargo, Nícholas F/B-3389-2019	Camargo, Nícholas/0000-0001-6859-8780; Camargo, Nícholas F/0000-0001-6859-8780; Oliveira, Hernani/0000-0001-7040-8317				ALDRIDGE HDJN, 1987, J ANIM ECOL, V56, P763, DOI 10.2307/4947; Altringham JD, 1998, BATS BIOLOGY BEHAV; Barlow KE, 1997, P ROY SOC B-BIOL SCI, V264, P1695, DOI 10.1098/rspb.1997.0235; Baylac M, 2003, BIOL J LINN SOC, V80, P89, DOI 10.1046/j.1095-8312.2003.00221.x; Birch JM, 1997, J MAMMAL, V78, P1187, DOI 10.2307/1383062; BONACCORSO F J, 1979, Bulletin of the Florida State Museum Biological Sciences, V24, P359; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; BURNETT C D, 1983, Annals of Carnegie Museum, V52, P139; Cordeiro-Estrela P, 2008, BIOL J LINN SOC, V94, P365, DOI 10.1111/j.1095-8312.2008.00982.x; Development Core Team, 2011, R LANG ENV STAT COMP; dos Reis SF, 2002, J MAMMAL, V83, P345, DOI 10.1644/1545-1542(2002)083<0345:GVICMI>2.0.CO;2; FARNEY J, 1969, J MAMMAL, V50, P362, DOI 10.2307/1378361; Fenton MB, 1972, CAN J ZOOL, V50, P363; Findley J.S., 1993, BATS COMMUNITY PERSP; Fleiss J.L., 1986, DESIGN ANAL CLIN EXP; Freeman P.W., 1981, FIELDIANA ZOOL CHICA, V7, P1, DOI DOI 10.5962/BHL.TITLE.3128; FREEMAN PW, 1981, J MAMMAL, V62, P166, DOI 10.2307/1380489; Hayssen V, 1996, J MAMMAL, V77, P476, DOI 10.2307/1382823; Herrera LG, 2002, OECOLOGIA, V133, P280, DOI 10.1007/s00442-002-1036-z; Herrera LG, 2001, BIOTROPICA, V33, P520, DOI 10.1111/j.1744-7429.2001.tb00206.x; HUGHES P, 1993, J ZOOL, V230, P541, DOI 10.1111/j.1469-7998.1993.tb02705.x; Jacobs DS, 1996, FUNCT ECOL, V10, P622, DOI 10.2307/2390172; KALCOUNIS MC, 1995, CAN J ZOOL, V73, P89, DOI 10.1139/z95-011; Kurta A., 1987, Symposia of the Zoological Society of London, P79; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; MCNAB BK, 1971, ECOLOGY, V52, P352, DOI 10.2307/1934596; Mello MAR, 2008, J MAMMAL, V89, P485, DOI 10.1644/06-MAMM-A-411R.1; MIRANDA AC, 1993, J TROP ECOL, V9, P313, DOI 10.1017/S0266467400007367; MYERS P, 1978, AM NAT, V112, P701, DOI 10.1086/283312; Norberg U., 1990, VERTEBRATE FLIGHT ME; NORBERG U M, 1987, Philosophical Transactions of the Royal Society of London B Biological Sciences, V316, P335, DOI 10.1098/rstb.1987.0030; Norberg Ulla M., 1994, P205; NORBERG UM, 1981, PHILOS T R SOC B, V292, P359, DOI 10.1098/rstb.1981.0034; Pennycuick C.J., 1975, AVIAN BIOL, P1, DOI DOI 10.1016/B978-0-12-249405-5.50009-4; Peters A., 2002, R NEWS, V2, P33; Pickle J., 2008, MEASURING LENGTH ARE; RALLS K, 1976, Q REV BIOL, V51, P245, DOI 10.1086/409310; Ribeiro JF., 1998, CERRADO AMBIENTE FLO, P89; Rohlf F.J., 1999, TPSDIG V 1 18; Rohlf FJ, 2005, TPSREGR V 1 38; Rohlf FJ, 1999, TPSRELW V 1 18; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; VAUGHAN TA, 1966, J MAMMAL, V47, P249, DOI 10.2307/1378121; Weihs C, 2005, ST CLASS DAT ANAL, P335; WILLIAMS DF, 1979, AM MIDL NAT, V102, P113, DOI 10.2307/2425072; WILLIG MR, 1985, J MAMMAL, V66, P618, DOI 10.2307/1380788; WILLIG MR, 1986, SYST ZOOL, V35, P195, DOI 10.2307/2413430; WILLIG MR, 1995, J MAMMAL, V76, P981, DOI 10.2307/1382592	49	19	23	3	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49734	10.1371/journal.pone.0049734	http://dx.doi.org/10.1371/journal.pone.0049734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166759	gold, Green Published			2022-12-27	WOS:000311151900186
J	Forthun, RB; SenGupta, T; Skjeldam, HK; Lindvall, JM; McCormack, E; Gjertsen, BT; Nilsen, H				Forthun, Rakel Brendsdal; SenGupta, Tanima; Skjeldam, Hanne Kim; Lindvall, Jessica Margareta; McCormack, Emmet; Gjertsen, Bjorn Tore; Nilsen, Hilde			Cross-Species Functional Genomic Analysis Identifies Resistance Genes of the Histone Deacetylase Inhibitor Valproic Acid	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; TRANS-RETINOIC ACID; DNA-DAMAGE RESPONSE; BIOLOGICAL NETWORKS; CANCER; CELLS; EXPRESSION; CHROMATIN; AML; UTX	The mechanisms of successful epigenetic reprogramming in cancer are not well characterized as they involve coordinated removal of repressive marks and deposition of activating marks by a large number of histone and DNA modification enzymes. Here, we have used a cross-species functional genomic approach to identify conserved genetic interactions to improve therapeutic effect of the histone deacetylase inhibitor (HDACi) valproic acid, which increases survival in more than 20% of patients with advanced acute myeloid leukemia (AML). Using a bidirectional synthetic lethality screen revealing genes that increased or decreased VPA sensitivity in C. elegans, we identified novel conserved sensitizers and synthetic lethal interactors of VPA. One sensitizer identified as a conserved determinant of therapeutic success of HDACi was UTX (KDM6A), which demonstrates a functional relationship between protein acetylation and lysine-specific methylation. The synthetic lethal screen identified resistance programs that compensated for the HDACi-induced global hyper-acetylation, and confirmed MAPKAPK2, HSP90AA1, HSP90AB1 and ACTB as conserved hubs in a resistance program for HDACi that are drugable in human AML cell lines. Hence, these resistance hubs represent promising novel targets for refinement of combinatorial epigenetic anti-cancer therapy.	[Forthun, Rakel Brendsdal; McCormack, Emmet; Gjertsen, Bjorn Tore] Univ Bergen, Hematol Sect, Inst Med, Bergen, Norway	University of Bergen	Forthun, RB (corresponding author), Univ Bergen, Hematol Sect, Inst Med, Bergen, Norway.	bjorn.gjertsen@med.uib.no; hilde.nilsen@biotek.uio.no	Cormack, Emmet Mc/D-2922-2012; Gjertsen, Bjorn T/O-1542-2015; Lindvall, Jessica M/A-1762-2013; Gjertsen, Bjørn T/AAP-3281-2020; Nilsen, Hilde/F-6432-2014	Cormack, Emmet Mc/0000-0002-7621-4625; Gjertsen, Bjorn T/0000-0001-9358-9704; Gjertsen, Bjørn T/0000-0001-9358-9704; Lindvall, Jessica/0000-0002-5042-8481; Nilsen, Hilde/0000-0003-2115-2663				Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Alexeyenko A, 2009, GENOME RES, V19, P1107, DOI 10.1101/gr.087528.108; Band AM, 2009, J BIOL CHEM, V284, P35441, DOI 10.1074/jbc.M109.029488; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bellos F, 2008, ONKOLOGIE, V31, P629, DOI 10.1159/000160599; Blaheta RA, 2005, MED RES REV, V25, P383, DOI 10.1002/med.20027; Bruserud O, 2006, EXPERT OPIN THER TAR, V10, P51, DOI 10.1517/14728222.10.1.51; Bull VH, 2010, ELECTROPHORESIS, V31, P1873, DOI 10.1002/elps.200900780; Cimino G, 2006, CANCER RES, V66, P8903, DOI 10.1158/0008-5472.CAN-05-2726; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Corpet A, 2009, EMBO J, V28, P1828, DOI 10.1038/emboj.2009.180; Craig AL, 2012, METHOD CELL BIOL, V107, P321, DOI 10.1016/B978-0-12-394620-1.00011-4; Di Gennaro E, 2009, CANCER BIOL THER, V8, P782, DOI 10.4161/cbt.8.9.8118; Duenas-Gonzalez A, 2008, CANCER TREAT REV, V34, P206, DOI 10.1016/j.ctrv.2007.11.003; Gausdal G, 2008, BLOOD, V111, P2866, DOI 10.1182/blood-2007-07-103242; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Hahn CK, 2009, CANCER CELL, V16, P281, DOI 10.1016/j.ccr.2009.08.018; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kantarjian H, 2010, BLOOD, V116, P4422, DOI 10.1182/blood-2010-03-276485; Koensgen D, 2007, GYNECOL ONCOL, V107, P266, DOI 10.1016/j.ygyno.2007.06.023; Kooistra SM, 2012, NAT REV MOL CELL BIO, V13, P297, DOI 10.1038/nrm3327; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Kostrouchova M, 2007, FOLIA BIOL-PRAGUE, V53, P37; Lagneaux L, 2007, EXP HEMATOL, V35, P1527, DOI 10.1016/j.exphem.2007.06.014; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Marchion DC, 2005, CANCER RES, V65, P3815, DOI 10.1158/0008-5472.CAN-04-2478; Marina O, 2010, CANCER RES, V70, P1344, DOI 10.1158/0008-5472.CAN-09-3143; Mazurkiewicz-Beldzinska M, 2010, SEIZURE-EUR J EPILEP, V19, P195, DOI 10.1016/j.seizure.2010.01.014; McCormack E, 2012, LEUKEMIA, V26, P910, DOI 10.1038/leu.2011.315; McCormack E, 2010, NUTR CANCER, V62, P574, DOI 10.1080/01635580903532416; McDevitt MA, 2012, SEMIN ONCOL, V39, P109, DOI 10.1053/j.seminoncol.2011.11.003; McLellan J, 2009, MOL BIOL CELL, V20, P5306, DOI 10.1091/mbc.E09-08-0699; Mielnicki LM, 2001, J MAMMARY GLAND BIOL, V6, P169, DOI 10.1023/A:1011356623442; Morita K, 2001, P NATL ACAD SCI USA, V98, P6284, DOI 10.1073/pnas.111409798; Nie D, 2012, LEUKEMIA LYMPHOMA; Quintas-Cardama A, 2011, LEUKEMIA, V25, P226, DOI 10.1038/leu.2010.276; Ryningen A, 2009, LEUKEMIA RES, V33, P779, DOI 10.1016/j.leukres.2008.10.005; Schaner CE, 2003, DEV CELL, V5, P747, DOI 10.1016/S1534-5807(03)00327-7; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Stapnes C, 2007, INT J ONCOL, V31, P1529; Tibes R, 2012, BLOOD, V119, P2863, DOI 10.1182/blood-2011-07-367557; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Wergeland L, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-33; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	51	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48992	10.1371/journal.pone.0048992	http://dx.doi.org/10.1371/journal.pone.0048992			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155442	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900077
J	McDonald, KK; Stajich, J; Blach, C; Ashley-Koch, AE; Hauser, MA				McDonald, Kristin K.; Stajich, Jeffrey; Blach, Colette; Ashley-Koch, Allison E.; Hauser, Michael A.			Exome Analysis of Two Limb-Girdle Muscular Dystrophy Families: Mutations Identified and Challenges Encountered	PLOS ONE			English	Article							DISCOVERY; FRAMEWORK; PHENOTYPE; MYOPATHY	The molecular diagnosis of muscle disorders is challenging: genetic heterogeneity (>100 causal genes for skeletal and cardiac muscle disease) precludes exhaustive clinical testing, prioritizing sequencing of specific genes is difficult due to the similarity of clinical presentation, and the number of variants returned through exome sequencing can make the identification of the disease-causing variant difficult. We have filtered variants found through exome sequencing by prioritizing variants in genes known to be involved in muscle disease while examining the quality and depth of coverage of those genes. We ascertained two families with autosomal dominant limb-girdle muscular dystrophy of unknown etiology. To identify the causal mutations in these families, we performed exome sequencing on five affected individuals using the Agilent SureSelect Human All Exon 50 Mb kit and the Illumina HiSeq 2000 (2 x 100 bp). We identified causative mutations in desmin (IVS3+3A>G) and filamin C (p.W2710X), and augmented the phenotype data for individuals with muscular dystrophy due to these mutations. We also discuss challenges encountered due to depth of coverage variability at specific sites and the annotation of a functionally proven splice site variant as an intronic variant.	[McDonald, Kristin K.; Stajich, Jeffrey; Blach, Colette; Ashley-Koch, Allison E.; Hauser, Michael A.] Duke Univ, Ctr Human Genet, Durham, NC 27708 USA	Duke University	McDonald, KK (corresponding author), Duke Univ, Ctr Human Genet, Durham, NC 27708 USA.	mike.hauser@duke.edu		Ashley-Koch, Allison/0000-0001-5409-9155; McDonald Gibson, Kristin/0000-0002-3297-2002	NHLBI NIH HHS [UC2 HL102925, RC2 HL102925, UC2 HL102926, UC2 HL102923, RC2 HL102926, RC2 HL103010, UC2 HL102924, RC2 HL102924, UC2 HL103010, RC2 HL102923] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Biesecker LG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-128; Boyden SE, 2010, NEUROGENETICS, V11, P449, DOI 10.1007/s10048-010-0250-9; Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033; Dalakas MC, 2000, NEW ENGL J MED, V342, P770, DOI 10.1056/NEJM200003163421104; Daoud H, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.11.012; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dias C, 2012, HUM MUTAT, V33, P614, DOI 10.1002/humu.22032; Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300; Greenberg SA, 2012, ANN NEUROL, V71, P141, DOI 10.1002/ana.22649; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Kley RA, 2007, BRAIN, V130, P3250, DOI 10.1093/brain/awm271; Kouloumenta A, 2007, J BIOL CHEM, V282, P35211, DOI 10.1074/jbc.M704733200; Ku CS, 2012, ANN NEUROL, V71, P5, DOI 10.1002/ana.22647; Landstrom AP, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.08.001; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lowe T, 2007, HUM MOL GENET, V16, P1351, DOI 10.1093/hmg/ddm085; Malayeri Fardeen Ali, 2011, Acta Med Iran, V49, P142; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Odgerel Z, 2010, CLIN CHEM LAB MED, V48, P1409, DOI 10.1515/CCLM.2010.272; Park KY, 2000, J MED GENET, V37, P851, DOI 10.1136/jmg.37.11.851; Sirmaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032000; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Untergasser A, 2007, NUCLEIC ACIDS RES, V35, pW71, DOI 10.1093/nar/gkm306; van der Flier A, 2001, BBA-MOL CELL RES, V1538, P99, DOI 10.1016/S0167-4889(01)00072-6; Vasli N, 2012, ACTA NEUROPATHOL; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Wheeler M, 2009, J CARDIOVASC TRANSL, V2, P381, DOI 10.1007/s12265-009-9139-0; Willemsen MH, 2012, J MED GENET, V49, P179, DOI 10.1136/jmedgenet-2011-100542	28	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48864	10.1371/journal.pone.0048864	http://dx.doi.org/10.1371/journal.pone.0048864			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155419	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900053
J	Melnik, TN; Povarnitsyna, TV; Glukhov, AS; Melnik, BS				Melnik, Tatiana N.; Povarnitsyna, Tatiana V.; Glukhov, Anatoly S.; Melnik, Bogdan S.			Multi-State Proteins: Approach Allowing Experimental Determination of the Formation Order of Structure Elements in the Green Fluorescent Protein	PLOS ONE			English	Article							IRREVERSIBLE THERMAL-DENATURATION; FOLDING TRANSITION-STATE; VARYING TEMPERATURE; DISULFIDE BRIDGES; HEAT DENATURATION; CROSS-LINKING; INTERMEDIATE; PHOSPHORYLASE; STABILITY; MECHANISM	The most complex problem in studying multi-state protein folding is the determination of the sequence of formation of protein intermediate states. A far more complex issue is to determine at what stages of protein folding its various parts (secondary structure elements) develop. The structure and properties of different intermediate states depend in particular on these parts. An experimental approach, named mu-analysis, which allows understanding the order of formation of structural elements upon folding of a multi-state protein was used in this study. In this approach the same elements of the protein secondary structure are "tested" by substitutions of single hydrophobic amino acids and by incorporation of cysteine bridges. Single substitutions of hydrophobic amino acids contribute to yielding information on the late stages of protein folding while incorporation of ss-bridges allows obtaining data on the initial stages of folding. As a result of such an mu-analysis, we have determined the order of formation of beta-hairpins upon folding of the green fluorescent protein.	[Melnik, Tatiana N.; Povarnitsyna, Tatiana V.; Glukhov, Anatoly S.; Melnik, Bogdan S.] RAS, Inst Prot Res, Pushchino, Moscow Region, Russia	Russian Academy of Sciences	Melnik, TN (corresponding author), RAS, Inst Prot Res, Pushchino, Moscow Region, Russia.	bmelnik@phys.protres.ru	Melnik, Bogdan/U-1988-2017	Melnik, Bogdan/0000-0002-9176-6452; Melnik, Tatiana/0000-0002-9081-4678				Chiti F, 1998, J MOL BIOL, V283, P893, DOI 10.1006/jmbi.1998.2010; Clarke J, 2000, PROTEIN SCI, V9, P2394, DOI 10.1110/ps.9.12.2394; Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+; Enoki S, 2006, J MOL BIOL, V361, P969, DOI 10.1016/j.jmb.2006.07.009; FERSHT AR, 1994, P NATL ACAD SCI USA, V91, P10426, DOI 10.1073/pnas.91.22.10426; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; FREIRE E, 1990, ANNU REV BIOPHYS BIO, V19, P159; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Grantcharova VP, 2000, P NATL ACAD SCI USA, V97, P7084, DOI 10.1073/pnas.97.13.7084; Huang JR, 2008, HFSP J, V2, P378, DOI 10.2976/1.2976660; Kurganov BI, 2000, BIOCHEMISTRY-US, V39, P13144, DOI 10.1021/bi000975w; Kurganov BI, 1997, BIOPHYS CHEM, V69, P125, DOI 10.1016/S0301-4622(97)80552-2; Lyubarev AE, 1998, BIOCHEMISTRY-MOSCOW+, V63, P434; Lyubarev AE, 1999, BIOCHEMISTRY-MOSCOW+, V64, P832; Lyubarev AE, 1999, BIOPHYS CHEM, V79, P199, DOI 10.1016/S0301-4622(99)00050-2; Lyubarev AE, 1998, BIOPHYS CHEM, V70, P247, DOI 10.1016/S0301-4622(97)00133-6; MATOUSCHEK A, 1991, METHOD ENZYMOL, V202, P82; MATOUSCHEK A, 1990, NATURE, V346, P440, DOI 10.1038/346440a0; Melnik BS, 2008, BIOCHEM BIOPH RES CO, V369, P701, DOI 10.1016/j.bbrc.2008.02.096; Melnik BS, 2009, BIOCHEM BIOPH RES CO, V390, P1167, DOI 10.1016/j.bbrc.2009.10.109; Melnik BS, 2011, BBA-PROTEINS PROTEOM, V1814, P1930, DOI 10.1016/j.bbapap.2011.07.017; Melnik BS, 2012, J BIOMOL STRUCT DYN, V29, P815, DOI 10.1080/07391102.2012.10507414; Melnik T, 2011, THERMOCHIM ACTA, V512, P71, DOI 10.1016/j.tca.2010.09.002; Melnik TN, 2011, BIOCHEMISTRY-US, V50, P7735, DOI 10.1021/bi2006674; MILARDI D, 1994, BIOPHYS CHEM, V52, P183, DOI 10.1016/0301-4622(94)00033-G; Moran LB, 1999, P NATL ACAD SCI USA, V96, P10699, DOI 10.1073/pnas.96.19.10699; PARKER MJ, 1995, J MOL BIOL, V253, P771, DOI 10.1006/jmbi.1995.0590; Potekhin SA, 1999, BIOCHEMISTRY-US, V38, P4121, DOI 10.1021/bi982789k; Potekhin SA, 1998, BIOPHYS CHEM, V73, P241, DOI 10.1016/S0301-4622(98)00149-5; Privalov P L, 1986, Methods Enzymol, V131, P4; Samatova EN, 2010, BIOPHYS J, V98, P1694, DOI 10.1016/j.bpj.2009.12.4326; Samatova EN, 2009, PROTEIN SCI, V18, P2152, DOI 10.1002/pro.229; Senin AA, 2000, J THERM ANAL CALORIM, V62, P153, DOI 10.1023/A:1010171013669; Shandiz AT, 2007, BIOCHEMISTRY-US, V46, P13711, DOI 10.1021/bi701042e; Siadat Omid Ranaei, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-12; Siddiqui KS, 2005, J BACTERIOL, V187, P6206, DOI 10.1128/JB.187.17.6206-6212.2005; Viguera AR, 2002, P NATL ACAD SCI USA, V99, P5349, DOI 10.1073/pnas.072387799; Villegas V, 1998, J MOL BIOL, V283, P1027, DOI 10.1006/jmbi.1998.2158; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; Went HM, 2005, PROTEIN ENG DES SEL, V18, P229, DOI 10.1093/protein/gzi025; ZAHLER WL, 1968, J BIOL CHEM, V243, P716	41	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48604	10.1371/journal.pone.0048604	http://dx.doi.org/10.1371/journal.pone.0048604			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155397	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900031
J	Munoz, L; Dimov, N; Carot-Sans, G; Bula, WP; Guerrero, A; Gardeniers, HJGE				Munoz, Lourdes; Dimov, Nikolay; Carot-Sans, Gerard; Bula, Wojciech P.; Guerrero, Angel; Gardeniers, Han J. G. E.			Mimicking Insect Communication: Release and Detection of Pheromone, Biosynthesized by an Alcohol Acetyl Transferase Immobilized in a Microreactor	PLOS ONE			English	Article							SEX-PHEROMONE; CHEMICAL COMMUNICATION; QUANTITATIVE-ANALYSIS; PROTEINS; BEHAVIOR; MALES; PURIFICATION; ADSORPTION; CAUTELLA; ENZYMES	Infochemical production, release and detection of (Z, E)- 9,11-tetradecadienyl acetate, the major component of the pheromone of the moth Spodoptera littoralis, is achieved in a novel microfluidic system designed to mimic the final step of the pheromone biosynthesis by immobilized recombinant alcohol acetyl transferase. The microfluidic system is part of an "artificial gland", i.e., a chemoemitter that comprises a microreactor connected to a microevaporator and is able to produce and release a pre-defined amount of the major component of the pheromone from the corresponding (Z, E)-9,11-tetradecadienol. Performance of the entire chemoemitter has been assessed in electrophysiological and behavioral experiments. Electroantennographic depolarizations of the pheromone produced by the chemoemitter were ca. 40% relative to that evoked by the synthetic pheromone. In a wind tunnel, the pheromone released from the evaporator elicited on males a similar attraction behavior as 3 virgin females in most of the parameters considered.	[Munoz, Lourdes; Carot-Sans, Gerard; Guerrero, Angel] IQAC CSIC, Dept Biol Chem & Mol Modeling, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion y Desarrollo Pascual Vila (CID-CSIC); CSIC - Instituto de Quimica Avanzada de Cataluna (IQAC)	Munoz, L (corresponding author), IQAC CSIC, Dept Biol Chem & Mol Modeling, Barcelona, Spain.	j.g.e.gardeniers@utwente.nl	Dimov, Nikolay G/AAD-1806-2019; Muñoz, Lourdes/GXW-1225-2022; Guerrero, Angel/AAW-3731-2020; Gardeniers, Johannes GE/B-6309-2013; Guerrero, Angel/G-8495-2015	Dimov, Nikolay G/0000-0002-2873-1505; Muñoz, Lourdes/0000-0001-6247-9334; Gardeniers, Johannes GE/0000-0003-0581-2668; Guerrero, Angel/0000-0003-2323-2691				Asanomi Y, 2011, MOLECULES, V16, P6041, DOI 10.3390/molecules16076041; Beekwilder J, 2004, PLANT PHYSIOL, V135, P1865, DOI 10.1104/pp.104.042580; Blomquist GJ, 2003, INSECT PHEROMONE BIO; Bornhorst JA, 2000, METHOD ENZYMOL, V326, P245; Bula W P, 2010, PROC 14TH INT CONF M, P671; Cao L, 2005, CARRIER-BOUND IMMOBILIZED ENZYMES: PRINCIPLES, APPLICATIONS AND DESIGN, P1, DOI 10.1002/3527607668; Carde RT, 1997, INSECT PHEROMONE RESEARCH, P275; CAZALS M, 1983, CAN J ZOOL, V61, P673, DOI 10.1139/z83-089; CHANG SH, 1976, J CHROMATOGR, V120, P321, DOI 10.1016/S0021-9673(76)80009-X; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Cometto-Muniz JE, 2003, CHEM SENSES, V28, P467, DOI 10.1093/chemse/28.6.467; DECHER G, 1992, THIN SOLID FILMS, V210, P831, DOI 10.1016/0040-6090(92)90417-A; DeLouise LA, 2005, ANAL CHEM, V77, P1950, DOI 10.1021/ac0486185; Dimov N, 2011, PROCEDIA COMPUT SCI, V7, P142, DOI 10.1016/j.procs.2011.09.055; Dimov N, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3608138; Garcia R, 2000, BIOCHEM ENG J, V5, P185, DOI 10.1016/S1369-703X(00)00056-5; Girling RD, 2007, J CHEM ECOL, V33, P1927, DOI 10.1007/s10886-007-9349-3; HOCHULI E, 1988, BIO-TECHNOL, V6, P1321, DOI 10.1038/nbt1188-1321; ITOH N, 1986, P NATL ACAD SCI USA, V83, P4081, DOI 10.1073/pnas.83.11.4081; Jarriault D, 2009, J EXP BIOL, V212, P1191, DOI 10.1242/jeb.024166; Jones OT, 1998, PRACTICAL APPL PHERO, P263; Kalscheuer R, 2006, APPL ENVIRON MICROB, V72, P1373, DOI 10.1128/AEM.72.2.1373-1379.2006; Kindl J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026476; Lee MY, 2003, BIOTECHNOL BIOENG, V83, P20, DOI 10.1002/bit.10642; Ludden MLW, 2008, CHEM-EUR J, V14, P2044, DOI 10.1002/chem.200701478; Miyazaki M, 2006, TRENDS BIOTECHNOL, V24, P463, DOI 10.1016/j.tibtech.2006.08.002; Munoz L, 2008, PHYSIOL ENTOMOL, V33, P275, DOI 10.1111/j.1365-3032.2008.00645.x; Nordlund DA, 1976, J CHEM ECOL, V2, P211, DOI 10.1007/BF00987744; Olsson SB, 2011, J NEUROSCI METH, V195, P1, DOI 10.1016/j.jneumeth.2010.09.020; PORATH J, 1983, BIOCHEMISTRY-US, V22, P1621, DOI 10.1021/bi00276a015; Quero C, 1996, J CHEM ECOL, V22, P1087, DOI 10.1007/BF02027947; Quero C, 1995, J CHEM ECOL, V21, P1957, DOI 10.1007/BF02033855; Raina AK, 2000, ARTHROPOD STRUCT DEV, V29, P343, DOI 10.1016/S1467-8039(01)00014-7; Rouyar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026443; SPANGLER HG, 1984, PHYSIOL ENTOMOL, V9, P87, DOI 10.1111/j.1365-3032.1984.tb00684.x; Srinivasan A, 2004, BIOTECHNOL BIOENG, V88, P528, DOI 10.1002/bit.20285; Svensson GP, 2003, ENTOMOL EXP APPL, V106, P187, DOI 10.1046/j.1570-7458.2003.00022.x; Tischer W, 1999, TOP CURR CHEM, V200, P95; TREMATERRA P, 1995, J STORED PROD RES, V31, P43, DOI 10.1016/0022-474X(94)00034-Q; Uthoff S, 2005, APPL ENVIRON MICROB, V71, P790, DOI 10.1128/AEM.71.2.790-796.2005; WILSON EO, 1965, SCIENCE, V149, P1064, DOI 10.1126/science.149.3688.1064; WILSON EO, 1963, SCI AM, V208, P100, DOI 10.1038/scientificamerican0563-100	42	7	7	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e47751	10.1371/journal.pone.0047751	http://dx.doi.org/10.1371/journal.pone.0047751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155372	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900006
J	Rogala, B; Li, YH; Li, S; Chen, XY; Kirouac, GJ				Rogala, Benjamin; Li, Yonghui; Li, Sa; Chen, Xiaoyu; Kirouac, Gilbert J.			Effects of a Post-Shock Injection of the Kappa Opioid Receptor Antagonist Norbinaltorphimine (norBNI) on Fear and Anxiety in Rats	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; INDUCED BEHAVIORAL-RESPONSES; DEFENSIVE-WITHDRAWAL; EXTENDED AMYGDALA; LASTING CHANGES; ANIMAL-MODELS; FOOT-SHOCKS; DYNORPHIN; BINALTORPHIMINE; SENSITIZATION	Exposure of rats to footshocks leads to an enduring behavioral state involving generalized fear responses and avoidance. Recent evidence suggests that the expression of negative emotional behaviors produced by a stressor is in part mediated by dynorphin and its main receptor, the kappa opioid receptor (KOR). The purpose of this study was to determine if a subcutaneous injection of the long-acting KOR antagonist norbinaltorphimine (norBNI; 15.0 and 30.0 mg/kg) given 2 days after an acute exposure of rats to footshooks (5x2 s episodes of 1.5 mA delivered over 5 min) attenuates the expression of lasting fear and anxiety. We report that exposure of rats to acute footshock produced long-lasting (>4 weeks) fear (freezing) and anxiety (avoidance of an open area in the defensive withdrawal test). The 30 mg dose of norBNI attenuated the fear expressed when shock rats were placed in the shock context at Day 9 but not Day 27 post-shock. The same dose of norBNI had no effect on the expression of generalized fear produced when shock rats were placed in a novel chamber at Days 8 and 24. In contrast, the 30 mg dose of norBNI produced consistent anxiolytic effects in shock and nonshock rats. First, the 30 mg dose was found to decrease the latency to enter the open field in the defensive withdrawal test done 30 days after the shock exposure. Second, the same high dose also had anxiolytic effects in both nonshock and shock rats as evidence by a decrease in the mean time spent in the withdrawal box. The present study shows that systemic injection of the KOR antagonist norBNI had mixed effect on fear. In contrast, norBNI had an anxiolytic effect which included the attenuation of the enhanced avoidance of a novel area produced by a prior shock experience.	[Rogala, Benjamin; Li, Sa; Chen, Xiaoyu; Kirouac, Gilbert J.] Univ Manitoba, Fac Dent, Dept Oral Biol, Winnipeg, MB, Canada	University of Manitoba	Rogala, B (corresponding author), Univ Manitoba, Fac Dent, Dept Oral Biol, Winnipeg, MB, Canada.	kirouac@cc.umanitoba.ca		Kirouac, Gilbert/0000-0002-3632-2189; Chen, Xiaoyu/0000-0002-9020-9590	Canadian Institutes of Health Research [MOP68909] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		BALSKUBIK R, 1993, J PHARMACOL EXP THER, V264, P489; Berger W, 2009, PROG NEURO-PSYCHOPH, V33, P169, DOI 10.1016/j.pnpbp.2008.12.004; Berrendero F, 2002, PSYCHOPHARMACOLOGY, V163, P111, DOI 10.1007/s00213-002-1144-9; Bisson JI, 2007, BMJ-BRIT MED J, V334, P789, DOI 10.1136/bmj.39162.538553.80; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; Bonne O, 2004, NEUROSCI BIOBEHAV R, V28, P65, DOI 10.1016/j.neubiorev.2003.12.001; Bruijnzeel AW, 2001, PSYCHOPHARMACOLOGY, V158, P132; Bruijnzeel AW, 2001, EUR J PHARMACOL, V426, P77, DOI 10.1016/S0014-2999(01)01210-9; Carlezon WA, 2006, J PHARMACOL EXP THER, V316, P440, DOI 10.1124/jpet.105.092304; Carlezon WA, 2009, PHARMACOL THERAPEUT, V123, P334, DOI 10.1016/j.pharmthera.2009.05.008; Carobrez AP, 2005, NEUROSCI BIOBEHAV R, V29, P1193, DOI 10.1016/j.neubiorev.2005.04.017; Carr GV, 2011, PSYCHOPHARMACOLOGY, V213, P265, DOI [10.1007/s00213-010-1832-9, 10.1007/s00213-010-2097-z]; Carr GV, 2010, NEUROPSYCHOPHARMACOL, V35, P752, DOI 10.1038/npp.2009.183; CHARNEY DS, 1993, ARCH GEN PSYCHIAT, V50, P294; CHAVKIN C, 1982, SCIENCE, V215, P413, DOI 10.1126/science.6120570; Chen XY, 2012, BEHAV BRAIN RES, V226, P112, DOI 10.1016/j.bbr.2011.09.004; Cole S, 2011, LEARN MEMORY, V18, P88, DOI 10.1101/lm.2049511; Davis M, 1999, ANN NY ACAD SCI, V877, P281, DOI 10.1111/j.1749-6632.1999.tb09273.x; Davis M, 1998, BIOL PSYCHIAT, V44, P1239, DOI 10.1016/S0006-3223(98)00288-1; Davis M, 2010, NEUROPSYCHOPHARMACOL, V35, P105, DOI 10.1038/npp.2009.109; Daviu N, 2010, NEUROBIOL LEARN MEM, V94, P183, DOI 10.1016/j.nlm.2010.05.005; Ebner SR, 2010, PSYCHOPHARMACOLOGY, V210, P241, DOI 10.1007/s00213-010-1836-5; ENDOH T, 1992, ARCH INT PHARMACOD T, V316, P30; FANSELOW MS, 1991, PEPTIDES, V12, P1033, DOI 10.1016/0196-9781(91)90056-U; Gutman DA, 2003, J PHARMACOL EXP THER, V304, P874, DOI 10.1124/jpet.102.042788; JONES DNC, 1992, EUR J PHARMACOL, V215, P345, DOI 10.1016/0014-2999(92)90055-9; Kamprath K, 2004, LEARN MEMORY, V11, P770, DOI 10.1101/lm.86104; Knoll AT, 2007, J PHARMACOL EXP THER, V323, P838, DOI 10.1124/jpet.107.127415; Knoll AT, 2010, BRAIN RES, V1314, P56, DOI 10.1016/j.brainres.2009.09.074; Land BB, 2008, J NEUROSCI, V28, P407, DOI 10.1523/JNEUROSCI.4458-07.2008; Li YH, 2010, PSYCHOPHARMACOLOGY, V212, P251, DOI 10.1007/s00213-010-1948-y; Louvart H, 2006, PSYCHONEUROENDOCRINO, V31, P92, DOI 10.1016/j.psyneuen.2005.05.014; Louvart N, 2005, PSYCHONEUROENDOCRINO, V30, P316, DOI 10.1016/j.psyneuen.2004.09.003; Mague SD, 2003, J PHARMACOL EXP THER, V305, P323, DOI 10.1124/jpet.102.046433; McLaughlin J, 2003, PSYCHOPHARMACOLOGY, V168, P57, DOI 10.1007/s00213-002-1196-x; McLaughlin JP, 2006, NEUROPSYCHOPHARMACOL, V31, P1241, DOI 10.1038/sj.npp.1300872; McLaughlin JP, 2003, J NEUROSCI, V23, P5674, DOI 10.1523/jneurosci.23-13-05674.2003; Mikics E, 2008, PSYCHONEUROENDOCRINO, V33, P1198, DOI 10.1016/j.psyneuen.2008.06.006; Mikics E, 2008, PHYSIOL BEHAV, V94, P341, DOI 10.1016/j.physbeh.2008.01.023; Nestler EJ, 2006, BIOL PSYCHIAT, V59, P1151, DOI 10.1016/j.biopsych.2005.09.018; North CS, 2009, AM J PSYCHIAT, V166, P34, DOI 10.1176/appi.ajp.2008.08050644; Ohl F, 2001, BEHAV NEUROSCI, V115, P429, DOI 10.1037/0735-7044.115.2.429; Pamplona FA, 2011, J PSYCHIATR RES, V45, P354, DOI 10.1016/j.jpsychires.2010.06.015; Perrine SA, 2006, BRIT J PHARMACOL, V147, P864, DOI 10.1038/sj.bjp.0706686; Peters MF, 2011, EUR J PHARMACOL, V661, P27, DOI 10.1016/j.ejphar.2011.04.017; PFEIFFER A, 1986, SCIENCE, V233, P774, DOI 10.1126/science.3016896; Rodgers RJ, 2006, PSYCHOPHARMACOLOGY, V187, P345, DOI 10.1007/s00213-006-0435-y; Rodgers RJ, 1997, BEHAV PHARMACOL, V8, P477, DOI 10.1097/00008877-199711000-00003; Roman E, 2009, BEHAV BRAIN RES, V202, P303, DOI 10.1016/j.bbr.2009.04.019; Rosen JB, 1998, PSYCHOL REV, V105, P325, DOI 10.1037/0033-295X.105.2.325; Saitoh A, 2006, J PHARMACOL SCI, V102, P377, DOI 10.1254/jphs.FP0060837; Schank JR, 2012, ADDICT BIOL, V17, P634, DOI 10.1111/j.1369-1600.2012.00455.x; Schwarzer C, 2009, PHARMACOL THERAPEUT, V123, P353, DOI 10.1016/j.pharmthera.2009.05.006; Shalev AY, 2009, PSYCHIAT CLIN N AM, V32, P687, DOI 10.1016/j.psc.2009.06.001; Shirayama Y, 2004, J NEUROCHEM, V90, P1258, DOI 10.1111/j.1471-4159.2004.02589.x; Siegmund A, 2007, J PSYCHIATR RES, V41, P848, DOI 10.1016/j.jpsychires.2006.07.017; SPANAGEL R, 1993, SYNAPSE, V14, P243, DOI 10.1002/syn.890140307; Stam R, 2007, NEUROSCI BIOBEHAV R, V31, P530, DOI 10.1016/j.neubiorev.2006.11.010; Stam R, 2007, NEUROSCI BIOBEHAV R, V31, P558, DOI 10.1016/j.neubiorev.2007.01.001; Steckler T., 2011, NEUROPHARMACOLOGY; TAKAHASHI LK, 1989, BEHAV NEUROSCI, V103, P648, DOI 10.1037/0735-7044.103.3.648; VANDIJKEN HH, 1992, PHYSIOL BEHAV, V52, P945, DOI 10.1016/0031-9384(92)90375-C; VANDIJKEN HH, 1992, PSYCHOPHARMACOLOGY, V109, P395, DOI 10.1007/BF02247714; White DA, 2007, BRAIN RES, V1149, P141, DOI 10.1016/j.brainres.2007.02.050; Wittmann W, 2009, NEUROPSYCHOPHARMACOL, V34, P775, DOI 10.1038/npp.2008.142; Yehuda R, 2002, NEW ENGL J MED, V346, P108, DOI 10.1056/NEJMra012941; Zhang H, 2007, EUR J PHARMACOL, V570, P89, DOI 10.1016/j.ejphar.2007.05.045	67	18	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49669	10.1371/journal.pone.0049669	http://dx.doi.org/10.1371/journal.pone.0049669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166745	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900182
J	Trawalter, S; Hoffman, KM; Waytz, A				Trawalter, Sophie; Hoffman, Kelly M.; Waytz, Adam			Racial Bias in Perceptions of Others' Pain	PLOS ONE			English	Article							PREJUDICE; ETHNICITY; RACE; DISPARITIES	The present work provides evidence that people assume a priori that Blacks feel less pain than do Whites. It also demonstrates that this bias is rooted in perceptions of status and the privilege (or hardship) status confers, not race per se. Archival data from the National Football League injury reports reveal that, relative to injured White players, injured Black players are deemed more likely to play in a subsequent game, possibly because people assume they feel less pain. Experiments 1-4 show that White and Black Americans-including registered nurses and nursing students-assume that Black people feel less pain than do White people. Finally, Experiments 5 and 6 provide evidence that this bias is rooted in perceptions of status, not race per se. Taken together, these data have important implications for understanding race-related biases and healthcare disparities.	[Trawalter, Sophie] Univ Virginia, Frank Batten Sch Leadership & Publ Policy, Charlottesville, VA 22903 USA	University of Virginia	Trawalter, S (corresponding author), Univ Virginia, Frank Batten Sch Leadership & Publ Policy, Charlottesville, VA 22903 USA.	strawalter@virginia.edu						Agency for Healthcare Research and Quality, 2009, DISP HLTH CAR QUAL R; Avenanti A, 2010, CURR BIOL, V20, P1018, DOI 10.1016/j.cub.2010.03.071; Blatt B, 2010, ACAD MED, V85, P1445, DOI 10.1097/ACM.0b013e3181eae5ec; Bonham VL, 2001, J LAW MED ETHICS, V29, P52, DOI 10.1111/j.1748-720X.2001.tb00039.x; Cottrell CA, 2005, J PERS SOC PSYCHOL, V88, P770, DOI 10.1037/0022-3514.88.5.770; Dovidio J., 2010, PROSOCIAL MOTIVES EM, P393; Drwecki BB, 2011, PAIN, V152, P1001, DOI 10.1016/j.pain.2010.12.005; Forgiarini M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00108; Freeman HP, 2000, NEW ENGL J MED, V342, P1045, DOI 10.1056/NEJM200004063421411; Goff PA, 2008, J PERS SOC PSYCHOL, V94, P292, DOI 10.1037/0022-3514.94.2.292; Green CR, 2003, PAIN MED, V4, P277, DOI 10.1046/j.1526-4637.2003.03034.x; Greenwald AG, 1998, J PERS SOC PSYCHOL, P111; hooks, 2003, WE REAL COOL BLACK M; Hugenberg K, 2004, PSYCHOL SCI, V15, P342, DOI 10.1111/j.0956-7976.2004.00680.x; Hugenberg K, 2003, PSYCHOL SCI, V14, P640, DOI 10.1046/j.0956-7976.2003.psci_1478.x; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Maner JK, 2005, J PERS SOC PSYCHOL, V88, P63, DOI 10.1037/0022-3514.88.1.63; McConahay JB., 1986, PREJUDICE DISCRIMINA, P91; Minear M, 2004, BEHAV RES METH INS C, V36, P630, DOI 10.3758/BF03206543; Payne BK, 2001, J PERS SOC PSYCHOL, V81, P181, DOI 10.1037/0022-3514.81.2.181; Plant EA, 1998, J PERS SOC PSYCHOL, V75, P811, DOI 10.1037/0022-3514.75.3.811; Shapiro JR, 2009, PERS SOC PSYCHOL B, V35, P1356, DOI 10.1177/0146167209339627; Shavers VL, 2010, J HEALTH CARE POOR U, V21, P177, DOI 10.1353/hpu.0.0255; Staton LJ, 2007, J NATL MED ASSOC, V99, P532; Swim JK, 1999, PERS SOC PSYCHOL B, V25, P500, DOI 10.1177/0146167299025004008; Todd KH, 2000, ANN EMERG MED, V35, P11, DOI 10.1016/S0196-0644(00)70099-0; *US DEP HHS, 2007, NAT HEALTHC DISP REP; Wood W., 2010, HDB SOCIAL PSYCHOL, V5th ed., DOI [10.1002/9780470561119.socpsy001017, DOI 10.1002/9780470561119.SOCPSY001017]; Xu XJ, 2009, J NEUROSCI, V29, P8525, DOI 10.1523/JNEUROSCI.2418-09.2009	29	130	131	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48546	10.1371/journal.pone.0048546	http://dx.doi.org/10.1371/journal.pone.0048546			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155390	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900024
J	Yu, AL; Birke, K; Burger, J; Welge-Lussen, U				Yu, Alice L.; Birke, Kerstin; Burger, Johannes; Welge-Lussen, Ulrich			Biological Effects of Cigarette Smoke in Cultured Human Retinal Pigment Epithelial Cells	PLOS ONE			English	Article							HUMAN-DIPLOID FIBROBLASTS; CAUSES OXIDATIVE DAMAGE; GROWTH-FACTOR-BETA; MACULAR DEGENERATION; IN-VITRO; EXTRACELLULAR-MATRIX; GEOGRAPHIC ATROPHY; SENESCENCE; STRESS; EXPRESSION	The goal of the present study was to determine whether treatment with cigarette smoke extract (CSE) induces cell loss, cellular senescence, and extracellular matrix (ECM) synthesis in primary human retinal pigment epithelial (RPE) cells. Primary cultured human RPE cells were exposed to 2, 4, 8, and 12% of CSE concentration for 24 hours. Cell loss was detected by cell viability assay. Lipid peroxidation was assessed by loss of cis-parinaric acid (PNA) fluorescence. Senescence-associated beta-galactosidase (SA-beta-Gal) activity was detected by histochemical staining. Expression of apolipoprotein J (Apo J), connective tissue growth factor (CTGF), fibronectin, and laminin were examined by real-time PCR, western blot, or ELISA experiments. The results showed that exposure of cells to 12% of CSE concentration induced cell death, while treatment of cells with 2, 4, and 8% CSE increased lipid peroxidation. Exposure to 8% of CSE markedly increased the number of SA-beta-Gal positive cells to up to 82%, and the mRNA expression of Apo J, CTGF, and fibronectin by approximately 3-4 fold. Treatment with 8% of CSE also increased the protein expression of Apo J and CTGF and the secretion of fibronectin and laminin. Thus, treatment with CSE can induce cell loss, senescent changes, and ECM synthesis in primary human RPE cells. It may be speculated that cigarette smoke could be involved in cellular events in RPE cells as seen in age-related macular degeneration.	[Yu, Alice L.; Burger, Johannes] Univ Muenchen, Dept Ophthalmol, Munich, Germany	University of Munich	Yu, AL (corresponding author), Univ Muenchen, Dept Ophthalmol, Munich, Germany.	alice.yu@med.uni-muenchen.de						An E, 2006, J PROTEOME RES, V5, P2599, DOI 10.1021/pr060121j; Baglole CJ, 2008, AM J PHYSIOL-LUNG C, V295, pL624, DOI 10.1152/ajplung.90215.2008; Bernhard D, 2003, FASEB J, V17, P2302, DOI 10.1096/fj.03-0312fje; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; CAMPOCHIARO PA, 1986, INVEST OPHTH VIS SCI, V27, P1615; Cardoso JF, 2009, TOXICOL PATHOL, V37, P175, DOI 10.1177/0192623308328134; Carini M, 2000, FARMACO, V55, P526, DOI 10.1016/S0014-827X(00)00037-9; CARP H, 1978, AM REV RESPIR DIS, V118, P617; Chakravarthy U, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-31; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1729, DOI 10.1152/ajpheart.01103.2005; Chen YH, 2010, MOL INTERV, V10, P271, DOI 10.1124/mi.10.5.4; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; DORDJEVIC MV, 1995, CARCINOGENESIS, V16, P2015; Dumont P, 2000, FREE RADICAL BIO MED, V28, P361, DOI 10.1016/S0891-5849(99)00249-X; Ehrlich R, 2009, GRAEF ARCH CLIN EXP, V247, P583, DOI 10.1007/s00417-008-1018-x; Espinosa-Heidmann DG, 2006, INVEST OPHTH VIS SCI, V47, P729, DOI 10.1167/iovs.05-0719; FERRIS FL, 1983, AM J EPIDEMIOL, V118, P132, DOI 10.1093/oxfordjournals.aje.a113624; Francis PJ, 2011, CLIN OPHTHALMOL, V5, P1127, DOI 10.2147/OPTH.S11627; Fuchshofer R, 2009, EXP EYE RES, V88, P889, DOI 10.1016/j.exer.2008.11.036; Fujihara M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003119; Hodges NJ, 2007, MUTAGENESIS, V22, P189, DOI 10.1093/mutage/gem001; Honda S, 2002, BRIT J OPHTHALMOL, V86, P159, DOI 10.1136/bjo.86.2.159; Jia LH, 2007, INVEST OPHTH VIS SCI, V48, P339, DOI 10.1167/iovs.06-0248; Kaarniranta K, 2009, AGEING RES REV, V8, P128, DOI 10.1016/j.arr.2009.01.001; Kalariya NM, 2009, EXP EYE RES, V89, P494, DOI 10.1016/j.exer.2009.05.011; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Kim KH, 2004, BIOCHEM BIOPH RES CO, V318, P819, DOI 10.1016/j.bbrc.2004.04.108; KLEIN R, 1995, INVEST OPHTH VIS SCI, V36, P182; Klein R, 2008, ARCH OPHTHALMOL-CHIC, V126, P115, DOI 10.1001/archopht.126.1.115; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; LESCHEY KH, 1990, INVEST OPHTH VIS SCI, V31, P839; LOFFLER KU, 1986, GRAEF ARCH CLIN EXP, V224, P493, DOI 10.1007/BF02154735; Matsunaga H, 1999, INVEST OPHTH VIS SCI, V40, P197; Mishima K, 1999, INVEST OPHTH VIS SCI, V40, P1590; Nagai N, 2009, INVEST OPHTH VIS SCI, V50, P1903, DOI 10.1167/iovs.08-2383; NEWSOME DA, 1987, AM J OPHTHALMOL, V104, P373, DOI 10.1016/0002-9394(87)90227-3; Patil AJ, 2009, TOXICOLOGY, V259, P69, DOI 10.1016/j.tox.2009.02.004; Petrukhin K, 2007, EXPERT OPIN THER TAR, V11, P625, DOI 10.1517/14728222.11.5.625; Roth F, 2004, GRAEF ARCH CLIN EXP, V242, P710, DOI 10.1007/s00417-004-0976-x; Sakaguchi H, 2002, EXP EYE RES, V74, P547, DOI 10.1006/exer.2002.1186; SARKS JP, 1988, EYE, V2, P552, DOI 10.1038/eye.1988.106; Shapiro SD, 2004, AM J RESP CELL MOL, V31, P481, DOI 10.1165/rcmb.F285; Sharma A, 2008, INVEST OPHTH VIS SCI, V49, P5111, DOI 10.1167/iovs.08-2060; Smith CJ, 2000, FOOD CHEM TOXICOL, V38, P637, DOI 10.1016/S0278-6915(00)00051-X; Solberg Y, 1998, SURV OPHTHALMOL, V42, P535, DOI 10.1016/S0039-6257(98)00002-2; Terman A, 2001, REDOX REP, V6, P15, DOI 10.1179/135100001101535996; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; Toussaint O, 2000, EXP GERONTOL, V35, P927, DOI 10.1016/S0531-5565(00)00180-7; VANDERSCHAFT TL, 1994, GRAEF ARCH CLIN EXP, V232, P40, DOI 10.1007/BF00176436; Wang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010329; Wang XF, 2004, EXP EYE RES, V79, P209, DOI 10.1016/j.exer.2004.03.013; Welge-Lussen U, 1999, INVEST OPHTH VIS SCI, V40, P2235; YOUNG RW, 1987, SURV OPHTHALMOL, V31, P291, DOI 10.1145/1165387.275645; Yu AL, 2009, EXP EYE RES, V88, P495, DOI 10.1016/j.exer.2008.10.028; Yu AL, 2009, INVEST OPHTH VIS SCI, V50, P926, DOI 10.1167/iovs.07-1003; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; ZUCCARO P, 1993, J CHROMATOGR-BIOMED, V621, P257, DOI 10.1016/0378-4347(93)80103-B	58	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48501	10.1371/journal.pone.0048501	http://dx.doi.org/10.1371/journal.pone.0048501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155386	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900020
J	Arevalo-Martin, A; Garcia-Ovejero, D; Sierra-Palomares, Y; Paniagua-Torija, B; Gonzalez-Gil, I; Ortega-Gutierrez, S; Molina-Holgado, E				Arevalo-Martin, Angel; Garcia-Ovejero, Daniel; Sierra-Palomares, Yolanda; Paniagua-Torija, Beatriz; Gonzalez-Gil, Ines; Ortega-Gutierrez, Silvia; Molina-Holgado, Eduardo			Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; LOCOMOTOR PATTERN; MURINE MODEL; IN-VIVO; NEUROPROTECTION; RAT; CANNABINOIDS; REGENERATION; INFLAMMATION; MODULATION	Spinal cord injury (SCI) induces a cascade of processes that may further expand the damage (secondary injury) or, alternatively, may be part of a safeguard response. Here we show that after a moderate-severe contusive SCI in rats there is a significant and very early increase in the spinal cord content of the endocannabinoids 2-arachidonoylglycerol (2-AG) and arachidonoyl ethanolamide (anandamide, AEA). Since 2-AG and AEA act through CB1 and CB2 cannabinoid receptors, we administered at 20 minutes after lesion a single injection of their respective antagonists AM281 and AM630 alone or in combination to block the effects of this early endocannabinoid accumulation. We observed that AM281, AM630 or AM281 plus AM630 administration impairs the spontaneous motor recovery of rats according to the Basso-Beattie-Bresnahan (BBB) locomotor scale. However, blockade of CB1, CB2 or both receptors produced different effects at the histopathological level. Thus, AM630 administration results at 90 days after lesion in increased MHC-II expression by spinal cord microglia/monocytes and reduced number of serotoninergic fibres in lumbar spinal cord (below the lesion). AM281 exerted the same effects but also increased oedema volume estimated by MRI. Co-administration of AM281 and AM630 produced the effects observed with the administration of either AM281 or AM630 and also reduced white matter and myelin preservation and enhanced microgliosis in the epicentre. Overall, our results suggest that the endocannabinoids acting through CB1 and CB2 receptors are part of an early neuroprotective response triggered after SCI that is involved in the spontaneous recovery after an incomplete lesion.	[Arevalo-Martin, Angel; Garcia-Ovejero, Daniel; Sierra-Palomares, Yolanda; Paniagua-Torija, Beatriz; Molina-Holgado, Eduardo] Hosp Nacl Paraplejicos, SESCAM, Lab Neuroinflamac, Toledo, Spain; [Gonzalez-Gil, Ines; Ortega-Gutierrez, Silvia] Univ Complutense Madrid, Fac Ciencias Quim, Dept Quim Organ 1, E-28040 Madrid, Spain	Hospital Nacional de Paraplejicos; Complutense University of Madrid	Arevalo-Martin, A (corresponding author), Hosp Nacl Paraplejicos, SESCAM, Lab Neuroinflamac, Toledo, Spain.	aarevalom@sescam.jccm.es; eduardom@sescam.jccm.es	Ortega-Gutierrez, Silvia/ABC-7653-2021; Molina-Holgado, Eduardo/C-2714-2008; Arevalo-Martin, Angel/A-5376-2011; Garcia-Ovejero, Daniel/H-9090-2019; Ortega-Gutierrez, Silvia/I-1935-2017	Molina-Holgado, Eduardo/0000-0001-6693-1682; Garcia-Ovejero, Daniel/0000-0002-7479-5104; Ortega-Gutierrez, Silvia/0000-0002-0257-6754; Arevalo-Martin, Angel/0000-0002-0549-6098; Sierra-Palomares, Yolanda/0000-0001-5591-6292	Spanish Ministerio de Ciencia e Innovacion (Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III) [08/1999]; Gobierno de Castilla-La Mancha (Fundacion para la Investigacion Sanitaria en Castilla-La Mancha) [FISCAM 2008/37]; Fundacion Mutua Madrilena; Spanish Ministerio de Ciencia e Innovacion (MICINN) [SAF2010-22198-C02-01]; Comunidad Autonoma de Madrid [P2010/BMD-2353]	Spanish Ministerio de Ciencia e Innovacion (Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III); Gobierno de Castilla-La Mancha (Fundacion para la Investigacion Sanitaria en Castilla-La Mancha); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Spanish Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid)	This work was supported by grants from Spanish Ministerio de Ciencia e Innovacion (Fondo de Investigaciones Sanitarias, Instituto de Salud Carlos III; 08/1999), from Gobierno de Castilla-La Mancha (Fundacion para la Investigacion Sanitaria en Castilla-La Mancha; FISCAM 2008/37) and from Fundacion Mutua Madrilena. SOG is a Ramon y Cajal Scholar funded by Spanish Ministerio de Ciencia e Innovacion (MICINN, SAF2010-22198-C02-01) and Comunidad Autonoma de Madrid (P2010/BMD-2353). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary S, 2011, J NEUROTRAUM, V28, P2417, DOI 10.1089/neu.2011.1853; Alger BE, 2011, TRENDS NEUROSCI, V34, P304, DOI 10.1016/j.tins.2011.03.003; ANDEN NE, 1964, ACTA PHYSIOL SCAND, V62, P115, DOI 10.1111/j.1748-1716.1964.tb03958.x; Arevalo-Martin A, 2003, J NEUROSCI, V23, P2511; Arevalo-Martin A, 2012, NEUROPHARMACOLOGY, V63, P385, DOI 10.1016/j.neuropharm.2012.04.012; Arevalo-Martin A, 2010, NEUROBIOL DIS, V38, P304, DOI 10.1016/j.nbd.2010.02.002; BARBEAU H, 1990, BRAIN RES, V514, P55, DOI 10.1016/0006-8993(90)90435-E; BARBEAU H, 1991, BRAIN RES, V546, P250, DOI 10.1016/0006-8993(91)91489-N; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Benowitz LI, 2011, CURR OPIN NEUROL, V24, P577, DOI 10.1097/WCO.0b013e32834c208d; Cadotte DW, 2011, CLIN ORTHOP RELAT R, V469, P732, DOI 10.1007/s11999-010-1674-0; CARLSSON A, 1964, ACTA PHYSIOL SCAND, V60, P112, DOI 10.1111/j.1748-1716.1964.tb02874.x; Cernak I, 2004, J CEREBR BLOOD F MET, V24, P564, DOI 10.1097/00004647-200405000-00011; DAHLSTROM A, 1964, ACTA PHYSIOL SCAND, V60, P293, DOI 10.1111/j.1748-1716.1964.tb02891.x; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; Feraboli-Lohnherr D, 1999, J NEUROSCI RES, V55, P87, DOI 10.1002/(SICI)1097-4547(19990101)55:1<87::AID-JNR10>3.0.CO;2-#; FeraboliLohnherr D, 1997, EXP BRAIN RES, V113, P443, DOI 10.1007/PL00005597; Fong AJ, 2005, J NEUROSCI, V25, P11738, DOI 10.1523/JNEUROSCI.1523-05.2005; Garcia-Ovejero D, 2009, NEUROBIOL DIS, V33, P57, DOI 10.1016/j.nbd.2008.09.015; Gerin CG, 2010, SYNAPSE, V64, P855, DOI 10.1002/syn.20802; Grider MH, 2006, J NEUROSCI METH, V155, P172, DOI 10.1016/j.jneumeth.2005.12.021; Guindon J, 2009, CNS NEUROL DISORD-DR, V8, P403, DOI 10.2174/187152709789824660; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Heifets BD, 2009, ANNU REV PHYSIOL, V71, P283, DOI 10.1146/annurev.physiol.010908.163149; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; Lastres-Becker I, 2005, NEUROBIOL DIS, V19, P96, DOI 10.1016/j.nbd.2004.11.009; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Melis M, 2006, NEUROBIOL DIS, V24, P15, DOI 10.1016/j.nbd.2006.04.010; Ortega-Gutierrez S, 2005, FASEB J, V19, P1338, DOI 10.1096/fj.04-2464fje; Panikashvili D, 2001, NATURE, V413, P527, DOI 10.1038/35097089; Rossignol S, 2009, PHYSIOLOGY, V24, P127, DOI 10.1152/physiol.00042.2008; van der Stelt M, 2001, J NEUROSCI, V21, P8765, DOI 10.1523/JNEUROSCI.21-22-08765.2001; Veldhuis WB, 2003, J NEUROSCI, V23, P4127; Witting A, 2004, J NEUROCHEM, V89, P1555, DOI 10.1111/j.1471-4159.2004.02544.x	36	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49057	10.1371/journal.pone.0049057	http://dx.doi.org/10.1371/journal.pone.0049057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152849	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234600020
J	McGowan, MP; Tardif, JC; Ceska, R; Burgess, LJ; Soran, H; Gouni-Berthold, I; Wagener, G; Chasan-Taber, S				McGowan, Mary P.; Tardif, Jean-Claude; Ceska, Richard; Burgess, Lesley J.; Soran, Handrean; Gouni-Berthold, Ioanna; Wagener, Gilbert; Chasan-Taber, Scott			Randomized, Placebo-Controlled Trial of Mipomersen in Patients with Severe Hypercholesterolemia Receiving Maximally Tolerated Lipid-Lowering Therapy	PLOS ONE			English	Article							CHEMISTRY STANDARDIZATION PROJECT; B SYNTHESIS INHIBITOR; APOLIPOPROTEIN-A-I; FAMILIAL HYPERCHOLESTEROLEMIA; DOUBLE-BLIND; INTERNATIONAL-FEDERATION; CARDIOVASCULAR RISK; LDL CHOLESTEROL; EFFICACY; STATIN	Objectives: Mipomersen, an antisense oligonucleotide targeting apolipoprotein B synthesis, significantly reduces LDL-C and other atherogenic lipoproteins in familial hypercholesterolemia when added to ongoing maximally tolerated lipid-lowering therapy. Safety and efficacy of mipomersen in patients with severe hypercholesterolemia was evaluated. Methods and Results: Randomized, double-blind, placebo-controlled, multicenter trial. Patients (n = 58) were >= 18 years with LDL-C >= 7.8 mmol/L or LDL-C >= 5.1 mmol/L plus CHD disease, on maximally tolerated lipid-lowering therapy that excluded apheresis. Weekly subcutaneous injections of mipomersen 200 mg (n = 39) or placebo (n = 19) were added to lipid-lowering therapy for 26 weeks. Main outcome: percent reduction in LDL-C from baseline to 2 weeks after the last dose of treatment. Mipomersen (n = 27) reduced LDL-C by 36%, from a baseline of 7.2 mmol/L, for a mean absolute reduction of 2.6 mmol/L. Conversely, mean LDL-C increased 13% in placebo (n = 18) from a baseline of 6.5 mmol/L (mipomersen vs placebo p < 0.001). Mipomersen produced statistically significant (p < 0.001) reductions in apolipoprotein B and lipoprotein(a), with no change in high-density lipoprotein cholesterol. Mild-to-moderate injection site reactions were the most frequently reported adverse events with mipomersen. Mild-to-moderate flu-like symptoms were reported more often with mipomersen. Alanine transaminase increase, aspartate transaminase increase, and hepatic steatosis occurred in 21%, 13% and 13% of mipomersen treated patients, respectively. Adverse events by category for the placebo and mipomersen groups respectively were: total adverse events, 16(84.2%), 39(100%); serious adverse events, 0(0%), 6(15.4%); discontinuations due to adverse events, 1(5.3%), 8(20.5%) and cardiac adverse events, 1(5.3%), 5(12.8%). Conclusion: Mipomersen significantly reduced LDL-C, apolipoprotein B, total cholesterol and non-HDL-cholesterol, and lipoprotein(a). Mounting evidence suggests it may be a potential pharmacologic option for lowering LDL-C in patients with severe hypercholesterolemia not adequately controlled using existing therapies. Future studies will explore alternative dosing schedules aimed at minimizing side effects. Trial Registration: ClinicalTrials.gov NCT00794664.	[McGowan, Mary P.] Cardiometab Risk Reduct & Res Ctr New England, Bedford, NH USA; [Tardif, Jean-Claude] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Ceska, Richard] Charles Univ Prague, Gen Teaching Hosp, Ctr Prevent Cardiol, Prague, Czech Republic; [Ceska, Richard] Charles Univ Prague, Fac Med 1, Prague, Czech Republic; [Burgess, Lesley J.] Univ Stellenbosch, Cardiol Unit, Parow, South Africa; [Burgess, Lesley J.] Tygerberg Hosp, Parow, South Africa; [Soran, Handrean] Cent Manchester Fdn Trust, Univ Dept Med, Manchester, Lancs, England; [Gouni-Berthold, Ioanna] Univ Cologne, Ctr Endocrinol Diabet & Prevent Med, D-50931 Cologne, Germany; [Chasan-Taber, Scott] Genzyme Corp, Biostat, Cambridge, MA USA	Universite de Montreal; Charles University Prague; General University Hospital Prague; Charles University Prague; Stellenbosch University; Tygerberg Hospital; University of Manchester; University of Cologne; Sanofi-Aventis; Genzyme Corporation	McGowan, MP (corresponding author), Cardiometab Risk Reduct & Res Ctr New England, Bedford, NH USA.	mpfmcgowan@gmail.com	Ceska, Richard/A-1840-2017	Ceska, Richard/0000-0002-2541-5179	Genzyme Corporation; Genzyme; MSD Sharp Dohme; Pfizer; Bayer Healthcare	Genzyme Corporation(Sanofi-AventisGenzyme Corporation); Genzyme(Sanofi-AventisGenzyme Corporation); MSD Sharp Dohme; Pfizer(Pfizer); Bayer Healthcare(Bayer AGBayer Healthcare Pharmaceuticals)	This trial was supported by Genzyme Corporation (http://www.genzyme.com/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MPM has consulted for and participated in two Genzyme Advisory Board Meetings. She is currently an employee of Genzyme; however, this manuscript was completed prior to this employment. MPM was the lead investigator and developed the manuscript. She has served on the following speaker's bureaus: Glaxo Smith Kline and Merck-Schering Plough. JCT acknowledges grants from Genzyme to his institution. RC is an advisory board member for: Genzyme, KOWA, and MSD; and is a speaker for Abbott, ASTRA-ZENECA, MSD, Pfizer, and Sanofi. LJB reports no conflicts. HS received fees for lectures and consultancy work from Genzyme as well as research grants from MSD Sharp & Dohme and Pfizer. IGB received payments for lectures and speakers bureaus from MSD Sharp & Dohme and Genzyme. She has received travel expenses and meeting expenses from Otsuka and Novartis as well as a grant for research from Bayer Healthcare. GW and is an employee of Genzyme, a Sanofi Company. SCT is a past employee of Genzyme. This does not alter the authors' adherence to all PLOS One policies on sharing data and materials.	Akdim F, 2011, EUR HEART J, V32, P2650, DOI 10.1093/eurheartj/ehr148; Akdim F, 2010, AM J CARDIOL, V105, P1413, DOI 10.1016/j.amjcard.2010.01.003; Akdim F, 2010, J AM COLL CARDIOL, V55, P1611, DOI 10.1016/j.jacc.2009.11.069; Avis HJ, 2007, ARTERIOSCL THROM VAS, V27, P1803, DOI 10.1161/ATVBAHA.107.145151; Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bhardwaj Sidharth S, 2007, Clin Liver Dis, V11, P597, DOI 10.1016/j.cld.2007.06.010; Civeira F, 2004, ATHEROSCLEROSIS, V173, P55, DOI 10.1016/j.atherosclerosis.2003.11.010; Eckstein F, 2007, EXPERT OPIN BIOL TH, V7, P1021, DOI 10.1517/14712598.7.7.1021; Geary RS, 2009, EXPERT OPIN DRUG MET, V5, P381, DOI [10.1517/17425250902877680, 10.1517/17425250902877680 ]; GLUECK CJ, 1976, J LAB CLIN MED, V88, P941; Gould AL, 2007, CLIN THER, V29, P778, DOI 10.1016/j.clinthera.2007.05.012; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hopkins PN, 2011, J CLIN LIPIDOL, V5, pS9, DOI 10.1016/j.jacl.2011.03.452; Hudgins LC, 2002, CARDIOVASC DRUG REV, V20, P271; Marais A David, 2004, Clin Biochem Rev, V25, P49; MARCOVINA SM, 1993, CLIN CHEM, V39, P773; MARCOVINA SM, 1994, CLIN CHEM, V40, P586; McKenney JM, 2007, ATHEROSCLEROSIS, V192, P432, DOI 10.1016/j.atherosclerosis.2006.11.037; Moriarty PM, 2007, CONT CARDIOLOGY THER, P267; National Institute for Health and Clinical Excellence, 2008, ID MAN FAM HYP NICE; Nordestgaard BG, 2010, EUR HEART J, V31, P2844, DOI 10.1093/eurheartj/ehq386; Preiss D, 2009, CLIN ENDOCRINOL, V70, P815, DOI 10.1111/j.1365-2265.2008.03490.x; Raal FJ, 2010, LANCET, V375, P998, DOI 10.1016/S0140-6736(10)60284-X; Rodenburg J, 2007, CIRCULATION, V116, P664, DOI 10.1161/CIRCULATIONAHA.106.671016; Sankatsing RR, 2005, ARTERIOSCL THROM VAS, V25, P1979, DOI 10.1161/01.ATV.0000176191.64314.07; Stein EA, 2010, EUR HEART J, V31, P898; Thompson GR, 2008, ATHEROSCLEROSIS, V198, P247, DOI 10.1016/j.atherosclerosis.2008.02.009; Visser ME, 2012, EUR HEART J, V33, P1142, DOI 10.1093/eurheartj/ehs023; Yokoo T, 2009, RADIOLOGY, V251, P67, DOI 10.1148/radiol.2511080666	31	170	177	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49006	10.1371/journal.pone.0049006	http://dx.doi.org/10.1371/journal.pone.0049006			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152839	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600018
J	Carson, CG; Rasmussen, MA; Thyssen, JP; Menne, T; Bisgaard, H				Carson, Charlotte Giwercman; Rasmussen, Morten Arendt; Thyssen, Jacob P.; Menne, Torkil; Bisgaard, Hans			Clinical Presentation of Atopic Dermatitis by Filaggrin Gene Mutation Status during the First 7 Years of Life in a Prospective Cohort Study	PLOS ONE			English	Article							OF-FUNCTION MUTATIONS; NULL-MUTATIONS; HAND ECZEMA; ICHTHYOSIS VULGARIS; PHENOTYPES; ASTHMA; SKIN; PREDISPOSE; PREVALENCE; VARIANTS	Background: Filaggrin null mutations result in impaired skin barrier functions, increase the risk of early onset atopic dermatitis and lead to a more severe and chronic disease. We aimed to characterize the clinical presentation and course of atopic dermatitis associated with filaggrin mutations within the first 7 years of life. Method: The COPSAC cohort is a prospective, clinical birth cohort study of 411 children born to mothers with a history of asthma followed during their first 7 years of life with scheduled visits every 6 months, as well as visits for acute exacerbations of dermatitis. Atopic dermatitis was defined in accordance with international guidelines and described at every visit using 35 predefined localizations and 10 different characteristics. Results: A total of 170 (43%) of 397 Caucasian children developed atopic dermatitis. The R501X and/or 2282del4 filaggrin null mutations were present in 26 (15%) of children with atopic dermatitis and were primarily associated with predilection to exposed skin areas (especially the cheeks and back of the hands) and an up-regulation of both acute and chronic dermatitis. Furthermore, we found the filaggrin mutations to be associated with a higher number of unscheduled visits (3.6 vs. 2.7; p = 0.04) and more severe (moderate-severe SCORAD 44% vs. 31%; p = 0.14), and widespread dermatitis (10% vs. 6% of the body area, p<0.001) with an earlier age at onset (246 vs. 473 days, p<0.0001) compared to wild-type. Conclusion: In children, filaggrin mutations seem to define a specific endotype of atopic dermatitis primarily characterized by predilection to exposed areas of the body, in particular hands and cheeks, and an up-regulation in both acute and chronic morphological markers. Secondary, this endotype is characterized by an early onset of dermatitis and a more severe course, with more generalized dermatitis resulting in more frequent medical consultations.	[Carson, Charlotte Giwercman; Bisgaard, Hans] Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood COPS, Copenhagen, Denmark; [Rasmussen, Morten Arendt] Univ Copenhagen, Fac Life Sci, Frederiksberg, Denmark; [Thyssen, Jacob P.; Menne, Torkil] Univ Copenhagen, Gentofte Hosp, Dept Dermatoallergol, Natl Allergy Res Ctr, Hellerup, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; Herlev & Gentofte Hospital	Bisgaard, H (corresponding author), Univ Copenhagen, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood COPS, Copenhagen, Denmark.	bisgaard@copsac.dk	Bisgaard, Hans/N-4761-2016; Arendt, Morten/S-8843-2017; Thyssen, Jacob/ABD-8517-2020; Rasmussen, Morten/AAE-9517-2020; Kronow, Joern/B-1054-2011	Bisgaard, Hans/0000-0003-4131-7592; Arendt, Morten/0000-0001-7431-5206; Rasmussen, Morten/0000-0001-7431-5206; Thyssen, Jacob Pontoppidan/0000-0003-3770-1743	private and public research funds; Lundbeck Foundation; Pharmacy Foundation of 1991; Augustinus Foundation; Danish Medical Research Council; Danish Pediatric Asthma Centre	private and public research funds; Lundbeck Foundation(Lundbeckfonden); Pharmacy Foundation of 1991; Augustinus Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Pediatric Asthma Centre	COPSAC is funded by private and public research funds. Grants above 100.000 Euro were donated by the Lundbeck Foundation, the Pharmacy Foundation of 1991, Augustinus Foundation, the Danish Medical Research Council and the Danish Pediatric Asthma Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, LANCET, V351, P1225; Barker JNWN, 2007, J INVEST DERMATOL, V127, P564, DOI 10.1038/sj.jid.5700587; Barker M, 2003, J CHEMOMETR, V17, P166, DOI 10.1002/cem.785; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bonnelykke K, 2010, PEDIAT ALLERG IMM-UK, V21, P954, DOI 10.1111/j.1399-3038.2010.01073.x; Brown SJ, 2009, BRIT J DERMATOL, V161, P884, DOI 10.1111/j.1365-2133.2009.09339.x; BROWN SJ, 2007, J INVEST DERMATOL; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Fahy CMR, 2011, BRIT ASS DEM ANN M; Gruber R, 2011, AM J PATHOL, V178, P2252, DOI 10.1016/j.ajpath.2011.01.053; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Irvine AD, 2007, J INVEST DERMATOL, V127, P504, DOI 10.1038/sj.jid.5700695; Kaiser Henry F, 1958, PSYCHOMETRIKA, V23, P187; Kezic S, 2011, ALLERGY; Marenholz I, 2006, J ALLERGY CLIN IMMUN, V118, P866, DOI 10.1016/j.jaci.2006.07.026; O'Regan GM, 2010, J ALLERGY CLIN IMMUN, V126, P574, DOI 10.1016/j.jaci.2010.04.038; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pugliarello S, 2011, J DTSCH DERMATOL GES, V9, P12, DOI 10.1111/j.1610-0387.2010.07508.x; Sergeant A, 2009, J INVEST DERMATOL, V129, P1042, DOI 10.1038/jid.2008.324; Simpson EL, 2006, DERMATITIS, V17, P123, DOI 10.2310/6620.2006.06005; Smith FJD, 2006, NAT GENET, V38, P337, DOI 10.1038/ng1743; Thyssen JP, 2012, BRIT J DERMATOL, V166, P46, DOI 10.1111/j.1365-2133.2011.10530.x; Thyssen JP, 2012, J EUR ACAD DERMATOL, V26, P386, DOI 10.1111/j.1468-3083.2011.04073.x; Thyssen JP, 2010, BRIT J DERMATOL, V163, P115, DOI 10.1111/j.1365-2133.2010.09822.x; Thyssen JP, 2010, ACTA DERM-VENEREOL, V90, P528, DOI 10.2340/00015555-0883; Weidinger S, 2006, J ALLERGY CLIN IMMUN, V118, P214, DOI 10.1016/j.jaci.2006.05.004; WILLIAMS HC, 1994, BRIT J DERMATOL, V131, P397, DOI 10.1111/j.1365-2133.1994.tb08531.x; 1993, DERMATOLOGY, V186, P23	30	50	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48678	10.1371/journal.pone.0048678	http://dx.doi.org/10.1371/journal.pone.0048678			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166590	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300011
J	Goto-Inoue, N; Hayasaka, T; Zaima, N; Nakajima, K; Holleran, WM; Sano, S; Uchida, Y; Setou, M				Goto-Inoue, Naoko; Hayasaka, Takahiro; Zaima, Nobuhiro; Nakajima, Kimiko; Holleran, Walter M.; Sano, Shigetoshi; Uchida, Yoshikazu; Setou, Mitsutoshi			Imaging Mass Spectrometry Visualizes Ceramides and the Pathogenesis of Dorfman-Chanarin Syndrome Due to Ceramide Metabolic Abnormality in the Skin	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; EPIDERMAL PERMEABILITY BARRIER; STRATUM-CORNEUM CERAMIDES; HIGH-SPATIAL-RESOLUTION; LIPIDS; DISEASE; PHOSPHATIDYLCHOLINES; GLUCOSYLCERAMIDE; INSTRUMENTATION; SPHINGOMYELINS	Imaging mass spectrometry (IMS) is a useful cutting edge technology used to investigate the distribution of biomolecules such as drugs and metabolites, as well as to identify molecular species in tissues and cells without labeling. To protect against excess water loss that is essential for survival in a terrestrial environment, mammalian skin possesses a competent permeability barrier in the stratum corneum (SC), the outermost layer of the epidermis. The key lipids constituting this barrier in the SC are the ceramides (Cers) comprising of a heterogeneous molecular species. Alterations in Cer composition have been reported in several skin diseases that display abnormalities in the epidermal permeability barrier function. Not only the amounts of different Cers, but also their localizations are critical for the barrier function. We have employed our new imaging system, capable of high-lateral-resolution IMS with an atmospheric-pressure ionization source, to directly visualize the distribution of Cers. Moreover, we show an ichthyotic disease pathogenesis due to abnormal Cer metabolism in Dorfman-Chanarin syndrome, a neutral lipid storage disorder with ichthyosis in human skin, demonstrating that IMS is a novel diagnostic approach for assessing lipid abnormalities in clinical setting, as well as for investigating physiological roles of lipids in cells/tissues.	[Holleran, Walter M.; Uchida, Yoshikazu] Univ Calif San Francisco, Sch Med, Dept Dermatol, Dept Vet Affairs Med Ctr, San Francisco, CA 94143 USA; [Holleran, Walter M.; Uchida, Yoshikazu] No Calif Inst Res & Educ, San Francisco, CA USA; [Goto-Inoue, Naoko; Hayasaka, Takahiro; Setou, Mitsutoshi] Hamamatsu Univ Sch Med, Dept Cell Biol & Anat, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Zaima, Nobuhiro] Kinki Univ, Dept Appl Biol Chem, Nara, Japan; [Nakajima, Kimiko; Sano, Shigetoshi] Kochi Univ, Kochi Med Sch, Dept Dermatol, Nanko Ku, Nankoku, Kochi, Japan	University of California System; University of California San Francisco; Northern California Institute for Research & Education; Hamamatsu University School of Medicine; Kindai University (Kinki University); Kochi University	Uchida, Y (corresponding author), Univ Calif San Francisco, Sch Med, Dept Dermatol, Dept Vet Affairs Med Ctr, San Francisco, CA 94143 USA.	uchiday@derm.ucsf.edu; setou@hama-med.ac.jp		Uchida, Yoshikazu/0000-0002-4980-3416	SENTAN program of the Japan Science and Technology Agency; National Institutes of Health [AR051077, AR062025]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051077, R01AR062025] Funding Source: NIH RePORTER	SENTAN program of the Japan Science and Technology Agency; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a Grant-in-Aid under the SENTAN program of the Japan Science and Technology Agency to TH, Grant-in-Aid for Scientific Research (C) for NG-I, Grant-in-aid for the scientific research project "Machinery of bioactive lipids in homeostatis and diseases" for MS, and National Institutes of Health Grant (AR051077 and AR062025) for YU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleck O, 1999, J INVEST DERMATOL, V113, P894, DOI 10.1046/j.1523-1747.1999.00809.x; Bouwstra JA, 1998, J LIPID RES, V39, P186; Cornett DS, 2007, NAT METHODS, V4, P828, DOI 10.1038/NMETH1094; Demerjian M, 2006, J INVEST DERMATOL, V126, P2032, DOI 10.1038/sj.jid.5700332; Deutskens F, 2011, J MASS SPECTROM, V46, P568, DOI 10.1002/jms.1926; Dobrzyn A, 2002, AM J PHYSIOL-ENDOC M, V282, pE277, DOI 10.1152/ajpendo.00151.2001; ELIAS PM, 1991, ADV LIPID RES, V24, P1; Farwanah H, 2007, J CHROMATOGR B, V852, P562, DOI 10.1016/j.jchromb.2007.02.030; Gorska M, 2002, HORM METAB RES, V34, P466, DOI 10.1055/s-2002-33597; Goto-Inoue N, 2010, ANAL SCI, V26, P821, DOI 10.2116/analsci.26.821; Hamanaka S, 2005, BRIT J DERMATOL, V152, P426, DOI 10.1111/J.1365-2133.2004.06333.X; Hankin JA, 2011, J AM SOC MASS SPECTR, V22, P1014, DOI 10.1007/s13361-011-0122-z; Harada T, 2009, ANAL CHEM, V81, P9153, DOI 10.1021/ac901872n; Hart PJ, 2011, ANAL BIOANAL CHEM, V401, P115, DOI 10.1007/s00216-011-5090-4; Hayasaka T, 2008, RAPID COMMUN MASS SP, V22, P3415, DOI 10.1002/rcm.3751; Hayasaka T, 2009, LIPIDS, V44, P837, DOI 10.1007/s11745-009-3331-5; Holleran WM, 2006, FEBS LETT, V580, P5456, DOI 10.1016/j.febslet.2006.08.039; HOLLERAN WM, 1993, J CLIN INVEST, V91, P1656, DOI 10.1172/JCI116374; HOLLERAN WM, 1994, J CLIN INVEST, V93, P1756, DOI 10.1172/JCI117160; IMOKAWA G, 1991, J INVEST DERMATOL, V96, P523, DOI 10.1111/1523-1747.ep12470233; Jensen JM, 1999, J CLIN INVEST, V104, P1761, DOI 10.1172/JCI5307; Kasumov T, 2010, ANAL BIOCH; Kobayashi Y, 2010, PLACENTA, V31, P245, DOI 10.1016/j.placenta.2009.12.026; Laiko VV, 2000, ANAL CHEM, V72, P652, DOI 10.1021/ac990998k; Morita Y, 2010, CANCER SCI, V101, P267, DOI 10.1111/j.1349-7006.2009.01384.x; MOTTA S, 1993, BIOCHIM BIOPHYS ACTA, V1182, P147, DOI 10.1016/0925-4439(93)90135-N; Munoz-Garcia A, 2006, J CHROMATOGR A, V1133, P58, DOI 10.1016/j.chroma.2006.06.067; Nakamura K, 2006, ANAL CHEM, V78, P5736, DOI 10.1021/ac0605501; PAIGE DG, 1994, BRIT J DERMATOL, V131, P23, DOI 10.1111/j.1365-2133.1994.tb08452.x; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; PONEC M, 1988, J LIPID RES, V29, P949; PREISS JE, 1987, METHOD ENZYMOL, V141, P294; Radner FPW, 2010, J BIOL CHEM, V285, P7300, DOI 10.1074/jbc.M109.081877; Schmuth M, 2000, J INVEST DERMATOL, V115, P459, DOI 10.1046/j.1523-1747.2000.00081.x; Shimma S, 2008, ANAL CHEM, V80, P878, DOI 10.1021/ac071301v; Spengler B, 2002, J AM SOC MASS SPECTR, V13, P735, DOI 10.1016/S1044-0305(02)00376-8; Spraggins JM, 2011, J AM SOC MASS SPECTR, V22, P1022, DOI 10.1007/s13361-011-0121-0; Sugiura Y, 2009, J LIPID RES, V50, P1776, DOI 10.1194/jlr.M900047-JLR200; Tserng KY, 2003, ANAL BIOCHEM, V323, P84, DOI 10.1016/j.ab.2003.08.026; Uchida Y, 2008, J INVEST DERMATOL, V128, pS92; Uchida Y, 2010, J INVEST DERMATOL, V130, P2497, DOI 10.1038/jid.2010.145; Vielhaber G, 2001, J INVEST DERMATOL, V117, P1126, DOI 10.1046/j.0022-202x.2001.01527.x; Vietzke JP, 2001, LIPIDS, V36, P299, DOI 10.1007/s11745-001-0721-9; WERTZ PW, 1982, SCIENCE, V217, P1261, DOI 10.1126/science.7112128; Yang JH, 2011, ANAL CHEM, V83, P5728, DOI 10.1021/ac200998a; Yano M, 1998, J LIPID RES, V39, P2091; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052; Zaima N, 2010, RAPID COMMUN MASS SP, V24, P2723, DOI 10.1002/rcm.4693; Zaima N, 2009, J OLEO SCI, V58, P415, DOI 10.5650/jos.58.415	49	18	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49519	10.1371/journal.pone.0049519	http://dx.doi.org/10.1371/journal.pone.0049519			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166695	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300048
J	Ishikawa, M; Nakatani, H; Hori, K				Ishikawa, Masahito; Nakatani, Hajime; Hori, Katsutoshi			AtaA, a New Member of the Trimeric Autotransporter Adhesins from Acinetobacter sp Tol 5 Mediating High Adhesiveness to Various Abiotic Surfaces	PLOS ONE			English	Article							YERSINIA-ENTEROCOLITICA; MONOLAYER ADSORPTION; BIOFILM FORMATION; COLLAGEN-BINDING; CELL APPENDAGES; SP ADP1; PROTEIN; YADA; ADHERENCE; BACTERIUM	Acinetobacter sp. Tol 5 exhibits an autoagglutinating nature and noteworthy adhesiveness to various abiotic surfaces from hydrophobic plastics to hydrophilic glass and stainless steel. Although previous studies have suggested that bacterionanofibers on Tol 5 cells are involved in the adhesive phenotype of Tol 5, the fiber that directly mediates Tol 5 adhesion has remained unknown. Here, we present a new member of trimeric autotransporter adhesins designated AtaA, which we discovered by analyzing a less adhesive mutant of Tol 5, T1, obtained by transposon mutagenesis. AtaA forms thinner and shorter nanofibers than fimbriae on Tol 5 cells. We performed target disruption of ataA by allelic marker exchange, and the resulting Delta ataA strain was complemented with ataA on the Escherichia coli- Acinetobacter shuttle vector, which was newly constructed. These results proved that AtaA is essential for Tol 5' s autoagglutinating nature and high adhesiveness to surfaces of various materials. In addition, the adhesiveness to solid surfaces mediated by AtaA is notably higher than that mediated by YadA of Yersinia enterocolitica WA-314. Moreover, and importantly, these characteristics can be conferred to the non-adhesive, non-agglutinating bacterium Acinetobacter sp. ADP1 in trans by transformation with ataA, with expected applications to microbial immobilization.	[Ishikawa, Masahito; Nakatani, Hajime; Hori, Katsutoshi] Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Nagoya University	Ishikawa, M (corresponding author), Nagoya Univ, Grad Sch Engn, Dept Biotechnol, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	khori@nubio.nagoya-u.ac.jp	Ishikawa, Masahito/AAL-5459-2021; Hori, Katsutoshi/K-5289-2012	Ishikawa, Masahito/0000-0001-6390-1031; Hori, Katsutoshi/0000-0003-1994-3124	Grants-in-Aid for Scientific Research [11J08845] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abdel-el-haleem D., 2003, AFR J BIOTECHNOL, V2, P71, DOI 10.5897/AJB2003.000-1014; Barbe V, 2004, NUCLEIC ACIDS RES, V32, P5766, DOI 10.1093/nar/gkh910; Bieber D, 1998, SCIENCE, V280, P2114, DOI 10.1126/science.280.5372.2114; Bullard B, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-65; Carballeira JD, 2009, BIOTECHNOL ADV, V27, P686, DOI 10.1016/j.biotechadv.2009.05.001; Cassidy MB, 1996, J IND MICROBIOL, V16, P79, DOI 10.1007/BF01570068; Charbonneau ME, 2007, J BACTERIOL, V189, P9020, DOI 10.1128/JB.01238-07; Conners R, 2008, EMBO J, V27, P1779, DOI 10.1038/emboj.2008.101; Edwards TE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012803; El Tahir Y, 2001, INT J MED MICROBIOL, V291, P209, DOI 10.1078/1438-4221-00119; Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155; Girard V, 2006, RES MICROBIOL, V157, P407, DOI 10.1016/j.resmic.2006.02.001; HEESEMANN J, 1983, J BACTERIOL, V155, P761, DOI 10.1128/JB.155.2.761-767.1983; Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989; Hori K, 2001, J CHEM ENG JPN, V34, P1120, DOI 10.1252/jcej.34.1120; Hori K, 2008, APPL ENVIRON MICROB, V74, P2511, DOI 10.1128/AEM.02229-07; Hori K, 2011, J BIOSCI BIOENG, V111, P31, DOI 10.1016/j.jbiosc.2010.08.009; Hori K, 2010, BIOCHEM ENG J, V48, P424, DOI 10.1016/j.bej.2009.11.014; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Ishii S, 2004, APPL ENVIRON MICROB, V70, P5026, DOI 10.1128/AEM.70.8.5026-5029.2004; Ishii SI, 2006, BIOSCI BIOTECH BIOCH, V70, P2635, DOI 10.1271/bbb.60236; Ishikawa M, 2012, J BIOSCI BIOENG, V113, P719, DOI 10.1016/j.jbiosc.2012.01.011; Kachlany SC, 2001, MOL MICROBIOL, V40, P542, DOI 10.1046/j.1365-2958.2001.02422.x; Kaiser PO, 2008, CELL MICROBIOL, V10, P2223, DOI 10.1111/j.1462-5822.2008.01201.x; Laarmann S, 2002, MOL MICROBIOL, V46, P731, DOI 10.1046/j.1365-2958.2002.03189.x; Leduc I, 2009, INFECT IMMUN, V77, P657, DOI 10.1128/IAI.00819-08; Leo JC, 2011, STRUCTURE, V19, P1021, DOI 10.1016/j.str.2011.03.021; Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Merz AJ, 2002, CURR BIOL, V12, pR297, DOI 10.1016/S0960-9822(02)00806-0; Metzgar D, 2004, NUCLEIC ACIDS RES, V32, P5780, DOI 10.1093/nar/gkh881; Muller NF, 2011, INFECT IMMUN, V79, P2544, DOI 10.1128/IAI.01309-10; Newman JR, 1999, GENE, V227, P197, DOI 10.1016/S0378-1119(98)00601-5; Nummelin H, 2004, EMBO J, V23, P701, DOI 10.1038/sj.emboj.7600100; Pearson MM, 2006, INFECT IMMUN, V74, P1588, DOI 10.1128/IAI.74.3.1588-1596.2006; QUANDT J, 1993, GENE, V127, P15, DOI 10.1016/0378-1119(93)90611-6; Raghunathan D, 2011, INFECT IMMUN, V79, P4342, DOI 10.1128/IAI.05592-11; Ray SK, 2002, MOL MICROBIOL, V46, P637, DOI 10.1046/j.1365-2958.2002.03188.x; ROGGENKAMP A, 1995, MOL MICROBIOL, V16, P1207, DOI 10.1111/j.1365-2958.1995.tb02343.x; Scarselli M, 2006, MOL MICROBIOL, V61, P631, DOI 10.1111/j.1365-2958.2006.05261.x; Serruto D, 2009, CELL MICROBIOL, V11, P1044, DOI 10.1111/j.1462-5822.2009.01306.x; Sheets AJ, 2008, J BACTERIOL, V190, P4313, DOI 10.1128/JB.01963-07; Sheets AJ, 2011, J BACTERIOL, V193, P329, DOI 10.1128/JB.00933-10; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Soto GE, 1999, J BACTERIOL, V181, P1059, DOI 10.1128/JB.181.4.1059-1071.1999; Szczesny P, 2008, BIOINFORMATICS, V24, P1251, DOI 10.1093/bioinformatics/btn118; Tsang PH, 2006, P NATL ACAD SCI USA, V103, P5764, DOI 10.1073/pnas.0601705103; Valle J, 2008, J BACTERIOL, V190, P4147, DOI 10.1128/JB.00122-08; Watanabe H, 2008, J BIOSCI BIOENG, V106, P226, DOI 10.1263/jbb.106.226; Yue G, 2007, INFECT IMMUN, V75, P4440, DOI 10.1128/IAI.02020-06	50	36	38	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48830	10.1371/journal.pone.0048830	http://dx.doi.org/10.1371/journal.pone.0048830			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155410	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900044
J	Nespital, T; Strous, GJ				Nespital, Tobias; Strous, Ger J.			The Jak/Stat Signaling Pathway Is Downregulated at Febrile Temperatures	PLOS ONE			English	Article							GROWTH-HORMONE RECEPTOR; INTERLEUKIN-6-TYPE CYTOKINES; IMMUNE SURVEILLANCE; PROTEIN AGGREGATION; HEAT-STRESS; FEVER; UBIQUITINATION; JAK2; DEGRADATION; KINASES	Background: The Janus family of kinases (JAKs), Jak1, Jak2, Jak3, and Tyk2, constitute a subgroup of non-receptor protein tyrosine kinases. Upon cytokine binding, the receptor-associated kinases are activated and phosphorylate tyrosine residues in their cognate cytokine receptors. Their activities are controlled at several levels and include cellular concentration, auto-activation, and degradation. Principal Findings: Our findings show that elevated temperatures in the fever range irreversibly aggregate Jak2 and considerably reduce functional Jak2 protein levels. Jak2 synthesis remains unaltered. We observed that also the protein level of the signal transducer and activator of transcription, STAT5b, is transiently decreased at temperatures above 37 degrees C. Consequently, the signaling response, e. g. via the growth hormone receptor, is reduced. Conclusions/Significance: These findings predict that elevated body temperatures lower the responsiveness of cytokine receptors.	[Nespital, Tobias] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center	Nespital, T (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	gstrous@umcutrecht.nl						Argetsinger LS, 1996, PHYSIOL REV, V76, P1089, DOI 10.1152/physrev.1996.76.4.1089; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; DuBose DA, 2002, SHOCK, V17, P217, DOI 10.1097/00024382-200203000-00010; EGAN SE, 1993, NATURE, V365, P781, DOI 10.1038/365781a0; Fairchild KD, 2000, J INTERF CYTOK RES, V20, P1049, DOI 10.1089/107999000750053708; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; GREEN H, 1985, DIFFERENTIATION, V29, P195, DOI 10.1111/j.1432-0436.1985.tb00316.x; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Jiang QQ, 1999, AM J PHYSIOL-REG I, V276, pR1653; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kapuria V, 2011, CELL SIGNAL, V23, P2076, DOI 10.1016/j.cellsig.2011.08.002; Kluger MJ, 1998, ANN NY ACAD SCI, V856, P224, DOI 10.1111/j.1749-6632.1998.tb08329.x; Kohlhuber F, 1997, MOL CELL BIOL, V17, P695, DOI 10.1128/MCB.17.2.695; KULKA RG, 1988, J BIOL CHEM, V263, P15726; Lei JT, 2011, J BIOL CHEM, V286, P40091, DOI 10.1074/jbc.M111.273482; Leon LR, 1999, AM J PHYSIOL-REG I, V276, pR81, DOI 10.1152/ajpregu.1999.276.1.R81; Leon LR, 2002, J APPL PHYSIOL, V92, P2648, DOI 10.1152/japplphysiol.01005.2001; Mackiewicz A, 1995, ANN NY ACAD SCI, V762, P361; Mackowiak PA, 1998, ARCH INTERN MED, V158, P1870, DOI 10.1001/archinte.158.17.1870; Martinez-Moczygemba M, 2007, J LEUKOCYTE BIOL, V81, P1137, DOI 10.1189/jlb.0706465; Marubayashi S, 2010, J CLIN INVEST, V120, P3578, DOI 10.1172/JCI42442; Matsuda T, 2004, BIOCHEM BIOPH RES CO, V325, P586, DOI 10.1016/j.bbrc.2004.10.071; Murray PJ, 2007, J IMMUNOL, V178, P2623, DOI 10.4049/jimmunol.178.5.2623; O'Brien KB, 2002, J BIOL CHEM, V277, P8673, DOI 10.1074/jbc.M109165200; Olzmann JA, 2008, AUTOPHAGY, V4, P85, DOI 10.4161/auto.5172; Ostberg JR, 2000, J LEUKOCYTE BIOL, V68, P815; Putters J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014676; Radtke S, 2005, J BIOL CHEM, V280, P25760, DOI 10.1074/jbc.M500822200; Rhoads ML, 2010, J DAIRY SCI, V93, P170, DOI 10.3168/jds.2009-2469; Roth J, 2006, NEUROL CLIN, V24, P421, DOI 10.1016/j.ncl.2006.03.004; Royer Y, 2005, J BIOL CHEM, V280, P27251, DOI 10.1074/jbc.M501376200; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Sehgal PB, 1995, ANN NY ACAD SCI, V762, P1; Shah M, 2002, J BIOL CHEM, V277, P45662, DOI 10.1074/jbc.M205935200; Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226; Skitzki JJ, 2007, J MOL MED-JMM, V85, P1361, DOI 10.1007/s00109-007-0245-7; Strous GJ, 1996, EMBO J, V15, P3806, DOI 10.1002/j.1460-2075.1996.tb00754.x; Sulahian R, 2009, BLOOD, V113, P5287, DOI 10.1182/blood-2008-09-179572; Swaminathan G, 2008, J ENDOCRINOL, V196, pR1, DOI 10.1677/JOE-07-0554; Tan JC, 2005, PEDIATR NEPHROL, V20, P567, DOI 10.1007/s00467-004-1766-8; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Ungureanu D, 2002, MOL CELL BIOL, V22, P3316, DOI 10.1128/MCB.22.10.3316-3326.2002; Vardain TD, 2007, CYTOKINE, V39, P84, DOI 10.1016/j.cyto.2007.07.184; Vidair CA, 1996, INT J HYPERTHER, V12, P681, DOI 10.3109/02656739609027676; WETZEL R, 1994, TRENDS BIOTECHNOL, V12, P193, DOI 10.1016/0167-7799(94)90082-5; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253	47	7	8	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49374	10.1371/journal.pone.0049374	http://dx.doi.org/10.1371/journal.pone.0049374			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166650	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900132
J	Robinson, E; Higgs, S				Robinson, Eric; Higgs, Suzanne			Liking Food Less: The Impact of Social Influence on Food Liking Evaluations in Female Students	PLOS ONE			English	Article							CONFORMITY; NORMS; CHOICE; ENJOYMENT	Social factors are known to influence food intake and choice. However, whether social influence acts on evaluations of food and drink liking has not been studied. Across two studies, we tested whether leading a participant to believe that other people do not like a food affects food liking evaluations. In Study 1, we exposed participants to social normative information suggesting a) that an in-group disliked orange juice, b) that an out-group disliked orange juice or c) that an in-group were neutral about orange juice. We then examined how much participants believed they liked orange juice. In Study 2, participants consumed a snack food before being led to believe that two previous participants had also eaten the food and either disliked or quite liked it. We asked participants to rate how much they had enjoyed eating the snack food. Across both studies, social influence was observed, as underlined by decreases in liking evaluations. In Study 1, beliefs about liking were only influenced by social normative information when the norm was expressed by an in-group. In Study 2, exposure to others' accounts of a negative experience with a food decreased evaluated liking of the recent consumption experience. These results suggest that social influence can act upon food liking evaluations.	[Robinson, Eric; Higgs, Suzanne] Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Robinson, E (corresponding author), Univ Birmingham, Sch Psychol, Birmingham B15 2TT, W Midlands, England.	e.robinson@bham.ac.uk	Higgs, Suzanne/A-9632-2008	Higgs, Suzanne/0000-0002-9225-7692				Addessi E, 2005, APPETITE, V45, P264, DOI 10.1016/j.appet.2005.07.007; ASCH SE, 1956, PSYCHOL MONOGR, V70, P1, DOI 10.1037/h0093718; Barthomeuf L, 2009, APPETITE, V52, P27, DOI 10.1016/j.appet.2008.07.002; BIRCH LL, 1980, CHILD DEV, V51, P489, DOI 10.2307/1129283; Blissett J., 2012, BRIT J NUTR IN PRESS; Bond R, 1996, PSYCHOL BULL, V119, P111, DOI 10.1037/0033-2909.119.1.111; Braun KA, 1999, J CONSUM RES, V25, P319, DOI 10.1086/209542; Cardello A. V., 1992, Journal of Sensory Studies, V7, P253, DOI 10.1111/j.1745-459X.1992.tb00194.x; Christensen PN, 2004, PERS SOC PSYCHOL B, V30, P1295, DOI 10.1177/0146167204264480; Crutchfield RS, 1955, AM PSYCHOL, V10, P191, DOI 10.1037/h0040237; Cruwys T, 2012, APPETITE, V58, P754, DOI 10.1016/j.appet.2011.12.002; de Graaf C, 2005, APPETITE, V44, P23, DOI 10.1016/j.appet.2004.08.008; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Echterhoff G, 2009, SOC PSYCHOL-GERMANY, V40, P106, DOI 10.1027/1864-9335.40.3.106; Galef BG, 2008, ANIM BEHAV, V75, P2035, DOI 10.1016/j.anbehav.2007.11.012; GARNER DM, 1982, INT J EAT DISORDER, V1, P3, DOI 10.1002/1098-108X(198224)1:2<3::AID-EAT2260010202>3.0.CO;2-J; Gibson EL, 2006, PROGR BRAIN RES APPE, P271; Gilbert DT, 2007, SCIENCE, V317, P1351, DOI 10.1126/science.1144161; Haslam S. Alexander, 1996, WHATS SOCIAL SOCIAL, P29, DOI [10.4135/9781483327648.N2, DOI 10.4135/9781483327648]; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Herman CP, 2003, PSYCHOL BULL, V129, P873, DOI 10.1037/0033-2909.129.6.873; Horsburgh-McLeod G, 2009, EAT WEIGHT DISORD-ST, V14, pE153, DOI 10.1007/BF03327815; Jolles JW, 2011, ANIM COGN, V14, P769, DOI 10.1007/s10071-011-0395-4; Lally P, 2011, APPETITE, V57, P623, DOI 10.1016/j.appet.2011.07.015; Platow MJ, 2005, J EXP SOC PSYCHOL, V41, P542, DOI 10.1016/j.jesp.2004.09.005; Pliner P, 2004, APPETITE, V42, P227, DOI 10.1016/j.appet.2003.12.001; Raghunathan R, 2006, J MARKETING, V70, P170, DOI 10.1509/jmkg.70.4.170; Reysen MB, 2007, MEM COGNITION, V35, P59, DOI 10.3758/BF03195942; Robinson E, 2013, FOOD QUAL PREFER, V27, P101, DOI 10.1016/j.foodqual.2012.07.001; Robinson E, 2011, J AM DIET ASSOC, V111, P1543, DOI 10.1016/j.jada.2011.07.012; Robinson E, 2011, APPETITE, V56, P747, DOI 10.1016/j.appet.2011.03.001; Roth DA, 2001, APPETITE, V36, P165, DOI 10.1006/appe.2000.0388; Rozin P, 1986, SWEETNESS, P99; Sabini J, 1994, SOCIAL PSYCHOL; Sclafani A, 1997, APPETITE, V29, P153, DOI 10.1006/appe.1997.0120; Smith JR, 2007, BRIT J SOC PSYCHOL, V46, P769, DOI 10.1348/014466606X164439; STUNKARD AJ, 1985, J PSYCHOSOM RES, V29, P71, DOI 10.1016/0022-3999(85)90010-8; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1	38	22	22	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48858	10.1371/journal.pone.0048858	http://dx.doi.org/10.1371/journal.pone.0048858			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155416	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900050
J	Su, PT; Liao, CT; Roan, JR; Wang, SH; Chiou, A; Syu, WJ				Su, Pin-Tzu; Liao, Chih-Tang; Roan, Jiunn-Ren; Wang, Shao-Hung; Chiou, Arthur; Syu, Wan-Jr			Bacterial Colony from Two-Dimensional Division to Three-Dimensional Development	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOFILM; GROWTH; POPULATIONS; MICROSCOPY; CELL	On agar surface, bacterial daughter cells form a 4-cell array after the first two rounds of division, and this phenomenon has been previously attributed to a balancing of interactions among the daughter bacteria and the underneath agar. We studied further the organization and development of colony after additional generations. By confocal laser scanning microscopy and real-time imaging, we observed that bacterial cells were able to self-organize and resulted in a near circular micro-colony consisting of monolayer cells. After continuous dividing, bacteria transited from two-dimensional expansion into three-dimensional growth and formed two to multi-layers in the center but retained a monolayer in the outer ring of the circular colony. The transverse width of this outer ring appeared to be approximately constant once the micro-colony reached a certain age. This observation supports the notion that balanced interplays of the forces involved lead to a gross morphology as the bacteria divide into offspring on agar surface. In this case, the result is due to a balance between the expansion force of the dividing bacteria, the non-covalent force among bacterial offspring and that between bacteria and substratum.	[Su, Pin-Tzu; Syu, Wan-Jr] Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University	Su, PT (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	wjsyu@ym.edu.tw	wang, shaohung/E-4017-2015	wang, shaohung/0000-0002-6824-0372				Bae E, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3463003; Ben-Jacob E, 2006, J R SOC INTERFACE, V3, P197, DOI 10.1098/rsif.2005.0089; Ben-Jacob E, 2012, TRENDS MICROBIOL; Chiu HJ, 2005, MICROBIOL-SGM, V151, P3277, DOI 10.1099/mic.0.28115-0; Cho HJ, 2007, PLOS BIOL, V5, P2614, DOI 10.1371/journal.pbio.0050302; DONACHIE WD, 1970, NATURE, V227, P1220, DOI 10.1038/2271220a0; DONNELLY JP, 1995, J ANTIMICROB CHEMOTH, V36, P59; GS G-S, 1910, PARASITOLOGY, V3, P17; Harrison JJ, 2006, BIOL PROCED ONLINE, V8, P194, DOI 10.1251/bpo127; Hooshangi S, 2008, CURR OPIN BIOTECH, V19, P550, DOI 10.1016/j.copbio.2008.10.007; Ito A, 2009, APPL ENVIRON MICROB, V75, P4093, DOI 10.1128/AEM.02949-08; Jefferson KK, 2004, FEMS MICROBIOL LETT, V236, P163, DOI 10.1016/j.femsle.2004.06.005; Lopez D, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000398; Palmer RJ, 1999, CURR OPIN BIOTECH, V10, P263, DOI 10.1016/S0958-1669(99)80046-9; Pelling AE, 2006, CELL MOTIL CYTOSKEL, V63, P141, DOI 10.1002/cm.20112; PIRT SJ, 1967, J GEN MICROBIOL, V47, P181, DOI 10.1099/00221287-47-2-181; Shapiro JA, 1998, ANNU REV MICROBIOL, V52, P81, DOI 10.1146/annurev.micro.52.1.81; Smith JP, 2004, CRIT REV FOOD SCI, V44, P19, DOI 10.1080/10408690490263774; Su PT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009147; Volfson D, 2008, P NATL ACAD SCI USA, V105, P15346, DOI 10.1073/pnas.0706805105; WIMPENNY JWT, 1977, J GEN MICROBIOL, V103, P9, DOI 10.1099/00221287-103-1-9; Zhang HP, 2010, P NATL ACAD SCI USA, V107, P13626, DOI 10.1073/pnas.1001651107	22	47	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48098	10.1371/journal.pone.0048098	http://dx.doi.org/10.1371/journal.pone.0048098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155376	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900010
J	Vashisht, S; Bagler, G				Vashisht, Shikha; Bagler, Ganesh			An Approach for the Identification of Targets Specific to Bone Metastasis Using Cancer Genes Interactome and Gene Ontology Analysis	PLOS ONE			English	Article							PROSTATE-CANCER; NETWORK BIOLOGY; EXPRESSION; RESOURCE; PATHWAY; OSTEOPONTIN; MECHANISMS; OSTEOLYSIS; CENTRALITY; MIGRATION	Metastasis is one of the most enigmatic aspects of cancer pathogenesis and is a major cause of cancer-associated mortality. Secondary bone cancer (SBC) is a complex disease caused by metastasis of tumor cells from their primary site and is characterized by intricate interplay of molecular interactions. Identification of targets for multifactorial diseases such as SBC, the most frequent complication of breast and prostate cancers, is a challenge. Towards achieving our aim of identification of targets specific to SBC, we constructed a 'Cancer Genes Network', a representative protein interactome of cancer genes. Using graph theoretical methods, we obtained a set of key genes that are relevant for generic mechanisms of cancers and have a role in biological essentiality. We also compiled a curated dataset of 391 SBC genes from published literature which serves as a basis of ontological correlates of secondary bone cancer. Building on these results, we implement a strategy based on generic cancer genes, SBC genes and gene ontology enrichment method, to obtain a set of targets that are specific to bone metastasis. Through this study, we present an approach for probing one of the major complications in cancers, namely, metastasis. The results on genes that play generic roles in cancer phenotype, obtained by network analysis of 'Cancer Genes Network', have broader implications in understanding the role of molecular regulators in mechanisms of cancers. Specifically, our study provides a set of potential targets that are of ontological and regulatory relevance to secondary bone cancer.	[Vashisht, Shikha; Bagler, Ganesh] CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Himalayan Bioresource Technology (IHBT)	Vashisht, S (corresponding author), CSIR, Inst Himalayan Bioresource Technol, Div Biotechnol, Palampur, Himachal Prades, India.	bagler@ihbt.res.in	; Bagler, Ganesh/A-1102-2009	Vashisht, Shikha/0000-0003-4512-2629; Bagler, Ganesh/0000-0003-1924-6070				Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Ashburner M, 2001, GENOME RES, V11, P1425; Bailey CL, 2009, CANCER RES, V69, P4962, DOI 10.1158/0008-5472.CAN-08-4269; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Batada NN, 2006, PLOS COMPUT BIOL, V2, P748, DOI 10.1371/journal.pcbi.0020088; Blake JA, 2011, NUCLEIC ACIDS RES, V39, pD842, DOI 10.1093/nar/gkq1008; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Bu GJ, 2008, INT J CANCER, V123, P1034, DOI 10.1002/ijc.23625; Cerami E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008918; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Chang WJ, 2009, INT J CANCER, V125, P2844, DOI 10.1002/ijc.24699; Chen G, 2006, CANCER-AM CANCER SOC, V107, P289, DOI 10.1002/cncr.21978; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Cicek M, 2006, CANCER METAST REV, V25, P635, DOI 10.1007/s10555-006-9035-x; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Coleman RE, 1997, CANCER, V80, P1588, DOI 10.1002/(SICI)1097-0142(19971015)80:8+<1588::AID-CNCR9>3.0.CO;2-G; Dai JL, 1999, P NATL ACAD SCI USA, V96, P1427, DOI 10.1073/pnas.96.4.1427; Dorogovtsev S, 2004, CONDMAT0404593 ARXIV, P1; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emmert-Streib F, 2007, J COMPUT BIOL, V14, P961, DOI 10.1089/cmb.2007.0041; Eppert K, 2005, MODERN PATHOL, V18, P388, DOI 10.1038/modpathol.3800265; Ergun A, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100125; FREEMAN LC, 1977, SOCIOMETRY, V40, P35, DOI 10.2307/3033543; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Guise TA, 2009, GENE DEV, V23, P2117, DOI 10.1101/gad.1854909; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187; Hess KR, 2006, CANCER, V106, P1624, DOI 10.1002/cncr.21778; Higgins ME, 2007, NUCLEIC ACIDS RES, V35, pD721, DOI 10.1093/nar/gkl811; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jia PL, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-S3-S12; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Jonsson PF, 2006, BIOINFORMATICS, V22, P2291, DOI 10.1093/bioinformatics/btl390; Joy MP, 2005, J BIOMED BIOTECHNOL, P96, DOI 10.1155/JBB.2005.96; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Koreckij T, 2009, BRIT J CANCER, V101, P263, DOI 10.1038/sj.bjc.6605178; Kozlow W, 2005, J MAMMARY GLAND BIOL, V10, P169, DOI 10.1007/s10911-005-5399-8; Lascorz Jesus, 2011, J Carcinog, V10, P7, DOI 10.4103/1477-3163.78268; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lu X, 2009, GENE DEV, V23, P1882, DOI 10.1101/gad.1824809; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Matsumoto K, 2001, GENES CELLS, V6, P1101, DOI 10.1046/j.1365-2443.2001.00482.x; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Ortutay C, 2009, NUCLEIC ACIDS RES, V37, P622, DOI 10.1093/nar/gkn982; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Rhee SY, 2008, NAT REV GENET, V9, P509, DOI 10.1038/nrg2363; Rittling SR, 2004, BRIT J CANCER, V90, P1877, DOI 10.1038/sj.bjc.6601839; Secondini C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016078; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sloan EK, 2002, CELL MOL LIFE SCI, V59, P1491, DOI 10.1007/s00018-002-8524-5; Smid M, 2006, J CLIN ONCOL, V24, P2261, DOI 10.1200/JCO.2005.03.8802; Smith CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2004-6-1-r7; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taichman RS, 2002, CANCER RES, V62, P1832; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Valta MP, 2008, INT J CANCER, V123, P22, DOI 10.1002/ijc.23422; Virk MS, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2169; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wang HS, 2005, EXP CELL RES, V304, P116, DOI 10.1016/j.yexcr.2004.10.015; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017; Zhang XT, 2009, PROSTATE, V69, P727, DOI 10.1002/pros.20920	76	13	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49401	10.1371/journal.pone.0049401	http://dx.doi.org/10.1371/journal.pone.0049401			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166660	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900138
J	Yang, EC; Chang, HC; Wu, WY; Chen, YW				Yang, En-Cheng; Chang, Hui-Chun; Wu, Wen-Yen; Chen, Yu-Wen			Impaired Olfactory Associative Behavior of Honeybee Workers Due to Contamination of Imidacloprid in the Larval Stage	PLOS ONE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTORS; CLASSICAL CONDITIONED-RESPONSE; SHORT-TERM-MEMORY; APIS-MELLIFERA L; MUSHROOM BODIES; LEARNING PERFORMANCES; COLONY COLLAPSE; PESTICIDE-RESIDUES; FORAGING ACTIVITY; ANTENNAL LOBES	The residue of imidacloprid in the nectar and pollens of the plants is toxic not only to adult honeybees but also the larvae. Our understanding of the risk of imidacloprid to larvae of the honeybees is still in a very early stage. In this study, the capped-brood, pupation and eclosion rates of the honeybee larvae were recorded after treating them directly in the hive with different dosages of imidacloprid. The brood-capped rates of the larvae decreased significantly when the dosages increased from 24 to 8000 ng/larva. However, there were no significant effects of DMSO or 0.4 ng of imidacloprid per larva on the brood-capped, pupation and eclosion rates. Although the sublethal dosage of imidacloprid had no effect on the eclosion rate, we found that the olfactory associative behavior of the adult bees was impaired if they had been treated with 0.04 ng/larva imidacloprid in the larval stage. These results demonstrate that a sublethal dosage of imidacloprid given to the larvae affects the subsequent associative ability of the adult honeybee workers. Thus, a low dose of imidacloprid may affect the survival condition of the entire colony, even though the larvae survive to adulthood.	[Yang, En-Cheng; Chang, Hui-Chun; Wu, Wen-Yen] Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan	National Taiwan University	Yang, EC (corresponding author), Natl Taiwan Univ, Dept Entomol, Taipei 10764, Taiwan.	ecyang@ntu.edu.tw		Wu, Wen-Yen/0000-0002-8522-7911; YANG, EN-CHENG/0000-0002-5793-5427				Abbott VA, 2008, J ECON ENTOMOL, V101, P784, DOI 10.1603/0022-0493(2008)101[784:LASEOI]2.0.CO;2; Abramson CI, 1999, ARCH ENVIRON CON TOX, V37, P529, DOI 10.1007/s002449900548; Armengaud C, 2000, BRAIN RES, V859, P390, DOI 10.1016/S0006-8993(00)02016-3; Aupinel Pierrick, 2005, Bulletin of Insectology, V58, P107; BICKER G, 1994, J NEUROPHYSIOL, V71, P808, DOI 10.1152/jn.1994.71.2.808; Bicker G, 1999, MICROSC RES TECHNIQ, V45, P174, DOI 10.1002/(SICI)1097-0029(19990501)45:3<174::AID-JEMT5>3.3.CO;2-L; Blanchard P, 2008, J INVERTEBR PATHOL, V99, P348, DOI 10.1016/j.jip.2008.07.006; Bonmatin JM, 2005, J AGR FOOD CHEM, V53, P5336, DOI 10.1021/jf0479362; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Bortolotti Laura, 2003, Bulletin of Insectology, V56, P63; Buckingham SD, 1997, J EXP BIOL, V200, P2685; Chauzat MP, 2009, ENVIRON ENTOMOL, V38, P514, DOI 10.1603/022.038.0302; Chauzat MP, 2006, J ECON ENTOMOL, V99, P253, DOI 10.1603/0022-0493-99.2.253; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Colin ME, 2004, ARCH ENVIRON CON TOX, V47, P387, DOI 10.1007/s00244-004-3052-y; Cure G, 1999, C INRA 98 HAZ PEST B, P49; Dacher M, 2005, NEUROSCIENCE, V130, P37, DOI 10.1016/j.neuroscience.2004.09.006; Decourtye A, 2005, ARCH ENVIRON CON TOX, V48, P242, DOI 10.1007/s00244-003-0262-7; Decourtye A, 2004, ECOTOX ENVIRON SAFE, V57, P410, DOI 10.1016/j.ecoenv.2003.08.001; Decourtye A, 2004, PESTIC BIOCHEM PHYS, V78, P83, DOI 10.1016/j.pestbp.2003.10.001; Decourtye A, 2003, PEST MANAG SCI, V59, P269, DOI 10.1002/ps.631; Decourtye A, 2005, ENJEUX PHYTOSANITAIR, P283; Decourtye A, 2010, ADV EXP MED BIOL, V683, P85; Deglise P, 2002, NEUROSCI LETT, V321, P13, DOI 10.1016/S0304-3940(01)02400-4; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Dwyer JB, 2009, PHARMACOL THERAPEUT, V122, P125, DOI 10.1016/j.pharmthera.2009.02.003; Eiri DM, 2012, J EXP BIOL, V215, P2022, DOI 10.1242/jeb.068718; Elbert A., 1991, Pflanzenschutz-Nachrichten Bayer, V44, P113; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; Farris SM, 1999, J COMP NEUROL, V414, P97, DOI 10.1002/(SICI)1096-9861(19991108)414:1&lt;97::AID-CNE8&gt;3.0.CO;2-Q; Faucon JP, 2005, PEST MANAG SCI, V61, P111, DOI 10.1002/ps.957; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Goldberg F, 1999, J PHYSIOL-LONDON, V514, P759, DOI 10.1111/j.1469-7793.1999.759ad.x; Gregorc A, 2011, PESTIC BIOCHEM PHYS, V99, P200, DOI 10.1016/j.pestbp.2010.12.005; Guez D, 2003, PHARMACOL BIOCHEM BE, V75, P217, DOI 10.1016/S0091-3057(03)00070-4; Halm MP, 2006, ENVIRON SCI TECHNOL, V40, P2448, DOI 10.1021/es051392i; Henry M, 2012, SCIENCE, V336, P348, DOI 10.1126/science.1215039; Higes M, 2009, ENV MICROBIOL REP, V1, P110, DOI 10.1111/j.1758-2229.2009.00014.x; Jones AK, 2006, GENOME RES, V16, P1422, DOI 10.1101/gr.4549206; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Kirchner WH, 1999, APIDOLOGIE, V30, P293, DOI 10.1051/apido:19990405; Koch H, 1997, APIDOLOGIE, V28, P439, DOI 10.1051/apido:19970610; KREISSL S, 1989, J COMP NEUROL, V286, P71, DOI 10.1002/cne.902860105; Laurent FM, 2003, J AGR FOOD CHEM, V51, P8005, DOI 10.1021/jf034310n; LIU MY, 1993, PESTIC BIOCHEM PHYS, V46, P40, DOI 10.1006/pest.1993.1034; Lozano VC, 1996, BEHAV BRAIN RES, V81, P215, DOI 10.1016/S0166-4328(96)89081-4; Lozano VC, 2001, J COMP PHYSIOL A, V187, P249, DOI 10.1007/s003590100196; Malun D, 1998, LEARN MEMORY, V5, P90; MAMOOD AN, 1990, PHYSIOL ENTOMOL, V15, P55, DOI 10.1111/j.1365-3032.1990.tb00492.x; Maori E, 2009, INSECT MOL BIOL, V18, P55, DOI 10.1111/j.1365-2583.2009.00847.x; Matsuda K, 2005, BIOSCI BIOTECH BIOCH, V69, P1442, DOI 10.1271/bbb.69.1442; Matsuda K, 2001, TRENDS PHARMACOL SCI, V22, P573, DOI 10.1016/S0165-6147(00)01820-4; Medrzycki Piotr, 2003, Bulletin of Insectology, V56, P59; Menzel R., 1974, P195; Nauen R, 2001, PEST MANAG SCI, V57, P577, DOI 10.1002/ps.331; Pareja L, 2011, INT J ENV RES PUB HE, V8, P3844, DOI 10.3390/ijerph8103844; Porrini Claudio, 2003, Bulletin of Insectology, V56, P147; Ramirez-Romero R, 2005, APIDOLOGIE, V36, P601, DOI 10.1051/apido:2005039; Ray S, 1999, DEV PSYCHOBIOL, V34, P21, DOI 10.1002/(SICI)1098-2302(199901)34:1<21::AID-DEV4>3.3.CO;2-B; SCHEIDLER A, 1990, BRAIN RES, V534, P332, DOI 10.1016/0006-8993(90)90152-2; Schmuck R, 2001, PEST MANAG SCI, V57, P225, DOI 10.1002/ps.270; Schmuck R., 1999, PFLANZENSCHUTZ NACHR, V52, P257; SEELEY TD, 1982, BEHAV ECOL SOCIOBIOL, V11, P287, DOI 10.1007/BF00299306; SMIRLE MJ, 1989, J INSECT BEHAV, V2, P285, DOI 10.1007/BF01053300; Stokstad E, 2007, SCIENCE, V316, P970, DOI 10.1126/science.316.5827.970; Stone JC, 1997, B ENVIRON CONTAM TOX, V58, P177, DOI 10.1007/s001289900317; Suchail S, 2000, ENVIRON TOXICOL CHEM, V19, P1901, DOI [10.1897/1551-5028(2000)019&lt;1901:COITIT&gt;2.3.CO;2, 10.1002/etc.5620190726]; Suchail S, 2004, PEST MANAG SCI, V60, P291, DOI 10.1002/ps.772; Suchail S, 2004, PEST MANAG SCI, V60, P1056, DOI 10.1002/ps.895; Suchail S, 2001, ENVIRON TOXICOL CHEM, V20, P2482, DOI [10.1002/etc.5620201113, 10.1897/1551-5028(2001)020&lt;2482:DBAACT&gt;2.0.CO;2]; Swinton SM, 2007, ECOL ECON, V64, P245, DOI 10.1016/j.ecolecon.2007.09.020; TAKEDA K, 1961, J INSECT PHYSIOL, V6, P168, DOI 10.1016/0022-1910(61)90060-9; Tasei JN, 2001, J ECON ENTOMOL, V94, P623, DOI 10.1603/0022-0493-94.3.623; TAYLOR KS, 1987, APIDOLOGIE, V18, P243, DOI 10.1051/apido:19870304; Thany SH, 2005, BRAIN RES, V1039, P216, DOI 10.1016/j.brainres.2005.01.056; Thany SH, 2005, GENE, V344, P125, DOI 10.1016/j.gene.2004.09.010; Thany SH, 2003, INSECT MOL BIOL, V12, P255, DOI 10.1046/j.1365-2583.2003.00409.x; TOMIZAWA M, 1992, J PESTIC SCI, V17, P231; Wallner K, 1999, APIDOLOGIE, V30, P235, DOI 10.1051/apido:19990212; Wallner K, 1999, C INRA 98 HAZ PEST B, P91; Wang Chung-Hsiung, 2009, Formosan Entomologist, V29, P119; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wilhelmy H, 2000, SUBSTANCE A ACUTE EF; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; Yang EC, 2008, J ECON ENTOMOL, V101, P1743, DOI 10.1603/0022-0493-101.6.1743	85	124	140	4	168	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49472	10.1371/journal.pone.0049472	http://dx.doi.org/10.1371/journal.pone.0049472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166680	gold, Green Published			2022-12-27	WOS:000311151900149
J	Zhang, DD; Wang, LL; Luo, Y; Luo, YJ				Zhang, Dandan; Wang, Lili; Luo, Yi; Luo, Yuejia			Individual Differences in Detecting Rapidly Presented Fearful Faces	PLOS ONE			English	Article							EVENT-RELATED DESYNCHRONIZATION; VISUAL AWARENESS; TIME-COURSE; CONSCIOUS PERCEPTION; BRAIN; ATTENTION; DYNAMICS; ERP; RESPONSES; RECOGNITION	Rapid detection of evolutionarily relevant threats (e.g., fearful faces) is important for human survival. The ability to rapidly detect fearful faces exhibits high variability across individuals. The present study aimed to investigate the relationship between behavioral detection ability and brain activity, using both event-related potential (ERP) and event-related oscillation (ERO) measurements. Faces with fearful or neutral facial expressions were presented for 17 ms or 200 ms in a backward masking paradigm. Forty-two participants were required to discriminate facial expressions of the masked faces. The behavioral sensitivity index d' showed that the detection ability to rapidly presented and masked fearful faces varied across participants. The ANOVA analyses showed that the facial expression, hemisphere, and presentation duration affected the grand-mean ERP (N1, P1, and N170) and ERO (below 20 Hz and lasted from 100 ms to 250 ms post-stimulus, mainly in theta band) brain activity. More importantly, the overall detection ability of 42 subjects was significantly correlated with the emotion effect (i.e., fearful vs. neutral) on ERP (r = 0.403) and ERO (r = 0.552) measurements. A higher d' value was corresponding to a larger size of the emotional effect (i.e., fearful -neutral) of N170 amplitude and a larger size of the emotional effect of the specific ERO spectral power at the right hemisphere. The present results suggested a close link between behavioral detection ability and the N170 amplitude as well as the ERO spectral power below 20 Hz in individuals. The emotional effect size between fearful and neutral faces in brain activity may reflect the level of conscious awareness of fearful faces.	[Zhang, Dandan; Wang, Lili; Luo, Yi; Luo, Yuejia] Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China	Beijing Normal University	Zhang, DD (corresponding author), Beijing Normal Univ, Natl Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	wll_1008@126.com; luoyj@bnu.edu.cn	Luo, Yi/AAK-7918-2021	Luo, Yi/0000-0002-6169-8938	FIC NIH HHS [1R01TW007897, R01 TW007897] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [R01TW007897] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))		Balconi M, 2006, NEUROSCI LETT, V392, P118, DOI 10.1016/j.neulet.2005.09.004; Balconi M, 2009, PHYSIOL BEHAV, V97, P455, DOI 10.1016/j.physbeh.2009.03.023; Basar E, 2006, PROG BRAIN RES, V159, P43, DOI 10.1016/S0079-6123(06)59004-1; Batty M, 2003, COGNITIVE BRAIN RES, V17, P613, DOI 10.1016/S0926-6410(03)00174-5; Bentin S, 1996, J COGNITIVE NEUROSCI, V8, P551, DOI 10.1162/jocn.1996.8.6.551; Blau Vera C, 2007, Behav Brain Funct, V3, P7; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Del Cul A, 2007, PLOS BIOL, V5, P2408, DOI 10.1371/journal.pbio.0050260; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eimer M, 2000, NEUROREPORT, V11, P2319, DOI 10.1097/00001756-200007140-00050; Eimer M, 2002, NEUROREPORT, V13, P427, DOI 10.1097/00001756-200203250-00013; Eimer M, 2007, NEUROPSYCHOLOGIA, V45, P15, DOI 10.1016/j.neuropsychologia.2006.04.022; Eimer M, 2008, J NEUROPSYCHOL, V2, P165, DOI 10.1348/174866407X245411; ESTEVES F, 1993, SCAND J PSYCHOL, V34, P1, DOI 10.1111/j.1467-9450.1993.tb01096.x; George N, 1996, COGNITIVE BRAIN RES, V4, P65, DOI 10.1016/0926-6410(95)00045-3; [龚栩 Gong Xu], 2011, [中国心理卫生杂志, Chinese Mental Health Journal], V25, P40; Guntekin B, 2007, INT J PSYCHOPHYSIOL, V64, P91, DOI 10.1016/j.ijpsycho.2006.07.003; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jacques C, 2004, NEUROREPORT, V15, P2417, DOI 10.1097/00001756-200410250-00023; Japee S, 2009, EMOTION, V9, P59, DOI 10.1037/a0014487; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P318, DOI 10.1111/j.1469-8986.2007.00634.x; Knyazev GG, 2009, NEUROSCIENCE, V164, P1588, DOI 10.1016/j.neuroscience.2009.09.057; Knyazev GG, 2008, BRAIN RES, V1227, P174, DOI 10.1016/j.brainres.2008.06.108; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Leppanen JM, 2007, CHILD DEV, V78, P232, DOI 10.1111/j.1467-8624.2007.00994.x; Luck SJ., 2011, OXFORD HDB EVENT REL, DOI DOI 10.1093/OXFORDHB/9780195374148.013.0089; Luo Q, 2009, CEREB CORTEX, V19, P1896, DOI 10.1093/cercor/bhn216; Luo WB, 2010, NEUROIMAGE, V49, P1857, DOI 10.1016/j.neuroimage.2009.09.018; Macmillan N. A., 1991, DETECTION THEORY USE; Makeig S, 2004, PLOS BIOL, V2, P747, DOI 10.1371/journal.pbio.0020176; MAKEIG S, 1993, ELECTROEN CLIN NEURO, V86, P283, DOI 10.1016/0013-4694(93)90110-H; Maxwell JS, 2004, COGNITION EMOTION, V18, P1009, DOI 10.1080/02699930441000003; Morris JS, 1999, P NATL ACAD SCI USA, V96, P1680, DOI 10.1073/pnas.96.4.1680; Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976; Nasr S, 2009, J VISION, V9, DOI 10.1167/9.5.5; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Pegna AJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00088; Pegna AJ, 2008, INT J PSYCHOPHYSIOL, V70, P127, DOI 10.1016/j.ijpsycho.2008.08.007; Pessoa L, 2006, CEREB CORTEX, V16, P366, DOI 10.1093/cercorbhi115; Pessoa L, 2005, EMOTION, V5, P243, DOI 10.1037/1528-3542.5.2.243; Pessoa L, 2005, CURR OPIN NEUROBIOL, V15, P188, DOI 10.1016/j.conb.2005.03.002; Pfabigan DM, 2011, PSYCHOPHYSIOLOGY, V48, P656, DOI 10.1111/j.1469-8986.2010.01136.x; PFURTSCHELLER G, 1977, ELECTROEN CLIN NEURO, V42, P817, DOI 10.1016/0013-4694(77)90235-8; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Pourtois G, 2005, HUM BRAIN MAPP, V26, P65, DOI 10.1002/hbm.20130; Pourtois G, 2004, CEREB CORTEX, V14, P619, DOI 10.1093/cercor/bhh023; Pourtois G, 2005, NEUROIMAGE, V26, P149, DOI 10.1016/j.neuroimage.2005.01.015; Schyns PG, 2007, CURR BIOL, V17, P1580, DOI 10.1016/j.cub.2007.08.048; Smith ML, 2011, CEREBRAL CORTEX; Sun J, 2012, NEUROSCIENCE, V203, P91, DOI 10.1016/j.neuroscience.2011.12.038; Super H, 2001, NAT NEUROSCI, V4, P304, DOI 10.1038/85170; Szczepanowski R, 2007, J VISION, V7, DOI 10.1167/7.4.10; Tamietto M, 2010, NAT REV NEUROSCI, V11, P697, DOI 10.1038/nrn2889; Tse PU, 2005, P NATL ACAD SCI USA, V102, P17178, DOI 10.1073/pnas.0508010102; Vlamings PHJM, 2009, J VISION, V9, DOI 10.1167/9.5.12; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Wang LL, 2012, NEUROSCI LETT, V506, P317, DOI 10.1016/j.neulet.2011.11.034; Williams LM, 2004, HUM BRAIN MAPP, V21, P64, DOI 10.1002/hbm.10154	60	36	39	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49517	10.1371/journal.pone.0049517	http://dx.doi.org/10.1371/journal.pone.0049517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166693	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900153
J	Zhang, XW; Li, JP; Liu, AL; Zou, J; Zhou, XY; Xiang, JH; Rerksiri, W; Peng, Y; Xiong, XY; Chen, XB				Zhang, Xianwen; Li, Jiaping; Liu, Ailing; Zou, Jie; Zhou, Xiaoyun; Xiang, Jianhua; Rerksiri, Wirat; Peng, Yan; Xiong, Xingyao; Chen, Xinbo			Expression Profile in Rice Panicle: Insights into Heat Response Mechanism at Reproductive Stage	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; GENOME-WIDE ANALYSIS; LIGHT-INDUCIBLE PROTEIN; GENE-EXPRESSION; HYDROGEN-PEROXIDE; ABIOTIC STRESS; ABSCISIC-ACID; ORYZA-SATIVA; FUNCTIONAL-CHARACTERIZATION; SIGNALING PATHWAY	Rice at reproductive stage is more sensitive to environmental changes, and little is known about the mechanism of heat response in rice panicle. Here, using rice microarray, we provided a time course gene expression profile of rice panicle at anther developmental stage 8 after 40 degrees C treatment for 0 min, 20 min, 60 min, 2 h, 4 h, and 8 h. The identified differentially expressed genes were mainly involved in transcriptional regulation, transport, cellular homeostasis, and stress response. The predominant transcription factor gene families responsive to heat stress were Hsf, NAC, AP2/ERF, WRKY, MYB, and C2H2. KMC analysis discovered the time-dependent gene expression pattern under heat stress. The motif co-occurrence analysis on the promoters of genes from an early up-regulated cluster showed the important roles of GCC box, HSE, ABRE, and CE3 in response to heat stress. The regulation model central to ROS combined with transcriptome and ROS quantification data in rice panicle indicated the great importance to maintain ROS balance and the existence of wide cross-talk in heat response. The present study increased our understanding of the heat response in rice panicle and provided good candidate genes for crop improvement.	[Zhang, Xianwen; Liu, Ailing; Zhou, Xiaoyun; Peng, Yan; Xiong, Xingyao; Chen, Xinbo] Hunan Agr Univ, Key Lab Crop Germplasm Innovat & Utilizat Hunan P, Changsha, Hunan, Peoples R China	Hunan Agricultural University	Zhang, XW (corresponding author), Hunan Agr Univ, Key Lab Crop Germplasm Innovat & Utilizat Hunan P, Changsha, Hunan, Peoples R China.	xiongxingyao@yahoo.cn; xinbochen@live.cn	Chen, Xinbo/J-6708-2012	Chen, Xinbo/0000-0002-8758-0591; Peng, Yan/0000-0003-3374-3209; Zhang, Xianwen/0000-0001-5329-7571				ADAMSKA I, 1992, J BIOL CHEM, V267, P24732; Agarwal M, 2003, PLANT MOL BIOL, V51, P543, DOI 10.1023/A:1022324920316; Agarwal P, 2007, PLANT MOL BIOL, V65, P467, DOI 10.1007/s11103-007-9199-y; Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Almagro L, 2009, J EXP BOT, V60, P377, DOI 10.1093/jxb/ern277; Atkinson NJ, 2012, J EXP BOT, V63, P3523, DOI 10.1093/jxb/ers100; Awad W, 2008, P NATL ACAD SCI USA, V105, P1164, DOI 10.1073/pnas.0702132105; Ben-Zvi AP, 2001, J STRUCT BIOL, V135, P84, DOI 10.1006/jsbi.2001.4352; Bhattacharya A, 2009, J MOL BIOL, V388, P475, DOI 10.1016/j.jmb.2009.01.062; Bienert GP, 2007, J BIOL CHEM, V282, P1183, DOI 10.1074/jbc.M603761200; Blokhina O, 2010, PLANT PHYSIOL BIOCH, V48, P359, DOI 10.1016/j.plaphy.2010.01.007; Bonnecarrere V, 2011, PLANT SCI, V180, P726, DOI 10.1016/j.plantsci.2011.01.023; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; Brown PO, 1999, NAT GENET, V21, P33, DOI 10.1038/4462; Cao YunYing, 2008, Acta Agronomica Sinica, V34, P2134, DOI 10.1016/S1875-2780(09)60022-5; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Chang WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-561; Chauhan H, 2011, MOL GENET GENOMICS, V286, P171, DOI 10.1007/s00438-011-0638-8; Chen JP, 2006, PLANT J, V48, P73, DOI 10.1111/j.1365-313X.2006.02855.x; Chen L, 2010, PLANT CELL PHYSIOL, V51, P585, DOI 10.1093/pcp/pcq024; Cheng C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-175; Chi WC, 2011, PLANT MOL BIOL, V77, P591, DOI 10.1007/s11103-011-9841-6; Cohen-Peer R, 2010, PLANT MOL BIOL, V74, P33, DOI 10.1007/s11103-010-9652-1; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1583, DOI 10.1093/pcp/pcr107; Dafny-Yelin M, 2008, PLANT MOL BIOL, V67, P363, DOI 10.1007/s11103-008-9326-4; Darwish E, 2009, PLANT CELL PHYSIOL, V50, P986, DOI 10.1093/pcp/pcp051; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Endo M, 2009, PLANT CELL PHYSIOL, V50, P1911, DOI 10.1093/pcp/pcp135; Foyer CH, 2011, PLANT PHYSIOL, V155, P93, DOI 10.1104/pp.110.166181; Fujita M, 2010, PLANT CELL PHYSIOL, V51, P2060, DOI 10.1093/pcp/pcq165; Fukao T, 2011, PLANT CELL, V23, P412, DOI 10.1105/tpc.110.080325; Gonzali S, 2005, ANN BOT-LONDON, V96, P661, DOI 10.1093/aob/mci218; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guo HW, 2003, CELL, V115, P667, DOI 10.1016/S0092-8674(03)00969-3; Guo JK, 2008, J GENET GENOMICS, V35, P105, DOI 10.1016/S1673-8527(08)60016-8; Gusev NB, 2005, BIOCHEMISTRY-MOSCOW+, V70, P629, DOI 10.1007/s10541-005-0162-8; Harari-Steinberg O, 2001, PLANT PHYSIOL, V127, P986, DOI 10.1104/pp.010270; He JM, 2011, J EXP BOT, V62, P2657, DOI 10.1093/jxb/erq431; Hobo T, 2008, PLANT CELL PHYSIOL, V49, P1417, DOI 10.1093/pcp/pcn128; Huang XY, 2009, GENE DEV, V23, P1805, DOI 10.1101/gad.1812409; Ishibashi Y, 2012, PLANT PHYSIOL, V158, P1705, DOI 10.1104/pp.111.192740; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jakubowicz M, 2010, J EXP BOT, V61, P3475, DOI 10.1093/jxb/erq177; Jiang CH, 2009, PLANT CELL ENVIRON, V32, P1046, DOI 10.1111/j.1365-3040.2009.01987.x; Jung KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003337; Kant S, 2009, PLANT PHYSIOL, V151, P691, DOI 10.1104/pp.109.143875; Kaplan B, 2006, PLANT CELL, V18, P2733, DOI 10.1105/tpc.106.042713; Kim JS, 2011, PLANT CELL PHYSIOL, V52, P2136, DOI 10.1093/pcp/pcr143; Kim KH, 2012, BIOTECHNOL LETT, V34, P371, DOI 10.1007/s10529-011-0769-3; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; Konigshofer H, 2008, PLANT CELL ENVIRON, V31, P1771, DOI 10.1111/j.1365-3040.2008.01880.x; Kotak S, 2007, CURR OPIN PLANT BIOL, V10, P310, DOI 10.1016/j.pbi.2007.04.011; Kriechbaumer V, 2007, J EXP BOT, V58, P4225, DOI 10.1093/jxb/erm279; Kundu S, 2011, J PROTEOMICS, V74, P337, DOI 10.1016/j.jprot.2010.11.012; Lee S, 2009, PLANT PHYSIOL, V150, P786, DOI 10.1104/pp.109.135418; Lee U, 2007, PLANT J, V49, P115, DOI 10.1111/j.1365-313X.2006.02940.x; Lee YP, 2010, J EXP BOT, V61, P2499, DOI 10.1093/jxb/erq085; Li G, 2007, CELL RES, V17, P881, DOI 10.1038/cr.2007.77; Li W, 2012, PLANT PHYSIOL, V158, P1279, DOI 10.1104/pp.111.188789; Liu AL, 2010, J PLANT BIOL, V53, P142, DOI 10.1007/s12374-010-9099-6; Liu DL, 2009, CURR MICROBIOL, V58, P129, DOI 10.1007/s00284-008-9288-4; Liu XQ, 2005, CELL RES, V15, P593, DOI 10.1038/sj.cr.7290329; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Long SP, 2010, CURR OPIN PLANT BIOL, V13, P241, DOI 10.1016/j.pbi.2010.04.008; Luo LiHua, 2005, Journal of Hunan Agricultural University, V31, P593; Ma LY, 2012, J EXP BOT, V63, P305, DOI 10.1093/jxb/err280; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mazzucotelli E, 2006, CURR GENOMICS, V7, P509, DOI 10.2174/138920206779315728; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mogk A, 2008, BIOCHEM SOC T, V36, P120, DOI 10.1042/BST0360120; Montero-Barrientos M, 2010, J PLANT PHYSIOL, V167, P659, DOI 10.1016/j.jplph.2009.11.012; Mori IC, 2004, PLANT PHYSIOL, V135, P702, DOI 10.1104/pp.104.042069; Nakashima K, 2012, BBA-GENE REGUL MECH, V1819, P97, DOI 10.1016/j.bbagrm.2011.10.005; Nijhawan A, 2008, PLANT PHYSIOL, V146, P333, DOI 10.1104/pp.107.112821; Nishizawa-Yokoi A, 2011, PLANT CELL PHYSIOL, V52, P933, DOI 10.1093/pcp/pcr045; Park HC, 2010, PLANT CELL ENVIRON, V33, P1923, DOI 10.1111/j.1365-3040.2010.02195.x; Peng SB, 2004, P NATL ACAD SCI USA, V101, P9971, DOI 10.1073/pnas.0403720101; Pinot F, 2011, FEBS J, V278, P195, DOI 10.1111/j.1742-4658.2010.07948.x; Qi YC, 2011, FEBS LETT, V585, P231, DOI 10.1016/j.febslet.2010.11.051; Qin F, 2011, PLANT CELL PHYSIOL, V52, P1569, DOI 10.1093/pcp/pcr106; Qiu C, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022603, 10.1371/journal.pone.0025216]; Qudeimat E, 2008, P NATL ACAD SCI USA, V105, P19555, DOI 10.1073/pnas.0800864105; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Ray S, 2011, FUNCT INTEGR GENOMIC, V11, P157, DOI 10.1007/s10142-010-0187-y; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; REIMMANN C, 1993, PLANT MOL BIOL, V22, P165, DOI 10.1007/BF00039006; Rombauts S, 1999, NUCLEIC ACIDS RES, V27, P295, DOI 10.1093/nar/27.1.295; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sakata T, 2010, P NATL ACAD SCI USA, V107, P8569, DOI 10.1073/pnas.1000869107; Sakurai J, 2005, PLANT CELL PHYSIOL, V46, P1568, DOI 10.1093/pcp/pci172; Sarkar NK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-393; Sato M, 2007, BIOSCI BIOTECH BIOCH, V71, P1021, DOI 10.1271/bbb.60691; Savenstrand H, 2004, PLANT CELL REP, V22, P532, DOI 10.1007/s00299-003-0743-1; Scafaro AP, 2010, J EXP BOT, V61, P191, DOI 10.1093/jxb/erp294; Seabra MC, 2004, CURR OPIN CELL BIOL, V16, P451, DOI 10.1016/j.ceb.2004.06.014; Semenov MA, 2009, J EXP BOT, V60, P2791, DOI 10.1093/jxb/erp164; Seo JS, 2011, PLANT J, V65, P907, DOI 10.1111/j.1365-313X.2010.04477.x; SESSA G, 1995, PLANT MOL BIOL, V28, P145, DOI 10.1007/BF00042046; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharoni AM, 2012, MOL GENET GENOMICS, V287, P1, DOI 10.1007/s00438-011-0659-3; Sharoni AM, 2011, PLANT CELL PHYSIOL, V52, P344, DOI 10.1093/pcp/pcq196; Song XF, 2006, PLANT PHYSIOL, V141, P966, DOI 10.1104/pp.106.077818; Speth EB, 2009, PLANT PHYSIOL, V149, P1824, DOI 10.1104/pp.108.132092; Su CF, 2010, PLANT PHYSIOL, V153, P145, DOI 10.1104/pp.110.153015; Sun H, 2012, MOL BIOTECHNOL, V52, P101, DOI 10.1007/s12033-011-9477-4; Takasaki H, 2010, MOL GENET GENOMICS, V284, P173, DOI 10.1007/s00438-010-0557-0; Tang XA, 2010, PLANT PHYSIOL, V154, P1855, DOI 10.1104/pp.110.161661; Thangasamy S, 2011, NEW PHYTOL, V189, P869, DOI 10.1111/j.1469-8137.2010.03538.x; Tonsor SJ, 2008, MOL ECOL, V17, P1614, DOI 10.1111/j.1365-294X.2008.03690.x; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Volkov RA, 2006, PLANT MOL BIOL, V61, P733, DOI 10.1007/s11103-006-0045-4; Wang L, 2010, PLANT J, V61, P752, DOI 10.1111/j.1365-313X.2009.04100.x; Wang X, 2006, PLANT PHYSIOL, V140, P91, DOI 10.1104/pp.105.071670; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Wu AH, 2012, PLANT CELL, V24, P482, DOI 10.1105/tpc.111.090894; Wu HM, 2011, PLANT CELL, V23, P1208, DOI 10.1105/tpc.111.083907; Wu XL, 2009, PLANT CELL REP, V28, P21, DOI 10.1007/s00299-008-0614-x; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xu XB, 2010, BIOTECHNOL LETT, V32, P979, DOI 10.1007/s10529-010-0240-x; Xu ZS, 2011, J INTEGR PLANT BIOL, V53, P570, DOI 10.1111/j.1744-7909.2011.01062.x; Yamakawa H, 2010, PLANT CELL PHYSIOL, V51, P795, DOI 10.1093/pcp/pcq034; Yamamoto A, 2005, J BIOL CHEM, V280, P11911, DOI 10.1074/jbc.M411256200; Yamamoto YY, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-39; Zhai H, 2010, BIOCHEM BIOPH RES CO, V394, P1018, DOI 10.1016/j.bbrc.2010.03.114; Zhang DB, 2009, CHINESE SCI BULL, V54, P2342, DOI 10.1007/s11434-009-0348-3; [张桂莲 ZHANG GuiLian], 2008, [生态学报, Acta Ecologica Sinica], V28, P1089; Zhang HW, 2004, PLANTA, V220, P262, DOI 10.1007/s00425-004-1347-x; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhang W, 2009, PLANT PHYSIOL, V149, P1773, DOI 10.1104/pp.108.133744; Zhang Y, 2009, BIOSCIENCE REP, V29, P375, DOI 10.1042/BSR20080133; Zhang ZL, 2009, PLANT PHYSIOL BIOCH, V47, P954, DOI 10.1016/j.plaphy.2009.06.003; Zhang ZL, 2009, PLANT MOL BIOL, V70, P139, DOI 10.1007/s11103-009-9463-4; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042; Zhou J, 2009, J PLANT PHYSIOL, V166, P1296, DOI 10.1016/j.jplph.2009.02.007; Zhu GH, 2011, J EXP BOT, V62, P3907, DOI 10.1093/jxb/err088; Zou MJ, 2008, PLANT MOL BIOL, V66, P675, DOI 10.1007/s11103-008-9298-4	138	69	82	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49652	10.1371/journal.pone.0049652	http://dx.doi.org/10.1371/journal.pone.0049652			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155476	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900180
J	Zweers, JC; Nicolas, P; Wiegert, T; van Dijl, JM; Denham, EL				Zweers, Jessica C.; Nicolas, Pierre; Wiegert, Thomas; van Dijl, Jan Maarten; Denham, Emma L.			Definition of the sigma(W) Regulon of Bacillus subtilis in the Absence of Stress	PLOS ONE			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; ABC TRANSPORTER; CELL-ENVELOPE; ANTIMICROBIAL PEPTIDES; RESISTANCE; EXPRESSION; CLEAVAGE; GENES; IDENTIFICATION; OVERLAP	Bacteria employ extracytoplasmic function (ECF) sigma factors for their responses to environmental stresses. Despite intensive research, the molecular dissection of ECF sigma factor regulons has remained a major challenge due to overlaps in the ECF sigma factor-regulated genes and the stimuli that activate the different ECF sigma factors. Here we have employed tiling arrays to single out the ECF sigma(W) regulon of the Gram-positive bacterium Bacillus subtilis from the overlapping ECF sigma(X), sigma(Y), and sigma(M) regulons. For this purpose, we profiled the transcriptome of a B. subtilis sigW mutant under non-stress conditions to select candidate genes that are strictly sigma(W)-regulated. Under these conditions, sigma(W) exhibits a basal level of activity. Subsequently, we verified the sigma(W)-dependency of candidate genes by comparing their transcript profiles to transcriptome data obtained with the parental B. subtilis strain 168 grown under 104 different conditions, including relevant stress conditions, such as salt shock. In addition, we investigated the transcriptomes of rasP or prsW mutant strains that lack the proteases involved in the degradation of the sigma(W) anti-sigma factor RsiW and subsequent activation of the sigma(W)-regulon. Taken together, our studies identify 89 genes as being strictly sigma(W)-regulated, including several genes for non-coding RNAs. The effects of rasP or prsW mutations on the expression of sigma(W)-dependent genes were relatively mild, which implies that sigma(W)-dependent transcription under non-stress conditions is not strictly related to RasP and PrsW. Lastly, we show that the pleiotropic phenotype of rasP mutant cells, which have defects in competence development, protein secretion and membrane protein production, is not mirrored in the transcript profile of these cells. This implies that RasP is not only important for transcriptional regulation via sigma(W), but that this membrane protease also exerts other important post-transcriptional regulatory functions.	[Zweers, Jessica C.; van Dijl, Jan Maarten; Denham, Emma L.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	University of Groningen	Zweers, JC (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands.	j.m.van.dijl01@umcg.nl	van Dijl, Jan Maarten/G-1205-2013; Denham, Emma/P-3979-2014	Denham, Emma/0000-0002-5123-4099				Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; Asai K, 2003, FEMS MICROBIOL LETT, V220, P155, DOI 10.1016/S0378-1097(03)00093-4; Bisicchia P, 2010, MOL MICROBIOL, V75, P972, DOI 10.1111/j.1365-2958.2009.07036.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Butcher BG, 2006, MOL MICROBIOL, V60, P765, DOI 10.1111/j.1365-2958.2006.05131.x; Cao M, 2004, J BACTERIOL, V186, P1136, DOI 10.1128/JB.186.4.1136-1146.2004; Cao M, 2002, MOL MICROBIOL, V45, P1267, DOI 10.1046/j.1365-2958.2002.03050.x; Cao M, 2002, J MOL BIOL, V316, P443, DOI 10.1006/jmbi.2001.5372; Chen G, 2010, PROTEIN SCI, V19, P2015, DOI 10.1002/pro.496; Cheng JB, 1997, MOL MICROBIOL, V23, P1107, DOI 10.1046/j.1365-2958.1997.2951656.x; Dalbey RE, 2012, MICROBIOL MOL BIOL R, V76, P311, DOI 10.1128/MMBR.05019-11; Dubrac S, 2008, MOL MICROBIOL, V70, P1307, DOI 10.1111/j.1365-2958.2008.06483.x; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Ellermeier CD, 2006, GENE DEV, V20, P1911, DOI 10.1101/gad.1440606; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; FLOREZ LA, 2009, COMMUNITY CURATED CO; Hahne H, 2010, J BACTERIOL, V192, P870, DOI 10.1128/JB.01106-09; Heinrich J, 2008, MICROBIOL-SGM, V154, P1989, DOI 10.1099/mic.0.2008/018648-0; Heinrich J, 2006, MOL MICROBIOL, V62, P566, DOI 10.1111/j.1365-2958.2006.05391.x; Heinrich J, 2009, MOL MICROBIOL, V74, P1412, DOI 10.1111/j.1365-2958.2009.06940.x; Heinrich J, 2009, RES MICROBIOL, V160, P696, DOI 10.1016/j.resmic.2009.08.019; Helmann JD, 2002, ADV MICROB PHYSIOL, V46, P47; Ho TD, 2012, CURR OPIN MICROBIOL, V15, P182, DOI 10.1016/j.mib.2012.01.001; Huang XJ, 1998, J BACTERIOL, V180, P3765, DOI 10.1128/JB.180.15.3765-3770.1998; Huang XJ, 1999, MOL MICROBIOL, V31, P361, DOI 10.1046/j.1365-2958.1999.01180.x; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Jervis AJ, 2007, J BACTERIOL, V189, P4534, DOI 10.1128/JB.00130-07; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; Kingston AW, 2011, MOL MICROBIOL, V81, P69, DOI 10.1111/j.1365-2958.2011.07679.x; Leskela S, 1996, MICROBIOL-SGM, V142, P71, DOI 10.1099/13500872-142-1-71; Luo Y, 2009, J BACTERIOL, V191, P4951, DOI 10.1128/JB.00549-09; Mascher T, 2007, J BACTERIOL, V189, P6919, DOI 10.1128/JB.00904-07; Nicolas P, 2012, SCIENCE, V335, P1103, DOI 10.1126/science.1206848; Ogura M, 2007, MICROBIOL-SGM, V153, P667, DOI 10.1099/mic.0.2006/003673-0; Osterberg S, 2011, ANNU REV MICROBIOL, V65, P37, DOI 10.1146/annurev.micro.112408.134219; PADAN E, 1994, BBA-BIOENERGETICS, V1185, P129, DOI 10.1016/0005-2728(94)90204-6; Petersohn A, 2001, J BACTERIOL, V183, P5617, DOI 10.1128/JB.183.19.5617-5631.2001; Pietiainen M, 2005, MICROBIOL-SGM, V151, P1577, DOI 10.1099/mic.0.27761-0; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Saito A, 2011, P NATL ACAD SCI USA, V108, P13740, DOI 10.1073/pnas.1108376108; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Steil L, 2003, J BACTERIOL, V185, P6358, DOI 10.1128/JB.185.21.6358-6370.2003; Strimmer K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-303; Tojo S, 2003, J BIOCHEM, V134, P935, DOI 10.1093/jb/mvg225; Turner MS, 2000, J BACTERIOL, V182, P5202, DOI 10.1128/JB.182.18.5202-5210.2000; Wadenpohl I, 2010, J BACTERIOL, V192, P5260, DOI 10.1128/JB.00287-10; Wiegert T, 2001, MOL MICROBIOL, V41, P59, DOI 10.1046/j.1365-2958.2001.02489.x; Yoshimura M, 2004, MICROBIOL-SGM, V150, P591, DOI 10.1099/mic.0.26712-0; Zweers JC, 2009, APPL ENVIRON MICROB, V75, P7356, DOI 10.1128/AEM.01560-09	50	22	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48471	10.1371/journal.pone.0048471	http://dx.doi.org/10.1371/journal.pone.0048471			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155385	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900019
J	Hackney, JF; Zolali-Meybodi, O; Cherbas, P				Hackney, Jennifer F.; Zolali-Meybodi, Omid; Cherbas, Peter			Tissue Damage Disrupts Developmental Progression and Ecdysteroid Biosynthesis in Drosophila	PLOS ONE			English	Article							ECDYSONE-INDUCIBLE GENE; PROTHORACICOTROPIC HORMONE; MOLTING HORMONE; IMAGINAL DISKS; BROAD-COMPLEX; RECEPTOR SUPERFAMILY; GALLERIA-MELLONELLA; PATTERN FORMATION; TNF SUPERFAMILY; INDUCED DELAY	In humans, chronic inflammation, severe injury, infection and disease can result in changes in steroid hormone titers and delayed onset of puberty; however the pathway by which this occurs remains largely unknown. Similarly, in insects injury to specific tissues can result in a global developmental delay (e.g. prolonged larval/pupal stages) often associated with decreased levels of ecdysone - a steroid hormone that regulates developmental transitions in insects. We use Drosophila melanogaster as a model to examine the pathway by which tissue injury disrupts developmental progression. Imaginal disc damage inflicted early in larval development triggers developmental delays while the effects are minimized in older larvae. We find that the switch in injury response (e.g. delay/no delay) is coincident with the mid-3rd instar transition - a developmental time-point that is characterized by widespread changes in gene expression and marks the initial steps of metamorphosis. Finally, we show that developmental delays induced by tissue damage are associated with decreased expression of genes involved in ecdysteroid synthesis and signaling.	[Hackney, Jennifer F.; Zolali-Meybodi, Omid; Cherbas, Peter] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Cherbas, P (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	cherbas@indiana.edu			National Institutes of Health - Child Health and Human Development [5-T32HD49336-07]; METAcyte Initiative; Lilly Endowment; Indiana University Cox Research Scholars Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD049336] Funding Source: NIH RePORTER	National Institutes of Health - Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); METAcyte Initiative; Lilly Endowment; Indiana University Cox Research Scholars Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by a Common Themes in Reproductive Diversity training grant from the National Institutes of Health - Child Health and Human Development (5-T32HD49336-07), funds from the METAcyte Initiative awarded to Indiana University from the Lilly Endowment, and support from the Indiana University Cox Research Scholars Program. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRES AJ, 1992, DEVELOPMENT, V116, P865; ASHBURNER M, 1974, DEV BIOL, V39, P141, DOI 10.1016/S0012-1606(74)80016-3; Ashburner M., 1989, DROSOPHILA LAB HDB M; BAKKER K., 1959, Entomologia Experimentalis et Applicata, V2, P171, DOI 10.1007/BF00302537; BELYAEVA ES, 1980, CHROMOSOMA, V81, P281, DOI 10.1007/BF00285954; BERREUR P, 1979, J EXP ZOOL, V210, P347, DOI 10.1002/jez.1402100218; Biyasheva A, 2001, DEV BIOL, V231, P234, DOI 10.1006/dbio.2000.0126; Bodenstein D., 1950, BIOL DROSOPHILA, P275; Bonnier G, 1926, BR J EXP BIOL, V4, P186; BOTELLA LM, 1985, J INSECT PHYSIOL, V31, P179, DOI 10.1016/0022-1910(85)90118-0; BOURGIN RC, 1956, RADIAT RES, V5, P657, DOI 10.2307/3570585; Chavez VM, 2000, DEVELOPMENT, V127, P4115; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; DIBELLO PR, 1991, GENETICS, V129, P385; Freeman MR, 1999, DEVELOPMENT, V126, P4591; Fristrom D, 1993, DEV DROSOPHILA MELAN, P843; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; GAREN A, 1977, P NATL ACAD SCI USA, V74, P5099, DOI 10.1073/pnas.74.11.5099; GEBHARDT MD, 1993, J EVOLUTION BIOL, V6, P1, DOI 10.1046/j.1420-9101.1993.6010001.x; GILBERT LI, 1988, BIOESSAYS, V8, P153, DOI 10.1002/bies.950080506; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; Henrich VC, 1999, VITAM HORM, V55, P73; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; JANKNECHT R, 1989, NUCLEIC ACIDS RES, V17, P4455, DOI 10.1093/nar/17.12.4455; KARIM FD, 1993, DEVELOPMENT, V118, P977; KISS I, 1988, GENETICS, V118, P247; KNOBLOCH CA, 1988, J INSECT PHYSIOL, V34, P507, DOI 10.1016/0022-1910(88)90192-8; KUNKEL JG, 1977, BIOL BULL, V153, P145, DOI 10.2307/1540698; LUDWIG DANIEL, 1933, PHYSIOL ZOOL, V6, P493; MADHAVAN K, 1969, BIOL BULL-US, V137, P321, DOI 10.2307/1540104; MALA J, 1987, ARCH INSECT BIOCHEM, V4, P113, DOI 10.1002/arch.940040205; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Mensch J, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-78; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Moreno E, 2002, CURR BIOL, V12, P1263, DOI 10.1016/S0960-9822(02)00954-5; Muth FW, 1961, DEV GENES EVOL, V153, P370; Neubueser D, 2005, DEV BIOL, V280, P362, DOI 10.1016/j.ydbio.2005.01.023; Nijhout H, 2003, DEV BIOL, V261, P1, DOI 10.1016/S0012-1606(03)00276-8; OFARRELL AF, 1954, AUST J BIOL SCI, V7, P525, DOI 10.1071/BI9540525; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Petryk A, 2003, P NATL ACAD SCI USA, V100, P13773, DOI 10.1073/pnas.2336088100; Pohley H. J., 1967, Wilhelm Roux Archiv fur Entwicklungsmechanik der Organismen, V158, P341, DOI 10.1007/BF01380536; Polgar LA, 1996, COMP BIOCHEM PHYS C, V115, P179, DOI 10.1016/S0742-8413(96)00104-1; POODRY CA, 1990, ROUX ARCH DEV BIOL, V199, P219, DOI 10.1007/BF01682081; PORCHERON P, 1976, FEBS LETT, V61, P159, DOI 10.1016/0014-5793(76)81027-7; PORCHERON P, 1989, INSECT BIOCHEM, V19, P117, DOI 10.1016/0020-1790(89)90081-4; Riddiford L., 1993, DEV DROSOPHILA MELAN, V2, P899; Riddiford LM, 2003, INSECT BIOCHEM MOLEC, V33, P1327, DOI 10.1016/j.ibmb.2003.06.001; ROBERTS B, 1984, GEN COMP ENDOCR, V54, P469, DOI 10.1016/0016-6480(84)90164-3; RUSSELL MA, 1974, DEV BIOL, V40, P24, DOI 10.1016/0012-1606(74)90104-3; SAVAKIS C, 1980, CELL, V22, P665, DOI 10.1016/0092-8674(80)90542-5; SEGRAVES W A, 1984, Genetics, V107, pS96; SEGRAVES WA, 1990, GENE DEV, V4, P204, DOI 10.1101/gad.4.2.204; SEHNAL F, 1993, J INSECT PHYSIOL, V39, P1051, DOI 10.1016/0022-1910(93)90129-F; SIMPSON P, 1980, J EMBRYOL EXP MORPH, V57, P155; SIMPSON P, 1975, ROUX ARCH DEV BIOL, V178, P247, DOI 10.1007/BF00848432; SIMPSON P, 1976, ROUX ARCH DEV BIOL, V179, P215, DOI 10.1007/BF00848647; SMITH WA, 1986, MOL CELL ENDOCRINOL, V47, P25, DOI 10.1016/0303-7207(86)90012-2; SMITH WA, 1985, MOL CELL ENDOCRINOL, V39, P71, DOI 10.1016/0303-7207(85)90093-0; Smith WA, 2012, INSECT ENDOCRINOLOGY, P1, DOI [10.1016/B978-0-12-384749-2.10001-9, DOI 10.1016/B978-0-12-384749-2.10001-9]; Smith-Bolton RK, 2009, DEV CELL, V16, P797, DOI 10.1016/j.devcel.2009.04.015; St Pierre SE, 2002, DEVELOPMENT, V129, P1273; Steel CGH, 1985, COMPREHENSIVE INSECT; Stenzhorn HJ, 1975, DEV GENES EVOL, V176, P207; Stieper BC, 2008, DEV BIOL, V321, P18, DOI 10.1016/j.ydbio.2008.05.556; STONE BL, 1993, CELL, V75, P307, DOI 10.1016/0092-8674(93)80072-M; Takeuchi H, 2005, BIOCHEM J, V389, P637, DOI 10.1042/BJ20050498; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; VILLEE CA, 1946, J EXP ZOOL, V101, P261, DOI 10.1002/jez.1401010206; Warren JT, 2004, INSECT BIOCHEM MOLEC, V34, P991, DOI 10.1016/j.ibmb.2004.06.009; Warren JT, 2002, P NATL ACAD SCI USA, V99, P11043, DOI 10.1073/pnas.162375799; Wismar J, 2000, DEV BIOL, V226, P1, DOI 10.1006/dbio.2000.9811; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; YAO TP, 1992, CELL, V71, P63, DOI 10.1016/0092-8674(92)90266-F; Yoshiyama T, 2006, DEVELOPMENT, V133, P2565, DOI 10.1242/dev.02428; ZDAREK J, 1971, GEN COMP ENDOCR, V17, P483, DOI 10.1016/0016-6480(71)90183-3	78	26	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49105	10.1371/journal.pone.0049105	http://dx.doi.org/10.1371/journal.pone.0049105			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23166607	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234600022
J	Septer, AN; Stabb, EV				Septer, Alecia N.; Stabb, Eric V.			Coordination of the Arc Regulatory System and Pheromone-Mediated Positive Feedback in Controlling the Vibrio fischeri lux Operon	PLOS ONE			English	Article							HOMOSERINE LACTONE PRODUCTION; PSEUDOMONAS-AERUGINOSA; ESCHERICHIA-COLI; GENE-EXPRESSION; CYCLIC-AMP; BACTERIAL BIOLUMINESCENCE; STREPTOCOCCUS-PNEUMONIAE; SYMBIOTIC COLONIZATION; 2-COMPONENT SYSTEM; AUTOINDUCER	Bacterial pheromone signaling is often governed both by environmentally responsive regulators and by positive feedback. This regulatory combination has the potential to coordinate a group response among distinct subpopulations that perceive key environmental stimuli differently. We have explored the interplay between an environmentally responsive regulator and pheromone-mediated positive feedback in intercellular signaling by Vibrio fischeri ES114, a bioluminescent bacterium that colonizes the squid Euprymna scolopes. Bioluminescence in ES114 is controlled in part by N-(3-oxohexanoyl)-L-homoserine lactone (3OC6), a pheromone produced by LuxI that together with LuxR activates transcription of the luxICDABEG operon, initiating a positive feedback loop and inducing luminescence. The lux operon is also regulated by environmentally responsive regulators, including the redox-responsive ArcA/ArcB system, which directly represses lux in culture. Here we show that inactivating arcA leads to increased 3OC6 accumulation to initiate positive feedback. In the absence of positive feedback, arcA-mediated control of luminescence was only similar to 2-fold, but luxI-dependent positive feedback contributed more than 100 fold to the net induction of luminescence in the arcA mutant. Consistent with this overriding importance of positive feedback, 3OC6 produced by the arcA mutant induced luminescence in nearby wild-type cells, overcoming their ArcA repression of lux. Similarly, we found that artificially inducing ArcA could effectively repress luminescence before, but not after, positive feedback was initiated. Finally, we show that 3OC6 produced by a subpopulation of symbiotic cells can induce luminescence in other cells co-colonizing the host. Our results suggest that even transient loss of ArcA-mediated regulation in a sub-population of cells can induce luminescence in a wider community. Moreover, they indicate that 3OC6 can communicate information about both cell density and the state of ArcA/ArcB.	[Septer, Alecia N.; Stabb, Eric V.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Stabb, EV (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	estabb@uga.edu			National Science Foundation (NSF) [MCB-0347317, IOS-0841480, IOS-1121106]; University of Georgia Graduate School; DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) [32 CFR 168a]	National Science Foundation (NSF)(National Science Foundation (NSF)); University of Georgia Graduate School; DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This research was supported by the National Science Foundation (NSF) under grants CAREER MCB-0347317, IOS-0841480, and IOS-1121106. ANS was supported by funds awarded by the University of Georgia Graduate School and the DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate (NDSEG) Fellowship, 32 CFR 168a. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albus AM, 1997, J BACTERIOL, V179, P3928, DOI 10.1128/jb.179.12.3928-3935.1997; Antunes LCM, 2008, J BACTERIOL, V190, P4392, DOI 10.1128/JB.01443-07; Antunes LCM, 2007, J BACTERIOL, V189, P8387, DOI 10.1128/JB.00736-07; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; BOETTCHER KJ, 1995, J BACTERIOL, V177, P1053, DOI 10.1128/jb.177.4.1053-1058.1995; Bollinger N, 2001, J BACTERIOL, V183, P1990, DOI 10.1128/JB.183.6.1990-1996.2001; Bose JL, 2008, ARCH MICROBIOL, V190, P169, DOI 10.1007/s00203-008-0387-1; Bose JL, 2007, MOL MICROBIOL, V65, P538, DOI 10.1111/j.1365-2958.2007.05809.x; Bose JL, 2011, APPL ENVIRON MICROB, V77, P2445, DOI 10.1128/AEM.02643-10; Chancey ST, 1999, APPL ENVIRON MICROB, V65, P2294; Chatterjee J, 2002, MOL MICROBIOL, V46, P101, DOI 10.1046/j.1365-2958.2002.03128.x; CUI Y, 1995, J BACTERIOL, V177, P5108, DOI 10.1128/jb.177.17.5108-5115.1995; DEVINE JH, 1989, P NATL ACAD SCI USA, V86, P5688, DOI 10.1073/pnas.86.15.5688; Dilanji GE, 2012, J AM CHEM SOC, V134, P5618, DOI 10.1021/ja211593q; DUNLAP PV, 1989, J BACTERIOL, V171, P1199, DOI 10.1128/jb.171.2.1199-1202.1989; Dunn AK, 2006, APPL ENVIRON MICROB, V72, P802, DOI 10.1128/AEM.72.1.802-810.2006; Dunn AK, 2005, PLASMID, V54, P114, DOI 10.1016/j.plasmid.2005.01.003; Dunn AK, 2010, MOL MICROBIOL, V77, P44, DOI 10.1111/j.1365-2958.2010.07194.x; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; Flavier AB, 1997, J BACTERIOL, V179, P7089, DOI 10.1128/jb.179.22.7089-7097.1997; Flickinger ST, 2011, J AM CHEM SOC, V133, P5966, DOI 10.1021/ja111131f; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; FUQUA WC, 1994, J BACTERIOL, V176, P2796, DOI 10.1128/JB.176.10.2796-2806.1994; Georgellis D, 2001, SCIENCE, V292, P2314, DOI 10.1126/science.1059361; GILSON L, 1995, J BACTERIOL, V177, P6946, DOI 10.1128/jb.177.23.6946-6951.1995; GRAY KM, 1992, J BACTERIOL, V174, P4384, DOI 10.1128/JB.174.13.4384-4390.1992; Gristwood T, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-112; Guina T, 2003, J AM SOC MASS SPECTR, V14, P742, DOI 10.1016/S1044-0305(03)00133-8; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hao GX, 2006, J BACTERIOL, V188, P2173, DOI 10.1128/JB.188.6.2173-2183.2006; HERRERO M, 1990, J BACTERIOL, V172, P6557, DOI 10.1128/jb.172.11.6557-6567.1990; IUCHI S, 1993, J BIOL CHEM, V268, P23972; IUCHI S, 1990, J BACTERIOL, V172, P6020, DOI 10.1128/jb.172.10.6020-6025.1990; Jensen V, 2006, J BACTERIOL, V188, P8601, DOI 10.1128/JB.01378-06; Ji GY, 1995, P NATL ACAD SCI USA, V92, P12055, DOI 10.1073/pnas.92.26.12055; Kim EJ, 2005, MICROBIOL-SGM, V151, P1127, DOI 10.1099/mic.0.27566-0; Krol E, 2004, MOL GENET GENOMICS, V272, P1, DOI 10.1007/s00438-004-1030-8; KUO A, 1994, J BACTERIOL, V176, P7558, DOI 10.1128/JB.176.24.7558-7565.1994; Latifi A, 1996, MOL MICROBIOL, V21, P1137, DOI 10.1046/j.1365-2958.1996.00063.x; LEE KH, 1994, J BACTERIOL, V176, P1985, DOI 10.1128/jb.176.7.1985-1991.1994; Lenz DH, 2005, MOL MICROBIOL, V58, P1186, DOI 10.1111/j.1365-2958.2005.04902.x; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Liang W, 2007, MICROBIOL-SGM, V153, P2964, DOI 10.1099/mic.0.2007/006668-0; Liang W, 2008, FEBS LETT, V582, P3744, DOI 10.1016/j.febslet.2008.10.008; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Loh J, 2002, P NATL ACAD SCI USA, V99, P14446, DOI 10.1073/pnas.222336799; Lupp C, 2004, J BACTERIOL, V186, P3873, DOI 10.1128/JB.186.12.3873-3881.2004; Lupp C, 2003, MOL MICROBIOL, V50, P319, DOI 10.1046/j.1365-2958.2003.t01-1-03585.x; Lyell NL, 2010, J BACTERIOL, V192, P5103, DOI 10.1128/JB.00524-10; MAKEMSON JC, 1982, CURR MICROBIOL, V7, P181, DOI 10.1007/BF01568972; Malpica R, 2004, P NATL ACAD SCI USA, V101, P13318, DOI 10.1073/pnas.0403064101; MCFALLNGAI MJ, 1991, SCIENCE, V254, P1491, DOI 10.1126/science.1962208; Miller J. H., 1992, SHORT COURSE BACTERI, P456; Moris M, 2005, J BACTERIOL, V187, P5460, DOI 10.1128/JB.187.15.5460-5469.2005; NEALSON KH, 1970, J BACTERIOL, V104, P313, DOI 10.1128/JB.104.1.313-322.1970; Niu C, 2008, J BACTERIOL, V190, P3386, DOI 10.1128/JB.01929-07; NOVICK RP, 1995, MOL GEN GENET, V248, P446, DOI 10.1007/BF02191645; Perez PD, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-153; Pessi G, 2001, J BACTERIOL, V183, P6676, DOI 10.1128/JB.183.22.6676-6683.2001; Pestova EV, 1996, MOL MICROBIOL, V21, P853, DOI 10.1046/j.1365-2958.1996.501417.x; Peterson S, 2000, J BACTERIOL, V182, P6192, DOI 10.1128/JB.182.21.6192-6202.2000; Ravcheev DA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-54; Reverchon S, 1998, MOL MICROBIOL, V29, P1407, DOI 10.1046/j.1365-2958.1998.01023.x; Rolfe MD, 2011, J BIOL CHEM, V286, P10147, DOI 10.1074/jbc.M110.211144; Schaefer AL, 1996, P NATL ACAD SCI USA, V93, P9505, DOI 10.1073/pnas.93.18.9505; Schaefer AL, 1996, J BACTERIOL, V178, P2897, DOI 10.1128/jb.178.10.2897-2901.1996; Schaefer AL, 2000, METHOD ENZYMOL, V305, P288; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; SEED PC, 1995, J BACTERIOL, V177, P654, DOI 10.1128/jb.177.3.654-659.1995; Septer AN, 2011, ENVIRON MICROBIOL, V13, P2855, DOI 10.1111/j.1462-2920.2011.02558.x; Stabb EV, 2008, CHEMICAL COMMUNICATION AMONG BACTERIA, P233; Stabb EV, 2006, BIOLOGY OF VIBRIOS, P204; Stabb EV, 2002, METHOD ENZYMOL, V358, P413; Stabb EV, 2001, J BACTERIOL, V183, P309, DOI 10.1128/JB.183.1.309-317.2001; Stauff DL, 2011, J BACTERIOL, V193, P3871, DOI 10.1128/JB.05125-11; Van Delden C, 2001, J BACTERIOL, V183, P5376, DOI 10.1128/JB.183.18.5376-5384.2001; Wang L, 2005, J BACTERIOL, V187, P2066, DOI 10.1128/JB.187.6.2066-2076.2005; WEI SL, 1989, MAR BIOL, V103, P541, DOI 10.1007/BF00399586; Whistler CA, 2003, J BACTERIOL, V185, P7202, DOI 10.1128/JB.185.24.7202-7212.2003; Williams JW, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.70; Yakhnin H, 2011, J BACTERIOL, V193, P6162, DOI 10.1128/JB.05975-11; Yan Q, 2009, MICROBIOL RES, V164, P18, DOI 10.1016/j.micres.2008.02.001	82	21	21	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49590	10.1371/journal.pone.0049590	http://dx.doi.org/10.1371/journal.pone.0049590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152924	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234600047
J	Burnham-Marusich, AR; Snodgrass, CJ; Johnson, AM; Kiyoshi, CM; Buzby, SE; Gruner, MR; Berninsone, PM				Burnham-Marusich, Amanda R.; Snodgrass, Casey J.; Johnson, Anna M.; Kiyoshi, Conrad M.; Buzby, Sarah E.; Gruner, Matt R.; Berninsone, Patricia M.			Metabolic Labeling of Caenorhabditis elegans Primary Embryonic Cells with Azido-Sugars as a Tool for Glycoprotein Discovery	PLOS ONE			English	Article							GLCNAC-MODIFIED PROTEINS; PRIMARY CULTURE; ATP SYNTHASE; C-ELEGANS; GLYCOSYLATION; SURFACE; IDENTIFICATION; CYCLOADDITION; CHEMISTRY; PROTEASES	Glycobiology research with Caenorhabditis elegans (C. elegans) has benefitted from the numerous genetic and cell biology tools available in this system. However, the lack of a cell line and the relative inaccessibility of C. elegans somatic cells in vivo have limited the biochemical approaches available in this model. Here we report that C. elegans primary embryonic cells in culture incorporate azido-sugar analogs of N-acetylgalactosamine (GalNAc) and N-acetylglucosamine (GlcNAc), and that the labeled glycoproteins can be analyzed by mass spectrometry. By using this metabolic labeling approach, we have identified a set of novel C. elegans glycoprotein candidates, which include several mitochondrially-annotated proteins. This observation was unexpected given that mitochondrial glycoproteins have only rarely been reported, and it suggests that glycosylation of mitochondrially-annotated proteins might occur more frequently than previously thought. Using independent experimental strategies, we validated a subset of our glycoprotein candidates. These include a mitochondrial, atypical glycoprotein (ATP synthase alpha-subunit), a predicted glycoprotein (aspartyl protease, ASP-4), and a protein family with established glycosylation in other species (actin). Additionally, we observed a glycosylated isoform of ATP synthase alpha-subunit in bovine heart tissue and a primate cell line (COS-7). Overall, our finding that C. elegans primary embryonic cells are amenable to metabolic labeling demonstrates that biochemical studies in C. elegans are feasible, which opens the door to labeling C. elegans cells with other radioactive or azido-substrates and should enable the identification of additional post-translationally modified targets and analysis of the genes required for their modification using C. elegans mutant libraries.	[Burnham-Marusich, Amanda R.; Snodgrass, Casey J.; Johnson, Anna M.; Kiyoshi, Conrad M.; Buzby, Sarah E.; Gruner, Matt R.; Berninsone, Patricia M.] Univ Nevada, Dept Biol, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno	Berninsone, PM (corresponding author), Univ Nevada, Dept Biol, Reno, NV 89557 USA.	berninsone@unr.edu		Kiyoshi, Conrad/0000-0001-8938-5100; Burnham-Marusich, Amanda/0000-0003-2320-2222	National Institutes of Health (NIH) from the INBRE Program of the National Center for Research Resources [P20 RR-016464]; National Institutes of Health (NIH) from the COBRE Program of the National Center for Research Resources [P20 RR024210]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016464, P20RR024210] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103554] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health (NIH) from the INBRE Program of the National Center for Research Resources; National Institutes of Health (NIH) from the COBRE Program of the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health (NIH) Grants P20 RR-016464 from the INBRE Program of the National Center for Research Resources and P20 RR024210 from the COBRE Program of the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Baskin JM, 2007, P NATL ACAD SCI USA, V104, P16793, DOI 10.1073/pnas.0707090104; BLAXTER ML, 1993, J BIOL CHEM, V268, P6600; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; BRENNER S, 1974, GENETICS, V77, P71; Burnham-Marusich AR, 2012, MITOCHONDRION, V12, P423, DOI 10.1016/j.mito.2012.04.004; Chandra NC, 1998, J BIOL CHEM, V273, P19715, DOI 10.1074/jbc.273.31.19715; Chi SL, 2006, ANN MED, V38, P429, DOI 10.1080/07853890600928698; Christensen M, 2002, NEURON, V33, P503, DOI 10.1016/S0896-6273(02)00591-3; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Dube DH, 2006, P NATL ACAD SCI USA, V103, P4819, DOI 10.1073/pnas.0506855103; Hang HC, 2007, J AM CHEM SOC, V129, P2744, DOI 10.1021/ja0685001; Hanover JA, 2005, P NATL ACAD SCI USA, V102, P11266, DOI 10.1073/pnas.0408771102; Hu Y, 2009, J BIOL CHEM, V284, P547, DOI 10.1074/jbc.M808518200; Hulme SE, 2011, ANGEW CHEM INT EDIT, V50, P4774, DOI 10.1002/anie.201005461; Kho Y, 2004, P NATL ACAD SCI USA, V101, P12479, DOI 10.1073/pnas.0403413101; Kung LA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.64; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Laughlin ST, 2009, ACS CHEM BIOL, V4, P1068, DOI 10.1021/cb900254y; LEVRAT C, 1989, INT J BIOCHEM, V21, P265, DOI 10.1016/0020-711X(89)90184-5; Nandi A, 2006, ANAL CHEM, V78, P452, DOI 10.1021/ac051207j; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Rahman MM, 2010, AGING-US, V2, P678, DOI 10.18632/aging.100208; Ramirez-Correa GA, 2008, CIRC RES, V103, P1354, DOI 10.1161/CIRCRESAHA.108.184978; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Schmidt C, 2008, MOL PSYCHIATR, V13, P953, DOI 10.1038/sj.mp.4002077; Schwientek T, 2007, PROTEOMICS, V7, P3264, DOI 10.1002/pmic.200600793; Smith, 1967, METHOD ENZYMOL, V10, P81, DOI DOI 10.1016/0076-6879(67)10016-5; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Tcherepanova I, 2000, J BIOL CHEM, V275, P26359, DOI 10.1074/jbc.M000956200; Zhang SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019505	34	17	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49020	10.1371/journal.pone.0049020	http://dx.doi.org/10.1371/journal.pone.0049020			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152843	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234000046
J	Khmelinskii, A; Groen, HC; Baiker, M; de Jong, M; Lelieveldt, BPF				Khmelinskii, Artem; Groen, Harald C.; Baiker, Martin; de Jong, Marion; Lelieveldt, Boudewijn P. F.			Segmentation and Visual Analysis of Whole-Body Mouse Skeleton microSPECT	PLOS ONE			English	Article							REGISTRATION	Whole-body SPECT small animal imaging is used to study cancer, and plays an important role in the development of new drugs. Comparing and exploring whole-body datasets can be a difficult and time-consuming task due to the inherent heterogeneity of the data (high volume/throughput, multi-modality, postural and positioning variability). The goal of this study was to provide a method to align and compare side-by-side multiple whole-body skeleton SPECT datasets in a common reference, thus eliminating acquisition variability that exists between the subjects in cross-sectional and multi-modal studies. Six whole-body SPECT/CT datasets of BALB/c mice injected with bone targeting tracers Tc-99m-methylene diphosphonate (Tc-99m-MDP) and Tc-99m-hydroxymethane diphosphonate (Tc-99m-HDP) were used to evaluate the proposed method. An articulated version of the MOBY whole-body mouse atlas was used as a common reference. Its individual bones were registered one-by-one to the skeleton extracted from the acquired SPECT data following an anatomical hierarchical tree. Sequential registration was used while constraining the local degrees of freedom (DoFs) of each bone in accordance to the type of joint and its range of motion. The Articulated Planar Reformation (APR) algorithm was applied to the segmented data for side-by-side change visualization and comparison of data. To quantitatively evaluate the proposed algorithm, bone segmentations of extracted skeletons from the correspondent CT datasets were used. Euclidean point to surface distances between each dataset and the MOBY atlas were calculated. The obtained results indicate that after registration, the mean Euclidean distance decreased from 11.5 +/- 12.1 to 2.6 +/- 2.1 voxels. The proposed approach yielded satisfactory segmentation results with minimal user intervention. It proved to be robust for "incomplete'' data (large chunks of skeleton missing) and for an intuitive exploration and comparison of multi-modal SPECT/CT cross-sectional mouse data.	[Khmelinskii, Artem; Baiker, Martin; Lelieveldt, Boudewijn P. F.] Leiden Univ, Div Image Proc, Dept Radiol, Med Ctr, Leiden, Netherlands; [Groen, Harald C.; de Jong, Marion] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands; [de Jong, Marion] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Lelieveldt, Boudewijn P. F.] Delft Univ Technol, Dept Intelligent Syst, Delft, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Lelieveldt, BPF (corresponding author), Leiden Univ, Div Image Proc, Dept Radiol, Med Ctr, Leiden, Netherlands.	b.p.f.lelieveldt@lumc.nl	Lelieveldt, Boudewijn/B-6501-2008; Khmelinskii, Artem/L-3714-2013	Lelieveldt, Boudewijn/0000-0001-8269-7603; Khmelinskii, Artem/0000-0002-2665-7380; Baiker, Martin/0000-0002-3774-6821	Medical Delta	Medical Delta	This work was funded by Medical Delta (http://www.medicaldelta.nl/research/large-research-programs-and-initiatives/molecular-image-processing). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	99mTc-MDP, MICAD MOL IM PROB CO; Bab I, 2007, MICROTEOMOGRAPHIC AT; Baiker M, 2010, MED IMAGE ANAL, V14, P723, DOI 10.1016/j.media.2010.04.008; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; COOK M.J, 1965, ANATOMY LAB MOUSE; Franc BL, 2008, J NUCL MED, V49, P1651, DOI 10.2967/jnumed.108.055442; Hindorf C, 2010, EUR J NUCL MED MOL I, V37, pS274; Joshi AA, 2009, I S BIOMED IMAGING, P366, DOI 10.1109/ISBI.2009.5193060; Khmelinskii A, 2011, I S BIOMED IMAGING, P437, DOI 10.1109/ISBI.2011.5872440; Khmelinskii A, 2011, MOL IMAGING BIOL, V13, P898, DOI 10.1007/s11307-010-0386-x; Kok P, 2010, IEEE T VIS COMPUT GR, V16, P1396, DOI 10.1109/TVCG.2010.134; LKEB, ART ATL DOWNL SECT; Mathe D, 2010, NUCL MED BIOL, V37, P215, DOI 10.1016/j.nucmedbio.2009.09.004; Ostendorf B, 2006, ARTHRITIS RHEUM-US, V54, P1096, DOI 10.1002/art.21732; Savinaud M, 2010, LECT NOTES COMPUT SC, V6362, P668; Segars WP, 2004, MOL IMAGING BIOL, V6, P149, DOI 10.1016/j.mibio.2004.03.002; Suh JW, 2011, MED IMAGE ANAL, V15, P96, DOI 10.1016/j.media.2010.08.002; Wildeman MH, 2009, I S BIOMED IMAGING, P987, DOI 10.1109/ISBI.2009.5193220	18	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48976	10.1371/journal.pone.0048976	http://dx.doi.org/10.1371/journal.pone.0048976			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152834	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000042
J	Hocqueloux, L; Choisy, P; Le Moal, G; Borsa-Lebas, F; Plainchamp, D; Legac, E; Prazuck, T; de la Tribonniere, X; Yazdanpanah, Y; Parienti, JJ				Hocqueloux, Laurent; Choisy, Philippe; Le Moal, Gwenael; Borsa-Lebas, Francoise; Plainchamp, David; Legac, Eric; Prazuck, Thierry; de la Tribonniere, Xavier; Yazdanpanah, Yazdan; Parienti, Jean-Jacques			Pharmacologic Boosting of Atazanavir in Maintenance HIV-1 Therapy: The COREYA Propensity-Score Adjusted Study	PLOS ONE			English	Article							INFECTED PATIENTS; MYOCARDIAL-INFARCTION; UNBOOSTED ATAZANAVIR; VIROLOGICAL SUPPRESSION; EFFICACY; RISK; RITONAVIR; SAFETY; ADHERENCE; TENOFOVIR	Background: Among HIV-1 infected patients who achieved virologic suppression, the use of atazanavir without pharmacologic boosting is debated. We evaluated the efficacy and tolerance of maintenance therapy with unboosted atazanavir in clinical practice. Methods and Results: This multicenter retrospective cohort study evaluated the efficacy of switching HIV-1-infected patients controlled on triple therapy to unboosted (ATV(0), n = 98) versus ritonavir-boosted atazanavir (ATV/r, n = 254) +2 nucleos(t)ide reverse transcriptase inhibitors. The primary endpoint was time to virologic failure (VF, > 200 copies/mL). ATV groups were compared controlling for potential confounding bias by inverse probability weighted Cox analysis and propensity-score matching. Overall and adjusted VF rates were similar for both strategies. Both strategies improved dyslipidemia and creatininemia, with less jaundice in the ATV(0) group. Conclusion: In previously well-suppressed patients, within an observational cohort setting, ATV(0)-based triple-therapy appeared as effective as ATV/r-based triple-therapy to maintain virologic suppression, even if co-administered with TDF, but was better tolerated.	[Parienti, Jean-Jacques] CHU Cote Nacre, Unite Biostat & Rech Clin, Caen, France; [Hocqueloux, Laurent; Prazuck, Thierry] Ctr Hosp Reg, Serv Malad Infect & Trop, Orleans, France; [Choisy, Philippe; de la Tribonniere, Xavier; Yazdanpanah, Yazdan] Hop Gustave Dron, Serv Univ Malad Infect & Voyageur, Tourcoing, France; [Le Moal, Gwenael; Plainchamp, David] Hop Miletrie, Serv Malad Infect, Poitiers, France; [Borsa-Lebas, Francoise] Hop Charles Nicolle, Serv Malad Infect, Rouen, France; [Legac, Eric] Ctr Hosp Reg, Biol Lab, Orleans, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; Centre Hospitalier Annecy Genevois; Centre Hospitalier Regional d'Orleans; CHU Poitiers; Universite de Poitiers; CHU de Rouen; Centre Hospitalier Annecy Genevois; Centre Hospitalier Regional d'Orleans	Parienti, JJ (corresponding author), CHU Cote Nacre, Unite Biostat & Rech Clin, Caen, France.	parienti-jj@chu-caen.fr	Parienti, Jean-Jacques/AAD-1701-2021	Parienti, Jean-Jacques/0000-0002-4774-5590	Caen University, France; Bristol-Myers-Squibb Inc.; Boehringer Ingelheim; Abbott; BMS; MSD; Gilead	Caen University, France; Bristol-Myers-Squibb Inc.(Bristol-Myers Squibb); Boehringer Ingelheim(Boehringer Ingelheim); Abbott(Abbott Laboratories); BMS(Bristol-Myers Squibb); MSD; Gilead(Gilead Sciences)	BMS through an academic grant to Caen University, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; English language writing support was provided by Nicola Ryan of inScience Communications. This assistance was funded by Bristol-Myers-Squibb Inc. The authors thank Fabien Chaillot for administrative support.; Dr. Parienti has received grant support, travel grants, and/or honoria from Boehringer Ingelheim, Abbott, BMS, MSD and Gilead. Other authors have declared that no competing interests exist.	Aldous JL, 2009, CURR OPIN HIV AIDS, V4, P459, DOI 10.1097/COH.0b013e328331dea5; Austin PC, 2007, STAT MED, V26, P734, DOI 10.1002/sim.2580; Caleagno A, 2009, JAIDS-J ACQ IMM DEF, V52, P431, DOI 10.1097/QAI.0b013e3181b08f09; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; D'Arminio Monforte A, 2012, 19 C RETR OPP INF 5; Ding X, 2012, J ACQUIR IMMUNE DEFI; Friis-Moller N, 2010, EUR J CARDIOV PREV R, V17, P491, DOI 10.1097/HJR.0b013e328336a150; Gatell J, 2007, CLIN INFECT DIS, V44, P1484, DOI 10.1086/517497; Ghosn J, 2010, ANTIVIR THER, V15, P993, DOI 10.3851/IMP1666; Giuntini R, 2010, HIV MED, V11, P40, DOI 10.1111/j.1468-1293.2009.00740.x; Guidelines for the Use of Antiretroviral Agents in HIV-1 Infected Adults and Adolescents, 2011, GUID US ANT AG HIV 1, P1; Ickovics JR, 2002, ANTIVIR THER, V7, P185; Lang S, 2010, ARCH INTERN MED, V170, P1228, DOI 10.1001/archinternmed.2010.197; Lang S, 2010, AIDS, V24, P1228, DOI 10.1097/QAD.0b013e328339192f; Obel N, 2010, HIV MED, V11, P130, DOI 10.1111/j.1468-1293.2009.00751.x; Parienti JJ, 2010, CLIN INFECT DIS, V50, P1192, DOI 10.1086/651419; Pavie J, 2011, J ANTIMICROB CHEMOTH, V66, P2372, DOI 10.1093/jac/dkr316; Ribaudo H, 2009, 16 C RETR OPP INF FE; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; Ryom L, 2012, 19 C RETR OPP INF 5; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Squires KE, 2010, AIDS, V24, P2019, DOI 10.1097/QAD.0b013e32833bee1b; Taburet AM, 2004, ANTIMICROB AGENTS CH, V48, P2091, DOI 10.1128/AAC.48.6.2091-2096.2004; Valantin MA, 2010, J ANTIMICROB CHEMOTH, V65, P556, DOI 10.1093/jac/dkp462; Yeni P, 2010, PRISE CHARGE MED PER	25	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49289	10.1371/journal.pone.0049289	http://dx.doi.org/10.1371/journal.pone.0049289			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152890	Green Published, Green Submitted, gold			2022-12-27	WOS:000312272600057
J	Zhou, JP; Joplin, DG; Cross, JV; Templeton, DJ				Zhou, Jiping; Joplin, Denise G.; Cross, Janet V.; Templeton, Dennis J.			Sulforaphane Inhibits Prostaglandin E2 Synthesis by Suppressing Microsomal Prostaglandin E Synthase 1	PLOS ONE			English	Article							COLON-CANCER CELLS; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; FACTOR-KAPPA-B; LUNG-CANCER; DNA-BINDING; OSTEOARTHRITIC CARTILAGE; ANTIINFLAMMATORY DRUGS; SYNOVIAL FIBROBLASTS; TUMOR-SUPPRESSOR; E-2 SYNTHASE-1	Sulforaphane (SFN) is a dietary cancer preventive with incompletely characterized mechanism(s) of cancer prevention. Since prostaglandin E2 (PGE2) promotes cancer progression, we hypothesized that SFN may block PGE2 synthesis in cancer cells. We found that SFN indeed blocked PGE2 production in human A549 cancer cells not by inhibiting COX-2, but rather by suppressing the expression of microsomal prostaglandin E synthase (mPGES-1), the enzyme that directly synthesizes PGE2. We identified the Hypoxia Inducible Factor 1 alpha (HIF-1 alpha) as the target of SFN-mediated mPGES-1 suppression. SFN suppressed HIF-1 alpha protein expression and the presence of HIF-1 alpha at the mPGES-1 promoter, resulting in reduced transcription of mPGES-1. Finally, SFN also reduced expression of mPGES-1 and PGE2 production in A549 xenograft tumors in mice. Together, these results point to the HIF-1 alpha, mPGES-1 and PGE2 axis as a potential mediator of the anti-cancer effects of SFN, and illustrate the potential of SFN for therapeutic control of cancer and inflammation. Harmful side effects in patients taking agents that target the more upstream COX-2 enzyme render the downstream target mPGES-1 a significant target for anti-inflammatory therapy. Thus, SFN could prove to be an important therapeutic approach to both cancer and inflammation.	[Zhou, Jiping; Joplin, Denise G.; Cross, Janet V.; Templeton, Dennis J.] Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA	University of Virginia	Templeton, DJ (corresponding author), Univ Virginia, Sch Med, Dept Pathol, Charlottesville, VA 22908 USA.	dtempleton@virginia.edu	Cross, Janet V/F-8276-2011; Templeton, Dennis J/F-7695-2011		National Institutes of Health [R01CA113899, R01AT004323]; UVA Cancer Center through the Patients and Friends Research Fund; NCI Cancer Center Support Grant [P30CA44579]; NATIONAL CANCER INSTITUTE [R01CA113899, P30CA044579] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UVA Cancer Center through the Patients and Friends Research Fund; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by National Institutes of Health grant R01CA113899 (to DJT) and R01AT004323 (to JVC) as well as support from the UVA Cancer Center through the Patients and Friends Research Fund and the NCI Cancer Center Support Grant, P30CA44579 (to JVC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosone CB, 2004, J NUTR, V134, P1134, DOI 10.1093/jn/134.5.1134; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Banning A, 2008, ANTIOXID REDOX SIGN, V10, P1491, DOI 10.1089/ars.2008.2047; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; Bertl E, 2006, MOL CANCER THER, V5, P575, DOI 10.1158/1535-7163.MCT-05-0324; Bianchi A, 2005, ARTHRITIS RES THER, V7, pR1325, DOI 10.1186/ar1830; Cheng S, 2004, J BIOL CHEM, V279, P22057, DOI 10.1074/jbc.M402828200; Cheung K, 2009, PHARM RES-DORDR, V26, P224, DOI 10.1007/s11095-008-9734-9; Chiao JW, 2002, INT J ONCOL, V20, P631; Cho SJ, 2006, J BIOL CHEM, V281, P8161, DOI 10.1074/jbc.M506770200; Choi S, 2007, CARCINOGENESIS, V28, P151, DOI 10.1093/carcin/bgl144; CHRISTY B, 1989, P NATL ACAD SCI USA, V86, P8737, DOI 10.1073/pnas.86.22.8737; CLYMAN RI, 1980, J PEDIATR-US, V96, P94, DOI 10.1016/S0022-3476(80)80338-6; Cross JV, 2009, BIOCH J; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; Deems R, 2007, METHOD ENZYMOL, V432, P59, DOI 10.1016/S0076-6879(07)32003-X; Ding YF, 2005, CARCINOGENESIS, V26, P65, DOI 10.1093/carcin/bgh277; Egerod FL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-385; Fahey JW, 1999, FOOD CHEM TOXICOL, V37, P973, DOI 10.1016/S0278-6915(99)00082-4; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gamet-Payrastre L, 2000, CANCER RES, V60, P1426; Gamet-Payrastre L, 1998, ANTI-CANCER DRUG, V9, P141, DOI 10.1097/00001813-199802000-00005; Gingras D, 2004, CANCER LETT, V203, P35, DOI 10.1016/j.canlet.2003.08.025; Gomez-Hernandez A, 2006, ATHEROSCLEROSIS, V187, P139, DOI 10.1016/j.atherosclerosis.2005.08.035; Graham DJ, 2005, LANCET, V365, P475, DOI 10.1016/S0140-6736(05)17864-7; Grimmer C, 2007, ARTHRITIS RHEUM, V56, P4084, DOI 10.1002/art.23136; Hanaka H, 2009, P NATL ACAD SCI USA, V106, P18757, DOI 10.1073/pnas.0910218106; Heiss E, 2001, J BIOL CHEM, V276, P32008, DOI 10.1074/jbc.M104794200; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Iyer JP, 2009, EXPERT OPIN THER TAR, V13, P849, DOI 10.1517/14728220903018932; Jackson SJT, 2004, CARCINOGENESIS, V25, P219, DOI 10.1093/carcin/bgg192; Jackson SJT, 2007, VASC PHARMACOL, V46, P77, DOI 10.1016/j.vph.2006.06.015; Komatsu DE, 2004, BONE, V34, P680, DOI 10.1016/j.bone.2003.12.024; Kudo I, 2005, J BIOCHEM MOL BIOL, V38, P633; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Lee JJ, 2010, CARCINOGENESIS, V31, P427, DOI 10.1093/carcin/bgp326; Li XF, 2005, J RHEUMATOL, V32, P887; Lin W, 2008, BIOCHEM PHARMACOL, V76, P967, DOI 10.1016/j.bcp.2008.07.036; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maheo K, 1997, CANCER RES, V57, P3649; Maxwell PH, 2005, SEMIN CELL DEV BIOL, V16, P523, DOI 10.1016/j.semcdb.2005.03.001; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MILLER AM, 1991, AM J OBSTET GYNECOL, V165, P1006, DOI 10.1016/0002-9378(91)90459-5; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Mohammed SI, 2001, PROSTAG LEUKOTR ESS, V64, P1, DOI 10.1054/plef.2000.0231; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Naraba H, 2002, J BIOL CHEM, V277, P28601, DOI 10.1074/jbc.M203618200; Nishikawa T, 2010, ANGIOGENESIS, V13, P227, DOI 10.1007/s10456-010-9180-2; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Rainsford K. D., 2007, V42, P3; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen GX, 2006, CANCER CHEMOTH PHARM, V57, P317, DOI 10.1007/s00280-005-0050-3; Sinha P, 2007, CANCER RES, V67, P4507, DOI 10.1158/0008-5472.CAN-06-4174; SMITH WL, 1989, BIOCHEM J, V259, P315, DOI 10.1042/bj2590315; Stichtenoth DO, 2001, J IMMUNOL, V167, P469, DOI 10.4049/jimmunol.167.1.469; Stiehl DP, 2002, FEBS LETT, V512, P157, DOI 10.1016/S0014-5793(02)02247-0; SWIRNOFF AH, 1995, MOL CELL BIOL, V15, P2275; Thornton RD, 2000, BIOCHEM J, V350, P307, DOI 10.1042/0264-6021:3500307; Williams CS, 1999, ONCOGENE, V18, P7908, DOI 10.1038/sj.onc.1203286; Woo KJ, 2007, INT IMMUNOPHARMACOL, V7, P1776, DOI 10.1016/j.intimp.2007.09.018; ZHANG YS, 1994, CANCER RES, V54, pS1976; Zhao B, 2001, CANCER EPIDEM BIOMAR, V10, P1063	63	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49744	10.1371/journal.pone.0049744	http://dx.doi.org/10.1371/journal.pone.0049744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166763	Green Published, gold, Green Submitted			2022-12-27	WOS:000311885300067
J	Lacape, JM; Claverie, M; Vidal, RO; Carazzolle, MF; Pereira, GAG; Ruiz, M; Pre, M; Llewellyn, D; Al-Ghazi, Y; Jacobs, J; Dereeper, A; Huguet, S; Giband, M; Lanaud, C				Lacape, Jean-Marc; Claverie, Michel; Vidal, Ramon O.; Carazzolle, Marcelo F.; Guimaraes Pereira, Goncalo A.; Ruiz, Manuel; Pre, Martial; Llewellyn, Danny; Al-Ghazi, Yves; Jacobs, John; Dereeper, Alexis; Huguet, Stephanie; Giband, Marc; Lanaud, Claire			Deep Sequencing Reveals Differences in the Transcriptional Landscapes of Fibers from Two Cultivated Species of Cotton	PLOS ONE			English	Article							CELL-WALL; GENE-EXPRESSION; MESSENGER-RNA; FUNCTIONAL GENOMICS; VACUOLAR INVERTASE; ELONGATION; PROTEIN; IDENTIFICATION; ANNOTATION; EVOLUTION	Cotton (Gossypium) fiber is the most prevalent natural product used in the textile industry. The two major cultivated species, G. hirsutum (Gh) and G. barbadense (Gb), are allotetraploids with contrasting fiber quality properties. To better understand the molecular basis for their fiber differences, EST pyrosequencing was used to document the fiber transcriptomes at two key development stages, 10 days post anthesis (dpa), representing the peak of fiber elongation, and 22 dpa, representing the transition to secondary cell wall synthesis. The 617,000 high quality reads (89% of the total 692,000 reads) from 4 libraries were assembled into 46,072 unigenes, comprising 38,297 contigs and 7,775 singletons. Functional annotation of the unigenes together with comparative digital gene expression (DGE) revealed a diverse set of functions and processes that were partly linked to specific fiber stages. Globally, 2,770 contigs (7%) showed differential expression (>2-fold) between 10 and 22 dpa (irrespective of genotype), with 70% more highly expressed at 10 dpa, while 2,248 (6%) were differentially expressed between the genotypes (irrespective of stage). The most significant genes with differential DGE at 10 dpa included expansins and lipid transfer proteins (higher in Gb), while at 22 dpa tubulins, cellulose, and sucrose synthases showed higher expression in Gb. DGE was compared with expression data of 10 dpa-old fibers from Affymetrix microarrays. Among 543 contigs showing differential expression on both platforms, 74% were consistent in being either over-expressed in Gh (242 genes) or in Gb (161 genes). Furthermore, the unigene set served to identify 339 new SSRs and close to 21,000 inter-genotypic SNPs. Subsets of 88 SSRs and 48 SNPs were validated through mapping and added 65 new loci to a RIL genetic map. The new set of fiber ESTs and the gene-based markers complement existing available resources useful in basic and applied research for crop improvement in cotton.	[Lacape, Jean-Marc; Claverie, Michel; Ruiz, Manuel; Pre, Martial; Giband, Marc; Lanaud, Claire] CIRAD, UMR AGAP, Montpellier, France; [Vidal, Ramon O.; Carazzolle, Marcelo F.; Guimaraes Pereira, Goncalo A.] Univ Estadual Campinas, Lab Genom & Express, Campinas, SP, Brazil; [Llewellyn, Danny; Al-Ghazi, Yves] CSIRO Plant Ind, Canberra, ACT, Australia; [Jacobs, John] Bayer BioSci NV, Ghent, Belgium; [Dereeper, Alexis] IRD, UMR RPB, Montpellier, France; [Huguet, Stephanie] URGV, UMR INRA 1165, Evry, France; [Giband, Marc] EMBRAPA Algodao, Nucleo Cerrado Embrapa Algoda, Santo Antonio De Goias, Go, Brazil	CIRAD; Universite de Montpellier; Universidade Estadual de Campinas; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Bayer AG; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Lacape, JM (corresponding author), CIRAD, UMR AGAP, Montpellier, France.	marc.lacape@cirad.fr	Pereira, Gonçalo A. G./B-7944-2012; Lacape, JM/Y-1806-2019; Lacape, Jean-Marc/B-4326-2008; Carazzolle, Marcelo Falsarella/C-6503-2012; Llewellyn, Danny J/D-5230-2009	Lacape, Jean-Marc/0000-0003-0891-8329; Carazzolle, Marcelo Falsarella/0000-0002-5474-2830; Llewellyn, Danny J/0000-0001-9535-8707; Ruiz, Manuel/0000-0001-8153-276X; Lanaud, Claire/0000-0001-6411-7310	French National Research Agency, ANR [ANR-06-GPLA-018]	French National Research Agency, ANR(French National Research Agency (ANR))	The French National Research Agency, ANR, through its program specialized in plant genomics, Genoplante, has sponsored this research (project nr ANR-06-GPLA-018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Al-Ghazi Y, 2009, PLANT CELL PHYSIOL, V50, P1364, DOI 10.1093/pcp/pcp084; Alabady MS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-295; Alagna F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-399; Arpat AB, 2004, PLANT MOL BIOL, V54, P911, DOI 10.1007/s11103-004-0392-y; Barakat A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-51; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Betancur L, 2010, J INTEGR PLANT BIOL, V52, P205, DOI 10.1111/j.1744-7909.2010.00934.x; Brill E, 2011, PLANT PHYSIOL, V157, P40, DOI 10.1104/pp.111.178574; Byers RL, 2012, THEOR APPL GENET, V124, P1201, DOI 10.1007/s00122-011-1780-8; Cedroni ML, 2003, PLANT MOL BIOL, V51, P313, DOI 10.1023/A:1022051100610; Chaudhary B, 2009, GENETICS, V182, P503, DOI 10.1534/genetics.109.102608; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Claverie M, 2012, THEOR APPL GENET, V124, P665, DOI 10.1007/s00122-011-1738-x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dereeper A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-134; Dirk LMA, 2010, PHYSIOLOGY OF COTTON, P383, DOI 10.1007/978-90-481-3195-2_34; Feng JX, 2004, ACTA BIOCH BIOPH SIN, V36, P51, DOI 10.1093/abbs/36.1.51; Gagnot S, 2008, NUCLEIC ACIDS RES, V36, pD986, DOI 10.1093/nar/gkm757; Gaudet M, 2007, PLANT MOL BIOL REP, V25, P1, DOI 10.1007/s11105-007-0003-6; Ge H, 2003, TEST, V12, P1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Girke T, 2004, PLANT PHYSIOL, V136, P3003, DOI 10.1104/pp.104.049965; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gou JY, 2007, CELL RES, V17, P422, DOI 10.1038/sj.cr.7310150; Guo SG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-454; Guo SG, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-384; Haigler CH, 2005, PHYSIOL PLANTARUM, V124, P285, DOI 10.1111/j.1399-3054.2005.00480.x; Hinchliffe DJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-445; Hovav R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040025; Hovav R, 2008, P NATL ACAD SCI USA, V105, P6191, DOI 10.1073/pnas.0711569105; Hovav R, 2008, PLANTA, V227, P319, DOI 10.1007/s00425-007-0619-7; Huang GQ, 2008, PHYSIOL PLANTARUM, V134, P348, DOI 10.1111/j.1399-3054.2008.01139.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji SJ, 2003, NUCLEIC ACIDS RES, V31, P2534, DOI 10.1093/nar/gkg358; John ME, 1996, PLANT MOL BIOL, V30, P297, DOI 10.1007/BF00020115; JOHN ME, 1992, P NATL ACAD SCI USA, V89, P5769, DOI 10.1073/pnas.89.13.5769; JOHN ME, 1995, PLANT PHYSIOL, V108, P669, DOI 10.1104/pp.108.2.669; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kaur S, 2012, PLANT BIOTECHNOL J, V10, P125, DOI 10.1111/j.1467-7652.2011.00644.x; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kim HJ, 2001, PLANT PHYSIOL, V127, P1361, DOI 10.1104/pp.010724; Kim HJ, 2007, WORLD COTTON RES C; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li CH, 2002, PLANT SCI, V163, P1113, DOI 10.1016/S0168-9452(02)00320-5; Li XB, 2005, PLANT CELL, V17, P859, DOI 10.1105/tpc.104.029629; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Liu DQ, 2008, PLANT MOL BIOL REP, V26, P98, DOI 10.1007/s11105-008-0026-7; Loguercio LL, 1999, MOL GEN GENET, V261, P660; Martin JA, 2011, NAT REV GENET, V12, P671, DOI 10.1038/nrg3068; Maughan PJ, 2010, PLANT GENOME-US, V3, P166, DOI 10.3835/plantgenome2010.07.0016; Milne I, 2009, BIOINFORMATICS, V25, P126, DOI 10.1093/bioinformatics/btp666; Nicol F, 1998, CURR OPIN PLANT BIOL, V1, P12, DOI 10.1016/S1369-5266(98)80121-0; Okamoto-Nakazato A, 2001, PLANT CELL PHYSIOL, V42, P952, DOI 10.1093/pcp/pce121; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Padmalatha KV, 2012, PLANT MOL BIOL, V78, P223, DOI 10.1007/s11103-011-9857-y; Paterson A. H., 2010, Tropical Plant Biology, V3, P71, DOI 10.1007/s12042-010-9051-4; Paterson AH, 2003, THEOR APPL GENET, V106, P384, DOI 10.1007/s00122-002-1025-y; Qin YM, 2005, CELL RES, V15, P465, DOI 10.1038/sj.cr.7290315; Qin YM, 2007, PLANT CELL, V19, P3692, DOI 10.1105/tpc.107.054437; Rabinowicz PD, 2005, GENOME RES, V15, P1431, DOI 10.1101/gr.4100405; Rapp RA, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-139; Rinehart JA, 1996, PLANT PHYSIOL, V112, P1331, DOI 10.1104/pp.112.3.1331; Rong J, 2007, GENETICS, V176, P2577, DOI 10.1534/genetics.107.074518; Ruan YL, 2004, PLANT PHYSIOL, V136, P4104, DOI 10.1104/pp.104.051540; Ruan YL, 2001, PLANT CELL, V13, P47, DOI 10.1105/tpc.13.1.47; Scheible WR, 2004, CURR OPIN PLANT BIOL, V7, P285, DOI 10.1016/j.pbi.2004.03.006; Sergeeva LI, 2006, P NATL ACAD SCI USA, V103, P2994, DOI 10.1073/pnas.0511015103; Shimizu Y, 1997, PLANT CELL PHYSIOL, V38, P375, DOI 10.1093/oxfordjournals.pcp.a029178; Stekel DJ, 2000, GENOME RES, V10, P2055, DOI 10.1101/gr.GR-1325RR; Suo JF, 2003, BBA-GENE STRUCT EXPR, V1630, P25, DOI 10.1016/j.bbaexp.2003.08.009; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Torres TT, 2008, GENOME RES, V18, P172, DOI 10.1101/gr.6984908; Tu LL, 2007, PLANT CELL REP, V26, P1309, DOI 10.1007/s00299-007-0337-4; Udall JA, 2006, GENOME RES, V16, P441, DOI 10.1101/gr.4602906; Villar E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-538; Walford SA, 2011, PLANT J, V65, P785, DOI 10.1111/j.1365-313X.2010.04464.x; Wall PK, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-347; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang L, 2010, PLANT SIGNAL BEHAV, V5, P1561, DOI 10.4161/psb.5.12.13568; Wang L, 2010, PLANT PHYSIOL, V154, P744, DOI 10.1104/pp.110.162487; Wang S, 2004, PLANT CELL, V16, P2323, DOI 10.1105/tpc.104.024844; Wendel JF, 2003, ADV AGRON, V78, P139, DOI 10.1016/S0065-2113(02)78004-8; Whittaker DJ, 1999, PLANT PHYSIOL, V121, P181, DOI 10.1104/pp.121.1.181; Wilkins TA, 2005, PHYSIOL PLANTARUM, V124, P295, DOI 10.1111/j.1399-3054.2005.00514.x; Wilkins TA, 1999, COTTON FIBERS: DEVELOPMENTAL BIOLOGY, QUALITY IMPROVEMENT, AND TEXTILE PROCESSING, P231; Wu YR, 2006, PLANT CELL PHYSIOL, V47, P107, DOI 10.1093/pcp/pci228; Yanagisawa S, 2004, PLANT CELL PHYSIOL, V45, P386, DOI 10.1093/pcp/pch055; Yang SS, 2006, PLANT J, V47, P761, DOI 10.1111/j.1365-313X.2006.02829.x; Yang YW, 2008, J PROTEOME RES, V7, P4623, DOI 10.1021/pr800550q; You FM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-253; Yu JZ, 2012, G3-GENES GENOM GENET, V2, P43, DOI 10.1534/g3.111.001552; Yuan DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022758; Zhang DS, 2004, PLANT MOL BIOL, V54, P353, DOI 10.1023/B:PLAN.0000036369.55253.dd; Zhao PM, 2010, J PROTEOME RES, V9, P1076, DOI 10.1021/pr900975t	99	31	35	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48855	10.1371/journal.pone.0048855	http://dx.doi.org/10.1371/journal.pone.0048855			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166598	Green Published, gold			2022-12-27	WOS:000311272300018
J	Boaglio, AC; Zucchetti, AE; Toledo, FD; Barosso, IR; Pozzi, EJS; Crocenzi, FA; Roma, MG				Boaglio, Andrea C.; Zucchetti, Andres E.; Toledo, Flavia D.; Barosso, Ismael R.; Sanchez Pozzi, Enrique J.; Crocenzi, Fernando A.; Roma, Marcelo G.			ERK1/2 and p38 MAPKs Are Complementarily Involved in Estradiol 17 beta-D-Glucuronide-Induced Cholestasis: Crosstalk with cPKC and PI3K	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; SALT EXPORT PUMP; CULTURED CHICKEN HEPATOCYTES; RAT-LIVER; GROWTH-FACTOR; CYCLIC-AMP; PHOSPHATIDYLINOSITOL 3-KINASE; CANALICULAR MEMBRANE; SIGNALING PATHWAYS; INDUCED CHOLERESIS	Objective: The endogenous, cholestatic metabolite estradiol 17 beta-D-glucuronide (E(2)17G) induces endocytic internalization of the canalicular transporters relevant to bile formation, Bsep and Mrp2. We evaluated here whether MAPKs are involved in this effect. Design: ERK1/2, JNK1/2, and p38 MAPK activation was assessed by the increase in their phosphorylation status. Hepatocanalicular function was evaluated in isolated rat hepatocyte couplets (IRHCs) by quantifying the apical secretion of fluorescent Bsep and Mrp2 substrates, and in isolated, perfused rat livers (IPRLs), using taurocholate and 2,4-dinitrophenyl-S-glutathione, respectively. Protein kinase participation in E(2)17G-induced secretory failure was assessed by co-administering selective inhibitors. Internalization of Bsep/Mrp2 was assessed by confocal microscopy and image analysis. Results: E(2)17G activated all kinds of MAPKs. The PI3K inhibitor wortmannin prevented ERK1/2 activation, whereas the cPKC inhibitor Go6976 prevented p38 activation, suggesting that ERK1/2 and p38 are downstream of PI3K and cPKC, respectively. The p38 inhibitor SB203580 and the ERK1/2 inhibitor PD98059, but not the JNK1/2 inhibitor SP600125, partially prevented E(2)17G-induced changes in transporter activity and localization in IRHCs. p38 and ERK1/2 co-inhibition resulted in additive protection, suggesting complementary involvement of these MAPKs. In IPRLs, E(2)17G induced endocytosis of canalicular transporters and a rapid and sustained decrease in bile flow and biliary excretion of Bsep/Mrp2 substrates. p38 inhibition prevented this initial decay, and the internalization of Bsep/Mrp2. Contrarily, ERK1/2 inhibition accelerated the recovery of biliary secretion and the canalicular reinsertion of Bsep/Mrp2. Conclusions: cPKC/p38 MAPK and PI3K/ERK1/2 signalling pathways participate complementarily in E(2)17G-induced cholestasis, through internalization and sustained intracellular retention of canalicular transporters, respectively.	[Boaglio, Andrea C.; Zucchetti, Andres E.; Toledo, Flavia D.; Barosso, Ismael R.; Sanchez Pozzi, Enrique J.; Crocenzi, Fernando A.; Roma, Marcelo G.] Natl Univ Rosario, Inst Expt Physiol, Natl Sci & Tech Res Council, Rosario, Santa Fe, Argentina	National University of Rosario	Boaglio, AC (corresponding author), Natl Univ Rosario, Inst Expt Physiol, Natl Sci & Tech Res Council, Rosario, Santa Fe, Argentina.	crocenzi@ifise-conicet.gov.ar; mroma@fbioyf.unr.edu.ar	Crocenzi, Fernando/P-7522-2018	Crocenzi, Fernando/0000-0001-6893-916X; Zucchetti, Andres Ernesto/0000-0001-7067-1182; Sanchez Pozzi, Enrique Juan/0000-0002-3752-214X				Alvaro D, 2002, HEPATOLOGY, V36, P297, DOI 10.1053/jhep.2002.34741; Apodaca G, 2001, TRAFFIC, V2, P149, DOI 10.1034/j.1600-0854.2001.020301.x; Band CJ, 1997, J BIOL CHEM, V272, P138; BERTHELOT P, 1970, AM J PHYSIOL, V219, P809; Bessems M, 2006, LAB ANIM-UK, V40, P236, DOI 10.1258/002367706777611460; Beuers U, 2003, J BIOL CHEM, V278, P17810, DOI 10.1074/jbc.M209898200; Boaglio AC, 2010, HEPATOLOGY, V52, P1465, DOI 10.1002/hep.23846; Cavalli V, 2001, MOL CELL, V7, P421, DOI 10.1016/S1097-2765(01)00189-7; Chapman MS, 2011, EXPERT OPIN INV DRUG, V20, P209, DOI 10.1517/13543784.2011.548803; Crocenzi FA, 2003, GUT, V52, P1170, DOI 10.1136/gut.52.8.1170; Crocenzi FA, 2003, AM J PHYSIOL-GASTR L, V285, pG449, DOI 10.1152/ajpgi.00508.2002; Crocenzi FA, 2012, FRONT BIOSCI-LANDMRK, V17, P1201, DOI 10.2741/3981; Crocenzi FA, 2008, HEPATOLOGY, V48, P1885, DOI 10.1002/hep.22532; Denk GU, 2008, HEPATOL RES, V38, P717, DOI 10.1111/j.1872-034X.2008.00321.x; Garcia F, 2001, J BIOL CHEM, V276, P12147, DOI 10.1074/jbc.M009403200; Geraldes P, 2003, CIRC RES, V93, P399, DOI 10.1161/01.RES.0000088640.18462.42; Gnocchi D, 2012, STEROIDS, V77, P589, DOI 10.1016/j.steroids.2012.01.022; Grandal MV, 2012, TRAFFIC, V13, P576, DOI 10.1111/j.1600-0854.2011.01322.x; Haussinger D, 2003, GASTROENTEROLOGY, V124, P1476, DOI 10.1016/S0016-5085(03)00274-9; Huang CC, 2004, J BIOL CHEM, V279, P12286, DOI 10.1074/jbc.M312868200; KAN KS, 1989, BIOCHEM J, V261, P297, DOI 10.1042/bj2610297; Kimura M, 2007, J PHARMACOL SCI, V103, P398, DOI 10.1254/jphs.FP0061192; Kubitz R, 2004, GASTROENTEROLOGY, V126, P541, DOI 10.1053/j.gastro.2003.11.003; Kurz AK, 2001, GASTROENTEROLOGY, V121, P407, DOI 10.1053/gast.2001.26262; Kurz AK, 2000, BIOCHEM J, V350, P207, DOI 10.1042/0264-6021:3500207; Lam P, 2012, HEPATOLOGY, V55, P1901, DOI 10.1002/hep.25523; Lee MY, 2006, AM J PHYSIOL-GASTR L, V291, pG744, DOI 10.1152/ajpgi.00551.2005; Lee SH, 2008, J CELL BIOCHEM, V104, P1598, DOI 10.1002/jcb.21657; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mace T, 2005, EMBO J, V24, P3235, DOI 10.1038/sj.emboj.7600799; MAGLOVA LM, 1995, HEPATOLOGY, V22, P637; Marino M, 2001, EXP PHYSIOL, V86, P39, DOI 10.1113/eph8602069; Marino M, 2001, J CELL PHYSIOL, V188, P170, DOI 10.1002/jcp.1105; Mita S, 2006, DRUG METAB DISPOS, V34, P1575, DOI 10.1124/dmd.105.008748; Mottino AD, 2005, AM J PHYSIOL-GASTR L, V288, pG327, DOI 10.1152/ajpgi.00227.2004; Mottino AD, 2002, HEPATOLOGY, V35, P1409, DOI 10.1053/jhep.2002.33327; Mottino AD, 2001, AM J PHYSIOL-GASTR L, V280, pG1261, DOI 10.1152/ajpgi.2001.280.6.G1261; Nuedling S, 1999, FEBS LETT, V454, P271, DOI 10.1016/S0014-5793(99)00816-9; Philips MR, 2005, BIOCHEM SOC T, V33, P657, DOI 10.1042/BST0330657; Philips MR, 2004, MOL CELL, V15, P168, DOI 10.1016/j.molcel.2004.07.003; Pimienta G, 2007, CELL CYCLE, V6, P2628, DOI 10.4161/cc.6.21.4930; Pol A, 1997, BIOCHEM J, V327, P741, DOI 10.1042/bj3270741; Pol A, 1998, FEBS LETT, V441, P34, DOI 10.1016/S0014-5793(98)01517-8; Qiao L, 2002, HEPATOLOGY, V35, P779, DOI 10.1053/jhep.2002.32533; Rahner C, 2000, GASTROENTEROLOGY, V119, P1692, DOI 10.1053/gast.2000.20233; Roelofsen H, 1998, J CELL SCI, V111, P1137; Roma MG, 2000, HEPATOLOGY, V32, P1342, DOI 10.1053/jhep.2000.20519; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Scassa ME, 2001, EXP CELL RES, V271, P201, DOI 10.1006/excr.2001.5386; Schliess F, 1997, GASTROENTEROLOGY, V113, P1306, DOI 10.1053/gast.1997.v113.pm9322526; Schonhoff CM, 2010, AM J PHYSIOL-GASTR L, V298, pG667, DOI 10.1152/ajpgi.00506.2009; Seachrist JL, 2003, LIFE SCI, V74, P225, DOI 10.1016/j.lfs.2003.09.009; Singh M, 1999, J NEUROSCI, V19, P1179; Soroka CJ, 1999, J BIOL CHEM, V274, P26416, DOI 10.1074/jbc.274.37.26416; Spector M, 2000, EXP CELL RES, V258, P109, DOI 10.1006/excr.2000.4907; Stieger B, 2000, GASTROENTEROLOGY, V118, P422, DOI 10.1016/S0016-5085(00)70224-1; Torres LM, 2006, MOL CELL BIOCHEM, V288, P191, DOI 10.1007/s11010-006-9139-1; Vagnoni A, 2011, J CELL SCI, V124, P1032, DOI 10.1242/jcs.075168; Vergarajauregui S, 2006, TRAFFIC, V7, P686, DOI 10.1111/j.1600-0854.2006.00420.x; Vore M, 1997, DRUG METAB REV, V29, P183, DOI 10.3109/03602539709037580; Wakabayashi Y, 2004, MOL BIOL CELL, V15, P3485, DOI 10.1091/mbc.E03-10-0737; Wang YB, 1998, J BIOL CHEM, V273, P2161, DOI 10.1074/jbc.273.4.2161; WILTON JC, 1991, HEPATOLOGY, V14, P180, DOI 10.1002/hep.1840140129; Zucchetti AE, 2011, MOL BIOL CELL, V22, P3902, DOI 10.1091/mbc.E11-01-0047	64	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49255	10.1371/journal.pone.0049255	http://dx.doi.org/10.1371/journal.pone.0049255			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166621	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900110
J	Bussard, KM; Smith, GH				Bussard, Karen M.; Smith, Gilbert H.			Human Breast Cancer Cells Are Redirected to Mammary Epithelial Cells upon Interaction with the Regenerating Mammary Gland Microenvironment In-Vivo	PLOS ONE			English	Article							TUMOR STEM-CELLS; TERATOCARCINOMA CELLS; DIFFERENTIATION; METASTASIS; SUPPRESSOR; EXPRESSION; PROLACTIN; PREGNANCY; TISSUES; BRMS1	Breast cancer is the second leading cause of cancer deaths in the United States. At present, the etiology of breast cancer is unknown; however the possibility of a distinct cell of origin, i.e. a cancer stem cell, is a heavily investigated area of research. Influencing signals from the tissue niche are known to affect stem cells. Literature has shown that cancer cells lose their tumorigenic potential and display 'normal' behavior when placed into 'normal' ontogenic environments. Therefore, it may be the case that the tissue microenvironment is able to generate signals to redirect cancer cell fate. Previously, we showed that pluripotent human embryonal carcinoma cells could be redirected by the regenerating mammary gland microenvironment to contribute epithelial progeny for 'normal' gland development in-vivo. Here, we show that that human metastatic, non-metastatic, and metastasis-suppressed breast cancer cells proliferate and contribute to normal mammary gland development in-vivo without tumor formation. Immunochemistry for human-specific mitochondria, keratin 8 and 14, as well as human-specific milk proteins (alpha-lactalbumin, impregnated transplant hosts) confirmed the presence of human cell progeny. Features consistent with normal mammary gland development as seen in intact hosts (duct, lumen formation, development of secretory acini) were recapitulated in both primary and secondary outgrowths from chimeric implants. These results suggest the dominance of the tissue microenvironment over cancer cell fate. This work demonstrates that cultured human breast cancer cells (metastatic and non-metastatic) respond developmentally to signals generated by the mouse mammary gland microenvironment during gland regeneration in-vivo.	[Bussard, Karen M.; Smith, Gilbert H.] NCI, Mammary Biol & Tumorigenesis Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Bussard, KM (corresponding author), NCI, Mammary Biol & Tumorigenesis Lab, NIH, Bethesda, MD 20892 USA.	gs4d@nih.gov		Bussard, Karen/0000-0002-6519-9300	NATIONAL CANCER INSTITUTE [ZIABC010021] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Agrawal G, 2007, J CLIN ONCOL, V25, P2618, DOI 10.1200/JCO.2007.11.3084; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ANDREWS PW, 1984, LAB INVEST, V50, P147; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bussard KM, 2010, CANCER RES, V70, P6336, DOI 10.1158/0008-5472.CAN-10-0591; Bussard KM, 2010, CLIN EXP METASTAS, V27, P331, DOI 10.1007/s10585-010-9330-3; Bussard KM, 2011, INT J CELL BIOL, V451676, P1; CAILLEAU R, 1978, IN VITRO CELL DEV B, V14, P911; Clontech, 2000, CLONTECHNIQUES, V15, P12; Felsher DW, 2003, NAT REV CANCER, V3, P375, DOI 10.1038/nrc1070; Ginestier C, 2009, CELL CYCLE, V8, P3297, DOI 10.4161/cc.8.20.9761; Hochedlinger K, 2004, GENE DEV, V18, P1875, DOI 10.1101/gad.1213504; ILLMENSEE K, 1976, P NATL ACAD SCI USA, V73, P549, DOI 10.1073/pnas.73.2.549; Ip M. M., 2000, METHODS MAMMARY GLAN; Jones JL, 1997, EXP CELL RES, V235, P325, DOI 10.1006/excr.1997.3662; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Louderbough JMV, 2011, MOL CANCER RES, V9, P1573, DOI 10.1158/1541-7786.MCR-11-0156; Marx J, 2003, SCIENCE, V301, P1308, DOI 10.1126/science.301.5638.1308; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; PARK CH, 1971, JNCI-J NATL CANCER I, V46, P411; Peirce SK, 2001, J ENDOCRINOL, V171, pR1, DOI 10.1677/joe.0.171R001; Phadke PA, 2008, AM J PATHOL, V172, P809, DOI 10.2353/ajpath.2008.070772; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Seraj MJ, 2000, CANCER RES, V60, P2764; SHAY JW, 1993, ONCOGENE, V8, P1407; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith GH, 1996, BREAST CANCER RES TR, V39, P21, DOI 10.1007/BF01806075; SMITH GH, 1984, CANCER RES, V44, P3426; SMITH GH, 1990, CELL GROWTH DIFFER, V1, P161; Spector D. L., 1998, CELLS LAB MANUAL; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; TELENIUS H, 1992, GENE CHROMOSOME CANC, V4, P257, DOI 10.1002/gcc.2870040311; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zhang QB, 2006, CELL RES, V16, P909, DOI 10.1038/sj.cr.7310104	38	35	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49221	10.1371/journal.pone.0049221	http://dx.doi.org/10.1371/journal.pone.0049221			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155468	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900103
J	Collins, T				Collins, Therese			Probability of Seeing Increases Saccadic Readiness	PLOS ONE			English	Article							SUPERIOR COLLICULUS; EYE-MOVEMENTS; GAIN; MODULATION; CAPTURE; TIME; BIAS	Associating movement directions or endpoints with monetary rewards or costs influences movement parameters in humans, and associating movement directions or endpoints with food reward influences movement parameters in non-human primates. Rewarded movements are facilitated relative to non-rewarded movements. The present study examined to what extent successful foveation facilitated saccadic eye movement behavior, with the hypothesis that foveation may constitute an informational reward. Human adults performed saccades to peripheral targets that either remained visible after saccade completion or were extinguished, preventing visual feedback. Saccades to targets that were systematically extinguished were slower and easier to inhibit than saccades to targets that afforded successful foveation, and this effect was modulated by the probability of successful foveation. These results suggest that successful foveation facilitates behavior, and that obtaining the expected sensory consequences of a saccadic eye movement may serve as a reward for the oculomotor system.	[Collins, Therese] Univ Paris 05, Lab Psychol Percept, Paris, France	UDICE-French Research Universities; Universite Paris Cite	Collins, T (corresponding author), Univ Paris 05, Lab Psychol Percept, Paris, France.	collins.th@gmail.com						Basso MA, 1998, J NEUROSCI, V18, P7519; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Harwood MR, 2008, J NEUROPHYSIOL, V99, P1743, DOI 10.1152/jn.00589.2007; Ikeda T, 2003, NEURON, V39, P693, DOI 10.1016/S0896-6273(03)00464-1; Kawagoe R, 1998, NAT NEUROSCI, V1, P411, DOI 10.1038/1625; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lauwereyns J, 2002, NATURE, V418, P413, DOI 10.1038/nature00892; Madelain L, 2011, J NEUROPHYSIOL, V106, P219, DOI 10.1152/jn.01094.2009; Melcher D, 2008, TRENDS COGN SCI, V12, P466, DOI 10.1016/j.tics.2008.09.003; Miall RC, 1996, NEURAL NETWORKS, V9, P1265, DOI 10.1016/S0893-6080(96)00035-4; Milstein DM, 2007, J NEUROSCI, V27, P4810, DOI 10.1523/JNEUROSCI.0577-07.2007; Milstein DM, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00122; Paeye C, 2011, J EXP ANAL BEHAV, V95, P149, DOI 10.1901/jeab.2011.95-149; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Roitman JD, 2002, J NEUROSCI, V22, P9475; Stritzke M, 2009, J OPT SOC AM A, V26, pB1, DOI 10.1364/JOSAA.26.0000B1; Takikawa Y, 2002, EXP BRAIN RES, V142, P284, DOI 10.1007/s00221-001-0928-1; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; Theeuwes J, 1999, J EXP PSYCHOL HUMAN, V25, P1595, DOI 10.1037/0096-1523.25.6.1595; Trommershauser J, 2006, PSYCHOL SCI, V17, P981, DOI 10.1111/j.1467-9280.2006.01816.x	20	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49454	10.1371/journal.pone.0049454	http://dx.doi.org/10.1371/journal.pone.0049454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166674	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900144
J	Lauria, F; Siani, A; Bammann, K; Foraita, R; Huybrechts, I; Iacoviello, L; Koni, AC; Kourides, Y; Marild, S; Molnar, D; Moreno, LA; Pigeot, I; Pitsiladis, YP; Veidebaum, T; Russo, P				Lauria, Fabio; Siani, Alfonso; Bammann, Karin; Foraita, Ronja; Huybrechts, Inge; Iacoviello, Licia; Koni, Anna C.; Kourides, Yannis; Marild, Staffan; Molnar, Denes; Moreno, Luis A.; Pigeot, Iris; Pitsiladis, Yannis P.; Veidebaum, Toomas; Russo, Paola		IDEFICS Consortium	Prospective Analysis of the Association of a Common Variant of FTO (rs9939609) with Adiposity in Children: Results of the IDEFICS Study	PLOS ONE			English	Article							BODY-MASS INDEX; OBESITY-RELATED TRAITS; LIFE-STYLE INTERVENTION; CHILDHOOD OBESITY; GENE VARIANT; FAT MASS; DIABETES PREVENTION; ADULT OBESITY; BIRTH COHORT; WEIGHT-LOSS	Objectives: We investigated cross-sectionally and longitudinally the relationship between FTO rs9939609 and obesity-related characteristics in the European children of the IDEFICS project and the interaction of this variant with a lifestyle intervention. Population and Methods: A cohort of 16224 children (2-9 years) was recruited into a population-based survey (T0) from eight European countries. A second survey (T1) reassessed the children two years later. A random sample of 4405 children was extracted for genetic studies. 3168 children were re-examined two years later. Half of them underwent a lifestyle intervention program. The FTO rs9939609 was genotyped. Weight, height, waist circumference, triceps and subscapular skinfolds were measured at T0 and T1. Results: At T0, the risk A allele of rs9939609 was significantly associated with higher values of body mass index (BMI), waist circumference and skinfolds (age, sex, and country-adjusted p-values: all p<0.001) and with a statistically significant increased risk of overweight/obesity. Over the two year follow-up, no interaction between genotype and intervention was observed. The A allele was associated to a significantly higher increase in all the anthropometric variables examined at T0 independently from the study group (intervention versus control) (p-values: all p<0.002, adjusted for age, sex, country, intervention/control study group, T0 values, and individual time interval between T0 and T1). Over the two-year follow-up, 210 new cases of overweight/obesity occurred. A statistically significant higher incidence of overweight/obesity was associated to the A allele [ORA = 1.95, 95% CI = (1.29; 2.97)]. Conclusions: We confirmed the association between the FTO rs9939609 and body mass and overweight/obesity risk in European children. The main finding of the study is that the A allele carriers present higher increase of body mass and central adiposity over time and higher risk of developing overweight/obesity during growth, independently from intervention measures.	[Lauria, Fabio; Siani, Alfonso; Russo, Paola] CNR, Inst Food Sci, Unit Epidemiol & Populat Genet, Avellino, Italy; [Bammann, Karin; Foraita, Ronja; Pigeot, Iris] BIPS Inst Epidemiol & Prevent Res, Bremen, Germany; [Huybrechts, Inge] Univ Ghent, Unit Nutr & Food Safety, Dept Publ Hlth, Fac Med & Hlth Sci, Ghent, Belgium; [Iacoviello, Licia] Univ Cattolica del Sacro Cuore, Fdn Ric & Cura Giovanni Paolo II, Campobasso, Italy; [Koni, Anna C.; Pitsiladis, Yannis P.] Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland; [Kourides, Yannis] Res & Educ Fdn Child Hlth, Strovolos, Cyprus; [Marild, Staffan] Univ Gothenburg, Queen Silvia Childrens Hosp, Dept Paediat, Gothenburg, Sweden; [Molnar, Denes] Univ Pecs, Fac Med, Dept Paediat, Pecs, Hungary; [Moreno, Luis A.] Univ Zaragoza, Growth Exercise Nutr & Dev GENUD Res Grp, Zaragoza, Spain; [Veidebaum, Toomas] Natl Inst Hlth Dev, Tallinn, Estonia	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Leibniz Institute for Prevention Research & Epidemiology (BIPS); Ghent University; Catholic University of the Sacred Heart; IRCCS Istituto Tumori Bari Giovanni Paolo II; University of Glasgow; Queen Silvia Children's Hospital; University of Gothenburg; University of Pecs; University of Zaragoza; National Institute for Health Development - Estonia	Lauria, F (corresponding author), CNR, Inst Food Sci, Unit Epidemiol & Populat Genet, Avellino, Italy.	asiani@isa.cnr.it	Lauria, Fabio/ABF-6895-2020; Iacoviello, Licia/AGX-7071-2022; Iacoviello, Licia/K-4676-2016; Lauria, Fabio/B-4709-2012; Russo, Paola/AAW-8308-2020; Pigeot, Iris/A-2722-2012; Moreno, Luis/S-1780-2019; Siani, Alfonso/B-7925-2015; Molnár, Dénes/AAB-6820-2022	Iacoviello, Licia/0000-0003-0514-5885; Iacoviello, Licia/0000-0003-0514-5885; Pigeot, Iris/0000-0001-7483-0726; Moreno, Luis/0000-0003-0454-653X; Marild, Staffan/0000-0001-6517-2020; Bammann, Karin/0000-0002-5623-8160; Pitsiladis, Yannis/0000-0001-6210-2449; Lauria, Fabio/0000-0002-1663-1582				Ahrens W, 2006, NUTR METAB CARDIOVAS, V16, P302, DOI 10.1016/j.numecd.2006.01.011; Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30; Bammann K, 2006, J PUBLIC HEALTH-HEID, V14, P279, DOI 10.1007/s10389-006-0058-0; Bradfield JP, 2012, NAT GENET, V44, P526, DOI 10.1038/ng.2247; Cauchi S, 2009, J MOL MED, V87, P537, DOI 10.1007/s00109-009-0451-6; Cole TJ, 2007, BMJ-BRIT MED J, V335, P194, DOI 10.1136/bmj.39238.399444.55; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; De Henauw S, 2011, INT J OBESITY, V35, pS16, DOI 10.1038/ijo.2011.31; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Fernandez JR, 2012, INT J OBESITY, V36, P479, DOI 10.1038/ijo.2011.236; Franks PW, 2008, DIABETOLOGIA, V51, P2214, DOI 10.1007/s00125-008-1158-x; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hakanen M, 2009, J CLIN ENDOCR METAB, V94, P1281, DOI 10.1210/jc.2008-1199; Hallman DM, 2012, INT J OBESITY, V36, P61, DOI 10.1038/ijo.2011.190; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haupt A, 2008, OBESITY, V16, P1969, DOI 10.1038/oby.2008.283; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Jess T, 2008, INT J OBESITY, V32, P1388, DOI 10.1038/ijo.2008.110; Kaakinen M, 2010, AM J EPIDEMIOL, V172, P653, DOI 10.1093/aje/kwq178; Koni AC, 2011, INT J OBESITY, V35, pS113, DOI 10.1038/ijo.2011.43; Lappalainen TJ, 2009, OBESITY, V17, P832, DOI 10.1038/oby.2008.618; Larder R, 2011, TRENDS ENDOCRIN MET, V22, P53, DOI 10.1016/j.tem.2010.11.001; Liu GF, 2011, EUR J EPIDEMIOL, V26, P463, DOI 10.1007/s10654-011-9583-4; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Marvelle AF, 2008, DIABETES, V57, P1987, DOI 10.2337/db07-1700; Muller TD, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-85; Peng SH, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-71; Peters T, 2002, MAMM GENOME, V13, P186, DOI 10.1007/s00335-001-2142-7; Qi L, 2008, DIABETES, V57, P3145, DOI 10.2337/db08-0006; Razquin C, 2010, INT J OBESITY, V34, P266, DOI 10.1038/ijo.2009.233; Reinehr T, 2009, ARCH DIS CHILD, V94, P965, DOI 10.1136/adc.2008.147652; Rendo T, 2009, OBESITY FACTS, V2, P393, DOI 10.1159/000262296; Russo P, 2010, NUTR METAB CARDIOVAS, V20, P691, DOI 10.1016/j.numecd.2010.09.007; Rutters F, 2011, J CLIN ENDOCR METAB, V96, pE939, DOI 10.1210/jc.2010-2413; Rzehak P, 2010, OBESITY FACTS, V3, P173, DOI 10.1159/000314612; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Stomfai S, 2011, INT J OBESITY, V35, pS45, DOI 10.1038/ijo.2011.34; Vimaleswaran KS, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001389; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594	40	21	22	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48876	10.1371/journal.pone.0048876	http://dx.doi.org/10.1371/journal.pone.0048876			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155422	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900057
J	Ma, JH; Wei, HL; Song, MZ; Pang, CY; Liu, J; Wang, L; Zhang, JF; Fan, SL; Yu, SX				Ma, Jianhui; Wei, Hengling; Song, Meizhen; Pang, Chaoyou; Liu, Ji; Wang, Long; Zhang, Jinfa; Fan, Shuli; Yu, Shuxun			Transcriptome Profiling Analysis Reveals That Flavonoid and Ascorbate-Glutathione Cycle Are Important during Anther Development in Upland Cotton	PLOS ONE			English	Article							MALE GAMETOPHYTE DEVELOPMENT; GENE-EXPRESSION PROFILES; POLLEN DEVELOPMENT; VITAMIN-C; ARABIDOPSIS; RICE; BIOSYNTHESIS; PLANTS; ACID; TAPETUM	Background: Previous transcriptome profiling studies have investigated the molecular mechanisms of pollen and anther development, and identified many genes involved in these processes. However, only 51 anther ESTs of Upland cotton (Gossypium hirsutum) were found in NCBI and there have been no reports of transcriptome profiling analyzing anther development in Upland cotton, a major fiber crop in the word. Methodology/Principal Finding: Ninety-eight hundred and ninety-six high quality ESTs were sequenced from their 3'-ends and assembled into 6,643 unigenes from a normalized, full-length anther cDNA library of Upland cotton. Combined with previous sequenced anther-related ESTs, 12,244 unigenes were generated as the reference genes for digital gene expression (DGE) analysis. The DGE was conducted on anthers that were isolated at tetrad pollen (TTP), uninucleate pollen (UNP), binucleate pollen (BNP) and mature pollen (MTP) periods along with four other tissues, i.e., roots (RO), stems (ST), leaves (LV) and embryos (EB). Through transcriptome profiling analysis, we identified 1,165 genes that were enriched at certain anther development periods, and many of them were involved in starch and sucrose metabolism, pentose and glucuronate interconversion, flavonoid biosynthesis, and ascorbate and aldarate metabolism. Conclusions/Significance: We first generated a normalized, full-length cDNA library from anthers and performed transcriptome profiling analysis of anther development in Upland cotton. From these results, 10,178 anther expressed genes were identified, among which 1,165 genes were stage-enriched in anthers. And many of these stage-enriched genes were involved in some important processes regulating anther development.	[Ma, Jianhui; Liu, Ji; Yu, Shuxun] NW A&F Univ, Coll Agron, Yangling, Shanxi, Peoples R China	Northwest A&F University - China	Ma, JH (corresponding author), NW A&F Univ, Coll Agron, Yangling, Shanxi, Peoples R China.	fansl@cricaas.com.cn; yu@cricaas.com.cn		Ma, Jianhui/0000-0002-9909-5569				Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Badawi GH, 2004, PHYSIOL PLANTARUM, V121, P231, DOI 10.1111/j.0031-9317.2004.00308.x; BERNARDO FA, 1965, STAIN TECHNOL, V40, P205, DOI 10.3109/10520296509116408; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Curtiss J, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-49; Deveshwar P, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-78; Dobritsa AA, 2011, PLANT PHYSIOL, V157, P947, DOI 10.1104/pp.111.179523; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eriksson S, 2010, CURR BIOL, V20, P527, DOI 10.1016/j.cub.2010.01.039; Filkowski J, 2004, PLANT J, V38, P60, DOI 10.1111/j.1365-313X.2004.02020.x; GOLDBERG RB, 1993, PLANT CELL, V5, P1217, DOI 10.1105/tpc.5.10.1217; Hobo T, 2008, PLANT CELL PHYSIOL, V49, P1417, DOI 10.1093/pcp/pcn128; Honys D, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r85; Hsieh K, 2007, PLANT CELL, V19, P582, DOI 10.1105/tpc.106.049049; Jung KH, 2006, PLANT CELL, V18, P3015, DOI 10.1105/tpc.106.042044; Kim SS, 2010, PLANT CELL, V22, P4045, DOI 10.1105/tpc.110.080028; KOLTUNOW AM, 1990, PLANT CELL, V2, P1201, DOI 10.1105/tpc.2.12.1201; Lai DY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028676; Leong SY, 2012, FOOD CHEM, V134, P2075, DOI 10.1016/j.foodchem.2012.04.002; Li H, 2010, PLANT CELL, V22, P173, DOI 10.1105/tpc.109.070326; Li YJ, 2011, FEBS J, V278, P156, DOI 10.1111/j.1742-4658.2010.07941.x; Li Z.L., 1979, MORPHOLOGY OF COTTON; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-12-r181; Marques MC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-428; MO YY, 1992, P NATL ACAD SCI USA, V89, P7213, DOI 10.1073/pnas.89.15.7213; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; Peng JR, 2009, J INTEGR PLANT BIOL, V51, P1064, DOI 10.1111/j.1744-7909.2009.00881.x; Rotman N, 2005, CURR BIOL, V15, P244, DOI 10.1016/j.cub.2005.01.013; SCOTT R, 1991, PLANT SCI, V80, P167, DOI 10.1016/0168-9452(91)90281-C; Shao SQ, 2010, J GENET GENOMICS, V37, P805, DOI 10.1016/S1673-8527(09)60098-9; Smirnoff N, 2000, CRIT REV BIOCHEM MOL, V35, P291, DOI 10.1080/10409230008984166; Suwabe K, 2008, PLANT CELL PHYSIOL, V49, P1407, DOI 10.1093/pcp/pcn124; TANAKA I, 1993, J PLANT RES, V106, P55, DOI 10.1007/BF02344373; VANDERMEER IM, 1992, PLANT CELL, V4, P253, DOI 10.1105/tpc.4.3.253; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang J, 2010, J INSECT PHYSIOL, V56, P998, DOI 10.1016/j.jinsphys.2010.05.009; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang XL, 2009, PLANT J, V57, P473, DOI 10.1111/j.1365-313X.2008.03700.x; Wang Y, 2008, PLANT PHYSIOL, V148, P1201, DOI 10.1104/pp.108.126375; Wei LQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-338; Wilson ZA, 2011, J EXP BOT, V62, P1633, DOI 10.1093/jxb/err014; Wilson ZA, 2009, J EXP BOT, V60, P1479, DOI 10.1093/jxb/erp095; Wu HM, 2000, PLANT MOL BIOL, V44, P267, DOI 10.1023/A:1026536324081; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; YLSTRA B, 1994, PLANT J, V6, P201, DOI 10.1046/j.1365-313X.1994.6020201.x; Zhang DB, 2009, CHINESE SCI BULL, V54, P2342, DOI 10.1007/s11434-009-0348-3; Zhang JX, 1996, PLANT SCI, V113, P139, DOI 10.1016/0168-9452(95)04295-4; Zhang W, 2006, DEVELOPMENT, V133, P3085, DOI 10.1242/dev.02463	52	25	29	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49244	10.1371/journal.pone.0049244	http://dx.doi.org/10.1371/journal.pone.0049244			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155472	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900107
J	Slingerland, BCGC; Tavakol, M; McCarthy, AJ; Lindsay, JA; Snijders, SV; Wagenaar, JA; van Belkum, A; Vos, MC; Verbrugh, HA; van Wamel, WJB				Slingerland, Bibi C. G. C.; Tavakol, Mehri; McCarthy, Alex J.; Lindsay, Jodi A.; Snijders, Susan V.; Wagenaar, Jaap A.; van Belkum, Alex; Vos, Margreet C.; Verbrugh, Henri A.; van Wamel, Willem J. B.			Survival of Staphylococcus aureus ST398 in the Human Nose after Artificial Inoculation	PLOS ONE			English	Article							METHICILLIN-RESISTANT; NASAL COLONIZATION; CARRIAGE; INFECTIONS; HOST; BACTERIOPHAGES; PREVALENCE; EVOLUTION; STRAINS; GENES	There is evidence that MRSA ST398 of animal origin is only capable of temporarily occupying the human nose, and it is therefore, often considered a poor human colonizer. We inoculated 16 healthy human volunteers with a mixture of the human MSSA strain 1036 (ST931, CC8) and the bovine MSSA strain 5062 (ST398, CC398), 7 weeks after a treatment with mupirocin and chlorhexidine-containing soap. Bacterial survival was studied by follow-up cultures over 21 days. The human strain 1036 was eliminated faster (median 14 days; range 2-21 days) than the bovine strain 5062 (median 21 days; range 7-21 days) but this difference was not significant (p = 0.065). The bacterial loads were significantly higher for the bovine strain on day 7 and day 21. 4/14 volunteers (28.6%) showed elimination of both strains within 21 days. Of the 10 remaining volunteers, 5 showed no differences in bacterial counts between both strains, and in the other 5 the ST398 strain far outnumbered the human S. aureus strain. Within the 21 days of follow-up, neither human strain 1036 nor bovine strain 5062 appeared to acquire or lose any mobile genetic elements. In conclusion, S. aureus ST398 strain 5062 is capable of adequately competing for a niche with a human strain and survives in the human nose for at least 21 days.	[Slingerland, Bibi C. G. C.; Tavakol, Mehri; Snijders, Susan V.; van Belkum, Alex; Vos, Margreet C.; Verbrugh, Henri A.; van Wamel, Willem J. B.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC	Slingerland, BCGC (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	b.slingerland@erasmusmc.nl	Lindsay, Jodi/ABH-8205-2020; Lindsay, Jodi/B-9565-2008	Lindsay, Jodi/0000-0002-5219-1625; Lindsay, Jodi/0000-0002-5219-1625; van Wamel, Willem/0000-0001-9145-9121; McCarthy, Alex/0000-0002-4105-3737				Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Deurenberg RH, 2008, INFECT GENET EVOL, V8, P747, DOI 10.1016/j.meegid.2008.07.007; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Gilot P, 2002, J CLIN MICROBIOL, V40, P4060, DOI 10.1128/JCM.40.11.4060-4067.2002; Graveland H, 2011, INT J MED MICROBIOL, V301, P630, DOI 10.1016/j.ijmm.2011.09.004; Graveland H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016830; Graveland H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010990; Grisold AJ, 2009, J INFECTION, V58, P168, DOI 10.1016/j.jinf.2008.12.004; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hwang SY, 2007, INT J FOOD MICROBIOL, V117, P99, DOI 10.1016/j.ijfoodmicro.2007.02.013; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; JEVONS MP, 1963, LANCET, V1, P904; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; McCarthy AJ, 2011, GENOME BIOL EVOL, V3, P1164, DOI 10.1093/gbe/evr092; McCarthy AJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-173; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nouwen J, 2004, INFECT IMMUN, V72, P6685, DOI 10.1128/IAI.72.11.6685-6688.2004; Schijffelen MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-376; Stegger M, 2011, J CLIN MICROBIOL, V49, P732, DOI 10.1128/JCM.01970-10; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P343, DOI 10.1111/j.1469-0691.2010.03227.x; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x; Welinder-Olsson C, 2008, EMERG INFECT DIS, V14, P1271, DOI 10.3201/eid1408.071427; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Wu DJ, 2010, DIAGN MICR INFEC DIS, V67, P1, DOI 10.1016/j.diagmicrobio.2009.12.006; Wulf MWH, 2008, CLIN MICROBIOL INFEC, V14, P29, DOI 10.1111/j.1469-0691.2007.01873.x	33	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48896	10.1371/journal.pone.0048896	http://dx.doi.org/10.1371/journal.pone.0048896			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155425	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900060
J	Sturdy, P; Bremner, S; Harper, G; Mayhew, L; Eldridge, S; Eversley, J; Sheikh, A; Hunter, S; Boomla, K; Feder, G; Prescott, K; Griffiths, C				Sturdy, Pat; Bremner, Stephen; Harper, Gill; Mayhew, Les; Eldridge, Sandra; Eversley, John; Sheikh, Aziz; Hunter, Susan; Boomla, Kambiz; Feder, Gene; Prescott, Keith; Griffiths, Chris			Impact of Asthma on Educational Attainment in a Socioeconomically Deprived Population: A Study Linking Health, Education and Social Care Datasets	PLOS ONE			English	Article							SCHOOL PERFORMANCE; CHILDHOOD ASTHMA; CHILDREN; MORBIDITY; CONSEQUENCES; MANAGEMENT; ATTENDANCE	Background: Asthma has the potential to adversely affect children's school examination performance, and hence longer term life chances. Asthma morbidity is especially high amongst UK ethnic minority children and those experiencing social adversity, populations which also have poor educational outcomes. We tested the hypothesis that asthma adversely affects performance in national school examinations in a large cohort from an area of ethnic diversity and social deprivation. Methods and Findings: With a novel method (using patient and address-matching algorithms) we linked administrative and clinical data for 2002-2005 for children in east London aged 5-14 years to contemporaneous education and social care datasets. We modelled children's performance in school examinations in relation to socio-demographic and clinical variables. The dataset captured examination performance for 12,136 children who sat at least one national examination at Key Stages 1-3. For illustration, estimates are presented as percentage changes in Key Stage 2 results. Having asthma was associated with a 1.1% increase in examination scores (95%CI 0.4 to 1.7)%, p = 0.02. Worse scores were associated with Bangladeshi ethnicity -1.3%(-2.5 to -0.1)%, p = 0.03; special educational need -14.6%(-15.7 to -13.5)%, p = 0.02; mental health problems -2.5%(-4.1 to -0.9)%, p = 0.003, and social adversity: living in a smoking household -1.2(-1.7 to -0.6)%, p<0.001; living in social housing -0.8%(-1.3 to -0.2)% p = 0.01, and entitlement to free school meals -0.8%(-0.8% to -0.8%)%,p<0.001. Conclusions: Social adversity and ethnicity, but not asthma, are associated with poorer performance in national school examinations. Policies to improve educational attainment in socially deprived areas should focus on these factors.	[Sturdy, Pat; Bremner, Stephen; Eldridge, Sandra; Hunter, Susan; Boomla, Kambiz; Prescott, Keith; Griffiths, Chris] Barts & London Med Sch, Blizard Inst, Ctr Primary Care & Publ Hlth, London, England	University of London; Queen Mary University London	Sturdy, P (corresponding author), Barts & London Med Sch, Blizard Inst, Ctr Primary Care & Publ Hlth, London, England.	c.j.griffiths@qmul.ac.uk	Bremner, Stephen/R-4038-2016; Sheikh, Aziz/D-2818-2009	Bremner, Stephen/0000-0003-0790-7070; Sheikh, Aziz/0000-0001-7022-3056; Eldridge, Sandra/0000-0001-5638-2317; Harper, Gillian/0000-0002-3492-2076; Feder, Gene/0000-0002-7890-3926	Medical Research Council [G1000758B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		ANDERSON HR, 1983, ARCH DIS CHILD, V58, P777, DOI 10.1136/adc.58.10.777; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Austin JK, 1998, DEV MED CHILD NEUROL, V40, P248, DOI 10.1111/j.1469-8749.1998.tb15457.x; Baker D, 1998, J EPIDEMIOL COMMUN H, V52, P451, DOI 10.1136/jech.52.7.451; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2007, BTS SIGN BRIT GUID M; Bush A, 2010, LANCET, V376, P814, DOI 10.1016/S0140-6736(10)61054-9; CLARK NM, 1984, J SCHOOL HEALTH, V54, P143, DOI 10.1111/j.1746-1561.1984.tb08796.x; Diette GB, 2000, ARCH PEDIAT ADOL MED, V154, P923, DOI 10.1001/archpedi.154.9.923; Duran-Tauleria E, 1999, THORAX, V54, P476, DOI 10.1136/thx.54.6.476; Eagan TML, 2004, RESP MED, V98, P730, DOI 10.1016/j.rmed.2004.02.008; Ellison-Loschmann L, 2007, EUR RESPIR J, V29, P897, DOI 10.1183/09031936.00101606; FOWLER MG, 1992, PEDIATRICS, V90, P939; Free S, 2010, J EPIDEMIOL COMMUN H, V64, P379, DOI 10.1136/jech.2008.086520; GUTSTADT LB, 1989, AM J DIS CHILD, V143, P471, DOI 10.1001/archpedi.1989.02150160101020; Kitch BT, 2000, ENVIRON HEALTH PERSP, V108, P301, DOI 10.2307/3454347; Kleinert S, 2007, LANCET, V369, P1057, DOI 10.1016/S0140-6736(07)60374-2; Mielck A, 1996, INT J EPIDEMIOL, V25, P388, DOI 10.1093/ije/25.2.388; Milton B, 2004, CHILD CARE HLTH DEV, V30, P711, DOI 10.1111/j.1365-2214.2004.00486.x; Netuveli G, 2005, LANCET, V365, P312, DOI 10.1016/S0140-6736(05)17785-X; ONEIL SL, 1985, J SCHOOL HEALTH, V55, P237, DOI 10.1111/j.1746-1561.1985.tb04129.x; PARCEL GS, 1979, PEDIATRICS, V64, P878; Richards M, 2004, ARCH DIS CHILD, V89, P922, DOI 10.1136/adc.2003.032490; Silverstein MD, 2001, J PEDIATR-US, V139, P278, DOI 10.1067/mpd.2001.115573; Spencer N, 2018, POVERTY CHILD HLTH, DOI [10.1201/9781315385297, DOI 10.1201/9781315385297]; StataCorp, 2007, STAT STAT SOFTW REL; Taras H, 2005, J SCHOOL HEALTH, V75, P296, DOI 10.1111/j.1746-1561.2005.00041.x; TAYLOR WR, 1992, PEDIATRICS, V90, P657; WEST AM, 1992, J BIOSOC SCI, V24, P539, DOI 10.1017/S0021932000020095; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934	29	9	9	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e43977	10.1371/journal.pone.0043977	http://dx.doi.org/10.1371/journal.pone.0043977			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155367	gold, Green Published, Green Accepted			2022-12-27	WOS:000311151900001
J	Tarailo-Graovac, M; Chen, NS				Tarailo-Graovac, Maja; Chen, Nansheng			Mos1-Mediated Transgenesis to Probe Consequences of Single Gene Mutations in Variation- Rich Isolates of Caenorhabditis elegans	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM; LINKAGE DISEQUILIBRIUM; NATURAL VARIATION; WILD POPULATIONS; ZYG-9 FORM; TAC-1; DIVERSITY; DISCOVERY; COMPLEX; RNAI	Caenorhabditis elegans, especially the N2 isolate, is an invaluable biological model system. Numerous additional natural C. elegans isolates have been shown to have unexpected genotypic and phenotypic variations which has encouraged researchers to use next generation sequencing methodology to develop a more complete picture of genotypic variations among the isolates. To understand the phenotypic effects of a genomic variation (GV) on a single gene, in a variation-rich genetic background, one should analyze that particular GV in a well understood genetic background. In C. elegans, the analysis is usually done in N2, which requires extensive crossing to bring in the GV. This can be a very time consuming procedure thus it is important to establish a fast and efficient approach to test the effect of GVs from different isolates in N2. Here we use a Mos1-mediated single-copy insertion (MosSCI) method for phenotypic assessments of GVs from the variation-rich Hawaiian strain CB4856 in N2. Specifically, we investigate effects of variations identified in the CB4856 strain on tac-1 which is an essential gene that is necessary for mitotic spindle elongation and pronuclear migration. We show the usefulness of the MosSCI method by using EU1004 tac-1(or402) as a control. or402 is a temperature sensitive lethal allele within a well-conserved TACC domain (transforming acidic coiled-coil) that results in a leucine to phenylalanine change at amino acid 229. CB4856 contains a variation that affects the second exon of tac-1 causing a cysteine to tryptophan change at amino acid 94 also within the TACC domain. Using the MosSCI method, we analyze tac-1 from CB4856 in the N2 background and demonstrate that the C94W change, albeit significant, does not cause any obvious decrease in viability. This MosSCI method has proven to be a rapid and efficient way to analyze GVs.	[Tarailo-Graovac, Maja; Chen, Nansheng] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Tarailo-Graovac, M (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	mta57@sfu.ca		Tarailo-Graovac, Maja/0000-0002-4472-8584	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Andersen EC, 2012, NAT GENET, V44, P285, DOI 10.1038/ng.1050; Barriere A, 2005, CURR BIOL, V15, P1176, DOI 10.1016/j.cub.2005.06.022; Barriere Antoine, 2005, P1; Barriere A, 2007, GENETICS, V176, P999, DOI 10.1534/genetics.106.067223; Bellanger JM, 2007, J CELL SCI, V120, P2963, DOI 10.1242/jcs.004812; Bellanger JM, 2003, CURR BIOL, V13, P1488, DOI 10.1016/S0960-9822(03)00582-7; Bonetta L, 2008, CELL, V133, P753, DOI 10.1016/j.cell.2008.05.008; BRENNER S, 1974, GENETICS, V77, P71; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Capra EJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004055; Cutter AD, 2006, GENETICS, V172, P171, DOI 10.1534/genetics.105.048207; Cutter AD, 2003, MOL BIOL EVOL, V20, P665, DOI 10.1093/molbev/msg072; Cutter AD, 2006, GENETICS, V173, P2021, DOI 10.1534/genetics.106.058651; Cutter AD, 2006, GENETICS, V174, P901, DOI 10.1534/genetics.106.061879; Denver DR, 2003, MOL BIOL EVOL, V20, P393, DOI 10.1093/molbev/msg044; Dolgin ES, 2008, HEREDITY, V100, P304, DOI 10.1038/sj.hdy.6801079; Flibotte S, 2009, GENETICS, V181, P33, DOI 10.1534/genetics.108.096487; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Frokjaer-Jensen C, 2012, NAT METHODS, V9, P117, DOI 10.1038/nmeth.1865; Ghosh R, 2012, SCIENCE, V335, P574, DOI 10.1126/science.1214318; Graustein A, 2002, GENETICS, V161, P99; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Hillier LW, 2008, NAT METHODS, V5, P183, DOI 10.1038/NMETH.1179; Hodgkin J, 1997, GENETICS, V146, P149; Kiontke Karin, 2005, P1; Le Bot N, 2003, CURR BIOL, V13, P1499, DOI 10.1016/S0960-9822(03)00577-3; Lehner B, 2011, TRENDS GENET, V27, P323, DOI 10.1016/j.tig.2011.05.007; Liu T, 2011, GENOME RES, V21, P227, DOI 10.1101/gr.115519.110; Maydan JS, 2007, GENOME RES, V17, P337, DOI 10.1101/gr.5690307; Maydan JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-62; Riddle DL, 1997, INTRO C ELEGANS; Sivasundar A, 2005, CURR BIOL, V15, P1598, DOI 10.1016/j.cub.2005.08.034; Sivasundar A, 2003, GENETICS, V163, P147; Srayko M, 2003, CURR BIOL, V13, P1506, DOI 10.1016/S0960-9822(03)00597-9; Swan KA, 2002, GENOME RES, V12, P1100, DOI 10.1101/gr.208902; Tarailo-Graovac M, 2012, G3-GENES GENOM GENET, V2, P865, DOI 10.1534/g3.112.002782; Tarailo-Graovac M, 2010, CELL CYCLE, V9, P4858, DOI 10.4161/cc.9.24.14137; Tijsterman M, 2002, CURR BIOL, V12, P1535, DOI 10.1016/S0960-9822(02)01110-7; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Vallin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030482; Vinuela A, 2012, G3-GENES GENOM GENET, V2, P597, DOI 10.1534/g3.112.002212; Wicks SR, 2001, NAT GENET, V28, P160, DOI 10.1038/88878	43	1	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48762	10.1371/journal.pone.0048762	http://dx.doi.org/10.1371/journal.pone.0048762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155404	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900038
J	Wood, KA; Stillman, RA; Clarke, RT; Daunt, F; O'Hare, MT				Wood, Kevin A.; Stillman, Richard A.; Clarke, Ralph T.; Daunt, Francis; O'Hare, Matthew T.			Understanding Plant Community Responses to Combinations of Biotic and Abiotic Factors in Different Phases of the Plant Growth Cycle	PLOS ONE			English	Article							WATERFOWL HERBIVORY; CATASTROPHIC SHIFTS; NUTRIENT DYNAMICS; STANDING CROP; CHALK-STREAM; RIVER; VEGETATION; MACROPHYTES; IMPACT; EUTROPHICATION	Understanding plant community responses to combinations of biotic and abiotic factors is critical for predicting ecosystem response to environmental change. However, studies of plant community regulation have seldom considered how responses to such factors vary with the different phases of the plant growth cycle. To address this deficit we studied an aquatic plant community in an ecosystem subject to gradients in mute swan (Cygnus olor) herbivory, riparian shading, water temperature and distance downstream of the river source. We quantified abundance, species richness, evenness, flowering and dominance in relation to biotic and abiotic factors during the growth-, peak-, and recession-phases of the plant growth cycle. We show that the relative importance of biotic and abiotic factors varied between plant community properties and between different phases of the plant growth cycle. Herbivory became more important during the later phases of peak abundance and recession due to an influx of swans from adjacent pasture fields. Shading by riparian vegetation also had a greater depressing effect on biomass in later seasons, probably due to increased leaf abundance reducing light intensity reaching the aquatic plants. The effect of temperature on community diversity varied between upstream and downstream sites by altering the relative competitiveness of species at these sites. These results highlight the importance of seasonal patterns in the regulation of plant community structure and function by multiple factors.	[Wood, Kevin A.; Daunt, Francis; O'Hare, Matthew T.] Ctr Ecol & Hydrol, Edinburgh, Midlothian, Scotland	UK Centre for Ecology & Hydrology (UKCEH)	Wood, KA (corresponding author), Ctr Ecol & Hydrol, Bush Estate, Edinburgh, Midlothian, Scotland.	kevinwoodecology@hotmail.co.uk	Clarke, Ralph T/B-3859-2009; Daunt, Francis/K-6688-2012; Wood, Kevin/C-7312-2012; O'Hare, Matthew T/F-3648-2011	Daunt, Francis/0000-0003-4638-3388; Wood, Kevin/0000-0001-9170-6129; 	Natural Environment Research Council [ceh010022, CEH010021] Funding Source: researchfish	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Arnott S, 2009, HYDROL RES, V40, P533, DOI 10.2166/nh.2009.017; Arnott S, 2008, THESIS U EXETER UK; BACON PJ, 1986, BIRD STUDY, V33, P145, DOI 10.1080/00063658609476913; BARKO JW, 1982, CAN J BOT, V60, P877, DOI 10.1139/b82-113; BERRIE AD, 1992, HYDROBIOLOGIA, V248, P3, DOI 10.1007/BF00008881; Bornette G, 2011, AQUAT SCI, V73, P1, DOI 10.1007/s00027-010-0162-7; Bowes MJ, 2012, SCI TOTAL ENVIRON, V434, P201, DOI 10.1016/j.scitotenv.2011.09.082; Bowes MJ, 2005, SCI TOTAL ENVIRON, V336, P225, DOI 10.1016/j.scitotenv.2004.05.026; Bullock JM, 2001, J APPL ECOL, V38, P253, DOI 10.1046/j.1365-2664.2001.00599.x; Chaichana R, 2011, AQUAT BOT, V95, P39, DOI 10.1016/j.aquabot.2011.03.008; Cotton JA, 2006, GEOMORPHOLOGY, V77, P320, DOI 10.1016/j.geomorph.2006.01.010; CYR H, 1993, NATURE, V361, P148, DOI 10.1038/361148a0; DAWSON F H, 1976, Aquatic Botany, V2, P51, DOI 10.1016/0304-3770(76)90007-3; Dawson F. H., 1978, Verhandlungen der Internationalen Vereinigung fur Theoretische und Angewandte Limnologie, V20, P1451; DAWSON FH, 1981, HYDROBIOLOGIA, V77, P277, DOI 10.1007/BF00019675; DAWSON FH, 1980, AQUAT BOT, V9, P145, DOI 10.1016/0304-3770(80)90015-7; Delany S, 2005, DUCKS GEESE SWANS, P231; Engelhardt KAM, 2001, NATURE, V411, P687, DOI 10.1038/35079573; Gayet G, 2012, AQUAT BOT, V103, P98, DOI 10.1016/j.aquabot.2012.07.002; Gayet G, 2011, EUR J WILDLIFE RES, V57, P1051, DOI 10.1007/s10344-011-0518-x; Gillham ME, 1956, BIRD STUDY, V3, P205; Grime J.P., 2002, PLANT STRATEGIES VEG; Gu Lianhong, 2009, P35, DOI 10.1007/978-1-4419-0026-5_2; Hidding B, 2010, OECOLOGIA, V162, P199, DOI 10.1007/s00442-009-1450-6; Hilton J, 2006, SCI TOTAL ENVIRON, V365, P66, DOI 10.1016/j.scitotenv.2006.02.055; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Jones JI, 2003, ECOLOGY, V84, P2155, DOI 10.1890/02-0422; Kohler J, 2010, AQUAT BOT, V92, P129, DOI 10.1016/j.aquabot.2009.10.018; LOUDA SM, 1987, VEGETATIO, V72, P141; MILCHUNAS DG, 1993, ECOL MONOGR, V63, P327, DOI 10.2307/2937150; Mitchell SF, 1996, OIKOS, V76, P573, DOI 10.2307/3546351; Morison JIL, 1999, PLANT CELL ENVIRON, V22, P659, DOI 10.1046/j.1365-3040.1999.00443.x; O'Hare MT, 2007, FRESHWATER BIOL, V52, P2463, DOI 10.1111/j.1365-2427.2007.01841.x; OWENS M, 1961, J ECOL, V49, P119, DOI 10.2307/2257429; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Pilon J, 2001, NEW PHYTOL, V151, P659, DOI 10.1046/j.0028-646x.2001.00212.x; Polis GA, 1999, OIKOS, V86, P3, DOI 10.2307/3546565; POWER ME, 1992, ECOLOGY, V73, P733, DOI 10.2307/1940153; Pretty JL, 2006, J HYDROL, V330, P84, DOI 10.1016/j.jhydrol.2006.04.013; Rietkerk M, 2004, SCIENCE, V305, P1926, DOI 10.1126/science.1101867; Sandsten H, 2008, OECOLOGIA, V156, P569, DOI 10.1007/s00442-008-1010-5; Santamaria L, 2002, ARCH HYDROBIOL, V153, P353; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; SCOTT DK, 1984, IBIS, V126, P168, DOI 10.1111/j.1474-919X.1984.tb07996.x; SCOTT DK, 1983, J ZOOL, V200, P539; SPINK AJ, 1993, J AQUAT PLANT MANAGE, V31, P113; Stafford JD, 2012, WETLANDS, V32, P851, DOI 10.1007/s13157-012-0316-6; Weisner SEB, 1997, OECOLOGIA, V109, P592, DOI 10.1007/s004420050121; Wood K.A, 2012, THESIS BOURNEMOUTH U; Wood KA, 2012, AQUAT BOT, V102, P28, DOI 10.1016/j.aquabot.2012.04.006; Wood Kevin A., 2012, P339; Wood KA, 2012, HYDROBIOLOGIA, V686, P157, DOI 10.1007/s10750-012-1007-2	52	36	36	0	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49824	10.1371/journal.pone.0049824	http://dx.doi.org/10.1371/journal.pone.0049824			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166777	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900197
J	Tang, GX; Zhou, HJ; Xu, JW; Xu, JM; Ji, MJ; Wu, HW; Wu, GL				Tang, Gui-Xia; Zhou, He-Jun; Xu, Jin-Wei; Xu, Jin-Mei; Ji, Min-Jun; Wu, Hai-Wei; Wu, Guan-Ling			Schistosoma japonicum Soluble Egg Antigens Attenuate IFN-gamma-Induced MHC Class II Expression in RAW 264.7 Macrophages	PLOS ONE			English	Article							MANSONI-INFECTED MICE; CD4 T-CELLS; INTERFERON-GAMMA; GRANULOMA-FORMATION; INNATE IMMUNITY; TLR EXPRESSION; GENE; RESPONSES; IL-10; HYPERSENSITIVITY	Innate immune response plays the key role in initiating and guiding the immune response. Elucidating the innate immune related molecular events involved in the interaction between the parasite and the host will aid in the development of an effective vaccine and anti-schistosome pharmaceuticals. In this study, we examined the regulatory effect of Schistosoma japonicum soluble egg antigen (SEA) on MHC class II expression in macrophage cell line RAW 264.7. We demonstrated that SEA possesses the ability to down-regulate IFN-gamma-induced MHC class II expression in RAW 264.7 cells. The production of IL-10 and IL-6 in RAW 264.7 cells, induced by SEA, was responsible for mediating the down-regulation of MHC class II. Our findings suggest that in RAW 264.7 cells (1) IFN-gamma provides a condition for lower concentrations of SEA to attenuate MHC class II expression; (2) SEA attenuated IFN-gamma-induced MHC class II expression and the IL-10 and IL-6 production is mediated at least partly by the interaction of SEA with TLR4; and (3) SEA attenuated IFN-gamma-induced MHC class II expression at the transcriptional level.	[Tang, Gui-Xia; Xu, Jin-Wei; Ji, Min-Jun; Wu, Hai-Wei; Wu, Guan-Ling] Nanjing Med Univ, Dept Pathogen Biol & Immunol, Nanjing, Jiangsu, Peoples R China; [Ji, Min-Jun; Wu, Hai-Wei; Wu, Guan-Ling] Jiangsu Prov Key Lab Modern Pathogen Biol, Nanjing, Jiangsu, Peoples R China; [Wu, Hai-Wei] Rhode Isl Hosp, Ctr Int Hlth Res, Providence, RI USA; [Zhou, He-Jun] WHO Collaborating Ctr Malaria Schistosomiasis & F, Shanghai, Peoples R China; [Xu, Jin-Mei] MacroStat Clin Res Co Ltd, Shanghai, Peoples R China	Nanjing Medical University; Lifespan Health Rhode Island; Rhode Island Hospital; World Health Organization	Tang, GX (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China.	guixiatang@163.com; wu@njmu.edu.cn			National Natural Science Foundation of China [30430600, 30901354]; National Basic Research Program of China (973 Program) [2007CB513106]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by grants from the National Natural Science Foundation of China (No. 30430600), the National Natural Science Foundation of China (No. 30901354) and the National Basic Research Program of China (973 Program 2007CB513106) (http://159.226.244.22/portal/Proj_List.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Hafeez EH, 2009, PARASITOL INT, V58, P36, DOI 10.1016/j.parint.2008.09.004; Berger AC, 2009, J CELL SCI, V122, P1, DOI 10.1242/jcs.035089; BOROJEVIC R, 1992, MEM I OSWALDO CRUZ, V87, P171, DOI 10.1590/S0074-02761992000800026; BOROS DL, 1975, J IMMUNOL, V114, P1437; Delvig AA, 2002, J LEUKOCYTE BIOL, V72, P163; DOMINGO EO, 1968, AM J PATHOL, V52, P369; Dunne DW, 2005, NAT REV IMMUNOL, V5, P420, DOI 10.1038/nri1601; Fallon PG, 1999, J IMMUNOL, V162, P4122; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Heise MT, 1998, J EXP MED, V187, P1037, DOI 10.1084/jem.187.7.1037; Herbert DR, 2008, J IMMUNOL, V181, P7214, DOI 10.4049/jimmunol.181.10.7214; Hernandez HJ, 1997, EUR J IMMUNOL, V27, P1170, DOI 10.1002/eji.1830270518; Hesse M, 2004, J IMMUNOL, V172, P3157, DOI 10.4049/jimmunol.172.5.3157; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Kincaid EZ, 2007, J IMMUNOL, V179, P3187, DOI 10.4049/jimmunol.179.5.3187; King CH, 2009, NEW ENGL J MED, V360, P106, DOI 10.1056/NEJMp0808041; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller LS, 2005, J IMMUNOL, V174, P6137, DOI 10.4049/jimmunol.174.10.6137; Mueller T, 2006, J IMMUNOL, V176, P5805, DOI 10.4049/jimmunol.176.10.5805; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Oliveira AC, 2004, J IMMUNOL, V173, P5688, DOI 10.4049/jimmunol.173.9.5688; Oliveira VR, 2000, MICROBES INFECT, V2, P1817, DOI 10.1016/S1286-4579(00)01341-1; PHILLIPS SM, 1977, J IMMUNOL, V118, P594; Redpath S, 1999, J IMMUNOL, V162, P6701; REINER NE, 1987, J IMMUNOL, V138, P1926; Rolland A, 2006, J IMMUNOL, V176, P7636, DOI 10.4049/jimmunol.176.12.7636; SCHOOK LB, 1983, INFECT IMMUN, V42, P882, DOI 10.1128/IAI.42.3.882-886.1983; Schroder K, 2004, J LEUKOCYTE BIOL, V75, P163, DOI 10.1189/jlb.0603252; Sendide K, 2005, J IMMUNOL, V175, P5324, DOI 10.4049/jimmunol.175.8.5324; Singh KP, 2005, IMMUNOLOGY, V114, P410, DOI 10.1111/j.1365-2567.2004.02083.x; STADECKER MJ, 1984, AM J PATHOL, V116, P245; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Thomas PG, 2003, J IMMUNOL, V171, P5837, DOI 10.4049/jimmunol.171.11.5837; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; van Niel G, 2008, CURR OPIN CELL BIOL, V20, P437, DOI 10.1016/j.ceb.2008.05.011; WARREN KS, 1967, AM J PATHOL, V51, P735; WARREN KS, 1978, AM J TROP MED HYG, V27, P271, DOI 10.4269/ajtmh.1978.27.271; Wojciechowski W, 1999, J IMMUNOL, V163, P2688; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Zheng XP, 2008, J NEUROIMMUNOL, V194, P107, DOI 10.1016/j.jneuroim.2007.12.001	41	5	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49234	10.1371/journal.pone.0049234	http://dx.doi.org/10.1371/journal.pone.0049234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152879	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234600031
J	Zhao, H; Li, QS; Wang, J; Su, XW; Ng, KM; Qiu, T; Shan, L; Ling, Y; Wang, LF; Cai, JQ; Ying, JM				Zhao, Hong; Li, Qinshan; Wang, Jian; Su, Xianwei; Ng, Ka Man; Qiu, Tian; Shan, Ling; Ling, Yun; Wang, Linfang; Cai, Jianqiang; Ying, Jianming			Frequent Epigenetic Silencing of the Folate-Metabolising Gene Cystathionine-Beta-Synthase in Gastrointestinal Cancer	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; PROMOTER HYPERMETHYLATION; COLORECTAL-CANCER; STAGE-II; DNA; METHYLATION; SUSCEPTIBILITY; MUTATIONS; MULTIPLE; REPAIR	Background: Both gastric and colorectal cancers (CRC) are the most frequently occurring malignancies worldwide with the overall survival of these patients remains unsatisfied. Identification of tumor suppressor genes (TSG) silenced by promoter CpG methylation uncovers mechanisms of tumorigenesis and identifies new epigenetic biomarkers for early cancer detection and prognosis assessment. Cystathionine-beta-synthase (CBS) functions in the folate metabolism pathway, which is intricately linked to methylation of genomic DNA. Dysregulation of DNA methylation contributes substantially to cancer development. Methodology/Principal Findings: To identify potential TSGs silenced by aberrant promoter methylation in CRC, we analyzed tumor and adjacent tissues from CRC cases using the Illumina Human Methylation45 BeadChip. We identified hypermethylation of the CBS gene in CRC samples, compared to adjacent tissues. Methylation and decreased mRNA expression of CBS were detected in most CRC cell lines by methylation-specific PCR and semiquantitative RT-PCR, as well as in gastric cancer. Treatment with 5-aza-2'-deoxycytidine and/or trichostatin A reversed methylation and restored CBS mRNA expression indicating a direct effect. Aberrant methylation was further detected in 31% of primary CRCs (29 of 96) and 55% of gastric tumors (11 of 20). In contrast, methylation was seldom found in normal tissues adjacent to the tumor. CBS methylation was associated with KRAS mutations in primary CRCs (P = 0.04, by chi(2)-test). However, no association was found between CBS methylation or KRAS mutations with cancer relapse/metastasis in Stage II CRC patients. Conclusion: A novel finding from this study is that the folate metabolism enzyme CBS mRNA levels are frequently downregulated through CpG methylation of the CBS gene in gastric cancer and CRC, suggesting that CBS functions as a tumor suppressor gene. These findings warrant further study of CBS as an epigenetic biomarker for molecular diagnosis of gastrointestinal cancers.	[Zhao, Hong; Wang, Jian; Cai, Jianqiang] Peking Union Med Coll, Canc Hosp, Dept Abdominal Surg Oncol, Beijing 100021, Peoples R China; [Zhao, Hong; Li, Qinshan; Wang, Jian; Qiu, Tian; Shan, Ling; Ling, Yun; Wang, Linfang; Cai, Jianqiang; Ying, Jianming] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Li, Qinshan; Wang, Linfang] Peking Union Med Coll, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing 100021, Peoples R China; [Su, Xianwei; Ng, Ka Man] Chinese Univ Hong Kong, Sir YK Pao Ctr Canc, State Key Lab Oncol S China, Canc Epigenet Lab,Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Su, Xianwei; Ng, Ka Man] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Hong Kong, Peoples R China; [Qiu, Tian; Shan, Ling; Ling, Yun; Ying, Jianming] Peking Union Med Coll, Canc Hosp, Dept Pathol, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cai, JQ (corresponding author), Peking Union Med Coll, Canc Hosp, Dept Abdominal Surg Oncol, Beijing 100021, Peoples R China.	caijianqiang188@sina.com; jmying@hotmail.com			National Natural Science Foundation of China [30801344]; Beijing Nova Program [2009A70]; State Key Laboratory program [2060204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Nova Program(Beijing Municipal Science & Technology Commission); State Key Laboratory program	This study was supported by grants from the National Natural Science Foundation of China (No. 30801344), the Beijing Nova Program (No. 2009A70) and the State Key Laboratory program (No. 2060204). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JB, 2011, CANCER-AM CANCER SOC, V117, P1847, DOI 10.1002/cncr.25737; Andreyev HJN, 2001, BRIT J CANCER, V85, P692, DOI 10.1054/bjoc.2001.1964; Audebert M, 2004, J BIOL CHEM, V279, P55117, DOI 10.1074/jbc.M404524200; Bao LM, 1998, ARCH BIOCHEM BIOPHYS, V350, P95, DOI 10.1006/abbi.1997.0486; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dedeurwaerder S, 2011, EPIGENOMICS-UK, V3, P771, DOI [10.2217/EPI.11.105, 10.2217/epi.11.105]; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Dutta S, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-25; Edge S.B., 2010, AJCC CANC STAGING MA, V7th ed., P143; Esteller M, 2001, CANCER RES, V61, P4689; Farina-Sarasqueta A, 2010, ANN ONCOL, V21, P2396, DOI 10.1093/annonc/mdq258; Guerrero S, 2000, CANCER RES, V60, P6750; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jin HC, 2007, P NATL ACAD SCI USA, V104, P12353, DOI 10.1073/pnas.0700153104; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kim BN, 2005, INT J ONCOL, V26, P1217; Kim J, 2009, ONCOL REP, V21, P1449, DOI 10.3892/or_00000373; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kraus JP, 1999, HUM MUTAT, V13, P362; Laval J, 1996, PATHOL BIOL, V44, P14; Leung WK, 2001, CANCER-AM CANCER SOC, V91, P2294; Linnebank M, 2004, BRIT J CANCER, V90, P1969, DOI 10.1038/sj.bjc.6601777; Majors AK, 2000, MOL GENET METAB, V70, P252, DOI 10.1006/mgme.2000.3024; Marchand LL, 2002, CANCER CAUSE CONTROL, V13, P239, DOI 10.1023/A:1015057614870; Ott N, 2008, J CANCER RES CLIN, V134, P405, DOI 10.1007/s00432-007-0301-2; Parl FF, 2005, CANCER LETT, V221, P123, DOI 10.1016/j.canlet.2004.06.016; Paz MF, 2002, CANCER RES, V62, P4519; Prudova A, 2006, P NATL ACAD SCI USA, V103, P6489, DOI 10.1073/pnas.0509531103; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Rosado JO, 2007, MOL CELL BIOCHEM, V301, P1, DOI 10.1007/s11010-006-9389-y; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; Shannon B, 2002, GUT, V50, P520, DOI 10.1136/gut.50.4.520; Galbiatti ALS, 2012, EUR J CANCER, V48, P1525, DOI 10.1016/j.ejca.2011.09.025; Tao Q, 2002, HUM MOL GENET, V11, P2091, DOI 10.1093/hmg/11.18.2091; Ying J, 2006, ONCOGENE, V25, P1070, DOI 10.1038/sj.onc.1209154; Ying J, 2009, BRIT J CANCER, V100, P663, DOI 10.1038/sj.bjc.6604888; Ying JM, 2005, CLIN CANCER RES, V11, P6442, DOI 10.1158/1078-0432.CCR-05-0267; Zlobec I, 2011, J PATHOL, V225, P336, DOI 10.1002/path.2879	41	26	36	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49683	10.1371/journal.pone.0049683	http://dx.doi.org/10.1371/journal.pone.0049683			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152928	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600051
J	Nausch, H; Mikschofsky, H; Koslowski, R; Meyer, U; Broer, I; Huckauf, J				Nausch, Henrik; Mikschofsky, Heike; Koslowski, Roswitha; Meyer, Udo; Broer, Inge; Huckauf, Jana			High-Level Transient Expression of ER-Targeted Human Interleukin 6 in Nicotiana benthamiana	PLOS ONE			English	Article							RECOMBINANT HUMAN INTERLEUKIN-6; HIGH-YIELD PRODUCTION; STORAGE VACUOLES; MOSAIC-VIRUS; ENDOPLASMIC-RETICULUM; PROTEIN-PRODUCTION; PLANT; ANTIBODIES; ACCUMULATION; SYSTEMS	Tobacco plants can be used to express recombinant proteins that cannot be produced in a soluble and active form using traditional platforms such as Escherichia coli. We therefore expressed the human glycoprotein interleukin 6 (IL6) in two commercial tobacco cultivars (Nicotiana tabacum cv. Virginia and cv. Geudertheimer) as well as the model host N. benthamiana to compare different transformation strategies (stable vs. transient expression) and subcellular targeting (apoplast, endoplasmic reticulum (ER) and vacuole). In T-0 transgenic plants, the highest expression levels were achieved by ER targeting but the overall yields of IL6 were still low in the leaves (0.005% TSP in the ER, 0.0008% in the vacuole and 0.0005% in the apoplast). The apoplast variant accumulated to similar levels in leaves and seeds, whereas the ER-targeted variant was 1.2-fold more abundant in seeds and the vacuolar variant was 6-fold more abundant in seeds. The yields improved in subsequent generations, with the best-performing T-2 plants producing the ER-targeted IL6 at 0.14% TSP in both leaves and seeds. Transient expression of ER-targeted IL6 in leaves using the MagnICON system resulted in yields of up to 7% TSP in N. benthamiana, but only 1% in N. tabacum cv. Virginia and 0.5% in cv. Geudertheimer. Although the commercial tobacco cultivars produced up to threefold more biomass than N. benthamiana, this was not enough to compensate for the lower overall yields. The recombinant IL6 produced by transient and stable expression in plants was biologically active and presented as two alternative bands matching the corresponding native protein.	[Nausch, Henrik; Mikschofsky, Heike; Broer, Inge; Huckauf, Jana] Univ Rostock, Dept Agrobiotechnol, Agr & Environm Fac, Rostock, Germany; [Koslowski, Roswitha; Meyer, Udo] Bioserv GmbH, Rostock, Germany	University of Rostock	Broer, I (corresponding author), Univ Rostock, Dept Agrobiotechnol, Agr & Environm Fac, Rostock, Germany.	inge.broer@uni-rostock.de		Nausch, Henrik/0000-0001-5393-3267	doctorate program of the University of Rostock	doctorate program of the University of Rostock	The first author was partially supported by a grant from the doctorate program of the University of Rostock. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ALI H, 1993, J BIOL CHEM, V268, P24247; Balkwill FR, 2001, CYTOKINE CELL BIOL P, P214; Barton BE, 2005, EXPERT OPIN THER TAR, V9, P737, DOI 10.1517/14728222.9.4.737; Benchabane M, 2008, PLANT BIOTECHNOL J, V6, P633, DOI 10.1111/j.1467-7652.2008.00344.x; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Boothe J, 2010, PLANT BIOTECHNOL J, V8, P588, DOI 10.1111/j.1467-7652.2010.00511.x; Bosch D, 2010, EXPERT REV VACCINES, V9, P835, DOI 10.1586/erv.10.83; BRAKENHOFF JPJ, 1987, J IMMUNOL, V139, P4116; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1323, DOI 10.1094/MPMI-20-11-1323; Cakir C, 2010, PHYSIOL MOL PLANT P, V74, P246, DOI 10.1016/j.pmpp.2010.04.001; Castilho A, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200032; Chalfie M, 2012, METHODS BIOCH ANAL; Conley AJ, 2011, PLANT BIOTECHNOL J, V9, P434, DOI 10.1111/j.1467-7652.2010.00563.x; Conrad U, 1998, J PLANT PHYSIOL, V152, P708, DOI 10.1016/S0176-1617(98)80034-5; Davies HM, 2010, PLANT BIOTECHNOL J, V8, P845, DOI 10.1111/j.1467-7652.2010.00550.x; de Marco A, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-26; DENECKE J, 1992, EMBO J, V11, P2345, DOI 10.1002/j.1460-2075.1992.tb05294.x; Ejima D, 1999, BIOTECHNOL BIOENG, V62, P301, DOI 10.1002/(SICI)1097-0290(19990205)62:3<301::AID-BIT6>3.3.CO;2-N; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Ferrer-Miralles N, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-17; Fischer R, 2012, BIOTECHNOL ADV, V30, P434, DOI 10.1016/j.biotechadv.2011.08.007; Frigerio L, 2001, J PLANT PHYSIOL, V158, P499, DOI 10.1078/0176-1617-00362; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P3257, DOI 10.1093/nar/15.8.3257; Giritch A, 2006, P NATL ACAD SCI USA, V103, P14701, DOI 10.1073/pnas.0606631103; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Gomord V, 2010, PLANT BIOTECHNOL J, V8, P564, DOI 10.1111/j.1467-7652.2009.00497.x; Hausmann L, 1999, ENTWICKLUNG PLASTIDV, P153; HERRERAESTRELLA L, 1983, EMBO J, V2, P987, DOI 10.1002/j.1460-2075.1983.tb01532.x; Hood EE, 2007, PLANT BIOTECHNOL J, V5, P709, DOI 10.1111/j.1467-7652.2007.00275.x; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Huang CJ, 2012, J IND MICROBIOL BIOT, V39, P383, DOI 10.1007/s10295-011-1082-9; Huang Z, 2008, PLANT BIOTECHNOL J, V6, P202, DOI 10.1111/j.1467-7652.2007.00316.x; Huhns M, 2008, PLANT BIOTECHNOL J, V6, P321, DOI 10.1111/j.1467-7652.2007.00320.x; Jacobs PP, 2009, CURR MOL MED, V9, P774, DOI 10.2174/156652409789105552; Khan I, 2012, J BIOTECHNOL; Khanuja SPS, 1999, PLANT MOL BIOL REP, V17, P74, DOI 10.1023/A:1007528101452; Kim TG, 2008, PLANT CELL REP, V27, P885, DOI 10.1007/s00299-008-0514-0; Kim TW, 2005, BIOTECHNOL PROGR, V21, P524, DOI 10.1021/bp049645j; Komarnytsky S, 2006, PLANT PHYSIOL, V141, P1185, DOI 10.1104/pp.105.074419; Komarova TV, 2010, EXPERT REV VACCINES, V9, P859, DOI [10.1586/erv.10.85, 10.1586/ERV.10.85]; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; KWON SY, 1995, MOL CELLS, V5, P486; Lau OS, 2009, BIOTECHNOL ADV, V27, P1015, DOI 10.1016/j.biotechadv.2009.05.005; Lawrence DM, 2001, J VIROL, V75, P8712, DOI 10.1128/JVI.75.18.8712-8723.2001; Lee EG, 2009, ENZYME MICROB TECH, V44, P254, DOI 10.1016/j.enzmictec.2008.12.014; Liu JZ, 2005, PLANT PHYSIOL, V138, P1853, DOI 10.1104/pp.105.065722; Llave C, 2000, P NATL ACAD SCI USA, V97, P13401, DOI 10.1073/pnas.230334397; Llave C, 2010, TRENDS PLANT SCI, V15, P701, DOI 10.1016/j.tplants.2010.09.001; Madan M, 2008, ATHEROSCLEROSIS, V197, P504, DOI 10.1016/j.atherosclerosis.2007.02.023; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; Murakami M, 2011, CURR OPIN RHEUMATOL, V23, P273, DOI 10.1097/BOR.0b013e3283456797; Nagels B, 2012, CRIT REV PLANT SCI, V31, P148, DOI 10.1080/07352689.2011.616075; Nausch H, 2012, PLOS ONE UNPUB; Nishimoto N, 2010, CLIN PHARMACOL THER, V87, P483, DOI 10.1038/clpt.2009.313; Obembe OO, 2011, BIOTECHNOL ADV, V29, P210, DOI 10.1016/j.biotechadv.2010.11.004; ODELL JT, 1985, NATURE, V313, P810, DOI 10.1038/313810a0; ORITA T, 1994, J BIOCHEM-TOKYO, V115, P345, DOI 10.1093/oxfordjournals.jbchem.a124340; Palukaitis P, 2011, PLANT PATHOLOGY J, V27, P197, DOI 10.5423/PPJ.2011.27.3.197; Pantaleo V, 2011, ADV EXP MED BIOL, V722, P39, DOI 10.1007/978-1-4614-0332-6_3; Petruccelli S, 2006, PLANT BIOTECHNOL J, V4, P511, DOI 10.1111/j.1467-7652.2006.00200.x; Pinkhasov J, 2011, PLANT BIOTECHNOL J, V9, P991, DOI 10.1111/j.1467-7652.2011.00614.x; Rivard D, 2006, PLANT BIOTECHNOL J, V4, P359, DOI 10.1111/j.1467-7652.2006.00187.x; Robinson DG, 2005, TRAFFIC, V6, P615, DOI 10.1111/j.1600-0854.2005.00303.x; Sawant SV, 2001, PLANT PHYSIOL, V126, P1630, DOI 10.1104/pp.126.4.1630; Schillberg S, 1999, TRANSGENIC RES, V8, P255, DOI 10.1023/A:1008937011213; Simpson RJ, 1997, PROTEIN SCI, V6, P929, DOI 10.1002/pro.5560060501; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Smolen JS, 2006, ARTHRITIS RES THERAP, V8; Spiridonova VA, 2007, BIOCHEMISTRY-MOSCOW+, V72, P424, DOI 10.1134/S0006297907040098; Swardfager W, 2010, BIOL PSYCHIAT, V68, P930, DOI 10.1016/j.biopsych.2010.06.012; TONOUCHI N, 1988, J BIOCHEM-TOKYO, V104, P30, DOI 10.1093/oxfordjournals.jbchem.a122416; Tremblay R, 2010, BIOTECHNOL ADV, V28, P214, DOI 10.1016/j.biotechadv.2009.11.008; Vezina LP, 2009, PLANT BIOTECHNOL J, V7, P442, DOI 10.1111/j.1467-7652.2009.00414.x; Vitale A, 2005, MOL INTERV, V5, P216, DOI 10.1124/mi.5.4.5; Vitale A, 2005, TRENDS PLANT SCI, V10, P316, DOI 10.1016/j.tplants.2005.05.001; Webster DE, 2012, BIOTECHNOL ADV, V30, P410, DOI 10.1016/j.biotechadv.2011.07.015; Werner S, 2011, P NATL ACAD SCI; Wilken LR, 2012, BIOTECHNOL ADV, V30, P419, DOI 10.1016/j.biotechadv.2011.07.020; Yang JJ, 2005, TRANSGENIC RES, V14, P313, DOI 10.1007/s11248-005-0272-5; Yang SJ, 2004, P NATL ACAD SCI USA, V101, P6297, DOI 10.1073/pnas.0304346101	81	27	27	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48938	10.1371/journal.pone.0048938	http://dx.doi.org/10.1371/journal.pone.0048938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152824	Green Submitted, gold, Green Published			2022-12-27	WOS:000311234000036
J	Bousquet, E; Zhao, M; Ly, A; Jardins, GLL; Goldenberg, B; Naud, MC; Jonet, L; Besson-Lescure, B; Jaisser, F; Farman, N; De Kozak, Y; Behar-Cohen, F				Bousquet, Elodie; Zhao, Min; Ly, Andre; Jardins, Guillaume Leroux Les; Goldenberg, Brigitte; Naud, Marie-Christine; Jonet, Laurent; Besson-Lescure, Bernadette; Jaisser, Frederic; Farman, Nicolette; De Kozak, Yvonne; Behar-Cohen, Francine			The Aldosterone-Mineralocorticoid Receptor Pathway Exerts Anti-Inflammatory Effects in Endotoxin-Induced Uveitis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; RAT OCULAR-TISSUES; DIABETIC-NEPHROPATHY; CILIARY BODY; INFLAMMATION; EXPRESSION; CELLS; SPIRONOLACTONE; INHIBITOR	We have previously shown that the eye is a mineralocorticoid-sensitive organ and we now question the role of mineralocorticoid receptor (MR) in ocular inflammation. The endotoxin-induced uveitis (EIU), a rat model of human intraocular inflammation, was induced by systemic administration of lipopolysaccharide (LPS). Evaluations were made 6 and 24 hours after intraocular injection of aldosterone (simultaneous to LPS injection). Three hours after onset of EIU, the MR and the glucocorticoid metabolizing enzyme 11-beta hydroxysteroid dehydrogenase type 2 (11 beta-HSD2) expression were down-regulated in iris/ciliary body and the corticosterone concentration was increased in aqueous humor, altering the normal MR/glucocorticoid receptor (GR) balance. At 24 hours, the GR expression was also decreased. In EIU, aldosterone reduced the intensity of clinical inflammation in a dose-dependent manner. The clinical benefit of aldosterone was abrogated in the presence of the MR antagonist (RU26752) and only partially with the GR antagonist (RU38486). Aldosterone reduced the release of inflammatory mediators (6 and 24 hours: TNF-alpha, IFN-gamma, MIP-1 alpha) in aqueous humor and the number of activated microglia/macrophages. Aldosterone partly prevented the uveitis-induced MR down-regulation. These results suggest that MR expression and activation in iris/ciliary body could protect the ocular structures against damages induced by EIU. Citation: Bousquet E, Zhao M, Ly A, Leroux les Jardins G, Goldenberg B, et al. (2012) The Aldosterone-Mineralocorticoid Receptor Pathway Exerts Anti-Inflammatory Effects in Endotoxin-Induced Uveitis. PLoS ONE 7(11): e49036. doi:10.1371/journal.pone.0049036	[Bousquet, Elodie; Zhao, Min; Ly, Andre; Jardins, Guillaume Leroux Les; Goldenberg, Brigitte; Naud, Marie-Christine; Jonet, Laurent; De Kozak, Yvonne; Behar-Cohen, Francine] Univ Rene Descartes Sorbonne Paris Cite, INSERM, Team 17, Ctr Rech Cordeliers,U872, Paris, France; [Bousquet, Elodie; Zhao, Min; Ly, Andre; Jardins, Guillaume Leroux Les; Goldenberg, Brigitte; Naud, Marie-Christine; Jonet, Laurent; De Kozak, Yvonne; Behar-Cohen, Francine] Univ Rene Descartes Sorbonne, Paris, France; [Jardins, Guillaume Leroux Les; Behar-Cohen, Francine] Hop Hotel Dieu, Assistance Publ Hop Paris, Paris, France; [Besson-Lescure, Bernadette] Hop St Antoine, IFR65 IRSSA, Paris, France; [Jaisser, Frederic; Farman, Nicolette] Univ Paris 06, Team 1, U872, INSERM,Ctr Rech Cordeliers, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Behar-Cohen, F (corresponding author), Univ Rene Descartes Sorbonne Paris Cite, INSERM, Team 17, Ctr Rech Cordeliers,U872, Paris, France.	francine.behar@crc.jussieu.fr	Zhao, Min/AAX-7664-2020; Jaisser, Frederic/P-4287-2017	Zhao, Min/0000-0002-5418-7275; Jaisser, Frederic/0000-0001-9051-1901	Fondation pour la Recherche Medicale; INSERM funds	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); INSERM funds	The Fondation pour la Recherche Medicale is acknowledged for supporting Elodie Bousquet. This work has been supported by INSERM funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bergmann A, 2010, HYPERTENSION, V55, P370, DOI 10.1161/HYPERTENSIONAHA.109.141309; Berka JLW, 2009, CIRC RES, V104, P124, DOI 10.1161/CIRCRESAHA.108.176008; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; de Kozak Y, 2007, AM J PATHOL, V170, P1241, DOI 10.2353/ajpath.2007.060236; Denniston AK, 2012, INVEST OPHTH VIS SCI, V53, P888, DOI 10.1167/iovs.11-8802; Deuchar GA, 2011, ENDOCRINOLOGY, V152, P236, DOI 10.1210/en.2010-0925; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P3873; DEVOS AF, 1994, INVEST OPHTH VIS SCI, V35, P1100; Farman N, 2001, AM J PHYSIOL-RENAL, V280, pF181, DOI 10.1152/ajprenal.2001.280.2.F181; Fiebeler A, 2007, CURR OPIN NEPHROL HY, V16, P134; Freddo TF, 2001, EXP EYE RES, V73, P581, DOI 10.1006/exer.2001.1056; Frieler RA, 2011, STROKE, V42, P179, DOI 10.1161/STROKEAHA.110.598441; Funder JW, 2007, AM J CARDIOVASC DRUG, V7, P151, DOI 10.2165/00129784-200707030-00001; Gilbert KC, 2010, CURR OPIN ENDOCRINOL, V17, P199, DOI 10.1097/MED.0b013e3283391989; GOUREAU O, 1995, J IMMUNOL, V154, P6518; Hicks CW, 2012, CRIT CARE MED, V40, P199, DOI 10.1097/CCM.0b013e31822efa14; Jacquemin E, 1996, INVEST OPHTH VIS SCI, V37, P1187; Johnson LA, 2012, INFLAMM BOWEL DIS, V18, P1315, DOI 10.1002/ibd.21929; Martinez ED, 2005, EXP CELL RES, V308, P320, DOI 10.1016/j.yexcr.2005.03.040; Matsumoto S, 2006, METABOLISM, V55, P1645, DOI 10.1016/j.metabol.2006.07.025; MCMENAMIN PG, 1995, INVEST OPHTH VIS SCI, V36, P1949; Messaoudi S, 2009, FASEB J, V23, P2176, DOI 10.1096/fj.08-125302; Michel F, 2004, CIRCULATION, V109, P1933, DOI 10.1161/01.CIR.0000127112.36796.9B; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Pascual-Le Tallec L, 2005, MOL ENDOCRINOL, V19, P2211, DOI 10.1210/me.2005-0089; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; PLANCK SR, 1994, INVEST OPHTH VIS SCI, V35, P924; Rautureau Y, 2011, STEROIDS, V76, P834, DOI 10.1016/j.steroids.2011.02.015; ROSENBAUM JT, 1980, NATURE, V286, P611, DOI 10.1038/286611a0; Schwartz B, 1997, OPHTHALMIC RES, V29, P42, DOI 10.1159/000267990; Sierra A, 2008, GLIA, V56, P659, DOI 10.1002/glia.20644; Smith JR, 1998, IMMUNOL CELL BIOL, V76, P497, DOI 10.1046/j.1440-1711.1998.00783.x; Smith JR, 2007, INVEST OPHTH VIS SCI, V48, P2676, DOI 10.1167/iovs.06-0598; Stokes J, 2000, INVEST OPHTH VIS SCI, V41, P1629; Streilein JW, 2003, NAT REV IMMUNOL, V3, P879, DOI 10.1038/nri1224; Takebayashi K, 2006, J CLIN ENDOCR METAB, V91, P2214, DOI 10.1210/jc.2005-1718; Touchard E, 2010, INVEST OPHTH VIS SCI, V51, P4683, DOI 10.1167/iovs.09-4733; Trapp T, 1996, TRENDS PHARMACOL SCI, V17, P145, DOI 10.1016/0165-6147(96)81590-2; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Viengchareun Say, 2007, Nucl Recept Signal, V5, pe012, DOI 10.1621/nrs.05012; Wada T, 2009, ENDOCRINOLOGY, V150, P1662, DOI 10.1210/en.2008-1018; Yang PZ, 1996, INVEST OPHTH VIS SCI, V37, P77; Zhao M, 2012, J CLIN INVEST, V122, P2672, DOI 10.1172/JCI61427; Zhao M, 2010, FASEB J, V24, P3405, DOI 10.1096/fj.09-154344	45	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49036	10.1371/journal.pone.0049036	http://dx.doi.org/10.1371/journal.pone.0049036			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152847	Green Published, gold, Green Submitted			2022-12-27	WOS:000312272600039
J	Westman, JO; Taherzadeh, MJ; Franzen, CJ				Westman, Johan O.; Taherzadeh, Mohammad J.; Franzen, Carl Johan			Proteomic Analysis of the Increased Stress Tolerance of Saccharomyces cerevisiae Encapsulated in Liquid Core Alginate-Chitosan Capsules	PLOS ONE			English	Article							ANAEROBIC BATCH FERMENTATION; GEL-ELECTROPHORESIS; QUANTITATIVE PROTEOMICS; ETHANOL-PRODUCTION; YEAST-CELLS; EXPRESSION; PROTEIN; CONVERSION; GLUCOSE; MICROENCAPSULATION	Saccharomyces cerevisiae CBS8066 encapsulated in semi-permeable alginate or alginate-chitosan liquid core capsules have been shown to have an enhanced tolerance towards complex dilute-acid lignocellulose hydrolysates and the lignocellulose-derived inhibitor furfural, as well as towards high temperatures. The underlying molecular reasons for these effects have however not been elucidated. In this study we have investigated the response of the encapsulation on the proteome level in the yeast cells, in comparison with cells grown freely in suspension under otherwise similar conditions. The proteomic analysis was performed on whole cell protein extracts using nLC-MS/MS with TMT (R) labelling and 2-D DIGE. 842 and 52 proteins were identified using each method, respectively. The abundances of 213 proteins were significantly different between encapsulated and suspended cells, with good correlation between the fold change ratios obtained by the two methods for proteins identified in both. Encapsulation of the yeast caused an up-regulation of glucose-repressed proteins and of both general and starvation-specific stress responses, such as the trehalose biosynthesis pathway, and down-regulation of proteins linked to growth and protein synthesis. The encapsulation leads to a lack of nutrients for cells close to the core of the capsule due to mass transfer limitations. The triggering of the stress response may be beneficial for the cells in certain conditions, for example leading to the increased tolerance towards high temperatures and certain inhibitors.	[Westman, Johan O.; Franzen, Carl Johan] Chalmers Univ Technol, S-41296 Gothenburg, Sweden; [Westman, Johan O.; Taherzadeh, Mohammad J.] Univ Boras, Sch Engn, Boras, Sweden	Chalmers University of Technology; University of Boras	Franzen, CJ (corresponding author), Chalmers Univ Technol, S-41296 Gothenburg, Sweden.	franzen@chalmers.se	Westman, Johan/A-2589-2015; Taherzadeh, Mohammad/AAM-5414-2021; Franzén, Carl Johan/D-2211-2016; Taherzadeh, Mohammad/B-5950-2009	Westman, Johan/0000-0001-8510-4658; Taherzadeh, Mohammad/0000-0003-4887-2433; Franzén, Carl Johan/0000-0001-7540-2002; Taherzadeh, Mohammad/0000-0003-4887-2433	Swedish Research Council [2009-4514]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was financed by the Swedish Research Council (http://vr.se/inenglish.4.12fff4451215cbd83e4800015152.html) via grant no. 2009-4514. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alban A, 2003, PROTEOMICS, V3, P36, DOI 10.1002/pmic.200390006; Albanese V, 2010, J CELL BIOL, V189, P69, DOI 10.1083/jcb.201001054; Almeida JRM, 2007, J CHEM TECHNOL BIOT, V82, P340, DOI 10.1002/jctb.1676; [Anonymous], 1988, BIOTECHNOL TECH, DOI DOI 10.1007/BF01875541; Boender LGM, 2011, FEMS YEAST RES, V11, P603, DOI 10.1111/j.1567-1364.2011.00750.x; Boender LGM, 2009, APPL ENVIRON MICROB, V75, P5607, DOI 10.1128/AEM.00429-09; Brandberg T, 2007, BIOTECHNOL BIOENG, V98, P80, DOI 10.1002/bit.21410; Brandberg T, 2007, ENZYME MICROB TECH, V40, P585, DOI 10.1016/j.enzmictec.2006.05.032; Chang HN, 1996, BIOTECHNOL BIOENG, V51, P157, DOI 10.1002/(SICI)1097-0290(19960720)51:2<157::AID-BIT4>3.0.CO;2-I; CHEONG SH, 1993, BIOTECHNOL TECH, V7, P879, DOI 10.1007/BF00156366; Delgado ML, 2001, MICROBIOL-SGM, V147, P411, DOI 10.1099/00221287-147-2-411; GALIAZZO F, 1991, EUR J BIOCHEM, V196, P545, DOI 10.1111/j.1432-1033.1991.tb15848.x; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gaserod O, 1999, BIOMATERIALS, V20, P773, DOI 10.1016/S0142-9612(98)00230-0; Ge XM, 2006, ENZYME MICROB TECH, V39, P289, DOI 10.1016/j.enzmictec.2005.10.026; Gygi SP, 2000, P NATL ACAD SCI USA, V97, P9390, DOI 10.1073/pnas.160270797; Hober R, 1946, PHYS CHEM CELLS TISS, pxiii; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Kolkman A, 2005, MOL CELL PROTEOMICS, V4, P255, DOI 10.1074/mcp.M400121-MCP200; Liang H, 1996, MOL BIOL CELL, V7, P1953, DOI 10.1091/mbc.7.12.1953; Lin FM, 2009, PROTEOMICS, V9, P5471, DOI 10.1002/pmic.200900100; Lin FM, 2009, APPL ENVIRON MICROB, V75, P3765, DOI 10.1128/AEM.02594-08; LIU H, 1989, CELL, V57, P233, DOI 10.1016/0092-8674(89)90961-6; Miyake T, 2004, J BIOL CHEM, V279, P34865, DOI 10.1074/jbc.M405156200; Mochida J, 2002, GENETICS, V160, P923; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Panek AD, 1975, APPL MICROBIOL BIOT, V2, P39; Pham TK, 2008, J PROTEOME RES, V7, P515, DOI 10.1021/pr070391h; R Development Core Team, 2012, R LANG ENV STAT COMP; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; Stoldt V, 1996, YEAST, V12, P523, DOI 10.1002/(SICI)1097-0061(199605)12:6<523::AID-YEA962>3.3.CO;2-3; Taherzadeh MJ, 1999, BIORESOURCE TECHNOL, V69, P59, DOI 10.1016/S0960-8524(98)00169-2; Taherzadeh MJ, 1999, J BIOSCI BIOENG, V87, P169, DOI 10.1016/S1389-1723(99)89007-0; Taherzadeh MJ, 1996, APPL MICROBIOL BIOT, V46, P176, DOI 10.1007/s002530050801; Taherzadeh MJ, 1997, IND ENG CHEM RES, V36, P4659, DOI 10.1021/ie9700831; Taherzadeh MJ, 2008, INT J MOL SCI, V9, P1621, DOI 10.3390/ijms9091621; Talebnia F, 2005, BIOTECHNOL BIOENG, V90, P345, DOI 10.1002/bit.20432; Talebnia F, 2007, ENZYME MICROB TECH, V41, P683, DOI 10.1016/j.enzmictec.2007.05.020; Talebnia F, 2006, J BIOTECHNOL, V125, P377, DOI 10.1016/j.jbiotec.2006.03.013; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Voit EO, 2003, J THEOR BIOL, V223, P55, DOI 10.1016/S0022-5193(03)00072-9; Westman JO, 2012, INT J MOL SCI, V13, P11881, DOI 10.3390/ijms130911881; Wu WW, 2006, J PROTEOME RES, V5, P651, DOI 10.1021/pr050405o; Ylitervo P, 2011, J BIOTECHNOL, V156, P22, DOI 10.1016/j.jbiotec.2011.07.018; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	47	18	19	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49335	10.1371/journal.pone.0049335	http://dx.doi.org/10.1371/journal.pone.0049335			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152898	Green Submitted, Green Published, gold			2022-12-27	WOS:000312272600058
J	Hirata, H; Yimin; Segawa, S; Ozaki, M; Kobayashi, N; Shigyo, T; Chiba, H				Hirata, Hiroshi; Yimin; Segawa, Shuichi; Ozaki, Moeko; Kobayashi, Naoyuki; Shigyo, Tatsuro; Chiba, Hitoshi			Xanthohumol Prevents Atherosclerosis by Reducing Arterial Cholesterol Content via CETP and Apolipoprotein E in CETP-Transgenic Mice	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; ESTER TRANSFER PROTEIN; LIPID TRANSFER PROTEIN; HDL; INHIBITION; EFFLUX; APOE	Background: Xanthohumol is expected to be a potent anti-atherosclerotic agent due to its inhibition of cholesteryl ester transfer protein (CETP). In this study, we hypothesized that xanthohumol prevents atherosclerosis in vivo and used CETP-transgenic mice (CETP-Tg mice) to evaluate xanthohumol as a functional agent. Methodology/Principal Findings: Two strains of mice, CETP-Tg and C57BL/6N (wild-type), were fed a high cholesterol diet with or without 0.05% (w/w) xanthohumol ad libitum for 18 weeks. In CETP-Tg mice, xanthohumol significantly decreased accumulated cholesterol in the aortic arch and increased HDL cholesterol (HDL-C) when compared to the control group (without xanthohumol). Xanthohumol had no significant effect in wild-type mice. CETP activity was significantly decreased after xanthohumol addition in CETP-Tg mice compared with the control group and it inversely correlated with HDL-C (%) (P<0.05). Furthermore, apolipoprotein E (apoE) was enriched in serum and the HDL-fraction in CETP-Tg mice after xanthohumol addition, suggesting that xanthohumol ameliorates reverse cholesterol transport via apoE-rich HDL resulting from CETP inhibition. Conclusions: Our results suggest xanthohumol prevents cholesterol accumulation in atherogenic regions by HDL-C metabolism via CETP inhibition leading to apoE enhancement.	[Chiba, Hitoshi] Hokkaido Univ, Sch Med, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido 060, Japan; [Hirata, Hiroshi; Segawa, Shuichi; Ozaki, Moeko; Kobayashi, Naoyuki; Shigyo, Tatsuro] Sapporo Breweries Ltd, Frontier Labs Value Creat, Yaizu, Shizuoka, Japan; [Yimin] Hokkaido Univ, Dept Adv Med, Grad Sch Med, Kita Ku, Sapporo, Hokkaido, Japan	Hokkaido University; Sapporo Holdings Limited; Hokkaido University	Chiba, H (corresponding author), Hokkaido Univ, Sch Med, Fac Hlth Sci, Kita Ku, Sapporo, Hokkaido 060, Japan.	chibahit@med.hokudai.ac.jp			Japan Society for the Promotion of Science; Sapporo Biocluster "Bio-S"; Sapporo Breweries Ltd.; Regional Innovation Cluster Program; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sapporo Biocluster "Bio-S"; Sapporo Breweries Ltd.; Regional Innovation Cluster Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and also by Sapporo Biocluster "Bio-S", the Regional Innovation Cluster Program, the Ministry of Education, Culture, Sports, Science and Technology, Japan. No additional external funding received for this study.; The authors have read the journal's policy and have the following conflicts: HH, SS, MO, NK and TS are employed by Sapporo Breweries Ltd. Sapporo Breweries Ltd also funded this study and provided the xanthohumol chemical. Sapporo Breweries Ltd. and Hokkaido University have a patent application on this study. The patent application numbers are JP2010/132005 and JP2011/525858. The authors also declare patent: Application number: JP2010/132005, Publication number: JP2011/256133, SR-B1, Protein Expression Enhancer. There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; BROWN ML, 1989, NATURE, V342, P448, DOI 10.1038/342448a0; BROWN MS, 1976, SCIENCE, V191, P150, DOI 10.1126/science.174194; Chiba H, 1997, J LIPID RES, V38, P1204; Clark RW, 2004, ARTERIOSCL THROM VAS, V24, P490, DOI 10.1161/01.ATV.0000118278.21719.17; Dorn C, 2010, MOL NUTR FOOD RES, V54, pS205, DOI 10.1002/mnfr.200900314; FOLCH J, 1957, J BIOL CHEM, V226, P497; GORDON T, 1977, AM J MED, V62, P707, DOI 10.1016/0002-9343(77)90874-9; Hambruch E, 2012, J PHARM EXP THER; Hirata H, 2012, FOOD CHEM, V134, P1432, DOI 10.1016/j.foodchem.2012.03.043; INAZU A, 1990, NEW ENGL J MED, V323, P1234, DOI 10.1056/NEJM199011013231803; Lewis GF, 2005, CIRC RES, V96, P1221, DOI 10.1161/01.RES.0000170946.56981.5c; Libby P, 2002, NAT MED, V8, P1257, DOI 10.1038/nm1102-1257; Mahley RW, 2006, J CLIN INVEST, V116, P1226, DOI 10.1172/JCI28632; MAROTTI KR, 1993, NATURE, V364, P73, DOI 10.1038/364073a0; Matsuura F, 2006, J CLIN INVEST, V116, P1435, DOI 10.1172/JCI27602; Nicholls Stephen J, 2011, Curr Cardiol Rep, V13, P537, DOI 10.1007/s11886-011-0223-0; Nozawa H, 2005, BIOCHEM BIOPH RES CO, V336, P754, DOI 10.1016/j.bbrc.2005.08.159; Okamoto H, 2000, NATURE, V406, P203, DOI 10.1038/35018119; QUINET E, 1991, J CLIN INVEST, V87, P1559, DOI 10.1172/JCI115169; Schwartz GG, 2012, CURR ATHEROSCLER REP, V14, P41, DOI 10.1007/s11883-011-0217-9; Spieker Lukas E., 2004, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V4, P51, DOI 10.2174/1568008043340044; Strathmann J, 2010, FASEB J, V24, P2938, DOI 10.1096/fj.10-155846; Tabata N, 1997, PHYTOCHEMISTRY, V46, P683, DOI 10.1016/S0031-9422(97)00157-X; TALL AR, 1993, J LIPID RES, V34, P1255; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P1430, DOI 10.1161/ATVBAHA.110.207142; Zhang B, 2004, ARTERIOSCL THROM VAS, V24, P1910, DOI 10.1161/01.ATV.0000143389.00252.bc; Zhang YQ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.083899	28	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49415	10.1371/journal.pone.0049415	http://dx.doi.org/10.1371/journal.pone.0049415			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166663	Green Published, gold, Green Submitted			2022-12-27	WOS:000311885300037
J	Dove, ADM; Leisen, J; Zhou, MS; Byrne, JJ; Lim-Hing, K; Webb, HD; Gelbaum, L; Viant, MR; Kubanek, J; Fernandez, FM				Dove, Alistair D. M.; Leisen, Johannes; Zhou, Manshui; Byrne, Jonathan J.; Lim-Hing, Krista; Webb, Harry D.; Gelbaum, Leslie; Viant, Mark R.; Kubanek, Julia; Fernandez, Facundo M.			Biomarkers of Whale Shark Health: A Metabolomic Approach	PLOS ONE			English	Article							RHINCODON-TYPUS; LEPTOGORGIA-VIRGULATA; MASS-SPECTROMETRY; DIVING BEHAVIOR; HOMARINE; MARINE; FISH; METABOLITES; ORGANISMS; ECOLOGY	In a search for biomarkers of health in whale sharks and as exploration of metabolomics as a modern tool for understanding animal physiology, the metabolite composition of serum in six whale sharks (Rhincodon typus) from an aquarium collection was explored using 1 H nuclear magnetic resonance (NMR) spectroscopy and direct analysis in real time (DART) mass spectrometry (MS). Principal components analysis (PCA) of spectral data showed that individual animals could be resolved based on the metabolite composition of their serum and that two unhealthy individuals could be discriminated from the remaining healthy animals. The major difference between healthy and unhealthy individuals was the concentration of homarine, here reported for the first time in an elasmobranch, which was present at substantially lower concentrations in unhealthy whale sharks, suggesting that this metabolite may be a useful biomarker of health status in this species. The function(s) of homarine in sharks remain uncertain but it likely plays a significant role as an osmolyte. The presence of trimethylamine oxide (TMAO), another well-known protective osmolyte of elasmobranchs, at 0.1-0.3 mol L-1 was also confirmed using both NMR and MS. Twenty-three additional potential biomarkers were identified based on significant differences in the frequency of their occurrence between samples from healthy and unhealthy animals, as detected by DART MS. Overall, NMR and MS provided complementary data that showed that metabolomics is a useful approach for biomarker prospecting in poorly studied species like elasmobranchs.	[Dove, Alistair D. M.; Webb, Harry D.] Georgia Aquarium, Georgia Aquarium Res Ctr, Atlanta, GA USA; [Leisen, Johannes; Zhou, Manshui; Gelbaum, Leslie; Kubanek, Julia; Fernandez, Facundo M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Byrne, Jonathan J.; Viant, Mark R.] Univ Birmingham, Sch Biosci, NERC Biomol Anal Facil Metabol Node NBAF B, Birmingham, W Midlands, England; [Lim-Hing, Krista; Kubanek, Julia] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); University of Birmingham; University System of Georgia; Georgia Institute of Technology	Dove, ADM (corresponding author), Georgia Aquarium, Georgia Aquarium Res Ctr, Atlanta, GA USA.	adove@georgiaaquarium.org	Dove, Alistair D.M./AAN-6738-2020; Fernandez, Facundo Martin/B-7015-2008; Viant, Mark R/B-6339-2009; Dove, Alistair/D-1173-2013	Dove, Alistair D.M./0000-0003-3239-4772; Fernandez, Facundo Martin/0000-0002-0302-2534; Viant, Mark R/0000-0001-5898-4119; leisen, johannes/0000-0003-0474-670X; Kubanek, Julia/0000-0003-4482-1831	Conservation, Research and Animal Care Committee at Georgia Aquarium; Georgia Tech's NSF; NSF [OCE-0726689, OCE-1060300]; Natural Environment Research Council (NERC) [R8-H10-61]; NERC [NBAF010004] Funding Source: UKRI; Division Of Ocean Sciences [1060300] Funding Source: National Science Foundation; Natural Environment Research Council [NBAF010004] Funding Source: researchfish	Conservation, Research and Animal Care Committee at Georgia Aquarium; Georgia Tech's NSF; NSF(National Science Foundation (NSF)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Major financial support for this project came from the Conservation, Research and Animal Care Committee at Georgia Aquarium. Additional support came from Georgia Tech's NSF undergraduate research program in mathematical biology for KLH, from NSF grant OCE-0726689 to JK, NSF grant OCE-1060300 to J.K. and F. M. F., and from the Natural Environment Research Council (NERC) contract R8-H10-61 to MRV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello A, 1996, BIOCHEM SYST ECOL, V24, P521, DOI 10.1016/0305-1978(96)00058-0; Bandaranayake WM, 1999, MAR BIOL, V133, P163, DOI 10.1007/s002270050455; BERKING S, 1987, DEVELOPMENT, V99, P211; Bocchetti R, 2008, MAR ENVIRON RES, V66, P99; Brunnschweiler JM, 2009, J FISH BIOL, V74, P706, DOI 10.1111/j.1095-8649.2008.02155.x; Carr WES, 1996, BIOL BULL, V190, P149, DOI 10.2307/1542535; Colman JG, 1997, J FISH BIOL, V51, P1219, DOI 10.1111/j.1095-8649.1997.tb01138.x; DALL W, 1971, COMP BIOCHEM PHYSIOL, V39, P31, DOI 10.1016/0305-0491(71)90250-1; De la Parra Venegas R, 2011, PLOS ONE UNPUB; Dove ADM, 2010, P 2 US RUSS BIL C AQ; Dove ADM, 2010, AQUAT BIOL, V9, P177, DOI 10.3354/ab00252; GASTEIGER EL, 1960, ANN NY ACAD SCI, V90, P622, DOI 10.1111/j.1749-6632.1960.tb26410.x; Graham RT, 2006, J ROY SOC INTERFACE, V3, P109, DOI 10.1098/rsif.2005.0082; Harris GA, 2010, J AM SOC MASS SPECTR, V21, P855, DOI 10.1016/j.jasms.2010.01.019; Hines A, 2007, ENVIRON SCI TECHNOL, V41, P3375, DOI 10.1021/es062745w; ITO Y, 1994, COMP BIOCHEM PHYS B, V109, P115, DOI 10.1016/0305-0491(94)90148-1; Karsten AH, 2004, MAR ENVIRON RES, V58, P747, DOI 10.1016/j.marenvres.2004.03.089; Keller MD, 2004, CAN J FISH AQUAT SCI, V61, P685, DOI 10.1139/F04-058; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Martin RA, 2007, FISH RES, V84, P10, DOI 10.1016/j.fishres.2006.11.010; MCCLINTOCK JB, 1994, J CHEM ECOL, V20, P2539, DOI 10.1007/BF02036190; Merino M, 1997, J MARINE SYST, V13, P101, DOI 10.1016/S0924-7963(96)00123-6; Miller RA, 2007, J CHROMATOGR B, V852, P655, DOI 10.1016/j.jchromb.2007.01.040; Polychronopoulos P, 2001, NAT PROD LETT, V15, P411, DOI 10.1080/10575630108041311; Robertson DG, 2005, TOXICOL SCI, V85, P809, DOI 10.1093/toxsci/kfi102; Rosenblum ES, 2006, ENVIRON SCI TECHNOL, V40, P7077, DOI 10.1021/es061354e; Samuelsson LM, 2006, AQUAT TOXICOL, V78, P341, DOI 10.1016/j.aquatox.2006.04.008; Shapo JL, 2007, COMP BIOCHEM PHYS B, V148, P65, DOI 10.1016/j.cbpb.2007.04.019; SHINAGAWA A, 1995, CRUSTACEANA, V68, P129, DOI 10.1163/156854095X00016; Shirai T, 1997, FISHERIES SCI, V63, P939, DOI 10.2331/fishsci.63.939; Slattery M, 1997, MAR ECOL PROG SER, V161, P133, DOI 10.3354/meps161133; Sole M, 2008, SCI TOTAL ENVIRON, V402, P306, DOI 10.1016/j.scitotenv.2008.04.041; Sole M, 2010, MAR ENVIRON RES, V70, P181, DOI 10.1016/j.marenvres.2010.04.008; Stevens JD, 2007, FISH RES, V84, P4, DOI 10.1016/j.fishres.2006.11.008; TARGETT NM, 1983, J CHEM ECOL, V9, P817, DOI 10.1007/BF00987807; Treberg JR, 2006, J EXP BIOL, V209, P860, DOI 10.1242/jeb.02055; Ulrich EL, 2008, NUCLEIC ACIDS RES, V36, pD402, DOI 10.1093/nar/gkm957; Viana TP, 2008, MAR ENVIRON RES, V66, P171; Viant MR, 2007, MAR ECOL PROG SER, V332, P301, DOI 10.3354/meps332301; Viant MR, 2003, BIOCHEM BIOPH RES CO, V310, P943, DOI 10.1016/j.bbrc.2003.09.092; Wishart DS, 2009, NUCLEIC ACIDS RES, V37, pD603, DOI 10.1093/nar/gkn810; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; Zhou M, 2010, J AM SOC MASS SPECTR, V21, P68, DOI 10.1016/j.jasms.2009.09.004; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	44	31	31	1	107	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49379	10.1371/journal.pone.0049379	http://dx.doi.org/10.1371/journal.pone.0049379			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166652	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300040
J	Kasza, I; Varady, G; Andrikovics, H; Koszarska, M; Tordai, A; Scheffer, GL; Nemeth, A; Szakacs, G; Sarkadi, B				Kasza, Ildiko; Varady, Gyoergy; Andrikovics, Hajnalka; Koszarska, Magdalena; Tordai, Attila; Scheffer, George L.; Nemeth, Adrienn; Szakacs, Gergely; Sarkadi, Balazs			Expression Levels of the ABCG2 Multidrug Transporter in Human Erythrocytes Correspond to Pharmacologically Relevant Genetic Variations	PLOS ONE			English	Article							CANCER RESISTANCE PROTEIN; MONOCLONAL-ANTIBODY; DRUG-RESISTANCE; PLASMA-MEMBRANE; HUMAN TISSUES; NULL ALLELES; POLYMORPHISMS; PHARMACOKINETICS; BCRP/ABCG2; VARIANTS	We have developed a rapid, simple and reliable, antibody-based flow cytometry assay for the quantitative determination of membrane proteins in human erythrocytes. Our method reveals significant differences between the expression levels of the wild-type ABCG2 protein and the heterozygous Q141K polymorphic variant. Moreover, we find that nonsense mutations on one allele result in a 50% reduction in the erythrocyte expression of this protein. Since ABCG2 polymorphisms are known to modify essential pharmacokinetic parameters, uric acid metabolism and cancer drug resistance, a direct determination of the erythrocyte membrane ABCG2 protein expression may provide valuable information for assessing these conditions or for devising drug treatments. Our findings suggest that erythrocyte membrane protein levels may reflect genotype-dependent tissue expression patterns. Extension of this methodology to other disease-related or pharmacologically important membrane proteins may yield new protein biomarkers for personalized diagnostics.	[Kasza, Ildiko; Varady, Gyoergy; Sarkadi, Balazs] Semmelweis Univ, Hungarian Acad Sci, Membrane Res Grp, H-1085 Budapest, Hungary; [Kasza, Ildiko; Varady, Gyoergy; Nemeth, Adrienn] CellPharma Kft, Budapest, Hungary; [Andrikovics, Hajnalka; Koszarska, Magdalena; Tordai, Attila; Sarkadi, Balazs] Hungarian Natl Blood Transfus Serv, Budapest, Hungary; [Scheffer, George L.] Free Univ Med Ctr, Amsterdam, Netherlands; [Varady, Gyoergy; Szakacs, Gergely; Sarkadi, Balazs] Hungarian Acad Sci, Inst Mol Pharmacol, Budapest, Hungary; [Varady, Gyoergy; Szakacs, Gergely; Sarkadi, Balazs] Hungarian Acad Sci, Inst Enzymol, Res Ctr Nat Sci, Budapest, Hungary	Hungarian Academy of Sciences; Semmelweis University; Vrije Universiteit Amsterdam; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences	Sarkadi, B (corresponding author), Semmelweis Univ, Hungarian Acad Sci, Membrane Res Grp, H-1085 Budapest, Hungary.	sarkadi@biomembrane.hu	György, Várady/J-8118-2017; Sarkadi, Balazs/I-5024-2013; Szakacs, Gergely/A-2580-2009	Szakacs, Gergely/0000-0002-9311-7827	OTKA (Hungarian: National Scientific Research Fund) [NK83533]; KMOP (The Central Hungary Region Operational Programme) [1.1.2 07/1 2008 0003]; Hungarian Academy of Sciences	OTKA (Hungarian: National Scientific Research Fund)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); KMOP (The Central Hungary Region Operational Programme); Hungarian Academy of Sciences(Hungarian Academy of Sciences)	This work has been supported by grants from OTKA (Hungarian: National Scientific Research Fund) NK83533 and KMOP (The Central Hungary Region Operational Programme) 1.1.2 07/1 2008 0003. Gergely Szakacs is supported by the Lendulet grant from the Hungarian Academy of Sciences. Hajnalka Andrikovics is a recipient of the Janos Bolyai Research Scholarship from the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka K, 2010, CANCER CHEMOTH PHARM, V66, P691, DOI 10.1007/s00280-009-1211-6; Alexandre BM, 2010, EXPERT REV PROTEOMIC, V7, P165, DOI 10.1586/EPR.09.96; Allen JD, 2002, MOL CANCER THER, V1, P427; Basseville Agnes, 2011, F1000 Biol Rep, V3, P23, DOI 10.3410/B3-23; Caride AJ, 1996, BIOCHEM J, V316, P353, DOI 10.1042/bj3160353; Cervenak J, 2006, CANCER LETT, V234, P62, DOI 10.1016/j.canlet.2005.01.061; Cotte S, 2009, BRAIN, V132, P2517, DOI 10.1093/brain/awp164; Cusatis G, 2008, PHARMACOGENOMICS, V9, P1005, DOI 10.2217/14622416.9.8.1005; Cusatis G, 2006, J NATL CANCER I, V98, P1739, DOI 10.1093/jnci/djj469; de Wolf CJF, 2007, FEBS J, V274, P439, DOI 10.1111/j.1742-4658.2006.05591.x; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Fischer S, 2007, SCAND J GASTROENTERO, V42, P726, DOI 10.1080/00365520601101559; Furukawa T, 2009, PHARM RES-DORDR, V26, P469, DOI 10.1007/s11095-008-9752-7; Gardner ER, 2006, CLIN PHARMACOL THER, V80, P192, DOI 10.1016/j.clpt.2006.05.003; Goodman SR, 2007, EXP BIOL MED, V232, P1391, DOI 10.3181/0706-MR-156; Hegedus C, 2009, BRIT J PHARMACOL, V158, P1153, DOI 10.1111/j.1476-5381.2009.00383.x; Honjo Y, 2002, CANCER BIOL THER, V1, P696, DOI 10.4161/cbt.322; Ichida K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1756; Imai Y, 2002, MOL CANCER THER, V1, P611; Ishikawa T, 2010, ADV PHARMACOL SCI, V2010, DOI 10.1155/2010/587306; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kobayashi D, 2005, DRUG METAB DISPOS, V33, P94, DOI 10.1124/dmd.104.001628; Kondo C, 2004, PHARM RES-DORDR, V21, P1895, DOI 10.1023/B:PHAM.0000045245.21637.d4; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2006, ANNU REV PHARMACOL, V46, P381, DOI 10.1146/annurev.pharmtox.46.120604.141238; Leimanis ML, 2007, BIOCHEM BIOPH RES CO, V354, P345, DOI 10.1016/j.bbrc.2006.12.219; Li J, 2007, CANCER BIOL THER, V6, P432, DOI 10.4161/cbt.6.3.3763; Li N, 2009, ANAL CHEM, V81, P2251, DOI 10.1021/ac8024009; Maliepaard M, 2001, CANCER RES, V61, P3458; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Mizuarai S, 2004, INT J CANCER, V109, P238, DOI 10.1002/ijc.11669; Morisaki K, 2005, CANCER CHEMOTH PHARM, V56, P161, DOI 10.1007/s00280-004-0931-x; Nakagawa H, 2011, J PHARM SCI-US, V100, P3602, DOI 10.1002/jps.22615; Ozvegy-Laczka C, 2008, J BIOL CHEM, V283, P26059, DOI 10.1074/jbc.M803230200; Pasini EM, 2006, BLOOD, V108, P791, DOI 10.1182/blood-2005-11-007799; Pasini EM, 2010, J PROTEOMICS, V73, P403, DOI 10.1016/j.jprot.2009.06.005; Robey RW, 2007, CANCER METAST REV, V26, P39, DOI 10.1007/s10555-007-9042-6; Robey RW, 2011, CURR PHARM BIOTECHNO, V12, P595; Saison C, 2012, NAT GENET, V44, P174, DOI 10.1038/ng.1070; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Scheffer GL, 2000, CANCER RES, V60, P2589; Sissung TM, 2010, MOL BIOTECHNOL, V44, P152, DOI 10.1007/s12033-009-9220-6; Sparreboom A, 2004, CLIN PHARMACOL THER, V76, P38, DOI 10.1016/j.clpt.2004.03.003; Szakacs G, 2008, DRUG DISCOV TODAY, V13, P379, DOI 10.1016/j.drudis.2007.12.010; Tamura A, 2007, DRUG METAB PHARMACOK, V22, P428, DOI 10.2133/dmpk.22.428; Warren RB, 2008, J INVEST DERMATOL, V128, P1925, DOI 10.1038/jid.2008.16; Yang QO, 2010, CIRC-CARDIOVASC GENE, V3, P523, DOI 10.1161/CIRCGENETICS.109.934455; Zelinski T, 2012, NAT GENET, V44, P131, DOI 10.1038/ng.1075; Zhou S, 2005, BLOOD, V105, P2571, DOI 10.1182/blood-2004-04-1566	50	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48423	10.1371/journal.pone.0048423	http://dx.doi.org/10.1371/journal.pone.0048423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166586	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300007
J	Peltola, T; Marttinen, P; Vehtari, A				Peltola, Tomi; Marttinen, Pekka; Vehtari, Aki			Finite Adaptation and Multistep Moves in the Metropolis-Hastings Algorithm for Variable Selection in Genome-Wide Association Analysis	PLOS ONE			English	Article							MARKOV-CHAINS; REGRESSION; SEARCH	High-dimensional datasets with large amounts of redundant information are nowadays available for hypothesis-free exploration of scientific questions. A particular case is genome-wide association analysis, where variations in the genome are searched for effects on disease or other traits. Bayesian variable selection has been demonstrated as a possible analysis approach, which can account for the multifactorial nature of the genetic effects in a linear regression model. Yet, the computation presents a challenge and application to large-scale data is not routine. Here, we study aspects of the computation using the Metropolis-Hastings algorithm for the variable selection: finite adaptation of the proposal distributions, multistep moves for changing the inclusion state of multiple variables in a single proposal and multistep move size adaptation. We also experiment with a delayed rejection step for the multistep moves. Results on simulated and real data show increase in the sampling efficiency. We also demonstrate that with application specific proposals, the approach can overcome a specific mixing problem in real data with 3822 individuals and 1,051,811 single nucleotide polymorphisms and uncover a variant pair with synergistic effect on the studied trait. Moreover, we illustrate multimodality in the real dataset related to a restrictive prior distribution on the genetic effect sizes and advocate a more flexible alternative.	[Peltola, Tomi; Vehtari, Aki] Aalto Univ, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Marttinen, Pekka] Aalto Univ, Dept Informat & Comp Sci, Espoo, Finland	Aalto University; Aalto University	Peltola, T (corresponding author), Aalto Univ, Dept Biomed Engn & Computat Sci, Espoo, Finland.	tomi.peltola@aalto.fi	Vehtari, Aki/A-7584-2008; Marttinen, Pekka E/N-6234-2015	Vehtari, Aki/0000-0003-2164-9469; Marttinen, Pekka E/0000-0001-7078-7927	Finnish Doctoral Programme in Computational Sciences FICS; Academy of Finland [218248, 129230]	Finnish Doctoral Programme in Computational Sciences FICS; Academy of Finland(Academy of Finland)	This work was supported by the Finnish Doctoral Programme in Computational Sciences FICS (http://fics.hiit.fi/; TP); and the Academy of Finland (http://www.aka.fi/; grant 218248 to AV, and Pubgensens project grant 129230 to AV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottolo L, 2010, BAYESIAN ANAL, V5, P583, DOI 10.1214/10-BA523; Clyde MA, 2011, J COMPUT GRAPH STAT, V20, P80, DOI 10.1198/jcgs.2010.09049; GELMAN A, 2004, BAYESIAN DATA ANAL, P294; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Geyer C. J., 1992, STAT SCI, V7, P473, DOI [10.1214/ss/1177011137, DOI 10.1214/SS/1177011137]; Green PJ, 2001, BIOMETRIKA, V88, P1035, DOI 10.1093/biomet/88.4.1035; Guan YT, 2011, ANN APPL STAT, V5, P1780, DOI 10.1214/11-AOAS455; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; Hindorff L, 2012, CATALOG PUBLISHED GE; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Kohn R, 2001, STAT COMPUT, V11, P313, DOI 10.1023/A:1011916902934; Lamnisos D, 2011, TECHNICAL REPORT; Lamnisos D, 2009, J COMPUT GRAPH STAT, V18, P592, DOI 10.1198/jcgs.2009.08027; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mira A., 2001, METRON, V59, P231; Nott DJ, 2005, BIOMETRIKA, V92, P747, DOI 10.1093/biomet/92.4.747; Pasarica C, 2010, STAT SINICA, V20, P343; Peltola T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029115; Perttila J, 2009, J MOL MED, V87, P825, DOI 10.1007/s00109-009-0490-z; PESKUN PH, 1973, BIOMETRIKA, V60, P607; Richardson S, 1997, J ROY STAT SOC B MET, V59, P731, DOI 10.1111/1467-9868.00095; Storvik G, 2011, SCAND J STAT, V38, P342, DOI 10.1111/j.1467-9469.2010.00709.x; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Wilson MA, 2010, ANN APPL STAT, V4, P1342, DOI 10.1214/09-AOAS322	26	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49445	10.1371/journal.pone.0049445	http://dx.doi.org/10.1371/journal.pone.0049445			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166669	Green Submitted, gold, Green Published			2022-12-27	WOS:000311272300044
J	Swaminathan, A; Barnes, VL; Fox, S; Gammouh, S; Pile, LA				Swaminathan, Aishwarya; Barnes, Valerie L.; Fox, Stephanie; Gammouh, Sarah; Pile, Lori A.			Identification of Genetic Suppressors of the Sin3A Knockdown Wing Phenotype	PLOS ONE			English	Article							MEDIATOR COMPLEX SUBUNITS; DROSOPHILA CYCLIN-A; RNA-POLYMERASE-II; CELL-CYCLE; TRANSCRIPTION FACTORS; HISTONE DEACETYLASE; COACTIVATOR COMPLEX; SIGNALING PATHWAY; EYE-GONE; PROTEIN	The role of the Sin3A transcriptional corepressor in regulating the cell cycle is established in various metazoans. Little is known, however, about the signaling pathways that trigger or are triggered by Sin3A function. To discover genes that work in similar or opposing pathways to Sin3A during development, we have performed an unbiased screen of deficiencies of the Drosophila third chromosome. Additionally, we have performed a targeted loss of function screen to identify cell cycle genes that genetically interact with Sin3A. We have identified genes that encode proteins involved in regulation of gene expression, signaling pathways and cell cycle that can suppress the curved wing phenotype caused by the knockdown of Sin3A. These data indicate that Sin3A function is quite diverse and impacts a wide variety of cellular processes.	[Barnes, Valerie L.; Fox, Stephanie; Gammouh, Sarah; Pile, Lori A.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Swaminathan, Aishwarya] Univ Massachusetts, Dept Microbiol, Amherst, MA 01003 USA	Wayne State University; University of Massachusetts System; University of Massachusetts Amherst	Pile, LA (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	loripile@wayne.edu	Swaminathan, Aishwarya/I-4242-2019	Swaminathan, Aishwarya/0000-0001-9082-502X	Wayne State University Department of Biological Sciences Graduate Student Enhancement Fund; American Cancer Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084947] Funding Source: NIH RePORTER	Wayne State University Department of Biological Sciences Graduate Student Enhancement Fund; American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding sources include the following: Wayne State University Department of Biological Sciences Graduate Student Enhancement Fund to AS, and a Research Scholar Grant from the American Cancer Society to LAP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Y, 1998, CELL, V93, P1171, DOI 10.1016/S0092-8674(00)81461-0; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Aldaz S, 2003, DEVELOPMENT, V130, P4473, DOI 10.1242/dev.00643; Amoros M, 2002, INT J DEV BIOL, V46, P321; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Aoyagi N, 2000, J CELL BIOL, V150, pF45, DOI 10.1083/jcb.150.2.F45; Aoyagi N, 2001, MOL CELL BIOL, V21, P6808, DOI 10.1128/MCB.21.20.6808-6819.2001; Bach I, 1999, NAT GENET, V22, P394, DOI 10.1038/11970; Bahri SM, 2001, MECH DEVELOP, V100, P291, DOI 10.1016/S0925-4773(00)00539-6; Baltus GA, 2009, J BIOL CHEM, V284, P6998, DOI 10.1074/jbc.M807670200; Bandura JL, 2005, CURR BIOL, V15, P755, DOI 10.1016/j.cub.2005.02.063; Barnes VL, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-26; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Bejarano F, 2008, GENETICS, V178, P307, DOI 10.1534/genetics.107.081869; Beltran S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r67; Blanco E, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-94; Bond D, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000655; Boube M, 2000, GENE DEV, V14, P2906, DOI 10.1101/gad.17900; Boulanger MC, 2004, BIOCHEM J, V379, P283, DOI 10.1042/BJ20031176; Cakouros D, 2004, J BIOL CHEM, V279, P18467, DOI 10.1074/jbc.M400972200; Cao W, 2008, GENETICS, V178, P1457, DOI 10.1534/genetics.107.078394; Carreira VP, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-32; Carrera I, 2008, P NATL ACAD SCI USA, V105, P6644, DOI 10.1073/pnas.0709749105; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Collins RT, 1999, EMBO J, V18, P7029, DOI 10.1093/emboj/18.24.7029; COTTERILL S, 1992, NUCLEIC ACIDS RES, V20, P4325, DOI 10.1093/nar/20.16.4325; Cowley SM, 2005, MOL CELL BIOL, V25, P6990, DOI 10.1128/MCB.25.16.6990-7004.2005; Cravatt BF, 2002, CHEM PHYS LIPIDS, V121, P135, DOI 10.1016/S0009-3084(02)00147-0; Dannenberg JH, 2005, GENE DEV, V19, P1581, DOI 10.1101/gad.1286905; DasGupta R, 2005, SCIENCE, V308, P826, DOI 10.1126/science.1109374; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Du W, 1999, EMBO J, V18, P916, DOI 10.1093/emboj/18.4.916; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; Gildea JJ, 2000, GENETICS, V156, P645; Grandinetti KB, 2008, CELL CYCLE, V7, P1550, DOI 10.4161/cc.7.11.6052; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; HAMILTON BJ, 1993, GENETICS, V134, P517; HECHT PM, 1993, GENETICS, V135, P405; Hendriksen J, 2005, J CELL BIOL, V171, P785, DOI 10.1083/jcb.200502141; Hoyt MA, 1997, CELL, V91, P149, DOI 10.1016/S0092-8674(00)80396-7; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522; Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925; Jun S, 1998, P NATL ACAD SCI USA, V95, P13720, DOI 10.1073/pnas.95.23.13720; Kategaya LS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006129; Kavi Harsh H, 2009, BMC Res Notes, V2, P217, DOI 10.1186/1756-0500-2-217; Kiger JA, 2007, DEV BIOL, V301, P178, DOI 10.1016/j.ydbio.2006.08.011; Kim YO, 2004, P NATL ACAD SCI USA, V101, P159, DOI 10.1073/pnas.0307205101; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Kolonin MG, 2000, DEV BIOL, V227, P661, DOI 10.1006/dbio.2000.9916; Lagarou A, 2008, GENE DEV, V22, P2799, DOI 10.1101/gad.484208; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; Lee YS, 2009, NAT CELL BIOL, V11, P1150, DOI 10.1038/ncb1930; Legent K, 2006, GENES CELLS, V11, P907, DOI 10.1111/j.1365-2443.2006.00993.x; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; LEHNER CF, 1990, EMBO J, V9, P3573, DOI 10.1002/j.1460-2075.1990.tb07568.x; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Li L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001221; Lin TY, 1996, DEVELOPMENT, V122, P1331; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loncle N, 2007, EMBO J, V26, P1045, DOI 10.1038/sj.emboj.7601566; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Ma J, 2002, INSECT MOL BIOL, V11, P627, DOI 10.1046/j.1365-2583.2002.00374.x; Malik S, 2010, NAT REV GENET, V11, P761, DOI 10.1038/nrg2901; Martin-Castellanos C, 2002, DEVELOPMENT, V129, P1003; Matsushima Y, 2004, J BIOL CHEM, V279, P26900, DOI 10.1074/jbc.M401643200; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; McQuilton P., 2012, NUCLEIC ACIDS RES, V40, P29; Miotto B, 2006, GENE DEV, V20, P101, DOI 10.1101/gad.359506; Missirlis F, 2007, GENETICS, V177, P89, DOI 10.1534/genetics.107.075150; Mohan M, 2010, GENE DEV, V24, P574, DOI 10.1101/gad.1898410; Molnar C, 2006, GENETICS, V174, P1635, DOI 10.1534/genetics.106.061283; Mottus R, 2000, GENETICS, V154, P657; Mummery-Widmer JL, 2009, NATURE, V458, P987, DOI 10.1038/nature07936; Muratoglu S, 2003, MOL CELL BIOL, V23, P306, DOI 10.1128/MCB.23.1.306-321.2003; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Neufeld TP, 1998, GENETICS, V148, P277; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Neumuller RA, 2011, CELL STEM CELL, V8, P580, DOI 10.1016/j.stem.2011.02.022; Pankotai T, 2010, MOL GENET GENOMICS, V283, P89, DOI 10.1007/s00438-009-0499-6; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Pennetta G, 1998, DEV GENES EVOL, V208, P531, DOI 10.1007/s004270050212; Pile LA, 2000, EMBO J, V19, P6131, DOI 10.1093/emboj/19.22.6131; Pile LA, 2003, J BIOL CHEM, V278, P37840, DOI 10.1074/jbc.M305996200; Pile LA, 2002, MOL CELL BIOL, V22, P4965, DOI 10.1128/MCB.22.14.4965-4976.2002; Pile LA, 2001, CELL MOL LIFE SCI, V58, P1715, DOI 10.1007/PL00000809; Qi D, 2004, MOL CELL BIOL, V24, P8080, DOI 10.1128/MCB.24.18.8080-8089.2004; Raisin S, 2003, GENETICS, V164, P1015; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Ren N, 2005, GENETICS, V171, P625, DOI 10.1534/genetics.105.043687; RIPOLL P, 1985, CELL, V41, P907, DOI 10.1016/S0092-8674(85)80071-4; Royzman I, 1997, GENE DEV, V11, P1999, DOI 10.1101/gad.11.15.1999; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Sachs LM, 2001, INT J MOL MED, V8, P595; SCHONBAUM CP, 1992, DEV BIOL, V151, P431, DOI 10.1016/0012-1606(92)90183-H; Schweizer L, 2003, P NATL ACAD SCI USA, V100, P5846, DOI 10.1073/pnas.1037533100; Seeds AM, 2004, J BIOL CHEM, V279, P47222, DOI 10.1074/jbc.M408295200; Sepp KJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000111; Sharma V, 2008, DEV DYNAM, V237, P3040, DOI 10.1002/dvdy.21706; SHEARN A, 1971, P NATL ACAD SCI USA, V68, P2594, DOI 10.1073/pnas.68.10.2594; Smith ER, 1998, NUCLEIC ACIDS RES, V26, P2948, DOI 10.1093/nar/26.12.2948; Spain MM, 2010, J BIOL CHEM, V285, P27457, DOI 10.1074/jbc.M110.130245; Stivers C, 2000, MECH DEVELOP, V97, P205, DOI 10.1016/S0925-4773(00)00409-3; Su Y, 1997, EUR J BIOCHEM, V248, P231, DOI 10.1111/j.1432-1033.1997.t01-1-00231.x; Swaminathan A, 2010, MECH DEVELOP, V127, P96, DOI 10.1016/j.mod.2009.10.003; Terriente-Felix A, 2010, GENETICS, V185, P671, DOI 10.1534/genetics.109.113670; Terriente-Felix A, 2009, DEV BIOL, V329, P350, DOI 10.1016/j.ydbio.2009.03.010; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tsuda M, 2006, FEBS LETT, V580, P3296, DOI 10.1016/j.febslet.2006.05.005; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Weake VM, 2011, GENE DEV, V25, P1499, DOI 10.1101/gad.2046211; Weber KE, 2008, GENETICS, V178, P1093, DOI 10.1534/genetics.107.078014; WHITFIELD WGF, 1990, EMBO J, V9, P2563, DOI 10.1002/j.1460-2075.1990.tb07437.x; YOKOMORI K, 1993, GENE DEV, V7, P2235, DOI 10.1101/gad.7.11.2235; Yuan CX, 1998, P NATL ACAD SCI USA, V95, P7939, DOI 10.1073/pnas.95.14.7939; Zielke N, 2008, GENE DEV, V22, P1690, DOI 10.1101/gad.469108	120	6	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49563	10.1371/journal.pone.0049563	http://dx.doi.org/10.1371/journal.pone.0049563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166712	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300054
J	Armstrong, H; Wolmarans, A; Mercier, R; Mai, B; LaPointe, P				Armstrong, Heather; Wolmarans, Annemarie; Mercier, Rebecca; Mai, BaoChan; LaPointe, Paul			The Co-Chaperone Hch1 Regulates Hsp90 Function Differently than Its Homologue Aha1 and Confers Sensitivity to Yeast to the Hsp90 Inhibitor NVP-AUY922	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE HSP90; MOLECULAR CHAPERONE; COCHAPERONE AHA1; MIDDLE DOMAIN; ATP BINDING; IN-VIVO; ANTITUMOR-ACTIVITY; ESSENTIAL PROTEIN; EXPRESSION; COMPLEX	Hsp90 is a dimeric ATPase responsible for the activation or maturation of a specific set of substrate proteins termed 'clients'. This molecular chaperone acts in the context of a structurally dynamic and highly regulated cycle involving ATP, co-chaperone proteins and clients. Co-chaperone proteins regulate conformational transitions that may be impaired in mutant forms of Hsp90. We report here that the in vivo impairment of commonly studied Hsp90 variants harbouring the G313S or A587T mutation are exacerbated by the co-chaperone Hch1p. Deletion of HCH1, but not AHA1, mitigates the temperature sensitive phenotype and high sensitivity to Hsp90 inhibitor drugs observed in Saccharomyces cerevisiae that express either of these two Hsp90 variants. Moreover, the deletion of HCH1 results in high resistance to Hsp90 inhibitors in yeast that express wildtype Hsp90. Conversely, the overexpression of Hch1p greatly increases sensitivity to Hsp90 inhibition in yeast expressing wildtype Hsp90. We conclude that despite the similarity between these two co-chaperones, Hch1p and Aha1p regulate Hsp90 function in distinct ways and likely independent of their roles as ATPase stimulators. We further conclude that Hch1p plays a critical role in regulating Hsp90 inhibitor drug sensitivity in yeast.	[Armstrong, Heather; Wolmarans, Annemarie; Mercier, Rebecca; Mai, BaoChan; LaPointe, Paul] Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB, Canada	University of Alberta	Armstrong, H (corresponding author), Univ Alberta, Fac Med & Dent, Dept Cell Biol, Edmonton, AB, Canada.	paul.lapointe@ualberta.ca		Armstrong, Heather/0000-0003-3991-9201; LaPointe, Paul/0000-0002-5465-1795	Canadian Institutes of Health Research [97870] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; Ansar S, 2007, BIOORG MED CHEM LETT, V17, P1984, DOI 10.1016/j.bmcl.2007.01.017; BARDWELL JCA, 1988, J BACTERIOL, V170, P2977, DOI 10.1128/jb.170.7.2977-2983.1988; Barral JM, 2004, SEMIN CELL DEV BIOL, V15, P17, DOI 10.1016/j.semcdb.2003.12.010; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; BORKOVICH KA, 1989, MOL CELL BIOL, V9, P3919, DOI 10.1128/MCB.9.9.3919; Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318; Citri A, 2004, EMBO REP, V5, P1165, DOI 10.1038/sj.embor.7400300; Citri A, 2004, CELL CYCLE, V3, P51; Cox MB, 2004, CELL STRESS CHAPERON, V9, P4, DOI 10.1379/1466-1268(2004)009<0004:COHSPA>2.0.CO;2; Eccles SA, 2008, CANCER RES, V68, P2850, DOI 10.1158/0008-5472.CAN-07-5256; EVAN GI, 1985, MOL CELL BIOL, V5, P3610, DOI 10.1128/MCB.5.12.3610; Flom G, 2006, GENETICS, V172, P41, DOI 10.1534/genetics.105.045815; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Hawle P, 2006, MOL CELL BIOL, V26, P8385, DOI 10.1128/MCB.02188-05; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Jensen MR, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1996; Johnson JL, 2007, MOL CELL BIOL, V27, P768, DOI 10.1128/MCB.01034-06; JOHNSON JL, 1995, MOL ENDOCRINOL, V9, P670, DOI 10.1210/me.9.6.670; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Koulov AV, 2010, MOL BIOL CELL, V21, P871, DOI 10.1091/mbc.E09-12-1017; Krukenberg KA, 2011, Q REV BIOPHYS, V44, P229, DOI 10.1017/S0033583510000314; Lee CT, 2012, EMBO J; Li J, 2011, BIOCH BIOPHYS ACTA; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Lotz GP, 2003, J BIOL CHEM, V278, P17228, DOI 10.1074/jbc.M212761200; Meyer P, 2004, EMBO J, V23, P1402, DOI 10.1038/sj.emboj.7600141; Millson SH, 2008, BIOCHEM J, V413, P261, DOI 10.1042/BJ20080105; Mollapour M, 2011, MOL CELL, V41, P672, DOI 10.1016/j.molcel.2011.02.011; Mollapour M, 2010, MOL CELL, V37, P333, DOI 10.1016/j.molcel.2010.01.005; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Nathan DF, 1999, P NATL ACAD SCI USA, V96, P1409, DOI 10.1073/pnas.96.4.1409; NATHAN DF, 1995, MOL CELL BIOL, V15, P3917; Nimmanapalli R, 2003, CANCER RES, V63, P5126; Obermann WMJ, 1998, J CELL BIOL, V143, P901, DOI 10.1083/jcb.143.4.901; Panaretou B, 1998, EMBO J, V17, P4829, DOI 10.1093/emboj/17.16.4829; Panaretou B, 2002, MOL CELL, V10, P1307, DOI 10.1016/S1097-2765(02)00785-2; Pimienta G, 2011, MOL PHARMACEUT, V8, P2252, DOI 10.1021/mp200346y; Piper PW, 2003, EUR J BIOCHEM, V270, P4689, DOI 10.1046/j.1432-1033.2003.03866.x; Piper PW, 2003, GENE, V302, P165, DOI 10.1016/S0378-1119(02)01102-2; Prodromou C, 2000, EMBO J, V19, P4383, DOI 10.1093/emboj/19.16.4383; Prodromou C, 2012, BBA-MOL CELL RES, V1823, P614, DOI 10.1016/j.bbamcr.2011.07.020; Ratzke C, 2012, P NATL ACAD SCI USA, V109, P161, DOI 10.1073/pnas.1107930108; Retzlaff M, 2010, MOL CELL, V37, P344, DOI 10.1016/j.molcel.2010.01.006; Richter K, 2004, J MOL BIOL, V342, P1403, DOI 10.1016/j.jmb.2004.07.064; Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2; Scroggins BT, 2007, MOL CELL, V25, P151, DOI 10.1016/j.molcel.2006.12.008; Shiotsu Y, 2002, LEUKEMIA LYMPHOMA, V43, P961, DOI 10.1080/10428190290021371; Siligardi G, 2004, J BIOL CHEM, V279, P51989, DOI 10.1074/jbc.M410562200; Stuhmer T, 2008, LEUKEMIA, V22, P1604, DOI 10.1038/leu.2008.111; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Wang CG, 2003, J BIOL CHEM, V278, P2066, DOI 10.1074/jbc.M206697200; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Wegele H, 2006, J MOL BIOL, V356, P802, DOI 10.1016/j.jmb.2005.12.008; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Yang XX, 2006, FEMS YEAST RES, V6, P195, DOI 10.1111/j.1567-1364.2006.00026.x; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079; Yu XD, 2002, J NATL CANCER I, V94, P504	60	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49322	10.1371/journal.pone.0049322	http://dx.doi.org/10.1371/journal.pone.0049322			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166640	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900123
J	Chambers, JP; Behpouri, A; Bird, A; Ng, CKY				Chambers, John P.; Behpouri, Ali; Bird, Alison; Ng, Carl K-Y.			Evaluation of the Use of the Polyubiquitin Genes, Ubi4 and Ubi10 as Reference Genes for Expression Studies in Brachypodium distachyon	PLOS ONE			English	Article								Background: Brachypodium distachyon is emerging as the model plant for temperate grass research and the genome of the community line Bd21 has been sequenced. Additionally, techniques have been developed for Agrobacterium-mediated transformation for the generation of T-DNA insertional lines. Recently, it was reported that expression of the polyubiquitin genes, Ubi4 and Ubi10 are stable in different tissues and growth hormone-treated plant samples, leading to the conclusion that both Ubi4 and Ubi10 are good reference genes for normalization of gene expression data using real-time, quantitative PCR (qPCR). Principal Findings: Mining of the Joint Genome Institute (JGI) 8X Brachypodium distachyon genome assembly showed that Ubi4 and Ubi10 share a high level of sequence identity (89%), and in silico analyses of the sequences of Ubi4 (Bradi3g04730) and Ubi10 (Bradi1g32860) showed that the primers used previously exhibit multiple binding sites within the coding sequences arising from the presence of tandem repeats of the coding regions. This can potentially result in over-estimation of steady-state levels of Ubi4 and Ubi10. Additionally, due to the high level of sequence identity between both genes, primers used previously for amplification of Ubi4 can bind to Ubi10 and vice versa, resulting in the formation of non-specific amplification products. Conclusions: The results from this study indicate that the primers used previously were not sufficiently robust and specific. Additionally, their use would result in over-estimation of the steady-state expression levels of Ubi4. Our results question the validity of using the previously proposed primer sets for qPCR amplification of Ubi4 and Ubi10. We demonstrate that primers designed to target the 3'-UTRs of Ubi4 and Ubi10 are better suited for real-time normalization of steady-state expression levels in Brachypodium distachyon.	[Chambers, John P.; Behpouri, Ali; Bird, Alison; Ng, Carl K-Y.] Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland	University College Dublin	Chambers, JP (corresponding author), Univ Coll Dublin, Sch Biol & Environm Sci, Dublin 2, Ireland.	carl.ng@ucd.ie		Ng, Carl/0000-0001-5832-3265				Alves SC, 2009, NAT PROTOC, V4, P638, DOI 10.1038/nprot.2009.30; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Bubner B, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-14; CALLIS J, 1995, GENETICS, V139, P921; Gachon C, 2004, J EXP BOT, V55, P1445, DOI 10.1093/jxb/erh181; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747	8	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49372	10.1371/journal.pone.0049372	http://dx.doi.org/10.1371/journal.pone.0049372			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166649	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900131
J	Hou, YZ; Chen, XL; Xu, BN				Hou, YuanZheng; Chen, XiaoLei; Xu, BaiNan			Prediction of the Location of the Pyramidal Tract in Patients with Thalamic or Basal Ganglia Tumors	PLOS ONE			English	Article							FIBER-TRACKING; TRACTOGRAPHY METHODS; DIFFUSION; RESECTION; NEURONAVIGATION; PRINCIPLES; GLIOMAS; BRAIN	Background: Locating the pyramidal tract (PT) is difficult in patients with thalamic or basal ganglia tumors, especially when the surrounding anatomical structures cannot be identified using computed tomography or magnetic resonance images. Hence, we objected to find a way to predict the location of the PT in patients with thalamic and basal ganglia tumors Methodology/Principal Findings: In 59 patents with thalamic or basal ganglia tumors, the PTs were constructed by with diffusion tensor imaging (DTI)-based fiber tracking (FT). In axial slices crossing the foramen of Monro, the tumor position was classified according to three lines. Line 1 was vertical and crossed the vertex point of the anterior limbs of the internal capsule. Lines 2 and line 3 were horizontal and crossed the foramen of Monro and joint of the middle and lateral thirds of the posterior limbs, respectively. Six (10.17%) patients were diagnosed with type 1 tumor, six (10.17%) with type 2, seven (11.86%) with type 3a, five (8.47%) with type 3b, 17 (28.81%) with type 4a, six (10.17%) with type 4b, three (5.08%) with type 5, and nine (15.25%) with type 6. In type 1 tumors, the PTs were located at the 12 o'clock position of the tumor, type 2 at six o'clock, type 3a between nine and 12 o'clock, type 3 between six and nine o'clock, type 4a between 12 and three o'clock, type 4b at three o'clock, type 5 between six and nine o'clock, and type 6 between three and six o'clock. Conclusions/Significance: The position of the PT relative to the tumor could be determined according to the tumor location. These results could prove helpful in determining the location of the PT preoperatively.	[Hou, YuanZheng; Chen, XiaoLei; Xu, BaiNan] Chinese Peoples Liberat Army PLA Gen Hosp, Dept Neurosurg, Beijing, Peoples R China		Hou, YZ (corresponding author), Chinese Peoples Liberat Army PLA Gen Hosp, Dept Neurosurg, Beijing, Peoples R China.	kkmmhouyz@sina.com		Hess, Christopher/0000-0002-5132-5302				Baroncini M, 2007, CHILD NERV SYST, V23, P753, DOI 10.1007/s00381-007-0299-4; Berman JI, 2007, J NEUROSURG, V107, P488, DOI 10.3171/JNS-07/09/0488; Burgel U, 2009, CENT EUR NEUROSURG, V70, P27, DOI 10.1055/s-0028-1087212; Burgel U, 2006, NEUROIMAGE, V29, P1092, DOI 10.1016/j.neuroimage.2005.08.040; Hahn HK, 2006, ACTA NEUROCHIR SUPPL, V98, P33; Holodny AI, 2005, ANN NY ACAD SCI, V1064, P88, DOI 10.1196/annals.1340.016; Kim YH, 2008, NEUROREPORT, V19, P817, DOI 10.1097/WNR.0b013e328300a086; Kinoshita M, 2005, NEUROIMAGE, V25, P424, DOI 10.1016/j.neuroimage.2004.07.076; Lazar M, 2003, NEUROIMAGE, V20, P1140, DOI 10.1016/S1053-8119(03)00277-5; Mandonnet E, 2006, J NEURO-ONCOL, V78, P179, DOI 10.1007/s11060-005-9084-y; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Mori S, 2006, NEURON, V51, P527, DOI 10.1016/j.neuron.2006.08.012; Moshel YA, 2007, NEUROSURGERY, V61, P66, DOI 10.1227/01.neu.0000279725.13521.a3; Moshel YA, 2009, J NEUROSURG-PEDIATR, V4, P495, DOI 10.3171/2009.7.PEDS09128; Mukherjee P, 2008, AM J NEURORADIOL, V29, P843, DOI 10.3174/ajnr.A1052; Mukherjee P, 2008, AM J NEURORADIOL, V29, P632, DOI 10.3174/ajnr.A1051; Nimsky C, 2006, NEUROSURGERY, V58, P292, DOI 10.1227/01.NEU.0000204726.00088.6D; Nimsky C, 2007, NEUROSURGERY, V61, P178, DOI [10.1227/01.neu.0000279214.00139.3b, 10.1227/01.NEU.0000144842.18771.30]; Ozek MM, 2002, CHILD NERV SYST, V18, P450, DOI 10.1007/s00381-002-0608-x; Provenzale JM, 2004, RADIOLOGY, V232, P451, DOI 10.1148/radiol.2322030959; Rademacher J, 2001, BRAIN, V124, P2232, DOI 10.1093/brain/124.11.2232; Rhoton AL, 2002, NEUROSURGERY, V51, pS1, DOI 10.1227/01.NEU.0000028086.48597.4F; Stadlbauer A, 2007, NEUROIMAGE, V34, P949, DOI 10.1016/j.neuroimage.2006.08.051; Steiger HJ, 2000, ACTA NEUROCHIR, V142, P1327, DOI 10.1007/s007010070001; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wu JS, 2007, NEUROSURGERY, V61, P935, DOI 10.1227/01.neu.0000303189.80049.ab	26	8	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48585	10.1371/journal.pone.0048585	http://dx.doi.org/10.1371/journal.pone.0048585			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155395	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900029
J	Jallu, V; Poulain, P; Fuchs, PFJ; Kaplan, C; de Brevern, AG				Jallu, Vincent; Poulain, Pierre; Fuchs, Patrick F. J.; Kaplan, Cecile; de Brevern, Alexandre G.			Modeling and Molecular Dynamics of HPA-1a and-1b Polymorphisms: Effects on the Structure of the beta 3 Subunit of the alpha IIb beta 3 Integrin	PLOS ONE			English	Article							PLATELET GLYCOPROTEIN RECEPTOR; PARTICLE MESH EWALD; B-CELL EPITOPES; PROTEIN; IIIA; BINDING; RISK; CONFORMATION; METAANALYSIS; ALLOANTIGEN	Background: The HPA-1 alloimmune system carried by the platelet integrin alpha IIb beta 3 is the primary cause of alloimmune thrombocytopenia in Caucasians and the HPA-1b allele might be a risk factor for thrombosis. HPA-1a and -1b alleles are defined by a leucine and a proline, respectively, at position 33 in the beta 3 subunit. Although the structure of alpha IIb beta 3 is available, little is known about structural effects of the L33P substitution and its consequences on immune response and integrin functions. Methodology/Principal Findings: A complete 3D model of the L33-beta 3 extracellular domain was built and a P33 model was obtained by in silico mutagenesis. We then performed molecular dynamics simulations. Analyses focused on the PSI, I-EGF-1, and I-EGF-2 domains and confirmed higher exposure of residue 33 in the L33 beta 3 form. These analyses also showed major structural flexibility of all three domains in both forms, but increased flexibility in the P33 beta 3 form. The L33P substitution does not alter the local structure (residues 33 to 35) of the PSI domain, but modifies the structural equilibrium of the three domains. Conclusions: These results provide a better understanding of HPA-1 epitopes complexity and alloimmunization prevalence of HPA-1a. p33 gain of structure flexibility in the beta 3 knee may explain the increased adhesion capacity of HPA-1b platelets and the associated thrombotic risk. Our study provides important new insights into the relationship between HPA-1 variants and beta 3 structure that suggest possible effects on the alloimmune response and platelet function.	[Jallu, Vincent; Kaplan, Cecile] INTS, Lab Immunol Plaquettaire, Paris, France		Jallu, V (corresponding author), INTS, Lab Immunol Plaquettaire, Paris, France.	alexandre.debrevern@univ-paris-diderot.fr	de Brevern, Alexandre G./B-4788-2009; FUCHS, Patrick/C-8425-2016; Poulain, Pierre/A-8287-2009	de Brevern, Alexandre G./0000-0001-7112-5626; FUCHS, Patrick/0000-0001-7117-994X; Poulain, Pierre/0000-0003-4177-3619				Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Barron-Casella EA, 1999, BLOOD, V93, P2959; Bennett JS, 2001, BLOOD, V97, P3093, DOI 10.1182/blood.V97.10.3093; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Burr D, 2003, STAT MED, V22, P1741, DOI 10.1002/sim.1375; Byzova TV, 2000, J CLIN INVEST, V105, P697, DOI 10.1172/JCI9629; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Brevern AG, 2000, PROTEINS, V41, P271, DOI 10.1002/1097-0134(20001115)41:3<271::AID-PROT10>3.0.CO;2-Z; de Brevern AG, 2005, BBA-GEN SUBJECTS, V1724, P288, DOI 10.1016/j.bbagen.2005.05.016; de Brevern Alexandre G., 2005, In Silico Biology, V5, P283; Deckmyn H, 2004, VOX SANG, V87, P105, DOI 10.1111/j.1741-6892.2004.00464.x; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Di Castelnuovo A, 2001, THROMB HAEMOSTASIS, V85, P626; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Faure G, 2008, BIOCHIMIE, V90, P626, DOI 10.1016/j.biochi.2007.11.007; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Jallu V, 2010, HUM MUTAT, V31, P237, DOI 10.1002/humu.21179; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Joseph Agnel Praveen, 2010, Biophys Rev, V2, P137, DOI 10.1007/s12551-010-0036-1; Joseph AP, 2012, BIOCHIMIE IN PRESS; Kaplan C., 2006, THROMBOCYTOPENIA, P223; Kaplan C, 2007, PLATELETS, 2ND EDITION, P971, DOI 10.1016/B978-012369367-9/50815-6; KUIJPERS RWA, 1992, HUM IMMUNOL, V34, P253, DOI 10.1016/0198-8859(92)90024-H; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAVER WG, 1990, CELL, V61, P553, DOI 10.1016/0092-8674(90)90464-P; Liu LX, 1996, BLOOD, V88, P3601, DOI 10.1182/blood.V88.9.3601.bloodjournal8893601; Liu R., 2011, J PROTEOM BIOINFORM, V4, P10; Lollier V, 2011, MOL IMMUNOL, V48, P577, DOI 10.1016/j.molimm.2010.10.011; Loncar R, 2007, THROMB J, V5, P1; MACARTHUR MW, 1991, J MOL BIOL, V218, P397, DOI 10.1016/0022-2836(91)90721-H; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; NEWMAN PJ, 1989, J CLIN INVEST, V83, P1778, DOI 10.1172/JCI114082; Rubinstein ND, 2008, MOL IMMUNOL, V45, P3477, DOI 10.1016/j.molimm.2007.10.016; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Santoso S, 2006, TRANSFUSION, V46, P790, DOI 10.1111/j.1537-2995.2006.00797.x; Sarab GA, 2009, BLOOD, V114, P1954, DOI 10.1182/blood-2009-04-211839; SAVAGE B, 1991, J BIOL CHEM, V266, P11227; Schurpf T, 2011, EMBO J, V30, P4712, DOI 10.1038/emboj.2011.333; Stafford P, 2008, J THROMB HAEMOST, V6, P366, DOI 10.1111/j.1538-7836.2007.02858.x; Tyagi M, 2009, COMPUT BIOL CHEM, V33, P329, DOI 10.1016/j.compbiolchem.2009.06.002; VALENTIN N, 1990, HUM IMMUNOL, V27, P73, DOI 10.1016/0198-8859(90)90104-W; VALENTIN N, 1995, BLOOD, V85, P3028, DOI 10.1182/blood.V85.11.3028.bloodjournal85113028; Vijayan KV, 2000, J CLIN INVEST, V105, P793, DOI 10.1172/JCI6982; Vijayan KV, 2006, EXP BIOL MED, V231, P505; Weiss EJ, 1996, NEW ENGL J MED, V334, P1090, DOI 10.1056/NEJM199604253341703; Wu SH, 1997, J IMMUNOL, V158, P3221; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2009, J CELL BIOL, V186, P589, DOI 10.1083/jcb.200905085; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	52	28	28	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e47304	10.1371/journal.pone.0047304	http://dx.doi.org/10.1371/journal.pone.0047304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155369	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900003
J	Quayle, SN; Lee, JY; Cheung, LWT; Ding, L; Wiedemeyer, R; Dewan, RW; Huang-Hobbs, E; Zhuang, L; Wilson, RK; Ligon, KL; Mills, GB; Cantley, LC; Chin, L				Quayle, Steven N.; Lee, Jennifer Y.; Cheung, Lydia W. T.; Ding, Li; Wiedemeyer, Ruprecht; Dewan, Robert W.; Huang-Hobbs, Emmet; Zhuang, Li; Wilson, Richard K.; Ligon, Keith L.; Mills, Gordon B.; Cantley, Lewis C.; Chin, Lynda			Somatic Mutations of PIK3R1 Promote Gliomagenesis	PLOS ONE			English	Article							HIGH-FREQUENCY; GLIOBLASTOMA-MULTIFORME; ANAPLASTIC ASTROCYTOMA; ENDOMETRIAL CANCER; PTEN; AKT; ACTIVATION; P85-ALPHA; GLIOMA; GENE	The phosphoinositide 3-kinase (PI3K) pathway is targeted for frequent alteration in glioblastoma (GBM) and is one of the core GBM pathways defined by The Cancer Genome Atlas. Somatic mutations of PIK3R1 are observed in multiple tumor types, but the tumorigenic activity of these mutations has not been demonstrated in GBM. We show here that somatic mutations in the iSH2 domain of PIK3R1 act as oncogenic driver events. Specifically, introduction of a subset of the mutations identified in human GBM, in the nSH2 and iSH2 domains, increases signaling through the PI3K pathway and promotes tumorigenesis of primary normal human astrocytes in an orthotopic xenograft model. Furthermore, we show that cells that are dependent on mutant P85 alpha-mediated PI3K signaling exhibit increased sensitivity to a small molecule inhibitor of AKT. Together, these results suggest that GBM patients whose tumors carry mutant PIK3R1 alleles may benefit from treatment with inhibitors of AKT.	[Quayle, Steven N.; Wiedemeyer, Ruprecht; Dewan, Robert W.; Huang-Hobbs, Emmet; Zhuang, Li; Ligon, Keith L.; Chin, Lynda] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Quayle, SN (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	lchin@mdanderson.org	Cantley, Lewis C/D-1800-2014; Wilson, Richard K./AAF-4139-2019	Cantley, Lewis C/0000-0002-1298-7653; Wilson, Richard K./0000-0002-1992-1358; Huang-Hobbs, Emmet/0000-0002-2071-2588; Cheung, Lydia Wai Ting/0000-0003-1137-3200	NATIONAL CANCER INSTITUTE [U01CA141508, RC2CA148268, P01CA095616, U01CA168394, P50CA098258, U24CA143845, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041890] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; NCI NIH HHS [U24CA143845, P30 CA016672, U01CA168394, U01 CA141508, P01 CA095616, RC2CA148268, P01CA095616, U01 CA168394, U24 CA143845, P50 CA098258, RC2 CA148268, U01CA141508] Funding Source: Medline; NIGMS NIH HHS [R01 GM041890] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CIHR(Canadian Institutes of Health Research (CIHR)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Holland EC, 2000, NAT GENET, V25, P55, DOI 10.1038/75596; Jaiswal BS, 2009, CANCER CELL, V16, P463, DOI 10.1016/j.ccr.2009.10.016; Kang SY, 2005, P NATL ACAD SCI USA, V102, P802, DOI 10.1073/pnas.0408864102; Kinross KM, 2012, J CLIN INVEST, V122, P553, DOI 10.1172/JCI59309; Knobbe CB, 2003, BRAIN PATHOL, V13, P507; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; SERUNIAN LA, 1991, METHOD ENZYMOL, V198, P78; Sonoda Y, 2001, CANCER RES, V61, P4956; Sonoda Y, 2001, CANCER RES, V61, P6674; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun MH, 2010, P NATL ACAD SCI USA, V107, P15547, DOI 10.1073/pnas.1009652107; Urick ME, 2011, CANCER RES, V71, P4061, DOI 10.1158/0008-5472.CAN-11-0549; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	22	39	39	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49466	10.1371/journal.pone.0049466	http://dx.doi.org/10.1371/journal.pone.0049466			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166678	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900147
J	Rodriguez-Zamora, L; Iglesias, X; Barrero, A; Chaverri, D; Erola, P; Rodriguez, FA				Rodriguez-Zamora, Lara; Iglesias, Xavier; Barrero, Anna; Chaverri, Diego; Erola, Pau; Rodriguez, Ferran A.			Physiological Responses in Relation to Performance during Competition in Elite Synchronized Swimmers	PLOS ONE			English	Article							BREATH-HOLD DIVERS; ARTERIAL OXYGEN DESATURATION; HEART-RATE RESPONSE; PERCEIVED EXERTION; DIVING RESPONSE; BLOOD LACTATE; CARDIOVASCULAR-RESPONSES; FACE IMMERSION; CARDIAC DECELERATION; DYNAMIC APNEA	Purpose: We aimed to characterize the cardiovascular, lactate and perceived exertion responses in relation to performance during competition in junior and senior elite synchronized swimmers. Methods: 34 high level senior (21.4 +/- 3.6 years) and junior (15.9 +/- 1.0) synchronized swimmers were monitored while performing a total of 96 routines during an official national championship in the technical and free solo, duet and team competitive programs. Heart rate was continuously monitored. Peak blood lactate was obtained from serial capillary samples during recovery. Post-exercise rate of perceived exertion was assessed using the Borg CR-10 scale. Total competition scores were obtained from official records. Results: Data collection was complete in 54 cases. Pre-exercise mean heart rate (beats.min(-1)) was 129.1 +/- 13.1, and quickly increased during the exercise to attain mean peak values of 191.7 +/- 8.7, with interspersed bradycardic events down to 88.8 +/- 28.5. Mean peak blood lactate (mmol.L-1) was highest in the free solo (8.5 +/- 1.8) and free duet (7.6 +/- 1.8) and lowest at the free team (6.2 +/- 1.9). Mean RPE (0-10+) was higher in juniors (7.8 +/- 0.9) than in seniors (7.1 +/- 1.4). Multivariate analysis revealed that heart rate before and minimum heart rate during the routine predicted 26% of variability in final total score. Conclusions: Cardiovascular responses during competition are characterized by intense anticipatory pre-activation and rapidly developing tachycardia up to maximal levels with interspersed periods of marked bradycardia during the exercise bouts performed in apnea. Moderate blood lactate accumulation suggests an adaptive metabolic response as a result of the specific training adaptations attributed to influence of the diving response in synchronized swimmers. Competitive routines are perceived as very to extremely intense, particularly in the free solo and duets. The magnitude of anticipatory heart rate activation and bradycardic response appear to be related to performance variability.	[Rodriguez-Zamora, Lara; Iglesias, Xavier; Barrero, Anna; Chaverri, Diego; Rodriguez, Ferran A.] Univ Barcelona, Inst Nacl Educ Fis Catalunya, INEFC Barcelona Sports Sci Res Grp, Barcelona, Spain	University of Barcelona	Rodriguez-Zamora, L (corresponding author), Univ Barcelona, Inst Nacl Educ Fis Catalunya, INEFC Barcelona Sports Sci Res Grp, Barcelona, Spain.	xiglesias@gmail.com	Iglesias, X/M-7292-2013; Erola, Pau/A-6272-2011; Chaverri, Diego DCJ/L-5830-2017; Rodriguez, Ferran A./H-4892-2011	Iglesias, X/0000-0001-6813-6527; Erola, Pau/0000-0003-4440-0068; Chaverri, Diego DCJ/0000-0003-1885-2677; Rodriguez, Ferran A./0000-0002-2280-8962				Abernethy B, 2012, HDB SPORT PSYCHOL, P245, DOI [10.1002/9781118270011, DOI 10.1002/9781118270011.CHL]; Aleksandraviciene R, 2005, ED PHYS TRAINING SPO, V3, P4; Alentejano TC, 2010, RES SPORTS MED, V18, P97, DOI 10.1080/15438620903323678; Andersson J, 1998, UNDERSEA HYPERBAR M, V25, P21; Andersson JPA, 2009, SCAND J MED SCI SPOR, V19, P87, DOI 10.1111/j.1600-0838.2008.00777.x; Andersson JPA, 2004, J APPL PHYSIOL, V96, P1005, DOI 10.1152/japplphysiol.01057.2002; Andersson JPA, 2002, J APPL PHYSIOL, V93, P882, DOI 10.1152/japplphysiol.00863.2001; Bante S, 2007, J SPORT MED PHYS FIT, V47, P291; BAUMEISTER RF, 1984, J PERS SOC PSYCHOL, V46, P610, DOI 10.1037/0022-3514.46.3.610; BJERTNAES L, 1984, ACTA PHYSIOL SCAND, V120, P605, DOI 10.1111/j.1748-1716.1984.tb07427.x; BJURSTROM RL, 1987, J APPL PHYSIOL, V63, P1019, DOI 10.1152/jappl.1987.63.3.1019; Borg G., 1998, BORGS PERCEIVED EXER; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BOUTCHER SH, 1990, J SPORT EXERCISE PSY, V12, P37, DOI 10.1123/jsep.12.1.37; Bridge CA, 2009, INT J SPORT PHYSIOL, V4, P485, DOI 10.1123/ijspp.4.4.485; Chatard JC, 1999, EUR J APPL PHYSIOL, V79, P479, DOI 10.1007/s004210050540; Chen MJ, 2002, J SPORT SCI, V20, P873, DOI 10.1080/026404102320761787; DAVIES BN, 1995, BRIT J SPORT MED, V29, P16, DOI 10.1136/bjsm.29.1.16; de Bruijn R, 2008, EUR J APPL PHYSIOL, V102, P609, DOI 10.1007/s00421-007-0639-9; Elstad M, 2009, ACTA PHYSIOL, V195, P289, DOI 10.1111/j.1748-1716.2008.01887.x; FERRETTI G, 1991, J APPL PHYSIOL, V70, P794, DOI 10.1152/jappl.1991.70.2.794; Ferrigno M, 1997, J APPL PHYSIOL, V83, P1282, DOI 10.1152/jappl.1997.83.4.1282; Figura F, 1993, J SPORT SCI, V11, P103, DOI 10.1080/02640419308729972; FINA, 2009, SYNCHR SWIMM RUL; GEMMA KE, 1987, PHYSICIAN SPORTSMED, V15, P99; Greenwood JD, 2008, J SPORT SCI, V26, P29, DOI 10.1080/02640410701287263; Hassmen P, 2001, PERCEPT MOTOR SKILL, V92, P947, DOI 10.2466/pms.2001.92.3c.947; Hoffmann U, 2005, INT J SPORTS MED, V26, P426, DOI 10.1055/s-2004-821113; HOMMA M, 1994, MED SPORT SCI, V39, P149; Homma M, 1999, SUIEI SUICHU UNDO KA, V11, P27; Jamnik V, 1987, EVALUATION PHYSL RES; Joulia F, 2003, RESP PHYSIOL NEUROBI, V137, P19, DOI 10.1016/S1569-9048(03)00110-1; Kjaer M, 1992, J SPORT SCI, V10, P29, DOI 10.1080/02640419208729904; Lacey B.C., 1974, CARDIOVASCULAR PSYCH, P538; LACEY BC, 1980, PSYCHOPHYSIOLOGY, V17, P209, DOI 10.1111/j.1469-8986.1980.tb00137.x; Lay BS, 2002, HUM MOVEMENT SCI, V21, P807, DOI 10.1016/S0167-9457(02)00166-5; LEMAITRE F, 2007, DIVING HYPERB MED, V34, P407; Lemaitre F, 2010, MED HYPOTHESES, V74, P413, DOI 10.1016/j.mehy.2009.09.051; Lemaitre F, 2009, J STRENGTH COND RES, V23, P1909, DOI 10.1519/JSC.0b013e3181b073a8; Liao CM, 2002, J SPORT EXERCISE PSY, V24, P289, DOI 10.1123/jsep.24.3.289; LIN YC, 1983, J APPL PHYSIOL, V54, P166, DOI 10.1152/jappl.1983.54.1.166; Lindholm P, 2006, UNDERSEA HYPERBAR M, V33, P119; Lindholm P, 2002, AM J PHYSIOL-REG I, V283, pR1227, DOI 10.1152/ajpregu.00036.2002; Lundy B, 2011, INT J SPORT NUTR EXE, V21, P436, DOI 10.1123/ijsnem.21.5.436; MASTERS RSW, 1992, BRIT J PSYCHOL, V83, P343, DOI 10.1111/j.2044-8295.1992.tb02446.x; Mateo M, 2012, EUR J APPL PHYSIOL, V112, P113, DOI 10.1007/s00421-011-1962-8; Maxwell JP, 2006, RES Q EXERCISE SPORT, V77, P271; Minganti C, 2011, INT J SPORT PHYSIOL, V6, P408, DOI 10.1123/ijspp.6.3.408; MOLANDER B, 1989, J GERONTOL, V44, pP80, DOI 10.1093/geronj/44.3.P80; MONTGOMERY DL, 1982, J SPORT MED PHYS FIT, V22, P358; PANDOLF KB, 1978, PERCEPT MOTOR SKILL, V46, P683, DOI 10.2466/pms.1978.46.3.683; Parlebas P, 2001, JEUX SPORTS SOC LEXI, P211; Pazikas Marina Guimarães Antunes, 2005, Rev Bras Med Esporte, V11, P357, DOI 10.1590/S1517-86922005000600010; Poole G W, 1980, Can J Appl Sport Sci, V5, P156; Psycharakis SG, 2011, J STRENGTH COND RES, V25, P420, DOI 10.1519/JSC.0b013e3181bff58c; Richardson MX, 2008, EUR J APPL PHYSIOL, V104, P395, DOI 10.1007/s00421-007-0623-4; Robertson R J, 1997, Exerc Sport Sci Rev, V25, P407; Schagatay E, 1998, UNDERSEA HYPERBAR M, V25, P13; Schagatay E, 2007, EUR J APPL PHYSIOL, V101, P125, DOI 10.1007/s00421-007-0483-y; Schagatay E, 2010, DIVING HYPERB MED, V40, P11; Sinclair WH, 2009, J SCI MED SPORT, V12, P101, DOI 10.1016/j.jsams.2007.10.008; Singer RN, 2002, J SPORT EXERCISE PSY, V24, P359, DOI 10.1123/jsep.24.4.359; Smith D., 1988, CANADIAN J APPL PHYS, V13, P2; Sparrow WA, 1999, HUM MOVEMENT SCI, V18, P137, DOI 10.1016/S0167-9457(99)00005-6; Stewart IB, 2005, MED SCI SPORT EXER, V37, P1871, DOI 10.1249/01.mss.0000176305.51360.7e; Wein J, 2007, EUR J APPL PHYSIOL, V100, P637, DOI 10.1007/s00421-007-0411-1; Wulf G, 2001, PSYCHON B REV, V8, P648, DOI 10.3758/BF03196201; Yamamura C, 2000, MED SCI SPORT EXER, V32, P1171, DOI 10.1097/00005768-200006000-00022; Yamamura C, 1999, INT J SPORTS MED, V20, P246, DOI 10.1055/s-2007-971125	69	24	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49098	10.1371/journal.pone.0049098	http://dx.doi.org/10.1371/journal.pone.0049098			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155452	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900087
J	Petersen, ALDA; Guedes, CES; Versoza, CL; Lima, JGB; de Freitas, LAR; Borges, VM; Veras, PST				de Oliveira Almeida Petersen, Antonio Luis; Sampaio Guedes, Carlos Eduardo; Versoza, Carolina Leite; Bomfim Lima, Jose Geraldo; Rodrigues de Freitas, Luiz Antonio; Borges, Valeria Matos; Tavares Veras, Patricia Sampaio			17-AAG Kills Intracellular Leishmania amazonensis while Reducing Inflammatory Responses in Infected Macrophages	PLOS ONE			English	Article							SHOCK-PROTEIN 90; HSP90 MOLECULAR CHAPERONE; PLASMODIUM-FALCIPARUM; ANTIMALARIAL ACTIVITY; NITRIC-OXIDE; CUTANEOUS LEISHMANIASIS; PROTOZOAN PARASITES; DRUG TARGET; IN-VITRO; HEAT-SHOCK-PROTEIN-90	Background: Leishmaniasis is a neglected endemic disease with a broad spectrum of clinical manifestations. Pentavalent antimonials have been the treatment of choice for the past 70 years and, due to the emergence of resistant cases, the efficacy of these drugs has come under scrutiny. Second-line drugs are less efficacious, cause a range of side effects and can be costly. The formulation of new generations of drugs, especially in developing countries, has become mandatory. Methodology/Principal Findings: We investigated the anti-leishmanial effect of 17-(allylamino)-17-demethoxygeldanamycin (17-AAG), an HSP90 inhibitor, in vitro. This inhibitor is currently in clinical trials for cancer treatment; however, its effects against intracellular Leishmania remain untested. Macrophages infected with L. amazonensis were treated with 17-AAG (25500 nM) and parasite load was quantified using optical microscopy. Parasite load declined in 17-AAG-treated macrophages in a dose- and time-dependent manner. Intracellular parasite death became irreversible after 4 h of treatment with 17-AAG, and occurred independent of nitric oxide (NO) and superoxide (O-2(-)) production. Additionally, intracellular parasite viability was severely reduced after 48 h of treatment. Interestingly, treatment with 17-AAG reduced pro-inflammatory mediator production, including TNF-alpha, IL-6 and MCP-1, yet IL-12 remained unaffected. Electron microscopy revealed morphological alterations, such as double-membrane vacuoles and myelin figures at 24 and 48 h after 17-AAG treatment. Conclusions/Significance: The HSP90 inhibitor, 17-AAG, possesses high potency under low dosage and reduces both pro-inflammatory and oxidative molecule production. Therefore, further studies are warranted to investigate this inhibitor's potential in the development of new generations of anti-leishmanials.	[de Oliveira Almeida Petersen, Antonio Luis; Sampaio Guedes, Carlos Eduardo; Versoza, Carolina Leite; Bomfim Lima, Jose Geraldo; Rodrigues de Freitas, Luiz Antonio; Tavares Veras, Patricia Sampaio] Fundacao Oswaldo Cruz BA, Lab Patol & Biointervencao, Salvador, BA, Brazil; [Borges, Valeria Matos] Fundacao Oswaldo Cruz BA, Lab Integrado Microbiol & Imunoregulacao, Salvador, BA, Brazil; [de Oliveira Almeida Petersen, Antonio Luis; Bomfim Lima, Jose Geraldo; Rodrigues de Freitas, Luiz Antonio] Univ Fed Bahia, Dept Anat Patol & Med Legal, Salvador, BA, Brazil	Universidade Federal da Bahia	Veras, PST (corresponding author), Fundacao Oswaldo Cruz BA, Lab Patol & Biointervencao, Salvador, BA, Brazil.	pveras@bahia.fiocruz.br	Borges, Val/N-6647-2019; Borges, Valeria/G-2009-2014; Veras, Patricia S T Sampaio Tavares/I-9632-2014	Borges, Val/0000-0002-2775-5409; Veras, Patricia S T Sampaio Tavares/0000-0001-8308-9263	FAPESB (Fundacao de Amparo a Pesquisa no Estado da Bahia); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); CNPq (Conselho Nacional de Pesquisa e Desenvolvimento) [306672/2008-1]	FAPESB (Fundacao de Amparo a Pesquisa no Estado da Bahia); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Conselho Nacional de Pesquisa e Desenvolvimento)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by grants and fellowships from FAPESB (Fundacao de Amparo a Pesquisa no Estado da Bahia), CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) and CNPq (Conselho Nacional de Pesquisa e Desenvolvimento). P.S.T. Veras holds a grant from CNPq for productivity in research (306672/2008-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2003, BIOCHEM BIOPH RES CO, V311, P654, DOI 10.1016/j.bbrc.2003.10.045; ANTOINE JC, 1990, INFECT IMMUN, V58, P779, DOI 10.1128/IAI.58.3.779-787.1990; Antoniou T, 2005, PHARMACOTHERAPY, V25, P899, DOI 10.1592/phco.2005.25.6.899; ASSAN R, 1995, DIABETES CARE, V18, P47, DOI 10.2337/diacare.18.1.47; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; BRANDAU S, 1995, BIOCHEM J, V310, P225, DOI 10.1042/bj3100225; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Chatterjee A, 2007, AM J RESP CRIT CARE, V176, P667, DOI 10.1164/rccm.200702-291OC; Chen F, 2011, ANTIOXID REDOX SIGN, V14, P2107, DOI 10.1089/ars.2010.3669; Chiosis G, 2003, MOL CANCER THER, V2, P123; Courret N, 2001, PARASITOLOGY, V122, P263, DOI 10.1017/S0031182001007387; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; de Sa MS, 2009, PARASITOL RES, V105, P275, DOI 10.1007/s00436-009-1394-0; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DING AH, 1988, J IMMUNOL, V141, P2407; Folgueira C, 2007, FEMS MICROBIOL REV, V31, P359, DOI 10.1111/j.1574-6976.2007.00069.x; Gomes IN, 2003, MICROBES INFECT, V5, P251, DOI 10.1016/S1286-4579(03)00025-X; Gomez-Monterrey I, 2012, RECENT PAT ANTICANCE; Grenert JP, 1997, J BIOL CHEM, V272, P23843, DOI 10.1074/jbc.272.38.23843; Hothersall JS, 1998, FEBS LETT, V434, P97, DOI 10.1016/S0014-5793(98)00959-4; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Kedzierski L, 2006, PARASITOLOGY, V133, pS87, DOI 10.1017/S0031182006001831; Kim YS, 2009, CURR TOP MED CHEM, V9, P1479, DOI 10.2174/156802609789895728; Kone BC, 2003, AM J PHYSIOL-RENAL, V285, pF178, DOI 10.1152/ajprenal.00048.2003; Kumar R, 2005, MOL BIOCHEM PARASIT, V141, P29, DOI 10.1016/j.molbiopara.2005.01.012; Kumar R, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-30; Lessa HA, 2001, AM J TROP MED HYG, V65, P87, DOI 10.4269/ajtmh.2001.65.87; Li QL, 2009, PARASITOL RES, V105, P1539, DOI 10.1007/s00436-009-1582-y; Liese J, 2008, IMMUNOBIOLOGY, V213, P377, DOI 10.1016/j.imbio.2007.12.005; Luo SX, 2011, AM J PHYSIOL-CELL PH, V301, pC227, DOI 10.1152/ajpcell.00493.2010; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Moll H, 1997, Behring Inst Mitt, P73; Nathan DF, 1997, P NATL ACAD SCI USA, V94, P12949, DOI 10.1073/pnas.94.24.12949; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; Neckers L, 2008, CELL HOST MICROBE, V4, P519, DOI 10.1016/j.chom.2008.10.011; Oliveira F, 2011, AM J TROP MED HYG, V85, P70, DOI 10.4269/ajtmh.2011.10-0680; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Poulaki V, 2007, FASEB J, V21, P2113, DOI 10.1096/fj.06-7637com; PRINA E, 1990, INFECT IMMUN, V58, P1730, DOI 10.1128/IAI.58.6.1730-1737.1990; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; ROMAGNANI S, 1991, INT J CLIN LAB RES, V21, P152; Roy N, 2012, BBA-MOL CELL RES, V1823, P707, DOI 10.1016/j.bbamcr.2011.12.003; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Scheibel T, 1998, BIOCHEM PHARMACOL, V56, P675, DOI 10.1016/S0006-2952(98)00120-8; Schulte TW, 1998, CANCER CHEMOTH PHARM, V42, P273, DOI 10.1007/s002800050817; Seifert Karin, 2011, Open Med Chem J, V5, P31, DOI 10.2174/1874104501105010031; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Shonhai A, 2011, PROTEIN PEPTIDE LETT, V18, P143, DOI 10.2174/092986611794475002; Veras PST, 2006, EXP PARASITOL, V113, P201, DOI 10.1016/j.exppara.2006.01.008; TITUS RG, 1989, J EXP MED, V170, P2097, DOI 10.1084/jem.170.6.2097; Tiuman TS, 2011, INT J INFECT DIS, V15, pE525, DOI 10.1016/j.ijid.2011.03.021; Usmani SZ, 2009, CURR MOL MED, V9, P654, DOI 10.2174/156652409788488757; Wax S, 2003, ARTHRITIS RHEUM, V48, P541, DOI 10.1002/art.10780; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Wiesgigl M, 2001, MOL BIOL CELL, V12, P3307, DOI 10.1091/mbc.12.11.3307; Williams RA, 2006, MOL MICROBIOL, V61, P655, DOI 10.1111/j.1365-2958.2006.05274.x; Yoshida M, 2003, J BIOL CHEM, V278, P36953, DOI 10.1074/jbc.M305214200	60	33	34	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49496	10.1371/journal.pone.0049496	http://dx.doi.org/10.1371/journal.pone.0049496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152914	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600043
J	Helbling, RE; Aeschimann, W; Simona, F; Stocker, A; Cascella, M				Helbling, Rachel E.; Aeschimann, Walter; Simona, Fabio; Stocker, Achim; Cascella, Michele			Engineering Tocopherol Selectivity in alpha-TTP: A Combined In Vitro/In Silico Study	PLOS ONE			English	Article							FREE-ENERGY CALCULATIONS; VITAMIN-E-DEFICIENCY; BOUND-CONSTRAINED OPTIMIZATION; ENDOPLASMIC-RETICULUM STRESS; MOLECULAR-DYNAMICS METHOD; BINDING FREE-ENERGY; TRANSFER PROTEIN; CANONICAL ENSEMBLE; LIGAND-BINDING; FORCE-FIELDS	We present a combined in vitro/in silico study to determine the molecular origin of the selectivity of alpha-tocopherol transfer protein (alpha-TTP) towards alpha-tocopherol. Molecular dynamics simulations combined to free energy perturbation calculations predict a binding free energy for alpha-tocopherol to alpha-TTP 8.26 +/- 2.13 kcal mol(-1) lower than that of gamma-tocopherol. Our calculations show that gamma-tocopherol binds to alpha-TTP in a significantly distorted geometry as compared to that of the natural ligand. Variations in the hydration of the binding pocket and in the protein structure are found as well. We propose a mutation, A156L, which significantly modifies the selectivity properties of alpha-TTP towards the two tocopherols. In particular, our simulations predict that A156L binds preferentially to gamma-tocopherol, with striking structural similarities to the wild-type-alpha-tocopherol complex. The affinity properties are confirmed by differential scanning fluorimetry as well as in vitro competitive binding assays. Our data indicate that residue A156 is at a critical position for determination of the selectivity of alpha-TTP. The engineering of TTP mutants with modulating binding properties can have potential impact at industrial level for easier purification of single tocopherols from vitamin E mixtures coming from natural oils or synthetic processes. Moreover, the identification of a gamma-tocopherol selective TTP offers the possibility to challenge the hypotheses for the evolutionary development of a mechanism for alpha-tocopherol selection in omnivorous animals.	[Helbling, Rachel E.; Aeschimann, Walter; Simona, Fabio; Stocker, Achim; Cascella, Michele] Univ Bern, Dept Chem & Biochem, Bern, Switzerland	University of Bern	Stocker, A (corresponding author), Univ Bern, Dept Chem & Biochem, Bern, Switzerland.	achim.stocker@ibc.unibe.ch; michele.cascella@iac.unibe.ch	Stocker, Achim/O-5217-2017; Cascella, Michele/K-3256-2012; Cascella, Michele/Q-6097-2019	Stocker, Achim/0000-0001-6862-7887; Cascella, Michele/0000-0003-2266-5399; Cascella, Michele/0000-0003-2266-5399	Swiss National Science Foundation [PP02_118930, PP00P2_139195, 31003A_130497]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The presented research was funded by the Swiss National Science Foundation (http://www.snf.ch; grants nn. PP02_118930, PP00P2_139195, 31003A_130497). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKUTAGAWA S, 1995, APPL CATAL A-GEN, V128, P171, DOI 10.1016/0926-860X(95)00097-6; Aravind L, 1999, CURR BIOL, V9, pR195, DOI 10.1016/S0960-9822(99)80127-4; Bankaitis VA, 2010, TRENDS BIOCHEM SCI, V35, P150, DOI 10.1016/j.tibs.2009.10.008; Baumann LS, 1999, DERMATOL SURG, V25, P311, DOI 10.1046/j.1524-4725.1999.08223.x; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; BEUTLER TC, 1994, CHEM PHYS LETT, V222, P529, DOI 10.1016/0009-2614(94)00397-1; Brigelius-Flohe R, 2003, BIOCHEM BIOPH RES CO, V305, P737, DOI 10.1016/S0006-291X(03)00811-8; Brigelius-Flohe R, 2006, NUTR RES REV, V19, P174, DOI 10.1017/S0954422407202938; Brigelius-Flohe R, 2009, FREE RADICAL BIO MED, V46, P543, DOI 10.1016/j.freeradbiomed.2008.12.007; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Campbell SE, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-13; CATIGNANI GL, 1975, BIOCHEM BIOPH RES CO, V67, P66, DOI 10.1016/0006-291X(75)90283-1; Christ CD, 2010, J COMPUT CHEM, V31, P1569, DOI 10.1002/jcc.21450; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Das P, 2009, J COMPUT CHEM, V30, P1654, DOI 10.1002/jcc.21274; Dersjant-Li Y, 2010, J SCI FOOD AGR, V90, P1571, DOI 10.1002/jsfa.3994; Di Donato I, 2010, NEUROL SCI, V31, P511, DOI 10.1007/s10072-010-0261-1; EPSTEIN SS, 1966, RADIAT RES, V28, P322, DOI 10.2307/3572200; Erion MD, 2007, J AM CHEM SOC, V129, P15480, DOI 10.1021/ja074869u; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Frisch M.J., 2003, GAUSSIAN 03 REVISION; Helms V, 1998, J AM CHEM SOC, V120, P2710, DOI 10.1021/ja9738539; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Holdgate GA, 2005, DRUG DISCOV TODAY, V10, P1543, DOI 10.1016/S1359-6446(05)03610-X; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Hosomi A, 1997, FEBS LETT, V409, P105, DOI 10.1016/S0014-5793(97)00499-7; Huang HY, 2003, AM J EPIDEMIOL, V157, P335, DOI 10.1093/aje/kwf210; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jensen SK, 2007, VITAMINS HORMONES AD, V76, P155, DOI DOI 10.1016/S0083-6729(07)76007-7; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaempf-Rotzoll DE, 2003, PLACENTA, V24, P439, DOI 10.1053/plac.2002.0966; Kalikin LM, 2001, MAMM GENOME, V12, P925, DOI 10.1007/s00335-001-2073-3; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Layton CJ, 2010, BIOCHEMISTRY-US, V49, P10831, DOI 10.1021/bi101414z; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; Meier R, 2003, J MOL BIOL, V331, P725, DOI 10.1016/S0022-2836(03)00724-1; Min KC, 2003, P NATL ACAD SCI USA, V100, P14713, DOI 10.1073/pnas.2136684100; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Muller DPR, 2010, MOL NUTR FOOD RES, V54, P710, DOI 10.1002/mnfr.200900460; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Netscher T, 2007, VITAM HORM, V76, P155, DOI 10.1016/S0083-6729(07)76007-7; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; Oostenbrink C, 2005, P NATL ACAD SCI USA, V102, P6750, DOI 10.1073/pnas.0407404102; OUAHCHI K, 1995, NAT GENET, V9, P141, DOI 10.1038/ng0295-141; PACE CN, 1989, BIOCHEMISTRY-US, V28, P2520, DOI 10.1021/bi00432a026; Packer L, 2001, J NUTR, V131, p369S, DOI 10.1093/jn/131.2.369S; Panagabko C, 2003, BIOCHEMISTRY-US, V42, P6467, DOI 10.1021/bi034086v; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; RASTELLI G, 1995, J AM CHEM SOC, V117, P7213, DOI 10.1021/ja00132a022; Reddy MR, 2001, J AM CHEM SOC, V123, P6246, DOI 10.1021/ja0103288; Rimbach G, 2002, P NUTR SOC, V61, P415, DOI 10.1079/PNS2002183; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Saito K, 2007, BBA-MOL CELL BIOL L, V1771, P719, DOI 10.1016/j.bbalip.2007.02.010; SATO Y, 1991, FEBS LETT, V288, P41, DOI 10.1016/0014-5793(91)80999-J; Scheuner D, 2005, NAT MED, V11, P757, DOI 10.1038/nm1259; Schwab F, 2008, BIOCHEMISTRY-US, V47, P2945, DOI 10.1021/bi702067h; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Stocker A, 2004, ANN NY ACAD SCI, V1031, P44, DOI 10.1196/annals.1331.005; TAPPEL AL, 1962, VITAM HORM, V20, P493, DOI 10.1016/S0083-6729(08)60732-3; THORNTON DE, 1995, FREE RADICAL BIO MED, V18, P963, DOI 10.1016/0891-5849(94)00210-B; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Traber MG, 1999, ANNU REV NUTR, V19, P343, DOI 10.1146/annurev.nutr.19.1.343; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Gunsteren WF, 1998, J CHEM PHYS, V108, P6109, DOI 10.1063/1.476021; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wang XH, 2006, P NATL ACAD SCI USA, V103, P3604, DOI 10.1073/pnas.0510962103; Zeevaart JG, 2008, J AM CHEM SOC, V130, P9492, DOI 10.1021/ja8019214; Zhang WX, 2011, J MOL BIOL, V405, P972, DOI 10.1016/j.jmb.2010.11.028; Zhou RH, 2008, J PHYS CHEM B, V112, P15813, DOI 10.1021/jp805529z; Zhu CY, 1997, ACM T MATH SOFTWARE, V23, P550, DOI 10.1145/279232.279236	74	11	12	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49195	10.1371/journal.pone.0049195	http://dx.doi.org/10.1371/journal.pone.0049195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152872	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600028
J	Leinonen, JT; Surakka, I; Havulinna, AS; Kettunen, J; Luoto, R; Salomaa, V; Widen, E				Leinonen, Jaakko T.; Surakka, Ida; Havulinna, Aki S.; Kettunen, Johannes; Luoto, Riitta; Salomaa, Veikko; Widen, Elisabeth			Association of LIN28B with Adult Adiposity-Related Traits in Females	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MENARCHE; LOCI; AGE; VARIANTS; RISK; PUBERTY; HEIGHT; SIZE; BMI	Context: Pubertal timing is under strong genetic control and its early onset associates with several adverse health outcomes in adulthood, including obesity, type 2 diabetes and cardiovascular disease. Recent data indicate strong association between pubertal timing and genetic variants near LIN28B, but it is currently unknown whether the gene contributes to the association between puberty and adult disease. Objective: To elucidate the putative genetic link between early puberty and adult disease risk, we examined the association of two genetic variants near LIN28B with adult body size and metabolic profiles in randomly ascertained adult Finnish males and females. Methods: Two single nucleotide polymorphisms (SNPs), rs7759938, the lead SNP previously associated with pubertal timing and height, and rs314279, previously also associated with menarcheal age but only partially correlated with rs7759938 (r(2) = 0.30), were genotyped in 26,636 study subjects participating in the Finnish population survey FINRISK. Marker associations with adult height, weight, body mass index (BMI), hip and waist circumference, blood glucose, serum insulin and lipid/lipoprotein levels were determined by linear regression analyses. Results: Both rs7759938 and rs314279 associated with adult height in both sexes (p = 2 x 10(-6) and p = 0.001). Furthermore, rs314279 associated with increased weight in females (p = 0.001). Conditioned analyses including both SNPs in the regression model verified that rs314279 independently associates with adult female weight, BMI and hip circumference (p<0.005). Neither SNP associated with glucose, lipid, or lipoprotein levels. Conclusion: Genetic variants near the puberty-associated gene LIN28B associate with adult weight and body shape in females, suggesting that the gene may tag molecular pathways influencing adult adiposity-related traits.	[Leinonen, Jaakko T.; Surakka, Ida; Kettunen, Johannes; Widen, Elisabeth] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Surakka, Ida; Havulinna, Aki S.; Kettunen, Johannes; Salomaa, Veikko] Natl Inst Hlth & Welf, Helsinki, Finland; [Luoto, Riitta] UKK Inst Hlth Promot, Tampere, Finland	University of Helsinki; Finland National Institute for Health & Welfare; UKK Institute	Widen, E (corresponding author), Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland.	elisabeth.widen@helsinki.fi	Havulinna, Aki/AAM-4769-2021	Surakka, Ida/0000-0002-6669-5541	Academy of Finland [129287, 134839, 120315, 218029]	Academy of Finland(Academy of Finland)	This study has been financially supported by the Academy of Finland (grant no. 129287, 134839, 120315 and 218029; http://www.aka.fi/en-GB/A/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Elks CE, 2010, NAT GENET, V42, P1077, DOI 10.1038/ng.714; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; KAPRIO J, 1995, HUM BIOL, V67, P739; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Medland SE, 2010, AM J HUM GENET, V86, P519, DOI 10.1016/j.ajhg.2010.02.017; Ong KK, 2011, J CLIN ENDOCR METAB, V96, pE125, DOI 10.1210/jc.2010-0941; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schousboe K, 2004, INT J OBESITY, V28, P39, DOI 10.1038/sj.ijo.0802524; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Vartiainen E, 2010, INT J EPIDEMIOL, V39, P504, DOI 10.1093/ije/dyp330; Widen E, 2010, AM J HUM GENET, V86, P773, DOI 10.1016/j.ajhg.2010.03.010; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033; Zhu H, 2010, NAT GENET, V42, P626, DOI 10.1038/ng.593	21	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48785	10.1371/journal.pone.0048785	http://dx.doi.org/10.1371/journal.pone.0048785			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152804	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600013
J	Anderson, NJ; Bonauto, DK; Fan, ZJ; Spector, JT				Anderson, Naomi J.; Bonauto, David K.; Fan, Z. Joyce; Spector, June T.			Distribution of Influenza-Like Illness (ILI) by Occupation in Washington State, September 2009-August 2010	PLOS ONE			English	Article							HEALTH-CARE WORKERS; 2009 H1N1 INFLUENZA; PANDEMIC INFLUENZA; UNITED-STATES; A H1N1; SEASONAL INFLUENZA; RISK; TRANSMISSION; OUTBREAK; STRESS	Objectives: : We aim to estimate the prevalence of influenza-like illness (ILI) by occupation and to identify occupations associated with increased ILI prevalence. Methods: Between September 2009 and August 2010, the Centers for Disease Control (CDC) included questions on ILI symptoms on the Behavioral Risk Factor Surveillance System (BRFSS). Washington State collects the occupation of all employed BRFSS respondents. ILI prevalence and prevalence ratios (PR) were calculated by occupational group. Results: There were 8,758 adult, currently employed, non-military respondents to the Washington BRFSS during the study period. The ILI prevalence for all employed respondents was 6.8% (95% Confidence Interval (95% CI) = 6.1, 7.6). PRs indicated a lower prevalence of ILI in Technicians (PR = 0.4, 95% CI = 0.2, 0.9) and Truck Drivers (PR = 0.2, 95% CI = 0.1, 0.7) and higher prevalence in Janitors and Cleaners (PR = 2.5, 95% CI = 1.3, 4.7) and Secretaries (PR = 2.4, 95% CI = 1.1, 5.4). Conclusions: Some occupations appear to have higher prevalence of ILI than others. These occupational differences may be explained, in part, by differing levels of social contact with the public or contact with contaminated surfaces at work, or by other occupational factors such as stress or access to health care resources.	[Anderson, Naomi J.; Bonauto, David K.; Fan, Z. Joyce] Washington State Dept Labor & Ind, Safety & Hlth Assessment & Res Prevent SHARP Prog, Olympia, WA 98504 USA; [Spector, June T.] Univ Washington, Sch Publ Hlth, Environm & Occupat Hlth Sci Dept, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Anderson, NJ (corresponding author), Washington State Dept Labor & Ind, Safety & Hlth Assessment & Res Prevent SHARP Prog, Olympia, WA 98504 USA.	anna235@lni.wa.gov		Anderson, Naomi/0000-0002-5392-7235	CDC-NIOSH [5U60 OH008487, 214-2010-M-34436]; Washington State Department of Labor and Industries; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [U60OH008487] Funding Source: NIH RePORTER	CDC-NIOSH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Washington State Department of Labor and Industries; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	This publication was supported in part by grant number 5U60 OH008487 from CDC-NIOSH, as well as by CDC-NIOSH contract 214-2010-M-34436; and the Washington State Department of Labor and Industries (http://www.cdc.gov/niosh/, http://www.lni.wa.gov/). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of CDC-NIOSH or the Washington State Department of Labor and Industries. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	[Anonymous], 1999, IND OCC COD DEATH 19; [Anonymous], 2001, STAND OCC IND COD VE; [Anonymous], 1999, IND OCC COD DEAT 19B; Arinaminpathy N, 2012, EPIDEMIOL INFECT, V140, P1102, DOI 10.1017/S0950268811001518; Boivin G, 2000, CLIN INFECT DIS, V31, P1166, DOI 10.1086/317425; BRFSS-Centers for Disease Control and Prevention (CDC), 2009, BEH RISK FACT SURV S; Calatayud L, 2010, EPIDEMIOL INFECT, V138, P183, DOI 10.1017/S0950268809991191; Center for Disease Control, 2011, OV INFL SURV US; Centers for Disease Control and Prevention (CDC), 2011, MMWR Morb Mortal Wkly Rep, V60, P37; Chan PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024734; Cohen S, 1995, AM J RESP CRIT CARE, V152, P553; GDC Healthcare Workers page Centers for Disease Control website, CDC HEALTHC WORK PAG; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; Godbout JP, 2006, J NEUROIMMUNE PHARM, V1, P421, DOI 10.1007/s11481-006-9036-0; GRAHAM NMH, 1986, AM J EPIDEMIOL, V124, P389, DOI 10.1093/oxfordjournals.aje.a114409; JAAKKOLA JJK, 1995, EUR J EPIDEMIOL, V11, P213, DOI 10.1007/BF01719490; Jhung MA, 2011, CLIN INFECT DIS, V52, pS13, DOI 10.1093/cid/ciq008; Karageorgopoulos D. E., 2011, PLoS ONE, pe21690, DOI 10.1371/journal.pone.0021690; Krause N, 2010, AM J IND MED, V53, P372, DOI 10.1002/ajim.20732; Kumar S, 2012, AM J PUBLIC HEALTH, V102, P134, DOI 10.2105/AJPH.2011.300307; Kuster SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026239; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Lovell, 2004, IWPR PUBLICATION; Luckhaupt SE, 2012, EMERG INFECT DIS, V18, P556, DOI 10.3201/eid1804.110337; Marshall C, 2011, EMERG INFECT DIS, V17, P1000, DOI [10.3201/eid1706.101030, 10.3201/eid/1706.101030]; Melchior M, 2005, AM J PUBLIC HEALTH, V95, P1206, DOI 10.2105/AJPH.2004.048835; Mohren DCL, 2003, J OCCUP ENVIRON MED, V45, P123, DOI 10.1097/01.jom.0000052954.59271.2f; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; OSHA, 2007, 332702N OSHA; Perez V, 2012, J EPIDEMIOL COMMUN H, V66, P605, DOI 10.1136/jech.2010.117002; Riphagen-Dalhuisen J, 2012, OCCUP ENVIRON MED, V69, P230, DOI 10.1136/oemed-2011-100134; Santos CD, 2010, DISASTER MED PUBLIC, V4, P47, DOI 10.1017/S193578930000241X; Shrestha SS, 2011, CLIN INFECT DIS, V52, pS75, DOI 10.1093/cid/ciq012; Smolderen KGE, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-339; Suarthana E, 2010, J OCCUP ENVIRON MED, V52, P1212, DOI 10.1097/JOM.0b013e3181fd32e4; Tak S, 2011, J SCHOOL HEALTH, V81, P560, DOI 10.1111/j.1746-1561.2011.00627.x; *US CENS BUR, 2006, AM COMM SURV; US Department of Commerce Bureau of the Census, 1990, CENS BUR ALPH IND IN; Wise ME, 2011, CLIN INFECT DIS, V52, pS198, DOI 10.1093/cid/ciq038	41	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48806	10.1371/journal.pone.0048806	http://dx.doi.org/10.1371/journal.pone.0048806			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039HA	23152808	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000030
J	Glister, C; Satchell, L; Michael, AE; Bicknell, AB; Knight, PG				Glister, Claire; Satchell, Leanne; Michael, Anthony E.; Bicknell, Andrew B.; Knight, Philip G.			The Anti-Epileptic Drug Valproic Acid (VPA) Inhibits Steroidogenesis in Bovine Theca and Granulosa Cells In Vitro	PLOS ONE			English	Article							POLYCYSTIC-OVARY-SYNDROME; FOLLICLE-STIMULATING-HORMONE; HISTONE DEACETYLASE INHIBITORS; BONE MORPHOGENETIC PROTEIN; ANDROGEN BIOSYNTHESIS; INTERNA CELLS; WISTAR RATS; WOMEN; EPILEPSY; ENDOCRINE	Valproic acid (VPA) is used widely to treat epilepsy and bipolar disorder. Women undergoing VPA treatment reportedly have an increased incidence of polycystic ovarian syndrome (PCOS)-like symptoms including hyperandrogenism and oligo- or amenorrhoea. To investigate potential direct effects of VPA on ovarian steroidogenesis we used primary bovine theca (TC) and granulosa (GC) cells maintained under conditions that preserve their 'follicular' phenotype. Effects of VPA (7.8-500 mu g/ml) on TC were tested with/without LH. Effects of VPA on GC were tested with/without FSH or IGF analogue. VPA reduced (P < 0.0001) both basal (70% suppression; IC50 67 +/- 10 mu g/ml) and LH-induced (93% suppression; IC50 58 +/- 10 mu g/ml) androstenedione secretion by TC. VPA reduced CYP17A1 mRNA abundance (> 99% decrease; P < 0.0001) with lesser effects on LHR, STAR, CYP11A1 and HSD3B1 mRNA (< 90% decrease; P < 0.05). VPA only reduced TC progesterone secretion induced by the highest (luteinizing) LH dose tested; TC number was unaffected by VPA. At higher concentrations (125-500 mu g/ml) VPA inhibited basal, FSH- and IGF-stimulated estradiol secretion (P < 0.0001) by GC without affecting progesterone secretion or cell number. VPA reversed FSH-induced upregulation of CYP19A1 and HSD17B1 mRNA abundance (P < 0.001). The potent histone deacetylase (HDAC) inhibitors trichostatin A and scriptaid also suppressed TC androstenedione secretion and granulosal cell oestrogen secretion suggesting that the action of VPA reflects its HDAC inhibitory properties. In conclusion, these findings refute the hypothesis that VPA has a direct stimulatory action on TC androgen output. On the contrary, VPA inhibits both LH-dependent androgen production and FSH/IGF-dependent estradiol production in this in vitro bovine model, likely by inhibition of HDAC.	[Glister, Claire; Satchell, Leanne; Bicknell, Andrew B.; Knight, Philip G.] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Michael, Anthony E.] St Georges Univ London, Div Biomed Sci, London, England	University of Reading; St Georges University London	Knight, PG (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	p.g.knight@reading.ac.uk		knight, philip/0000-0003-0300-1554	Biotechnology and Biological Sciences Research Council [BBS/B/10439, BB/G017174/1]; BBSRC [BB/G017174/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (www.bbsrc.ac.uk/) (grants BBS/B/10439 and BB/G017174/1 to PGK). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilo L, 2008, GYNECOL ENDOCRINOL, V24, P562, DOI 10.1080/09513590802288259; Bleach ECL, 2001, BIOL REPROD, V64, P743, DOI 10.1095/biolreprod64.3.743; Campbell BK, 2003, REPRODUCTION, P429; Chen WY, 2007, MOL CELL BIOL, V27, P7284, DOI 10.1128/MCB.00476-07; Dutta S, 2003, EPILEPSY RES, V53, P29, DOI 10.1016/S0920-1211(02)00252-8; Ferin M, 2003, J CLIN ENDOCR METAB, V88, P2908, DOI 10.1210/jc.2002-021614; Fisseha S, 2010, ENDOCRINE, V37, P187, DOI 10.1007/s12020-009-9287-7; Foldvary N, 2001, NEUROL CLIN, V19, P409, DOI 10.1016/S0733-8619(05)70024-4; Franks S, 2006, INT J ANDROL, V29, P278, DOI 10.1111/j.1365-2605.2005.00623.x; GillingSmith C, 1997, HUM REPROD, V12, P1621, DOI 10.1093/humrep/12.8.1621; Glister C, 2005, ENDOCRINOLOGY, V146, P1883, DOI 10.1210/en.2004-1303; Glister C, 2003, BIOL REPROD, V68, P758, DOI 10.1095/biolreprod.102.008698; Glister C, 2004, REPRODUCTION, V127, P239, DOI 10.1530/rep.1.00090; Glister C, 2001, BIOL REPROD, V65, P1020, DOI 10.1095/biolreprod65.4.1020; Glister C, 2011, REPRODUCTION, V142, P581, DOI 10.1530/REP-11-0150; Glister C, 2010, REPRODUCTION, V140, P699, DOI 10.1530/REP-10-0216; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gougeon A, 1996, ENDOCR REV, V17, P121, DOI 10.1210/er.17.2.121; Gutierrez CG, 1997, BIOL REPROD, V56, P608, DOI 10.1095/biolreprod56.3.608; Harden CL, 2005, EPILEPSY BEHAV, V7, pS2, DOI 10.1016/j.yebeh.2005.08.025; Hillier SG, 2001, MOL CELL ENDOCRINOL, V179, P39, DOI 10.1016/S0303-7207(01)00469-5; HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51, DOI 10.1016/0303-7207(94)90278-X; Isojarvi JIT, 1996, ANN NEUROL, V39, P579, DOI 10.1002/ana.410390506; ISOJARVI JIT, 1993, NEW ENGL J MED, V329, P1383, DOI 10.1056/NEJM199311043291904; Isojarvi J, 2008, SEIZURE-EUR J EPILEP, V17, P111, DOI 10.1016/j.seizure.2007.11.007; Kayani AR, 2009, REPRODUCTION, V137, P67, DOI 10.1530/REP-08-0198; Kendall NR, 2006, J ENDOCRINOL, V189, P455, DOI 10.1677/joe.1.06278; Kramer OH, 2009, TRENDS PHARMACOL SCI, V30, P647, DOI 10.1016/j.tips.2009.09.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mihm M, 2008, REPROD DOMEST ANIM, V43, P48, DOI 10.1111/j.1439-0531.2008.01142.x; Murialdo G, 1998, CLIN NEUROPHARMACOL, V21, P52; Nelson-DeGrave VL, 2004, ENDOCRINOLOGY, V145, P799, DOI 10.1210/en.2003-0940; O'Donovan C, 2002, J CLIN PSYCHIAT, V63, P322, DOI 10.4088/JCP.v63n0409; Pasquali R, 2006, BJOG-INT J OBSTET GY, V113, P1148, DOI 10.1111/j.1471-0528.2006.00990.x; Portela VM, 2010, BIOL REPROD, V83, P339, DOI 10.1095/biolreprod.110.084277; Reynolds MF, 2007, CURR MED CHEM, V14, P2799, DOI 10.2174/092986707782360088; Roste LS, 2002, REPROD TOXICOL, V16, P767; Schimmer BP, 2010, MOL ENDOCRINOL, V24, P1322, DOI 10.1210/me.2009-0519; Sheehan Michael T, 2004, Clin Med Res, V2, P13; Silva JM, 2006, REPRODUCTION, V132, P909, DOI 10.1530/REP-06-0058; Stephen LJ, 2001, EPILEPSIA, V42, P1002, DOI 10.1046/j.1528-1157.2001.0420081002.x; Tannetta DS, 1998, J ENDOCRINOL, V157, P157, DOI 10.1677/joe.0.1570157; Tauboll E, 2003, EPILEPSIA, V44, P1014, DOI 10.1046/j.1528-1157.2003.60702.x; Tauboll E, 1999, SEIZURE-EUR J EPILEP, V8, P490, DOI 10.1053/seiz.1999.0342; Tauboll E, 2008, SEIZURE-EUR J EPILEP, V17, P120, DOI 10.1016/j.seizure.2007.11.008; Tauboll E, 2009, EPILEPSIA, V50, P1868, DOI 10.1111/j.1528-1167.2009.02131.x; TSANG BK, 1985, J REPROD FERTIL, V74, P459, DOI 10.1530/jrf.0.0740459; Vanhaecke T, 2004, CURR MED CHEM, V11, P1629, DOI 10.2174/0929867043365099; Watterson JM, 2002, BRAIN RES, V934, P69, DOI 10.1016/S0006-8993(02)02362-4; Yuan PX, 2001, J BIOL CHEM, V276, P31674, DOI 10.1074/jbc.M104309200	50	26	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49553	10.1371/journal.pone.0049553	http://dx.doi.org/10.1371/journal.pone.0049553			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152920	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000311234000071
J	Jang, HC; Kang, SJ; Choi, SM; Park, KH; Shin, JH; Choy, HE; Jung, SI; Kim, HB				Jang, Hee-Chang; Kang, Seung-Ji; Choi, Su-Mi; Park, Kyung-Hwa; Shin, Jong-Hee; Choy, Hyon E.; Jung, Sook-In; Kim, Hong Bin			Difference in agr Dysfunction and Reduced Vancomycin Susceptibility between MRSA Bacteremia Involving SCCmec Types IV/IVa and I-III	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; MINIMUM INHIBITORY CONCENTRATION; METHICILLIN-RESISTANT; CLINICAL-FEATURES; S. AUREUS; STRAINS; MORTALITY; INFECTION; IMPACT; KOREA	Background: Dysfunction of agr, with reduced susceptibility or hetero-resistance to vancomycin, is thought to be associated with a worse outcome of methicillin-resistant Staphylococcus aureus (MRSA) bacteremia (MRSAB). However, the difference in agr dysfunction according to the SCCmec type in MRSA infection is undetermined. We compared the prevalence of agr dysfunction, reduced vancomycin susceptibility and the outcomes of SCCmec IV/IVa and I-III MRSAB. Methods: The study included 307 cases of MRSAB. SCCmec types were determined by multiplex PCR. The clinical and microbiological features and outcomes of 58 SCCmec IV/IVa MRSAB were compared with those of 249 SCCmec I-III MRSAB. Results: Compared with SCCmec I-III MRSAB, SCCmec IV/IVa MRSAB was associated with lower rates of agr dysfunction (3% vs. 43%), vancomycin minimum inhibitory concentration (MIC) = 2 mu g/mL (3% vs. 15%), and hetero-resistance to vancomycin (0% vs. 8%) (all P<0.05). However, the 30-day and S. aureus-related mortality in patients with SCCmec IV/IVa MRSAB were not different from those in patients with SCCmec I-III MRSAB in multivariate analyses (HR 1.168, 95% CI 0.705-1.938; HR 1.025, 95% CI 0.556-1.889). Conclusions: SCCmec IV/IVa MRSAB was associated with lower rates of agr dysfunction and hetero-resistance to vancomycin and a lower vancomycin MIC, compared with SCCmec I-III MRSAB. However, the outcomes of SCCmec IV/IVa MRSAB did not differ from those of SCCmec I-III MRSAB.	[Jang, Hee-Chang; Kang, Seung-Ji; Choi, Su-Mi; Park, Kyung-Hwa; Jung, Sook-In] Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea; [Shin, Jong-Hee] Chonnam Natl Univ, Sch Med, Dept Lab Med, Kwangju, South Korea; [Choy, Hyon E.] Chonnam Natl Univ, Sch Med, Dept Microbiol, Kwangju, South Korea; [Kim, Hong Bin] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Seoul National University (SNU)	Jung, SI (corresponding author), Chonnam Natl Univ, Sch Med, Dept Infect Dis, Kwangju, South Korea.	sijung@chonnam.ac.kr	Bin Kim, Hong/J-5452-2012	Bin Kim, Hong/0000-0001-6262-372X; Choi, Su-Mi/0000-0002-8187-5110; Kang, Seung ji/0000-0002-3298-0520; Jang, Hee-Chang/0000-0002-3407-8493	Chonnam National University [2009-0543]	Chonnam National University	This study was supported by research funds from Chonnam National University, 2009 (2009-0543). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariza J, 1999, LANCET, V353, P1587, DOI 10.1016/S0140-6736(99)01017-X; Bae IG, 2009, J INFECT DIS, V200, P1355, DOI 10.1086/606027; Cafiso V, 2007, FEMS IMMUNOL MED MIC, V51, P220, DOI 10.1111/j.1574-695X.2007.00298.x; Chen SY, 2010, MEDICINE, V89, P285, DOI 10.1097/MD.0b013e3181f1851e; Cosgrove SE, 2003, CLIN INFECT DIS, V36, P53, DOI 10.1086/345476; David MZ, 2008, J INFECT DIS, V197, P1235, DOI 10.1086/533502; Graber CJ, 2007, EMERG INFECT DIS, V13, P491, DOI 10.3201/eid1303.060960; Hageman JC, 2008, DIAGN MICR INFEC DIS, V62, P440, DOI 10.1016/j.diagmicrobio.2008.08.005; Han JH, 2012, J ANTIMICROB CHEMOTH; Horne KC, 2009, ANTIMICROB AGENTS CH, V53, P3447, DOI 10.1128/AAC.01365-08; Jang HC, 2008, 48 ANN INT C ANT AG; Jang HC, 2009, CLIN INFECT DIS, V49, P395, DOI 10.1086/600295; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Kempker RR, 2010, J INFECTION, V61, P372, DOI 10.1016/j.jinf.2010.09.021; Kennedy AD, 2010, J INFECT DIS, V202, P1050, DOI 10.1086/656043; Kim ES, 2007, J ANTIMICROB CHEMOTH, V60, P1108, DOI 10.1093/jac/dkm309; Kim ES, 2011, J CLIN MICROBIOL, V49, P1979, DOI 10.1128/JCM.00098-11; Kleinschmidt SL, 2006, INT J ANTIMICROB AG, V27, P168, DOI 10.1016/j.ijantimicag.2005.10.009; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Kreisel KM, 2011, DIAGN MICR INFEC DIS, V70, P285, DOI 10.1016/j.diagmicrobio.2011.03.010; Lalueza A, 2010, J INFECT DIS, V201, P311, DOI 10.1086/649572; Li JS, 2000, CLIN INFECT DIS, V30, P633, DOI 10.1086/313753; Lina G, 1999, CLIN INFECT DIS, V29, P1128, DOI 10.1086/313461; Maor Y, 2009, J INFECT DIS, V199, P619, DOI 10.1086/596629; Munckhof WJ, 2004, INT J ANTIMICROB AG, V24, P605, DOI 10.1016/j.ijantimicag.2004.08.009; Musta AC, 2009, J CLIN MICROBIOL, V47, P1640, DOI 10.1128/JCM.02135-08; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Oliveira DC, 2002, ANTIMICROB AGENTS CH, V46, P2155, DOI 10.1128/AAC.46.7.2155-2161.2002; Park C, 2007, J CLIN MICROBIOL, V45, P4021, DOI 10.1128/JCM.01147-07; Peleg AY, 2009, J INFECT DIS, V199, P532, DOI 10.1086/596511; Popovich KJ, 2008, CLIN INFECT DIS, V46, P787, DOI 10.1086/528716; Price J, 2009, CLIN INFECT DIS, V48, P997, DOI 10.1086/597359; Rose WE, 2007, J ANTIMICROB CHEMOTH, V59, P1190, DOI 10.1093/jac/dkm091; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; Schwaber MJ, 2003, EMERG INFECT DIS, V9, P657; Schweizer ML, 2011, ANTIMICROB AGENTS CH, V55, P1082, DOI 10.1128/AAC.00918-10; Shopsin B, 2008, J INFECT DIS, V198, P1171, DOI 10.1086/592051; Sola C, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-15; Soriano A, 2008, CLIN INFECT DIS, V46, P193, DOI 10.1086/524667; Tsuji BT, 2007, ANTIMICROB AGENTS CH, V51, P1089, DOI 10.1128/AAC.00671-06; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; Walraven CJ, 2011, J ANTIMICROB CHEMOTH, V66, P2386, DOI 10.1093/jac/dkr301; Wang JT, 2010, J INFECTION, V61, P449, DOI 10.1016/j.jinf.2010.09.029; Wang JL, 2008, CLIN INFECT DIS, V46, P799, DOI 10.1086/527389; Wong SSY, 1999, CLIN INFECT DIS, V29, P760, DOI 10.1086/520429; Wootton M, 2001, J ANTIMICROB CHEMOTH, V47, P399, DOI 10.1093/jac/47.4.399; Wright JS, 2005, P NATL ACAD SCI USA, V102, P1691, DOI 10.1073/pnas.0407661102	47	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49136	10.1371/journal.pone.0049136	http://dx.doi.org/10.1371/journal.pone.0049136			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152862	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000051
J	Tilburg, CE; McCartney, MA; Yund, PO				Tilburg, Charles E.; McCartney, Michael A.; Yund, Philip O.			Across-Shelf Transport of Bivalve Larvae: Can the Interface between a Coastal Current and Inshore Waters Act as an Ecological Barrier to Larval Dispersal?	PLOS ONE			English	Article							BLUE MUSSELS MYTILUS; CONTINENTAL-SHELF; DELAWARE BAY; VERTICAL-DISTRIBUTION; HOMARUS-AMERICANUS; CRAB LARVAE; TIME-SERIES; MAINE; GULF; CIRCULATION	Using an integrated physical and biological approach, we examined across-shelf advection and exchange and the associated transport of bivalve larvae in the presence of a strong coastal current separated from the coast by a stratified inshore environment. We tested the hypothesis that the interface of the coastal current and inshore waters can act as an ecological barrier to across-shelf transport of larvae but can be overcome by wind-or tidally-induced transport. Our study region in the Gulf of Maine encompasses a coastal current that diverges from the coast as it moves downshelf. The region inshore of this current is home to several species that exhibit limited recruitment in spite of extensive upshelf larval sources. Analysis of surface water temperatures and wind velocities revealed episodic decreases in temperature along the coast correlated with alongshelf (but not upwelling) winds, indicating wind-forced onshore movement of the cold coastal current. Such wind-driven onshore migrations are more common along the northern portion of the study region where the coastal current is near the coast, tidal currents are strong, and wind directions are more conducive to onshore migration, but rarer further south where the interface between inshore waters and the coastal current is further offshore and suitable wind events are less common. The distribution of bivalve larvae was consistent with the physical measurements. There was little across-shelf variation in larval abundance where the current abuts the coast, indicating strong across-shelf exchange of larvae, but strong across-shelf variation in larval density where the stratified inshore waters separate the current from the coast, indicating weak across-shelf transport of larvae. Our results suggest that the interface between the coastal current and inshore waters may constitute a major ecological barrier to larval dispersal in the southern part of the region that may only be overcome by rare, strong wind-forced events.	[Tilburg, Charles E.; Yund, Philip O.] Univ New England, Dept Marine Sci, Biddeford, ME USA; [McCartney, Michael A.] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC 28401 USA	University of New England - Maine; University of North Carolina; University of North Carolina Wilmington	Tilburg, CE (corresponding author), Univ New England, Dept Marine Sci, Biddeford, ME USA.	ctilburg@une.edu		Yund, Philip/0000-0003-0474-5205	National Science Foundation [OCE-0961157]; Directorate For Geosciences [1233868] Funding Source: National Science Foundation; Division Of Ocean Sciences [0961325] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Ocean Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This research was supported by funds from the National Science Foundation (OCE-0961157; www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annis ER, 2005, LIMNOL OCEANOGR, V50, P1972, DOI 10.4319/lo.2005.50.6.1972; [Anonymous], 2010, REPORT BY THE DEPART, P2; Austin JA, 2002, J PHYS OCEANOGR, V32, P2171, DOI 10.1175/1520-0485(2002)032<2171:TISRTW>2.0.CO;2; BAYNE BL, 1963, NATURE, V198, P406, DOI 10.1038/198406b0; BEARDSLEY RC, 1985, J PHYS OCEANOGR, V15, P713, DOI 10.1175/1520-0485(1985)015<0713:TNSFEP>2.0.CO;2; Bisagni JJ, 1996, CONT SHELF RES, V16, P1, DOI 10.1016/0278-4343(95)00002-I; Bishop TD, 2010, ESTUAR COAST, V33, P688, DOI 10.1007/s12237-009-9259-4; Bretherton CS, 1999, J CLIMATE, V12, P1990, DOI 10.1175/1520-0442(1999)012<1990:TENOSD>2.0.CO;2; BROOKS DA, 1985, J GEOPHYS RES-OCEANS, V90, P4687, DOI 10.1029/JC090iC03p04687; BROWN WS, 1992, J PHYS OCEANOGR, V22, P445, DOI 10.1175/1520-0485(1992)022<0445:TAEOGF>2.0.CO;2; Chicharo LMZ, 2000, J EXP MAR BIOL ECOL, V243, P81; Cowen RK, 2002, REPORT OF A WORKSHOP; Criales MM, 2007, MAR ECOL PROG SER, V345, P167, DOI 10.3354/meps06916; Cudaback CN, 2009, ESTUAR COAST SHELF S, V83, P349, DOI 10.1016/j.ecss.2008.12.018; DAVIS RE, 1985, J GEOPHYS RES-OCEANS, V90, P4741, DOI 10.1029/JC090iC03p04741; Dobretsov SV, 2001, MAR ECOL PROG SER, V218, P179, DOI 10.3354/meps218179; Emery WJ, 2001, DATA ANALYSIS METHOD; Epifanio CE, 2001, ESTUAR COAST SHELF S, V52, P51, DOI 10.1006/ecss.2000.0727; Epifanio CE, 2008, J MAR RES, V66, P723, DOI 10.1357/002224008788064586; Fong DA, 2001, J GEOPHYS RES-OCEANS, V106, P1067, DOI 10.1029/2000JC900134; Forward RB, 2001, OCEANOGR MAR BIOL, V39, P305; Freeman KR, 2002, J SHELLFISH RES, V21, P59; Garraffo ZD, 2001, J MARINE SYST, V29, P157, DOI 10.1016/S0924-7963(01)00015-X; Garvine R. W., 1971, J PHYS OCEANOGR, V1, P169, DOI [10.1175/1520-0485(1971)001<0169:ASMOCU>2.0.CO;2, DOI 10.1175/1520-0485(1971)001<0169:>ASMOCU>2.0.CO;2]; Garvine RW, 1997, ESTUAR COAST SHELF S, V45, P99, DOI 10.1006/ecss.1996.0161; GARVINE RW, 1991, J GEOPHYS RES-OCEANS, V96, P7049, DOI 10.1029/91JC00079; Geyer WR, 2004, CONT SHELF RES, V24, P1339, DOI 10.1016/j.csr.2004.04.001; Hayhurst S, 2009, J MOLLUS STUD, V75, P215, DOI 10.1093/mollus/eyp019; Hetland RD, 2005, DEEP-SEA RES PT II, V52, P2430, DOI 10.1016/j.dsr2.2005.06.024; HIDU H, 1978, ESTUARIES, V1, P252, DOI 10.2307/1351527; JONES MB, 1995, MAR ECOL PROG SER, V125, P67, DOI 10.3354/meps125067; KELLY KA, 1988, J PHYS OCEANOGR, V18, P906, DOI 10.1175/1520-0485(1988)018<0906:TROSSA>2.0.CO;2; Lutz RA, 1992, THE MUSSEL MYTILUS E, P53; Lynch DR, 1997, CONT SHELF RES, V17, P605, DOI 10.1016/S0278-4343(96)00055-6; Manning JP, 2009, CONT SHELF RES, V29, P835, DOI 10.1016/j.csr.2008.12.008; McNaught DC, 1998, FINAL REPORT TO THE; Morgan SG, 2010, MAR ECOL PROG SER, V404, P109, DOI 10.3354/meps08476; MORK M, 1981, PHILOS T R SOC A, V302, P635, DOI 10.1098/rsta.1981.0188; Mupparapu P, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/1999JC000116; Ogburn MB, 2009, MAR ECOL PROG SER, V389, P181, DOI 10.3354/meps08139; Pettigrew NR, 2005, DEEP-SEA RES PT II, V52, P2369, DOI 10.1016/j.dsr2.2005.06.033; Pettigrew NR, 1998, J GEOPHYS RES-OCEANS, V103, P30623, DOI 10.1029/98JC01625; Rawson PD, 1996, GENETICS, V144, P241; Sanders TM, 2001, J GEOPHYS RES-OCEANS, V106, P27087, DOI 10.1029/2001JC000802; Shanks AL, 2006, MAR BIOL, V148, P1383, DOI 10.1007/s00227-005-0162-7; Shanks AL, 2005, MAR ECOL PROG SER, V302, P1, DOI 10.3354/meps302001; Steneck RS, 2001, MAR FRESHWATER RES, V52, P1303, DOI 10.1071/MF01173; Tilburg CE, 2005, J MAR RES, V63, P471, DOI 10.1357/0022240053693699; Tilburg CE, 2003, J PHYS OCEANOGR, V33, P2675, DOI 10.1175/1520-0485(2003)033<2675:ATOACS>2.0.CO;2; Tilburg CE, 2003, J PHYS OCEANOGR, V33, P2113, DOI 10.1175/1520-0485(2003)033<2113:TFIASC>2.0.CO;2; WING SR, 1995, LIMNOL OCEANOGR, V40, P316, DOI 10.4319/lo.1995.40.2.0316; Woodson CB, 2012, LIMNOL OCEANOGR, V57, P582, DOI 10.4319/lo.2012.57.2.0582; Xue HJ, 2000, J PHYS OCEANOGR, V30, P1111, DOI 10.1175/1520-0485(2000)030<1111:AMSOTS>2.0.CO;2; Xue HJ, 2008, ECOL MODEL, V210, P193, DOI 10.1016/j.ecolmodel.2007.07.024	54	15	15	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48960	10.1371/journal.pone.0048960	http://dx.doi.org/10.1371/journal.pone.0048960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152830	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234000039
J	Banakh, I; Gonez, LJ; Sutherland, RM; Naselli, G; Harrison, LC				Banakh, Ilia; Gonez, Leonel J.; Sutherland, Robyn M.; Naselli, Gaetano; Harrison, Leonard C.			Adult Pancreas Side Population Cells Expand after beta Cell Injury and Are a Source of Insulin-Secreting Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PROGENITOR CELLS; ISLET TRANSPLANTATION; MOUSE PANCREAS; IN-VIVO; REGENERATION; PHENOTYPE; SURFACE; DIFFERENTIATION; MAINTENANCE	Pancreas stem cells are a potential source of insulin-producing beta cells for the therapy of diabetes. In adult tissues the 'side population' (SP) of cells that effluxes the DNA binding dye Hoechst 33342 through ATP-binding cassette transporters has stem cell properties. We hypothesised therefore that the SP would expand in response to b cell injury and give rise to functional b cells. SP cells were flow sorted from dissociated pancreas cells of adult mice, analysed for phenotype and cultured with growth promoting and differentiation factors before analysis for hormone expression and glucose-stimulated insulin secretion. SP cell number and colony forming potential (CFP) increased significantly in models of type diabetes, and after partial pancreatectomy, in the absence of hyperglycaemia. SP cells, similar to 1% of total pancreas cells at 1 week of age, were enriched >10-fold for CFP compared to non-SP cells. Freshly isolated SP cells contained no insulin protein or RNA but expressed the homeobox transcription factor Pdx1 required for pancreas development and beta cell function. Pdx1, along with surface expression of CD326 (Ep-Cam), was a marker of the colony forming and proliferation potential of SP cells. In serum-free medium with defined factors, SP cells proliferated and differentiated into islet hormone-expressing cells that secreted insulin in response to glucose. Insulin expression was maintained when tissue was transplanted within vascularised chambers into diabetic mice. SP cells in the adult pancreas expand in response to beta cell injury and are a source of beta cell progenitors with potential for the treatment of diabetes. Citation: Banakh I, Gonez LJ, Sutherland RM, Naselli G, Harrison LC (2012) Adult Pancreas Side Population Cells Expand after beta Cell Injury and Are a Source of Insulin-Secreting Cells. PLoS ONE 7(11): e48977. doi:10.1371/journal.pone.0048977	[Banakh, Ilia; Gonez, Leonel J.; Sutherland, Robyn M.; Naselli, Gaetano; Harrison, Leonard C.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Banakh, Ilia; Gonez, Leonel J.; Sutherland, Robyn M.; Naselli, Gaetano; Harrison, Leonard C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Melbourne	Harrison, LC (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	harrison@wehi.edu.au			Juvenile Diabetes Research Foundation (JDRF) [4-2006-1025]; National Health and Medical Research Council of Australia (Fellowship) [637301]	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); National Health and Medical Research Council of Australia (Fellowship)	This work was funded by the Juvenile Diabetes Research Foundation (JDRF) (Project Grant 4-2006-1025) and National Health and Medical Research Council of Australia (Fellowship 637301 to LCH) and made possible through Victorian State Government Operational Infrastructure Support and Australian Government NHMRC IRIIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augstein P, 1998, MOL MED, V4, P495, DOI 10.1007/BF03401754; Baetge EE, 2008, DIABETES OBES METAB, V10, P186, DOI 10.1111/j.1463-1326.2008.00956.x; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Best M, 2008, MOL CELL ENDOCRINOL, V288, P86, DOI 10.1016/j.mce.2008.03.008; Bhatt RI, 2003, CYTOM PART A, V54A, P89, DOI 10.1002/cyto.a.10058; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Bonner-Weir S, 2004, PEDIATR DIABETES, V5, P16, DOI 10.1111/j.1399-543X.2004.00075.x; Budak MT, 2005, J CELL SCI, V118, P1715, DOI 10.1242/jcs.02279; Butler AE, 2010, DIABETOLOGIA, V53, P21, DOI 10.1007/s00125-009-1556-8; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Cirulli V, 1998, J CELL BIOL, V140, P1519, DOI 10.1083/jcb.140.6.1519; Cnop M, 2011, DIABETES OBES METAB, V13, P39, DOI 10.1111/j.1463-1326.2011.01443.x; Cronin KJ, 2004, PLAST RECONSTR SURG, V113, P260, DOI 10.1097/01.PRS.0000095942.71618.9D; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Dekaney CM, 2005, GASTROENTEROLOGY, V129, P1567, DOI 10.1053/j.gastro.2005.08.011; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fukaya R, 2010, CANCER LETT, V291, P150, DOI 10.1016/j.canlet.2009.10.010; Gonzalez B, 2009, STEM CELLS, V27, P1782, DOI 10.1002/stem.97; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Hentze H, 2009, STEM CELL RES, V2, P198, DOI 10.1016/j.scr.2009.02.002; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Holland AM, 2004, DIABETES-METAB RES, V20, P13, DOI 10.1002/dmrr.430; Holland AM, 2006, GENESIS, V44, P304, DOI 10.1002/dvg.20214; Inada A, 2008, P NATL ACAD SCI USA, V105, P19915, DOI 10.1073/pnas.0805803105; Lardon J, 2008, PANCREAS, V36, pE1, DOI 10.1097/mpa.0b013e318149f2dc; Lechner A, 2002, BIOCHEM BIOPH RES CO, V293, P670, DOI 10.1016/S0006-291X(02)00275-9; Li WC, 2010, J CELL SCI, V123, P2792, DOI 10.1242/jcs.065268; Lin HT, 2006, WORLD J GASTROENTERO, V12, P4529, DOI 10.3748/wjg.v12.i28.4529; Meier JJ, 2006, DIABETOLOGIA, V49, P1838, DOI 10.1007/s00125-006-0308-2; Meier JJ, 2005, DIABETOLOGIA, V48, P2221, DOI 10.1007/s00125-005-1949-2; Montanaro F, 2003, P NATL ACAD SCI USA, V100, P9336, DOI 10.1073/pnas.1133179100; Nagano K, 2008, PROTEOMICS, V8, P4025, DOI 10.1002/pmic.200800073; Nash R, 2007, STEM CELLS, V25, P974, DOI 10.1634/stemcells.2006-0224; Nir T, 2007, J CLIN INVEST, V117, P2553, DOI 10.1172/JCI32959; Poliakova L, 2004, TRANSPL P, V36, P1166, DOI 10.1016/j.transproceed.2004.04.058; Rankin MM, 2009, DIABETES, V58, P1365, DOI 10.2337/db08-1198; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Sutherland Robyn M, 2002, Int J Exp Diabetes Res, V3, P37, DOI 10.1080/15604280212530; Suzuki S, 2004, DIABETES, V53, pA214, DOI 10.2337/diabetes.53.8.2143; Welm B, 2003, CELL PROLIFERAT, V36, P17, DOI 10.1046/j.1365-2184.36.s.1.3.x; Wiles MV, 1999, EXP CELL RES, V247, P241, DOI 10.1006/excr.1998.4353; Wulf GG, 2003, HAEMATOLOGICA, V88, P368; Xu G, 1999, DIABETES, V48, P2270, DOI 10.2337/diabetes.48.12.2270; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yano S, 2005, STEM CELLS, V23, P834, DOI 10.1634/stemcells.2004-0226; Zhang L, 2005, BIOCHEM BIOPH RES CO, V333, P603, DOI 10.1016/j.bbrc.2005.05.111	49	14	15	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48977	10.1371/journal.pone.0048977	http://dx.doi.org/10.1371/journal.pone.0048977			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152835	Green Published, gold			2022-12-27	WOS:000312272600034
J	Bush, EC; Clark, AE; DeBoever, CM; Haynes, LE; Hussain, S; Ma, S; McDermott, MM; Novak, AM; Wentworth, JS				Bush, Eliot C.; Clark, Anne E.; DeBoever, Chris M.; Haynes, Lillian E.; Hussain, Sidra; Ma, Singer; McDermott, Matthew M.; Novak, Adam M.; Wentworth, John S.			Modeling the Role of Negative Cooperativity in Metabolic Regulation and Homeostasis	PLOS ONE			English	Article							FEEDBACK-CONTROL; STRUCTURAL BASIS; OPTIMAL DESIGN; ENZYMES; INHIBITION; RECEPTOR; EQUATION; BINDING; SYSTEMS	A significant proportion of enzymes display cooperativity in binding ligand molecules, and such effects have an important impact on metabolic regulation. This is easiest to understand in the case of positive cooperativity. Sharp responses to changes in metabolite concentrations can allow organisms to better respond to environmental changes and maintain metabolic homeostasis. However, despite the fact that negative cooperativity is almost as common as positive, it has been harder to imagine what advantages it provides. Here we use computational models to explore the utility of negative cooperativity in one particular context: that of an inhibitor binding to an enzyme. We identify several factors which may contribute, and show that acting together they can make negative cooperativity advantageous. Citation: Bush EC, Clark AE, DeBoever CM, Haynes LE, Hussain S, et al. (2012) Modeling the Role of Negative Cooperativity in Metabolic Regulation and Homeostasis. PLoS ONE 7(11): e48920. doi:10.1371/journal.pone.0048920	[Bush, Eliot C.; Clark, Anne E.; DeBoever, Chris M.; Haynes, Lillian E.; Hussain, Sidra; Ma, Singer; McDermott, Matthew M.; Novak, Adam M.; Wentworth, John S.] Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA	Claremont Colleges; Harvey Mudd College	Bush, EC (corresponding author), Harvey Mudd Coll, Dept Biol, Claremont, CA 91711 USA.	eliot.bush@hmc.edu	DeBoever, Christopher/ABA-9512-2020	McDermott, Matthew/0000-0001-6048-9707; DeBoever, Christopher/0000-0002-1901-2576; Clark, Anne/0000-0003-2105-3032; Novak, Adam/0000-0001-5828-047X	National Science Foundation (NSF) [MCB-0918335]; Howard Hughes Medical Institute; Div Of Molecular and Cellular Bioscience [0918335] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Support was provided by National Science Foundation (NSF) grant to EB (MCB-0918335) (nsf.gov) and an institutional grant to Harvey Mudd College from the Howard Hughes Medical Institute (www.hhmi.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; BUCHER T, 1964, ANGEW CHEM INT EDIT, V3, P426, DOI 10.1002/anie.196404261; CORNISHBOWDEN A, 1975, J MOL BIOL, V95, P201, DOI 10.1016/0022-2836(75)90390-3; Fell D., 1997, UNDERSTANDING CONTRO; GERHART JC, 1962, J BIOL CHEM, V237, P891; HILL CM, 1977, MOL CELL BIOCHEM, V15, P173, DOI 10.1007/BF01734107; HOFMEYR JHS, 1991, EUR J BIOCHEM, V200, P223, DOI 10.1111/j.1432-1033.1991.tb21071.x; Hofmeyr JHS, 1997, COMPUT APPL BIOSCI, V13, P377; HOPKINSON DA, 1976, ANN HUM GENET, V39, P383, DOI 10.1111/j.1469-1809.1976.tb00144.x; Koshland D E Jr, 1968, Adv Enzyme Regul, V6, P291, DOI 10.1016/0065-2571(68)90018-6; Koshland DE, 1996, CURR OPIN STRUC BIOL, V6, P757, DOI 10.1016/S0959-440X(96)80004-2; Koshland DE, 2002, J BIOL CHEM, V277, P46841, DOI 10.1074/jbc.R200014200; LEVITZKI A, 1969, P NATL ACAD SCI USA, V62, P1121, DOI 10.1073/pnas.62.4.1121; MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1; Pizard A, 1998, J BIOL CHEM, V273, P1309, DOI 10.1074/jbc.273.3.1309; Savageau M, 1976, BIOCH SYSTEMS ANAL S, V56; SAVAGEAU MA, 1975, J MOL EVOL, V5, P199, DOI 10.1007/BF01741242; SAVAGEAU MA, 1974, J MOL EVOL, V4, P139, DOI 10.1007/BF01732019; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; TRAUT TW, 1994, CRIT REV BIOCHEM MOL, V29, P125, DOI 10.3109/10409239409086799; TRAUT TW, 1988, CRC CR REV BIOCH MOL, V23, P121, DOI 10.3109/10409238809088318	21	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48920	10.1371/journal.pone.0048920	http://dx.doi.org/10.1371/journal.pone.0048920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152821	Green Published, gold, Green Submitted			2022-12-27	WOS:000312272600029
J	Liu, H; Xu, JY; Shan, BC; Li, YZ; Li, L; Xue, JQ; Nie, BB				Liu, Hua; Xu, Jianyang; Shan, Baoci; Li, Yongzhong; Li, Lin; Xue, Jingquan; Nie, Binbin			Determining the Precise Cerebral Response to Acupuncture: An Improved fMRI Study	PLOS ONE			English	Article							HUMAN BRAIN; STIMULATION; PAIN; ELECTROACUPUNCTURE; EXPERIENCE; EXPECTANCY; MODULATION; MECHANISMS; NEEDLE; SYSTEM	Background: In acupuncture brain imaging trials, there are many non-acupuncture factors confounding the neuronal mapping. The modality of the placebo, subjects' psychological attitude to acupuncture and their physical state are the three most confounding factors. Objective: To obtain more precise and accurate cerebral fMRI mapping of acupuncture. Design and Setting: A 2x2 randomized, controlled, participant-blinded cross-over factorial acupuncture trial was conducted at Xuanwu Hospital in Beijing, China. Participants: Forty-one college students with myopia were recruited to participate in our study and were allocated randomly to four groups, Group A, Group B, Group C and Group D. Interventions: Group A received real acupuncture (RA) and treatment instruction (TI); Group B received RA and non-treatment instruction (NI); Group C received sham acupuncture (SA) and TI; Group D received SA and NI. Results: Stimulation at LR3 activated some areas of the visual cortex, and the cerebral response to non-acupuncture factors was complex and occurred in multiple areas. Conclusions: The results provide more evidence regarding the credibility of acupuncture therapy and suggest that more precise experimental designs are needed to eliminate sources of bias in acupuncture controlled trials and to obtain sound results. Citation: Liu H, Xu J, Shan B, Li Y, Li L, et al. (2012) Determining the Precise Cerebral Response to Acupuncture: An Improved fMRI Study. PLoS ONE 7(11): e49154. doi: 10.1371/journal.pone.0049154	[Liu, Hua; Shan, Baoci; Li, Lin; Xue, Jingquan; Nie, Binbin] Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China; [Liu, Hua] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Liu, Hua; Shan, Baoci; Li, Lin; Xue, Jingquan; Nie, Binbin] Chinese Acad Sci, Key Lab Nucl Anal Tech LNAT, Beijing, Peoples R China; [Xu, Jianyang] Gen Hosp Armed Police Forces, Beijing, Peoples R China; [Li, Yongzhong] Capital Med Univ, Xuanwu Hosp, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of High Energy Physics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Capital Medical University	Liu, H (corresponding author), Chinese Acad Sci, Inst High Energy Phys, Beijing, Peoples R China.	liuhua@ihep.ac.cn		Nie, Binbin/0000-0002-8038-7772; Shan, Baoci/0000-0001-7417-5063; Liu, Hua/0000-0002-0301-3144				Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; DUNDEE JW, 1992, BRIT J ANAESTH, V68, P225, DOI 10.1093/bja/68.2.225-a; Fang B, 1999, Diagn Imaging (San Franc), V21, P19; Ghose GM, 2002, J NEUROPHYSIOL, V87, P1867, DOI 10.1152/jn.00690.2001; Hui KKS, 2000, HUM BRAIN MAPP, V9, P13, DOI 10.1002/(SICI)1097-0193(2000)9:1<13::AID-HBM2>3.0.CO;2-F; Kim MS, 2005, J VET MED SCI, V67, P1281, DOI 10.1292/jvms.67.1281; Kong JA, 2002, J ALTERN COMPLEM MED, V8, P411, DOI 10.1089/107555302760253603; LEWITH GT, 1983, PAIN, V16, P111, DOI 10.1016/0304-3959(83)90202-6; Pariente J, 2005, NEUROIMAGE, V25, P1161, DOI 10.1016/j.neuroimage.2005.01.016; Park H, 2002, AM J CHINESE MED, V30, P45, DOI 10.1142/S0192415X02000053; Price DD, 2000, SCIENCE, V288, P1769, DOI 10.1126/science.288.5472.1769; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Schmahmann JD, 1997, INT REV NEUROBIOL, V41, P31, DOI 10.1016/S0074-7742(08)60346-3; Streitberger K, 1998, LANCET, V352, P364, DOI 10.1016/S0140-6736(97)10471-8; Ueda K, 2003, NEUROREPORT, V14, P51, DOI 10.1097/00001756-200301200-00010; Uhrig S, 2003, FORSCH KOMP KLAS NAT, V10, P256, DOI 10.1159/000074780; VINCENT C, 1995, J ROY SOC MED, V88, P199; VINCENT CA, 1986, PAIN, V24, P1, DOI 10.1016/0304-3959(86)90022-9; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wu MT, 1999, RADIOLOGY, V212, P133, DOI 10.1148/radiology.212.1.r99jl04133; Wu MT, 2002, NEUROIMAGE, V16, P1028, DOI 10.1006/nimg.2002.1145; Yan B, 2005, NEUROSCI LETT, V383, P236, DOI 10.1016/j.neulet.2005.04.021; Yoo SS, 2004, NEUROIMAGE, V22, P932, DOI 10.1016/j.neuroimage.2004.02.017; Zhang WT, 2003, NEUROREPORT, V14, P1591, DOI 10.1097/00001756-200308260-00010	24	10	11	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49154	10.1371/journal.pone.0049154	http://dx.doi.org/10.1371/journal.pone.0049154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152865	Green Published, Green Submitted, gold			2022-12-27	WOS:000312272600049
J	Gao, M; Danielsen, JR; Wei, LZ; Zhou, DP; Xu, Q; Li, MM; Wang, ZQ; Tong, WM; Yang, YG				Gao, Min; Danielsen, Jannie Rendtlew; Wei, Lei-Zhen; Zhou, Dong-Ping; Xu, Qian; Li, Miao-Miao; Wang, Zhao-Qi; Tong, Wei-Min; Yang, Yun-Gui			A Novel Role of Human Holliday Junction Resolvase GEN1 in the Maintenance of Centrosome Integrity	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE; S-PHASE; AMPLIFICATION; RESOLUTION; NUCLEAR; SGS1; CROSSOVERS; LOCALIZES; PHENOTYPE	The maintenance of genomic stability requires accurate genome replication, repair of DNA damage, and the precise segregation of chromosomes in mitosis. GEN1 possesses Holliday junction resolvase activity in vitro and presumably functions in homology driven repair of DNA double strand breaks. However, little is currently known about the cellular functions of human GEN1. In the present study we demonstrate that GEN1 is a novel centrosome associated protein and we characterize the various phenotypes associated with GEN1 deficiency. We identify an N-terminal centrosome localization signal in GEN1, which is required and sufficient for centrosome localization. We report that GEN1 depletion results in aberrant centrosome numbers associated with the formation of multiple spindle poles in mitosis, an increased number of cells with multi-nuclei, increased apoptosis and an elevated level of spontaneous DNA damage. We find homologous recombination severely impaired in GEN1 deficient cells, suggesting that GEN1 functions as a Holliday junction resolvase in vivo as well as in vitro. Complementation of GEN1 depleted cells with various GEN1 constructs revealed that centrosome association but not catalytic activity of GEN1 is required for preventing centrosome hyper-amplification, formation of multiple mitotic spindles, and multi-nucleation. Our findings provide novel insight into the biological functions of GEN1 by uncovering an important role of GEN1 in the regulation of centrosome integrity.	[Gao, Min; Danielsen, Jannie Rendtlew; Wei, Lei-Zhen; Zhou, Dong-Ping; Xu, Qian; Li, Miao-Miao; Yang, Yun-Gui] Chinese Acad Sci, Beijing Inst Genom, Dis Genom & Individualized Med Lab, Beijing, Peoples R China; [Danielsen, Jannie Rendtlew] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Wang, Zhao-Qi] Univ Jena, Leibniz Inst Age Res, Fritz Lipmann Inst eV, Jena, Germany; [Wang, Zhao-Qi] Univ Jena, Fac Biol Pharm, Jena, Germany; [Tong, Wei-Min] Chinese Acad Med Sci, Dept Pathol, Beijing 100730, Peoples R China; [Tong, Wei-Min] Chinese Acad Med Sci, Ctr Expt Anim Res, Beijing 100730, Peoples R China; [Tong, Wei-Min] Peking Union Med Coll, Beijing 100021, Peoples R China; [Gao, Min; Li, Miao-Miao] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Copenhagen; Friedrich Schiller University of Jena; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Friedrich Schiller University of Jena; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, YG (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Dis Genom & Individualized Med Lab, Beijing, Peoples R China.	ygyang@big.ac.cn	Yang, Yungui/ABF-2507-2021	/0000-0002-5592-9349	973 programs [2011CB510103]; China Natural Science Foundation [30871235, 31150110143]; Danish Medical Research Council [10-094962, 10-094964]; NSFC [81000866]	973 programs(National Basic Research Program of China); China Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by the 973 programs (2011CB510103 to Y.G.Y.), China Natural Science Foundation (30871235 to Y.G.Y., 31150110143 to J.R.M.D.), and Danish Medical Research Council (10-094962 and 10-094964 to J.M.R.D). One of the co-first authors L. W. was supported by NSFC (81000866). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham J, 2003, EMBO J, V22, P6137, DOI 10.1093/emboj/cdg580; Alderton GK, 2004, HUM MOL GENET, V13, P3127, DOI 10.1093/hmg/ddh335; Bailly AP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001025; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Blanco MG, 2010, DNA REPAIR, V9, P394, DOI 10.1016/j.dnarep.2009.12.017; Bourke E, 2007, EMBO REP, V8, P603, DOI 10.1038/sj.embor.7400962; Cappelli E, 2011, EXP CELL RES, V317, P1203, DOI 10.1016/j.yexcr.2011.01.021; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; ELBOROUGH KM, 1990, EMBO J, V9, P2931, DOI 10.1002/j.1460-2075.1990.tb07484.x; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fukasawa K, 1996, SCIENCE, V271, P1744, DOI 10.1126/science.271.5256.1744; Gravel S, 2008, GENE DEV, V22, P2767, DOI 10.1101/gad.503108; Griffin CS, 2000, NAT CELL BIOL, V2, P757, DOI 10.1038/35036399; Gromley A, 2003, J CELL BIOL, V161, P535, DOI 10.1083/jcb.200301105; Guiducci C, 2001, ONCOGENE, V20, P714, DOI 10.1038/sj.onc.1204145; Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Ip SCY, 2008, NATURE, V456, P357, DOI 10.1038/nature07470; Ira G, 2003, CELL, V115, P401, DOI 10.1016/S0092-8674(03)00886-9; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lorenz A, 2010, NUCLEIC ACIDS RES, V38, P1866, DOI 10.1093/nar/gkp1179; Matos J, 2011, CELL, V147, P158, DOI 10.1016/j.cell.2011.08.032; Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544; Meigs TE, 2008, CSH PROT 2008; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Meraldi P, 1999, NAT CELL BIOL, V1, P88, DOI 10.1038/10054; Mimitou EP, 2008, NATURE, V455, P770, DOI 10.1038/nature07312; Nakanishi A, 2007, BIOCHEM BIOPH RES CO, V355, P34, DOI 10.1016/j.bbrc.2007.01.100; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Osman F, 2003, MOL CELL, V12, P761, DOI 10.1016/S1097-2765(03)00343-5; Pardo B, 2009, CELL MOL LIFE SCI, V66, P1039, DOI 10.1007/s00018-009-8740-3; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Prasanth SG, 2004, EMBO J, V23, P2651, DOI 10.1038/sj.emboj.7600255; Shimada M, 2009, J RADIAT RES, V50, P295, DOI 10.1269/jrr.09039; Sibon OCM, 2003, NAT GENET, V34, P6, DOI 10.1038/ng0503-6; Svendsen JM, 2010, GENE DEV, V24, P521, DOI 10.1101/gad.1903510; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Wechsler T, 2011, NATURE, V471, P642, DOI 10.1038/nature09790; West SC, 2009, BIOCHEM SOC T, V37, P519, DOI 10.1042/BST0370519; Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Xia B, 2006, MOL CELL, V22, P719, DOI 10.1016/j.molcel.2006.05.022; Xu XL, 1999, MOL CELL, V3, P389, DOI 10.1016/S1097-2765(00)80466-9; Yang YG, 2004, ONCOGENE, V23, P3872, DOI 10.1038/sj.onc.1207491; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Zhang J, 2009, J BIOL CHEM, V284, P21659, DOI 10.1074/jbc.M109.007278; Zhu Z, 2008, CELL, V134, P981, DOI 10.1016/j.cell.2008.08.037	52	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49687	10.1371/journal.pone.0049687	http://dx.doi.org/10.1371/journal.pone.0049687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166748	Green Published, gold, Green Submitted			2022-12-27	WOS:000311885300059
J	Monk, JM; Hou, TY; Turk, HF; Weeks, B; Wu, CD; McMurray, DN; Chapkin, RS				Monk, Jennifer M.; Hou, Tim Y.; Turk, Harmony F.; Weeks, Brad; Wu, Chaodong; McMurray, David N.; Chapkin, Robert S.			Dietary n-3 Polyunsaturated Fatty Acids (PUFA) Decrease Obesity-Associated Th17 Cell-Mediated Inflammation during Colitis	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; BODY-MASS INDEX; INSULIN-RESISTANCE; CROHNS-DISEASE; CLINICAL-COURSE; MACROPHAGES; MICE; RECEPTOR; ACCUMULATION; PATHOGENESIS	Clinical and experimental evidence suggests that obesity-associated inflammation increases disease activity during colitis, attributed in part to the effects of Th17 cells. Using a model of concurrent obesity and colitis, we monitored changes in critical immune cell subsets and inflammatory biomarker expression in three key tissues: visceral adipose tissue, colon (local inflammatory site) and spleen (systemic inflammatory site), and we hypothesized that n-3 PUFA would reduce the percentage of inflammatory immune cell subsets and suppress inflammatory gene expression, thereby improving the disease phenotype. Obesity was induced in C57BL/6 mice by feeding a high fat (HF) diet (59.2% kcal) alone or an isocaloric HF diet supplemented with fish oil (HF-FO) for 12 weeks. Colitis was induced via a 2.5% trinitrobenzene sulfonic acid (TNBS) enema. The HF-FO diet improved the obese phenotype by reducing i) serum hormone concentrations (leptin and resistin), ii) adipose tissue mRNA expression of inflammatory cytokines (MCP-1, IFN gamma, IL-6, IL17F and IL-21) and iii) total (F4/80(+) CD11b(+)) and inflammatory adipose tissue M1 (F4/80(+) CD11c(+)) macrophage content compared to HF (P<0.05). In addition, the HF-FO diet reduced both colitis-associated disease severity and colonic mRNA expression of the Th17 cell master transcription factor (ROR gamma tau) and critical cytokines (IL-6, IL-17A, IL-17F, IL-21, IL-23 and IFN gamma) versus HF (P<0.05). Compared to HF, the percentage of both splenic Th17 and Th1 cells were reduced by the HF-FO group (P<0.05). Under ex vivo polarizing conditions, the percentage of HF-FO derived CD4(+) T cells that reached Th17 cell effector status was suppressed (P = 0.05). Collectively, these results indicate that n-3 PUFA suppress Th1/Th17 cells and inflammatory macrophage subsets and reconfigure the inflammatory gene expression profile in diverse tissue sites in obese mice following the induction of colitis.	[Monk, Jennifer M.; Hou, Tim Y.; Turk, Harmony F.; Chapkin, Robert S.] Texas A&M Univ, Program Integrat Nutr & Complex Dis, College Stn, TX 77843 USA; [Monk, Jennifer M.; Turk, Harmony F.; Wu, Chaodong; McMurray, David N.; Chapkin, Robert S.] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Hou, Tim Y.; Chapkin, Robert S.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Weeks, Brad] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA; [Chapkin, Robert S.] Texas A&M AgriLife, Vegetable & Fruit Improvement Ctr, College Stn, TX USA; [McMurray, David N.; Chapkin, Robert S.] Texas A&M Univ Syst Hlth Sci Ctr, Dept Microbial & Mol Pathogenesis, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Chapkin, RS (corresponding author), Texas A&M Univ, Program Integrat Nutr & Complex Dis, College Stn, TX 77843 USA.	r-chapkin@tamu.edu		Weeks, Brad/0000-0002-5509-5719; Chapkin, Robert/0000-0002-6515-3898	NIH [DK071707]; USDA [2010-34402-20875]; Natural Sciences and Engineering Research Council of Canada (NSERC) [PDF-388466-2010, PGSD2-403986-2011]; NATIONAL CANCER INSTITUTE [R01CA059034] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071707] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USDA(United States Department of Agriculture (USDA)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work was supported by NIH grants DK071707 (Chapkin RS & McMurray DN) and USDA 2010-34402-20875 (Chapkin RS), Natural Sciences and Engineering Research Council of Canada (NSERC) Postdoctoral Fellowship PDF-388466-2010 (Monk JM) and Predoctoral Fellowship PGSD2-403986-2011 (Hou TY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Abraham C, 2009, ANNU REV MED, V60, P97, DOI 10.1146/annurev.med.60.051407.123757; Batra A, 2009, INFLAMM BOWEL DIS, V15, P1897, DOI 10.1002/ibd.20937; Bertin B, 2010, CURR OPIN CLIN NUTR, V13, P574, DOI 10.1097/MCO.0b013e32833cf0f4; Blain A, 2002, CLIN NUTR, V21, P51, DOI 10.1054/clnu.2001.0503; Claria J, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00049; Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808; Depner CM, 2012, J NUTR, V142, P1495, DOI 10.3945/jn.112.158865; Desreumaux P, 1999, GASTROENTEROLOGY, V117, P73, DOI 10.1016/S0016-5085(99)70552-4; Eastaff-Leung N, 2010, J CLIN IMMUNOL, V30, P80, DOI 10.1007/s10875-009-9345-1; Elson CO, 2007, GASTROENTEROLOGY, V132, P2359, DOI 10.1053/j.gastro.2007.03.104; Fan YY, 2012, J LIPID RES, V53, P1287, DOI 10.1194/jlr.M024216; Flachs P, 2006, DIABETOLOGIA, V49, P394, DOI 10.1007/s00125-005-0053-y; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Flachs P, 2011, DIABETOLOGIA, V54, P2626, DOI 10.1007/s00125-011-2233-2; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gu Y, 2008, EUR J IMMUNOL, V38, P1807, DOI 10.1002/eji.200838331; Hass DJ, 2006, CLIN GASTROENTEROL H, V4, P482, DOI 10.1016/j.cgh.2005.12.015; Holtta V, 2008, INFLAMM BOWEL DIS, V14, P1175, DOI 10.1002/ibd.20475; Hou TY, 2012, BIOCHEM J, V443, P27, DOI 10.1042/BJ20111589; Hsueh HW, 2011, J NUTR, V141, P1260, DOI 10.3945/jn.110.132571; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Ivanov II, 2007, SEMIN IMMUNOL, V19, P409, DOI 10.1016/j.smim.2007.10.011; Jia Q, 2008, CANCER RES, V68, P3985, DOI 10.1158/0008-5472.CAN-07-6251; John BJ, 2006, ALIMENT PHARM THER, V23, P1511, DOI 10.1111/j.1365-2036.2006.02915.x; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI 10.3945/an.111.000505; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Kanneganti TD, 2012, NAT IMMUNOL, V13, P707, DOI 10.1038/ni.2343; Kelsall BL, 2008, J PATHOL, V214, P242, DOI 10.1002/path.2286; Kim W, 2010, PROSTAG LEUKOTR ESS, V82, P155, DOI 10.1016/j.plefa.2010.02.028; Kong SC, 2005, J CLIN GASTROENTEROL, V39, P138; Liu ZJ, 2009, WORLD J GASTROENTERO, V15, P5784, DOI 10.3748/wjg.15.5784; Lumeng CN, 2007, DIABETES, V56, P16, DOI 10.2337/db06-1076; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; Monk JM, 2012, J NUTR, V142, P117, DOI 10.3945/jn.111.147058; Mori T, 2007, J NUTR, V137, P2629, DOI 10.1093/jn/137.12.2629; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nieto N, 2002, J NUTR, V132, P11, DOI 10.1093/jn/132.1.11; Paul G, 2006, INFLAMM BOWEL DIS, V12, P471, DOI 10.1097/00054725-200606000-00005; Peyrin-Biroulet L, 2007, GUT, V56, P577, DOI 10.1136/gut.2005.082925; Riordan NH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-29; Ruzickova J, 2004, LIPIDS, V39, P1177, DOI 10.1007/s11745-004-1345-9; Sarra M, 2010, INFLAMM BOWEL DIS, V16, P1808, DOI 10.1002/ibd.21248; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; SHEEHAN AL, 1992, BRIT J SURG, V79, P955, DOI 10.1002/bjs.1800790934; Shih DQ, 2008, WORLD J GASTROENTERO, V14, P390, DOI 10.3748/wjg.14.390; SMEDH K, 1993, BRIT J SURG, V80, P897, DOI 10.1002/bjs.1800800732; Stienstra R, 2008, J BIOL CHEM, V283, P22620, DOI 10.1074/jbc.M710314200; Takahashi Y, 2000, BRIT J NUTR, V84, P175; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Turner D, 2010, INFLAMM BOWEL DIS; Waldner Maximilian J, 2009, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0555s46; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer S, 2009, EUR J IMMUNOL, V39, P2629, DOI 10.1002/eji.200838893; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002; Zhang P, 2005, J NUTR, V135, P1745, DOI 10.1093/jn/135.7.1745; Zhang P, 2006, J NUTR, V136, P2391, DOI 10.1093/jn/136.9.2391	65	58	62	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49739	10.1371/journal.pone.0049739	http://dx.doi.org/10.1371/journal.pone.0049739			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166761	gold, Green Published, Green Submitted			2022-12-27	WOS:000311885300066
J	Nugraha, J; Marpaung, FR; Tam, FCH; Lim, PL				Nugraha, Jusak; Marpaung, Ferdy R.; Tam, Frankie C. H.; Lim, Pak Leong			Microbiological Culture Simplified Using Anti-O12 Monoclonal Antibody in TUBEX Test to Detect Salmonella Bacteria from Blood Culture Broths of Enteric Fever Patients	PLOS ONE			English	Article							LATEX AGGLUTINATION-TEST; TYPHOID-FEVER; RAPID DETECTION; CHILDREN; ANTIGENS; IDENTIFICATION; INFECTIONS; DIAGNOSIS; BURDEN	Definitive diagnosis of infectious diseases, including food poisoning, requires culture and identification of the infectious agent. We described how antibodies could be used to shorten this cumbersome process. Specifically, we employed an anti-Salmonella lipopolysaccharide O12 monoclonal antibody in an epitope-inhibition 10-min test (TUBEX TP) to detect O12(+) Salmonella organisms directly from routine blood culture broths. The aim is to obviate the need to subculture the broth and subsequently identify the colonies. Thus, blood from 78 young outpatients suspected of having enteric fever was incubated in an enrichment broth, and after 2 or 4 days, broth samplings were examined by TUBEX TP as well as by conventional agar culture and identification. TUBEX TP was performed before the culture results. Eighteen isolates of S. Typhi (15 after 2 days) and 10 isolates of S. Paratyphi A (4 after 2 days) were obtained by conventional culture. Both these Salmonella serotypes, the main causes of enteric fever, share the O12 antigen. In all instances where either of these organisms was present (cultured), TUBEX TP was positive (score 4 [light blue] - to - score 10 [dark blue]; negative is 0 [pink-colored]) i.e. 100% sensitive. Identification of the specific Salmonella serotype in TUBEX-positive cases was achieved subsequently by conventional slide agglutination using appropriate polyclonal antisera against the various serotypes. Twelve Escherichia coli, 1 Alcaligenes spp. and 1 Enterobacter spp. were isolated. All of these cases, including all the 36 culture-negative broths, were TUBEX-negative i.e. TUBEX TP was 100% specific. In a separate study using known laboratory strains, TUBEX TF, which detects S. Typhi but not S. Paratyphi A via the O9 antigen, was found to efficiently complement TUBEX TP as a differential test. Thus, TUBEX TP and TUBEX TF are useful adjuncts to conventional culture because they can save considerable time (>2 days), costs and manpower.	[Tam, Frankie C. H.; Lim, Pak Leong] IgGENE, Fotan, Hong Kong, Peoples R China; [Nugraha, Jusak; Marpaung, Ferdy R.] Airlangga Univ, Dept Clin Pathol, Fac Med, Dr Soetomo Hosp, Surabaya, Indonesia; [Nugraha, Jusak] Airlangga Univ, Trop Dis Ctr, Surabaya, Indonesia	Airlangga University; Dr Soetomo General Hospital Surabaya; Airlangga University	Lim, PL (corresponding author), IgGENE, Fotan, Hong Kong, Peoples R China.	pllim@iggene.com	Marpaung, Ferdy Royland/AAF-7733-2019; Nugraha, Jusak/J-1712-2017	Marpaung, Ferdy Royland/0000-0001-6570-1877; Nugraha, Jusak/0000-0001-6700-9921				Crump JA, 2011, CLIN INFECT DIS, V50, P241; DAMATO RF, 1990, J CLIN MICROBIOL, V28, P2134, DOI 10.1128/JCM.28.9.2134-2135.1990; Engler KH, 1997, J CLIN MICROBIOL, V35, P495, DOI 10.1128/JCM.35.2.495-498.1997; Gordon MA, 2008, CLIN INFECT DIS, V46, P963, DOI 10.1086/529146; JESUDASON MV, 1994, DIAGN MICR INFEC DIS, V18, P75, DOI 10.1016/0732-8893(94)90068-X; Karkey A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013988; KAUFFMANN F., 1957, ACTA PATHOL ET MICROBIOL SCAND, V41, P242; Kawano RL, 2007, J CLIN MICROBIOL, V45, P246, DOI 10.1128/JCM.01403-06; Ley B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-147; Maskey AP, 2006, CLIN INFECT DIS, V42, P1247, DOI 10.1086/503033; Maskey AP, 2008, T ROY SOC TROP MED H, V102, P91, DOI 10.1016/j.trstmh.2007.10.003; MCGOWAN KL, 1989, AM J CLIN PATHOL, V92, P679, DOI 10.1093/ajcp/92.5.679; Mtove G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009244; NORDLANDER E, 1990, DIAGN MICR INFEC DIS, V13, P273, DOI 10.1016/0732-8893(90)90073-5; Ochiai RL, 2008, B WORLD HEALTH ORGAN, V86, P260, DOI 10.2471/BLT.06.039818; Rahman M, 2007, DIAGN MICR INFEC DIS, V58, P275, DOI 10.1016/j.diagmicrobio.2007.01.010; ROHNER P, 1992, J CLIN MICROBIOL, V30, P3274, DOI 10.1128/JCM.30.12.3274-3276.1992; Rose AMC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007326; SIPPEL JE, 1984, J CLIN MICROBIOL, V20, P884, DOI 10.1128/JCM.20.5.884-886.1984; Tabu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031237; Tam FCH, 2008, J MED MICROBIOL, V57, P316, DOI 10.1099/jmm.0.47365-0; THORNS CJ, 1994, INT J FOOD MICROBIOL, V21, P47, DOI 10.1016/0168-1605(94)90199-6; Tran VTN, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-125; Voetsch AC, 2004, CLIN INFECT DIS, V38, pS127, DOI 10.1086/381578; Vollaard AM, 2005, T ROY SOC TROP MED H, V99, P440, DOI 10.1016/j.trstmh.2004.09.012; Wain J, 1998, J CLIN MICROBIOL, V36, P1683, DOI 10.1128/JCM.36.6.1683-1687.1998; World Health Organization, 2011, PUBL HLTH REV ANT ES; Yan MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024743	28	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49586	10.1371/journal.pone.0049586	http://dx.doi.org/10.1371/journal.pone.0049586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166719	Green Submitted, gold, Green Published			2022-12-27	WOS:000311885300054
J	Poor, EE; Loucks, C; Jakes, A; Urban, DL				Poor, Erin E.; Loucks, Colby; Jakes, Andrew; Urban, Dean L.			Comparing Habitat Suitability and Connectivity Modeling Methods for Conserving Pronghorn Migrations	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; COLUMBIA RIVER; CIRCUIT-THEORY; LANDSCAPE; MORTALITY; ECOLOGY; RANGE; PREDICTION; SALMONIDS; SELECTION	Terrestrial long-distance migrations are declining globally: in North America, nearly 75% have been lost. Yet there has been limited research comparing habitat suitability and connectivity models to identify migration corridors across increasingly fragmented landscapes. Here we use pronghorn (Antilocapra americana) migrations in prairie habitat to compare two types of models that identify habitat suitability: maximum entropy (Maxent) and expert-based (Analytic Hierarchy Process). We used distance to wells, distance to water, NDVI, land cover, distance to roads, terrain shape and fence presence to parameterize the models. We then used the output of these models as cost surfaces to compare two common connectivity models, least-cost modeling (LCM) and circuit theory. Using pronghorn movement data from spring and fall migrations, we identified potential migration corridors by combining each habitat suitability model with each connectivity model. The best performing model combination was Maxent with LCM corridors across both seasons. Maxent out-performed expert-based habitat suitability models for both spring and fall migrations. However, expert-based corridors can perform relatively well and are a cost-effective alternative if species location data are unavailable. Corridors created using LCM out-performed circuit theory, as measured by the number of pronghorn GPS locations present within the corridors. We suggest the use of a tiered approach using different corridor widths for prioritizing conservation and mitigation actions, such as fence removal or conservation easements.	[Poor, Erin E.; Loucks, Colby] World Wildlife Fund, Conservat Sci Program, Washington, DC 20037 USA; [Jakes, Andrew] Univ Calgary, Fac Environm Design, Calgary, AB T2N 1N4, Canada; [Urban, Dean L.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA	World Wildlife Fund; University of Calgary; Duke University	Poor, EE (corresponding author), World Wildlife Fund, Conservat Sci Program, 1250 24th St,NW, Washington, DC 20037 USA.	erinpoor@vt.edu		Poor, Erin/0000-0002-8799-3193	Counter Assault, Inc Grant, MT TWS; ACCELERATE Grad Research Intern Award, MITACS; Graduate Student Support Award, University of Calgary; F&W Student Award, Saskatchewan Ministry of Environment; AB SRPWF Award, Alberta SRPWF; Glaholt Scholarship, University of Calgary [030-00-40-106-4000]; ACA-PetroCanada; University of Calgary [080018]; Montana Fish Wildlife and Parks; Kathryn Fuller Grant, The Kathryn Fuller Science for Nature; Counter Assault, Inc. Grant; ACA-PetroCanada [030-00-40-106-4000]	Counter Assault, Inc Grant, MT TWS; ACCELERATE Grad Research Intern Award, MITACS; Graduate Student Support Award, University of Calgary; F&W Student Award, Saskatchewan Ministry of Environment; AB SRPWF Award, Alberta SRPWF; Glaholt Scholarship, University of Calgary; ACA-PetroCanada; University of Calgary; Montana Fish Wildlife and Parks; Kathryn Fuller Grant, The Kathryn Fuller Science for Nature; Counter Assault, Inc. Grant; ACA-PetroCanada	Counter Assault, Inc Grant, MT TWS (http://counterassault.com/), ACCELERATE Grad Research Intern Award, MITACS (http://www.mitacs.ca/accelerate), Graduate Student Support Award, University of Calgary (http://evds.ucalgary.ca/), F&W Student Award, Saskatchewan Ministry of Environment (http://www.environment.gov.sk.ca), AB SRPWF Award, Alberta SRPWF (http://www.asrpwf.ca/), Glaholt Scholarship, University of Calgary (http://ucalgary.ca/), Student Stipend, #030-00-40-106-4000, ACA-PetroCanada (http://www.ab-conservation.com/go/default), Dean's Entrance Scholarship, University of Calgary (http://ucalgary.ca/), Graduate Research Stipend, #080018, Montana Fish Wildlife and Parks (http://fwp.mt.gov), and Kathryn Fuller Grant, The Kathryn Fuller Science for Nature (http://www.worldwildlife.org/science/fellowships/fuller/item22744.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have the following interests. This study was partially funded by a Counter Assault, Inc. Grant and by a Student Stipend, #030-00-40-106-4000, from ACA-PetroCanada. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; [Anonymous], 2006, CONNECTIVITY CONSERV; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; BARRETT MW, 1982, J WILDLIFE MANAGE, V46, P991, DOI 10.2307/3808232; BEALE DM, 1970, J WILDLIFE MANAGE, V34, P570, DOI 10.2307/3798865; Beckmann JP, 2012, BIOL CONSERV, V147, P222, DOI 10.1016/j.biocon.2012.01.003; BECKMANN JP, 2009, WILDLIFE ENERGY DEV; Beier P., 2007, CONCEPTUAL STEPS DES; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Benhamou S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014592; Berger J, 2004, CONSERV BIOL, V18, P320, DOI 10.1111/j.1523-1739.2004.00548.x; Boccadori SJ, 2008, J MAMMAL, V89, P1031, DOI 10.1644/07-MAMM-A-173.1; Bolger DT, 2008, ECOL LETT, V11, P63; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; BROWN JH, 1984, AM NAT, V124, P255, DOI 10.1086/284267; Caudill CC, 2007, CAN J FISH AQUAT SCI, V64, P979, DOI 10.1139/F07-065; Channell R, 2000, J BIOGEOGR, V27, P169, DOI 10.1046/j.1365-2699.2000.00382.x; CHAPE S, 2003, UN LIST PROTECTED AR; CLARY WP, 1983, J RANGE MANAGE, V36, P749, DOI 10.2307/3898201; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; FRYXELL JM, 1988, TRENDS ECOL EVOL, V3, P237, DOI 10.1016/0169-5347(88)90166-8; Gavin SD, 2006, CAN J ZOOL, V84, P1775, DOI 10.1139/Z06-175; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Hamel S, 2009, J APPL ECOL, V46, P582, DOI 10.1111/j.1365-2664.2009.01643.x; HANNAH L, 1995, BIODIVERS CONSERV, V4, P128, DOI 10.1007/BF00137781; Harrington JL, 2006, WILDLIFE SOC B, V34, P1295, DOI 10.2193/0091-7648(2006)34[1295:COUBAM]2.0.CO;2; Harris Grant, 2009, Endangered Species Research, V7, P55, DOI 10.3354/esr00173; Hebblewhite M, 2008, ECOL MONOGR, V78, P141, DOI 10.1890/06-1708.1; Hervert JJ, 2005, WILDLIFE SOC B, V33, P8, DOI 10.2193/0091-7648(2005)33[8:HAHPOS]2.0.CO;2; Hilty JA, 2006, BIODIVERS CONSERV, V15, P2853, DOI 10.1007/s10531-005-1534-5; Horne JS, 2007, ECOLOGY, V88, P2354, DOI 10.1890/06-0957.1; Hurley MV, 2009, J WILDLIFE MANAGE, V73, P278, DOI 10.2193/2008-136; Kaczensky P, 2011, BIOL CONSERV, V144, P920, DOI 10.1016/j.biocon.2010.12.013; Keefer ML, 2005, CAN J FISH AQUAT SCI, V62, P930, DOI 10.1139/F04-246; Kolar JL, 2011, J WILDLIFE MANAGE, V75, P198, DOI 10.1002/jwmg.32; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Luan XF, 2011, J ENVIRON MANAGE, V92, P31, DOI 10.1016/j.jenvman.2010.08.001; MARTINKA CJ, 1967, J WILDLIFE MANAGE, V31, P159, DOI 10.2307/3798371; McRae B.H., 2009, CIRCUITSCAPE USERS G; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; McRae BH, 2006, EVOLUTION, V60, P1551, DOI 10.1111/j.0014-3820.2006.tb00500.x; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Prosser DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017622; Riley J.L., 2007, CONSERVATION BLUEPRI; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Sanderson FJ, 2006, BIOL CONSERV, V131, P93, DOI 10.1016/j.biocon.2006.02.008; Sawyer H, 2011, J ANIM ECOL, V80, P1078, DOI 10.1111/j.1365-2656.2011.01845.x; Sawyer H, 2009, ECOL APPL, V19, P2016, DOI 10.1890/08-2034.1; Smith DG, 2000, PRAIRIE AGR LANDSCAP; Spillet JJ, 1967, LIVESTOCK FENCES THE; Urban D, 2001, ECOLOGY, V82, P1205, DOI 10.1890/0012-9658(2001)082[1205:LCAGTP]2.0.CO;2; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Wal EV, 2009, J WILDLIFE MANAGE, V73, P1189, DOI 10.2193/2008-137; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x; Wilcove DS, 2008, PLOS BIOL, V6, P1361, DOI 10.1371/journal.pbio.0060188; Yackulic CB, 2011, P NATL ACAD SCI USA, V108, P4024, DOI 10.1073/pnas.1015097108; Yoakum J.D., 1996, P211	69	89	93	3	170	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49390	10.1371/journal.pone.0049390	http://dx.doi.org/10.1371/journal.pone.0049390			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166656	Green Published, gold			2022-12-27	WOS:000311885300034
J	Verma-Kumar, S; Abraham, D; Dendukuri, N; Cheeran, JV; Sukumar, R; Balaji, KN				Verma-Kumar, Shalu; Abraham, David; Dendukuri, Nandini; Cheeran, Jacob Varghese; Sukumar, Raman; Balaji, Kithiganahalli Narayanaswamy			Serodiagnosis of Tuberculosis in Asian Elephants (Elephas maximus) in Southern India: A Latent Class Analysis	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; MYCOBACTERIUM-TUBERCULOSIS; BOVINE TUBERCULOSIS; ANTIBODY-RESPONSES; AFRICAN ELEPHANT; VIRUS-INFECTION; VALIDATION; DIAGNOSIS; ANTIGENS; PROTEIN	Background: Mycobacterium tuberculosis, a causative agent of chronic tuberculosis disease, is widespread among some animal species too. There is paucity of information on the distribution, prevalence and true disease status of tuberculosis in Asian elephants (Elephas maximus). The aim of this study was to estimate the sensitivity and specificity of serological tests to diagnose M. tuberculosis infection in captive elephants in southern India while simultaneously estimating sero-prevalence. Methodology/Principal Findings: Health assessment of 600 elephants was carried out and their sera screened with a commercially available rapid serum test. Trunk wash culture of select rapid serum test positive animals yielded no animal positive for M. tuberculosis isolation. Under Indian field conditions where the true disease status is unknown, we used a latent class model to estimate the diagnostic characteristics of an existing (rapid serum test) and new (four in-house ELISA) tests. One hundred and seventy nine sera were randomly selected for screening in the five tests. Diagnostic sensitivities of the four ELISAs were 91.3-97.6% (95% Credible Interval (CI): 74.8-99.9) and diagnostic specificity were 89.6-98.5% (95% CI: 79.4-99.9) based on the model we assumed. We estimate that 53.6% (95% CI: 44.6-62.8) of the samples tested were free from infection with M. tuberculosis and 15.9% (97.5% CI: 9.8 - to 24.0) tested positive on all five tests. Conclusions/Significance: Our results provide evidence for high prevalence of asymptomatic M. tuberculosis infection in Asian elephants in a captive Indian setting. Further validation of these tests would be important in formulating area-specific effective surveillance and control measures.	[Verma-Kumar, Shalu; Balaji, Kithiganahalli Narayanaswamy] Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India; [Verma-Kumar, Shalu; Sukumar, Raman] Indian Inst Sci, Ctr Ecol Sci, Bangalore 560012, Karnataka, India; [Abraham, David] Asian Nat Conservat Fdn, Bangalore, Karnataka, India; [Dendukuri, Nandini] McGill Univ, Dept Med, Montreal, PQ, Canada; [Dendukuri, Nandini] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Cheeran, Jacob Varghese] Cheerans Lab P Ltd, Trichur, Kerala, India	Indian Institute of Science (IISC) - Bangalore; Indian Institute of Science (IISC) - Bangalore; McGill University; McGill University	Balaji, KN (corresponding author), Indian Inst Sci, Dept Microbiol & Cell Biol, Bangalore 560012, Karnataka, India.	balaji@mcbl.iisc.ernet.in	Raman, Sukumar/C-9809-2013		Department of Science and Technology, Government of India [SR/WOS-A/LS-128/2009]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The study was funded by the Department of Science and Technology, Government of India by award of grant SR/WOS-A/LS-128/2009 to Dr. Shalu Verma-Kumar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard C, 2006, J CLIN MICROBIOL, V44, P4326, DOI 10.1128/JCM.01184-06; Abraham D, 2008, GAJAH, V28, P46; Aguirre AA, 2009, REV SCI TECH OIE, V28, P597, DOI 10.20506/rst.28.2.1902; Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Ameni G, 2006, CLIN VACCINE IMMUNOL, V13, P1030, DOI 10.1128/CVI.00134-06; Archie EA, 2010, IMMUNOGENETICS, V62, P85, DOI 10.1007/s00251-009-0413-8; Arloing S., 1898, C R ACAD SCI, V126, P1398; Banoo S, 2010, NAT REV MICROBIOL, pS17, DOI [10.1038/nrmico1523, 10.1038/nrmicro1523]; Bansal K, 2010, J IMMUNOL, V184, P3495, DOI 10.4049/jimmunol.0903299; Bist S S, 2006, GAJAH, V25, P27; Boelaert M, 1999, EPIDEMIOL INFECT, V123, P499, DOI 10.1017/S0950268899003040; Chaturvedi R, 2010, J BIOL CHEM, V285, P30389, DOI 10.1074/jbc.M110.135251; Choudhury A, 2010, ELEPHAS MAXIMUS IUCN; CHU LS, 1955, SCIENCE, V122, P1189, DOI 10.1126/science.122.3181.1189; CLARK HW, 1980, J ZOO ANIM MED, V11, P3, DOI 10.2307/20094451; Clegg TA, 2011, VET MICROBIOL, V151, P68, DOI 10.1016/j.vetmic.2011.02.027; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Davidow A, 2005, INFECT IMMUN, V73, P6846, DOI 10.1128/IAI.73.10.6846-6851.2005; DAVIES FG, 1977, VET REC, V100, P291, DOI 10.1136/vr.100.14.291; Davis M, 2001, Appl Occup Environ Hyg, V16, P350, DOI 10.1080/104732201750154125; Dendukuri N, 2009, STAT MED, V28, P441, DOI 10.1002/sim.3470; Diel R, 2010, CHEST, V137, P952, DOI 10.1378/chest.09-2350; Espitia C, 1999, MICROBIOL-UK, V145, P3487, DOI 10.1099/00221287-145-12-3487; Fernando Prithiviraj, 2011, Gajah, V35, P15; Frossling J, 2003, PREV VET MED, V57, P141, DOI 10.1016/S0167-5877(02)00216-7; Greenwald R, 2009, CLIN VACCINE IMMUNOL, V16, P605, DOI 10.1128/CVI.00038-09; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Guo YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016889; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kania S. A., 1997, Journal of Veterinary Allergy and Clinical Immunology, V5, P125; Keilty RA, 1914, J EXP MED, V22, P612; Kelly PJ, 1998, COMP IMMUNOL MICROB, V21, P65, DOI 10.1016/S0147-9571(97)80053-7; Khan IH, 2008, CLIN VACCINE IMMUNOL, V15, P433, DOI 10.1128/CVI.00354-07; Kumar AS, 2012, MOL IMMUNOL, V49, P655, DOI 10.1016/j.molimm.2011.11.011; Kunnath-Velayudhan S, 2011, CLIN MICROBIOL REV, V24, P792, DOI 10.1128/CMR.00014-11; Kunnath-Velayudhan S, 2010, P NATL ACAD SCI USA, V107, P14703, DOI 10.1073/pnas.1009080107; Lafferty KD, 2002, CONSERV BIOL, V16, P593, DOI 10.1046/j.1523-1739.2002.00446.x; Larsen RS, 2000, J ZOO WILDLIFE MED, V31, P291, DOI 10.1638/1042-7260(2000)031[0291:EOAMAE]2.0.CO;2; Lewerin SS, 2005, VET REC, V156, P171; Lyashchenko KP, 2006, CLIN VACCINE IMMUNOL, V13, P722, DOI 10.1128/CVI.00133-06; Lyashchenko KP, 2012, CLIN VACCINE IMMUNOL; MACDONALD P., 2010, MIXDIST FINITE MIXTU; Manual AAL, 1988, PROTOCOLS IMMUNAFFIN, P519; Michalak K, 1998, EMERG INFECT DIS, V4, P283, DOI 10.3201/eid0402.980217; Michel AL, 2003, J ZOO WILDLIFE MED, V34, P364, DOI 10.1638/02-063; Mikota SK, 2001, J ZOO WILDLIFE MED, V32, P1, DOI 10.1638/1042-7260(2001)032[0001:EADOMT]2.0.CO;2; Mikota SK, 2011, TUBERCULOSIS, V91, P208, DOI 10.1016/j.tube.2011.02.007; Moller T., 2005, Proceedings of the Institute for Zoo and Wildlife Research, Berlin, P173; Montali RJ, 2001, REV SCI TECH OIE, V20, P291, DOI 10.20506/rst.20.1.1268; More SJ, 2009, PREV VET MED, V90, P254, DOI 10.1016/j.prevetmed.2009.03.013; Morton JM, 2012, PREV VET MED, V104, P136, DOI 10.1016/j.prevetmed.2011.10.009; Murphree R, 2011, EMERG INFECT DIS, V17, P366, DOI 10.3201/eid1703.101668; Mushi E.Z., 1990, Bulletin of Animal Health and Production in Africa, V38, P475; Narayana Y, 2007, CLIN VACCINE IMMUNOL, V14, P1334, DOI 10.1128/CVI.00181-07; Oh P, 2002, EMERG INFECT DIS, V8, P1290; Pai M, 2008, INT J TUBERC LUNG D, V12, P895; Payeur JB, 2002, ANN NY ACAD SCI, V969, P256, DOI 10.1111/j.1749-6632.2002.tb04388.x; Pepe MS, 2007, BIOSTATISTICS, V8, P474, DOI 10.1093/biostatistics/kxl038; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Rachow A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020458; Rajan A, 1980, AFRICAN J CLIN EXPT, V2, P357; RINDSKOPF D, 1986, STAT MED, V5, P21, DOI 10.1002/sim.4780050105; Rose N, 2010, J VIROL METHODS, V163, P329, DOI 10.1016/j.jviromet.2009.10.019; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Singh KK, 2005, INFECT IMMUN, V73, P5004, DOI 10.1128/IAI.73.8.5004-5014.2005; Skjot RLV, 2000, INFECT IMMUN, V68, P214, DOI 10.1128/IAI.68.1.214-220.2000; Steingart KR, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001062; Steingart KR, 2009, CLIN VACCINE IMMUNOL, V16, P260, DOI 10.1128/CVI.00355-08; The National Tuberculosis Working Group for Zoo and Wildlife Species, 2008, GUID CONTR TUB EL 20; van Beeck FAL, 2009, MOL IMMUNOL, V46, P1424, DOI 10.1016/j.molimm.2008.12.009; World Organization for Animal Health (OIE), 2010, PRINC VAL DIAGN ASS, P1	72	19	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49548	10.1371/journal.pone.0049548	http://dx.doi.org/10.1371/journal.pone.0049548			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166708	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000311885300052
J	Shaw, TI; Srivastava, A; Chou, WC; Liu, L; Hawkinson, A; Glenn, TC; Adams, R; Schountz, T				Shaw, Timothy I.; Srivastava, Anuj; Chou, Wen-Chi; Liu, Liang; Hawkinson, Ann; Glenn, Travis C.; Adams, Rick; Schountz, Tony			Transcriptome Sequencing and Annotation for the Jamaican Fruit Bat (Artibeus jamaicensis)	PLOS ONE			English	Article							PHYLOGENETIC ANALYSIS; TACARIBE VIRUS; PROTEIN; INFECTION; ALIGNMENT; GENES; KEGG; IDENTIFICATION; CONSTRUCTION; GENERATION	The Jamaican fruit bat (Artibeus jamaicensis) is one of the most common bats in the tropical Americas. It is thought to be a potential reservoir host of Tacaribe virus, an arenavirus closely related to the South American hemorrhagic fever viruses. We performed transcriptome sequencing and annotation from lung, kidney and spleen tissues using 454 and Illumina platforms to develop this species as an animal model. More than 100,000 contigs were assembled, with 25,000 genes that were functionally annotated. Of the remaining unannotated contigs, 80% were found within bat genomes or transcriptomes. Annotated genes are involved in a broad range of activities ranging from cellular metabolism to genome regulation through ncRNAs. Reciprocal BLAST best hits yielded 8,785 sequences that are orthologous to mouse, rat, cattle, horse and human. Species tree analysis of sequences from 2,378 loci was used to achieve 95% bootstrap support for the placement of bat as sister to the clade containing horse, dog, and cattle. Through substitution rate estimation between bat and human, 32 genes were identified with evidence for positive selection. We also identified 466 immune-related genes, which may be useful for studying Tacaribe virus infection of this species. The Jamaican fruit bat transcriptome dataset is a resource that should provide additional candidate markers for studying bat evolution and ecology, and tools for analysis of the host response and pathology of disease.	[Hawkinson, Ann; Adams, Rick; Schountz, Tony] Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA; [Shaw, Timothy I.; Chou, Wen-Chi] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Srivastava, Anuj] Jackson Lab, Bar Harbor, ME 04609 USA; [Liu, Liang] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Glenn, Travis C.] Univ Georgia, Dept Environm Hlth Sci, Athens, GA 30602 USA	University of Northern Colorado; University System of Georgia; University of Georgia; Jackson Laboratory; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Schountz, T (corresponding author), Univ No Colorado, Sch Biol Sci, Greeley, CO 80639 USA.	tony.schountz@unco.edu	Srivastava, Anuj/L-4705-2019; Schountz, Tony/I-2161-2017; Glenn, Travis C/A-2390-2008; Shaw, Timothy I/AAE-8523-2019	Glenn, Travis C/0000-0001-7725-3637; Shaw, Timothy I/0000-0002-9316-1924; Chou, Wen-Chi/0000-0001-8408-3533	UGA's Georgia Advanced Computing Resource Center; Institute of Bioinformatics; National Institutes of Health [AI089419]; NIH Emerging Virus Diseases Unit [AI25489]; University of Northern Colorado; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089419, N01AI025489] Funding Source: NIH RePORTER	UGA's Georgia Advanced Computing Resource Center; Institute of Bioinformatics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Emerging Virus Diseases Unit; University of Northern Colorado; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Jason Shaw for assistance with bat handling and Stephanie James for laboratory assistance, and UGA's Georgia Advanced Computing Resource Center and Institute of Bioinformatics for computational resources and support. We thank Anthony Papenfuss for providing the assembled transcriptome for P. alecto.; This work was supported by National Institutes of Health grant AI089419 (TS), NIH Emerging Virus Diseases Unit contract AI25489 (TS, AH), and the University of Northern Colorado Provost Fund (AH, RA, and TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altenhoff AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000262; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bininda-Emonds ORP, 2007, EVOL BIOINFORM, V3, P59; Bowen MD, 1996, VIROLOGY, V219, P285, DOI 10.1006/viro.1996.0248; Bowen MD, 1997, MOL PHYLOGENET EVOL, V8, P301, DOI 10.1006/mpev.1997.0436; Bromham L, 1996, J MOL EVOL, V43, P610, DOI 10.1007/BF02202109; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; CALISHER CH, 1982, AM J TROP MED HYG, V31, P1260, DOI 10.4269/ajtmh.1982.31.1260; Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chen YW, 2001, P NATL ACAD SCI USA, V98, P7218, DOI 10.1073/pnas.131076098; Cogswell-Hawkinson A, 2012, J VIROL, V86, P5791, DOI 10.1128/JVI.00201-12; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Criscuolo A, 2011, MOL PHYLOGENET EVOL, V61, P944, DOI 10.1016/j.ympev.2011.08.029; DOWNS WG, 1963, AM J TROP MED HYG, V12, P640, DOI 10.4269/ajtmh.1963.12.640; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gery S, 2007, EXP HEMATOL, V35, P572, DOI 10.1016/j.exphem.2007.01.049; Gomez RM, 2011, MICROBES INFECT, V13, P303, DOI 10.1016/j.micinf.2010.12.006; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6; Gunnell Gregg F., 2005, Journal of Mammalian Evolution, V12, P209, DOI 10.1007/s10914-005-6945-2; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Hu ZL, 2008, ONLINE J BIOINFORMAT, V9, P108, DOI DOI 10.1186/1471-2105-13-134; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; IUCN, 2012, IUCN RED LIST VERS 2; Joslyn CA, 2004, BIOINFORMATICS, V20, P169, DOI 10.1093/bioinformatics/bth921; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lindblad-Toh K, 2011, NATURE, V478, P476, DOI 10.1038/nature10530; Liu L, 2011, SYST BIOL, V60, P661, DOI 10.1093/sysbio/syr027; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Malagelada C, 2006, J NEUROSCI, V26, P9996, DOI 10.1523/JNEUROSCI.3292-06.2006; Marth GT, 1999, NAT GENET, V23, P452, DOI 10.1038/70570; McCormack JE, 2012, GENOME RES, V22, P746, DOI 10.1101/gr.125864.111; MCMURRAY DN, 1978, AM J TROP MED HYG, V27, P815, DOI 10.4269/ajtmh.1978.27.815; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW677, DOI 10.1093/nar/gki394; Muller J, 2010, BIOINFORMATICS, V26, P263, DOI 10.1093/bioinformatics/btp651; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Murphy WJ, 2004, TRENDS GENET, V20, P631, DOI 10.1016/j.tig.2004.09.005; Nabholz B, 2008, GENETICS, V178, P351, DOI 10.1534/genetics.107.073346; Nery MF, 2012, MOL PHYLOGENET EVOL, V64, P685, DOI 10.1016/j.ympev.2012.04.012; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nishihara H, 2006, P NATL ACAD SCI USA, V103, P9929, DOI 10.1073/pnas.0603797103; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; Ortega Jorge, 2001, Mammalian Species, P1; Papenfuss AT, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-261; PATANJALI SR, 1991, P NATL ACAD SCI USA, V88, P1943, DOI 10.1073/pnas.88.5.1943; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Prasad AB, 2008, MOL BIOL EVOL, V25, P1795, DOI 10.1093/molbev/msn104; PRICE JL, 1978, AM J TROP MED HYG, V27, P162, DOI 10.4269/ajtmh.1978.27.162; Quinlan AR, 2008, NAT METHODS, V5, P179, DOI 10.1038/NMETH.1172; Ranwez V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022594; Reid JE, 2001, J NEUROVIROL, V7, P511, DOI 10.1080/135502801753248097; Seo TK, 2008, MOL BIOL EVOL, V25, P960, DOI 10.1093/molbev/msn043; Sewer A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-267; Shaw TI, 2011, J BIOINF COMPUT BIOL, V9, P283, DOI 10.1142/S0219720011005495; SOARES MB, 1994, P NATL ACAD SCI USA, V91, P9228, DOI 10.1073/pnas.91.20.9228; Tang H, 2006, MOL BIOL EVOL, V23, P372, DOI 10.1093/molbev/msj043; Thompson JD, 2003, BIOINFORMATICS, V19, P1155, DOI 10.1093/bioinformatics/btg133; Vallender EJ, 2004, HUM MOL GENET, V13, pR245, DOI 10.1093/hmg/ddh253; Welch JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-53; Wibbelt G, 2010, BIOL LETTERS, V6, P438, DOI 10.1098/rsbl.2010.0267; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JD, 2009, BIOINFORMATICS, V25, P1470, DOI 10.1093/bioinformatics/btp167; Zhou XM, 2012, SYST BIOL, V61, P150, DOI 10.1093/sysbio/syr089	74	50	70	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48472	10.1371/journal.pone.0048472	http://dx.doi.org/10.1371/journal.pone.0048472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166587	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300008
J	Andersson, MA; Hoglund, E				Andersson, Madelene Aberg; Hoglund, Erik			Linking Personality to Larval Energy Reserves in Rainbow Trout (Oncorhynchus mykiss)	PLOS ONE			English	Article							WEANING SOCIAL-ISOLATION; ATLANTIC SALMON; COPING STYLES; ENVIRONMENT INTERACTIONS; INDIVIDUAL-DIFFERENCES; EVOLUTIONARY; EMERGENCE; ECOLOGY; BEHAVIOR; CONSEQUENCES	There is a surging interest in the evolution, ecology and physiology of personality differences. However, most of the studies in this research area have been performed in adult animals. Trait variations expressed early in development and how they are related to the ontogeny of an animal's personality are far less studied. Genetic differences as well as environmental factors causing functional variability of the central serotonergic system have been related to personality differences in vertebrates, including humans. Such gene-environment interplay suggests that the central serotonergic system plays an important role in the ontogeny of personality traits. In salmonid fishes, the timing of emergence from spawning nests is related to energy reserves, aggression, and social dominance. However, it is currently unknown how the size of the yolk reserve is reflected on aggression and dominance, or if these traits are linked to differences in serotonergic transmission in newly emerged larvae. In this study we investigated the relationship between yolk reserves, social dominance, and serotonergic transmission in newly emerged rainbow trout (Oncorhynchus mykiss) larvae. This was conducted by allowing larvae with the same emergence time, but with different yolk sizes, to interact in pairs for 24 h. The results show that individuals with larger yolks performed more aggressive acts, resulting in a suppression of aggression in individuals with smaller yolks. A higher brain serotonergic activity confirmed subordination in larvae with small yolks. The relationship between social dominance and yolk size was present in siblings, demonstrating a link between interfamily variation in energy reserves and aggression, and suggests that larger yolk reserves fuel a more aggressive personality during the initial territorial establishment in salmonid fishes. Furthermore, socially naive larvae with big yolks had lower serotonin levels, suggesting that other factors than the social environment causes variation in serotonergic transmission, underlying individual variation in aggressive behavior.	[Andersson, Madelene Aberg; Hoglund, Erik] Tech Univ Denmark, DTU Aqua, Aquaculture Sect, N Sea Res Ctr, Hirtshals, Denmark	Technical University of Denmark	Andersson, MA (corresponding author), Tech Univ Denmark, DTU Aqua, Aquaculture Sect, N Sea Res Ctr, Hirtshals, Denmark.							Andersson MA, 2011, HORM BEHAV, V60, P699, DOI 10.1016/j.yhbeh.2011.09.008; Barber I, 2010, PHILOS T R SOC B, V365, P4077, DOI 10.1098/rstb.2010.0182; Barr CS, 2003, GENES BRAIN BEHAV, V2, P336, DOI 10.1046/j.1601-1848.2003.00051.x; Bell AM, 2010, PHILOS T R SOC B, V365, P4001, DOI 10.1098/rstb.2010.0185; Bernardo J, 1996, AM ZOOL, V36, P83; BRANNAS E, 1987, CAN J ZOOL, V65, P1503, DOI 10.1139/z87-232; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Daubert EA, 2010, TRENDS NEUROSCI, V33, P424, DOI 10.1016/j.tins.2010.05.005; de Boer SF, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.052.2009; DELEANIZ CG, 1993, CAN J ZOOL, V71, P1454, DOI 10.1139/z93-201; Dingemanse NJ, 2010, PHILOS T R SOC B, V365, P3947, DOI 10.1098/rstb.2010.0221; Dochtermann NA, 2010, PHILOS T R SOC B, V365, P4013, DOI 10.1098/rstb.2010.0129; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Frost AJ, 2007, P ROY SOC B-BIOL SCI, V274, P333, DOI 10.1098/rspb.2006.3751; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Hoglund E, 2001, PHYSIOL BEHAV, V74, P381, DOI 10.1016/S0031-9384(01)00571-6; Jensen LF, 2008, FISHERIES MANAG ECOL, V15, P81, DOI 10.1111/j.1365-2400.2007.00569.x; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Lesch KP, 2005, PROG NEURO-PSYCHOPH, V29, P1062, DOI 10.1016/j.pnpbp.2005.03.012; Lukkes JL, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.018.2009; METCALFE NB, 1992, J FISH BIOL, V41, P93, DOI 10.1111/j.1095-8649.1992.tb03871.x; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Nettle D, 2010, PHILOS T R SOC B, V365, P4043, DOI 10.1098/rstb.2010.0061; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; Parent A., 1984, Handbook of Chemical Neuroanatomy, V2, P409; Pavlov KA, 2012, J APPL GENET, V53, P61, DOI 10.1007/s13353-011-0069-6; Plomin R, 2001, CAN J PSYCHIAT, V46, P225, DOI 10.1177/070674370104600302; PRICE T, 1992, TRENDS ECOL EVOL, V7, P307, DOI 10.1016/0169-5347(92)90229-5; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reale D, 2010, PHILOS T R SOC B, V365, P4051, DOI 10.1098/rstb.2010.0208; Reale D, 2010, PHILOS T R SOC B, V365, P3937, DOI 10.1098/rstb.2010.0222; Regnier T, 2012, OECOLOGIA, V168, P371, DOI 10.1007/s00442-011-2109-7; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; Summers CH, 2005, PHYSIOL BIOCHEM ZOOL, V78, P679, DOI 10.1086/432139; Suomi SJ, 2006, ANN NY ACAD SCI, V1094, P52, DOI 10.1196/annals.1376.006; van Oers K, 2010, PHILOS T R SOC B, V365, P3991, DOI 10.1098/rstb.2010.0178; Vaz-Serrano J, 2011, PHYSIOL BEHAV, V103, P359, DOI 10.1016/j.physbeh.2011.02.025; Weigensberg I, 1998, J EVOLUTION BIOL, V11, P135, DOI 10.1007/s000360050071; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WINBERG S, 1993, COMP BIOCHEM PHYS C, V106, P597, DOI 10.1016/0742-8413(93)90216-8; Wolf M, 2008, P NATL ACAD SCI USA, V105, P15825, DOI 10.1073/pnas.0805473105; Wolf M, 2010, PHILOS T R SOC B, V365, P3959, DOI 10.1098/rstb.2010.0215	52	14	14	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49247	10.1371/journal.pone.0049247	http://dx.doi.org/10.1371/journal.pone.0049247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155473	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900108
J	Davis, TS; Horton, DR; Munyaneza, JE; Landolt, PJ				Davis, Thomas Seth; Horton, David R.; Munyaneza, Joseph E.; Landolt, Peter J.			Experimental Infection of Plants with an Herbivore-Associated Bacterial Endosymbiont Influences Herbivore Host Selection Behavior	PLOS ONE			English	Article							POTATO PLANTS; ZEBRA CHIP; SEED PREDATORS; VIRUS ATTRACT; VOLATILES; DISEASE; VECTOR; LIBERIBACTER; POLLINATORS; HOMOPTERA	Although bacterial endosymbioses are common among phloeophagous herbivores, little is known regarding the effects of symbionts on herbivore host selection and population dynamics. We tested the hypothesis that plant selection and reproductive performance by a phloem-feeding herbivore (potato psyllid, Bactericera cockerelli) is mediated by infection of plants with a bacterial endosymbiont. We controlled for the effects of herbivory and endosymbiont infection by exposing potato plants (Solanum tuberosum) to psyllids infected with "Candidatus Liberibacter solanacearum" or to uninfected psyllids. We used these treatments as a basis to experimentally test plant volatile emissions, herbivore settling and oviposition preferences, and herbivore population growth. Three important findings emerged: (1) plant volatile profiles differed with respect to both herbivory and herbivory plus endosymbiont infection when compared to undamaged control plants; (2) herbivores initially settled on plants exposed to endosymbiont-infected psyllids but later defected and oviposited primarily on plants exposed only to uninfected psyllids; and (3) plant infection status had little effect on herbivore reproduction, though plant flowering was associated with a 39% reduction in herbivore density on average. Our experiments support the hypothesis that plant infection with endosymbionts alters plant volatile profiles, and infected plants initially recruited herbivores but later repelled them. Also, our findings suggest that the endosymbiont may not place negative selection pressure on its host herbivore in this system, but plant flowering phenology appears correlated with psyllid population performance.			Davis, TS (corresponding author), Univ Idaho, Dept Plant Soil & Entomol Sci, Moscow, ID 83843 USA.	tsdavis1@gmail.com						Agelopoulos NG, 2000, J CHEM ECOL, V26, P497, DOI 10.1023/A:1005473825335; AUGSPURGER CK, 1981, ECOLOGY, V62, P775, DOI 10.2307/1937745; Baumann P, 2005, ANNU REV MICROBIOL, V59, P155, DOI 10.1146/annurev.micro.59.030804.121041; Belliure B, 2005, ECOL LETT, V8, P70, DOI 10.1111/j.1461-0248.2004.00699.x; Bourtzis K, 2003, CONT T ENT, P217; Brody AK, 1997, ECOLOGY, V78, P1624, DOI 10.1890/0012-9658(1997)078[1624:EOPHAS]2.0.CO;2; Brown RD, 1996, J CHEM INF COMP SCI, V36, P572, DOI 10.1021/ci9501047; Buchman JL, 2012, AM J POTATO RES, V89, P159, DOI 10.1007/s12230-012-9238-3; Casteel CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035191; Crosslin JM, 2009, AM J POTATO RES, V86, P183, DOI 10.1007/s12230-009-9070-6; Dale C, 1999, INT J SYST BACTERIOL, V49, P267, DOI 10.1016/S0020-7519(01)00151-5; Daugherty MP, 2011, ECOL ENTOMOL, V36, P654, DOI 10.1111/j.1365-2311.2011.01309.x; Davis TS, 2011, MYCOLOGIA, V103, P1201, DOI 10.3852/11-083; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; DOUGLAS AE, 1992, J INSECT PHYSIOL, V38, P565, DOI 10.1016/0022-1910(92)90107-O; Eigenbrode SD, 2002, P ROY SOC B-BIOL SCI, V269, P455, DOI 10.1098/rspb.2001.1909; Gibson CM, 2010, ECOL LETT, V13, P223, DOI 10.1111/j.1461-0248.2009.01416.x; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Ingwell LL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00578; Karlsson MF, 2009, J AGR FOOD CHEM, V57, P5903, DOI 10.1021/jf803730h; Mann RS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002610; Mauck KE, 2010, P NATL ACAD SCI USA, V107, P3600, DOI 10.1073/pnas.0907191107; McMenemy LS, 2012, ENTOMOL EXP APPL, V144, P56, DOI 10.1111/j.1570-7458.2012.01248.x; Moran NA, 2003, P NATL ACAD SCI USA, V100, P14543, DOI 10.1073/pnas.2135345100; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; MUNYANEZA JE, 2007, SUBTROPICAL PLANT SC, V59, P30; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Nachappa P, 2012, PHYTOPATHOLOGY, V102, P41, DOI 10.1094/PHYTO-03-11-0084; Pilson D, 2000, OECOLOGIA, V122, P72, DOI 10.1007/PL00008838; Pontes MH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003541; RAFFA KF, 1982, CAN ENTOMOL, V114, P97, DOI 10.4039/Ent11497-2; ROSER BP, 1988, CHEM GEOL, V67, P119, DOI 10.1016/0009-2541(88)90010-1; Simelane DO, 2008, BIOL CONTROL, V44, P128, DOI 10.1016/j.biocontrol.2007.10.004; STOUTHAMER R, 1990, P NATL ACAD SCI USA, V87, P2424, DOI 10.1073/pnas.87.7.2424; Thaler JS, 1999, NATURE, V399, P686, DOI 10.1038/21420; Vorburger C, 2009, EVOLUTION, V63, P1439, DOI 10.1111/j.1558-5646.2009.00660.x; WADE MJ, 1985, SCIENCE, V227, P527, DOI 10.1126/science.3966160; WALLIS R. L., 1955, Technical Bulletin. United States Department of Agriculture; Weeks AR, 2003, P ROY SOC B-BIOL SCI, V270, P1857, DOI 10.1098/rspb.2003.2425; Weissbecker B, 1997, TALANTA, V44, P2217, DOI 10.1016/S0039-9140(97)00037-4	40	44	45	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49330	10.1371/journal.pone.0049330	http://dx.doi.org/10.1371/journal.pone.0049330			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166641	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900124
J	Feng, YM; Hans, C; McIlwain, E; Varner, KJ; Lazartigues, E				Feng, Yumei; Hans, Chetan; McIlwain, Elizabeth; Varner, Kurt J.; Lazartigues, Eric			Angiotensin-Converting Enzyme 2 Over-Expression in the Central Nervous System Reduces Angiotensin-II-Mediated Cardiac Hypertrophy	PLOS ONE			English	Article							LEFT-VENTRICULAR HYPERTROPHY; ACE2; OVEREXPRESSION; HYPERTENSION; ANGIOTENSIN-CONVERTING-ENZYME-2; CARDIOMYOPATHY; MECHANISMS; FIBROSIS	Angiotensin-converting enzyme type 2 (ACE2) has been shown to be an important member of the renin angiotensin system. Previously, we observed that central ACE2 reduces the development of hypertension following chronic angiotensin II (Ang-II) infusion in syn-hACE2 transgenic (SA) mice, in which the human ACE2 transgene is selectively targeted to neurons. To study the physiological consequences of central ACE2 over-expression on cardiac function and cardiac hypertrophy, SA and non-transgenic (NT) mice were infused with Ang-II (600 ng/kg/min, sc) for 14 days, and cardiac function was assessed by echocardiography. Blood pressure (BP), hemodynamic parameters, left ventricle (LV) mass/tibia length, relative ventricle wall thickness (2PW/LVD), cardiomyocyte diameters and collagen deposition were similar (P>0.05) between NT and SA mice during saline infusion. After a 2-week infusion, BP was elevated in NT but not in SA mice. Although ejection fraction and fractional shortening were not altered, Ang-II infusion increased 2PW/LVD compared to saline infusion in NT mice. Interestingly, the 2PW/LVD and LV mass/tibia ratios were significantly lower in SA compared to NT mice at the end of infusion. Moreover, Ang-II infusion significantly increased arterial collagen deposition and cardiomyocytes diameter in NT mice but not in transgenic animals (P<0.05). More importantly, ACE2 over expression significantly reduced the Ang-II-mediated increase in urine norepinephrine levels in SA compared to NT mice. The protective effect of ACE2 appears to involve reductions in Ang-II-mediated hypertension and sympathetic nerve activity.	[Feng, Yumei; McIlwain, Elizabeth; Varner, Kurt J.; Lazartigues, Eric] Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Feng, YM (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA 70112 USA.	elazar@lsuhsc.edu	Hans, Chetan/C-5490-2012	Varner, Kurt/0000-0001-5460-8044; Lazartigues, Eric/0000-0001-7290-0786	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093178] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103514] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL093178, R01 HL093178] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Cowan BR, 2009, CURR HYPERTENS REP, V11, P167, DOI 10.1007/s11906-009-0030-9; Davisson RL, 2003, AM J PHYSIOL-REG I, V285, pR498, DOI 10.1152/ajpregu.00190.2003; Diez-Freire C, 2006, PHYSIOL GENOMICS, V27, P12, DOI 10.1152/physiolgenomics.00312.2005; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Doobay MF, 2007, AM J PHYSIOL-REG I, V292, pR373, DOI 10.1152/ajpregu.00292.2006; Esler M, 2000, J CARDIOVASC PHARM, V35, pS1, DOI 10.1097/00005344-200000004-00001; Feng YM, 2008, CIRC RES, V102, P729, DOI 10.1161/CIRCRESAHA.107.169110; Feng YM, 2010, EXP PHYSIOL, V95, P601, DOI 10.1113/expphysiol.2009.047407; Feng YM, 2010, CIRC RES, V106, P373, DOI 10.1161/CIRCRESAHA.109.208645; Ferrario CM, 2006, HYPERTENSION, V47, P515, DOI 10.1161/01.HYP.0000196268.08909.fb; Gonzalez A, 2002, J MOL CELL CARDIOL, V34, P1585, DOI 10.1006/jmcc.2002.2081; Huentelman MJ, 2005, EXP PHYSIOL, V90, P783, DOI 10.1113/expphysiol.2005.031096; Johnson AK, 1997, FRONT NEUROENDOCRIN, V18, P292, DOI 10.1006/frne.1997.0153; Kaiqiang Ji, 2009, Ther Adv Cardiovasc Dis, V3, P103, DOI 10.1177/1753944708098691; Lazartigues E, 2007, CURR PHARM DESIGN, V13, P1231, DOI 10.2174/138161207780618911; Leenen F H, 1999, Can J Cardiol, V15 Suppl A, p2A; Lieb W, 2006, J MOL MED, V84, P88, DOI 10.1007/s00109-005-0718-5; Lijnen P, 1999, J MOL CELL CARDIOL, V31, P949, DOI 10.1006/jmcc.1999.0934; Limbruno U, 1998, EUR HEART J, V19, P146, DOI 10.1053/euhj.1997.0743; Matsusaka T, 1999, TRENDS CARDIOVAS MED, V9, P180, DOI 10.1016/S1050-1738(00)00018-9; Mehta PK, 2007, AM J PHYSIOL-CELL PH, V292, pC82, DOI 10.1152/ajpcell.00287.2006; Pace L, 2004, Q J NUCL MED MOL IM, V48, P20; Palatini P, 2001, Curr Hypertens Rep, V3 Suppl 1, pS3, DOI 10.1007/s11906-001-0065-z; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Raizada V, 2007, J INVEST MED, V55, P341, DOI 10.2310/6650.2007.00020; Shu-Xia W, 2008, CHINESE MED J-PEKING, V121, P27, DOI 10.1097/00029330-200801010-00006; Tallant EA, 2006, FUTUR CARDIOL, V2, P335, DOI 10.2217/14796678.2.3.335; Tipnis SR, 2000, J BIOL CHEM, V275, P33238, DOI 10.1074/jbc.M002615200; Veerasingham SJ, 2003, BRIT J PHARMACOL, V139, P191, DOI 10.1038/sj.bjp.0705262; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Xia HJ, 2009, HYPERTENSION, V53, P210, DOI 10.1161/HYPERTENSIONAHA.108.123844; Xu P, 2011, AM J PHYSIOL-REG I, V300, pR804, DOI 10.1152/ajpregu.00222.2010; Yamazaki T, 2000, Z KARDIOL, V89, P1, DOI 10.1007/s003920050001; Yamazaki T, 1998, CELL SIGNAL, V10, P693, DOI 10.1016/S0898-6568(98)00036-9; Yamazato M, 2007, HYPERTENSION, V49, P926, DOI 10.1161/01.HYP.0000259942.38108.20; Zhong JC, 2004, HYPERTENSION, V44, P907, DOI 10.1161/01.HYP.0000146400.57221.74; Zimmer HG, 1997, J MOL MED-JMM, V75, P849, DOI 10.1007/s001090050176; Zimmerman MC, 2004, CIRC RES, V95, P210, DOI 10.1161/01.RES.0000135483.12297.e4; Zucker I H, 2000, Heart Fail Rev, V5, P27, DOI 10.1023/A:1009894007055; ZUCKER IH, 1995, PROG CARDIOVASC DIS, V37, P397, DOI 10.1016/S0033-0620(05)80020-9	40	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48910	10.1371/journal.pone.0048910	http://dx.doi.org/10.1371/journal.pone.0048910			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155428	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900063
J	Galamb, O; Wichmann, B; Sipos, F; Spisak, S; Krenacs, T; Toth, K; Leiszter, K; Kalmar, A; Tulassay, Z; Molnar, B				Galamb, Orsolya; Wichmann, Barnabas; Sipos, Ferenc; Spisak, Sandor; Krenacs, Tibor; Toth, Kinga; Leiszter, Katalin; Kalmar, Alexandra; Tulassay, Zsolt; Molnar, Bela			Dysplasia-Carcinoma Transition Specific Transcripts in Colonic Biopsy Samples	PLOS ONE			English	Article							DIFFERENTIAL GENE-EXPRESSION; MESSENGER-RNA EXPRESSION; CELL LUNG-CANCER; COLORECTAL-CANCER; CDNA MICROARRAY; STAGE-II; DUKES-B; ADENOMA; ADENOCARCINOMA; CLASSIFICATION	Background: The early molecular detection of the dysplasia-carcinoma transition may enhance the strength of diagnosis in the case of colonic biopsies. Our aims were to identify characteristic transcript sets in order to develop diagnostic mRNA expression patterns for objective classification of benign and malignant colorectal diseases and to test the classificatory power of these markers on an independent sample set. Methodology/Principal Findings: Colorectal cancer (CRC) and adenoma specific transcript sets were identified using HGU133plus2 microarrays and 53 biopsies (22 CRC, 20 adenoma and 11 normal). Ninety-four independent biopsies (27 CRC, 29 adenoma and 38 normal) were analyzed on microarrays for testing the classificatory power of the discriminatory genes. Array real-time PCR validation was done on 68 independent samples (24 CRC, 24 adenoma and 20 normal). A set of 11 transcripts (including CXCL1, CHI3L1 and GREM1) was determined which could correctly discriminate between high-grade dysplastic adenoma and CRC samples by 100% sensitivity and 88.9% specificity. The discriminatory power of the marker set was proved to be high on independent samples in both microarray and RT-PCR analyses. 95.6% of original and 94.1% of cross-validated samples was correctly classified in discriminant analysis. Conclusions/Significance: The identified transcripts could correctly characterize the dysplasia-carcinoma transition in biopsy samples, also on a large independent sample set. These markers can establish the basis of gene expression based diagnostic classification of colorectal cancer. Diagnostic RT-PCR cards can become part of the automated routine procedure.	[Galamb, Orsolya; Wichmann, Barnabas; Sipos, Ferenc; Spisak, Sandor; Toth, Kinga; Leiszter, Katalin; Kalmar, Alexandra; Tulassay, Zsolt; Molnar, Bela] Semmelweis Univ, Dept Med 2, Budapest, Hungary	Semmelweis University	Galamb, O (corresponding author), Semmelweis Univ, Dept Med 2, Budapest, Hungary.	wwbarna@yahoo.com	Sipos, Ferenc/GYV-6182-2022					Agrawal D, 2002, J NATL CANCER I, V94, P513; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Bingham S, 2004, NAT REV CANCER, V4, P206, DOI 10.1038/nrc1298; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; Birkenkamp-Demtroder K, 2005, GUT, V54, P374, DOI 10.1136/gut.2003.036848; Chiu ST, 2005, CANCER EPIDEM BIOMAR, V14, P437, DOI 10.1158/1055-9965.EPI-04-0396; Croner RS, 2005, INT J COLORECTAL DIS, V20, P353, DOI 10.1007/s00384-004-0664-7; Doll D, 2010, INT J COLORECTAL DIS, V25, P573, DOI 10.1007/s00384-010-0901-1; Frederiksen CM, 2003, J CANCER RES CLIN, V129, P263, DOI 10.1007/s00432-003-0434-x; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Galamb O, 2008, CANCER EPIDEM BIOMAR, V17, P2835, DOI 10.1158/1055-9965.EPI-08-0231; Galamb O, 2008, DIS MARKERS, V25, P1, DOI 10.1155/2008/586721; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Hoffman EP, 2004, NAT REV GENET, V5, P229, DOI 10.1038/nrg1297; Itoh Y, 2005, CYTOKINE, V29, P275, DOI 10.1016/j.cyto.2004.11.005; Junker N, 2005, LUNG CANCER, V48, P223, DOI 10.1016/j.lungcan.2004.11.011; Kaira K, 2009, CANCER SCI, V100, P249, DOI 10.1111/j.1349-7006.2008.01029.x; Kim HJ, 2008, BMB REP, V41, P685, DOI 10.5483/BMBRep.2008.41.10.685; Kobayashi K, 2008, NEUROSURGERY, V62, P493, DOI 10.1227/01.neu.0000316018.51292.19; Kwon HC, 2004, DIS COLON RECTUM, V47, P141, DOI 10.1007/s10350-003-0032-7; Ladanyi A, 2006, CYTOM PART A, V69A, P947, DOI 10.1002/cyto.a.20322; Landvik NE, 2009, CARCINOGENESIS, V30, P1186, DOI 10.1093/carcin/bgp122; Li MH, 2004, INT J ONCOL, V24, P305; Lurje G, 2009, PHARMACOGENET GENOM, V19, P95, DOI 10.1097/FPC.0b013e32831a9ad1; Matsuyama T, 2010, INT J CANCER, V127, P2292, DOI 10.1002/ijc.25256; McLachlan GJ, 2004, WILEY SERIES PROBABI, P1; Mikeska Thomas, 2009, BMC Res Notes, V2, P112, DOI 10.1186/1756-0500-2-112; Namkoong H, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-74; Notterman DA, 2001, CANCER RES, V61, P3124; Raychaudhuri S, 2000, Pac Symp Biocomput, P455; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Streit S, 2009, PANCREATOLOGY, V9, P577, DOI 10.1159/000212084; Sugiyama Y, 2005, GASTROENTEROLOGY, V128, P480, DOI 10.1053/j.gastro.2004.11.010; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Wang YX, 2004, J CLIN ONCOL, V22, P1564, DOI 10.1200/JCO.2004.08.186; Wen Y, 2006, CLIN CANCER RES, V12, P5951, DOI 10.1158/1078-0432.CCR-06-0736; Williams NS, 2003, CLIN CANCER RES, V9, P931; WINAWER SJ, 1993, NEW ENGL J MED, V329, P1977, DOI 10.1056/NEJM199312303292701; Zisman TL, 2008, WORLD J GASTROENTERO, V14, P2662, DOI 10.3748/wjg.14.2662	39	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48547	10.1371/journal.pone.0048547	http://dx.doi.org/10.1371/journal.pone.0048547			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155391	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900025
J	Krieger, J; Grandy, R; Drew, MM; Erland, S; Stensmyr, MC; Harzsch, S; Hansson, BS				Krieger, Jakob; Grandy, Ronald; Drew, Michelle M.; Erland, Susanne; Stensmyr, Marcus C.; Harzsch, Steffen; Hansson, Bill S.			Giant Robber Crabs Monitored from Space: GPS-Based Telemetric Studies on Christmas Island (Indian Ocean)	PLOS ONE			English	Article							HOMARUS-AMERICANUS; PATH-INTEGRATION; WATER-BALANCE; ORIENTATION; TRACKING; NAVIGATION; LOBSTER; MECHANISMS; AMPHIPODA; MOVEMENTS	We investigated the navigational capabilities of the world's largest land-living arthropod, the giant robber crab Birgus latro (Anomura, Coenobitidae); this crab reaches 4 kg in weight and can reach an age of up to 60 years. Populations are distributed over small Indo-Pacific islands of the tropics, including Christmas Island (Indian Ocean). Although this species has served as a crustacean model to explore anatomical, physiological, and ecological aspects of terrestrial adaptations, few behavioral analyses of it exist. We used a GPS-based telemetric system to analyze movements of freely roaming robber crabs, the first large-scale study of any arthropod using GPS technology to monitor behavior. Although female robber crabs are known to migrate to the coast for breeding, no such observations have been recorded for male animals. In total, we equipped 55 male robber crabs with GPS tags, successfully recording more than 1,500 crab days of activity, and followed some individual animals for as long as three months. Besides site fidelity with short-distance excursions, our data reveal long-distance movements (several kilometers) between the coast and the inland rainforest. These movements are likely related to mating, saltwater drinking and foraging. The tracking patterns indicate that crabs form route memories. Furthermore, translocation experiments show that robber crabs are capable of homing over large distances. We discuss if the search behavior induced in these experiments suggests path integration as another important navigation strategy.	[Krieger, Jakob; Harzsch, Steffen] Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany	Ernst Moritz Arndt Universitat Greifswald	Krieger, J (corresponding author), Ernst Moritz Arndt Univ Greifswald, Zool Inst & Museum, Greifswald, Germany.	jakob.krieger@uni-greifswald.de	Harzsch, Steffen/I-3816-2019; Hansson, Bill S/G-2774-2013	Harzsch, Steffen/0000-0002-8645-3320; Hansson, Bill S/0000-0002-4811-1223; Stensmyr, Marcus/0000-0003-4009-9212; Krieger, Jakob/0000-0001-8546-3319				Altevogt R, 1975, Bulletin Dep mar Sci Univ Cochin, V7, P11; Andrews C. W., 1900, MONOGRAPH CHRISTMAS; Bingman VP, 2005, ETHOL ECOL EVOL, V17, P295; Borradaile LA, 1902, ZOOLOGICAL RESULTS 5, P585; Burt W. H., 1943, J MAMMAL, V24, P346, DOI DOI 10.2307/1374834; Chapman JW, 2004, INT J PEST MANAGE, V50, P225, DOI 10.1080/09670870410001731961; Chapman WM, 1948, PACIFIC DISCOVERY, V1, P3; Cheng K, 2009, BEHAV PROCESS, V80, P261, DOI 10.1016/j.beproc.2008.10.015; Collett M, 2000, BIOL CYBERN, V83, P245, DOI 10.1007/s004220000168; CREASER EP, 1950, SCIENCE, V112, P169, DOI 10.1126/science.112.2902.169; Drew MM, 2010, ZOOL ANZ, V249, P45, DOI 10.1016/j.jcz.2010.03.001; FLETCHER W J, 1990, Pacific Science, V44, P407; Fraser PJ, 2006, MAR FRESHW BEHAV PHY, V39, P87, DOI 10.1080/10236240600708439; Gambineri S, 2008, CHEM ECOL, V24, P129, DOI 10.1080/02757540801966322; Gibson-Hill CA, B RAFFLES MUSEUM, V18, P43; Golet WJ, 2006, J CRUSTACEAN BIOL, V26, P610, DOI 10.1651/S-2729.1; Greenaway P., 1988, P211, DOI 10.1017/CBO9780511753428.008; Greenaway P, 2001, J CRUSTACEAN BIOL, V21, P317, DOI 10.1651/0278-0372(2001)021[0317:SAWBIF]2.0.CO;2; Greenaway Peter, 2003, Memoirs of Museum Victoria, V60, P13; Groeneveld JC, 2002, MAR ECOL PROG SER, V232, P225, DOI 10.3354/meps232225; GROSS WJ, 1955, AM NAT, V89, P205, DOI 10.1086/281884; GROSS WJ, 1964, BIOL BULL, V126, P54, DOI 10.2307/1539416; Hansson BS, 2011, CHEMICAL COMMUNICATION IN CRUSTACEANS, P149, DOI 10.1007/978-0-387-77101-4_8; Hartnoll R.G., 1988, P6, DOI 10.1017/CBO9780511753428.003; HELFMAN GS, 1979, NAT HIST, V88, P76; Herrnkind W.F., 1983, P41; Herrnkind W.F., 1980, P349; Herrnkind W. F., 1970, Nat. Hist., N.Y., V79, P36; HERRNKIND WF, 1971, ANN NY ACAD SCI, V188, P359, DOI 10.1111/j.1749-6632.1971.tb13109.x; Hoernle K, 2011, NAT GEOSCI, V4, P883, DOI [10.1038/NGEO1331, 10.1038/ngeo1331]; Kays R, 2011, ACTA OECOL, V37, P625, DOI 10.1016/j.actao.2011.06.007; Kenward RE., 2000, MANUAL WILDLIFE RADI; Kim TW, 2010, BEHAV ECOL, V21, P836, DOI 10.1093/beheco/arq067; Krieger J, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-25; Layne JE, 2003, J EXP BIOL, V206, P4425, DOI 10.1242/jeb.00661; Layne JE, 2003, J EXP BIOL, V206, P4413, DOI 10.1242/jeb.00660; LOHMANN KJ, 1995, J EXP BIOL, V198, P2041; Meschini E, 2008, ANIM BEHAV, V76, P25, DOI 10.1016/j.anbehav.2007.12.011; Powers LW., 1983, BIOL CRUSTACEA, P272; RODGERS AR, 2007, HRT HOME RANGE TOOLS; Scapini F, 1996, REV CHIL HIST NAT, V69, P553; Schiller C, 1991, COCONUT CRAB ASPECTS, P13; Schiller C.B, 1988, SPAWNING LARVAL RECR; SCHMIDHEMPEL P, 1984, BEHAV ECOL SOCIOBIOL, V14, P263, DOI 10.1007/BF00299497; Silverman B.W., 1986, DENSITY ESTIMATION S; Sims DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007351; Staaterman ER, 2011, AQUAT BIOL, V13, P97, DOI 10.3354/ab00361; Stensmyr MC, 2005, CURR BIOL, V15, P116, DOI 10.1016/j.cub.2004.12.069; Tsoar A, 2011, P NATL ACAD SCI USA, V108, pE718, DOI 10.1073/pnas.1107365108; Ugolini A, 2010, BIOL BULL-US, V219, P72, DOI 10.1086/BBLv219n1p72; UGOLINI A, 1988, J EXP MAR BIOL ECOL, V121, P79, DOI 10.1016/0022-0981(88)90025-1; Vannini M, 1995, J EXP MAR BIOL ECOL, V193, P67, DOI 10.1016/0022-0981(95)00111-5; VANNINI M, 1975, Monitore Zoologico Italiano Supplemento, V6, P233; VANNINI M, 1975, Monitore Zoologico Italiano Supplemento, V6, P57; VANNINI M, 1976, MONIT ZOOL ITAL, P255; Vannini M., 1976, Monitore Zoologico Italiano (NS), V7, P145; Warrant E, 2010, BRAIN BEHAV EVOLUT, V75, P156, DOI 10.1159/000314277; Watson WH, 1999, MAR BIOL, V134, P65, DOI 10.1007/s002270050525; Watson WH, 2010, CURR ZOOL, V56, P599, DOI 10.1093/czoolo/56.5.599; Watson WH, 2009, NEW ZEAL J MAR FRESH, V43, P411, DOI 10.1080/00288330909510010; Wehner R., 1992, P45; Wikelski M, 2007, J EXP BIOL, V210, P181, DOI 10.1242/jeb.02629; Wolf H, 2011, J EXP BIOL, V214, P1629, DOI 10.1242/jeb.038570; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Zeil J, 2006, J COMP PHYSIOL A, V192, P1, DOI 10.1007/s00359-005-0048-7; Zeil J, 1998, J COMP PHYSIOL A, V183, P367, DOI 10.1007/s003590050263	66	18	18	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49809	10.1371/journal.pone.0049809	http://dx.doi.org/10.1371/journal.pone.0049809			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166774	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900196
J	Peng, L; Men, XL; Zhang, WJ; Wang, HY; Xu, SQ; Fang, Q; Liu, HL; Yang, WY; Lou, JN				Peng, Liang; Men, Xiuli; Zhang, Wenjian; Wang, Haiyan; Xu, Shiqing; Fang, Qing; Liu, Honglin; Yang, Wenying; Lou, Jinning			Involvement of Dynamin-Related Protein 1 in Free Fatty Acid-Induced INS-1-Derived Cell Apoptosis	PLOS ONE			English	Article							CYTOCHROME-C RELEASE; PANCREATIC BETA-CELLS; MITOCHONDRIAL MORPHOLOGY; CASPASE ACTIVATION; MAMMALIAN-CELLS; FISSION; OVEREXPRESSION; DEPOLARIZATION; LIPOTOXICITY; PATHOGENESIS	Elevated extracellular free fatty acids (FFAs) can induce pancreatic beta cell apoptosis, thereby contributing to the pathogenesis of type 2 diabetes mellitus (T2D). Mitochondrial dysfunction has been implicated in FFA-induced beta cell apoptosis. However, molecular mechanisms linking mitochondrial dysfunction and FFA-induced beta cell apoptosis are not clear. Dynamin-related protein 1 (DRP-1) is a mitochondrial fission modulator. In this study, we investigated its role in FFA-induced INS-1 beta cell apoptosis. DRP-1 protein was promptly induced in INS-1 cells and rat islets after stimulation by FFAs, and this DRP-1 upregulation was accompanied by increased INS-1 cell apoptosis. Induction of DRP-1 expression significantly promoted FFA-induced apoptosis in DRP-1 WT (DRP-1 wild type) inducible INS-1-derived cell line, but not in DRP-1 K38A (a dominant negative mutant of DRP-1) inducible INS-1-derived cell line. To validate these in vitro results, we transplanted DRP-1 WT or DRP-1 K38A cells into renal capsules of streptozotocin (STZ)-treated diabetic mice to study the apoptosis in xenografts. Consistent with the in vitro results, the over-expression of DRP-1 led to aggravated INS-1-derived cell apoptosis triggered by FFAs. In contrast, dominant-negative suppression of DRP-1 function as represented by DRP-1 K38A significantly prevented FFA-induced apoptosis in xenografts. It was further demonstrated that mitochondrial membrane potential decreased, while cytochrome c release, caspase-3 activation, and generation of reactive oxygen species (ROS) were enhanced by the induction of DRP-1 WT, but prevented by DRP-1 K38A in INS-1-derived cells under FFA stimulation. These results indicated that DRP-1 mediates FFA-induced INS-1-derived cell apoptosis, suggesting that suppression of DRP-1 is a potentially useful therapeutic strategy for protecting against beta cell loss that leads to type 2 diabetes.	[Peng, Liang; Zhang, Wenjian; Xu, Shiqing; Fang, Qing; Liu, Honglin; Yang, Wenying; Lou, Jinning] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China	China-Japan Friendship Hospital	Peng, L (corresponding author), China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China.	Lou.j@mail.com	liu, honglin/HDN-0409-2022	liu, honglin/0000-0002-1254-3163				ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; Bell GI, 2001, NATURE, V414, P788, DOI 10.1038/414788a; Bossy-Wetzel E, 1998, EMBO J, V17, P37, DOI 10.1093/emboj/17.1.37; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Chen Q, 2003, CELL DEATH DIFFER, V10, P323, DOI 10.1038/sj.cdd.4401148; Chu KY, 2010, J BIOL CHEM, V285, P32606, DOI 10.1074/jbc.M110.157172; Fonseca SG, 2009, CURR OPIN PHARMACOL, V9, P763, DOI 10.1016/j.coph.2009.07.003; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Goldstein JC, 2000, NAT CELL BIOL, V2, P156, DOI 10.1038/35004029; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316; Jeffrey KD, 2008, P NATL ACAD SCI USA, V105, P8452, DOI 10.1073/pnas.0711232105; Karbowski M, 2003, CELL DEATH DIFFER, V10, P870, DOI 10.1038/sj.cdd.4401260; Koshkin V, 2008, J BIOL CHEM, V283, P7936, DOI 10.1074/jbc.M705652200; Krohn AJ, 1999, J NEUROSCI, V19, P7394, DOI 10.1523/JNEUROSCI.19-17-07394.1999; Lee SM, 2011, MOL CELL BIOCHEM, V354, P207, DOI 10.1007/s11010-011-0820-7; Lee Y, 1997, DIABETES, V46, P408, DOI 10.2337/diabetes.46.3.408; Li H, 2011, DIABETES METAB RES R; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Mao JN, 2008, J CELL BIOCHEM, V105, P1073, DOI 10.1002/jcb.21910; Martinou JC, 2006, CELL DEATH DIFFER, V13, P1291, DOI 10.1038/sj.cdd.4401985; Men XL, 2009, INT J BIOCHEM CELL B, V41, P879, DOI 10.1016/j.biocel.2008.08.031; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Perfettini JL, 2005, TRENDS CELL BIOL, V15, P179, DOI 10.1016/j.tcb.2005.02.005; Prentki M, 2002, DIABETES, V51, pS405, DOI 10.2337/diabetes.51.2007.S405; Qian B, 2008, J ENDOCRINOL, V199, P407, DOI 10.1677/JOE-08-0331; Rachek LI, 2006, DIABETES, V55, P1022, DOI 10.2337/diabetes.55.04.06.db05-0865; Ravnskjaer K, 2010, J LIPID RES, V51, P1370, DOI 10.1194/jlr.M001123; Santel A, 2001, J CELL SCI, V114, P867; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Tuo Y, 2011, ENDOCRINE, V39, P128, DOI 10.1007/s12020-010-9432-3; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Wang HY, 1997, P NATL ACAD SCI USA, V94, P4372, DOI 10.1073/pnas.94.9.4372; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2001, J BIOL CHEM, V276, P25279, DOI 10.1074/jbc.M101233200; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Youle RJ, 2005, NAT REV MOL CELL BIO, V6, P657, DOI 10.1038/nrm1697; Yu TZ, 2006, P NATL ACAD SCI USA, V103, P2653, DOI 10.1073/pnas.0511154103; Yuan HP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015726; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	44	24	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49258	10.1371/journal.pone.0049258	http://dx.doi.org/10.1371/journal.pone.0049258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166623	Green Published, gold			2022-12-27	WOS:000311151900112
J	Hu, XL; Wu, XL; Li, CH; Lu, MH; Liu, TX; Wang, Y; Wang, W				Hu, Xiuli; Wu, Xiaolin; Li, Chaohai; Lu, Minghui; Liu, Tianxue; Wang, Ying; Wang, Wei			Abscisic Acid Refines the Synthesis of Chloroplast Proteins in Maize (Zea mays) in Response to Drought and Light	PLOS ONE			English	Article							DEPENDENT PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; INDUCED ANTIOXIDANT DEFENSE; LUPINUS-LUTEUS COTYLEDONS; LARGE SUBUNIT; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; INORGANIC PYROPHOSPHATASE; STRESS TOLERANCE; LEAVES; ABA; EXPRESSION	To better understand abscisic acid (ABA) regulation of the synthesis of chloroplast proteins in maize (Zea mays L.) in response to drought and light, we compared leaf proteome differences between maize ABA-deficient mutant vp5 and corresponding wild-type Vp5 green and etiolated seedlings exposed to drought stress. Proteins extracted from the leaves of Vp5 and vp5 seedlings were used for two-dimensional electrophoresis (2-DE) and subsequent matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry (MS). After Coomassie brilliant blue staining, approximately 450 protein spots were reproducibly detected on 2-DE gels. A total of 36 differentially expressed protein spots in response to drought and light were identified using MALDI-TOF MS and their subcellular localization was determined based on the annotation of reviewed accession in UniProt Knowledgebase and the software prediction. As a result, corresponding 13 proteins of the 24 differentially expressed protein spots were definitely localized in chloroplasts and their expression was in an ABA-dependent way, including 6 up-regulated by both drought and light, 5 up-regulated by drought but down-regulated by light, 5 up-regulated by light but down-regulated by drought; 5 proteins down-regulated by drought were mainly those involved in photosynthesis and ATP synthesis. Thus, the results in the present study supported the vital role of ABA in regulating the synthesis of drought- and/or light-induced proteins in maize chloroplasts and would facilitate the functional characterization of ABA-induced chloroplast proteins in C-4 plants.	[Hu, Xiuli; Li, Chaohai; Liu, Tianxue; Wang, Wei] Henan Agr Univ, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China; [Hu, Xiuli; Wu, Xiaolin; Lu, Minghui; Wang, Ying; Wang, Wei] Henan Agr Univ, Coll Life Sci, Zhengzhou, Peoples R China; [Li, Chaohai; Liu, Tianxue] Henan Agr Univ, Coll Agron, Zhengzhou, Peoples R China	Henan Agricultural University; Henan Agricultural University; Henan Agricultural University	Wang, W (corresponding author), Henan Agr Univ, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	proteome@163.com	Hu, Xiuli/GXV-3994-2022	Liu, Tianxue/0000-0002-4733-6658	National Natural Science Foundation of China [31171470]; Fok Ying-Tong Education Foundation, China [122032]; Foundation for University Key Teacher by the Ministry of Education [2009GGJS-028]; Foundation of Henan Major Public Projects [091100910100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fok Ying-Tong Education Foundation, China(Fok Ying Tung Education Foundation); Foundation for University Key Teacher by the Ministry of Education; Foundation of Henan Major Public Projects	This work was supported by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default166.htm; Grant NO. 31171470 to XLH), the Fok Ying-Tong Education Foundation, China (www.nsitp.com/fytf/education.php; Grant No. 122032 to XLH), the Foundation for University Key Teacher by the Ministry of Education (grant No. 2009GGJS-028 to XLH) and the Foundation of Henan Major Public Projects (Grant No. 091100910100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie BAT, 2007, PLANT CELL, V19, P1665, DOI 10.1105/tpc.106.048041; Asakura T, 2007, BIOSCI BIOTECH BIOCH, V71, P1260, DOI 10.1271/bbb.60675; Baier M, 2004, PLANT CELL PHYSIOL, V45, P997, DOI 10.1093/pcp/pch114; BALDAUF SL, 1990, NATURE, V344, P262, DOI 10.1038/344262a0; BUTLER LG, 1969, PLANT PHYSIOL, V44, P1285, DOI 10.1104/pp.44.9.1285; Chattopadhyay A, 2011, PHYTOCHEMISTRY, V72, P1293, DOI 10.1016/j.phytochem.2011.01.024; Chen JH, 2012, PLANT PHYSIOL, V158, P340, DOI 10.1104/pp.111.181875; Chen XF, 2004, MOL BIOL REP, V31, P249, DOI 10.1007/s11033-005-2491-5; Desimone M, 1996, PLANT PHYSIOL, V111, P789, DOI 10.1104/pp.111.3.789; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fulda S, 2011, PLANT BIOLOGY, V13, P632, DOI 10.1111/j.1438-8677.2010.00426.x; Ge P, 2012, ANAL BIOANAL CHEM, V402, P1297, DOI 10.1007/s00216-011-5532-z; George GM, 2010, PLANT PHYSIOL, V154, P55, DOI 10.1104/pp.110.157776; Hable WE, 1998, MOL GEN GENET, V257, P167; Hu XL, 2008, PLANT GROWTH REGUL, V55, P183, DOI 10.1007/s10725-008-9272-9; Hu XL, 2006, PLANT CELL PHYSIOL, V47, P1484, DOI 10.1093/pcp/pcl014; Hu XL, 2007, NEW PHYTOL, V173, P27, DOI 10.1111/j.1469-8137.2006.01888.x; Hu XL, 2010, J PLANT GROWTH REGUL, V29, P455, DOI 10.1007/s00344-010-9157-9; Huseynova IM, 2009, BIOCHEMISTRY-MOSCOW+, V74, P903, DOI 10.1134/S0006297909080124; Ishida H, 1998, PLANTA, V204, P305, DOI 10.1007/s004250050260; Jha B, 2011, MOL BIOL REP, V38, P4823, DOI 10.1007/s11033-010-0625-x; Jiang HW, 2010, PLANT PHYSIOL, V154, P1646, DOI 10.1104/pp.110.159152; Kim J, 2003, PLANT CELL PHYSIOL, V44, P491, DOI 10.1093/pcp/pcg061; Komatsu S, 1999, ELECTROPHORESIS, V20, P630, DOI 10.1002/(SICI)1522-2683(19990301)20:3&lt;630::AID-ELPS630&gt;3.0.CO;2-Z; Kopka J, 1997, PLANT J, V11, P871, DOI 10.1046/j.1365-313X.1997.11040871.x; Kusnetsov V, 1998, MOL GEN GENET, V259, P21, DOI 10.1007/PL00008626; KUSNETSOV VV, 1994, PLANTA, V194, P318, DOI 10.1007/BF00197531; Lawlor DW, 2002, PLANT CELL ENVIRON, V25, P275, DOI 10.1046/j.0016-8025.2001.00814.x; Lee JK, 1997, J PARALLEL DISTR COM, V40, P227, DOI 10.1006/jpdc.1996.1278; Leister D, 2003, TRENDS GENET, V19, P47, DOI 10.1016/S0168-9525(02)00003-3; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Masuda T, 2004, PHOTOSYNTH RES, V81, P1, DOI 10.1023/B:PRES.0000028392.80354.7c; Memon AR, 2004, BBA-BIOMEMBRANES, V1664, P9, DOI 10.1016/j.bbamem.2004.04.005; Mittler R, 2002, TRENDS PLANT SCI, V7, P405, DOI 10.1016/S1360-1385(02)02312-9; Munoz-Bertomeu J, 2011, J EXP BOT, V62, P1229, DOI 10.1093/jxb/erq353; Oliver MJ, 2011, PHYTOCHEMISTRY, V72, P1273, DOI 10.1016/j.phytochem.2010.10.020; Paddock T, 2012, PLANT MOL BIOL, V78, P447, DOI 10.1007/s11103-012-9873-6; Perez-Ruiz JM, 2006, PLANT CELL, V18, P2356, DOI 10.1105/tpc.106.041541; Rajabi Abazar, 2007, Pak J Biol Sci, V10, P3599, DOI 10.3923/pjbs.2007.3599.3605; ROBICHAUD CS, 1980, DEV GENET, V1, P325, DOI 10.1002/dvg.1020010405; Shen YY, 2006, NATURE, V443, P823, DOI 10.1038/nature05176; Shen Z, 2009, MOL CELL PROTEOMICS, V8, P2443, DOI 10.1074/mcp.M900187-MCP200; Singh BN, 2004, BIOCHEM BIOPH RES CO, V320, P523, DOI 10.1016/j.bbrc.2004.05.192; Teng NJ, 2006, NEW PHYTOL, V172, P92, DOI 10.1111/j.1469-8137.2006.01818.x; Wang PT, 2011, CHINESE SCI BULL, V56, P3538, DOI 10.1007/s11434-011-4802-7; Wawer I, 2010, BIOCHEM J, V429, P73, DOI 10.1042/BJ20100492; WEILER EW, 1981, PLANTA, V153, P561, DOI 10.1007/BF00385542; Xu SB, 2008, PLANT PHYSIOL, V148, P908, DOI 10.1104/pp.108.125633; Xu YH, 2012, J EXP BOT, V63, P1095, DOI 10.1093/jxb/err315; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhao Y, 2011, PHYSIOL PLANTARUM, V141, P40, DOI 10.1111/j.1399-3054.2010.01419.x	51	23	28	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49500	10.1371/journal.pone.0049500	http://dx.doi.org/10.1371/journal.pone.0049500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152915	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600044
J	Luo, YJ; Wen, XZ; Ding, P; He, YH; Xie, CB; Liu, T; Lin, JM; Yuan, SX; Guo, XL; Jia, DQ; Chen, LH; Huang, BZ; Chen, WQ				Luo, Yi-Juan; Wen, Xiao-Zhong; Ding, Peng; He, Yan-Hui; Xie, Chuan-Bo; Liu, Tao; Lin, Jian-miao; Yuan, Shi-Xin; Guo, Xiao-Ling; Jia, De-Qin; Chen, Li-Hua; Huang, Bao-Zhen; Chen, Wei-Qing			Interaction between Maternal Passive Smoking during Pregnancy and CYP1A1 and GSTs Polymorphisms on Spontaneous Preterm Delivery	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; AIR-POLLUTION; CIGARETTE-SMOKING; DNA-ADDUCTS; BIOMARKERS; EXPOSURE; DISEASE; SUSCEPTIBILITY; EPIDEMIOLOGY; RELEVANCE	Objective: The present study aimed to examine the association between maternal passive smoking during pregnancy and the risk of spontaneous PTD and to explore the potential interaction of the single or joint gene polymorphism of CYP1A1 and GSTs with maternal passive smoking on the risk of spontaneous PTD. Method: We investigated whether the association between maternal passive smoking and PTD can be modified by 2 metabolic genes, i.e. cytochrome P4501A1 (CYP1A1) and glutathione S-transferases (GSTs), in a case-control study with 198 spontaneous preterm and 524 term deliveries in Shenzhen and Foshan, China. We used logistic regression to test gene-passive smoking interaction, adjusting for maternal socio-demographics and prepregnancy body mass index. Results: Overall, maternal passive smoking during pregnancy was associated with higher risk of PTD (adjusted odds ratio = 2.20 [95% confidence interval: 1.56-3.12]). This association was modified by CYP1A1 and GSTs together, but not by any single genotype. For cross-categories of CYP1A1 Msp I and GSTs, maternal passive smoking was associated with higher risk of PTD among those women with CYP1A1 "TC/CC'' + GSTs "null'', but not among women with other genotypes; and this interaction was significant (OR = 2.66 [95% CI: 1.19-5.97]; P-value: 0.017). For cross-categories of CYP1A1 BsrD I and GSTs, maternal passive smoking was associated with higher risk of PTD only among those women with CYP1A1 "AG/GG'' + GSTs "null'', but not among women with other genotypes; and this interaction was significant (OR = 3.00 [95% CI: 1.17-7.74]; Pvalue: 0.023). Conclusions: Our findings suggest that the combined genotypes of CYP1A1 and GSTs can help to identify vulnerable pregnant women who are subject to high risk of spontaneous PTD due to passive smoking.	[Luo, Yi-Juan; Ding, Peng; He, Yan-Hui; Xie, Chuan-Bo; Liu, Tao; Chen, Wei-Qing] Sun Yat Sen Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Xiao-Zhong] Harvard Univ, Sch Med, Dept Populat Med, Obes Prevent Program, Boston, MA USA; [Wen, Xiao-Zhong] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Lin, Jian-miao; Yuan, Shi-Xin; Chen, Li-Hua; Huang, Bao-Zhen] Shenzhen Women & Childrens Hosp, Shenzhen, Guangdong, Peoples R China; [Guo, Xiao-Ling; Jia, De-Qin] Foshan Women & Childrens Hosp, Foshan, Guangdong, Peoples R China	Sun Yat Sen University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care	Chen, WQ (corresponding author), Sun Yat Sen Univ, Sch Publ Hlth, Dept Biostat & Epidemiol, Guangzhou 510275, Guangdong, Peoples R China.	chenwq@mail.sysu.edu.cn			Natural Science Foundation of China (NSFC) [30872164]; Shenzhen Women and Children's Hospital; Foshan Women and Children's Hospital	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shenzhen Women and Children's Hospital; Foshan Women and Children's Hospital	The research was funded by the Natural Science Foundation of China (NSFC; grant number: 30872164). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support of Shenzhen Women and Children's Hospital and Foshan Women and Children's Hospital.	American Lung Association, 2006, SMOK 101 FACT SHEET; Ashford KB, 2010, JOGNN-J OBST GYN NEO, V39, P525, DOI 10.1111/j.1552-6909.2010.01169.x; Baggia S, 1996, J SOC GYNECOL INVEST, V3, P121, DOI 10.1016/1071-5576(96)00002-0; Bartsch H, 1996, MUTAT RES-REV GENET, V340, P67, DOI 10.1016/S0165-1110(96)90040-8; BARTSCH H, 1995, PHARMACOGENETICS, V5, pS84, DOI 10.1097/00008571-199512001-00007; Buhimschi CS, 2008, AM J PERINAT, V25, P175, DOI 10.1055/s-2008-1061497; Chang HH, 2012, AM J EPIDEMIOL, V175, P91, DOI 10.1093/aje/kwr403; Crider KS, 2005, GENET MED, V7, P593, DOI 10.1097/01.gim.0000187223.69947.db; Delpisheh A, 2007, BR J MIDWIFERY, V15, P216; Delpisheh A, 2009, EUR J OBSTET GYN R B, V143, P38, DOI 10.1016/j.ejogrb.2008.11.006; Escriba-Aguir V, 2001, Gac Sanit, V15, P6; Fantuzzi G, 2007, PAEDIATR PERINAT EP, V21, P194, DOI 10.1111/j.1365-3016.2007.00815.x; Froen JF, 2007, AM J OBSTET GYNECOL, V197, P438, DOI 10.1016/j.ajog.2007.06.080; Gabbe SG, 1996, OBSTET NORMAL ROBLEM; Gajewska Ewa, 2008, Przegl Lek, V65, P712; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Gracie SK, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-87; Gravett MG, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-S1-S2; Grazuleviciene R, 2009, INT J ENV RES PUB HE, V6, P1282, DOI 10.3390/ijerph6031282; Holst D, 2008, EUR J OBSTET GYN R B, V141, P3, DOI 10.1016/j.ejogrb.2008.07.020; Jaddoe VWV, 2008, PAEDIATR PERINAT EP, V22, P162, DOI 10.1111/j.1365-3016.2007.00916.x; Khader YS, 2011, MATERN CHILD HLTH J, V15, P453, DOI 10.1007/s10995-010-0599-2; Kriek E, 1998, MUTAT RES-FUND MOL M, V400, P215, DOI 10.1016/S0027-5107(98)00065-7; Menon R, 2008, ACTA OBSTET GYN SCAN, V87, P590, DOI 10.1080/00016340802005126; Monaghan SC, 2001, PAEDIATR PERINAT EP, V15, P123, DOI 10.1046/j.1365-3016.2001.00327.x; Moutquin JM, 2003, BJOG-INT J OBSTET GY, V110, P30, DOI 10.1016/S1470-0328(03)00021-1; Ng SP, 2007, REPROD TOXICOL, V23, P428, DOI 10.1016/j.reprotox.2006.11.008; Olsson D, 2012, INT J ENV RES PUB HE, V9, P272, DOI 10.3390/ijerph9010272; Perera FP, 2004, ENVIRON HEALTH PERSP, V112, P1133, DOI 10.1289/ehp.6833; Ritz B, 2000, EPIDEMIOLOGY, V11, P502, DOI 10.1097/00001648-200009000-00004; Sagiv SK, 2005, ENVIRON HEALTH PERSP, V113, P602, DOI 10.1289/ehp.7646; Steer P, 2005, BJOG-INT J OBSTET GY, V112, P1, DOI 10.1111/j.1471-0528.2005.00575.x; Tsai HJ, 2008, HUM GENET, V123, P359, DOI 10.1007/s00439-008-0485-9; Wang XB, 2002, JAMA-J AM MED ASSOC, V287, P195, DOI 10.1001/jama.287.2.195; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Xie X, 2006, OBSTET GYNECOLOGY; Zhang J, 2011, RESPIROLOGY, V16, P1165, DOI 10.1111/j.1440-1843.2011.02062.x	37	18	20	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49155	10.1371/journal.pone.0049155	http://dx.doi.org/10.1371/journal.pone.0049155			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152866	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234600024
J	Bombeiro, AL; Goncalves, LA; Penha-Goncalves, C; Marinho, CRF; Lima, MRD; Chadi, G; Alvarez, JM				Bombeiro, Andre Luis; Goncalves, Ligia Antunes; Penha-Goncalves, Carlos; Farias Marinho, Claudio Romero; D'Imperio Lima, Maria Regina; Chadi, Gerson; Alvarez, Jose Maria			IL-12p40 Deficiency Leads to Uncontrolled Trypanosoma cruzi Dissemination in the Spinal Cord Resulting in Neuronal Death and Motor Dysfunction	PLOS ONE			English	Article							CHAGAS-DISEASE; NITRIC-OXIDE; IFN-GAMMA; IL-12P40-DEFICIENT MICE; CEREBROSPINAL-FLUID; IMMUNE FUNCTION; PARTIAL LESION; T-CELLS; INFECTION; NEURODEGENERATION	Chagas' disease is a protozoosis caused by Trypanosoma cruzi that frequently shows severe chronic clinical complications of the heart or digestive system. Neurological disorders due to T. cruzi infection are also described in children and immunosuppressed hosts. We have previously reported that IL-12p40 knockout (KO) mice infected with the T. cruzi strain Sylvio X10/4 develop spinal cord neurodegenerative disease. Here, we further characterized neuropathology, parasite burden and inflammatory component associated to the fatal neurological disorder occurring in this mouse model. Forelimb paralysis in infected IL-12p40KO mice was associated with 60% (p<0.05) decrease in spinal cord neuronal density, glutamate accumulation (153%, p<0.05) and strong demyelization in lesion areas, mostly in those showing heavy protein nitrosylation, all denoting a neurotoxic degenerative profile. Quantification of T. cruzi 18S rRNA showed that parasite burden was controlled in the spinal cord of WT mice, decreasing from the fifth week after infection, but progressive parasite dissemination was observed in IL-12p40KO cords concurrent with significant accumulation of the astrocytic marker GFAP (317.0%, p<0.01) and 8-fold increase in macrophages/microglia (p<0.01), 36.3% (p<0.01) of which were infected. Similarly, mRNA levels for CD3, TNF-alpha, IFN-gamma, iNOS, IL-10 and arginase I declined in WT spinal cords about the fourth or fifth week after infection, but kept increasing in IL-12p40KO mice. Interestingly, compared to WT tissue, lower mRNA levels for IFN-gamma were observed in the IL-12p40KO spinal cords up to the fourth week of infection. Together the data suggest that impairments of parasite clearance mechanisms in IL-12p40KO mice elicit prolonged spinal cord inflammation that in turn leads to irreversible neurodegenerative lesions.	[Bombeiro, Andre Luis; D'Imperio Lima, Maria Regina; Alvarez, Jose Maria] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil; [Bombeiro, Andre Luis; Chadi, Gerson] Univ Sao Paulo, Sch Med, Neuroregenerat Ctr, Dept Neurol, Sao Paulo, Brazil; [Goncalves, Ligia Antunes; Penha-Goncalves, Carlos] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Farias Marinho, Claudio Romero] Univ Sao Paulo, Dept Parasitol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Gulbenkian de Ciencia; Universidade de Sao Paulo	Bombeiro, AL (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.	andrelb@icb.usp.br	Alvarez, Jose M/I-6181-2012; Marinho, Claudio Romero Farias/F-7507-2012; D'Império Lima, Maria Regina/I-4747-2012; Penha-Goncalves, Carlos/F-4640-2012; Gonçalves, Lígia Antunes/F-6242-2014	Alvarez, Jose M/0000-0002-9711-4914; Marinho, Claudio Romero Farias/0000-0002-1227-3845; D'Império Lima, Maria Regina/0000-0002-4683-7709; Gonçalves, Lígia Antunes/0000-0001-9804-6899; Penha-Goncalves, Carlos/0000-0001-7225-1907; Chadi, Gerson/0000-0002-9667-0716	FAPESP; CAPES; CNPq	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	Financial support for this study provided by FAPESP, CAPES and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsohn IA, 1996, EXP PARASITOL, V84, P231, DOI 10.1006/expr.1996.0109; Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Andrade MSR, 2008, TISSUE CELL, V40, P143, DOI 10.1016/j.tice.2007.11.002; Bal-Price A, 2002, GLIA, V40, P312, DOI 10.1002/glia.10124; Bastos KRB, 2002, J LEUKOCYTE BIOL, V71, P271; Becher B, 2002, J CLIN INVEST, V110, P493, DOI 10.1172/JCI200215751; Benitez-Hernandez I, 2010, IMMUNOBIOLOGY, V215, P413, DOI 10.1016/j.imbio.2009.06.001; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bombeiro AL, 2010, NEUROIMMUNOMODULAT, V17, P67, DOI 10.1159/000258689; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Carpentier PA, 2005, GLIA, V49, P360, DOI 10.1002/glia.20117; Chadi G, 2004, CELL BIOL INT, V28, P849, DOI 10.1016/j.cellbi.2004.08.005; Chadi G, 2001, INT J NEUROSCI, V111, P137, DOI 10.3109/00207450108994227; Chagas C., 1909, Memorias do Instituto Oswaldo Cruz, V1; CHAO CC, 1994, DEV NEUROSCI-BASEL, V16, P172, DOI 10.1159/000112104; Conti B, 1999, MOL BRAIN RES, V67, P46, DOI 10.1016/S0169-328X(99)00034-0; Cooper AM, 1997, J EXP MED, V186, P39, DOI 10.1084/jem.186.1.39; Cordova E, 2008, INT J INFECT DIS; Guedes PMD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000604; Dewar D, 2003, J CEREBR BLOOD F MET, V23, P263, DOI 10.1097/01.WCB.0000053472.41007.F9; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Domercq M, 2007, J IMMUNOL, V178, P6549, DOI 10.4049/jimmunol.178.10.6549; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Erdmann H, 2009, CELL MICROBIOL, V11, P1600, DOI 10.1111/j.1462-5822.2009.01350.x; Foran E, 2009, ANTIOXID REDOX SIGNA; Franklin BS, 2009, P NATL ACAD SCI USA, V106, P5789, DOI 10.1073/pnas.0809742106; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Hendriks JJA, 2005, BRAIN RES REV, V48, P185, DOI 10.1016/j.brainresrev.2004.12.008; HOFF R, 1978, NEW ENGL J MED, V298, P604, DOI 10.1056/NEJM197803162981106; JARDIM E, 1994, J TROP MED HYG, V97, P367; Junqueira C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001560; LEIGUARDA R, 1990, NEUROLOGY, V40, P850, DOI 10.1212/WNL.40.5.850; Marchiori PE, 2007, J HEART LUNG TRANSPL, V26, P1091, DOI 10.1016/j.healun.2007.07.043; Marinho CRF, 2007, SCAND J IMMUNOL, V66, P297, DOI 10.1111/j.1365-3083.2007.01958.x; Marinho CRF, 2009, MICROBES INFECT, V11, P1037, DOI 10.1016/j.micinf.2009.07.011; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; Merrill JE, 1999, NEUROPATH APPL NEURO, V25, P435; Michailowsky V, 2001, AM J PATHOL, V159, P1723, DOI 10.1016/S0002-9440(10)63019-2; MILES MA, 1974, T ROY SOC TROP MED H, V68, P256, DOI 10.1016/0035-9203(74)90126-6; Miyazaki Y, 2010, J IMMUNOL, V185, P1150, DOI 10.4049/jimmunol.0900047; Morel CM, 2003, NAT REV MICROBIOL, V1, P14, DOI 10.1038/nrmicro735; Muller U, 2001, J IMMUNOL, V167, P3346, DOI 10.4049/jimmunol.167.6.3346; PETRAY P, 1995, IMMUNOL LETT, V47, P121, DOI 10.1016/0165-2478(95)00083-H; POSTAN M, 1987, T ROY SOC TROP MED H, V81, P415, DOI 10.1016/0035-9203(87)90155-6; Prinz M, 1999, J NEUROCHEM, V72, P2215, DOI 10.1046/j.1471-4159.1999.0722215.x; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; ROCHA A, 1994, AM J TROP MED HYG, V50, P261, DOI 10.4269/ajtmh.1994.50.261; ROSEMBERG S, 1992, NEUROLOGY, V42, P640, DOI 10.1212/WNL.42.3.640; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Tessema TS, 2009, IMMUNOBIOLOGY, V214, P454, DOI 10.1016/j.imbio.2008.11.015; THERY C, 1991, EUR J NEUROSCI, V3, P1155, DOI 10.1111/j.1460-9568.1991.tb00050.x; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102	53	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49022	10.1371/journal.pone.0049022	http://dx.doi.org/10.1371/journal.pone.0049022			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152844	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234000047
J	Parkash, B; Ranjan, A; Tiwari, V; Gupta, SK; Kaur, N; Tandon, V				Parkash, Braham; Ranjan, Atul; Tiwari, Vinod; Gupta, Sharad Kumar; Kaur, Navrinder; Tandon, Vibha			Inhibition of 5 '-UTR RNA Conformational Switching in HIV-1 Using Antisense PNAs	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; DIMERIZATION INITIATION SITE; TYPE-1 PACKAGING SIGNAL; PEPTIDE NUCLEIC-ACIDS; MAJOR SPLICE DONOR; IN-VITRO EVIDENCE; GENOMIC-RNA; REVERSE TRANSCRIPTION; LEADER RNA; STEM-LOOP	Background: The genome of retroviruses, including HIV-1, is packaged as two homologous (+) strand RNA molecules, noncovalently associated close to their 5'-end in a region called dimer linkage structure (DLS). Retroviral HIV-1 genomic RNAs dimerize through complex interactions between dimerization initiation sites (DIS) within the (5'-UTR). Dimer formation is prevented by so calledLong Distance Interaction (LDI) conformation, whereas Branched Multiple Hairpin (BMH) conformation leads to spontaneous dimerization. Methods and Results: We evaluated the role of SL1 (DIS), PolyA Hairpin signal and a long distance U5-AUG interaction by in vitro dimerization, conformer assay and coupled dimerization and template-switching assays using antisense PNAs. Our data suggests evidence that PNAs targeted against SL1 produced severe inhibitory effect on dimerization and template-switching processes while PNAs targeted against U5 region do not show significant effect on dimerization and template switching, while PNAs targeted against AUG region showed strong inhibition of dimerization and template switching processes. Conclusions: Our results demonstrate that PNA can be used successfully as an antisense to inhibit dimerization and template switching process in HIV-1 and both of the processes are closely linked to each other. Different PNA oligomers have ability of switching between two thermodynamically stable forms. PNA targeted against DIS and SL1 switch, LDI conformer to more dimerization friendly BMH form. PNAs targeted against PolyA haipin configuration did not show a significant change in dimerization and template switching process. The PNA oligomer directed against the AUG strand of U5-AUG duplex structure also showed a significant reduction in RNA dimerization as well as template-switching efficiency. The antisense PNA oligomers can be used to regulate the shift in the LDI/BMH equilibrium.	[Ranjan, Atul; Tiwari, Vinod; Tandon, Vibha] Univ Delhi, Dept Chem, Delhi 110007, India; [Parkash, Braham; Gupta, Sharad Kumar; Kaur, Navrinder] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	University of Delhi; University of Delhi	Tandon, V (corresponding author), Univ Delhi, Dept Chem, Delhi 110007, India.	vtandon@acbr.du.ac.in	Tiwari, Vinod/ABD-5836-2021; TIWARI, VINOD K/L-9595-2019	Tiwari, Vinod/0000-0003-2341-0953; TIWARI, VINOD K/0000-0001-9244-8889	University Grant Commission (UGC), Delhi, India; Department of Science & Technology, Delhi, India; Council of Scientific & Industrial Research (CSIR), Delhi, India; Indian council of Medical Research (ICMR) Delhi, India	University Grant Commission (UGC), Delhi, India(University Grants Commission, India); Department of Science & Technology, Delhi, India(Department of Science & Technology (India)); Council of Scientific & Industrial Research (CSIR), Delhi, India; Indian council of Medical Research (ICMR) Delhi, India(Indian Council of Medical Research (ICMR))	This work was supported in part by University Grant Commission (UGC), Delhi, India and Department of Science & Technology, Delhi, India. PhD Fellowship from Council of Scientific & Industrial Research (CSIR), Delhi, India and Indian council of Medical Research (ICMR) Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink TEM, 2005, BIOCHEMISTRY-US, V44, P9058, DOI 10.1021/bi0502588; Abbink TEM, 2003, J BIOL CHEM, V278, P11601, DOI 10.1074/jbc.M210291200; AGRAWAL S, 1989, P NATL ACAD SCI USA, V86, P7790, DOI 10.1073/pnas.86.20.7790; Andersen ES, 2003, J VIROL, V77, P3020, DOI 10.1128/JVI.77.5.3020-3030.2003; Bai H, 2012, PLOS ONE, V7, P196, DOI 10.1371/journal.pone.0029886; Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; BAUDIN F, 1993, J MOL BIOL, V229, P382, DOI 10.1006/jmbi.1993.1041; BENDER W, 1976, CELL, V7, P595, DOI 10.1016/0092-8674(76)90210-5; Berkhout B, 2002, J BIOL CHEM, V277, P19967, DOI 10.1074/jbc.M200950200; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Berkhout B, 2001, RNA, V7, P1097, DOI 10.1017/S1355838201002035; Berkhout B, 1996, J VIROL, V70, P6723, DOI 10.1128/JVI.70.10.6723-6732.1996; Berkhout B, 2000, RNA, V6, P282, DOI 10.1017/S1355838200991684; BUCHARDT O, 1993, TRENDS BIOTECHNOL, V11, P384, DOI 10.1016/0167-7799(93)90097-S; Clever JL, 2002, J VIROL, V76, P12381, DOI 10.1128/JVI.76.23.12381-12387.2002; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; Damgaard CK, 2004, J MOL BIOL, V336, P369, DOI 10.1016/j.jmb.2003.12.010; DARLIX JL, 1990, J MOL BIOL, V216, P689, DOI 10.1016/0022-2836(90)90392-Y; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Elmen J, 2004, FEBS LETT, V578, P285, DOI 10.1016/j.febslet.2004.11.015; FU W, 1993, J VIROL, V67, P5443, DOI 10.1128/JVI.67.9.5443-5449.1993; GOODCHILD J, 1988, P NATL ACAD SCI USA, V85, P5507, DOI 10.1073/pnas.85.15.5507; Gotte M, 1999, ARCH BIOCHEM BIOPHYS, V365, P199, DOI 10.1006/abbi.1999.1209; HARRISON GP, 1992, J VIROL, V66, P4144, DOI 10.1128/JVI.66.7.4144-4153.1992; Harrison GP, 1998, J VIROL, V72, P5886, DOI 10.1128/JVI.72.7.5886-5896.1998; Hill MK, 2003, J VIROL, V77, P8329, DOI 10.1128/JVI.77.15.8329-8335.2003; Hoglund S, 1997, VIROLOGY, V233, P271, DOI 10.1006/viro.1997.8585; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; Jalalirad M, 2012, BIOCHEMISTRY-US, V51, P3744, DOI 10.1021/bi300111p; Jalalirad M, 2010, VIROLOGY, V407, P225, DOI 10.1016/j.virol.2010.08.013; LAUGHREA M, 1994, BIOCHEMISTRY-US, V33, P13464, DOI 10.1021/bi00249a035; Laughrea M, 2001, VIROLOGY, V281, P109, DOI 10.1006/viro.2000.0778; Laughrea M, 1997, J VIROL, V71, P3397, DOI 10.1128/JVI.71.5.3397-3406.1997; Lodmell JS, 1998, ANTISENSE NUCLEIC A, V8, P517, DOI 10.1089/oli.1.1998.8.517; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; MURIAUX D, 1995, J BIOL CHEM, V270, P8209, DOI 10.1074/jbc.270.14.8209; Muriaux D, 1996, BIOCHEMISTRY-US, V35, P5075, DOI 10.1021/bi952822s; Ooms M, 2004, J VIROL, V78, P10814, DOI 10.1128/JVI.78.19.10814-10819.2004; Ooms M, 2007, NUCLEIC ACIDS RES, V35, P1649, DOI 10.1093/nar/gkm046; Paillart JC, 2004, NAT REV MICROBIOL, V2, P461, DOI 10.1038/nrmicro903; Paillart JC, 2004, J BIOL CHEM, V279, P48397, DOI 10.1074/jbc.M408294200; Paillart JC, 2002, J BIOL CHEM, V277, P5995, DOI 10.1074/jbc.M108972200; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Paillart JC, 1996, J VIROL, V70, P8348, DOI 10.1128/JVI.70.12.8348-8354.1996; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; Russell Rodney S, 2004, Retrovirology, V1, P23, DOI 10.1186/1742-4690-1-23; Sakuragi J, 2003, J VIROL, V77, P4060, DOI 10.1128/JVI.77.7.4060-4069.2003; Sakuragi J, 2012, NUCLEIC ACIDS RES, V40, P5012, DOI 10.1093/nar/gks156; Shen N, 2000, J VIROL, V74, P5729, DOI 10.1128/JVI.74.12.5729-5735.2000; Shen N, 2001, J VIROL, V75, P10543, DOI 10.1128/JVI.75.21.10543-10549.2001; Skripkin E, 1996, J BIOL CHEM, V271, P28812, DOI 10.1074/jbc.271.46.28812; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Song R, 2008, BIOCHEMISTRY-US, V47, P3283, DOI 10.1021/bi7023173; Song R, 2007, J MOL BIOL, V371, P1084, DOI 10.1016/j.jmb.2007.06.010; Turner JJ, 2006, BBA-BIOMEMBRANES, V1758, P290, DOI 10.1016/j.bbamem.2005.10.013; Vrolijk MM, 2008, NUCLEIC ACIDS RES, V36, P4352, DOI 10.1093/nar/gkn364; Vrolijk MM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-13; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Zhang SJ, 1997, AIDS RES HUM RETROV, V13, P865, DOI 10.1089/aid.1997.13.865	61	5	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49310	10.1371/journal.pone.0049310	http://dx.doi.org/10.1371/journal.pone.0049310			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152893	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234000061
J	Wiertsema, SP; Corscadden, KJ; Mowe, EN; Zhang, GC; Vijayasekaran, S; Coates, HL; Mitchell, TJ; Thomas, WR; Richmond, PC; Kirkham, LAS				Wiertsema, Selma P.; Corscadden, Karli J.; Mowe, Eva N.; Zhang, Guicheng; Vijayasekaran, Shyan; Coates, Harvey L.; Mitchell, Timothy J.; Thomas, Wayne R.; Richmond, Peter C.; Kirkham, Lea-Ann S.			IgG Responses to Pneumococcal and Haemophilus Influenzae Protein Antigens Are Not Impaired in Children with a History of Recurrent Acute Otitis Media	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; ANTIBODY-RESPONSE; CAPSULAR POLYSACCHARIDES; STREPTOCOCCUS-PNEUMONIAE; SURFACE ADHESIN; PRONE CHILDREN; PNEUMOLYSIN; CARRIAGE; SERUM; P6	Background: Vaccines including conserved antigens from Streptococcus pneumoniae and nontypeable Haemophilus influenzae (NTHi) have the potential to reduce the burden of acute otitis media. Little is known about the antibody response to such antigens in young children with recurrent acute otitis media, however, it has been suggested antibody production may be impaired in these children. Methods: We measured serum IgG levels against 4 pneumococcal (PspA1, PspA 2, CbpA and Ply) and 3 NTHi (P4, P6 and PD) proteins in a cross-sectional study of 172 children under 3 years of age with a history of recurrent acute otitis media (median 7 episodes, requiring ventilation tube insertion) and 63 healthy age-matched controls, using a newly developed multiplex bead assay. Results: Children with a history of recurrent acute otitis media had significantly higher geometric mean serum IgG levels against NTHi proteins P4, P6 and PD compared with healthy controls, whereas there was no difference in antibody levels against pneumococcal protein antigens. In both children with and without a history of acute otitis media, antibody levels increased with age and were significantly higher in children colonised with S. pneumoniae or NTHi compared with children that were not colonised. Conclusions: Proteins from S. pneumoniae and NTHi induce serum IgG in children with a history of acute otitis media. The mechanisms in which proteins induce immunity and potential protection requires further investigation but the dogma of impaired antibody responses in children with recurrent acute otitis media should be reconsidered.	[Wiertsema, Selma P.; Zhang, Guicheng; Richmond, Peter C.; Kirkham, Lea-Ann S.] Univ Western Australia, Sch Paediat & Child Hlth, Perth, WA 6009, Australia; [Wiertsema, Selma P.; Corscadden, Karli J.; Mowe, Eva N.; Thomas, Wayne R.; Richmond, Peter C.; Kirkham, Lea-Ann S.] Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA, Australia; [Vijayasekaran, Shyan; Coates, Harvey L.] Univ Western Australia, Dept Otolaryngol Head & Neck Surg, Perth, WA 6009, Australia; [Mitchell, Timothy J.] Univ Glasgow, Div Infect & Immun, Glasgow, Lanark, Scotland	University of Western Australia; Telethon Kids Institute; University of Western Australia; University of Western Australia; University of Glasgow	Wiertsema, SP (corresponding author), Crucell, Leiden, Netherlands.	swiertsema@meddent.uwa.edu.au; lkirkham@meddent.uwa.edu.au	Zhang, Brad/AAF-8719-2021; Kirkham, Lea-Ann S/A-5847-2013; Coates, Harvey Larry Charles/AAR-2846-2020; vijayasekaran, shyan/AAB-7538-2022; Richmond, Peter C/G-3379-2012	Kirkham, Lea-Ann S/0000-0001-5421-8126; vijayasekaran, shyan/0000-0001-7990-6742; Richmond, Peter C/0000-0001-7562-7228; Zhang, Guicheng/0000-0001-9888-5385; Mitchell, Timothy/0000-0002-8309-5556	Australian National Health and Medical Research Project grant [1011306]; European Society for Peadiatric Infectious Diseases; University of Western Australia Priming and Safety net Grants; Bright Spark Foundation Fellowship; GlaxoSmithKline; Wyeth Vaccines; CSL	Australian National Health and Medical Research Project grant; European Society for Peadiatric Infectious Diseases; University of Western Australia Priming and Safety net Grants; Bright Spark Foundation Fellowship; GlaxoSmithKline(GlaxoSmithKline); Wyeth Vaccines; CSL	This work was supported by an Australian National Health and Medical Research Project grant (1011306), the European Society for Peadiatric Infectious Diseases and University of Western Australia Priming and Safety net Grants. G. Zhang is supported by a Bright Spark Foundation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; SW and LK have received institutional funding for studies investigating bacterial pathogens in children with rAOM and travel funding from GlaxoSmithKline. TM has received institutional funding from Wyeth Vaccines and GlaxoSmithKline. LK and TM are co-inventors on patents PCT/GB2007/002242, PCT/GB2005/001792 and PCT/GB2005/001774. HC and SV have served as consultants and have received travel funding from GlaxoSmithKline Biologicals. PR has received institutional funding for epidemiological research from GlaxoSmithKline and CSL and served on advisory boards for CSL and Wyeth Vaccines. All other authors have indicated they have no conflicts of interest.	Baynam G, 2007, J ALLERGY CLIN IMMUN, V119, P366, DOI 10.1016/j.jaci.2006.09.018; Block SL, 2004, PEDIATR INFECT DIS J, V23, P829, DOI 10.1097/01.inf.0000136868.91756.80; Casey JR, 2010, PEDIATR INFECT DIS J, V29, P304, DOI 10.1097/INF.0b013e3181c1bc48; DeMaria TF, 1997, LARYNGOSCOPE, V107, P369, DOI 10.1097/00005537-199703000-00017; Hales BJ, 2009, CLIN EXP ALLERGY, V39, P1170, DOI 10.1111/j.1365-2222.2009.03252.x; Hotomi M, 1999, ACTA OTO-LARYNGOL, V119, P703, DOI 10.1080/00016489950180667; Kaur R, 2011, PEDIAT INFECT DIS J; Kaur R, 2011, VACCINE, V29, P1023, DOI 10.1016/j.vaccine.2010.11.055; Kaur R, 2010, PEDIATR INFECT DIS J, V29, P741, DOI 10.1097/INF.0b013e3181d9e639; Melin MM, 2008, CLIN VACCINE IMMUNOL, V15, P1529, DOI 10.1128/CVI.00181-08; Novotny LA, 2006, VACCINE, V24, P4804, DOI 10.1016/j.vaccine.2006.03.021; Pichichero ME, 2010, VACCINE, V28, P7184, DOI 10.1016/j.vaccine.2010.08.063; Plaisier CL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000642; Pletz MW, 2008, INT J ANTIMICROB AG, V32, P199, DOI 10.1016/j.ijantimicag.2008.01.021; Prymula R, 2006, LANCET, V367, P740, DOI 10.1016/S0140-6736(06)68304-9; Rapola S, 2001, PEDIATR INFECT DIS J, V20, P482, DOI 10.1097/00006454-200105000-00003; Rapola S, 2000, J INFECT DIS, V182, P1146, DOI 10.1086/315822; Simell B, 2007, J INFECT DIS, V196, P1528, DOI 10.1086/522607; Simell B, 2009, VACCINE, V27, P4615, DOI 10.1016/j.vaccine.2009.05.071; Vergison A, 2008, VACCINE, V26, pG5, DOI 10.1016/j.vaccine.2008.11.006; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; VIROLAINEN A, 1995, ACTA OTO-LARYNGOL, V115, P796, DOI 10.3109/00016489509139404; White P, 1999, ORL J OTO-RHINO-LARY, V61, P206, DOI 10.1159/000027672; Wiertsema SP, 2011, VACCINE, V29, P5163, DOI 10.1016/j.vaccine.2011.05.035; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; YAMANAKA N, 1993, ACTA OTO-LARYNGOL, V113, P524, DOI 10.3109/00016489309135857; YAMANAKA N, 1993, J PEDIATR-US, V122, P212, DOI 10.1016/S0022-3476(06)80115-0; Zhang QB, 2006, EUR J IMMUNOL, V36, P46, DOI 10.1002/eji.200535101	28	24	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49061	10.1371/journal.pone.0049061	http://dx.doi.org/10.1371/journal.pone.0049061			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152850	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234000048
J	Gupta, S; Li, SN; Abedin, MJ; Noppakun, K; Wang, L; Kaur, T; Najafian, B; Rodrigues, CMP; Steer, CJ				Gupta, Sandeep; Li, Shunan; Abedin, Md. Joynal; Noppakun, Kajohnsak; Wang, Lawrence; Kaur, Tarundeep; Najafian, Behzad; Rodrigues, Cecilia M. P.; Steer, Clifford J.			Prevention of Acute Kidney Injury by Tauroursodeoxycholic Acid in Rat and Cell Culture Models	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; DELAYED GRAFT FUNCTION; ACUTE-RENAL-FAILURE; PROXIMAL TUBULAR CELLS; CYTOCHROME-C RELEASE; URSODEOXYCHOLIC ACID; COLD ISCHEMIA; RISK-FACTORS; TRANSPLANT RECIPIENTS; MITOCHONDRIAL PATHWAY	Background: Acute kidney injury (AKI) has grave short- and long-term consequences. Often the onset of AKI is predictable, such as following surgery that compromises blood flow to the kidney. Even in such situations, present therapies cannot prevent AKI. As apoptosis is a major form of cell death following AKI, we determined the efficacy and mechanisms of action of tauroursodeoxycholic acid (TUDCA), a molecule with potent anti-apoptotic and pro-survival properties, in prevention of AKI in rat and cell culture models. TUDCA is particularly attractive from a translational standpoint, as it has a proven safety record in animals and humans. Methodology/Principal Findings: We chose an ischemia-reperfusion model in rats to simulate AKI in native kidneys, and a human kidney cell culture model to simulate AKI associated with cryopreservation in transplanted kidneys. TUDCA significantly ameliorated AKI in the test models due to inhibition of the mitochondrial pathway of apoptosis and upregulation of survival pathways. Conclusions: This study sets the stage for testing TUDCA in future clinical trials for prevention of AKI, an area that needs urgent attention due to lack of effective therapies. Citation: Gupta S, Li S, Abedin MJ, Noppakun K, Wang L, et al. (2012) Prevention of Acute Kidney Injury by Tauroursodeoxycholic Acid in Rat and Cell Culture Models. PLoS ONE 7(11): e48950. doi:10.1371/journal.pone.0048950	[Gupta, Sandeep; Li, Shunan; Abedin, Md. Joynal; Noppakun, Kajohnsak; Wang, Lawrence; Kaur, Tarundeep; Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA; [Najafian, Behzad] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Rodrigues, Cecilia M. P.] Univ Lisbon, Fac Pharm, Res Inst Med & Pharmaceut Sci iMed UL, P-1699 Lisbon, Portugal; [Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Universidade de Lisboa; University of Minnesota System; University of Minnesota Twin Cities	Gupta, S (corresponding author), Univ Minnesota, Sch Med, Dept Med, Minneapolis, MN 55455 USA.	gupta024@gmail.com; steer001@umn.edu	Noppakun, Kajohnsak/AAQ-9583-2020; iMed.ULisboa, CellFun/A-4244-2014; Rodrigues, Cecilia MP/M-3572-2013	Noppakun, Kajohnsak/0000-0002-5783-8766; Rodrigues, Cecilia MP/0000-0002-4829-754X; Najafian, Behzad/0000-0002-0904-6721	National Institutes of Health [R21 DK078706]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK078706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health grant R21 DK078706 to Sandeep Gupta. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral JD, 2009, J LIPID RES, V50, P1721, DOI 10.1194/jlr.R900011-JLR200; Anderson CD, 2004, AM J TRANSPLANT, V4, P352, DOI 10.1111/j.1600-6143.2004.00357.x; Arat M, 2005, CLIN TRANSPLANT, V19, P798, DOI 10.1111/j.1399-0012.2005.00424.x; Azzaroli F, 2002, HEPATOLOGY, V36, P49, DOI 10.1053/jhep.2002.34511; Bailly-Maitre B, 2006, P NATL ACAD SCI USA, V103, P2809, DOI 10.1073/pnas.0506854103; Bando Y, 2004, FASEB J, V18, P1401, DOI 10.1096/fj.03-1161fje; BEERI R, 1995, KIDNEY INT, V47, P1806, DOI 10.1038/ki.1995.249; Bronzatto EJM, 2009, TRANSPL P, V41, P849, DOI 10.1016/j.transproceed.2009.02.004; Burns AT, 1998, TRANSPLANTATION, V66, P872, DOI 10.1097/00007890-199810150-00010; Chen Y, 2008, AM J NEPHROL, V28, P1014, DOI 10.1159/000148209; Chien CT, 2007, TRANSPLANTATION, V84, P1183, DOI 10.1097/01.tp.0000287334.38933.e3; Colak A, 2008, J CLIN NEUROSCI, V15, P665, DOI 10.1016/j.jocn.2007.06.002; Duan WM, 2002, CELL TRANSPLANT, V11, P195; Falasca L, 2001, TRANSPLANTATION, V71, P1268, DOI 10.1097/00007890-200105150-00015; Festi D, 2007, CURR CLIN PHARMACOL, V2, P155, DOI 10.2174/157488407780598171; FINKENSTAEDT JT, 1956, NEW ENGL J MED, V254, P1023, DOI 10.1056/NEJM195605312542203; Gupta S, 2010, AM J PHYSIOL-RENAL, V298, pF209, DOI 10.1152/ajprenal.00451.2009; HAGEY LR, 1993, J LIPID RES, V34, P1911; Hall AM, 2009, J AM SOC NEPHROL, V20, P1293, DOI 10.1681/ASN.2008070759; Hausenloy DJ, 2006, CARDIOVASC RES, V70, P240, DOI 10.1016/j.cardiores.2006.01.017; Huang JH, 2005, CIRCULATION, V112, P76, DOI 10.1161/CIRCULATIONAHA.105.535740; Inagi R, 2009, NEPHRON EXP NEPHROL, V112, pE1, DOI 10.1159/000210573; Ishani A, 2009, J AM SOC NEPHROL, V20, P223, DOI 10.1681/ASN.2007080837; Jushinskis J, 2009, TRANSPL P, V41, P746, DOI 10.1016/j.transproceed.2009.01.037; Kars M, 2010, DIABETES, V59, P1899, DOI 10.2337/db10-0308; Kindt N, 2008, FASEB J, V22, P510, DOI 10.1096/fj.07-8882com; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Kuznetsov AV, 2004, AM J PHYSIOL-HEART C, V286, pH1633, DOI 10.1152/ajpheart.00701.2003; Lee YY, 2010, BIOCHEM BIOPH RES CO, V397, P735, DOI 10.1016/j.bbrc.2010.06.022; LOWE KG, 1952, LANCET, V262, P1086; Malo A, 2010, AM J PHYSIOL-GASTR L, V299, pG877, DOI 10.1152/ajpgi.00423.2009; Mikhalski D, 2008, TRANSPLANTATION, V85, pS3, DOI 10.1097/TP.0b013e318169c29e; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Ojo AO, 1997, TRANSPLANTATION, V63, P968, DOI 10.1097/00007890-199704150-00011; Omata M, 2007, GUT, V56, P1747, DOI 10.1136/gut.2007.120956; Omori K, 2007, AM J TRANSPLANT, V7, P1224, DOI 10.1111/j.1600-6143.2007.01741.x; Omori K, 2005, TRANSPL P, V37, P3422, DOI 10.1016/j.transproceed.2005.09.089; Ortiz A., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P181; Park KM, 2001, J BIOL CHEM, V276, P11870, DOI 10.1074/jbc.M007518200; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Quiroga I, 2006, NEPHROL DIAL TRANSPL, V21, P1689, DOI 10.1093/ndt/gfl042; Ramalho RM, 2008, MOL MED, V14, P309, DOI 10.2119/2007-00133.Ramalho; Rivard AL, 2007, AM J CHINESE MED, V35, P279, DOI 10.1142/S0192415X07004813; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Rodrigues CMP, 1999, CELL DEATH DIFFER, V6, P842, DOI 10.1038/sj.cdd.4400560; Rodrigues CMP, 2000, J NEUROCHEM, V75, P2368, DOI 10.1046/j.1471-4159.2000.0752368.x; Rodrigues TMP, 2002, J CEREBR BLOOD F MET, V22, P463, DOI 10.1097/00004647-200204000-00010; Salahudeen AK, 2004, KIDNEY INT, V65, P713, DOI 10.1111/j.1523-1755.2004.00416.x; Salahudeen AK, 2003, AM J TRANSPLANT, V3, P273, DOI 10.1034/j.1600-6143.2003.00042.x; Salahudeen AK, 2001, TRANSPLANTATION, V72, P798, DOI 10.1097/00007890-200109150-00010; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; Sola S, 2007, CURR ISSUES MOL BIOL, V9, P123; Sola S, 2006, COMP BIOCHEM PHYS C, V143, P204, DOI 10.1016/j.cbpc.2006.02.002; Soni SS, 2009, BLOOD PURIFICAT, V28, P165, DOI 10.1159/000227785; Stroh C, 2002, FASEB J, V16, P1651, DOI 10.1096/fj.02-0034fje; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yagi T, 2001, HEPATOLOGY, V33, P1432, DOI 10.1053/jhep.2001.24560; Yie Q, 2002, HEPATOLOGY, V36, P592, DOI 10.1053/jhep.2002.35441; Yoshinari D, 2001, TRANSPLANTATION, V72, P22, DOI 10.1097/00007890-200107150-00007	61	14	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48950	10.1371/journal.pone.0048950	http://dx.doi.org/10.1371/journal.pone.0048950			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152827	Green Submitted, Green Published, gold			2022-12-27	WOS:000312272600032
J	Yu, DJ; Chen, Y; Wu, SH; Wang, BH; Tang, YW; Li, LJ				Yu, Daojun; Chen, Yu; Wu, Shenghai; Wang, Baohong; Tang, Yi-Wei; Li, Lanjuan			Simultaneous Detection and Differentiation of Human Papillomavirus Genotypes 6, 11, 16 and 18 by AllGlo Quadruplex Quantitative PCR	PLOS ONE			English	Article							HPV VACCINE; INTRAEPITHELIAL NEOPLASIA; VIRAL LOAD; HIGH-RISK; RT-PCR; INFECTION; WOMEN; ASSAY; IMMUNOGENICITY; PREVALENCE	Human papillomaviruses (HPV) are classified into high-risk HPV and low-risk HPV. The most common high-risk HPV types in cervical cancer are HPV 16 and 18, and the most common low-risk types causing genital warts are HPV 6 and HPV 11. In this study, applying novel AllGlo fluorescent probes, we established a quadruplex quantitative PCR method to simultaneously detect and differentiate HPV 6, 11, 16 and 18 in a single tube. Methods: The specificity, the sensitivity, the detection limit, the reproducibility and the standard curve of this method were examined. Finally, clinical samples that had been tested previously by TaqMan PCR and HPV GenoArray (GA) test were used to verify the accuracy and sensitivity of the method. Results: The assay has a sensitivity of 10(1) to 10(2) copies/test and a linear detection range from 10(1) to 10(8) copies/test. The mean amplification efficiencies for HPV 6, 11, 16, and 18 were 0.97, 1.10, 0.93 and 1.20, respectively, and the mean correlation coefficient (r(2)) of each standard curve was above 0.99 for plasmid templates ranging from 10(3) to 10(7) copies/test. There was 100% agreement between the AllGlo quadruplex quantitative PCR, HPV GA test and TaqMan uniplex qPCR methods. Conclusions: AllGlo quadruplex quantitative PCR in a single tube has the advantages of relatively high throughput, good reproducibility, high sensitivity, high specificity, and a wide linear range of detection. The convenient single tube format makes this assay a powerful tool for the studies of mixed infections by multiple pathogens, viral typing and viral load quantification. Citation: Yu D, Chen Y, Wu S, Wang B, Tang Y-W, et al. (2012) Simultaneous Detection and Differentiation of Human Papillomavirus Genotypes 6, 11, 16 and 18 by AllGlo Quadruplex Quantitative PCR. PLoS ONE 7(11): e48972. doi:10.1371/journal.pone.0048972	[Yu, Daojun; Chen, Yu; Wang, Baohong; Li, Lanjuan] Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China; [Yu, Daojun; Wu, Shenghai] Hangzhou First Peoples Hosp, Dept Clin Labs, Hangzhou, Zhejiang, Peoples R China; [Tang, Yi-Wei] Mem Sloan Kettering Canc Ctr, Clin Microbiol Serv, New York, NY 10021 USA	Zhejiang University; Memorial Sloan Kettering Cancer Center	Li, LJ (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Hangzhou 310003, Zhejiang, Peoples R China.	ljli@zju.edu.cn	Chen, Yi/HIR-2608-2022; Chen, Yu/Y-3292-2019	Tang, Yi-Wei/0000-0003-4888-6771	Major National S&T Projects for Infectious Diseases [2008ZX10002-007]; Zhejiang Provincial Natural Science Foundation of China [Y2101267]; Bureau of Science and Technology of Hangzhou [20070733B02]	Major National S&T Projects for Infectious Diseases; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Bureau of Science and Technology of Hangzhou	The work was supported by the Major National S&T Projects for Infectious Diseases (2008ZX10002-007), the Zhejiang Provincial Natural Science Foundation of China under Grant No. Y2101267 and Bureau of Science and Technology of Hangzhou Grants 20070733B02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan V, 2010, TRANSBOUND EMERG DIS, V57, P383, DOI 10.1111/j.1865-1682.2010.01160.x; Castellsague X, 2011, BRIT J CANCER, V105, P28, DOI 10.1038/bjc.2011.185; Chen Ming-yu, 2009, Nan Fang Yi Ke Da Xue Xue Bao, V29, P2112; Chen MY, 2009, NAN FANG YI KE DA XU, V29, P2121; Chuang LC, 2012, CANCER-AM CANCER SOC, V118, P223, DOI 10.1002/cncr.26227; De Santis R, 2010, MOL CELL PROBE, V24, P298, DOI 10.1016/j.mcp.2010.06.004; Dunne EF, 2011, J INFECT DIS, V204, P562, DOI 10.1093/infdis/jir342; Dupont M, 2002, BIOTECHNIQUES, V33, P158, DOI 10.2144/02331md04; Einstein MH, 2011, HUM VACCINES, V7, P1359, DOI 10.4161/hv.7.12.18282; el Khair MM, 2009, J MED VIROL, V81, P678, DOI 10.1002/jmv.21279; Fontaine J, 2008, J CLIN VIROL, V43, P307, DOI 10.1016/j.jcv.2008.07.013; Garson JA, 2009, AIDS RES HUM RETROV, V25, P377, DOI 10.1089/aid.2008.0270; Girkin JM, 2011, FARADAY DISCUSS, V149, P115, DOI 10.1039/c005271j; Giuliano AR, 2011, NEW ENGL J MED, V364, P401, DOI 10.1056/NEJMoa0909537; Han J, 2006, J CLIN MICROBIOL, V44, P4157, DOI 10.1128/JCM.01762-06; Hanfler J, 2003, MED MICROBIOL IMMUN, V192, P197, DOI 10.1007/s00430-002-0166-6; Hiller T, 2006, CANCER EPIDEM BIOMAR, V15, P1262, DOI 10.1158/1055-9965.EPI-05-0778; Hong JH, 2009, J KOREAN MED SCI, V24, P579, DOI 10.3346/jkms.2009.24.4.579; Jenison R, 2001, CLIN CHEM, V47, P1894; Jong E, 2009, INT J STD AIDS, V20, P262, DOI 10.1258/ijsa.2008.008359; Kalogianni DP, 2007, ANAL CHEM, V79, P6655, DOI 10.1021/ac070902j; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Kutyavin IV, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1138; Lassauniere R, 2010, J VIROL METHODS, V165, P254, DOI 10.1016/j.jviromet.2010.02.005; Lenselink CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003743; Li H, 2010, CHEMBIOCHEM, V11, P2132, DOI 10.1002/cbic.201000329; Li PL, 2010, J VIROL METHODS, V170, P115, DOI 10.1016/j.jviromet.2010.09.011; Munoz N, 2010, JNCI-J NATL CANCER I, V102, P325, DOI 10.1093/jnci/djp534; Neuzil KM, 2011, JAMA-J AM MED ASSOC, V305, P1424, DOI 10.1001/jama.2011.407; O'Regan E, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-156; Palefsky JM, 2011, NEW ENGL J MED, V365, P1576, DOI 10.1056/NEJMoa1010971; Sahasrabuddhe VV, 2011, FUTURE MICROBIOL, V6, P1083, DOI [10.2217/FMB.11.87, 10.2217/fmb.11.87]; Samson MC, 2010, J SCI FOOD AGR, V90, P1437, DOI 10.1002/jsfa.3961; Schmitz M, 2009, J CLIN VIROL, V44, P302, DOI 10.1016/j.jcv.2009.01.006; Shen-Gunther J, 2011, GYNECOL ONCOL, V123, P263, DOI 10.1016/j.ygyno.2011.07.017; Swillens S, 2008, ANAL BIOCHEM, V373, P370, DOI 10.1016/j.ab.2007.10.019; Takacs T, 2008, J VIROL METHODS, V149, P153, DOI 10.1016/j.jviromet.2007.12.009; Tang JF, 2011, MOL BIOL REP, V38, P5341, DOI 10.1007/s11033-011-0685-6; Tinelli A, 2011, INT J GYNECOL CANCER, V21, P545, DOI 10.1097/IGC.0b013e31820f5eed; Ursu RG, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-558; Vince A, 2010, MED GLAS, V7, P18; Wang W, 2009, J CLIN MICROBIOL, V47, P86, DOI 10.1128/JCM.01090-08; Wiley DJ, 2002, CLIN INFECT DIS, V35, pS210, DOI 10.1086/342109; Xie ZX, 2008, ARCH VIROL, V153, P2245, DOI 10.1007/s00705-008-0253-0	45	10	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48972	10.1371/journal.pone.0048972	http://dx.doi.org/10.1371/journal.pone.0048972			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152833	Green Submitted, Green Published, gold			2022-12-27	WOS:000312272600033
J	Ibrahim, M; Shi, Y; Qiu, H; Li, B; Jabeen, A; Li, LP; Liu, H; Kube, M; Xie, GL; Wang, YL; Sun, GC				Ibrahim, Muhammad; Shi, Yu; Qiu, Hui; Li, Bin; Jabeen, Amara; Li, Liping; Liu, He; Kube, Michael; Xie, Guanlin; Wang, Yanli; Sun, Guochang			Differential Expression of In Vivo and In Vitro Protein Profile of Outer Membrane of Acidovorax avenae Subsp avenae	PLOS ONE			English	Article							ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PROTEOMIC ANALYSIS; SECRETION SYSTEM; PREDICTION; TRANSPORT; VIRULENCE; MACHINE; ENCODES; CULTURE	Outer membrane (OM) proteins play a significant role in bacterial pathogenesis. In this work, we examined and compared the expression of the OM proteins of the rice pathogen Acidovorax avenae subsp. avenae strain RS-1, a Gram-negative bacterium, both in an in vitro culture medium and in vivo rice plants. Global proteomic profiling of A. avenae subsp. avenae strain RS-1 comparing in vivo and in vitro conditions revealed the differential expression of proteins affecting the survival and pathogenicity of the rice pathogen in host plants. The shotgun proteomics analysis of OM proteins resulted in the identification of 97 proteins in vitro and 62 proteins in vivo by mass spectrometry. Among these OM proteins, there is a high number of porins, TonB-dependent receptors, lipoproteins of the NodT family, ABC transporters, flagellins, and proteins of unknown function expressed under both conditions. However, the major proteins such as phospholipase and OmpA domain containing proteins were expressed in vitro, while the proteins such as the surface anchored protein F, ATP-dependent Clp protease, OmpA and MotB domain containing proteins were expressed in vivo. This may indicate that these in vivo OM proteins have roles in the pathogenicity of A. avenae subsp. avenae strain RS-1. In addition, the LC-MS/MS identification of OmpA and MotB validated the in silico prediction of the existance of Type VI secretion system core components. To the best of our knowledge, this is the first study to reveal the in vitro and in vivo protein profiles, in combination with LC-MS/MS mass spectra, in silico OM proteome and in silico genome wide analysis, of pathogenicity or plant host required proteins of a plant pathogenic bacterium.	[Ibrahim, Muhammad; Shi, Yu; Qiu, Hui; Li, Bin; Liu, He; Xie, Guanlin] Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Liping] Zhejiang Univ, Inst Bioinformat, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Yanli; Sun, Guochang] Zhejiang Acad Agr Sci, Inst Plant Protect & Microbiol, State Key Lab Breeding Base Zhejiang Sustainable, Hangzhou, Zhejiang, Peoples R China; [Ibrahim, Muhammad; Jabeen, Amara] COMSATS Inst Informat Technol, Dept Biosci, Sahiwal, Pakistan; [Kube, Michael] Humboldt Univ, Fac Agr & Hort, D-10099 Berlin, Germany	Zhejiang University; Zhejiang University; Zhejiang Academy of Agricultural Sciences; COMSATS University Islamabad (CUI); Humboldt University of Berlin	Li, B (corresponding author), Zhejiang Univ, Inst Biotechnol, State Key Lab Rice Biol, Hangzhou 310003, Zhejiang, Peoples R China.	libin0571@zju.edu.cn	Santiviago, Carlos/N-9991-2018; Jabeen, Amara/AAV-4264-2021; Ibrahim, Muhammad I/O-2585-2014; Ibrahim, Muhammad/G-6471-2019	Santiviago, Carlos/0000-0002-7043-7908; Jabeen, Amara/0000-0002-7606-0195; Ibrahim, Muhammad I/0000-0001-7161-2483; Li, Bin/0000-0002-4581-4775	Zhejiang Provincial Natural Science Foundation of China [Y3090150]; Zhejiang Provincial Project [2010R10091]; Fundamental Research Funds for the Central Universities; Agricultural Ministry of China [nyhyzx 201003029, 201003066]; State Education Ministry; Key Subject Construction Program of Zhejiang for Modern Agricultural Biotechnology and Crop Disease Control [2010DS700124-KF1101]	Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Agricultural Ministry of China(Ministry of Agriculture & Rural Affairs); State Education Ministry; Key Subject Construction Program of Zhejiang for Modern Agricultural Biotechnology and Crop Disease Control	This project was supported by Zhejiang Provincial Natural Science Foundation of China (Y3090150), Zhejiang Provincial Project (2010R10091), the Fundamental Research Funds for the Central Universities, the Agricultural Ministry of China (nyhyzx 201003029; 201003066), State Education Ministry and Key Subject Construction Program of Zhejiang for Modern Agricultural Biotechnology and Crop Disease Control (2010DS700124-KF1101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JC, 2005, BIOINFORMATICS, V21, P3665, DOI 10.1093/bioinformatics/bti601; Akama H, 2004, J BIOL CHEM, V279, P52816, DOI 10.1074/jbc.C400445200; Aschtgen MS, 2008, J BACTERIOL, V190, P7523, DOI 10.1128/JB.00945-08; Babujee L, 2007, J PROTEOME RES, V6, P62, DOI 10.1021/pr060423l; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Baldi DL, 2012, INFECT IMMUN, V80, P2042, DOI 10.1128/IAI.06160-11; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BENZ R, 1988, EUR J BIOCHEM, V176, P1, DOI 10.1111/j.1432-1033.1988.tb14245.x; Blanvillain S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000224; Boyer F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-104; Buchanan SK, 2001, TRENDS BIOCHEM SCI, V26, P3, DOI 10.1016/S0968-0004(00)01733-3; Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553; Cash P, 2011, PROTEOMICS, V11, P3190, DOI 10.1002/pmic.201100029; Choi HW, 2011, MOL PLANT MICROBE IN, V24, P68, DOI 10.1094/MPMI-02-10-0030; Chung JW, 2007, PROTEOMICS, V7, P1854, DOI 10.1002/pmic.200600979; Cotter P, 2011, NATURE, V475, P301, DOI 10.1038/475301a; D'Alessandro B, 2011, FEMS IMMUNOL MED MIC, V63, P174, DOI 10.1111/j.1574-695X.2011.00839.x; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; DEROSIER DJ, 1995, CURR OPIN STRUC BIOL, V5, P187, DOI 10.1016/0959-440X(95)80074-3; Dumetz F, 2007, J APPL MICROBIOL, V103, P1461, DOI 10.1111/j.1365-2672.2007.03359.x; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Hossain MJ, 2012, MICROBIOL-SGM, V158, P474, DOI 10.1099/mic.0.054866-0; Jagannadham MV, 2008, ELECTROPHORESIS, V29, P4341, DOI 10.1002/elps.200700750; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Knief C, 2011, PROTEOMICS, V11, P3086, DOI 10.1002/pmic.201000818; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; LAEMMLI UK, 1970, J MOL BIOL, V49, P99, DOI 10.1016/0022-2836(70)90379-7; Li B, 2011, J GEN PLANT PATHOL, V77, P64, DOI 10.1007/s10327-010-0280-z; Li G, 2010, MOL MICROBIOL, V76, P772, DOI 10.1111/j.1365-2958.2010.07138.x; Minet AD, 2000, GENE, V257, P87, DOI 10.1016/S0378-1119(00)00388-7; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; NOBLE JA, 1993, P NATL ACAD SCI USA, V90, P10866, DOI 10.1073/pnas.90.22.10866; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Ozkanca R, 2002, LETT APPL MICROBIOL, V35, P533, DOI 10.1046/j.1472-765X.2002.01230.x; Pallen MJ, 2003, CURR OPIN MICROBIOL, V6, P519, DOI 10.1016/j.mib.2003.09.005; Peabody CR, 2003, MICROBIOL-SGM, V149, P3051, DOI 10.1099/mic.0.26364-0; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pieper R, 2008, PROTEOMICS, V8, P1442, DOI 10.1002/pmic.200700923; Pilsl H, 1999, J BACTERIOL, V181, P3578, DOI 10.1128/JB.181.11.3578-3581.1999; Py B, 2001, EMBO REP, V2, P244, DOI 10.1093/embo-reports/kve042; Ricci DP, 2012, P NATL ACAD SCI USA, V109, P3487, DOI 10.1073/pnas.1201362109; Schell MA, 2011, J PROTEOME RES, V10, P2417, DOI 10.1021/pr1012398; Selvaraj V, 2007, J ANDROL, V28, P588, DOI 10.2164/jandrol.106.002279; Shrivastava S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002955; Sidhu VK, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-87; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tjalsma H, 2008, PROTEOMICS, V8, P1415, DOI 10.1002/pmic.200700550; Tsolis RM, 1996, INFECT IMMUN, V64, P4549, DOI 10.1128/IAI.64.11.4549-4556.1996; van den Berg B, 2005, CURR OPIN STRUC BIOL, V15, P401, DOI 10.1016/j.sbi.2005.06.003; Xie GL, 2011, J BACTERIOL, V193, P5013, DOI 10.1128/JB.05594-11; Xie GuanLin, 1998, Chinese Journal of Rice Science, V12, P165; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249	53	18	18	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49657	10.1371/journal.pone.0049657	http://dx.doi.org/10.1371/journal.pone.0049657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166741	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300064
J	Sharma, R; Arora, N; Goossens, B; Nater, A; Morf, N; Salmona, J; Bruford, MW; Van Schaik, CP; Krutzen, M; Chikhi, L				Sharma, Reeta; Arora, Natasha; Goossens, Benoit; Nater, Alexander; Morf, Nadja; Salmona, Jordi; Bruford, Michael W.; Van Schaik, Carel P.; Kruetzen, Michael; Chikhi, Lounes			Effective Population Size Dynamics and the Demographic Collapse of Bornean Orang-Utans	PLOS ONE			English	Article							PONGO-PYGMAEUS; GENETIC DIVERSITY; EVOLUTIONARY HISTORY; FRAGMENTATION; SABAH; ENVIRONMENTS; CONSERVATION; KINABATANGAN; KALIMANTAN; SIGNATURE	Bornean orang-utans experienced a major demographic decline and local extirpations during the Pleistocene and Holocene due to climate change, the arrival of modern humans, of farmers and recent commercially-driven habitat loss and fragmentation. The recent loss of habitat and its dramatic fragmentation has affected the patterns of genetic variability and differentiation among the remaining populations and increased the extinction risk of the most isolated ones. However, the contribution of recent demographic events to such genetic patterns is still not fully clear. Indeed, it can be difficult to separate the effects of recent anthropogenic fragmentation from the genetic signature of prehistoric demographic events. Here, we investigated the genetic structure and population size dynamics of orang-utans from different sites. Altogether 126 individuals were analyzed and a full-likelihood Bayesian approach was applied. All sites exhibited clear signals of population decline. Population structure is known to generate spurious bottleneck signals and we found that it does indeed contribute to the signals observed. However, population structure alone does not easily explain the observed patterns. The dating of the population decline varied across sites but was always within the 200-2000 years period. This suggests that in some sites at least, orang-utan populations were affected by demographic events that started before the recent anthropogenic effects that occurred in Borneo. These results do not mean that the recent forest exploitation did not leave its genetic mark on orang-utans but suggests that the genetic pool of orang-utans is also impacted by more ancient events. While we cannot identify the main cause for this decline, our results suggests that the decline may be related to the arrival of the first farmers or climatic events, and that more theoretical work is needed to understand how multiple demographic events impact the genome of species and how we can assess their relative contributions.	[Sharma, Reeta; Salmona, Jordi; Chikhi, Lounes] Inst Gulbenkian Ciencias, Oeiras, Portugal; [Arora, Natasha; Nater, Alexander; Morf, Nadja; Van Schaik, Carel P.; Kruetzen, Michael] Univ Zurich, Anthropol Inst & Museum, Zurich, Switzerland; [Goossens, Benoit; Bruford, Michael W.] Cardiff Univ, Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales; [Goossens, Benoit] Sabah Wildlife Dept, Danau Girang Field Ctr, Kota Kinabalu, Sabah, Malaysia; [Chikhi, Lounes] Univ Toulouse 3, CNRS, Lab Evolut & Divers Biol, F-31062 Toulouse, France; [Chikhi, Lounes] Univ Toulouse, Toulouse, France	Instituto Gulbenkian de Ciencia; University of Zurich; Cardiff University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse	Sharma, R (corresponding author), Inst Gulbenkian Ciencias, Oeiras, Portugal.	rsharma@igc.gulbenkian.pt	Salmona, Jordi/P-5996-2017; Krutzen, Michael C/D-9550-2011; Bruford, Michael/Y-7463-2019; Bruford, Michael W/D-3750-2009; Goossens, Benoit R/E-8812-2010; Nater, Alexander/ABF-5719-2020; Arora, Natasha/L-6579-2014	Salmona, Jordi/0000-0002-1950-5805; Bruford, Michael/0000-0001-6357-6080; Bruford, Michael W/0000-0001-6357-6080; Nater, Alexander/0000-0002-4805-5575; Arora, Natasha/0000-0002-6144-4743; Krutzen, Michael/0000-0003-1055-5299; Morf, Nadja V./0000-0002-8716-1143; Chikhi, Lounes/0000-0002-1140-0718; Sharma, Reeta/0000-0001-9862-9218	Portuguese Science Foundation ("Fundacao para a Ciencia e a Tecnologia" (FCT) [SFRH/BPD/64837/2009]; FCT [PTDC/BIA-BDE/71299/2006]; Laboratoire d'Excellence (LABEX) [ANR - 10-LABX-41]; Swiss National Science Foundation [31003A-116848]; Messerli Foundation; Claraz Schenkung; AH Schultz-Stiftung; Darwin Initiative for the Survival of Species (DEFRA, UK) [09/016]; HERMES, FCT [H200741/re-equip/2005]; Fundação para a Ciência e a Tecnologia [SFRH/BD/136590/2018, PTDC/BIA-BDE/71299/2006] Funding Source: FCT	Portuguese Science Foundation ("Fundacao para a Ciencia e a Tecnologia" (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Laboratoire d'Excellence (LABEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Messerli Foundation; Claraz Schenkung; AH Schultz-Stiftung; Darwin Initiative for the Survival of Species (DEFRA, UK)(Department for Environment, Food & Rural Affairs (DEFRA)); HERMES, FCT; Fundação para a Ciência e a Tecnologia	This work was supported by Portuguese Science Foundation ("Fundacao para a Ciencia e a Tecnologia" (FCT)) individual fellowship (ref. SFRH/BPD/64837/2009) to RS and FCT project (ref. PTDC/BIA-BDE/71299/2006) to LC. LC was also supported by the "Laboratoire d'Excellence (LABEX)" entitled TULIP (ANR - 10-LABX-41). Further significant financial support was provided by the Swiss National Science Foundation (31003A-116848 to MK and CvS), and grants from the Messerli Foundation, Claraz Schenkung, and AH Schultz-Stiftung to MK. BG was also supported by a grant from the Darwin Initiative for the Survival of Species (Grant no. 09/016, DEFRA, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank P. Fernandes for his help in using the 'High-Performance Computing Centre' at IGC. The demographic analyses were performed using the 'High-Performance Computing Centre' (HERMES, FCT grant H200741/re-equip/2005). Erik Willems providing us with the Borneo map and Vitor Sousa for numerous helpful discussions. We are grateful to all people involved in the collection and coordination of samples, including Maria van Noordwijk, Helen Morrogh-Bernard, Cheryl Knott, Meredith Bastian, Noko Kuze, Tomoko Kanamori and numerous students in the field. Samples were exported from Indonesia, Malaysia, and the U. K. to Switzerland under permits 07279/IV/SATS-LN/2009, 00961/IV/SATS-LN/2007, 4645, 06968/IV/SATS-LN/2005, and 290569/01 from the Convention on International Trade in Endangered Species of Wild Fauna and Flora. We are also grateful to the Indonesian Institute of Sciences, the Indonesian State Ministry for Research and Technology, and the Sabah Wildlife Department. BG thanks the Economic Planning Unit (Malaysia) for permission to conduct research in Sabah and Laurentius Ambu, Director of Sabah Wildlife Department, for permission to conduct research in the Lower Kinabatangan Wildlife Sanctuary.	Ancrenaz M, 2004, ANIM CONSERV, V7, P375, DOI 10.1017/S136794300400157X; Arora N, 2012, MOL ECOL, V21, P3352, DOI 10.1111/j.1365-294X.2012.05608.x; Arora N, 2010, P NATL ACAD SCI USA, V107, P21376, DOI 10.1073/pnas.1010169107; Barker G., 2002, P PREHIST SOC, V68, P147, DOI [10.1017/s0079497x00001481, DOI 10.1017/S0079497X00001481]; Beaumont MA, 1999, GENETICS, V153, P2013; Beaumont MA, 2002, GENETICS, V162, P2025; Belkhir K., 2004, GENETIX 4 05 LOGICIE; Bertorelle G, 2010, MOL ECOL, V19, P2609, DOI 10.1111/j.1365-294X.2010.04690.x; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Bourke BP, 2010, CONSERV GENET, V11, P1837, DOI 10.1007/s10592-010-0076-x; Broquet T, 2010, CONSERV BIOL, V24, P1596, DOI 10.1111/j.1523-1739.2010.01556.x; Bruford Michael W., 2010, Endangered Species Research, V12, P249, DOI 10.3354/esr00295; Chikhi L, 2010, GENETICS, V186, P983, DOI 10.1534/genetics.110.118661; Cribb, 2000, HIST ATLAS INDONESIA, DOI 10.4324/9780203824610; Cunningham M, 1998, BIOL CONSERV, V83, P19, DOI 10.1016/S0006-3207(97)00046-3; Delgado RA, 2000, EVOL ANTHROPOL, V9, P201; Fuller DO, 2004, CONSERV BIOL, V18, P249, DOI 10.1111/j.1523-1739.2004.00018.x; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Girod C, 2010, GENETICS; Girod C, 2011, GENETICS, V188, P165, DOI 10.1534/genetics.110.121764; Goossens B, 2006, PLOS BIOL, V4, P285, DOI 10.1371/journal.pbio.0040025; Goossens B, 2005, MOL ECOL, V14, P441, DOI 10.1111/j.1365-294X.02421.x; Harrison T., 2000, B INDOPACIFIC PREHIS, V20, P133; HARRISON T, 1996, INDOPACIFIC PREHISTO, V14, P90; Harrison T, 2006, DEV PRIMATOL, P331; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Higham CFW, 2011, ANTIQUITY, V85, P529, DOI 10.1017/S0003598X00067922; Hooijer D. A., 1960, Zoologische Verhandelingen, VNo. 46, P1; JABLONSKI NG, 1993, FOLIA PRIMATOL, V60, P118, DOI 10.1159/000156681; Jalil MF, 2008, MOL ECOL, V17, P2898, DOI 10.1111/j.1365-294X.2008.03793.x; Langergraber KE, 2012, P NATL ACAD SCI; Locke DP, 2011, NATURE, V469, P529, DOI 10.1038/nature09687; Martinez-Cruz B, 2007, MOL ECOL, V16, P477, DOI 10.1111/j.1365-294X.2007.03147.x; MEDWAY, 1977, ASIAN PERSPECT, V20, P51; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012042; Morrogh-Bernard H, 2003, BIOL CONSERV, V110, P141, DOI 10.1016/S0006-3207(02)00186-6; Nater A, 2011, MOL BIOL EVOL, V28, P2275, DOI 10.1093/molbev/msr042; NEI M, 1978, GENETICS, V89, P583; Okello JBA, 2008, MOL ECOL, V17, P3788, DOI 10.1111/j.1365-294X.2008.03871.x; Olivieri GL, 2008, BIOL CONSERV, V141, P1257, DOI 10.1016/j.biocon.2008.02.025; Peter BM, 2010, MOL ECOL, V19, P4648, DOI 10.1111/j.1365-294X.2010.04783.x; Quemere E, 2012, P NATL ACAD IN PRESS; Rijksen HD, 1999, OUR VANISHING RELATI; Russon AE, 2001, BIOL CONSERV, V97, P21, DOI 10.1016/S0006-3207(00)00087-2; Salmona J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043524; Sousa V, 2008, CONSERV GENET, V9, P791, DOI 10.1007/s10592-007-9399-7; Stadler T, 2009, GENETICS, V182, P205, DOI 10.1534/genetics.108.094904; Steiper ME, 2006, J HUM EVOL, V50, P509, DOI 10.1016/j.jhevol.2005.12.005; Storz JF, 2002, EVOLUTION, V56, P154; Vandergast AG, 2007, MOL ECOL, V16, P977, DOI 10.1111/j.1365-294X.2006.03216.x; Wakeley J, 1999, GENETICS, V153, P1863; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wich S. A., 2009, ORANGUTANS GEOGRAPHI; Woodruff DS, 2009, J BIOGEOGR, V36, P803, DOI 10.1111/j.1365-2699.2008.02071.x; Ziegler T, 2007, MOL PHYLOGENET EVOL, V42, P807, DOI 10.1016/j.ympev.2006.11.015	55	17	17	0	94	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49429	10.1371/journal.pone.0049429	http://dx.doi.org/10.1371/journal.pone.0049429			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166666	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000311272300042
J	Brost, BM; Beier, P				Brost, Brian M.; Beier, Paul			Comparing Linkage Designs Based on Land Facets to Linkage Designs Based on Focal Species	PLOS ONE			English	Article							GEOMORPHOLOGICAL HETEROGENEITY; EVOLUTIONARY PROCESSES; CLIMATE-CHANGE; BIODIVERSITY; MANAGEMENT; DIVERSITY; PLAN	Least-cost modeling for focal species is the most widely used method for designing conservation corridors and linkages. However, these designs depend on today's land covers, which will be altered by climate change. We recently proposed an alternative approach based on land facets (recurring landscape units of relatively uniform topography and soils). The rationale is that corridors with high continuity of individual land facets will facilitate movement of species associated with each facet today and in the future. Conservation practitioners might like to know whether a linkage design based on land facets is likely to provide continuity of modeled breeding habitat for species needing connectivity today, and whether a linkage for focal species provides continuity and interspersion of land facets. To address these questions, we compared linkages designed for focal species and land facets in three landscapes in Arizona, USA. We used two variables to measure linkage utility, namely distances between patches of modeled breeding habitat for 5-16 focal species in each linkage, and resistance profiles for focal species and land facets between patches connected by the linkage. Compared to focal species designs, linkage designs based on land facets provided as much or more modeled habitat connectivity for 25 of 28 species-landscape combinations, failing only for the three species with the most narrowly distributed habitat. Compared to land facets designs, focal species linkages provided lower connectivity for about half the land facets in two landscapes. In areas where a focal species approach to linkage design is not possible, our results suggest that conservation practitioners may be able to implement a land facets approach with some confidence that the linkage design would serve most potential focal species. In areas where focal species designs are possible, we recommend using the land facet approach to complement, rather than replace, focal species approaches.	[Brost, Brian M.] No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA; No Arizona Univ, Merriam Powell Ctr Environm Res, Flagstaff, AZ 86011 USA	Northern Arizona University; Northern Arizona University	Brost, BM (corresponding author), No Arizona Univ, Sch Forestry, Flagstaff, AZ 86011 USA.	bmbrost@gmail.com	Beier, Paul/K-9294-2013	Beier, Paul/0000-0002-4297-4343; Brost, Brian/0000-0002-9810-3950	USDA McIntire-Stennis Cooperative Forestry Research Program; Arizona Board of Forest Research; USDA Rocky Mountain Research Station [08-JV-11221636-171]	USDA McIntire-Stennis Cooperative Forestry Research Program; Arizona Board of Forest Research; USDA Rocky Mountain Research Station	Sources of funding include the USDA McIntire-Stennis Cooperative Forestry Research Program (http://www.csrees.usda.gov/business/awards/formula/mcintire_stennis.html), The Arizona Board of Forest Research, and USDA Rocky Mountain Research Station (#08-JV-11221636-171; http://www.fs.fed.us/rmrs/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Anderson MG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011554; Beier P, 2007, LINKAGE DESIGNS FOR; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; Beier P, 2009, ECOL APPL, V19, P2067, DOI 10.1890/08-1898.1; Brost BM, 2012, ECOL APPL, V22, P87, DOI 10.1890/11-0213.1; Burnett MR, 1998, CONSERV BIOL, V12, P363, DOI 10.1046/j.1523-1739.1998.96238.x; Cowling R. M., 1999, Diversity and Distributions, V5, P51, DOI 10.1046/j.1472-4642.1999.00038.x; Cowling RM, 2003, BIOL CONSERV, V112, P191, DOI 10.1016/S0006-3207(02)00425-1; Crooks K. R., 2006, CONNECTIVITY CONSERV; Fairbanks DHK, 2001, BIOL CONSERV, V98, P365, DOI 10.1016/S0006-3207(00)00179-8; Franklin J., 2010, MAPPING SPECIES DIST, DOI DOI 10.1017/CBO9780511810602; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; HUNTER ML, 1988, CONSERV BIOL, V2, P375, DOI 10.1111/j.1523-1739.1988.tb00202.x; KIRKPATRICK JB, 1994, CONSERV BIOL, V8, P217, DOI 10.1046/j.1523-1739.1994.08010217.x; Klein C, 2009, ECOL APPL, V19, P206, DOI 10.1890/07-1684.1; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; Manly BFJ, 2005, MULTIVARIATE STATIST; McCoy JE, 2005, J WILDLIFE MANAGE, V69, P366, DOI 10.2193/0022-541X(2005)069&lt;0366:DBYMWD&gt;2.0.CO;2; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Nichols WF, 1998, CONSERV BIOL, V12, P371, DOI 10.1046/j.1523-1739.1998.96237.x; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; Pressey RL, 2007, TRENDS ECOL EVOL, V22, P583, DOI 10.1016/j.tree.2007.10.001; Reyers B, 2002, AFR ZOOL, V37, P185; Rouget M, 2006, CONSERV BIOL, V20, P549, DOI 10.1111/j.1523-1739.2006.00297.x; Sweanor LL, 2000, CONSERV BIOL, V14, P798, DOI 10.1046/j.1523-1739.2000.99079.x; Thompson DJ, 2005, J WILDLIFE MANAGE, V69, P818, DOI 10.2193/0022-541X(2005)069[0818:LDBASM]2.0.CO;2; Wessels KJ, 1999, BIOL CONSERV, V89, P21, DOI 10.1016/S0006-3207(98)00133-5	30	30	30	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48965	10.1371/journal.pone.0048965	http://dx.doi.org/10.1371/journal.pone.0048965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152831	gold, Green Submitted, Green Published			2022-12-27	WOS:000311234000040
J	Ledizet, M; Murray, TS; Puttagunta, S; Slade, MD; Quagliarello, VJ; Kazmierczak, BI				Ledizet, Michel; Murray, Thomas S.; Puttagunta, Sailaja; Slade, Martin D.; Quagliarello, Vincent J.; Kazmierczak, Barbara I.			The Ability of Virulence Factor Expression by Pseudomonas aeruginosa to Predict Clinical Disease in Hospitalized Patients	PLOS ONE			English	Article							III SECRETION SYSTEM; VENTILATOR-ASSOCIATED PNEUMONIA; NOSOCOMIAL INFECTIONS; PROTEIN SECRETION; URINARY-TRACT; IN-VITRO; MOTILITY; IMMUNIZATION; PATHOGENESIS; PHENOTYPES	Background: Pseudomonas aeruginosa is an opportunistic pathogen that frequently causes hospital acquired colonization and infection. Accurate identification of host and bacterial factors associated with infection could aid treatment decisions for patients with P. aeruginosa cultured from clinical sites. Methods: We identified a prospective cohort of 248 hospitalized patients with positive P. aeruginosa cultures. Clinical data were analyzed to determine whether an individual met predefined criteria for infection versus colonization. P. aeruginosa isolates were tested for the expression of multiple phenotypes previously associated with virulence in animal models and humans. Logistic regression models were constructed to determine the degree of association between host and bacterial factors with P. aeruginosa infection of the bloodstream, lung, soft tissue and urinary tract. Results: One host factor (i.e. diabetes mellitus), and one bacterial factor, a Type 3 secretion system positive phenotype, were significantly associated with P. aeruginosa infection in our cohort. Subgroup analysis of patients with P. aeruginosa isolated from the urinary tract revealed that the presence of a urinary tract catheter or stent was an additional factor for P. aeruginosa infection. Conclusions: Among hospitalized patients with culture-documented P. aeruginosa, infection is more likely to be present in those with diabetes mellitus and those harboring a Type 3 secretion positive bacterial strain.	[Puttagunta, Sailaja; Quagliarello, Vincent J.; Kazmierczak, Barbara I.] Yale Univ, Sch Med, Dept Med, Infect Dis Sect, New Haven, CT 06510 USA; [Murray, Thomas S.] Yale Univ, Sch Med, Dept Pediat Infect Dis, New Haven, CT USA; [Ledizet, Michel] L2 Diagnost, New Haven, CT USA; [Slade, Martin D.] Yale Univ, Sch Med, Dept Occupat & Environm Med, New Haven, CT USA; [Kazmierczak, Barbara I.] Yale Univ, Sch Med, Dept Microbial Pathogenesis, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Kazmierczak, BI (corresponding author), Yale Univ, Sch Med, Dept Med, Infect Dis Sect, New Haven, CT 06510 USA.	barbara.kazmierczak@yale.edu		Kazmierczak, Barbara/0000-0002-8162-803X	National Institutes of Health (NIH) [T32 AI007517, T32 AI07210, R42 AI058659]; Patrick and Catherine Weldon Donaghue Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081825, T32AI007517, R41AI058659, R42AI058659, T32AI007210] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Patrick and Catherine Weldon Donaghue Medical Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants T32 AI007517 (to SP), T32 AI07210 (to TSM), R42 AI058659 (to BIK) and the Patrick and Catherine Weldon Donaghue Medical Research Foundation (to BIK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MANDELL DOUGLAS BENN; Arnoldo A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000005; Arora SK, 2005, INFECT IMMUN, V73, P4395, DOI 10.1128/IAI.73.7.4395-4398.2005; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Battle SE, 2008, J BACTERIOL, V190, P7130, DOI 10.1128/JB.00785-08; Caballero AR, 2001, ANAL BIOCHEM, V290, P330, DOI 10.1006/abio.2001.4999; Cardo D, 2004, AM J INFECT CONTROL, V32, P470, DOI 10.1016/j.ajic.2004.10.001; Carter MQ, 2010, J BACTERIOL, V192, P3249, DOI 10.1128/JB.00041-10; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Cortes P, 2001, INFECT CONT HOSP EP, V22, P720, DOI 10.1086/501853; El Solh AA, 2008, AM J RESP CRIT CARE, V178, P513, DOI 10.1164/rccm.200802-239OC; El-Solh AA, 2012, CRIT CARE MED, V40, P1157, DOI 10.1097/CCM.0b013e3182377906; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Francois B, 2012, CRIT CARE MED, V40, P2320, DOI 10.1097/CCM.0b013e31825334f6; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gaynes R, 2005, CLIN INFECT DIS, V41, P848, DOI 10.1086/432803; Hamood AN, 1996, J SURG RES, V61, P425, DOI 10.1006/jsre.1996.0140; Harrison EM, 2010, INFECT IMMUN, V78, P1437, DOI 10.1128/IAI.00621-09; Hatcher L., 1994, STEP BY STEP APPROAC; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; He JX, 2004, P NATL ACAD SCI USA, V101, P2530, DOI 10.1073/pnas.0304622101; Holder IA, 2001, INFECT IMMUN, V69, P5908, DOI 10.1128/IAI.69.9.5908-5910.2001; Hu H, 2012, CLIN MICROBIOL INFEC; Jain M, 2004, J CLIN MICROBIOL, V42, P5229, DOI 10.1128/JCM.42.11.5229-5237.2004; Kulasekara BR, 2006, J BACTERIOL, V188, P4037, DOI 10.1128/JB.02000-05; Kumar R, 2009, KIDNEY INT, V76, P286, DOI 10.1038/ki.2009.183; Lambert PA, 2002, J ROY SOC MED, V95, P22; Lee DG, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r90; Lee VT, 2007, INFECT IMMUN, V75, P1089, DOI 10.1128/IAI.01184-06; Lee VT, 2005, INFECT IMMUN, V73, P1695, DOI 10.1128/IAI.73.3.1695-1705.2005; Li Li, 2005, Ann Clin Microbiol Antimicrob, V4, P22, DOI 10.1186/1476-0711-4-22; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Mittal Rahul, 2009, J Infect Public Health, V2, P101, DOI 10.1016/j.jiph.2009.08.003; Miyata S, 2003, INFECT IMMUN, V71, P2404, DOI 10.1128/IAI.71.5.2404-2413.2003; Mun JJ, 2009, INFECT IMMUN, V77, P2392, DOI 10.1128/IAI.00173-09; Murray TS, 2010, J MED MICROBIOL, V59, P511, DOI 10.1099/jmm.0.017715-0; Nguyen D, 2007, PEDIATR PULM, V42, P533, DOI 10.1002/ppul.20620; Parsek MR, 2003, ANNU REV MICROBIOL, V57, P677, DOI 10.1146/annurev.micro.57.030502.090720; Preston MJ, 1997, INFECT IMMUN, V65, P3086, DOI 10.1128/IAI.65.8.3086-3090.1997; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Sawa T, 1999, NAT MED, V5, P392, DOI 10.1038/7391; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Talon D, 1998, AM J RESP CRIT CARE, V157, P978, DOI 10.1164/ajrccm.157.3.9702096; TANG H, 1995, INFECT IMMUN, V63, P1278, DOI 10.1128/IAI.63.4.1278-1285.1995; Vance RE, 2005, INFECT IMMUN, V73, P1706, DOI 10.1128/IAI.73.3.1706-1713.2005; Wenzel RP, 2001, EMERG INFECT DIS, V7, P174, DOI 10.3201/eid0702.010203; Wiehlmann L, 2007, P NATL ACAD SCI USA, V104, P8101, DOI 10.1073/pnas.0609213104; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; WOODS DE, 1986, J CLIN MICROBIOL, V24, P260, DOI 10.1128/JCM.24.2.260-264.1986	52	21	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49578	10.1371/journal.pone.0049578	http://dx.doi.org/10.1371/journal.pone.0049578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152923	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234000074
J	Yu, M; Gong, DP; Lim, M; Arutyunyan, A; Groffen, J; Heisterkamp, N				Yu, Min; Gong, Dapeng; Lim, Min; Arutyunyan, Anna; Groffen, John; Heisterkamp, Nora			Lack of Bcr and Abr Promotes Hypoxia-Induced Pulmonary Hypertension in Mice	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; OXIDATIVE STRESS; GROWTH-FACTOR; STIMULATES GROWTH; ANGIOTENSIN-II; NADPH OXIDASE; RAC1 ACTIVITY; RHO GTPASES; P38 MAPK	Background: Bcr and Abr are GTPase activating proteins that specifically downregulate activity of the small GTPase Rac in restricted cell types in vivo. Rac1 is expressed in smooth muscle cells, a critical cell type involved in the pathogenesis of pulmonary hypertension. The molecular mechanisms that underlie hypoxia-associated pulmonary hypertension are not well-defined. Methodology/Principal Findings: Bcr and abr null mutant mice were compared to wild type controls for the development of pulmonary hypertension after exposure to hypoxia. Also, pulmonary arterial smooth muscle cells from those mice were cultured in hypoxia and examined for proliferation, p38 activation and IL-6 production. Mice lacking Bcr or Abr exposed to hypoxia developed increased right ventricular pressure, hypertrophy and pulmonary vascular remodeling. Perivascular leukocyte infiltration in the lungs was increased, and under hypoxia bcr(-/-) and abr(-/-) macrophages generated more reactive oxygen species. Consistent with a contribution of inflammation and oxidative stress in pulmonary hypertension-associated vascular damage, Bcr and Abr-deficient animals showed elevated endothelial leakage after hypoxia exposure. Hypoxia-treated pulmonary arterial smooth muscle cells from Bcr- or Abr-deficient mice also proliferated faster than those of wild type mice. Moreover, activated Rac1, phosphorylated p38 and interleukin 6 were increased in these cells in the absence of Bcr or Abr. Inhibition of Rac1 activation with Z62954982, a novel Rac inhibitor, decreased proliferation, p38 phosphorylation and IL-6 levels in pulmonary arterial smooth muscle cells exposed to hypoxia. Conclusions: Bcr and Abr play a critical role in down-regulating hypoxia-induced pulmonary hypertension by deactivating Rac1 and, through this, reducing both oxidative stress generated by leukocytes as well as p38 phosphorylation, IL-6 production and proliferation of pulmonary arterial smooth muscle cells.	[Yu, Min; Gong, Dapeng; Arutyunyan, Anna; Groffen, John; Heisterkamp, Nora] Childrens Hosp Los Angeles, Sect Mol Carcinogenesis, Div Hematol Oncol, Los Angeles, CA 90027 USA; [Yu, Min; Gong, Dapeng; Arutyunyan, Anna; Groffen, John; Heisterkamp, Nora] Childrens Hosp Los Angeles, Saban Res Inst, Los Angeles, CA 90027 USA; [Lim, Min; Groffen, John; Heisterkamp, Nora] Univ So Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Lim, Min; Groffen, John; Heisterkamp, Nora] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; Children's Hospital Los Angeles; University of Southern California; University of Southern California	Heisterkamp, N (corresponding author), Childrens Hosp Los Angeles, Sect Mol Carcinogenesis, Div Hematol Oncol, Los Angeles, CA 90027 USA.	heisterk@hsc.usc.edu	Heisterkamp, Nora/C-1698-2012; lim, min/B-3494-2014	Heisterkamp, Nora/0000-0003-2769-2273; lim, min/0000-0002-5437-7263; Lim, Min Jeong/0000-0001-7572-2591	Children's Hospital Los Angeles Research Career Development award; National Institutes of Health [HL071945]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071945] Funding Source: NIH RePORTER	Children's Hospital Los Angeles Research Career Development award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a Children's Hospital Los Angeles Research Career Development award to MY and the National Institutes of Health (HL071945) to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berk BC, 2001, PHYSIOL REV, V81, P999, DOI 10.1152/physrev.2001.81.3.999; Bernards A, 2004, TRENDS CELL BIOL, V14, P377, DOI 10.1016/j.tcb.2004.05.003; Boureux A, 2005, J CELL SCI, V118, P3717, DOI 10.1242/jcs.02491; Carlin CM, 2007, AM J RESP CELL MOL, V37, P447, DOI 10.1165/rcmb.2007-0012OC; Chanakira A, 2012, AM J PHYSIOL-HEART C, V302, pH1173, DOI 10.1152/ajpheart.00411.2011; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Ciuclan L, 2011, AM J RESP CRIT CARE, V184, P1171, DOI 10.1164/rccm.201103-0412OC; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; Crosswhite P, 2010, J HYPERTENS, V28, P201, DOI 10.1097/HJH.0b013e328332bcdb; Cunnick JM, 2009, MOL CELL BIOL, V29, P5742, DOI 10.1128/MCB.00357-09; Das M, 2001, J BIOL CHEM, V276, P15631, DOI 10.1074/jbc.M010690200; Davie N, 2002, AM J RESP CRIT CARE, V165, P398, DOI 10.1164/ajrccm.165.3.2104059; Diebold I, 2010, ANTIOXID REDOX SIGN, V13, P399, DOI 10.1089/ars.2009.3013; Diebold I, 2008, THROMB HAEMOSTASIS, V100, P1021, DOI 10.1160/TH08-07-0473; DIEKMANN D, 1991, NATURE, V351, P400, DOI 10.1038/351400a0; DUNNILL M. S., 1962, THORAX, V17, P320, DOI 10.1136/thx.17.4.320; Feng HZ, 2011, J CLIN INVEST, V121, P4670, DOI 10.1172/JCI58559; Ferri N, 2009, J MED CHEM, V52, P4087, DOI 10.1021/jm8015987; Galie N, 2009, EUR HEART J, V30, P394, DOI 10.1093/eurheartj/ehp022; Grimminger F, 2010, ADV EXP MED BIOL, V661, P435, DOI 10.1007/978-1-60761-500-2_28; Grobe AC, 2006, AM J PHYSIOL-LUNG C, V290, pL1069, DOI 10.1152/ajplung.00408.2005; Hattori Y, 2002, HYPERTENSION, V39, P22, DOI 10.1161/hy1201.097300; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; HEISTERKAMP N, 1985, NATURE, V315, P758, DOI 10.1038/315758a0; Hirota K, 2001, J BIOL CHEM, V276, P21166, DOI 10.1074/jbc.M100677200; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; HUMBERT M, 1995, AM J RESP CRIT CARE, V151, P1628, DOI 10.1164/ajrccm.151.5.7735624; IKEDA U, 1991, AM J PHYSIOL, V260, pH1713, DOI 10.1152/ajpheart.1991.260.5.H1713; JANSSENS SP, 1991, J APPL PHYSIOL, V71, P2218, DOI 10.1152/jappl.1991.71.6.2218; Kaartinen V, 2001, DEVELOPMENT, V128, P4217; Karakiulakis G, 2007, J BIOL CHEM, V282, P908, DOI 10.1074/jbc.M602178200; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Liu JQ, 2006, AM J PHYSIOL-LUNG C, V290, pL2, DOI 10.1152/ajplung.00135.2005; Lu J, 2004, J THORAC CARDIOV SUR, V128, P850, DOI 10.1016/j.jtcvs.2004.03.003; Macchia A, 2007, AM HEART J, V153, P1037, DOI 10.1016/j.ahj.2007.02.037; Meller N, 2005, J CELL SCI, V118, P4937, DOI 10.1242/jcs.02671; Morrell NW, 1999, AM J PHYSIOL-LUNG C, V277, pL440, DOI 10.1152/ajplung.1999.277.3.L440; Oh D, 2010, J NEUROSCI, V30, P14134, DOI 10.1523/JNEUROSCI.1711-10.2010; Patterson C, 1999, J BIOL CHEM, V274, P19814, DOI 10.1074/jbc.274.28.19814; Price LC, 2012, CHEST, V141, P210, DOI 10.1378/chest.11-0793; Qi YX, 2010, J CELL BIOCHEM, V109, P906, DOI 10.1002/jcb.22465; RABINOVITCH M, 1979, AM J PHYSIOL, V236, pH818, DOI 10.1152/ajpheart.1979.236.6.H818; Sakao S, 2011, RESPIRATION, V81, P253, DOI 10.1159/000322011; Sano M, 2001, CIRC RES, V89, P661, DOI 10.1161/hh2001.098873; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Selimovic N, 2009, EUR RESPIR J, V34, P662, DOI 10.1183/09031936.00174908; Sodhi CP, 2001, DIABETES, V50, P1482, DOI 10.2337/diabetes.50.6.1482; Soon E, 2010, CIRCULATION, V122, P921, DOI 10.1161/CIRCULATIONAHA.109.933762; Steiner MK, 2009, CIRC RES, V104, P236, DOI 10.1161/CIRCRESAHA.108.182014; Stenmark KR, 1997, ANNU REV PHYSIOL, V59, P89, DOI 10.1146/annurev.physiol.59.1.89; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Tamm M, 1998, AM J RESP CELL MOL, V19, P653, DOI 10.1165/ajrcmb.19.4.3058; Teng RJ, 2009, AM J PHYSIOL-LUNG C, V297, pL184, DOI 10.1152/ajplung.90455.2008; Tian Y, 2007, AM J PHYSIOL-CELL PH, V292, pC841, DOI 10.1152/ajpcell.00334.2006; Tokunou T, 2001, ARTERIOSCL THROM VAS, V21, P1759, DOI 10.1161/hq1101.098489; Tuder RM, 2003, AM J RESP CELL MOL, V29, P88, DOI 10.1165/rcmb.2002-0228OC; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; VONCKEN JW, 1995, CELL, V80, P719, DOI 10.1016/0092-8674(95)90350-X; Yu LY, 2011, J VASC RES, V48, P465, DOI 10.1159/000327005	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49756	10.1371/journal.pone.0049756	http://dx.doi.org/10.1371/journal.pone.0049756			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152932	gold, Green Submitted, Green Published			2022-12-27	WOS:000311234000076
J	Roest, HJ; van Gelderen, B; Dinkla, A; Frangoulidis, D; van Zijderveld, F; Rebel, J; van Keulen, L				Roest, Hendrik-Jan; van Gelderen, Betty; Dinkla, Annemieke; Frangoulidis, Dimitrios; van Zijderveld, Fred; Rebel, Johanna; van Keulen, Lucien			Q Fever in Pregnant Goats: Pathogenesis and Excretion of Coxiella burnetii	PLOS ONE			English	Article							BRUCELLA-ABORTUS; NATURAL-HISTORY; NETHERLANDS; INFECTION; OUTBREAK; PLACENTITIS; AGENT	Coxiella burnetii is an intracellular bacterial pathogen that causes Q fever. Infected pregnant goats are a major source of human infection. However, the tissue dissemination and excretion pathway of the pathogen in goats are still poorly understood. To better understand Q fever pathogenesis, we inoculated groups of pregnant goats via the intranasal route with a recent Dutch outbreak C. burnetii isolate. Tissue dissemination and excretion of the pathogen were followed for up to 95 days after parturition. Goats were successfully infected via the intranasal route. PCR and immunohistochemistry showed strong tropism of C. burnetii towards the placenta at two to four weeks after inoculation. Bacterial replication seemed to occur predominantly in the trophoblasts of the placenta and not in other organs of goats and kids. The amount of C. burnetii DNA in the organs of goats and kids increased towards parturition. After parturition it decreased to undetectable levels: after 81 days post-parturition in goats and after 28 days post-parturition in kids. Infected goats gave birth to live or dead kids. High numbers of C. burnetii were excreted during abortion, but also during parturition of liveborn kids. C. burnetii was not detected in faeces or vaginal mucus before parturition. Our results are the first to demonstrate that pregnant goats can be infected via the intranasal route. C. burnetii has a strong tropism for the trophoblasts of the placenta and is not excreted before parturition; pathogen excretion occurs during birth of dead as well as healthy animals. Besides abortions, normal deliveries in C. burnetii-infected goats should be considered as a major zoonotic risk for Q fever in humans. Citation: Roest H-J, van Gelderen B, Dinkla A, Frangoulidis D, van Zijderveld F, et al. (2012) Q Fever in Pregnant Goats: Pathogenesis and Excretion of Coxiella burnetii. PLoS ONE 7(11): e48949. doi:10.1371/journal.pone.0048949	[Roest, Hendrik-Jan; van Gelderen, Betty; Dinkla, Annemieke; van Zijderveld, Fred] Cent Vet Inst, Dept Bacteriol, Lelystad, Netherlands; [Roest, Hendrik-Jan; van Gelderen, Betty; Dinkla, Annemieke; van Zijderveld, Fred] Cent Vet Inst, TSEs, Lelystad, Netherlands; [Frangoulidis, Dimitrios] Bundeswehr Inst Microbiol, Munich, Germany; [Rebel, Johanna; van Keulen, Lucien] Cent Vet Inst, Dept Infect Biol, Lelystad, Netherlands	Wageningen University & Research; Wageningen University & Research; Bundeswehr Institute of Microbiology (IMB); Wageningen University & Research	Roest, HJ (corresponding author), Cent Vet Inst, Dept Bacteriol, Lelystad, Netherlands.	hendrikjan.roest@wur.nl		Frangoulidis, Dimitrios/0000-0002-2864-3820; Rebel, Annemarie/0000-0003-4765-4215	Dutch Ministry of Economic Affairs, Agriculture and Innovation [1640020100]; DG Sanco of the European Commission, European Union [2011/89/EU]	Dutch Ministry of Economic Affairs, Agriculture and Innovation; DG Sanco of the European Commission, European Union	This study was financially supported by the Dutch Ministry of Economic Affairs, Agriculture and Innovation (project number 1640020100) and by DG Sanco of the European Commission, European Union (decision 2011/89/EU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaleh A, 2011, COMP IMMUNOL MICROB, V34, P355, DOI 10.1016/j.cimid.2011.05.002; Anderson T. D., 1986, Veterinary Pathology, V23, P219; ANDERSON TD, 1986, VET PATHOL, V23, P227, DOI 10.1177/030098588602300302; Angelakis E, 2010, VET MICROBIOL, V140, P297, DOI 10.1016/j.vetmic.2009.07.016; Arricau-Bouvery N, 2005, VACCINE, V23, P4392, DOI 10.1016/j.vaccine.2005.04.010; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; BABUDIERI B., 1959, ADVANCES VET SCI, V5, P81; Bamberg WM, 2007, VECTOR-BORNE ZOONOT, V7, P394, DOI 10.1089/vbz.2007.0104; Berri M, 2007, RES VET SCI, V83, P47, DOI 10.1016/j.rvsc.2006.11.001; Berri M, 2005, VET REC, V156, P548, DOI 10.1136/vr.156.17.548; Bouvery NA, 2003, VET RES, V34, P423, DOI 10.1051/vetres:2003017; BUXTON D, 1990, J COMP PATHOL, V102, P221, DOI 10.1016/S0021-9975(08)80127-2; Greenslade E, 2003, EMERG INFECT DIS, V9, P138, DOI 10.3201/eid0901.010305; Hatchette T, 2003, VECTOR-BORNE ZOONOT, V3, P11, DOI 10.1089/153036603765627415; Lang G. H., 1990, Q fever. Volume 1. The disease., P23; Oyston PCF, 2011, J MED MICROBIOL, V60, P9, DOI 10.1099/jmm.0.024778-0; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Rodolakis A, 1998, VET RES, V29, P275; Rodolakis A, 2009, ANN NY ACAD SCI, V1166, P90, DOI 10.1111/j.1749-6632.2009.04511.x; Roest HIJ, 2011, TIJDSCHR DIERGENEESK, V136, P340; Roest HIJ, 2011, EPIDEMIOL INFECT, V139, P1, DOI 10.1017/S0950268810002268; Roest HIJ, 2011, EMERG INFECT DIS, V17, P668, DOI 10.3201/eid1704.101562; Rousset E, 2009, APPL ENVIRON MICROB, V75, P428, DOI 10.1128/AEM.00690-08; Sanchez J, 2006, J COMP PATHOL, V135, P108, DOI 10.1016/j.jcpa.2006.06.003; SANFORD SE, 1994, CAN VET J, V35, P376; Tilburg JJHC, 2012, J CLIN MICROBIOL, V50, P1076, DOI 10.1128/JCM.05497-11; Van Steenbergen J E, 2007, Ned Tijdschr Geneeskd, V151, P1998; WELSH HH, 1958, ANN NY ACAD SCI, V70, P528, DOI 10.1111/j.1749-6632.1958.tb35409.x; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001; Wouda W, 2007, TIJDSCHR DIERGENEESK, V132, P908	30	111	114	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48949	10.1371/journal.pone.0048949	http://dx.doi.org/10.1371/journal.pone.0048949			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152826	Green Submitted, Green Published, gold			2022-12-27	WOS:000312272600031
J	Archer, BN; Tempia, S; White, LF; Pagano, M; Cohen, C				Archer, Brett N.; Tempia, Stefano; White, Laura F.; Pagano, Marcello; Cohen, Cheryl			Reproductive Number and Serial Interval of the First Wave of Influenza A(H1N1)pdm09 Virus in South Africa	PLOS ONE			English	Article							A H1N1 VIRUS; PANDEMIC INFLUENZA; SEASONAL INFLUENZA; UNITED-STATES; TRANSMISSION; HOUSEHOLDS; EPIDEMIC	Background/Objective: Describing transmissibility parameters of past pandemics from diverse geographic sites remains critical to planning responses to future outbreaks. We characterize the transmissibility of influenza A(H1N1)pdm09 (hereafter pH1N1) in South Africa during 2009 by estimating the serial interval (SI), the initial effective reproductive number (initial R-t) and the temporal variation of R-t. Methods: We make use of data from a central registry of all pH1N1 laboratory-confirmed cases detected throughout South Africa. Whenever date of symptom onset is missing, we estimate it from the date of specimen collection using a multiple imputation approach repeated 100 times for each missing value. We apply a likelihood-based method (method 1) for simultaneous estimation of initial R-t and the SI; estimate initial R-t from SI distributions established from prior field studies (method 2); and the Wallinga and Teunis method (method 3) to model the temporal variation of R-t. Results: 12,360 confirmed pH1N1 cases were reported in the central registry. During the period of exponential growth of the epidemic (June 21 to August 3, 2009), we simultaneously estimate a mean R-t of 1.47 (95% CI: 1.30-1.72) and mean SI of 2.78 days (95% CI: 1.80-3.75) (method 1). Field studies found a mean SI of 2.3 days between primary cases and laboratory-confirmed secondary cases, and 2.7 days when considering both suspected and confirmed secondary cases. Incorporating the SI estimate from field studies using laboratory-confirmed cases, we found an initial R-t of 1.43 (95% CI: 1.38-1.49) (method 2). The mean R-t peaked at 2.91 (95% CI: 0.85-2.91) on June 21, as the epidemic commenced, and R-t>1 was sustained until August 22 (method 3). Conclusions: Transmissibility characteristics of pH1N1 in South Africa are similar to estimates reported by countries outside of Africa. Estimations using the likelihood-based method are in agreement with field findings.	[Tempia, Stefano; Cohen, Cheryl] NHLS, NICD, US Ctr Dis Control & Prevent, Johannesburg, Gauteng, South Africa; [White, Laura F.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Pagano, Marcello] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Cohen, Cheryl] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, Gauteng, South Africa	National Health Laboratory Service; National Institute for Communicable Diseases (NICD); Boston University; Harvard University; Harvard T.H. Chan School of Public Health; University of Witwatersrand	Cohen, C (corresponding author), NHLS, NICD, US Ctr Dis Control & Prevent, Johannesburg, Gauteng, South Africa.	cherylc@nicd.ac.za	Archer, Brett Nicholas/A-5610-2012	Archer, Brett Nicholas/0000-0002-4144-1094; White, Laura F/0000-0002-0588-8235; Cohen, Cheryl/0000-0003-0376-2302	National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service (NHLS); United States Centers for Disease Control and Prevention (CDC) [5U51/IP000155]; National Institute of General Medical Sciences (NIGMS) [U54GM088558]; NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES [U51IP000155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088558] Funding Source: NIH RePORTER	National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service (NHLS); United States Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR IMMUNICATION AND RESPIRATORY DISEASES(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partly supported by the National Institute for Communicable Diseases (NICD), a division of the National Health Laboratory Service (NHLS). Laboratory testing and influenza surveillance activities at the NICD are funded, in part, by an unrestricted grant from the United States Centers for Disease Control and Prevention (CDC) [grant number 5U51/IP000155]. Dr. White and Dr. Pagano were supported by the National Institute of General Medical Sciences (NIGMS) [award number U54GM088558]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NICD, NHLS, US CDC, NIGMS, NIH or the affiliated universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer B, 2009, EURO SURVEILL, V14; Archer BN, 2012, J INFECT DIS S; Boelle PY, 2011, INFLUENZA OTHER RESP, V5, P306, DOI 10.1111/j.1750-2659.2011.00234.x; Boelle PY, 2009, EURO SURVEILL, V14; Cauchemez S, 2009, NEW ENGL J MED, V361, P2619, DOI 10.1056/NEJMoa0905498; Chowell G, 2008, EPIDEMIOL INFECT, V136, P852, DOI 10.1017/S0950268807009144; Chowell G, 2007, J R SOC INTERFACE, V4, P155, DOI 10.1098/rsif.2006.0161; Chowell G, 2010, P ROY SOC B-BIOL SCI, V277, P1857, DOI 10.1098/rspb.2009.1897; Cowling BJ, 2010, NEW ENGL J MED, V362, P2175, DOI 10.1056/NEJMoa0911530; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; DESILVA UC, 2009, EURO SURVEILL, V14; Donnelly CA, 2011, CLIN INFECT DIS, V52, pS123, DOI 10.1093/cid/ciq028; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gani R, 2005, EMERG INFECT DIS, V11, P1355; Grassly NC, 2008, NAT REV MICROBIOL, V6, P477, DOI 10.1038/nrmicro1845; Jackson C, 2010, AM J EPIDEMIOL, V171, P465, DOI 10.1093/aje/kwp394; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; McBryde E, 2009, EURO SURVEILL, V14; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Morgan OW, 2010, EMERG INFECT DIS, V16, P631, DOI 10.3201/eid1604.091658; Munayco C, 2009, EURO SURVEILL, V14; Nishiura H, 2010, THEOR BIOL MED MODEL, V7, DOI 10.1186/1742-4682-7-1; Nishiura H, 2009, NEW ZEAL MED J, V122, P73; Odaira F, 2009, EURO SURVEILL, V14; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; Rubin D.B., 2002, STAT ANAL MISSING DA; Tuite AR, 2010, CAN MED ASSOC J, V182, P128, DOI 10.1503/cmaj.091807; Viboud C, 2004, BRIT J GEN PRACT, V54, P684; Vynnycky E, 2007, INT J EPIDEMIOL, V36, P881, DOI 10.1093/ije/dym071; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136; White Laura F, 2010, Epidemiol Perspect Innov, V7, P12, DOI 10.1186/1742-5573-7-12; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x; White LF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001498; World Health Organization, 2010, PAND H1N1 2009 UPD 1; World Health Organization, 2009, CDC PROT REALT RTPCR; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	39	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49482	10.1371/journal.pone.0049482	http://dx.doi.org/10.1371/journal.pone.0049482			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166682	Green Submitted, gold, Green Published			2022-12-27	WOS:000311885300046
J	Petrov, MN; Shilo, VY; Tarasov, AV; Schwartz, DE; Garcia, JGN; Kost, OA; Danilov, SM				Petrov, Maxim N.; Shilo, Valery Y.; Tarasov, Alexandr V.; Schwartz, David E.; Garcia, Joe G. N.; Kost, Olga A.; Danilov, Sergei M.			Conformational Changes of Blood ACE in Chronic Uremia	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; CHRONIC-RENAL-FAILURE; MONOCLONAL-ANTIBODIES; N-DOMAIN; HEMODIALYSIS-PATIENTS; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; OXIDANT STRESS; HUMAN-SERUM; INHIBITORS	Background: The pattern of binding of monoclonal antibodies (mAbs) to 16 epitopes on human angiotensin I-converting enzyme (ACE) comprise a conformational ACE fingerprint and is a sensitive marker of subtle protein conformational changes. Hypothesis: Toxic substances in the blood of patients with uremia due to End Stage Renal Disease (ESRD) can induce local conformational changes in the ACE protein globule and alter the efficacy of ACE inhibitors. Methodology/Principal Findings: The recognition of ACE by 16 mAbs to the epitopes on the N and C domains of ACE was estimated using an immune-capture enzymatic plate precipitation assay. The precipitation pattern of blood ACE by a set of mAbs was substantially influenced by the presence of ACE inhibitors with the most dramatic local conformational change noted in the N-domain region recognized by mAb 1G12. The "short" ACE inhibitor enalaprilat (tripeptide analog) and "long" inhibitor teprotide (nonapeptide) produced strikingly different mAb 1G12 binding with enalaprilat strongly increasing mAb 1G12 binding and teprotide decreasing binding. Reduction in S-S bonds via glutathione and dithiothreitol treatment increased 1G12 binding to blood ACE in a manner comparable to enalaprilat. Some patients with uremia due to ESRD exhibited significantly increased mAb 1G12 binding to blood ACE and increased ACE activity towards angiotensin I accompanied by reduced ACE inhibition by inhibitory mAbs and ACE inhibitors. Conclusions/Significance: The estimation of relative mAb 1G12 binding to blood ACE detects a subpopulation of ESRD patients with conformationally changed ACE, which activity is less suppressible by ACE inhibitors. This parameter may potentially serve as a biomarker for those patients who may need higher concentrations of ACE inhibitors upon antihypertensive therapy.	[Schwartz, David E.; Danilov, Sergei M.] Univ Illinois, Dept Anesthesiol, Chicago, IL 60607 USA; [Petrov, Maxim N.; Tarasov, Alexandr V.; Kost, Olga A.] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia; [Shilo, Valery Y.] Moscow Univ Med & Dent, Dept Nephrol, Moscow, Russia; [Garcia, Joe G. N.; Danilov, Sergei M.] Univ Illinois, Inst Personalized Resp Med, Chicago, IL USA; [Danilov, Sergei M.] Natl Cardiol Res Ctr, Moscow, Russia	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Lomonosov Moscow State University; Moscow State University of Medicine & Dentistry; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; National Medical Research Center of Cardiology	Danilov, SM (corresponding author), Univ Illinois, Dept Anesthesiol, Chicago, IL 60607 USA.	danilov@uic.edu		Shilo, Valeriy/0000-0001-9025-8061	Russian Fund for Basic Research [11-04-01923-a]	Russian Fund for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was partly financially supported by the Russian Fund for Basic Research (grant number 11-04-01923-a). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ALHENCGELAS F, 1991, J LAB CLIN MED, V117, P33; Balyasnikova IV, 2008, TISSUE ANTIGENS, V72, P354, DOI 10.1111/j.1399-0039.2008.01112.x; Balyasnikova IV, 2007, J PROTEOME RES, V6, P1580, DOI 10.1021/pr060658x; Balyasnikova IV, 2006, TISSUE ANTIGENS, V67, P10, DOI 10.1111/j.1399-0039.2005.00516.x; Balyasnikova IV, 2005, PULM PHARMACOL THER, V18, P251, DOI 10.1016/j.pupt.2004.12.008; Balyasnikova IV, 2005, J PROTEOME RES, V4, P258, DOI 10.1021/pr049859w; Balyasnikova IV, 2005, HYBRIDOMA, V24, P14, DOI 10.1089/hyb.2005.24.14; Balyasnikova IV, 2005, TISSUE ANTIGENS, V65, P240, DOI 10.1111/j.1399-0039.2005.00364.x; Balyasnikova IV, 2003, TISSUE ANTIGENS, V61, P49, DOI 10.1034/j.1399-0039.2003.610104.x; Balyasnikova IV, 2002, BIOCHEM J, V362, P585, DOI 10.1042/0264-6021:3620585; Balyasnikova IV, 1999, TUMOR TARGET, V4, P70; Balyasnikova IV, 1998, IN VITRO CELL DEV-AN, V34, P545; BENETEAUBURNAT B, 1991, CRIT REV CL LAB SCI, V28, P337, DOI 10.3109/10408369109106868; Bernstein KE, 2005, CIRC RES, V96, P1135, DOI 10.1161/01.RES.0000169536.73576.66; Brecher AS, 1996, ARCH INT PHARMACOD T, V331, P301; BRUNEVAL P, 1986, HISTOCHEMISTRY, V85, P73, DOI 10.1007/BF00508656; CALDWELL PRB, 1976, SCIENCE, V191, P1050, DOI 10.1126/science.175444; Chang TI, 2011, AM HEART J, V162, P324, DOI 10.1016/j.ahj.2011.05.004; Chen HL, 2010, MICRON, V41, P674, DOI 10.1016/j.micron.2010.01.005; CHING SF, 1983, ARTERIOSCLEROSIS, V3, P581, DOI 10.1161/01.ATV.3.6.581; Corradi HR, 2006, J MOL BIOL, V357, P964, DOI 10.1016/j.jmb.2006.01.048; DANILOV S, 1994, J BIOL CHEM, V269, P26806; Danilov S, 1996, J HYPERTENS, V14, P719, DOI 10.1097/00004872-199606000-00007; Danilov SM, 2008, J CARDIOVASC PHARM, V52, P90, DOI 10.1097/FJC.0b013e31817fd3bc; Danilov SM, 2007, BIOCHEMISTRY-US, V46, P9019, DOI 10.1021/bi700489v; Danilov SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025952; Danilov SM, 2010, J PROTEOME RES, V9, P5782, DOI 10.1021/pr100564r; Danilov SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010438; Danilov SM, 2005, CLIN CHEM, V51, P1040, DOI 10.1373/clinchem.2004.045633; Danilov SM, 2003, EXP HEMATOL, V31, P1301, DOI 10.1016/j.exphem.2003.08.018; Danser AHJ, 2007, PHARMACOL THERAPEUT, V113, P607, DOI 10.1016/j.pharmthera.2006.12.001; DEFENDINI R, 1983, NEUROENDOCRINOLOGY, V37, P32, DOI 10.1159/000123512; DUX S, 1984, ISRAEL J MED SCI, V20, P1138; Silva ACSE, 2006, PEDIATR RES, V60, P734, DOI 10.1203/01.pdr.0000246100.14061.bc; Efrati S, 2002, AM J KIDNEY DIS, V40, P1023, DOI 10.1053/ajkd.2002.36340; EHLERS MRW, 1991, P NATL ACAD SCI USA, V88, P1009, DOI 10.1073/pnas.88.3.1009; EHLERS MRW, 1989, BIOCHEMISTRY-US, V28, P5311, DOI 10.1021/bi00439a001; Franke FE., 1997, LEUCOCYTE TYPING, P749; FRIEDLAND J, 1976, AM J CLIN PATHOL, V66, P416; [Гендлин Г.Е. Gendlin G.E.], 2009, [Клиническая нефрология, Klinicheskaya nefrologiya], P22; Giustarini D, 2004, FREE RADICAL RES, V38, P1101, DOI 10.1080/10715760400008854; Gordon K, 2010, TISSUE ANTIGENS, V75, P136, DOI 10.1111/j.1399-0039.2009.01416.x; HAZATO T, 1986, BIOCHEM BIOPH RES CO, V139, P52, DOI 10.1016/S0006-291X(86)80078-X; Herzog CA, 2002, CIRCULATION, V105, P1336, DOI 10.1161/hc1102.100075; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; HOOPER NM, 1987, BIOCHEM J, V241, P625, DOI 10.1042/bj2410625; IKEMOTO F, 1989, BIOCHEM BIOPH RES CO, V159, P1093, DOI 10.1016/0006-291X(89)92221-3; Inrig JK, 2010, SEMIN DIALYSIS, V23, P290, DOI 10.1111/j.1525-139X.2009.00697.x; Jokubaitis VJ, 2008, BLOOD, V111, P4055, DOI 10.1182/blood-2007-05-091710; Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8; Kishimoto, 1997, LEUCOCYTE TYPING, P746; Kost OA, 2003, BIOCHEMISTRY-US, V42, P6965, DOI 10.1021/bi034645y; Kramer AB, 2003, J PATHOL, V201, P160, DOI 10.1002/path.1405; LIEBERMAN J, 1976, NEW ENGL J MED, V294, P1442, DOI 10.1056/NEJM197606242942609; LIEBERMAN J, 1986, CHEST, V90, P869, DOI 10.1378/chest.90.6.869; LIEBERMAN J, 1975, AM J MED, V59, P365, DOI 10.1016/0002-9343(75)90395-2; Lucchi L, 2005, ARTIF ORGANS, V29, P67, DOI 10.1111/j.1525-1594.2004.29011.x; McCullough PA, 2002, J RENIN-ANGIO-ALDO S, V3, P188, DOI 10.3317/jraas.2002.040; Menard J, 2001, ADV PROTEIN CHEM, V56, P13; Metzger R, 2011, MICROVASC RES, V81, P206, DOI 10.1016/j.mvr.2010.12.003; Morena Marion, 2005, Hemodial Int, V9, P37, DOI 10.1111/j.1492-7535.2005.01116.x; Naperova IA, 2008, J PROTEOME RES, V7, P3396, DOI 10.1021/pr800142w; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Nesterovitch AB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008282; Nikolaeva MA, 2006, AM J REPROD IMMUNOL, V55, P54, DOI 10.1111/j.1600-0897.2005.00326.x; Parkin ET, 2004, PROTEIN PEPTIDE LETT, V11, P423, DOI 10.2174/0929866043406544; PATEL K, 1979, CLIN CHIM ACTA, V92, P491, DOI 10.1016/0009-8981(79)90232-8; PIQUILLO.Y, 1970, BIOCHIM BIOPHYS ACTA, V206, P136, DOI 10.1016/0005-2744(70)90090-2; Romer F K, 1984, Acta Med Scand Suppl, V690, P3; Ryan J W, 1979, Adv Exp Med Biol, V120B, P599; RYAN US, 1976, TISSUE CELL, V8, P125, DOI 10.1016/0040-8166(76)90025-2; Scharplatz M, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-16; SILVERSTEIN E, 1978, ISRAEL J MED SCI, V14, P314; SILVERSTEIN E, 1976, ANN NY ACAD SCI, V278, P498, DOI 10.1111/j.1749-6632.1976.tb47062.x; SILVERSTEIN E, 1984, NEPHRON, V37, P206, DOI 10.1159/000183246; Skirgello OE, 2006, BIOCHEMISTRY-US, V45, P4831, DOI 10.1021/bi052591h; SOUBRIER F, 1988, P NATL ACAD SCI USA, V85, P9386, DOI 10.1073/pnas.85.24.9386; Stepniewska J, 2006, ARCH MED RES, V37, P353, DOI 10.1016/j.arcmed.2005.07.012; Sturrock ED, 1996, BIOCHEMISTRY-US, V35, P9560, DOI 10.1021/bi960243x; Sturrock ED, 2012, HDB PROTEOL IN PRESS; Suzuki Hiromichi, 2009, Ther Adv Cardiovasc Dis, V3, P397, DOI 10.1177/1753944709338339; Thevananther S, 1999, CAN J PHYSIOL PHARM, V77, P216, DOI 10.1139/cjpp-77-3-216; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Ward RA, 2003, ARTIF ORGANS, V27, P230, DOI 10.1046/j.1525-1594.2003.07170.x; WEI L, 1991, J BIOL CHEM, V266, P5540; Windt WAKM, 2008, EUR J PHARMACOL, V580, P231, DOI 10.1016/j.ejphar.2007.10.060; Zannad F, 2006, KIDNEY INT, V70, P1318, DOI 10.1038/sj.ki.5001657	87	11	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49290	10.1371/journal.pone.0049290	http://dx.doi.org/10.1371/journal.pone.0049290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166630	Green Published, gold			2022-12-27	WOS:000311885300025
J	Chen, S; Zhao, BW; Li, YF; Feng, XY; Sun, XW; Li, W; Zhou, ZW; Zhan, YQ; Qian, CN; Chen, YB				Chen, Shi; Zhao, Bai-Wei; Li, Yuan-Fang; Feng, Xing-Yu; Sun, Xiao-Wei; Li, Wei; Zhou, Zhi-Wei; Zhan, You-Qing; Qian, Chao-Nan; Chen, Ying-Bo			The Prognostic Value of Harvested Lymph Nodes and the Metastatic Lymph Node Ratio for Gastric Cancer Patients: Results of a Study of 1,101 Patients	PLOS ONE			English	Article							SURVIVAL; NUMBER; DISSECTION; TRIAL; STAGE	Aim: To investigate whether the recommendation to remove 15 lymph nodes that is used in the staging system is necessary to assess gastric cancer progression and to evaluate whether our metastatic lymph node ratio dividing method, adapted from the AJCC's (American Joint Committee on Cancer) 7th TNM staging system, is helpful for the patients with fewer than 15 harvested lymph nodes. Methods: We performed a retrospective study of 1101 patients with histologically diagnosed gastric cancer who underwent a D2 gastrectomy at the Sun Yat-sen University Cancer Center between January 2001 and December 2010. The Kappa and Chi-squared tests were employed to compare the clinicopathological variables. The Kaplan-Meier method and Cox regression were employed for the univariate and multivariate survival analyses. Results: In the trial, 346, 601 and 154 patients had 0-14, 15-30 and more than 30 lymph nodes harvested, respectively. The median survival times of patients with different lymph nodes harvested in N0, N1, N2 and N3a groups were 45.43, 54.28 and 66.95 months (p = 0.068); 49.22, 44.25 and 56.72 months (p < 0.001), 43.94, 47.97 and 35.19 months (p = 0.042); 32.88, 42.76 and 23.50 months (p = 0.016). Dividing the patients who had fewer than 15 lymph nodes harvested by the metastatic lymph node ratio at 0, 0.13 and 0.40, the median survival times of these 4 groups were 70.6, 50.5, 53.5 and 30.7 months (p < 0.001). After re-categorising these 4 groups into the N0, N1, N2, N3a groups, the histological grade, T staging, premier N staging, and restaged N staging were the independent prognostic factors. Conclusions: Large numbers of lymph nodes harvested in radical gastrectomy do not cause stage migration. For those patients with a small number of harvested lymph nodes, their stage should be divided by the metastatic lymph node ratio, referred to in the TNM staging system, to assign them an accurate stage.	[Chen, Shi; Zhao, Bai-Wei; Li, Yuan-Fang; Feng, Xing-Yu; Sun, Xiao-Wei; Li, Wei; Zhou, Zhi-Wei; Zhan, You-Qing; Chen, Ying-Bo] Sun Yat Sen Univ, Ctr Canc, Dept Gastropancreat Surg, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Shi; Zhao, Bai-Wei; Li, Yuan-Fang; Sun, Xiao-Wei; Li, Wei; Zhou, Zhi-Wei; Zhan, You-Qing; Qian, Chao-Nan; Chen, Ying-Bo] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol S China, Guangzhou 510275, Guangdong, Peoples R China; [Qian, Chao-Nan] Van Andel Res Inst, Lab Canc & Dev Cell Biol, Grand Rapids, MI USA	Sun Yat Sen University; Sun Yat Sen University; Van Andel Institute	Chen, YB (corresponding author), Sun Yat Sen Univ, Ctr Canc, Dept Gastropancreat Surg, Guangzhou 510275, Guangdong, Peoples R China.	chenyb@sysucc.org.cn	Li, Yuan/GXV-1310-2022		Science and Technology Department of Guangdong Province [2011B061300052]	Science and Technology Department of Guangdong Province	This work was supported by a research grant from the plan program of the Science and Technology Department of Guangdong Province(2011B061300052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani JA, 2012, J CLIN ONCOL, V30, P1017, DOI 10.1200/JCO.2011.40.9607; Aurello P, 2007, AM SURGEON, V73, P359; Bonenkamp JJ, 1999, NEW ENGL J MED, V340, P908, DOI 10.1056/NEJM199903253401202; Chen Bo, 2005, Zhonghua Wai Ke Za Zhi, V43, P702; Coburn NG, 2006, CANCER-AM CANCER SOC, V107, P2143, DOI 10.1002/cncr.22229; Cuschieri A, 1999, BRIT J CANCER, V79, P1522, DOI 10.1038/sj.bjc.6690243; Espin F, 2012, EJSO-EUR J SURG ONC, V38, P497, DOI 10.1016/j.ejso.2012.01.012; Hartgrink HH, 2004, J CLIN ONCOL, V22, P2069, DOI 10.1200/JCO.2004.08.026; Ichikawa D, 2003, HEPATO-GASTROENTEROL, V50, P301; Japanese Gastric Cancer A, 1998, GASTRIC CANC, V1, P10; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kong SH, 2012, ANN SURG, V255, P50, DOI 10.1097/SLA.0b013e31821d4d75; Lee SY, 2010, INT J ONCOL, V36, P1461, DOI 10.3892/ijo_00000632; Lee SR, 2012, WORLD J SURG, V36, P1096, DOI 10.1007/s00268-012-1520-5; Liang Han, 2007, Zhonghua Wei Chang Wai Ke Za Zhi, V10, P528; McCulloch P, 2004, COCHRANE DB SYST REV; Schwarz RE, 2007, ANN SURG ONCOL, V14, P317, DOI 10.1245/s10434-006-9218-2; Sobin LH., 2010, TNM CLASSIFICATION M; Wang JP, 2012, ANN SURG, V255, P478, DOI 10.1097/SLA.0b013e31824857e2; Wang Wei, 2010, Chin J Cancer, V29, P923; Wei Wen-Qiang, 2011, Chin J Cancer, V30, P213; Xu DZ, 2009, ANN SURG ONCOL, V16, P319, DOI 10.1245/s10434-008-0240-4	23	13	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49424	10.1371/journal.pone.0049424	http://dx.doi.org/10.1371/journal.pone.0049424			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166665	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300041
J	Gorlov, IP; Logothetis, CJ; Fang, SY; Gorlova, OY; Amos, C				Gorlov, Ivan P.; Logothetis, Christopher J.; Fang, Shenying; Gorlova, Olga Y.; Amos, Christopher			Building a Statistical Model for Predicting Cancer Genes	PLOS ONE			English	Article							PROSTATE-CANCER; SOMATIC MUTATIONS; EXPRESSION; DATABASE; SELECTION; PATHWAYS; ONTOLOGY; CATALOG; CENSUS	More than 400 cancer genes have been identified in the human genome. The list is not yet complete. Statistical models predicting cancer genes may help with identification of novel cancer gene candidates. We used known prostate cancer (PCa) genes (identified through KnowledgeNet) as a training set to build a binary logistic regression model identifying PCa genes. Internal and external validation of the model was conducted using a validation set (also from KnowledgeNet), permutations, and external data on genes with recurrent prostate tumor mutations. We evaluated a set of 33 gene characteristics as predictors. Sixteen of the original 33 predictors were significant in the model. We found that a typical PCa gene is a prostate-specific transcription factor, kinase, or phosphatase with high interindividual variance of the expression level in adjacent normal prostate tissue and differential expression between normal prostate tissue and primary tumor. PCa genes are likely to have an antiapoptotic effect and to play a role in cell proliferation, angiogenesis, and cell adhesion. Their proteins are likely to be ubiquitinated or sumoylated but not acetylated. A number of novel PCa candidates have been proposed. Functional annotations of novel candidates identified antiapoptosis, regulation of cell proliferation, positive regulation of kinase activity, positive regulation of transferase activity, angiogenesis, positive regulation of cell division, and cell adhesion as top functions. We provide the list of the top 200 predicted PCa genes, which can be used as candidates for experimental validation. The model may be modified to predict genes for other cancer sites.	[Gorlov, Ivan P.; Logothetis, Christopher J.] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Fang, Shenying] Univ Texas MD Anderson Canc Ctr, Dept Canc Genet, Houston, TX 77030 USA; [Gorlova, Olga Y.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Amos, Christopher] Dartmouth Coll, Geisel Sch Med, Dept Community & Family Med, Lebanon, NH 03756 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Dartmouth College	Gorlov, IP (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	ipgorlov@mdanderson.org		Fang, Shenying/0000-0002-0604-793X	David H. Koch Center for Applied Research of Genitourinary Cancers; National Institutes of Health [CA140388-01]; National Institutes of Health Cancer Center [5 P30 CA016672]; NATIONAL CANCER INSTITUTE [P50CA140388, P30CA016672] Funding Source: NIH RePORTER	David H. Koch Center for Applied Research of Genitourinary Cancers; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by the David H. Koch Center for Applied Research of Genitourinary Cancers, the National Institutes of Health Prostate SPORE grant CA140388-01, and the National Institutes of Health Cancer Center Support Grant 5 P30 CA016672. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babenko VN, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-36; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Byun JY, 2009, INT J CANC; Camon Evelyn, 2004, In Silico Biology, V4, P5; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; Choi JK, 2007, GENETICS, V175, P199, DOI 10.1534/genetics.106.066027; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Fernandez PL, 2002, PATHOBIOLOGY, V70, P1, DOI 10.1159/000065998; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gorlov IP, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-599; Gorlov IP, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-48; Gorlov IP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006511; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hui ES, 2006, FERTIL STERIL, V85, P1502, DOI 10.1016/j.fertnstert.2005.10.071; Kumar A, 2011, P NATL ACAD SCI USA, V108, P17087, DOI 10.1073/pnas.1108745108; LALEZARI P, 1971, J CLIN INVEST, V50, P1108, DOI 10.1172/JCI106582; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Matsumoto K, 2008, UROLOGY, V72, P444, DOI 10.1016/j.urology.2007.11.128; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Wilson E M, 1987, Prog Clin Biol Res, V239, P205; Yue P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-166	28	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49175	10.1371/journal.pone.0049175	http://dx.doi.org/10.1371/journal.pone.0049175			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166609	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300025
J	Ying, H; Zhang, YH; Zhou, X; Qu, XY; Wang, PF; Liu, SJ; Lu, DR; Zhu, HZ				Ying, Hao; Zhang, Yuhao; Zhou, Xin; Qu, Xiying; Wang, Pengfei; Liu, Sijie; Lu, Daru; Zhu, Huanzhang			Selective Histonedeacetylase Inhibitor M344 Intervenes in HIV-1 Latency through Increasing Histone Acetylation and Activation of NF-kappaB	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ACTIVE ANTIRETROVIRAL THERAPY; CHROMATIN-REMODELING COMPLEX; T-CELLS; DEACETYLASE INHIBITORS; B ACTIVATION; TRANSCRIPTIONAL REPRESSION; POSTINTEGRATION LATENCY; SYNERGISTIC ACTIVATION; TAT TRANSACTIVATION	Background: Histone deacetylase (HDAC) inhibitors present an exciting new approach to activate HIV production from latently infected cells to potentially enhance elimination of these cells and achieve a cure. M344, a novel HDAC inhibitor, shows robust activity in a variety of cancer cells and relatively low toxicity compared to trichostatin A (TSA). However, little is known about the effects and action mechanism of M344 in inducing HIV expression in latently infected cells. Methodology/Principal Findings: Using the Jurkat T cell model of HIV latency, we demonstrate that M344 effectively reactivates HIV-1 gene expression in latently infected cells. Moreover, M344-mediated activation of the latent HIV LTR can be strongly inhibited by a NF-kappa B inhibitor aspirin. We further show that M344 acts by increasing the acetylation of histone H3 and histone H4 at the nucleosome 1 (nuc-1) site of the HIV-1 long terminal repeat (LTR) and by inducing NF-kappa B p65 nuclear translocation and direct RelA DNA binding at the nuc-1 region of the HIV-1 LTR. We also found that M344 synergized with prostratin to activate the HIV-1 LTR promoter in latently infected cells. Conclusions/Significance: These results suggest the potential of M344 in anti-latency therapies and an important role for histone modifications and NF-kappa B transcription factors in regulating HIV-1 LTR gene expression.	[Ying, Hao; Zhang, Yuhao; Zhou, Xin; Qu, Xiying; Wang, Pengfei; Liu, Sijie; Lu, Daru; Zhu, Huanzhang] Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China	Fudan University	Zhu, HZ (corresponding author), Fudan Univ, Sch Life Sci, Inst Genet, State Key Lab Genet Engn, Shanghai 200433, Peoples R China.	hzzhu@fudan.edu.cn	zhang, yuhao/O-4356-2015	Wang, Pengfei/0000-0003-2454-7652	National Grand Program on Key Infectious Disease [2012ZX10001003]; National Natural Science Funding of China [31171247]	National Grand Program on Key Infectious Disease; National Natural Science Funding of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Grand Program on Key Infectious Disease (2012ZX10001003), National Natural Science Funding of China (No. 31171247). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam E, 2003, MOL CELL BIOL, V23, P6200, DOI 10.1128/MCB.23.17.6200-6209.2003; Archin NM, 2009, AIDS, V23, P1799, DOI 10.1097/QAD.0b013e32832ec1dc; Archin NM, 2009, AIDS RES HUM RETROV, V25, P207, DOI 10.1089/aid.2008.0191; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Bren GD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002112; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Choudhary SK, 2008, J INFECT DIS, V197, P1162, DOI 10.1086/529525; Chun TW, 1998, J EXP MED, V188, P83, DOI 10.1084/jem.188.1.83; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Coiras M, 2009, NAT REV MICROBIOL, V7, P798, DOI 10.1038/nrmicro2223; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Coull JJ, 2000, J VIROL, V74, P6790, DOI 10.1128/JVI.74.15.6790-6799.2000; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; du Chene I, 2007, EMBO J, V26, P424, DOI 10.1038/sj.emboj.7601517; Duverger A, 2009, J VIROL, V83, P3078, DOI 10.1128/JVI.02058-08; Emiliani S, 1996, P NATL ACAD SCI USA, V93, P6377, DOI 10.1073/pnas.93.13.6377; Emiliani S, 1998, J VIROL, V72, P1666, DOI 10.1128/JVI.72.2.1666-1670.1998; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Furchert SE, 2007, INT J CANCER, V120, P1787, DOI 10.1002/ijc.22401; Girdwood D, 2003, MOL CELL, V11, P1043, DOI 10.1016/S1097-2765(03)00141-2; Greene WC, 2002, NAT MED, V8, P673, DOI 10.1038/nm0702-673; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Han Y, 2007, NAT MED, V13, P1138, DOI 10.1038/nm1007-1138; He GC, 2002, MOL CELL BIOL, V22, P2965, DOI 10.1128/MCB.22.9.2965-2973.2002; Heltweg B, 2004, J MED CHEM, V47, P5235, DOI 10.1021/jm0497592; Henderson A, 2004, MOL CELL BIOL, V24, P389, DOI 10.1128/MCB.24.1.389-397.2004; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Huber K, 2011, J BIOL CHEM, V286, P22211, DOI 10.1074/jbc.M110.180224; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Jiang GC, 2007, J VIROL, V81, P10914, DOI 10.1128/JVI.01208-07; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Kiefer HLB, 2004, J BIOL CHEM, V279, P43604, DOI 10.1074/jbc.M408069200; Klichko V, 2006, J VIROL, V80, P4570, DOI 10.1128/JVI.80.9.4570-4579.2006; Korin YD, 2002, J VIROL, V76, P8118, DOI 10.1128/JVI.76.16.8118-8123.2002; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Kutsch O, 2002, J VIROL, V76, P8776, DOI 10.1128/JVI.76.17.8776-8786.2002; Kutuk O, 2004, CYTOKINE, V25, P229, DOI 10.1016/j.cyto.2003.11.007; Lassen K, 2004, TRENDS MOL MED, V10, P525, DOI 10.1016/j.molmed.2004.09.006; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Li Xiaohua, 2009, Am J Biomed Sci, V1, P352; Lusic M, 2003, EMBO J, V22, P6550, DOI 10.1093/emboj/cdg631; Mahmoudi T, 2006, J BIOL CHEM, V281, P19960, DOI 10.1074/jbc.M603336200; Mai A, 2007, EXPERT OPIN THER TAR, V11, P835, DOI 10.1517/14728222.11.6.835; Malcolm T, 2007, VIRUS GENES, V35, P215, DOI 10.1007/s11262-007-0109-9; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; Marsden MD, 2009, J ANTIMICROB CHEMOTH, V63, P7, DOI 10.1093/jac/dkn455; Nunnari G, 2005, EXPERT OPIN BIOL TH, V5, P1421, DOI 10.1517/14712598.5.11.1421; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Palijan A, 2009, J BIOL CHEM, V284, P30264, DOI 10.1074/jbc.M109.045526; Pande V, 2003, CURR MED CHEM, V10, P1603, DOI 10.2174/0929867033457250; PERKINS ND, 1993, EMBO J, V12, P3551, DOI 10.1002/j.1460-2075.1993.tb06029.x; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Quivy V, 2002, J VIROL, V76, P11091, DOI 10.1128/JVI.76.21.11091-11103.2002; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Sabo A, 2008, MOL CELL BIOL, V28, P2201, DOI 10.1128/MCB.01557-07; Savarino A, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-52; Scripture-Adams DD, 2002, J VIROL, V76, P13077, DOI 10.1128/JVI.76.24.13077-13082.2002; Shehu-Xhilaga M, 2009, AIDS, V23, P2047, DOI 10.1097/QAD.0b013e328330342c; Sheridan PL, 1997, GENE DEV, V11, P3327, DOI 10.1101/gad.11.24.3327; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Stellbrink HJ, 2002, AIDS, V16, P1479, DOI 10.1097/00002030-200207260-00004; Strain MC, 2003, P NATL ACAD SCI USA, V100, P4819, DOI 10.1073/pnas.0736332100; SUNE C, 1995, J VIROL, V69, P6572; Takai N, 2006, GYNECOL ONCOL, V101, P108, DOI 10.1016/j.ygyno.2005.09.044; Treand C, 2006, EMBO J, V25, P1690, DOI 10.1038/sj.emboj.7601074; Triboulet R, 2007, SCIENCE, V315, P1579, DOI 10.1126/science.1136319; Trono D, 2010, SCIENCE, V329, P174, DOI 10.1126/science.1191047; Tyagi M, 2007, EMBO J, V26, P4985, DOI 10.1038/sj.emboj.7601928; Van Praag RME, 2001, J CLIN IMMUNOL, V21, P218, DOI 10.1023/A:1011091300321; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Verdin E, 2003, TRENDS GENET, V19, P286, DOI 10.1016/S0168-9525(03)00073-8; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Williams SA, 2006, EMBO J, V25, P139, DOI 10.1038/sj.emboj.7600900; Williams SA, 2004, J BIOL CHEM, V279, P42008, DOI 10.1074/jbc.M402124200; WINSLOW BJ, 1993, VIROLOGY, V196, P849, DOI 10.1006/viro.1993.1545; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xie B, 2007, J VIROL, V81, P4226, DOI 10.1128/JVI.01888-06; Ylisastigui L, 2004, J INFECT DIS, V190, P1429, DOI 10.1086/423822; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101; Zhang WZ, 2002, AM J PHYSIOL-RENAL, V283, pF904, DOI 10.1152/ajprenal.00156.2002; Zhu GY, 2007, DERMATOL SURG, V33, P697, DOI 10.1111/j.1524-4725.2007.33146.x	93	31	32	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48832	10.1371/journal.pone.0048832	http://dx.doi.org/10.1371/journal.pone.0048832			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166597	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300017
J	Arnspang, EC; Brewer, JR; Lagerholm, BC				Arnspang, Eva C.; Brewer, Jonathan R.; Lagerholm, B. Christoffer			Multi-Color Single Particle Tracking with Quantum Dots	PLOS ONE			English	Article							DIFFUSION; MOLECULE; BLINKING; MICRODOMAINS; RECEPTOR; PROTEIN	Quantum dots (QDs) have long promised to revolutionize fluorescence detection to include even applications requiring simultaneous multi-species detection at single molecule sensitivity. Despite the early promise, the unique optical properties of QDs have not yet been fully exploited in e. g. multiplex single molecule sensitivity applications such as single particle tracking (SPT). In order to fully optimize single molecule multiplex application with QDs, we have in this work performed a comprehensive quantitative investigation of the fluorescence intensities, fluorescence intensity fluctuations, and hydrodynamic radii of eight types of commercially available water soluble QDs. In this study, we show that the fluorescence intensity of CdSe core QDs increases as the emission of the QDs shifts towards the red but that hybrid CdSe/CdTe core QDs are less bright than the furthest red-shifted CdSe QDs. We further show that there is only a small size advantage in using blue-shifted QDs in biological applications because of the additional size of the water-stabilizing surface coat. Extending previous work, we finally also show that parallel four color multicolor (MC)-SPT with QDs is possible at an image acquisition rate of at least 25 Hz. We demonstrate the technique by measuring the lateral dynamics of a lipid, biotincap-DPPE, in the cellular plasma membrane of live cells using four different colors of QDs; QD565, QD605, QD655, and QD705 as labels.	[Arnspang, Eva C.; Lagerholm, B. Christoffer] Univ So Denmark, Dept Phys Chem & Pharm, Odense M, Denmark	University of Southern Denmark	Arnspang, EC (corresponding author), Univ So Denmark, Dept Phys Chem & Pharm, Odense M, Denmark.	lagerholm@memphys.sdu.dk	Arnspang, Eva C/Y-1132-2018; Brewer, Jonathan/C-7079-2012	Arnspang, Eva C/0000-0002-3095-4070; Brewer, Jonathan/0000-0002-3444-1715; Lagerholm, Christoffer/0000-0003-4678-5168				Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Andrews NL, 2009, IMMUNITY, V31, P469, DOI 10.1016/j.immuni.2009.06.026; ARNSPANG C, 2012, PLOS ONE, V0007; Bannai H, 2006, NAT PROTOC, V1, P2628, DOI 10.1038/nprot.2006.429; Bauer R, 1997, BBA-GEN SUBJECTS, V1334, P98, DOI 10.1016/S0304-4165(96)00078-5; Brewer J, 2010, BBA-BIOMEMBRANES, V1798, P1301, DOI 10.1016/j.bbamem.2010.02.024; Clausen MP, 2011, CURR PROTEIN PEPT SC, V12, P699; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Hohng S, 2004, J AM CHEM SOC, V126, P1324, DOI 10.1021/ja039686w; Itano MS, 2011, BIOPHYS J, V100, P2662, DOI 10.1016/j.bpj.2011.04.044; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Kenworthy Anne K., 2007, V398, P179, DOI 10.1007/978-1-59745-513-8_13; Kusumi A, 2010, FEBS LETT, V584, P1814, DOI 10.1016/j.febslet.2010.02.047; Lagerholm BC, 2006, BIOPHYS J, V91, P3050, DOI 10.1529/biophysj.105.079178; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lagerholm BC, 2004, NANO LETT, V4, P2019, DOI 10.1021/nl049295v; Lee SF, 2009, CHEMPHYSCHEM, V10, P2174, DOI 10.1002/cphc.200900200; Liu W, 2008, J AM CHEM SOC, V130, P1274, DOI 10.1021/ja076069p; Low-Nam ST, 2011, NAT STRUCT MOL BIOL, V18, P1244, DOI 10.1038/nsmb.2135; Mittal R, 2011, BIOCONJUGATE CHEM, V22, P362, DOI 10.1021/bc100321c; Pinaud F, 2010, NAT METHODS, V7, P275, DOI [10.1038/nmeth.1444, 10.1038/NMETH.1444]; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; Rosenthal SJ, 2011, CHEM BIOL, V18, P10, DOI 10.1016/j.chembiol.2010.11.013; Saxton MJ, 1997, ANNU REV BIOPH BIOM, V26, P373, DOI 10.1146/annurev.biophys.26.1.373; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Sperling RA, 2006, ADV FUNCT MATER, V16, P943, DOI 10.1002/adfm.200500589; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Tinoco I, 2011, GENE DEV, V25, P1205, DOI 10.1101/gad.2050011; Tu RS, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041914; Wang XY, 2009, NATURE, V459, P686, DOI 10.1038/nature08072; Wieser S, 2007, BIOPHYS J, V92, P3719, DOI 10.1529/biophysj.106.095398; Wu XY, 2003, NAT BIOTECHNOL, V21, P41, DOI 10.1038/nbt764; You CJ, 2010, ANGEW CHEM INT EDIT, V49, P4108, DOI 10.1002/anie.200907032	33	30	30	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48521	10.1371/journal.pone.0048521	http://dx.doi.org/10.1371/journal.pone.0048521			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155388	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900022
J	Bennett, SW; Zhou, DX; Mielke, R; Keller, AA				Bennett, Samuel W.; Zhou, Dongxu; Mielke, Randall; Keller, Arturo A.			Photoinduced Disaggregation of TiO2 Nanoparticles Enables Transdermal Penetration	PLOS ONE			English	Article							METAL-OXIDE NANOPARTICLES; TITANIUM-DIOXIDE; ENGINEERED NANOPARTICLES; AGGREGATION; ECOTOXICITY; ABSORPTION; STABILITY; ROUTE	Under many aqueous conditions, metal oxide nanoparticles attract other nanoparticles and grow into fractal aggregates as the result of a balance between electrostatic and Van Der Waals interactions. Although particle coagulation has been studied for over a century, the effect of light on the state of aggregation is not well understood. Since nanoparticle mobility and toxicity have been shown to be a function of aggregate size, and generally increase as size decreases, photo-induced disaggregation may have significant effects. We show that ambient light and other light sources can partially disaggregate nanoparticles from the aggregates and increase the dermal transport of nanoparticles, such that small nanoparticle clusters can readily diffuse into and through the dermal profile, likely via the interstitial spaces. The discovery of photoinduced disaggregation presents a new phenomenon that has not been previously reported or considered in coagulation theory or transdermal toxicological paradigms. Our results show that after just a few minutes of light, the hydrodynamic diameter of TiO2 aggregates is reduced from similar to 280 nm to similar to 230 nm. We exposed pigskin to the nanoparticle suspension and found 200 mg kg(-1) of TiO2 for skin that was exposed to nanoparticles in the presence of natural sunlight and only 75 mg kg(-1) for skin exposed to dark conditions, indicating the influence of light on NP penetration. These results suggest that photoinduced disaggregation may have important health implications.	[Bennett, Samuel W.] Univ Calif Santa Barbara, Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Bennett, SW (corresponding author), Univ Calif Santa Barbara, Ctr Environm Implicat Nanotechnol, Santa Barbara, CA 93106 USA.	keller@bren.ucsb.edu	Zhou, Dongxu/C-1255-2013					Addamo M, 2007, RES CHEM INTERMEDIAT, V33, P465, DOI 10.1163/156856707779238685; Albanese A, 2011, ACS NANO, V5, P5478, DOI 10.1021/nn2007496; [Anonymous], NAT SOL RAD DAT; Battin TJ, 2009, ENVIRON SCI TECHNOL, V43, P8098, DOI 10.1021/es9017046; Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y; Cevc G, 2010, J CONTROL RELEASE, V141, P277, DOI 10.1016/j.jconrel.2009.10.016; Chen KL, 2009, ENVIRON SCI TECHNOL, V43, P7270, DOI 10.1021/es900185p; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; DERJAGUIN BV, 1954, DISCUSS FARADAY SOC, P85, DOI 10.1039/df9541800085; Domingos RF, 2009, ENVIRON SCI TECHNOL, V43, P1282, DOI 10.1021/es8023594; Elimelech M., 2013, PARTICLE DEPOSITION; French RA, 2009, ENVIRON SCI TECHNOL, V43, P1354, DOI 10.1021/es802628n; Gamer AO, 2006, TOXICOL IN VITRO, V20, P301, DOI 10.1016/j.tiv.2005.08.008; Garkusha I, 2008, CHEM PHYS, V353, P115, DOI 10.1016/j.chemphys.2008.08.003; Godwin HA, 2009, ENVIRON SCI TECHNOL, V43, P6453, DOI 10.1021/es8034544; Hashimoto K, 2005, JPN J APPL PHYS 1, V44, P8269, DOI 10.1143/JJAP.44.8269; Keller AA, 2010, ENVIRON SCI TECHNOL, V44, P1962, DOI 10.1021/es902987d; Lademann J, 1999, SKIN PHARMACOL APPL, V12, P247, DOI 10.1159/000066249; Landsiedel R, 2010, ADV MATER, V22, P2601, DOI 10.1002/adma.200902658; Mattin E N-SM, 1996, SKIN PHARMACOL, V9, P69; MONTEIRORIVIERE NA, 1991, TOXICOL LETT, V57, P329, DOI 10.1016/0378-4274(91)90207-M; Navarro E, 2008, ECOTOXICOLOGY, V17, P372, DOI 10.1007/s10646-008-0214-0; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Peralta-Videa JR, 2011, J HAZARD MATER, V186, P1, DOI 10.1016/j.jhazmat.2010.11.020; Sadrieh N, 2003, TOXICOL SCI, V115, P156; Thio BJR, 2011, J HAZARD MATER, V189, P556, DOI 10.1016/j.jhazmat.2011.02.072; Tinkle SS, 2003, ENVIRON HEALTH PERSP, V111, P1202, DOI 10.1289/ehp.5999; Verwey E.J., 1948, THEORY STABILITY LYO; Wang HL, 2009, PHYS CHEM CHEM PHYS, V11, P2649, DOI 10.1039/b821849h; Wang X, 2010, ACS NANO, V4, P7241, DOI 10.1021/nn102112b; Wokovich A, 2009, DRUG DEV IND PHARM, V35, P1180, DOI 10.1080/03639040902838043; Wu JH, 2009, TOXICOL LETT, V191, P1, DOI 10.1016/j.toxlet.2009.05.020; Zhang Y, 2008, WATER RES, V42, P2204, DOI 10.1016/j.watres.2007.11.036; Zhou DX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037363	34	29	29	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48719	10.1371/journal.pone.0048719	http://dx.doi.org/10.1371/journal.pone.0048719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155401	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900035
J	Ekerljung, L; Lennartsson, J; Gedda, L				Ekerljung, Lina; Lennartsson, Johan; Gedda, Lars			The HER2-Binding Affibody Molecule (Z(HER2:342))(2) Increases Radiosensitivity in SKBR-3 Cells	PLOS ONE			English	Article							BREAST-CANCER; ERBB RECEPTORS; HER2; OVEREXPRESSION; RADIATION; AFFINITY; BINDING; TARGET	We have previously shown that the HER2-specific affibody molecule (Z(HER2:342))(2) inhibits proliferation of SKBR-3 cells. Here, we continue to investigate its biological effects in vitro by studying receptor dimerization and clonogenic survival following irradiation. We found that (Z(HER2:342))(2) sensitizes the HER2-overexpressing cell line SKBR-3 to ionizing radiation. The survival after exposure to (Z(HER2:342))(2) and 8 Gy (S-8Gy 0.006) was decreased by a factor four compared to the untreated (S-8Gy 0.023). The low HER2-expressing cell line MCF-7 was more radiosensitive than SKBR-3 but did not respond to (Z(HER2:342))(2).Treatment by (Z(HER2:342))(2) strongly increased the levels of dimerized and phosphorylated HER2 even after 5 minutes of stimulation. The monomeric Z(HER2:342) does not seem to be able to induce receptor phosphorylation and dimerization or sensitize cells to irradiation.	[Ekerljung, Lina; Gedda, Lars] Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Div Biomed Radiat Sci, Rudbeck Lab, Uppsala, Sweden	Uppsala University	Ekerljung, L (corresponding author), Uppsala Univ, Dept Radiol Oncol & Radiat Sci, Div Biomed Radiat Sci, Rudbeck Lab, Uppsala, Sweden.	Johan.Lennartsson@LICR.uu.se		Gedda, Lars/0000-0002-3746-6811				Aguilar Z, 1999, ONCOGENE, V18, P6050, DOI 10.1038/sj.onc.1202993; Baum RP, 2010, J NUCL MED, V51, P892, DOI 10.2967/jnumed.109.073239; Bjorke H, 2006, APPL RADIAT ISOTOPES, V64, P32, DOI 10.1016/j.apradiso.2005.06.007; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024739; Bonner JA, 2010, LANCET ONCOL, V11, P21, DOI 10.1016/S1470-2045(09)70311-0; Cao N, 2009, RADIAT RES, V171, P9, DOI 10.1667/RR1472.1; Chen JS, 2003, DRUG RESIST UPDATE, V6, P129, DOI 10.1016/S1368-7646(03)00040-2; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Eigenbrot C, 2010, P NATL ACAD SCI USA, V107, P15039, DOI 10.1073/pnas.1005025107; Ekerljung L, 2006, TUMOR BIOL, V27, P201, DOI 10.1159/000093023; Ekerljung L, 2008, BIOCHEM BIOPH RES CO, V377, P489, DOI 10.1016/j.bbrc.2008.10.027; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; HOLBRO T, 2004, ERBB RECEPTORS DIREC, V44, P195; Ignatoski KMW, 1999, ENDOCRINOLOGY, V140, P3615, DOI 10.1210/en.140.8.3615; JOHANSSON L, 1981, ACTA RADIOL ONCOL, V20, P51, DOI 10.3109/02841868109130189; LENNARTSSON J, 2006, DISCOVERY, V3, P357; Liang K, 2003, MOL CANCER THER, V2, P1113; Marmor MD, 2004, INT J RADIAT ONCOL, V58, P903, DOI 10.1016/j.ijrobp.2003.06.002; Meyn RE, 2009, RADIOTHER ONCOL, V92, P316, DOI 10.1016/j.radonc.2009.06.031; Nordberg E, 2010, INT J ONCOLOGY, V36; Nygren PA, 2008, FEBS J, V275, P2668, DOI 10.1111/j.1742-4658.2008.06438.x; Orlova A, 2006, CANCER RES, V66, P4339, DOI 10.1158/0008-5472.CAN-05-3521; Ross JS, 2003, ONCOLOGIST, V8, P307, DOI 10.1634/theoncologist.8-4-307; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Steffen AC, 2008, EUR J NUCL MED MOL I, V35, P1179, DOI 10.1007/s00259-007-0713-x; Yang S, 2007, J CELL SCI, V120, P2763, DOI 10.1242/jcs.007658	28	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49579	10.1371/journal.pone.0049579	http://dx.doi.org/10.1371/journal.pone.0049579			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166716	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900167
J	Hufford, MB; Martinez-Meyer, E; Gaut, BS; Eguiarte, LE; Tenaillon, MI				Hufford, Matthew B.; Martinez-Meyer, Enrique; Gaut, Brandon S.; Eguiarte, Luis E.; Tenaillon, Maud I.			Inferences from the Historical Distribution of Wild and Domesticated Maize Provide Ecological and Evolutionary Insight	PLOS ONE			English	Article							BALSAS RIVER VALLEY; ZEA-MAYS L.; POPULATION-STRUCTURE; CLIMATE-CHANGE; GENETIC DIVERSITY; TEOSINTE; RACES; HYBRIDIZATION; PLEISTOCENE; MAXIMUM	Background: The species Zea mays includes both domesticated maize (ssp. mays) and its closest wild relatives known as the teosintes. While genetic and archaeological studies have provided a well-established history of Z. mays evolution, there is currently minimal description of its current and past distribution. Here, we implemented species distribution modeling using paleoclimatic models of the last interglacial (LI; similar to 135,000 BP) and the last glacial maximum (LGM; similar to 21,000 BP) to hindcast the distribution of Zea mays subspecies over time and to revisit current knowledge of its phylogeography and evolutionary history. Methodology/Principal Findings: Using a large occurrence data set and the distribution modeling MaxEnt algorithm, we obtained robust present and past species distributions of the two widely distributed teosinte subspecies (ssps. parviglumis and mexicana) revealing almost perfect complementarity, stable through time, of their occupied distributions. We also investigated the present distributions of primitive maize landraces, which overlapped but were broader than those of the teosintes. Our data reinforced the idea that little historical gene flow has occurred between teosinte subspecies, but maize has served as a genetic bridge between them. We observed an expansion of teosinte habitat from the LI, consistent with population genetic data. Finally, we identified locations potentially serving as refugia for the teosintes throughout epochs of climate change and sites that should be targeted in future collections. Conclusion/Significance: The restricted and highly contrasting ecological niches of the wild teosintes differ substantially from domesticated maize. Variables determining the distributions of these taxa can inform future considerations of local adaptation and the impacts of climate change. Our assessment of the changing distributions of Zea mays taxa over time offers a unique glimpse into the history of maize, highlighting a strategy for the study of domestication that may prove useful for other species.	[Hufford, Matthew B.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Hufford, MB (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	tenaillon@moulon.inra.fr	Hufford, Matthew/E-7810-2012	Hufford, Matthew/0000-0003-3945-1143; Martinez-Meyer, Enrique/0000-0003-1184-9264; Tenaillon, Maud/0000-0002-0867-3678	NCI NIH HHS [CN-10-393, CB-2011-01 167826] Funding Source: Medline; PHS HHS [ANR-12-ADAP-002, IOS-0922703, IN224309-3] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Andersson M. S., 2010, GENE FLOW CROPS THEI; [Anonymous], 2004, K 1 COUPLED GCM MIRO; Baltazar BM, 2005, THEOR APPL GENET, V110, P519, DOI 10.1007/s00122-004-1859-6; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Buckler ES, 2006, MAYDICA, V51, P123; Bush MB, 2004, PALAEOGEOGR PALAEOCL, V214, P359, DOI 10.1016/j.palaeo.2004.07.031; Colinvaux PA, 1996, SCIENCE, V274, P85, DOI 10.1126/science.274.5284.85; Collins WD, 2006, J CLIMATE, V19, P2122, DOI 10.1175/JCLI3761.1; Correa-Metrio A, 2012, QUATERNARY SCI REV, V38, P63, DOI 10.1016/j.quascirev.2012.01.025; DOEBLEY JF, 1980, AM J BOT, V67, P982, DOI 10.2307/2442441; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Ellstrand NC, 2007, J HERED, V98, P183, DOI 10.1093/jhered/esm002; Evans MMS, 2001, THEOR APPL GENET, V103, P259, DOI 10.1007/s001220100549; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fukunaga K, 2005, GENETICS, V169, P2241, DOI 10.1534/genetics.104.031393; Grobman A, 2012, P NATL ACAD SCI USA, V109, P1755, DOI 10.1073/pnas.1120270109; Hanson MA, 1996, GENETICS, V143, P1395; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hodell DA, 2008, QUATERNARY SCI REV, V27, P1152, DOI 10.1016/j.quascirev.2008.02.008; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Lauter N, 2004, GENETICS, V167, P1949, DOI 10.1534/genetics.104.026997; LONG A, 1989, RADIOCARBON, V31, P1035; Mangelsdorf Paul C., 1974, CORN ITS ORIGIN EVOL; Martinez-Meyer E, 2006, J BIOGEOGR, V33, P1779, DOI [10.1111/j.1365-2699.2006.01612.x, 10.1111/j.1365-2699.2006.01482_33_10.x]; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; Metcalfe SE, 2006, ANN MO BOT GARD, V93, P258, DOI 10.3417/0026-6493(2006)93[258:LQEOTN]2.0.CO;2; Moeller DA, 2007, GENETICS, V176, P1799, DOI 10.1534/genetics.107.070631; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Bernal JP, 2011, QUATERNARY RES, V75, P104, DOI 10.1016/j.yqres.2010.09.002; Park J, 2010, QUATERNARY SCI REV, V29, P618, DOI 10.1016/j.quascirev.2009.10.017; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Piperno DR, 2007, P NATL ACAD SCI USA, V104, P11874, DOI 10.1073/pnas.0703442104; Piperno DR, 2009, P NATL ACAD SCI USA, V106, P5019, DOI 10.1073/pnas.0812525106; Piperno DR, 2001, P NATL ACAD SCI USA, V98, P2101, DOI 10.1073/pnas.98.4.2101; Pohl MED, 2007, P NATL ACAD SCI USA, V104, P6870, DOI 10.1073/pnas.0701425104; Ranere AJ, 2009, P NATL ACAD SCI USA, V106, P5014, DOI 10.1073/pnas.0812590106; Ross-Ibarra J, 2009, GENETICS, V181, P1397, DOI 10.1534/genetics.108.097238; Corral JAR, 2008, CROP SCI, V48, P1502, DOI 10.2135/cropsci2007.09.0518; Sanchez JJ, 2000, ECON BOT, V54, P43, DOI 10.1007/BF02866599; Sluyter A, 2006, P NATL ACAD SCI USA, V103, P1147, DOI 10.1073/pnas.0510473103; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Tenaillon MI, 2011, ESSENTIAL REV EXPT B, P89; Ureta C, 2012, GLOBAL CHANGE BIOL, V18, P1073, DOI 10.1111/j.1365-2486.2011.02607.x; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Vielle-Calzada Jean-Philippe, 2009, P543, DOI 10.1007/978-0-387-79418-1_27; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Wellhausen EJ, 1951, RAZAS MAIZ MEXICO OR; Wilkes H.G., 1967, TEOSINTE CLOSEST REL; Wright SI, 2005, SCIENCE, V308, P1310, DOI 10.1126/science.1107891	51	44	46	1	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e47659	10.1371/journal.pone.0047659	http://dx.doi.org/10.1371/journal.pone.0047659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	038CD	23155371	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900005
J	Nakano, RT; Matsushima, R; Nagano, AJ; Fukao, Y; Fujiwara, M; Kondo, M; Nishimura, M; Hara-Nishimura, I				Nakano, Ryohei Thomas; Matsushima, Ryo; Nagano, Atsushi J.; Fukao, Yoichiro; Fujiwara, Masayuki; Kondo, Maki; Nishimura, Mikio; Hara-Nishimura, Ikuko			ERMO3/MVP1/GOLD36 Is Involved in a Cell Type-Specific Mechanism for Maintaining ER Morphology in Arabidopsis thaliana	PLOS ONE			English	Article							CORTICAL ENDOPLASMIC-RETICULUM; BETA-GLUCOSIDASE; GOLGI-APPARATUS; PROTEIN TRAFFICKING; MEMBRANE-PROTEINS; MISSENSE MUTATION; STORAGE PROTEINS; PLANT-CELLS; BODY; ORGANIZATION	The endoplasmic reticulum (ER) has a unique, network-like morphology. The ER structures are composed of tubules, cisternae, and three-way junctions. This morphology is highly conserved among eukaryotes, but the molecular mechanism that maintains ER morphology has not yet been elucidated. In addition, certain Brassicaceae plants develop a unique ER-derived organelle called the ER body. This organelle accumulates large amounts of PYK10, a beta-glucosidase, but its physiological functions are still obscure. We aimed to identify a novel factor required for maintaining the morphology of the ER, including ER bodies, and employed a forward-genetic approach using transgenic Arabidopsis thaliana (GFP-h) with fluorescently-labeled ER. We isolated and investigated a mutant (designated endoplasmic reticulum morphology3, ermo3) with huge aggregates and abnormal punctate structures of ER. ERMO3 encodes a GDSL-lipase/esterase family protein, also known as MVP1. Here, we showed that, although ERMO3/MVP1/GOLD36 was expressed ubiquitously, the morphological defects of ermo3 were specifically seen in a certain type of cells where ER bodies developed. Coimmunoprecipitation analysis combined with mass spectrometry revealed that ERMO3/MVP1/GOLD36 interacts with the PYK10 complex, a huge protein complex that is thought to be important for ER body-related defense systems. We also found that the depletion of transcription factor NAI1, a master regulator for ER body formation, suppressed the formation of ER-aggregates in ermo3 cells, suggesting that NAI1 expression plays an important role in the abnormal aggregation of ER. Our results suggest that ERMO3/MVP1/GOLD36 is required for preventing ER and other organelles from abnormal aggregation and for maintaining proper ER morphology in a coordinated manner with NAI1.	[Nakano, Ryohei Thomas; Matsushima, Ryo; Nagano, Atsushi J.; Hara-Nishimura, Ikuko] Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto, Japan; [Fukao, Yoichiro; Fujiwara, Masayuki] Nara Inst Sci & Technology, Grad Sch Biol Sci, Ikoma, Japan; [Kondo, Maki; Nishimura, Mikio] Natl Inst Basic Biol, Dept Cell Biol, Okazaki, Japan	Kyoto University; Nara Institute of Science & Technology; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB)	Nakano, RT (corresponding author), Kyoto Univ, Grad Sch Sci, Dept Bot, Kyoto, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp	Nagano, Atsushi J./A-2957-2019; Nakano, Ryohei Thomas/K-1509-2015; Fukao, Yoichiro/E-7137-2013	Nagano, Atsushi J./0000-0001-7891-5049; Nakano, Ryohei Thomas/0000-0001-5973-2300; Nishimura, Mikio/0000-0001-7960-9721	Grants-in-Aid for Scientific Research [22000014] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Agee AE, 2010, PLANT PHYSIOL, V152, P120, DOI 10.1104/pp.109.145078; Ahn YO, 2010, PLANT CELL PHYSIOL, V51, P132, DOI 10.1093/pcp/pcp174; Avisar D, 2008, PLANT PHYSIOL, V146, P1098, DOI 10.1104/pp.107.113647; Chen J, 2011, J CELL SCI, V124, P2241, DOI 10.1242/jcs.084624; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; Faso C, 2009, PLANT CELL, V21, P3655, DOI 10.1105/tpc.109.068262; Gomord V, 1997, PLANT J, V11, P313, DOI 10.1046/j.1365-313X.1997.11020313.x; Hara-Nishimura I, 2003, CURR OPIN PLANT BIOL, V6, P583, DOI 10.1016/j.pbi.2003.09.015; Hatano K, 1997, PLANT CELL PHYSIOL, V38, P344, DOI 10.1093/oxfordjournals.pcp.a029172; Hayashi Y, 2001, PLANT CELL PHYSIOL, V42, P894, DOI 10.1093/pcp/pce144; Hu JJ, 2008, SCIENCE, V319, P1247, DOI 10.1126/science.1153634; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S; Marti L, 2010, PLANT J, V63, P901, DOI 10.1111/j.1365-313X.2010.04296.x; Matsushima R, 2004, PLANT CELL, V16, P1536, DOI 10.1105/tpc.021154; Matsushima R, 2003, PLANT J, V33, P493, DOI 10.1046/j.1365-313X.2003.01636.x; Matsushima R, 2002, PLANT PHYSIOL, V130, P1807, DOI 10.1104/pp.009464; Nagano AJ, 2005, PLANT CELL PHYSIOL, V46, P1140, DOI 10.1093/pcp/pci126; Nagano AJ, 2008, PLANT CELL PHYSIOL, V49, P969, DOI 10.1093/pcp/pcn075; Nakano RT, 2009, PLANT CELL, V21, P3672, DOI 10.1105/tpc.109.068270; NAPIER RM, 1992, J CELL SCI, V102, P261; Nziengui H, 2009, CELL MOL LIFE SCI, V66, P584, DOI 10.1007/s00018-008-8373-y; Nziengui H, 2007, FEBS LETT, V581, P3356, DOI 10.1016/j.febslet.2007.06.032; Ogasawara K, 2009, PLANT CELL PHYSIOL, V50, P480, DOI 10.1093/pcp/pcp007; Park SH, 2010, EMBO REP, V11, P515, DOI 10.1038/embor.2010.92; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Shibata Y, 2008, J BIOL CHEM, V283, P18892, DOI 10.1074/jbc.M800986200; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Shimada T, 2003, J BIOL CHEM, V278, P32292, DOI 10.1074/jbc.M305740200; Sparkes I, 2009, PLANT CELL, V21, P3937, DOI 10.1105/tpc.109.072249; Sparkes I, 2010, PLANT CELL, V22, P1333, DOI 10.1105/tpc.110.074385; Stefano G, 2012, PLANT J, V69, P957, DOI 10.1111/j.1365-313X.2011.04846.x; Sugano SS, 2010, NATURE, V463, P241, DOI 10.1038/nature08682; Tamura K, 2005, PLANT CELL, V17, P1764, DOI 10.1105/tpc.105.031930; Tamura K, 2007, PLANT CELL, V19, P320, DOI 10.1105/tpc.106.046631; Tolley N, 2008, TRAFFIC, V9, P94, DOI 10.1111/j.1600-0854.2007.00670.x; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Yamada K, 2008, PLANT CELL, V20, P2529, DOI 10.1105/tpc.108.059345; Zhang ZY, 2006, PLANT CELL, V18, P1524, DOI 10.1105/tpc.105.039602	43	15	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49103	10.1371/journal.pone.0049103	http://dx.doi.org/10.1371/journal.pone.0049103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155454	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900089
J	Semenov, A; Moykkynen, T; Coleman, SK; Korpi, ER; Keinanen, K				Semenov, Artur; Moykkynen, Tommi; Coleman, Sarah K.; Korpi, Esa R.; Keinanen, Kari			Autoinactivation of the Stargazin-AMPA Receptor Complex: Subunit-Dependency and Independence from Physical Dissociation	PLOS ONE			English	Article							IONOTROPIC GLUTAMATE RECEPTORS; 2 DISTINCT MECHANISMS; AUXILIARY SUBUNITS; REGULATORY PROTEINS; TRAFFICKING; TARP; FAMILY; ISOFORM; DOMAINS; ACID	Agonist responses and channel kinetics of native alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors are modulated by transmembrane accessory proteins. Stargazin, the prototypical accessory protein, decreases desensitization and increases agonist potency at AMPA receptors. Furthermore, in the presence of stargazin, the steady-state responses of AMPA receptors show a gradual decline at higher glutamate concentrations. This "autoinactivation" has been assigned to physical dissociation of the stargazin-AMPA receptor complex and suggested to serve as a protective mechanism against overactivation. Here, we analyzed autoinactivation of GluA1-A4 AMPA receptors (all flip isoform) expressed in the presence of stargazin. Homomeric GluA1, GluA3, and GluA4 channels showed pronounced autoinactivation indicated by the bell-shaped steady-state dose response curves for glutamate. In contrast, homomeric GluA2i channels did not show significant autoinactivation. The resistance of GluA2 to autoinactivation showed striking dependence on the splice form as GluA2-flop receptors displayed clear autoinactivation. Interestingly, the resistance of GluA2-flip containing receptors to autoinactivation was transferred onto heteromeric receptors in a dominant fashion. To examine the relationship of autoinactivation to physical separation of stargazin from the AMPA receptor, we analyzed a GluA4-stargazin fusion protein. Notably, the covalently linked complex and separately expressed proteins expressed a similar level of autoinactivation. We conclude that autoinactivation is a subunit and splice form dependent property of AMPA receptor-stargazin complexes, which involves structural rearrangements within the complex rather than any physical dissociation.	[Semenov, Artur; Moykkynen, Tommi; Coleman, Sarah K.; Keinanen, Kari] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, Helsinki, Finland	University of Helsinki	Semenov, A (corresponding author), Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, Helsinki, Finland.	kari.keinanen@helsinki.fi		Coleman, Sarah/0000-0002-1066-8296; Korpi, Esa R./0000-0003-0683-4009				Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Bedoukian MA, 2006, J BIOL CHEM, V281, P23908, DOI 10.1074/jbc.M600679200; Chen L, 2000, NATURE, V408, P936, DOI 10.1038/35050030; Cokic B, 2008, NEUROPHARMACOLOGY, V54, P1062, DOI 10.1016/j.neuropharm.2008.02.012; Coleman SK, 2006, J NEUROSCI, V26, P11220, DOI 10.1523/JNEUROSCI.2301-06.2006; Coleman SK, 2010, J BIOL CHEM, V285, P36032, DOI 10.1074/jbc.M110.156943; Greger IH, 2003, NEURON, V40, P763, DOI 10.1016/S0896-6273(03)00668-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Jackson AC, 2011, NEURON, V70, P178, DOI 10.1016/j.neuron.2011.04.007; Jespersen T, 2002, BIOTECHNIQUES, V32, P536, DOI 10.2144/02323st05; Kato AS, 2008, NEURON, V59, P986, DOI 10.1016/j.neuron.2008.07.034; Kato AS, 2007, J NEUROSCI, V27, P4969, DOI 10.1523/JNEUROSCI.5561-06.2007; Kato AS, 2010, TRENDS NEUROSCI, V33, P241, DOI 10.1016/j.tins.2010.02.004; Korber C, 2007, J BIOL CHEM, V282, P18758, DOI 10.1074/jbc.M611182200; Kott S, 2007, J NEUROSCI, V27, P3780, DOI 10.1523/JNEUROSCI.4185-06.2007; Liu X. Shawn, 2006, V322, P31; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Morimoto-Tomita M, 2009, NEURON, V61, P101, DOI 10.1016/j.neuron.2008.11.009; Nakagawa T, 2005, NATURE, V433, P545, DOI 10.1038/nature03328; Pasternack A, 2002, J BIOL CHEM, V277, P49662, DOI 10.1074/jbc.M208349200; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Sager C, 2009, J BIOL CHEM, V284, P32413, DOI 10.1074/jbc.M109.039891; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Soto D, 2007, NAT NEUROSCI, V10, P1260, DOI 10.1038/nn1966; Soto D, 2009, NAT NEUROSCI, V12, P277, DOI 10.1038/nn.2266; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2004, SCIENCE, V303, P1508, DOI 10.1126/science.1090262; Tomita S, 2007, P NATL ACAD SCI USA, V104, P18784, DOI 10.1073/pnas.0708970104; Tomita S, 2007, NEUROPHARMACOLOGY, V52, P87, DOI 10.1016/j.neuropharm.2006.07.012; Tomita S, 2006, P NATL ACAD SCI USA, V103, P10064, DOI 10.1073/pnas.0603128103; Tomita S, 2010, PHYSIOLOGY, V25, P41, DOI 10.1152/physiol.00033.2009; Turetsky D, 2005, J NEUROSCI, V25, P7438, DOI 10.1523/JNEUROSCI.1108-05.2005; Vandenberghe W, 2005, P NATL ACAD SCI USA, V102, P485, DOI 10.1073/pnas.0408269102; Yamazaki M, 2004, NEUROSCI RES, V50, P369, DOI 10.1016/j.neures.2004.10.002; Yan D, 2012, J PHYSIOL-LONDON, V590, P21, DOI 10.1113/jphysiol.2011.213868	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49282	10.1371/journal.pone.0049282	http://dx.doi.org/10.1371/journal.pone.0049282			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166629	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900116
J	Unger, WWJ; Pearson, T; Abreu, JRF; Laban, S; van der Slik, AR; Mulder-van der Kracht, S; Kester, MGD; Serreze, DV; Shultz, LD; Griffioen, M; Drijfhout, JW; Greiner, DL; Roep, BO				Unger, Wendy W. J.; Pearson, Todd; Abreu, Joana R. F.; Laban, Sandra; van der Slik, Arno R.; Mulder-van der Kracht, Sacha; Kester, Michel G. D.; Serreze, Dave V.; Shultz, Leonard D.; Griffioen, Marieke; Drijfhout, Jan Wouter; Greiner, Dale L.; Roep, Bart O.			Islet-Specific CTL Cloned from a Type 1 Diabetes Patient Cause Beta-Cell Destruction after Engraftment into HLAA2 Transgenic NOD/SCID/IL2RG Null Mice	PLOS ONE			English	Article							CD8(+) T-CELLS; SCID IL2R-GAMMA(NULL) MICE; MHC CLASS-I; NOD MICE; ALPHA-3 DOMAIN; RECENT-ONSET; MOUSE MODEL; RESPONSES; RECEPTOR; IDENTIFICATION	Despite increasing evidence that autoreactive CD8 T-cells are involved in both the initiation of type 1 diabetes (T1D) and the destruction of beta-cells, direct evidence for their destructive role in-vivo is lacking. To address a destructive role for autoreactive CD8 T-cells in human disease, we assessed the pathogenicity of a CD8 T-cell clone derived from a T1D donor and specific for an HLA-A2-restricted epitope of islet-specific glucose-6-phosphatase catalytic-subunit related protein (IGRP). HLA-A2/IGRP tetramer staining revealed a higher frequency of IGRP-specific CD8 T-cells in the peripheral blood of recent onset human individuals than of healthy donors. IGRP(265-273)-specific CD8 T-cells that were cloned from the peripheral blood of a recent onset T1D individual were shown to secrete IFN gamma and Granzyme B after antigen-specific activation and lyse HLAA2- expressing murine islets in-vitro. Lytic capacity was also demonstrated in-vivo by specific killing of peptide-pulsed target cells. Using the HLA-A2 NOD-scid IL2r gamma(null) mouse model, HLA-A2-restricted IGRP-specific CD8 T-cells induced a destructive insulitis. Together, this is the first evidence that human HLA-restricted autoreactive CD8 T-cells target HLA-expressing betacells in-vivo, demonstrating the translational value of humanized mice to study mechanisms of disease and therapeutic intervention strategies.			Unger, WWJ (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	boroep@lumc.nl	Griffioen, Marieke/ABA-1561-2021; Roep, Bart/AAD-7609-2021; Drijfhout, Jan Wouter/ABA-6318-2021	Griffioen, Marieke/0000-0002-3001-4441; Drijfhout, Jan Wouter/0000-0003-4808-5296; van der Slik, Arno/0000-0002-8920-0118; Laban, Sandra/0000-0003-2710-4531	NIAID NIH HHS [AI46629, P01 AI046629] Funding Source: Medline; NIDDK NIH HHS [P30 DK032520, DK32520, R01 DK095735, R01 DK046266] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI046629] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095735, R01DK046266, P30DK032520] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; ATKINSON MA, 1994, NEW ENGL J MED, V331, P1428; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; FENNESSY M, 1994, DIABETOLOGIA, V37, P937, DOI 10.1007/s001250050200; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Halteren AGS, 2005, DIABETOLOGIA, V48, P75, DOI 10.1007/s00125-004-1613-2; Hamilton-Williams EE, 2003, P NATL ACAD SCI USA, V100, P6688, DOI 10.1073/pnas.1131954100; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; In't Veld P, 2007, DIABETES, V56, P2400, DOI 10.2337/db07-0416; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jaiswal S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007251; Jarchum I, 2008, CLIN IMMUNOL, V127, P359, DOI 10.1016/j.clim.2008.01.015; Jarchum I, 2007, DIABETES, V56, P2551, DOI 10.2337/db07-0332; KANTWERK G, 1987, CLIN EXP IMMUNOL, V70, P585; King M, 2008, CLIN IMMUNOL, V126, P303, DOI 10.1016/j.clim.2007.11.001; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Laugel B, 2007, J BIOL CHEM, V282, P23799, DOI 10.1074/jbc.M700976200; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Levisetti MG, 2008, DIABETES, V57, P1852, DOI 10.2337/db08-0068; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Mallone R, 2007, DIABETES, V56, P613, DOI 10.2337/db06-1419; Marron MP, 2002, P NATL ACAD SCI USA, V99, P13753, DOI 10.1073/pnas.212221199; MURRAY AG, 1994, P NATL ACAD SCI USA, V91, P9146, DOI 10.1073/pnas.91.19.9146; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Niens M, 2011, DIABETES, V60, P1229, DOI 10.2337/db10-1523; Pinkse GGM, 2005, P NATL ACAD SCI USA, V102, P18425, DOI 10.1073/pnas.0508621102; Pittet MJ, 2003, J IMMUNOL, V171, P1844, DOI 10.4049/jimmunol.171.4.1844; Rhode A, 2005, J IMMUNOL, V175, P3516, DOI 10.4049/jimmunol.175.6.3516; Roep BO, 2010, CLIN EXP IMMUNOL, V159, P338, DOI 10.1111/j.1365-2249.2009.04087.x; Roep BO, 2004, NAT REV IMMUNOL, V4, P989, DOI 10.1038/nri1502; SALTER RD, 1990, NATURE, V345, P41, DOI 10.1038/345041a0; SANTAMARIA P, 1995, J IMMUNOL, V154, P2494; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; SERREZE DV, 1994, DIABETES, V43, P505, DOI 10.2337/diabetes.43.3.505; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; Strowig T, 2009, J EXP MED, V206, P1423, DOI 10.1084/jem.20081720; Takaki T, 2006, J IMMUNOL, V176, P3257, DOI 10.4049/jimmunol.176.5.3257; Unger WWJ, 2007, ANN NY ACAD SCI, V1103, P192, DOI 10.1196/annals.1394.024; van Halteren AGS, 2002, J AUTOIMMUN, V18, P139, DOI 10.1006/jaut.2001.0578; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Velthuis JH, 2009, DIABETOLOGIA, V52, P494, DOI 10.1007/s00125-008-1237-z; Whitfield-Larry F, 2011, DIABETES, V60, P1726, DOI 10.2337/db10-1287; WICKER LS, 1994, DIABETES, V43, P500, DOI 10.2337/diabetes.43.3.500; Wong FS, 1996, J EXP MED, V183, P67, DOI 10.1084/jem.183.1.67; Yamanouchi J, 2003, J IMMUNOL, V171, P6900, DOI 10.4049/jimmunol.171.12.6900	52	49	49	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49213	10.1371/journal.pone.0049213	http://dx.doi.org/10.1371/journal.pone.0049213			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155466	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900101
J	Liu, W; Fan, LX; Zhou, X; Sweeney, WE; Avner, ED; Li, XG				Liu, Wei; Fan, Lucy X.; Zhou, Xia; Sweeney, William E., Jr.; Avner, Ellis D.; Li, Xiaogang			HDAC6 Regulates Epidermal Growth Factor Receptor (EGFR) Endocytic Trafficking and Degradation in Renal Epithelial Cells	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; CYST FORMATION; INHIBITION; EXPRESSION; PATHOPHYSIOLOGY; PROLIFERATION; STIMULATION; ACETYLATION; DEACETYLASE; PHYSIOLOGY	We present for the first time that histone deacetylase 6 (HDAC6) regulates EGFR degradation and trafficking along microtubules in Pkd1 mutant renal epithelial cells. HDAC6, the microtubule-associated a-tubulin deacetylase, demonstrates increased expression and activity in Pkd1 mutant mouse embryonic kidney cells. Targeting HDAC6 with a general HDAC inhibitor, trichostatin (TSA), or a specific HDAC6 inhibitor, tubacin, increased the acetylation of alpha-tubulin and downregulated the expression of EGFR in Pkd1 mutant renal epithelial cells. HDAC6 was co-localized with EGF induced endocytic EGFR and endosomes, respectively. Inhibition of the activity of HDAC6 accelerated the trafficking of EGFR from early endosomes to late endosomes along the microtubules. Without EGF stimulation EGFR was randomly distributed while after stimulation with EGF for 30 min, EGFR was accumulated around alpha-tubulin labeled microtubule bundles. These data suggested that the Pkd1 mutation induced upregulation of HDAC6 might act to slow the trafficking of EGFR from early endosomes to late endosomes along the microtubules for degradation through deacetylating alpha-tubulin. In addition, inhibition of HDAC activity decreased the phosphorylation of ERK1/2, the downstream target of EGFR axis, and normalized EGFR localization from apical to basolateral in Pkd1 knockout mouse kidneys. Thus, targeting HDAC6 to downregulate EGFR activity may provide a potential therapeutic approach to treat polycystic kidney disease.	[Liu, Wei; Fan, Lucy X.; Zhou, Xia; Sweeney, William E., Jr.; Avner, Ellis D.; Li, Xiaogang] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Avner, Ellis D.; Li, Xiaogang] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Liu, Wei; Fan, Lucy X.; Zhou, Xia; Sweeney, William E., Jr.; Avner, Ellis D.; Li, Xiaogang] Childrens Hosp Wisconsin, Childrens Res Inst, Milwaukee, WI 53201 USA; [Liu, Wei] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Nephrol, Wuhan 430074, Peoples R China	Medical College of Wisconsin; Medical College of Wisconsin; Children's Hospital of Wisconsin; Huazhong University of Science & Technology	Li, XG (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	xxli@mcw.edu			Polycystic Kidney Disease Research and Education Foundation; Children's Research Institute; National Institutes of Health [R01DK084097, P50DK079306]; George M O'Brien Kidney Center at Yale University, NIH [P30 DK079310]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK079306, R01DK084097, P30DK079310] Funding Source: NIH RePORTER	Polycystic Kidney Disease Research and Education Foundation; Children's Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); George M O'Brien Kidney Center at Yale University, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	X. Li acknowledgments support from the Polycystic Kidney Disease Research and Education Foundation grant, Children's Research Institute grant and National Institutes of Health grant R01DK084097. E.D. Avner acknowledgments support from National Institutes of Health grant P50DK079306 (RCEPN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for cell lines PH2 and PN24 provided by Dr. S. Somlo through the George M O'Brien Kidney Center at Yale University, NIH grant P30 DK079310.	Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; DU J, 1995, AM J PHYSIOL-CELL PH, V269, pC487, DOI 10.1152/ajpcell.1995.269.2.C487; Fan LX, 2012, KIDNEY INT, V81, P76, DOI 10.1038/ki.2011.296; Gao YS, 2007, MOL CELL BIOL, V27, P8637, DOI 10.1128/MCB.00393-07; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Kamemura K, 2008, BIOCHEM BIOPH RES CO, V374, P84, DOI 10.1016/j.bbrc.2008.06.092; Lantinga-van Leeuwen IS, 2004, HUM MOL GENET, V13, P3069, DOI 10.1093/hmg/ddh336; Li XG, 2008, NAT MED, V14, P863, DOI 10.1038/nm1783; Li XG, 2011, BBA-MOL BASIS DIS, V1812, P1213, DOI 10.1016/j.bbadis.2010.10.008; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Melenhorst WBWH, 2008, HYPERTENSION, V52, P987, DOI 10.1161/HYPERTENSIONAHA.108.113860; NAUTA J, 1995, PEDIATR RES, V37, P755, DOI 10.1203/00006450-199506000-00014; ORELLANA SA, 1995, KIDNEY INT, V47, P490, DOI 10.1038/ki.1995.62; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Richards WG, 1998, J CLIN INVEST, V101, P935, DOI 10.1172/JCI2071; Shibazaki S, 2008, HUM MOL GENET, V17, P1505, DOI 10.1093/hmg/ddn039; Sweeney WE, 1998, AM J PHYSIOL-RENAL, V275, pF387, DOI 10.1152/ajprenal.1998.275.3.F387; Sweeney WE, 2000, KIDNEY INT, V57, P33, DOI 10.1046/j.1523-1755.2000.00829.x; Sweeney WE, 2006, CELL TISSUE RES, V326, P671, DOI 10.1007/s00441-006-0226-0; Torres VE, 2003, KIDNEY INT, V64, P1573, DOI 10.1046/j.1523-1755.2003.00256.x; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; Wang ZX, 1999, MOL BIOL CELL, V10, P1621, DOI 10.1091/mbc.10.5.1621; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Xia S, 2010, DEVELOPMENT, V137, P1075, DOI 10.1242/dev.049437; Zeng FH, 2009, EXP CELL RES, V315, P602, DOI 10.1016/j.yexcr.2008.08.005	28	51	53	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49418	10.1371/journal.pone.0049418	http://dx.doi.org/10.1371/journal.pone.0049418			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152903	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600036
J	Chhetri, RK; Phillips, ZF; Troester, MA; Oldenburg, AL				Chhetri, Raghav K.; Phillips, Zachary F.; Troester, Melissa A.; Oldenburg, Amy L.			Longitudinal Study of Mammary Epithelial and Fibroblast Co-Cultures Using Optical Coherence Tomography Reveals Morphological Hallmarks of Pre-Malignancy	PLOS ONE			English	Article							CARCINOMA IN-SITU; CANCER CELL-LINES; BREAST-CANCER; TISSUE; MODEL; ARCHITECTURE; CULTURES; VITRO; VIVO; MICROENVIRONMENT	The human mammary gland is a complex and heterogeneous organ, where the interactions between mammary epithelial cells (MEC) and stromal fibroblasts are known to regulate normal biology and tumorigenesis. We aimed to longitudinally evaluate morphology and size of organoids in 3D co-cultures of normal (MCF10A) or pre-malignant (MCF10DCIS.com) MEC and hTERT-immortalized fibroblasts from reduction mammoplasty (RMF). This co-culture model, based on an isogenic panel of cell lines, can yield insights to understand breast cancer progression. However, 3D cultures pose challenges for quantitative assessment and imaging, especially when the goal is to measure the same organoid structures over time. Using optical coherence tomography (OCT) as a non-invasive method to longitudinally quantify morphological changes, we found that OCT provides excellent visualization of MEC-fibroblast co-cultures as they form ductal acini and remodel over time. Different concentrations of fibroblasts and MEC reflecting reported physiological ratios [1] were evaluated, and we found that larger, hollower, and more aspherical acini were formed only by pre-malignant MEC (MCF10DCIS.com) in the presence of fibroblasts, whereas in comparable conditions, normal MEC (MCF10A) acini remained smaller and less aspherical. The ratio of fibroblast to MEC was also influential in determining organoid phenotypes, with higher concentrations of fibroblasts producing more aspherical structures in MCF10DCIS.com. These findings suggest that stromal-epithelial interactions between fibroblasts and MEC can be modeled in vitro, with OCT imaging as a convenient means of assaying time dependent changes, with the potential for yielding important biological insights about the differences between benign and pre-malignant cells.	[Chhetri, Raghav K.; Oldenburg, Amy L.] Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA; [Phillips, Zachary F.] Univ N Carolina, Curriculum Appl Sci & Engn, Chapel Hill, NC USA; [Troester, Melissa A.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Oldenburg, Amy L.] Univ N Carolina, Biomed Res Imaging Ctr, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Oldenburg, AL (corresponding author), Univ N Carolina, Dept Phys & Astron, Chapel Hill, NC 27599 USA.	aold@physics.unc.edu	Oldenburg, Amy/H-2635-2013	Chhetri, Raghav/0000-0001-6039-4505	Carolina Cancer Center for Nanotechnology Excellence (C-CCNE NIH (National Cancer Institute) [U54CA119343]; UNC-Chapel Hill; National Cancer Institute; National Institute of Environmental Health Sciences [U01019472, R01-CA138255]; NATIONAL CANCER INSTITUTE [R01CA138255, U54CA119343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	Carolina Cancer Center for Nanotechnology Excellence (C-CCNE NIH (National Cancer Institute); UNC-Chapel Hill; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by a grant from the Carolina Cancer Center for Nanotechnology Excellence (C-CCNE NIH (National Cancer Institute) #U54CA119343) and by startup funds at UNC-Chapel Hill. M.A.T. lab was supported in the development of the co-culture model system by grants from National Cancer Institute and National Institute of Environmental Health Sciences (U01019472 and R01-CA138255). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backman V, 2011, GASTROENTEROLOGY, V140, P35, DOI 10.1053/j.gastro.2010.11.023; Baish JW, 2000, CANCER RES, V60, P3683; Bissell MJ, 2001, NAT REV CANCER, V1, P46, DOI 10.1038/35094059; Boppart SA, 2004, BREAST CANCER RES TR, V84, P85, DOI 10.1023/B:BREA.0000018401.13609.54; Boppart SA, 1998, RADIOLOGY, V208, P81, DOI 10.1148/radiology.208.1.9646796; Boppart SA, 1998, NAT MED, V4, P861, DOI 10.1038/nm0798-861; BOURHIS XFDL, 1997, J INT CANC, V71, P42; Brezinski ME, 1996, AM J CARDIOL, V77, P92, DOI 10.1016/S0002-9149(97)89143-6; Camp JT, 2011, MOL CANCER RES, V9, P3, DOI 10.1158/1541-7786.MCR-10-0372; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fujimoto JG, 2009, OPT EXPRESS, V17, P3978, DOI 10.1364/OE.17.003978; Gefen Amit, 2007, Technol Health Care, V15, P259; Jedeszko C, 2009, CANCER RES, V69, P9148, DOI 10.1158/0008-5472.CAN-09-1043; Johnson KR, 2007, METHOD CELL BIOL, V83, P547, DOI 10.1016/S0091-679X(07)83023-8; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Krause S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-263; Latrive A, 2011, BIOMED OPT EXPRESS, V2, P2897, DOI 10.1364/BOE.2.002897; Maller O, 2010, J MAMMARY GLAND BIOL, V15, P301, DOI 10.1007/s10911-010-9189-6; McLaughlin RA, 2010, CANCER RES, V70, P2579, DOI 10.1158/0008-5472.CAN-09-4062; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Nelson CM, 2006, ANNU REV CELL DEV BI, V22, P287, DOI 10.1146/annurev.cellbio.22.010305.104315; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nguyen FT, 2009, CANCER RES, V69, P8790, DOI 10.1158/0008-5472.CAN-08-4340; Oldenburg AL, 2010, BIOPHYS J, V99, P2374, DOI 10.1016/j.bpj.2010.08.007; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; PETERSEN OW, 1992, P NATL ACAD SCI USA, V89, P9064, DOI 10.1073/pnas.89.19.9064; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Sadlonova A, 2005, BREAST CANCER RES, V7, pR46, DOI 10.1186/bcr949; Shekhar MPV, 2008, CANCER BIOL THER, V7, P1774, DOI 10.4161/cbt.7.11.6781; SOULE HD, 1990, CANCER RES, V50, P6075; Sullivan AC, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3590746; Tambasco M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-140; Tan W, 2006, OPT EXPRESS, V14, P7159, DOI 10.1364/OE.14.007159; Tang J, 2011, INTEGR BIOL-UK, V3, P408, DOI 10.1039/c0ib00092b; Tearney GJ, 1997, SCIENCE, V276, P2037, DOI 10.1126/science.276.5321.2037; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Yu M, 2007, AM J SURG, V194, P594, DOI 10.1016/j.amjsurg.2007.08.007; Zysk AM, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2358964; Zysk AM, 2009, TECHNOL CANCER RES T, V8, P315, DOI 10.1177/153303460900800501	44	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49148	10.1371/journal.pone.0049148	http://dx.doi.org/10.1371/journal.pone.0049148			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152864	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234000052
J	Finke, M; Escera, C; Barcelo, F				Finke, Mareike; Escera, Carles; Barcelo, Francisco			The Effects of Foreknowledge and Task-Set Shifting as Mirrored in Cue- and Target-Locked Event-Related Potentials	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; SWITCH-COSTS; COMPUTATIONAL MODEL; CONTROL MECHANISMS; EXECUTIVE CONTROL; ERP; PARADIGM; P300; IMPLEMENTATION	The present study examined the use of foreknowledge in a task-cueing protocol while manipulating sensory updating and executive control in both, informatively and non-informatively pre-cued trials. Foreknowledge, sensory updating (cue switch effects) and task-switching were orthogonally manipulated in order to address the question of whether, and to which extent, the sensory processing of cue changes can partly or totally explain the final task switch costs. Participants responded faster when they could prepare for the upcoming task and if no task-set updating was necessary. Sensory cue switches influenced cue-locked ERPs only when they contained conceptual information about the upcoming task: frontal P2 amplitudes were modulated by task-relevant cue changes, mid-parietal P3 amplitudes by the anticipatory updating of stimulus-response mappings, and P3 peak latencies were modulated by task switching. Task preparation was advantageous for efficient stimulus-response re-mapping at target-onset as mirrored in target N2 amplitudes. However, N2 peak latencies indicate that this process is faster for all repeat trials. The results provide evidence to support a very fast detection of task-relevance in sensory (cue) changes and argue against the view of task repetition benefits as secondary to purely perceptual repetition priming. Advanced preparation may have a stronger influence on behavioral performance and target-locked brain activity than the local effect of repeating or switching the task-set in the current trial.	[Finke, Mareike; Escera, Carles; Barcelo, Francisco] Univ Barcelona, Cognit Neurosci Res Grp, Dept Psychiat & Clin Psychobiol, Barcelona, Spain; [Finke, Mareike; Escera, Carles; Barcelo, Francisco] Univ Barcelona, Inst Brain Cognit & Behav IR3C, Barcelona, Spain; [Barcelo, Francisco] Univ Balearic Isl, Dept Psychol, Lab Clin Neuropsychol, Palma De Mallorca, Spain	University of Barcelona; University of Barcelona; Universitat de les Illes Balears	Barcelo, F (corresponding author), Univ Barcelona, Cognit Neurosci Res Grp, Dept Psychiat & Clin Psychobiol, Barcelona, Spain.	f.barcelo@uib.es	Barceló, Francisco/B-3629-2011; Escera, Carles/A-8658-2010; 2010, BRAINGLOT Consolider Ingenio/D-1235-2009	Barceló, Francisco/0000-0001-6012-7116; Escera, Carles/0000-0001-8203-2951; 	Spanish Ministry of Science and Innovation [PSI2010-17419, CSD2007-00012, PSI2008-05803-C02-02]; Catalan Government [2009SGR-11, FI MF052362]; Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Distinguished Professorship	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Government; Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Distinguished Professorship(ICREA)	This work was supported by grants from the Spanish Ministry of Science and Innovation (PSI2010-17419, Consolider-Ingenio 2010 CSD2007-00012, PSI2008-05803-C02-02), by the 2009SGR-11 and FI MF052362 grant from the Catalan Government and the Institucio Catalana de Recerca i Estudis Avancats (ICREA) Academia Distinguished Professorship awarded to C.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrover-Roig D, 2010, CORTEX, V46, P434, DOI 10.1016/j.cortex.2009.09.012; Barcelo F, 2003, BRAIN RES PROTOC, V11, P27, DOI 10.1016/S1385-299X(03)00013-8; Barcelo F, 2006, J COGNITIVE NEUROSCI, V18, P1734, DOI 10.1162/jocn.2006.18.10.1734; Barcelo F, 2008, FRONT HUM NEUROSCI, V1, DOI 10.3389/neuro.09.013.2007; Belouchrani A, 1997, IEEE T SIGNAL PROCES, V45, P434, DOI 10.1109/78.554307; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Braver TS, 2003, NEURON, V39, P713, DOI 10.1016/S0896-6273(03)00466-5; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Brown JW, 2007, COGNITIVE PSYCHOL, V55, P37, DOI 10.1016/j.cogpsych.2006.09.005; Carter CS, 2007, COGN AFFECT BEHAV NE, V7, P367, DOI 10.3758/CABN.7.4.367; Donchin E, 1998, BEHAV BRAIN SCI, V21, P152, DOI 10.1017/S0140525X98230950; Finke M, 2011, BIOL PSYCHOL, V87, P358, DOI 10.1016/j.biopsycho.2011.04.006; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gajewski PD, 2008, BRAIN RES, V1189, P127, DOI 10.1016/j.brainres.2007.10.076; Gajewski PD, 2010, CORTEX, V46, P1138, DOI 10.1016/j.cortex.2009.07.014; Garcia-Garcia M, 2010, EUR J NEUROSCI, V31, P754, DOI 10.1111/j.1460-9568.2010.07102.x; Hackley SA, 1998, NATURE, V391, P786, DOI 10.1038/35849; Hsieh SL, 2011, BRAIN RES, V1423, P41, DOI 10.1016/j.brainres.2011.09.018; Jamadar S, 2010, NEUROIMAGE, V51, P432, DOI 10.1016/j.neuroimage.2010.01.090; Jost K, 2008, COGN AFFECT BEHAV NE, V8, P74, DOI 10.3758/CABN.8.1.74; Karayanidis F, 2003, PSYCHOPHYSIOLOGY, V40, P329, DOI 10.1111/1469-8986.00037; Karayanidis F, 2006, CLIN NEUROPHYSIOL, V117, P2172, DOI 10.1016/j.clinph.2006.06.716; Kieffaber PD, 2005, PSYCHOPHYSIOLOGY, V42, P56, DOI 10.1111/j.1469-8986.2005.00262.x; Kray J, 2005, PSYCHOPHYSIOLOGY, V42, P407, DOI 10.1111/j.1469-8986.2005.00298.x; Leleu A, 2012, ACTA PSYCHOL, V139, P492, DOI 10.1016/j.actpsy.2012.01.004; Li FH, 2008, NEUROSCI LETT, V430, P269, DOI 10.1016/j.neulet.2007.11.008; Logan GD, 2003, J EXP PSYCHOL HUMAN, V29, P575, DOI 10.1037/0096-1523.29.3.575; MAGLIERO A, 1984, PSYCHOPHYSIOLOGY, V21, P171, DOI 10.1111/j.1469-8986.1984.tb00201.x; Martin CD, 2011, BIOL PSYCHOL, V86, P210, DOI 10.1016/j.biopsycho.2010.12.001; Mayr U, 2003, J EXP PSYCHOL LEARN, V29, P362, DOI 10.1037/0278-7393.29.3.362; Meiran N, 2000, COGNITIVE PSYCHOL, V41, P211, DOI 10.1006/cogp.2000.0736; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monsell S, 2003, TRENDS COGN SCI, V7, P134, DOI 10.1016/S1364-6613(03)00028-7; Monsell S, 2006, J EXP PSYCHOL HUMAN, V32, P493, DOI 10.1037/0096-1523.32.3.493; Nicholson R, 2005, PSYCHOPHYSIOLOGY, V42, P540, DOI 10.1111/j.1469-8986.2005.00350.x; Nicholson R, 2006, BRAIN RES, V1095, P107, DOI 10.1016/j.brainres.2006.04.016; Perianez JA, 2009, NEUROPSYCHOLOGIA, V47, P1160, DOI 10.1016/j.neuropsychologia.2009.01.014; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Potts GF, 2004, BRAIN COGNITION, V56, P5, DOI 10.1016/j.bandc.2004.03.006; Rubinstein JS, 2001, J EXP PSYCHOL HUMAN, V27, P763, DOI 10.1037//0096-1523.27.4.763; Ruchsow M, 2007, J NEURAL TRANSM, V114, P1595, DOI 10.1007/s00702-007-0779-4; Sohn MH, 2000, P NATL ACAD SCI USA, V97, P13448, DOI 10.1073/pnas.240460497; Steinhauser M, 2009, NEUROPSYCHOLOGIA, V47, P1826, DOI 10.1016/j.neuropsychologia.2009.02.022; Swainson R, 2003, J COGNITIVE NEUROSCI, V15, P785, DOI 10.1162/089892903322370717; Tieges Z, 2007, PSYCHOPHYSIOLOGY, V44, P561, DOI 10.1111/j.1469-8986.2007.00534.x; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; West R, 2011, PSYCHOPHYSIOLOGY, V48, P612, DOI 10.1111/j.1469-8986.2010.01123.x; Wylie G, 2000, PSYCHOL RES-PSYCH FO, V63, P212, DOI 10.1007/s004269900003	48	15	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49486	10.1371/journal.pone.0049486	http://dx.doi.org/10.1371/journal.pone.0049486			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039HA	23152912	gold, Green Published			2022-12-27	WOS:000311234000068
J	Christianson, HC; van Kuppevelt, TH; Belting, M				Christianson, Helena C.; van Kuppevelt, Toin H.; Belting, Mattias			ScFv Anti-Heparan Sulfate Antibodies Unexpectedly Activate Endothelial and Cancer Cells through p38 MAPK: Implications for Antibody-Based Targeting of Heparan Sulfate Proteoglycans in Cancer	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BINDING; ANGIOGENESIS; KINASE; IDENTIFICATION; SYNDECAN-4; INTEGRINS; FRAGMENT; PATHWAY; SURFACE	Tumor development requires angiogenesis and anti-angiogenic therapies have been introduced in the treatment of cancer. In this context, heparan sulfate proteoglycans (HSPGs) emerge as interesting targets, owing to their function as co-receptors of major, pro-angiogenic factors. Accordingly, previous studies have suggested anti-tumor effects of heparin, i.e. over-sulfated HS, and various heparin mimetics; however, a significant drawback is their unspecific mechanism of action and potentially serious side-effects related to their anticoagulant properties. Here, we have explored the use of human ScFv anti-HS antibodies (alpha HS) as a more rational approach to target HSPG function in endothelial cells (ECs). alpha HS were initially selected for their recognition of HS epitopes localized preferentially to the vasculature of patient glioblastoma tumors, i.e. highly angiogenic brain tumors. Unexpectedly, we found that these alpha HS exhibited potent pro-angiogenic effects in primary human ECs. alpha HS were shown to stimulate EC differentiation, which was associated with increased EC tube formation and proliferation. Moreover, alpha HS supported EC survival under hypoxia and starvation, i.e. conditions typical of the tumor microenvironment. Importantly, alpha HS-mediated proliferation was efficiently counter-acted by heparin and was absent in HSPG-deficient mutant cells, confirming HS-specific effects. On a mechanistic level, binding of aHS to HSPGs of ECs as well as glioblastoma cells was found to trigger p38 MAPK-dependent signaling resulting in increased proliferation. We conclude that several aHS that recognize HS epitopes abundant in the tumor vasculature may elicit a pro-angiogenic response, which has implications for the development of antibody-based targeting of HSPGs in cancer. Citation: Christianson HC, van Kuppevelt TH, Belting M (2012) ScFv Anti-Heparan Sulfate Antibodies Unexpectedly Activate Endothelial and Cancer Cells through p38 MAPK: Implications for Antibody-Based Targeting of Heparan Sulfate Proteoglycans in Cancer. PLoS ONE 7(11): e49092. doi:10.1371/journal.pone.0049092	[Christianson, Helena C.; Belting, Mattias] Lund Univ, Sect Oncol, Dept Clin Sci, Lund, Sweden; [Christianson, Helena C.; Belting, Mattias] Skane Univ Hosp, Lund, Sweden; [van Kuppevelt, Toin H.] Nijmegen Ctr Mol Life Sci, Dept Biochem, Nijmegen, Netherlands; [Belting, Mattias] Oncol Clin, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Radboud University Nijmegen	Belting, M (corresponding author), Lund Univ, Sect Oncol, Dept Clin Sci, Lund, Sweden.	Mattias.Belting@med.lu.se	van Kuppevelt, A.H.M.S.M./L-4463-2015	Belting, Mattias/0000-0003-1585-5434	Swedish Cancer Fund; Swedish Research Council; Swedish Society of Medicine; Physiographic Society, Lund; Gunnar Nilsson Foundation; Lundgren Foundation; Kamprad Foundation; Skane University Hospital; Governmental funding of clinical research within the national health services (ALF)	Swedish Cancer Fund; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Society of Medicine; Physiographic Society, Lund; Gunnar Nilsson Foundation; Lundgren Foundation; Kamprad Foundation; Skane University Hospital; Governmental funding of clinical research within the national health services (ALF)	This work was supported by grants from the Swedish Cancer Fund; the Swedish Research Council; the Swedish Society of Medicine; the Physiographic Society, Lund; the Gunnar Nilsson, Lundgren and Kamprad Foundations; the Skane University Hospital donation funds; and the Governmental funding of clinical research within the national health services (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Accardi L, 2010, CURR MED CHEM, V17, P1730, DOI 10.2174/092986710791111215; Afratis N, 2012, FEBS J, V279, P1177, DOI 10.1111/j.1742-4658.2012.08529.x; Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8; BonnehBarkay D, 1997, J BIOL CHEM, V272, P12415, DOI 10.1074/jbc.272.19.12415; Casaletto JB, 2012, NAT REV CANCER, V12, P386, DOI 10.1038/nrc3277; Chiodelli P, 2011, ARTERIOSCL THROM VAS, V31, pE116, DOI 10.1161/ATVBAHA.111.235184; Couchman JR, 1999, J CELL SCI, V112, P3415; Couchman JR, 2002, J BIOL CHEM, V277, P49296, DOI 10.1074/jbc.M209679200; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; GITAYGOREN H, 1992, J BIOL CHEM, V267, P6093; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; Katayama T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040813; Kerbel RS, 2008, NEW ENGL J MED, V358, P2039, DOI 10.1056/NEJMra0706596; Kucharzewska P, 2010, IN VITRO CELL DEV-AN, V46, P577, DOI 10.1007/s11626-010-9313-3; Li J, 2002, J CELL SCI, V115, P1951; Lindblom P, 2003, GENE DEV, V17, P1835, DOI 10.1101/gad.266803; Mani K, 2004, GLYCOBIOLOGY, V14, P387, DOI 10.1093/glycob/cwh035; Mani K, 2007, MOL CANCER THER, V6, P782, DOI 10.1158/1535-7163.MCT-06-0370; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Morimoto-Tomita M, 2005, NEOPLASIA, V7, P1001, DOI 10.1593/neo.05496; Mueller J, 2009, MOL CANCER RES, V7, P1078, DOI 10.1158/1541-7786.MCR-08-0538; Narita K, 2006, CANCER RES, V66, P6025, DOI 10.1158/0008-5472.CAN-05-3582; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Oliver L, 2009, Curr Mol Pharmacol, V2, P263; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Parish CR, 1999, CANCER RES, V59, P3433; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Qiao DH, 2003, J BIOL CHEM, V278, P16045, DOI 10.1074/jbc.M211259200; Ritchie JP, 2011, CLIN CANCER RES, V17, P1382, DOI 10.1158/1078-0432.CCR-10-2476; Ronca R, 2010, MOL CANCER THER, V9, P3244, DOI 10.1158/1535-7163.MCT-10-0417; Ruhrberg C, 2002, GENE DEV, V16, P2684, DOI 10.1101/gad.242002; Schenk S, 1999, MOL BIOL CELL, V10, P2933, DOI 10.1091/mbc.10.9.2933; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Simizu S, 2004, CANCER SCI, V95, P553, DOI 10.1111/j.1349-7006.2004.tb02485.x; Tan Y, 1996, EMBO J, V15, P4629, DOI 10.1002/j.1460-2075.1996.tb00840.x; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; van Kuppevelt TH, 1998, J BIOL CHEM, V273, P12960, DOI 10.1074/jbc.273.21.12960; Welch JE, 2008, INT J ONCOL, V32, P749; Wijnhoven TJ, 2008, GLYCOCONJUGATE J, V25, P177, DOI 10.1007/s10719-007-9070-z; Wittrup A, 2010, P NATL ACAD SCI USA, V107, P13342, DOI 10.1073/pnas.1002622107; Wittrup A, 2009, J BIOL CHEM, V284, P32959, DOI 10.1074/jbc.M109.036129; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yoshizuka N, 2012, MOL CELL BIOL, V32, P606, DOI 10.1128/MCB.06301-11; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021106	49	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49092	10.1371/journal.pone.0049092	http://dx.doi.org/10.1371/journal.pone.0049092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152853	Green Published, Green Submitted, gold			2022-12-27	WOS:000312272600042
J	Gonzalez-Ruiz, M; Santos, C; Jordana, X; Simon, M; Lalueza-Fox, C; Gigli, E; Aluja, MP; Malgosa, A				Gonzalez-Ruiz, Mercedes; Santos, Cristina; Jordana, Xavier; Simon, Marc; Lalueza-Fox, Carles; Gigli, Elena; Pilar Aluja, Maria; Malgosa, Assumpcio			Tracing the Origin of the East-West Population Admixture in the Altai Region (Central Asia)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA ANALYSIS; Y-CHROMOSOME VARIATION; GENETIC-ANALYSIS; MTDNA SEQUENCES; SOUTH SIBERIA; HUMAN REMAINS; ANCIENT DNA; MIGRATIONS; DIVERSITY; HISTORY	A recent discovery of Iron Age burials (Pazyryk culture) in the Altai Mountains of Mongolia may shed light on the mode and tempo of the generation of the current genetic east-west population admixture in Central Asia. Studies on ancient mitochondrial DNA of this region suggest that the Altai Mountains played the role of a geographical barrier between West and East Eurasian lineages until the beginning of the Iron Age. After the 7th century BC, coinciding with Scythian expansion across the Eurasian steppes, a gradual influx of East Eurasian sequences in Western steppes is detected. However, the underlying events behind the genetic admixture in Altai during the Iron Age are still unresolved: 1) whether it was a result of migratory events (eastward firstly, westward secondly), or 2) whether it was a result of a local demographic expansion in a 'contact zone' between European and East Asian people. In the present work, we analyzed the mitochondrial DNA lineages in human remains from Bronze and Iron Age burials of Mongolian Altai. Here we present support to the hypothesis that the gene pool of Iron Age inhabitants of Mongolian Altai was similar to that of western Iron Age Altaians (Russia and Kazakhstan). Thus, this people not only shared the same culture (Pazyryk), but also shared the same genetic east-west population admixture. In turn, Pazyryks appear to have a similar gene pool that current Altaians. Our results further show that Iron Age Altaians displayed mitochondrial lineages already present around Altai region before the Iron Age. This would provide support for a demographic expansion of local people of Altai instead of westward or eastward migratory events, as the demographic event behind the high population genetic admixture and diversity in Central Asia. Citation: Gonzalez-Ruiz M, Santos C, Jordana X, Simon M, Lalueza-Fox C, et al. (2012) Tracing the Origin of the East-West Population Admixture in the Altai Region (Central Asia). PLoS ONE 7(11): e48904. doi:10.1371/journal.pone.0048904	[Gonzalez-Ruiz, Mercedes; Santos, Cristina; Simon, Marc; Pilar Aluja, Maria; Malgosa, Assumpcio] Univ Autonoma Barcelona, Dept BABVE, Unitat Antropol Biol, E-08193 Barcelona, Spain; [Jordana, Xavier] Univ Autonoma Barcelona, Inst Catala Paleontol Miquel Crusafont ICP, E-08193 Barcelona, Spain; [Lalueza-Fox, Carles; Gigli, Elena] CSIC UPF, Inst Biol Evolut, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Institut Catala de Paleontologia Miquel Crusafont (ICP); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-UPF - Institut de Biologia Evolutiva (IBE); Pompeu Fabra University	Malgosa, A (corresponding author), Univ Autonoma Barcelona, Dept BABVE, Unitat Antropol Biol, E-08193 Barcelona, Spain.	Assumpcio.Malgosa@uab.cat	LALUEZA-FOX, CARLES/AAG-5341-2020; Santos, Cristina/AAE-7665-2020; Malgosa, Assumpció/K-2406-2014; Jordana, Xavier/L-9301-2014; Jordana, Xavier/G-7537-2017; santos, cristina/K-2348-2014; Aluja, Maria Pilar/K-1952-2014	LALUEZA-FOX, CARLES/0000-0002-1730-5914; Santos, Cristina/0000-0002-7014-8014; Malgosa, Assumpció/0000-0003-1723-3671; Jordana, Xavier/0000-0001-8990-4388; Jordana, Xavier/0000-0002-6016-6630; santos, cristina/0000-0002-7014-8014; Aluja, Maria Pilar/0000-0002-0407-9356; Simon, Marc/0000-0002-9569-0416	Generalitat de Catalunya [SRG 2009-566]; European Union, INTERREG III [I3A-10-319-E]; Ministerio de Economia y Competitividad, Gobierno de Espana, Programa Juan de la Cierva [JCI-2010-08157]	Generalitat de Catalunya(Generalitat de Catalunya); European Union, INTERREG III; Ministerio de Economia y Competitividad, Gobierno de Espana, Programa Juan de la Cierva	The authors acknowledge the following grants: Generalitat de Catalunya: SRG 2009-566; European Union, INTERREG III: I3A-10-319-E; Ministerio de Economia y Competitividad, Gobierno de Espana, Programa Juan de la Cierva: JCI-2010-08157. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2005, EUR J HUM GENET, V13, P1106, DOI 10.1038/sj.ejhg.5201476; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Calafell F, 1996, ANN HUM GENET, V60, P35, DOI 10.1111/j.1469-1809.1996.tb01170.x; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chandrasekar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007447; Chikisheva T.A., 2007, ARCHEOL ETHNOL ANTHR, V32, P130, DOI [10.1134/S156301100704012, DOI 10.1134/S156301100704012]; Clisson I, 2002, INT J LEGAL MED, V116, P304, DOI 10.1007/s00414-002-0295-x; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; Comas D, 2004, EUR J HUM GENET, V12, P495, DOI 10.1038/sj.ejhg.5201160; Comas D, 2000, AM J PHYS ANTHROPOL, V112, P5, DOI 10.1002/(SICI)1096-8644(200005)112:1<5::AID-AJPA2>3.0.CO;2-Z; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032179; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Dulik MC, 2012, AM J HUM GENET, V90, P229, DOI 10.1016/j.ajhg.2011.12.014; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Gao SZ, 2007, AM J PHYS ANTHROPOL, V133, P1128, DOI 10.1002/ajpa.20623; Gao SZ, 2008, SCI CHINA SER C, V51, P205, DOI 10.1007/s11427-008-0034-8; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Gilbert MTP, 2003, AM J HUM GENET, V72, P32, DOI 10.1086/345378; Gokcumen O, 2008, AM J PHYS ANTHROPOL, V136, P278, DOI 10.1002/ajpa.20802; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jordana X, 2009, J ARCHAEOL SCI, V36, P1319, DOI 10.1016/j.jas.2009.01.008; Keyser C, 2009, HUM GENET, V126, P395, DOI 10.1007/s00439-009-0683-0; Keyser-Tracqui C, 2003, AM J HUM GENET, V73, P247, DOI 10.1086/377005; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kong QP, 2003, HUM GENET, V113, P391, DOI 10.1007/s00439-003-1004-7; Lalueza-Fox C, 2004, P ROY SOC B-BIOL SCI, V271, P941, DOI 10.1098/rspb.2004.2698; Lalueza-Fox C, 2011, P NATL ACAD SCI USA, V108, P250, DOI 10.1073/pnas.1011553108; Li CX, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-15; Malgosa A., 2005, Recent Research Developments in Microbiology, Vol. 9, Part II, P213; Mallory J. P., 1989, SEARCH INDOEUROPEANS; Mergen H, 2004, J GENET, V83, P39, DOI 10.1007/BF02715828; Metspalu M, 2006, NUCL ACID M, V18, P181; Minajev S., 1996, DOSSIERS ARCHEOLOGIE, V212, P74; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Montiel R., 1997, J ANCIENT BIOMOL, V1, P221; Montiel R., 2007, RECENT ADV MOL BIOL, P209; Murphy E, 2002, AM J ARCHAEOL, V106, P1, DOI 10.2307/507186; NAKAHORI Y, 1991, AM J MED GENET, V39, P472, DOI 10.1002/ajmg.1320390420; Nasidze I, 2008, ANN HUM GENET, V72, P241, DOI 10.1111/j.1469-1809.2007.00413.x; Nasidze I, 2006, CURR BIOL, V16, P668, DOI 10.1016/j.cub.2006.02.021; Nasidze I, 2005, AM J PHYS ANTHROPOL, V128, P846, DOI 10.1002/ajpa.20159; Nasidze I, 2005, ANN HUM GENET, V69, P401, DOI 10.1046/j.1529-8817.2005.00174.x; Nei M., 1987, MOL EVOLUTIONARY GEN; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Pakendorf B, 2007, AM J PHYS ANTHROPOL, V133, P1013, DOI 10.1002/ajpa.20590; Pakendorf B, 2006, HUM GENET, V120, P334, DOI 10.1007/s00439-006-0213-2; Pilipenko AS, 2010, ARCHAEOL ANTHROP SCI, V2, P231, DOI 10.1007/s12520-010-0042-z; POLOSMAK N, 1995, RECHERCHE, V26, P524; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Ricaut FX, 2004, HUM BIOL, V76, P109, DOI 10.1353/hub.2004.0025; Ricaut FX, 2004, AM J PHYS ANTHROPOL, V123, P351, DOI 10.1002/ajpa.10323; Rudenko S. I, 1970, FROZEN TOMBS SIBERIA; Santos C, 2010, AM J PHYS ANTHROPOL, V141, P610, DOI 10.1002/ajpa.21180; Santos FR, 1998, NAT GENET, V18, P103, DOI 10.1038/ng0298-103; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; SHIELDS GF, 1993, AM J HUM GENET, V53, P549; Simon M, 2011, AM J PHYS ANTHROPOL, V146, P406, DOI 10.1002/ajpa.21590; SLATKIN M, 1995, GENETICS, V139, P457; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Starikovskaya EB, 2005, ANN HUM GENET, V69, P67, DOI 10.1046/j.1529-8817.2003.00127.x; Starikovskaya YB, 1998, AM J HUM GENET, V63, P1473, DOI 10.1086/302087; TAJIMA F, 1983, GENETICS, V105, P437; Turbat T, 2005, MONGOLIAN J ANTHR AR, V2, P209; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; VANNOTEN F, 1995, ENDEAVOUR, V19, P76, DOI 10.1016/0160-9327(95)93588-6; Voevoda MI, 1998, DOKL AKAD NAUK+, V358, P564; Voevoda ML, 2000, ARCHAEOL ETHNOL ANTH, V4, P88; Volodko NV, 2008, AM J HUM GENET, V82, P1084, DOI 10.1016/j.ajhg.2008.03.019; Yu CC, 2006, FEBS LETT, V580, P6242, DOI 10.1016/j.febslet.2006.10.030; Zvelebil M., 1980, CAMBRIDGE ENCY ARCHA, P252	73	35	36	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48904	10.1371/journal.pone.0048904	http://dx.doi.org/10.1371/journal.pone.0048904			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053LI	23152818	Green Published, Green Submitted, gold			2022-12-27	WOS:000312272600026
J	Azim, K; Fiorelli, R; Zweifel, S; Hurtado-Chong, A; Yoshikawa, K; Slomianka, L; Raineteau, O				Azim, Kasum; Fiorelli, Roberto; Zweifel, Stefan; Hurtado-Chong, Anahi; Yoshikawa, Kazuaki; Slomianka, Lutz; Raineteau, Olivier			3-Dimensional Examination of the Adult Mouse Subventricular Zone Reveals Lineage-Specific Microdomains	PLOS ONE			English	Article							NEURAL STEM-CELLS; ROSTRAL MIGRATORY STREAM; PROGENITOR CELLS; NEURONAL SUBTYPES; RADIAL GLIA; GENERATION; BRAIN; NEUROGENESIS; FATE; FOREBRAIN	Recent studies suggest that the subventricular zone (SVZ) of the lateral ventricle is populated by heterogeneous populations of stem and progenitor cells that, depending on their exact location, are biased to acquire specific neuronal fates. This newly described heterogeneity of SVZ stem and progenitor cells underlines the necessity to develop methods for the accurate quantification of SVZ stem and progenitor subpopulations. In this study, we provide 3-dimensional topographical maps of slow cycling "stem" cells and progenitors based on their unique cell cycle properties. These maps revealed that both cell populations are present throughout the lateral ventricle wall as well as in discrete regions of the dorsal wall. Immunodetection of transcription factors expressed in defined progenitor populations further reveals that divergent lineages have clear regional enrichments in the rostro-caudal as well as in the dorso-ventral span of the lateral ventricle. Thus, progenitors expressing Tbr2 and Dlx2 were confined to dorsal and dorso-lateral regions of the lateral ventricle, respectively, while Mash1+ progenitors were more homogeneously distributed. All cell populations were enriched in the rostral-most region of the lateral ventricle. This diversity and uneven distribution greatly impede the accurate quantification of SVZ progenitor populations. This is illustrated by measuring the coefficient of error of estimates obtained by using increasing section sampling interval. Based on our empirical data, we provide such estimates for all progenitor populations investigated in this study. These can be used in future studies as guidelines to judge if the precision obtained with a sampling scheme is sufficient to detect statistically significant differences between experimental groups if a biological effect is present. Altogether, our study underlines the need to consider the SVZ of the lateral ventricle as a complex 3D structure and define methods to accurately assess neural stem cells or progenitor diversity and population sizes in physiological or experimental paradigms.	[Azim, Kasum; Fiorelli, Roberto; Zweifel, Stefan; Hurtado-Chong, Anahi; Raineteau, Olivier] Univ Zurich ETHZ, Brain Res Inst, Zurich, Switzerland; [Slomianka, Lutz] Univ Zurich, Inst Anat, Zurich, Switzerland; [Yoshikawa, Kazuaki] Osaka Univ, Inst Prot Res, Osaka, Japan	University of Zurich; Osaka University	Raineteau, O (corresponding author), Univ Zurich ETHZ, Brain Res Inst, Zurich, Switzerland.	raineteau@hifo.uzh.ch	Raineteau, Olivier/I-1190-2014; Slomianka, Lutz/I-3889-2012; Zweifel, Stefan/M-8082-2014	Raineteau, Olivier/0000-0003-4294-2496; 	National Research Project (NRP63) from the Swiss National Fund [406340_128291, 31003A_127082]; Mexican Government (CONACYT); Japan Society for the Promotion of Science [21300138]	National Research Project (NRP63) from the Swiss National Fund; Mexican Government (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	KA and RF are supported by a National Research Project (NRP63; 406340_128291) grant and a research grant (31003A_127082) from the Swiss National Fund. AHC is supported by a grant from the Mexican Government (CONACYT). KY is supported by a Grant-in-Aid for Scientific Research B2 (21300138) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Azim K, 2012, CEREB CORTEX; Beckervordersandforth R, 2010, CELL STEM CELL, V7, P744, DOI 10.1016/j.stem.2010.11.017; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Brill MS, 2009, NAT NEUROSCI, V12, P1524, DOI 10.1038/nn.2416; Collin T, 2005, EXP NEUROL, V195, P71, DOI 10.1016/j.expneurol.2005.03.017; De Marchis S, 2007, J NEUROSCI, V27, P657, DOI 10.1523/JNEUROSCI.2870-06.2007; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Eyre MD, 2009, EUR J NEUROSCI, V29, P1397, DOI 10.1111/j.1460-9568.2009.06703.x; Fernandez ME, 2011, NEURAL DEV IN PRESS; Golmohammadi MG, 2008, STEM CELLS, V26, P979, DOI 10.1634/stemcells.2007-0919; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Ihrie RA, 2011, NEURON, V71, P250, DOI 10.1016/j.neuron.2011.05.018; Kelsch W, 2007, PLOS BIOL, V5, P2501, DOI 10.1371/journal.pbio.0050300; Kim EJ, 2007, J NEUROSCI, V27, P12764, DOI 10.1523/JNEUROSCI.3178-07.2007; Kim Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008122; Kohwi M, 2007, J NEUROSCI, V27, P6878, DOI 10.1523/JNEUROSCI.0254-07.2007; Liu F, 2009, J NEUROSCI, V29, P5075, DOI 10.1523/JNEUROSCI.0201-09.2009; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Marques F, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-10; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Mendoza-Torreblanca JG, 2008, NEUROSCI RES, V60, P289, DOI 10.1016/j.neures.2007.11.013; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Parras CM, 2007, J NEUROSCI, V27, P4233, DOI 10.1523/JNEUROSCI.0126-07.2007; Parras CM, 2002, GENE DEV, V16, P324, DOI 10.1101/gad.940902; Pencea V, 2001, EXP NEUROL, V172, P1, DOI 10.1006/exnr.2001.7768; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; Smith CM, 1998, DEV DYNAM, V213, P220, DOI 10.1002/(SICI)1097-0177(199810)213:2<220::AID-AJA7>3.0.CO;2-I; Stoeber K, 2001, J CELL SCI, V114, P2027; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Weinandy F, 2011, EUR J NEUROSCI, V33, P1045, DOI 10.1111/j.1460-9568.2011.07602.x; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Winpenny E, 2011, NEURAL DEV IN PRESS; Winpenny E, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-12; Young KM, 2007, J NEUROSCI, V27, P8286, DOI 10.1523/JNEUROSCI.0476-07.2007	52	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49087	10.1371/journal.pone.0049087	http://dx.doi.org/10.1371/journal.pone.0049087			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166605	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300022
J	Chastre, A; Belanger, M; Beauchesne, E; Nguyen, BN; Desjardins, P; Butterworth, RF				Chastre, Anne; Belanger, Mireille; Beauchesne, Elizabeth; Nguyen, Bich N.; Desjardins, Paul; Butterworth, Roger F.			Inflammatory Cascades Driven by Tumor Necrosis Factor-Alpha Play a Major Role in the Progression of Acute Liver Failure and Its Neurological Complications	PLOS ONE			English	Article							PROINFLAMMATORY CYTOKINES; HEPATIC-ENCEPHALOPATHY; FULMINANT-HEPATITIS; EXPERIMENTAL-MODEL; BRAIN EDEMA; ETANERCEPT; MECHANISMS; INTERLEUKIN-6; PATHOGENESIS; ANTIOXIDANT	Background/aims: Acute liver failure (ALF) due to ischemic or toxic liver injury is a clinical condition that results from massive loss of hepatocytes and may lead to hepatic encephalopathy (HE), a serious neuropsychiatric complication. Although increased expression of tumor necrosis factor-alpha (TNF-alpha) in liver, plasma and brain has been observed, conflicting results exist concerning its roles in drug-induced liver injury and on the progression of HE. The present study aimed to investigate the therapeutic value of etanercept, a TNF-alpha neutralizing molecule, on the progression of liver injury and HE in mice with ALF resulting from azoxymethane (AOM) hepatotoxicity. Methods/Principal Findings: Mice were administered saline or etanercept (10 mg/kg; i.p.) 30 minutes prior to, or up to 6 h after AOM. Etanercept-treated ALF mice were sacrificed in parallel with vehicle-treated comatose ALF mice and controls. AOM induced severe hepatic necrosis, leading to HE, and etanercept administered prior or up to 3 h after AOM significantly delayed the onset of coma stages of HE. Etanercept pretreatment attenuated AOM-induced liver injury, as assessed by histological examination, plasma ammonia and transaminase levels, and by hepatic glutathione content. Peripheral inflammation was significantly reduced by etanercept as shown by decreased plasma IL-6 (4.1-fold; p<0.001) and CD40L levels (3.7-fold; p<0.001) compared to saline-treated ALF mice. Etanercept also decreased IL-6 levels in brain (1.2-fold; p<0.05), attenuated microglial activation (assessed by OX-42 immunoreactivity), and increased brain glutathione concentrations. Conclusions: These results indicate that systemic sequestration of TNF-alpha attenuates both peripheral and cerebral inflammation leading to delayed progression of liver disease and HE in mice with ALF due to toxic liver injury. These results suggest that etanercept may provide a novel therapeutic approach for the management of ALF patients awaiting liver transplantation.	[Chastre, Anne; Belanger, Mireille; Beauchesne, Elizabeth; Desjardins, Paul; Butterworth, Roger F.] Hop St Luc, CRCHUM, Neurosci Res Unit, Montreal, PQ H2X 1P1, Canada; [Nguyen, Bich N.] Hop St Luc, CHUM, Dept Pathol, Montreal, PQ H2X 1P1, Canada	Universite de Montreal; Universite de Montreal	Butterworth, RF (corresponding author), Hop St Luc, CRCHUM, Neurosci Res Unit, 264 Rene Levesque Blvd E, Montreal, PQ H2X 1P1, Canada.	roger.butterworth@umontreal.ca			Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This research was supported by the Canadian Institutes of Health Research (CIHR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S K, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS268, DOI 10.1046/j.1440-1746.17.s3.12.x; Acharya SK, 2009, GASTROENTEROLOGY, V136, P2159, DOI 10.1053/j.gastro.2009.02.050; Alldred A, 2001, Expert Opin Pharmacother, V2, P1137, DOI 10.1517/14656566.2.7.1137; Belanger M, 2006, NEUROCHEM INT, V48, P434, DOI 10.1016/j.neuint.2005.11.022; Bemeur C, 2010, METAB BRAIN DIS, V25, P241, DOI 10.1007/s11011-010-9201-2; Bemeur C, 2010, METAB BRAIN DIS, V25, P23, DOI 10.1007/s11011-010-9186-x; Bemeur C, 2010, NEUROCHEM INT, V56, P213, DOI 10.1016/j.neuint.2009.11.010; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; BLAZKA ME, 1995, TOXICOL APPL PHARM, V133, P43, DOI 10.1006/taap.1995.1125; Boess F, 1998, HEPATOLOGY, V27, P1021, DOI 10.1002/hep.510270418; Butterworth RF, 2011, NEUROCHEM INT, V59, P830, DOI 10.1016/j.neuint.2011.07.014; Capuron L, 2011, PHARMACOL THERAPEUT, V130, P226, DOI 10.1016/j.pharmthera.2011.01.014; Chastre A, 2010, METAB BRAIN DIS, V25, P17, DOI 10.1007/s11011-010-9185-y; Chen KQ, 2006, CELL MOL IMMUNOL, V3, P163; Chio CC, 2010, J NEUROCHEM, V115, P921, DOI 10.1111/j.1471-4159.2010.06969.x; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Duchini A, 1996, J INVEST MED, V44, P474; Ferenci P, 2002, HEPATOLOGY, V35, P716, DOI 10.1053/jhep.2002.31250; Genovese T, 2006, J PHARMACOL EXP THER, V316, P1006, DOI 10.1124/jpet.105.097188; Ichai P, 2008, LIVER TRANSPLANT, V14, pS67, DOI 10.1002/lt.21612; Ito H, 2009, J IMMUNOL, V182, P391, DOI 10.4049/jimmunol.182.1.391; IZUMI S, 1994, GUT, V35, P982, DOI 10.1136/gut.35.7.982; Jalan R, 2005, NEUROCHEM INT, V47, P78, DOI 10.1016/j.neuint.2005.04.010; Kerensky TA, 2012, EXPERT OPIN DRUG SAF, V11, P121, DOI 10.1517/14740338.2012.633509; Koziel MJ, 1999, SEMIN LIVER DIS, V19, P157, DOI 10.1055/s-2007-1007107; Lee WM, 2008, HEPATOLOGY, V47, P1401, DOI 10.1002/hep.22177; Leifeld L, 1999, AM J PATHOL, V154, P1711, DOI 10.1016/S0002-9440(10)65427-2; MacEwan DJ, 2002, CELL SIGNAL, V14, P477, DOI 10.1016/S0898-6568(01)00262-5; MOHLER KM, 1993, J IMMUNOL, V151, P1548; Nagaki M, 2000, J INFECT DIS, V182, P1103, DOI 10.1086/315826; Odeh M, 2007, EUR J CLIN INVEST, V37, P291, DOI 10.1111/j.1365-2362.2007.01778.x; Scallon B, 2002, J PHARMACOL EXP THER, V301, P418, DOI 10.1124/jpet.301.2.418; Schmitz V, 2006, HEPATOLOGY, V44, P430, DOI 10.1002/hep.21274; Sener G, 2006, HEPATOL RES, V35, P62, DOI 10.1016/j.hepres.2006.02.005; Simpson KJ, 2000, J PATHOL, V190, P489; Streetz K, 2000, GASTROENTEROLOGY, V119, P446, DOI 10.1053/gast.2000.9364; Szabo G, 2007, SEMIN LIVER DIS, V27, P339, DOI 10.1055/s-2007-991511; Tracey D, 2008, PHARMACOL THERAPEUT, V117, P244, DOI 10.1016/j.pharmthera.2007.10.001; Wu ZG, 2010, LIVER INT, V30, P782, DOI 10.1111/j.1478-3231.2010.02262.x; Zheng YB, 2008, J INT MED RES, V36, P728, DOI 10.1177/147323000803600415	40	58	63	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49670	10.1371/journal.pone.0049670	http://dx.doi.org/10.1371/journal.pone.0049670			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166746	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300066
J	Sommese, L; Pagliuca, C; Avallone, B; Ippolito, R; Casamassimi, A; Costa, V; Colicchio, R; Cerciello, R; D'Armiento, M; Scarpato, M; Giovane, A; Pastore, G; Infante, T; Ciccodicola, A; Fiorito, C; D'Armiento, FP; Salvatore, P; Napoli, C				Sommese, Linda; Pagliuca, Chiara; Avallone, Bice; Ippolito, Rossana; Casamassimi, Amelia; Costa, Valerio; Colicchio, Roberta; Cerciello, Raimondo; D'Armiento, Maria; Scarpato, Margherita; Giovane, Alfonso; Pastore, Gabiria; Infante, Teresa; Ciccodicola, Alfredo; Fiorito, Carmela; D'Armiento, Francesco Paolo; Salvatore, Paola; Napoli, Claudio			Evidence of Bacteroides fragilis Protection from Bartonella henselae-Induced Damage	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; DEMYELINATING DISEASE; IMMUNE-SYSTEM; EXPRESSION; INFECTION; PATHOGENS; COMMENSAL; POLYSACCHARIDES; MICROBIOTA; INVASION	Bartonella henselae is able to internalize endothelial progenitor cells (EPCs), which are resistant to the infection of other common pathogens. Bacteroides fragilis is a gram-negative anaerobe belonging to the gut microflora. It protects from experimental colitis induced by Helicobacter hepaticus through the polysaccharide A (PSA). The aim of our study was to establish: 1) whether B. fragilis colonization could protect from B. henselae infection; if this event may have beneficial effects on EPCs, vascular system and tissues. Our in vitro results establish for the first time that B. fragilis can internalize EPCs and competes with B. henselae during coinfection. We observed a marked activation of the inflammatory response by Real-time PCR and ELISA in coinfected cells compared to B. henselae-infected cells (63 vs 23 up-regulated genes), and after EPCs infection with mutant B. fragilis Delta PSA (congruent to 90% up-regulated genes) compared to B. fragilis. Interestingly, in a mouse model of coinfection, morphological and ultrastructural analyses by hematoxylin-eosin staining and electron microscopy on murine tissues revealed that damages induced by B. henselae can be prevented in the coinfection with B. fragilis but not with its mutant B. fragilis Delta PSA. Moreover, immunohistochemistry analysis with anti-Bartonella showed that the number of positive cells per field decreased of at least 50% in the liver (20 +/- 4 vs 50 +/- 8), aorta (5 +/- 1 vs 10 +/- 2) and spleen (25 +/- 3 vs 40 +/- 6) sections of mice coinfected compared to mice infected only with B. henselae. This decrease was less evident in the coinfection with Delta PSA strain (35 +/- 6 in the liver, 5 +/- 1 in the aorta and 30 +/- 5 in the spleen). Finally, B. fragilis colonization was also able to restore the EPC decrease observed in mice infected with B. henselae (0.65 vs 0.06 media). Thus, our data establish that B. fragilis colonization is able to prevent B. henselae damages through PSA.	[Pagliuca, Chiara; Salvatore, Paola] CEINGE Adv Biotechnol, Naples, Italy; [Sommese, Linda; Fiorito, Carmela; Napoli, Claudio] Univ Naples 2, Div Immunohematol Transfus Med & Transplant Immun, Reg Reference Lab Transplant Immunol, Azienda Univ Policlin,Sch Med 1, Naples, Italy; [Sommese, Linda] Univ Naples 2, Dept Expt Med, Microbiol Sect, Sch Med 1, Naples, Italy; [Avallone, Bice; Cerciello, Raimondo] Univ Naples Federico II, Dept Biol Sci, Naples, Italy; [Ippolito, Rossana; D'Armiento, Maria; D'Armiento, Francesco Paolo] Univ Naples Federico II, Dept Biomorphol & Funct Sci, Naples, Italy; [Casamassimi, Amelia; Napoli, Claudio] Univ Naples 2, Sch Med 1, Dept Gen Pathol & Excellence, Res Ctr Cardiovasc Dis, Naples, Italy; [Costa, Valerio; Scarpato, Margherita; Ciccodicola, Alfredo] CNR, Inst Genet & Biophys A Buzzati Traverso, I-80125 Naples, Italy; [Colicchio, Roberta; Infante, Teresa; Napoli, Claudio] IRCCS, Fdn SDN, Inst Diagnost & Nucl Dev, Naples, Italy; [Giovane, Alfonso] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy; [Pastore, Gabiria] Univ Sannio, Dept Sci Biol Geol & Environm, Benevento, Italy; [Salvatore, Paola] Univ Naples Federico II, Dept Cellular & Mol Biol & Pathol L Califano, Naples, Italy	CEINGE Biotecnologie Avanzate; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli; University of Naples Federico II; University of Naples Federico II; Universita della Campania Vanvitelli; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); IRCCS Fondazione Pascale; IRCCS Istituto di Ricerca Diagnostica e Nucleare (SDN); Universita della Campania Vanvitelli; University of Sannio; University of Naples Federico II	Salvatore, P (corresponding author), CEINGE Adv Biotechnol, Naples, Italy.	psalvato@unina.it	D'Armiento, Maria/AAI-1388-2019; Pagliuca, Chiara/P-5351-2016; Avallone, Bice/ABB-3425-2020; Casamassimi, Amelia/AAD-2816-2020; Costa, Valerio/K-4505-2016; Infante, Teresa/K-8735-2016	Pagliuca, Chiara/0000-0003-1704-6606; Avallone, Bice/0000-0002-5355-1557; Casamassimi, Amelia/0000-0002-6010-4261; Costa, Valerio/0000-0002-7294-6933; Infante, Teresa/0000-0002-1764-9610; Napoli, Claudio/0000-0002-5455-555X; D'ARMIENTO, Francesco Paolo/0000-0002-1391-6451; Giovane, Alfonso/0000-0002-2508-2597; SALVATORE, Paola/0000-0002-7294-9253; COLICCHIO, Roberta/0000-0002-4861-5085; Ciccodicola, Alfredo/0000-0002-9924-1482; Pastore, Gabiria/0000-0002-3219-6170	"Progetto di Rilevante Interesse Nazionale Ministero Italiano dell'Istruzione dell'Universita e della Ricerca" [0622153_002, T85HLH_002]; "Programmi di Rilevante Interesse Nazionale Ministero Italiano dell'Istruzione dell'Universita e della Ricerca" [2008232P4H_002]	"Progetto di Rilevante Interesse Nazionale Ministero Italiano dell'Istruzione dell'Universita e della Ricerca"; "Programmi di Rilevante Interesse Nazionale Ministero Italiano dell'Istruzione dell'Universita e della Ricerca"	This work was supported by a grant from the "Progetto di Rilevante Interesse Nazionale Ministero Italiano dell'Istruzione dell'Universita e della Ricerca" 2006 [Code 0622153_002 "Meccanismi fisiopatologici di danno vascolare/trombotico ed angiogenesis"] and 2008 [Code T85HLH_002 "Regolazione dell'espressione genica della via SIRT/Foxo1- dipendente in cellule endoteliali progenitrici nella nicchia vascolare] to the Second University of Naples for CN; by a grant from "Programmi di Rilevante Interesse Nazionale Ministero Italiano dell'Istruzione dell'Universita e della Ricerca" 2008 [prot. 2008232P4H_002 "Patogenicita batterica e sviluppo di vaccini"] for PS, CP and R. Colicchio. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balestrieri ML, 2008, J BIOCHEM, V143, P179, DOI 10.1093/jb/mvm209; Casamassimi A, 2007, J BIOCHEM, V141, P503, DOI 10.1093/jb/mvm060; Costa V, 2007, GENE, V402, P1, DOI 10.1016/j.gene.2007.07.001; Costa V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018493; Costa V, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-40; Coyne MJ, 2008, J BACTERIOL, V190, P736, DOI 10.1128/JB.01559-07; Dehio C, 2012, FEMS MICROBIOL REV, V36, P513, DOI 10.1111/j.1574-6976.2012.00336.x; Della Bella S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001520; Eicher SC, 2012, CELL MICROBIOL; Fiorito C, 2008, FREE RADICAL RES, V42, P754, DOI 10.1080/10715760802357057; Harms A, 2012, CLIN MICROBIOL REV, V25, P42, DOI 10.1128/CMR.05009-11; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Huang PH, 2012, ANGIOGENESIS; Koehler J E, 1995, AIDS Clin Care, V7, P97; Kolb-Maurer A, 2002, BLOOD, V100, P3703, DOI 10.1182/blood-2002-03-0898; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Maguina C, 2009, CLIN DERMATOL, V27, P271, DOI 10.1016/j.clindermatol.2008.10.006; Mandle T, 2005, BLOOD, V106, P1215, DOI 10.1182/blood-2004-12-4670; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; Mosepele M, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/612809; Nakano V, 2008, CLIN MICROBIOL INFEC, V14, P955, DOI 10.1111/j.1469-0691.2008.02069.x; Napoli C, 1997, J CLIN INVEST, V100, P2680, DOI 10.1172/JCI119813; Napoli C, 2011, ATHEROSCLEROSIS, V215, P9, DOI 10.1016/j.atherosclerosis.2010.10.039; Ochoa-Reparaz J, 2010, MUCOSAL IMMUNOL, V3, P487, DOI 10.1038/mi.2010.29; Ochoa-Reparaz J, 2010, J IMMUNOL, V185, P4101, DOI 10.4049/jimmunol.1001443; Pitassi LHU, 2007, ULTRASTRUCT PATHOL, V31, P369, DOI 10.1080/01913120701696510; Pulliainen AT, 2012, FEMS MICROBIOL REV, V36, P563, DOI 10.1111/j.1574-6976.2012.00324.x; Regnath T, 1998, INFECT IMMUN, V66, P5534, DOI 10.1128/IAI.66.11.5534-5536.1998; Richard J F, 1999, Int Microbiol, V2, P185; Round JL, 2011, SCIENCE, V332, P974, DOI 10.1126/science.1206095; Salvatore P, 2008, P NATL ACAD SCI USA, V105, P9427, DOI 10.1073/pnas.0803602105; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115; Sears CL, 2012, ANAEROBE, V18, P192, DOI 10.1016/j.anaerobe.2012.01.005; Sumegi J, 2011, BLOOD, V117, pE151, DOI 10.1182/blood-2010-08-300046; Surana NK, 2012, IMMUNOL REV, V245, P13, DOI 10.1111/j.1600-065X.2011.01075.x; Troy EB, 2010, FRONT BIOSCI-LANDMRK, V15, P25, DOI 10.2741/3603; VanderHeyden TR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-17; Vayssier-Taussat M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000946; Vieira JMBD, 2005, BIOCHEM BIOPH RES CO, V326, P607, DOI 10.1016/j.bbrc.2004.11.085; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Wisse E, 2010, WORLD J GASTROENTERO, V16, P2851, DOI 10.3748/wjg.v16.i23.2851	43	16	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49653	10.1371/journal.pone.0049653	http://dx.doi.org/10.1371/journal.pone.0049653			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166739	gold, Green Submitted, Green Published			2022-12-27	WOS:000311272300062
J	Strandberg, KL; Richards, SM; Tamayo, R; Reeves, LT; Gunn, JS				Strandberg, Kristi L.; Richards, Susan M.; Tamayo, Rita; Reeves, Linh T.; Gunn, John S.			An Altered Immune Response, but Not Individual Cationic Antimicrobial Peptides, Is Associated with the Oral Attenuation of Ara4N-Deficient Salmonella enterica Serovar Typhimurium in Mice	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; TOLL-LIKE RECEPTOR-4; PHOP-PHOQ; FUNCTIONAL-ANALYSIS; OUTER-MEMBRANE; VIRULENCE GENE; HOST-DEFENSE; LIPID-A; RESISTANCE; INNATE	Salmonella enterica serovar Typhimurium (S. Typhimurium) uses two-component regulatory systems (TCRS) to respond to stimuli in the local microenvironment. Upon infection, the Salmonella TCRSs PhoP-PhoQ (PhoPQ) and PmrA-PmrB (PmrAB) are activated by environmental signals in the intestinal lumen and within host cells. TCRS-mediated gene expression results in lipopolysaccharide (LPS) modification and cationic antimicrobial peptide resistance. The PmrA-regulated pmrHFIJKLM operon mediates 4-amino-4-deoxy-L-arabinose (Ara4N) production and attachment to the lipid A of LPS. A Delta pmrF S. Typhimurium strain cannot produce Ara4N, exhibits increased sensitivity to cationic antimicrobial peptide (CAMP)-mediated killing, and attenuated virulence in mice upon oral infection. CAMPs are predicted to play a role in elimination of Salmonella, and may activate PhoPQ and PmrAB in vivo, which could increase bacterial resistance to host defenses. Competition experiments between wild type (WT) and Delta pmrF mutant strains of S. Typhimurium indicated that selection against this mutant first occurs within the intestinal lumen early during infection. However, CRAMP and active cryptdins alone are not responsible for elimination of Ara4N-deficient bacteria in vivo. Investigation into the early immune response to Delta pmrF showed that it differed slightly from the early immune response to WT S. Typhimurium. Further investigation into the early immune response to infection of Peyer's patches suggests a role for IL-13 in the attenution of the Delta pmrF mutant strain. Thus, prominent CAMPs present in the mouse intestine are not responsible for the selection against the Delta pmrF strain in this location, but limited alterations in innate immune induction were observed that affect bacterial survival and virulence.	[Strandberg, Kristi L.; Richards, Susan M.; Gunn, John S.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Tamayo, Rita; Reeves, Linh T.; Gunn, John S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University System of Ohio; Ohio State University; University of Texas System; University of Texas Health San Antonio	Gunn, JS (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA.	gunn.43@osu.edu	Gunn, John/E-3167-2011		National Institutes of Health (NIH) [AI043521]; Ohio State University Graduate School through the Dean's Distinguished University Fellowship; T32 Lung Inflammation Training Grant [HL007946]; Department of Microbial Infection and Immunity/Center for Microbial Interface Biology at The Ohio State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043521] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Graduate School through the Dean's Distinguished University Fellowship; T32 Lung Inflammation Training Grant; Department of Microbial Infection and Immunity/Center for Microbial Interface Biology at The Ohio State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the National Institutes of Health (NIH) through an RO1 Grant awarded to J.S.G. (AI043521), The Ohio State University Graduate School through the Dean's Distinguished University Fellowship to S.M.R., and T32 Lung Inflammation Training Grant (HL007946) awarded to K.L.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the current and former members of the Gunn lab and the Department of Microbial Infection and Immunity/Center for Microbial Interface Biology at The Ohio State University for their guidance and support. Special thanks to Dr. McKenzie and Dr. Rothenberg for providing the IL-13 KO mice. Thanks to Dr. Bradford McGwire and the McGwire lab for providing CRAMP KO mice on the FvB and BALB/c backgrounds. Thanks to Sean P. Colgan (University of Colorado Health Science Center, Denver, CO) and Geraldine O. Canny (Central University Hospital of Vaud, Lausanne, Switzerland) for performing the BPI experiments.	Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bader MW, 2003, MOL MICROBIOL, V50, P219, DOI 10.1046/j.1365-2958.2003.03675.x; BELDEN WJ, 1994, INFECT IMMUN, V62, P5095, DOI 10.1128/IAI.62.11.5095-5101.1994; Danahay H, 2002, AM J PHYSIOL-LUNG C, V282, pL226, DOI 10.1152/ajplung.00311.2001; Froelich JM, 2006, J BACTERIOL, V188, P1180, DOI 10.1128/JB.188.3.1180-1183.2006; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; Gunn JS, 2008, TRENDS MICROBIOL, V16, P284, DOI 10.1016/j.tim.2008.03.007; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Gunn JS, 1996, J BACTERIOL, V178, P6857, DOI 10.1128/jb.178.23.6857-6864.1996; Gunn JS, 1998, MOL MICROBIOL, V27, P1171, DOI 10.1046/j.1365-2958.1998.00757.x; Guo L, 1997, SCIENCE, V276, P250, DOI 10.1126/science.276.5310.250; JONES DE, 1992, J BIOL CHEM, V267, P23216; Kawasaki K, 2004, J ENDOTOXIN RES, V10, P439, DOI 10.1179/096805104225006264; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; McPhee JB, 2006, J BACTERIOL, V188, P3995, DOI 10.1128/JB.00053-06; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Oyston PCF, 2000, INFECT IMMUN, V68, P3419, DOI 10.1128/IAI.68.6.3419-3425.2000; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Pastelin-Palacios R, 2011, IMMUNOLOGY, V133, P469, DOI 10.1111/j.1365-2567.2011.03459.x; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Radek K, 2007, SEMIN IMMUNOPATHOL, V29, P27, DOI 10.1007/s00281-007-0064-5; Richards SM, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00102; ROLAND KL, 1993, J BACTERIOL, V175, P4154, DOI 10.1128/JB.175.13.4154-4164.1993; Rosenberger CM, 2004, P NATL ACAD SCI USA, V101, P2422, DOI 10.1073/pnas.0304455101; Salzman NH, 2003, NATURE, V422, P522, DOI 10.1038/nature01520; SELSTED ME, 1992, J CELL BIOL, V118, P929, DOI 10.1083/jcb.118.4.929; Steinstraesser L, 2010, IMMUNOBIOLOGY; Tamayo R, 2005, FEMS IMMUNOL MED MIC, V43, P249, DOI 10.1016/j.femsim.2004.08.007; Tamayo R, 2002, INFECT IMMUN, V70, P6770, DOI 10.1128/IAI.70.12.6770-6778.2002; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; ZASLOFF M, 1992, CURR OPIN IMMUNOL, V4, P3, DOI 10.1016/0952-7915(92)90115-U	34	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49588	10.1371/journal.pone.0049588	http://dx.doi.org/10.1371/journal.pone.0049588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166721	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300057
J	Abella, J; Alba, DM; Robles, JM; Valenciano, A; Rotgers, C; Carmona, R; Montoya, P; Morales, J				Abella, Juan; Alba, David M.; Robles, Josep M.; Valenciano, Alberto; Rotgers, Cheyenn; Carmona, Rauel; Montoya, Plinio; Morales, Jorge			Kretzoiarctos gen. nov., the Oldest Member of the Giant Panda Clade	PLOS ONE			English	Article							CARNIVORA; PHYLOGENY; URSIDAE; RADIATION; EVOLUTION; MAMMALIA; SPAIN; SKULL	The phylogenetic position of the giant panda, Ailuropoda melanoleuca (Carnivora: Ursidae: Ailuropodinae), has been one of the most hotly debated topics by mammalian biologists and paleontologists during the last century. Based on molecular data, it is currently recognized as a true ursid, sister-taxon of the remaining extant bears, from which it would have diverged by the Early Miocene. However, from a paleobiogeographic and chronological perspective, the origin of the giant panda lineage has remained elusive due to the scarcity of the available Miocene fossil record. Until recently, the genus Ailurarctos from the Late Miocene of China (ca. 8-7 mya) was recognized as the oldest undoubted member of the Ailuropodinae, suggesting that the panda lineage might have originated from an Ursavus ancestor. The role of the purported ailuropodine Agriarctos, from the Miocene of Europe, in the origins of this clade has been generally dismissed due to the paucity of the available material. Here, we describe a new ailuropodine genus, Kretzoiarctos gen. nov., based on remains from two Middle Miocene (ca. 12-11 Ma) Spanish localities. A cladistic analysis of fossil and extant members of the Ursoidea confirms the inclusion of the new genus into the Ailuropodinae. Moreover, Kretzoiarctos precedes in time the previously-known, Late Miocene members of the giant panda clade from Eurasia (Agriarctos and Ailurarctos). The former can be therefore considered the oldest recorded member of the giant panda lineage, which has significant implications for understanding the origins of this clade from a paleobiogeographic viewpoint.	[Abella, Juan; Morales, Jorge] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Abella, J (corresponding author), CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain.	juan.abella@gmail.com	Morales, Jorge/L-1476-2014; Alba, David/G-9716-2015; Vaquero, Alberto Valenciano/N-8757-2019; Abella, Juan/AAB-1040-2020	Morales, Jorge/0000-0001-5170-5754; Alba, David/0000-0002-8886-5580; Vaquero, Alberto Valenciano/0000-0003-1633-2248; Abella, Juan/0000-0002-3433-6093; Robles Gimenez, Josep Maria/0000-0002-5410-3529				Abella J, 2011, ESTUD GEOL-MADRID, V67, P187, DOI 10.3989/egeol.40714.182; Agnarsson I, 2010, MOL PHYLOGENET EVOL, V54, P726, DOI 10.1016/j.ympev.2009.10.033; Alba D.M., 2006, Estudios Geologicos (Madrid), V62, P295; Alba D.M., 2011, PALEONTOL EVOL MEM E, V6, P95; Alba David M., 2009, Paleolusitana, V1, P59; Alvarez Sierra Ma. Angeles, 2003, Coloquios de Paleontologia Volumen Extraordinario, V1, P25; Baryshnikov Gennady F., 2002, Russian Journal of Theriology, V1, P83; Bernor Raymond L., 2003, P105; Bininda-Emonds Olaf R. P., 2004, P11; Bininda-Emonds ORP, 1999, BIOL REV, V74, P143, DOI 10.1017/S0006323199005307; Casanovas-Vilar I., 2011, PALEONTOL EVOL MEM E, V6, P55; Casanovas-Vilar I, 2011, P NATL ACAD SCI USA, V108, P5554, DOI 10.1073/pnas.1018562108; CHORN J, 1978, MAMMALIAN SPECIES, V110, P1, DOI DOI 10.2307/3503982; DAVIS D. DWIGHT, 1955, FIELDIANA ZOOL, V37, P25; Erdbrink DP, 1953, REV FOSSIL RECENT BE, P89; Ewer, 1998, CARNIVORES; Figueirido B, 2012, J ZOOL, V286, P293, DOI 10.1111/j.1469-7998.2011.00879.x; Figueirido B, 2010, J EVOLUTION BIOL, V23, P2579, DOI 10.1111/j.1420-9101.2010.02117.x; Figueirido B, 2011, NATURWISSENSCHAFTEN, V98, P107, DOI 10.1007/s00114-010-0748-x; Fraile S., 1997, AVANCES CONOCIMIENTO, P77; Fulton TL, 2006, MOL PHYLOGENET EVOL, V41, P165, DOI 10.1016/j.ympev.2006.05.025; Garces W, 2003, COLPA, P171; Ginsburg Leonard, 1998, Annales de Paleontologie, V84, P71, DOI 10.1016/S0753-3969(98)80003-7; Ginsburg Leonard, 1999, P109; Huang Wanpo, 1993, Vertebrata Palasiatica, V31, P191; Hunt Robert M. Jr., 2004, P45; Jin CZ, 2007, P NATL ACAD SCI USA, V104, P10932, DOI 10.1073/pnas.0704198104; Koufos GD, 2011, ESTUD GEOL-MADRID, V67, P291, DOI 10.3989/egeol.40560.190; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; KRETZOI MIKLOS, 1942, FOLDTANI KOZLONY, V72, P350; McKenna MC, 1997, CLASSIFICATION MAMMA; Mein Pierre, 2002, Cahiers Scientifiques Museum d'Histoire Naturelle de Lyon, V2, P7; Menouret Bernard, 2008, Documents des Laboratoires de Geologie Lyon, V165, P1; Montoya P., 2001, Scripta Geologica, V122, P123; Moya-Sola S, 2009, AM J PHYS ANTHROPOL, V139, P126, DOI 10.1002/ajpa.20891; Nash WG, 1998, CYTOGENET CELL GENET, V83, P182, DOI 10.1159/000015176; Pages M, 2008, MOL PHYLOGENET EVOL, V47, P73, DOI 10.1016/j.ympev.2007.10.019; Qi Guoqin, 2006, Chinese Science Bulletin, V51, P704, DOI 10.1007/s11434-006-0704-5; Qiu Zhanxiang, 1989, Vertebrata Palasiatica, V27, P153; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; THENIUS E, 1979, Z SAUGETIERKD, V44, P286; Tobien H., 1955, Notizblatt des Hessischen Landesamtes fuer Bodenforschung, V83, P7; Viret J., 1950, Eclogae Geologicae Helvetiae, V42, P469; Viret J., 1948, ANN PALEONTOL, V34, P19; Waits Lisette P., 2004, P36	45	40	41	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48985	10.1371/journal.pone.0048985	http://dx.doi.org/10.1371/journal.pone.0048985			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155439	Green Published, gold			2022-12-27	WOS:000311151900074
J	Beaumont, A; Burton, AR; Lemon, J; Bennett, BK; Lloyd, A; Vollmer-Conna, U				Beaumont, Alison; Burton, Alexander R.; Lemon, Jim; Bennett, Barbara K.; Lloyd, Andrew; Vollmer-Conna, Ute			Reduced Cardiac Vagal Modulation Impacts on Cognitive Performance in Chronic Fatigue Syndrome	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; PROCESSING SPEED; SLEEP QUALITY; INTEGRITY	Background: Cognitive difficulties and autonomic dysfunction have been reported separately in patients with chronic fatigue syndrome (CFS). A role for heart rate variability (HRV) in cognitive flexibility has been demonstrated in healthy individuals, but this relationship has not as yet been examined in CFS. The objective of this study was to examine the relationship between HRV and cognitive performance in patients with CFS. Methods: Participants were 30 patients with CFS and 40 healthy controls; the groups were matched for age, sex, education, body mass index, and hours of moderate exercise/week. Questionnaires were used to obtain relevant medical and demographic information, and assess current symptoms and functional impairment. Electrocardiograms, perceived fatigue/effort and performance data were recorded during cognitive tasks. Between-group differences in autonomic reactivity and associations with cognitive performance were analysed. Results: Patients with CFS showed no deficits in performance accuracy, but were significantly slower than healthy controls. CFS was further characterized by low and unresponsive HRV; greater heart rate (HR) reactivity and prolonged HR-recovery after cognitive challenge. Fatigue levels, perceived effort and distress did not affect cognitive performance. HRV was consistently associated with performance indices and significantly predicted variance in cognitive outcomes. Conclusions: These findings reveal for the first time an association between reduced cardiac vagal tone and cognitive impairment in CFS and confirm previous reports of diminished vagal activity.	[Beaumont, Alison; Burton, Alexander R.; Lemon, Jim; Vollmer-Conna, Ute] Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia	University of New South Wales Sydney	Beaumont, A (corresponding author), Univ New S Wales, Sch Psychiat, Sydney, NSW, Australia.	ute@unsw.edu.au	Burton, Alexander/AAZ-3504-2021; Lloyd, Andrew/E-7334-2017; Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/AAF-6071-2022	Burton, Alexander/0000-0003-4780-0753; Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887				Bernardi L, 2001, BRIT MED J, V323, P1446, DOI 10.1136/bmj.323.7327.1446; Boneva RS, 2007, AUTON NEUROSCI-BASIC, V137, P94, DOI 10.1016/j.autneu.2007.08.002; Burton AR, 2010, EXP BRAIN RES, V204, P71, DOI 10.1007/s00221-010-2296-1; Buysse D J, 1989, Psychiatry Res, V28, P193; Camm AJ, 1996, CIRCULATION, V93, P1043; Capuron L, 2006, NEUROPSYCHOPHARMACOL, V31, P1777, DOI 10.1038/sj.npp.1301005; Constant EL, 2011, CLIN NEUROL NEUROSUR, V113, P295, DOI 10.1016/j.clineuro.2010.12.002; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Critchley HD, 2009, INT J PSYCHOPHYSIOL, V73, P88, DOI 10.1016/j.ijpsycho.2009.01.012; Damasio A.R., 2005, DESCARTES ERROR EMOT; Del Pozo JM, 2004, AM HEART J, V147, pG1, DOI 10.1016/j.ahj.2003.08.013; Duschek S, 2008, J PSYCHOPHYSIOL, V22, P81, DOI 10.1027/0269-8803.22.2.81; Ebben MR, 2009, APPL PSYCHOPHYS BIOF, V34, P245, DOI 10.1007/s10484-009-9086-1; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Goldberger JJ, 2006, AM J PHYSIOL-HEART C, V290, pH2446, DOI 10.1152/ajpheart.01118.2005; Hansen AL, 2003, INT J PSYCHOPHYSIOL, V48, P263, DOI 10.1016/S0167-8760(03)00073-4; Hickie I, 2006, BRIT MED J, V333, P575, DOI 10.1136/bmj.38933.585764.AE; Hickie IB, 2001, MED J AUSTRALIA, V175, pS10; Johnsen BH, 2003, J ANXIETY DISORD, V17, P75, DOI 10.1016/S0887-6185(02)00178-0; Kadota Y, 2010, BIOL PSYCHOL, V85, P97, DOI 10.1016/j.biopsycho.2010.05.009; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kim DH, 2006, J AM GERIATR SOC, V54, P1751, DOI 10.1111/j.1532-5415.2006.00940.x; Lemon J., 1990, 9 NAT DRUG ALC RES C; Loo CK, 2012, EXPERT REV NEUROTHER, V12, P751, DOI [10.1586/ern.12.67, 10.1586/ERN.12.67]; Maier Steven F, 2006, Dialogues Clin Neurosci, V8, P397; Maier SF, 2010, BRAIN RES, V1355, P52, DOI 10.1016/j.brainres.2010.08.039; Martinmaki K, 2008, EUR J APPL PHYSIOL, V102, P353, DOI 10.1007/s00421-007-0594-5; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Michiels V, 2001, ACTA PSYCHIAT SCAND, V103, P84, DOI 10.1034/j.1600-0447.2001.00017.x; Penke L, 2012, MOL PSYCHIATR, V17, P1026, DOI 10.1038/mp.2012.66; Penke L, 2010, J NEUROSCI, V30, P7569, DOI 10.1523/JNEUROSCI.1553-10.2010; Rahman K, 2011, SLEEP, V34, P671, DOI 10.1093/sleep/34.5.671; Schrijvers D, 2009, J AFFECT DISORDERS, V115, P46, DOI 10.1016/j.jad.2008.08.010; Shcheslavskaya OV, 2010, PSYCHOSOM MED, V72, P128, DOI 10.1097/PSY.0b013e3181c94ca0; Short K, 2002, J PSYCHOSOM RES, V52, P475, DOI 10.1016/S0022-3999(02)00290-8; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Turken AU, 2008, NEUROIMAGE, V42, P1032, DOI 10.1016/j.neuroimage.2008.03.057; Vollmer-Conna U, 2006, PHARMACOGENOMICS, V7, P355, DOI 10.2217/14622416.7.3.355; Vollmer-Conna U, 2008, CLIN INFECT DIS, V47, P1418, DOI 10.1086/592967; Vollmer-Conna U, 2010, ARCH PEDIAT ADOL MED, V164, P879, DOI 10.1001/archpediatrics.2010.149; VollmerConna U, 1997, BRIT J PSYCHIAT, V171, P377, DOI 10.1192/bjp.171.4.377; VonKorff M, 1996, J CLIN EPIDEMIOL, V49, P297, DOI 10.1016/0895-4356(95)00512-9; Wyller VB, 2008, ANN NONINVAS ELECTRO, V13, P67, DOI 10.1111/j.1542-474X.2007.00202.x	45	62	63	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49518	10.1371/journal.pone.0049518	http://dx.doi.org/10.1371/journal.pone.0049518			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23166694	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900154
J	Brehmer, F; Bendix, I; Prager, S; van de Looij, Y; Reinboth, BS; Zimmermanns, J; Schlager, GW; Brait, D; Sifringer, M; Endesfelder, S; Sizonenko, S; Mallard, C; Buhrer, C; Felderhoff-Mueser, U; Gerstner, B				Brehmer, Felix; Bendix, Ivo; Prager, Sebastian; van de Looij, Yohan; Reinboth, Barbara S.; Zimmermanns, Julia; Schlager, Gerald W.; Brait, Daniela; Sifringer, Marco; Endesfelder, Stefanie; Sizonenko, Stephane; Mallard, Carina; Buehrer, Christoph; Felderhoff-Mueser, Ursula; Gerstner, Bettina			Interaction of Inflammation and Hyperoxia in a Rat Model of Neonatal White Matter Damage	PLOS ONE			English	Article							BACTERIAL-ENDOTOXIN SENSITIZES; NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; INDUCED CELL-DEATH; PERIVENTRICULAR LEUKOMALACIA; DEVELOPING OLIGODENDROCYTES; MICROGLIAL TOXICITY; DIFFUSION TENSOR; UP-REGULATION; BRAIN-DAMAGE	Intrauterine infection and inflammation are major reasons for preterm birth. The switch from placenta-mediated to lung-mediated oxygen supply during birth is associated with a sudden rise of tissue oxygen tension that amounts to relative hyperoxia in preterm infants. Both infection/inflammation and hyperoxia have been shown to be involved in brain injury of preterm infants. Hypothesizing that they might be additive or synergistic, we investigated the influence of a systemic lipopolysaccharide (LPS) application on hyperoxia-induced white matter damage (WMD) in newborn rats. Three-day-old Wistar rat pups received 0.25 mg/kg LPS i.p. and were subjected to 80% oxygen on P6 for 24 h. The extent of WMD was assessed by immunohistochemistry, western blots, and diffusion tensor (DT) magnetic resonance imaging (MRI). In addition, the effects of LPS and hyperoxia were studied in an in vitro co-culture system of primary rat oligodendrocytes and microglia cells. Both noxious stimuli, hyperoxia, and LPS caused hypomyelination as revealed by western blot, immunohistochemistry, and altered WM microstructure on DT-MRI. Even so, cellular changes resulting in hypomyelination seem to be different. While hyperoxia induces cell death, LPS induces oligodendrocyte maturity arrest without cell death as revealed by TUNEL-staining and immunohistological maturation analysis. In the two-hit scenario cell death is reduced compared with hyperoxia treated animals, nevertheless white matter alterations persist. Concordantly with these in vivo findings we demonstrate that LPS pre-incubation reduced premyelinating-oligodendrocyte susceptibility towards hyperoxia in vitro. This protective effect might be caused by upregulation of interleukin-10 and superoxide dismutase expression after LPS stimulation. Reduced expression of transcription factors controlling oligodendrocyte development and maturation further indicates oligodendrocyte maturity arrest. The knowledge about mechanisms that triggered hypomyelination contributes to a better understanding of WMD in premature born infants.	[Brehmer, Felix; Zimmermanns, Julia; Endesfelder, Stefanie; Buehrer, Christoph] Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Brehmer, F (corresponding author), Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany.	felix.brehmer@charite.de	Sizonenko, Stephane/GXV-9222-2022; Felderhoff-Müser, Ursula/AAU-9682-2020; Endesfelder, Stefanie/AAA-5534-2022	Endesfelder, Stefanie/0000-0002-4030-7969; Sizonenko, Stephane/0000-0003-0093-8747; Bendix, Ivo/0000-0002-9751-3640; Mallard, Carina/0000-0001-8953-919X; van de Looij, Yohan/0000-0003-2830-5482				Acarin L, 2007, GLIA, V55, P954, DOI 10.1002/glia.20518; Aden U, 2010, BRAIN BEHAV IMMUN, V24, P747, DOI 10.1016/j.bbi.2009.10.010; Andiman SE, 2010, BRAIN PATHOL, V20, P803, DOI 10.1111/j.1750-3639.2010.00380.x; Andrews WW, 1995, INFECT AGENT DIS, V4, P196; Back SA, 2001, J NEUROSCI, V21, P1302; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Baud O, 2004, EUR J NEUROSCI, V20, P29, DOI 10.1111/j.0953-816X.2004.03451.x; Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Boksa P, 2010, BRAIN BEHAV IMMUN, V24, P881, DOI 10.1016/j.bbi.2010.03.005; Buser JR, 2012, ANN NEUROL, V71, P93, DOI 10.1002/ana.22627; Cai ZW, 2003, BRAIN RES, V975, P37, DOI 10.1016/S0006-8993(03)02545-9; Castillo A, 2008, PEDIATRICS, V121, P882, DOI 10.1542/peds.2007-0117; Clancy B, 2001, NEUROSCIENCE, V105, P7, DOI 10.1016/S0306-4522(01)00171-3; Collins MP, 2001, PEDIATR RES, V50, P712, DOI 10.1203/00006450-200112000-00014; Dammann O, 1998, Semin Pediatr Neurol, V5, P190, DOI 10.1016/S1071-9091(98)80034-X; Deng Yi Yu, 2011, Front Biosci (Schol Ed), V3, P884; Deulofeut R, 2006, J PERINATOL, V26, P700, DOI 10.1038/sj.jp.7211608; Durukan A, 2010, EXP TRANSL STROKE ME, V21, P2, DOI DOI 10.1186/2040-7378-2-2; Dzietko M, 2008, ANN NEUROL, V64, P664, DOI 10.1002/ana.21516; Eklind S, 2001, EUR J NEUROSCI, V13, P1101, DOI 10.1046/j.0953-816x.2001.01474.x; Eklind S, 2005, PEDIATR RES, V58, P112, DOI 10.1203/01.PDR.0000163513.03619.8D; Eklind S, 2006, PEDIATR RES, V60, P161, DOI 10.1203/01.pdr.0000228323.32445.7d; Favrais G, 2011, ANN NEUROL, V70, P550, DOI 10.1002/ana.22489; Felderhoff-Mueser U, 2005, ANN NEUROL, V57, P50, DOI 10.1002/ana.20322; Felderhoff-Mueser U, 2004, NEUROBIOL DIS, V17, P273, DOI 10.1016/j.nbd.2004.07.019; Follett PL, 2000, J NEUROSCI, V20, P9235; French HM, 2009, J NEUROSCI RES, V87, P3076, DOI 10.1002/jnr.22139; Gerstner B, 2008, J NEUROSCI, V28, P1236, DOI 10.1523/JNEUROSCI.3213-07.2008; Gerstner B, 2006, J NEUROSCI RES, V84, P306, DOI 10.1002/jnr.20880; Hagberg H, 2002, MENT RETARD DEV D R, V8, P30, DOI 10.1002/mrdd.10007; Haynes RL, 2005, BRAIN PATHOL, V15, P225; Haynes RL, 2008, PEDIATR RES, V63, P656, DOI 10.1203/PDR.0b013e31816c825c; Hickey E, 2011, PEDIATR RES, V70, P10, DOI 10.1203/PDR.0b013e31821d02aa; Hoehn T, 2003, PEDIATR RES, V54, P179, DOI 10.1203/01.PDR.0000075220.17631.F1; Huppi PS, 2006, SEMIN FETAL NEONAT M, V11, P489, DOI 10.1016/j.siny.2006.07.006; Ikeda T, 2006, PEDIATR RES, V59, P56, DOI 10.1203/01.pdr.0000191140.87314.ce; Kaindl AN, 2009, J CHILD NEUROL, V24, P1112, DOI 10.1177/0883073809337920; Kramer BC, 2002, NEUROSCIENCE, V114, P361, DOI 10.1016/S0306-4522(02)00310-X; Kumral A, 2007, NEONATOLOGY, V92, P269, DOI 10.1159/000105493; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; Lehnardt S, 2002, J NEUROSCI, V22, P2478, DOI 10.1523/JNEUROSCI.22-07-02478.2002; Li JR, 2008, J NEUROSCI, V28, P5321, DOI 10.1523/JNEUROSCI.3995-07.2008; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Li JR, 2003, J NEUROSCI, V23, P5816; Ligam P, 2009, PEDIATR RES, V65, P524, DOI 10.1203/PDR.0b013e3181998baf; Lin HY, 2009, PEDIATR RES, V66, P254, DOI 10.1203/PDR.0b013e3181b0d336; Longhi L, 2011, J CEREBR BLOOD F MET, V31, P1919, DOI 10.1038/jcbfm.2011.42; Mallard C, 2007, SEMIN FETAL NEONAT M, V12, P280, DOI 10.1016/j.siny.2007.01.014; Mallard C, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/102153; Mathews TJ, 2011, PEDIATRICS, V127, P146, DOI 10.1542/peds.2010-3175; Miller BA, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-28; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; NEEMAN M, 1991, MAGNET RESON MED, V21, P138, DOI 10.1002/mrm.1910210117; Pang Y, 2005, DEV BRAIN RES, V157, P141, DOI 10.1016/j.devbrainres.2005.03.015; Pang Y, 2003, DEV BRAIN RES, V140, P205, DOI 10.1016/S0165-3806(02)00606-5; Pang Y, 2010, NEUROSCIENCE, V166, P464, DOI 10.1016/j.neuroscience.2009.12.040; Pierson CR, 2007, ACTA NEUROPATHOL, V114, P619, DOI 10.1007/s00401-007-0295-5; Randis TM, 2010, CLIN PERINATOL, V37, P677, DOI 10.1016/j.clp.2010.06.001; Rodts-Palenik S, 2004, AM J OBSTET GYNECOL, V191, P1387, DOI 10.1016/j.ajog.2004.06.093; Rosenberg PA, 2003, J NEUROSCI RES, V71, P237, DOI 10.1002/jnr.10472; Rosenzweig HL, 2007, J CEREBR BLOOD F MET, V27, P1663, DOI 10.1038/sj.jcbfm.9600464; Rousset CI, 2008, J NEUROPATH EXP NEUR, V67, P994, DOI 10.1097/NEN.0b013e31818894a1; Schlapbach LJ, 2011, PEDIATRICS, V128, pE348, DOI 10.1542/peds.2010-3338; Schmitz T, 2011, J NEUROSCI, V31, P4327, DOI 10.1523/JNEUROSCI.3942-10.2011; Sifringer M, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.133; Sifringer M, 2010, BRAIN BEHAV IMMUN, V24, P792, DOI 10.1016/j.bbi.2009.08.010; Sifringer M, 2009, DEV NEUROSCI-BASEL, V31, P394, DOI 10.1159/000232557; Takashima S, 2009, SEMIN PEDIATR NEUROL, V16, P226, DOI 10.1016/j.spen.2009.09.004; Tasaki K, 1997, BRAIN RES, V748, P267, DOI 10.1016/S0006-8993(96)01383-2; Velten M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024544; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Vottier G, 2011, DEV NEUROSCI-BASEL, V33, P261, DOI 10.1159/000327245; Wagner DC, 2011, BRAIN RES, V1381, P237, DOI 10.1016/j.brainres.2011.01.041; Wang L, 2006, J NEUROSCI, V26, P5996, DOI 10.1523/JNEUROSCI.5380-05.2006; Wang XY, 2007, J NEUROPATH EXP NEUR, V66, P552, DOI 10.1097/01.jnen.0000263870.91811.6f; Yang L, 2004, J OBSTET GYNAECOL RE, V30, P142, DOI 10.1111/j.1447-0756.2003.00174.x; Yao S, 2010, NITRIC OXIDE-BIOL CH, V22, P197, DOI 10.1016/j.niox.2009.12.001; Zindler E, 2010, BEST PRACT RES-CLIN, V24, P551, DOI 10.1016/j.bpa.2010.11.001	78	65	70	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49023	10.1371/journal.pone.0049023	http://dx.doi.org/10.1371/journal.pone.0049023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155446	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900081
J	Bulvik, BE; Berenshtein, E; Meyron-Holtz, EG; Konijn, AM; Chevion, M				Bulvik, Baruch E.; Berenshtein, Eduard; Meyron-Holtz, Esther G.; Konijn, Abraham M.; Chevion, Mordechai			Cardiac Protection by Preconditioning Is Generated via an Iron-Signal Created by Proteasomal Degradation of Iron Proteins	PLOS ONE			English	Article							POSSIBLE PREDICTIVE CRITERIA; MYOCARDIAL-ISCHEMIA; HEME OXYGENASE-1; INTRACELLULAR FERRITIN; REPERFUSION INJURY; GENE-EXPRESSION; TISSUE-INJURY; FREE-RADICALS; BRAIN; CELLS	Ischemia associated injury of the myocardium is caused by oxidative damage during reperfusion. Myocardial protection by ischemic preconditioning (IPC) was shown to be mediated by a transient 'iron-signal' that leads to the accumulation of apoferritin and sequestration of reactive iron released during the ischemia. Here we identified the source of this 'iron-signal' and evaluated its role in the mechanisms of cardiac protection by hypoxic preconditioning. Rat hearts were retrogradely perfused and the effect of proteasomal and lysosomal protease inhibitors on ferritin levels were measured. The iron-signal was abolished, ferritin levels were not increased and cardiac protection was diminished by inhibition of the proteasome prior to IPC. Similarly, double amounts of ferritin and better recovery after ex vivo ischemia-and-reperfusion (I/R) were found in hearts from in vivo hypoxia pre-conditioned animals. IPC followed by normoxic perfusion for 30 min ('delay') prior to I/R caused a reduced ferritin accumulation at the end of the ischemia phase and reduced protection. Full restoration of the IPC-mediated cardiac protection was achieved by employing lysosomal inhibitors during the 'delay'. In conclusion, proteasomal protein degradation of iron-proteins causes the generation of the 'iron-signal' by IPC, ensuing de-novo apoferritin synthesis and thus, sequestering reactive iron. Lysosomal proteases are involved in subsequent ferritin breakdown as revealed by the use of specific pathway inhibitors during the 'delay'. We suggest that proteasomal iron-protein degradation is a stress response causing an expeditious cytosolic iron release thus, altering iron homeostasis to protect the myocardium during I/R, while lysosomal ferritin degradation is part of housekeeping iron homeostasis.	[Bulvik, Baruch E.; Berenshtein, Eduard; Chevion, Mordechai] Hebrew Univ Jerusalem, Fac Med Dent, Dept Cellular Biochem, Jerusalem, Israel	Hebrew University of Jerusalem	Bulvik, BE (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Dept Cellular Biochem, Jerusalem, Israel.	amkonijn@gmail.com	Meyron-Holtz, Esther/B-5991-2013					Berenshtein E, 1997, J MOL CELL CARDIOL, V29, P3025, DOI 10.1006/jmcc.1997.0535; Berenshtein E, 2002, MOL CELL BIOCHEM, V234, P283, DOI 10.1023/A:1015923202082; BOLLI R, 1990, AM J PHYSIOL, V259, pH1901, DOI 10.1152/ajpheart.1990.259.6.H1901; BOLLI R, 1989, P NATL ACAD SCI USA, V86, P4695, DOI 10.1073/pnas.86.12.4695; BONI RE, 1993, PHARMACOLOGY, V47, P318, DOI 10.1159/000139113; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Calabrese V, 2002, J NEUROSCI RES, V68, P65, DOI 10.1002/jnr.10177; CAO W, 1988, NEUROSCI LETT, V88, P233, DOI 10.1016/0304-3940(88)90132-2; Chen BL, 2010, ACTA BIOCH BIOPH SIN, V42, P253, DOI 10.1093/abbs/gmq012; CHEVION M, 1993, P NATL ACAD SCI USA, V90, P1102, DOI 10.1073/pnas.90.3.1102; Chevion M, 2008, J MOL CELL CARDIOL, V45, P839, DOI 10.1016/j.yjmcc.2008.08.011; Choi AMK, 1996, AM J RESP CELL MOL, V15, P9, DOI 10.1165/ajrcmb.15.1.8679227; De Domenico I, 2006, EMBO J, V25, P5396, DOI 10.1038/sj.emboj.7601409; Divald A, 2006, FREE RADICAL BIO MED, V40, P156, DOI 10.1016/j.freeradbiomed.2005.09.022; Drapier JC, 1996, METHOD ENZYMOL, V269, P26; Emerson MR, 1999, BRAIN RES, V825, P189, DOI 10.1016/S0006-8993(99)01195-6; GOLDHABER JI, 1992, HYPERTENSION, V20, P118, DOI 10.1161/01.HYP.20.1.118; GRACE PA, 1994, BRIT J SURG, V81, P637, DOI 10.1002/bjs.1800810504; Guan J, 2008, J CELL BIOCHEM, V105, P1298, DOI 10.1002/jcb.21930; Gurusamy N, 2008, J MOL CELL CARDIOL, V44, P419, DOI 10.1016/j.yjmcc.2007.10.005; HAILE DJ, 1989, MOL CELL BIOL, V9, P5055, DOI 10.1128/MCB.9.11.5055; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Jamieson RW, 2008, FRONT BIOSCI-LANDMRK, V13, P221, DOI 10.2741/2672; Kidane TZ, 2006, AM J PHYSIOL-CELL PH, V291, pC445, DOI 10.1152/ajpcell.00505.2005; Konijn AM, 1999, BLOOD, V94, P2128, DOI 10.1182/blood.V94.6.2128.418k20_2128_2134; KONIJN AM, 1977, BRIT J HAEMATOL, V37, P7, DOI 10.1111/j.1365-2141.1977.tb08806.x; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mehlhase J, 2005, FREE RADICAL BIO MED, V38, P276, DOI 10.1016/j.freeradbiomed.2004.10.025; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Nilsson UA, 2002, FREE RADICAL RES, V36, P677, DOI 10.1080/10715760290029128; Obolensky A, 2008, FREE RADICAL BIO MED, V44, P1286, DOI 10.1016/j.freeradbiomed.2007.10.060; PARKS DA, 1986, AM J PHYSIOL, V250, P749; Piper HM, 2004, CARDIOVASC RES, V61, P365, DOI 10.1016/j.cardiores.2003.12.012; Ponka P, 1998, SEMIN HEMATOL, V35, P35; Reno C, 1997, BIOTECHNIQUES, V22, P1082, DOI 10.2144/97226bm16; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Shimizu H, 2000, CRIT CARE MED, V28, P809, DOI 10.1097/00003246-200003000-00033; Vaisman B, 1997, BLOOD, V90, P831, DOI 10.1182/blood.V90.2.831.831_831_838; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; Wu G, 2004, J CARD FAIL, V10, P519, DOI 10.1016/j.cardfail.2004.02.002; Yang XL, 2010, CARDIOVASC DRUG THER, V24, P225, DOI 10.1007/s10557-010-6236-x; Yi L, 2009, J BIOL CHEM, V284, P20556, DOI 10.1074/jbc.M109.015651	44	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48947	10.1371/journal.pone.0048947	http://dx.doi.org/10.1371/journal.pone.0048947			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155431	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900066
J	Demuru, E; Palagi, E				Demuru, Elisa; Palagi, Elisabetta			In Bonobos Yawn Contagion Is Higher among Kin and Friends	PLOS ONE			English	Article							PAN-PANISCUS; POSSIBLE EXPRESSION; BEHAVIOR; EMPATHY; CONSOLATION; CHIMPANZEES; EVOLUTION; PRIMATES; CONTEXT; BRAIN	In humans, the distribution of yawn contagion is shaped by social closeness with strongly bonded pairs showing higher levels of contagion than weakly bonded pairs. This ethological finding led the authors to hypothesize that the phenomenon of yawn contagion may be the result of certain empathic abilities, although in their most basal form. Here, for the first time, we show the capacity of bonobos (Pan paniscus) to respond to yawns of conspecifics. Bonobos spontaneously yawned more frequently during resting/relaxing compared to social tension periods. The results show that yawn contagion was context independent suggesting that the probability of yawning after observing others' yawns is not affected by the propensity to engage in spontaneous yawns. As it occurs in humans, in bonobos the yawing response mostly occurred within the first minute after the perception of the stimulus. Finally, via a Linear Mixed Model we tested the effect of different variables (e.g., sex, rank, relationship quality) on yawn contagion, which increased when subjects were strongly bonded and when the triggering subject was a female. The importance of social bonding in shaping yawn contagion in bonobos, as it occurs in humans, is consistent with the hypothesis that empathy may play a role in the modulation of this phenomenon in both species. The higher frequency of yawn contagion in presence of a female as a triggering subject supports the hypothesis that adult females not only represent the relational and decisional nucleus of the bonobo society, but also that they play a key role in affecting the emotional states of others.	[Demuru, Elisa] Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy	University of Parma	Demuru, E (corresponding author), Univ Parma, Dipartimento Biol Evolut & Funz, I-43100 Parma, Italy.	betta.palagi@museo.unipi.it	Demuru, Elisa/ABD-8569-2020					ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Anderson JR, 2007, CURR BIOL, V17, pR242, DOI 10.1016/j.cub.2007.02.005; Anderson JR, 2004, P ROY SOC B-BIOL SCI, V271, pS468, DOI 10.1098/rsbl.2004.0224; Anderson JR, 2003, CURR PSYCHOL LETT, V11; Arnott SR, 2009, COGN AFFECT BEHAV NE, V9, P335, DOI 10.3758/CABN.9.3.335; Campbell MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018283; Campbell MW, 2009, P R SOC B, V276, P4255, DOI 10.1098/rspb.2009.1087; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; de Waal Frans B.M., 2012, P121; DEPUTTE BL, 1994, ETHOLOGY, V98, P221; DEWAAL FBM, 1988, BEHAVIOUR, V106, P183, DOI 10.1163/156853988X00269; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Doran DM, 2002, BEHAVIOURAL DIVERSITY IN CHIMPANZEES AND BONOBOS, P14, DOI 10.1017/CBO9780511606397.004; ENOMOTO T, 1990, PRIMATES, V31, P469, DOI 10.1007/BF02382531; Eslinger PJ, 1998, EUR NEUROL, V39, P193, DOI 10.1159/000007933; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Feshbach N.D., 1989, AGGRESSION WAR THEIR, P101; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; Fraser ON, 2008, P NATL ACAD SCI USA, V105, P8557, DOI 10.1073/pnas.0804141105; Furuichi T, 2011, EVOL ANTHROPOL, V20, P131, DOI 10.1002/evan.20308; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 2003, PHILOS T R SOC B, V358, P517, DOI 10.1098/rstb.2002.1234; Gallup AC, 2008, PHYSIOL BEHAV, V95, P10, DOI 10.1016/j.physbeh.2008.05.003; GIGANTI F, 2009, CURR PSYCHOL LETT, V25, P1; Giganti F, 2011, J ETHOL, V29, P215, DOI 10.1007/s10164-010-0242-0; GRECO M, 1993, PSYCHOL REC, V43, P175; Guggisberg AG, 2010, NEUROSCI BIOBEHAV R, V34, P1267, DOI 10.1016/j.neubiorev.2010.03.008; Haker H, 2009, EUR ARCH PSY CLIN N, V259, P352, DOI 10.1007/s00406-009-0007-3; Hare B, 2007, CURR BIOL, V17, P619, DOI 10.1016/j.cub.2007.02.040; Hare Brian, 2012, P175; Hare B, 2012, ANIM BEHAV, V83, P573, DOI 10.1016/j.anbehav.2011.12.007; Hare B, 2010, CURR BIOL, V20, pR230, DOI 10.1016/j.cub.2009.12.038; Harr AL, 2009, ANIM COGN, V12, P833, DOI 10.1007/s10071-009-0233-0; Hecht EE, 2013, CEREB CORTEX, V23, P1014, DOI 10.1093/cercor/bhs097; Helt MS, 2010, CHILD DEV, V81, P1620, DOI 10.1111/j.1467-8624.2010.01495.x; Herrmann E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012438; Iacoboni M., 2012, PRIMATE MIND BUILT C, P32; Jaeggi AV, 2010, AM J PHYS ANTHROPOL, V143, P41, DOI 10.1002/ajpa.21288; JEANNEROD M, 1994, BEHAV BRAIN SCI, V17, P187, DOI 10.1017/S0140525X00034026; Joly-Mascheroni RM, 2008, BIOL LETTERS, V4, P446, DOI 10.1098/rsbl.2008.0333; Kano T., 1992, LAST APE; Kano T, 1980, HUM EVOL, V9, P243; Kuroda S., 1989, P184; Lanting F, 1997, BONOBO FORGOTTEN APE; LEHMANN HE, 1979, B MENNINGER CLIN, V43, P123; Makuuchi M, 2005, CEREB CORTEX, V15, P563, DOI 10.1093/cercor/bhh157; Martin P., 2007, MEASURING BEHAV INTR, V3; Massen JJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040697; Matikainen J, 2008, MED HYPOTHESES, V70, P488, DOI 10.1016/j.mehy.2007.06.027; Millen A, 2011, BIOL LETTERS, V7, P440, DOI 10.1098/rsbl.2010.0966; Mitani JC, 2002, ANIM BEHAV, V64, P727, DOI 10.1006/anbe.2002.4014; Nahab FB, 2009, HUM BRAIN MAPP, V30, P1744, DOI 10.1002/hbm.20638; Norscia I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028472; O'Hara SJ, 2011, ANIM BEHAV, V81, P335, DOI 10.1016/j.anbehav.2010.11.005; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; Palagi E, 2009, P NATL ACAD SCI USA, V106, P19262, DOI 10.1073/pnas.0910891106; Palagi E, 2006, INT J PRIMATOL, V27, P1257, DOI 10.1007/s10764-006-9071-y; Parish AR, 1996, HUM NATURE-INT BIOS, V7, P61, DOI 10.1007/BF02733490; Platek SM, 2003, COGNITIVE BRAIN RES, V17, P223, DOI 10.1016/S0926-6410(03)00109-5; Platek SM, 2005, COGNITIVE BRAIN RES, V23, P448, DOI 10.1016/j.cogbrainres.2004.11.011; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Provine RR, 2005, AM SCI, V93, P532, DOI 10.1511/2005.56.980; PROVINE RR, 1986, ETHOLOGY, V72, P109, DOI 10.1111/j.1439-0310.1986.tb00611.x; PROVINE RR, 1987, ETHOLOGY, V76, P152, DOI 10.1111/j.1439-0310.1987.tb00680.x; Rilling JK, 2012, SOC COGN AFFECT NEUR, V7, P369, DOI 10.1093/scan/nsr017; Rilling JK, 2006, EVOL ANTHROPOL, V15, P65, DOI 10.1002/evan.20095; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Roberts W, 1996, CHILD DEV, V67, P449, DOI 10.2307/1131826; Romero T, 2010, P NATL ACAD SCI USA, V107, P12110, DOI 10.1073/pnas.1006991107; Schurmann M, 2005, NEUROIMAGE, V24, P1260, DOI 10.1016/j.neuroimage.2004.10.022; Senju A, 2007, BIOLOGY LETT, V3, P706, DOI 10.1098/rsbl.2007.0337; Shamay-Tsoory SG, 2003, J COGNITIVE NEUROSCI, V15, P324, DOI 10.1162/089892903321593063; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Silva K, 2012, ANIM COGN, V15, P721, DOI 10.1007/s10071-012-0473-2; Stenberg RJ, 2009, COGNITIVE PSYCHOL; Strayer J, 2004, SOC DEV, V13, P1, DOI 10.1111/j.1467-9507.2004.00254.x; Tamietto M, 2009, P NATL ACAD SCI USA, V106, P17661, DOI 10.1073/pnas.0908994106; Vick SJ, 2010, AM J PRIMATOL, V72, P262, DOI 10.1002/ajp.20781; Walusinski O, 2004, REV NEUROL-FRANCE, V160, P1011, DOI 10.1016/S0035-3787(04)71138-8; Walusinski O, 2009, EUR NEUROL, V62, P180, DOI 10.1159/000228262; WRANGHAM RW, 1993, HUM NATURE-INT BIOS, V4, P47, DOI 10.1007/BF02734089; Yoon JMD, 2010, ANIM BEHAV, V79, pE1, DOI 10.1016/j.anbehav.2010.02.011; Zilli I, 2008, J SLEEP RES, V17, P303, DOI 10.1111/j.1365-2869.2008.00666.x	83	76	76	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49613	10.1371/journal.pone.0049613	http://dx.doi.org/10.1371/journal.pone.0049613			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166729	Green Published, gold			2022-12-27	WOS:000311151900174
J	Li, SL; Korkmaz, S; Loganathan, S; Weymann, A; Radovits, T; Barnucz, E; Hirschberg, K; Hegedus, P; Zhou, Y; Tao, L; Pali, S; Veres, G; Karck, M; Szabo, G				Li, Shiliang; Korkmaz, Sevil; Loganathan, Sivakkanan; Weymann, Alexander; Radovits, Tamas; Barnucz, Eniko; Hirschberg, Kristof; Hegedues, Peter; Zhou, Yan; Tao, Liang; Pali, Szabolcs; Veres, Gabor; Karck, Matthias; Szabo, Gabor			Acute Ethanol Exposure Increases the Susceptibility of the Donor Hearts to Ischemia/Reperfusion Injury after Transplantation in Rats	PLOS ONE			English	Article							REPERFUSION INJURY; TRANSCRIPTION FACTOR; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; DOWN-REGULATION; TIME-COURSE; TROPONIN-T; ALCOHOL; PROTEIN; INTOXICATION	Background: Many donor organs come from youths involved in alcohol-related accidental death. The use of cardiac allografts for transplantation from donors after acute poisoning is still under discussion while acute ethanol intoxication is associated with myocardial functional and morphological changes. The aims of this work were 1) to evaluate in rats the time-course cardiac effects of acute ethanol-exposure and 2) to explore how its abuse by donors might affect recipients in cardiac pump function after transplantation. Methods: Rats received saline or ethanol (3.45 g/kg, ip). We evaluated both the mechanical and electrical aspects of cardiac function 1 h, 6 h or 24 h after injection. Plasma cardiac troponin-T and glucose-levels were measured and histological examination of the myocardium was performed. In addition, heart transplantation was performed, in which donors received ethanol 6 h or 24 h prior to explantation. Graft function was measured 1 h or 24 h after transplantation. Myocardial TBARS-concentration was measured; mRNA and protein expression was assessed by quantitative real-time PCR and Western blot, respectively. Results: Ethanol administration resulted in decreased load-dependent (-34 +/- 9%) and load-independent (-33 +/- 12%) contractility parameters, LV end-diastolic pressure and elevated blood glucose levels at 1 h, which were reversed to the level of controls after 6 h and 24 h. In contrast to systolic dysfunction, active relaxation and passive stiffness are slowly recovered or sustained during 24 h. Moreover, troponin-T-levels were increased at 1 h, 6 h and 24 h after ethanol injection. ST-segment elevation (+47 +/- 10%), elongated QT-interval (+38 +/- 4%), enlarged cardiomyocyte, DNA-strand breaks, increased both mRNA and protein levels of superoxide dismutase-1, glutathione peroxydase-4, cytochrome-c-oxidase and metalloproteinase-9 were observed 24 h following ethanol-exposure. After heart transplantation, decreased myocardial contractility and relaxation, oxidative stress and altered protein expression were observed. Conclusions: These results demonstrate acute alcohol abuse increases the susceptibility of donor hearts to ischemia/reperfusion in a rat heart transplant model even though the global contractile function recovers 6 h after ethanol-administration.	[Li, Shiliang; Korkmaz, Sevil; Loganathan, Sivakkanan; Weymann, Alexander; Barnucz, Eniko; Hirschberg, Kristof; Hegedues, Peter; Pali, Szabolcs; Veres, Gabor; Karck, Matthias; Szabo, Gabor] Heidelberg Univ, Dept Cardiac Surg, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Li, SL (corresponding author), Heidelberg Univ, Dept Cardiac Surg, Heidelberg, Germany.	korkmaz@uni-heidelberg.de	Weymann, Alexander/AAQ-5115-2021; Hirschberg, Kristóf/AAH-9887-2020	Szabo, Gabor/0000-0001-6038-9968				Aasebo W, 2007, SCAND CARDIOVASC J, V41, P79, DOI 10.1080/14017430601091698; ANDO H, 1993, CLIN CARDIOL, V16, P443, DOI 10.1002/clc.4960160514; Buja LM, 2005, CARDIOVASC PATHOL, V14, P170, DOI 10.1016/j.carpath.2005.03.006; CHANG G, 1988, JAMA-J AM MED ASSOC, V260, P2533, DOI 10.1001/jama.260.17.2533; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Cox MJ, 2004, CIRCULATION, V109, P2123, DOI 10.1161/01.CIR.0000127429.53391.78; ETTINGER PO, 1978, AM HEART J, V95, P555, DOI 10.1016/0002-8703(78)90296-X; FORMAN DT, 1988, ANN CLIN LAB SCI, V18, P181; Freimark D, 1996, J HEART LUNG TRANSPL, V15, P150; GALINANES M, 1991, J HEART LUNG TRANSPL, V10, P79; Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Guan ZJ, 2004, J CARDIOVASC PHARM, V44, P696, DOI 10.1097/00005344-200412000-00012; Guo R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008757; GUPPY LJ, 1994, P W PHARMACOL SOC, V37, P77; Hajnoczky G, 2005, ALCOHOL CLIN EXP RES, V29, P693, DOI 10.1097/01.ALC.0000163493.45344.7A; Hannuksela ML, 2002, CRIT REV CL LAB SCI, V39, P225, DOI 10.1080/10408360290795529; Hantson P, 1999, QJM-MON J ASSOC PHYS, V92, P415, DOI 10.1093/qjmed/92.7.415; HEPP A, 1984, BASIC RES CARDIOL, V79, P230, DOI 10.1007/BF01908309; HEPP A, 1984, EUR HEART J, V5, P85; Kmecova J, 2010, EUR J PHARMACOL, V641, P187, DOI 10.1016/j.ejphar.2010.05.038; Korkmaz S, 2009, CIRCULATION, V120, P677, DOI 10.1161/CIRCULATIONAHA.109.870774; KUPARI M, 1990, AM J CARDIOL, V66, P1473, DOI 10.1016/0002-9149(90)90537-B; LANG F, 1993, RENAL PHYSIOL BIOCH, V16, P48; Limin T, 2009, ALCOHOL, V43, P51, DOI 10.1016/j.alcohol.2008.11.001; Ma H, 2011, EUR HEART J, V32, P1025, DOI 10.1093/eurheartj/ehq253; Ma H, 2009, J AM COLL CARDIOL, V54, P2187, DOI 10.1016/j.jacc.2009.04.100; Mandrekar P, 2008, J LEUKOCYTE BIOL, V84, P1335, DOI 10.1189/jlb.0407256; Moens AL, 2005, INT J CARDIOL, V100, P179, DOI 10.1016/j.ijcard.2004.04.013; Molina PE, 2003, ALCOHOL CLIN EXP RES, V27, P563, DOI 10.1097/01.ALC.0000057946.57330.F7; O'Keefe JH, 2007, J AM COLL CARDIOL, V50, P1009, DOI 10.1016/j.jacc.2007.04.089; Pacher P, 2008, NAT PROTOC, V3, P1422, DOI 10.1038/nprot.2008.138; Patel VB, 1997, ADVERSE DRUG REACT T, V16, P15; Patel VB, 2001, ALCOHOL CLIN EXP RES, V25, P882, DOI 10.1111/j.1530-0277.2001.tb02294.x; Potapov EV, 2001, TRANSPLANTATION, V71, P1394, DOI 10.1097/00007890-200105270-00007; Reilly ME, 1997, ALCOHOL CLIN EXP RES, V21, P792, DOI 10.1097/00000374-199708000-00005; RISINGER FO, 1992, LIFE SCI, V50, pPL113, DOI 10.1016/0024-3205(92)90463-Y; Spies C D, 2001, Curr Opin Crit Care, V7, P337; Szabo G, 1998, WORLD J SURG, V22, P791, DOI 10.1007/s002689900471; Szabo G, 2005, EUR J CARDIO-THORAC, V27, P226, DOI 10.1016/j.ejcts.2004.10.055; Szabo G, 2002, CIRC RES, V90, P100, DOI 10.1161/hh0102.102657; THOMAS AP, 1994, ALCOHOL CLIN EXP RES, V18, P121, DOI 10.1111/j.1530-0277.1994.tb00891.x; Wang GW, 2008, J MOL CELL CARDIOL, V44, P1016, DOI 10.1016/j.yjmcc.2008.03.020	42	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49237	10.1371/journal.pone.0049237	http://dx.doi.org/10.1371/journal.pone.0049237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155471	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900106
J	Miller, N; Gerlai, R				Miller, Noam; Gerlai, Robert			From Schooling to Shoaling: Patterns of Collective Motion in Zebrafish (Danio rerio)	PLOS ONE			English	Article							ANIMAL GROUPS; FISH SCHOOLS; EMERGENT PROPERTIES; BEHAVIOR; DEFINITIONS	Animal groups on the move can take different configurations. For example, groups of fish can either be 'shoals' or 'schools': shoals are simply aggregations of individuals; schools are shoals exhibiting polarized, synchronized motion. Here we demonstrate that polarization distributions of groups of zebrafish (Danio rerio) are bimodal, showing two distinct modes of collective motion corresponding to the definitions of shoaling and schooling. Other features of the group's motion also vary consistently between the two modes: zebrafish schools are faster and less dense than zebrafish shoals. Habituation to an environment can also alter the proportion of time zebrafish groups spend schooling or shoaling. Models of collective motion suggest that the degree and stability of group polarization increases with the group's density. Examining zebrafish groups of different sizes from 5 to 50, we show that larger groups are less polarized than smaller groups. Decreased fearfulness in larger groups may function similarly to habituation, causing them to spend more time shoaling than schooling, contrary to most models' predictions.	[Miller, Noam] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA	Princeton University	Miller, N (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	nymiller@princeton.edu; robert_gerlai@yahoo.com						Becco C, 2006, PHYSICA A, V367, P487, DOI 10.1016/j.physa.2005.11.041; Bode NWF, 2010, P ROY SOC B-BIOL SCI, V277, P3065, DOI 10.1098/rspb.2010.0855; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Czirok A, 2000, PHYSICA A, V281, P17, DOI 10.1016/S0378-4371(00)00013-3; Day RL, 2001, ANIM BEHAV, V62, P917, DOI 10.1006/anbe.2001.1820; Drai D, 2000, J NEUROSCI METH, V96, P119, DOI 10.1016/S0165-0270(99)00194-6; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; Krause J, 2002, LIVING GROUPS; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Miller N., 2012, ZEBRAFISH PROTOCOLS, P217; Miller N, 2007, BEHAV BRAIN RES, V184, P157, DOI 10.1016/j.bbr.2007.07.007; Miller N, 2011, BEHAV RES METHODS, V43, P964, DOI 10.3758/s13428-011-0090-z; Miller NY, 2008, BEHAV BRAIN RES, V193, P148, DOI 10.1016/j.bbr.2008.05.004; Mirabet V, 2007, ECOL MODEL, V201, P468, DOI 10.1016/j.ecolmodel.2006.10.018; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; PARTRIDGE BL, 1982, ANIM BEHAV, V30, P298, DOI 10.1016/S0003-3472(82)80270-4; PITCHER TJ, 1983, ANIM BEHAV, V31, P611, DOI 10.1016/S0003-3472(83)80087-6; Pitcher TJ., 1993, Behaviour of teleost fishes, P363, DOI 10.1007/978-94-011-1578-0_12; SHAW E, 1978, AM SCI, V66, P166; Viczek T, 1995, PHYS REV LETT, V75, P1226; Viscido SV, 2004, MAR ECOL PROG SER, V273, P239, DOI 10.3354/meps273239	23	133	137	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48865	10.1371/journal.pone.0048865	http://dx.doi.org/10.1371/journal.pone.0048865			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166599	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900054
J	Pang, XH; Liu, C; Shi, LC; Liu, R; Liang, D; Li, H; Cherny, SS; Chen, SL				Pang, Xiaohui; Liu, Chang; Shi, Linchun; Liu, Rui; Liang, Dong; Li, Huan; Cherny, Stacey S.; Chen, Shilin			Utility of the trnH-psbA Intergenic Spacer Region and Its Combinations as Plant DNA Barcodes: A Meta-Analysis	PLOS ONE			English	Article							LAND PLANTS; SPECIES IDENTIFICATION; PLASTID GENOME; RBCL; POLYPODIIDAE; COMPLEMENTS; PHYLOGENY; EVOLUTION; TAXONOMY; GENES	Background: The trnH-psbA intergenic spacer region has been used in many DNA barcoding studies. However, a comprehensive evaluation with rigorous sequence preprocessing and statistical testing on the utility of trnH-psbA and its combinations as DNA barcodes is lacking. Methodology/Principal Findings: Sequences were searched from GenBank for a meta-analysis on the usefulness of trnH-psbA and its combinations as DNA barcodes. After preprocessing, we constructed full and matching data sets that contained 17 983 trnH-psbA sequences and 2190 sets of trnH-psbA, matK, rbcL, and ITS2 sequences from the same sample, repectively. These datasets were used to analyze the ability of trnH-psbA and its combinations to discriminate species by the BLAST and BLAST+P methods. The Fisher's exact test was used to evaluate the significance of performance differences. For the full data set, the identification success rates of trnH-psbA exceeded 70% in 18 families and 12 genera, respectively. For the matching data set, the identification rates of trnH-psbA were significantly higher than those of the other loci in two families and four genera. Similarly, the identification rates of trnH-psbA+ITS2 were significantly higher than those of matK+rbcL in 18 families and 21 genera. Conclusion/Significane: This study provides valuable information on the higher utility of trnH-psbA and its combinations. We found that trnH-psbA+ITS2 combination performs better or equally well compared with other combinations in most taxonomic groups investigated. This information will guide the optimal usage of trnH-psbA and its combinations for species identification.	[Pang, Xiaohui; Liu, Chang; Shi, Linchun; Chen, Shilin] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS	Pang, XH (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	cliu@implad.ac.cn; slchen@implad.ac.cn	Liu, Chang/A-1148-2014; Cherny, Stacey S/B-3315-2008	Cherny, Stacey S/0000-0002-0269-3352				Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Borsch T, 2009, PLANT SYST EVOL, V282, P169, DOI 10.1007/s00606-009-0210-8; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; Evans KM, 2007, PROTIST, V158, P349, DOI 10.1016/j.protis.2007.04.001; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heinrich M, 2007, J ETHNOPHARMACOL, V111, P440; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Janssen T, 2005, PLANT SYST EVOL, V252, P175, DOI 10.1007/s00606-004-0264-6; Korotkova N, 2011, AM J BOT, V98, P1549, DOI 10.3732/ajb.1000502; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2008, P NATL ACAD SCI USA, V105, P2761, DOI 10.1073/pnas.0800476105; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kumar S, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-131; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mitchell A, 2008, AUST J ENTOMOL, V47, P169, DOI 10.1111/j.1440-6055.2008.00645.x; Newmaster SG, 2006, CAN J BOT, V84, P335, DOI 10.1139/B06-047; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Schneider H, 2004, SYST BOT, V29, P260, DOI 10.1600/036364404774195476; Seberg O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004598; Storchova H, 2007, PLANT SYST EVOL, V268, P235, DOI 10.1007/s00606-007-0582-6; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533	39	93	98	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48833	10.1371/journal.pone.0048833	http://dx.doi.org/10.1371/journal.pone.0048833			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155412	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900046
J	Patel, SR; Goodloe, R; De, G; Kowgier, M; Weng, J; Buxbaum, SG; Cade, B; Fulop, T; Gharib, SA; Gottlieb, DJ; Hillman, D; Larkin, EK; Lauderdale, DS; Li, L; Mukherjee, S; Palmer, L; Zee, P; Zhu, XF; Redline, S				Patel, Sanjay R.; Goodloe, Robert; De, Gourab; Kowgier, Matthew; Weng, Jia; Buxbaum, Sarah G.; Cade, Brian; Fulop, Tibor; Gharib, Sina A.; Gottlieb, Daniel J.; Hillman, David; Larkin, Emma K.; Lauderdale, Diane S.; Li, Li; Mukherjee, Sutapa; Palmer, Lyle; Zee, Phyllis; Zhu, Xiaofeng; Redline, Susan			Association of Genetic Loci with Sleep Apnea in European Americans and African-Americans: The Candidate Gene Association Resource (CARe)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HEART HEALTH; POPULATION; HYPOPNEA; PRESSURE; RISK; DESIGN; FAMILY; ADULTS; INDEX	Although obstructive sleep apnea (OSA) is known to have a strong familial basis, no genetic polymorphisms influencing apnea risk have been identified in cross-cohort analyses. We utilized the National Heart, Lung, and Blood Institute (NHLBI) Candidate Gene Association Resource (CARe) to identify sleep apnea susceptibility loci. Using a panel of 46,449 polymorphisms from roughly 2,100 candidate genes on a customized Illumina iSelect chip, we tested for association with the apnea hypopnea index (AHI) as well as moderate to severe OSA (AHI >= 15) in 3,551 participants of the Cleveland Family Study and two cohorts participating in the Sleep Heart Health Study. Among 647 African-Americans, rs11126184 in the pleckstrin (PLEK) gene was associated with OSA while rs7030789 in the lysophosphatidic acid receptor 1 (LPAR1) gene was associated with AHI using a chip-wide significance threshold of p-value<2 x 10(-6). Among 2,904 individuals of European ancestry, rs1409986 in the prostaglandin E2 receptor (PTGER3) gene was significantly associated with OSA. Consistency of effects between rs7030789 and rs1409986 in LPAR1 and PTGER3 and apnea phenotypes were observed in independent clinic-based cohorts. Novel genetic loci for apnea phenotypes were identified through the use of customized gene chips and meta-analyses of cohort data with replication in clinic-based samples. The identified SNPs all lie in genes associated with inflammation suggesting inflammation may play a role in OSA pathogenesis.	[Patel, Sanjay R.; Weng, Jia; Cade, Brian; Gottlieb, Daniel J.; Redline, Susan] Brigham & Womens Hosp, Div Sleep Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Patel, SR (corresponding author), Brigham & Womens Hosp, Div Sleep Med, 75 Francis St, Boston, MA 02115 USA.	spatel@partners.org	Palmer, Lyle John/N-1948-2019; Fulop, Tibor/H-7667-2019; Mukherjee, Sutapa/U-7262-2017; Cade, Brian/J-6770-2019; Zee, Phyllis C/GPF-3704-2022; Palmer, Lyle John/K-3196-2014; Buxbaum, Sarah G./E-1970-2013; Zhu, Xiaofeng/O-6874-2019	Palmer, Lyle John/0000-0002-1628-3055; Fulop, Tibor/0000-0002-3346-7040; Mukherjee, Sutapa/0000-0001-5021-1648; Cade, Brian/0000-0003-1424-0673; Palmer, Lyle John/0000-0002-1628-3055; Buxbaum, Sarah G./0000-0002-4886-3564; GHARIB, SINA A./0000-0002-2480-4367; Hillman, David/0000-0001-9987-539X; Zhu, Xiaofeng/0000-0003-0037-411X; Patel, Sanjay/0000-0002-9142-5172	NCI NIH HHS [U54 CA116867, CA116867] Funding Source: Medline; NCRR NIH HHS [UL1RR025005, UL1 RR025005] Funding Source: Medline; NHGRI NIH HHS [U01 HG004402, U01HG004402] Funding Source: Medline; NHLBI NIH HHS [R01 HL087641, N01 HC045133, HL081385, N01 HC035129, HHSN268201100006C, N01-HC-35129, N01 HC-55222, N01 HC-15103, HHSN268201100009I, N01HC85079, HHSN268201100012C, R01HL086694, HL080295, R01 HL080295, R01HL59367, R01 HL046380, HHSN268201100010C, HHSN268201100008C, U01 HL080295, HHSN268201100005G, HHSN268201100008I, K08 HL081385, R01 HL059367, N01-HC-85239, N01-HC-85079, HHSN268201100007I, N01-HC-45133, HHSN268201100007C, N01 HC015103, HHSN268201100005C, HHSN268201100011I, HHSN268201100011C, R01 HL086694, HL94092, R01HL087641, N01-HC-75150, HL46380, HHSN268201100005I, N01HC85086, N01HC75150, HHSN268201100009C, N01-HC-85086, N01HC55222] Funding Source: Medline; NIA NIH HHS [R01 AG015928, R56 AG020098, AG-027058, AG-15928, R01 AG027058, R01 AG020098, AG-20098, R56 AG023629, R01 AG023629, AG-023629] Funding Source: Medline; NIMHD NIH HHS [P20 MD006899] Funding Source: Medline; PHS HHS [268201100010C, 268201100005C, 268200625226C, 268201100009C, 268201100007C, 268201100008C, 268201100012C, 268201100011C, 268201100006C] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC035129, N01HC085079, N01HC085086, N01HC075150, N01HC055222, N01HC045133, N01HC015103] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [U54CA116867] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL087641, R01HL086694, R01HL046380, R01HL080295, U01HL080295] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027058, R01AG015928, R01AG023629, R56AG023629, R01AG020098, R56AG020098] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [P20MD006899] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))		Boyd JH, 2004, AM J RESP CRIT CARE, V170, P541, DOI 10.1164/rccm.200308-1100OC; Buxbaum SG, 2002, GENET EPIDEMIOL, V22, P243, DOI 10.1002/gepi.0170; Carmelli D, 2004, SLEEP, V27, P917, DOI 10.1093/sleep/27.5.917; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Ferreira MAR, 2009, AM J HUM GENET, V85, P745, DOI 10.1016/j.ajhg.2009.10.005; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Gottlieb DJ, 1999, AM J RESP CRIT CARE, V159, P502, DOI 10.1164/ajrccm.159.2.9804051; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kimoff RJ, 2011, EUR RESPIR J, V38, P89, DOI 10.1183/09031936.00048610; Kryger MH, 1996, SLEEP, V19, pS111, DOI 10.1093/sleep/19.suppl_9.S111; Larkin EK, 2010, AM J RESP CRIT CARE, V182, P947, DOI 10.1164/rccm.201002-0192OC; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lian LR, 2009, BLOOD, V113, P3577, DOI 10.1182/blood-2008-09-178913; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; MATHUR R, 1995, ANN INTERN MED, V122, P174, DOI 10.7326/0003-4819-122-3-199502010-00003; Maugeri N, 2011, HUM MUTAT, V32, P873, DOI 10.1002/humu.21536; Mukherjee S, 2012, SLEEP BREATH, V16, P205, DOI 10.1007/s11325-011-0491-3; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Palmer LJ, 2003, AM J HUM GENET, V72, P340, DOI 10.1086/346064; Patel SR, 2008, INT J OBESITY, V32, P795, DOI 10.1038/sj.ijo.0803803; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Punjabi NM, 2002, AM J RESP CRIT CARE, V165, P677, DOI 10.1164/ajrccm.165.5.2104087; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quan SF, 1997, SLEEP, V20, P1077; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 2003, SLEEP, V26, P703, DOI 10.1093/sleep/26.6.703; Redline S, 1998, SLEEP, V21, P759; Rosen CL, 2003, J PEDIATR-US, V142, P383, DOI 10.1067/mpd.2003.28; Rust G, 2004, J NATL MED ASSOC, V96, P1169; Sober S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006034; Teran-Santos J, 1999, NEW ENGL J MED, V340, P847, DOI 10.1056/NEJM199903183401104; Thompson CL, 2011, CANCER-AM CANCER SOC, V117, P841, DOI 10.1002/cncr.25507; Wilker E, 2009, ENVIRON HEALTH PERSP, V117, P935, DOI 10.1289/ehp.0800279; Wilker EH, 2009, ATHEROSCLEROSIS, V206, P480, DOI 10.1016/j.atherosclerosis.2009.03.004; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zhu XF, 2002, GENET EPIDEMIOL, V23, P181, DOI 10.1002/gepi.210; Zhu XF, 2011, HUM MOL GENET, V20, P2285, DOI 10.1093/hmg/ddr113	42	42	42	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48836	10.1371/journal.pone.0048836	http://dx.doi.org/10.1371/journal.pone.0048836			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155414	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900048
J	Talbot, B; Garant, D; Paquette, SR; Mainguy, J; Pelletier, F				Talbot, Benoit; Garant, Dany; Paquette, Sebastien Rioux; Mainguy, Julien; Pelletier, Fanie			Lack of Genetic Structure and Female-Specific Effect of Dispersal Barriers in a Rabies Vector, the Striped Skunk (Mephitis mephitis)	PLOS ONE			English	Article							RACCOON RABIES; POPULATION-STRUCTURE; LANDSCAPE BARRIERS; MULTIPLE-REGRESSION; COMPUTER-PROGRAM; FLOW; DISTANCE; SELECTION; ONTARIO; EPIDEMIOLOGY	Evaluating the permeability of potential barriers to movement, dispersal and gene exchanges can help describe spreading patterns of wildlife diseases. Here, we used landscape genetics methods to assess the genetic structure of the striped skunk (Mephitis mephitis), which is a frequent vector of rabies, a lethal zoonosis of great concern for public health. Our main objective was to identify landscape elements shaping the genetic structure of this species in Southern Quebec, Canada, in an area where the raccoon rabies variant has been detected. We hypothesised that geographic distance and landscape barriers, such as highways and major rivers, would modulate genetic structure. We genotyped a total of 289 individuals sampled across a large area (22,000 km(2)) at nice microsatellite loci. Genetic structure analyses identified a single genetic cluster in the study area. Major rivers and highways, however, influenced the genetic relatedness among sampled individuals. Sex-specific analyses revealed that rivers significantly limited dispersal only for females while highways only had marginal effects. Rivers and highways did not significantly affect male dispersal. These results support the contention that female skunks are more philopatric than males. Overall, our results suggest that the effects of major rivers and highways on dispersal are sex-specific and rather weak and are thus unlikely to prevent the spread of rabies within and among striped skunk populations.	[Talbot, Benoit; Garant, Dany; Paquette, Sebastien Rioux; Pelletier, Fanie] Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Talbot, B (corresponding author), Univ Sherbrooke, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada.	benoit.talbot@usherbrooke.ca	Garant, Dany/D-7406-2013; Talbot, Benoit/K-8225-2019	Garant, Dany/0000-0002-8091-1044; Mainguy, Julien/0000-0001-9532-5550; Talbot, Benoit/0000-0002-3567-1213; Rioux Paquette, Sebastien/0000-0002-7724-6813				Archie EA, 2009, TRENDS ECOL EVOL, V24, P21, DOI 10.1016/j.tree.2008.08.008; Banks SC, 2005, MOL ECOL, V14, P1667, DOI 10.1111/j.1365-294X.2005.02525.x; Barton HD, 2012, J MAMMAL, V93, P38, DOI 10.1644/10-MAMM-A-270.1; Barton HD, 2010, MOL ECOL, V19, P2725, DOI 10.1111/j.1365-294X.2010.04668.x; BJORGE RR, 1981, CAN FIELD NAT, V95, P149; Blanchong JA, 2008, BIOL LETTERS, V4, P130, DOI 10.1098/rsbl.2007.0523; Bretman A, 2011, MOL ECOL, V20, P3045, DOI 10.1111/j.1365-294X.2011.05140.x; Broadfoot JD, 2001, ECOL APPL, V11, P295, DOI 10.1890/1051-0761(2001)011[0295:RASPMF]2.0.CO;2; Broquet T, 2006, LANDSCAPE ECOL, V21, P877, DOI 10.1007/s10980-005-5956-y; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; Cegelski CC, 2003, MOL ECOL, V12, P2907, DOI 10.1046/j.1365-294X.2003.01969.x; Chambers JL, 2010, J HERED, V101, P413, DOI 10.1093/jhered/esq029; CHARLTON KM, 1988, REV INFECT DIS, V10, pS626; Coltman DW, 2003, MOL ECOL, V12, P733, DOI 10.1046/j.1365-294X.2003.01762.x; Costello CM, 2008, MOL ECOL, V17, P4713, DOI 10.1111/j.1365-294X.2008.03930.x; Cote H, 2012, EVOL APPL, V5, P393, DOI 10.1111/j.1752-4571.2012.00238.x; Cullingham CI, 2011, EVOL APPL, V4, P116, DOI 10.1111/j.1752-4571.2010.00142.x; Cullingham CI, 2009, MOL ECOL, V18, P43, DOI 10.1111/j.1365-294X.2008.03989.x; Cushman SA, 2006, AM NAT, V168, P486, DOI 10.1086/506976; Dragoo JW, 2009, MOL ECOL RESOUR, V9, P383, DOI 10.1111/j.1755-0998.2008.02463.x; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Epperson B. K., 2003, GEOGRAPHICAL GENETIC; Epps CW, 2007, J APPL ECOL, V44, P714, DOI 10.1111/j.1365-2664.2007.01325.x; Foerster K, 2006, MOL ECOL, V15, P4555, DOI 10.1111/j.1365-294X.2006.03091.x; Frantz AC, 2010, MOL ECOL, V19, P1663, DOI 10.1111/j.1365-294X.2010.04605.x; Frey SN, 2006, J WILDLIFE MANAGE, V70, P1111, DOI 10.2193/0022-541X(2006)70[1111:HUBMIA]2.0.CO;2; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Garant D, 2007, FUNCT ECOL, V21, P434, DOI 10.1111/j.1365-2435.2006.01228.x; Goldberg CS, 2010, MOL ECOL, V19, P3650, DOI 10.1111/j.1365-294X.2010.04673.x; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Guerra MA, 2003, EMERG INFECT DIS, V9, P1143; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; Hansen LA, 2003, WEST N AM NATURALIST, V63, P80; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keyghobadi N, 2005, MOL ECOL, V14, P1897, DOI 10.1111/j.1365-294X.2005.02563.x; Lambin X, 1998, J ANIM ECOL, V67, P1, DOI 10.1046/j.1365-2656.1998.00181.x; Lariviere S, 1999, AM MIDL NAT, V142, P96, DOI 10.1674/0003-0031(1999)142[0096:SBSSMM]2.0.CO;2; Lariviere S, 1998, J WILDLIFE MANAGE, V62, P199, DOI 10.2307/3802279; Lariviere S, 2000, CAN J ZOOL, V78, P366, DOI 10.1139/cjz-78-3-366; LEGENDRE P, 1994, EVOLUTION, V48, P1487, DOI 10.1111/j.1558-5646.1994.tb02191.x; Lichstein JW, 2007, PLANT ECOL, V188, P117, DOI 10.1007/s11258-006-9126-3; Macdonald DW, 2003, J BIOGEOGR, V30, P607, DOI 10.1046/j.1365-2699.2003.00874.x; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; MANTEL N, 1967, CANCER RES, V27, P209; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; Munguia-Vega A, 2009, CONSERV GENET RESOUR, V1, P437, DOI 10.1007/s12686-009-9101-0; Peterson MA, 1998, AM NAT, V152, P428, DOI 10.1086/286180; Poissant J, 2005, MOL ECOL, V14, P1321, DOI 10.1111/j.1365-294X.2005.02500.x; Porlier M, 2009, PHILOS T R SOC B, V364, P1543, DOI 10.1098/rstb.2009.0010; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rees EE, 2008, PREV VET MED, V86, P107, DOI 10.1016/j.prevetmed.2008.03.007; Rees EE, 2011, J WILDLIFE MANAGE, V75, P1406, DOI 10.1002/jwmg.178; Rees EE, 2009, BIOL LETTERS, V5, P387, DOI 10.1098/rsbl.2009.0094; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rosatte R, 2001, J WILDLIFE DIS, V37, P265, DOI 10.7589/0090-3558-37.2.265; Rosatte R., 2003, WILD MAMMALS N AM BI, P692; ROSATTE RC, 1984, CAN FIELD NAT, V98, P315; ROSATTE RC, 1991, NIUW SYMP S, V2, P31; Rosatte RC, 1997, WILDLIFE SOC B, V25, P110; RUPPRECHT CE, 1994, SEMIN VIROL, V5, P155, DOI 10.1006/smvy.1994.1016; Russell CA, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000027; SARGEANT AB, 1982, CAN FIELD NAT, V96, P312; Schulze K, 2005, ADV GEOSCI, V5, P133, DOI DOI 10.5194/ADGEO-5-133-2005; Selkoe KA, 2010, MOL ECOL, V19, P3708, DOI 10.1111/j.1365-294X.2010.04658.x; Shaw CN, 2003, J MAMMAL, V84, P123, DOI 10.1644/1545-1542(2003)084&lt;0123:ARMMOG&gt;2.0.CO;2; Shirk AJ, 2010, MOL ECOL, V19, P3603, DOI 10.1111/j.1365-294X.2010.04745.x; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Storfer A, 2007, HEREDITY, V98, P128, DOI 10.1038/sj.hdy.6800917; Ten Hwang Y, 2007, CAN J ZOOL, V85, P33, DOI 10.1139/Z06-192; Trenel P, 2008, MOL ECOL, V17, P3528, DOI 10.1111/j.1365-294X.2008.03853.x; Wang JL, 2002, GENETICS, V160, P1203; Zalewski A, 2009, MOL ECOL, V18, P1601, DOI 10.1111/j.1365-294X.2009.04131.x; Zhu LF, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-72	79	15	15	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49736	10.1371/journal.pone.0049736	http://dx.doi.org/10.1371/journal.pone.0049736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166760	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900187
J	Tao, XJ; Zhang, QF; Ling, K; Chen, YC; Yang, WZ; Gao, FF; Shi, GG				Tao, Xiaojun; Zhang, Qiufang; Ling, Kai; Chen, Yicun; Yang, Wenzhi; Gao, Fenfei; Shi, Ganggang			Effect of Pullulan Nanoparticle Surface Charges on HSA Complexation and Drug Release Behavior of HSA-Bound Nanoparticles	PLOS ONE			English	Article							CHOLESTEROL-BEARING PULLULAN; ASSEMBLED HYDROGEL NANOPARTICLE; SELF-AGGREGATED NANOPARTICLES; BOVINE SERUM-ALBUMIN; PHYSICOCHEMICAL CHARACTERISTICS; POLYMERIC NANOPARTICLES; PROTEIN ADSORPTION; GLYCOL CHITOSAN; PLASMA-PROTEINS; NANOGELS	Nanoparticle (NP) compositions such as hydrophobicity and surface charge are vital to determine the presence and amount of human serum albumin (HSA) binding. The HSA binding influences drug release, biocompatibility, biodistribution, and intercellular trafficking of nanoparticles (NPs). Here, we prepared 2 kinds of nanomaterials to investigate HSA binding and evaluated drug release of HSA-bound NPs. Polysaccharides (pullulan) carboxyethylated to provide ionic derivatives were then conjugated to cholesterol groups to obtain cholesterol-modified carboxyethyl pullulan (CHCP). Cholesterol-modified pullulan (CHP) conjugate was synthesized with a similar degree of substitution of cholesterol moiety to CHCP. CHCP formed self-aggregated NPs in aqueous solution with a spherical structure and zeta potential of -19.9 +/- 0.23 mV, in contrast to -1.21 +/- 0.12 mV of CHP NPs. NPs could quench albumin fluorescence intensity with maximum emission intensity gradually decreasing up to a plateau at 9 to 12 h. Binding constants were 1.12x10(5) M-1 and 0.70x10(5) M-1 to CHP and CHCP, respectively, as determined by Stern-Volmer analysis. The complexation between HSA and NPs was a gradual process driven by hydrophobic force and inhibited by NP surface charge and shell-core structure. HSA conformation was altered by NPs with reduction of alpha-helical content, depending on interaction time and particle surface charges. These NPs could represent a sustained release carrier for mitoxantrone in vitro, and the bound HSA assisted in enhancing sustained drug release.	[Tao, Xiaojun; Shi, Ganggang] Shantou Univ, Coll Med, Dept Cardiovasc Dis, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China	Shantou University	Tao, XJ (corresponding author), Shantou Univ, Coll Med, Dept Cardiovasc Dis, Affiliated Hosp 1, Shantou, Guangdong, Peoples R China.	ggshi@stu.edu.cn	Gao, Fenfei/S-5331-2019	Gao, Fenfei/0000-0003-4144-8891				Aggarwal P, 2009, ADV DRUG DELIVER REV, V61, P428, DOI 10.1016/j.addr.2009.03.009; Ahmad B, 2006, BIOMACROMOLECULES, V7, P1350, DOI 10.1021/bm050996b; Ahmad E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038372; Ahmad E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026186; Akiyama E, 2007, BIOMACROMOLECULES, V8, P2366, DOI 10.1021/bm070136q; Akiyoshi K, 1996, COLLOID SURFACE A, V112, P91, DOI 10.1016/0927-7757(96)03560-1; Akiyoshi K, 1997, MACROMOLECULES, V30, P857, DOI 10.1021/ma960786e; Akiyoshi K, 1998, J CONTROL RELEASE, V54, P313, DOI 10.1016/S0168-3659(98)00017-0; Alexis F, 2008, MOL PHARMACEUT, V5, P505, DOI 10.1021/mp800051m; Ayame H, 2008, BIOCONJUGATE CHEM, V19, P882, DOI 10.1021/bc700422s; Beduneau A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004343; Belatik A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036723; Boridy S, 2009, BIOMATERIALS, V30, P5583, DOI 10.1016/j.biomaterials.2009.06.010; Cedervall T, 2007, ANGEW CHEM INT EDIT, V46, P5754, DOI 10.1002/anie.200700465; Cedervall T, 2007, P NATL ACAD SCI USA, V104, P2050, DOI 10.1073/pnas.0608582104; Deguchi S, 1999, COLLOID SURFACE A, V147, P203, DOI 10.1016/S0927-7757(98)00754-7; Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f; Duan YR, 2006, J MATER SCI-MATER M, V17, P509, DOI 10.1007/s10856-006-8933-3; Dulong V, 2006, COLLOID SURFACE A, V274, P163, DOI 10.1016/j.colsurfa.2005.08.045; Froehlich E, 2009, J PHYS CHEM B, V113, P6986, DOI 10.1021/jp9011119; Fundueanu G, 2008, BIOMATERIALS, V29, P2767, DOI 10.1016/j.biomaterials.2008.03.025; Gessner A, 2002, EUR J PHARM BIOPHARM, V54, P165, DOI 10.1016/S0939-6411(02)00081-4; Ghaghada KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007628; Gokara M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008834; Grund S, 2012, J COLLOID INTERF SCI, V365, P33, DOI 10.1016/j.jcis.2011.09.003; Guven A, 2012, BIOMATERIALS, V33, P1455, DOI 10.1016/j.biomaterials.2011.10.060; Huang MH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012279; Jeong YI, 2006, J PHARM SCI-US, V95, P2348, DOI 10.1002/jps.20586; Karmali PP, 2011, EXPERT OPIN DRUG DEL, V8, P343, DOI 10.1517/17425247.2011.554818; Khan SN, 2008, EUR J PHARM SCI, V35, P371, DOI 10.1016/j.ejps.2008.07.010; Kwon S, 2003, LANGMUIR, V19, P10188, DOI 10.1021/la0350608; Lee ALZ, 2009, BIOMATERIALS, V30, P919, DOI 10.1016/j.biomaterials.2008.10.062; Lee I, 2004, BIOMATERIALS, V25, P2911, DOI 10.1016/j.biomaterials.2003.09.065; Lee KY, 1998, LANGMUIR, V14, P2329, DOI 10.1021/la970928d; Lindman S, 2007, NANO LETT, V7, P914, DOI 10.1021/nI062743+; Liu ZH, 2008, ADV DRUG DELIVER REV, V60, P1650, DOI 10.1016/j.addr.2008.09.001; Lundqvist M, 2004, LANGMUIR, V20, P10639, DOI 10.1021/la0484725; Lundqvist M, 2005, LANGMUIR, V21, P5974, DOI 10.1021/la050569j; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2008, NANO TODAY, V3, P40, DOI 10.1016/S1748-0132(08)70014-8; Lynch I, 2007, ADV COLLOID INTERFAC, V134-35, P167, DOI 10.1016/j.cis.2007.04.021; MAIA MBS, 1994, FUNDAM CLIN PHARM, V8, P178, DOI 10.1111/j.1472-8206.1994.tb00795.x; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Morimoto N, 2005, BIOMACROMOLECULES, V6, P1829, DOI 10.1021/bm050156x; Morimoto N, 2007, LANGMUIR, V23, P217, DOI 10.1021/la0616045; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; NISHIKAWA T, 1994, MACROMOLECULES, V27, P7654, DOI 10.1021/ma00104a021; Nishikawa T, 1996, J AM CHEM SOC, V118, P6110, DOI 10.1021/ja953843c; Roach P, 2006, J AM CHEM SOC, V128, P3939, DOI 10.1021/ja056278e; Sasaki Yoshihiro, 2011, Curr Drug Discov Technol, V8, P308; Shaikh VAE, 1998, J APPL POLYM SCI, V70, P195, DOI 10.1002/(SICI)1097-4628(19981003)70:1<195::AID-APP19>3.0.CO;2-6; Slomkowski S, 2011, CURR PHARM BIOTECHNO, V12, P1823, DOI 10.2174/138920111798377003; Tenzer S, 2011, ACS NANO, V5, P7155, DOI 10.1021/nn201950e; Vannoy CH, 2010, J PHYS CHEM B, V114, P10881, DOI 10.1021/jp1045904; Verma A, 2010, SMALL, V6, P12, DOI 10.1002/smll.200901158; Wang YS, 2007, CARBOHYD POLYM, V69, P597, DOI 10.1016/j.carbpol.2007.01.016; Wohlfart S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019121; Yang WZ, 2010, CURR NANOSCI, V6, P298, DOI 10.2174/157341310791171153; Yu JM, 2009, J PHARM PHARMACOL, V61, P713, DOI [10.1211/jpp/61.06.0003, 10.1211/jpp.61.06.0003]; Zhang XF, 2007, J PHYS CHEM C, V111, P14327, DOI 10.1021/jp073267u	60	19	19	5	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49304	10.1371/journal.pone.0049304	http://dx.doi.org/10.1371/journal.pone.0049304			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166632	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900118
J	Xu, XL; Ma, W; Zhu, YB; Wang, C; Wang, BY; An, N; An, L; Liu, Y; Wu, ZH; Tian, JH				Xu, Xiao-Ling; Ma, Wei; Zhu, Yu-Bo; Wang, Chao; Wang, Bing-Yuan; An, Na; An, Lei; Liu, Yan; Wu, Zhong-Hong; Tian, Jian-Hui			The Microtubule-Associated Protein ASPM Regulates Spindle Assembly and Meiotic Progression in Mouse Oocytes	PLOS ONE			English	Article							ACCURATE CHROMOSOME SEGREGATION; ABNORMAL SPINDLE; MITOTIC SPINDLE; ORGANIZATION; ACTIN; ENCODES; GENE; CYTOKINESIS; CALMODULIN; ROTATION	The microtubule-associated protein ASPM (abnormal spindle-like microcephaly-associated) plays an important role in spindle organization and cell division in mitosis and meiosis in lower animals, but its function in mouse oocyte meiosis has not been investigated. In this study, we characterized the localization and expression dynamics of ASPM during mouse oocyte meiotic maturation and analyzed the effects of the downregulation of ASPM expression on meiotic spindle assembly and meiotic progression. Immunofluorescence analysis showed that ASPM localized to the entire spindle at metaphase I (MI) and metaphase II (MII), colocalizing with the spindle microtubule protein acetylated tubulin (Ac-tubulin). In taxol-treated oocytes, ASPM colocalized with Ac-tubulin on the excessively polymerized microtubule fibers of enlarged spindles and the numerous asters in the cytoplasm. Nocodazole treatment induced the gradual disassembly of microtubule fibers, during which ASPM remained colocalized with the dynamic Ac-tubulin. The downregulation of ASPM expression by a gene-specific morpholino resulted in an abnormal meiotic spindle and inhibited meiotic progression; most of the treated oocytes were blocked in the MI stage with elongated meiotic spindles. Furthermore, coimmunoprecipitation combined with mass spectrometry and western blot analysis revealed that ASPM interacted with calmodulin in MI oocytes and that these proteins colocalized at the spindle. Our results provide strong evidence that ASPM plays a critical role in meiotic spindle assembly and meiotic progression in mouse oocytes.	[Xu, Xiao-Ling; Zhu, Yu-Bo; Wang, Chao; Wang, Bing-Yuan; An, Na; An, Lei; Wu, Zhong-Hong; Tian, Jian-Hui] China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China; [Xu, Xiao-Ling; Liu, Yan] Beijing Municipal Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing, Peoples R China; [Ma, Wei] Capital Med Univ, Sch Basic Med Sci, Dept Histol & Embryol, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; Beijing Academy of Agriculture & Forestry; Capital Medical University	Tian, JH (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Minist Agr, Key Lab Anim Genet & Breeding, Beijing 100094, Peoples R China.	tianjh@cau.edu.cn	An, Lei/GQB-0039-2022		National High-Tech RD program [2011AA100303]; National Key Technology RD program [2011BAD19B01]	National High-Tech RD program; National Key Technology RD program(National Key Technology R&D Program)	This study was supported by grant 2011AA100303 from the National High-Tech R&D program and grant 2011BAD19B01 from the National Key Technology R&D program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avides MD, 1999, SCIENCE, V283, P1733, DOI 10.1126/science.283.5408.1733; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Bezanilla M, 2009, CURR BIOL, V19, pR168, DOI 10.1016/j.cub.2008.12.026; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Ellefson ML, 2011, J CELL BIOL, V193, P1229, DOI 10.1083/jcb.201104008; Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015; Gimona M, 2002, FEBS LETT, V513, P98, DOI 10.1016/S0014-5793(01)03240-9; Guo XZ, 2009, CELL RES, V19, P838, DOI 10.1038/cr.2009.54; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Korenbaum E, 2002, J CELL SCI, V115, P3543, DOI 10.1242/jcs.00003; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Lin Sheng-Li, 2010, Front Biosci (Elite Ed), V2, P1254; Ma W, 2008, DEV BIOL, V320, P414, DOI 10.1016/j.ydbio.2008.05.550; Ma W, 2010, DEV BIOL, V339, P439, DOI 10.1016/j.ydbio.2010.01.009; Maro B, 2002, NAT CELL BIOL, V4, pE281, DOI 10.1038/ncb1202-e281; Martin SR, 2002, PROTEIN SCI, V11, P2909, DOI 10.1110/ps.0210402; Na J, 2006, CURR BIOL, V16, P1249, DOI 10.1016/j.cub.2006.05.023; Ou XH, 2010, CELL CYCLE, V9, P4130, DOI 10.4161/cc.9.20.13389; Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107; Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718; Saunders RDC, 1997, J CELL BIOL, V137, P881, DOI 10.1083/jcb.137.4.881; Schuh M, 2007, CELL, V130, P484, DOI 10.1016/j.cell.2007.06.025; Shin YH, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001190; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Wakefield JG, 2001, J CELL BIOL, V153, P637, DOI 10.1083/jcb.153.4.637; WINDER SJ, 1995, FEBS LETT, V357, P125, DOI 10.1016/0014-5793(94)01347-4; Wuhr M, 2008, CURR BIOL, V18, pR912, DOI 10.1016/j.cub.2008.08.043; Xiong B, 2008, BIOL REPROD, V79, P718, DOI 10.1095/biolreprod.108.069641; Zhong XY, 2005, CELL CYCLE, V4, P1227, DOI 10.4161/cc.4.9.2029; Zhu JL, 2011, DEV DYNAM, V240, P2281, DOI 10.1002/dvdy.22725	30	25	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49303	10.1371/journal.pone.0049303	http://dx.doi.org/10.1371/journal.pone.0049303			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152892	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234600034
J	Zhang, YF; Xu, HX; He, Y; Liu, C; Guo, LH; Liu, LN; Xu, JM				Zhang, Yi-Feng; Xu, Hui-Xiong; He, Yong; Liu, Chang; Guo, Le-Hang; Liu, Lin-Na; Xu, Jun-Mei			Virtual Touch Tissue Quantification of Acoustic Radiation Force Impulse: A New Ultrasound Elastic Imaging in the Diagnosis of Thyroid Nodules	PLOS ONE			English	Article							SHEAR-WAVE ELASTOGRAPHY; PREDICTING MALIGNANCY; BENIGN; DIFFERENTIATION; MANAGEMENT; CARCINOMA; CONSENSUS; LESIONS; GLAND; US	Objective: Virtual touch tissue quantification (VTQ) of acoustic radiation force impulse (ARFI) is a new quantitative technique to measure tissue stiffness. The study was aimed to assess the usefulness of VTQ in the diagnosis of thyroid nodules. Methods: 173 pathologically proven thyroid nodules in 142 patients were included and all were examined by conventional ultrasound (US), conventional elasticity imaging (EI) and VTQ of ARFI. The tissue stiffness for VTQ was expressed as shear wave velocity (SWV) (m/s). Receiver-operating characteristic curve (ROC) analyses were performed to assess the diagnostic performance. Intra-and inter-observer reproducibility of VTQ measurement was assessed. Results: The SWVs of benign and malignant thyroid nodules were 2.34 +/- 1.17 m/s (range: 0.61-9.00 m/s) and 4.82 +/- 2.53 m/s (range: 2.32-9.00 m/s) respectively (P<0.001). The mean SWV ratios between each nodule and the adjacent thyroid tissue were 1.19 +/- 0.67 (range: 0.31-6.87) for benign and 2.50 +/- 1.54 (range: 0.85-6.69) for malignant nodules (P<0.001). ROC analyses indicated that the area under the curve was 0.861 (95% CI : 0.804, 0.918) (P<0.001) for SWV and 0.831(95% CI : 0.761, 0.900)(P<0.001) for the SWV ratio. The cutoff points for the differential diagnosis were 2.87 m/s for SWV and 1.59 for SWV ratio. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value for EI were 65.9%, 66.7%, 66.5%, 40.3%, and 85.1%, respectively, and were 63.6%-75%, 82.2%-88.4%, 80.3%-82.1%, 58.9%-65.1%, and 87.7%-90.5%, respectively, for VTQ. The diagnostic value of VTQ is the highest for nodules >20 mm and lowest for those <= 10 mm. The correlation coefficients were 0.904 for intraobserver measurement and 0.864 for interobserver measurement. Conclusions: VTQ of ARFI provides quantitative and reproducible information about the tissue stiffness, which is useful for the differentiation between benign and malignant thyroid nodules. The diagnostic performance of VTQ is higher than that of conventional EI.	[Zhang, Yi-Feng; Xu, Hui-Xiong; He, Yong; Liu, Chang; Guo, Le-Hang; Liu, Lin-Na; Xu, Jun-Mei] Tongji Univ, Peoples Hosp 10, Dept Med Ultrasound, Shanghai 200092, Peoples R China; [He, Yong] China Three Gorges Univ, Coll Clin Med Sci 1, Dept Med Ultrasound, Yichang Cent Peoples Hosp, Yichang, Peoples R China	Tongji University; China Three Gorges University	Xu, HX (corresponding author), Tongji Univ, Peoples Hosp 10, Dept Med Ultrasound, Shanghai 200092, Peoples R China.	xuhuixiong@hotmail.com			Chinese Ministry of Education [NCET-06-0723]	Chinese Ministry of Education(Ministry of Education, China)	This work was supported in part by grant NCET-06-0723 from the Chinese Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Berker D, 2008, THYROID, V18, P603, DOI 10.1089/thy.2007.0313; Bojunga J, 2010, THYROID, V20, P1145, DOI 10.1089/thy.2010.0079; Cochlin DL, 2002, CLIN RADIOL, V57, P1014, DOI 10.1053/crad.2002.0989; COOPER DS, 2006, THYROID, V2, P2; D'Onofrio M, 2010, AM J ROENTGENOL, V195, P132, DOI 10.2214/AJR.09.3923; Frates MC, 2005, RADIOLOGY, V237, P794, DOI 10.1148/radiol.2373050220; Friedrich-Rust M, 2012, ULTRASONICS, V52, P69, DOI 10.1016/j.ultras.2011.06.012; Gallotti A, 2010, RADIOL MED, V115, P889, DOI 10.1007/s11547-010-0504-5; Garra BS, 1997, RADIOLOGY, V202, P79, DOI 10.1148/radiology.202.1.8988195; Gharib H, 2010, J ENDOCRINOL INVEST, V33, P1, DOI 10.4158/10024.GL; Gharib Hossein, 2006, Endocr Pract, V12, P63; Gietka-Czernel M, 2010, ENDOKRYNOL POL, V61, P652; Gu JY, 2012, J ULTRAS MED, V31, P763; Kwon HJ, 2011, WORLD J GASTROENTERO, V17, P1874, DOI 10.3748/wjg.v17.i14.1874; Lagalla R, 1993, Radiol Med, V85, P606; Lippolis PV, 2011, J CLIN ENDOCR METAB, V96, pE1826, DOI 10.1210/jc.2011-1021; Lyshchik A, 2005, RADIOLOGY, V237, P202, DOI 10.1148/radiol.2363041248; Magri F, 2012, CLIN ENDOCRINOL, V76, P137, DOI 10.1111/j.1365-2265.2011.04170.x; Meng W, 2011, ULTRASOUND MED BIOL, V37, P1436, DOI 10.1016/j.ultrasmedbio.2011.05.022; Nightingale K, 2002, ULTRASOUND MED BIOL, V28, P227, DOI 10.1016/S0301-5629(01)00499-9; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Papini E, 2002, J CLIN ENDOCR METAB, V87, P1941, DOI 10.1210/jc.87.5.1941; Rago T, 2007, J CLIN ENDOCR METAB, V92, P2917, DOI 10.1210/jc.2007-0641; Rago T, 1998, EUR J ENDOCRINOL, V138, P41, DOI 10.1530/eje.0.1380041; Rago T, 2007, CLIN ENDOCRINOL, V66, P13, DOI 10.1111/j.1365-2265.2006.02677.x; Remontet L, 2003, REV EPIDEMIOL SANTE, V51, P3; Sebag F, 2010, J CLIN ENDOCR METAB, V95, P5281, DOI 10.1210/jc.2010-0766; Smith BR, 2006, THYROID, V16, P109, DOI 10.1089/thy.2006.16.109; Stock KF, 2010, CLIN HEMORHEOL MICRO, V46, P139, DOI 10.3233/CH-2010-1340; Ueno E., 2004, EIZO JOHO MED, V36, P2; Yashima Y, 2012, J GASTROENTEROL, V47, P427, DOI 10.1007/s00535-011-0491-x; Yu HJ, 2011, ULTRASOUND Q, V27, P217, DOI 10.1097/RUQ.0b013e318239422e	32	62	80	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49094	10.1371/journal.pone.0049094	http://dx.doi.org/10.1371/journal.pone.0049094			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152855	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234600021
J	Servos, J; Hamann, A; Grimm, C; Osiewacz, HD				Servos, Joerg; Hamann, Andrea; Grimm, Carolin; Osiewacz, Heinz D.			A Differential Genome-Wide Transcriptome Analysis: Impact of Cellular Copper on Complex Biological Processes like Aging and Development	PLOS ONE			English	Article							FUNGUS PODOSPORA-ANSERINA; MITOCHONDRIAL-DNA REARRANGEMENTS; LIFE-SPAN CONTROL; ASPERGILLUS-FUMIGATUS; GENE-EXPRESSION; SIDEROPHORE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; IRON UPTAKE; CRYPTOCOCCUS-NEOFORMANS; TRIACETYLFUSARININE-C	The regulation of cellular copper homeostasis is crucial in biology. Impairments lead to severe dysfunctions and are known to affect aging and development. Previously, a loss-of-function mutation in the gene encoding the copper-sensing and copper-regulated transcription factor GRISEA of the filamentous fungus Podospora anserina was reported to lead to cellular copper depletion and a pleiotropic phenotype with hypopigmentation of the mycelium and the ascospores, affected fertility and increased lifespan by approximately 60% when compared to the wild type. This phenotype is linked to a switch from a copper-dependent standard to an alternative respiration leading to both a reduced generation of reactive oxygen species (ROS) and of adenosine triphosphate (ATP). We performed a genome-wide comparative transcriptome analysis of a wild-type strain and the copper-depleted grisea mutant. We unambiguously assigned 9,700 sequences of the transcriptome in both strains to the more than 10,600 predicted and annotated open reading frames of the P. anserina genome indicating 90% coverage of the transcriptome. 4,752 of the transcripts differed significantly in abundance with 1,156 transcripts differing at least 3-fold. Selected genes were investigated by qRT-PCR analyses. Apart from this general characterization we analyzed the data with special emphasis on molecular pathways related to the grisea mutation taking advantage of the available complete genomic sequence of P. anserina. This analysis verified but also corrected conclusions from earlier data obtained by single gene analysis, identified new candidates of factors as part of the cellular copper homeostasis system including target genes of transcription factor GRISEA, and provides a rich reference source of quantitative data for further in detail investigations. Overall, the present study demonstrates the importance of systems biology approaches also in cases were mutations in single genes are analyzed to explain the underlying mechanisms controlling complex biological processes like aging and development.	[Osiewacz, Heinz D.] Goethe Univ Frankfurt, Inst Mol Biosci, Fac Biosci, Frankfurt, Germany	Goethe University Frankfurt	Osiewacz, HD (corresponding author), Goethe Univ Frankfurt, Inst Mol Biosci, Fac Biosci, Frankfurt, Germany.	Osiewacz@bio.uni-frankfurt.de		Hamann, Andrea/0000-0001-9821-7491	Ministry of Education and Research (Germany); Cluster of Excellence Macromolecular Complexes	Ministry of Education and Research (Germany); Cluster of Excellence Macromolecular Complexes	This work was supported by the Ministry of Education andResearch (Germany) and the Cluster of Excellence Macromolecular Complexes. The unders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038138; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Averbeck NB, 2001, MOL GEN GENET, V264, P604, DOI 10.1007/s004380000346; Averbeck NB, 2000, CURR GENET, V37, P200, DOI 10.1007/s002940050520; Borghouts C, 2000, CURR GENET, V37, P268, DOI 10.1007/s002940050528; Borghouts C, 1997, P NATL ACAD SCI USA, V94, P10768, DOI 10.1073/pnas.94.20.10768; Borghouts C, 2002, INT J BIOCHEM CELL B, V34, P1355, DOI 10.1016/S1357-2725(02)00078-X; Borghouts C, 2002, BIOGERONTOLOGY, V3, P143, DOI 10.1023/A:1015696404723; Borghouts C, 1998, MOL GEN GENET, V260, P492, DOI 10.1007/s004380050922; Borghouts C, 2001, MOL CELL BIOL, V21, P390, DOI 10.1128/MCB.21.2.390-399.2001; Brust D, 2010, AGING CELL, V9, P761, DOI 10.1111/j.1474-9726.2010.00609.x; Cobine PA, 2004, J BIOL CHEM, V279, P14447, DOI 10.1074/jbc.M312693200; Cobine PA, 2006, BBA-MOL CELL RES, V1763, P759, DOI 10.1016/j.bbamcr.2006.03.002; Coppin E, 2007, MYCOL RES, V111, P901, DOI 10.1016/j.mycres.2007.05.011; Cuero R, 2003, J APPL MICROBIOL, V94, P953, DOI 10.1046/j.1365-2672.2003.01870.x; Dancis A, 1998, J PEDIATR-US, V132, pS24, DOI 10.1016/S0022-3476(98)70524-4; De Freitas JM, 2004, J BIOL CHEM, V279, P4450, DOI 10.1074/jbc.M212308200; Espagne E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r77; Esser K., 1974, BACTERIA BACTERIOPHA, P531; FernandezLarrea J, 1996, MOL GEN GENET, V252, P539, DOI 10.1007/s004380050261; Fischer F, 2012, TRENDS BIOCHEM SCI, V37, P284, DOI 10.1016/j.tibs.2012.02.004; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; Gilardoni PA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-66; Gredilla R, 2006, EXP GERONTOL, V41, P439, DOI 10.1016/j.exger.2006.01.010; Griffith GW, 2007, FEMS MICROBIOL LETT, V276, P165, DOI 10.1111/j.1574-6968.2007.00923.x; Groebe K, 2007, EXP GERONTOL, V42, P887, DOI 10.1016/j.exger.2007.07.001; Haas H, 1999, J BIOL CHEM, V274, P4613, DOI 10.1074/jbc.274.8.4613; Haas H, 2003, BIOCHEM J, V371, P505, DOI 10.1042/BJ20021685; Haas H, 2008, ANNU REV PHYTOPATHOL, V46, P149, DOI 10.1146/annurev.phyto.45.062806.094338; HARMAN D, 1972, AM J CLIN NUTR, V25, P839; Jiang N, 2009, FEMS MICROBIOL LETT, V296, P84, DOI 10.1111/j.1574-6968.2009.01619.x; JUNGMANN J, 1993, EMBO J, V12, P5051, DOI 10.1002/j.1460-2075.1993.tb06198.x; Kendziorski CM, 2003, BIOSTATISTICS, V4, P465, DOI 10.1093/biostatistics/4.3.465; Kiyota T, 2011, J BIOSCI BIOENG, V111, P512, DOI 10.1016/j.jbiosc.2010.12.022; Kragl C, 2007, EUKARYOT CELL, V6, P1278, DOI 10.1128/EC.00066-07; Kunstmann B, 2008, AGING CELL, V7, P651, DOI 10.1111/j.1474-9726.2008.00412.x; Langfelder K, 2003, FUNGAL GENET BIOL, V38, P143, DOI 10.1016/S1087-1845(02)00526-1; LILLEHOJ EB, 1974, APPL MICROBIOL, V28, P763, DOI 10.1128/AEM.28.5.763-767.1974; Luce K, 2009, NAT CELL BIOL, V11, P852, DOI 10.1038/ncb1893; MARBACH K, 1994, CURR GENET, V26, P184, DOI 10.1007/BF00313809; Molina C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-553; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Oberegger H, 2002, BIOCHEM SOC T, V30, P781, DOI 10.1042/bst0300781; Oberegger H, 2001, MOL MICROBIOL, V41, P1077, DOI 10.1046/j.1365-2958.2001.02586.x; Osiewacz HD, 1996, MOL GEN GENET, V252, P115, DOI 10.1007/BF02173211; Osiewacz HD, 2000, EXP GERONTOL, V35, P677, DOI 10.1016/S0531-5565(00)00142-X; OSIEWACZ HD, 2002, AGEING RES REV, V28, P1; Osiewacz HD, 2006, FREE RADICAL RES, V40, P1350, DOI 10.1080/10715760600921153; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pihet M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-177; PRILLINGER H, 1977, MOL GEN GENET, V156, P333, DOI 10.1007/BF00267190; RIZET G, 1953, CR HEBD ACAD SCI, V237, P838; Scheckhuber CQ, 2008, MOL GENET GENOMICS, V280, P365, DOI 10.1007/s00438-008-0378-6; Scheckhuber CQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016620; Scheckhuber CQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004919; Schrettl M, 2004, BIOMETALS, V17, P647, DOI 10.1007/s10534-004-1230-z; Schrettl M, 2008, MOL MICROBIOL, V70, P27, DOI 10.1111/j.1365-2958.2008.06376.x; Schrettl M, 2007, PLOS PATHOG, V3, P1195, DOI 10.1371/journal.ppat.0030128; Slot JC, 2011, CURR BIOL, V21, P134, DOI 10.1016/j.cub.2010.12.020; Stumpferl SW, 2004, EUKARYOT CELL, V3, P200, DOI 10.1128/EC.3.1.200-211.2004; Tominaga M, 2006, APPL ENVIRON MICROB, V72, P484, DOI 10.1128/AEM.72.1.484-490.2006; TUDZYNSKI P, 1979, MOL GEN GENET, V173, P71, DOI 10.1007/BF00267692; Weil A, 2011, CELL CYCLE, V10, P4280, DOI 10.4161/cc.10.24.18560; YamaguchiIwai Y, 1997, J BIOL CHEM, V272, P17711, DOI 10.1074/jbc.272.28.17711; YamaguchiIwai Y, 1996, EMBO J, V15, P3377, DOI 10.1002/j.1460-2075.1996.tb00703.x; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhu XD, 2003, MOL MICROBIOL, V50, P1271, DOI 10.1046/j.1365-2958.2003.03752.x; Zintel S, 2010, EXP GERONTOL, V45, P525, DOI 10.1016/j.exger.2010.01.006	68	9	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49292	10.1371/journal.pone.0049292	http://dx.doi.org/10.1371/journal.pone.0049292			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152891	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234000060
J	Doi, K; Oue, H; Morita, K; Kajihara, S; Kubo, T; Koretake, K; Perrotti, V; Iezzi, G; Piattelli, A; Akagawa, Y				Doi, Kazuya; Oue, Hiroshi; Morita, Koji; Kajihara, Shiho; Kubo, Takayasu; Koretake, Katsunori; Perrotti, Vittoria; Iezzi, Giovanna; Piattelli, Adriano; Akagawa, Yasumasa			Development of Implant/Interconnected Porous Hydroxyapatite Complex as New Concept Graft Material	PLOS ONE			English	Article							GUIDED BONE REGENERATION; INORGANIC POLYPHOSPHATE; BLOCK HYDROXYAPATITE; IMPLANT STABILITY; AUTOGENOUS BONE; ARTIFICIAL BONE; INTERFACE; INGROWTH; OSSEOINTEGRATION; CERAMICS	Background: Dental implant has been successfully used to replace missing teeth. However, in some clinical situations, implant placement may be difficult because of a large bone defect. We designed novel complex biomaterial to simultaneously restore bone and place implant. This complex was incorporated implant into interconnected porous calcium hydroxyapatite (IP-CHA). We then tested this Implant/IP-CHA complex and evaluated its effect on subsequent bone regeneration and implant stability in vivo. Methodology/Principal Findings: A cylinder-type IP-CHA was used in this study. After forming inside of the cylinder, an implant was placed inside to fabricate the Implant/IP-CHA complex. This complex was then placed into the prepared bone socket in the femur of four beagle-Labrador hybrid dogs. As a control, implants were placed directly into the femur without any bone substrate. Bone sockets were allowed to heal for 2, 3 and 6 months and implant stability quotients (ISQ) were measured. Finally, tissue blocks containing the Implant/IP-CHA complexes were harvested. Specimens were processed for histology and stained with toluidine blue and bone implant contact (BIC) was measured. The ISQs of complex groups was 77.8 +/- 2.9 in the 6-month, 72.0 +/- 5.7 in the 3-month and 47.4 +/- 11.0 in the 2-month. There was no significant difference between the 3- or 6-month complex groups and implant control groups. In the 2-month group, connective tissue, including capillary angiogenesis, was predominant around the implants, although newly formed bone could also be observed. While, in the 3 and 6-month groups, newly formed bone could be seen in contact to most of the implant surface. The BICs of complex groups was 2.18 +/- 3.77 in the 2-month, 44.03 +/- 29.58 in the 3- month, and 51.23 +/- 8.25 in the 6-month. Significant difference was detected between the 2 and 6-month. Conclusions/Significance: Within the results of this study, the IP-CHA/implant complex might be able to achieve both bone reconstruction and implant stability. Citation: Doi K, Oue H, Morita K, Kajihara S, Kubo T, et al. (2012) Development of Implant/Interconnected Porous Hydroxyapatite Complex as New Concept Graft Material. PLoS ONE 7(11): e49051. doi:10.1371/journal.pone.0049051	[Doi, Kazuya; Oue, Hiroshi; Morita, Koji; Kajihara, Shiho; Kubo, Takayasu; Koretake, Katsunori; Akagawa, Yasumasa] Hiroshima Univ, Grad Sch Biomed Sci, Dept Adv Prosthodont, Hiroshima, Japan; [Perrotti, Vittoria; Iezzi, Giovanna; Piattelli, Adriano] Chieti Pescara Univ, Dept Med Oral & Biotechnol Sci, Chieti, Italy	Hiroshima University; G d'Annunzio University of Chieti-Pescara	Doi, K (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Adv Prosthodont, Hiroshima, Japan.	kazuya17@hiroshima-u.ac.jp	Iezzi, Giovanna/K-9403-2016; perrotti, vittoria/L-1028-2016; Doi, Kazuya/J-6554-2016	Iezzi, Giovanna/0000-0002-2391-6594; perrotti, vittoria/0000-0001-7652-1660; Doi, Kazuya/0000-0001-9452-4750; Morita, Koji/0000-0002-5724-5573	Ministry of Education, Culture, Sports, Science and Technology, Japan [24390435]; Brain circulation program to develop new leaders for international dental education course through international collaborative dental research	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Brain circulation program to develop new leaders for international dental education course through international collaborative dental research	This study was supported in part by a Grant-in Aid for Scientific Research (No24390435) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and Brain circulation program to develop new leaders for international dental education course through international collaborative dental research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsson I, 2009, CLIN ORAL IMPLAN RES, V20, P313, DOI 10.1111/j.1600-0501.2008.01646.x; ANDERSON HC, 1995, CLIN ORTHOP RELAT R, P266; Ayers RA, 1999, J BIOMED MATER RES, V47, P54, DOI 10.1002/(SICI)1097-4636(199910)47:1<54::AID-JBM7>3.3.CO;2-G; Ayers RA, 1998, J ORAL MAXIL SURG, V56, P1297, DOI 10.1016/S0278-2391(98)90613-9; Becker W, 1990, Int J Periodontics Restorative Dent, V10, P376; Blanco J, 2011, CLIN ORAL IMPLAN RES, V22, P92, DOI 10.1111/j.1600-0501.2010.02009.x; Bobyn JD, 1999, J BONE JOINT SURG BR, V81B, P907, DOI 10.1302/0301-620X.81B5.9283; Branemark PI, 1985, TISSUE INTEGRATED PR, P11; Chiapasco M, 1999, CLIN ORAL IMPLAN RES, V10, P278, DOI 10.1034/j.1600-0501.1999.100404.x; Cordioli G, 2001, CLIN ORAL IMPLAN RES, V12, P270, DOI 10.1034/j.1600-0501.2001.012003270.x; De Santis E, 2011, CLIN ORAL IMPLAN RES, V22, P430, DOI 10.1111/j.1600-0501.2010.02122.x; Deie M, 2008, KNEE SURG SPORT TR A, V16, P753, DOI 10.1007/s00167-008-0558-2; Doi K, 2007, DENT MATER J, V26, P162, DOI 10.4012/dmj.26.162; Friberg B, 1999, INT J ORAL MAX SURG, V28, P266, DOI 10.1034/j.1399-0020.1999.284280405.x; Glauser R, 2004, CLIN ORAL IMPLAN RES, V15, P428, DOI 10.1111/j.1600-0501.2004.01036.x; Hayashi K, 2007, DENT MATER J, V26, P170, DOI 10.4012/dmj.26.170; Hermann J S, 1996, Curr Opin Periodontol, V3, P168; Huang HM, 2000, ORAL SURG ORAL MED O, V90, P285, DOI 10.1067/moe.2000.108918; Hui E, 2001, Clin Implant Dent Relat Res, V3, P79, DOI 10.1111/j.1708-8208.2001.tb00235.x; Isoda K, 2012, CLIN ORAL IMPLAN RES, V23, P832, DOI 10.1111/j.1600-0501.2011.02203.x; Kalk WWI, 1996, J ORAL MAXIL SURG, V54, P1424, DOI 10.1016/S0278-2391(96)90257-8; Kubo T, 2011, J PROSTHODONT RES, V55, P104, DOI 10.1016/j.jpor.2010.10.001; Kuriyama K, 2009, MOD RHEUMATOL, V19, P180, DOI 10.1007/s10165-008-0147-8; Meredith N, 1996, CLIN ORAL IMPLAN RES, V7, P261, DOI 10.1034/j.1600-0501.1996.070308.x; Miyamoto I, 2005, BONE, V37, P776, DOI 10.1016/j.bone.2005.06.019; Morita K, 2010, ACTA BIOMATER, V6, P2808, DOI 10.1016/j.actbio.2009.12.055; Shigeishi H, 2012, DENT MATER J, V31, P54, DOI 10.4012/dmj.2011-089; STEINKAMP JA, 1976, J HISTOCHEM CYTOCHEM, V24, P292, DOI 10.1177/24.1.1254924; Tamai N, 2002, J BIOMED MATER RES, V59, P110, DOI 10.1002/jbm.1222; Tamai N, 2010, J ORTHOP SCI, V15, P560, DOI 10.1007/s00776-010-1479-8; Tawse-Smith A, 2001, Clin Implant Dent Relat Res, V3, P185, DOI 10.1111/j.1708-8208.2001.tb00140.x; Tsao AK, 2005, J BONE JOINT SURG AM, V87A, P22, DOI 10.2106/JBJS.E.00490; Woodard JR, 2007, BIOMATERIALS, V28, P45, DOI 10.1016/j.biomaterials.2006.08.021; Yoshikawa H, 2009, J R SOC INTERFACE, V6, pS341, DOI 10.1098/rsif.2008.0425.focus; Yuan Q, 2009, ACTA BIOMATER, V5, P1716, DOI 10.1016/j.actbio.2009.01.034; ZARB GA, 1991, BRIT DENT J, V170, P439, DOI 10.1038/sj.bdj.4807583	36	16	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49051	10.1371/journal.pone.0049051	http://dx.doi.org/10.1371/journal.pone.0049051			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152848	Green Published, Green Submitted, gold			2022-12-27	WOS:000312272600040
J	Giroux, MA; Dussault, C; Lecomte, N; Tremblay, JP; Cote, SD				Giroux, Marie-Andree; Dussault, Christian; Lecomte, Nicolas; Tremblay, Jean-Pierre; Cote, Steeve D.			A New Way of Assessing Foraging Behaviour at the Individual Level Using Faeces Marking and Satellite Telemetry	PLOS ONE			English	Article							WHITE-TAILED DEER; POPULATION-DYNAMICS; TROPHIC ECOLOGY; STABLE-ISOTOPES; FECAL PELLETS; BIRTH-DATE; SURVIVAL; SPECIALIZATION; RESPONSES; CHOICE	Heterogeneity in foraging behaviour can profoundly influence ecological processes shaping populations. To scale-up from individual foraging behaviour to processes occurring at the population scale, one needs to sample foraging behaviour at the individual level, and over large temporal scales or during critical seasons known to influence life-history traits. We developed an innovative technique to monitor foraging behaviour at the individual level in secretive species, a technique that can be ultimately used to investigate the links between foraging behaviour and life-history traits. First, the technique used a novel approach, namely the combination of telemetry tracking and biomarking of faeces with food dyes to locate fresh signs of presence left by individuals equipped with GPS collars. Second, the technique is based on the simultaneous or successive sampling of life-history traits and individual foraging behaviour, using tracks with high probabilities of recovery of dyed faeces. We first describe our methodological approach, using a case study of a large herbivore, and then provide recommendations and guidelines for its use. Sampling single snow tracks of individuals equipped with a GPS collar was a reliable way to assess individual winter foraging behaviour in a white-tailed deer (Odocoileus virginianus Zimmermann) population. During that period, the probability of recovery of dyed faeces within the range of the collar precision was very high for single snow tracks of equipped deer (97%). Our approach is well suited to study individual foraging behaviour, and could ultimately be used to investigate the interplay between intra-population heterogeneity in foraging behaviour, life-history traits, and demographic processes.	[Giroux, Marie-Andree; Dussault, Christian; Tremblay, Jean-Pierre; Cote, Steeve D.] Univ Laval, Dept Biol, NSERC Prod Forestiers Anticosti Ind Res Chair, Quebec City, PQ G1K 7P4, Canada; [Giroux, Marie-Andree; Dussault, Christian; Tremblay, Jean-Pierre; Cote, Steeve D.] Univ Laval, Ctr Etud Nord, Quebec City, PQ, Canada; [Dussault, Christian] Minist Ressources Nat & Faune, Direct Gen Expertise Faune & Ses Habitats, Quebec City, PQ, Canada; [Lecomte, Nicolas] Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada; [Lecomte, Nicolas] Govt Nunavut, Dept Environm, Igloolik, NU, Canada	Laval University; Laval University; University of Quebec	Giroux, MA (corresponding author), Univ Laval, Dept Biol, NSERC Prod Forestiers Anticosti Ind Res Chair, Quebec City, PQ G1K 7P4, Canada.	marie-andree.giroux.1@ulaval.ca; steeve.cote@bio.ulaval.ca		Tremblay, Jean-Pierre/0000-0003-0978-529X; Lecomte, Nicolas/0000-0002-8473-5375	Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits Forestiers Anticosti Industrial Research Chair, Universite Laval; Ministere des Ressources naturelles et de la Faune du Quebec; NSERC; Norwegian Research Council	Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits Forestiers Anticosti Industrial Research Chair, Universite Laval(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ministere des Ressources naturelles et de la Faune du Quebec; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Norwegian Research Council(Research Council of NorwayEuropean Commission)	This research was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC)-Produits Forestiers Anticosti Industrial Research Chair, Universite Laval, and the Ministere des Ressources naturelles et de la Faune du Quebec. MAG received scholarships from NSERC (Alexander Graham Bell, Michael Smith, and EnviroNorth scholarships) and the Norwegian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annett CA, 1999, ECOLOGY, V80, P288, DOI 10.1890/0012-9658(1999)080[0288:LTROIW]2.0.CO;2; [Anonymous], 2010, R LANG ENV STAT COMP; BAKER DL, 1987, CAN J ZOOL, V65, P1978, DOI 10.1139/z87-301; Bates D., 2011, IME4 LINEAR MIXED EF; Beauchamp G, 1997, ETHOL ECOL EVOL, V9, P105, DOI 10.1080/08927014.1997.9522890; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; Brinkman TJ, 2011, J WILDLIFE MANAGE, V75, P232, DOI 10.1002/jwmg.22; Brinkman TJ, 2010, CONSERV GENET, V11, P1547, DOI 10.1007/s10592-009-9928-7; BROWN L. Is., 1961, JOUR WILDIFE MANAGEMENT, V25, P199, DOI 10.2307/3798679; Budge SM, 2006, MAR MAMMAL SCI, V22, P759, DOI 10.1111/j.1748-7692.2006.00079.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cote SD, 2001, OECOLOGIA, V127, P230, DOI 10.1007/s004420000584; Cucherousset J, 2011, OECOLOGIA, V167, P75, DOI 10.1007/s00442-011-1974-4; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; EVANS J, 1973, J WILDLIFE MANAGE, V37, P73, DOI 10.2307/3799741; FAIRBANKS WS, 1993, J MAMMAL, V74, P129, DOI 10.2307/1381911; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; GILL RB, 1983, J WILDLIFE MANAGE, V47, P902, DOI 10.2307/3808149; Hansen MC, 2008, J WILDLIFE MANAGE, V72, P518, DOI 10.2193/2006-493; Kelly JF, 2000, CAN J ZOOL, V78, P1, DOI 10.1139/cjz-78-1-1; KINDEL FRED, 1960, JOUR WILDLIFE MANAGEMENT, V24, P429, DOI 10.2307/3796527; Knudsen R, 2004, J PARASITOL, V90, P1, DOI 10.1645/GE-3184; Lefort S, 2007, ECOSCIENCE, V14, P109, DOI 10.2980/1195-6860(2007)14[109:IOBFAW]2.0.CO;2; Litvaitis JA, 2000, RES TECHNIQUES ANIMA; Lomnicki A., 1988, POPULATION ECOLOGY I, DOI 10.12987/9780691209616; Masse A, 2011, THESIS U LAVAL; Maudet C, 2004, MOL ECOL NOTES, V4, P772, DOI 10.1111/j.1471-8286.2004.00787.x; MAUTZ WW, 1971, J WILDLIFE MANAGE, V35, P723, DOI 10.2307/3799778; McCulloch C. E., 2001, GEN LINEAR MIXED MOD; Miller BF, 2003, J WILDLIFE DIS, V39, P851, DOI 10.7589/0090-3558-39.4.851; Murray S, 2000, J WILDLIFE DIS, V36, P670, DOI 10.7589/0090-3558-36.4.670; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Parker KL, 1999, WILDLIFE MONOGR, P5; Sowls L. K., 1963, Journal of Wildlife Management, V27, P299, DOI 10.2307/3798413; Svanback R, 2004, J ANIM ECOL, V73, P973, DOI 10.1111/j.0021-8790.2004.00868.x; Swanson BO, 2003, ECOLOGY, V84, P1441, DOI 10.1890/02-0353; Valiere N, 2007, CONSERV GENET, V8, P69, DOI 10.1007/s10592-006-9149-2; Votier SC, 2010, J APPL ECOL, V47, P487, DOI 10.1111/j.1365-2664.2010.01790.x; Yoccoz N.G., 1991, B ECOL SOC AM, V72, P106	40	8	8	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49719	10.1371/journal.pone.0049719	http://dx.doi.org/10.1371/journal.pone.0049719			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166754	gold, Green Submitted, Green Published			2022-12-27	WOS:000311885300062
J	Ward, DM; Nislow, KH; Folt, CL				Ward, Darren M.; Nislow, Keith H.; Folt, Carol L.			Do Low-Mercury Terrestrial Resources Subsidize Low-Mercury Growth of Stream Fish? Differences between Species along a Productivity Gradient	PLOS ONE			English	Article							SALMON SALMO-SALAR; STABLE-ISOTOPE ANALYSIS; AQUATIC FOOD WEBS; ATLANTIC SALMON; BROOK TROUT; BIOACCUMULATION; INVERTEBRATES; RIVER; ECOSYSTEMS; REDUCE	Low productivity in aquatic ecosystems is associated with reduced individual growth of fish and increased concentrations of methylmercury (MeHg) in fish and their prey. However, many stream-dwelling fish species can use terrestrially-derived food resources, potentially subsidizing growth at low-productivity sites, and, because terrestrial resources have lower MeHg concentrations than aquatic resources, preventing an increase in diet-borne MeHg accumulation. We used a large-scale field study to evaluate relationships among terrestrial subsidy use, growth, and MeHg concentrations in two stream-dwelling fish species across an in-stream productivity gradient. We sampled young-of-the-year brook trout (Salvelinus fontinalis) and Atlantic salmon (Salmo salar), potential competitors with similar foraging habits, from 20 study sites in streams in New Hampshire and Massachusetts that encompassed a wide range of aquatic prey biomass. Stable isotope analysis showed that brook trout used more terrestrial resources than Atlantic salmon. Over their first growing season, Atlantic salmon tended to grow larger than brook trout at sites with high aquatic prey biomass, but brook grew two-fold larger than Atlantic salmon at sites with low aquatic prey biomass. The MeHg concentrations of brook trout and Atlantic salmon were similar at sites with high aquatic prey biomass and the MeHg concentrations of both species increased at sites with low prey biomass and high MeHg in aquatic prey. However, brook trout had three-fold lower MeHg concentrations than Atlantic salmon at low-productivity, high-MeHg sites. These results suggest that differential use of terrestrial resource subsidies reversed the growth asymmetry between potential competitors across a productivity gradient and, for one species, moderated the effect of low in-stream productivity on MeHg accumulation.	[Ward, Darren M.; Folt, Carol L.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Nislow, Keith H.] US Forest Serv, Ctr Res Ecosyst Change, USDA, Amherst, MA USA	Dartmouth College; United States Department of Agriculture (USDA); United States Forest Service	Ward, DM (corresponding author), Humboldt State Univ, Dept Fisheries Biol, Arcata, CA 95521 USA.	darren.ward@humboldt.edu	Ward, Darren/F-1203-2010	Ward, Darren/0000-0002-0049-5299	NIEHS-SBRP [ES007373]; USFS Northern Research Station; NOAA CIMEC; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007373] Funding Source: NIH RePORTER	NIEHS-SBRP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); USFS Northern Research Station(United States Department of Agriculture (USDA)United States Forest Service); NOAA CIMEC; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was funded by NIEHS-SBRP grant ES007373 to CLF and by the USFS Northern Research Station; DMW was supported during preparation of the manuscript by NOAA CIMEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter CV, 2007, OECOLOGIA, V153, P461, DOI 10.1007/s00442-007-0743-x; Baxter CV, 2005, FRESHWATER BIOL, V50, P201, DOI 10.1111/j.1365-2427.2004.01328.x; Chen CY, 2009, ENVIRON SCI TECHNOL, V43, P1804, DOI 10.1021/es8017122; Chen CY, 2005, ENVIRON SCI TECHNOL, V39, P115, DOI 10.1021/es0403007; Chetelat J, 2011, ENVIRON POLLUT, V159, P10, DOI 10.1016/j.envpol.2010.09.034; Cristol DA, 2008, SCIENCE, V320, P335, DOI 10.1126/science.1154082; Doucett RR, 2007, ECOLOGY, V88, P1587, DOI 10.1890/06-1184; Doucett RR, 1996, CAN J FISH AQUAT SCI, V53, P2058, DOI 10.1139/cjfas-53-9-2058; Driscoll CT, 2007, BIOSCIENCE, V57, P17, DOI 10.1641/B570106; Fausch KD, 1998, CAN J FISH AQUAT SCI, V55, P218, DOI 10.1139/cjfas-55-S1-218; Finlay JC, 2001, ECOLOGY, V82, P1052, DOI 10.2307/2679902; Fisk AT, 2002, ECOLOGY, V83, P2162, DOI 10.1890/0012-9658(2002)083[2162:UACASI]2.0.CO;2; Folt CL, 1998, CAN J FISH AQUAT SCI, V55, P9, DOI 10.1139/cjfas-55-S1-9; FRANCE R, 1995, CAN J FISH AQUAT SCI, V52, P651, DOI 10.1139/f95-065; Gephard S, 2004, AM FI SOC M, V9, P287; GIBSON R J, 1984, Naturaliste Canadien (Quebec), V111, P175; Grader M, 2006, J FRESHWATER ECOL, V21, P503, DOI 10.1080/02705060.2006.9665028; Herendeen RA, 2004, ECOL MODEL, V178, P349, DOI 10.1016/j.ecolmodel.2004.03.011; Hill WR, 2005, ENVIRON SCI TECHNOL, V39, P1513, DOI 10.1021/es049587y; Jardine TD, 2012, ECOL APPL, V22, P843, DOI 10.1890/11-0874.1; Lepak JM, 2009, ECOTOXICOLOGY, V18, P488, DOI 10.1007/s10646-009-0306-5; Letcher BH, 2011, EVOL APPL, V4, P602, DOI 10.1111/j.1752-4571.2011.00184.x; Marczak LB, 2007, J ANIM ECOL, V76, P687, DOI 10.1111/j.1365-2656.2007.01240.x; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Mookerji N, 2004, J FISH BIOL, V64, P680, DOI 10.1111/j.1095-8649.2004.00333.x; Nakano S, 1999, ECOLOGY, V80, P2435; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Nislow Keith H., 2011, P171; Ojala JV, 2008, THESIS U MASSACHUSET; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; Pickhardt PC, 2002, P NATL ACAD SCI USA, V99, P4419, DOI 10.1073/pnas.072531099; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rasmussen JB, 2010, J ANIM ECOL, V79, P393, DOI 10.1111/j.1365-2656.2009.01648.x; Sweka JA, 2008, T AM FISH SOC, V137, P224, DOI 10.1577/T05-034.1; Taylor BW, 2001, CAN J FISH AQUAT SCI, V58, P437, DOI 10.1139/cjfas-58-3-437; Trudel M, 2006, CAN J FISH AQUAT SCI, V63, P1890, DOI 10.1139/F06-081; Tucker S, 1999, CAN J FISH AQUAT SCI, V56, P875, DOI 10.1139/cjfas-56-5-875; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Walters DM, 2010, ENVIRON SCI TECHNOL, V44, P2849, DOI 10.1021/es9023139; Walters DM, 2008, ECOL APPL, V18, P1835, DOI 10.1890/08-0354.1; Ward DM, 2007, J ANIM ECOL, V76, P135, DOI 10.1111/j.1365-2656.2006.01169.x; Ward DM, 2009, T AM FISH SOC, V138, P135, DOI 10.1577/T08-128.1; Ward DM, 2011, CAN J FISH AQUAT SCI, V68, P2080, DOI 10.1139/F2011-123; Ward DM, 2010, ANN NY ACAD SCI, V1195, P62, DOI 10.1111/j.1749-6632.2010.05456.x; Ward DM, 2010, T AM FISH SOC, V139, P1, DOI 10.1577/T09-032.1; Ward DM, 2010, ENVIRON SCI TECHNOL, V44, P3245, DOI 10.1021/es902639a; Wesner JS, 2010, OIKOS, V119, P170, DOI 10.1111/j.1600-0706.2009.17687.x	48	9	9	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49582	10.1371/journal.pone.0049582	http://dx.doi.org/10.1371/journal.pone.0049582			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166717	Green Published, Green Submitted, gold			2022-12-27	WOS:000311885300053
J	Iorga, A; Dewey, S; Partow-Navid, R; Gomes, AV; Eghbali, M				Iorga, Andrea; Dewey, Shannamar; Partow-Navid, Rod; Gomes, Aldrin V.; Eghbali, Mansoureh			Pregnancy Is Associated with Decreased Cardiac Proteasome Activity and Oxidative Stress in Mice	PLOS ONE			English	Article							PROTEIN-DEGRADATION; HYPERTROPHY; HEART; DYSFUNCTION; SYSTEM; INHIBITION; EXPRESSION	During pregnancy, the heart develops physiological hypertrophy. Proteasomal degradation has been shown to be altered in various models of pathological cardiac hypertrophy. Since the molecular signature of pregnancy-induced heart hypertrophy differs significantly from that of pathological heart hypertrophy, we investigated whether the cardiac proteasomal proteolytic pathway is affected by pregnancy in mice. We measured the proteasome activity, expression of proteasome subunits, ubiquitination levels and reactive oxygen production in the hearts of four groups of female mice: i) non pregnant (NP) at diestrus stage, ii) late pregnant (LP), iii) one day post-partum (PP1) and iv) 7 days post-partum (PP7). The activities of the 26 S proteasome subunits beta 1 (caspase-like), and beta 2 (trypsin-like) were significantly decreased in LP (beta 1: 83.26 +/- 1.96%; beta 2: 74.74 +/- 1.7%, normalized to NP) whereas beta 5 (chymotrypsin-like) activity was not altered by pregnancy but significantly decreased 1 day post-partum. Interestingly, all three proteolytic activities of the proteasome were restored to normal levels 7 days post-partum. The decrease in proteasome activity in LP was not due to the surge of estrogen as estrogen treatment of ovariectomized mice did not alter the 26 S proteasome activity. The transcript and protein levels of RPN2 and RPT4 (subunits of 19 S), beta 2 and alpha 7 (subunits of 20 S) as well as PA28 alpha and beta 5i (protein only) were not significantly different among the four groups. High resolution confocal microscopy revealed that nuclear localization of both core (20S) and RPT4 in LP is increased similar to 2-fold and is fully reversed in PP7. Pregnancy was also associated with decreased production of reactive oxygen species and ubiquitinated protein levels, while the de-ubiquitination activity was not altered by pregnancy or parturition. These results indicate that late pregnancy is associated with decreased ubiquitin-proteasome proteolytic activity and oxidative stress.	[Iorga, Andrea; Partow-Navid, Rod; Eghbali, Mansoureh] Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Dewey, Shannamar; Gomes, Aldrin V.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Davis	Eghbali, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Mol Med, Dept Anesthesiol, Los Angeles, CA 90095 USA.	meghbali@ucla.edu	Gomes, Aldrin V/I-6529-2018	Gomes, Aldrin V/0000-0002-9819-3036	NIH [T32GM065823, HL096819, HL089876, HL089876S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065823] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants T32GM065823 (A.I.), HL096819 (A.V.G), HL089876 and HL089876S1 (M.E). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bader N, 2006, BIOL CHEM, V387, P1351, DOI 10.1515/BC.2006.169; DANIELS SR, 1988, J AM COLL CARDIOL, V12, P703, DOI 10.1016/S0735-1097(88)80060-3; Depre C, 2006, CIRCULATION, V114, P1821, DOI 10.1161/CIRCULATIONAHA.106.637827; Dorn GW, 2003, CIRC RES, V92, P1171, DOI 10.1161/01.RES.0000077012.11088.BC; Drews O, 2010, CIRC RES, V107, P1094, DOI 10.1161/CIRCRESAHA.110.222364; Eghbali M, 2005, CIRC RES, V96, P1208, DOI 10.1161/01.RES.0000170652.71414.16; Eghbali M, 2006, TRENDS CARDIOVAS MED, V16, P285, DOI 10.1016/j.tcm.2006.07.001; Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomes AV, 2006, ANTIOXID REDOX SIGN, V8, P1677, DOI 10.1089/ars.2006.8.1677; Gomes AV, 2009, MOL CELL PROTEOMICS, V8, P302, DOI 10.1074/mcp.M800058-MCP200; Hamel FG, 2004, CURR OPIN CLIN NUTR, V7, P255, DOI 10.1097/00075197-200405000-00003; Hedhli N, 2008, AM J PHYSIOL-HEART C, V295, pH1385, DOI 10.1152/ajpheart.00532.2008; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Kazi A, 2003, BIOCHEM PHARMACOL, V66, P965, DOI 10.1016/S0006-2952(03)00414-3; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li YF, 2011, BBA-GENE REGUL MECH, V1809, P141, DOI 10.1016/j.bbagrm.2010.09.001; Li YP, 2003, AM J PHYSIOL-CELL PH, V285, pC806, DOI 10.1152/ajpcell.00129.2003; Liu CW, 2006, MOL CELL, V24, P39, DOI 10.1016/j.molcel.2006.08.025; Mearini G, 2008, BBA-MOL BASIS DIS, V1782, P749, DOI 10.1016/j.bbadis.2008.06.009; Mone SM, 1996, CIRCULATION, V94, P667, DOI 10.1161/01.CIR.94.4.667; Otsuka K, 2010, HEART VESSELS, V25, P474, DOI 10.1007/s00380-010-0006-3; Pluim BM, 2000, CIRCULATION, V101, P336, DOI 10.1161/01.CIR.101.3.336; Predmore JM, 2010, CIRCULATION, V121, P997, DOI 10.1161/CIRCULATIONAHA.109.904557; Schannwell CM, 2002, CARDIOLOGY, V97, P73, DOI 10.1159/000057675; Seifert U, 2010, CELL, V142, P613, DOI 10.1016/j.cell.2010.07.036; Tsukamoto O, 2006, BIOCHEM BIOPH RES CO, V340, P1125, DOI 10.1016/j.bbrc.2005.12.120; Zong C, 2006, CIRC RES, V99, P372, DOI 10.1161/01.RES.0000237389.40000.02	29	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48601	10.1371/journal.pone.0048601	http://dx.doi.org/10.1371/journal.pone.0048601			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166589	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300010
J	Wei, X; Wang, RS; Cao, LR; Yuan, NN; Huang, J; Qiao, WH; Zhang, WX; Zeng, HL; Yang, QW				Wei, Xin; Wang, Rongsheng; Cao, Lirong; Yuan, Nannan; Huang, Juan; Qiao, Weihua; Zhang, Wanxia; Zeng, Hanlai; Yang, Qingwen			Origin of Oryza sativa in China Inferred by Nucleotide Polymorphisms of Organelle DNA	PLOS ONE			English	Article							ASIAN WILD-RICE; CULTIVATED RICE; POPULATION-STRUCTURE; MULTILOCUS ANALYSIS; GENETIC-STRUCTURE; RUFIPOGON GRIFF.; O. SATIVA; DOMESTICATION; CHLOROPLAST; DIVERSITY	China is rich of germplasm resources of common wild rice (Oryza rufipogon Griff.) and Asian cultivated rice (O. sativa L.) which consists of two subspecies, indica and japonica. Previous studies have shown that China is one of the domestication centers of O. sativa. However, the geographic origin and the domestication times of O. sativa in China are still under debate. To settle these disputes, six chloroplast loci and four mitochondrial loci were selected to examine the relationships between 50 accessions of Asian cultivated rice and 119 accessions of common wild rice from China based on DNA sequence analysis in the present study. The results indicated that Southern China is the genetic diversity center of O. rufipogon and it might be the primary domestication region of O. sativa. Molecular dating suggested that the two subspecies had diverged 0.1 million years ago, much earlier than the beginning of rice domestication. Genetic differentiations and phylogeography analyses indicated that indica was domesticated from tropical O. rufipogon while japonica was domesticated from O. rufipogon which located in higher latitude. These results provided molecular evidences for the hypotheses of (i) Southern China is the origin center of O. sativa in China and (ii) the two subspecies of O. sativa were domesticated multiple times.	[Wei, Xin; Zeng, Hanlai] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Huang, Juan] Guangxi Acad Agr Sci, Inst Rice Res, Nanning, Peoples R China; [Wei, Xin; Wang, Rongsheng; Cao, Lirong; Yuan, Nannan; Qiao, Weihua; Zhang, Wanxia; Yang, Qingwen] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100193, Peoples R China	Huazhong Agricultural University; Guangxi Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS	Zeng, HL (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China.	zenghl@mail.hzau.edu.cn; qwyang@mail.caas.net.cn	Zeng, Hanlai/Q-5719-2019; Wei, Xin/AAT-6009-2020	Wei, Xin/0000-0003-2294-3256	program of Conservation and Sustainable Utilization of Wild Relatives of Crops by China Ministry of Agriculture [201003021]	program of Conservation and Sustainable Utilization of Wild Relatives of Crops by China Ministry of Agriculture	This study was supported by the program of Conservation and Sustainable Utilization of Wild Relatives of Crops by China Ministry of Agriculture (201003021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Dong WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035071; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2003, GENETICS, V164, P1567; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Gao LH, 2004, MOL ECOL, V13, P1009, DOI 10.1111/j.1365-294X.2004.02108.x; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Gaut BS, 1996, P NATL ACAD SCI USA, V93, P10274, DOI 10.1073/pnas.93.19.10274; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He ZW, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002100; Huang CL, 2012, PLANT J, V70, P769, DOI 10.1111/j.1365-313X.2012.04915.x; Huang P, 2012, MOL ECOL, V21, P4593, DOI 10.1111/j.1365-294X.2012.05625.x; Jiang LP, 2006, ANTIQUITY, V80, P355, DOI 10.1017/S0003598X00093674; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kovach MJ, 2007, TRENDS GENET, V23, P578, DOI 10.1016/j.tig.2007.08.012; Kumagai M, 2010, GENE, V462, P44, DOI 10.1016/j.gene.2010.04.013; Liu ZM., 1975, ACTA GENET SIN, V2, P23; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Lu BR, 2009, PROG NAT SCI-MATER, V19, P1241, DOI 10.1016/j.pnsc.2009.01.011; Molina J, 2011, P NATL ACAD SCI USA, V108, P8351, DOI 10.1073/pnas.1104686108; Nei M., 1987, MOL EVOLUTIONARY GEN; Rakshit S, 2007, THEOR APPL GENET, V114, P731, DOI 10.1007/s00122-006-0473-1; Rozas J, 2009, METHODS MOL BIOL, V537, P337, DOI 10.1007/978-1-59745-251-9_17; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sang T, 2007, CURR OPIN GENET DEV, V17, P533, DOI 10.1016/j.gde.2007.09.005; Sang T, 2007, J INTEGR PLANT BIOL, V49, P760, DOI 10.1111/j.1744-7909.2007.00510.x; Smith BD, 2006, P NATL ACAD SCI USA, V103, P12223, DOI 10.1073/pnas.0604335103; Sun CQ, 2001, THEOR APPL GENET, V102, P157, DOI 10.1007/s001220051631; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Swofford DL, 2002, PAUP 4 0B10 PHYLOGEN; Tang JB, 2004, PLANT PHYSIOL, V135, P412, DOI 10.1104/pp.103.031245; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TING YING, 1957, Acta Agriculturae Sinica, V8, P243; Triboush SO, 1998, PLANT MOL BIOL REP, V16, P183, DOI 10.1023/A:1007487806583; Vaughan DA, 2003, CURR OPIN PLANT BIOL, V6, P139, DOI 10.1016/S1369-5266(03)00009-8; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Wang MX, 2008, HEREDITY, V101, P527, DOI 10.1038/hdy.2008.61; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wei X, 2012, MOL ECOL, V21, P5073, DOI 10.1111/j.1365-294X.2012.05748.x; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xu X, 2012, NAT BIOTECHNOL, V30, P105, DOI 10.1038/nbt.2050; Yang CC, 2012, MOL BIOL EVOL, V29, P1471, DOI 10.1093/molbev/msr315; Zhang HL, 2011, THEOR APPL GENET, V122, P49, DOI 10.1007/s00122-010-1421-7; Zhao KY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010780; Zheng XM, 2010, MOL ECOL, V19, P2439, DOI 10.1111/j.1365-294X.2010.04674.x; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	50	11	13	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49546	10.1371/journal.pone.0049546	http://dx.doi.org/10.1371/journal.pone.0049546			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166706	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300052
J	Gullon, S; Vicente, RL; Mellado, RP				Gullon, Sonia; Vicente, Rebeca L.; Mellado, Rafael P.			A Novel Two-Component System Involved in Secretion Stress Response in Streptomyces lividans	PLOS ONE			English	Article							BACILLUS-SUBTILIS; ESCHERICHIA-COLI; EXTRACELLULAR PROTEOME; CONJUGAL TRANSFER; GENE; HTRA; PROTEINS; PROTEASE; HEAT; TRANSLOCATION	Background: Misfolded proteins accumulating outside the bacterial cytoplasmic membrane can interfere with the secretory machinery, hence the existence of quality factors to eliminate these misfolded proteins is of capital importance in bacteria that are efficient producers of secretory proteins. These bacteria normally use a specific two-component system to respond to the stress produced by the accumulation of the misfolded proteins, by activating the expression of HtrA-like proteases to specifically eliminate the incorrectly folded proteins. Methodology/Principal Findings: Overproduction of alpha-amylase in S. lividans causing secretion stress permitted the identification of a two-component system (SCO4156-SCO4155) that regulates three HtrA-like proteases which appear to be involved in secretion stress response. Mutants in each of the genes forming part of the two-genes operon that encodes the sensor and regulator protein components accumulated misfolded proteins outside the cell, strongly suggesting the involvement of this two-component system in the S. lividans secretion stress response. Conclusions/Significance: To our knowledge this is the first time that a specific secretion stress response two-component system is found to control the expression of three HtrA-like protease genes in S. lividans, a bacterium that has been repeatedly used as a host for the synthesis of homologous and heterologous secretory proteins of industrial application.	[Gullon, Sonia; Vicente, Rebeca L.; Mellado, Rafael P.] Ctr Nacl Biotecnol CNB CSIC, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Gullon, S (corresponding author), Ctr Nacl Biotecnol CNB CSIC, Madrid, Spain.	rpmellado@cnb.csic.es	Gullón, Sonia/P-7460-2018; Mellado, Rafael P/D-2680-2009	Gullon, Sonia/0000-0003-1933-7984				ANNE J, 1993, FEMS MICROBIOL LETT, V114, P121, DOI 10.1016/0378-1097(93)90507-X; Antelmann H, 2003, MOL MICROBIOL, V49, P143, DOI 10.1046/j.1365-2958.2003.03565.x; Bellier A, 2006, MICROBIOL-SGM, V152, P1021, DOI 10.1099/mic.0.28564-0; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Bernfeld P, 1955, METHODS ENZYMOLOGY; BIERMAN M, 1992, GENE, V116, P43, DOI 10.1016/0378-1119(92)90627-2; Binni C, 1997, TRENDS BIOTECHNOL, V15, P315, DOI 10.1016/S0167-7799(97)01062-7; Chater KF, 2010, FEMS MICROBIOL REV, V34, P171, DOI 10.1111/j.1574-6976.2009.00206.x; Connolly L, 1997, GENE DEV, V11, P2012, DOI 10.1101/gad.11.15.2012; Danese PN, 1997, GENE DEV, V11, P1183, DOI 10.1101/gad.11.9.1183; Darmon E, 2002, J BACTERIOL, V184, P5661, DOI 10.1128/JB.184.20.5661-5671.2002; Diaz-Torres ML, 2001, FEMS MICROBIOL LETT, V204, P23, DOI 10.1111/j.1574-6968.2001.tb10856.x; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Escutia MR, 2006, PROTEOMICS, V6, P4137, DOI 10.1002/pmic.200500927; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Foucaud-Scheunemann C, 2003, FEMS MICROBIOL LETT, V224, P53, DOI 10.1016/S0378-1097(03)00419-1; GIBERT M, 1995, CRIT REV BIOTECHNOL, V15, P13, DOI 10.3109/07388559509150530; Hopwood D. A., 1985, GENETIC MANIPULATION; Hyyrylainen HL, 2005, APPL MICROBIOL BIOT, V67, P389, DOI 10.1007/s00253-005-1898-1; Hyyrylainen HL, 2001, MOL MICROBIOL, V41, P1159, DOI 10.1046/j.1365-2958.2001.02576.x; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lammertyn E, 1997, APPL ENVIRON MICROB, V63, P1808, DOI 10.1128/AEM.63.5.1808-1813.1997; Noone D, 2001, J BACTERIOL, V183, P654, DOI 10.1128/JB.183.2.654-663.2001; Nybo SE., 2010, CURRENT PROTOCOLS MI; Palacin A, 2002, J BACTERIOL, V184, P4875, DOI 10.1128/JB.184.17.4875-4880.2002; Palomino C, 2008, INT MICROBIOL, V11, P25, DOI 10.2436/20.1501.01.41; Pang XH, 2004, ANTIMICROB AGENTS CH, V48, P575, DOI 10.1128/AAC.48.2.575-588.2004; PARRO V, 1994, GENE, V145, P49, DOI 10.1016/0378-1119(94)90321-2; Poligliano J, 1997, GENE DEV, V11, P1169; Poquet I, 2000, MOL MICROBIOL, V35, P1042, DOI 10.1046/j.1365-2958.2000.01757.x; RABINDRAN SK, 1993, SCIENCE, V259, P230, DOI 10.1126/science.8421783; Rozas D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031760; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Smeds A, 1998, J BACTERIOL, V180, P6148; Spiess C, 1999, CELL, V97, P339, DOI 10.1016/S0092-8674(00)80743-6; STRUMEYE.DH, 1967, ANAL BIOCHEM, V19, P61, DOI 10.1016/0003-2697(67)90134-0; THOMPSON CJ, 1982, GENE, V20, P51, DOI 10.1016/0378-1119(82)90086-5; TIMMONS TM, 1990, METHOD ENZYMOL, V182, P679; Van Mellaert L, 1994, RECENT RES DEV MICRO, V3, P324; Wang GJ, 2008, APPL ENVIRON MICROB, V74, P2834, DOI 10.1128/AEM.02800-07; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103	43	14	14	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48987	10.1371/journal.pone.0048987	http://dx.doi.org/10.1371/journal.pone.0048987			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155440	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900075
J	Jacobs, C; de Graaf, TA; Goebel, R; Sack, AT				Jacobs, Christianne; de Graaf, Tom A.; Goebel, Rainer; Sack, Alexander T.			The Temporal Dynamics of Early Visual Cortex Involvement in Behavioral Priming	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; OBJECTIVE MEASURES; SUPPRESSION; TMS; PERCEPTION; MASKING; VISION; BLINDSIGHT; MOTION; V1/V2	Transcranial magnetic stimulation (TMS) allows for non-invasive interference with ongoing neural processing. Applied in a chronometric design over early visual cortex (EVC), TMS has proved valuable in indicating at which particular time point EVC must remain unperturbed for (conscious) vision to be established. In the current study, we set out to examine the effect of EVC TMS across a broad range of time points, both before (pre-stimulus) and after (post-stimulus) the onset of symbolic visual stimuli. Behavioral priming studies have shown that the behavioral impact of a visual stimulus can be independent from its conscious perception, suggesting two independent neural signatures. To assess whether TMS-induced suppression of visual awareness can be dissociated from behavioral priming in the temporal domain, we thus implemented three different measures of visual processing, namely performance on a standard visual discrimination task, a subjective rating of stimulus visibility, and a visual priming task. To control for non-neural TMS effects, we performed electrooculographical recordings, placebo TMS (sham), and control site TMS (vertex). Our results suggest that, when considering the appropriate control data, the temporal pattern of EVC TMS disruption on visual discrimination, subjective awareness and behavioral priming are not dissociable. Instead, TMS to EVC disrupts visual perception holistically, both when applied before and after the onset of a visual stimulus. The current findings are discussed in light of their implications on models of visual awareness and (subliminal) priming.	[Jacobs, Christianne; de Graaf, Tom A.; Goebel, Rainer; Sack, Alexander T.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands	Maastricht University	Jacobs, C (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Maastricht, Netherlands.	christianne.jacobs@maastrichtuniversity.nl		Goebel, Rainer/0000-0003-1780-2467; Sack, Alexander/0000-0002-1471-0885				Amassian VE, 1998, J CLIN NEUROPHYSIOL, V15, P288, DOI 10.1097/00004691-199807000-00002; AMASSIAN VE, 1989, ELECTROEN CLIN NEURO, V74, P458, DOI 10.1016/0168-5597(89)90036-1; BECKERS G, 1991, EXP BRAIN RES, V87, P421; Boyer JL, 2005, P NATL ACAD SCI USA, V102, P16875, DOI 10.1073/pnas.0505332102; Breitmeyer BG, 2004, CONSCIOUS COGN, V13, P829, DOI 10.1016/j.concog.2004.08.007; Breitmeyer BG, 2004, CONSCIOUS COGN, V13, P138, DOI 10.1016/j.concog.2003.07.004; Breitmeyer BG, 2000, PERCEPT PSYCHOPHYS, V62, P1572, DOI 10.3758/BF03212157; Bullier J, 2001, TRENDS COGN SCI, V5, P369, DOI 10.1016/S1364-6613(00)01730-7; Camprodon JA, 2010, J COGNITIVE NEUROSCI, V22, P1262, DOI 10.1162/jocn.2009.21253; Corthout E, 1999, NEUROPSYCHOLOGIA, V37, P137; Corthout E, 1999, NEUROREPORT, V10, P2631, DOI 10.1097/00001756-199908200-00035; Corthout E, 2000, NEUROREPORT, V11, P2345, DOI 10.1097/00001756-200008030-00003; de Graaf TA, 2011, NEUROSCI BIOBEHAV R, V35, P871, DOI 10.1016/j.neubiorev.2010.10.006; de Graaf TA, 2012, NEUROIMAGE, V61, P651, DOI 10.1016/j.neuroimage.2011.10.020; de Graaf TA, 2011, CONSCIOUS COGN, V20, P1244, DOI 10.1016/j.concog.2011.04.012; de Graaf TA, 2011, EXP BRAIN RES, V209, P19, DOI 10.1007/s00221-010-2512-z; Eimer M, 2003, BIOL PSYCHOL, V64, P7, DOI 10.1016/S0301-0511(03)00100-5; Fahrenfort JJ, 2007, J COGNITIVE NEUROSCI, V19, P1488, DOI 10.1162/jocn.2007.19.9.1488; Hackley SA, 2009, PSYCHOPHYSIOLOGY, V46, P225, DOI 10.1111/j.1469-8986.2008.00716.x; Harris JA, 2008, J COGNITIVE NEUROSCI, V20, P734, DOI 10.1162/jocn.2008.20048; Heinen K, 2005, NEUROREPORT, V16, P1483, DOI 10.1097/01.wnr.0000175611.26485.c8; Jacobs C, 2012, NEUROIMAGE, V59, P616, DOI 10.1016/j.neuroimage.2011.07.090; Jolij J, 2005, P NATL ACAD SCI USA, V102, P10747, DOI 10.1073/pnas.0500834102; Koivisto M, 2012, EUR J NEUROSCI, V35, P623, DOI 10.1111/j.1460-9568.2011.07973.x; Koivisto M, 2011, CONSCIOUS COGN, V20, P1293, DOI 10.1016/j.concog.2011.02.008; Koivisto M, 2011, CONSCIOUS COGN, V20, P288, DOI 10.1016/j.concog.2010.09.001; Koivisto M, 2011, J NEUROSCI, V31, P2488, DOI 10.1523/JNEUROSCI.3074-10.2011; Koivisto M, 2010, NEUROIMAGE, V51, P828, DOI 10.1016/j.neuroimage.2010.02.042; Kouider S, 2007, CEREB CORTEX, V17, P2019, DOI 10.1093/cercor/bhl110; Kouider S, 2009, EXP PSYCHOL, V56, P418, DOI 10.1027/1618-3169.56.6.418; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Lamme VAF, 2001, ACTA PSYCHOL, V107, P209, DOI 10.1016/S0001-6918(01)00020-8; Lamme VAF, 2006, TRENDS COGN SCI, V10, P193, DOI 10.1016/j.tics.2006.03.002; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; Lau HC, 2006, P NATL ACAD SCI USA, V103, P18763, DOI 10.1073/pnas.0607716103; Laycock R, 2007, J NEUROPHYSIOL, V98, P1253, DOI 10.1152/jn.00416.2007; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Ogmen H, 2003, VISION RES, V43, P1337, DOI 10.1016/S0042-6989(03)00138-X; Overgaard M, 2004, BRAIN COGNITION, V54, P58, DOI 10.1016/S0278-2626(03)00260-4; Pascual-Leone A, 2001, SCIENCE, V292, P510, DOI 10.1126/science.1057099; Paulus W, 1999, NEUROREPORT, V10, P1245, DOI 10.1097/00001756-199904260-00017; Rahnev D, 2012, J NEUROPHYSIOL, V107, P1556, DOI 10.1152/jn.00985.2011; Ro T, 2008, NEUROPSYCHOLOGIA, V46, P379, DOI 10.1016/j.neuropsychologia.2007.09.005; Ro T, 2009, ATTEN PERCEPT PSYCHO, V71, P95, DOI 10.3758/APP.71.1.95; Sack AT, 2009, NEUROIMAGE, V44, P284, DOI 10.1016/j.neuroimage.2008.07.030; Sack AT, 2006, NEUROIMAGE, V29, P1326, DOI 10.1016/j.neuroimage.2005.08.027; Salminen-Vaparanta N, 2012, HUM BRAIN MAPP, V33, P652, DOI 10.1002/hbm.21237; Schacter DL, 1998, NEURON, V20, P185, DOI 10.1016/S0896-6273(00)80448-1; Skotte JH, 2007, EUR J APPL PHYSIOL, V99, P113, DOI 10.1007/s00421-006-0322-6; Tapia E, 2011, PSYCHOL SCI, V22, P934, DOI 10.1177/0956797611413471; Thielscher A, 2010, CEREB CORTEX, V20, P328, DOI 10.1093/cercor/bhp102; Thut G, 2006, J NEUROSCI, V26, P9494, DOI 10.1523/JNEUROSCI.0875-06.2006; Tong F, 2003, NAT REV NEUROSCI, V4, P219, DOI 10.1038/nrn1055; Toscani M, 2010, EXP BRAIN RES, V207, P213, DOI 10.1007/s00221-010-2444-7; Van den Bussche E, 2009, EXP PSYCHOL, V56, P295, DOI 10.1027/1618-3169.56.5.295; Van Dijk H, 2008, J NEUROSCI, V28, P1816, DOI 10.1523/JNEUROSCI.1853-07.2008; van Gaal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011508; Vorberg D, 2003, P NATL ACAD SCI USA, V100, P6275, DOI 10.1073/pnas.0931489100; Weiskrantz L., 2009, BLINDSIGHT CASE STUD	60	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48808	10.1371/journal.pone.0048808	http://dx.doi.org/10.1371/journal.pone.0048808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155408	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900042
J	Jimenez-Preitner, M; Berney, X; Thorens, B				Jimenez-Preitner, Maria; Berney, Xavier; Thorens, Bernard			Plac8 is required for White Adipocyte Differentiation in vitro and Cell Number Control in vivo	PLOS ONE			English	Article							TRANSCRIPTIONAL REGULATION; ADIPOSE-TISSUE; MICE LACKING; ADIPOGENESIS; ONZIN; PLASTICITY; TARGET; GENE; SITE	Plac8 belongs to an evolutionary conserved family of proteins, mostly abundant in plants where they control fruit weight through regulation of cell number. In mice, Plac8 is expressed both in white and brown adipose tissues and we previously showed that Plac8(-/-) mice develop late-onset obesity, with abnormal brown fat differentiation and reduced thermogenic capacity. We also showed that in brown adipocytes, Plac8 is an upstream regulator of C/EBP beta expression. Here, we first assessed the role of Plac8 in white adipogenesis in vitro. We show that Plac8 is induced early after induction of 3T3-L1 adipocytes differentiation, a process that is prevented by Plac8 knockdown; similarly, embryonic fibroblasts obtained from Plac8 knockout mice failed to form adipocytes upon stimulation of differentiation. Knockdown of Plac8 in 3T3-L1 was associated with reduced expression of C/EBP beta, Krox20, and Klf4, early regulators of the white adipogenic program, and we show that Plac8 could transactivate the C/EBP beta promoter. In vivo, we show that absence of Plac8 led to increased white fat mass with enlarged adipocytes but reduced total number of adipocytes. Finally, even though Plac8(-/-) mice showed impaired thermogenesis due to brown fat dysfunction, this was not associated with changes in glycemia or plasma free fatty acid and triglyceride levels. Collectively, these data indicate that Plac8 is an upstream regulator of C/EBP beta required for adipogenesis in vitro. However, in vivo, Plac8 is dispensable for the differentiation of white adipocytes with preserved fat storage capacity but is required for normal fat cell number regulation.	[Jimenez-Preitner, Maria; Berney, Xavier; Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland	University of Lausanne	Jimenez-Preitner, M (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	Bernard.Thorens@unil.ch						BERTRAND HA, 1984, J NUTR, V114, P127, DOI 10.1093/jn/114.1.127; Birsoy K, 2008, CELL METAB, V7, P339, DOI 10.1016/j.cmet.2008.02.001; Chen Z, 2005, CELL METAB, V1, P93, DOI 10.1016/j.cmet.2004.12.009; DAXHELET GA, 1989, ANAL BIOCHEM, V179, P401, DOI 10.1016/0003-2697(89)90152-8; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Fisch S, 2007, P NATL ACAD SCI USA, V104, P7074, DOI 10.1073/pnas.0701981104; Jimenez M, 2002, EUR J BIOCHEM, V269, P2878, DOI 10.1046/j.1432-1033.2002.02953.x; Jimenez-Preitner M, 2011, CELL METAB, V14, P658, DOI 10.1016/j.cmet.2011.08.008; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kajimura S, 2010, CELL METAB, V11, P257, DOI 10.1016/j.cmet.2010.03.005; Ledford JG, 2007, J IMMUNOL, V178, P5132, DOI 10.4049/jimmunol.178.8.5132; LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115; Li YJ, 2006, MOL CELL BIOL, V26, P3401, DOI 10.1128/MCB.26.9.3401-3413.2006; Libault M, 2010, PLANT SIGNAL BEHAV, V5; Lumeng CN, 2011, J CLIN INVEST, V121, P2111, DOI 10.1172/JCI57132; Mori T, 2005, J BIOL CHEM, V280, P12867, DOI 10.1074/jbc.M410515200; Prunet-Marcassus B, 2006, EXP CELL RES, V312, P727, DOI 10.1016/j.yexcr.2005.11.021; Rogulski K, 2005, ONCOGENE, V24, P7524, DOI 10.1038/sj.onc.1208897; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200	23	22	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48767	10.1371/journal.pone.0048767	http://dx.doi.org/10.1371/journal.pone.0048767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155406	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900040
J	Kwak, DH; Lee, JH; Kim, T; Ahn, HS; Cho, WK; Ha, H; Hwang, YH; Ma, JY				Kwak, Dong Hoon; Lee, Ji-Hye; Kim, Taesoo; Ahn, Hyo Sun; Cho, Won-Kyung; Ha, Hyunil; Hwang, Youn-Hwan; Ma, Jin Yeul			Aristolochia Manshuriensis Kom Inhibits Adipocyte Differentiation by Regulation of ERK1/2 and Akt Pathway	PLOS ONE			English	Article							MITOTIC CLONAL EXPANSION; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR-I; PPAR-GAMMA; 3T3-L1 ADIPOCYTES; SIGNALING PATHWAYS; METABOLIC SYNDROME; MAP KINASE; ADIPOGENESIS; CELLS	Aristolochia manshuriensis Kom (AMK) is a traditional medicinal herb used for the treatment of arthritis, rheumatism, hepatitis, and anti-obesity. Because of nephrotoxicity and carcinogenicity of AMK, there are no pharmacological reports on anti-obesity potential of AMK. Here, we showed AMK has an inhibitory effect on adipocyte differentiation of 3T3-L1 cells along with significantly decrease in the lipid accumulation by downregulating several adipocyte-specific transcription factors including peroxisome proliferation-activity receptor gamma (PPAR-gamma), CCAAT/enhancer binding protein alpha (C/EBP-alpha) and C/EBP-beta, which are critical for adipogenesis in vitro. AMK also markedly activated the extracellular signal-regulated protein kinase 1/2 (ERK1/2) pathway including Ras, Raf1, and mitogen-activated protein kinase kinase 1 (MEK1), and significantly suppressed Akt pathway by inhibition of phosphoinositide-dependent kinase 1 (PDK1). Aristolochic acid (AA) and ethyl acetate (EtOAc) fraction of AMK with AA were significantly inhibited TG accumulation, and regulated two pathway (ERK1/2 and Akt) during adipocyte differentiation, and was not due to its cytotoxicity. These two pathways were upstream of PPAR-gamma and C/EBP alpha in the adipogenesis. In addition, gene expressions of secreting factors such as fatty acid synthase (FAS), adiponectin, lipopreotein lipase (LPL), and aP2 were significantly inhibited by treatment of AMK during adipogenesis. We used the high-fat diet (HFD)-induced obesity mouse model to determine the inhibitory effects of AMK on obesity. Oral administration of AMK (62.5 mg/kg/day) significantly decreased the fat tissue weight, total cholesterol (TC), and low density lipoprotein-cholesterol (LDL-C) concentration in the blood. The results of this study suggested that AMK inhibited lipid accumulation by the down-regulation of the major transcription factors of the adipogensis pathway including PPAR-gamma and C/EBP-alpha through regulation of Akt pathway and ERK 1/2 pathway in 3T3-L1 adipocytes and HFD-induced obesity mice, and AA may be main act in inhibitory effects of AMK during adipocyte differentiation.	[Kwak, Dong Hoon; Lee, Ji-Hye; Kim, Taesoo; Ahn, Hyo Sun; Cho, Won-Kyung; Ha, Hyunil; Hwang, Youn-Hwan; Ma, Jin Yeul] Korea Inst Oriental Med, Herbal Med Res Div, Taejon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Kwak, DH (corresponding author), Korea Inst Oriental Med, Herbal Med Res Div, Taejon, South Korea.	jyma@kiom.re.kr	Hwang, Youn-Hwan/AAU-9373-2021	Ha, Hyunil/0000-0001-5947-9982; Kwak, Dong Hoon/0000-0001-9820-3137				Abate N, 2000, J DIABETES COMPLICAT, V14, P154, DOI 10.1016/S1056-8727(00)00067-2; Arnott CH, 1997, FEBS LETT, V406, P179, DOI 10.1016/S0014-5793(97)00266-4; Aubert J, 1999, J BIOL CHEM, V274, P24965, DOI 10.1074/jbc.274.35.24965; CORNELIUS P, 1994, ANNU REV NUTR, V14, P99, DOI 10.1146/annurev.nu.14.070194.000531; Duvnjak L, 2009, J PHYSIOL PHARMACOL, V60, P19; Farmer S R, 2004, Obes Rev, V5, P189, DOI 10.1111/j.1467-789X.2004.00157.x; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Farnsworth NR, 1998, NAPRALERT DATABASE; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hiuge-Shimizu A, 2011, ARTERIOSCL THROM VAS, V31, P792, DOI 10.1161/ATVBAHA.110.221747; Hou YY, 2012, FREE RADICAL BIO MED, V52, P462, DOI 10.1016/j.freeradbiomed.2011.10.453; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Huang C, 2006, BIOCHEM BIOPH RES CO, V348, P571, DOI 10.1016/j.bbrc.2006.07.095; Hung PF, 2005, AM J PHYSIOL-CELL PH, V288, pC1094, DOI 10.1152/ajpcell.00569.2004; Hwang JT, 2005, BIOCHEM BIOPH RES CO, V338, P694, DOI 10.1016/j.bbrc.2005.09.195; Jessen BA, 2002, GENE, V299, P95, DOI 10.1016/S0378-1119(02)01017-X; Kim YK, 2007, BIOCHEM BIOPH RES CO, V358, P553, DOI 10.1016/j.bbrc.2007.04.165; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Liao QC, 2008, J CELL BIOCHEM, V104, P1853, DOI 10.1002/jcb.21753; Liu LH, 2004, ACTA PHARMACOL SIN, V25, P1052; Liu YB, 2012, BIOCHEM BIOPH RES CO, V417, P570, DOI 10.1016/j.bbrc.2011.12.007; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pozdzik AA, 2008, NEPHROL DIAL TRANSPL, V23, P2480, DOI 10.1093/ndt/gfn140; Prusty D, 2002, J BIOL CHEM, V277, P46226, DOI 10.1074/jbc.M207776200; Rayalam S, 2008, J NUTR BIOCHEM, V19, P717, DOI 10.1016/j.jnutbio.2007.12.007; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; SALE EM, 1995, EMBO J, V14, P674, DOI 10.1002/j.1460-2075.1995.tb07046.x; Schoonjans K, 1996, EMBO J, V15, P5336, DOI 10.1002/j.1460-2075.1996.tb00918.x; Seo JB, 2012, BIOCHEM BIOPH RES CO, V417, P800, DOI 10.1016/j.bbrc.2011.12.039; SMITH PJ, 1988, J BIOL CHEM, V263, P9402; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Su Zhen, 2002, Zhonghua Yufang Yixue Zazhi, V36, P301; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P850, DOI 10.1073/pnas.0337434100; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Unger RH, 2001, DIABETES, V50, pS118, DOI 10.2337/diabetes.50.2007.S118; Uto-Kondo H, 2009, J NUTR, V139, P51, DOI 10.3945/jn.108.096131; Xing YF, 2010, BIOCHEM BIOPH RES CO, V396, P691, DOI 10.1016/j.bbrc.2010.04.163; Xu JF, 2004, J BIOL CHEM, V279, P35914, DOI 10.1074/jbc.M402297200; Yang L, 2007, NEPHROL DIAL TRANSPL, V22, P445, DOI 10.1093/ndt/gfl556; Yang X C, 1986, Zhong Yao Tong Bao, V11, P19; YEH WC, 1995, GENE DEV, V9, P168, DOI 10.1101/gad.9.2.168; Zhu XL, 2011, J MOL BIOL, V410, P1035, DOI 10.1016/j.jmb.2011.03.055	47	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49530	10.1371/journal.pone.0049530	http://dx.doi.org/10.1371/journal.pone.0049530			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166699	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900156
J	McConnell, AD; Do, M; Neben, TY; Spasojevic, V; MacLaren, J; Chen, AP; Altobell, L; Macomber, JL; Berkebile, AD; Horlick, RA; Bowers, PM; King, DJ				McConnell, Audrey D.; Do, Minjee; Neben, Tamlyn Y.; Spasojevic, Vladimir; MacLaren, Josh; Chen, Andy P.; Altobell, Laurence, III; Macomber, John L.; Berkebile, Ashley D.; Horlick, Robert A.; Bowers, Peter M.; King, David J.			High Affinity Humanized Antibodies without Making Hybridomas; Immunization Paired with Mammalian Cell Display and In Vitro Somatic Hypermutation	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY; COMPLEMENT; DIVERSITY; REPERTOIRE; DISCOVERY; LIBRARIES; THERAPY; TRIAL	A method has been developed for the rapid generation of high-affinity humanized antibodies from immunized animals without the need to make conventional hybridomas. Rearranged IgH D(J) regions were amplified from the spleen and lymph tissue of mice immunized with the human complement protein C5, fused with a limited repertoire of human germline heavy chain V-genes to form intact humanized heavy chains, and paired with a human light chain library. Completed heavy and light chains were assembled for mammalian cell surface display and transfected into HEK 293 cells co-expressing activation-induced cytidine deaminase (AID). Numerous clones were isolated by fluorescence-activated cell sorting, and affinity maturation, initiated by AID, resulted in the rapid evolution of high affinity, functional antibodies. This approach enables the efficient sampling of an immune repertoire and the direct selection and maturation of high-affinity, humanized IgGs.	[McConnell, Audrey D.; Do, Minjee; Neben, Tamlyn Y.; Spasojevic, Vladimir; MacLaren, Josh; Chen, Andy P.; Altobell, Laurence, III; Macomber, John L.; Berkebile, Ashley D.; Horlick, Robert A.; Bowers, Peter M.; King, David J.] AnaptysBio Inc, San Diego, CA USA		McConnell, AD (corresponding author), AnaptysBio Inc, San Diego, CA USA.	pbowers@anaptysbio.com						Almagro JC, 2008, FRONT BIOSCI-LANDMRK, V13, P1619, DOI 10.2741/2786; Bowers PM, 2011, P NATL ACAD SCI USA, V108, P20455, DOI 10.1073/pnas.1114010108; Bramham J, 2005, J BIOL CHEM, V280, P10636, DOI 10.1074/jbc.M413126200; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Copland DA, 2010, CLIN EXP IMMUNOL, V159, P303, DOI 10.1111/j.1365-2249.2009.04070.x; de Wildt RMT, 1999, J MOL BIOL, V294, P701, DOI 10.1006/jmbi.1999.3289; Glanville J, 2009, P NATL ACAD SCI USA, V106, P20216, DOI 10.1073/pnas.0909775106; GOLDSTEIN G, 1985, NEW ENGL J MED, V313, P337; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067; Hoogenboom HR, 2005, NAT BIOTECHNOL, V23, P1105, DOI 10.1038/nbt1126; James LC, 2003, SCIENCE, V299, P1362, DOI 10.1126/science.1079731; Kasper LH, 2006, CURR MED RES OPIN, V22, P1671, DOI 10.1185/030079906X120931; Knappik A, 2000, J MOL BIOL, V296, P57, DOI 10.1006/jmbi.1999.3444; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lonberg N, 2005, NAT BIOTECHNOL, V23, P1117, DOI 10.1038/nbt1135; Martin PL, 2007, AM J REPROD IMMUNOL, V58, P138, DOI 10.1111/j.1600-0897.2007.00499.x; MULLEREBERHARD HJ, 1986, ANNU REV IMMUNOL, V4, P503, DOI 10.1146/annurev.iy.04.040186.002443; PADLAN EA, 1994, MOL IMMUNOL, V31, P169, DOI 10.1016/0161-5890(94)90001-9; Persic L, 1997, GENE, V187, P1, DOI 10.1016/S0378-1119(96)00627-0; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; Schwarz EM, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2171; Teeling JL, 2004, BLOOD, V104, P1793, DOI 10.1182/blood-2004-01-0039; Vendel MC, 2012, ARCH BIOCH BIOPHYS; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543	26	20	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49458	10.1371/journal.pone.0049458	http://dx.doi.org/10.1371/journal.pone.0049458			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166676	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900145
J	McMullan, BJ; Halliday, C; Sorrell, TC; Judd, D; Sleiman, S; Marriott, D; Olma, T; Chen, SCA				McMullan, Brendan J.; Halliday, Catriona; Sorrell, Tania C.; Judd, David; Sleiman, Sue; Marriott, Debbie; Olma, Tom; Chen, Sharon C. -A.			Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory	PLOS ONE			English	Article							EPIDEMIOLOGY; MENINGITIS; INFECTION; NEOFORMANS; GATTII; SERUM; HOST	Background: Cryptococcus neoformans causes life-threatening meningitis. A recently introduced lateral flow immunoassay (LFA) to detect cryptococcal antigen (CRAG) is reportedly more rapid and convenient than standard latex agglutination (LA), but has not yet been evaluated in a diagnostic laboratory setting. Methods: One hundred and six serum, 42 cerebrospinal fluid (CSF), and 20 urine samples from 92 patients with known or suspected cryptococcosis were tested by LA and LFA, and titres were compared. Results were correlated with laboratory-confirmed cryptococcosis. Serial samples were tested in nine treated patients. Results: Twenty-five of 92 patients had confirmed cryptococcosis; all sera (n = 56) from these patients were positive by LFA (sensitivity 100%, 95% confidence interval (CI) 93.6-100%) compared with 51/56 positive by LA (sensitivity 91.1%, 95% CI 80.7-96.1%). Fifty sera from 67 patients without cryptococcosis tested negative in both assays. While LA yielded more false negative results (5/56) this did not reach statistical significance (p = 0.063). Nine CSF samples from patients with cryptococcal meningitis yielded positive results using both assays while 17/18 urine samples from patients with cryptococcosis were positive by the LFA. The LFA detected CRAG in C. gattii infection (n = 4 patients). Agreement between titres obtained by both methods (n = 38 samples) was imperfect; correlation between log-transformed titres (r) was 0.84. Turn-around-time was 20 minutes for the LFA and 2 h for LA. The cost per qualitative sample was 18USD and 91 USD, respectively and per quantitative sample was 38USD and 144USD, respectively. Conclusions: Qualitative agreement between the LFA and LA assays performed on serum and CSF was good but agreement between titres was imperfect. Ease of performance of the LFA and the capacity for testing urine suggest it has a role in the routine laboratory as a rapid diagnostic test or point-of-care test.	[McMullan, Brendan J.; Halliday, Catriona; Judd, David; Sleiman, Sue; Olma, Tom; Chen, Sharon C. -A.] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia	University of Sydney	McMullan, BJ (corresponding author), Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia.	brendanoch@yahoo.co.uk	Halliday, Catriona/AAX-7689-2020; Sorrell, Tania/AAZ-5286-2020; McMullan, Brendan/AAR-6174-2020	McMullan, Brendan/0000-0001-5144-3416; Sorrell, Tania/0000-0001-9460-0960				BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286; Chau TTH, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-199; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Dromer F, 2007, PLOS MED, V4, P297, DOI 10.1371/journal.pmed.0040021; Galanis E, 2010, EMERG INFECT DIS, V16, P251, DOI [10.3201/eid1602.090900, 10.3201/eid1601.090900]; Harris JR, 2011, CLIN INFECT DIS, V53, P1188, DOI 10.1093/cid/cir723; Howell S, 2011, MANUAL CLIN MICROBIO, P1803; IMMY, IMMY CRYPT ANT LAT F; Jarvis JN, 2011, CLIN INFECT DIS, V53, P1019, DOI 10.1093/cid/cir613; Jenney A, 2004, J CLIN MICROBIOL, V42, P3865, DOI 10.1128/JCM.42.8.3865-3868.2004; Lau A, 2007, J CLIN MICROBIOL, V45, P380, DOI 10.1128/JCM.01862-06; Liechty CA, 2007, TROP MED INT HEALTH, V12, P929, DOI 10.1111/j.1365-3156.2007.01874.x; Lindsley MD, 2011, CLIN INFECT DIS, V53, P321, DOI 10.1093/cid/cir379; Lortholary O, 2006, AIDS, V20, P2183, DOI 10.1097/01.aids.0000252060.80704.68; Meridian Bioscience Inc, CRYPT ANT LAT AGGL S; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Pukkila-Worley R, 2008, EXPERT OPIN PHARMACO, V9, P551, DOI 10.1517/14656566.9.4.551; Rajasingham R, 2012, JAIDS-J ACQ IMM DEF, V59, pE85, DOI 10.1097/QAI.0b013e31824c837e; Shea Y, 2011, MANUAL CLIN MICROBIO, P1783; Snyder J, 2011, MANUAL CLIN MICROBIO, P1771; SPEED B, 1995, CLIN INFECT DIS, V21, P28, DOI 10.1093/clinids/21.1.28; World Health Organization (WHO) Guideline Development group, 2011, RAP ADV DIAGN PREV M	23	81	82	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49541	10.1371/journal.pone.0049541	http://dx.doi.org/10.1371/journal.pone.0049541			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166705	gold, Green Submitted, Green Published			2022-12-27	WOS:000311151900160
J	Mikkelsen, MD; Pedas, P; Schiller, M; Vincze, E; Mills, RF; Borg, S; Moller, A; Schjoerring, JK; Williams, LE; Baekgaard, L; Holm, PB; Palmgren, MG				Mikkelsen, Maria Dalgaard; Pedas, Pai; Schiller, Michaela; Vincze, Eva; Mills, Rebecca F.; Borg, Soren; Moller, Annette; Schjoerring, Jan K.; Williams, Lorraine E.; Baekgaard, Lone; Holm, Preben Bach; Palmgren, Michael G.			Barley HvHMA1 Is a Heavy Metal Pump Involved in Mobilizing Organellar Zn and Cu and Plays a Role in Metal Loading into Grains	PLOS ONE			English	Article							P-TYPE ATPASE; BINDING DOMAINS; ARABIDOPSIS-THALIANA; TRANSPORTING ATPASE; FUNCTIONAL-ANALYSIS; ZINC; COPPER; TRANSFORMATION; THAPSIGARGIN; DELIVERY	Heavy metal transporters belonging to the P-1B-ATPase subfamily of P-type ATPases are key players in cellular heavy metal homeostasis. Heavy metal transporters belonging to the P1B-ATPase subfamily of P-type ATPases are key players in cellular heavy metal homeostasis. In this study we investigated the properties of HvHMA1, which is a barley orthologue of Arabidopsis thaliana AtHMA1 localized to the chloroplast envelope. HvHMA1 was localized to the periphery of chloroplast of leaves and in intracellular compartments of grain aleurone cells. HvHMA1 expression was significantly higher in grains compared to leaves. In leaves, HvHMA1 expression was moderately induced by Zn deficiency, but reduced by toxic levels of Zn, Cu and Cd. Isolated barley chloroplasts exported Zn and Cu when supplied with Mg-ATP and this transport was inhibited by the AtHMA1 inhibitor thapsigargin. Down-regulation of HvHMA1 by RNA interference did not have an effect on foliar Zn and Cu contents but resulted in a significant increase in grain Zn and Cu content. Heterologous expression of HvHMA1 in heavy metal-sensitive yeast strains increased their sensitivity to Zn, but also to Cu, Co, Cd, Ca, Mn, and Fe. Based on these results, we suggest that HvHMA1 is a broad-specificity exporter of metals from chloroplasts and serve as a scavenging mechanism for mobilizing plastid Zn and Cu when cells become deficient in these elements. In grains, HvHMA1 might be involved in mobilizing Zn and Cu from the aleurone cells during grain filling and germination.	[Mikkelsen, Maria Dalgaard; Moller, Annette; Baekgaard, Lone; Palmgren, Michael G.] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Frederiksberg, Denmark	Danmarks Grundforskningsfond	Mikkelsen, MD (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Frederiksberg, Denmark.	palmgren@life.ku.dk	Mikkelsen, Maria/R-1243-2016; Mikkelsen, Maria Dalgaard/AAP-3139-2021; Stokholm, Michaela S/B-4593-2017; Schjoerring, Jan K./M-4044-2019; Pedas, Pai/G-3494-2014; Schjoerring, Jan K./A-5387-2009; Palmgren, Michael/A-9808-2013	Mikkelsen, Maria Dalgaard/0000-0003-4297-6119; Stokholm, Michaela S/0000-0003-3092-0281; Schjoerring, Jan K./0000-0002-2852-3298; Pedas, Pai/0000-0001-6733-7300; Schjoerring, Jan K./0000-0002-2852-3298; Palmgren, Michael/0000-0002-9982-6114				Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; Andres-Colas N, 2006, PLANT J, V45, P225, DOI 10.1111/j.1365-313X.2005.02601.x; Arguello JM, 2007, BIOMETALS, V20, P233, DOI 10.1007/s10534-006-9055-6; Axelsen KB, 2001, PLANT PHYSIOL, V126, P696, DOI 10.1104/pp.126.2.696; Axelsen KB, 1998, J MOL EVOL, V46, P84, DOI 10.1007/PL00006286; Baekgaard L, 2010, J BIOL CHEM, V285, P31243, DOI 10.1074/jbc.M110.111260; BECHTEL DB, 1982, ANN BOT-LONDON, V50, P507, DOI 10.1093/oxfordjournals.aob.a086391; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; BOWLER C, 1994, CRIT REV PLANT SCI, V13, P199, DOI 10.1080/713608062; Brinch-Pedersen H, 2007, J CEREAL SCI, V46, P308, DOI 10.1016/j.jcs.2007.02.004; Broadley MR, 2007, NEW PHYTOL, V173, P677, DOI 10.1111/j.1469-8137.2007.01996.x; Carciofi M, 2011, J CEREAL SCI, V54, P339, DOI 10.1016/j.jcs.2011.06.013; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Eren E, 2006, J BIOL CHEM, V281, P33881, DOI 10.1074/jbc.M605218200; Grusak MA, 2005, BIOL SCI SER, P265; Hansen TH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-12; Hegelund JN, 2012, PLANT SOIL, DOI [10.1007/s11104-012-1272, DOI 10.1007/S11104-012-1272]; Higuchi M, 2009, J PHOTOCH PHOTOBIO B, V94, P205, DOI 10.1016/j.jphotobiol.2008.12.002; Hirayama T, 1999, CELL, V97, P383, DOI 10.1016/S0092-8674(00)80747-3; Hussain D, 2004, PLANT CELL, V16, P1327, DOI 10.1105/tpc.020487; Kim YY, 2009, PLANT J, V58, P737, DOI 10.1111/j.1365-313X.2009.03818.x; Lange M, 2006, PLANT CELL REP, V25, P815, DOI 10.1007/s00299-006-0140-7; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lombi E, 2011, J EXP BOT, V62, P273, DOI 10.1093/jxb/erq270; Mana-Capelli S, 2003, J BIOL CHEM, V278, P40534, DOI 10.1074/jbc.M306907200; Mandal AK, 2003, BIOCHEMISTRY-US, V42, P11040, DOI 10.1021/bi034806y; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Marschner H., 1995, MINERAL NUTR HIGHER, V2nd ed.; Matthews PR, 2001, MOL BREEDING, V7, P195, DOI 10.1023/A:1011333321893; MAZZOLINI AP, 1985, NEW PHYTOL, V100, P483, DOI 10.1111/j.1469-8137.1985.tb02796.x; Mills RF, 2008, PLANT PHYSIOL, V146, P116, DOI 10.1104/pp.107.110817; Mills RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042640; Mills RF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013388; MORAN R, 1982, PLANT PHYSIOL, V69, P1376, DOI 10.1104/pp.69.6.1376; Moreno I, 2008, J BIOL CHEM, V283, P9633, DOI 10.1074/jbc.M800736200; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ozturk L, 2006, PHYSIOL PLANTARUM, V128, P144, DOI 10.1111/j.1399-3054.2006.00737.x; Palmgren MG, 1998, BBA-BIOENERGETICS, V1365, P37, DOI 10.1016/S0005-2728(98)00041-3; Palmgren MG, 2008, TRENDS PLANT SCI, V13, P464, DOI 10.1016/j.tplants.2008.06.005; Patrick JW, 2001, J EXP BOT, V52, P551, DOI 10.1093/jexbot/52.356.551; Pedas P, 2005, PLANT PHYSIOL, V139, P1411, DOI 10.1104/pp.105.067561; Pedas P, 2008, PLANT PHYSIOL, V148, P455, DOI 10.1104/pp.108.118851; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilon M, 2006, CURR OPIN PLANT BIOL, V9, P256, DOI 10.1016/j.pbi.2006.03.007; PLESNICAR M, 1970, BIOCHIM BIOPHYS ACTA, V216, P192, DOI 10.1016/0005-2728(70)90170-2; Poulsen LR, 2008, CELL MOL LIFE SCI, V65, P3119, DOI 10.1007/s00018-008-8341-6; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; REGENBERG B, 1995, PLANT CELL, V7, P1655, DOI 10.1105/tpc.7.10.1655; RHODES D, 1993, SCI AM, V268, P56, DOI 10.1038/scientificamerican0293-56; Seigneurin-Berny D, 2006, J BIOL CHEM, V281, P2882, DOI 10.1074/jbc.M508333200; Shikanai T, 2003, PLANT CELL, V15, P1333, DOI 10.1105/tpc.011817; Tauris B, 2009, J EXP BOT, V60, P1333, DOI 10.1093/jxb/erp023; Tingay S, 1997, PLANT J, V11, P1369, DOI 10.1046/j.1365-313X.1997.11061369.x; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Uauy C, 2006, J EXP BOT, V57, P2785, DOI 10.1093/jxb/erl047; VEIERSKOV B, 1991, PLANT PHYSIOL, V96, P4, DOI 10.1104/pp.96.1.4; Verret F, 2005, FEBS LETT, V579, P1515, DOI 10.1016/j.febslet.2005.01.065; Welch RM, 2004, J EXP BOT, V55, P353, DOI 10.1093/jxb/erh064; White PJ, 2005, TRENDS PLANT SCI, V10, P586, DOI 10.1016/j.tplants.2005.10.001; Williams LE, 2005, TRENDS PLANT SCI, V10, P491, DOI 10.1016/j.tplants.2005.08.008; Woeste KE, 2000, PLANT CELL, V12, P443, DOI 10.1105/tpc.12.3.443; Wong CKE, 2009, NEW PHYTOL, V181, P79, DOI 10.1111/j.1469-8137.2008.02637.x; Yamasaki H, 2008, PLANT SIGNAL BEHAV, V3, P231, DOI 10.4161/psb.3.4.5094; Zhang WH, 2007, FUNCT PLANT BIOL, V34, P314, DOI 10.1071/FP06271; ZHANG ZY, 1993, FEBS LETT, V335, P261, DOI 10.1016/0014-5793(93)80742-D; Zhong L, 1998, J BIOL CHEM, V273, P12994, DOI 10.1074/jbc.273.21.12994	69	43	46	3	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49027	10.1371/journal.pone.0049027	http://dx.doi.org/10.1371/journal.pone.0049027			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155447	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000311151900082
J	Pedraza-Lara, C; Doadrio, I; Breinholt, JW; Crandall, KA				Pedraza-Lara, Carlos; Doadrio, Ignacio; Breinholt, Jesse W.; Crandall, Keith A.			Phylogeny and Evolutionary Patterns in the Dwarf Crayfish Subfamily (Decapoda: Cambarellinae)	PLOS ONE			English	Article							DNA-SEQUENCES; MOLECULAR EVOLUTION; MITOCHONDRIAL-DNA; NUCLEAR; MODEL; DIVERGENCE; DIVERSIFICATION; SALAMANDERS; SYSTEMATICS; CAMBARIDAE	The Dwarf crayfish or Cambarellinae, is a morphologically singular subfamily of decapod crustaceans that contains only one genus, Cambarellus. Its intriguing distribution, along the river basins of the Gulf Coast of United States (Gulf Group) and into Central Mexico (Mexican Group), has until now lacked of satisfactory explanation. This study provides a comprehensive sampling of most of the extant species of Cambarellus and sheds light on its evolutionary history, systematics and biogeography. We tested the impact of Gulf Group versus Mexican Group geography on rates of cladogenesis using a maximum likelihood framework, testing different models of birth/extinction of lineages. We propose a comprehensive phylogenetic hypothesis for the subfamily based on mitochondrial and nuclear loci (3,833 bp) using Bayesian and Maximum Likelihood methods. The phylogenetic structure found two phylogenetic groups associated to the two main geographic components (Gulf Group and Mexican Group) and is partially consistent with the historical structure of river basins. The previous hypothesis, which divided the genus into three subgenera based on genitalia morphology was only partially supported (P = 0.047), resulting in a paraphyletic subgenus Pandicambarus. We found at least two cases in which phylogenetic structure failed to recover monophyly of recognized species while detecting several cases of cryptic diversity, corresponding to lineages not assigned to any described species. Cladogenetic patterns in the entire subfamily are better explained by an allopatric model of speciation. Diversification analyses showed similar cladogenesis patterns between both groups and did not significantly differ from the constant rate models. While cladogenesis in the Gulf Group is coincident in time with changes in the sea levels, in the Mexican Group, cladogenesis is congruent with the formation of the Trans-Mexican Volcanic Belt. Our results show how similar allopatric divergence in freshwater organisms can be promoted through diverse vicariant factors.	[Pedraza-Lara, Carlos; Doadrio, Ignacio] CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolutiva, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Pedraza-Lara, C (corresponding author), CSIC, Museo Nacl Ciencias Nat, Dept Biodiversidad & Biol Evolutiva, E-28006 Madrid, Spain.	carlospedrazal@yahoo.es	Doadrio, Ignacio/F-8448-2016; Breinholt, Jesse/F-4330-2014; Breinholt, Jesse/K-6252-2019; Crandall, Keith A./H-2789-2019	Doadrio, Ignacio/0000-0003-4863-9711; Breinholt, Jesse/0000-0002-3867-2430; Breinholt, Jesse/0000-0002-3867-2430; Crandall, Keith A./0000-0002-0836-3389; Pedraza-Lara, Carlos/0000-0001-7924-5286				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2014, TRACER V1 6; BARBOUR CD, 1973, COPEIA, P533; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Breinholt Jesse, 2009, Crustacean Issues, V18, P343; Buhay JE, 2009, J CRUSTACEAN BIOL, V29, P96, DOI 10.1651/08-3020.1; Burrows R.H., 1910, BOL SOC GEOL MEX, V7, P85, DOI [10.18268/bsgm1910v7n1a12, DOI 10.18268/BSGM1910V7N1A12]; Colgan DJ, 1998, AUST J ZOOL, V46, P419, DOI 10.1071/ZO98048; Conner J.V., 1986, P413; Contreras-Balderas Salvador, 1996, Ichthyological Exploration of Freshwaters, V7, P33; Cook BD, 2008, J HERED; Crandall KA, 1996, SYST BIOL, V45, P1; Crandall KA, 2000, TRENDS ECOL EVOL, V15, P290, DOI 10.1016/S0169-5347(00)01876-0; Crandall KA, 1999, EVOLUTION, V53, P123, DOI 10.1111/j.1558-5646.1999.tb05338.x; Cunningham C, 1992, EVOLUTION KING CRABS; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Doadrio I, 2004, MOL PHYLOGENET EVOL, V31, P416, DOI 10.1016/j.ympev.2003.08.022; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELDMANN RM, 1981, J PALEONTOL, V55, P788; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Ferrari L, 2000, TECTONOPHYSICS, V318, P161, DOI 10.1016/S0040-1951(99)00310-8; Ferrari L, 1999, GEOLOGY, V27, P303, DOI 10.1130/0091-7613(1999)027<0303:STPOCA>2.3.CO;2; Ferrari L., 2000, BOL SOC GEOL MEX, V53, P84, DOI [10.18268/BSGM2000v53n1a5, DOI 10.18268/BSGM2000V53N1A5]; Fisher-Reid MC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-300; FITZPATRICK JF, 1983, J CRUSTACEAN BIOL, V3, P266, DOI 10.2307/1548262; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; HARVEY PH, 1994, EVOLUTION, V48, P523, DOI 10.1111/j.1558-5646.1994.tb01341.x; Hobbs H.H. Jr., 1974, Smithsonian Contributions to Zoology, VNo. 164, P1; Hobbs HH, 1974, SMITHSONIAN CONTRIBU, V166, P161; HOBBS HORTON H., 1950, PROC BIOL SOC WASHINGTON, V63, P89; Hobbs Jr H. H., 1989, SMITHSONIAN CONTRIBU, V480, P1, DOI DOI 10.5479/SI.00810282.480; Huelsenbeck JP, 2005, STAT BIOL HEALTH, P183, DOI 10.1007/0-387-27733-1_7; Jobb G, 2008, TREEFINDER VERSION O; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; KNOWLTON N, 1993, SCIENCE, V260, P1629, DOI 10.1126/science.8503007; Kozak KH, 2006, P ROY SOC B-BIOL SCI, V273, P539, DOI 10.1098/rspb.2005.3326; Laguarda A, 1961, CONTRIBUCION ESTUDIO; Mateos M, 2002, EVOLUTION, V56, P972; McKinney Michael L., 1992, P349; Miller R.R, 1986, ZOOGEOGRAPHY N AM FR; Mokady O, 1999, J MOL EVOL, V49, P367, DOI 10.1007/PL00006560; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Ornelas-Garcia CP., 2008, BMC EVOL BIOL, V8, P1, DOI 10.1186/1471-2148-8-340; Pereira SL, 2002, SYST BIOL, V51, P946, DOI 10.1080/10635150290156051; Perry WL, 2001, EVOLUTION, V55, P1153; Porter ML, 2005, MOL PHYLOGENET EVOL, V37, P355, DOI 10.1016/j.ympev.2005.06.021; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rabosky D, 2006, LASER MAXIMUM LIKELI; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rambaut A., 2002, TREEEDIT PHYLOGENETI; Ricklefs RE, 2007, J EVOLUTION BIOL, V20, P1751, DOI 10.1111/j.1420-9101.2007.01388.x; RIGGS SR, 1984, SCIENCE, V223, P123, DOI 10.1126/science.223.4632.123; RODRIGUEZALMARAZ GA, 1994, J CRUSTACEAN BIOL, V14, P729, DOI 10.2307/1548866; Rojas Y, 2002, MODERN APPROACHES TO THE STUDY OF CRUSTACEA, P311; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; San Mauro D, 2009, SYST BIOL, V58, P425, DOI 10.1093/sysbio/syp043; Schoenhuth S, 2008, MOL PHYLOGENET EVOL, V47, P729, DOI 10.1016/j.ympev.2007.11.036; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913; Sites JW, 2004, ANNU REV ECOL EVOL S, V35, P199, DOI 10.1146/annurev.ecolsys.35.112202.130128; Slowinski JB, 2001, MOL PHYLOGENET EVOL, V19, P114, DOI 10.1006/mpev.2000.0897; Smith M.L., 1986, P457; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stillman JH, 2001, MOL PHYLOGENET EVOL, V19, P236, DOI 10.1006/mpev.2001.0924; Swift C.C., 1986, P213; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Taylor CA, 2002, J CRUSTACEAN BIOL, V22, P874, DOI 10.1651/0278-0372(2002)022[0874:POTCSC]2.0.CO;2; Thomas Ellen, 1992, P245; Toon A, 2009, DECAPOD CRUSTACEAN P; Villalobos A., 1943, Anales del Instituto de Biologia Mexico, V14, P587; Villalobos A., 1955, CAMBARINOS FAUNA MEX; Whiting MF, 2002, ZOOL SCR, V31, P93, DOI 10.1046/j.0300-3256.2001.00095.x; Whiting MF, 1997, SYST BIOL, V46, P1, DOI 10.1093/sysbio/46.1.1; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002	79	20	20	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48233	10.1371/journal.pone.0048233	http://dx.doi.org/10.1371/journal.pone.0048233			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155379	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900013
J	Stippekohl, B; Winkler, MH; Walter, B; Kagerer, S; Mucha, RF; Pauli, P; Vaitl, D; Stark, R				Stippekohl, Bastian; Winkler, Markus H.; Walter, Bertram; Kagerer, Sabine; Mucha, Ronald F.; Pauli, Paul; Vaitl, Dieter; Stark, Rudolf			Neural Responses to Smoking Stimuli Are Influenced by Smokers' Attitudes towards Their Own Smoking Behaviour	PLOS ONE			English	Article							ADDICTED HUMAN BRAIN; CUE-REACTIVITY; DRUG CUES; PHYSIOLOGICAL CONDITION; TRANSTHEORETICAL MODEL; CIGARETTE AVAILABILITY; APPETITIVE NATURE; HEALTHY SMOKERS; DECISION-MAKING; INSULA	An important feature of addiction is the high drug craving that may promote the continuation of consumption. Environmental stimuli classically conditioned to drug-intake have a strong motivational power for addicts and can elicit craving. However, addicts differ in the attitudes towards their own consumption behavior: some are content with drug taking (consonant users) whereas others are discontent (dissonant users). Such differences may be important for clinical practice because the experience of dissonance might enhance the likelihood to consider treatment. This fMRI study investigated in smokers whether these different attitudes influence subjective and neural responses to smoking stimuli. Based on self-characterization, smokers were divided into consonant and dissonant smokers. These two groups were presented smoking stimuli and neutral stimuli. Former studies have suggested differences in the impact of smoking stimuli depending on the temporal stage of the smoking ritual they are associated with. Therefore, we used stimuli associated with the beginning (BEGIN-smoking-stimuli) and stimuli associated with the terminal stage (END-smoking-stimuli) of the smoking ritual as distinct stimulus categories. Stimulus ratings did not differ between both groups. Brain data showed that BEGIN-smoking-stimuli led to enhanced mesolimbic responses (amygdala, hippocampus, insula) in dissonant compared to consonant smokers. In response to END-smoking-stimuli, dissonant smokers showed reduced mesocortical responses (orbitofrontal cortex, subcallosal cortex) compared to consonant smokers. These results suggest that smoking stimuli with a high incentive value (BEGIN-smoking-stimuli) are more appetitive for dissonant than consonant smokers at least on the neural level. To the contrary, smoking stimuli with low incentive value (END-smoking-stimuli) seem to be less appetitive for dissonant smokers than consonant smokers. These differences might be one reason why dissonant smokers experience difficulties in translating their attitudes into an actual behavior change.	[Stippekohl, Bastian; Walter, Bertram; Kagerer, Sabine; Vaitl, Dieter; Stark, Rudolf] Univ Giessen, Bender Inst Neuroimaging, Giessen, Germany	Justus Liebig University Giessen	Stippekohl, B (corresponding author), Univ Giessen, Bender Inst Neuroimaging, Giessen, Germany.	bastian.stippekohl@psychol.uni-giessen.de	Walter, Bertram/AAD-4695-2021	Pauli, Paul/0000-0003-0692-6720; Winkler, Markus H./0000-0001-7198-4025				Bailey SR, 2010, ADDICTION, V105, P364, DOI 10.1111/j.1360-0443.2009.02760.x; Baxter MG, 2002, NAT REV NEUROSCI, V3, P563, DOI 10.1038/nrn875; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Benowitz N L, 1990, NIDA Res Monogr, V99, P12; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Carter BL, 1999, ADDICTION, V94, P327, DOI 10.1046/j.1360-0443.1999.9433273.x; Carter BL, 2001, EXP CLIN PSYCHOPHARM, V9, P183, DOI 10.1037//1064-1297.9.2.183; Chase HW, 2011, BIOL PSYCHIAT, V70, P785, DOI 10.1016/j.biopsych.2011.05.025; Chouinard MC, 2007, EUR J CARDIOV PREV R, V14, P51, DOI 10.1097/HJR.0b013e328014027b; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Damasio A, 2000, FEELING WHAT HAPPENS; Damasio A.R., 2005, DESCARTES ERROR EMOT; Dempsey JP, 2007, PSYCHOPHARMACOLOGY, V194, P253, DOI 10.1007/s00213-007-0839-3; Deutsch R, 2006, HDB IMPLICIT COGNITI, P45, DOI DOI 10.4135/9781412976237.N4; Drummond DC, 2001, ADDICTION, V96, P33, DOI 10.1046/j.1360-0443.2001.961333.x; EISER JR, 1978, ADDICT BEHAV, V3, P99; Engelmann JM, 2012, NEUROIMAGE, V60, P252, DOI 10.1016/j.neuroimage.2011.12.024; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Everitt BJ, 1999, ANN NY ACAD SCI, V877, P412, DOI 10.1111/j.1749-6632.1999.tb09280.x; Garavan H, 2010, BRAIN STRUCT FUNCT, V214, P593, DOI 10.1007/s00429-010-0259-8; Geier A, 2000, PSYCHOPHARMACOLOGY, V150, P283, DOI 10.1007/s002130000404; Hannover W, 2003, ELEKT HDB ERHEBUNGSI; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; Hyman SE, 2001, NAT REV NEUROSCI, V2, P695, DOI 10.1038/35094560; Jarvik ME, 2000, PHARMACOL BIOCHEM BE, V66, P553, DOI 10.1016/S0091-3057(00)00261-6; Kalivas PW, 2005, AM J PSYCHIAT, V162, P1403, DOI 10.1176/appi.ajp.162.8.1403; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; KUHN S, 2011, BEHAV NEUROSCI, V33, P1318, DOI DOI 10.1111/J.1460-9568.2010.07590.X; Lang PJ, 1995, INT AFFECTIVE PICTUR; Lubman DI, 2004, ADDICTION, V99, P1491, DOI 10.1111/j.1360-0443.2004.00808.x; Martin-Soelch C, 2007, NEUROSCI BIOBEHAV R, V31, P426, DOI 10.1016/j.neubiorev.2006.11.002; McBride D, 2006, NEUROPSYCHOPHARMACOL, V31, P2728, DOI 10.1038/sj.npp.1301075; MCCOY SB, 1992, J BEHAV MED, V15, P469, DOI 10.1007/BF00844942; McDermut W, 1998, EXP CLIN PSYCHOPHARM, V6, P316, DOI 10.1037/1064-1297.6.3.316; McKee SA, 2005, ADDICT BEHAV, V30, P423, DOI 10.1016/j.addbeh.2004.05.027; Mucha RF, 1999, PSYCHOPHARMACOLOGY, V147, P306, DOI 10.1007/s002130051172; Mucha RF, 2000, PSYCHOPHARMACOLOGY, V151, P428, DOI 10.1007/s002130000508; MUCHA RF, 2006, HDB IMPLICIT COGNITI, P201; Mucha RF, 2008, PSYCHOPHARMACOLOGY, V201, P81, DOI 10.1007/s00213-008-1249-x; Muller V, 2001, Z KL PSYCH PSYCHOTH, V30, P164, DOI 10.1026/0084-5345.30.3.164; Munoz MS, 2011, PSYCHOPHARMACOLOGY, V218, P1; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Naqvi NH, 2010, BRAIN STRUCT FUNCT, V214, P435, DOI 10.1007/s00429-010-0268-7; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Nees F, 2012, ADDICT BIOL, V17, P441, DOI 10.1111/j.1369-1600.2011.00347.x; Pauli WM, 2012, J COGNITIVE NEUROSCI, V24, P351, DOI 10.1162/jocn_a_00155; PROCHASKA JO, 1983, J CONSULT CLIN PSYCH, V51, P390, DOI 10.1037//0022-006X.51.3.390; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38, DOI 10.4278/0890-1171-12.1.38; Robinson TE, 2003, ANNU REV PSYCHOL, V54, P25, DOI 10.1146/annurev.psych.54.101601.145237; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Rose JE, 1999, DRUG ALCOHOL DEPEN, V56, P99, DOI 10.1016/S0376-8716(99)00025-3; Schumann A, 2003, ELEKT HDB ERHEBUNGSI; See RE, 2003, ANN NY ACAD SCI, V985, P294; Skog OJ, 2003, CHOICE, BEHAVIOURAL ECONOMICS AND ADDICTION, P157, DOI 10.1016/B978-008044056-9/50047-6; STEWART J, 1984, PSYCHOL REV, V91, P251, DOI 10.1037/0033-295X.91.2.251; Stippekohl B, 2012, PSYCHOPHARMACOLOGY, V222, P593, DOI 10.1007/s00213-012-2670-8; Stippekohl B, 2010, NEUROPSYCHOPHARMACOL, V35, P1209, DOI 10.1038/npp.2009.227; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Volkow ND, 2004, NEUROPHARMACOLOGY, V47, P3, DOI 10.1016/j.neuropharm.2004.07.019; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Wertz JM, 2001, EXP CLIN PSYCHOPHARM, V9, P3, DOI 10.1037//1064-1297.9.1.3; Wertz JM, 2001, PSYCHOL ADDICT BEHAV, V15, P268, DOI 10.1037/0893-164X.15.3.268; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Winkler MH, 2011, PSYCHOPHARMACOLOGY, V213, P781, DOI 10.1007/s00213-010-2033-2; Worsley K.J., 2001, FUNCTIONAL MRI AN IN, P251, DOI [10.1093/acprof:oso/ 9780192630711.003.0014, DOI 10.1093/ACPROF:OSO/9780192630711.003.0014]	69	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e46782	10.1371/journal.pone.0046782	http://dx.doi.org/10.1371/journal.pone.0046782			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038CD	23155368	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900002
J	Cui, Y; Kim, SH; Kim, H; Yeom, J; Ko, K; Park, W; Park, S				Cui, Yidan; Kim, So Hyun; Kim, Hyunseok; Yeom, Jinki; Ko, Kisung; Park, Woojun; Park, Sungsu			AFM Probing the Mechanism of Synergistic Effects of the Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG) with Cefotaxime against Extended-Spectrum Beta-Lactamase (ESBL)-Producing Escherichia coli	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; ATOMIC-FORCE MICROSCOPY; GRAM-NEGATIVE BACTERIA; EPIGALLOCATECHIN GALLATE; ANTIBACTERIAL; ANTIBIOTICS; INFECTIONS; CATECHIN; THERAPY; BACILLI	Background: Extended-spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae poses serious challenges to clinicians because of its resistance to many classes of antibiotics. Methods and Findings: The mechanism of synergistic activity of a combination of (-)-epigallocatechin-3-gallate (EGCG) and beta-lactam antibiotics cefotaxime was studied on Extended-spectrum beta-lactamase producing Escherichia coli (ESBL-EC), by visualizing the morphological alteration on the cell wall induced by the combination using atomic force microscopy (AFM). Cells at sub-MICs (sub-minimum inhibitory concentrations) of cefotaxime were initially filamentated but recovered to the normal shape later, whereas cells at sub-MICs of EGCG experienced temporal disturbance on the cell wall such as leakage and release of cellular debris and groove formation, but later recovered to the normal shape. In contrast, the combination of cefotaxime and EGCG at their respective sub-MICs induced permanent cellular damages as well as continuous elongation in cells and eventually killed them. Flow cytometry showed that intracellular oxidative stress levels in the cell treated with a combination of EGCG and cefotaxime at sub-MICs were higher than those in the cells treated with either cefotaxime or EGCG at sub-MICs. Conclusions: These results suggest that the synergistic effect of EGCG between EGCG and cefotaxime against ESBL-EC is related to cooperative activity of exogenous and endogenous reactive oxygen species (ROS) generated by EGCG and cefotaxime, respectively.	[Cui, Yidan; Kim, So Hyun; Kim, Hyunseok; Park, Sungsu] Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea; [Yeom, Jinki; Park, Woojun] Korea Univ, Div Environm Sci & Ecol Engn, Seoul, South Korea; [Cui, Yidan; Park, Sungsu] Natl Univ Singapore, Mechanobiol Inst, Singapore 117548, Singapore; [Ko, Kisung] Chung Ang Univ, Coll Med, Dept Med, Seoul 156756, South Korea	Ewha Womans University; Korea University; National University of Singapore; Chung Ang University; Chung Ang University Hospital	Park, S (corresponding author), Ewha Womans Univ, Dept Chem & Nano Sci, Seoul, South Korea.	nanopark@ewha.ac.kr	Park, Sungsu/AAF-4792-2020; Park, Sungsu/L-1920-2013	Park, Sungsu/0000-0003-3062-1302; Yeom, Jinki/0000-0002-5332-2658	Korean National Research Foundation [2012-0000647, 20110021114, 2012-0001138]; Korean Rural Development Administration [PJ007492]	Korean National Research Foundation(National Research Foundation of Korea); Korean Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was equally supported by grants (SRC Program: 2012-0000647, #20110021114, #2012-0001138) from Korean National Research Foundation as well as a grant (Code #PJ007492) from Korean Rural Development Administration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Muharrmi Zakariya, 2008, Oman Med J, V23, P78; Arakawa H, 2004, BIOL PHARM BULL, V27, P277, DOI 10.1248/bpb.27.277; Bassetti M, 2008, CURR MED CHEM, V15, P517, DOI 10.2174/092986708783503186; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Braga PC, 1998, ANTIMICROB AGENTS CH, V42, P18, DOI 10.1128/AAC.42.1.18; Cabiscol Elisa, 2000, International Microbiology, V3, P3; Cho YS, 2011, PHYTOMEDICINE, V18, P941, DOI 10.1016/j.phymed.2011.03.012; Cho YS, 2008, CURR MICROBIOL, V57, P542, DOI 10.1007/s00284-008-9239-0; Cui Y, 2012, FOOD MICROBIOL, V29, P80, DOI 10.1016/j.fm.2011.08.019; HENDERSON LM, 1993, EUR J BIOCHEM, V217, P973, DOI 10.1111/j.1432-1033.1993.tb18328.x; Hou Z, 2005, CANCER RES, V65, P8049, DOI 10.1158/0008-5472.CAN-05-0480; Hu ZQ, 2002, J ANTIMICROB CHEMOTH, V50, P1051, DOI 10.1093/jac/dkf250; JACOBY GA, 1991, ANTIMICROB AGENTS CH, V35, P164, DOI 10.1128/AAC.35.1.164; Justice SS, 2008, NAT REV MICROBIOL, V6, P162, DOI 10.1038/nrmicro1820; Klibanov OM, 2004, ANN PHARMACOTHER, V38, P332, DOI 10.1345/aph.1D132; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Li A, 2007, BBA-BIOMEMBRANES, V1768, P411, DOI 10.1016/j.bbamem.2006.12.010; Liu Y, 2006, ANAL CHEM, V78, P7341; Meincken A, 2005, ANTIMICROB AGENTS CH, V49, P4085, DOI 10.1128/AAC.49.10.4085-4092.2005; Nicasio AM, 2008, PHARMACOTHERAPY, V28, P235, DOI 10.1592/phco.28.2.235; NORDEN CW, 1979, J INFECT DIS, V140, P629, DOI 10.1093/infdis/140.4.629; Osterburg A, 2009, CLIN MICROBIOL INFEC, V15, P341, DOI 10.1111/j.1469-0691.2009.02710.x; Rice L, 2001, CHEST, V119, p391S, DOI 10.1378/chest.119.2_suppl.391S; Sader HS, 2003, DIAGN MICR INFEC DIS, V47, P547, DOI 10.1016/S0732-8893(03)00158-5; Sahu K, 2009, J PHOTOCH PHOTOBIO B, V96, P9, DOI 10.1016/j.jphotobiol.2009.03.008; Semenza GL, 1999, CELL, V98, P281, DOI 10.1016/S0092-8674(00)81957-1; Shimamura Tadakatsu, 2007, Anti-Infective Agents in Medicinal Chemistry, V6, P57; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456; Zhao WH, 2003, J PHARM PHARMACOL, V55, P735, DOI 10.1211/002235703765951320; Zhao WH, 2001, ANTIMICROB AGENTS CH, V45, P1737, DOI 10.1128/AAC.45.6.1737-1742.2001	30	16	17	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48880	10.1371/journal.pone.0048880	http://dx.doi.org/10.1371/journal.pone.0048880			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152812	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234600015
J	Kuntzsch, D; Bergann, T; Dames, P; Fromm, A; Fromm, M; Davis, RA; Melzig, MF; Schulzke, JD				Kuntzsch, Dana; Bergann, Theresa; Dames, Petra; Fromm, Anja; Fromm, Michael; Davis, Rohan A.; Melzig, Matthias F.; Schulzke, Joerg D.			The Plant-Derived Glucocorticoid Receptor Agonist Endiandrin A Acts as Co-Stimulator of Colonic Epithelial Sodium Channels (ENaC) via SGK-1 and MAPKs	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE; NA+ CHANNEL; GENE-EXPRESSION; DOWN-REGULATION; GAMMA-ENAC; P38 MAPK; SERUM; ACTIVATION; BETA	In a search for secondary plant compounds that bind to the glucocorticoid receptor (GR), the cyclobutane lignan endiandrin A was discovered from the rainforest tree Endiandra anthropophagorum Domin. Our present study aims to characterize the effect of endiandrin A on GR-dependent induction of colonic sodium transport. The effect of endiandrin A was analyzed in GR-expressing colonic HT-29/B6 cells (HT-29/B6-GR). GR transactivation and subcellular localization were investigated by reporter gene assay and immunofluorescence. Epithelial sodium channel (ENaC) was analyzed by qRT-PCR and by measuring amiloride-sensitive short-circuit current (I-sc) in Ussing chambers. Endiandrin A (End A) has been identified as GR receptor binder. However, it did not cause significant GR transactivation as pGRE-luciferase activity was only 7% of that of the maximum effect of dexamethasone. Interestingly, endiandrin A had a significant impact on dexamethasone-dependent sodium absorption in cells co-exposed to tumor necrosis factor (TNF)-alpha. This was in part due to up-regulation of beta- and gamma-ENaC subunit expression. Endiandrin A potentiated GR-mediated transcription by increasing GR protein expression and phosphorylation. It inhibited c-Jun N-terminal kinase (JNK) activation induced by dexamethasone and/or TNF-alpha and increased levels of GR localized to the nucleus. Additionally, endiandrin A increased the serum- and glucocorticoid-induced kinase (sgk)-1 via activation of p38. Finally, the regulation of ENaC function by endiandrin A was confirmed in rat native colon. In conclusion, endiandrin A potentiates glucocorticoid-driven activation of colonic epithelial sodium channels via JNK inhibition and p38 activation due to transcriptional up-regulation of beta- and gamma-ENaC-subunits along with induction of sgk-1.	[Kuntzsch, Dana; Bergann, Theresa; Dames, Petra; Schulzke, Joerg D.] Charite, Div Nutr Med, Dept Gastroenterol, Berlin, Germany; [Fromm, Anja; Fromm, Michael] Charite, Inst Clin Physiol, Berlin, Germany; [Davis, Rohan A.] Griffith Univ, Eskitis Inst, Brisbane, Qld 4111, Australia; [Melzig, Matthias F.] Free Univ Berlin, Inst Pharm, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Griffith University; Free University of Berlin	Schulzke, JD (corresponding author), Charite, Div Nutr Med, Dept Gastroenterol, Campus Benjamin Franklin, Berlin, Germany.	joerg.schulzke@charite.de	Fromm, Michael/K-6203-2013; Davis, Rohan A/B-1689-2008	Fromm, Michael/0000-0003-4497-7983; Davis, Rohan A/0000-0003-4291-7573; Fromm, Anja/0000-0003-4091-9612	Deutsche Forschungsgemeinschaft [DFG Schu 559/10-2]; Sonnenfeld-Stiftung Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonnenfeld-Stiftung Berlin	This study was supported by grants from Deutsche Forschungsgemeinschaft (DFG Schu 559/10-2; http://www.dfg.de/index.jsp) and the Sonnenfeld-Stiftung Berlin (http://www.sonnenfeld-stiftung.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amasheh S, 2004, GASTROENTEROLOGY, V126, P1711, DOI 10.1053/j.gastro.2004.03.010; Barmeyer C, 2004, AM J PHYSIOL-GASTR L, V286, pG244, DOI 10.1152/ajpgi.00141.2003; Barnes PJ, 1998, CLIN SCI, V94, P557, DOI 10.1042/cs0940557; Bell LM, 2000, J BIOL CHEM, V275, P25262, DOI 10.1074/jbc.M002076200; Bergann T, 2009, GASTROENTEROLOGY, V136, P933, DOI 10.1053/j.gastro.2008.12.008; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Booth RE, 2003, AM J PHYSIOL-RENAL, V284, pF938, DOI 10.1152/ajprenal.00373.2002; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Davis RA, 2007, J NAT PROD, V70, P1118, DOI 10.1021/np070073x; Dean JLE, 2003, J BIOL CHEM, V278, P39470, DOI 10.1074/jbc.M306345200; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Du J, 2011, J IMMUNOL, V187, P942, DOI 10.4049/jimmunol.1002579; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; Haridas V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028037; Hattori T, 2008, NEPHRON PHYSIOL, V109, P19, DOI 10.1159/000142397; Hutter D, 2000, BIOCHEM J, V352, P155, DOI 10.1042/0264-6021:3520155; Itani OA, 2002, AM J PHYSIOL-ENDOC M, V283, pE971, DOI 10.1152/ajpendo.00021.2002; Kassel O, 2001, EMBO J, V20, P7108, DOI 10.1093/emboj/20.24.7108; Kim MJ, 2007, EMBO J, V26, P3075, DOI 10.1038/sj.emboj.7601755; Latella G, 2008, EUR J CLIN INVEST, V38, P410, DOI 10.1111/j.1365-2362.2008.01955.x; Lee CT, 2006, EUR J NEUROSCI, V23, P1311, DOI 10.1111/j.1460-9568.2006.04650.x; Lee YJ, 1997, MOL CELL ENDOCRINOL, V133, P135, DOI 10.1016/S0303-7207(97)00160-3; Meng FM, 2005, AM J PHYSIOL-CELL PH, V289, pC971, DOI 10.1152/ajpcell.00081.2005; Miyazawa K, 1998, J BIOL CHEM, V273, P24832, DOI 10.1074/jbc.273.38.24832; Mun SH, 2009, J PHARMACOL SCI, V111, P13, DOI 10.1254/jphs.09134FP; Naray-Fejes-Toth A, 2000, J STEROID BIOCHEM, V75, P51, DOI 10.1016/S0960-0760(00)00136-9; Niisato N, 2007, BIOCHEM BIOPH RES CO, V358, P819, DOI 10.1016/j.bbrc.2007.04.192; Pae HO, 2003, J ETHNOPHARMACOL, V88, P287, DOI 10.1016/S0378-8741(03)00228-9; RENARD S, 1995, PFLUG ARCH EUR J PHY, V430, P299, DOI 10.1007/BF00373903; Rogatsky I, 1998, P NATL ACAD SCI USA, V95, P2050, DOI 10.1073/pnas.95.5.2050; Rosen J, 2005, ENDOCR REV, V26, P452, DOI 10.1210/er.2005-0002; Russell L, 2002, AM J MED SCI, V324, P185, DOI 10.1097/00000441-200210000-00004; SANDLE GI, 1986, GUT, V27, P309, DOI 10.1136/gut.27.3.309; Schacke H, 2004, P NATL ACAD SCI USA, V101, P227, DOI 10.1073/pnas.0300372101; Shi HK, 2002, J BIOL CHEM, V277, P13539, DOI 10.1074/jbc.M111717200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Sullivan S, 2009, INFLAMM BOWEL DIS, V15, P261, DOI 10.1002/ibd.20743; Taniguchi-Yanai K, 2010, J RECEPT SIG TRANSD, V30, P88, DOI 10.3109/10799891003614816; Vogt A, 2005, J BIOL CHEM, V280, P19078, DOI 10.1074/jbc.M501467200; Waldegger S, 2000, CELL PHYSIOL BIOCHEM, V10, P203, DOI 10.1159/000016351; Wang XH, 2005, NEUROPSYCHOPHARMACOL, V30, P242, DOI 10.1038/sj.npp.1300606; Wang Z, 2002, J BIOL CHEM, V277, P26573, DOI 10.1074/jbc.M110530200; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; Won M, 2009, J HEPATOL, V51, P67, DOI 10.1016/j.jhep.2009.02.027; Zeissig S, 2006, BIOCHEM BIOPH RES CO, V344, P1065, DOI 10.1016/j.bbrc.2006.04.012; Zentner MD, 1998, J BIOL CHEM, V273, P30770, DOI 10.1074/jbc.273.46.30770; Ziera T, 2009, FASEB J, V23, P3936, DOI 10.1096/fj.09-134759	48	9	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49426	10.1371/journal.pone.0049426	http://dx.doi.org/10.1371/journal.pone.0049426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152905	Green Published, gold			2022-12-27	WOS:000311234600038
J	Kawamura, K; Chen, Y; Shu, YM; Cheng, Y; Qiao, J; Behr, B; Pera, RAR; Hsueh, AJW				Kawamura, Kazuhiro; Chen, Yuan; Shu, Yimin; Cheng, Yuan; Qiao, Jie; Behr, Barry; Pera, Renee A. Reijo; Hsueh, Aaron J. W.			Promotion of Human Early Embryonic Development and Blastocyst Outgrowth In Vitro Using Autocrine/Paracrine Growth Factors	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; PREIMPLANTATION EMBRYO; NEUROTROPHIC FACTOR; MOUSE EMBRYOS; HUMAN OOCYTES; IMPLANTATION; EXPRESSION; ALPHA; IVF; FERTILIZATION	Studies using animal models demonstrated the importance of autocrine/paracrine factors secreted by preimplantation embryos and reproductive tracts for embryonic development and implantation. Although in vitro fertilization-embryo transfer (IVF-ET) is an established procedure, there is no evidence that present culture conditions are optimal for human early embryonic development. In this study, key polypeptide ligands known to be important for early embryonic development in animal models were tested for their ability to improve human early embryo development and blastocyst outgrowth in vitro. We confirmed the expression of key ligand/receptor pairs in cleavage embryos derived from discarded human tri-pronuclear zygotes and in human endometrium. Combined treatment with key embryonic growth factors (brain-derived neurotrophic factor, colony-stimulating factor, epidermal growth factor, granulocyte macrophage colony-stimulating factor, insulin-like growth factor-1, glial cell-line derived neurotrophic factor, and artemin) in serum-free media promoted >2.5-fold the development of tri-pronuclear zygotes to blastocysts. For normally fertilized embryos, day 3 surplus embryos cultured individually with the key growth factors showed >3-fold increases in the development of 6-8 cell stage embryos to blastocysts and >7-fold increase in the proportion of high quality blastocysts based on Gardner's criteria. Growth factor treatment also led to a 2-fold promotion of blastocyst outgrowth in vitro when day 7 surplus hatching blastocysts were used. When failed-to-be-fertilized oocytes were used to perform somatic cell nuclear transfer (SCNT) using fibroblasts as donor karyoplasts, inclusion of growth factors increased the progression of reconstructed SCNT embryos to >4-cell stage embryos. Growth factor supplementation of serum-free cultures could promote optimal early embryonic development and implantation in IVF-ET and SCNT procedures. This approach is valuable for infertility treatment and future derivation of patient-specific embryonic stem cells.	[Kawamura, Kazuhiro; Shu, Yimin; Cheng, Yuan; Behr, Barry; Pera, Renee A. Reijo; Hsueh, Aaron J. W.] Stanford Univ, Sch Med, Dept Obstet & Gynecol, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA; [Kawamura, Kazuhiro] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita 010, Japan; [Chen, Yuan; Qiao, Jie] Peking Univ, Hosp 3, Ctr Reprod Med, Dept Obstet & Gynecol, Beijing 100871, Peoples R China	Stanford University; Akita University; Peking University	Hsueh, AJW (corresponding author), Stanford Univ, Sch Med, Dept Obstet & Gynecol, Program Reprod & Stem Cell Biol, Stanford, CA 94305 USA.	aaron.hsueh@stanford.edu		Reijo Pera, Renee/0000-0002-6487-1329	Uehara Memorial Foundation; Naito Foundation; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Major State Basic Research Development Program of China [2011CB944504]; National Natural Sciences Foundation of China [81000234]; California Institute of Regenerative Medicine (CIRM) [RC1-00137-1, RS1-00404, RB2-01553];  [24390376];  [23013004];  [24659722]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Major State Basic Research Development Program of China(National Basic Research Program of China); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); ; ; ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Grant-In-Aids for Scientific Research (K.K.; Grant-In-Aid for Scientific Research B: 24390376, Grant-in-Aid for Scientific Research on Priority Areas, THE GERMLINE: Its Developmental Cycle and Epigenome Network: 23013004, and Grant-in-Aid for Challenging Exploratory Research: 24659722) and research funds from the Uehara Memorial Foundation (K.K.), the Naito Foundation (K.K.), the Mochida Memorial Foundation for Medical and Pharmaceutical Research (K.K.); the Major State Basic Research Development Program of China (2011CB944504) and the National Natural Sciences Foundation of China (No. 81000234) (J.Q.); The RENEW Biobank at Stanford University School of Medicine is supported by the CIRM grant RC1-00137-1 (R.P.); California Institute of Regenerative Medicine (CIRM) grants RS1-00404 and RB2-01553 (A.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMANT DR, 1986, DEV BIOL, V116, P519, DOI 10.1016/0012-1606(86)90152-1; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; BHATNAGAR P, 1995, DEVELOPMENT, V121, P1333; Bontekoe S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007421.pub2; BOWMAN P, 1970, J EMBRYOL EXP MORPH, V24, P203; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; BRIGSTOCK DR, 1989, J REPROD FERTIL, V85, P747, DOI 10.1530/jrf.0.0850747; Brison DR, 1997, BIOL REPROD, V56, P1088, DOI 10.1095/biolreprod56.5.1088; Chai N, 1998, DEV BIOL, V198, P105, DOI 10.1016/S0012-1606(98)80031-6; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Friedleri S, 2007, HUM REPROD, V22, P2444, DOI 10.1093/humrep/dem220; Gardner DK, 2000, FERTIL STERIL, V73, P1155, DOI 10.1016/S0015-0282(00)00518-5; Hardy K, 2002, J ENDOCRINOL, V172, P221, DOI 10.1677/joe.0.1720221; HEINE UI, 1987, J CELL BIOL, V105, P2861, DOI 10.1083/jcb.105.6.2861; Kawamura K, 2008, DEV BIOL, V315, P189, DOI 10.1016/j.ydbio.2007.12.029; Kawamura K, 2007, DEV BIOL, V311, P147, DOI 10.1016/j.ydbio.2007.08.026; Kawamura K, 2009, ENDOCRINOLOGY, V150, P3774, DOI 10.1210/en.2009-0213; Khamsi F, 1996, MOL HUM REPROD, V2, P273, DOI 10.1093/molehr/2.4.273; KOLA I, 1987, BIOL REPROD, V37, P395, DOI 10.1095/biolreprod37.2.395; Kuwayama M, 2005, REPROD BIOMED ONLINE, V11, P608, DOI 10.1016/S1472-6483(10)61169-8; Kuwayama M, 2007, THERIOGENOLOGY, V67, P73, DOI 10.1016/j.theriogenology.2006.09.014; Li J, 2009, FEBS LETT, V583, P2479, DOI 10.1016/j.febslet.2009.06.050; MENEZO Y, 1992, FERTIL STERIL, V58, P977; PALMIERI SL, 1992, MECH DEVELOP, V39, P181, DOI 10.1016/0925-4773(92)90045-L; Richter KS, 2008, CURR OPIN OBSTET GYN, V20, P292, DOI 10.1097/GCO.0b013e3282fe743b; Sjoblom C, 1999, HUM REPROD, V14, P3069, DOI 10.1093/humrep/14.12.3069; Spanos S, 2000, BIOL REPROD, V63, P1413, DOI 10.1095/biolreprod63.5.1413; Thurin A, 2004, NEW ENGL J MED, V351, P2392, DOI 10.1056/NEJMoa041032; Valojerdi MR, 2006, J ASSIST REPROD GEN, V23, P207, DOI 10.1007/s10815-006-9031-7; van Loendersloot LL, 2010, HUM REPROD UPDATE, V16, P577, DOI 10.1093/humupd/dmq015; VEECK LL, 1988, ANN NY ACAD SCI, V541, P259, DOI 10.1111/j.1749-6632.1988.tb22263.x; Verberg MFG, 2009, HUM REPROD UPDATE, V15, P5, DOI 10.1093/humupd/dmn053	32	53	59	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49328	10.1371/journal.pone.0049328	http://dx.doi.org/10.1371/journal.pone.0049328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152897	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000064
J	Sen, T; Sen, N; Noordhuis, MG; Ravi, R; Wu, TC; Ha, PK; Sidransky, D; Hoque, MO				Sen, Tanusree; Sen, Nilkantha; Noordhuis, Maartje G.; Ravi, Rajani; Wu, T-C; Ha, Patrick K.; Sidransky, David; Hoque, Mohammad Obaidul			OGDHL Is a Modifier of AKT-Dependent Signaling and NF-kappa B Function	PLOS ONE			English	Article							ALPHA-KETOGLUTARATE; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; CANCER; APOPTOSIS; PATHWAY; EXPRESSION; PROTEINS; LOCALIZATION; CELLS; CHEMOTHERAPY	Oxoglutarate dehydrogenase (OGDH) is the first and rate-limiting component of the multi-enzyme OGDH complex (OGDHC) whose malfunction is associated with neuro-degeneration. The essential role of this complex is in the degradation of glucose and glutamate and the OGDHL gene (one component of OGDHC) is down-regulated by promoter hypermethylation in many different cancer types. These properties suggest a potential growth modulating role of OGDHL in cancer; however, the molecular mechanism through which OGDHL exerts its growth modulating function has not been elucidated. Here, we report that restoration of OGDHL expression in cervical cancer cells lacking endogenous OGDHL expression suppressed cell proliferation, invasion and soft agar colony formation in vitro. Knockdown of OGDHL expression in cervical cancer cells expressing endogenous OGDHL had the opposite effect. Forced expression of OGDHL increased the production of reactive oxygen species (ROS) leading to apoptosis through caspase 3 mediated down-regulation of the AKT signaling cascade and decreased NF-kappa B phosphorylation. Conversely, silencing OGDHL stimulated the signaling pathway via increased AKT phosphorylation. Moreover, the addition of caspase 3 or ROS inhibitors in the presence of OGDHL increased AKT signaling and cervical cancer cell proliferation. Taken together, these data suggest that inactivation of OGDHL can contribute to cervical tumorigenesis via activation of the AKT signaling pathway and thus support it as an important anti-proliferative gene in cervical cancer.	[Sen, Tanusree; Noordhuis, Maartje G.; Ravi, Rajani; Ha, Patrick K.; Sidransky, David; Hoque, Mohammad Obaidul] Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA; [Sen, Nilkantha] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD USA; [Wu, T-C] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA; [Ha, Patrick K.] Greater Baltimore Med Ctr, Milton J Dance Jr Head & Neck Ctr, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Greater Baltimore Medical Center	Hoque, MO (corresponding author), Johns Hopkins Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Baltimore, MD 21205 USA.	mhoque1@jhmi.edu	Sen, Nilkantha/AAW-9788-2020	Hoque, Mohammad Obaidul/0000-0001-6701-9978	Specialized Program of Research Excellence; National Institutes of Health (NIH)/National Cancer Institute (NCI) [P50 CA098252]; NATIONAL CANCER INSTITUTE [P50CA098252] Funding Source: NIH RePORTER	Specialized Program of Research Excellence; National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by a career development award to M. O. Hoque from Specialized Program of Research Excellence and P50 CA098252 (T-C Wu) National Institutes of Health (NIH)/National Cancer Institute (NCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler V, 1999, ONCOGENE, V18, P6104, DOI 10.1038/sj.onc.1203128; An J, 2004, J BIOL CHEM, V279, P19133, DOI 10.1074/jbc.M400295200; Arbyn M, 2009, EUR J CANCER, V45, P2640, DOI 10.1016/j.ejca.2009.07.018; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Brazil DP, 2001, TRENDS BIOCHEM SCI, V26, P657, DOI 10.1016/S0968-0004(01)01958-2; Bulkmans NWJ, 2007, LANCET, V370, P1764, DOI 10.1016/S0140-6736(07)61450-0; Bunik VI, 2008, PROTEINS, V71, P874, DOI 10.1002/prot.21766; Calabrese V, 2010, METHODS MOL BIOL, V610, P285, DOI 10.1007/978-1-60327-029-8_17; Cankaya M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-232; Cao J, 2009, FREE RADICAL BIO MED, V47, P536, DOI 10.1016/j.freeradbiomed.2009.05.024; Chatterjee A, 2010, CANCER RES, V70, P1419, DOI 10.1158/0008-5472.CAN-09-2613; Cheng JQ, 2005, ONCOGENE, V24, P7482, DOI 10.1038/sj.onc.1209088; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; Cuzick J, 2006, INT J CANCER, V119, P1095, DOI 10.1002/ijc.21955; de Moura MB, 2010, ENVIRON MOL MUTAGEN, V51, P391, DOI 10.1002/em.20575; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fraser M, 2003, CANCER RES, V63, P7081; Gao N, 2002, J BIOL CHEM, V277, P31963, DOI 10.1074/jbc.M200082200; GIBSON GE, 1988, ARCH NEUROL-CHICAGO, V45, P836, DOI 10.1001/archneur.1988.00520320022009; Han SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-97; Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103; Herrero A, 2000, J BIOENERG BIOMEMBR, V32, P609, DOI 10.1023/A:1005626712319; Hoque MO, 2008, CANCER RES, V68, P2661, DOI 10.1158/0008-5472.CAN-07-5913; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Hsu Y.L., 2010, J AGR FOOD CHEM; Jahani-Asl A, 2007, FEBS LETT, V581, P2883, DOI 10.1016/j.febslet.2007.05.033; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Ko LW, 2001, J MOL NEUROSCI, V17, P361, DOI 10.1385/JMN:17:3:361; Maduro JH, 2003, CANCER TREAT REV, V29, P471, DOI 10.1016/S0305-7372(03)00117-8; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Oelke K, 2004, INT REV IMMUNOL, V23, P315, DOI 10.1080/08830180490452567; OFALLON JV, 1977, BIOCHIM BIOPHYS ACTA, V499, P321, DOI 10.1016/0304-4165(77)90063-0; Ostrow KL, 2009, CLIN CANCER RES, V15, P1184, DOI 10.1158/1078-0432.CCR-08-1304; Page C, 2000, ANTICANCER RES, V20, P407; Pruitt K, 2005, J BIOL CHEM, V280, P23363, DOI 10.1074/jbc.M503083200; Ramdass B, 2007, GYNECOL ONCOL, V104, P352, DOI 10.1016/j.ygyno.2006.08.054; Shehata MF, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-10; Shin SW, 2009, CLIN CANCER RES, V15, P5414, DOI 10.1158/1078-0432.CCR-08-3101; Sinha D, 2008, MOL CELL NEUROSCI, V37, P85, DOI 10.1016/j.mcn.2007.08.016; Starkov AA, 2004, J NEUROSCI, V24, P7779, DOI 10.1523/JNEUROSCI.1899-04.2004; Tretter L, 2004, J NEUROSCI, V24, P7771, DOI 10.1523/JNEUROSCI.1842-04.2004; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Zerbini LF, 2003, CANCER RES, V63, P2206; Zhang XC, 2005, J BIOL CHEM, V280, P8714, DOI 10.1074/jbc.M408092200	52	50	50	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48770	10.1371/journal.pone.0048770	http://dx.doi.org/10.1371/journal.pone.0048770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152800	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000028
J	Tobon, KE; Chang, D; Kuzhikandathil, EV				Tobon, Krishna E.; Chang, Denis; Kuzhikandathil, Eldo V.			MicroRNA 142-3p Mediates Post-Transcriptional Regulation of D1 Dopamine Receptor Expression	PLOS ONE			English	Article							DENDRITIC CELLS; POSTNATAL-DEVELOPMENT; DIFFERENTIATION; PROTEIN; CAD; INTERLEUKIN-2; LOCALIZATION; LINE	The D1 dopamine receptor subtype is expressed in the brain, kidney and lymphocytes. D1 receptor function has been extensively studied and the receptor has been shown to modulate a wide range of physiological functions and behaviors. The expression of D1 receptor is known to change during development, disease states and chronic treatment; however, the molecular mechanisms that mediate the changes in D1 receptor expression under these circumstances are not well understood. While previous studies have identified extracellular factors and signaling mechanisms regulating the transcription of D1 receptor gene, very little is known about other regulatory mechanisms that modulate the expression of the D1 receptor gene. Here we report that the D1 receptor is post-transcriptionally regulated during postnatal mouse brain development and in the mouse CAD catecholaminergic neuronal cell line. We demonstrate that this post-transcriptional regulation is mediated by a molecular mechanism involving noncoding RNA. We show that the 1277 bp 3'untranslated region of D1 receptor mRNA is necessary and sufficient for mediating the post-transcriptional regulation. Using deletion and site-directed mutagenesis approaches, we show that the D1 receptor post-transcriptional regulation is specifically mediated by microRNA miR-142-3p interacting with a single consensus binding site in the 1277 bp 3'untranslated region of D1 receptor mRNA. Inhibiting endogenous miR-142-3p in CAD cells increased endogenous D1 receptor protein expression levels. The increase in D1 receptor protein levels was biologically significant as it resulted in enhanced D1 receptor-mediated signaling, determined by measuring the activation of both, adenylate cyclase and, the dopamine-and cAMP-regulated phosphoprotein, DARPP-32. We also show that there is an inverse correlation between miR-142-3p levels and D1 receptor protein expression in the mouse brain during postnatal development. This is the first study to demonstrate that the post-transcriptional regulation of D1 receptor expression is mediated by microRNA-induced translational suppression.	[Tobon, Krishna E.; Chang, Denis; Kuzhikandathil, Eldo V.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Kuzhikandathil, EV (corresponding author), Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Physiol & Pharmacol, 185 S Orange Ave, Newark, NJ 07103 USA.	kuzhikev@umdnj.edu		Chang, Denis/0000-0002-3843-5785	National Institutes of Health [R03DA026030, R03DA026030-02S1]; F. M. Kirby Foundation; PhRMA Foundation; NATIONAL INSTITUTE ON DRUG ABUSE [R03DA026030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); F. M. Kirby Foundation; PhRMA Foundation; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institutes of Health grants R03DA026030 and R03DA026030-02S1 and a grant from the F. M. Kirby Foundation to EVK. KET is supported by a PhRMA Foundation pre-doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Brana C, 1996, J COMP NEUROL, V370, P23, DOI 10.1002/(SICI)1096-9861(19960617)370:1<23::AID-CNE3>3.0.CO;2-N; Do T, 2007, J NEUROCHEM, V101, P619, DOI 10.1111/j.1471-4159.2006.04388.x; Do T, 2007, J NEUROCHEM, V100, P416, DOI 10.1111/j.1471-4159.2006.04249.x; Eipper-Mains JE, 2011, RNA, V17, P1529, DOI 10.1261/rna.2775511; Heyn J, 2012, SHOCK, V37, P156, DOI 10.1097/SHK.0b013e31823f16bc; Huang WH, 2009, BIOL PSYCHIAT, V65, P702, DOI 10.1016/j.biopsych.2008.11.024; Hurley MJ, 2001, MOL BRAIN RES, V87, P271, DOI 10.1016/S0169-328X(01)00022-5; Hussain T, 2003, EXP BIOL MED, V228, P134, DOI 10.1177/153537020322800202; Jensen KP, 2009, MOL PSYCHIATR, V14, P381, DOI 10.1038/mp.2008.15; Jung AB, 1996, DEV BRAIN RES, V94, P109, DOI 10.1016/0165-3806(96)00033-8; Karpa KD, 1999, MOL PHARMACOL, V56, P1071, DOI 10.1124/mol.56.5.1071; Kipnis J, 2004, J NEUROSCI, V24, P6133, DOI 10.1523/JNEUROSCI.0600-04.2004; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Nakano K, 2008, BIOCHEM BIOPH RES CO, V373, P286, DOI 10.1016/j.bbrc.2008.06.012; Nakano K, 2011, J IMMUNOL, V186, P3745, DOI 10.4049/jimmunol.1002475; Nakano K, 2009, INT IMMUNOL, V21, P645, DOI 10.1093/intimm/dxp033; Ozono R, 1997, HYPERTENSION, V30, P725, DOI 10.1161/01.HYP.30.3.725; Pacheco R, 2009, J NEUROIMMUNOL, V216, P8, DOI 10.1016/j.jneuroim.2009.07.018; Pasuit JB, 2004, J NEUROCHEM, V89, P1508, DOI 10.1111/j.1471-4159.2004.02450.x; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Qi YP, 1997, J NEUROSCI, V17, P1217; SCHAMBRA B, 1994, NEUROSCIENCE, V62, P65, DOI 10.1016/0306-4522(94)90315-8; Sun YP, 2011, BLOOD, V117, P6172, DOI 10.1182/blood-2010-12-325647; Tomassoni D, 2002, MECH AGEING DEV, V123, P491, DOI 10.1016/S0047-6374(01)00355-4; Undieh AS, 2010, PHARMACOL THERAPEUT, V128, P37, DOI 10.1016/j.pharmthera.2010.05.003; Wang WCH, 2011, P NATL ACAD SCI USA, V108, P6246, DOI 10.1073/pnas.1101439108; ZALCMAN S, 1994, BRAIN RES, V643, P40, DOI 10.1016/0006-8993(94)90006-X; Zalcman S, 1999, BRAIN RES, V847, P276, DOI 10.1016/S0006-8993(99)02063-6; Zalcman S, 1998, BRAIN RES, V811, P111, DOI 10.1016/S0006-8993(98)00904-4	31	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49288	10.1371/journal.pone.0049288	http://dx.doi.org/10.1371/journal.pone.0049288			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152889	Green Submitted, gold, Green Published			2022-12-27	WOS:000311234000059
J	Laine, R; Stuckey, DW; Manning, H; Warren, SC; Kennedy, G; Carling, D; Dunsby, C; Sardini, A; French, PMW				Laine, Romain; Stuckey, Daniel W.; Manning, Hugh; Warren, Sean C.; Kennedy, Gordon; Carling, David; Dunsby, Chris; Sardini, Alessandro; French, Paul M. W.			Fluorescence Lifetime Readouts of Troponin-C-Based Calcium FRET Sensors: A Quantitative Comparison of CFP and mTFP1 as Donor Fluorophores	PLOS ONE			English	Article							GENETICALLY ENCODED INDICATORS; IMAGING MICROSCOPY; LIVING CELLS; PROTEIN; GREEN; SENSITIVITY; BIOSENSOR; DYNAMICS; VARIANT; BRIGHT	We have compared the performance of two Troponin-C-based calcium FRET sensors using fluorescence lifetime read-outs. The first sensor, TN-L15, consists of a Troponin-C fragment inserted between CFP and Citrine while the second sensor, called mTFP-TnC-Cit, was realized by replacing CFP in TN-L15 with monomeric Teal Fluorescent Protein (mTFP1). Using cytosol preparations of transiently transfected mammalian cells, we have measured the fluorescence decay profiles of these sensors at controlled concentrations of calcium using time-correlated single photon counting. These data were fitted to discrete exponential decay models using global analysis to determine the FRET efficiency, fraction of donor molecules undergoing FRET and calcium affinity of these sensors. We have also studied the decay profiles of the donor fluorescent proteins alone and determined the sensitivity of the donor lifetime to temperature and emission wavelength. Live-cell fluorescence lifetime imaging (FLIM) of HEK293T cells expressing each of these sensors was also undertaken. We confirmed that donor fluorescence of mTFP-TnC-Cit fits well to a two-component decay model, while the TN-L15 lifetime data was best fitted to a constrained four-component model, which was supported by phasor analysis of the measured lifetime data. If the constrained global fitting is employed, the TN-L15 sensor can provide a larger dynamic range of lifetime readout than the mTFP-TnC-Cit sensor but the CFP donor is significantly more sensitive to changes in temperature and emission wavelength compared to mTFP and, while the mTFP-TnC-Cit solution phase data broadly agreed with measurements in live cells, this was not the case for the TN-L15 sensor. Our titration experiment also indicates that a similar precision in determination of calcium concentration can be achieved with both FRET biosensors when fitting a single exponential donor fluorescence decay model to the fluorescence decay profiles. We therefore suggest that mTFP-based probes are more suitable for FLIM experiments than CFP-based probes.	[Laine, Romain] Univ London Imperial Coll Sci Technol & Med, ICB, London, England; [Laine, Romain; Manning, Hugh; Warren, Sean C.; Kennedy, Gordon; Dunsby, Chris; French, Paul M. W.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Photon Grp, London, England; [Laine, Romain; Stuckey, Daniel W.; Carling, David; Sardini, Alessandro] Univ London Imperial Coll Sci Technol & Med, Ctr Clin Sci, MRC, London, England	Imperial College London; Imperial College London; Imperial College London	Laine, R (corresponding author), Univ London Imperial Coll Sci Technol & Med, ICB, London, England.	romain.laine06@imperial.ac.uk	French, Paul/E-8649-2011; Carling, David/F-1943-2014; Warren, Sean C./A-9392-2016	Carling, David/0000-0002-2316-1830; Warren, Sean C./0000-0002-5253-7147; French, Paul/0000-0002-0478-6755; Laine, Romain/0000-0002-2151-4487	UK Biotechnology and Biological Sciences Research Council [BBSRC BB/E000495/1, BB/H00713X/1]; Institute of Chemical Biology Doctoral Training Centre; Engineering and Physical Sciences Research Council (EPSRC); Royal Society Wolfson Research Merit Award; BBSRC [BB/E000495/1, BB/H00713X/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000495/1, BB/H00713X/1] Funding Source: researchfish; Medical Research Council [MC_U120027537] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Institute of Chemical Biology Doctoral Training Centre; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society Wolfson Research Merit Award(Royal Society of London); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors gratefully acknowledge funding from the UK Biotechnology and Biological Sciences Research Council (BBSRC BB/E000495/1 and BB/H00713X/1). RL and HM acknowledge PhD studentships from the Institute of Chemical Biology Doctoral Training Centre funded by the Engineering and Physical Sciences Research Council (EPSRC). Paul French acknowledges a Royal Society Wolfson Research Merit Award. (BBSRC: www.bbsrc.ac.uk/, ICB: www3.imperial.ac.uk/chemicalbiology/, EPSRC: www.epsrc.ac.uk/, Royal Society: www.royalsociety.org/.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HW, 2006, BIOCHEM J, V400, P531, DOI 10.1042/BJ20060874; Becker W, 2004, MICROSC RES TECHNIQ, V63, P58, DOI 10.1002/jemt.10421; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Borst JW, 2008, BIOPHYS J, V95, P5399, DOI 10.1529/biophysj.107.114587; Bourett TM, 2002, FUNGAL GENET BIOL, V37, P211, DOI 10.1016/S1087-1845(02)00524-8; Carafoli E, 2004, TRENDS BIOCHEM SCI, V29, P371, DOI 10.1016/j.tibs.2004.05.006; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Clayton AHA, 2004, J MICROSC-OXFORD, V213, P1, DOI 10.1111/j.1365-2818.2004.01265.x; Day RN, 2008, J BIOMEDICAL OPTICS, V13; Garaschuk O, 2007, CELL CALCIUM, V42, P351, DOI 10.1016/j.ceca.2007.02.011; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Geiger A, 2012, BIOPHYS J, V102, P2401, DOI 10.1016/j.bpj.2012.03.065; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Heim N, 2004, J BIOL CHEM, V279, P14280, DOI 10.1074/jbc.M312751200; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Kim J, 2009, MOL BIOSYST, V5, P151, DOI 10.1039/b815445g; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Koushik SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008031; Kumar S, 2011, CHEMPHYSCHEM, V12, P609, DOI 10.1002/cphc.201000874; Lakowicz JR, 2006, PINCIPLES FLUORESCEN; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Mank M, 2008, CHEM REV, V108, P1550, DOI 10.1021/cr078213v; Manning HB, 2008, J BIOPHOTONICS, V1, P494, DOI 10.1002/jbio.200810051; Markova O, 2008, J NEUROSCI METH, V170, P67, DOI 10.1016/j.jneumeth.2007.12.016; McGinty J, 2011, BIOMED OPT EXPRESS, V2, P1907, DOI 10.1364/BOE.2.001907; Millington M, 2007, BIOPHYS CHEM, V127, P155, DOI 10.1016/j.bpc.2007.01.008; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nakai J, 2001, NAT BIOTECHNOL, V19, P137, DOI 10.1038/84397; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Palmer AE, 2006, NAT PROTOC, V1, P1057, DOI 10.1038/nprot.2006.172; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Seifert MH, 2002, J AM CHEM SOC, V124, P7932, DOI 10.1021/ja0257725; Subramaniam V, 2003, METHOD ENZYMOL, V360, P178; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; Sun YS, 2010, BIOPHYS J, V99, P1274, DOI 10.1016/j.bpj.2010.06.004; Sun YS, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3227036; Swaminathan R, 1997, BIOPHYS J, V72, P1900, DOI 10.1016/S0006-3495(97)78835-0; Tang S, 2011, P NATL ACAD SCI USA, V108, P16265, DOI 10.1073/pnas.1103015108; Ting AY, 2001, P NATL ACAD SCI USA, V98, P15003, DOI 10.1073/pnas.211564598; Tramier M, 2002, BIOPHYS J, V83, P3570, DOI 10.1016/S0006-3495(02)75357-5; Tramier M, 2006, MICROSC RES TECHNIQ, V69, P933, DOI 10.1002/jemt.20370; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Verveer PJ, 2003, J MICROSC-OXFORD, V209, P1, DOI 10.1046/j.1365-2818.2003.01093.x; Villoing A, 2008, BIOCHEMISTRY-US, V47, P12483, DOI 10.1021/bi801400d; Visser AJWG, 2010, EUR BIOPHYS J BIOPHY, V39, P241, DOI 10.1007/s00249-009-0528-8; Wouters FS, 1999, CURR BIOL, V9, P1127, DOI 10.1016/S0960-9822(99)80484-9; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	51	20	20	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49200	10.1371/journal.pone.0049200	http://dx.doi.org/10.1371/journal.pone.0049200			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152874	Green Submitted, Green Published, gold			2022-12-27	WOS:000312272600051
J	Rosains, J; Mango, SE				Rosains, Jacqueline; Mango, Susan E.			Genetic Characterization of smg-8 Mutants Reveals No Role in C. elegans Nonsense Mediated Decay	PLOS ONE			English	Article							MESSENGER-RNA SURVEILLANCE; CAENORHABDITIS-ELEGANS; EXPRESSION ANALYSIS; PROTEIN-KINASE; NMD PATHWAY; WIDE RNAI; COMPLEX; UPF1	The nonsense mediated decay (NMD) pathway degrades mRNAs bearing premature translation termination codons. In mammals, SMG-8 has been implicated in the NMD pathway, in part by its association with SMG-1 kinase. Here we use four independent assays to show that C. elegans smg-8 is not required to degrade nonsense-containing mRNAs. We examine the genetic requirement for smg-8 to destabilize the endogenous, natural NMD targets produced by alternative splicing of rpl-7a and rpl-12. We test smg-8 for degradation of the endogenous, NMD target generated by unc-54(r293), which lacks a normal polyadenylation site. We probe the effect of smg-8 on the exogenous NMD target produced by myo-3::GFP, which carries a long 39 untranslated region that destabilizes mRNAs. None of these known NMD targets is influenced by smg-8 mutations. In addition, smg-8 animals lack classical Smg mutant phenotypes such as a reduced brood size or abnormal vulva. We conclude that smg-8 is unlikely to encode a component critical for NMD.	[Rosains, Jacqueline; Mango, Susan E.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Mango, SE (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	smango@mcb.harvard.edu		Mango, Susan/0000-0002-2146-3237	National Institutes of Health NIH [GM056264]; John D. and Catherine T. MacArthur Foundation; Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM056264, R01GM056264] Funding Source: NIH RePORTER	National Institutes of Health NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John D. and Catherine T. MacArthur Foundation; Harvard University; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SEM received funding from the National Institutes of Health NIH (GM056264), the John D. and Catherine T. MacArthur Foundation and Harvard University. JR received funding from Harvard University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasaki C, 2011, NUCLEIC ACIDS RES, V39, P3686, DOI 10.1093/nar/gkq1319; Barberan-Soler S, 2009, RNA, V15, P1652, DOI 10.1261/rna.1711109; BRENNER S, 1974, GENETICS, V77, P71; Cali BM, 1999, GENETICS, V151, P605; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chiu SY, 2003, RNA, V9, P77, DOI 10.1261/rna.2137903; Eberle AB, 2009, NAT STRUCT MOL BIOL, V16, P49, DOI 10.1038/nsmb.1530; Fischer SEJ, 2008, NATURE, V455, P491, DOI 10.1038/nature07274; Grimson A, 2004, MOL CELL BIOL, V24, P7483, DOI 10.1128/MCB.24.17.7483-7490.2004; HODGKIN J, 1989, GENETICS, V123, P301; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Huntzinger E, 2008, RNA, V14, P2609, DOI 10.1261/rna.1386208; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kashima I, 2006, GENE DEV, V20, P355, DOI 10.1101/gad.1389006; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; Link CD, 2003, NEUROBIOL AGING, V24, P397, DOI 10.1016/S0197-4580(02)00224-5; Longman D, 2007, GENE DEV, V21, P1075, DOI 10.1101/gad.417707; Mango SE, 2001, TRENDS GENET, V17, P646, DOI 10.1016/S0168-9525(01)02479-9; Mitrovich QM, 2000, GENE DEV, V14, P2173, DOI 10.1101/gad.819900; Nicholson P, 2010, CELL MOL LIFE SCI, V67, P677, DOI 10.1007/s00018-009-0177-1; PULAK R, 1993, GENE DEV, V7, P1885, DOI 10.1101/gad.7.10.1885; Ramani AK, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r101; Sun YY, 2011, PROTEIN CELL, V2, P918, DOI 10.1007/s13238-011-1119-x; Unterholzner L, 2004, MOL CELL, V16, P587, DOI 10.1016/j.molcel.2004.10.013; Yamashita A, 2001, GENE DEV, V15, P2215, DOI 10.1101/gad.913001; Yamashita A, 2009, GENE DEV, V23, P1091, DOI 10.1101/gad.1767209; Zhuang JJ, 2011, GENETICS, V188, P235, DOI 10.1534/genetics.111.127209	27	6	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49490	10.1371/journal.pone.0049490	http://dx.doi.org/10.1371/journal.pone.0049490			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166684	Green Published, gold			2022-12-27	WOS:000311885300047
J	Nyfeler, B; Chen, Y; Li, XY; Pinzon-Ortiz, M; Wang, ZC; Reddy, A; Pradhan, E; Das, R; Lehar, J; Schlegel, R; Finan, PM; Cao, ZA; Murphy, LO; Huang, A				Nyfeler, Beat; Chen, Yan; Li, Xiaoyan; Pinzon-Ortiz, Maria; Wang, Zuncai; Reddy, Anupama; Pradhan, Elina; Das, Rita; Lehar, Joseph; Schlegel, Robert; Finan, Peter M.; Cao, Z. Alexander; Murphy, Leon O.; Huang, Alan			RAD001 Enhances the Potency of BEZ235 to Inhibit mTOR Signaling and Tumor Growth	PLOS ONE			English	Article							MAMMALIAN TARGET; RAPAMYCIN; NVP-BEZ235; PATHWAY	The mammalian target of rapamycin (mTOR) is regulated by oncogenic growth factor signals and plays a pivotal role in controlling cellular metabolism, growth and survival. Everolimus (RAD001) is an allosteric mTOR inhibitor that has shown marked efficacy in certain cancers but is unable to completely inhibit mTOR activity. ATP-competitive mTOR inhibitors such as NVP-BEZ235 can block rapamycin-insensitive mTOR readouts and have entered clinical development as anti-cancer agents. Here, we show the degree to which RAD001 and BEZ235 can be synergistically combined to inhibit mTOR pathway activation, cell proliferation and tumor growth, both in vitro and in vivo. RAD001 and BEZ235 synergized in cancer lines representing different lineages and genetic backgrounds. Strong synergy is seen in neuronal, renal, breast, lung, and haematopoietic cancer cells harboring abnormalities in PTEN, VHL, LKB1, Her2, or KRAS. Critically, in the presence of RAD001, the mTOR-4EBP1 pathway and tumorigenesis can be fully inhibited using lower doses of BEZ235. This is relevant since RAD001 is relatively well tolerated in patients while the toxicity profiles of ATP-competitive mTOR inhibitors are currently unknown.	[Nyfeler, Beat; Chen, Yan; Li, Xiaoyan; Pinzon-Ortiz, Maria; Wang, Zuncai; Reddy, Anupama; Pradhan, Elina; Das, Rita; Lehar, Joseph; Schlegel, Robert; Finan, Peter M.; Cao, Z. Alexander; Murphy, Leon O.; Huang, Alan] Novartis Inst BioMed Res, Cambridge, MA USA	Novartis	Nyfeler, B (corresponding author), Novartis Inst BioMed Res, Cambridge, MA USA.	alan.huang@novartis.com		Wilson, Christopher/0000-0002-9146-522X				Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Garcia-Echeverria C, 2011, BIOCHEM SOC T, V39, P451, DOI 10.1042/BST0390451; Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Lehar J, 2009, NAT BIOTECHNOL, V27, P659, DOI 10.1038/nbt.1549; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Nyfeler B, 2011, MOL CELL BIOL, V31, P2867, DOI 10.1128/MCB.05430-11; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Thomas HE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003923; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Vilar E, 2011, MOL CANCER THER, V10, P395, DOI 10.1158/1535-7163.MCT-10-0905; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu CX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020899; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Zhang JM, 2010, NATURE, V463, P501, DOI 10.1038/nature08675; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008	25	25	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e48548	10.1371/journal.pone.0048548	http://dx.doi.org/10.1371/journal.pone.0048548			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23155392	Green Submitted, Green Published, gold			2022-12-27	WOS:000311151900026
J	Pandey, RB; Farmer, BL				Pandey, Ras B.; Farmer, Barry L.			Random Coil to Globular Thermal Response of a Protein (H3.1) with Three Knowledge-Based Coarse-Grained Potentials	PLOS ONE			English	Article							HISTONE H3; PAIR POTENTIALS; AMINO-ACIDS; METHYLATION; STABILITY; PLATELETS; DESIGN; MODEL; CORE	The effect of temperature on the conformation of a histone (H3.1) is studied by a coarse-grained Monte Carlo simulation based on three knowledge-based contact potentials (MJ, BT, BFKV). Despite unique energy and mobility profiles of its residues, the histone H3.1 undergoes a systematic (possibly continuous) structural transition from a random coil to a globular conformation on reducing the temperature. The range over which such a systematic response in variation of the radius of gyration (R-g) with the temperature (T) occurs, however, depends on the potential, i.e. Delta T-MJ approximate to 0.013-0.020, Delta T-BT approximate to 0.018-0.026, and Delta T-BFKV approximate to 0.006-0.013 (in reduced unit). Unlike MJ and BT potentials, results from the BFKV potential show an anomaly where the magnitude of Rg decreases on raising the temperature in a range Delta T-A approximate to 0.015-0.018 before reaching its steady-state random coil configuration. Scaling of the structure factor, S(q) infinity q(-1/nu), with the wave vector, q = 2 pi/lambda, and the wavelength, lambda, reveals a systematic change in the effective dimension (D-e similar to/nu) of the histone with all potentials (MJ, BT, BFKV): D-e similar to 3 in the globular structure with D-e similar to 2 for the random coil. Reproducibility of the general yet unique (monotonic) structural transition of the protein H3.1 with the temperature (in contrast to non-monotonic structural response of a similar but different protein H2AX) with three interaction sets shows that the knowledge-based contact potential is viable tool to investigate structural response of proteins. Caution should be exercise with the quantitative comparisons due to differences in transition regimes with these interactions.	[Pandey, Ras B.] Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA	University of Southern Mississippi	Pandey, RB (corresponding author), Univ So Mississippi, Dept Phys & Astron, Hattiesburg, MS 39406 USA.	ras.pandey@usm.edu						[Anonymous], RESIDUE RESIDUE INTE; [Anonymous], SEQUENCE DETAILS INC; Bagci Z, 2003, PROTEINS, V53, P56, DOI 10.1002/prot.10435; Banavar JR, 2003, REV MOD PHYS, V75, P23, DOI 10.1103/RevModPhys.75.23; Bastolla U, 2001, PROTEINS, V44, P79, DOI 10.1002/prot.1075; Behringer H, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.128101; Betancourt MR, 1999, PROTEIN SCI, V8, P361; Binder K., 1995, MONTE CARLO MOL DYNA; BRYANT SH, 1993, PROTEINS, V16, P92, DOI 10.1002/prot.340160110; Chapagain PP, 2006, BIOPOLYMERS, V81, P167, DOI 10.1002/bip.20388; Cottingham Katie, 2008, J Proteome Res, V7, P4211, DOI 10.1021/pr800556r; Eby DM, 2011, PHYS CHEM CHEM PHYS, V13, P1123, DOI 10.1039/c0cp01364a; FIEBIG KM, 1993, J CHEM PHYS, V98, P3475, DOI 10.1063/1.464068; Freddolino PL, 2010, NAT PHYS, V6, P751, DOI 10.1038/NPHYS1713; Fritsche M., 2012, PLOS ONE, V7; Gerstman B, 1998, J POLYM SCI POL PHYS, V36, P2761, DOI 10.1002/(SICI)1099-0488(19981115)36:15<2761::AID-POLB10>3.0.CO;2-5; Gillespie B, 2004, ANNU REV BIOCHEM, V73, P837, DOI 10.1146/annurev.biochem.73.011303.073904; Godzik A, 1996, STRUCTURE, V4, P363, DOI 10.1016/S0969-2126(96)00041-X; Herges T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018101; HINDS DA, 1992, P NATL ACAD SCI USA, V89, P2536, DOI 10.1073/pnas.89.7.2536; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; LIWO A, 1993, PROTEIN SCI, V2, P1697, DOI 10.1002/pro.5560021015; MAIOROV VN, 1992, J MOL BIOL, V227, P876, DOI 10.1016/0022-2836(92)90228-C; Miyazawa S, 1996, J MOL BIOL, V256, P623, DOI 10.1006/jmbi.1996.0114; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Moskovitz Y, 2012, PHYS CHEM CHEM PHYS, V14, P8013, DOI 10.1039/c2cp00005a; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Pandey RB, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3358340; Pandey RB, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.031902; Pandey RB, 2008, J POLYM SCI POL PHYS, V46, P2696, DOI 10.1002/polb.21595; Pandey RB, 2010, J POLYM SCI POL PHYS, V48, P2566, DOI 10.1002/polb.22140; Peng S, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.041908; Pokarowski P, 2005, PROTEINS, V59, P49, DOI 10.1002/prot.20380; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Shen MY, 2002, PROTEINS, V49, P439, DOI 10.1002/prot.10230; Skepo M, 2006, J PHYS CHEM B, V110, P12141, DOI 10.1021/jp056033o; Skolnick J, 1997, PROTEIN SCI, V6, P676; Sorin EJ, 2005, BIOPHYS J, V88, P2472, DOI 10.1529/biophysj.104.051938; Strahl BD, 1999, P NATL ACAD SCI USA, V96, P14967, DOI 10.1073/pnas.96.26.14967; Tachiwana H, 2008, NUCLEIC ACIDS RES, V36, P2208, DOI 10.1093/nar/gkn060; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; TANAKA S, 1976, MACROMOLECULES, V9, P945, DOI 10.1021/ma60054a013; Tobi D, 2000, PROTEINS, V40, P71, DOI 10.1002/(SICI)1097-0134(20000701)40:1<71::AID-PROT90>3.0.CO;2-3; Vendruscolo M, 2000, PROTEINS, V38, P134, DOI 10.1002/(SICI)1097-0134(20000201)38:2<134::AID-PROT3>3.0.CO;2-A; Williams SK, 2008, P NATL ACAD SCI USA, V105, P9000, DOI 10.1073/pnas.0800057105; WOLYNES PG, 1995, SCIENCE, V267, P1619, DOI 10.1126/science.7886447; Zhou YQ, 1999, NATURE, V401, P400, DOI 10.1038/43940	47	6	6	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49352	10.1371/journal.pone.0049352	http://dx.doi.org/10.1371/journal.pone.0049352			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166645	Green Published, Green Submitted, gold			2022-12-27	WOS:000311151900128
J	Stein, U; Burock, S; Herrmann, P; Wendler, I; Niederstrasser, M; Wernecke, KD; Schlag, PM				Stein, Ulrike; Burock, Susen; Herrmann, Pia; Wendler, Ina; Niederstrasser, Markus; Wernecke, Klaus-Dieter; Schlag, Peter M.			Circulating MACC1 Transcripts in Colorectal Cancer Patient Plasma Predict Metastasis and Prognosis	PLOS ONE			English	Article							MESSENGER-RNA; COLON-CANCER; GASTRIC-CANCER; PROTEIN S100A4; NUCLEIC-ACIDS; CARCINOEMBRYONIC ANTIGEN; HEPATOCELLULAR-CARCINOMA; TUMOR-MARKER; MET; EXPRESSION	Background: Metastasis is the most frequent cause of treatment failure and death in colorectal cancer. Early detection of tumors and metastases is crucial for improving treatment strategies and patient outcome. Development of reliable biomarkers and simple tests routinely applicable in the clinic for detection, prognostication, and therapy monitoring is of special interest. We recently identified the novel gene Metastasis-Associated in Colon Cancer 1 (MACC1), a key regulator of the HGF/Met-pathway. MACC1 is a strong prognostic biomarker for colon cancer metastasis and allows identification of high-risk subjects in early stages, when determined in patients' primary tumors. To overcome the limitation of a restricted number of molecular analyses in tumor tissue, the establishment of a non-invasive blood test for early identification of high-risk cancer patients, for monitoring disease course and therapy response is strongly needed. Methodology/Principal Findings: For the first time, we describe a non-invasive assay for quantification of circulating MACC1 transcripts in blood of more than 300 colorectal cancer patients. MACC1 transcript levels are increased in all disease stages of the cancer patients compared to tumor-free volunteers. Highest MACC1 levels were determined in individuals with metastases (all P < 0.05). Importantly, high MACC1 levels correlate with unfavorable survival (P <.0001). Combining MACC1 with circulating transcripts of the metastasis gene S100A4, a transcriptional target of the Wnt/beta-catenin-pathway, improves survival prediction for newly diagnosed cancer patients. Conclusion/Significance: This blood-based assay for circulating MACC1 transcripts, which can be quantitated on a routine basis, is clinically applicable for diagnosis, prognosis, and therapeutic monitoring of cancer patients. Here we demonstrate the diagnostic and prognostic value of circulating MACC1 transcripts in patient plasma for metastasis and survival. Since MACC1 represents a promising target for anti-metastatic therapies, circulating MACC1 transcripts may prove to be an ideal read-out for monitoring therapeutic response of future interventions targeting MACC1-induced metastasis in cancer patients.	[Stein, Ulrike; Herrmann, Pia; Wendler, Ina; Niederstrasser, Markus; Schlag, Peter M.] Charite, Expt & Clin Res Ctr, Max Delbruck Ctr Mol Med, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Stein, U (corresponding author), Charite, Expt & Clin Res Ctr, Max Delbruck Ctr Mol Med, D-13353 Berlin, Germany.	ustein@mdc-berlin.de		Stein, Ulrike/0000-0001-7006-282X; Burock, Susen/0000-0002-0964-4174				Arlt F, 2009, INT J BIOCHEM CELL B, V41, P2356, DOI 10.1016/j.biocel.2009.08.001; Barzon L, 2004, INT J CANCER, V110, P914, DOI 10.1002/ijc.20182; Boye K, 2010, AM J PATHOL, V176, P528, DOI 10.2353/ajpath.2010.090526; Cheng HY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017745; Cho YG, 2005, WORLD J GASTROENTERO, V11, P4852, DOI 10.3748/wjg.v11.i31.4852; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; El-Hefnawy T, 2004, CLIN CHEM, V50, P564, DOI 10.1373/clinchem.2003.028506; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Garcia JM, 2007, CLIN CANCER RES, V13, P6351, DOI 10.1158/1078-0432.CCR-07-0882; Garcia JM, 2008, RNA, V14, P1424, DOI 10.1261/rna.755908; Garcia V, 2006, CLIN CANCER RES, V12, P2095, DOI 10.1158/1078-0432.CCR-05-1644; Garcia V, 2008, CANCER LETT, V263, P312, DOI 10.1016/j.canlet.2008.01.008; Garrett SC, 2006, J BIOL CHEM, V281, P677, DOI 10.1074/jbc.R500017200; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Goebel G, 2005, DIS MARKERS, V21, P105, DOI 10.1155/2005/218759; Goldstein MJ, 2005, CANCER INVEST, V23, P338, DOI 10.1081/CNV-200058878; Gongoll S, 2002, GASTROENTEROLOGY, V123, P1478, DOI 10.1053/gast.2002.36606; Gu CD, 2011, ANTICANCER RES, V31, P1141; Helfman DM, 2005, BRIT J CANCER, V92, P1955, DOI 10.1038/sj.bjc.6602613; Hemandas AK, 2006, J SURG ONCOL, V93, P498, DOI 10.1002/jso.20460; Kim JH, 2009, ONCOL REP, V22, P41, DOI 10.3892/or_00000404; Lang AH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-20; Lledo S M, 2004, Colorectal Dis, V6, P236, DOI 10.1111/j.1463-1318.2004.00627.x; Migliore C, 2012, CLIN CANCER RES, V18, P737, DOI 10.1158/1078-0432.CCR-11-1699; Miura N, 2006, CANCER SCI, V97, P1366, DOI 10.1111/j.1349-7006.2006.00342.x; Nielsen HJ, 2011, SCAND J GASTROENTERO, V46, P60, DOI 10.3109/00365521.2010.513060; O'Driscoll Lorraine, 2008, Cancer Genomics & Proteomics, V5, P95; Orozco AF, 2010, CYTOM PART A, V77A, P502, DOI 10.1002/cyto.a.20886; Qiu JL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-166; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shimokawa H, 2011, J THORAC CARDIOV SUR, V141, P895, DOI 10.1016/j.jtcvs.2010.09.044; Shirahata A, 2011, ANTICANCER RES, V31, P777; Shirahata A, 2010, ANTICANCER RES, V30, P3441; Shirahata A, 2010, ANTICANCER RES, V30, P2689; Silva JM, 2002, GUT, V50, P530, DOI 10.1136/gut.50.4.530; Stein U, 2006, GASTROENTEROLOGY, V131, P1486, DOI 10.1053/j.gastro.2006.08.041; Stein U, 2011, J MOL DIAGN, V13, P189, DOI 10.1016/j.jmoldx.2010.10.002; Stein U, 2010, J MOL MED, V88, P11, DOI 10.1007/s00109-009-0537-1; Stein U, 2009, CELL CYCLE, V8, P2467, DOI 10.4161/cc.8.15.9018; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Takenaga K, 1997, CLIN CANCER RES, V3, P2309; Tani N, 2007, ANTICANCER RES, V27, P1207; Wang JY, 2007, CLIN CANCER RES, V13, P2406, DOI 10.1158/1078-0432.CCR-06-2054; Wisniewski JR, 2011, J PROTEOME RES, V10, P3040, DOI 10.1021/pr200019m; Wong SCC, 2004, CLIN CANCER RES, V10, P1613, DOI 10.1158/1078-0432.CCR-1168-3; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Zhang RT, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-83; Zhang X, 2012, INT J CANCER, V131, P165, DOI 10.1002/ijc.26360	49	63	70	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49249	10.1371/journal.pone.0049249	http://dx.doi.org/10.1371/journal.pone.0049249			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166620	Green Published, Green Accepted, gold			2022-12-27	WOS:000311151900109
J	Umbers, KDL; Tatarnic, NJ; Holwell, GI; Herberstein, ME				Umbers, Kate D. L.; Tatarnic, Nikolai J.; Holwell, Gregory I.; Herberstein, Marie E.			Ferocious Fighting between Male Grasshoppers	PLOS ONE			English	Article							ACHETA-DOMESTICUS; SEXUAL SELECTION; ANIMAL CONTESTS; MALE-AGGRESSION; FIELD CRICKET; HOUSE CRICKET; MALE WEAPONRY; FIDDLER-CRAB; EVOLUTION; SIZE	Contests among individuals over mating opportunities are common across diverse taxa, yet physical conflict is relatively rare. Due to the potentially fatal consequences of physical fighting, most animals employ mechanisms of conflict resolution involving signalling and ritualistic assessment. Here we provide the first evidence of ubiquitous escalated fighting in grasshoppers. The chameleon grasshopper (Kosciuscola tristis) is an Australian alpine specialist, in which males engage in highly aggressive combat over ovipositing females. We describe discrete agonistic behaviours including mandible flaring, mounting, grappling, kicking and biting, and their use depending on the individual's role as challenger or defender. We show that male role predicts damage, with challengers being more heavily damaged than males defending females (defenders). Challengers also possess wider mandibles than defenders, but are similar in other metrics of body size. Our data suggest that fights escalate between males matched in body size and that mandibles are used as weapons in this species. This system represents an exciting opportunity for future research into the evolution of costly fighting behaviour in an otherwise placid group.	[Umbers, Kate D. L.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia	Australian National University	Umbers, KDL (corresponding author), Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia.	kate.umbers@anu.edu.au	Herberstein, Marie E./D-2042-2011; Umbers, Kate/D-3566-2011	Herberstein, Marie E./0000-0001-5071-2952; Umbers, Kate/0000-0002-9375-4527; Holwell, Gregory/0000-0002-6059-6032; Tatarnic, Nikolai/0000-0001-8641-4412				Arnott G, 2009, ANIM BEHAV, V77, P991, DOI 10.1016/j.anbehav.2009.02.010; AUSTAD SN, 1983, ANIM BEHAV, V31, P59, DOI 10.1016/S0003-3472(83)80173-0; Briffa M, 2008, ANIM BEHAV, V75, P1053, DOI 10.1016/j.anbehav.2007.08.016; Cook JM, 2006, ANIM BEHAV, V71, P1095, DOI 10.1016/j.anbehav.2005.07.027; DAVIES NB, 1978, ANIM BEHAV, V26, P138, DOI 10.1016/0003-3472(78)90013-1; De Souza LR, 2011, BEHAVIOUR, V148, P341, DOI 10.1163/000579511X559418; Emlen DJ, 2008, ANNU REV ECOL EVOL S, V39, P387, DOI 10.1146/annurev.ecolsys.39.110707.173502; GREENFIELD MD, 1993, ETHOLOGY, V95, P309, DOI 10.1111/j.1439-0310.1993.tb00480.x; Gwynne DT, 1999, EVOLUTION, V53, P546, DOI 10.2307/2640790; Hack MA, 1997, BEHAV ECOL, V8, P28, DOI 10.1093/beheco/8.1.28; HAMMERSTEIN P, 1981, ANIM BEHAV, V29, P193, DOI 10.1016/S0003-3472(81)80166-2; Hofmann HA, 2001, ANIM BEHAV, V62, P337, DOI 10.1006/anbe.2001.1746; Jaroensutasinee M, 2002, CRUSTACEANA, V75, P1107, DOI 10.1163/156854002763270509; Jennions MD, 1996, BIOL J LINN SOC, V57, P293, DOI 10.1111/j.1095-8312.1996.tb01851.x; Judge KA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003980; Kelly CD, 2005, BEHAV ECOL, V16, P145, DOI 10.1093/beheco/arh141; Kemp DJ, 2004, P ROY SOC B-BIOL SCI, V271, P1707, DOI 10.1098/rspb.2004.2775; Knell RJ, 2009, J ZOOL, V278, P83, DOI 10.1111/j.1469-7998.2009.00566.x; Lailvaux SP, 2004, P ROY SOC B-BIOL SCI, V271, P2501, DOI 10.1098/rspb.2004.2891; Lappin AK, 2006, AM NAT, V168, P100, DOI 10.1086/505161; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; Otte D., 1970, Misc. Publs Mus. Zool. Univ. Mich., VNo. 141, P1; PARKER GA, 1974, J THEOR BIOL, V47, P223, DOI 10.1016/0022-5193(74)90111-8; Shackleton MA, 2005, BEHAV ECOL SOCIOBIOL, V58, P1, DOI 10.1007/s00265-004-0907-1; Simmons LW, 2006, P NATL ACAD SCI USA, V103, P16346, DOI 10.1073/pnas.0603474103; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; SMITH JM, 1979, PROC R SOC SER B-BIO, V205, P475, DOI 10.1098/rspb.1979.0080; Tachon G, 1999, J INSECT BEHAV, V12, P533, DOI 10.1023/A:1020970908541; Umbers KDL, BRIGHT TURQ IN PRESS; Umbers KDL, PLOS ONE IN PRESS; WELLS MS, 1988, ANIM BEHAV, V36, P321, DOI 10.1016/S0003-3472(88)80001-0; Zuk M, 2006, BIOL LETTERS, V2, P521, DOI 10.1098/rsbl.2006.0539	32	23	23	1	367	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49600	10.1371/journal.pone.0049600	http://dx.doi.org/10.1371/journal.pone.0049600			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166725	Green Published, gold			2022-12-27	WOS:000311151900170
J	Monini, P; Cafaro, A; Srivastava, IK; Moretti, S; Sharma, VA; Andreini, C; Chiozzini, C; Ferrantelli, F; Cossut, MRP; Tripiciano, A; Nappi, F; Longo, O; Bellino, S; Picconi, O; Fanales-Belasio, E; Borsetti, A; Toschi, E; Schiavoni, I; Bacigalupo, I; Kan, E; Sernicola, L; Maggiorella, MT; Montin, K; Porcu, M; Leone, P; Leone, P; Collacchi, B; Palladino, C; Ridolfi, B; Falchi, M; Macchia, I; Ulmer, JB; Butto, S; Sgadari, C; Magnani, M; Federico, MPM; Titti, F; Banci, L; Dallocchio, F; Rappuoli, R; Ensoli, F; Barnett, SW; Garaci, E; Ensoli, B				Monini, Paolo; Cafaro, Aurelio; Srivastava, Indresh K.; Moretti, Sonia; Sharma, Victoria A.; Andreini, Claudia; Chiozzini, Chiara; Ferrantelli, Flavia; Cossut, Maria R. Pavone; Tripiciano, Antonella; Nappi, Filomena; Longo, Olimpia; Bellino, Stefania; Picconi, Orietta; Fanales-Belasio, Emanuele; Borsetti, Alessandra; Toschi, Elena; Schiavoni, Ilaria; Bacigalupo, Ilaria; Kan, Elaine; Sernicola, Leonardo; Maggiorella, Maria T.; Montin, Katy; Porcu, Marco; Leone, Patrizia; Leone, Pasqualina; Collacchi, Barbara; Palladino, Clelia; Ridolfi, Barbara; Falchi, Mario; Macchia, Iole; Ulmer, Jeffrey B.; Butto, Stefano; Sgadari, Cecilia; Magnani, Mauro; Federico, Maurizio P. M.; Titti, Fausto; Banci, Lucia; Dallocchio, Franco; Rappuoli, Rino; Ensoli, Fabrizio; Barnett, Susan W.; Garaci, Enrico; Ensoli, Barbara			HIV-1 Tat Promotes Integrin-Mediated HIV Transmission to Dendritic Cells by Binding Env Spikes and Competes Neutralization by Anti-HIV Antibodies	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; FIBROBLAST-GROWTH-FACTOR; PROTEIN-PROTEIN DOCKING; CYNOMOLGUS MONKEYS; ENVELOPE PROTEIN; KAPOSIS-SARCOMA; STRUCTURAL CHARACTERIZATION; THERAPEUTIC VACCINES; PARTIAL DELETION; GP120 CORE	Use of Env in HIV vaccine development has been disappointing. Here we show that, in the presence of a biologically active Tat subunit vaccine, a trimeric Env protein prevents in monkeys virus spread from the portal of entry to regional lymph nodes. This appears to be due to specific interactions between Tat and Env spikes that form a novel virus entry complex favoring R5 or X4 virus entry and productive infection of dendritic cells (DCs) via an integrin-mediated pathway. These Tat effects do not require Tat-transactivation activity and are blocked by anti-integrin antibodies (Abs). Productive DC infection promoted by Tat is associated with a highly efficient virus transmission to T cells. In the Tat/Env complex the cysteine-rich region of Tat engages the Env V3 loop, whereas the Tat RGD sequence remains free and directs the virus to integrins present on DCs. V2 loop deletion, which unshields the CCR5 binding region of Env, increases Tat/Env complex stability. Of note, binding of Tat to Env abolishes neutralization of Env entry or infection of DCs by anti-HIV sera lacking anti-Tat Abs, which are seldom present in natural infection. This is reversed, and neutralization further enhanced, by HIV sera containing anti-Tat Abs such as those from asymptomatic or Tat-vaccinated patients, or by sera from the Tat/Env vaccinated monkeys. Thus, both anti-Tat and anti-Env Abs are required for efficient HIV neutralization. These data suggest that the Tat/Env interaction increases HIV acquisition and spreading, as a mechanism evolved by the virus to escape anti-Env neutralizing Abs. This may explain the low effectiveness of Env-based vaccines, which are also unlikely to elicit Abs against new Env epitopes exposed by the Tat/Env interaction. As Tat also binds Envs from different clades, new vaccine strategies should exploit the Tat/Env interaction for both preventative and therapeutic interventions.	[Monini, Paolo; Cafaro, Aurelio; Moretti, Sonia; Chiozzini, Chiara; Ferrantelli, Flavia; Cossut, Maria R. Pavone; Tripiciano, Antonella; Nappi, Filomena; Longo, Olimpia; Bellino, Stefania; Picconi, Orietta; Fanales-Belasio, Emanuele; Borsetti, Alessandra; Toschi, Elena; Schiavoni, Ilaria; Bacigalupo, Ilaria; Sernicola, Leonardo; Maggiorella, Maria T.; Leone, Patrizia; Leone, Pasqualina; Collacchi, Barbara; Palladino, Clelia; Ridolfi, Barbara; Falchi, Mario; Macchia, Iole; Butto, Stefano; Sgadari, Cecilia; Federico, Maurizio P. M.; Titti, Fausto; Garaci, Enrico; Ensoli, Barbara] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy; [Srivastava, Indresh K.; Sharma, Victoria A.; Kan, Elaine; Ulmer, Jeffrey B.; Barnett, Susan W.] Novartis Vaccines & Diagnost Inc, Cambridge, MA USA; [Andreini, Claudia; Porcu, Marco; Banci, Lucia] Univ Florence, CERM, Florence, Italy; [Montin, Katy; Dallocchio, Franco] Univ Ferrara, Dept Biochem, I-44100 Ferrara, Italy; [Tripiciano, Antonella; Ensoli, Fabrizio] San Gallicano Hosp, Rome, Italy; [Rappuoli, Rino] Novartis Vaccines & Diagnost Inc, Siena, Italy; [Magnani, Mauro] Univ Urbino, Dept Biomol Sci, I-61029 Urbino, Italy	Istituto Superiore di Sanita (ISS); Novartis; University of Florence; University of Ferrara; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS San Gallicano Dermatological Institute (ISG); Novartis; University of Urbino	Ensoli, B (corresponding author), Ist Super Sanita, Natl AIDS Ctr, Viale Regina Elena 299, I-00161 Rome, Italy.	barbara.ensoli@iss.it	chiozzini, chiara/M-8906-2017; macchia, iole/AAD-1652-2021; Palladino, Clelia/K-7555-2016; Moretti, Sonia/K-5687-2016; Andreini, Claudia/AAB-2364-2022; Monini, Paolo/K-1429-2016; Federico, Maurizio/J-5867-2016; SCHIAVONI, ILARIA/M-4367-2015; Picconi, Orietta/L-4613-2016; GARACI, ENRICO/AAB-3349-2021; maggiorella, maria teresa/K-4072-2016; Tripiciano, Antonella/K-4635-2016; Chiozzini, Chiara/AAH-1790-2021; Cafaro, Aurelio/K-5314-2016; Magnani, Mauro/A-1919-2008; borsetti, alessandra/K-4103-2016; Ensoli, Barbara/J-9169-2016; Ferrantelli, Flavia/J-7794-2016; BELASIO, EMANUELE FANALES/C-7718-2016; Ensoli, Fabrizio/J-6540-2018; Toschi, Elena/M-7051-2017; schiavoni, ilaria/N-5524-2015; Andreini, Claudia/D-5614-2014; COLLACCHI, BARBARA/AAC-4491-2022; RIDOLFI, BARBARA/D-7967-2016; Sgadari, Cecilia/H-4302-2016; Buttò, Stefano/J-9324-2018	macchia, iole/0000-0002-3870-8202; Palladino, Clelia/0000-0003-0740-5863; Moretti, Sonia/0000-0003-4812-1496; Andreini, Claudia/0000-0003-4329-8225; Monini, Paolo/0000-0002-4941-6854; Federico, Maurizio/0000-0003-4154-1025; SCHIAVONI, ILARIA/0000-0003-1870-8907; Picconi, Orietta/0000-0003-3626-9952; maggiorella, maria teresa/0000-0001-5058-476X; Tripiciano, Antonella/0000-0001-7814-984X; Chiozzini, Chiara/0000-0002-4153-0927; borsetti, alessandra/0000-0002-5401-135X; Ensoli, Barbara/0000-0002-0545-8737; Ferrantelli, Flavia/0000-0002-0768-1078; BELASIO, EMANUELE FANALES/0000-0003-2369-9996; Ensoli, Fabrizio/0000-0003-4995-3067; Andreini, Claudia/0000-0003-4329-8225; COLLACCHI, BARBARA/0000-0001-6330-6283; RIDOLFI, BARBARA/0000-0002-6443-5500; Sgadari, Cecilia/0000-0003-0364-4912; Bellino, Stefania/0000-0003-1149-3835; Cafaro, Aurelio/0000-0001-9675-6344; Toschi, Elena/0000-0002-9720-5971; Bacigalupo, ilaria/0000-0002-4249-1982; Falchi, Mario/0000-0002-8290-5406; Nappi, Filomena/0000-0003-2313-7694; Butto, Stefano/0000-0002-3289-2686; BANCI, LUCIA/0000-0003-0562-5774; Magnani, Mauro/0000-0001-6456-6626	EC Commission under the VI Framework Programme of Research and Technological Development [LSHP-CT-2004-503487]; AIDS Vaccine Integrated Project ("AVIP''); Very Innovative AIDS Vaccine Project ("VIAV'', European Commission), from the Italian National AIDS Program; ISS; Italian Ministry of Health from the Italian Concerted Action for the Development of a Vaccine against HIV/Tat (ICAV); Italian Ministry of Health; Joint Program ISS/Novartis (Chiron) for the development of a combined vaccine against HIV/AIDS	EC Commission under the VI Framework Programme of Research and Technological Development; AIDS Vaccine Integrated Project ("AVIP''); Very Innovative AIDS Vaccine Project ("VIAV'', European Commission), from the Italian National AIDS Program; ISS; Italian Ministry of Health from the Italian Concerted Action for the Development of a Vaccine against HIV/Tat (ICAV); Italian Ministry of Health(Ministry of Health, Italy); Joint Program ISS/Novartis (Chiron) for the development of a combined vaccine against HIV/AIDS	This work was supported by grants from EC Commission under the VI Framework Programme of Research and Technological Development (2002 - 2006), project number LSHP-CT-2004-503487, AIDS Vaccine Integrated Project ("AVIP'') and from the Very Innovative AIDS Vaccine Project ("VIAV'', European Commission), from the Italian National AIDS Program, ISS, Italian Ministry of Health to the National AIDS Center, from the Italian Concerted Action for the Development of a Vaccine against HIV/Tat (ICAV), Italian Ministry of Health and from the "Joint Program ISS/Novartis (Chiron) for the development of a combined vaccine against HIV/AIDS'' to BE and RR, from the special project on the Development of a Vaccine against HIV/Tat, Italian Ministry of Health to BE, and by National Institutes of Health grants to S.W.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya AP, 2010, BIOMATERIALS, V31, P7444, DOI 10.1016/j.biomaterials.2010.06.025; Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x; Asada-Mikami R, 2001, JPN J CANCER RES, V92, P321, DOI 10.1111/j.1349-7006.2001.tb01098.x; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Barillari G, 1999, BLOOD, V94, P663; BARILLARI G, 1993, P NATL ACAD SCI USA, V90, P7941, DOI 10.1073/pnas.90.17.7941; Barillari G, 1999, J IMMUNOL, V163, P1929; Barnet SW, 2001, J VIROL, V75, P5526, DOI 10.1128/JVI.75.12.5526-5540.2001; Benelli R, 1998, AIDS, V12, P261, DOI 10.1097/00002030-199803000-00003; Borsetti A, 2009, VIRAL IMMUNOL, V22, P117, DOI 10.1089/vim.2008.0082; Brown KA, 1997, CLIN EXP IMMUNOL, V107, P601, DOI 10.1046/j.1365-2249.1997.d01-951.x; Cafaro A, 1999, NAT MED, V5, P643, DOI 10.1038/9488; Cafaro A, 2001, VACCINE, V19, P2862, DOI 10.1016/S0264-410X(01)00002-0; Cafaro A, 2000, J MED PRIMATOL, V29, P193, DOI 10.1034/j.1600-0684.2000.290313.x; Cafaro A, 2010, J VIROL, V84, P8953, DOI 10.1128/JVI.00377-10; Cafaro A, 2009, ADV EXP MED BIOL, V655, P189, DOI 10.1007/978-1-4419-1132-2_14; Cao J, 1997, J VIROL, V71, P9808, DOI 10.1128/JVI.71.12.9808-9812.1997; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Chohan B, 2005, J VIROL, V79, P6528, DOI 10.1128/JVI.79.10.6528-6531.2005; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Davis LS, 2002, AM J PATHOL, V160, P357, DOI 10.1016/S0002-9440(10)64379-9; Demberg T, 2007, J VIROL, V81, P3414, DOI 10.1128/JVI.02453-06; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; ENSOLI B, 1994, NATURE, V371, P674, DOI 10.1038/371674a0; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Ensoli B, 2005, MICROBES INFECT, V7, P1392, DOI 10.1016/j.micinf.2005.07.016; Ensoli B, 2008, AIDS, V22, P2207, DOI 10.1097/QAD.0b013e32831392d4; Ensoli B, 2006, AIDS, V20, P2245, DOI 10.1097/QAD.0b013e3280112cd1; Ensoli B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013540; Ensoli B, 2009, VACCINE, V28, P371, DOI 10.1016/j.vaccine.2009.10.038; Fanales-Belasio E, 2002, J IMMUNOL, V168, P197, DOI 10.4049/jimmunol.168.1.197; Fanales-Belasio E, 2009, J IMMUNOL, V182, P2888, DOI 10.4049/jimmunol.0711406; Ferrantelli F, 2004, CURR OPIN BIOTECH, V15, P543, DOI 10.1016/j.copbio.2004.10.008; Ferrantelli F, 2011, VACCINE, V29, P2918, DOI 10.1016/j.vaccine.2011.02.006; Gavioli R, 2004, J IMMUNOL, V173, P3838, DOI 10.4049/jimmunol.173.6.3838; Gavioli R, 2008, VACCINE, V26, P727, DOI 10.1016/j.vaccine.2007.11.040; Goletti D, 2006, MED SCI MONITOR, V12, pBR330; Gregoire C, 2001, BIOPOLYMERS, V62, P324, DOI 10.1002/bip.10000; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang L, 1998, J VIROL, V72, P8952, DOI 10.1128/JVI.72.11.8952-8960.1998; Koning GA, 2006, ARTHRITIS RHEUM-US, V54, P1198, DOI 10.1002/art.21719; Longo O, 2009, VACCINE, V27, P3306, DOI 10.1016/j.vaccine.2009.01.090; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Maggiorella MT, 2004, VACCINE, V22, P3258, DOI 10.1016/j.vaccine.2004.03.009; Marchio S, 2005, BLOOD, V105, P2802, DOI 10.1182/blood-2004-06-2212; Mochizuki H, 1998, J VIROL, V72, P8873, DOI 10.1128/JVI.72.11.8873-8883.1998; Muratori C, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-52; Nappi F, 2009, J GENE MED, V11, P955, DOI 10.1002/jgm.1381; Negri DRM, 2004, J IMMUNOL METHODS, V291, P153, DOI 10.1016/j.jim.2004.05.007; Palma PN, 2000, PROTEINS, V39, P372, DOI 10.1002/(SICI)1097-0134(20000601)39:4<372::AID-PROT100>3.0.CO;2-Q; Peloponese JM, 2000, CR ACAD SCI III-VIE, V323, P883, DOI 10.1016/S0764-4469(00)01228-2; Pizza M, 2001, VACCINE, V19, P2534, DOI 10.1016/S0264-410X(00)00137-7; Puig-Kroger A, 2000, J IMMUNOL, V165, P4338, DOI 10.4049/jimmunol.165.8.4338; Rayne F, 2010, EMBO J, V29, P1348, DOI 10.1038/emboj.2010.32; Re MC, 2001, J CLIN VIROL, V21, P81, DOI 10.1016/S1386-6532(00)00189-X; REISS P, 1991, J ACQ IMMUN DEF SYND, V4, P165; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rezza G, 2005, J INFECT DIS, V191, P1321, DOI 10.1086/428909; Richardson MW, 2003, BIOMED PHARMACOTHER, V57, P4, DOI 10.1016/S0753-3322(02)00327-X; Rong R, 2007, J VIROL, V81, P1350, DOI 10.1128/JVI.01839-06; Rossi C, 1997, GENE THER, V4, P1261, DOI 10.1038/sj.gt.3300522; ROSSI GB, 1987, ANN NY ACAD SCI, V511, P390, DOI 10.1111/j.1749-6632.1987.tb36268.x; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Saunders CJ, 2005, J VIROL, V79, P9069, DOI 10.1128/JVI.79.14.9069-9080.2005; Srivastava IK, 2003, J VIROL, V77, P11244, DOI 10.1128/JVI.77.20.11244-11259.2003; Stamatatos L, 1998, AIDS RES HUM RETROV, V14, P1129, DOI 10.1089/aid.1998.14.1129; Stupack DG, 2004, CURR TOP DEV BIOL, V64, P207, DOI 10.1016/S0070-2153(04)64009-9; VOGEL BE, 1993, J CELL BIOL, V121, P461, DOI 10.1083/jcb.121.2.461; WESTENDORP MO, 1995, NATURE, V375, P497, DOI 10.1038/375497a0; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Xiao H, 2000, P NATL ACAD SCI USA, V97, P11466, DOI 10.1073/pnas.97.21.11466; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Yu XB, 2003, MOL THER, V7, P827, DOI 10.1016/S1525-0016(03)00104-7; Zagury J F, 1998, J Hum Virol, V1, P282	82	40	42	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48781	10.1371/journal.pone.0048781	http://dx.doi.org/10.1371/journal.pone.0048781			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152803	Green Published, gold			2022-12-27	WOS:000311234600012
J	Vogel, SS; Nguyen, TA; van der Meer, BW; Blank, PS				Vogel, Steven S.; Nguyen, Tuan A.; van der Meer, B. Wieb; Blank, Paul S.			The Impact of Heterogeneity and Dark Acceptor States on FRET: Implications for Using Fluorescent Protein Donors and Acceptors	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; LIVING CELLS; MOLECULAR-SPECTROSCOPY; ORIENTATION FACTOR; HOMO-FRET; DYNAMICS; STOICHIOMETRY; MICROSCOPY; ANISOTROPY; BIOSENSOR	Forster resonance energy transfer (FRET) microscopy is widely used to study protein interactions in living cells. Typically, spectral variants of the Green Fluorescent Protein (FPs) are incorporated into proteins expressed in cells, and FRET between donor and acceptor FPs is assayed. As appreciable FRET occurs only when donors and acceptors are within 10 nm of each other, the presence of FRET can be indicative of aggregation that may denote association of interacting species. By monitoring the excited-state (fluorescence) decay of the donor in the presence and absence of acceptors, dual-component decay analysis has been used to reveal the fraction of donors that are FRET positive (i.e., in aggregates). However, control experiments using constructs containing both a donor and an acceptor FP on the same protein repeatedly indicate that a large fraction of these donors are FRET negative, thus rendering the interpretation of dual-component analysis for aggregates between separately donor-containing and acceptor-containing proteins problematic. Using Monte-Carlo simulations and analytical expressions, two possible sources for such anomalous behavior are explored: 1) conformational heterogeneity of the proteins, such that variations in the distance separating donor and acceptor FPs and/or their relative orientations persist on time-scales long in comparison with the excited-state lifetime, and 2) FP dark states.	[Vogel, Steven S.; Nguyen, Tuan A.] NIAAA, Lab Mol Physiol, NIH, Bethesda, MD USA; [van der Meer, B. Wieb] Western Kentucky Univ, Dept Phys & Astron, Bowling Green, KY 42101 USA; [Blank, Paul S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Western Kentucky University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Vogel, SS (corresponding author), NIAAA, Lab Mol Physiol, NIH, Bethesda, MD USA.	stevevog@mail.nih.gov	Blank, Paul/Q-9673-2019	Vogel, Steven/0000-0002-3005-2667	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda [MD 20892]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001409] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000452] Funding Source: NIH RePORTER	National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the intramural programs of the National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, MD 20892. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cantor C. R., 1980, BIOPHYS CHEM 2; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen Y, 2010, METHOD ENZYMOL, V472, P345, DOI 10.1016/S0076-6879(10)72026-7; Chiang JJH, 2006, IEEE T NANOBIOSCI, V5, P41, DOI 10.1109/TNB.2005.864020; Clegg RM, 2009, LAB TECH BIOCHEM MOL, V33, P1, DOI 10.1016/S0075-7535(08)00001-6; DALE RE, 1979, BIOPHYS J, V26, P161, DOI 10.1016/S0006-3495(79)85243-1; DALE RE, 1976, P NATL ACAD SCI USA, V73, P271, DOI 10.1073/pnas.73.2.271; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; EISINGER J, 1974, J MOL BIOL, V84, P643, DOI 10.1016/0022-2836(74)90122-3; Forster, 1951, FLUORESZENZ ORGANISC; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; GELL C, 2006, HDB SINGLE MOL FLUOR; GRYCZYNSKI I, 1988, BIOPHYS J, V54, P577, DOI 10.1016/S0006-3495(88)82992-8; Ha T, 2001, METHODS, V25, P78, DOI 10.1006/meth.2001.1217; HAAS E, 1978, BIOCHEMISTRY-US, V17, P5064, DOI 10.1021/bi00616a032; Heikal AA, 2000, P NATL ACAD SCI USA, V97, P11996, DOI 10.1073/pnas.97.22.11996; Heikal AA, 2001, CHEM PHYS, V274, P37, DOI 10.1016/S0301-0104(01)00486-4; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Hoppe A, 2002, BIOPHYS J, V83, P3652, DOI 10.1016/S0006-3495(02)75365-4; Hunt J, 2012, J BIOL CHEM, V287, P17459, DOI 10.1074/jbc.M111.331967; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Knox RS, 2002, J PHYS CHEM B, V106, P5289, DOI 10.1021/jp013927+; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Koushik SV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008031; Liu YX, 2006, J PHYS CHEM B, V110, P24138, DOI 10.1021/jp062164t; Malo GD, 2007, BIOCHEMISTRY-US, V46, P9865, DOI 10.1021/bi602664c; Nguyen TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038209; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Pham E, 2007, STRUCTURE, V15, P515, DOI 10.1016/j.str.2007.03.009; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Rekas A, 2002, J BIOL CHEM, V277, P50573, DOI 10.1074/jbc.M209524200; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rizzo MA, 2006, MICROSC MICROANAL, V12, P238, DOI 10.1017/S1431927606060235; Sarkar P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3156842; Schwille P, 2000, P NATL ACAD SCI USA, V97, P151, DOI 10.1073/pnas.97.1.151; Sekar RB, 2003, J CELL BIOL, V160, P629, DOI 10.1083/jcb.200210140; Steinberg I. Z., 1983, TIME RESOLVED FLUORE, P411; STEINBERG IZ, 1971, ANNU REV BIOCHEM, V40, P83, DOI 10.1146/annurev.bi.40.070171.000503; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Suhling K, 2002, J FLUORESC, V12, P91, DOI 10.1023/A:1015323606154; Sun YS, 2011, NAT PROTOC, V6, P1324, DOI 10.1038/nprot.2011.364; Thaler C, 2005, BIOPHYS J, V89, P2736, DOI 10.1529/biophysj.105.061853; Thaler C, 2009, P NATL ACAD SCI USA, V106, P6369, DOI 10.1073/pnas.0901913106; TOMPA H, 1979, BIOPHYS CHEM, V9, P211, DOI 10.1016/0301-4622(79)85003-6; Tramier M, 2003, METHOD ENZYMOL, V360, P580; van der Meer B W, 2002, J Biotechnol, V82, P181, DOI 10.1016/S1389-0352(01)00037-X; VanBeek DB, 2007, BIOPHYS J, V92, P4168, DOI 10.1529/biophysj.106.092650; Vogel SS, 2010, FLIM MICROSCOPY BIOL, P245; Vogel Steven S, 2006, Sci STKE, V2006, pre2; Volkmer A, 2000, BIOPHYS J, V78, P1589, DOI 10.1016/S0006-3495(00)76711-7; Wlodarczyk J, 2008, BIOPHYS J, V94, P986, DOI 10.1529/biophysj.107.111773; Yasuda R, 2006, NAT NEUROSCI, V9, P283, DOI 10.1038/nn1635; Yuan HF, 2011, PHYS CHEM CHEM PHYS, V13, P1762, DOI 10.1039/c0cp01772h	54	51	51	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49593	10.1371/journal.pone.0049593	http://dx.doi.org/10.1371/journal.pone.0049593			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152925	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600048
J	Lucek, K; Sivasundar, A; Seehausen, O				Lucek, Kay; Sivasundar, Arjun; Seehausen, Ole			Evidence of Adaptive Evolutionary Divergence during Biological Invasion	PLOS ONE			English	Article							THREESPINE STICKLEBACK; STREAM STICKLEBACK; GASTEROSTEUS-ACULEATUS; ANCESTRAL PLASTICITY; NATURAL-SELECTION; FRESH-WATER; GENE FLOW; DIVERSIFICATION; POPULATION; ADAPTATION	Rapid phenotypic diversification during biological invasions can either arise by adaptation to alternative environments or by adaptive phenotypic plasticity. Where experimental evidence for adaptive plasticity is common, support for evolutionary diversification is rare. Here, we performed a controlled laboratory experiment using full-sib crosses between ecologically divergent threespine stickleback populations to test for a genetic basis of adaptation. Our populations are from two very different habitats, lake and stream, of a recently invaded range in Switzerland and differ in ecologically relevant morphological traits. We found that in a lake-like food treatment lake fish grow faster than stream fish, resembling the difference among wild type individuals. In contrast, in a stream-like food treatment individuals from both populations grow similarly. Our experimental data suggest that genetically determined diversification has occurred within less than 140 years after the arrival of stickleback in our studied region.	[Lucek, Kay; Sivasundar, Arjun; Seehausen, Ole] Univ Bern, Inst Ecol & Evolut, Bern, Switzerland; [Lucek, Kay; Sivasundar, Arjun; Seehausen, Ole] EAWAG Swiss Fed Inst Aquat Sci & Technol, Dept Fish Ecol & Evolut, Ctr Ecol Evolut & Biogeochem, Kastanienbaum, Switzerland	University of Bern; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Lucek, K (corresponding author), Univ Bern, Inst Ecol & Evolut, Bern, Switzerland.	kay.lucek@eawag.ch	Lucek, Kay/AAC-9893-2021; Seehausen, Ole/C-8272-2011	Lucek, Kay/0000-0002-2253-2556; Seehausen, Ole/0000-0001-6598-1434	University of Bern, Switzerland; Swiss Federal Institute of Aquatic Science and Technology (EAWAG)	University of Bern, Switzerland; Swiss Federal Institute of Aquatic Science and Technology (EAWAG)	Funding was provided by the University of Bern, Switzerland and the Swiss Federal Institute of Aquatic Science and Technology (EAWAG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Adachi T, 2012, ECOL EVOL, V2, P1083, DOI 10.1002/ece3.234; Baker JA, 2005, EVOL ECOL RES, V7, P121; Barrett RDH, 2008, SCIENCE, V322, P255, DOI 10.1126/science.1159978; Bell MA, 2004, EVOLUTION, V58, P814; Berner D, 2010, MOL ECOL, V19, P4963, DOI 10.1111/j.1365-294X.2010.04858.x; Bolnick DI, 2008, AM NAT, V172, P1, DOI 10.1086/587805; DAY T, 1994, EVOLUTION, V48, P1723, DOI 10.1111/j.1558-5646.1994.tb02208.x; Frommen JG, 2011, EVOL ECOL, V25, P641, DOI 10.1007/s10682-010-9454-6; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Hendry AP, 2002, EVOLUTION, V56, P1199; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Keller SR, 2008, ECOL LETT, V11, P852, DOI 10.1111/j.1461-0248.2008.01188.x; Kristjansson BK, 2005, ENVIRON BIOL FISH, V74, P357, DOI 10.1007/s10641-005-1487-2; Lavergne S, 2007, P NATL ACAD SCI USA, V104, P3883, DOI 10.1073/pnas.0607324104; Le Rouzic A, 2011, MOL ECOL, V20, P2483, DOI 10.1111/j.1365-294X.2011.05071.x; Lucek K, 2010, MOL ECOL, V19, P3995, DOI 10.1111/j.1365-294X.2010.04781.x; Mathys BA, 2011, P ROY SOC B-BIOL SCI, V278, P2392, DOI 10.1098/rspb.2010.2302; Miler O, 2008, FUND APPL LIMNOL, V173, P187, DOI 10.1127/1863-9135/2008/0173-0187; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Pfennig DW, 2010, TRENDS ECOL EVOL, V25, P459, DOI 10.1016/j.tree.2010.05.006; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Sharpe DMT, 2008, EVOL ECOL RES, V10, P849; Vellend M, 2007, TRENDS ECOL EVOL, V22, P481, DOI 10.1016/j.tree.2007.02.017; Wund MA, 2008, AM NAT, V172, P449, DOI 10.1086/590966; Wund MA, 2012, BIOL J LINN SOC, V105, P573, DOI 10.1111/j.1095-8312.2011.01815.x; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x	28	31	31	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49377	10.1371/journal.pone.0049377	http://dx.doi.org/10.1371/journal.pone.0049377			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152900	Green Published, Green Accepted, gold			2022-12-27	WOS:000311234000066
J	Scherpenisse, M; Mollers, M; Schepp, RM; Boot, HJ; Meijer, CJLM; Berbers, GAM; van der Klis, FRM; de Melker, HE				Scherpenisse, Mirte; Mollers, Madelief; Schepp, Rutger M.; Boot, Hein J.; Meijer, Chris J. L. M.; Berbers, Guy A. M.; van der Klis, Fiona R. M.; de Melker, Hester E.			Changes in Antibody Seroprevalence of Seven High-Risk HPV Types between Nationwide Surveillance Studies from 1995-96 and 2006-07 in The Netherlands	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS TYPES; SEXUALLY-TRANSMITTED-DISEASES; TIME TRENDS; CERVICAL NEOPLASIA; PRIMIPAROUS WOMEN; NATURAL-HISTORY; PREVALENCE; INFECTION; STABILITY; HEALTH	Objective: This study evaluates trends in antibody seroprevalences of seven high-risk human papillomavirus (hr-HPV) serotypes (HPV16, 18, 31, 33, 45, 52, and 58) between the 1995-96 and 2006-07 sero-surveys among the Dutch general population in the pre-vaccination era. Methods: Serum samples of men and women (0-79 years of age) from two cross-sectional population-based serosurveillance studies performed in 1995-96 (n = 3303) and 2006-07 (n = 6384) were tested for HPV-specific antibodies in a VLP-based multiplex immunoassay. Results: HPV16-specific antibody seroprevalence increased during adolescence and shifted to younger ages in the 2006-07 survey compared to the 1995-96 survey. This step-up in HPV16 seroprevalence was most pronounced in women, while a more gradual increase was observed in men. Also in cohorts older than 49 years, HPV16 seroprevalence was higher in 2006-07 as compared to 1995-96 survey. A higher overall seroprevalence in individuals older than 15 years of age was found for HPV16, 18, 31 and 45 in 2006-07 as compared to 1995-96. For HPV33, 52 and 58 seroprevalences were comparable over this 11-year time period. Seropositivity for one or more HPV types was significantly higher in 2006-07 (23.1%) than in 1995-96 (20.0%) (p = 0.013). Multi-seropositivity increased from 7.1% in 1995-96 up to 10.2% in 2006-07 (p<0.0001). Differences in HPV seropositivity for at least one of the seven HPV types between both surveys could be explained in addition to demographic characteristics (age, sex, urbanization degree and ethnicity), also by changes in sexual behaviour (marital status, age of sexual debut and ever reported an STI). Conclusion: The observed increase in particular HPV16 seroprevalence could be due to changes in sexual behaviour over the years, and especially in age of sexual debut. Seroprevalence studies provide insight into the distribution of HPV types and infection dynamics in the general population over time, which is important to assess the impact of HPV-vaccination.	[Scherpenisse, Mirte; Schepp, Rutger M.; Boot, Hein J.; Berbers, Guy A. M.; van der Klis, Fiona R. M.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Mollers, Madelief; de Melker, Hester E.] Natl Inst Publ Hlth & Environm, Dept Epidemiol & Surveillance, NL-3720 BA Bilthoven, Netherlands; [Scherpenisse, Mirte; Mollers, Madelief; Meijer, Chris J. L. M.] Vrije Univ Amsterdam Med Ctr, Dept Pathol, Amsterdam, Netherlands	Netherlands National Institute for Public Health & the Environment; Netherlands National Institute for Public Health & the Environment; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Scherpenisse, M (corresponding author), Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands.	Mirte.Scherpenisse@rivm.nl			MSD [HPV01E]	MSD	This work was supported by an unrestricted grant of MSD (study code HPV01E). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Geijersstam V, 1998, J INFECT DIS, V177, P1710, DOI 10.1086/517428; [Anonymous], 2011, LANDELIJKE EVALUATIE; Antonsson A, 2010, VIROLOGY, V407, P26, DOI 10.1016/j.virol.2010.07.046; Anttila A, 1999, INT J CANCER, V83, P59, DOI 10.1002/(SICI)1097-0215(19990924)83:1<59::AID-IJC12>3.3.CO;2-E; ARMSTRONG BK, 1986, BRIT J CANCER, V54, P669, DOI 10.1038/bjc.1986.225; Austin PC, 2010, J CLIN EPIDEMIOL, V63, P2, DOI 10.1016/j.jclinepi.2008.11.004; Bodley-Tickell AT, 2008, SEX TRANSM INFECT, V84, P312, DOI 10.1136/sti.2007.027847; Brugman E., 1995, JEUGD SEKS 95 RESULT; Carter JJ, 2000, J INFECT DIS, V181, P1911, DOI 10.1086/315498; Castle PE, 2005, J INFECT DIS, V191, P1808, DOI 10.1086/428779; Dal Bello B, 2009, GYNECOL ONCOL, V115, P262, DOI 10.1016/j.ygyno.2009.07.029; De Melker HE, 1998, EPIDEMIOL INFECT, V121, P637, DOI 10.1017/S0950268898001587; Dillner J, 2000, J CLIN VIROL, V19, P7, DOI 10.1016/S1386-6532(00)00126-8; Einstein MH, 2009, LANCET INFECT DIS, V9, P347, DOI 10.1016/S1473-3099(09)70108-2; Hd Graaf, 2005, SEKS ONDER JE 25E SE; Heiligenberg M, 2010, SEX TRANSM DIS, V37, P672, DOI 10.1097/OLQ.0b013e3181e71069; Hemminki K, 2002, EUR J OBSTET GYN R B, V101, P64, DOI 10.1016/S0301-2115(01)00508-5; Ho GYF, 1998, NEW ENGL J MED, V338, P423, DOI 10.1056/NEJM199802123380703; Ivansson EL, 2009, INT J CANCER, V125, P2930, DOI 10.1002/ijc.24631; Jena AB, 2010, ANN INTERN MED, V153, P1, DOI 10.7326/0003-4819-153-1-201007060-00003; Kibur M, 2000, SEX TRANSM INFECT, V76, P13, DOI 10.1136/sti.76.1.13; Kramer M, 2010, SEX TRANSM INFECT, V86, P494, DOI 10.1136/sti.2009.041210; Laukkanen P, 2003, J GEN VIROL, V84, P2105, DOI 10.1099/vir.0.18995-0; Lazcano-Ponce E, 2001, INT J CANCER, V91, P412, DOI 10.1002/1097-0215(20010201)91:3&lt;412::AID-IJC1071&gt;3.0.CO;2-M; Li N, 2011, INT J CANCER, V128, P927, DOI 10.1002/ijc.25396; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Markowitz LE, 2009, J INFECT DIS, V200, P1059, DOI 10.1086/604729; Newall AT, 2008, CLIN INFECT DIS, V46, P1647, DOI 10.1086/587895; Nielsen A, 2011, INT J CANC; Poulos CA, 2008, J ELDER ABUSE NEGL, V20, P323, DOI 10.1080/08946560802359243; Rama CH, 2010, INT J GYNECOL CANCER, V20, P1405, DOI 10.1111/IGC.0b013e3181f3c85e; Scherpenisse M, 2012, VACCINE; Siebers AG, 2009, JAMA-J AM MED ASSOC, V302, P1757, DOI 10.1001/jama.2009.1569; Stanley Margaret, 2010, Infect Agent Cancer, V5, P19, DOI 10.1186/1750-9378-5-19; Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354; Syrjanen S, 2010, APMIS, V118, P494, DOI 10.1111/j.1600-0463.2010.02620.x; Vaccarella S, 2010, CANCER EPIDEM BIOMAR, V19, P2379, DOI 10.1158/1055-9965.EPI-10-0336; van der Klis FRM, 2009, NETH J MED, V67, P301; van Veen MG, 2009, AIDS CARE, V21, P683, DOI 10.1080/09540120802511984; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Woodman CBJ, 2007, NAT REV CANCER, V7, P11, DOI 10.1038/nrc2050	41	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48807	10.1371/journal.pone.0048807	http://dx.doi.org/10.1371/journal.pone.0048807			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152809	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000031
J	de Vienne, DM; Aze, J				de Vienne, Damien M.; Aze, Jerome			Efficient Prediction of Co-Complexed Proteins Based on Coevolution	PLOS ONE			English	Article							DATABASE; INFORMATION; SIMILARITY; ALIGNMENTS; INFERENCE; SELECTION	The prediction of the network of protein-protein interactions (PPI) of an organism is crucial for the understanding of biological processes and for the development of new drugs. Machine learning methods have been successfully applied to the prediction of PPI in yeast by the integration of multiple direct and indirect biological data sources. However, experimental data are not available for most organisms. We propose here an ensemble machine learning approach for the prediction of PPI that depends solely on features independent from experimental data. We developed new estimators of the coevolution between proteins and combined them in an ensemble learning procedure. We applied this method to a dataset of known co-complexed proteins in Escherichia coli and compared it to previously published methods. We show that our method allows prediction of PPI with an unprecedented precision of 95.5% for the first 200 sorted pairs of proteins compared to 28.5% on the same dataset with the previous best method. A close inspection of the best predicted pairs allowed us to detect new or recently discovered interactions between chemotactic components, the flagellar apparatus and RNA polymerase complexes in E. coli. Citation: de Vienne DM, Aze J (2012) Efficient Prediction of Co-Complexed Proteins Based on Coevolution. PLoS ONE 7(11): e48728. doi:10.1371/journal.pone.0048728	[de Vienne, Damien M.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona, Spain; [de Vienne, Damien M.] Univ Pompeu Fabra, Barcelona, Spain; [Aze, Jerome] Univ Paris 11, Rech Informat Lab, CNRS, UMR 8623, F-91405 Orsay, France	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	de Vienne, DM (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona, Spain.	damien.de-vienne@crg.es		de Vienne, Damien/0000-0001-9532-5251	Centre National de la Recherche Scientifique (CNRS) [UMR 8623]; University Paris-Sud 11; French National Agency for Research [ANR-05-MMSA-0009 MDMS NV 10]; ANR\Microbiogenomics	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); University Paris-Sud 11; French National Agency for Research(French National Research Agency (ANR)); ANR\Microbiogenomics(French National Research Agency (ANR))	The work was funded by the Centre National de la Recherche Scientifique (CNRS) (UMR 8623), the University Paris-Sud 11 and the French National Agency for Research (ANR-05-MMSA-0009 MDMS NV 10). DdV acknowledges a postodctoral grant from the ANR\Microbiogenomics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R., 1994, P 20 INT C VER LARG, P487; Leon E, 2009, NUCLEIC ACIDS RES, V37, pD629, DOI 10.1093/nar/gkn853; Az J., 2002, P 16 EUR M CYB SYST, V2, P781; BLOOM M, 1986, J BACTERIOL, V166, P380, DOI 10.1128/jb.166.2.380-384.1986; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/bf00058655; Brin S., 1997, SIGMOD REC, P265, DOI [DOI 10.1145/253262.253327, 10.1145/253260.253327]; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cohen J., 1960, ED PSYCHOL MEASUREME; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Craig RA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-6; Dandekar T, 1998, TRENDS BIOCHEM SCI, V23, P324, DOI 10.1016/S0968-0004(98)01274-2; Date SV, 2003, NAT BIOTECHNOL, V21, P1055, DOI 10.1038/nbt861; de Vienne DM, 2007, BIOINFORMATICS, V23, P3119, DOI 10.1093/bioinformatics/btm500; Delory M, 2006, J BACTERIOL, V188, P7707, DOI 10.1128/JB.00644-06; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Domigos P., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P155; Dzeroski Saso., 2002, P INT C MACHINE LEAR, P123; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ganascia JG, 1987, INT JOINT C ART INT, P345; Garcia-Jimenez B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009969; Goh CS, 2000, J MOL BIOL, V299, P283, DOI 10.1006/jmbi.2000.3732; Good IJ, 2003, ESTIMATION PROBABILI; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hanks P., 1990, COMPUT LINGUIST, V16, P22, DOI DOI 10.3115/981623.981633; Jaccard P., 1908, B SOC VAUD SCI N, V44, P223; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Juan D, 2008, P NATL ACAD SCI USA, V105, P934, DOI 10.1073/pnas.0709671105; Kann MG, 2007, PROTEINS, V67, P811, DOI 10.1002/prot.21347; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Lallich S, 2004, EVALUATION VALIDATIO; Lavrac N, 1999, LECT NOTES ARTIF INT, V1634, P174; Lin N, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-154; Loevinger J, 1947, PSYCHOL MONOGR, V61, P1; Lovell SC, 2010, MOL BIOL EVOL, V27, P2567, DOI 10.1093/molbev/msq144; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Pazos F, 2005, J MOL BIOL, V352, P1002, DOI 10.1016/j.jmb.2005.07.005; Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074; Pazos F, 2001, PROTEIN ENG, V14, P609, DOI 10.1093/protein/14.9.609; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Pearson K., 1900, CRITERION GIVEN SYST; Qi YJ, 2006, PROTEINS, V63, P490, DOI 10.1002/prot.20865; Qiu J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000054; Rajagopala SV, 2009, PROTEOMICS, V9, P5296, DOI 10.1002/pmic.200900282; Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Zhang T, 2000, LECT NOTES ARTIF INT, V1805, P245; Zhu XY, 1997, J BIOL CHEM, V272, P23758, DOI 10.1074/jbc.272.38.23758	49	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48728	10.1371/journal.pone.0048728	http://dx.doi.org/10.1371/journal.pone.0048728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152796	Green Published, gold, Green Submitted			2022-12-27	WOS:000312272600018
J	Malhotra, S; Zodpey, SP; Chandra, S; Vashist, RP; Satyanaryana, S; Zachariah, R; Harries, AD				Malhotra, Sumit; Zodpey, Sanjay P.; Chandra, Shivani; Vashist, Ram Pal; Satyanaryana, Srinath; Zachariah, Rony; Harries, Anthony D.			Should Sputum Smear Examination Be Carried Out at the End of the Intensive Phase and End of Treatment in Sputum Smear Negative Pulmonary TB Patients?	PLOS ONE			English	Article								Background: The Indian guidelines on following up sputum smear-negative Pulmonary tuberculosis (PTB) patients differ from the current World Health Organization (WHO) guidelines in that the former recommends two follow up sputum examinations (once at the end of intensive phase and the other at the end of treatment) while the latter recommends only one follow up sputum smear microscopy examination, which is done at the end of the intensive phase. This study was conducted to examine if there was any added value in performing an additional sputum smear examination at the end of treatment within the context of a national TB program. Methods: This study was a descriptive record based review conducted in nine tuberculosis (TB) units in Delhi, India. All consecutive new sputum smear-negative PTB patients registered in these nine TB units from 1st January 2009 to 31st December 2009 were included in the study. Results: Of 2567 new sputum smear-negative TB patients, 1973 (90%) had sputum specimens examined at the end of the intensive phase, of whom 36 (2%) were smear-positive: the majority (n = 28) successfully completed treatment with either the same or a re-treatment regimen. At treatment completion, 1766 (85%) patients had sputum specimens examined, of whom 16 (0.9%) were smear-positive: all these were changed to a re-treatment regimen. Amongst the sputum-positive patients identified as a result of follow up (n = 52), four were diagnosed with multi-drug resistant TB (MDR-TB), three of whom were detected after smear examination at the end of treatment. Conclusions: Given the high burden of TB in India, a 0.9% additional yield of smear-positive sputum smears at the end of treatment translates to 3,297 cases of smear-positive PTB. End-of-treatment smear is a low-yield strategy for detection of smear-positive TB cases, although further studies are needed to determine its population-level impact and cost, particularly in relation to other TB control interventions.	[Malhotra, Sumit] All India Inst Med Sci, New Delhi, India; [Zodpey, Sanjay P.] Publ Hlth Fdn India, New Delhi, India; [Chandra, Shivani; Vashist, Ram Pal] State TB Off, New Delhi, India; [Satyanaryana, Srinath] S E Asia Reg Off, Int Union TB & Lung Dis Union, New Delhi, India; [Zachariah, Rony] MSF Luxembourg, Brussels Operat Ctr, Med Dept Operat Res, Luxembourg, Luxembourg; [Harries, Anthony D.] Int Union TB & Lung Dis Union, Paris, France; [Harries, Anthony D.] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England	All India Institute of Medical Sciences (AIIMS) New Delhi; Public Health Foundation of India; Doctors Without Borders; University of London; London School of Hygiene & Tropical Medicine	Malhotra, S (corresponding author), All India Inst Med Sci, New Delhi, India.	drmalhotrasumit@gmail.com		zachariah, rony/0000-0002-2915-9328; Satyanarayana, Srinath/0000-0002-5420-2551	operational research course; Centre for Operational Research at The International Union Against Tuberculosis and Lung Disease (The Union); Public Health Foundation of India (PHFI)	operational research course; Centre for Operational Research at The International Union Against Tuberculosis and Lung Disease (The Union); Public Health Foundation of India (PHFI)	This research was supported through an operational research course which was funded through a memorandum of understanding between the Centre for Operational Research at The International Union Against Tuberculosis and Lung Disease (The Union) and the Public Health Foundation of India (PHFI). The course was facilitated by faculty from the PHFI, The Union and the Operational Research Unit, Medecins sans Frontieres, Brussels Operational Centre, Luxembourg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Central Tuberculosis Division, 2011, TB IND 2011 REV NAT; Central Tuberculosis Division, 2005, TECHN OP GUID TUB CO; Central Tuberculosis Division, 2008, REV SCHEM NGOS PRIV; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Satyanarayana S, 2011, PUBLIC HEALTH ACTION, V1, P27, DOI 10.5588/pha.11.0013; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; World Health Organization, 2010, GLOB TUB CONTR WHO R	8	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49238	10.1371/journal.pone.0049238	http://dx.doi.org/10.1371/journal.pone.0049238			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152880	Green Published, gold			2022-12-27	WOS:000312272600053
J	Shapiro, MM; Chakravartty, V; Cronan, JE				Shapiro, Madelyn M.; Chakravartty, Vandana; Cronan, John E.			Remarkable Diversity in the Enzymes Catalyzing the Last Step in Synthesis of the Pimelate Moiety of Biotin	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; FATTY-ACID SYNTHESIS; ESCHERICHIA-COLI; BIOH GENE; PROTEIN; BIOSYNTHESIS; DELETION; MUSCLE; COA	Biotin synthesis in Escherichia coli requires the functions of the bioH and bioC genes to synthesize the precursor pimelate moiety by use of a modified fatty acid biosynthesis pathway. However, it was previously noted that bioH has been replaced with bioG or bioK within the biotin synthetic gene clusters of other bacteria. We report that each of four BioG proteins from diverse bacteria and two cyanobacterial BioK proteins functionally replace E. coli BioH in vivo. Moreover, purified BioG proteins have esterase activity against pimeloyl-ACP methyl ester, the physiological substrate of BioH. Two of the BioG proteins block biotin synthesis when highly expressed and these toxic proteins were shown to have more promiscuous substrate specificities than the non-toxic BioG proteins. A postulated BioG-BioC fusion protein was shown to functionally replace both the BioH and BioC functions of E. coli. Although the BioH, BioG and BioK esterases catalyze a common reaction, the proteins are evolutionarily distinct. Citation: Shapiro MM, Chakravartty V, Cronan JE (2012) Remarkable Diversity in the Enzymes Catalyzing the Last Step in Synthesis of the Pimelate Moiety of Biotin. PLoS ONE 7(11): e49440. doi: 10.1371/journal.pone.0049440	[Shapiro, Madelyn M.; Chakravartty, Vandana; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, 131 Burrill Hall, Urbana, IL 61801 USA.	j-cronan@life.uiuc.edu	Cronan, John/V-6626-2019		NIH NIAID [AI15650]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI015650, R37AI015650] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding was provided by NIH NIAID AI15650. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal V, 2012, P NATL ACAD IN PRESS, V109; Akatsuka H, 2003, GENE, V302, P185, DOI 10.1016/S0378111902011502; Attwood PV, 2002, ACCOUNTS CHEM RES, V35, P113, DOI 10.1021/ar000049+; Balaban M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002420; BARKER DF, 1980, J BACTERIOL, V143, P789, DOI 10.1128/JB.143.2.789-800.1980; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; CLEARY PP, 1972, J BACTERIOL, V112, P830, DOI 10.1128/JB.112.2.830-839.1972; Cronan JE, 2006, PLASMID, V55, P152, DOI 10.1016/j.plasmid.2005.07.001; Cronan JE, 2002, J BIOL CHEM, V277, P22520, DOI 10.1074/jbc.M201249200; CRONAN JE, 1989, CELL, V58, P427, DOI 10.1016/0092-8674(89)90421-2; Cronan JE, 2009, METHOD ENZYMOL, V459, P395, DOI 10.1016/S0076-6879(09)04617-5; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flores H, 2012, PROTEIN ENG DES SEL, V25, P387, DOI 10.1093/protein/gzs035; Heikinheimo P, 1999, STRUCTURE, V7, pR141, DOI 10.1016/S0969-2126(99)80079-3; IFUKU O, 1994, EUR J BIOCHEM, V220, P585, DOI 10.1111/j.1432-1033.1994.tb18659.x; Jochens H, 2011, CHEMBIOCHEM, V12, P1508, DOI 10.1002/cbic.201000771; KNOWLES JR, 1989, ANNU REV BIOCHEM, V58, P195, DOI 10.1146/annurev.bi.58.070189.001211; Koga N, 1996, J FERMENT BIOENG, V81, P482, DOI 10.1016/0922-338X(96)81466-8; LEZIUS A, 1963, BIOCHEM Z, V336, P510; Lin S, 2012, J BIOL CHEM IN PRESS; Lin S, 2010, NAT CHEM BIOL, V6, P682, DOI [10.1038/nchembio.420, 10.1038/NCHEMBIO.420]; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Polgar L, 2005, CELL MOL LIFE SCI, V62, P2161, DOI 10.1007/s00018-005-5160-x; Rodionov DA, 2002, GENOME RES, V12, P1507, DOI 10.1101/gr.314502; Sanishvili R, 2003, J BIOL CHEM, V278, P26039, DOI 10.1074/jbc.M303867200; SANYAL I, 1994, J AM CHEM SOC, V116, P2637, DOI 10.1021/ja00085a061; SCHWARTZ M, 1966, J BACTERIOL, V92, P1083, DOI 10.1128/JB.92.4.1083-1089.1966; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomczyk NH, 2002, FEBS LETT, V513, P299, DOI 10.1016/S0014-5793(02)02342-6; Xie XK, 2007, METAB ENG, V9, P379, DOI 10.1016/j.ymben.2007.05.006	32	24	37	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49440	10.1371/journal.pone.0049440	http://dx.doi.org/10.1371/journal.pone.0049440			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152908	Green Published, Green Submitted, gold			2022-12-27	WOS:000312272600061
J	Zhang, H; John, R; Peng, ZC; Yuan, JL; Chu, CJ; Du, GZ; Zhou, SR				Zhang, Hui; John, Robert; Peng, Zechen; Yuan, Jianli; Chu, Chengjin; Du, Guozhen; Zhou, Shurong			The Relationship between Species Richness and Evenness in Plant Communities along a Successional Gradient: A Study from Sub-Alpine Meadows of the Eastern Qinghai-Tibetan Plateau, China	PLOS ONE			English	Article							OLD-FIELD SUCCESSION; LEAF-AREA; FUNCTIONAL TRAITS; DIVERSITY; PATTERNS; NICHE; ABUNDANCE; DYNAMICS; INDEXES; ACCUMULATION	The relationship between species richness and evenness across communities remains an unsettled issue in ecology from both theoretical and empirical perspectives. As a result, we do not know the mechanisms that could generate a relationship between species richness and evenness, and how this responds to spatial scale. Here we examine the relationship between species richness(S) and evenness (Pielou's J' evenness) using a chronosequence of successional sub-alpine meadow communities in the eastern Qinghai-Tibetan Plateau. These meadows range from natural community (never farmed), to those that have been protected from agricultural exploitation for periods ranging from 1 to 10 years. A total of 30 sampling quadrats with size of 0.5 m x 0.5 m were laid out along two transects at each meadow. Using correlation analyses we found a consistent negative correlation between S and J' in these communities along the successional gradient at the sampling scale of 0.5 m x 0.5 m. We also explored the relationship between S and J' at different sampling scales (from 0.5 m x 0.5 m to 10 m x 10 m) using properly measured ramet-mapped data of a10 m x 10 m quadrat in the natural community. We found that S was negatively corrected with J' at the scales of 0.5 m x 0.5 m to 2 m x 2 m, but such a relationships disappeared at relative larger scales (>= 2 m x 4 m). When fitting different species abundance models combined with trait-specific methods, we found that niche preemption may be the determining mechanism of species evenness along the succession gradient. Considering all results together, we can conclude that such niche differentiation and spatial scale effects may help to explain the maintenance of high species richness in sub-alpine meadow communities. Citation: Zhang H, John R, Peng Z, Yuan J, Chu C, et al. (2012) The Relationship between Species Richness and Evenness in Plant Communities along a Successional Gradient: A Study from Sub-Alpine Meadows of the Eastern Qinghai-Tibetan Plateau, China. PLoS ONE 7(11): e49024. doi:10.1371/journal.pone.0049024	[Zhou, Shurong] Fudan Univ, Sch Life Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200433, Peoples R China; [John, Robert] Indian Inst Sci Educ & Res, Dept Biol Sci, Kolkata, W Bengal, India; [Zhang, Hui; Peng, Zechen; Yuan, Jianli; Chu, Chengjin; Du, Guozhen] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland Farming Syst, Lanzhou 730000, Gansu, Peoples R China	Fudan University; Indian Institute of Science Education & Research (IISER) - Kolkata; Lanzhou University	Zhou, SR (corresponding author), Fudan Univ, Sch Life Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200433, Peoples R China.	zhshrong@fudan.edu.cn	Chu, Chu/T-6038-2019	Chu, Chengjin/0000-0002-0606-449X; Zhou, Shurong/0000-0002-7093-1703	Natural Science Foundation of China (NSFC) [31170355, 30970314]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by Natural Science Foundation of China (NSFC) No. 31170355 and No. 30970314. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 2006, AM NAT, V167, P329, DOI 10.1086/499382; ALLEN JC, 1979, AGR METEOROL, V20, P411, DOI 10.1016/0002-1571(79)90016-5; ARMESTO JJ, 1985, ECOLOGY, V66, P230, DOI 10.2307/1941323; Arrhenius O, 1921, J ECOL, V9, P95, DOI 10.2307/2255763; Ashton IW, 2010, ECOLOGY, V91, P3252, DOI 10.1890/09-1849.1; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; BERENDSE F, 1990, J ECOL, V78, P413, DOI 10.2307/2261121; Burns KC, 2004, DIVERS DISTRIB, V10, P105, DOI 10.1111/j.1366-9516.2004.00058.x; Chu CJ, 2007, ANN BOT-LONDON, V100, P807, DOI 10.1093/aob/mcm166; Cingolani AM, 2005, J APPL ECOL, V42, P50, DOI 10.1111/j.1365-2664.2004.00978.x; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Crawley Michael J., 1997, P475; Dahlgren JP, 2006, J VEG SCI, V17, P577, DOI 10.1111/j.1654-1103.2006.tb02481.x; DEBENEDI.PA, 1973, AM NAT, V107, P295, DOI 10.1086/282831; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Douma JC, 2012, J ECOL, V100, P366, DOI 10.1111/j.1365-2745.2011.01932.x; Garnier E, 2004, ECOLOGY, V85, P2630, DOI 10.1890/03-0799; Gibson DJ, 2005, J VEG SCI, V16, P415, DOI 10.1111/j.1654-1103.2005.tb02381.x; Gleason HA, 1922, ECOLOGY, V3, P158, DOI 10.2307/1929150; GLEESON SK, 1990, ECOLOGY, V71, P1144, DOI 10.2307/1937382; Gosselin F, 2006, J THEOR BIOL, V242, P591, DOI 10.1016/j.jtbi.2006.04.017; Grime JP, 1997, J ECOL, V85, P97, DOI 10.2307/2960631; Hamer KC, 2000, CONSERV BIOL, V14, P1435, DOI 10.1046/j.1523-1739.2000.99417.x; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; INOUYE RS, 1987, ECOLOGY, V68, P12, DOI 10.2307/1938801; JOST L, 2010, DIVERSITY-BASEL, V2, P207, DOI [DOI 10.3390/d2020207, 10.3390/d2020207]; Kardol P, 2012, OIKOS, V10, P121; Kindt R, 2005, TREE DIVERSITY ANAL; Knops JMH, 2000, ECOLOGY, V81, P88, DOI 10.1890/0012-9658(2000)081[0088:DOSNAC]2.0.CO;2; Kraft NJB, 2008, SCIENCE, V322, P580, DOI 10.1126/science.1160662; Krebs CJ., 1999, ECOLOGICAL METHODOLO; Legendre P., 1998, NUMERICAL ECOLOGY; Li XL, 2011, LAND DEGRAD DEV, V10, P13; Lu YH, 2011, ENVIRON MANAGE, V48, P13, DOI 10.1007/s00267-011-9684-6; Magurran A.E., 1988, ECOLOGICAL DIVERSITY; MAY RM, 1972, P NATL ACAD SCI USA, V69, P1109, DOI 10.1073/pnas.69.5.1109; McGill B, 2003, OIKOS, V102, P679, DOI 10.1034/j.1600-0706.2003.12617.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; MCNAUGHTON SJ, 1977, AM NAT, V111, P515, DOI 10.1086/283181; MELLINGER MV, 1975, ECOL MONOGR, V45, P161, DOI 10.2307/1942405; ODUM EP, 1969, SCIENCE, V164, P262, DOI 10.1126/science.164.3877.262; Pielou E. C., 1975, ECOLOGICAL DIVERSITY; Rainey PB, 1998, NATURE, V394, P69, DOI 10.1038/27900; SHELDON AL, 1969, ECOLOGY, V50, P466, DOI 10.2307/1933900; Shipley B, 2006, ECOLOGY, V87, P535, DOI 10.1890/05-1051; Shipley B, 2006, SCIENCE, V314, P812, DOI 10.1126/science.1131344; Smith B, 1996, OIKOS, V76, P70, DOI 10.2307/3545749; Soininen J, 2011, OECOLOGIA, V107, P1; Stirling G, 2001, AM NAT, V158, P286, DOI 10.1086/321317; Symonds MRE, 2008, AM NAT, V171, P480, DOI 10.1086/528960; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tognetti PM, 2005, BIOL INVASIONS, V11, P1; TOKESHI M, 1993, ADV ECOL RES, V24, P111, DOI 10.1016/S0065-2504(08)60042-2; Wilsey BJ, 2005, ECOLOGY, V86, P1178, DOI 10.1890/04-0394; Wilsey BJ, 2000, ECOLOGY, V81, P887, DOI 10.1890/0012-9658(2000)081[0887:BAEFIO]2.0.CO;2; Wilson JB, 1999, J VEG SCI, V10, P463, DOI 10.2307/3237181; Wilson PJ, 1999, NEW PHYTOL, V143, P155, DOI 10.1046/j.1469-8137.1999.00427.x; Wootton JT, 2005, NATURE, V433, P309, DOI 10.1038/nature03211; Young TP, 2001, ECOL RESTOR, V19, P5, DOI [10.3368/er.19.1.5, DOI 10.3368/ER.19.1.5]	63	24	25	8	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49024	10.1371/journal.pone.0049024	http://dx.doi.org/10.1371/journal.pone.0049024			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152845	gold, Green Submitted, Green Published			2022-12-27	WOS:000312272600038
J	Binda, P; Morrone, MC; Bremmer, F				Binda, Paola; Morrone, M. Concetta; Bremmer, Frank			Saccadic Compression of Symbolic Numerical Magnitude	PLOS ONE			English	Article							EYE-MOVEMENTS; VISUAL SPACE; NUMBER; TIME; REPRESENTATION; COMMON; POSITION	Stimuli flashed briefly around the time of saccadic eye movements are subject to complex distortions: compression of space and time; underestimate of numerosity. Here we show that saccadic distortions extend to abstract quantities, affecting the representation of symbolic numerical magnitude. Subjects consistently underestimated the results of rapidly computed mental additions and subtractions, when the operands were briefly displayed before a saccade. However, the recognition of the number symbols was unimpaired. These results are consistent with the hypothesis of a common, abstract metric encoding magnitude along multiple dimensions. They suggest that a surprising link exists between the preparation of action and the representation of abstract quantities.	[Binda, Paola; Morrone, M. Concetta] Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy; [Binda, Paola] Univ Washington, Dept Psychol, Seattle, WA 98195 USA; [Morrone, M. Concetta] Sci Inst Stella Maris, Pisa, Italy; [Bremmer, Frank] Univ Marburg, Dept Neurophys, Marburg, Germany	University of Pisa; University of Washington; University of Washington Seattle; IRCCS Fondazione Stella Maris; Philipps University Marburg	Binda, P (corresponding author), Univ Pisa, Dept Translat Res New Technol Med & Surg, Pisa, Italy.	pbinda1@uw.edu	Bremmer, Frank/F-3268-2012; Morrone, Maria Concetta/C-6756-2014; Binda, Paola/Q-6196-2016	Bremmer, Frank/0000-0003-1597-7407; Morrone, Maria Concetta/0000-0002-1025-0316; Binda, Paola/0000-0002-7200-353X	Marie Curie International Outgoing Fellowship (project AWESoMe, 7th European Community Framework Programme); European Research Council (project STANIB, 7th European Community Framework Programme); Deutsche Forschungsgemeinschaft [FOR 560]; Italian Ministry of University and Research (PRIN)	Marie Curie International Outgoing Fellowship (project AWESoMe, 7th European Community Framework Programme); European Research Council (project STANIB, 7th European Community Framework Programme); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Italian Ministry of University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This research was funded by: Marie Curie International Outgoing Fellowship to PB (project AWESoMe, 7th European Community Framework Programme) (http://cordis.europa.eu/fp7/mariecurieactions/), European Research Council (project STANIB, 7th European Community Framework Programme) (http://erc.europa.eu/), the Deutsche Forschungsgemeinschaft (FOR 560) (http://www.dfg.de/en/index.jsp), and the Italian Ministry of University and Research (PRIN 2009) (http://prin.miur.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCRAFT MH, 1981, MEM COGNITION, V9, P185, DOI 10.3758/BF03202334; Binda P, 2011, VISION RES, V51, P34, DOI 10.1016/j.visres.2010.09.028; BRIDGEMAN B, 1994, BEHAV BRAIN SCI, V17, P247, DOI 10.1017/S0140525X00034361; Burr DC, 2010, TRENDS COGN SCI, V14, P528, DOI 10.1016/j.tics.2010.09.005; Cantlon JF, 2009, TRENDS COGN SCI, V13, P83, DOI 10.1016/j.tics.2008.11.007; Cicchini GM, 2009, J VISION, V9, DOI 10.1167/9.1.9; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Dehaene S, 1999, SCIENCE, V284, P970, DOI 10.1126/science.284.5416.970; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; Deubel H, 2002, PROG BRAIN RES, V140, P165; Deubel H, 1996, VISION RES, V36, P1827, DOI 10.1016/0042-6989(95)00294-4; DUHAMEL JR, 1992, SCIENCE, V255, P90, DOI 10.1126/science.1553535; Eger E, 2009, CURR BIOL, V19, P1608, DOI 10.1016/j.cub.2009.08.047; Gallistel CR, 2000, TRENDS COGN SCI, V4, P59, DOI 10.1016/S1364-6613(99)01424-2; Hubbard EM, 2005, NAT REV NEUROSCI, V6, P435, DOI 10.1038/nrn1684; Irwin DE, 2007, PERCEPT PSYCHOPHYS, V69, P450, DOI 10.3758/BF03193765; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Knops A, 2009, ATTEN PERCEPT PSYCHO, V71, P803, DOI 10.3758/APP.71.4.803; Loetscher T, 2010, CURR BIOL, V20, pR264, DOI 10.1016/j.cub.2010.01.015; MATIN E, 1993, PERCEPT PSYCHOPHYS, V53, P372, DOI 10.3758/BF03206780; Morrone MC, 2005, NAT NEUROSCI, V8, P950, DOI 10.1038/nn1488; MOYER RS, 1967, NATURE, V215, P1519, DOI 10.1038/2151519a0; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Ross J, 1997, NATURE, V386, P598, DOI 10.1038/386598a0; SPERRY RW, 1950, J COMP PHYSIOL PSYCH, V43, P482, DOI 10.1037/h0055479; Stanescu-Cosson R, 2000, BRAIN, V123, P2240, DOI 10.1093/brain/123.11.2240; Stoianov Ivilin, 2004, Cortex, V40, P194, DOI 10.1016/S0010-9452(08)70948-1; Verguts T, 2004, J COGNITIVE NEUROSCI, V16, P1493, DOI 10.1162/0898929042568497; VONHOLST E, 1950, NATURWISSENSCHAFTEN, V37, P464, DOI 10.1007/BF00622503; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; WATSON AB, 1983, PERCEPT PSYCHOPHYS, V33, P113, DOI 10.3758/BF03202828; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1314, DOI 10.3758/BF03194545; Zorzi M., 2005, HDB MATH COGNITION, V19, P67	33	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49587	10.1371/journal.pone.0049587	http://dx.doi.org/10.1371/journal.pone.0049587			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166720	Green Submitted, gold, Green Published			2022-12-27	WOS:000311272300056
J	Boran, ADW; Seco, J; Jayaraman, V; Jayaraman, G; Zhao, S; Reddy, S; Chen, YB; Iyengar, R				Boran, Aislyn D. W.; Seco, Joseph; Jayaraman, Vinodh; Jayaraman, Gomathi; Zhao, Shan; Reddy, Sushmitha; Chen, Yibang; Iyengar, Ravi			A Potential Peptide Therapeutic Derived from the Juxtamembrane Domain of the Epidermal Growth Factor Receptor	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; EGF RECEPTOR; LUNG-CANCER; ACTIVATION; RESISTANCE; EXPRESSION; MUTATION; REGION; PHOSPHORYLATION; TRANSDUCTION	The epidermal growth factor receptor (EGFR) is involved in many cancers and EGFR has been heavily pursued as a drug target. Drugs targeting EGFR have shown promising clinical results for several cancer types. However, resistance to EGFR inhibitors often occurs, such as with KRAS mutant cancers, therefore new methods of targeting EGFR are needed. The juxtamembrane (JXM) domain of EGFR is critical for receptor activation and targeting this region could potentially be a new method of inhibiting EGFR. We hypothesized that the structural role of the JXM region could be mimicked by peptides encoding a JXM amino acid sequence, which could interfere with EGFR signaling and consequently could have anti-cancer activity. A peptide encoding EGFR 645-662 conjugated to the Tat sequence (TE-64562) displayed anti-cancer activity in multiple human cancer cell types with diminished activity in non-EGFR expressing cells and non-cancerous cells. In nude mice, TE-64562 delayed MDA-MB-231 tumor growth and prolonged survival, without inducing toxicity. TE-64562 induced non-apoptotic cell death after several hours and caspase-3-mediated apoptotic cell death with longer treatment. Mechanistically, TE-64562 bound to EGFR, inhibited its dimerization and caused its down-regulation. TE-64562 reduced phosphorylated and total EGFR levels but did not inhibit kinase activity and instead prolonged it. Our analysis of patient data from The Cancer Genome Atlas supported the hypothesis that down-regulation of EGFR is a potential therapeutic strategy, since phospho- and total-EGFR levels were strongly correlated in a large majority of patient tumor samples, indicating that lower EGFR levels are associated with lower phospho-EGFR levels and presumably less proliferative signals in breast cancer. Akt and Erk were inhibited by TE-64562 and this inhibition was observed in vivo in tumor tissue upon treatment with TE-64562. These results are the first to indicate that the JXM domain of EGFR is a viable drug target for several cancer types.	[Boran, Aislyn D. W.; Seco, Joseph; Jayaraman, Vinodh; Jayaraman, Gomathi; Zhao, Shan; Reddy, Sushmitha; Chen, Yibang; Iyengar, Ravi] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Iyengar, R (corresponding author), Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA.	ravi.iyengar@mssm.edu			National Institutes of Health [GM-54508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (Grant number GM-54508). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 2009, CANCER LETT, V277, P108, DOI 10.1016/j.canlet.2008.11.034; Aifa S, 2005, EXP CELL RES, V302, P108, DOI 10.1016/j.yexcr.2004.08.032; Bennasroune A, 2004, MOL BIOL CELL, V15, P3464, DOI 10.1091/mbc.E03-10-0753; Burgess AW, 2008, GROWTH FACTORS, V26, P263, DOI 10.1080/08977190802312844; CHEN P, 1994, J CELL BIOL, V127, P847, DOI 10.1083/jcb.127.3.847; Console S, 2003, J BIOL CHEM, V278, P35109, DOI 10.1074/jbc.M301726200; De Roock W, 2010, JAMA-J AM MED ASSOC, V304, P1812, DOI 10.1001/jama.2010.1535; deFazio A, 2000, INT J CANCER, V87, P487, DOI 10.1002/1097-0215(20000815)87:4<487::AID-IJC5>3.0.CO;2-J; Garbe JC, 2007, CELL CYCLE, V6, P1927, DOI 10.4161/cc.6.15.4519; Giovannini MG, 2001, J NEUROSCI, V21, P7053, DOI 10.1523/JNEUROSCI.21-18-07053.2001; HAMMOND SL, 1984, P NATL ACAD SCI-BIOL, V81, P5435, DOI 10.1073/pnas.81.17.5435; Janmaat ML, 2005, MOL PHARMACOL, V68, P502, DOI 10.1124/mol.105.011361; Johnston JB, 2006, CURR MED CHEM, V13, P3483, DOI 10.2174/092986706779026174; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; LOFTS FJ, 1993, ONCOGENE, V8, P2813; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; Martin-Nieto J, 1998, BIOCHEMISTRY-US, V37, P227, DOI 10.1021/bi971765v; Michailidis IE, 2011, PFLUG ARCH EUR J PHY, V461, P387, DOI 10.1007/s00424-010-0904-3; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pines G, 2010, FEBS LETT, V584, P2699, DOI 10.1016/j.febslet.2010.04.019; PRUSS RM, 1977, P NATL ACAD SCI USA, V74, P3918, DOI 10.1073/pnas.74.9.3918; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Ronai Z, 1999, ONCOGENE, V18, P6084, DOI 10.1038/sj.onc.1203175; Rosette C, 1996, SCIENCE, V274, P1194, DOI 10.1126/science.274.5290.1194; Rusnak DW, 2007, CELL PROLIFERAT, V40, P580, DOI 10.1111/j.1365-2184.2007.00455.x; Sato T, 2006, BIOCHEMISTRY-US, V45, P12704, DOI 10.1021/bi061264m; Schaefer KL, 2006, NEOPLASIA, V8, P613, DOI 10.1593/neo.06238; Schoeberl B, 2010, CANCER RES, V70, P2485, DOI 10.1158/0008-5472.CAN-09-3145; Stampfer MR, 2003, CANCER LETT, V194, P199, DOI 10.1016/S0304-3835(02)00707-3; STAMPFER MR, 1982, IN VITRO CELL DEV B, V18, P531; Takeuchi K, 2010, FEBS J, V277, P316, DOI 10.1111/j.1742-4658.2009.07450.x; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; Vakiani E, 2011, J PATHOL, V223, P219, DOI 10.1002/path.2796; Verneris MR, 2005, CLIN CANCER RES, V11, P4561, DOI 10.1158/1078-0432.CCR-05-0157; Wang LM, 1998, P NATL ACAD SCI USA, V95, P6809, DOI 10.1073/pnas.95.12.6809; Watanabe T, 2005, BIOCHEM BIOPH RES CO, V333, P562, DOI 10.1016/j.bbrc.2005.05.151; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	40	18	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49702	10.1371/journal.pone.0049702	http://dx.doi.org/10.1371/journal.pone.0049702			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166750	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300068
J	Chen, WP; Xie, T; Shao, YC; Chen, FS				Chen, Wanping; Xie, Ting; Shao, Yanchun; Chen, Fusheng			Phylogenomic Relationships between Amylolytic Enzymes from 85 Strains of Fungi	PLOS ONE			English	Article							ALPHA-AMYLASE FAMILY; CARBOHYDRATE-BINDING MODULE; STARCH-BINDING; RHIZOPUS-ORYZAE; FERMENTATION CHARACTERISTICS; LIPOMYCES-KONONENKOAE; EVOLUTION; SEQUENCE; GLUCOAMYLASE; DOMAIN	Fungal amylolytic enzymes, including alpha-amylase, gluocoamylase and alpha-glucosidase, have been extensively exploited in diverse industrial applications such as high fructose syrup production, paper making, food processing and ethanol production. In this paper, amylolytic genes of 85 strains of fungi from the phyla Ascomycota, Basidiomycota, Chytridiomycota and Zygomycota were annotated on the genomic scale according to the classification of glycoside hydrolase (GH) from the Carbohydrate-Active enZymes (CAZy) Database. Comparisons of gene abundance in the fungi suggested that the repertoire of amylolytic genes adapted to their respective lifestyles. Amylolytic enzymes in family GH13 were divided into four distinct clades identified as heterologous alpha-amylases, eukaryotic alpha-amylases, bacterial and fungal alpha-amylases and GH13 alpha-glucosidases. Family GH15 had two branches, one for gluocoamylases, and the other with currently unknown function. GH31 alpha-glucosidases showed diverse branches consisting of neutral alpha-glucosidases, lysosomal acid alpha-glucosidases and a new clade phylogenetically related to the bacterial counterparts. Distribution of starch-binding domains in above fungal amylolytic enzymes was related to the enzyme source and phylogeny. Finally, likely scenarios for the evolution of amylolytic enzymes in fungi based on phylogenetic analyses were proposed. Our results provide new insights into evolutionary relationships among subgroups of fungal amylolytic enzymes and fungal evolutionary adaptation to ecological conditions.	[Chen, Fusheng] Huazhong Agr Univ, Natl Key Lab Agromicrobiol, Wuhan, Hubei Province, Peoples R China; [Shao, Yanchun; Chen, Fusheng] Huazhong Agr Univ, Minist Educ, Key Lab Environm Correlat Dietol, Wuhan, Hubei Province, Peoples R China; [Chen, Wanping; Xie, Ting; Shao, Yanchun; Chen, Fusheng] Huazhong Agr Univ, Coll Food Sci & Technol, Wuhan, Hubei Province, Peoples R China	Huazhong Agricultural University; Huazhong Agricultural University; Huazhong Agricultural University	Chen, FS (corresponding author), Huazhong Agr Univ, Natl Key Lab Agromicrobiol, Wuhan, Hubei Province, Peoples R China.	chenfs@mail.hzau.edu.cn		Xie, Ting/0000-0002-6648-7697	National Natural Science Foundation of China [31171649]; Fundamental Research Funds for the Central Universities [52902-0900201123]; Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation [2012YB06]; National High Technology Research and Development Program of the People's Republic of China (863 Program) [2006AA10Z1A3]; Program for New Century Excellent Talents in University of the Ministry of Education of the People's Republic of China [NCET-05-0667]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation; National High Technology Research and Development Program of the People's Republic of China (863 Program)(National High Technology Research and Development Program of China); Program for New Century Excellent Talents in University of the Ministry of Education of the People's Republic of China(Program for New Century Excellent Talents in University (NCET))	This research work was financially supported by the National Natural Science Foundation of China (Program No. 31171649), the Fundamental Research Funds for the Central Universities (Program No. 52902-0900201123), the Huazhong Agricultural University Scientific and Technological Self-Innovation Foundation (2012YB06), the National High Technology Research and Development Program of the People's Republic of China (863 Program No. 2006AA10Z1A3) and Program for New Century Excellent Talents in University of the Ministry of Education of the People's Republic of China (NCET-05-0667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleshin AE, 2003, J MOL BIOL, V327, P61, DOI 10.1016/S0022-2836(03)00084-6; Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; ASHIKARI T, 1986, AGR BIOL CHEM TOKYO, V50, P957; Battaglia E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-38; Birol G, 1998, ENZYME MICROB TECH, V22, P672, DOI 10.1016/S0141-0229(97)00244-5; Blesak K, 2012, EXTREMOPHILES, V16, P497, DOI 10.1007/s00792-012-0449-9; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Chen WP, 2012, GENE, V497, P116, DOI 10.1016/j.gene.2012.01.016; Cheng J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030088, 10.1371/journal.pone.0042436]; Chou WI, 2006, BIOCHEM J, V396, P469, DOI 10.1042/BJ20051982; Christiansen C, 2009, FEBS J, V276, P5006, DOI 10.1111/j.1742-4658.2009.07221.x; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Coutinho PM, 1997, PROTEINS, V29, P334, DOI [10.1002/(SICI)1097-0134(199711)29:3<334::AID-PROT7>3.0.CO;2-A, 10.1002/(SICI)1097-0134(199711)29:3&lt;334::AID-PROT7&gt;3.0.CO;2-A]; Da Lage JL, 2004, CELL MOL LIFE SCI, V61, P97, DOI 10.1007/s00018-003-3334-y; Da Lage JL, 2002, BIOLOGIA, V57, P181; de Oliveira JMPF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020865; Eksteen JM, 2003, BIOTECHNOL BIOENG, V84, P639, DOI 10.1002/bit.10797; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Frandsen TP, 1998, PLANT MOL BIOL, V37, P1, DOI 10.1023/A:1005925819741; Gabrisko M, 2011, J MOL EVOL, V72, P104, DOI 10.1007/s00239-010-9406-3; Hata Y, 1997, J FERMENT BIOENG, V84, P532, DOI 10.1016/S0922-338X(97)81907-1; Horvathova V, 2001, GEN PHYSIOL BIOPHYS, V20, P7; Horvathova V, 2000, BIOLOGIA, V55, P605; Janecek S, 2003, EUR J BIOCHEM, V270, P635, DOI 10.1046/j.1432-1033.2003.03404.x; Janecek S, 1999, FEBS LETT, V456, P119, DOI 10.1016/S0014-5793(99)00919-9; Janecek S, 2002, BIOLOGIA, V57, P29; JANECEK S, 1994, EUR J BIOCHEM, V224, P519, DOI 10.1111/j.1432-1033.1994.00519.x; Janecek S, 1997, PROG BIOPHYS MOL BIO, V67, P67, DOI 10.1016/S0079-6107(97)00015-1; Janecek S, 2012, FEBS LETT; Janecek S, 2007, FEBS LETT, V581, P1261, DOI 10.1016/j.febslet.2007.02.036; Janecek S, 2011, ENZYME MICROB TECH, V49, P429, DOI 10.1016/j.enzmictec.2011.07.002; Jiang TY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041131; Knox AM, 2004, ENZYME MICROB TECH, V34, P453, DOI 10.1016/j.enzmictec.2003.12.010; Kobayashi T, 2007, BIOSCI BIOTECH BIOCH, V71, P646, DOI 10.1271/bbb.60550; Kumar V, 2011, BIOINFORMATION, V6, P61, DOI 10.6026/97320630006061; Kumar V, 2010, CARBOHYD RES, V345, P893, DOI 10.1016/j.carres.2010.02.007; Kuriki T, 1999, J BIOSCI BIOENG, V87, P557, DOI 10.1016/S1389-1723(99)80114-5; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li S, 2011, PROTEIN EXPRES PURIF, V79, P142, DOI 10.1016/j.pep.2011.05.007; Liu Y, 2012, MAR BIOTECHNOL, V14, P253, DOI 10.1007/s10126-011-9414-3; MacGregor EA, 2001, BBA-PROTEIN STRUCT M, V1546, P1, DOI 10.1016/S0167-4838(00)00302-2; Machovic M, 2005, FEBS J, V272, P5497, DOI 10.1111/j.1742-4658.2005.04942.x; Machovic M, 2003, BIOLOGIA, V58, P1127; Machovic M, 2006, FEBS LETT, V580, P6349, DOI 10.1016/j.febslet.2006.10.041; Machovic M, 2008, BIOLOGIA, V63, P1057, DOI 10.2478/s11756-008-0162-4; Maczkowiak F, 2006, GENETICA, V128, P145, DOI 10.1007/s10709-005-5578-y; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Nakamura T, 2006, BIOSCI BIOTECH BIOCH, V70, P2363, DOI 10.1271/bbb.50694; Papagianni M, 2004, BIOTECHNOL ADV, V22, P189, DOI 10.1016/j.biotechadv.2003.09.005; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Rigden DJ, 2002, FEBS LETT, V523, P17, DOI 10.1016/S0014-5793(02)02879-X; Rodriguez-Sanoja R, 2005, CURR OPIN MICROBIOL, V8, P260, DOI 10.1016/j.mib.2005.04.013; Sato A, 2011, DNA RES, V18, P165, DOI 10.1093/dnares/dsr009; Sauer J, 2000, BBA-PROTEIN STRUCT M, V1543, P275, DOI 10.1016/S0167-4838(00)00232-6; SOCCOL CR, 1994, J FOOD SCI TECH MYS, V31, P320; Stam MR, 2006, PROTEIN ENG DES SEL, V19, P555, DOI 10.1093/protein/gzl044; Sumitani J, 2000, BIOCHEM J, V350, P477, DOI 10.1042/0264-6021:3500477; Tsukagoshi N, 2001, J GEN APPL MICROBIOL, V47, P1, DOI 10.2323/jgam.47.1; Uma Maheswar Rao JL, 2011, MYCOFACTORIES, P3; van der Kaaij RM, 2007, MICROBIOL-SGM, V153, P4003, DOI 10.1099/mic.0.2007/008607-0; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; VIHINEN M, 1989, CRIT REV BIOCHEM MOL, V24, P329, DOI 10.3109/10409238909082556; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Yuan XL, 2008, MOL GENET GENOMICS, V279, P545, DOI 10.1007/s00438-008-0332-7	64	14	15	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49679	10.1371/journal.pone.0049679	http://dx.doi.org/10.1371/journal.pone.0049679			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166747	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300067
J	Liu, G; Huang, QQ; Lin, ZG; Huang, FF; Liao, HX; Peng, SL				Liu, Gang; Huang, Qiao-Qiao; Lin, Zhen-Guang; Huang, Fang-Fang; Liao, Hui-Xuan; Peng, Shao-Lin			High Tolerance to Salinity and Herbivory Stresses May Explain the Expansion of Ipomoea Cairica to Salt Marshes	PLOS ONE			English	Article							ENEMY RELEASE; SPARTINA-ALTERNIFLORA; COMPETITIVE ABILITY; INVASIVE PLANTS; DIFFERENT RESPONSES; MOLECULAR ANALYSIS; METHYL JASMONATE; ELYMUS-ATHERICUS; POPULATIONS; RESISTANCE	Background: Invasive plants are often confronted with heterogeneous environments and various stress factors during their secondary phase of invasion into more stressful habitats. A high tolerance to stress factors may allow exotics to successfully invade stressful environments. Ipomoea cairica, a vigorous invader in South China, has recently been expanding into salt marshes. Methodology/Principal Findings: To examine why this liana species is able to invade a stressful saline environment, we utilized I. cairica and 3 non-invasive species for a greenhouse experiment. The plants were subjected to three levels of salinity (i.e., watered with 0, 4 and 8 g L-1 NaCl solutions) and simulated herbivory (0, 25 and 50% of the leaf area excised) treatments. The relative growth rate (RGR) of I. cairica was significantly higher than the RGR of non-invasive species under both stress treatments. The growth performance of I. cairica was not significantly affected by either stress factor, while that of the non-invasive species was significantly inhibited. The leaf condensed tannin content was generally lower in I. cairica than in the non-invasive I. triloba and Paederia foetida. Ipomoea cairica exhibited a relatively low resistance to herbivory, however, its tolerance to stress factors was significantly higher than either of the non-invasive species. Conclusions/Significance: This is the first study examining the expansion of I. cairica to salt marshes in its introduced range. Our results suggest that the high tolerance of I. cairica to key stress factors (e. g., salinity and herbivory) contributes to its invasion into salt marshes. For I. cairica, a trade-off in resource reallocation may allow increased resources to be allocated to tolerance and growth. This may contribute to a secondary invasion into stressful habitats. Finally, we suggest that I. cairica could spread further and successfully occupy salt marshes, and countermeasures based on herbivory could be ineffective for controlling this invasion.	[Liu, Gang; Huang, Qiao-Qiao; Lin, Zhen-Guang; Huang, Fang-Fang; Liao, Hui-Xuan; Peng, Shao-Lin] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Liu, Gang; Huang, Qiao-Qiao; Lin, Zhen-Guang; Huang, Fang-Fang; Liao, Hui-Xuan; Peng, Shao-Lin] Sun Yat Sen Univ, Sch Life Sci, Guangdong Key Lab Plant Resources, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Qiao-Qiao] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Danzhou, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Chinese Academy of Tropical Agricultural Sciences	Peng, SL (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	lsspsl@mail.sysu.edu.cn	Liao, Huixuan/HDM-6510-2022	Liu, Gang/0000-0002-5633-4216	National Natural Science Foundation of China [31030015, U0633002]; Guangdong Natural Science Fund [9251027501000006]; Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Fund; Sun Yat-sen University	This work was supported by the National Natural Science Foundation of China (31030015; U0633002), the Guangdong Natural Science Fund (9251027501000006) and the Scientific Research Fund of Hongda Zhang, Sun Yat-sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam P, 2002, ENVIRON CONSERV, V29, P39, DOI 10.1017/S0376892902000048; Agrawal AA, 2005, ECOLOGY, V86, P2979, DOI 10.1890/05-0219; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; Arnold TA, 2008, AQUAT BOT, V89, P27, DOI 10.1016/j.aquabot.2008.02.001; Ashton IW, 2008, DIVERS DISTRIB, V14, P169, DOI 10.1111/j.1472-4642.2007.00425.x; Atala C, 2009, ACTA OECOL, V35, P236, DOI 10.1016/j.actao.2008.10.006; Baker H., 1986, ECOLOGY BIOL INVASIO, P44; Baldwin IT, 1996, ENTOMOL EXP APPL, V80, P213, DOI 10.1007/BF00194760; Beaton LL, 2011, OIKOS, V120, P1413, DOI 10.1111/j.1600-0706.2011.18893.x; Bellingham PJ, 2005, J VEG SCI, V16, P135, DOI 10.1111/j.1654-1103.2005.tb02347.x; BERTNESS MD, 1991, ECOLOGY, V72, P138, DOI 10.2307/1938909; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Bockelmann AC, 1999, J ECOL, V87, P503, DOI 10.1046/j.1365-2745.1999.00368.x; Boege K, 2005, AM J BOT, V92, P1632, DOI 10.3732/ajb.92.10.1632; Bultman TL, 2004, ECOLOGY, V85, P679, DOI 10.1890/03-0073; Burns JH, 2006, ECOL APPL, V16, P1367, DOI 10.1890/1051-0761(2006)016[1367:RAEATA]2.0.CO;2; Burns JH, 2004, DIVERS DISTRIB, V10, P387, DOI 10.1111/j.1366-9516.2004.00105.x; CHAPIN FS, 1993, AM NAT, V142, pS78, DOI 10.1086/285524; Chauhan BS, 2012, WEED SCI, V60, P199, DOI 10.1614/WS-D-11-00137.1; Cipollini D, 2005, J CHEM ECOL, V31, P1255, DOI 10.1007/s10886-005-5284-3; Cipollini D, 2003, BASIC APPL ECOL, V4, P79, DOI 10.1078/1439-1791-00134; Cipollini D, 2007, NEW PHYTOL, V173, P146, DOI 10.1111/j.1469-8137.2006.01882.x; [CJB-SANBI Conservatoire Et Jardin Botaniques de la Ville De Geneve and South African National Biodiversity Institute], 2007, AFR PLANT DAT VERS 3; Crous CJ, 2012, BIOL INVASIONS, V14, P619, DOI 10.1007/s10530-011-0103-y; D'Antonio C.M., 1999, ECOSYSTEMOSF DKTURBE, P413; Daehler CC, 2003, ANNU REV ECOL EVOL S, V34, P183, DOI 10.1146/annurev.ecolsys.34.011802.132403; Dietz H, 2006, ECOLOGY, V87, P1359, DOI 10.1890/0012-9658(2006)87[1359:RTCPCD]2.0.CO;2; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Eranen JK, 2009, J EVOLUTION BIOL, V22, P840, DOI 10.1111/j.1420-9101.2009.01684.x; Erfmeier A, 2011, BIOL INVASIONS, V13, P1599, DOI 10.1007/s10530-010-9917-2; FAO IAEA, 2000, QUANT TANN TREE FOL, P1; FARRIS MA, 1987, OECOLOGIA, V72, P434, DOI 10.1007/BF00377576; Feng YL, 2011, J ECOL, V99, P1116, DOI 10.1111/j.1365-2745.2011.01843.x; Feng YL, 2009, P NATL ACAD SCI USA, V106, P1853, DOI 10.1073/pnas.0808434106; Fornoni J, 2011, FUNCT ECOL, V25, P399, DOI 10.1111/j.1365-2435.2010.01805.x; Gianoli E, 2009, ACTA OECOL, V35, P752, DOI 10.1016/j.actao.2009.08.002; Goecker ME, 2005, MAR ECOL PROG SER, V286, P239, DOI 10.3354/meps286239; Grotkopp E, 2002, AM NAT, V159, P396, DOI 10.1086/338995; Holm L., 1997, WORLD WEEDS NATURAL; Hu YJ, 2001, ACTA SCI NATURALIUM, V40, P93; Huang QQ, 2009, BIODIVERS CONSERV, V18, P305, DOI 10.1007/s10531-008-9485-2; Huang W, 2010, J ECOL, V98, P1157, DOI 10.1111/j.1365-2745.2010.01704.x; Hunt R., 1990, Basic growth analysis.; IBCAS, 1974, FIELD GUID CHIN HIGH; Jiang LF, 2009, ESTUAR COAST SHELF S, V81, P74, DOI 10.1016/j.ecss.2008.09.018; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Karez R, 1998, OIKOS, V81, P471, DOI 10.2307/3546769; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kohi EM, 2010, AFR J ECOL, V48, P190, DOI 10.1111/j.1365-2028.2009.01099.x; Lee CE, 2003, PHYSIOL BIOCHEM ZOOL, V76, P296, DOI 10.1086/375433; Lefeuvre Jean-Claude, 2000, Wetlands Ecology and Management, V8, P147, DOI 10.1023/A:1008440401950; Liao YY, 2006, ACTA AGR JIANGXI, V6, P112; Lonsdale WM, 1999, ECOLOGY, V80, P1522, DOI 10.2307/176544; [马瑞燕 Ma Ruiyan], 2005, [应用与环境生物学报, Chinese Journal of Applied and Environmental Biology], V11, P246; Major IT, 2006, NEW PHYTOL, V172, P617, DOI 10.1111/j.1469-8137.2006.01877.x; Maron JL, 2001, OIKOS, V95, P361, DOI 10.1034/j.1600-0706.2001.950301.x; Mauricio R, 1997, EVOLUTION, V51, P1435, DOI [10.2307/2411196, 10.1111/j.1558-5646.1997.tb01467.x]; McCarthy BC., 1997, ASSESSMENT MANAGEMEN, DOI 10.1007/978-1-4612-1926-2_11; Muller-Scharer H, 2004, TRENDS ECOL EVOL, V19, P417, DOI 10.1016/j.tree.2004.05.010; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Murren CJ, 2005, EVOL ECOL, V19, P583, DOI 10.1007/s10682-005-2005-x; Pauchard A, 2009, FRONT ECOL ENVIRON, V7, P479, DOI 10.1890/080072; Pemberton RW, 2011, FLA ENTOMOL, V94, P112, DOI 10.1653/024.094.0116; PENNINGS SC, 1992, ECOLOGY, V73, P681, DOI 10.2307/1940774; Peters DJ, 2002, PLANT J, V32, P701, DOI 10.1046/j.1365-313X.2002.01458.x; Petillon J, 2005, BIOL CONSERV, V126, P103, DOI 10.1016/j.biocon.2005.05.003; Prasser N., 2010, Ecological Restoration, V28, P238; RAVEN JA, 1985, NEW PHYTOL, V101, P25, DOI 10.1111/j.1469-8137.1985.tb02816.x; Rejmanek M., 2005, Invasive alien species: a new synthesis, P161; REJMANEK M, 1995, PLANT INVASIONS, P3; Reynolds LV, 2010, J VEG SCI, V21, P733, DOI 10.1111/j.1654-1103.2010.01179.x; Richard S, 2000, PLANT CELL PHYSIOL, V41, P982, DOI 10.1093/pcp/pcd017; Rogers WE, 2004, J APPL ECOL, V41, P561, DOI 10.1111/j.0021-8901.2004.00914.x; ROSENTHAL JP, 1994, TRENDS ECOL EVOL, V9, P145, DOI 10.1016/0169-5347(94)90180-5; Rozema J, 1988, PLANT POPULATION ECO, P137; Salgado-Luarte C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011460; Schooler S, 2006, BIOL CONTROL, V36, P74, DOI 10.1016/j.biocontrol.2005.06.012; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Simms EL, 2000, EVOL ECOL, V14, P563, DOI 10.1023/A:1010956716539; Song LY, 2009, ACTA OECOL, V35, P128, DOI 10.1016/j.actao.2008.09.002; Stastny M, 2005, J ECOL, V93, P27, DOI 10.1111/j.1365-2745.2004.00962.x; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Sun Y, 2009, BIOL CONTROL, V48, P287, DOI 10.1016/j.biocontrol.2008.12.002; Thaler JS, 1996, J CHEM ECOL, V22, P1767, DOI 10.1007/BF02028503; Thomsen MS, 2007, BIOL INVASIONS, V9, P499, DOI 10.1007/s10530-006-9043-3; VALIELA I, 1979, NATURE, V280, P55, DOI 10.1038/280055a0; van Kleunen M, 2004, BASIC APPL ECOL, V5, P173, DOI 10.1078/1439-1791-00225; van Kleunen M, 2010, ECOL LETT, V13, P235, DOI 10.1111/j.1461-0248.2009.01418.x; Vasquez EA, 2005, MAR ECOL PROG SER, V298, P1, DOI 10.3354/meps298001; Vasquez EA, 2006, AM J BOT, V93, P1784, DOI 10.3732/ajb.93.12.1784; Vila M, 2005, OECOLOGIA, V142, P474, DOI 10.1007/s00442-004-1731-z; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Wang Y, 2011, ECOL APPL, V21, P729, DOI 10.1890/09-2406.1; Yokoi S., 2002, JIRCAS Working Report, P25; Zhu J., 2007, ENCY LIFE SCI, P1, DOI [10.1002/9780470015902.a0001300.pub2, DOI 10.1002/9780470015902.A0001300.PUB2]; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0; Zou JW, 2008, ECOGRAPHY, V31, P663, DOI 10.1111/j.0906-7590.2008.05540.x	97	17	24	2	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48829	10.1371/journal.pone.0048829	http://dx.doi.org/10.1371/journal.pone.0048829			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166596	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300016
J	Pai, AB; Patel, H; Prokopienko, AJ; Alsaffar, H; Gertzberg, N; Neumann, P; Punjabi, A; Johnson, A				Pai, Amy Barton; Patel, Heena; Prokopienko, Alexander J.; Alsaffar, Hiba; Gertzberg, Nancy; Neumann, Paul; Punjabi, Anjoli; Johnson, Arnold			Lipoteichoic Acid from Staphylococcus aureus Induces Lung Endothelial Cell Barrier Dysfunction: Role of Reactive Oxygen and Nitrogen Species	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INNATE IMMUNE-SYSTEM; TOLL-LIKE RECEPTORS; PROTEIN-KINASE-C; KAPPA-B ACTIVATION; TNF-ALPHA; NADPH OXIDASE; PEPTIDOGLYCAN; LIPOPOLYSACCHARIDE; PHOSPHORYLATION	Tunneled central venous catheters (TCVCs) are used for dialysis access in 82% of new hemodialysis patients and are rapidly colonized with Gram-positive organism (e. g. Staphylococcus aureus) biofilm, a source of recurrent infections and chronic inflammation. Lipoteichoic acid (LTA), a cell wall ribitol polymer from Gram-positive organisms, mediates inflammation through the Toll-like receptor 2 (TLR2). The effect of LTA on lung endothelial permeability is not known. We tested the hypothesis that LTA from Staphylococcus aureus induces alterations in the permeability of pulmonary microvessel endothelial monolayers (PMEM) that result from activation of TLR2 and are mediated by reactive oxygen/nitrogen species (RONS). The permeability of PMEM was assessed by the clearance rate of Evans blue-labeled albumin, the activation of the TLR2 pathway was assessed by Western blot, and the generation of RONS was measured by the fluorescence of oxidized dihydroethidium and a dichlorofluorescein derivative. Treatment with LTA or the TLR2 agonist Pam((3))CSK((4)) induced significant increases in albumin permeability, IkBa phosphorylation, IRAK1 degradation, RONS generation, and endothelial nitric oxide synthase (eNOS) activation (as measured by the p-eNOS(ser1177):p-eNOS(thr495) ratio). The effects on permeability and RONS were effectively prevented by co-administration of the superoxide scavenger Tiron, the peroxynitrite scavenger Urate, or the eNOS inhibitor L-NAME and these effects as well as eNOS activation were reduced or prevented by pretreatment with an IRAK1/4 inhibitor. The results indicate that the activation of TLR2 and the generation of ROS/RNS mediates LTA-induced barrier dysfunction in PMEM.	[Pai, Amy Barton; Patel, Heena; Prokopienko, Alexander J.] Albany Coll Pharm & Hlth Sci, Dept Pharm Practice, Albany, NY USA; [Alsaffar, Hiba; Gertzberg, Nancy; Neumann, Paul; Punjabi, Anjoli; Johnson, Arnold] Albany Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, Albany, NY USA	Albany College of Pharmacy & Health Sciences; Albany College of Pharmacy & Health Sciences	Pai, AB (corresponding author), Albany Coll Pharm & Hlth Sci, Dept Pharm Practice, Albany, NY USA.	amy.bartonpai@acphs.edu		Prokopienko, Alexander/0000-0002-8828-8365	National Institutes of Health (NIH) [5R01HL05990112]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funded in part by National Institutes of Health (NIH) 5R01HL05990112 (AJ) (www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri G, 2011, J MED CHEM, V54, P8148, DOI 10.1021/jm201071e; [Anonymous], 2009, ATL CHRON KIDN DIS E; Bosma JW, 2010, NEPHROL DIAL TRANSPL, V25, P1213, DOI 10.1093/ndt/gfp651; Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen Hong, 2010, Expert Rev Respir Med, V4, P773, DOI 10.1586/ers.10.71; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Deininger S, 2007, CLIN VACCINE IMMUNOL, V14, P1629, DOI 10.1128/CVI.00007-07; DEKIMPE SJ, 1995, BRIT J PHARMACOL, V114, P1317; Dunne A, 2010, J BIOL CHEM, V285, P18276, DOI 10.1074/jbc.M109.098137; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Gertzberg N, 2004, AM J PHYSIOL-LUNG C, V286, pL37, DOI 10.1152/ajplung.00116.2003; Gertzberg N, 2007, AM J PHYSIOL-LUNG C, V293, pL1219, DOI 10.1152/ajplung.00083.2007; Hoogerwerf JJ, 2008, AM J RESP CRIT CARE, V178, P34, DOI 10.1164/rccm.200708-1261OC; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kao SJ, 2005, IMMUNOLOGY, V115, P366, DOI 10.1111/j.1365-2567.2005.02160.x; Kawagoe T, 2008, NAT IMMUNOL, V9, P684, DOI 10.1038/ni.1606; Kengatharan KM, 1998, J EXP MED, V188, P305, DOI 10.1084/jem.188.2.305; Kumar S, 2010, AM J PHYSIOL-LUNG C, V298, pL105, DOI 10.1152/ajplung.00290.2009; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lee IT, 2008, J IMMUNOL, V181, P5098, DOI 10.4049/jimmunol.181.7.5098; Lee IT, 2010, AM J PATHOL, V176, P1671, DOI 10.2353/ajpath.2010.090714; Leemans JC, 2003, CLIN DIAGN LAB IMMUN, V10, P950, DOI 10.1128/CDLI.10.5.950-953.2003; Li CJ, 2009, J MOL SIGNAL, V25, P1; Lindner SC, 2009, J LEUKOCYTE BIOL, V86, P389, DOI 10.1189/jlb.1008591; Lum H, 2001, AM J PHYSIOL-CELL PH, V280, pC719; Maitra U, 2009, J BIOL CHEM, V284, P35403, DOI 10.1074/jbc.M109.059501; Morath S, 2005, J ENDOTOXIN RES, V11, P348, DOI 10.1179/096805105X67328; Neumann P, 2006, AM J PHYSIOL-LUNG C, V290, pL674, DOI 10.1152/ajplung.00391.2005; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; PATTERSON CE, 1992, J APPL PHYSIOL, V72, P865, DOI 10.1152/jappl.1992.72.3.865; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P841, DOI [10.1089/ars.2008.2231, 10.1089/ARS.2008.2231]; PHELPS DT, 1995, AM J PHYSIOL-LUNG C, V269, pL551, DOI 10.1152/ajplung.1995.269.4.L551; Pietrocola G, 2011, INT J ARTIF ORGANS, V34, P799, DOI 10.5301/ijao.5000030; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Santini M, 2010, SCAND J INFECT DIS, V42, P172, DOI 10.3109/00365540903384141; Shin HS, 2011, J IMMUNOL, V186, P1119, DOI 10.4049/jimmunol.1001647; Su CT, 2010, INT J ANTIMICROB AG, V35, P511, DOI 10.1016/j.ijantimicag.2009.12.016; Tang CH, 2010, BIOCHEM PHARMACOL, V79, P1648, DOI 10.1016/j.bcp.2010.01.025; Tiwari RL, 2011, J IMMUNOL, V187, P2632, DOI 10.4049/jimmunol.1002526; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Tuanzhu HY, 2010, CARDIOVASC RES, V87, P694; Volz T, 2010, FASEB J, V24, P4089, DOI 10.1096/fj.09-151001; Xing JJ, 2011, J APPL PHYSIOL, V110, P213, DOI 10.1152/japplphysiol.00284.2010; Xiong HB, 2004, J BIOL CHEM, V279, P10776, DOI 10.1074/jbc.M313416200; Yipp BG, 2002, J IMMUNOL, V168, P4650, DOI 10.4049/jimmunol.168.9.4650; Zivkovic A, 2011, J IMMUNOL, V186, P1608, DOI 10.4049/jimmunol.1001665	49	19	19	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49209	10.1371/journal.pone.0049209	http://dx.doi.org/10.1371/journal.pone.0049209			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166614	Green Submitted, gold, Green Published			2022-12-27	WOS:000311272300030
J	Bonaduce, I; Carlyle, L; Colombini, MP; Duce, C; Ferrari, C; Ribechini, E; Selleri, P; Tine, MR				Bonaduce, Ilaria; Carlyle, Leslie; Colombini, Maria Perla; Duce, Celia; Ferrari, Carlo; Ribechini, Erika; Selleri, Paola; Tine, Maria Rosaria			New Insights into the Ageing of Linseed Oil Paint Binder: A Qualitative and Quantitative Analytical Study	PLOS ONE			English	Article							THERMAL-ANALYSIS; CROSS-SECTIONS; COMPONENTS; TEMPERA; MEDIA	This paper presents an analytical investigation of paint reconstructions prepared with linseed oil that have undergone typical 19th century treatments in preparation for painting. The oil was mechanically extracted from the same seed lot, which was then processed by various methods: water washing, heat treatments, and the addition of driers, with and without heat. A modern process lead white (Dutch source, Schoonhoven) and a commercially available vine black were used as pigments. The reconstructions were prepared in 1999, and naturally aged from then onwards. We compared thermogravimetric analysis (TG), which yields macromolecular information, with gas chromatography-mass spectrometry (GC-MS) and direct exposure mass spectrometry (DEMS), which both provide molecular information. The study enabled us to quantitatively demonstrate, for the first time, that the parameters used to identify drying oils are deeply influenced by the history of the paint. In particular, here we show that the ratio between the relative amounts of palmitic and stearic acid (P/S), which is used as an index for differentiating between drying oils, is extremely dependent on the pigments present and the age of the paint. Moreover the study revealed that neither the P/S parameter nor the ratios between the relative amounts of the various dicarboxylic acids (azelaic over suberic and azelaic over sebacic) can be used to trace the sorts of pre-treatment undergone by the oil investigated in this study. The final results represent an important milestone for the scientific community working in the field, highlighting that further research is still necessary to solve the identification of drying oils in works of art.	[Bonaduce, Ilaria; Colombini, Maria Perla; Duce, Celia; Ribechini, Erika; Selleri, Paola; Tine, Maria Rosaria] Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy	University of Pisa	Bonaduce, I (corresponding author), Univ Pisa, Dipartimento Chim & Chim Ind, Pisa, Italy.	ilariab@dcci.unipi.it	Ribechini, Erika/AAH-3769-2020; Ribechini, Erika/M-7210-2014; Carlyle, Leslie/D-7173-2013; Tine, Maria Rosaria/K-6866-2017; BONADUCE, ILARIA/I-8801-2012	Ribechini, Erika/0000-0002-4978-2782; Ribechini, Erika/0000-0002-4978-2782; DUCE, CELIA/0000-0001-9354-7993; Carlyle, Leslie/0000-0001-9480-4613; Tine, Maria Rosaria/0000-0003-4537-1211; colombini, maria perla/0000-0002-1666-8596; BONADUCE, ILARIA/0000-0003-0346-8373				Andreotti A, 2008, NEW TRENDS ANAL ENV, P491; [Anonymous], 2001, STUD CONSERV, DOI [DOI 10.1179/SIC.2001.46.SUPPLEMENT-1.47, 10.1179/sic.2001.46]; Bonaduce I, 2008, NEW TRENDS ANAL ENV, P389; Bonaduce I, 2012, J THERM ANAL CALORIM, V107, P1055, DOI 10.1007/s10973-011-1586-6; Boon J. J., 2001, JOINT M ICOM CC WORK, P19; Boon JJ, 2001, CHIMIA, V55, P952; Boon JJ, 2002, ICOM COMM CONS ICOM, P5; Carlyle L., 2000, 72894 CAN CONS I; Carlyle L, 2005, HART PROJECT REPORT; Carlyle L., 2001, ARTISTS ASSISTANT OI; Ciomartan DA, 1996, J CHEM SOC DALTON, P3639, DOI 10.1039/dt9960003639; Cohen NS, 2000, THERMOCHIM ACTA, V365, P45, DOI 10.1016/S0040-6031(00)00612-2; Colombini M. P., 2009, ORG MASS SPECTROM, P191; Colombini MP, 2010, ACCOUNTS CHEM RES, V43, P715, DOI 10.1021/ar900185f; Donato DI, 2010, J THERM ANAL CALORIM, V101, P1085, DOI 10.1007/s10973-010-0717-9; Duce C, 2012, ANAL BIOANAL CHEM, V402, P2183, DOI 10.1007/s00216-011-5684-x; Fessas D, 2000, THERMOCHIM ACTA, V348, P129, DOI 10.1016/S0040-6031(00)00350-6; Gettens R. J, 1993, ARTISTS PIGMENTS; Kalinina KB, 2012, J CULT HERIT, V13, P259, DOI 10.1016/j.culher.2011.11.005; Katsibiri O, 2004, SPECTROCHIM ACTA B, V59, P1593, DOI 10.1016/j.sab.2004.07.026; Keune K., 2005, THESIS U AMSTERDAM; Keune K, 2002, ART 2002, P9; Keune K., 2008, ICOM COMM CONS 15 TR, VII, P833; Keune K, 2005, ICOM COMM CONS 14 TR, V2, P796; Keune K, 2007, STUD CONSERV, V52, P161, DOI 10.1179/sic.2007.52.3.161; Kimb J, 2010, BIORESOURCE TECHNOLO, V101, P9797; Kuhn H, 1993, HDB THEIR HIST CHARA; LAZZARI M, 1999, POLYM DEGRAD STABIL, V65, P10; Liuveras A, 2010, ANAL CHEM, V82, P376, DOI 10.1021/ac902141m; Mazzeo R, 2008, ANAL BIOANAL CHEM, V392, P65, DOI 10.1007/s00216-008-2126-5; Mills J., 2000, ORGANIC CHEM MUSEUM, V2; Mills J, 1982, NATL GALLERY TECH B, V6, P3; Mills J.S., 1994, ORGANIC CHEM MUSEUM; Mills J. S., 1966, STUDIES CONSERVATION, V11, P92, DOI DOI 10.1021/JASMS.0C00272; Pires J, 2007, J THERM ANAL CALORIM, V87, P411, DOI 10.1007/s10973-004-6775-0; Plater MJ, 2003, POLYHEDRON, V22, P3171, DOI 10.1016/S0277-5387(03)00461-3; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; Rivenc R, 2008, POTENTIAL APPL EVAPO; Scott G, 1980, STUD CONSERV, V25, P145, DOI DOI 10.1179/SIC.1980.25.4.145; Shilling M.R., 1996, ICOM COMM CONS PREPR, P220; Shilling MR, 1998, W ASS ART CONSERVATI, P21; Spyros A, 2004, ANAL CHEM, V76, P4929, DOI 10.1021/ac049350k; Sutherland K, 2000, STUD CONSERV, V45, P54, DOI 10.2307/1506683; Sutherland K, 2003, STUD CONSERV, V48, P111, DOI 10.1179/sic.2003.48.2.111; SUTHERLAND K, 2003, WORKSH BIND MED ID A; van den Berg JDJ, 2004, J SEP SCI, V27, P181, DOI 10.1002/jssc.200301610; van den Berg JDJ, 2002, J CHROMATOGR A, V950, P195, DOI 10.1016/S0021-9673(02)00049-3; van den Berg JDJ, 2002, THESIS U AMSTERDAM A; van den Berg JDJ, 2001, ADV MASS SPECTROM, V15, P822; Van den Berg KJ, 2004, MASC M; van der Weerd J., 2002, Z KUNSTTECHNOLOGIE K, V16, P36; van Loon A, 2004, SPECTROCHIM ACTA B, V59, P1601, DOI 10.1016/j.sab.2004.03.021; [No title captured]; [No title captured]	54	83	83	4	100	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49333	10.1371/journal.pone.0049333	http://dx.doi.org/10.1371/journal.pone.0049333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	038CD	23166642	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900125
J	Guo, RB; Wang, GF; Zhao, AP; Gu, J; Sun, XL; Hu, G				Guo, Ruo-Bing; Wang, Guo-Feng; Zhao, An-Peng; Gu, Jun; Sun, Xiu-Lan; Hu, Gang			Paeoniflorin Protects against Ischemia-Induced Brain Damages in Rats via Inhibiting MAPKs/NF-kappa B-Mediated Inflammatory Responses	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; INTRACEREBRAL HEMORRHAGE; NEUROVASCULAR UNIT; NITRIC-OXIDE; STROKE; ACTIVATION; MECHANISMS; EXPRESSION; PATHWAY; NEUROPROTECTION	Paeoniflorin (PF), the principal component of Paeoniae Radix prescribed in traditional Chinese medicine, has been reported to exhibit many pharmacological effects including protection against ischemic injury. However, the mechanisms underlying the protective effects of PF on cerebral ischemia are still under investigation. The present study showed that PF treatment for 14 days could significantly inhibit transient middle cerebral artery occlusion (MCAO)-induced over-activation of astrocytes and microglia, and prevented up-regulations of pro-inflamamtory mediators (TNF alpha, IL-1 beta, iNOS, COX2 and 5-LOX) in plasma and brain. Further study demonstrated that chronic treatment with PF suppressed the activations of JNK and p38 MAPK, but enhanced ERK activation. And PF could reverse ischemia-induced activation of NF-kappa B signaling pathway. Moreover, our in vitro study revealed that PF treatment protected against TNF alpha-induced cell apoptosis and neuronal loss. Taken together, the present study demonstrates that PF produces a delayed protection in the ischemia-injured rats via inhibiting MAPKs/NF-kappa B mediated peripheral and cerebral inflammatory response. Our study reveals that PF might be a potential neuroprotective agent for stroke.	[Guo, Ruo-Bing; Zhao, An-Peng; Gu, Jun; Sun, Xiu-Lan; Hu, Gang] Nanjing Med Univ, Dept Pharmacol, Jiangsu Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University	Guo, RB (corresponding author), Nanjing Med Univ, Dept Pharmacol, Jiangsu Key Lab Neurodegenerat, Nanjing, Jiangsu, Peoples R China.	xiulans@njmu.edu.cn; ghu@njmu.edu.cn	Sun, Xiu-Lan/AAW-5376-2021	Sun, Xiu-Lan/0000-0001-8741-3833				Adrie C, 2010, SHOCK, V33, P353, DOI 10.1097/SHK.0b013e3181b65b99; Auriel E, 2010, J CELL MOL MED, V14, P2200, DOI 10.1111/j.1582-4934.2010.01135.x; Barone FC, 2000, EXPERT OPIN INV DRUG, V9, P2281, DOI 10.1517/13543784.9.10.2281; Barone FC, 2001, MED RES REV, V21, P129, DOI 10.1002/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H; Barone FC, 2009, CURR OPIN INVEST DR, V10, P220; Batti L, 2010, J NEUROIMMUNOL, V218, P21, DOI 10.1016/j.jneuroim.2009.11.002; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chen DM, 2006, J PHARMACOL EXP THER, V319, P165, DOI 10.1124/jpet.106.104380; Cho S, 2005, J CEREBR BLOOD F MET, V25, P493, DOI 10.1038/sj.jcbfm.9600058; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; Denes A, 2011, CEREBROVASC DIS, V32, P517, DOI 10.1159/000332205; Fong WH, 2010, MOL NEUROBIOL, V41, P180, DOI 10.1007/s12035-010-8103-y; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; GIULIAN D, 1993, STROKE, V24, pI84; Grotta JC, 2001, ARCH NEUROL-CHICAGO, V58, P2009, DOI 10.1001/archneur.58.12.2009; He XH, 2004, J ETHNOPHARMACOL, V94, P339, DOI 10.1016/j.jep.2004.06.009; Hung JY, 2008, CLIN EXP PHARMACOL P, V35, P141, DOI 10.1111/j.1440-1681.2007.04795.x; Irving EA, 2000, MOL BRAIN RES, V77, P65, DOI 10.1016/S0169-328X(00)00043-7; Jahan Reza, 2009, Expert Rev Cardiovasc Ther, V7, P375, DOI 10.1586/erc.09.13; Jijon HB, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/207398; Kaushal V, 2008, J NEUROSCI, V28, P2221, DOI 10.1523/JNEUROSCI.5643-07.2008; KIMURA M, 1985, JPN J PHARMACOL, V37, P395, DOI 10.1254/jjp.37.395; Lai CW, 1998, LIFE SCI, V62, P1591, DOI 10.1016/S0024-3205(98)00112-X; Liang X, 2005, LIFE SCI, V78, P413, DOI 10.1016/j.lfs.2005.04.069; Liu DZ, 2005, BRIT J PHARMACOL, V146, P604, DOI 10.1038/sj.bjp.0706335; Liu J, 2006, BRAIN RES, V1089, P162, DOI 10.1016/j.brainres.2006.02.115; Liu Shimin, 2010, J Exp Stroke Transl Med, V3, P47; Maddahi A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-14; Mander P, 2005, J NEUROSCI RES, V79, P208, DOI 10.1002/jnr.20285; Mao QQ, 2010, CELL MOL NEUROBIOL, V30, P1059, DOI 10.1007/s10571-010-9537-5; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nizamutdinova IT, 2008, PLANTA MED, V74, P14, DOI 10.1055/s-2007-993775; Perez-Paya E, 2011, MED RES REV, V31, P649, DOI 10.1002/med.20198; Piao CS, 2003, J NEUROSCI RES, V73, P537, DOI 10.1002/jnr.10671; Pickering M, 2007, PROG BRAIN RES, V163, P339, DOI 10.1016/S0079-6123(07)63020-9; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Sekiguchi M, 2005, EXP NEUROL, V191, P266, DOI 10.1016/j.expneurol.2004.09.012; Sinn DI, 2007, NEUROSCI RES, V58, P12, DOI 10.1016/j.neures.2007.01.006; Sun Rong, 2006, Zhongguo Zhong Yao Za Zhi, V31, P832; Tabata K, 2000, JPN J PHARMACOL, V83, P25, DOI 10.1254/jjp.83.25; Tang Y, 2002, EUR J NEUROSCI, V15, P1937, DOI 10.1046/j.1460-9568.2002.02030.x; Uchino K, 2005, CEREBROVASC DIS, V19, P260, DOI 10.1159/000084090; Vexler ZS, 2006, CLIN NEUROSCI RES, V6, P293, DOI 10.1016/j.cnr.2006.09.008; Vosler PS, 2009, STROKE, V40, P3149, DOI 10.1161/STROKEAHA.108.543769; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wang T, 2009, PHYSIOL BEHAV, V96, P155, DOI 10.1016/j.physbeh.2008.09.024; Wang ZQ, 2004, BRAIN RES, V996, P55, DOI 10.1016/j.brainres.2003.09.074; Willis CL, 2011, TOXICOL PATHOL, V39, P172, DOI 10.1177/0192623310385830; Wullaert A, 2006, BIOCHEM PHARMACOL, V72, P1090, DOI 10.1016/j.bcp.2006.07.003; Yang M, 2010, CELL TRANSPLANT, V19, P1073, DOI 10.3727/096368910X503415; Ye JF, 2001, PLANTA MED, V67, P766, DOI 10.1055/s-2001-18364; Yermakova A, 2000, CURR PHARM DESIGN, V6, P1755, DOI 10.2174/1381612003398672; Zhang XJ, 2009, PHARMACOL BIOCHEM BE, V94, P88, DOI 10.1016/j.pbb.2009.07.013	53	138	162	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49701	10.1371/journal.pone.0049701	http://dx.doi.org/10.1371/journal.pone.0049701			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166749	gold, Green Published			2022-12-27	WOS:000311151900183
J	Jerlhag, E; Janson, AC; Waters, S; Engel, JA				Jerlhag, Elisabet; Janson, Anna Carin; Waters, Susanna; Engel, Jorgen A.			Concomitant Release of Ventral Tegmental Acetylcholine and Accumbal Dopamine by Ghrelin in Rats	PLOS ONE			English	Article							CHROMATOGRAPHY/TANDEM MASS-SPECTROMETRY; STIMULATES LOCOMOTOR-ACTIVITY; CONDITIONED PLACE PREFERENCE; REWARDING BRAIN-STIMULATION; NUCLEUS-ACCUMBENS; CHOLINERGIC NEURONS; PEDUNCULOPONTINE NUCLEUS; MICRODIALYSIS SAMPLES; SYSTEMIC GHRELIN; FOOD-INTAKE	Ghrelin, an orexigenic peptide, regulates energy balance specifically via hypothalamic circuits. Growing evidence suggest that ghrelin increases the incentive value of motivated behaviours via activation of the cholinergic-dopaminergic reward link. It encompasses the cholinergic afferent projection from the laterodorsal tegmental area (LDTg) to the dopaminergic cells of the ventral tegmental area (VTA) and the mesolimbic dopamine system projecting from the VTA to nucleus accumbens (N.Acc.). Ghrelin receptors (GHS-R1A) are expressed in these reward nodes and ghrelin administration into the LDTg increases accumbal dopamine, an effect involving nicotinic acetylcholine receptors in the VTA. The present series of experiments were undertaken directly to test this hypothesis. Here we show that ghrelin, administered peripherally or locally into the LDTg concomitantly increases ventral tegmental acetylcholine as well as accumbal dopamine release. A GHS-R1A antagonist blocks this synchronous neurotransmitter release induced by peripheral ghrelin. In addition, local perfusion of the unselective nicotinic antagonist mecamylamine into the VTA blocks the ability of ghrelin (administered into the LDTg) to increase N.Acc.-dopamine, but not VTA-acetylcholine. Collectively our data indicate that ghrelin activates the LDTg causing a release of acetylcholine in the VTA, which in turn activates local nicotinic acetylcholine receptors causing a release of accumbal dopamine. Given that a dysfunction in the cholinergic-dopaminergic reward system is involved in addictive behaviours, including compulsive overeating and alcohol use disorder, and that hyperghrelinemia is associated with such addictive behaviours, ghrelin-responsive circuits may serve as a novel pharmacological target for treatment of alcohol use disorder as well as binge eating.	[Jerlhag, Elisabet; Engel, Jorgen A.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Pharmacol Sect, Gothenburg, Sweden	University of Gothenburg	Jerlhag, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Pharmacol Sect, Gothenburg, Sweden.	elisabet.jerlhag@pharm.gu.se		Waters, Susanna/0000-0002-8688-880X				Abizaid A, 2006, J CLIN INVEST, V116, P3229, DOI 10.1172/JCI29867; Addolorato G, 2006, ALCOHOL CLIN EXP RES, V30, P1933, DOI 10.1111/j.1530-0277.2006.00238.x; Badaoui A, 2008, EUR J CLIN INVEST, V38, P397, DOI 10.1111/j.1365-2362.2008.01947.x; Banks WA, 2002, J PHARMACOL EXP THER, V302, P822, DOI 10.1124/jpet.102.034827; BECHARA A, 1992, BEHAV NEUROSCI, V106, P351, DOI 10.1037/0735-7044.106.2.351; BECHARA A, 1989, J NEUROSCI, V9, P3400; Blaha CD, 1996, J NEUROSCI, V16, P714; Clifford P. S., 2011, ADDICT BIOL; Corrigall WA, 2002, PSYCHOPHARMACOLOGY, V160, P198, DOI 10.1007/s00213-001-0965-2; Cowley MA, 2003, NEURON, V37, P649, DOI 10.1016/S0896-6273(03)00063-1; Davis KW, 2007, REGUL PEPTIDES, V140, P148, DOI 10.1016/j.regpep.2006.12.003; Dickson SL, 2010, NEUROSCIENCE, V171, P1180, DOI 10.1016/j.neuroscience.2010.10.005; Dickson SL, 2011, MOL CELL ENDOCRINOL, V340, P80, DOI 10.1016/j.mce.2011.02.017; Disse E, 2010, PHYSIOL BEHAV, V101, P277, DOI 10.1016/j.physbeh.2010.05.017; Egecioglu E, 2010, ADDICT BIOL, V15, P304, DOI 10.1111/j.1369-1600.2010.00216.x; ENGEL JA, 1988, ALCOHOL ALCOHOLISM, V23, pA13; Guan XM, 1997, MOL BRAIN RES, V48, P23, DOI 10.1016/S0169-328X(97)00071-5; Jerlhag E, 2008, ADDICT BIOL, V13, P358, DOI 10.1111/j.1369-1600.2008.00125.x; Jerlhag E, 2008, EUR NEUROPSYCHOPHARM, V18, P508, DOI 10.1016/j.euroneuro.2008.02.006; Jerlhag E, 2007, ADDICT BIOL, V12, P6, DOI 10.1111/j.1369-1600.2006.00041.x; Jerlhag E, 2006, ADDICT BIOL, V11, P45, DOI 10.1111/j.1369-1600.2006.00002.x; Jerlhag E, 2011, DRUG ALCOHOL DEPEN, V117, P126, DOI 10.1016/j.drugalcdep.2011.01.010; Jerlhag E, 2011, ADDICT BIOL, V16, P82, DOI 10.1111/j.1369-1600.2010.00231.x; Jerlhag E, 2010, PSYCHOPHARMACOLOGY, V211, P415, DOI 10.1007/s00213-010-1907-7; Jerlhag E, 2009, P NATL ACAD SCI USA, V106, P11318, DOI 10.1073/pnas.0812809106; Jiang H, 2006, MOL ENDOCRINOL, V20, P1772, DOI 10.1210/me.2005-0084; Kaur S, 2010, ALCOHOL CLIN EXP RES, V34, P1525, DOI 10.1111/j.1530-0277.2010.01237.x; Kern A, 2012, NEURON, V73, P317, DOI 10.1016/j.neuron.2011.10.038; Kim DJ, 2005, ALCOHOL ALCOHOLISM, V40, P76, DOI 10.1093/alcalc/agh108; Kippin TE, 2003, EUR J NEUROSCI, V18, P2581, DOI 10.1046/j.1460-9568.2003.02918.x; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Koopmann A, 2012, PSYCHONEUROENDOCRINO, V37, P980, DOI 10.1016/j.psyneuen.2011.11.005; Kraus T, 2005, ALCOHOL CLIN EXP RES, V29, P2154, DOI 10.1097/01.alc.0000191753.82554.7e; Lanca AJ, 2000, NEUROSCIENCE, V96, P735, DOI 10.1016/S0306-4522(99)00607-7; Landgren S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018170; Landgren S, 2011, BEHAV BRAIN RES, V221, P182, DOI 10.1016/j.bbr.2011.03.003; Landgren S, 2012, ADDICT BIOL, V17, P86, DOI 10.1111/j.1369-1600.2010.00280.x; Larsson A, 2005, ALCOHOL ALCOHOLISM, V40, P349, DOI 10.1093/alcalc/agh180; Larsson A, 2004, ALCOHOL, V34, P239, DOI 10.1016/j.alcohol.2004.10.002; Larsson A, 2004, NEUROSCI BIOBEHAV R, V27, P713, DOI 10.1016/j.neubiorev.2003.11.010; Leggio L, 2012, ADDICT BIOL, V17, P452, DOI 10.1111/j.1369-1600.2010.00308.x; Lof E, 2007, PSYCHOPHARMACOLOGY, V195, P333, DOI 10.1007/s00213-007-0899-4; Moulin A, 2007, J MED CHEM, V50, P5790, DOI 10.1021/jm0704550; OAKMAN SA, 1995, J NEUROSCI, V15, P5859; Paxinos G, 1998, BRAIN STEREOTAXIC CO; Perello M, 2010, BIOL PSYCHIAT, V67, P880, DOI 10.1016/j.biopsych.2009.10.030; Quarta D, 2009, NEUROCHEM INT, V54, P89, DOI 10.1016/j.neuint.2008.12.006; Rada PV, 2000, PHARMACOL BIOCHEM BE, V65, P375, DOI 10.1016/S0091-3057(99)00218-X; Reuter J, 2005, NAT NEUROSCI, V8, P147, DOI 10.1038/nn1378; Salome N, 2009, J NEUROENDOCRINOL; Skibicka KP, 2011, NEUROSCIENCE, V180, P129, DOI 10.1016/j.neuroscience.2011.02.016; STEFURAK TL, 1994, BEHAV NEUROSCI, V108, P972, DOI 10.1037/0735-7044.108.5.972; Tanaka M, 2003, J PSYCHIAT RES, V37, P17, DOI 10.1016/S0022-3956(02)00067-5; Tessari M, 2007, ADDICT BIOL, V12, P22, DOI 10.1111/j.1369-1600.2007.00052.x; Thiele TE, 2003, NEUROPEPTIDES, V37, P321, DOI 10.1016/j.npep.2003.10.002; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Uutela P, 2005, RAPID COMMUN MASS SP, V19, P2950, DOI 10.1002/rcm.2160; Volkow ND, 2004, NAT REV NEUROSCI, V5, P963, DOI 10.1038/nrn1539; Volkow ND, 2003, INT J EAT DISORDER, V33, P136, DOI 10.1002/eat.10118; Wellman PJ, 2011, REGUL PEPTIDES, V172, P77, DOI 10.1016/j.regpep.2011.08.014; Wellman PJ, 2005, REGUL PEPTIDES, V125, P151, DOI 10.1016/j.regpep.2004.08.013; Wellman PJ, 2011, ADDICT BIOL; Westerink BHC, 1996, J NEUROSCI, V16, P2605; WISE RA, 1989, ANNU REV PSYCHOL, V40, P191, DOI 10.1146/annurev.ps.40.020189.001203; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Wren AM, 2001, DIABETES, V50, P2540, DOI 10.2337/diabetes.50.11.2540; YEOMANS JS, 1993, BEHAV NEUROSCI, V107, P1077, DOI 10.1037/0735-7044.107.6.1077; YEOMANS JS, 1985, BRAIN RES, V329, P19, DOI 10.1016/0006-8993(85)90508-6; Zhang MY, 2007, J PHARMACEUT BIOMED, V44, P586, DOI 10.1016/j.jpba.2007.02.024	70	71	72	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49557	10.1371/journal.pone.0049557	http://dx.doi.org/10.1371/journal.pone.0049557			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166710	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900164
J	Shanks, SG; Carpp, LN; Struthers, MS; McCann, RK; Bryant, NJ				Shanks, Scott G.; Carpp, Lindsay N.; Struthers, Marion S.; McCann, Rebecca K.; Bryant, Nia J.			The Sec1/Munc18 Protein Vps45 Regulates Cellular Levels of Its SNARE Binding Partners Tlg2 and Snc2 in Saccharomyces cerevisiae	PLOS ONE			English	Article							LATE SECRETORY PATHWAY; SM-PROTEIN; SYNTAXIN TLG2P; PREVACUOLAR COMPARTMENT; MEMBRANE-PROTEINS; COMPLEX-FORMATION; SHUTTLE VECTORS; YEAST VACUOLE; TRANSPORT; MUTANTS	Intracellular membrane trafficking pathways must be tightly regulated to ensure proper functioning of all eukaryotic cells. Central to membrane trafficking is the formation of specific SNARE (soluble N-ethylmeleimide-sensitive factor attachment protein receptor) complexes between proteins on opposing lipid bilayers. The Sec1/Munc18 (SM) family of proteins play an essential role in SNARE-mediated membrane fusion, and like the SNAREs are conserved through evolution from yeast to humans. The SM protein Vps45 is required for the formation of yeast endosomal SNARE complexes and is thus essential for traffic through the endosomal system. Here we report that, in addition to its role in regulating SNARE complex assembly, Vps45 regulates cellular levels of its SNARE binding partners: the syntaxin Tlg2 and the v-SNARE Snc2: Cells lacking Vps45 have reduced cellular levels of Tlg2 and Snc2; and elevation of Vps45 levels results in concomitant increases in the levels of both Tlg2 and Snc2. As well as regulating traffic through the endosomal system, the Snc v-SNAREs are also required for exocytosis. Unlike most vps mutants, cells lacking Vps45 display multiple growth phenotypes. Here we report that these can be reversed by selectively restoring Snc2 levels in vps45 mutant cells. Our data indicate that as well as functioning as part of the machinery that controls SNARE complex assembly, Vps45 also plays a key role in determining the levels of its cognate SNARE proteins; another key factor in regulation of membrane traffic.	[Shanks, Scott G.; Carpp, Lindsay N.; Struthers, Marion S.; McCann, Rebecca K.; Bryant, Nia J.] Univ Glasgow, Henry Wellcome Lab Cell Biol, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland	University of Glasgow	Shanks, SG (corresponding author), Univ Glasgow, Henry Wellcome Lab Cell Biol, Inst Mol Cell & Syst Biol, Coll Med Vet & Life Sci, Glasgow, Lanark, Scotland.	nia.bryant@glasgow.ac.uk	Bryant, Nia/AAS-5637-2021; Carpp, Lindsay/AAM-1148-2021	Bryant, Nia Jane/0000-0001-7431-3809	Biotechnology and Biological Sciences Research Council [BB/H009817/1, BB/E024904/1] Funding Source: Medline; Wellcome Trust Funding Source: Medline; Biotechnology and Biological Sciences Research Council [BB/I024496/1, BB/H024867/1] Funding Source: researchfish; BBSRC [BB/E024904/1, BB/H009817/1, BB/I024496/1, BB/H024867/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		AALTO MK, 1993, EMBO J, V12, P4095, DOI 10.1002/j.1460-2075.1993.tb06093.x; Abeliovich H, 1998, J BIOL CHEM, V273, P11719, DOI 10.1074/jbc.273.19.11719; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bracher A, 2002, EMBO J, V21, P6114, DOI 10.1093/emboj/cdf608; Braun S, 2007, EMBO REP, V8, P1176, DOI 10.1038/sj.embor.7401105; Bryant NJ, 2003, J CELL BIOL, V161, P691, DOI 10.1083/jcb.200212078; Bryant NJ, 2001, EMBO J, V20, P3380, DOI 10.1093/emboj/20.13.3380; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Carpp LN, 2007, BIOCHEM BIOPH RES CO, V363, P857, DOI 10.1016/j.bbrc.2007.09.067; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Carr CM, 2010, CURR OPIN CELL BIOL, V22, P488, DOI 10.1016/j.ceb.2010.04.006; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; COWLES CR, 1994, J CELL SCI, V107, P3449; Cowles CR, 1997, CELL, V91, P109, DOI 10.1016/S0092-8674(01)80013-1; Furgason MLM, 2009, P NATL ACAD SCI USA, V106, P14303, DOI 10.1073/pnas.0902976106; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613; Gerrard SR, 2000, TRAFFIC, V1, P45, DOI 10.1034/j.1600-0854.2000.010108.x; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gurunathan S, 2000, MOL BIOL CELL, V11, P3629, DOI 10.1091/mbc.11.10.3629; HARVEY RJ, 1973, J BACTERIOL, V114, P287, DOI 10.1128/JB.114.1.287-293.1973; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Nichols BJ, 1998, EUR J CELL BIOL, V77, P263, DOI 10.1016/S0171-9335(98)80084-8; Nickerson DP, 2009, CURR OPIN CELL BIOL, V21, P543, DOI 10.1016/j.ceb.2009.05.007; NOTHWEHR SF, 1995, J CELL BIOL, V129, P35, DOI 10.1083/jcb.129.1.35; PIPER RC, 1994, EUR J CELL BIOL, V65, P305; Piper RC, 1997, J CELL BIOL, V138, P531, DOI 10.1083/jcb.138.3.531; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; PROTOPOPOV V, 1993, CELL, V74, P855, DOI 10.1016/0092-8674(93)90465-3; Rahajeng J, 2010, EXP CELL RES, V316, P859, DOI 10.1016/j.yexcr.2009.11.007; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; ROTHMAN JH, 1986, CELL, V47, P1041, DOI 10.1016/0092-8674(86)90819-6; Sherman F, 1986, METHODS YEAST GENETI, P146; Struthers MS, 2009, J CELL SCI, V122, P2292, DOI 10.1242/jcs.046441; Toonen RFG, 2005, J NEUROCHEM, V93, P1393, DOI 10.1111/j.1471-4159.2005.03128.x; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; WADA Y, 1992, J BIOL CHEM, V267, P18665; Wada Y, 1997, J CELL SCI, V110, P1299; Willett HP, 1980, ZINSSER MICROBIOLOGY, P88; Wollert T, 2009, J CELL SCI, V122, P2163, DOI 10.1242/jcs.029884; Zouhar J, 2009, PLANT PHYSIOL, V149, P1668, DOI 10.1104/pp.108.134361	44	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49628	10.1371/journal.pone.0049628	http://dx.doi.org/10.1371/journal.pone.0049628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166732	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000311151900176
J	Bjasch, D; Bockisch, CJ; Straumann, D; Tarnutzer, AA				Bjasch, Daniel; Bockisch, Christopher J.; Straumann, Dominik; Tarnutzer, Alexander A.			Differential Effects of Visual Feedback on Subjective Visual Vertical Accuracy and Precision	PLOS ONE			English	Article							BODY-TILT; SPACE ORIENTATION; PERCEPTION; GRAVITY; ROLL; HEAD; LABYRINTHINE; MOTION; INFORMATION; INTEGRATION	The brain constructs an internal estimate of the gravitational vertical by integrating multiple sensory signals. In darkness, systematic head-roll dependent errors in verticality estimates, as measured by the subjective visual vertical (SVV), occur. We hypothesized that visual feedback after each trial results in increased accuracy, as physiological adjustment errors (A-/E-effect) are likely based on central computational mechanisms and investigated whether such improvements were related to adaptational shifts of perceived vertical or to a higher cognitive strategy. We asked 12 healthy human subjects to adjust a luminous arrow to vertical in various head-roll positions (0 to 120deg right-ear down, 15deg steps). After each adjustment visual feedback was provided (lights on, display of previous adjustment and of an earth-vertical cross). Control trials consisted of SVV adjustments without feedback. At head-roll angles with the largest A-effect (90, 105, and 120deg), errors were reduced significantly (p<0.001) by visual feedback, i.e. roll under-compensation decreased, while precision of SVV was not significantly (p>0.05) influenced. In seven subjects an additional session with two consecutive blocks (first with, then without visual feedback) was completed at 90, 105 and 120deg head-roll. In these positions the error-reduction by the previous visual feedback block remained significant over the consecutive 18-24 min (post-feedback block), i.e., was still significantly (p<0.002) different from the control trials. Eleven out of 12 subjects reported having consciously added a bias to their perceived vertical based on visual feedback in order to minimize errors. We conclude that improvements of SVV accuracy by visual feedback, which remained effective after removal of feedback for >= 18 min, rather resulted from a cognitive strategy than by adapting the internal estimate of the gravitational vertical. The mechanisms behind the SVV therefore, remained stable, which is also supported by the fact that SVV precision -depending mostly on otolith input - was not affected by visual feedback.	[Bjasch, Daniel; Bockisch, Christopher J.; Straumann, Dominik; Tarnutzer, Alexander A.] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Otorhinolaryngol, CH-8091 Zurich, Switzerland; [Bockisch, Christopher J.] Univ Zurich Hosp, Dept Ophthalmol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Tarnutzer, AA (corresponding author), Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland.	alexander.tarnutzer@access.uzh.ch	Tarnutzer, Alexander/H-3236-2019	Tarnutzer, Alexander/0000-0002-6984-6958; Bockisch, Christopher/0000-0003-1054-2578	Swiss National Science Foundation [3200B0-105434]; Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; Center of Integrative Human Physiology, University of Zurich, Switzerland	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; Center of Integrative Human Physiology, University of Zurich, Switzerland	This work received financial support from the Swiss National Science Foundation (3200B0-105434); the Betty and David Koetser Foundation for Brain Research, Zurich, Switzerland; and the Center of Integrative Human Physiology, University of Zurich, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anastasopoulos D, 1999, ANN NY ACAD SCI, V871, P379, DOI 10.1111/j.1749-6632.1999.tb09199.x; Angelaki DE, 2009, CURR OPIN NEUROBIOL, V19, P452, DOI 10.1016/j.conb.2009.06.008; ASCH SE, 1948, J EXP PSYCHOL, V38, P325, DOI 10.1037/h0057855; Aubert H., 1861, ARCH PATHOL ANAT, V20, P381, DOI DOI 10.1007/BF02355256; BAUERMEISTER M, 1964, AM J PSYCHOL, V77, P451, DOI 10.2307/1421016; Bedford FL, 1999, TRENDS COGN SCI, V3, P4, DOI 10.1016/S1364-6613(98)01266-2; Bompas A, 2006, J VISION, V6, P145, DOI 10.1167/6.2.5; Bortolami SB, 2006, EXP BRAIN RES, V173, P364, DOI 10.1007/s00221-006-0385-y; BRANDT T, 2000, VERTIGO ITS MULTISEN; Bronstein AM, 1996, NEUROLOGY, V47, P651, DOI 10.1212/WNL.47.3.651; Bronstein AM, 1999, ANN NY ACAD SCI, V871, P324, DOI 10.1111/j.1749-6632.1999.tb09195.x; CLARK B, 1963, J EXP PSYCHOL, V65, P490, DOI 10.1037/h0045606; De Vrijer M, 2008, J NEUROPHYSIOL, V99, P915, DOI 10.1152/jn.00921.2007; De Vrijer M, 2009, J VISION, V9, DOI 10.1167/9.2.9; DICHGANS J, 1974, ACTA OTO-LARYNGOL, V78, P391, DOI 10.3109/00016487409126371; Eggert T, 1998, EINFLUSS ORIENTIERTE, P1; Ernst MO, 2009, CURR BIOL, V19, pR23, DOI 10.1016/j.cub.2008.10.039; Fine I, 2002, J VISION, V2, P190, DOI 10.1167/2.2.5; FRIEDMANN G, 1970, BRAIN, V93, P313, DOI 10.1093/brain/93.2.313; Gilbert CD, 2001, NEURON, V31, P681, DOI 10.1016/S0896-6273(01)00424-X; Graybiel A, 1968, Acta Otolaryngol, V65, P599, DOI 10.3109/00016486809121003; Green AM, 2007, PROG BRAIN RES, V165, P155, DOI 10.1016/S0079-6123(06)65010-3; Howard I. P., 1982, HUMAN VISUAL ORIENTA; HOWARD IP, 1994, PERCEPTION, V23, P753, DOI 10.1068/p230753; Jaggi-Schwarz K, 2003, EXP BRAIN RES, V149, P340, DOI 10.1007/s00221-002-1343-y; Kaptein RG, 2004, J NEUROPHYSIOL, V91, P2205, DOI 10.1152/jn.00804.2003; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kording KP, 2004, NATURE, V427, P244, DOI 10.1038/nature02169; Krakauer JW, 2011, CURR OPIN NEUROBIOL, V21, P636, DOI 10.1016/j.conb.2011.06.012; Laurens J, 2007, BIOL CYBERN, V96, P389, DOI 10.1007/s00422-006-0133-1; LECHNERSTEINLEITNER S, 1978, PSYCHOL RES-PSYCH FO, V40, P65, DOI 10.1007/BF00308464; MacNeilage PR, 2007, EXP BRAIN RES, V179, P263, DOI 10.1007/s00221-006-0792-0; Mast F, 1996, BRAIN RES BULL, V40, P393, DOI 10.1016/0361-9230(96)00132-3; Mast FW, 2000, JPN PSYCHOL RES, V42, P194, DOI 10.1111/1468-5884.00146; MILLER EF, 1968, AM J PSYCHOL, V81, P488; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; Mueller GE, 1916, Z PSYCHOL PHYSL SINN, V49, P109; Pansell T, 2005, STRABISMUS, V13, P115, DOI 10.1080/09273970500216408; Pavlou M, 2003, J NEUROPHYSIOL, V90, P622, DOI 10.1152/jn.00960.2002; POGGIO T, 1992, SCIENCE, V256, P1018, DOI 10.1126/science.1589770; ROSENHALL U, 1972, ANN OTO RHINOL LARYN, V81, P339, DOI 10.1177/000348947208100305; Sagi D, 2011, VISION RES, V51, P1552, DOI 10.1016/j.visres.2010.10.019; SCHONE H, 1964, AEROSPACE MED, V35, P764; SCHONE H, 1968, Z VERGL PHYSIOL, V60, P440, DOI 10.1007/BF00297938; Schuler JR, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-83; Seitz AR, 2007, CURR OPIN NEUROBIOL, V17, P148, DOI 10.1016/j.conb.2007.02.004; Tarnutzer AA, 2012, J VESTIBUL RES-EQUIL, V22, P41, DOI 10.3233/VES-2011-0436; Tarnutzer AA, 2010, J NEUROPHYSIOL, V103, P934, DOI 10.1152/jn.00407.2009; Tarnutzer AA, 2009, J NEUROPHYSIOL, V102, P1657, DOI 10.1152/jn.00007.2008; Tarnutzer AA, 2011, 41 ANN C SOC NEUR NO; Tarnutzer AA, 2009, EXP BRAIN RES, V195, P621, DOI 10.1007/s00221-009-1823-4; Torre K, 2009, HUM MOVEMENT SCI, V28, P297, DOI 10.1016/j.humov.2009.01.001; Tsodyks M, 2004, NATURE, V431, P775, DOI 10.1038/nature03013; van Beuzekom AD, 2000, J NEUROPHYSIOL, V84, P11, DOI 10.1152/jn.2000.84.1.11; Van Beuzekom AD, 2001, VISION RES, V41, P3229, DOI 10.1016/S0042-6989(01)00144-4; Van Huffel S, 1991, COMPUTATIONAL ASPECT; WADE NJ, 1973, BRIT J PSYCHOL, V64, P351, DOI 10.1111/j.2044-8295.1973.tb01360.x; WADE NJ, 1970, Q J EXP PSYCHOL, V22, P423, DOI 10.1080/14640747008401916; Wade SW, 1997, VISION RES, V37, P1071, DOI 10.1016/S0042-6989(96)00252-0; WITKIN HA, 1948, J EXP PSYCHOL, V38, P762, DOI 10.1037/h0053671; YARDLEY L, 1990, PERCEPT PSYCHOPHYS, V48, P131, DOI 10.3758/BF03207079	61	10	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49311	10.1371/journal.pone.0049311	http://dx.doi.org/10.1371/journal.pone.0049311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152894	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000311234000062
J	Strepparava, N; Wahli, T; Segner, H; Polli, B; Petrini, O				Strepparava, Nicole; Wahli, Thomas; Segner, Helmut; Polli, Bruno; Petrini, Orlando			Fluorescent In Situ Hybridization: A New Tool for the Direct Identification and Detection of F. psychrophilum	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; FLAVOBACTERIUM-PSYCHROPHILUM; OLIGONUCLEOTIDE PROBES; CYTOPHAGA-PSYCHROPHILA; RAPID IDENTIFICATION; FISH; ACCESSIBILITY; SECTIONS; TISSUE; CELLS	F. psychrophilum is the causative agent of Bacterial Cold Water Disease (BCW) and Rainbow Trout Fry Syndrome (RTFS). To date, diagnosis relies mainly on direct microscopy or cultural methods. Direct microscopy is fast but not very reliable, whereas cultural methods are reliable but time-consuming and labor-intensive. So far fluorescent in situ hybridization (FISH) has not been used in the diagnosis of flavobacteriosis but it has the potential to rapidly and specifically detect F. psychrophilum in infected tissues. Outbreaks in fish farms, caused by pathogenic strains of Flavobacterium species, are increasingly frequent and there is a need for reliable and cost-effective techniques to rapidly diagnose flavobacterioses. This study is aimed at developing a FISH that could be used for the diagnosis of F. psychrophilum infections in fish. We constructed a generic probe for the genus Flavobacterium ("Pan-Flavo'') and two specific probes targeting F. psychrophilum based on 16S rRNA gene sequences. We tested their specificity and sensitivity on pure cultures of different Flavobacterium and other aquatic bacterial species. After assessing their sensitivity and specificity, we established their limit of detection and tested the probes on infected fresh tissues (spleen and skin) and on paraffin-embedded tissues. The results showed high sensitivity and specificity of the probes (100% and 91% for the Pan-Flavo probe and 100% and 97% for the F. psychrophilum probe, respectively). FISH was able to detect F. psychrophilum in infected fish tissues, thus the findings from this study indicate this technique is suitable as a fast and reliable method for the detection of Flavobacterium spp. and F. psychrophilum.	[Strepparava, Nicole; Petrini, Orlando] Cantonal Inst Microbiol, Bellinzona, Switzerland; [Wahli, Thomas; Segner, Helmut] Univ Bern, Ctr Fish & Wildlife Hlth, Bern, Switzerland; [Polli, Bruno] Cantonal Off Hunting & Fisheries, Bellinzona, Switzerland	University of Bern	Strepparava, N (corresponding author), Cantonal Inst Microbiol, Bellinzona, Switzerland.	nicole.strepparava@bluewin.ch	Segner, Helmut/D-5714-2014; Petrini, Orlando/G-4392-2010	Petrini, Orlando/0000-0002-1234-7832	Intramural fund from the Cantonal Institute of Microbiology	Intramural fund from the Cantonal Institute of Microbiology	This work was supported by the Intramural fund from the Cantonal Institute of Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Angelidis AS, 2011, INT J FOOD MICROBIOL, V151, P252, DOI 10.1016/j.ijfoodmicro.2011.09.007; Benagli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016424; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/00207713-52-3-1049; BERNARDET JF, 1989, APPL ENVIRON MICROB, V55, P1796, DOI 10.1128/AEM.55.7.1796-1800.1989; Bottari B, 2006, APPL MICROBIOL BIOT, V73, P485, DOI 10.1007/s00253-006-0615-z; Bowman J.P., 2006, PROKARYOTES, P677, DOI DOI 10.1007/0-387-30747-8_26; Ciantar M, 2005, J CLIN MICROBIOL, V43, P1894, DOI 10.1128/JCM.43.4.1894-1901.2005; CIPRIANO RC, 1995, J WILDLIFE DIS, V31, P166, DOI 10.7589/0090-3558-31.2.166; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Decostere A, 2002, VET REC, V150, P694, DOI 10.1136/vr.150.22.694; Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Fuchs BM, 2000, APPL ENVIRON MICROB, V66, P3603, DOI 10.1128/AEM.66.8.3603-3607.2000; Fuchs BM, 2000, ENVIRON MICROBIOL, V2, P191, DOI 10.1046/j.1462-2920.2000.00092.x; Kempf VAJ, 2000, J CLIN MICROBIOL, V38, P830, DOI 10.1128/JCM.38.2.830-838.2000; Kirby AL, 2010, VET DERMATOL, V21, P175, DOI 10.1111/j.1365-3164.2009.00783.x; Kondo M, 2003, DIS AQUAT ORGAN, V55, P261, DOI 10.3354/dao055261; KRAEMER HC, 1992, EVALUATING MED TESTS; Laguna-Del Estal P, 2010, REV NEUROLOGIA, V50, P458, DOI 10.33588/rn.5008.2009455; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; Manz W, 1996, MICROBIOL-SGM, V142, P1097, DOI 10.1099/13500872-142-5-1097; Marquardt BJ, 2004, LEBENSM-WISS TECHNOL, V37, P1, DOI 10.1016/S0023-6438(03)00114-2; McKenzie DP, 1997, PSYCHIAT RES, V69, P207, DOI 10.1016/S0165-1781(96)02952-6; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Nematollahi A, 2003, J FISH DIS, V26, P563, DOI 10.1046/j.1365-2761.2003.00488.x; Nilsson SK, 1996, J HISTOCHEM CYTOCHEM, V44, P1069, DOI 10.1177/44.9.8773573; Ridderstrale KK, 2005, BIOTECHNIQUES, V39, P316, DOI 10.2144/05393BM04; Rigby S, 2002, J CLIN MICROBIOL, V40, P2182, DOI 10.1128/JCM.40.6.2182-2186.2002; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Weller R, 2000, SYST APPL MICROBIOL, V23, P107, DOI 10.1016/S0723-2020(00)80051-X; Werckenthin C, 2012, VET MICROBIOL, V156, P330, DOI 10.1016/j.vetmic.2011.10.007; Wiklund T, 2000, J APPL MICROBIOL, V88, P299, DOI 10.1046/j.1365-2672.2000.00959.x; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020	36	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e49280	10.1371/journal.pone.0049280	http://dx.doi.org/10.1371/journal.pone.0049280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152887	Green Published, Green Submitted, gold			2022-12-27	WOS:000312272600055
J	Koyama, N; Tokura, Y; Munch, D; Sahl, HG; Schneider, T; Shibagaki, Y; Ikeda, H; Tomoda, H				Koyama, Nobuhiro; Tokura, Yuriko; Muench, Daniela; Sahl, Hans-Georg; Schneider, Tanja; Shibagaki, Yoshio; Ikeda, Haruo; Tomoda, Hiroshi			The Nonantibiotic Small Molecule Cyslabdan Enhances the Potency of beta-Lactams against MRSA by Inhibiting Pentaglycine Interpeptide Bridge Synthesis	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STREPTOMYCES SP K04-0144; METHICILLIN-RESISTANT; IMIPENEM ACTIVITY; PBP 2A; PEPTIDOGLYCAN; PROTEINS; IDENTIFICATION; CEPHALOSPORIN; POTENTIATOR	The nonantibiotic small molecule cyslabdan, a labdan-type diterpene produced by Streptomyces sp. K04-0144, markedly potentiated the activity of the beta-lactam drug imipenem against methicillin-resistant Staphylococcus aureus (MRSA). To study the mechanism of action of cyslabdan, the proteins that bind to cyslabdan were investigated in an MRSA lysate, which led to the identification of FemA, which is involved in the synthesis of the pentaglycine interpeptide bridge of the peptidoglycan of MRSA. Furthermore, binding assay of cyslabdan to FemB and FemX with the function similar to FemA revealed that cyslabdan had an affinity for FemB but not FemX. In an enzyme-based assay, cyslabdan inhibited FemA activity, where as did not affected FemX and FemB activities. Nonglycyl and monoglycyl murein monomers were accumulated by cyslabdan in the peptidoglycan of MRSA cell walls. These findings indicated that cyslabdan primarily inhibits FemA, thereby suppressing pentaglycine interpeptide bridge synthesis. This protein is a key factor in the determination of beta-lactam resistance in MRSA, and our findings provide a new strategy for combating MRSA.	[Koyama, Nobuhiro; Tokura, Yuriko; Shibagaki, Yoshio; Tomoda, Hiroshi] Kitasato Univ, Grad Sch Pharmaceut Sci, Tokyo, Japan; [Muench, Daniela; Sahl, Hans-Georg; Schneider, Tanja] Univ Bonn, Inst Med Microbiol, Bonn, Germany; [Ikeda, Haruo] Kitasato Univ, Kitasato Inst Life Sci, Kanagawa, Japan	Kitasato University; University of Bonn; Kitasato University	Tomoda, H (corresponding author), Kitasato Univ, Grad Sch Pharmaceut Sci, Tokyo, Japan.	tomodah@pharm.kitasato-u.ac.jp	Schneider, Tanja/L-8049-2013	Schneider, Tanja/0000-0001-7269-4716; Rausch, Daniela/0000-0003-3211-5745	Uehara Memorial Foundation; Takeda Science Foundation; Kakenhi from the Ministry of Education, Culture, Sports, Science, and Technology of Japan [21310146, 23790020]; Grants-in-Aid for Scientific Research [23790020] Funding Source: KAKEN	Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Kakenhi from the Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants from the Uehara Memorial Foundation (to H.T.) and the Takeda Science Foundation (to N.K.) and Kakenhi grants 21310146 (to H.T.) and 23790020 (to N.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayer E A, 1980, Methods Biochem Anal, V26, P1; BERGERBACHI B, 1989, MOL GEN GENET, V219, P263; Breukink E, 2003, J BIOL CHEM, V278, P19898, DOI 10.1074/jbc.M301463200; DEJONGE BLM, 1992, J BIOL CHEM, V267, P11248; Ejim L, 2011, NAT CHEM BIOL, V7, P348, DOI [10.1038/NCHEMBIO.559, 10.1038/nchembio.559]; Fukumoto A, 2008, J ANTIBIOT, V61, P7, DOI 10.1038/ja.2008.102; Fukumoto A, 2008, J ANTIBIOT, V61, P1, DOI 10.1038/ja.2008.101; HACKBARTH CJ, 1993, ANTIMICROB AGENTS CH, V37, P1144, DOI 10.1128/AAC.37.5.1144; HANAKI H, 1995, ANTIMICROB AGENTS CH, V39, P1120, DOI 10.1128/AAC.39.5.1120; Hiramatsu K, 1997, J ANTIMICROB CHEMOTH, V40, P135, DOI 10.1093/jac/40.1.135; Huber J, 2009, CHEM BIOL, V16, P837, DOI 10.1016/j.chembiol.2009.05.012; MAIDHOF H, 1991, J BACTERIOL, V173, P3507, DOI 10.1128/jb.173.11.3507-3513.1991; Malouin F, 2003, ANTIMICROB AGENTS CH, V47, P658, DOI 10.1128/AAC.47.2.658-664.2003; MURAKAMI K, 1987, ANTIMICROB AGENTS CH, V31, P1307, DOI 10.1128/AAC.31.9.1307; Nicolson K, 1999, FEMS MICROBIOL LETT, V179, P233, DOI 10.1111/j.1574-6968.1999.tb08733.x; NORBECK J, 1995, ELECTROPHORESIS, V16, P149, DOI 10.1002/elps.1150160124; Omura S, 1999, Nihon Saikingaku Zasshi, V54, P795; Rick PD, 1998, GLYCOBIOLOGY, V8, P557, DOI 10.1093/glycob/8.6.557; Rohrer S, 2003, MICROBIOL-SGM, V149, P2733, DOI 10.1099/mic.0.26315-0; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Shiota S, 2004, MICROBIOL IMMUNOL, V48, P67, DOI 10.1111/j.1348-0421.2004.tb03489.x; Stranden AM, 1997, J BACTERIOL, V179, P9, DOI 10.1128/jb.179.1.9-16.1997; TOMASZ A, 1994, NEW ENGL J MED, V330, P1247, DOI 10.1056/NEJM199404283301725; Zhao WH, 2001, ANTIMICROB AGENTS CH, V45, P1737, DOI 10.1128/AAC.45.6.1737-1742.2001	25	27	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 6	2012	7	11							e48981	10.1371/journal.pone.0048981	http://dx.doi.org/10.1371/journal.pone.0048981			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	040IE	23166602	gold, Green Published, Green Submitted			2022-12-27	WOS:000311315300067
J	Nordmann, S; Biard, L; Ravaud, P; Esposito-Farese, M; Tubach, F				Nordmann, Sandra; Biard, Lucie; Ravaud, Philippe; Esposito-Farese, Marina; Tubach, Florence			Case-Only Designs in Pharmacoepidemiology: A Systematic Review	PLOS ONE			English	Article							CASE-CROSSOVER DESIGN; CASE SERIES ANALYSIS; VACCINE SAFETY; ADVERSE REACTIONS	Background: Case-only designs have been used since late 1980's. In these, as opposed to case-control or cohort studies for instance, only cases are required and are self-controlled, eliminating selection biases and confounding related to control subjects, and time-invariant characteristics. The objectives of this systematic review were to analyze how the two main case-only designs - case-crossover (CC) and self-controlled case series (SCCS) - have been applied and reported in pharmacoepidemiology literature, in terms of applicability assumptions and specificities of these designs. Methodology/Principal Findings: We systematically selected all reports in this field involving case-only designs from MEDLINE and EMBASE up to September 15, 2010. Data were extracted using a standardized form. The analysis included 93 reports 50 (54%) of CC and 45 (48%) SCCS, 2 reports combined both designs. In 12 (24%) CC and 18 (40%) SCCS articles, all applicable validity assumptions of the designs were fulfilled, respectively. Fifty (54%) articles (15 CC (30%) and 35 (78%) SCCS) adequately addressed the specificities of the case-only analyses in the way they reported results. Conclusions/Significance: Our systematic review underlines that implementation of CC and SCCS designs needs to be more rigorous with regard to validity assumptions, as well as improvement in results reporting.	[Nordmann, Sandra; Tubach, Florence] Univ Paris Diderot, UMR S 738, Paris, France; [Nordmann, Sandra; Ravaud, Philippe; Tubach, Florence] INSERM, UMR S 738, Paris, France; [Esposito-Farese, Marina; Tubach, Florence] INSERM, CIE 801, Paris, France; [Biard, Lucie; Esposito-Farese, Marina; Tubach, Florence] Hop Bichat Claude Bernard, APHP, Dept Epidemiol & Rech Clin, F-75877 Paris, France; [Ravaud, Philippe] Hop Hotel Dieu, APHP, Ctr Epidemiol Clin, F-75181 Paris, France; [Ravaud, Philippe] Univ Paris 05, Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Tubach, F (corresponding author), Univ Paris Diderot, UMR S 738, Paris, France.	florence.tubach@bch.aphp.fr	ravaud, philippe/C-1694-2009; Biard, Lucie/AAE-8265-2022	Biard, Lucie/0000-0003-0660-1264; Ravaud, Philippe/0000-0001-8264-9206				Albert PS, 2001, AM J EPIDEMIOL, V154, P687, DOI 10.1093/aje/154.8.687; Carracedo-Martinez E, 2009, GAC SANIT, V23, P161, DOI 10.1016/j.gaceta.2008.10.010; Farrington CP, 2006, J R STAT SOC C-APPL, V55, P553, DOI 10.1111/j.1467-9876.2006.00554.x; Farrington CP, 2011, J AM STAT ASSOC, V106, P417, DOI 10.1198/jasa.2011.ap10108; Farrington CP, 2009, BIOSTATISTICS, V10, P3, DOI 10.1093/biostatistics/kxn013; Farrington CP, 2004, VACCINE, V22, P2064, DOI 10.1016/j.vaccine.2004.01.017; Farrington CP, 1996, AM J EPIDEMIOL, V143, P1165; FARRINGTON CP, 1995, BIOMETRICS, V51, P228, DOI 10.2307/2533328; FARRINGTON CP, 1993, INT J EPIDEMIOL, V22, P742, DOI 10.1093/ije/22.4.742; Greenland S, 1996, EPIDEMIOLOGY, V7, P231, DOI 10.1097/00001648-199605000-00003; Grosso A, 2011, EXPERT OPIN DRUG SAF, V10, P337, DOI 10.1517/14740338.2011.562187; Janes H, 2005, STAT MED, V24, P285, DOI 10.1002/sim.1889; Kuhnert R, 2011, STAT MED, V30, P666, DOI 10.1002/sim.4120; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; MACLURE M, 1991, AM J EPIDEMIOL, V133, P144, DOI 10.1093/oxfordjournals.aje.a115853; Maclure M, 2007, PHARMACOEPIDEM DR S, V16, P850, DOI 10.1002/pds.1438; Maclure M, 2012, PHARMACOEPIDEM DR S, V21, P50, DOI 10.1002/pds.2330; Martin-Rodriguez J, 2010, GAC MED MEX, V146, P37; Musonda P, 2006, STAT MED, V25, P2618, DOI 10.1002/sim.2477; PETRI H, 1988, STAT MED, V7, P1171, DOI 10.1002/sim.4780071110; PIEGORSCH WW, 1994, STAT MED, V13, P153, DOI 10.1002/sim.4780130206; Schneeweiss S, 1997, PHARMACOEPIDEM DR S, V6, pS51, DOI 10.1002/(SICI)1099-1557(199710)6:3+<S51::AID-PDS301>3.3.CO;2-J; Smeeth L, 2006, FAM PRACT, V23, P597, DOI 10.1093/fampra/cml025; SUISSA S, 1995, EPIDEMIOLOGY, V6, P248, DOI 10.1097/00001648-199505000-00010; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Viboud C, 2001, J CLIN EPIDEMIOL, V54, P1218, DOI 10.1016/S0895-4356(01)00404-8; Vines SK, 2001, STAT MED, V20, P3039, DOI 10.1002/sim.960.abs; Weldeselassie YG, 2011, EPIDEMIOL INFECT, V139, P1805, DOI 10.1017/S0950268811001531; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Xu SL, 2011, STAT MED, V30, P742, DOI 10.1002/sim.4125	30	28	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49444	10.1371/journal.pone.0049444	http://dx.doi.org/10.1371/journal.pone.0049444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166668	Green Submitted, gold, Green Published			2022-12-27	WOS:000311885300041
J	Twiss, SD; Cairns, C; Culloch, RM; Richards, SA; Pomeroy, PP				Twiss, Sean D.; Cairns, Charlotte; Culloch, Ross M.; Richards, Shane A.; Pomeroy, Patrick P.			Variation in Female Grey Seal (Halichoerus grypus) Reproductive Performance Correlates to Proactive-Reactive Behavioural Types	PLOS ONE			English	Article							STABLE-ISOTOPES; INDIVIDUAL-DIFFERENCES; ANTIPREDATOR BEHAVIOR; ANIMAL PERSONALITY; NORTH-RONA; LACTATION PERFORMANCE; FITNESS CONSEQUENCES; AVIAN PERSONALITIES; NATURAL-SELECTION; COPING STYLES	Consistent individual differences (CIDs) in behaviour, indicative of behavioural types or personalities, have been shown in taxa ranging from Cnidaria to Mammalia. However, despite numerous theoretical explanations there remains limited empirical evidence for selective mechanisms that maintain such variation within natural populations. We examined behavioural types and fitness proxies in wild female grey seals at the North Rona breeding colony. Experiments in 2009 and 2010 employed a remotely-controlled vehicle to deliver a novel auditory stimulus to females to elicit changes in pup-checking behaviour. Mothers tested twice during lactation exhibited highly repeatable individual pup-checking rates within and across breeding seasons. Observations of undisturbed mothers (i.e. experiencing no disturbance from conspecifics or experimental test) also revealed CIDs in pup-checking behaviour. However, there was no correlation between an individuals' pup-checking rate during undisturbed observations with the rate in response to the auditory test, indicating plasticity across situations. The extent to which individuals changed rates of pup-checking from undisturbed to disturbed conditions revealed a continuum of behavioural types from proactive females, who maintained a similar rate throughout, to reactive females, who increased pup-checking markedly in response to the test. Variation in maternal expenditure (daily mass loss rate) was greater among more reactive mothers than proactive mothers. Consequently pups of more reactive mothers had more varied growth rates centred around the long-term population mean. These patterns could not be accounted for by other measured covariates as behavioural type was unrelated to a mother's prior experience, degree of inter-annual site fidelity, physical characteristics of their pupping habitat, pup sex or pup activity. These findings are consistent with the hypothesis that variation in behavioural types is maintained by spatial and temporal environmental variation combined with limits to phenotype-environment matching.	[Twiss, Sean D.; Cairns, Charlotte; Culloch, Ross M.; Richards, Shane A.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Culloch, Ross M.; Pomeroy, Patrick P.] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland	Durham University; University of St Andrews	Twiss, SD (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	s.d.twiss@durham.ac.uk		pomeroy, patrick/0000-0003-1603-5630; Twiss, Sean/0000-0002-1923-8874; Richards, Shane/0000-0002-9638-5827	Natural Environment Research Council (UK); NERC [NE/G008930/1]; Esmee Fairbairn Foundation [EFF 08-1037]; Natural Environment Research Council [smru10001, NE/G008930/1] Funding Source: researchfish	Natural Environment Research Council (UK)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Esmee Fairbairn Foundation; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Dr. Pomeroy's long term research on grey seal reproductive energetics was supported by Natural Environment Research Council (UK) core funding (http://www.nerc.ac.uk/index.asp). Dr. Pomeroy's Photo-Id database was supported by NERC Grant NE/G008930/1 and the Esmee Fairbairn Foundation (EFF 08-1037) (esmeefairbairn.org.uk/). The studies on consistent individual differences in behaviour (personality) were unfunded. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers PCH, 1999, BEHAVIOUR, V136, P469, DOI 10.1163/156853999501423; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; [Anonymous], 2010, R LANG ENV STAT COMP; Archard GA, 2010, J ZOOL, V281, P149, DOI 10.1111/j.1469-7998.2010.00714.x; Austin D, 2004, OIKOS, V105, P15, DOI 10.1111/j.0030-1299.1999.12730.x; Bardi M, 2002, DEV PSYCHOBIOL, V48, P1; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bell AM, 2007, P ROY SOC B-BIOL SCI, V274, P755, DOI 10.1098/rspb.2006.0199; Bell AM, 2010, PHILOS T R SOC B, V365, P4001, DOI 10.1098/rstb.2010.0185; Bell AM, 2009, ANIM BEHAV, V77, P771, DOI 10.1016/j.anbehav.2008.12.022; Betini GS, 2012, ANIM BEHAV, V83, P137, DOI 10.1016/j.anbehav.2011.10.018; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Biro PA, 2010, TRENDS ECOL EVOL, V25, P653, DOI 10.1016/j.tree.2010.08.003; BOAKE CRB, 1989, EVOL ECOL, V3, P173, DOI 10.1007/BF02270919; Bolnick DI, 2003, AM NAT, V161, P1, DOI 10.1086/343878; BONESS DJ, 1979, J ZOOL, V188, P477, DOI 10.1111/j.1469-7998.1979.tb03430.x; Boon AK, 2007, ECOL LETT, V10, P1094, DOI 10.1111/j.1461-0248.2007.01106.x; Briffa M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021963; Briffa M, 2010, CURR BIOL, V20, pR912, DOI 10.1016/j.cub.2010.09.019; Brodie ED, 1999, ANIM BEHAV, V57, P445, DOI 10.1006/anbe.1998.0990; Carere C, 2005, ANIM BEHAV, V70, P795, DOI 10.1016/j.anbehav.2005.01.003; Carere C, 2010, CURR ZOOL, V56, P728, DOI 10.1093/czoolo/56.6.728; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cherel Y, 2007, J ANIM ECOL, V76, P826, DOI 10.1111/j.1365-2656.2007.01238.x; Coppens CM, 2010, PHILOS T R SOC B, V365, P4021, DOI 10.1098/rstb.2010.0217; Couchoux C, 2012, BEHAV ECOL, V23, P290, DOI 10.1093/beheco/arr185; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; Deutsch CJ, 2003, WILDLIFE MONOGR, P1; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Dingemanse NJ, 2010, TRENDS ECOL EVOL, V25, P81, DOI 10.1016/j.tree.2009.07.013; Dingemanse NJ, 2005, BEHAVIOUR, V142, P1159, DOI 10.1163/156853905774539445; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Dochtermann NA, 2010, PHILOS T R SOC B, V365, P4013, DOI 10.1098/rstb.2010.0129; Duckworth RA, 2010, AUK, V127, P752, DOI 10.1525/auk.2010.127.4.752; Duckworth RA, 2009, EVOLUTION, V63, P968, DOI 10.1111/j.1558-5646.2009.00625.x; Ellenberg U, 2009, ANIM BEHAV, V77, P289, DOI 10.1016/j.anbehav.2008.09.021; Estes JA, 2003, J ANIM ECOL, V72, P144, DOI 10.1046/j.1365-2656.2003.00690.x; Gerber LR, 2006, FRONT ECOL ENVIRON, V4, P419, DOI 10.1890/1540-9295(2006)4[419:IBDIDM]2.0.CO;2; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Groothuis TGG, 2011, DEV PSYCHOBIOL, V53, P641, DOI 10.1002/dev.20574; Hayes JP, 1997, J MAMMAL, V78, P274, DOI 10.2307/1382882; Herborn KA, 2010, ANIM BEHAV, V79, P835, DOI 10.1016/j.anbehav.2009.12.026; HEWER H. R., 1964, PROC ZOOL SOC LONDON, V142, P593; Kassen R, 2002, J EVOLUTION BIOL, V15, P173, DOI 10.1046/j.1420-9101.2002.00377.x; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; KOVACS KM, 1987, J ZOOL, V213, P697, DOI 10.1111/j.1469-7998.1987.tb03735.x; Lang SLC, 2009, ECOLOGY, V90, P2513, DOI 10.1890/08-1386.1; LESSELLS CM, 1987, AUK, V104, P116, DOI 10.2307/4087240; Martin JGA, 2008, ANIM BEHAV, V75, P309, DOI 10.1016/j.anbehav.2007.05.026; McConnell BJ, 1999, J APPL ECOL, V36, P573, DOI 10.1046/j.1365-2664.1999.00429.x; Mellish JAE, 1999, PHYSIOL BIOCHEM ZOOL, V72, P677, DOI 10.1086/316708; Minderman J, 2009, BEHAV ECOL, V20, P830, DOI 10.1093/beheco/arp067; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Nussey DH, 2005, J ANIM ECOL, V74, P387, DOI 10.1111/j.1365-2656.2005.00941.x; Pomeroy PP, 1999, J ANIM ECOL, V68, P235, DOI 10.1046/j.1365-2656.1999.00281.x; POMEROY PP, 1994, J ZOOL, V233, P429, DOI 10.1111/j.1469-7998.1994.tb05275.x; Reale D, 2000, ANIM BEHAV, V60, P589, DOI 10.1006/anbe.2000.1530; Reale D, 2003, ANIM BEHAV, V65, P463, DOI 10.1006/anbe.2003.2100; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Reddon AR, 2012, BEHAV ECOL, V23, P242, DOI 10.1093/beheco/arr210; Redman P, 2001, CAN J ZOOL, V79, P1073, DOI 10.1139/cjz-79-6-1073; Revelle W., 2010, PSYCH PROCEDURES PER; Roff DA, 2006, INTRODUCTION TO COMPUTER-INTENSIVE METHODS OF DATA ANALYSIS IN BIOLOGY, P1, DOI 10.2277/ 0521608651; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sih A, 2003, ANIM BEHAV, V65, P29, DOI 10.1006/anbe.2002.2025; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; Sih A, 2004, TRENDS ECOL EVOL, V19, P372, DOI 10.1016/j.tree.2004.04.009; Sih A, 2008, ADV STUD BEHAV, V38, P227, DOI 10.1016/S0065-3454(08)00005-3; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Smout S, 2011, ENVIRON ECOL STAT, V18, P331, DOI 10.1007/s10651-010-0135-y; Sokal R.R., 2012, BIOMETRY; Stamps J, 2010, BIOL REV, V85, P301, DOI 10.1111/j.1469-185X.2009.00103.x; Stamps JA, 2007, ECOL LETT, V10, P355, DOI 10.1111/j.1461-0248.2007.01034.x; Stamps JA, 2010, PHILOS T R SOC B, V365, P4029, DOI 10.1098/rstb.2010.0218; Tinker MT, 2007, DEEP-SEA RES PT II, V54, P330, DOI 10.1016/j.dsr2.2006.11.012; Tucker S, 2008, MAR ECOL PROG SER, V354, P267, DOI 10.3354/meps07263; Tucker S, 2007, MAR ECOL PROG SER, V339, P271, DOI 10.3354/meps339271; Twiss SD, 2000, ANIM BEHAV, V59, P327, DOI 10.1006/anbe.1999.1320; Twiss SD, 2001, ECOGRAPHY, V24, P257, DOI 10.1034/j.1600-0587.2001.240303.x; Twiss SD, 2007, BIOL LETTERS, V3, P12, DOI 10.1098/rsbl.2006.0559; Twiss SD, 2006, MOL ECOL, V15, P1939, DOI 10.1111/j.1365-294X.2006.02927.x; Twiss SD, 2012, MAR MAMMAL SCI, V28, pE280, DOI 10.1111/j.1748-7692.2011.00523.x; Twiss SD, 2010, AQUAT MAMM, V36, P234, DOI 10.1578/AM.36.3.2010.234; van Oers K, 2010, PHILOS T R SOC B, V365, P3991, DOI 10.1098/rstb.2010.0178; VOWLES DM, 1971, ANIM BEHAV, V19, P80, DOI 10.1016/S0003-3472(71)80138-0; WILSON DS, 1993, J COMP PSYCHOL, V107, P250, DOI 10.1037/0735-7036.107.3.250; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Wolf M, 2010, PHILOS T R SOC B, V365, P3959, DOI 10.1098/rstb.2010.0215; [No title captured]	92	22	22	1	102	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 16	2012	7	11							e49598	10.1371/journal.pone.0049598	http://dx.doi.org/10.1371/journal.pone.0049598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	048BN	23166723	Green Accepted, Green Published, gold			2022-12-27	WOS:000311885300056
J	Enoki, S; Iino, R; Morone, N; Kaihatsu, K; Sakakihara, S; Kato, N; Noji, H				Enoki, Sawako; Iino, Ryota; Morone, Nobuhiro; Kaihatsu, Kunihiro; Sakakihara, Shouichi; Kato, Nobuo; Noji, Hiroyuki			Label-Free Single-Particle Imaging of the Influenza Virus by Objective-Type Total Internal Reflection Dark-Field Microscopy	PLOS ONE			English	Article							PLASMA-MEMBRANE INTERFACE; ELECTRON TOMOGRAPHY; TRACKING	Here we report label-free optical imaging of single particles of the influenza virus attached on a glass surface with a simple objective-type total internal reflection dark-field microscopy (TIRDFM). The capability of TIRDFM for the imaging of single viral particles was confirmed from fine correlation of the TIRDFM images with fluorescent immunostaining image and scanning electron microscopy image. The density of scattering spots in the TIRDFM images showed a good linearity against the virus concentration, giving the limit of detection as 1.2 x 10(4) plaque-forming units per milliliter. Our label-free optical imaging method does require neither elaborated sample preparation nor complex optical systems, offering a good platform for rapid and sensitive counting of viral particles.	[Enoki, Sawako; Iino, Ryota; Noji, Hiroyuki] Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo, Japan; [Enoki, Sawako; Iino, Ryota; Noji, Hiroyuki] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo, Japan; [Morone, Nobuhiro] Kyoto Univ, Inst Integrated Cell Mat Sci, Sakyo Ku, Kyoto, Japan; [Kaihatsu, Kunihiro; Sakakihara, Shouichi; Kato, Nobuo] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan	University of Tokyo; Japan Science & Technology Agency (JST); Kyoto University; Osaka University	Noji, H (corresponding author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo, Japan.	hnoji@appchem.t.u-tokyo.ac.jp	Iino, Ryota/B-7746-2011	Iino, Ryota/0000-0003-0110-5704; Morone, Nobuhiro/0000-0002-7672-158X	Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST); Health Labor Science Research Grant [Nano-001];  [23310087]; Grants-in-Aid for Scientific Research [23310087] Funding Source: KAKEN	Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST); Health Labor Science Research Grant; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by the Japan Science and Technology Agency for Core Research for Evolutional Science and Technology (CREST), and supported in part by Grant-in-Aid for Scientific Research (B) (23310087 to NM) and by a Health Labor Science Research Grant (Nano-001 to NM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Daaboul GG, 2010, NANO LETT, V10, P4727, DOI 10.1021/nl103210p; Ewers H, 2007, NANO LETT, V7, P2263, DOI 10.1021/nl070766y; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Kukura P, 2009, NAT METHODS, V6, P923, DOI 10.1038/nmeth.1395; Lamb R.A., 2001, FIELDS VIROLOGY; Mitamura Keiko, 2003, Nihon Rinsho, V61, P1914; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Morone N, 2010, METHODS MOL BIOL, V657, P275, DOI 10.1007/978-1-60761-783-9_22; Nishikawa S, 2010, CELL, V142, P879, DOI 10.1016/j.cell.2010.08.033; TOBITA K, 1975, MED MICROBIOL IMMUN, V162, P23, DOI 10.1007/BF02123574; Ueno H, 2010, BIOPHYS J, V98, P2014, DOI 10.1016/j.bpj.2010.01.011; van de Hulst H.C., 1981, LIGHT SCATTERING SMA; Wang SP, 2010, P NATL ACAD SCI USA, V107, P16028, DOI 10.1073/pnas.1005264107	13	28	29	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49208	10.1371/journal.pone.0049208	http://dx.doi.org/10.1371/journal.pone.0049208			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166613	Green Published, gold			2022-12-27	WOS:000311272300029
J	Gargiulo, F; Ramasco, JJ				Gargiulo, Floriana; Ramasco, Jose J.			Influence of Opinion Dynamics on the Evolution of Games	PLOS ONE			English	Article							PRISONERS-DILEMMA; COOPERATION; EMERGENCE; STRATEGIES; NETWORKS	Under certain circumstances such as lack of information or bounded rationality, human players can take decisions on which strategy to choose in a game on the basis of simple opinions. These opinions can be modified after each round by observing own or others payoff results but can be also modified after interchanging impressions with other players. In this way, the update of the strategies can become a question that goes beyond simple evolutionary rules based on fitness and become a social issue. In this work, we explore this scenario by coupling a game with an opinion dynamics model. The opinion is represented by a continuous variable that corresponds to the certainty of the agents respect to which strategy is best. The opinions transform into actions by making the selection of an strategy a stochastic event with a probability regulated by the opinion. A certain regard for the previous round payoff is included but the main update rules of the opinion are given by a model inspired in social interchanges. We find that the fixed points of the dynamics of the coupled model are different from those of the evolutionary game or the opinion models alone. Furthermore, new features emerge such as the independence of the fraction of cooperators with respect to the topology of the social interaction network or the presence of a small fraction of extremist players.	[Ramasco, Jose J.] IFISC CSIC UIB, Palma de Mallorca, Spain; [Gargiulo, Floriana] CNRS, CAMS, Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; CSIC-UIB - Instituto de Fisica Interdisciplinar y Sistemas Complejos (IFISC); Centre National de la Recherche Scientifique (CNRS)	Ramasco, JJ (corresponding author), IFISC CSIC UIB, Palma de Mallorca, Spain.	jramasco@ifisc.uib-csic.es	Gargiulo, Floriana/GYJ-8061-2022; Ramasco, Jose Javier/F-2860-2010	Ramasco, Jose Javier/0000-0003-2499-6095	French Research National Agency; Spanish Ministry of Economy and Competitiveness (MINECO); MINECO [FIS2011-24785]	French Research National Agency(French National Research Agency (ANR)); Spanish Ministry of Economy and Competitiveness (MINECO)(Spanish Government); MINECO(Spanish Government)	FG receives funding from the French Research National Agency through the project SIMPA. JJR is funded by the Ramon y Cajal program of the Spanish Ministry of Economy and Competitiveness (MINECO). Partial support was received also from MINECO through the project MODASS (FIS2011-24785). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREONI J, 1993, ECON J, V103, P570, DOI 10.2307/2234532; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benaim M, 2003, ECONOMETRICA, V71, P873, DOI 10.1111/1468-0262.00429; Blume LE, 2003, GAME ECON BEHAV, V44, P251, DOI [10.1016/S0899-8256(02)00554-7, 10.1016/S0899-8256(03)00554-7]; BLUME LE, 1993, GAME ECON BEHAV, V5, P387, DOI 10.1006/game.1993.1023; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Claussen JC, 2008, BANACH CTR PUBLICATI, V80, P17, DOI DOI 10.4064/bc80-0-1; Cristelli M, 2012, P INT SCH PHYS, V176, P235, DOI 10.3254/978-1-61499-071-0-235; Deffuant G, 2000, APPLICATIONS OF SIMULATION TO SOCIAL SCIENCES, P87, DOI 10.1142/S0219525900000078; Delton AW, 2011, P NATL ACAD SCI USA, V108, P13335, DOI 10.1073/pnas.1102131108; FOSTER D, 1990, THEOR POPUL BIOL, V38, P219, DOI 10.1016/0040-5809(90)90011-J; Galam S, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046123; Galam S, 2004, PHYSICA A, V333, P453, DOI 10.1016/j.physa.2003.10.041; Galam S, 2007, PHYSICA A, V381, P366, DOI 10.1016/j.physa.2007.03.034; Gardner D., 2009, RISK SCI POLITICFE; Gomez-Gardenes J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.108103; Gracia-Lazaro C, 2012, P NATL ACAD SCI USA, V109, P12922, DOI 10.1073/pnas.1206681109; Gracia-Lazaro C, 2012, SCI REP-UK, V2, DOI 10.1038/srep00325; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hardin G, 1995, LIVING LIMITS ECOLOG; Hofbauer J, 2003, B AM MATH SOC, V40, P479, DOI 10.1090/S0273-0979-03-00988-1; Masuda N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00646; Maynard Smith J., 1982, pi; Mobilia M, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.011134; Nowak MA, 2004, SCIENCE, V303, P793, DOI 10.1126/science.1093411; NOWAK MA, 1992, NATURE, V359, P826, DOI 10.1038/359826a0; Nowak MA, 2004, NATURE, V428, P646, DOI 10.1038/nature02414; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; Roca CP, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.158701; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2008, NATURE, V454, P213, DOI 10.1038/nature06940; Schlag KH, 1998, J ECON THEORY, V78, P130, DOI 10.1006/jeth.1997.2347; SCHUSTER P, 1983, J THEOR BIOL, V100, P533, DOI 10.1016/0022-5193(83)90445-9; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Suri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016836; Sysi-Aho M, 2005, EUR PHYS J B, V44, P129, DOI 10.1140/epjb/e2005-00108-5; Szabo G, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.047107; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/38002; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Traulsen A, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.238701; Traulsen A, 2010, P NATL ACAD SCI USA, V107, P2962, DOI 10.1073/pnas.0912515107; Traulsen A, 2009, P NATL ACAD SCI USA, V106, P709, DOI 10.1073/pnas.0808450106; Vilone D, 2012, SCI REP-UK, V2, DOI 10.1038/srep00686; Vilone D, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.038101; YOUNG HP, 1993, ECONOMETRICA, V61, P57, DOI 10.2307/2951778; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	51	14	14	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48916	10.1371/journal.pone.0048916	http://dx.doi.org/10.1371/journal.pone.0048916			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166600	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300019
J	Guzman, F; Almerao, MP; Korbes, AP; Loss-Morais, G; Margis, R				Guzman, Frank; Almerao, Mauricio P.; Koerbes, Ana P.; Loss-Morais, Guilherme; Margis, Rogerio			Identification of MicroRNAs from Eugenia uniflora by High-Throughput Sequencing and Bioinformatics Analysis	PLOS ONE			English	Article							CONSERVED MICRORNAS; GRAPEVINE MICRORNAS; SHOOT MATURATION; ESSENTIAL OILS; SMALL RNAS; DISCOVERY; GENES; L.; EXPRESSION; ULTRAFAST	Background: microRNAs or miRNAs are small non-coding regulatory RNAs that play important functions in the regulation of gene expression at the post-transcriptional level by targeting mRNAs for degradation or inhibiting protein translation. Eugenia uniflora is a plant native to tropical America with pharmacological and ecological importance, and there have been no previous studies concerning its gene expression and regulation. To date, no miRNAs have been reported in Myrtaceae species. Results: Small RNA and RNA-seq libraries were constructed to identify miRNAs and pre-miRNAs in Eugenia uniflora. Solexa technology was used to perform high throughput sequencing of the library, and the data obtained were analyzed using bioinformatics tools. From 14,489,131 small RNA clean reads, we obtained 1,852,722 mature miRNA sequences representing 45 conserved families that have been identified in other plant species. Further analysis using contigs assembled from RNA-seq allowed the prediction of secondary structures of 25 known and 17 novel pre-miRNAs. The expression of twenty-seven identified miRNAs was also validated using RT-PCR assays. Potential targets were predicted for the most abundant mature miRNAs in the identified pre-miRNAs based on sequence homology. Conclusions: This study is the first large scale identification of miRNAs and their potential targets from a species of the Myrtaceae family without genomic sequence resources. Our study provides more information about the evolutionary conservation of the regulatory network of miRNAs in plants and highlights species-specific miRNAs.	[Guzman, Frank; Koerbes, Ana P.; Margis, Rogerio] Univ Fed Rio Grande do Sul, PPGGBM, Dept Genet, Porto Alegre, RS, Brazil; [Guzman, Frank; Almerao, Mauricio P.; Loss-Morais, Guilherme; Margis, Rogerio] Univ Fed Rio Grande do Sul, PPGBCM, Ctr Biotecnol, Porto Alegre, RS, Brazil; [Margis, Rogerio] Univ Fed Rio Grande do Sul, Dept Biofis, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Margis, R (corresponding author), Univ Fed Rio Grande do Sul, PPGGBM, Dept Genet, Porto Alegre, RS, Brazil.	rogerio.margis@ufrgs.br	Margis, Rogerio/A-7230-2008; Guzman, Fanny fg/K-5592-2013; Almerão, Mauricio/AAF-7961-2019; Morais, Guilherme/M-9853-2013; Guzman, Frank L/H-1271-2014; Almerão, Mauricio P/I-3312-2012	Margis, Rogerio/0000-0002-2871-4473; Guzman, Fanny fg/0000-0003-1537-0904; Guzman, Frank L/0000-0002-5048-4213; 	FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior); PNPD/CAPES; PDJ/CNPq; Research/CNPq	FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PNPD/CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); PDJ/CNPq; Research/CNPq	This research was supported by grants from FAPERGS (Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul) and CNPq (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico). FG received a PhD fellowship from CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior). APK, MPA and RM have PNPD/CAPES, PDJ/CNPq Research/CNPq fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Almeida DJ, 2012, AMBIENCIA GUARAPUAVA, V8, P159; Arai I, 1999, J ETHNOPHARMACOL, V68, P307, DOI 10.1016/S0378-8741(99)00066-5; Axtell MJ, 2011, VIVE DIFFERENCE BIOG, P1; Burt S, 2004, INT J FOOD MICROBIOL, V94, P223, DOI 10.1016/j.ijfoodmicro.2004.03.022; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chuck G, 2007, NAT GENET, V39, P544, DOI 10.1038/ng2001; Colaiacovo M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-595; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Consolini AE, 1999, J ETHNOPHARMACOL, V66, P33, DOI 10.1016/S0378-8741(98)00194-9; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Dezulian T., 2005, GENOME BIOL, V6, pP13, DOI DOI 10.1186/GB-2005-6-11-P13; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Fujii S, 2011, NEW PHYTOL, V191, P37, DOI 10.1111/j.1469-8137.2011.03746.x; Gambino G, 2008, PHYTOCHEM ANALYSIS, V19, P520, DOI 10.1002/pca.1078; Gonzalez-Ibeas D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-393; He SM, 2008, NUCLEIC ACIDS RES, V36, pD170, DOI 10.1093/nar/gkm1011; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kleinow T, 2000, PLANT J, V23, P115, DOI 10.1046/j.1365-313x.2000.00809.x; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Lago JHG, 2011, MOLECULES, V16, P9827, DOI 10.3390/molecules16129827; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Luzia D. M. M., 2010, Revista do Instituto Adolfo Lutz, V69, P175; Lv SZ, 2012, INT J MOL SCI, V13, P2973, DOI 10.3390/ijms13032973; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Martinez G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019523; Matsumura T, 2000, PHARM BIOL, V38, P302, DOI 10.1076/1388-0209(200009)3841-AFT302; Milne I, 2010, BIOINFORMATICS, V26, P401, DOI 10.1093/bioinformatics/btp666; Moxon S, 2008, BIOINFORMATICS, V24, P2252, DOI 10.1093/bioinformatics/btn428; Ogunwande I. A., 2005, International Journal of Aromatherapy, V15, P147, DOI 10.1016/j.ijat.2005.07.004; Okoh-Esene R. U., 2011, Journal of Natural Product and Plant Resources, V1, P1; Pantaleo V, 2010, PLANT J, V62, P960, DOI [10.1111/j.1365-313X.2010.04208.x, 10.1111/j.0960-7412.2010.04208.x]; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Poethig RS, 2009, CURR OPIN GENET DEV, V19, P374, DOI 10.1016/j.gde.2009.06.001; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Puzey JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033034; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Santos KK a, 2012, EXPT PARASITOLOGY; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schreiber AW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-129; Schwarz S, 2008, PLANT MOL BIOL, V67, P183, DOI 10.1007/s11103-008-9310-z; Shikata M, 2009, PLANT CELL PHYSIOL, V50, P2133, DOI 10.1093/pcp/pcp148; Simon SA, 2011, CURR OPIN PLANT BIOL, V14, P148, DOI 10.1016/j.pbi.2010.11.007; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Victoria FN, 2012, FOOD CHEM TOXICOL, V50, P2668, DOI 10.1016/j.fct.2012.05.002; Wang C, 2011, PHYSIOL PLANTARUM, V143, P64, DOI 10.1111/j.1399-3054.2011.01481.x; Wang JW, 2005, PLANT CELL, V17, P2204, DOI 10.1105/tpc.105.033076; Wu G, 2009, CELL, V138, P750, DOI 10.1016/j.cell.2009.06.031; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie KB, 2006, PLANT PHYSIOL, V142, P280, DOI 10.1104/pp.106.084475; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xu CY, 2007, ANN BOT-LONDON, V99, P439, DOI 10.1093/aob/mcl285; Yamada T, 2011, NUCLEIC ACIDS RES, V39, pW412, DOI 10.1093/nar/gkr313; Yang JH, 2006, NUCLEIC ACIDS RES, V34, P1892, DOI 10.1093/nar/gkl118; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang JZ, 2012, MOL BIOTECHNOL, V51, P44, DOI 10.1007/s12033-011-9439-x; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3	63	24	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49811	10.1371/journal.pone.0049811	http://dx.doi.org/10.1371/journal.pone.0049811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166775	Green Published, Green Submitted, gold			2022-12-27	WOS:000311272300071
J	Shah, SN; Kerr, C; Cope, L; Zambidis, E; Liu, C; Hillion, J; Belton, A; Huso, DL; Resar, LMS				Shah, Sandeep N.; Kerr, Candace; Cope, Leslie; Zambidis, Elias; Liu, Cyndi; Hillion, Joelle; Belton, Amy; Huso, David L.; Resar, Linda M. S.			HMGA1 Reprograms Somatic Cells into Pluripotent Stem Cells by Inducing Stem Cell Transcriptional Networks	PLOS ONE			English	Article							GENE-EXPRESSION; TRANSGENIC MICE; TARGET GENE; MYC TARGET; PROTEINS; SEQUENCE; GROWTH; MOUSE; I/Y; TRANSFORMATION	Background: Although recent studies have identified genes expressed in human embryonic stem cells (hESCs) that induce pluripotency, the molecular underpinnings of normal stem cell function remain poorly understood. The high mobility group A1 (HMGA1) gene is highly expressed in hESCs and poorly differentiated, stem-like cancers; however, its role in these settings has been unclear. Methods/Principal Findings: We show that HMGA1 is highly expressed in fully reprogrammed iPSCs and hESCs, with intermediate levels in ECCs and low levels in fibroblasts. When hESCs are induced to differentiate, HMGA1 decreases and parallels that of other pluripotency factors. Conversely, forced expression of HMGA1 blocks differentiation of hESCs. We also discovered that HMGA1 enhances cellular reprogramming of somatic cells to iPSCs together with the Yamanaka factors (OCT4, SOX2, KLF4, cMYC - OSKM). HMGA1 increases the number and size of iPSC colonies compared to OSKM controls. Surprisingly, there was normal differentiation in vitro and benign teratoma formation in vivo of the HMGA1-derived iPSCs. During the reprogramming process, HMGA1 induces the expression of pluripotency genes, including SOX2, LIN28, and cMYC, while knockdown of HMGA1 in hESCs results in the repression of these genes. Chromatin immunoprecipitation shows that HMGA1 binds to the promoters of these pluripotency genes in vivo. In addition, interfering with HMGA1 function using a short hairpin RNA or a dominant-negative construct blocks cellular reprogramming to a pluripotent state. Conclusions: Our findings demonstrate for the first time that HMGA1 enhances cellular reprogramming from a somatic cell to a fully pluripotent stem cell. These findings identify a novel role for HMGA1 as a key regulator of the stem cell state by inducing transcriptional networks that drive pluripotency. Although further studies are needed, these HMGA1 pathways could be exploited in regenerative medicine or as novel therapeutic targets for poorly differentiated, stem-like cancers.	[Shah, Sandeep N.; Hillion, Joelle; Belton, Amy; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Div Hematol, Baltimore, MD 21218 USA; [Shah, Sandeep N.; Belton, Amy; Resar, Linda M. S.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Resar, LMS (corresponding author), Johns Hopkins Univ, Sch Med, Div Hematol, Baltimore, MD 21218 USA.	lresar@jhmi.edu			National Institutes of Health; Alex's Lemonade Stand Foundation; St. Baldrick's Foundation; Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL099775, R03HL096220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alex's Lemonade Stand Foundation; St. Baldrick's Foundation; Maryland Stem Cell Research Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the National Institutes of Health (LR, CK, DLH), Alex's Lemonade Stand Foundation (LR, AB, JH), St. Baldrick's Foundation (LR) and the Maryland Stem Cell Research Fund (SNS, LC, EZ, AB, LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS PW, 1984, LAB INVEST, V50, P147; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Battista S, 2003, FASEB J, V17, P1496, DOI 10.1096/fj.02-0977fje; Belton A, 2012, AACR 2012; Belton A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030034; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Chaerkady R, 2010, PROTEOMICS, V10, P1359, DOI 10.1002/pmic.200900483; Chaerkady R, 2009, J PROTEOME RES, V8, P1315, DOI 10.1021/pr8006667; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chou BK, 2011, CELL RES, V21, P518, DOI 10.1038/cr.2011.12; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; Dhar A, 2004, ONCOGENE, V23, P4466, DOI 10.1038/sj.onc.1207581; Di Cello F, 2008, MOL CANCER THER, V7, P2090, DOI 10.1158/1535-7163.MCT-07-2282; Di Cello F, 2008, MOL CANCER RES, V6, P743, DOI 10.1158/1541-7786.MCR-07-0095; Dolde CE, 2002, BREAST CANCER RES TR, V71, P181, DOI 10.1023/A:1014444114804; Fedele M, 2005, ONCOGENE, V24, P3427, DOI 10.1038/sj.onc.1208501; Flohr AM, 2003, HISTOL HISTOPATHOL, V18, P999, DOI 10.14670/HH-18.999; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Hillion J, 2012, PANCREATOLOGY, V12, P372, DOI 10.1016/j.pan.2012.05.005; Hillion J, 2009, MOL CANCER RES, V7, P1803, DOI 10.1158/1541-7786.MCR-08-0336; Hillion J, 2008, CANCER RES, V68, P10121, DOI 10.1158/0008-5472.CAN-08-2121; Himes SR, 2000, J IMMUNOL, V164, P3157, DOI 10.4049/jimmunol.164.6.3157; Hommura F, 2004, MOL CANCER RES, V2, P305; Hristov AC, 2010, MODERN PATHOL, V23, P98, DOI 10.1038/modpathol.2009.139; Hristov AC, 2009, MODERN PATHOL, V22, P43, DOI 10.1038/modpathol.2008.140; JOHNSON KR, 1992, GENOMICS, V12, P503, DOI 10.1016/0888-7543(92)90441-T; JOHNSON KR, 1988, J BIOL CHEM, V263, P18338; Karp JE, 2011, BLOOD, V117, P3302, DOI 10.1182/blood-2010-09-310862; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Liau SS, 2006, CANCER RES, V66, P11613, DOI 10.1158/0008-5472.CAN-06-1460; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Mali P, 2010, METHODS MOL BIOL, V636, P191, DOI 10.1007/978-1-60761-691-7_12; Mali P, 2010, STEM CELLS, V28, P713, DOI 10.1002/stem.402; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; Moliterno AR, 2011, CELL RES, V21, P1528, DOI 10.1038/cr.2011.96; Nagai K, 2010, BIOCHEM BIOPH RES CO, V395, P258, DOI 10.1016/j.bbrc.2010.03.176; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nelson DM, 2011, LEUKEMIA LYMPHOMA, V52, P1999, DOI 10.3109/10428194.2011.591012; Ohm JE, 2010, CANCER RES, V70, P7662, DOI 10.1158/0008-5472.CAN-10-1361; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pedulla ML, 2001, GENE, V271, P51, DOI 10.1016/S0378-1119(01)00500-5; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Pomeroy SL, 2002, NATURE, V415, P436, DOI 10.1038/415436a; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; Reeves R, 2001, BBA-GENE STRUCT EXPR, V1519, P13, DOI 10.1016/S0167-4781(01)00215-9; Reeves R, 2001, MOL CELL BIOL, V21, P575, DOI 10.1128/MCB.21.2.575-594.2001; Resar LM, 2011, BLOOD, V117, P5788, DOI 10.1182/blood-2011-04-346668; Resar LMS, 2010, CANCER RES, V70, P436, DOI 10.1158/0008-5472.CAN-09-1212; Sarhadi V, 2006, J PATHOL, V209, P206, DOI 10.1002/path.1960; Schuldenfrei A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-549; Shah SN, 2012, HISTOL HISTOPATHOL, V27, P567, DOI 10.14670/HH-27.567; Takaha N, 2004, PROSTATE, V60, P160, DOI 10.1002/pros.20049; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tesfaye A, 2007, CANCER RES, V67, P3998, DOI 10.1158/0008-5472.CAN-05-1684; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Wang Y, 2008, STEM CELL REV REP, V6, P282; Wood LJ, 2000, MOL CELL BIOL, V20, P5490, DOI 10.1128/MCB.20.15.5490-5502.2000; Wood LJ, 2000, CANCER RES, V60, P4256; Xu Y, 2004, CANCER RES, V64, P3371, DOI 10.1158/0008-5472.CAN-04-0044; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zambidis ET, 2008, BLOOD, V112, P3601, DOI 10.1182/blood-2008-03-144766; Zeller KI, 2001, J BIOL CHEM, V276, P48285, DOI 10.1074/jbc.M108506200; Zhao R, 2008, J CELL BIOCHEM, V105, P949, DOI 10.1002/jcb.21871; Zhao TB, 2011, NATURE, V474, P212, DOI 10.1038/nature10135; Zhou GL, 2001, P NATL ACAD SCI USA, V98, P13966, DOI 10.1073/pnas.241526198; ZHOU XJ, 1995, NATURE, V376, P771, DOI 10.1038/376771a0	69	62	66	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e48533	10.1371/journal.pone.0048533	http://dx.doi.org/10.1371/journal.pone.0048533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166588	gold, Green Submitted, Green Published			2022-12-27	WOS:000311272300009
J	Yoon, G; Westermeyer, J; Warwick, M; Kuskowski, MA				Yoon, Gihyun; Westermeyer, Joseph; Warwick, Marion; Kuskowski, Michael A.			Substance Use Disorders and Adoption: Findings from a National Sample	PLOS ONE			English	Article							ALCOHOL-USE DISORDER; INTERVIEW SCHEDULE AUDADIS; ENVIRONMENTAL RISK-FACTORS; GENERAL-POPULATION SAMPLE; MENTAL-HEALTH; INTERCOUNTRY ADOPTEES; PSYCHIATRIC-DISORDERS; BEHAVIOR PROBLEMS; DRUG-DEPENDENCE; UNITED-STATES	Background: Prior research has shown that adoptees have a higher rate of substance use disorders (SUDs) than nonadoptees. But these findings have not been verified with a population-based sample of adult adoptees in the United States. Also, no previous adoption study has measured the prevalence of each specific substance use disorder (SUD). We aimed to compare lifetime prevalence rates and odds ratios of SUDs in adopted and nonadopted adults. Methods and Findings: The data come from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). The main outcome measure was the prevalence of lifetime SUDs in adopted (n = 378) and nonadopted adults (n = 42503). Adoptees and nonadoptees were compared to estimate the odds of lifetime SUDs using logistic regression analysis. Adoptees had higher prevalence rates of lifetime SUDs than nonadoptees. Overall, adoptees had a 1.87-fold increase (adjusted odds ratio [AOR] 1.87, 95% CI 1.51-2.31) in the odds of any lifetime SUD compared to nonadoptees. For each SUD, adoptees had higher odds for alcohol abuse/dependence (AOR 1.84), nicotine dependence (AOR 1.78), cannabis abuse/dependence (AOR 1.77), cocaine abuse/dependence (AOR 2.54), amphetamine abuse/dependence (AOR 3.14), hallucinogen abuse/dependence (AOR 2.85), opioid abuse/dependence (AOR 2.21), and other drug abuse/dependence (AOR 2.87) compared to nonadoptees. This study also identified two adoption-specific risk factors (Hispanic, never married) associated with any lifetime SUD. Conclusions: This study demonstrated an increased risk of lifetime SUDs in adopted adults. The findings can be useful for clinicians and policy makers to provide education, prevention, and support for adoptees and their families.	[Yoon, Gihyun; Westermeyer, Joseph; Warwick, Marion; Kuskowski, Michael A.] Univ Minnesota, Sch Med, Minneapolis VA Hlth Care Syst, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Yoon, G (corresponding author), Univ Minnesota, Sch Med, Minneapolis VA Hlth Care Syst, Minneapolis, MN 55455 USA.	yoonx033@umn.edu						Agrawal A, 2006, ADDICTION, V101, P801, DOI 10.1111/j.1360-0443.2006.01399.x; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; ANDRESEN ILK, 1992, J CHILD PSYCHOL PSYC, V33, P427, DOI 10.1111/j.1469-7610.1992.tb00877.x; Bezdjian S, 2011, CLIN PSYCHOL REV, V31, P1209, DOI 10.1016/j.cpr.2011.07.005; BOHMAN M, 1979, ACTA PSYCHIAT SCAND, V60, P106, DOI 10.1111/j.1600-0447.1979.tb00269.x; Brand AE, 1999, J CHILD PSYCHOL PSYC, V40, P1221, DOI 10.1111/1469-7610.00538; Brodzinsky D., 1990, PSYCHOL ADOPTION; Buster MA, 2000, J BIOSOC SCI, V32, P177, DOI 10.1017/S0021932000001772; CADORET RJ, 1995, ARCH GEN PSYCHIAT, V52, P42; CADORET RJ, 1986, ARCH GEN PSYCHIAT, V43, P1131; Cantor-Graae E, 2007, J CHILD PSYCHOL PSYC, V48, P1053, DOI 10.1111/j.1469-7610.2007.01788.x; Child Welfare Information Gateway, 2011, MAN CHILDR WER AD 20; Cottler LB, 1997, DRUG ALCOHOL DEPEN, V47, P195, DOI 10.1016/S0376-8716(97)00090-2; FERGUSSON DM, 1995, J CHILD PSYCHOL PSYC, V36, P597, DOI 10.1111/j.1469-7610.1995.tb02316.x; Goldman D, 2005, NAT REV GENET, V6, P521, DOI 10.1038/nrg1635; Grant B., 2001, ALCOHOL USE DISORDER; Grant BF, 2003, DRUG ALCOHOL DEPEN, V71, P7, DOI 10.1016/S0376-8716(03)00070-X; Grant BF, 2004, ARCH GEN PSYCHIAT, V61, P807, DOI 10.1001/archpsyc.61.8.807; GRANT BF, 1995, DRUG ALCOHOL DEPEN, V39, P37, DOI 10.1016/0376-8716(95)01134-K; Grant BF, 2003, SOURCE ACCURACY STAT; Hasin D, 1997, DRUG ALCOHOL DEPEN, V44, P133, DOI 10.1016/S0376-8716(97)01332-X; Hjern A, 2002, LANCET, V360, P443, DOI 10.1016/S0140-6736(02)09674-5; Juffer F, 2005, JAMA-J AM MED ASSOC, V293, P2501, DOI 10.1001/jama.293.20.2501; Kendler KS, 2003, AM J PSYCHIAT, V160, P687, DOI 10.1176/appi.ajp.160.4.687; Kendler KS, 2012, ARCH GEN PH IN PRESS; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Keyes MA, 2008, ARCH PEDIAT ADOL MED, V162, P419, DOI 10.1001/archpedi.162.5.419; Kim WJ, 2002, LANCET, V360, P423, DOI 10.1016/S0140-6736(02)09681-2; Langbehn DR, 2003, DRUG ALCOHOL DEPEN, V69, P151, DOI 10.1016/S0376-8716(02)00310-1; Marsiglia Flavio F, 2012, J Ethn Subst Abuse, V11, P226, DOI 10.1080/15332640.2012.701566; Miller BC, 2000, CHILD DEV, V71, P1458, DOI 10.1111/1467-8624.00239; Miller LC, 2005, JAMA-J AM MED ASSOC, V293, P2533, DOI 10.1001/jama.293.20.2533; Newlin DB, 2000, ALCOHOL CLIN EXP RES, V24, P1785, DOI 10.1097/00000374-200012000-00007; Ornoy A, 2010, CHILD ABUSE NEGLECT, V34, P354, DOI 10.1016/j.chiabu.2009.09.012; REGIER DA, 1988, ARCH GEN PSYCHIAT, V45, P977; Sigvardsson S, 1996, ARCH GEN PSYCHIAT, V53, P681; Slap G, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e30; Tieman W, 2005, AM J PSYCHIAT, V162, P592, DOI 10.1176/appi.ajp.162.3.592; United Nations, 2009, CHILD AD TRENDS POL; van der Vegt EJM, 2009, SOC PSYCH PSYCH EPID, V44, P724, DOI 10.1007/s00127-009-0494-6; van Ijzendoorn MH, 2005, PSYCHOL BULL, V131, P301, DOI 10.1037/0033-2909.131.2.301; Westermeyer J, 2007, AM J DRUG ALCOHOL AB, V33, P455, DOI 10.1080/00952990701315541; Yates WR, 1998, ALCOHOL CLIN EXP RES, V22, P914, DOI 10.1111/j.1530-0277.1998.tb03889.x; Yates WR, 1996, DRUG ALCOHOL DEPEN, V41, P9, DOI 10.1016/0376-8716(96)01221-5	44	17	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49655	10.1371/journal.pone.0049655	http://dx.doi.org/10.1371/journal.pone.0049655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	039UP	23166740	Green Published, gold, Green Submitted			2022-12-27	WOS:000311272300063
J	Halavaty, AS; Borek, D; Tyson, GH; Veesenmeyer, JL; Shuvalova, L; Minasov, G; Otwinowski, Z; Hauser, AR; Anderson, WF				Halavaty, Andrei S.; Borek, Dominika; Tyson, Gregory H.; Veesenmeyer, Jeff L.; Shuvalova, Ludmilla; Minasov, George; Otwinowski, Zbyszek; Hauser, Alan R.; Anderson, Wayne F.			Structure of the Type III Secretion Effector Protein ExoU in Complex with Its Chaperone SpcU	PLOS ONE			English	Article							MEMBRANE LOCALIZATION DOMAIN; AERUGINOSA CYTOTOXIN EXOU; PHOSPHOLIPASE-ACTIVITY; CRYSTAL-STRUCTURE; PLASMA-MEMBRANE; OMEGA-LOOPS; PSEUDOMONAS; TOXIN; IDENTIFICATION; ACTIVATION	Disease causing bacteria often manipulate host cells in a way that facilitates the infectious process. Many pathogenic gram-negative bacteria accomplish this by using type III secretion systems. In these complex secretion pathways, bacterial chaperones direct effector proteins to a needle-like secretion apparatus, which then delivers the effector protein into the host cell cytosol. The effector protein ExoU and its chaperone SpcU are components of the Pseudomonas aeruginosa type III secretion system. Secretion of ExoU has been associated with more severe infections in both humans and animal models. Here we describe the 1.92 angstrom X-ray structure of the ExoU-SpcU complex, a full-length type III effector in complex with its full-length cognate chaperone. Our crystallographic data allow a better understanding of the mechanism by which ExoU kills host cells and provides a foundation for future studies aimed at designing inhibitors of this potent toxin.	[Halavaty, Andrei S.; Shuvalova, Ludmilla; Minasov, George; Anderson, Wayne F.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Halavaty, AS (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.	wf-anderson@northwestern.edu	Borek, Dominika M/D-2943-2011	Borek, Dominika M/0000-0002-4321-6253; Tyson, Gregory/0000-0002-2729-5035; Minasov, George/0000-0001-5460-3462; Otwinowski, Zbyszek/0000-0003-3640-8545	NCI NIH HHS [CA060553, P30 CA060553] Funding Source: Medline; NIAID NIH HHS [K24 AI104831, R01 AI075191, R01AI075191, HHSN272200700058C, R01AI053674, R01 AI053674] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053674, R01AI075191, K24AI104831] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anderson DM, 2011, MOL MICROBIOL, V82, P1454, DOI 10.1111/j.1365-2958.2011.07904.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benson MA, 2011, BIOPHYS J, V100, P1335, DOI 10.1016/j.bpj.2011.01.056; Birtalan SC, 2002, MOL CELL, V9, P971, DOI 10.1016/S1097-2765(02)00529-4; Borek D, 2007, J SYNCHROTRON RADIAT, V14, P24, DOI 10.1107/S0909049506046589; Borek D, 2010, ACTA CRYSTALLOGR D, V66, P426, DOI 10.1107/S0907444909040177; Cowtan K, 1998, ACTA CRYSTALLOGR D, V54, P487, DOI 10.1107/S0907444997011980; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; FETROW JS, 1995, FASEB J, V9, P708, DOI 10.1096/fasebj.9.9.7601335; Finck-Barbancon V, 1998, J BACTERIOL, V180, P6224; Finck-Barbancon V, 2001, J BACTERIOL, V183, P4330, DOI 10.1128/JB.183.14.4330-4344.2001; Geissler B, 2012, CELL MICROBIOL, V14, P286, DOI 10.1111/j.1462-5822.2011.01718.x; Geissler B, 2010, P NATL ACAD SCI USA, V107, P5581, DOI 10.1073/pnas.0908700107; Gendrin C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002637; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kitadokoro K, 2007, P NATL ACAD SCI USA, V104, P5139, DOI 10.1073/pnas.0608197104; Knablein J, 1997, J MOL BIOL, V270, P1, DOI 10.1006/jmbi.1997.1074; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Lykken GL, 2006, J BACTERIOL, V188, P6832, DOI 10.1128/JB.00884-06; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Minasov G, 2012, PROTEIN DATA BANK PD, DOI [10.2210/pdb4err/pdb, DOI 10.2210/PDB4ERR/PDB]; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Myszka DG, 1998, TRENDS BIOCHEM SCI, V23, P149, DOI 10.1016/S0968-0004(98)01183-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Otwinowski Z, 1991, MAXIMUM LIKELIHOOD R; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Pal M, 2003, PROTEINS, V51, P591, DOI 10.1002/prot.10376; Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4; Pei JM, 2009, PROTEINS, V77, P413, DOI 10.1002/prot.22447; Phan J, 2004, ACTA CRYSTALLOGR D, V60, P1591, DOI 10.1107/S0907444904017597; Phillips RM, 2003, J BIOL CHEM, V278, P41326, DOI 10.1074/jbc.M302472200; Prochazkova K, 2009, J BIOL CHEM, V284, P26557, DOI 10.1074/jbc.M109.025510; Rabin SDP, 2006, INFECT IMMUN, V74, P2552, DOI 10.1128/IAI.74.5.2552-2561.2006; Rabin SDP, 2005, INFECT IMMUN, V73, P573, DOI 10.1128/IAI.73.1.573-582.2005; Reinert DJ, 2005, J MOL BIOL, V351, P973, DOI 10.1016/j.jmb.2005.06.071; RISLER JL, 1988, J MOL BIOL, V204, P1019, DOI 10.1016/0022-2836(88)90058-7; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2006, BIOCHEMISTRY-US, V45, P10368, DOI 10.1021/bi060788j; Schmalzer KM, 2010, J BACTERIOL, V192, P1801, DOI 10.1128/JB.00904-09; Schubot FD, 2005, J MOL BIOL, V346, P1147, DOI 10.1016/j.jmb.2004.12.036; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Six DA, 2003, J BIOL CHEM, V278, P23842, DOI 10.1074/jbc.M301386200; Stebbins CE, 2001, NATURE, V414, P77, DOI 10.1038/35102073; Stirling FR, 2006, CELL MICROBIOL, V8, P1294, DOI 10.1111/j.1462-5822.2006.00710.x; Tamura M, 2004, BIOCHEM BIOPH RES CO, V316, P323, DOI 10.1016/j.bbrc.2004.02.050; Veesenmeyer JL, 2010, INFECT IMMUN, V78, P3346, DOI 10.1128/IAI.00223-10; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002	62	34	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49388	10.1371/journal.pone.0049388	http://dx.doi.org/10.1371/journal.pone.0049388			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166655	gold, Green Published, Green Submitted			2022-12-27	WOS:000311151900135
J	Massat, I; Slama, H; Kavec, M; Linotte, S; Mary, A; Baleriaux, D; Metens, T; Mendlewicz, J; Peigneux, P				Massat, Isabelle; Slama, Hichem; Kavec, Martin; Linotte, Sylvie; Mary, Alison; Baleriaux, Daniele; Metens, Thierry; Mendlewicz, Julien; Peigneux, Philippe			Working Memory-Related Functional Brain Patterns in Never Medicated Children with ADHD	PLOS ONE			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY-DISORDER; DEFAULT-MODE; LIFE-SPAN; ACTIVATION; ADULTS; CONNECTIVITY; METAANALYSIS; DYSFUNCTION; BACK	Attention Deficit/Hyperactivity Disorder (ADHD) is a pervasive neurodevelopmental disorder characterized by 3 clusters of age-inappropriate cardinal symptoms: inattention, hyperactivity and impulsivity. These clinical/behavioural symptoms are assumed to result from disturbances within brain systems supporting executive functions including working memory (WM), which refers to the ability to transiently store and flexibly manipulate task-relevant information. Ongoing or past medications, co-morbidity and differences in task performance are potential, independent confounds in assessing the integrity of cerebral patterns in ADHD. In the present study, we recorded WM-related cerebral activity during a memory updating N-back task using functional Magnetic Resonance Imaging (fMRI) in control children and never medicated, prepubescent children with ADHD but without comorbid symptoms. Despite similar updating performance than controls, children with ADHD exhibited decreased, below baseline WM-related activation levels in a widespread cortico-subcortical network encompassing bilateral occipital and inferior parietal areas, caudate nucleus, cerebellum and functionally connected brainstem nuclei. Distinctive functional connectivity patterns were also found in the ADHD in these regions, with a tighter coupling in the updating than in the control condition with a distributed WM-related cerebral network. Especially, cerebellum showed tighter coupling with activity in an area compatible with the brainstem red nucleus. These results in children with clinical core symptoms of ADHD but without comorbid affections and never treated with medication yield evidence for a core functional neuroanatomical network subtending WM-related processes in ADHD, which may participate to the pathophysiology and expression of clinical symptoms.	[Massat, Isabelle; Slama, Hichem; Mary, Alison; Peigneux, Philippe] Univ Libre Bruxelles, CRCN Ctr Res Cognit & Neurosci, UR2NF Neuropsychol & Funct Neuroimaging Res, Brussels, Belgium	Universite Libre de Bruxelles	Massat, I (corresponding author), Univ Libre Bruxelles, CRCN Ctr Res Cognit & Neurosci, UR2NF Neuropsychol & Funct Neuroimaging Res, Brussels, Belgium.	philippe.peigneux@ulb.ac.be	Slama, Hichem/HGA-3213-2022; Metens, Thierry/AAF-8100-2020	Slama, Hichem/0000-0003-3856-4488; Mary, Alison/0000-0002-4298-1922; Peigneux, Philippe/0000-0003-4745-1434; Metens, Thierry/0000-0002-3404-7224; MASSAT, ISABELLE/0000-0002-3139-102X				Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bayerl M, 2010, NEUROREPORT, V21, P442, DOI 10.1097/WNR.0b013e328338b9be; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bush G, 2010, NEUROPSYCHOPHARMACOL, V35, P278, DOI 10.1038/npp.2009.120; Carmona S, 2009, BIOL PSYCHIAT, V66, P972, DOI 10.1016/j.biopsych.2009.05.013; CASEY BJ, 1995, NEUROIMAGE, V2, P221, DOI 10.1006/nimg.1995.1029; Castellanos FX, 2002, JAMA-J AM MED ASSOC, V288, P1740, DOI 10.1001/jama.288.14.1740; Castellanos FX, 2006, TRENDS COGN SCI, V10, P117, DOI 10.1016/j.tics.2006.01.011; Cherkasova MV, 2009, CAN J PSYCHIAT, V54, P651, DOI 10.1177/070674370905401002; Ciesielski KT, 2006, NEUROIMAGE, V33, P980, DOI 10.1016/j.neuroimage.2006.07.028; Crone EA, 2006, P NATL ACAD SCI USA, V103, P9315, DOI 10.1073/pnas.0510088103; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Ellison-Wright I, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-51; Fassbender C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027240; Finn AS, 2010, J NEUROSCI, V30, P11062, DOI 10.1523/JNEUROSCI.6266-09.2010; Friston K.J., 2003, HUMAN BRAIN FUNCTION; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Gevins A, 2000, CEREB CORTEX, V10, P829, DOI 10.1093/cercor/10.9.829; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Habas C, 2010, CEREBELLUM, V9, P167, DOI 10.1007/s12311-009-0145-1; Habas C, 2010, CEREBELLUM, V9, P22, DOI 10.1007/s12311-009-0119-3; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hechtman L, 2009, CAN J PSYCHIAT, V54, P649, DOI 10.1177/070674370905401001; Helps SK, 2010, BRAIN RES, V1322, P134, DOI 10.1016/j.brainres.2010.01.057; Johnson MH, 2001, CURR OPIN NEUROBIOL, V11, P213, DOI 10.1016/S0959-4388(00)00199-9; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kobel M, 2009, EUR J PAEDIATR NEURO, V13, P516, DOI 10.1016/j.ejpn.2008.10.008; Lewis SJG, 2004, EUR J NEUROSCI, V19, P755, DOI 10.1111/j.1460-9568.2004.03108.x; Mackie S, 2007, AM J PSYCHIAT, V164, P647, DOI 10.1176/appi.ajp.164.4.647; Marvel CL, 2010, CORTEX, V46, P880, DOI 10.1016/j.cortex.2009.08.017; Mazaheri A, 2010, BIOL PSYCHIAT, V67, P617, DOI 10.1016/j.biopsych.2009.11.022; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Penny W., 2003, HUMAN BRAIN FUNCTION; Polanczyk G, 2007, CURR OPIN PSYCHIATR, V20, P386, DOI 10.1097/YCO.0b013e3281568d7a; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Schweitzer JB, 2004, BIOL PSYCHIAT, V56, P597, DOI 10.1016/j.biopsych.2004.07.011; Schweitzer JB, 2003, NEUROPSYCHOPHARMACOL, V28, P967, DOI 10.1038/sj.npp.1300110; Sheridan MA, 2010, J ATTEN DISORD, V14, P69, DOI 10.1177/1087054709347444; Silk T, 2005, BRIT J PSYCHIAT, V187, P282, DOI 10.1192/bjp.187.3.282; Sonuga-Barke EJS, 2007, NEUROSCI BIOBEHAV R, V31, P977, DOI 10.1016/j.neubiorev.2007.02.005; Sonuga-Barke EJS, 2005, BIOL PSYCHIAT, V57, P1231, DOI 10.1016/j.biopsych.2004.09.008; Thomason ME, 2009, J COGNITIVE NEUROSCI, V21, P316, DOI 10.1162/jocn.2008.21028; Valera EM, 2005, BIOL PSYCHIAT, V57, P439, DOI 10.1016/j.biopsych.2004.11.034; Valera EM, 2007, BIOL PSYCHIAT, V61, P1361, DOI 10.1016/j.biopsych.2006.06.011; Valera EM, 2010, AM J PSYCHIAT, V167, P86, DOI 10.1176/appi.ajp.2009.09020249; Vance A, 2007, MOL PSYCHIATR, V12, P826, DOI 10.1038/sj.mp.4001999; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wilens TE, 2002, ANNU REV MED, V53, P113, DOI 10.1146/annurev.med.53.082901.103945; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006; Woodward TS, 2006, NEUROSCIENCE, V139, P317, DOI 10.1016/j.neuroscience.2005.05.043; Worsley KJ, 1996, HUM BRAIN MAPP, V4, P58, DOI 10.1002/(SICI)1097-0193(1996)4:1<58::AID-HBM4>3.0.CO;2-O	52	49	49	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49392	10.1371/journal.pone.0049392	http://dx.doi.org/10.1371/journal.pone.0049392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166657	Green Published, gold, Green Submitted			2022-12-27	WOS:000311151900136
J	Pagabeleguem, S; Sangare, M; Bengaly, Z; Akoudjin, M; Belem, AMG; Bouyer, J				Pagabeleguem, Soumaila; Sangare, Mamadou; Bengaly, Zakaria; Akoudjin, Massouroudin; Belem, Adrien M. G.; Bouyer, Jeremy			Climate, Cattle Rearing Systems and African Animal Trypanosomosis Risk in Burkina Faso	PLOS ONE			English	Article							RIVERINE TSETSE-FLIES; DIAGNOSIS; EXAMPLE; IMPACT	Background: In sub-Saharan countries infested by tsetse flies, African Animal Trypanosomosis (AAT) is considered as the main pathological constraint to cattle breeding. Africa has known a strong climatic change and its population was multiplied by four during the last half-century. The aim of this study was to characterize the impact of production practices and climate on tsetse occurrence and abundance, and the associated prevalence of AAT in Burkina Faso. Methodology/Principal Findings: Four sites were selected along a South-north transect of increasing aridity. The study combines parasitological and entomological surveys. For the parasitological aspect, blood samples were collected from 1,041 cattle selected through a stratified sampling procedure including location and livestock management system (long transhumance, short transhumance, sedentary). Parasitological and serological prevalence specific to livestock management systems show a gradual increase from the Sahelian to the Sudano-Guinean area (P<0.05). Livestock management system had also a significant impact on parasitological prevalence (P<0.05). Tsetse diversity, apparent densities and their infection rates overall decreased with aridity, from four species, an apparent density of 53.1 flies/trap/day and an infection rate of 13.7% to an absence at the northern edge of the transect, where the density and diversity of other biting flies were on the contrary highest (p<0.001). Conclusions/Significance: The climatic pressure clearly had a negative impact on tsetse abundance and AAT risk. However, the persistency of tsetse habitats along the Mouhoun river loop maintains a high risk of cyclical transmission of T. vivax. Moreover, an "epidemic mechanical livestock trypanosomosis'' cycle is likely to occur in the northern site, where trypanosomes are brought in by cattle transhuming from the tsetse infested area and are locally transmitted by mechanical vectors. In Burkina Faso, the impact of tsetse thus extends to a buffer area around their distribution belt, corresponding to the herd transhumance radius.	[Pagabeleguem, Soumaila; Sangare, Mamadou; Bengaly, Zakaria; Akoudjin, Massouroudin] Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso		Pagabeleguem, S (corresponding author), Ctr Int Rech Dev Elevage Zone Subhumide CIRDES, Bobo Dioulasso, Burkina Faso.	bouyer@cirad.fr	Bouyer, Jérémy/AAK-7370-2020; Pagabeleguem, Soumaïla/S-3195-2019	Bouyer, Jérémy/0000-0002-1913-416X; Pagabeleguem, Soumaïla/0000-0001-8620-5231				Bouyer J, 2005, MED VET ENTOMOL, V19, P372, DOI 10.1111/j.1365-2915.2005.00584.x; Bouyer J, 2009, MOL ECOL, V18, P2787, DOI 10.1111/j.1365-294X.2009.04233.x; Bouyer J, 2009, VET PARASITOL, V161, P187, DOI 10.1016/j.vetpar.2009.01.018; Bouyer J, 2007, BIOL LETT-UK, V3, P113, DOI 10.1098/rsbl.2006.0578; Bouyer J, 2006, VET RES, V37, P633, DOI 10.1051/vetres:2006025; Bouyer J, 2010, J MED ENTOMOL, V47, P543, DOI 10.1603/ME09149; CHALLIER A, 1973, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V11, P251; Cherenet T, 2004, MED VET ENTOMOL, V11, P246; Courtin F., 2011, NAT SCI SOCI T S, V19, P256, DOI [DOI 10.1051/NSS/2011146, 10.1051/nss/2011146]; Courtin F, 2010, INT J ENV RES PUB HE, V7, P1708, DOI 10.3390/ijerph7041708; CUISANCE D, 2003, PRINCIPALES MALADIES, P1627; Dayo GK, 2010, RES VET SCI, V88, P470, DOI 10.1016/j.rvsc.2009.10.010; Desquesnes M, 2002, VET PARASITOL, V109, P213, DOI 10.1016/S0304-4017(02)00270-4; Desquesnes M, 1997, ACTA TROP, V65, P139, DOI 10.1016/S0001-706X(96)00643-2; Desquesnes M, 2009, INT J PARASITOL, V39, P333, DOI 10.1016/j.ijpara.2008.07.004; Guerrini L, 2008, J MED ENTOMOL, V45, P1180, DOI 10.1603/0022-2585(2008)45[1180:FAFPOS]2.0.CO;2; Guerrini Laure, 2007, Vet Ital, V43, P643; HOLLANDER M, 1973, NONPARAMETRIC STAT I; Hulme M, 2001, CLIM RES, V17, P145, DOI 10.3354/cr017145; Itard J, 1966, Rev Elev Med Vet Pays Trop, V19, P331; Kone N, 2011, MED VET ENTOMOL, V25, P156, DOI 10.1111/j.1365-2915.2010.00938.x; Muller C, 2009, CLIMATE CHANGE IMPAC; Munzel U, 2001, BIOMETRICAL J, V43, P553, DOI 10.1002/1521-4036(200109)43:5<553::AID-BIMJ553>3.0.CO;2-N; MURRAY M, 1977, T ROY SOC TROP MED H, V71, P325, DOI 10.1016/0035-9203(77)90110-9; Negash M, 2007, ACTA TROP, V102, P100, DOI 10.1016/j.actatropica.2007.04.004; Reifenberg JM, 1997, MED VET ENTOMOL, V11, P246, DOI 10.1111/j.1365-2915.1997.tb00402.x; Rouamba J, 2009, PARASITE, V16, P11, DOI 10.1051/parasite/2009161011; Swallow BM., 1999, IMPACTS TRYPANOSOMIA; TerraAfrica, 2009, LAND CLIM ROL SUST L; Van den Bossche P, 2011, PARASITE IMMUNOL, V33, P456, DOI 10.1111/j.1365-3024.2010.01277.x; Van den Bossche P, 2010, TRENDS PARASITOL, V26, P236, DOI 10.1016/j.pt.2010.02.010; WACHER TJ, 1993, ANN TROP MED PARASIT, V87, P517, DOI 10.1080/00034983.1993.11812804	32	18	18	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49762	10.1371/journal.pone.0049762	http://dx.doi.org/10.1371/journal.pone.0049762			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23166765	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900189
J	Fuhrmann-Stroissnigg, H; Noiges, R; Descovich, L; Fischer, I; Albrecht, DE; Nothias, F; Froehner, SC; Propst, F				Fuhrmann-Stroissnigg, Heike; Noiges, Rainer; Descovich, Luise; Fischer, Irmgard; Albrecht, Douglas E.; Nothias, Fatiha; Froehner, Stanley C.; Propst, Friedrich			The Light Chains of Microtubule-Associated Proteins MAP1A and MAP1B Interact with alpha 1-Syntrophin in the Central and Peripheral Nervous System	PLOS ONE			English	Article							DYSTROPHIN-ASSOCIATED PROTEIN; NITRIC-OXIDE SYNTHASE; PDZ DOMAIN; CYTOPLASMIC DYNEIN; FILAMENT-BINDING; SODIUM-CHANNELS; SKELETAL-MUSCLE; MESSENGER-RNA; SCHWANN-CELLS; RAT-BRAIN	Microtubule-associated proteins of the MAP1 family (MAP1A, MAP1B, and MAP1S) share, among other features, a highly conserved COOH-terminal domain approximately 125 amino acids in length. We conducted a yeast 2-hybrid screen to search for proteins interacting with this domain and identified alpha 1-syntrophin, a member of a multigene family of adapter proteins involved in signal transduction. We further demonstrate that the interaction between the conserved COOH-terminal 125-amino acid domain (which is located in the light chains of MAP1A, MAP1B, and MAP1S) and alpha 1-syntrophin is direct and occurs through the pleckstrin homology domain 2 (PH2) and the postsynaptic density protein 95/disk large/zonula occludens-1 protein homology domain (PDZ) of alpha 1-syntrophin. We confirmed the interaction of MAP1B and alpha 1-syntrophin by co-localization of the two proteins in transfected cells and by co-immunoprecipitation experiments from mouse brain. In addition, we show that MAP1B and alpha 1-syntrophin partially co-localize in Schwann cells of the murine sciatic nerve during postnatal development and in the adult. However, intracellular localization of alpha 1-syntrophin and other Schwann cell proteins such as ezrin and dystrophin-related protein 2 (DRP2) and the localization of the axonal node of Ranvier-associated protein Caspr1/paranodin were not affected in MAP1B null mice. Our findings add to a growing body of evidence that classical MAPs are likely to be involved in signal transduction not only by directly modulating microtubule function, but also through their interaction with signal transduction proteins.	[Fuhrmann-Stroissnigg, Heike; Noiges, Rainer; Descovich, Luise; Fischer, Irmgard; Propst, Friedrich] Univ Vienna, Dept Biochem & Cell Biol, Max F Perutz Labs, Vienna, Austria; [Albrecht, Douglas E.; Froehner, Stanley C.] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA; [Nothias, Fatiha] Univ Paris 06, CNRS, INSERM, U952,UMR 7224, Paris, France	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Washington; University of Washington Seattle; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Propst, F (corresponding author), Univ Vienna, Dept Biochem & Cell Biol, Max F Perutz Labs, Vienna, Austria.	friedrich.propst@univie.ac.at		Nothias-Chahir, Fatiha/0000-0002-2497-2096	Austrian Science Fund (FWF) [F607]; City of Vienna [J-15/05]; National Institutes of Health [NS33145]; Austrian Academy of Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033145] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 20839] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); City of Vienna; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Austrian Academy of Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by grant F607 from the Austrian Science Fund (FWF) and grant J-15/05 of the City of Vienna and the Austrian Academy of Sciences (to F.P.) and National Institutes of Health grant NS33145 (to S.C.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerl R, 2007, J CELL SCI, V120, P2435, DOI 10.1242/jcs.004481; Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385; ADAMS ME, 1995, J BIOL CHEM, V270, P25859, DOI 10.1074/jbc.270.43.25859; ADAMS ME, 1993, NEURON, V11, P531, DOI 10.1016/0896-6273(93)90157-M; Ahn AH, 1996, J BIOL CHEM, V271, P2724, DOI 10.1074/jbc.271.5.2724; AHN AH, 1995, J CELL BIOL, V128, P363, DOI 10.1083/jcb.128.3.363; Albrecht DE, 2008, GLIA, V56, P611, DOI 10.1002/glia.20636; Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P2106, DOI 10.1073/pnas.0437946100; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Brenman JE, 1998, J NEUROSCI, V18, P8805; Dallol A, 2004, CANCER RES, V64, P4112, DOI 10.1158/0008-5472.CAN-04-0267; Ding JQ, 2006, HUM MOL GENET, V15, P1451, DOI 10.1093/hmg/ddl069; Ding JQ, 2002, J CELL BIOL, V158, P427, DOI 10.1083/jcb.200202055; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Edelmann W, 1996, P NATL ACAD SCI USA, V93, P1270, DOI 10.1073/pnas.93.3.1270; Einheber S, 1997, J CELL BIOL, V139, P1495, DOI 10.1083/jcb.139.6.1495; FISCHER I, 1990, J NEUROSCI RES, V27, P112, DOI 10.1002/jnr.490270117; FISCHER I, 1990, J NEUROCHEM, V55, P328, DOI 10.1111/j.1471-4159.1990.tb08855.x; FROEHNER SC, 1987, J CELL BIOL, V104, P1633, DOI 10.1083/jcb.104.6.1633; Gee SH, 1998, J NEUROSCI, V18, P128; Gonzalez-Billault C, 2000, MOL CELL NEUROSCI, V16, P408, DOI 10.1006/mcne.2000.0880; Gordon-Weeks PR, 2000, MICROSC RES TECHNIQ, V48, P63, DOI 10.1002/(SICI)1097-0029(20000115)48:2<63::AID-JEMT2>3.0.CO;2-1; HAGIWARA H, 1994, J BIOL CHEM, V269, P3581; Hanley JG, 1999, NATURE, V397, P66, DOI 10.1038/16258; Hasegawa M, 1999, J BIOL CHEM, V274, P12626, DOI 10.1074/jbc.274.18.12626; Hashida-Okumura A, 1999, J BIOL CHEM, V274, P11736, DOI 10.1074/jbc.274.17.11736; Hillier BJ, 1999, SCIENCE, V284, P812, DOI 10.1126/science.284.5415.812; Ikeda A, 2002, NAT GENET, V30, P401, DOI 10.1038/ng838; Ives JH, 2004, J BIOL CHEM, V279, P31002, DOI 10.1074/jbc.M402214200; Iwata Y, 2004, EUR J CELL BIOL, V83, P555, DOI 10.1078/0171-9335-00415; LANGKOPF A, 1992, J BIOL CHEM, V267, P16561; Liu LY, 2002, IN VITRO CELL DEV-AN, V38, P582; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; Lumeng C, 1999, NAT NEUROSCI, V2, P611, DOI 10.1038/10165; Ma DL, 1999, BRAIN RES, V823, P141, DOI 10.1016/S0006-8993(99)01148-8; Magiera MM, 2004, BIOCHEM J, V382, P803, DOI 10.1042/BJ20040122; Magnani E, 2007, EMBO J, V26, P4546, DOI 10.1038/sj.emboj.7601878; Maurer MH, 2004, J NEUROCHEM, V91, P1007, DOI 10.1111/j.1471-4159.2004.02799.x; Meixner A, 2000, J CELL BIOL, V151, P1169, DOI 10.1083/jcb.151.6.1169; Menegoz M, 1997, NEURON, V19, P319, DOI 10.1016/S0896-6273(00)80942-3; Montenegro-Venegas C, 2010, MOL BIOL CELL, V21, P3518, DOI 10.1091/mbc.E09-08-0709; Nakayama A, 2001, BBA-GENE STRUCT EXPR, V1518, P260, DOI 10.1016/S0167-4781(01)00173-7; Noiges R, 2002, J NEUROSCI, V22, P2106, DOI 10.1523/JNEUROSCI.22-06-02106.2002; Noiges R, 2006, BBA-MOL CELL RES, V1763, P1011, DOI 10.1016/j.bbamcr.2006.08.029; Opal P, 2003, J BIOL CHEM, V278, P34691, DOI 10.1074/jbc.M302785200; Orban-Nemeth Z, 2005, J BIOL CHEM, V280, P2257, DOI 10.1074/jbc.M408984200; Osmanagic-Myers S, 2004, J BIOL CHEM, V279, P18701, DOI 10.1074/jbc.M312382200; Park SM, 2004, FEBS LETT, V570, P143, DOI 10.1016/j.febslet.2004.06.037; PASCHAL BM, 1989, NATURE, V342, P569, DOI 10.1038/342569a0; Peters MF, 1997, J CELL BIOL, V138, P81, DOI 10.1083/jcb.138.1.81; Sambrook J., 2002, MOL CLONING LAB MANU; Scherer SS, 2001, J NEUROSCI RES, V65, P150, DOI 10.1002/jnr.1138; SCHOENFELD TA, 1994, INT REV CYTOL, V151, P67, DOI 10.1016/S0074-7696(08)62631-5; Schultz J, 1998, NAT STRUCT BIOL, V5, P19, DOI 10.1038/nsb0198-19; Seog DH, 2004, BIOSCI BIOTECH BIOCH, V68, P1808, DOI 10.1271/bbb.68.1808; Sherman DL, 2001, NEURON, V30, P677, DOI 10.1016/S0896-6273(01)00327-0; Song MS, 2005, J BIOL CHEM, V280, P3920, DOI 10.1074/jbc.M409115200; Steinbock FA, 2000, J CELL SCI, V113, P483; Stroissnigg H, 2007, NAT CELL BIOL, V9, P1035, DOI 10.1038/ncb1625; Takei Y, 1997, J CELL BIOL, V137, P1615, DOI 10.1083/jcb.137.7.1615; Togel M, 1998, J CELL BIOL, V143, P695, DOI 10.1083/jcb.143.3.695; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Trinczek B, 1999, J CELL SCI, V112, P2355; ULLOA L, 1994, GLIA, V10, P266, DOI 10.1002/glia.440100405; Vershinin M, 2008, TRAFFIC, V9, P882, DOI 10.1111/j.1600-0854.2008.00741.x; VOUYIOUKLIS DA, 1993, J NEUROSCI RES, V35, P257, DOI 10.1002/jnr.490350305; Wolff S, 2005, BBA-MOL CELL RES, V1745, P196, DOI 10.1016/j.bbamcr.2005.05.004; YANG B, 1994, J BIOL CHEM, V269, P6040; YANG B, 1995, J BIOL CHEM, V270, P4975, DOI 10.1074/jbc.270.10.4975	72	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e49722	10.1371/journal.pone.0049722	http://dx.doi.org/10.1371/journal.pone.0049722			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152929	Green Published, gold, Green Submitted			2022-12-27	WOS:000311234600052
J	Hooijmans, CR; de Vries, RBM; Rovers, MM; Gooszen, HG; Ritskes-Hoitinga, M				Hooijmans, Carlijn R.; de Vries, Rob B. M.; Rovers, Maroeska M.; Gooszen, Hein G.; Ritskes-Hoitinga, Merel			The Effects of Probiotic Supplementation on Experimental Acute Pancreatitis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							ACUTE NECROTIZING PANCREATITIS; OXIDATIVE STRESS; SEARCH FILTER; IMPROVE; EFFICIENCY; QUALITY; THERAPY; RATS	Background: In February 2008, the results of the PRObiotics in PAncreatitis TRIAl (PROPATRIA) were published. This study investigated the use of probiotics in patients suffering from severe acute pancreatitis. No differences between the groups were found for any of the primary endpoints. However, mortality in the probiotics group was significantly higher than in the placebo group. This result was unexpected in light of the results of the animal studies referred to in the trial protocol. We used the methods of systematic review and meta-analysis to take a closer look at the relation between the animal studies on probiotics and pancreatitis and the PROPATRIA-trial, focussing on indications for harmful effects and efficacy. Methods and results: Both PubMed and Embase were searched for original articles concerning the effects of probiotics in experimental acute pancreatitis, yielding thirteen studies that met the inclusion criteria. Data on mortality, bacterial translocation and histological damage to the pancreas were extracted, as well as study quality indicators. Meta-analysis of the four animal studies published before PROPATRIA showed that probiotic supplementation did not diminish mortality, reduced the overall histopathological score of the pancreas and reduced bacterial translocation to pancreas and mesenteric lymph nodes. Comparable results were found when all relevant studies published so far were taken into account. Conclusions: A more thorough analysis of all relevant animal studies carried out before (and after) the publication of the study protocol of the PROPATRIA trial could not have predicted the harmful effects of probiotics found in the PROPATRIA-trial. Moreover, meta-analysis of the preclinical animal studies did show evidence for efficacy. It may be suggested, however, that the most appropriate animal experiments in relation to the design of the human trial have not yet been conducted, which compromises a fair comparison between the results of the animal studies and the PROPATRIA trial.	[Hooijmans, Carlijn R.; de Vries, Rob B. M.; Ritskes-Hoitinga, Merel] Radboud Univ Nijmegen, Med Ctr, SYRCLE, Cent Anim Lab, NL-6525 ED Nijmegen, Netherlands; [Rovers, Maroeska M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & HTA, NL-6525 ED Nijmegen, Netherlands; [Rovers, Maroeska M.; Gooszen, Hein G.] Radboud Univ Nijmegen, Med Ctr, Dept Operating Rooms, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Hooijmans, CR (corresponding author), Radboud Univ Nijmegen, Med Ctr, SYRCLE, Cent Anim Lab, NL-6525 ED Nijmegen, Netherlands.	C.Hooijmans@cdl.umcn.nl	Vries, R.B.M./L-4732-2015; Gooszen, H.G./H-8036-2014; Ritskes-Hoitinga, Merel/GLT-8517-2022; Rovers, Maroeska/F-2969-2014; Hooijmans, C.R./L-4390-2015; Ritskes-Hoitinga, J./H-8083-2014	Ritskes-Hoitinga, Merel/0000-0001-5315-284X; Rovers, Maroeska/0000-0002-3095-170X; Hooijmans, C.R./0000-0001-6435-5714; 	ZonMW program 'Dierproeven begrensd' in the Netherlands (ZonMW is a scientific organization for health research and development [114000089, 114000103]	ZonMW program 'Dierproeven begrensd' in the Netherlands (ZonMW is a scientific organization for health research and development	The ZonMW program 'Dierproeven begrensd' in the Netherlands (ZonMW is a scientific organization for health research and development); Grant No. 114000089 and 114000103 funded this project. ZonMW had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akyol S, 2003, PANCREAS, V26, P363, DOI 10.1097/00006676-200305000-00009; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Besselink Marc G H, 2004, BMC Surg, V4, P12, DOI 10.1186/1471-2482-4-12; Chen L, 2007, CHINESE J CLIN NUTR, V15, P30; de Vries RBM, 2011, LAB ANIM-UK, V45, P268, DOI 10.1258/la.2011.011056; Deng Q, 2000, Zhonghua Wai Ke Za Zhi, V38, P625; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M., 2009, SYSTEMATIC REV HLTH; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; Hooijmans CR, 2010, ATLA-ALTERN LAB ANIM, V38, P167, DOI 10.1177/026119291003800208; Horst NL, 2009, CURR THER RES CLIN E, V70, P136, DOI 10.1016/j.curtheres.2009.04.004; Karen M, 2010, J SURG RES, V160, P139, DOI 10.1016/j.jss.2009.02.008; Kilkenny C, 2010, J GENE MED, V12, P561, DOI 10.1002/jgm.1473; Kilkenny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007824; LUTGENDORFF F, 2006, EUR J GASTROEN HEPAT, V18, pA2; Lutgendorff F, 2008, AM J PHYSIOL-GASTR L, V295, pG1111, DOI 10.1152/ajpgi.00603.2007; Macleod M, 2011, NATURE, V477, P511, DOI 10.1038/477511a; Macleod MR, 2005, BMJ-BRIT MED J, V331, P110, DOI 10.1136/bmj.331.7508.110-b; Mangiante G, 2001, DIGEST SURG, V18, P47, DOI 10.1159/000050096; Muftuoglu MAT, 2006, EUR J CLIN NUTR, V60, P464, DOI 10.1038/sj.ejcn.1602338; Pound P, 2004, BMJ-BRIT MED J, V328, P514, DOI 10.1136/bmj.328.7438.514; Qin H, 2006, CHIN J CLIN NUTR, V14, P82; Sahin T, 2007, HUM EXP TOXICOL, V26, P653, DOI 10.1177/0960327107077596; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Tarasenko VS, 2000, B EXP BIOL MED+, V129, P176, DOI 10.1007/BF02434804; van Minnen LP, 2007, SURGERY, V141, P470, DOI 10.1016/j.surg.2006.10.007; Van Santvoort HC, 2006, NEDERLANDS TIJDSCHRI, V150, P2006; Yang J, 2006, WORLD CHIN J DIGESTO, V14, P953	28	46	53	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 13	2012	7	11							e48811	10.1371/journal.pone.0048811	http://dx.doi.org/10.1371/journal.pone.0048811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HF	23152810	gold, Green Published, Green Submitted			2022-12-27	WOS:000311234600014
J	Morales-Hojas, R; Vieira, J				Morales-Hojas, Ramiro; Vieira, Jorge			Phylogenetic Patterns of Geographical and Ecological Diversification in the Subgenus Drosophila	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; DIVERGENCE TIMES; MYCOPHAGOUS DROSOPHILA; REPRODUCTIVE ISOLATION; EVOLUTIONARY HISTORY; NEMATODE PARASITES; ADAPTIVE RADIATION; SPECIES GROUP; DIPTERA; MITOCHONDRIAL	Colonisation of new geographic regions and/or of new ecological resources can result in rapid species diversification into the new ecological niches available. Members of the subgenus Drosophila are distributed across the globe and show a large diversity of ecological niches. Furthermore, taxonomic classification of Drosophila includes the rank radiation, which refers to closely related species groups. Nevertheless, it has never been tested if these taxonomic radiations correspond to evolutionary radiations. Here we present a study of the patterns of diversification of Drosophila to test for increased diversification rates in relation to the geographic and ecological diversification processes. For this, we have estimated and dated a phylogeny of 218 species belonging to the major species groups of the subgenus. The obtained phylogenies are largely consistent with previous studies and indicate that the major groups appeared during the Oligocene/Miocene transition or early Miocene, characterized by a trend of climate warming with brief periods of glaciation. Ancestral reconstruction of geographic ranges and ecological resource use suggest at least two dispersals to the Neotropics from the ancestral Asiatic tropical disribution, and several transitions to specialized ecological resource use (mycophagous and cactophilic). Colonisation of new geographic regions and/or of new ecological resources can result in rapid species diversification into the new ecological niches available. However, diversification analyses show no significant support for adaptive radiations as a result of geographic dispersal or ecological resource shift. Also, cactophily has not resulted in an increase in the diversification rate of the repleta and related groups. It is thus concluded that the taxonomic radiations do not correspond to adaptive radiations.	[Morales-Hojas, Ramiro; Vieira, Jorge] Univ Porto, Mol Evolut Lab, Inst Biol Mol & Celular, P-4100 Oporto, Portugal	Universidade do Porto	Morales-Hojas, R (corresponding author), Univ Porto, Mol Evolut Lab, Inst Biol Mol & Celular, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	rmhojas@ibmc.up.pt	Vieira, Jorge/J-7477-2013	Vieira, Jorge/0000-0001-7032-5220; Morales Hojas, Ramiro/0000-0002-4120-5964	Fundacao para a Ciencia e Tecnologia (FCT) [PTDC/BIA-BDE/66765/2006, PTDC/BIA-BEC/099933/2008]; Programa Operacional para a Ciencia e Inovacao [POCI-2010]; Fundo Europeu para o Desenvolvimento Regional (FEDER); Programa Operacional para a Promocao da competividade (COMPETE); Ciencia contract	Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional para a Ciencia e Inovacao; Fundo Europeu para o Desenvolvimento Regional (FEDER)(European Commission); Programa Operacional para a Promocao da competividade (COMPETE); Ciencia contract	This work was funded by the Fundacao para a Ciencia e Tecnologia (FCT) through research projects PTDC/BIA-BDE/66765/2006 and PTDC/BIA-BEC/099933/2008, funded by Programa Operacional para a Ciencia e Inovacao (POCI-2010), co-funded by Fundo Europeu para o Desenvolvimento Regional (FEDER) and Programa Operacional para a Promocao da competividade (COMPETE). Ramiro Morales-Hojas is supported by a Ciencia 2007 contract. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfaro ME, 2008, MOL PHYLOGENET EVOL, V46, P576, DOI 10.1016/j.ympev.2007.10.024; Alfaro ME, 2009, P NATL ACAD SCI USA, V106, P13410, DOI 10.1073/pnas.0811087106; [Anonymous], 2014, TRACER V1 6; Barker J.S.F., 1982, ECOLOGICAL GENETICS; BEVERLEY SM, 1984, J MOL EVOL, V21, P1, DOI 10.1007/BF02100622; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bonacum J, 2005, MOL PHYLOGENET EVOL, V37, P73, DOI 10.1016/j.ympev.2005.03.008; Bono JM, 2008, MOL ECOL, V17, P3211, DOI 10.1111/j.1365-294X.2008.03823.x; Brock CD, 2011, SYST BIOL, V60, P410, DOI 10.1093/sysbio/syr007; Cutter AD, 2008, MOL BIOL EVOL, V25, P778, DOI 10.1093/molbev/msn024; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond CS, 2012, SYST BIOL, V61, P443, DOI 10.1093/sysbio/syr126; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Glor RE, 2010, ANNU REV ECOL EVOL S, V41, P251, DOI 10.1146/annurev.ecolsys.39.110707.173447; Grimaldi DA, 1987, AM MUS NOVIT, V2880, P1; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Hatadani LM, 2009, MOL PHYLOGENET EVOL, V51, P595, DOI 10.1016/j.ympev.2009.02.022; Hollocher H, 2000, EVOLUTION, V54, P2046, DOI 10.1111/j.0014-3820.2000.tb01248.x; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Hurtado LA, 2004, MOL ECOL, V13, P1365, DOI 10.1111/j.1365-294X.2004.02169.x; JAENIKE J, 1995, OIKOS, V72, P235, DOI 10.2307/3546226; Katoh T, 2007, ZOOL SCI, V24, P913, DOI 10.2108/zsj.24.913; Kircher H.W., 1982, P143; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Maddison W., 2018, MESQUITE MODULAR SYS; Maddison WP, 2007, SYST BIOL, V56, P701, DOI 10.1080/10635150701607033; Magnacca KN, 2008, ZOOTAXA, P1; Markow TA, 2008, FUNCT ECOL, V22, P747, DOI 10.1111/j.1365-2435.2008.01457.x; Markow T. A., 2006, DROSOPHILA GUIDE SPE; Markow TA, 2002, EVOLUTION, V56, P546, DOI 10.1111/j.0014-3820.2002.tb01365.x; MARKOW TA, 1983, EVOLUTION, V37, P649, DOI 10.1111/j.1558-5646.1983.tb05585.x; Miller M.A., 2010, P GAT COMP ENV WORKS; Morales-Hojas R, 2009, HEREDITY, V102, P573, DOI 10.1038/hdy.2009.11; Morales-Hojas R, 2011, MOL PHYLOGENET EVOL, V60, P249, DOI 10.1016/j.ympev.2011.04.022; O'Grady P, 2008, BIOL LETTERS, V4, P195, DOI 10.1098/rsbl.2007.0575; O'Grady PM, 2011, MOL PHYLOGENET EVOL, V58, P244, DOI 10.1016/j.ympev.2010.11.022; O'Grady PM, 2009, FLY, V3, P10, DOI 10.4161/fly.3.1.7748; Obbard DJ, 2012, MOL BIOL EVOL, V29, P3459, DOI 10.1093/molbev/mss150; Oliveira DCSG, 2012, MOL PHYLOGENET EVOL, V64, P533, DOI 10.1016/j.ympev.2012.05.012; Patterson J. T., 1952, EVOLUTION GENUS DROS; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; Phillimore AB, 2008, PLOS BIOL, V6, P483, DOI 10.1371/journal.pbio.0060071; Powell J. R., 1997, PROGR PROSPECTS EVOL; Pybus OG, 2000, P ROY SOC B-BIOL SCI, V267, P2267, DOI 10.1098/rspb.2000.1278; Rabosky DL, 2008, P ROY SOC B-BIOL SCI, V275, P2363, DOI 10.1098/rspb.2008.0630; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Rabosky DL, 2006, EVOLUTION, V60, P1152; Rabosky DL, 2006, EVOL BIOINFORM, V2, P247; Reed LK, 2007, MOL ECOL, V16, P1007, DOI 10.1111/j.1365-294X.2006.02941.x; Remsen J, 2002, MOL PHYLOGENET EVOL, V24, P249, DOI 10.1016/S1055-7903(02)00226-9; Robe LJ, 2005, MOL PHYLOGENET EVOL, V36, P623, DOI 10.1016/j.ympev.2005.05.005; RUSSO CAM, 1995, MOL BIOL EVOL, V12, P391; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Silva-Bernardi ECC, 2006, GENET MOL BIOL, V29, P566, DOI 10.1590/S1415-47572006000300029; Simpson G. G., 1953, MAJOR FEATURES EVOLU, DOI DOI 10.7312/SIMP93764; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tatarenkov A, 2001, MOL PHYLOGENET EVOL, V20, P321, DOI 10.1006/mpev.2001.0967; Tatarenkov A, 2001, MOL PHYLOGENET EVOL, V21, P327, DOI 10.1006/mpev.2001.1002; Throckmorton L.H., 1975, P421; van der Linde K, 2010, GENET RES, V92, P25, DOI 10.1017/S001667231000008X; Venditti C, 2010, NATURE, V463, P349, DOI 10.1038/nature08630; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Wang BC, 2006, MOL PHYLOGENET EVOL, V40, P484, DOI 10.1016/j.ympev.2006.03.026; Weir JT, 2006, EVOLUTION, V60, P842; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Yoder JB, 2010, J EVOLUTION BIOL, V23, P1581, DOI 10.1111/j.1420-9101.2010.02029.x; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	73	41	42	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e49552	10.1371/journal.pone.0049552	http://dx.doi.org/10.1371/journal.pone.0049552			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152919	Green Published, Green Submitted, gold			2022-12-27	WOS:000311234000070
J	Tarazon, E; Rivera, M; Rosello-Lleti, E; Molina-Navarro, MM; Sanchez-Lazaro, IJ; Espana, F; Montero, JA; Lago, F; Gonzalez-Juanatey, JR; Portoles, M				Tarazon, Estefania; Rivera, Miguel; Rosello-Lleti, Esther; Micaela Molina-Navarro, Maria; Jose Sanchez-Lazaro, Ignacio; Espana, Francisco; Anastasio Montero, Jose; Lago, Francisca; Ramon Gonzalez-Juanatey, Jose; Portoles, Manuel			Heart Failure Induces Significant Changes in Nuclear Pore Complex of Human Cardiomyocytes	PLOS ONE			English	Article							MESSENGER-RNA EXPORT; NUCLEOCYTOPLASMIC TRANSPORT; NUCLEOPORINS; EXPRESSION; GUIDELINES; DISEASE; BINDING; NUP153; CELLS; NDC1	Aims: The objectives of this study were to analyse the effect of heart failure (HF) on several proteins of nuclear pore complex (NPC) and their relationship with the human ventricular function. Methods and Results: A total of 88 human heart samples from ischemic (ICM, n = 52) and dilated (DCM, n = 36) patients undergoing heart transplant and control donors (CNT, n = 9) were analyzed by Western blot. Subcellular distribution of nucleoporins was analysed by fluorescence and immunocytochemistry. When we compared protein levels according to etiology, ICM showed significant higher levels of NDC1 (65%, p<0.0001), Nup160 (88%, p<0.0001) and Nup153 (137%, p = 0.004) than those of the CNT levels. Furthermore, DCM group showed significant differences for NDC1 (41%, p<0.0001), Nup160 (65%, p<0.0001), Nup153 (155%, p = 0.006) and Nup93 (88%, p<0.0001) compared with CNT. However, Nup155 and translocated promoter region (TPR) did not show significant differences in their levels in any etiology. Regarding the distribution of these proteins in cell nucleus, only NDC1 showed differences in HF. In addition, in the pathological group we obtained good relationship between the ventricular function parameters (LVEDD and LVESD) and Nup160 (r = -0382, p = 0.004; r = -0.290, p = 0.033; respectively). Conclusions: This study shows alterations in specific proteins (NDC1, Nup160, Nup153 and Nup93) that compose NPC in ischaemic and dilated human heart. These changes, related to ventricular function, could be accompanied by alterations in the nucleocytoplasmic transport. Therefore, our findings may be the basis for a new approach to HF management.	[Portoles, Manuel] Hosp Univ La Fe, Cell Biol & Pathol Unit, Res Ctr, Valencia, Spain; [Tarazon, Estefania; Rivera, Miguel; Rosello-Lleti, Esther; Micaela Molina-Navarro, Maria] Hosp Univ La Fe, Cardiocirculatory Unit, Res Ctr, Valencia, Spain; [Jose Sanchez-Lazaro, Ignacio] Hosp Univ La Fe, Heart Failure & Transplantat Unit, Dept Cardiol, Valencia, Spain; [Espana, Francisco] Hosp Univ La Fe, Biochem Unit, Res Ctr, Valencia, Spain; [Anastasio Montero, Jose] Hosp Univ La Fe, Serv Cirugia Cardiovasc, Valencia, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Cellular & Mol Cardiol Res Unit, Dept Cardiol, Santiago De Compostela, Spain; [Lago, Francisca; Ramon Gonzalez-Juanatey, Jose] Univ Clin Hosp, Inst Biomed Res, Santiago De Compostela, Spain	Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Hospital Universitari i Politecnic La Fe; Complexo Hospitalario Universitario de Santiago de Compostela; Complexo Hospitalario Universitario de Santiago de Compostela	Portoles, M (corresponding author), Hosp Univ La Fe, Cell Biol & Pathol Unit, Res Ctr, Valencia, Spain.	portoles_man@gva.es	Tarazón, Estefanía/D-6950-2017; Roselló-Lletí, Esther/B-2695-2017; Sanchez-Lazaro, Ignacio/GZH-1063-2022; PORTOLES, MANUEL/B-4789-2009; Roselló Lletí, Esther/ABG-8503-2020; España, Francisco/A-7286-2008	Tarazón, Estefanía/0000-0003-3466-2558; Roselló-Lletí, Esther/0000-0003-2627-6104; PORTOLES, MANUEL/0000-0002-4415-7160; Roselló Lletí, Esther/0000-0003-2627-6104; Espana, Francisco/0000-0001-7829-2021; Sanchez-Lazaro, Ignacio J./0000-0003-2851-4153; Gonzalez Juanatey, Jose Ramon/0000-0001-9681-3388; , Micaela/0000-0002-2103-0351	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III'' [REDINSCOR 06/0003/1001, PI10/00275]	National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III''	This work was supported by grants from the National Institute of Health "Fondo de Investigaciones Sanitarias del Instituto de Salud Carlos III'' [REDINSCOR 06/0003/1001, Project PI10/00275]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azorin I, 2004, ALCOHOL ALCOHOLISM, V39, P203, DOI 10.1093/alcalc/agh043; Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Capelson M, 2010, COLD SH Q B, V75, P585, DOI 10.1101/sqb.2010.75.059; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Cortes R, 2009, TRANSPL P, V41, P2227, DOI 10.1016/j.transproceed.2009.06.013; Cortes R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030915; Cortes R, 2010, CARDIOVASC RES, V85, P464, DOI 10.1093/cvr/cvp336; de Boer J, 2002, SCIENCE, V296, P1276, DOI 10.1126/science.1070174; Dickstein K, 2010, EUR J HEART FAIL, V12, P1143, DOI [10.1093/eurjhf/hfq192, 10.1093/europace/euq392]; Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620; Jamali T, 2011, INT REV CEL MOL BIO, V287, P233, DOI 10.1016/B978-0-12-386043-9.00006-2; Kaffman A, 1999, ANNU REV CELL DEV BI, V15, P291, DOI 10.1146/annurev.cellbio.15.1.291; Kajstura J, 2010, CIRC RES, V107, P305, DOI 10.1161/CIRCRESAHA.110.223024; MacKenzie L, 2012, HUM PATHOL, V43, P1491, DOI 10.1016/j.humpath.2011.11.009; Macrae Duncan J, 2007, Proc Am Thorac Soc, V4, P176, DOI 10.1513/pats.200701-011GC; Madrid AS, 2006, J CELL BIOL, V173, P361, DOI 10.1083/jcb.200506199; Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015; Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709; Pawlak A, 2012, J INTERN MED, V272, P287, DOI 10.1111/j.1365-2796.2012.02524.x; Phillips D, 2010, J MOL CELL CARDIOL, V48, P582, DOI 10.1016/j.yjmcc.2009.10.033; PORTOLES M, 1994, J CELL SCI, V107, P3601; Rasala BA, 2008, MOL BIOL CELL, V19, P3982, DOI 10.1091/mbc.E08-01-0012; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rosca MG, 2010, CARDIOVASC RES, V88, P40, DOI 10.1093/cvr/cvq240; Rosello-Lleti E, 2012, BIOCHEM BIOPH RES CO, V418, P222, DOI 10.1016/j.bbrc.2011.12.151; Tomas M, 2002, J NEUROCHEM, V83, P601, DOI 10.1046/j.1471-4159.2002.01167.x; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Winters AL, 2005, ANAL BIOCHEM, V346, P43, DOI 10.1016/j.ab.2005.07.041; Yoneda Y, 2000, GENES CELLS, V5, P777, DOI 10.1046/j.1365-2443.2000.00366.x; Zhang XQ, 2008, CELL, V135, P1017, DOI 10.1016/j.cell.2008.10.022; Zwerger M, 2011, ANNU REV BIOMED ENG, V13, P397, DOI 10.1146/annurev-bioeng-071910-124736	32	28	29	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2012	7	11							e48957	10.1371/journal.pone.0048957	http://dx.doi.org/10.1371/journal.pone.0048957			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039HA	23152829	Green Submitted, Green Published, gold			2022-12-27	WOS:000311234000038
J	La Rosa, PS; Shands, B; Deych, E; Zhou, Y; Sodergren, E; Weinstock, G; Shannon, WD				La Rosa, Patricio S.; Shands, Berkley; Deych, Elena; Zhou, Yanjiao; Sodergren, Erica; Weinstock, George; Shannon, William D.			Statistical Object Data Analysis of Taxonomic Trees from Human Microbiome Data	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; COMMUNITIES; PROJECT; METAGENOMES; LIBRARIES; ARB	Human microbiome research characterizes the microbial content of samples from human habitats to learn how interactions between bacteria and their host might impact human health. In this work a novel parametric statistical inference method based on object-oriented data analysis (OODA) for analyzing HMP data is proposed. OODA is an emerging area of statistical inference where the goal is to apply statistical methods to objects such as functions, images, and graphs or trees. The data objects that pertain to this work are taxonomic trees of bacteria built from analysis of 16S rRNA gene sequences (e. g. using RDP); there is one such object for each biological sample analyzed. Our goal is to model and formally compare a set of trees. The contribution of our work is threefold: first, a weighted tree structure to analyze RDP data is introduced; second, using a probability measure to model a set of taxonomic trees, we introduce an approximate MLE procedure for estimating model parameters and we derive LRT statistics for comparing the distributions of two metagenomic populations; and third the Jumpstart HMP data is analyzed using the proposed model providing novel insights and future directions of analysis. Citation: La Rosa PS, Shands B, Deych E, Zhou Y, Sodergren E, et al. (2012) Statistical Object Data Analysis of Taxonomic Trees from Human Microbiome Data. PLoS ONE 7(11): e48996. doi:10.1371/journal.pone.0048996	[La Rosa, Patricio S.; Shands, Berkley; Deych, Elena; Shannon, William D.] Washington Univ St Louis, Div Gen Med Sci, St Louis, MO USA; [Zhou, Yanjiao; Sodergren, Erica; Weinstock, George] Washington Univ St Louis, Genome Inst, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL)	Shannon, WD (corresponding author), Washington Univ St Louis, Div Gen Med Sci, St Louis, MO USA.	wshannon@wustl.edu	Weinstock, George M/C-6314-2013	Weinstock, George M/0000-0002-2997-4592	National Institutes of Health (NIH) Grant "Human Microbiome Project Consortium Sequencing of Healthy People'' [U54 HG004968]; NIH Grant "The Neonatal Microbiome and Necrotizing Enterocolotis'' [1UH2AI083265]; St. Louis Children's Hospital Grant "The St. Louis Neonatal Gut Microbiome Initiative''; Children Discovery Institute Grant "The St. Louis Neonatal Gut Microbiome Initiative''; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004968] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UH2AI083265] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Grant "Human Microbiome Project Consortium Sequencing of Healthy People''; NIH Grant "The Neonatal Microbiome and Necrotizing Enterocolotis''; St. Louis Children's Hospital Grant "The St. Louis Neonatal Gut Microbiome Initiative''; Children Discovery Institute Grant "The St. Louis Neonatal Gut Microbiome Initiative''; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by National Institutes of Health (NIH) Grant U54 HG004968 "Human Microbiome Project Consortium Sequencing of Healthy People''; NIH Grant 1UH2AI083265 "The Neonatal Microbiome and Necrotizing Enterocolotis''; and St. Louis Children's Hospital and Children Discovery Institute Grant "The St. Louis Neonatal Gut Microbiome Initiative''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], HUM MICR PROJ 16S RR; [Anonymous], HMP DAT REL RES SHAR; Banks D, 1998, J CLASSIF, V15, P199, DOI 10.1007/s003579900031; BANKS D, 1994, J CLASSIF, V11, P121, DOI 10.1007/BF01201026; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; FELSENSTEIN J, 1973, SYST ZOOL, V22, P240, DOI 10.2307/2412304; Golub GH., 2013, MATRIX COMPUTATIONS; Gould H, 2007, INTRO COMPUTER SIMUL, Vxviii; Holmes S, 2005, MATHEMATICS OF EVOLUTION AND PHYLOGENY, P91; La Rosa P. S., 2011, HMP TREE STAT OBJECT; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MARGUSH T, 1981, B MATH BIOL, V43, P239, DOI 10.1007/BF02459446; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD534, DOI 10.1093/nar/gkm869; Mitra S, 2009, BIOINFORMATICS, V25, P1849, DOI 10.1093/bioinformatics/btp341; Parks DH, 2010, BIOINFORMATICS, V26, P715, DOI 10.1093/bioinformatics/btq041; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Schloss PD, 2008, ISME J, V2, P265, DOI 10.1038/ismej.2008.5; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P6773, DOI 10.1128/AEM.00474-06; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schloss PD, 2006, APPL ENVIRON MICROB, V72, P2379, DOI 10.1128/AEM.72.4.2379-2384.2006; Schloss PD, 2005, APPL ENVIRON MICROB, V71, P1501, DOI 10.1128/AEM.71.3.1501-1506.2005; Schloss PD, 2004, APPL ENVIRON MICROB, V70, P5485, DOI 10.1128/AEM.70.9.5485-5492.2004; Shannon WD, 1999, STAT MED, V18, P727, DOI 10.1002/(SICI)1097-0258(19990330)18:6<727::AID-SIM61>3.3.CO;2-U; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Steel M, 2008, SYSTEMATIC BIOL, V57, P243, DOI 10.1080/10635150802033014; Sul WJ, 2011, P NATL ACAD SCI; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Vardi Y, 2001, MATH PROGRAM, V90, P559, DOI 10.1007/PL00011435; Wang H, 2007, ANN STAT, V35, P1849, DOI 10.1214/009053607000000217; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wooley JC, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000667	42	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48996	10.1371/journal.pone.0048996	http://dx.doi.org/10.1371/journal.pone.0048996			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152838	Green Published, Green Submitted, gold			2022-12-27	WOS:000312272600036
J	Singh, A; Pallikadavath, S; Ogollah, R; Stones, W				Singh, Abhishek; Pallikadavath, Saseendran; Ogollah, Reuben; Stones, William			Maternal Tetanus Toxoid Vaccination and Neonatal Mortality in Rural North India	PLOS ONE			English	Article							ANTENATAL CARE; CHILD-MORTALITY; UTTAR-PRADESH; HEALTH; IMMUNIZATION; INTERVENTIONS; DURATION; DEATHS; IMPACT; RATES	Objectives: Preventable neonatal mortality due to tetanus infection remains common. We aimed to examine antenatal vaccination impact in a context of continuing high neonatal mortality in rural northern India. Methods and Findings: Using the third round of the Indian National Family Health Survey (NFHS) 2005-06, mortality of most recent singleton births was analysed in discrete-time logistic model with maternal tetanus vaccination, together with antenatal care utilisation and supplementation with iron and folic acid. 59% of mothers reported receiving antenatal care, 48% reported receiving iron and folic acid supplementation and 68% reported receiving two or more doses of tetanus toxoid (TT) vaccination. The odds of all-cause neonatal death were reduced following one or more antenatal dose of TT with odds ratios (OR) of 0.46 (95% CI 0.26 to 0.78) after one dose and 0.45 (95% CI 0.31 to 0.66) after two or more doses. Reported utilisation of antenatal care and iron-folic acid supplementation did not influence neonatal mortality. In the statistical model, 16% (95% CI 5% to 27%) of neonatal deaths could be attributed to a lack of at least two doses of TT vaccination during pregnancy, representing an estimated 78,632 neonatal deaths in absolute terms. Conclusions: Substantial gains in newborn survival could be achieved in rural North India through increased coverage of antenatal TT vaccination. The apparent substantial protective effect of a single antenatal dose of TT requires further study. It may reflect greater population vaccination coverage and indicates that health programming should prioritise universal antenatal coverage with at least one dose. Citation: Singh A, Pallikadavath S, Ogollah R, Stones W (2012) Maternal Tetanus Toxoid Vaccination and Neonatal Mortality in Rural North India. PLoS ONE 7(11): e48891. doi: 10.1371/journal.pone.0048891	[Singh, Abhishek; Pallikadavath, Saseendran; Ogollah, Reuben] Univ Portsmouth, Sch Hlth Sci & Social Work, Global Hlth & Social Care Unit, Portsmouth, Hants, England; [Stones, William] Aga Khan Univ, Dept Obstet & Gynaecol, Nairobi, Kenya	University of Portsmouth; Aga Khan University	Singh, A (corresponding author), Univ Portsmouth, Sch Hlth Sci & Social Work, Global Hlth & Social Care Unit, Portsmouth, Hants, England.	abhi_iips@yahoo.co.in	Stones, William/R-8618-2016; Singh, Abhishek/ABC-7813-2020	Stones, William/0000-0003-0699-2381; Singh, Abhishek/0000-0001-6263-4410; Pallikadavath, Saseendran/0000-0002-2598-9949; Ogollah, Reuben/0000-0002-5777-4117				Arokiasamy P, 2008, J BIOSOC SCI, V40, P183, DOI 10.1017/S0021932007002623; Awasthi S, 1998, J TROP PEDIATRICS, V44, P358, DOI 10.1093/tropej/44.6.358; Baqui AH, 2006, Bull World Health Organ, V84, P706, DOI 10.2471/BLT.05.026443; Bassani DG, 2010, LANCET, V376, P1853, DOI 10.1016/S0140-6736(10)61461-4; BLACK RE, 1980, B WORLD HEALTH ORGAN, V58, P927; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Bloom SS, 1999, HEALTH POLICY PLANN, V14, P38, DOI 10.1093/heapol/14.1.38; Chandrashekar S, 1998, TROP DOCT, V28, P206, DOI 10.1177/004947559802800406; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Demicheli V, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002959.pub2; Dutt D, 1997, Indian Pediatr, V34, P785; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; IndiaStat.com website, 2008, STAT NUMB CAS DEATHS; IndiaStat.com website, 1999, STAT WIS NUMB CAS DE; Institute for Population Sciences (IIPS), 2010, DISTR LEV HOUS SURV; [International Institute for Population Sciences (IIPS) Macro International], 2007, NAT FAM HLTH SURV NF, VI and II; Koenig MA, 1998, AM J PUBLIC HEALTH, V88, P903, DOI 10.2105/AJPH.88.6.903; KUMAR V, 1988, Indian Pediatrics, V25, P167; Lahariya C, 2010, INDIAN J PEDIATR, V77, P1303, DOI 10.1007/s12098-010-0246-3; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2005, ESTIMATING CAUSES 4; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Ministry of Health and Family Welfare (MoHFW), 2005, NAT RUR HLTH MISS 20; MoHFW, 2010, ANN REP PEOPL HLTH; NEWELL KW, 1966, B WORLD HEALTH ORGAN, V35, P863; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Pradhan J, 2006, POPUL SPACE PLACE, V12, P187, DOI 10.1002/psp.408; Ram F, 2006, J BIOSOC SCI, V38, P433, DOI 10.1017/S0021932005026453; Ray B, 2007, IMMUNOLOGICAL BASIS; RGI, 2010, COMP IND FERT MORT I; RGI (Registrar General and Census Commissioner of India), 2006, POP PROJ IND STAT 20; Ronsmans C, 2008, PAEDIATR PERINAT EP, V22, P269, DOI 10.1111/j.1365-3016.2008.00939.x; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; Singh Abhishek, 2011, PLoS One, V6, pe26856, DOI 10.1371/journal.pone.0026856; Singh A, 2013, MATERN CHILD HLTH J, V17, P493, DOI 10.1007/s10995-012-1023-x; Singh A, 2012, POP STUD-J DEMOG, V66, P223, DOI 10.1080/00324728.2012.697568; Srinivas M. N, 1962, CASTE MODERN INDIA O; United Nations, 2000, MILL DEV GOALS; WHO, 2009, WHO IMM SURV ASS MON; World Health Organization, 2008, The global burden of disease: 2004 update	41	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48891	10.1371/journal.pone.0048891	http://dx.doi.org/10.1371/journal.pone.0048891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	053LI	23152814	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000312272600024
J	Zhang, JW; Zhang, YM; Zhong, YH; Qu, YB; Wang, TH				Zhang, Jiwei; Zhang, Yanmei; Zhong, Yaohua; Qu, Yinbo; Wang, Tianhong			Ras GTPases Modulate Morphogenesis, Sporulation and Cellulase Gene Expression in the Cellulolytic Fungus Trichoderma reesei	PLOS ONE			English	Article							BETA-GLUCOSIDASE; FILAMENTOUS GROWTH; PROTEIN-KINASE; TRANSCRIPTIONAL REGULATION; SACCHAROMYCES-CEREVISIAE; TRANSFORMATION SYSTEM; SIGNAL-TRANSDUCTION; PHEROMONE RESPONSE; SECRETORY PATHWAY; ENZYME-SYSTEM	Background: The model cellulolytic fungus Trichoderma reesei (teleomorph Hypocrea jecorina) is capable of responding to environmental cues to compete for nutrients in its natural saprophytic habitat despite its genome encodes fewer degradative enzymes. Efficient signalling pathways in perception and interpretation of environmental signals are indispensable in this process. Ras GTPases represent a kind of critical signal proteins involved in signal transduction and regulation of gene expression. In T. reesei the genome contains two Ras subfamily small GTPases TrRas1 and TrRas2 homologous to Ras1 and Ras2 from S. cerevisiae, but their functions remain unknown. Methodology/Principal Findings: Here, we have investigated the roles of GTPases TrRas1 and TrRas2 during fungal morphogenesis and cellulase gene expression. We show that both TrRas1 and TrRas2 play important roles in some cellular processes such as polarized apical growth, hyphal branch formation, sporulation and cAMP level adjustment, while TrRas1 is more dominant in these processes. Strikingly, we find that TrRas2 is involved in modulation of cellulase gene expression. Deletion of TrRas2 results in considerably decreased transcription of cellulolytic genes upon growth on cellulose. Although the strain carrying a constitutively activated TrRas2(G16V) allele exhibits increased cellulase gene transcription, the cbh1 and cbh2 expression in this mutant still strictly depends on cellulose, indicating TrRas2 does not directly mediate the transmission of the cellulose signal. In addition, our data suggest that the effect of TrRas2 on cellulase gene is exerted through regulation of transcript abundance of cellulase transcription factors such as Xyr1, but the influence is independent of cAMP signalling pathway. Conclusions/Significance: Together, these findings elucidate the functions for Ras signalling of T. reesei in cellular morphogenesis, especially in cellulase gene expression, which contribute to deciphering the powerful competitive ability of plant cell wall degrading fungi in nature. Citation: Zhang J, Zhang Y, Zhong Y, Qu Y, Wang T (2012) Ras GTPases Modulate Morphogenesis, Sporulation and Cellulase Gene Expression in the Cellulolytic Fungus Trichoderma reesei. PLoS ONE 7(11): e48786. doi:10.1371/journal.pone.0048786	[Zhang, Jiwei; Zhang, Yanmei; Zhong, Yaohua; Qu, Yinbo; Wang, Tianhong] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China	Shandong University	Qu, YB (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Peoples R China.	quyinbo@sdu.edu.cn; wangtianhong@sdu.edu.cn			National Basic Research Program of China [2011CB707403]; National Natural Science Foundation of China [31030001, 30970026, 31070036]; Excellent Young and Middle-Aged Scientist Award Grant of Shandong Province of China [BS2011SW017]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Young and Middle-Aged Scientist Award Grant of Shandong Province of China	This work was supported by grants from the National Basic Research Program of China (No. 2011CB707403), the National Natural Science Foundation of China (No. 31030001, 30970026 and 31070036) and the Excellent Young and Middle-Aged Scientist Award Grant of Shandong Province of China (No. BS2011SW017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alspaugh JA, 2000, MOL MICROBIOL, V36, P352, DOI 10.1046/j.1365-2958.2000.01852.x; Aro N, 2005, FEMS MICROBIOL REV, V29, P719, DOI 10.1016/j.femsre.2004.11.006; Aro N, 2001, J BIOL CHEM, V276, P24309, DOI 10.1074/jbc.M003624200; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; BOS JL, 1989, CANCER RES, V49, P4682; Boyce KJ, 2005, MOL MICROBIOL, V55, P1487, DOI 10.1111/j.1365-2958.2005.04485.x; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Fillinger S, 2002, MOL MICROBIOL, V44, P1001, DOI 10.1046/j.1365-2958.2002.02933.x; Fortwendel JR, 2005, EUKARYOT CELL, V4, P1982, DOI 10.1128/EC.4.12.1982-1989.2005; FOWLER T, 1992, MOL MICROBIOL, V6, P3225, DOI 10.1111/j.1365-2958.1992.tb01777.x; Furukawa T, 2009, FUNGAL GENET BIOL, V46, P564, DOI 10.1016/j.fgb.2009.04.001; Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1016/S0168-6445(00)00056-5; GRUBER F, 1990, CURR GENET, V18, P71, DOI 10.1007/BF00321118; Hall A, 1998, SCIENCE, V280, P2074, DOI 10.1126/science.280.5372.2074; Ilmen M, 1997, APPL ENVIRON MICROB, V63, P1298; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kanauchi A, 1997, MOL GEN GENET, V254, P427, DOI 10.1007/s004380050435; KATAOKA T, 1984, CELL, V37, P437, DOI 10.1016/0092-8674(84)90374-X; Leberer E, 2001, MOL MICROBIOL, V42, P673, DOI 10.1046/j.1365-2958.2001.02672.x; Lee N, 2002, EUKARYOT CELL, V1, P954, DOI 10.1128/EC.1.6.954-966.2002; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Lim CJ, 2001, EMBO J, V20, P4490, DOI 10.1093/emboj/20.16.4490; LIU HP, 1993, SCIENCE, V262, P1741, DOI 10.1126/science.8259520; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOWY DR, 1993, ANNU REV BIOCHEM, V62, P851, DOI 10.1146/annurev.bi.62.070193.004223; Mach RL, 2003, APPL MICROBIOL BIOT, V60, P515, DOI 10.1007/s00253-002-1162-x; Mach-Aigner AR, 2008, APPL ENVIRON MICROB, V74, P6554, DOI 10.1128/AEM.01143-08; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; MATTERN IE, 1987, MOL GEN GENET, V210, P460, DOI 10.1007/BF00327197; Momany M, 2002, CURR OPIN MICROBIOL, V5, P580, DOI 10.1016/S1369-5274(02)00368-5; Mosch HU, 1999, MOL BIOL CELL, V10, P1325, DOI 10.1091/mbc.10.5.1325; Mosch HU, 1996, P NATL ACAD SCI USA, V93, P5352, DOI 10.1073/pnas.93.11.5352; Muller P, 2003, EUKARYOT CELL, V2, P609, DOI 10.1128/EC.2.3.609-617.2003; Murray P, 2004, PROTEIN EXPRES PURIF, V38, P248, DOI 10.1016/j.pep.2004.08.006; PENTTILA M, 1987, GENE, V61, P155, DOI 10.1016/0378-1119(87)90110-7; PENTTILA M, 1986, GENE, V45, P253, DOI 10.1016/0378-1119(86)90023-5; Portnoy T, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-269; POWERS S, 1984, CELL, V36, P607, DOI 10.1016/0092-8674(84)90340-4; Roze LV, 1999, FUNGAL GENET BIOL, V28, P171, DOI 10.1006/fgbi.1999.1177; Saloheimo A, 2000, J BIOL CHEM, V275, P5817, DOI 10.1074/jbc.275.8.5817; Saloheimo M, 2002, APPL ENVIRON MICROB, V68, P4546, DOI 10.1128/AEM.68.9.4546-4553.2002; Saloheimo M, 2004, APPL ENVIRON MICROB, V70, P459, DOI 10.1128/AEM.70.1.459-467.2004; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmoll M, 2005, EUKARYOT CELL, V4, P1998, DOI 10.1128/EC.4.12.1998-2007.2005; Schuster A, 2012, APPL ENVIRON MICROB, V78, P2168, DOI 10.1128/AEM.06959-11; SESTAK S, 1993, CAN J MICROBIOL, V39, P342, DOI 10.1139/m93-048; Shoji J, 2008, BIOTECHNOL LETT, V30, P7, DOI 10.1007/s10529-007-9516-1; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; STERNBERG D, 1979, J BACTERIOL, V139, P761, DOI 10.1128/JB.139.3.761-769.1979; Stricker AR, 2008, APPL MICROBIOL BIOT, V78, P211, DOI 10.1007/s00253-007-1322-0; Stricker AR, 2006, EUKARYOT CELL, V5, P2128, DOI 10.1128/EC.00211-06; Sun JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025654; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; TATCHELL K, 1984, NATURE, V309, P523, DOI 10.1038/309523a0; TEERI T, 1983, BIO-TECHNOL, V1, P696, DOI 10.1038/nbt1083-696; Tisch D, 2011, FUNGAL GENET BIOL, V48, P631, DOI 10.1016/j.fgb.2010.12.009; WANG P, 1995, P NATL ACAD SCI USA, V92, P11529, DOI 10.1073/pnas.92.25.11529; Waugh MS, 2002, MICROBIOL-SGM, V148, P191, DOI 10.1099/00221287-148-1-191; Zeilinger S, 2003, MOL GENET GENOMICS, V270, P46, DOI 10.1007/s00438-003-0895-2; Zeilinger S, 2001, MOL GENET GENOMICS, V266, P56; Zhang JW, 2010, BIORESOURCE TECHNOL, V101, P9815, DOI 10.1016/j.biortech.2010.07.078; Zhu Y, 2009, MOL MICROBIOL, V74, P862, DOI 10.1111/j.1365-2958.2009.06898.x	62	32	34	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 9	2012	7	11							e48786	10.1371/journal.pone.0048786	http://dx.doi.org/10.1371/journal.pone.0048786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	053LI	23152805	Green Submitted, gold, Green Published			2022-12-27	WOS:000312272600020
J	Yuan, Q; Pump, J; Conrad, R				Yuan, Quan; Pump, Judith; Conrad, Ralf			Partitioning of CH4 and CO2 Production Originating from Rice Straw, Soil and Root Organic Carbon in Rice Microcosms	PLOS ONE			English	Article							METHANE EMISSION; ISOTOPE FRACTIONATION; FIELDS; FLOW; QUANTIFICATION; COMMUNITY; PATHWAYS; PHOTOSYNTHATES; FERTILIZATION; TRANSLOCATION	Flooded rice fields are an important source of the greenhouse gas CH4. Possible carbon sources for CH4 and CO2 production in rice fields are soil organic matter (SOM), root organic carbon (ROC) and rice straw (RS), but partitioning of the flux between the different carbon sources is difficult. We conducted greenhouse experiments using soil microcosms planted with rice. The soil was amended with and without C-13-labeled RS, using two C-13-labeled RS treatments with equal RS (5 g kg(-1) soil) but different delta C-13 of RS. This procedure allowed to determine the carbon flux from each of the three sources (SOM, ROC, RS) by determining the delta C-13 of CH4 and CO2 in the different incubations and from the delta C-13 of RS. Partitioning of carbon flux indicated that the contribution of ROC to CH4 production was 41% at tillering stage, increased with rice growth and was about 60% from the booting stage onwards. The contribution of ROC to CO2 was 43% at tillering stage, increased to around 70% at booting stage and stayed relatively constant afterwards. The contribution of RS was determined to be in a range of 12-24% for CH4 production and 11-31% for CO2 production; while the contribution of SOM was calculated to be 23-35% for CH4 production and 13-26% for CO2 production. The results indicate that ROC was the major source of CH4 though RS application greatly enhanced production and emission of CH4 in rice field soil. Our results also suggest that data of CH4 dissolved in rice field could be used as a proxy for the produced CH4 after tillering stage.	[Yuan, Quan; Pump, Judith; Conrad, Ralf] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany	Max Planck Society	Conrad, R (corresponding author), Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany.	conrad@mpi-marburg.mpg.de	yuan, quan/GZM-5597-2022		German Research Foundation; Ministry of Hessen	German Research Foundation(German Research Foundation (DFG)); Ministry of Hessen	The study is part of the ICON Project funded by the German Research Foundation and the SYNMICRO Program funded by the Ministry of Hessen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER JF, 1981, NATURE, V293, P289, DOI 10.1038/293289a0; Bodelier PLE, 2000, BIOGEOCHEMISTRY, V51, P225, DOI 10.1023/A:1006438802362; Brand WA, 1995, ISOT ENVIRON HEALT S, V31, P277, DOI 10.1080/10256019508036271; Brand WA, 1996, J MASS SPECTROM, V31, P225, DOI 10.1002/(SICI)1096-9888(199603)31:3<225::AID-JMS319>3.0.CO;2-L; Cai ZC, 2000, J GEOPHYS RES-ATMOS, V105, P17231, DOI 10.1029/2000JD900014; Carney KM, 2007, P NATL ACAD SCI USA, V104, P4990, DOI 10.1073/pnas.0610045104; Chanton JP, 2005, ORG GEOCHEM, V36, P753, DOI 10.1016/j.orggeochem.2004.10.007; Chanton JP, 1997, GLOBAL BIOGEOCHEM CY, V11, P15, DOI 10.1029/96GB03761; Chidthaisong A, 1997, SOIL BIOL BIOCHEM, V29, P1173, DOI 10.1016/S0038-0717(97)00034-5; Chin KJ, 2004, MICROB ECOL, V47, P59, DOI 10.1007/s00248-003-2014-7; Conrad R, 2005, ORG GEOCHEM, V36, P739, DOI 10.1016/j.orggeochem.2004.09.006; Conrad R, 2005, SOIL BIOL BIOCHEM, V37, P2099, DOI 10.1016/j.soilbio.2005.03.012; Conrad R, 2011, BIOGEOSCIENCES, V8, P795, DOI 10.5194/bg-8-795-2011; Conrad R, 2012, SOIL BIOL BIOCHEM, V49, P193, DOI 10.1016/j.soilbio.2012.02.030; Dannenberg S, 1999, BIOGEOCHEMISTRY, V45, P53, DOI 10.1007/BF00992873; Denef K, 2007, BIOGEOSCIENCES, V4, P769, DOI 10.5194/bg-4-769-2007; DEUSER WG, 1967, NATURE, V215, P1033, DOI 10.1038/2151033a0; Fumoto T, 2008, GLOBAL CHANGE BIOL, V14, P382, DOI 10.1111/j.1365-2486.2007.01475.x; HOLZAPFELPSCHORN A, 1986, J GEOPHYS RES-ATMOS, V91, P1803, DOI 10.1029/JD091iD11p11803; Kimura M, 2004, SOIL BIOL BIOCHEM, V36, P1399, DOI 10.1016/j.soilbio.2004.03.006; Kruger M, 2002, GLOBAL CHANGE BIOL, V8, P265, DOI 10.1046/j.1365-2486.2002.00476.x; Kruger M, 2001, GLOBAL CHANGE BIOL, V7, P49, DOI 10.1046/j.1365-2486.2001.00395.x; Langley JA, 2009, SOIL BIOL BIOCHEM, V41, P54, DOI 10.1016/j.soilbio.2008.09.016; Lehmann-Richter S, 1999, ENVIRON MICROBIOL, V1, P159; Lelieveld J, 1998, TELLUS B, V50, P128, DOI 10.1034/j.1600-0889.1998.t01-1-00002.x; Li CS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002045; MEHARG AA, 1994, PLANT SOIL, V166, P55, DOI 10.1007/BF02185481; Minoda T, 1996, J GEOPHYS RES-ATMOS, V101, P21091, DOI 10.1029/96JD01710; OLEARY MH, 1981, PHYTOCHEMISTRY, V20, P553, DOI 10.1016/0031-9422(81)85134-5; Ostle N, 2007, SOIL BIOL BIOCHEM, V39, P768, DOI 10.1016/j.soilbio.2006.09.025; Penning H, 2006, GEOBIOLOGY, V4, P109, DOI 10.1111/j.1472-4669.2006.00075.x; Penning H, 2006, GEOCHIM COSMOCHIM AC, V70, P2283, DOI 10.1016/j.gca.2006.01.017; Penning H, 2007, ORG GEOCHEM, V38, P2058, DOI 10.1016/j.orggeochem.2007.08.004; Sass RL, 1991, GLOBAL BIOGEOCHEM CY, V5, P275, DOI 10.1029/91GB01304; SCHUTZ H, 1989, J GEOPHYS RES-ATMOS, V94, P16405, DOI 10.1029/JD094iD13p16405; Templeton AS, 2006, GEOCHIM COSMOCHIM AC, V70, P1739, DOI 10.1016/j.gca.2005.12.002; Tokida T, 2010, BIOGEOSCIENCES, V7, P2639, DOI 10.5194/bg-7-2639-2010; Tokida T, 2011, GLOBAL CHANGE BIOL, V17, P3327, DOI 10.1111/j.1365-2486.2011.02475.x; Tyler SC, 1997, GLOBAL BIOGEOCHEM CY, V11, P323, DOI 10.1029/97GB01624; Watanabe A, 2004, PLANT SOIL, V258, P151, DOI 10.1023/B:PLSO.0000016545.36421.bc; Watanabe A, 1998, J GEOPHYS RES-ATMOS, V103, P8237, DOI 10.1029/97JD03460; Watanabe A, 1999, J GEOPHYS RES-ATMOS, V104, P23623, DOI 10.1029/1999JD900467; WATANABE A, 1995, PLANT SOIL, V173, P225, DOI 10.1007/BF00011459; WHITICAR MJ, 1986, GEOCHIM COSMOCHIM AC, V50, P693, DOI 10.1016/0016-7037(86)90346-7; YAGI K, 1990, SOIL SCI PLANT NUTR, V36, P599, DOI 10.1080/00380768.1990.10416797; Zhang XY, 2012, PEDOSPHERE, V22, P13, DOI 10.1016/S1002-0160(11)60187-2	46	33	36	5	99	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 5	2012	7	11							e49073	10.1371/journal.pone.0049073	http://dx.doi.org/10.1371/journal.pone.0049073			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	032TG	23162678	Green Published, gold, Green Submitted			2022-12-27	WOS:000310741400067
J	Lanaspa, MA; Sanchez-Lozada, LG; Cicerchi, C; Li, NX; Roncal-Jimenez, CA; Ishimoto, T; Le, M; Garcia, GE; Thomas, JB; Rivard, CJ; Andres-Hernando, A; Hunter, B; Schreiner, G; Rodriguez-Iturbe, B; Sautin, YY; Johnson, RJ				Lanaspa, Miguel A.; Sanchez-Lozada, Laura G.; Cicerchi, Christina; Li, Nanxing; Roncal-Jimenez, Carlos A.; Ishimoto, Takuji; Le, Myphuong; Garcia, Gabriela E.; Thomas, Jeffrey B.; Rivard, Christopher J.; Andres-Hernando, Ana; Hunter, Brandi; Schreiner, George; Rodriguez-Iturbe, Bernardo; Sautin, Yuri Y.; Johnson, Richard J.			Uric Acid Stimulates Fructokinase and Accelerates Fructose Metabolism in the Development of Fatty Liver	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; DIETARY FRUCTOSE; HYPERINSULINEMIC MEN; RISK-FACTORS; DISEASE; GLUCOSE; EXPRESSION; RAT; HOMEOSTASIS; STEATOHEPATITIS	Excessive dietary fructose intake may have an important role in the current epidemics of fatty liver, obesity and diabetes as its intake parallels the development of these syndromes and because it can induce features of metabolic syndrome. The effects of fructose to induce fatty liver, hypertriglyceridemia and insulin resistance, however, vary dramatically among individuals. The first step in fructose metabolism is mediated by fructokinase (KHK), which phosphorylates fructose to fructose-1-phosphate; intracellular uric acid is also generated as a consequence of the transient ATP depletion that occurs during this reaction. Here we show in human hepatocytes that uric acid up-regulates KHK expression thus leading to the amplification of the lipogenic effects of fructose. Inhibition of uric acid production markedly blocked fructose-induced triglyceride accumulation in hepatocytes in vitro and in vivo. The mechanism whereby uric acid stimulates KHK expression involves the activation of the transcription factor ChREBP, which, in turn, results in the transcriptional activation of KHK by binding to a specific sequence within its promoter. Since subjects sensitive to fructose often develop phenotypes associated with hyperuricemia, uric acid may be an underlying factor in sensitizing hepatocytes to fructose metabolism during the development of fatty liver.	[Lanaspa, Miguel A.; Sanchez-Lozada, Laura G.; Cicerchi, Christina; Li, Nanxing; Roncal-Jimenez, Carlos A.; Ishimoto, Takuji; Le, Myphuong; Garcia, Gabriela E.; Thomas, Jeffrey B.; Rivard, Christopher J.; Andres-Hernando, Ana; Hunter, Brandi; Johnson, Richard J.] Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, Aurora, CO 80045 USA; [Sanchez-Lozada, Laura G.] INC Ignacio Chavez, Lab Renal Physiopathol, Mexico City, DF, Mexico; [Sanchez-Lozada, Laura G.] INC Ignacio Chavez, Dept Nephrol, Mexico City, DF, Mexico; [Schreiner, George] Cardero Therapeut Inc, Menlo Pk, CA USA; [Rodriguez-Iturbe, Bernardo] Inst Venezolano Invest Cient Zuli, Maracaibo, Venezuela; [Rodriguez-Iturbe, Bernardo] Hosp Univ & Univ Zulia, Maracaibo, Venezuela; [Sautin, Yuri Y.] Univ Florida, Dept Med, Div Nephrol Hypertens & Transplantat, Gainesville, FL USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; State University System of Florida; University of Florida	Lanaspa, MA (corresponding author), Univ Colorado Denver, Div Renal Dis & Hypertens, Dept Med, Aurora, CO 80045 USA.	miguel.lanaspagarcia@ucdenver.edu	Sanchez-Lozada, Laura/AAS-2104-2021; Ishimoto, Takuji/M-4873-2014; Lanaspa, Miguel/AAO-4971-2020	Ishimoto, Takuji/0000-0002-9861-5331; Andres-Hernando, Ana/0000-0002-0676-0188; Sanchez-Lozada, Laura-Gabriela/0000-0003-0348-9617; Sautin, Yuri/0000-0003-3618-5134	University of Colorado [HL-68607, RC4 DK090859-01]; CONACyT, Mexico [081054]; National Institutes of Health; Amway; Cardero; Danone; Questcor; Sugar Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068607] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [RC4DK090859] Funding Source: NIH RePORTER	University of Colorado; CONACyT, Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amway; Cardero; Danone(Danone Nutricia); Questcor; Sugar Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Grants HL-68607 and RC4 DK090859-01, and startup funds from the University of Colorado (to RJJ) and by grant 081054 from CONACyT, Mexico (to LGSL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: MAL, TI, and RJJ are listed as inventors on a patent application from the University of Colorado related to developing isoform-specific fructokinase inhibitors in the treatment of disorders associated with obesity and insulin resistance. Patent international number PCT/US11/46938 filed on August 8, 2011. TI and RJJ are listed as inventors on several patent applications related to lowering uric acid as a means to prevent or treat metabolic syndrome, as follows: US Patent No. 6,352,975 B1, Issued March 5, 2002 (Application No. 09/392,932, filed 09/09/1999) "Methods of Treating Hypertension and Compositions for Use Therein." US Patent No 6,677,300. Issued Jan 13, 2004. (Application No. 09/392, 931, filed 09/09/99) "Treatment of Microvascular Angiopathies." US Patent No. 7,030,083 B2 Issued April 18, 2006 (Application No. 10/418,529, Filed 4/16/2003) Issued Nov 10, 2005 "Treatment of eclampsia and preeclampsia." US Patent No 7,799,794 B2, Issued Sep 21, 2010, (Application 09/892,505; Filed Jun 28, 2001 Treatment for Cardiovascular Disease. RJJ also has a patent with the University of Washington and Merck for the use of allopurinol to treat hypertension. RJJ also discloses that he has consulted for Ardea, Astellas, Danone and Novartis, that he is on the scientific board of Amway, and that he has received grants from the National Institutes of Health and from Amway, Cardero, Danone, Questcor and the Sugar Foundation. GS is employed by a commercial company (Cardero Therapeutics). There are no further patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.	Abdelmalek MF, 2012, HEPATOLOGY, V56, P952, DOI 10.1002/hep.25741; BODE JC, 1973, EUR J CLIN INVEST, V3, P436, DOI 10.1111/j.1365-2362.1973.tb02211.x; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; BURANT CF, 1994, AM J PHYSIOL, V267, pG71, DOI 10.1152/ajpgi.1994.267.1.G71; Chung SSM, 2003, J AM SOC NEPHROL, V14, pS233, DOI 10.1097/01.ASN.0000077408.15865.06; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Couchepin C, 2008, DIABETES CARE, V31, P1254, DOI 10.2337/dc07-2001; FACCHINI F, 1991, JAMA-J AM MED ASSOC, V266, P3008, DOI 10.1001/jama.266.21.3008; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Ferreira VSG, 2010, ARQ BRAS ENDOCRINOL, V54, P362, DOI 10.1590/S0004-27302010000400004; Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331; HALLFRISCH J, 1983, AM J CLIN NUTR, V37, P740, DOI 10.1093/ajcn/37.5.740; HALLFRISCH J, 1986, J AM COLL NUTR, V5, P61; HALLFRISCH J, 1983, J NUTR, V113, P1819, DOI 10.1093/jn/113.9.1819; HALLFRISCH J, 1990, FASEB J, V4, P2652, DOI 10.1096/fasebj.4.9.2189777; Havel PJ, 2005, NUTR REV, V63, P133, DOI [10.1301/nr.2005.may.133-157, 10.1111/j.1753-4887.2005.tb00132.x]; Johnson Richard J, 2010, Trans Am Clin Climatol Assoc, V121, P295; Johnson RJ, 2009, ENDOCR REV, V30, P96, DOI 10.1210/er.2008-0033; Johnson RJ, 2003, HYPERTENSION, V41, P1183, DOI 10.1161/01.HYP.0000069700.62727.C5; Johnson RJ, 2010, T AM CLIN CLIMAT ASS, V121, P305; Kanellis J, 2003, HYPERTENSION, V41, P1287, DOI 10.1161/01.HYP.0000072820.07472.3B; Kang DH, 2005, J AM SOC NEPHROL, V16, P3553, DOI 10.1681/ASN.2005050572; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Koo HY, 2008, BBA-MOL BASIS DIS, V1782, P341, DOI 10.1016/j.bbadis.2008.02.007; Koo HY, 2009, BIOCHEM BIOPH RES CO, V390, P285, DOI 10.1016/j.bbrc.2009.09.109; KORIEH A, 1991, ARCH INT PHYSIOL BIO, V99, P455; Kuo CF, 2010, SCAND J RHEUMATOL, V39, P466, DOI 10.3109/03009741003742797; Lanaspa MA, 2010, J BIOL CHEM, V285, P31694, DOI 10.1074/jbc.M109.093690; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Lee K, 2009, DIABETES METAB, V35, P447, DOI 10.1016/j.diabet.2009.04.011; Ma L, 2006, J BIOL CHEM, V281, P28721, DOI 10.1074/jbc.M601576200; Masuo K, 2003, HYPERTENSION, V42, P474, DOI 10.1161/01.HYP.0000091371.53502.D3; Nakagawa T, 2006, AM J PHYSIOL-RENAL, V290, pF625, DOI 10.1152/ajprenal.00140.2005; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Stanhope KL, 2009, J CLIN INVEST, V119, P1322, DOI 10.1172/JCI37385; Tappy L, 2010, PHYSIOL REV, V90, P23, DOI 10.1152/physrev.00019.2009; Van den Berghe G, 1986, Prog Biochem Pharmacol, V21, P1; WANLESS IR, 1990, HEPATOLOGY, V12, P1106, DOI 10.1002/hep.1840120505; Xu CF, 2010, HEPATOLOGY, V52, P1865, DOI 10.1002/hep.23798; Xu CF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011578; Yamada T, 2010, ACTA GASTRO-ENT BELG, V73, P12; Yu MA, 2010, J HYPERTENS, V28, P1234, DOI 10.1097/HJH.0b013e328337da1d; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	45	181	192	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47948	10.1371/journal.pone.0047948	http://dx.doi.org/10.1371/journal.pone.0047948			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23112875	gold, Green Submitted, Green Published			2022-12-27	WOS:000310310200116
J	Huang, BT; Chang, PY; Su, CH; Chao, CCK; Sue, LC				Huang, Bo-Tsang; Chang, Pu-Yuan; Su, Ching-Hua; Chao, Chuck C-K; Sue Lin-Chao			Gas7-Deficient Mouse Reveals Roles in Motor Function and Muscle Fiber Composition during Aging	PLOS ONE			English	Article							MYOSIN HEAVY-CHAIN; TERMINAL SCHWANN-CELLS; RAT SOLEUS MUSCLE; MULTIJOINT MOVEMENTS; GAS7; PROTEIN; GROWTH; ISOFORMS; MODEL; LEADS	Background: Growth arrest-specific gene 7 (Gas7) has previously been shown to be involved in neurite outgrowth in vitro; however, its actual role has yet to be determined. To investigate the physiological function of Gas7 in vivo, here we generated a Gas7-deficient mouse strain with a labile Gas7 mutant protein whose functions are similar to wild-type Gas7. Methodology/Principal Findings: Our data show that aged Gas7-deficient mice have motor activity defects due to decreases in the number of spinal motor neurons and in muscle strength, of which the latter may be caused by changes in muscle fiber composition as shown in the soleus. In cross sections of the soleus of Gas7-deficient mice, gross morphological features and levels of myosin heavy chain I (MHC I) and MHC II markers revealed significantly fewer fast fibers. In addition, we found that nerve terminal sprouting, which may be associated with slow and fast muscle fiber composition, was considerably reduced at neuromuscular junctions (NMJ) during aging. Conclusions/Significance: These findings indicate that Gas7 is involved in motor neuron function associated with muscle strength maintenance.	[Huang, Bo-Tsang; Sue Lin-Chao] Acad Sinica, Inst Mol Biol, Taipei, Taiwan; [Huang, Bo-Tsang; Su, Ching-Hua] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan; [Chang, Pu-Yuan; Chao, Chuck C-K] Chang Gung Univ, Dept Biochem & Mol Biol, Tao Yuan, Taiwan	Academia Sinica - Taiwan; Taipei Medical University; Chang Gung University	Huang, BT (corresponding author), Acad Sinica, Inst Mol Biol, Taipei, Taiwan.	mbsue@gate.sinica.edu.tw	Lin-Chao, Sue/AGI-2030-2022; Lin-Chao, Sue/AAZ-8246-2021	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304	Institute of Molecular Biology, Academia Sinica; National Science Council [NSC 92-2311-B-001-083, 93-2311-B-001-025, 94-2311-B-001-011]; Academia Sinica [2323]	Institute of Molecular Biology, Academia Sinica(Academia Sinica - Taiwan); National Science Council(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan)	This work was supported by an intramural fund from the Institute of Molecular Biology, Academia Sinica, and by a grant from the National Science Council (NSC 92-2311-B-001-083, 93-2311-B-001-025, 94-2311-B-001-011), http://web1.nsc.gov.tw/mp.aspx?mp=7 and theme project of Academia Sinica (2323), http://www.sinica.edu.tw/main_e.shtml. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama H, 2009, J BIOL CHEM, V284, P32695, DOI 10.1074/jbc.M109.035998; Basco D, 2010, EUR J APPL PHYSIOL, V110, P1215, DOI 10.1007/s00421-010-1592-6; Bear MF, 1996, NEUROSCIENCE EXPLORI; Bento-Abreu A, 2010, EUR J NEUROSCI, V31, P2247, DOI 10.1111/j.1460-9568.2010.07260.x; Boron WF, 2003, MEDICAL PHYSL; BRENNER DG, 1989, P NATL ACAD SCI USA, V86, P5517, DOI 10.1073/pnas.86.14.5517; BROWN MC, 1981, ANNU REV NEUROSCI, V4, P17, DOI 10.1146/annurev.ne.04.030181.000313; BULLER AJ, 1960, J PHYSIOL-LONDON, V150, P417, DOI 10.1113/jphysiol.1960.sp006395; Campana ALM, 2003, EUR J NEUROSCI, V17, P2135, DOI 10.1046/j.1460-9568.2003.02631.x; CASTON J, 1995, NEUROBIOL LEARN MEM, V64, P195, DOI 10.1006/nlme.1995.0002; Chao CCK, 2003, J NEUROSCI RES, V74, P248, DOI 10.1002/jnr.10763; Crawley JN, 1999, BRAIN RES, V835, P18, DOI 10.1016/S0006-8993(98)01258-X; Dupont E, 2011, AM J PHYSIOL-REG I, V300, pR408, DOI 10.1152/ajpregu.00793.2009; Durieux AC, 2009, J PHYSIOL-LONDON, V587, P3703, DOI 10.1113/jphysiol.2009.171355; Fine EJ, 2002, SEMIN NEUROL, V22, P375, DOI 10.1055/s-2002-36759; Garwicz M, 2002, BRAIN RES REV, V40, P152, DOI 10.1016/S0165-0173(02)00198-4; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Gordon T, 2004, NEUROL RES, V26, P174, DOI 10.1179/016164104225013806; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Gundersen K, 1998, ACTA PHYSIOL SCAND, V162, P333, DOI 10.1046/j.1365-201X.1998.0336e.x; GUTMANN E, 1972, Ceskoslovenska Fysiologie, V21, P9; Hayworth CR, 2006, J NEUROSCI, V26, P6873, DOI 10.1523/JNEUROSCI.1086-06.2006; Hsieh-Li HM, 2000, NAT GENET, V24, P66, DOI 10.1038/71709; Ilieva HS, 2008, P NATL ACAD SCI USA, V105, P12599, DOI 10.1073/pnas.0805422105; Jablonka S, 2000, HUM MOL GENET, V9, P341, DOI 10.1093/hmg/9.3.341; Ju YT, 1998, P NATL ACAD SCI USA, V95, P11423, DOI 10.1073/pnas.95.19.11423; Kakimoto T, 2006, J BIOL CHEM, V281, P29042, DOI 10.1074/jbc.M604025200; Kang H, 2003, J NEUROCYTOL, V32, P975, DOI 10.1023/B:NEUR.0000020636.27222.2d; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Krajewski KM, 2000, BRAIN, V123, P1516, DOI 10.1093/brain/123.7.1516; KUGELBERG E, 1976, J NEUROL SCI, V27, P269, DOI 10.1016/0022-510X(76)90001-0; Lain E, 2009, J BIOL CHEM, V284, P8921, DOI 10.1074/jbc.M809491200; LALONDE R, 1995, NEUROSCI RES, V22, P423, DOI 10.1016/0168-0102(95)00916-H; LARSSON L, 1995, PROG NEUROBIOL, V45, P397, DOI 10.1016/0301-0082(95)98601-Z; LARSSON L, 1995, J GERONTOL A-BIOL, V50, P91; Lazakovitch EM, 1999, GENOMICS, V61, P298, DOI 10.1006/geno.1999.5964; LEXELL J, 1995, J GERONTOL A-BIOL, V50, P11; Luff AR, 1998, ANN NY ACAD SCI, V854, P92, DOI 10.1111/j.1749-6632.1998.tb09895.x; Macaluso A, 2004, EUR J APPL PHYSIOL, V91, P450, DOI 10.1007/s00421-003-0991-3; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Mendler L, 2008, J HISTOCHEM CYTOCHEM, V56, P111, DOI 10.1369/jhc.7A7322.2007; O'Malley JP, 1999, J NEUROBIOL, V38, P270, DOI 10.1002/(SICI)1097-4695(19990205)38:2<270::AID-NEU9>3.0.CO;2-F; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 2001, HISTOCHEM CELL BIOL, V115, P359, DOI 10.1007/s004180100268; Prochazka A, 2002, PROG BRAIN RES, V137, P109; Quiat D, 2011, P NATL ACAD SCI USA, V108, P10196, DOI 10.1073/pnas.1107413108; REISER PJ, 1985, J BIOL CHEM, V260, P9077; RondiReig L, 1997, NEUROSCIENCE, V77, P955, DOI 10.1016/S0306-4522(96)00518-0; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; SCHANTZ P, 1983, CLIN PHYSIOL, V3, P141, DOI 10.1111/j.1475-097X.1983.tb00685.x; SCHENAU GJV, 1995, HUM MOVEMENT SCI, V14, P511, DOI 10.1016/0167-9457(95)00026-1; SCHIAFFINO S, 1988, DEV BIOL, V127, P1, DOI 10.1016/0012-1606(88)90183-2; She BR, 2002, EXP CELL RES, V273, P34, DOI 10.1006/excr.2001.5435; Song YN, 2006, NEUROSCIENCE, V140, P33, DOI 10.1016/j.neuroscience.2006.01.045; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Stigger F, 2011, EXP NEUROL, V228, P183, DOI 10.1016/j.expneurol.2011.01.001; SUGIURA T, 1992, ACTA PHYSIOL SCAND, V144, P419, DOI 10.1111/j.1748-1716.1992.tb09315.x; Uchida T, 2009, J MOL BIOL, V391, P849, DOI 10.1016/j.jmb.2009.06.081; VANSOEST AJ, 1995, HUM MOVEMENT SCI, V14, P391, DOI 10.1016/0167-9457(95)00022-4; Windisch A, 1998, J PHYSIOL-LONDON, V510, P623, DOI 10.1111/j.1469-7793.1998.623bk.x; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Wolansky MJ, 2008, NEUROTOXICOL TERATOL, V30, P55, DOI 10.1016/j.ntt.2007.10.005; You JJ, 2010, J BIOL CHEM, V285, P11652, DOI 10.1074/jbc.M109.051094	64	18	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 25	2012	7	5							e37702	10.1371/journal.pone.0037702	http://dx.doi.org/10.1371/journal.pone.0037702			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959UY	23166618	Green Published, Green Submitted, gold			2022-12-27	WOS:000305342300085
J	Tang, RB; Chai, WM; Yang, GY; Xie, HL; Chen, KM				Tang, Rongbiao; Chai, Wei-Min; Yang, Guo-Yuan; Xie, Honglan; Chen, Ke-Min			X-ray Phase Contrast Imaging of Cell Isolation with Super-Paramagnetic Microbeads	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TUMOR-GROWTH; MICROBUBBLES; ANGIOGENESIS; AGENT	Super-paramagnetic microbeads are widely used for cell isolation. Evaluation of the binding affinity of microbeads to cells using optical microscopy has been limited by its small scope. Here, magnetic property of microbeads was first investigated by using synchrotron radiation (SR) in-line x-ray phase contrast imaging (PCI). The cell line mouse LLC (Lewis lung carcinoma) was selected for cell adhesion studies. Targeted microbeads were prepared by attaching anti-VEGFR2 (vascular endothelial growth factor receptor-2) antibody to the shell of the microbeads. The bound microbeads were found to better adhere to LLC cells than unbound ones. PCI dynamically and clearly showed the magnetization and demagnetization of microbeads in PE-50 tube. The cells incubated with different types of microbeads were imaged by PCI, which provided clear and real-time visualization of the cell isolation. Therefore, PCI might be considered as a novel and efficient tool for further cell isolation studies.	[Tang, Rongbiao; Chai, Wei-Min; Chen, Ke-Min] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Radiol, Shanghai 200030, Peoples R China; [Yang, Guo-Yuan] Shanghai Jiao Tong Univ, Med X Res Inst, Neurosci & Neuroengn Ctr, Shanghai 200030, Peoples R China; [Xie, Honglan] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Chen, KM (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Dept Radiol, Shanghai 200030, Peoples R China.	keminchenrj1@yahoo.com.cn	Tang, Rui/I-6391-2015; Tang, Rui/AAR-8048-2020	Tang, Rui/0000-0002-9313-0802; 	Nation Basic Research Program of China (973 Program) [2010CB834305]; Shanghai Leading Academic Discipline Project; Jiao Tong University Med-Science Cross Research Foundation [YG2010MS20]	Nation Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); Jiao Tong University Med-Science Cross Research Foundation	This work was financially supported by grants from the Nation Basic Research Program of China (973 Program 2010CB834305), Shanghai Leading Academic Discipline Project, and Jiao Tong University Med-Science Cross Research Foundation (YG2010MS20). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen J., 2005, IMMUNODIAGNOSTIC, V29, P22; Brzeska M, 2004, J BIOTECHNOL, V112, P25, DOI 10.1016/j.jbiotec.2004.04.018; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Higgins KJ, 2006, ENDOCRINOLOGY, V147, P3285, DOI 10.1210/EN.2006-0081; Kim KJ, 1993, INHIBITION VASCULAR; Lewis RA, 2004, PHYS MED BIOL, V49, P3573, DOI 10.1088/0031-9155/49/16/005; Lien KY, 2010, LAB CHIP, V10, P2875, DOI 10.1039/c005178k; Lien KY, 2010, PROC IEEE MICR ELECT, P100, DOI 10.1109/MEMSYS.2010.5442557; Lin PN, 1998, CELL GROWTH DIFFER, V9, P49; Liu P, 2008, J SYNCHROTRON RADIAT, V15, P36, DOI 10.1107/S0909049507045761; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; PLATE KH, 1994, INT J CANCER, V59, P520, DOI 10.1002/ijc.2910590415; Shibuya M, 2001, CELL STRUCT FUNCT, V26, P25, DOI 10.1247/csf.26.25; Tang RBA, 2012, PHYS MED BIOL, V57, P3051, DOI 10.1088/0031-9155/57/10/3051; Tang RB, 2011, PHYS MED BIOL, V56, P3503, DOI 10.1088/0031-9155/56/12/004; Wen J, 2005, MOL VIS, V11, P256; Willmann JK, 2008, RADIOLOGY, V246, P508, DOI 10.1148/radiol.2462070536; Xi Y, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3607292	19	31	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 24	2012	7	9							e45597	10.1371/journal.pone.0045597	http://dx.doi.org/10.1371/journal.pone.0045597			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	016YB	23029126	Green Published, Green Submitted, gold			2022-12-27	WOS:000309554700048
J	Tang, R; Zhang, JP; Zhang, ZN				Tang, Rui; Zhang, Jin Ping; Zhang, Zhong Ning			Electrophysiological and Behavioral Responses of Male Fall Webworm Moths (Hyphantria cunea) to Herbivory-Induced Mulberry (Morus alba) Leaf Volatiles	PLOS ONE			English	Article							(E)-BETA-OCIMENE SYNTHASE; PLANT VOLATILES; SEX-PHEROMONE; BOLL-WEEVIL; EMISSIONS; IDENTIFICATION; LEPIDOPTERA; FEMALES	Volatile organic compounds (VOCs) were collected from damaged and intact mulberry leaves (Morus alba L., Moraceae) and from Hyphantria cunea larvae by headspace absorption with Super Q columns. We identified their constituents using gas chromatography-mass spectrometry, and evaluated the responses of male H. cunea antennae to the compounds using gas chromatography-flame ionization detection coupled with electroantennographic detection. Eleven VOC constituents were found to stimulate antennae of male H. cunea moths: beta-ocimene, hexanal, cis-3-hexenal, limonene, trans-2-hexenal, cyclohexanone, cis-2-penten-1-ol, 6-methyl-5-hepten-2-one, 4-hydroxy-4-methyl-2-pentanone, trans-3-hexen-1-ol, and 2,4-dimethyl-3-pentanol. Nine of these chemicals were released by intact, mechanically-damaged, and herbivore-damaged leaves, while cis-2-penten-1-ol was released only by intact and mechanically-damaged leaves and beta-ocimene was released only by herbivore-damaged leaves. Results from wind tunnel experiments conducted with volatile components indicated that male moths were significantly more attracted to herbivory-induced volatiles than the solvent control. Furthermore, male moths' attraction to a sex pheromone lure was increased by herbivory-induced compounds and beta-ocimene, but reduced by cis-2-penten-1-ol. A proof long-range field trapping experiment showed that the efficiency of sex pheromone lures in trapping male moths was increased by beta-ocimene and reduced by cis-2-penten-1-ol.	[Tang, Rui; Zhang, Jin Ping; Zhang, Zhong Ning] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Tang, R (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	zhangzn@ioz.ac.cn	Tang, Rui/I-6391-2015; Tang, Rui/AAR-8048-2020	Tang, Rui/0000-0002-9313-0802; 				Angerosa F, 2000, FOOD CHEM, V68, P283, DOI 10.1016/S0308-8146(99)00189-2; Arimura G, 2004, PLANT PHYSIOL, V135, P1976, DOI 10.1104/pp.104.042929; Arimura G, 2004, PLANT J, V37, P603, DOI 10.1111/j.1365-313X.2003.01987.x; Cao MQ, 2010, TERRITORY NATURAL RE, P86; Cha DH, 2008, J CHEM ECOL, V34, P622, DOI 10.1007/s10886-008-9474-7; Chen MZ, 2011, J FOOD SCI, V76, pC1032, DOI 10.1111/j.1750-3841.2011.02328.x; Dicke M, 2003, BASIC APPL ECOL, V4, P3, DOI 10.1078/1439-1791-00129; DICKENS JC, 1984, J CHEM ECOL, V10, P1759, DOI 10.1007/BF00987360; DICKENS JC, 1993, J INSECT PHYSIOL, V39, P503, DOI 10.1016/0022-1910(93)90083-4; DICKENS JC, 1989, ENTOMOL EXP APPL, V52, P191, DOI 10.1007/BF00414044; Dickens Joseph C., 1993, Chemoecology, V4, P175, DOI 10.1007/BF01256553; Hartvigsen K, 2000, J AGR FOOD CHEM, V48, P4858, DOI 10.1021/jf991385b; Howard RW, 2005, ANNU REV ENTOMOL, V50, P371, DOI 10.1146/annurev.ento.50.071803.130359; ITO Y, 1968, Researches on Population Ecology (Tokyo), V10, P177, DOI 10.1007/BF02510872; JAENIKE J, 1980, ENTOMOL EXP APPL, V27, P31, DOI 10.1007/BF00377237; Kessler A, 2001, SCIENCE, V291, P2141, DOI 10.1126/science.291.5511.2141; Kishimoto K, 2005, PLANT CELL PHYSIOL, V46, P1093, DOI 10.1093/pcp/pci122; Kishimoto K, 2006, PHYTOCHEMISTRY, V67, P1520, DOI 10.1016/j.phytochem.2006.05.027; Li JieHong, 2007, Chemistry and Industry of Forest Products, V27, P107; [李卫国 LI Wei-Guo], 2009, [蚕业科学, Acta Sericologica Sinica], V35, P355; Lu Yu-Jie, 2003, Acta Ecologica Sinica, V23, P308; Maisonnasse A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013531; Navia-Gine WG, 2009, PLANT PHYSIOL BIOCH, V47, P416, DOI 10.1016/j.plaphy.2009.01.008; Noe SM, 2006, ATMOS ENVIRON, V40, P4649, DOI 10.1016/j.atmosenv.2006.04.049; Ruther J, 2002, ECOL ENTOMOL, V27, P76, DOI 10.1046/j.1365-2311.2002.0373a.x; SAAD AD, 1981, ENTOMOL EXP APPL, V30, P123, DOI 10.1007/BF00300876; Stelinski LL, 2003, J INSECT PHYSIOL, V49, P845, DOI 10.1016/S0022-1910(03)00136-7; Su MW, 2008, CHINESE SCI BULL, V53, P555, DOI 10.1007/s11434-008-0124-9; Tanaka K, 2009, CURR BIOL, V19, P881, DOI 10.1016/j.cub.2009.04.035; Tang R, 2012, CHINESE SCI IN PRESS, V57; Tasin M, 2006, CHEMOECOLOGY, V16, P87, DOI 10.1007/s00049-005-0332-6; TEAL PEA, 1981, J CHEM ECOL, V7, P1011, DOI 10.1007/BF00987623; Travis HJ, 2005, AM MIDL NAT, V153, P270, DOI 10.1674/0003-0031(2005)153[0270:TEOETC]2.0.CO;2; WILLIAMS KS, 1984, OECOLOGIA, V63, P166, DOI 10.1007/BF00379873; Yang ZQ, 2006, BIOCONTROL, V51, P401, DOI 10.1007/s10526-006-9010-z	35	31	37	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2012	7	11							e49256	10.1371/journal.pone.0049256	http://dx.doi.org/10.1371/journal.pone.0049256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038CD	23029126	Green Submitted, gold, Green Published			2022-12-27	WOS:000311151900111
J	Huang, BL; Lv, CQ; Zhao, YL; Huang, R				Huang, Baoling; Lv, Chengqun; Zhao, Yili; Huang, Rong			A Novel Strain D5 Isolated from Acacia confusa	PLOS ONE			English	Article							NITROGEN-FIXATION; SP NOV.; SYM PLASMID; NODULATION; RHIZOBIA; NODULES; LEGUMES; MIMOSA; ROOTS	We isolated a novel strain D5 from nodules of Acacia confusa. Under strict sterile conditions the strain could successfully nodulate Acacia confusa, A. crassicarpa and A. mangium, with nitrogenase activity ranging from 18.90 to 19.86 nmol.g(-1).min(-1). In the phylogenetic tree based on a complete 16S rRNA gene sequence, the sequence of strain D5 shared 99% homology with that of four species of genus Pseudomonas. The 685 bp nodA fragment amplified from strain D5 shared 95% homology with the nodA sequence of 9 species of genus Bradyrhizobium, with a genetic distance of 0.01682. The 740 bp nifH gene fragment was amplified from strain D5. This strain D5 nifH gene and Bradyrhizobium spp. formed a branch, showing 98% homology and a genetic distance of 0. The homology between this branch and the Bradyrhizobium spp. DG in another branch was 99%, with a genetic distance of 0.007906. These results indicate that this strain D5 is a new type of nitrogen-fixing bacterium.	[Huang, Baoling; Lv, Chengqun; Zhao, Yili; Huang, Rong] Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China	Guangxi University	Huang, BL (corresponding author), Guangxi Univ, Coll Forestry, Nanning 530004, Peoples R China.	hnboln@126.com	Lin-Chao, Sue/AGI-2030-2022; Lin-Chao, Sue/AAZ-8246-2021	Lin-Chao, Sue/0000-0002-8415-9304; Lin-Chao, Sue/0000-0002-8415-9304	Department of Education, Guangxi Zhuang Autonomous Region [201012MS002]	Department of Education, Guangxi Zhuang Autonomous Region	This research was supported by the Scientific Research Project (201012MS002) of the Department of Education, Guangxi Zhuang Autonomous Region. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen WenXin, 2004, Scientia Agricultura Sinica, V37, P81; Chen WM, 2001, INT J SYST EVOL MICR, V51, P1729, DOI 10.1099/00207713-51-5-1729; de Lajudie P, 1998, INT J SYST BACTERIOL, V48, P369, DOI 10.1099/00207713-48-2-369; Desnoues N, 2003, MICROBIOL-SGM, V149, P2251, DOI 10.1099/mic.0.26270-0; [樊利勤 FAN Liqin], 2007, [生态科学, Ecologic Science], V26, P107; He S, 2008, ARCH MICROBIOL, V190, P1, DOI 10.1007/s00203-008-0354-x; HOOYKAAS PJJ, 1981, NATURE, V291, P351, DOI 10.1038/291351a0; Huang BL, 2007, SCI CHINA SER C, V50, P228, DOI 10.1007/s11427-007-0034-0; Huang BaoLing, 2006, Journal of Beijing Forestry University, V28, P102; Huang BaoLing, 2004, Journal of Nanjing Forestry University (Natural Sciences Edition), V28, P29; Lu Cheng-Qun, 2006, Journal of Tropical and Subtropical Botany, V14, P19; [吕成群 Lu Chengqun], 2003, [微生物学通报, Microbiology], V30, P1; [吕成群 LV ChengQun], 2008, [微生物学通报, Microbiology], V35, P215; Mantelin S, 2006, INT J SYST EVOL MICR, V56, P827, DOI 10.1099/ijs.0.63911-0; [缪礼鸿 MIAO Lihong], 2007, [华中农业大学学报, Journal of Huazhong Agricultural University], V26, P428; Moulin L, 2001, NATURE, V411, P948, DOI 10.1038/35082070; PLAZINSKI J, 1985, J BACTERIOL, V162, P1261, DOI 10.1128/JB.162.3.1261-1269.1985; Shang JH, 2005, BIOTECHNOLOGY, V15, P72; Shang Jun-hong, 2005, Forest Research, V18, P177; TRINICK M. J., 1965, Australian Journal of Science, V27, P263; TRINICK MJ, 1980, J APPL BACTERIOL, V49, P39, DOI 10.1111/j.1365-2672.1980.tb01042.x; TRINICK MJ, 1968, EXP AGR, V4, P243, DOI 10.1017/S0014479700004257; Trujillo ME, 2005, APPL ENVIRON MICROB, V71, P1318, DOI 10.1128/AEM.71.3.1318-1327.2005; Vandamme P, 2002, SYST APPL MICROBIOL, V25, P507, DOI 10.1078/07232020260517634; Wang Fengqin, 2008, Weishengwu Xuebao, V48, P1; Wang Su-ying, 2006, Weishengwu Xuebao, V46, P132; Wang XD, 2006, BIOTECHNOLOGY, V16, P24; [韦原莲 WEI Yuanlian], 2006, [西北林学院学报, Journal of Northwest Forestry College], V21, P120; Xie ZH, 2006, MICROBIOL-SGM, V152, P3535, DOI 10.1099/mic.0.29171-0; Yan YL, 2008, J AGR SCI TECHNOLOGY, V10, P45; Yan YL, 2008, P NATL ACAD SCI USA, V105, P7564, DOI 10.1073/pnas.0801093105; Yi YouJin, 2007, Acta Phytopathologica Sinica, V37, P301; Zurdo-Pineiro JL, 2007, INT J SYST EVOL MICR, V57, P784, DOI 10.1099/ijs.0.64613-0	33	18	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2012	7	11							e49236	10.1371/journal.pone.0049236	http://dx.doi.org/10.1371/journal.pone.0049236			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	039UP	23166618	Green Submitted, Green Published, gold			2022-12-27	WOS:000311272300034
J	Zheng, DH; Limmon, GV; Yin, L; Leung, NHN; Yu, H; Chow, VTK; Chen, JZ				Zheng, Dahai; Limmon, Gino V.; Yin, Lu; Leung, Nicola H. N.; Yu, Hanry; Chow, Vincent T. K.; Chen, Jianzhu			Regeneration of Alveolar Type I and II Cells from Scgb1a1-Expressing Cells following Severe Pulmonary Damage Induced by Bleomycin and Influenza	PLOS ONE			English	Article							LUNG STEM-CELLS; MOUSE LUNG; PROGENITOR CELLS; MAINTENANCE; EPITHELIUM; REPAIR; AIRWAY; TOXICITY; CANCER; MICE	The lung comprises an extensive surface of epithelia constantly exposed to environmental insults. Maintaining the integrity of the alveolar epithelia is critical for lung function and gaseous exchange. However, following severe pulmonary damage, what progenitor cells give rise to alveolar type I and II cells during the regeneration of alveolar epithelia has not been fully determined. In this study, we have investigated this issue by using transgenic mice in which Scgb1a1-expressing cells and their progeny can be genetically labeled with EGFP. We show that following severe alveolar damage induced either by bleomycin or by infection with influenza virus, the majority of the newly generated alveolar type II cells in the damaged parenchyma were labeled with EGFP. A large proportion of EGFP-expressing type I cells were also observed among the type II cells. These findings strongly suggest that Scgb1a1-expressing cells, most likely Clara cells, are a major cell type that gives rise to alveolar type I and II cells during the regeneration of alveolar epithelia in response to severe pulmonary damage in mice.	[Chow, Vincent T. K.] Natl Univ Singapore, Sch Med, Dept Microbiol, Human Genome Lab, Singapore 117548, Singapore; [Zheng, Dahai; Limmon, Gino V.; Yin, Lu; Leung, Nicola H. N.; Chen, Jianzhu] Singapore Massachusetts Inst Technol Alliance Res, Interdisciplinary Res Grp Infect Dis, Singapore, Singapore; [Chen, Jianzhu] MIT, Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Chen, Jianzhu] MIT, Dept Biol, Cambridge, MA USA; [Yu, Hanry] Agcy Sci Technol & Res, Inst Bioengn & Nanotechnol, Singapore, Singapore; [Yu, Hanry] Natl Univ Singapore, Dept Physiol & Mechanobiol, Singapore 117548, Singapore	National University of Singapore; Massachusetts Institute of Technology (MIT); Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); National University of Singapore	Chow, VTK (corresponding author), Natl Univ Singapore, Sch Med, Dept Microbiol, Human Genome Lab, Singapore 117548, Singapore.	vincent_chow@nuhs.edu.sg; jchen@mit.edu	Yu, Hanry/L-6050-2019; Limmon, Gino/X-5913-2019; Yu, Hanry/C-7375-2011; Yu, Hanry/C-1031-2013	Yu, Hanry/0000-0002-0339-3685; Limmon, Gino/0000-0003-3030-7022; Yu, Hanry/0000-0002-0339-3685; Chow, Vincent/0000-0003-2634-6213; Zheng, Dawei/0000-0002-7545-167X; Yin, Lu/0000-0002-3651-8608	National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's Infectious Disease-IRG research programme	National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's Infectious Disease-IRG research programme	This research was supported by the National Research Foundation Singapore through the Singapore MIT Alliance for Research and Technology's Infectious Disease-IRG research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON IYR, 1976, ENVIRON HEALTH PERSP, V16, P119, DOI 10.2307/3428592; [Anonymous], 2011, NAT MED, V17, P788; ASO Y, 1976, LAB INVEST, V35, P558; Azambuja E, 2005, PULM PHARMACOL THER, V18, P363, DOI 10.1016/j.pupt.2005.01.007; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Gothelf A, 2003, CANCER TREAT REV, V29, P371, DOI 10.1016/S0305-7372(03)00073-2; Kajstura J, 2011, NEW ENGL J MED, V364, P1795, DOI 10.1056/NEJMoa1101324; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kumar PA, 2011, CELL, V147, P525, DOI 10.1016/j.cell.2011.10.001; Liu XM, 2006, METHOD ENZYMOL, V419, P285, DOI 10.1016/S0076-6879(06)19012-6; McQualter JL, 2012, STEM CELLS, V30, P811, DOI 10.1002/stem.1055; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Pacheco-Pinedo EC, 2011, J CLIN INVEST, V121, P1935, DOI 10.1172/JCI44871; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Reynolds SD, 2010, INT J BIOCHEM CELL B, V42, P1, DOI 10.1016/j.biocel.2009.09.002; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Rock JR, 2011, ANNU REV CELL DEV BI, V27, P493, DOI 10.1146/annurev-cellbio-100109-104040; Schraufnagel Dean E, 2010, Pathophysiology, V17, P337, DOI 10.1016/j.pathophys.2009.10.008; Siniscalco Dario, 2008, Ther Adv Respir Dis, V2, P173, DOI 10.1177/1753465808092340; Stripp Barry R, 2008, Proc Am Thorac Soc, V5, P328, DOI 10.1513/pats.200711-167DR; Teisanu RM, 2009, STEM CELLS, V27, P612, DOI 10.1634/stemcells.2008-0838; Volckaert T, 2011, J CLIN INVEST, V121, P4409, DOI 10.1172/JCI58097; WOOLFENDEN JM, 1979, CANCER, V43, P1652, DOI 10.1002/1097-0142(197905)43:5<1652::AID-CNCR2820430514>3.0.CO;2-I	26	134	139	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2012	7	10							e48451	10.1371/journal.pone.0048451	http://dx.doi.org/10.1371/journal.pone.0048451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	030WJ	23119022	Green Published, gold, Green Submitted			2022-12-27	WOS:000310600500140
J	Yang, TZ; Rockett, IRH; Lv, QH; Cottrell, RR				Yang, Tingzhong; Rockett, Ian R. H.; Lv, Qiaohong; Cottrell, Randall R.			Stress Status and Related Characteristics among Urban Residents: A Six-Province Capital Cities Study in China	PLOS ONE			English	Article							MENTAL-HEALTH; INCOME INEQUALITY; PERCEIVED STRESS; ECONOMIC-GROWTH; WOMEN	Objectives: To estimate current prevalence levels of stress, and to identify related characteristics among urban residents in China. Design: A cross-sectional, multilevel study. Selected through multi-stage quota-sampling, survey participants were 4,735 urban residents aged 15 years and older who resided in one of six selected Chinese capital cities. Data were collected on stress levels and sociodemographic characteristics. Stress was assessed using the Perceived Stress Scale, Chinese version (CPSS). A multilevel variance component model was employed to analyze associations between sociodemographic variables and stress. Results: The mean stress score for urban residents was 22.34 (SD: 3.22), and 36.8% of those surveyed (95% CI: 33.5-40.2%) were severely stressed (>25). Multilevel regression analysis indicated that residents aged 55 years and older were less stressed than residents under age 25. The most educated and higher income earners had lower stress levels than the least educated and poorest. High levels of stress were apparent among all other occupational groups, relative to managers and clerks, except retirees and operational workers. Residents in the north of China exhibited higher stress levels than counterparts in the south. Conclusions: This study suggests that higher stress levels are positively associated with social class in China. Our findings could inform health policy, guide prevention strategies, and justify the design and implementation of targeted interventions.	[Yang, Tingzhong; Lv, Qiaohong] Zhejiang Univ, Sch Med, Ctr Tobacco Control Res, Hangzhou 310003, Zhejiang, Peoples R China; [Rockett, Ian R. H.] W Virginia Univ, Injury Control Res Ctr, Morgantown, WV 26506 USA; [Rockett, Ian R. H.] W Virginia Univ, Dept Community Med, Morgantown, WV 26506 USA; [Cottrell, Randall R.] Univ Cincinnati, Sch Human Serv, Hlth Promot & Educ Program, Cincinnati, OH USA	Zhejiang University; West Virginia University; West Virginia University; University System of Ohio; University of Cincinnati	Yang, TZ (corresponding author), Zhejiang Univ, Sch Med, Ctr Tobacco Control Res, Hangzhou 310003, Zhejiang, Peoples R China.	Ytingzhongyang@yahoo.com		Wu, Dan/0000-0003-0849-0297	World Health Organization (WHO) [WP/2002/IC/TFI/2.2/001/03.02.AW.03]; National Social Science Foundation of China [01BSH030]	World Health Organization (WHO)(World Health Organization); National Social Science Foundation of China	This study was partly funded by the World Health Organization (WHO) WP/2002/IC/TFI/2.2/001/03.02.AW.03) and the National Social Science Foundation of China (01BSH030). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Charney Dennis S, 2004, Sci STKE, V2004, pre5, DOI 10.1126/stke.2252004re5; Chen BZ, 2000, CHINA ECON REV, V11, P1, DOI 10.1016/S1043-951X(99)00014-0; Chen WQ, 2005, OCCUP ENVIRON MED, V62, P251, DOI 10.1136/oem.2004.013680; Cochrane J, 2003, ALCOHOL ALCOHOLISM, V38, P537, DOI 10.1093/alcalc/agg111; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cottrell R., 2011, HLTH PROMOTION ED RE; Deckro GR, 2002, J AM COLL HEALTH, V50, P281, DOI 10.1080/07448480209603446; Department of Comprehensive Statistics of National Bureau of Statistics, 2009, CHIN STAT YB REG EC, P202; Edmondson KA, 2005, J RELIG HEALTH, V44, P161, DOI 10.1007/s10943-005-2774-0; Farley Tillman, 2005, J Immigr Health, V7, P213, DOI 10.1007/s10903-005-3678-5; Field TM, 1985, STRESS COPING, P11; Fone DL, 2006, HEALTH PLACE, V12, P332, DOI 10.1016/j.healthplace.2005.02.002; Gary TL, 2007, HEALTH PLACE, V13, P569, DOI 10.1016/j.healthplace.2006.06.001; Goldstein H., 1995, MULTILEVEL STAT MODE, P6; Guo J, 2001, CHINESE RURAL EC, V6, P26; Hao C, 2006, CHINA ECON REV, V17, P347, DOI 10.1016/j.chieco.2006.01.001; Hao W, 2004, ALCOHOL ALCOHOLISM, V39, P43, DOI 10.1093/alcalc/agh018; Lee Sing, 2000, CHINESE SOC CHANGE C; LIN JYF, 1992, AM ECON REV, V82, P34; Liu X, 2002, XU XI HE SHI JIAN, V3, P55; Liu XC, 2000, J CLIN PSYCHOL, V56, P1565, DOI 10.1002/1097-4679(200012)56:12<1565::AID-7>3.0.CO;2-U; Meng X, 2004, REV INCOME WEALTH, P357; National Bureau of Statistics of China, RES 6 NAT CENS; Paul K, 2008, J NATL MED ASSOC, V100, P540, DOI 10.1016/S0027-9684(15)31300-6; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Phillips MR, 1999, CULT MED PSYCHIAT, V23, P25, DOI 10.1023/A:1005462530658; Pu Y, 2008, CHIN J HLTH ED, V24, P139; Rashash J, 2001, USERS GUIDE MLINN VE; Ritter C, 2000, HEALTH PSYCHOL, V19, P576, DOI 10.1037/0278-6133.19.6.576; Tang CSK, 2001, J ORGAN BEHAV, V22, P887, DOI 10.1002/job.120; Tseng WS, 1985, CHINESE CULTURE MENT, P192; WHO, 2009, DEATH DALY EST 2004; Yang T, 2009, PUBLIC HEALTH, V123, P694, DOI 10.1016/j.puhe.2009.08.003; Yang Ting-zhong, 2003, Zhonghua Liu Xing Bing Xue Za Zhi, V24, P760; Zhang S, 2003, AGR FARMER COUNTRYSI, P3; Zhou XG, 2000, AM J SOCIOL, V105, P1135, DOI 10.1086/210401	37	27	28	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 20	2012	7	1							e30521	10.1371/journal.pone.0030521	http://dx.doi.org/10.1371/journal.pone.0030521			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	909MH	23152832	Green Published, Green Submitted, gold			2022-12-27	WOS:000301568100053
J	Williams, LJ; Dunlop, JP; Abdi, H				Williams, Lynne J.; Dunlop, Joseph P.; Abdi, Herve			Effect of Age on Variability in the Production of Text-Based Global Inferences	PLOS ONE			English	Article							INTRAINDIVIDUAL VARIABILITY; INDIVIDUAL VARIABILITY; MEMORY PERFORMANCE; OLD-AGE; BOOTSTRAP; DISCOURSE; SPEED; GIST; RECOGNITION; CONFIDENCE	As we age, our differences in cognitive skills become more visible, an effect especially true for memory and problem solving skills (i.e., fluid intelligence). However, by contrast with fluid intelligence, few studies have examined variability in measures that rely on one's world knowledge (i.e., crystallized intelligence). The current study investigated whether age increased the variability in text based global inference generation-a measure of crystallized intelligence. Global inference generation requires the integration of textual information and world knowledge and can be expressed as a gist or lesson. Variability in generating two global inferences for a single text was examined in young-old (62 to 69 years), middle-old (70 to 76 years) and old-old (77 to 94 years) adults. The older two groups showed greater variability, with the middle elderly group being most variable. These findings suggest that variability may be a characteristic of both fluid and crystallized intelligence in aging.	[Williams, Lynne J.] Rotman Res Inst Baycrest, Ctr Brain Fitness, Toronto, ON, Canada; [Dunlop, Joseph P.; Abdi, Herve] Univ Texas Dallas, Sch Behav & Brain Sci, Richardson, TX 75083 USA	University of Toronto; University Toronto Affiliates; Baycrest; University of Texas System; University of Texas Dallas	Williams, LJ (corresponding author), Rotman Res Inst Baycrest, Ctr Brain Fitness, Toronto, ON, Canada.	lwilliams@research.baycrest.org; herve@utdallas.edu	Williams, Lynne/P-4799-2019; Beutels, Philippe/A-1919-2010; Hens, Niel/M-4445-2017	Williams, Lynne/0000-0001-6790-1362; Abdi, Herve/0000-0002-9522-1978; Chao, Dennis/0000-0002-8253-6321; Beutels, Philippe/0000-0001-5034-3595; Hens, Niel/0000-0003-1881-0637; Willem, Lander/0000-0002-9210-1196	NIGMS NIH HHS [U01-GM070749, U01 GM070749] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdi H, 2007, ENCY MEASUREMENT STA, V2, P651; Abdi H., 2010, ENCY RES DESIGN, P655; Abdi H., 2007, ENCY MEASUREMENT STA, P270; Abdi H, 1985, B PSYCHOL, V38, P633; Abdi H, 2010, ENCY RES DESIGN, P267; Abdi H, 1990, CUMFID, V16, P99; Abdi H, 2012, WILEY INTERDISCIP RE, V4, P124, DOI 10.1002/wics.198; Abdi H, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/634165; Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Abdi H, 2010, WIRES COMPUT STAT, V2, P97, DOI 10.1002/wics.51; Abdi H, 2009, NEUROIMAGE, V45, P89, DOI 10.1016/j.neuroimage.2008.11.008; Adam S, 2007, EC STAT, V403, P83; ADAMS C, 1990, J GERONTOL, V45, pP17, DOI 10.1093/geronj/45.1.P17; ADAMS C, 1991, PSYCHOL AGING, V6, P323, DOI 10.1037/0882-7974.6.3.323; Allaire JC, 2005, PSYCHOL AGING, V20, P390, DOI 10.1037/0882-7974.20.3.390; Anstey Kaarin J, 2004, Aust Fam Physician, V33, P783; Benzecri Jean-Paul, 1973, ANAL DONNEES, V2; Benzecri Jean-Paul, 1973, ANAL DONNEES, V1; Bielak AAM, 2010, NEUROPSYCHOLOGY, V24, P731, DOI 10.1037/a0019802; Bielak AAM, 2010, PSYCHOL AGING, V25, P575, DOI 10.1037/a0019503; Blasius J, 2006, STAT SOC BEHAV SCI, P3; Bonsang E, DOES RETIREMENT AFFE; Brose A, 2010, RES HUM DEV, V7, P61, DOI 10.1080/15427600903578177; Burke Deborah M., 2006, LIFESPAN COGNITION M, P193; Carnes P, 1988, PROVERBIA FABULA ESS; Caskie GIL, 1999, GER SOC AM C; Chastaing M, 1980, J PSYCHOL NORMALE PA, V77, P31; Chesneau S, 2007, PSYCHOL NEUROPSYCHIA, V5, P47, DOI 10.1684/pnv.2007.0037; Chi YY, 2011, WILEY INTERDISCIPLIN, V4, P35; Christensen H, 2005, NEUROPSYCHOLOGY, V19, P309, DOI 10.1037/0894-4105.19.3.309; Christensen H, 2001, AUST NZ J PSYCHIAT, V35, P768, DOI 10.1046/j.1440-1614.2001.00966.x; Clausen S.E., 1998, APPL CORRES ANAL INT, V121; Daly DL, 1963, INTELLIGENCE, P33; DIXON RA, 1993, NARRATIVE DISCOURSE IN NEUROLOGICALLY IMPAIRED AND NORMAL AGING ADULTS, P77; Dixon RA, 2007, NEUROPSYCHOLOGY, V21, P381, DOI 10.1037/0894-4105.21.3.381; Dolby-Stahl SK, 1980, FOLKLORE 2 CONTINENT, P160; DORFMAN MH, 1994, DISCOURSE PROCESS, V17, P105, DOI 10.1080/01638539409544861; EFRON B, 1987, J AM STAT ASSOC, V82, P171, DOI 10.2307/2289144; EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552; EFRON B, 1983, AM STAT, V37, P36, DOI 10.2307/2685844; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FISKE DW, 1957, EDUC PSYCHOL MEAS, V17, P317, DOI 10.1177/001316445701700301; Garrett DD, 2011, J NEUROSCI, V31, P4496, DOI 10.1523/JNEUROSCI.5641-10.2011; GAUDREAULT R, 1994, SEMIOTICA, V99, P297, DOI 10.1515/semi.1994.99.3-4.297; GRAESSER AC, 1994, PSYCHOL REV, V101, P371, DOI 10.1037/0033-295X.101.3.371; Greenacre M., 2007, CORRES ANAL PRACTICE; Greenacre Michael, 1984, THEORY APPL CORRES A; Gutchess AH, 2012, NEUROIMAGE, V59, P3418, DOI 10.1016/j.neuroimage.2011.11.078; HAMM VP, 1992, PSYCHOL AGING, V7, P56, DOI 10.1037/0882-7974.7.1.56; Hanauer DI, 2000, DISCOURSE PROCESS, V30, P107, DOI 10.1207/S15326950DP3002_02; HART R. P., 1988, CLIN NEUROPSYCHOL, V2, P49, DOI [10.1080/13854048808520085, DOI 10.1080/13854048808520085]; HERTZOG C, 1992, BRAIN LANG, V42, P248, DOI 10.1016/0093-934X(92)90100-S; Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659; Hosokawa A, 2006, JPN PSYCHOL RES, V48, P77, DOI 10.1111/j.1468-5884.2006.00308.x; Hultsch DF, 2002, J GERONTOL B-PSYCHOL, V57, pP101, DOI 10.1093/geronb/57.2.P101; Hultsch DF, 2005, MEASURING MIND SPEED; Hwang DH, 2002, BIOINFORMATICS, V18, P1184, DOI 10.1093/bioinformatics/18.9.1184; Jackson JD, 2012, NEUROPSYCHOLOGIA, V50, P357, DOI 10.1016/j.neuropsychologia.2011.11.024; Jamet MC, 1988, LINGUE MONDO, V53, P79; Kintsch W, 1998, COMPREHENSION PARADI; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LAVER GD, 1993, PSYCHOL AGING, V8, P34, DOI 10.1037/0882-7974.8.1.34; Le Roux B., 2010, MULTIPLE CORRES ANAL; Lebart L, 2006, JOURNEES INT ANAL ST, V8; Li SC, 2001, GERONTOLOGY, V47, P100, DOI 10.1159/000052782; Lindenberger U, 1997, PSYCHOL AGING, V12, P410, DOI 10.1037/0882-7974.12.3.410; LINDENBERGER U, 1993, PSYCHOL AGING, V8, P207, DOI 10.1037/0882-7974.8.2.207; Luszcz MA, 2004, GERONTOLOGY, V50, P5, DOI 10.1159/000074381; MacDonald SWS, 2003, PSYCHOL AGING, V18, P510, DOI 10.1037/0882-7974.18.3.510; MAGLIANO JP, 1991, POETICS, V20, P193, DOI 10.1016/0304-422X(91)90007-C; Martin M, 2004, GERONTOLOGY, V50, P7, DOI 10.1159/000074382; MCKOON G, 1992, PSYCHOL REV, V99, P440, DOI 10.1037/0033-295X.99.3.440; Meyer BI, 1987, ANN REV GERONTOLOGY, V7; Miller MB, 2007, INT J PSYCHOPHYSIOL, V63, P205, DOI 10.1016/j.ijpsycho.2006.03.019; Nesselroade J. R., 2004, RES HUMAN DEV, V1, P9, DOI [DOI 10.1080/15427609.2004.9683328, 10.1207/s15427617rhd0101&2_3]; NORTH AJ, 1986, INT J AGING HUM DEV, V23, P267, DOI 10.2190/BPF0-2BWD-BGNQ-HWCW; Olness G, 2000, THESIS U TEXAS DALLA; Papenberg G, 2011, NEUROPSYCHOLOGIA, V49, P1879, DOI 10.1016/j.neuropsychologia.2011.03.013; Park D. C., 1999, COGNITIVE AGING PRIM; Pinkham AE, J ABNORMAL IN PRESS, P121; Radvansky GA, 2001, PSYCHOL AGING, V16, P145, DOI 10.1037//0882-7974.16.1.145; Ram N, 2005, PSYCHOL AGING, V20, P623, DOI 10.1037/0882-7974.20.4.623; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; REYNA VF, 1994, DEV PSYCHOL, V30, P178, DOI 10.1037/0012-1649.30.2.178; Salthouse TA, 2003, PSYCHOL AGING, V18, P91, DOI 10.1037/0882-7974.18.1.91; Salthouse TA, 1998, PSYCHOL AGING, V13, P445, DOI 10.1037/0882-7974.13.3.445; Salthouse TA, 2001, PSYCHOL AGING, V16, P251, DOI 10.1037//0882-7974.16.2.251; Saporta G, 2006, STAT SOC BEHAV SCI, P371; Schank RC., 1977, SCRIPTS PLANS GOALS; SEIFERT CM, 1985, J MEM LANG, V24, P405, DOI 10.1016/0749-596X(85)90037-3; Shammi P, 1998, AGING NEUROPSYCHOL C, V5, P1, DOI 10.1076/anec.5.1.1.23; SIEGLER RS, 1994, CURR DIR PSYCHOL SCI, V3, P1, DOI 10.1111/1467-8721.ep10769817; Sims DG, 1975, J ACADEMY REHABILITA, V8, P70; Smith M., 1915, J ENGLISH GERMANIC P, V14, P519; Solomon P R, 1998, Fam Med, V30, P265; Solomon PR, 1998, ARCH NEUROL-CHICAGO, V55, P349, DOI 10.1001/archneur.55.3.349; Stahl C, 2008, J EXP PSYCHOL LEARN, V34, P570, DOI 10.1037/0278-7393.34.3.570; Tucker-Drob EA, 2008, PSYCHOL AGING, V23, P453, DOI 10.1037/0882-7974.23.2.453; Ulatowska HK, 2005, BRAIN LANG, V95, P109, DOI 10.1016/j.bandl.2005.07.059; Ulatowska HK, 1998, APHASIOLOGY, V12, P619, DOI 10.1080/02687039808249562; Ulatowska HK, 2000, APHASIOLOGY, V14, P227, DOI 10.1080/026870300401450; van Dijk T., 1983, STRATEGIES DISCOURSE; van Dijk T. A., 1977, COGNITIVE PROCESS, P03; van Dijk TA, 1980, MACROSTRUCTURES; Wechsler D., 1998, WECHSLER ADULT INTEL; Wechsler D, 1998, WECHSLER MEMORY SCAL; Williams LJ, 2010, J SPEECH LANG HEAR R, V53, P1372, DOI 10.1044/1092-4388(2010/08-0141); Zelinski E. M., 1988, LANGUAGE MEMORY AGIN, P117	111	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36161	10.1371/journal.pone.0036161	http://dx.doi.org/10.1371/journal.pone.0036161			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	959TF	22590523	gold, Green Submitted, Green Published			2022-12-27	WOS:000305335500008
J	Anderson, AM; Carter, KW; Anderson, D; Wise, MJ				Anderson, Alison M.; Carter, Kim W.; Anderson, Denise; Wise, Michael J.			Coexpression of Nuclear Receptors and Histone Methylation Modifying Genes in the Testis: Implications for Endocrine Disruptor Modes of Action	PLOS ONE			English	Article							NEONATAL EXPOSURE; MECHANISMS; DNA; METHYLTRANSFERASES; NOMENCLATURE; ACTIVATION; EXPRESSION; CHEMICALS; MLL3; MARK	Background: Endocrine disruptor chemicals elicit adverse health effects by perturbing nuclear receptor signalling systems. It has been speculated that these compounds may also perturb epigenetic mechanisms and thus contribute to the early origin of adult onset disease. We hypothesised that histone methylation may be a component of the epigenome that is susceptible to perturbation. We used coexpression analysis of publicly available data to investigate the combinatorial actions of nuclear receptors and genes involved in histone methylation in normal testis and when faced with endocrine disruptor compounds. Methodology/Principal Findings: The expression patterns of a set of genes were profiled across testis tissue in human, rat and mouse, plus control and exposed samples from four toxicity experiments in the rat. Our results indicate that histone methylation events are a more general component of nuclear receptor mediated transcriptional regulation in the testis than previously appreciated. Coexpression patterns support the role of a gatekeeper mechanism involving the histone methylation modifiers Kdm1, Prdm2, and Ehmt1 and indicate that this mechanism is a common determinant of transcriptional integrity for genes critical to diverse physiological endpoints relevant to endocrine disruption. Coexpression patterns following exposure to vinclozolin and dibutyl phthalate suggest that coactivity of the demethylase Kdm1 in particular warrants further investigation in relation to endocrine disruptor mode of action. Conclusions/Significance: This study provides proof of concept that a bioinformatics approach that profiles genes related to a specific hypothesis across multiple biological settings can provide powerful insight into coregulatory activity that would be difficult to discern at an individual experiment level or by traditional differential expression analysis methods.	[Anderson, Alison M.; Carter, Kim W.; Anderson, Denise] Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia	Telethon Kids Institute; University of Western Australia	Anderson, AM (corresponding author), Univ Western Australia, Telethon Inst Child Hlth Res, Ctr Child Hlth Res, Perth, WA 6009, Australia.	alisona@ichr.uwa.edu.au	Anderson, Alison/J-6786-2014; Wise, Michael/B-5676-2012	Anderson, Alison/0000-0002-1490-2262; Wise, Michael/0000-0001-6559-4303; Anderson, Denise/0000-0003-0643-4136	William and Marlene Schrader Trust [F6787]	William and Marlene Schrader Trust	AA was supported by a William and Marlene Schrader Postgraduate Scholarship [F6787] awarded by the William and Marlene Schrader Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Allocco DJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-18; Ansari KI, 2011, BIOCHEMISTRY-US, V50, P3517, DOI 10.1021/bi102037t; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Bulynko YA, 2011, BIOCHEMISTRY-US, V50, P313, DOI 10.1021/bi101762x; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Crawford BD, 2006, ACS CHEM BIOL, V1, P495, DOI 10.1021/cb600367v; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Dreijerink KMA, 2006, CANCER RES, V66, P4929, DOI 10.1158/0008-5472.CAN-05-4461; Dreijerink KMA, 2009, MOL CELL BIOL, V29, P5060, DOI 10.1128/MCB.01001-08; Foster PMD, 2006, INT J ANDROL, V29, P140, DOI 10.1111/j.1365-2605.2005.00563.x; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hiroi H, 2004, MOL ENDOCRINOL, V18, P791, DOI 10.1210/me.2003-0305; Hotchkiss AK, 2010, REPROD TOXICOL, V30, P261, DOI 10.1016/j.reprotox.2010.06.001; Hublitz P, 2009, INT J DEV BIOL, V53, P335, DOI 10.1387/ijdb.082717ph; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Kim SM, 2010, NUCLEIC ACIDS RES, V38, P6389, DOI 10.1093/nar/gkq491; LeBaron MJ, 2010, MUTAT RES-REV MUTAT, V705, P83, DOI 10.1016/j.mrrev.2010.04.003; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Lee S, 2009, MOL ENDOCRINOL, V23, P610, DOI 10.1210/me.2008-0455; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Narita M, 2007, ADDICT BIOL, V12, P167, DOI 10.1111/j.1369-1600.2007.00048.x; Newbold RR, 2011, AM J CLIN NUTR, V94, p1939S, DOI 10.3945/ajcn.110.001057; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; Okada Y, 2010, J ANDROL, V31, P75, DOI 10.2164/jandrol.109.008052; Vicent GP, 2011, GENE DEV, V25, P845, DOI 10.1101/gad.621811; Sato K, 2009, ENDOCR J, V56, P131, DOI 10.1507/endocrj.K08E-239; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sun LC, 2008, CANCER RES, V68, P2726, DOI 10.1158/0008-5472.CAN-07-6654; Viswakarma N, 2010, PPAR RES; Wang J, 2009, NAT GENET, V41, P125, DOI 10.1038/ng.268; Wilson VS, 2008, INT J ANDROL, V31, P178, DOI 10.1111/j.1365-2605.2007.00861.x; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Yang J, 2010, CANCER RES, V70, P6456, DOI 10.1158/0008-5472.CAN-10-0413; Zhang XA, 2011, J MOL ENDOCRINOL, V46, pR11, DOI 10.1677/JME-10-0053	42	24	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 4	2012	7	4							e34158	10.1371/journal.pone.0034158	http://dx.doi.org/10.1371/journal.pone.0034158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	953GO	22496781	Green Published, Green Submitted, gold			2022-12-27	WOS:000304855200033
J	Chen, SS; Luetje, CW				Chen, Sisi; Luetje, Charles W.			Identification of New Agonists and Antagonists of the Insect Odorant Receptor Co-Receptor Subunit	PLOS ONE			English	Article							MOLECULAR-BASIS; SYSTEM; TASTE	Background: Insects detect attractive and aversive chemicals using several families of chemosensory receptors, including the OR family of olfactory receptors, making these receptors appealing targets for the control of insects. Insect ORs are odorant-gated ion channels, comprised of at least one common subunit (the odorant receptor co-receptor subunit, Orco) and at least one variable odorant specificity subunit. Each of the many ORs of an insect species is activated or inhibited by an unique set of odorants that interact with the variable odorant specificity subunits, making the development of OR directed insect control agents complex and laborious. However, several N-,2-substituted triazolothioacetamide compounds (VUAA1, VU0450667 and VU0183254) were recently shown to act directly on the highly conserved Orco subunit, suggesting that broadly active compounds can be developed. We have explored the chemical space around the VUAA1 structure in order to identify new Orco ligands. Principal Findings: We screened ORs from several insect species, using heterologous expression in Xenopus oocytes and an electrophysiological assay, with a panel of 22 compounds structurally related to VUAA1. By varying the nitrogen position in the pyridine ring and altering the moieties decorating the phenyl ring, we identified two new agonists and a series of competitive antagonists. Screening smaller compounds, similar to portions of the VUAA1 structure, also yielded competitive antagonists. Importantly, we show that Orco antagonists inhibit odorant activation of ORs from several insect species. Detailed examination of one antagonist demonstrated inhibition to be through a non-competitive mechanism. Conclusions: A similar pattern of agonist and antagonist sensitivity displayed by Orco subunits from different species suggests a highly conserved binding site structure. The susceptibility to inhibition of odorant activation by Orco antagonism is conserved across disparate insect species, suggesing the ligand binding site on Orco as a promising target for the development of novel, broadly active insect repellants.	[Chen, Sisi; Luetje, Charles W.] Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA	University of Miami	Chen, SS (corresponding author), Univ Miami, Miller Sch Med, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA.	cluetje@med.miami.edu	CHEN, SI/GZL-4800-2022; WU, CHUN-HU/P-3958-2018	WU, CHUN-HU/0000-0001-6851-7936; Hung, Tai-Ho/0000-0003-2354-7060; Chen, Shaohua/0000-0001-8306-2626	National Institutes of Health [RO1 DC011091]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011091] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the National Institutes of Health [RO1 DC011091 to CWL]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bohbot JD, 2012, NEUROPHARMACOLOGY, V62, P2086, DOI 10.1016/j.neuropharm.2012.01.004; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Hallem EA, 2004, CELL, V117, P965, DOI 10.1016/j.cell.2004.05.012; Hughes DT, 2010, J CHEM ECOL, V36, P797, DOI 10.1007/s10886-010-9828-9; Jones PL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030304; Jones PL, 2011, P NATL ACAD SCI USA, V108, P8821, DOI 10.1073/pnas.1102425108; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Neuhaus EM, 2005, NAT NEUROSCI, V8, P15, DOI 10.1038/nn1371; Nichols AS, 2011, CHEM SENSES, V36, P781, DOI 10.1093/chemse/bjr053; Nichols AS, 2010, J BIOL CHEM, V285, P11854, DOI 10.1074/jbc.M109.058321; Pask GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028774; Pellegrino M, 2011, NATURE, V478, P511, DOI 10.1038/nature10438; Pelletier J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010090; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Smart R, 2008, INSECT BIOCHEM MOLEC, V38, P770, DOI 10.1016/j.ibmb.2008.05.002; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang GR, 2010, P NATL ACAD SCI USA, V107, P4418, DOI 10.1073/pnas.0913392107; Wanner KW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008685; Wetzel CH, 2001, P NATL ACAD SCI USA, V98, P9377, DOI 10.1073/pnas.151103998; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Xia YF, 2008, P NATL ACAD SCI USA, V105, P6433, DOI 10.1073/pnas.0801007105	33	338	351	8	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 8	2012	7	5							e36784	10.1371/journal.pone.0036784	http://dx.doi.org/10.1371/journal.pone.0036784			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	959TF	23226289	gold, Green Published, Green Submitted			2022-12-27	WOS:000305335500028
